Citrus Sinensis ID: 039310
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 241 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LMN8 | 741 | Wall-associated receptor | yes | no | 0.983 | 0.319 | 0.555 | 5e-74 | |
| Q39191 | 735 | Wall-associated receptor | no | no | 0.983 | 0.322 | 0.543 | 8e-74 | |
| Q9LMN7 | 733 | Wall-associated receptor | no | no | 0.983 | 0.323 | 0.547 | 1e-73 | |
| Q9LMN6 | 738 | Wall-associated receptor | no | no | 0.983 | 0.321 | 0.539 | 4e-73 | |
| Q9LMP1 | 732 | Wall-associated receptor | no | no | 0.983 | 0.323 | 0.543 | 6e-73 | |
| Q9S9M5 | 730 | Wall-associated receptor | no | no | 0.983 | 0.324 | 0.514 | 2e-67 | |
| Q9LSV3 | 433 | Putative wall-associated | no | no | 0.958 | 0.533 | 0.529 | 3e-67 | |
| Q9C9L5 | 792 | Wall-associated receptor | no | no | 0.991 | 0.301 | 0.520 | 4e-66 | |
| Q9LMT9 | 764 | Putative wall-associated | no | no | 0.979 | 0.308 | 0.524 | 1e-65 | |
| Q8VYA3 | 769 | Wall-associated receptor | no | no | 0.983 | 0.308 | 0.520 | 2e-65 |
| >sp|Q9LMN8|WAK3_ARATH Wall-associated receptor kinase 3 OS=Arabidopsis thaliana GN=WAK3 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 277 bits (709), Expect = 5e-74, Method: Compositional matrix adjust.
Identities = 135/243 (55%), Positives = 181/243 (74%), Gaps = 6/243 (2%)
Query: 3 ISFVVAIMSISWLHFLWTRRRHMKLKEKFFKQNGGSILRQELSKLQGRSSEKAKIFIEEE 62
I +V +++ + +R++ KL+ +FF+QNGG +L Q LS G S+ KIF EE
Sbjct: 349 IGVLVLLLAAICIQHATKQRKYTKLRRQFFEQNGGGMLIQRLSG-AGLSNIDFKIFTEEG 407
Query: 63 IKTVTNNYAD--VIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQIN 120
+K TN Y + ++G GG G VYKG LPD T VA+KK+++ D ++D+FI+E++V+SQIN
Sbjct: 408 MKEATNGYDESRILGQGGQGTVYKGILPDNTIVAIKKARLADSRQVDQFIHEVLVLSQIN 467
Query: 121 RRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHK---NGNLTWERRLRIAAETAGVLSY 177
RNVV++L CCLET+VPLLVYEF+ NGTLF+H+H + +LTWE RLRIA E AG L+Y
Sbjct: 468 HRNVVKILGCCLETEVPLLVYEFITNGTLFDHLHGSIFDSSLTWEHRLRIAIEVAGTLAY 527
Query: 178 LHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEY 237
LHS ++PIIHRD+K+ANILLDEN T KV+DFGASKL+P+D Q T+VQGTLGY+DPEY
Sbjct: 528 LHSSASIPIIHRDIKTANILLDENLTAKVADFGASKLIPMDKEQLTTMVQGTLGYLDPEY 587
Query: 238 LQT 240
T
Sbjct: 588 YTT 590
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q39191|WAK1_ARATH Wall-associated receptor kinase 1 OS=Arabidopsis thaliana GN=WAK1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 276 bits (707), Expect = 8e-74, Method: Compositional matrix adjust.
Identities = 132/243 (54%), Positives = 182/243 (74%), Gaps = 6/243 (2%)
Query: 3 ISFVVAIMSISWLHFLWTRRRHMKLKEKFFKQNGGSILRQELSKLQGRSSEKAKIFIEEE 62
I F+V ++ ++ + + KL+E+FF+QNGG +L Q LS G S+ KIF E+
Sbjct: 343 IGFLVILLGVACIQQRMKHLKDTKLREQFFEQNGGGMLTQRLSG-AGPSNVDVKIFTEDG 401
Query: 63 IKTVTNNYAD--VIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQIN 120
+K TN YA+ ++G GG G VYKG LPD + VA+KK+++ D +++++FINE++V+SQIN
Sbjct: 402 MKKATNGYAESRILGQGGQGTVYKGILPDNSIVAIKKARLGDSSQVEQFINEVLVLSQIN 461
Query: 121 RRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHK---NGNLTWERRLRIAAETAGVLSY 177
RNVV+LL CCLET+VPLLVYEF+ NGTLF+H+H + +LTWE RL+IA E AG L+Y
Sbjct: 462 HRNVVKLLGCCLETEVPLLVYEFITNGTLFDHLHGSMIDSSLTWEHRLKIAIEVAGTLAY 521
Query: 178 LHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEY 237
LHS ++PIIHRD+K+ANILLD N T KV+DFGAS+L+P+D + T+VQGTLGY+DPEY
Sbjct: 522 LHSSASIPIIHRDIKTANILLDVNLTAKVADFGASRLIPMDKEELETMVQGTLGYLDPEY 581
Query: 238 LQT 240
T
Sbjct: 582 YNT 584
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Required during plant's response to pathogen infection and in plant defense against heavy metal toxicity. Phosphorylates the oxygen-evolving enhancer protein 2 (OEE2) in an GRP-3-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMN7|WAK5_ARATH Wall-associated receptor kinase 5 OS=Arabidopsis thaliana GN=WAK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 276 bits (705), Expect = 1e-73, Method: Compositional matrix adjust.
Identities = 133/243 (54%), Positives = 186/243 (76%), Gaps = 6/243 (2%)
Query: 3 ISFVVAIMSISWLHFLWTRRRHMKLKEKFFKQNGGSILRQELSKLQGRSSEKAKIFIEEE 62
I F++ +++IS++ R++ +L+++FF+QNGG +L Q LS G S+ KIF EE
Sbjct: 342 IGFLIILLTISYIQQKMRHRKNTELRQQFFEQNGGGMLIQRLSG-AGPSNVDVKIFTEEG 400
Query: 63 IKTVTNNYAD--VIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQIN 120
+K T+ Y + ++G GG G VYKG L D + VA+KK+++ D++++++FINE++V+SQIN
Sbjct: 401 MKEATDGYNESRILGQGGQGTVYKGILQDNSIVAIKKARLGDRSQVEQFINEVLVLSQIN 460
Query: 121 RRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHK---NGNLTWERRLRIAAETAGVLSY 177
RNVV+LL CCLET+VPLLVYEF+ +GTLF+H+H + +LTWE RLRIA E AG L+Y
Sbjct: 461 HRNVVKLLGCCLETEVPLLVYEFISSGTLFDHLHGSMFDSSLTWEHRLRIAIEVAGTLAY 520
Query: 178 LHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEY 237
LHS ++PIIHRDVK+ANILLDEN T KV+DFGAS+L+P+D Q T+VQGTLGY+DPEY
Sbjct: 521 LHSYASIPIIHRDVKTANILLDENLTAKVADFGASRLIPMDQEQLTTMVQGTLGYLDPEY 580
Query: 238 LQT 240
T
Sbjct: 581 YNT 583
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMN6|WAK4_ARATH Wall-associated receptor kinase 4 OS=Arabidopsis thaliana GN=WAK4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 274 bits (701), Expect = 4e-73, Method: Compositional matrix adjust.
Identities = 131/243 (53%), Positives = 182/243 (74%), Gaps = 6/243 (2%)
Query: 3 ISFVVAIMSISWLHFLWTRRRHMKLKEKFFKQNGGSILRQELSKLQGRSSEKAKIFIEEE 62
I F+V +++IS + + +L+++FF+QNGG +L Q LS G S+ KIF EE
Sbjct: 344 IGFLVILLAISCIEHKMKNTKDTELRQQFFEQNGGGMLMQRLSG-AGPSNVDVKIFTEEG 402
Query: 63 IKTVTNNYAD--VIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQIN 120
+K T+ Y + ++G GG G VYKG LPD + VA+KK+++ D +++++FINE++V+SQIN
Sbjct: 403 MKEATDGYDENRILGQGGQGTVYKGILPDNSIVAIKKARLGDNSQVEQFINEVLVLSQIN 462
Query: 121 RRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHK---NGNLTWERRLRIAAETAGVLSY 177
RNVV+LL CCLET+VPLLVYEF+ +GTLF+H+H + +LTWE RLR+A E AG L+Y
Sbjct: 463 HRNVVKLLGCCLETEVPLLVYEFISSGTLFDHLHGSMFDSSLTWEHRLRMAVEIAGTLAY 522
Query: 178 LHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEY 237
LHS ++PIIHRD+K+ANILLDEN T KV+DFGAS+L+P+D T+VQGTLGY+DPEY
Sbjct: 523 LHSSASIPIIHRDIKTANILLDENLTAKVADFGASRLIPMDKEDLATMVQGTLGYLDPEY 582
Query: 238 LQT 240
T
Sbjct: 583 YNT 585
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMP1|WAK2_ARATH Wall-associated receptor kinase 2 OS=Arabidopsis thaliana GN=WAK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 273 bits (699), Expect = 6e-73, Method: Compositional matrix adjust.
Identities = 132/243 (54%), Positives = 184/243 (75%), Gaps = 6/243 (2%)
Query: 3 ISFVVAIMSISWLHFLWTRRRHMKLKEKFFKQNGGSILRQELSKLQGRSSEKAKIFIEEE 62
I F V ++ IS L R++ +L++KFF+QNGG +L Q +S G S+ KIF E+
Sbjct: 338 IGFSVIMLGISCLQQKIKHRKNTELRQKFFEQNGGGMLIQRVSG-AGPSNVDVKIFTEKG 396
Query: 63 IKTVTNNYAD--VIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQIN 120
+K TN Y + ++G GG G VYKG LPD + VA+KK+++ +++++++FINE++V+SQIN
Sbjct: 397 MKEATNGYHESRILGQGGQGTVYKGILPDNSIVAIKKARLGNRSQVEQFINEVLVLSQIN 456
Query: 121 RRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHK---NGNLTWERRLRIAAETAGVLSY 177
RNVV++L CCLET+VPLLVYEF+ +GTLF+H+H + +LTWE RLRIA E AG L+Y
Sbjct: 457 HRNVVKVLGCCLETEVPLLVYEFINSGTLFDHLHGSLYDSSLTWEHRLRIATEVAGSLAY 516
Query: 178 LHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEY 237
LHS ++PIIHRD+K+ANILLD+N T KV+DFGAS+L+P+D Q T+VQGTLGY+DPEY
Sbjct: 517 LHSSASIPIIHRDIKTANILLDKNLTAKVADFGASRLIPMDKEQLTTIVQGTLGYLDPEY 576
Query: 238 LQT 240
T
Sbjct: 577 YNT 579
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M5|WAKLA_ARATH Wall-associated receptor kinase-like 1 OS=Arabidopsis thaliana GN=WAKL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 255 bits (651), Expect = 2e-67, Method: Compositional matrix adjust.
Identities = 125/243 (51%), Positives = 175/243 (72%), Gaps = 6/243 (2%)
Query: 1 IGISFVVAIMSISWLHFLWTRRRHMKLKEKFFKQNGGSILRQELSKLQGRSSEKAKIFIE 60
IG+S +V + + WL L +RR++ +KFFK+NGG +L+Q+L+ G + E +KIF
Sbjct: 361 IGLSGLVFFVGLFWLFKLIKKRRNINRSKKFFKRNGGLLLKQQLTTKDG-NVEMSKIFSS 419
Query: 61 EEIKTVTNNYA--DVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQ 118
+E++ T+N++ V+G GG G VYKG L D + VAVK+SK+VD+ K++EFINE+V++SQ
Sbjct: 420 KELRKATDNFSIDRVLGQGGQGTVYKGMLVDGSIVAVKRSKVVDEDKMEEFINEIVLLSQ 479
Query: 119 INRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGN---LTWERRLRIAAETAGVL 175
IN RN+V+LL CCLET+VP+LVYE++ NG LF+ +H + +TWE RLRIA E AG L
Sbjct: 480 INHRNIVKLLGCCLETEVPILVYEYIPNGDLFKRLHDESDDYTMTWEVRLRIAIEIAGAL 539
Query: 176 SYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDP 235
+Y+HS + PI HRD+K+ NILLDE Y KVSDFG S+ V +D T+V GT GY+DP
Sbjct: 540 TYMHSAASFPIFHRDIKTTNILLDEKYRAKVSDFGTSRSVTLDQTHLTTLVAGTFGYMDP 599
Query: 236 EYL 238
EY
Sbjct: 600 EYF 602
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LSV3|WAKLS_ARATH Putative wall-associated receptor kinase-like 16 OS=Arabidopsis thaliana GN=WAKL16 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 254 bits (650), Expect = 3e-67, Method: Compositional matrix adjust.
Identities = 126/238 (52%), Positives = 175/238 (73%), Gaps = 7/238 (2%)
Query: 9 IMSISWLHFLWTRRRHMKLKEK-FFKQNGGSILRQELSKLQGRSSEKAKIFIEEEIKTVT 67
+ SIS++ + ++ K++ + FF++NGG +L + LS G S+ KIF EE++K T
Sbjct: 47 VRSISYIKNIRKHQKDTKIQRQLFFEKNGGGMLIERLSG-AGSSNIDFKIFTEEDMKEAT 105
Query: 68 NNY--ADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVV 125
N Y + ++G GG VYKG LPD + VA+KK+++ D ++++FINE++V+SQIN RNVV
Sbjct: 106 NGYDVSRILGQGGQWTVYKGILPDNSIVAIKKTRLGDNNQVEQFINEVLVLSQINHRNVV 165
Query: 126 RLLACCLETQVPLLVYEFVGNGTLFEHIHKN---GNLTWERRLRIAAETAGVLSYLHSET 182
+LL CCLET+VPLLVYEF+ G+LF+H+H + +LTWE RL IA E AG ++YLHS
Sbjct: 166 KLLGCCLETEVPLLVYEFITGGSLFDHLHGSMFVSSLTWEHRLEIAIEVAGAIAYLHSGA 225
Query: 183 NVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQT 240
++PIIHRD+K+ NILLDEN T KV+DFGASKL P+D Q T+VQGTLGY+DPEY T
Sbjct: 226 SIPIIHRDIKTENILLDENLTAKVADFGASKLKPMDKEQLTTMVQGTLGYLDPEYYTT 283
|
Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9C9L5|WAKLH_ARATH Wall-associated receptor kinase-like 9 OS=Arabidopsis thaliana GN=WAKL9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 251 bits (640), Expect = 4e-66, Method: Compositional matrix adjust.
Identities = 129/248 (52%), Positives = 172/248 (69%), Gaps = 9/248 (3%)
Query: 1 IGISF--VVAIMSISWLHFLWTRRRHMKLKEKFFKQNGGSILRQELSKLQGRSSEKAKIF 58
+G SF ++ ++ I L+ ++R + K+KFFK+NGG +L+Q+L G EK +F
Sbjct: 377 LGASFGSLIFVVGIYLLYKFIKKQRKLNQKKKFFKRNGGLLLQQQLISTVGMV-EKTIVF 435
Query: 59 IEEEIKTVTNNYAD--VIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVV 116
E++ T N++ ++G GG G VYKG L D VAVKKSK+VD+ K++EFINE+V++
Sbjct: 436 SSRELEKATENFSSNRILGQGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVVIL 495
Query: 117 SQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIH----KNGNLTWERRLRIAAETA 172
SQIN RN+V+LL CCLET+VP+LVYEF+ NG LFEH+H +N TW RLRIA + A
Sbjct: 496 SQINHRNIVKLLGCCLETKVPVLVYEFIPNGNLFEHLHDEFDENIMATWNIRLRIAIDIA 555
Query: 173 GVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGY 232
G LSYLHS + PI HRDVKS NI+LDE Y KVSDFG S+ V +D TVV GT+GY
Sbjct: 556 GALSYLHSSASSPIYHRDVKSTNIMLDEKYRAKVSDFGTSRTVTVDHTHLTTVVSGTVGY 615
Query: 233 IDPEYLQT 240
+DPEY Q+
Sbjct: 616 MDPEYFQS 623
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMT9|WAKLL_ARATH Putative wall-associated receptor kinase-like 13 OS=Arabidopsis thaliana GN=WAKL13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 249 bits (637), Expect = 1e-65, Method: Compositional matrix adjust.
Identities = 128/244 (52%), Positives = 166/244 (68%), Gaps = 8/244 (3%)
Query: 1 IGISFVVAIMS--ISWLHFLWTRRRHMKLKEKFFKQNGGSILRQELSKLQGRSSEKAKIF 58
+G F V I+ I W L +RR K KFFK+NGG +L+Q+L+ QGR EK K+F
Sbjct: 384 LGAGFFVLIVGGGIWWWRKLLRKRRMTNRKRKFFKRNGGLLLQQQLNTTQGRV-EKTKLF 442
Query: 59 IEEEIKTVTNNYAD--VIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVV 116
E++ T+N+ D VIG GG G VYKG L D VAVKKS +VD+ K+ EFINE++++
Sbjct: 443 SSRELEKATDNFNDNRVIGQGGQGTVYKGMLVDGRSVAVKKSNVVDEDKLQEFINEVIIL 502
Query: 117 SQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHK---NGNLTWERRLRIAAETAG 173
SQIN R+VV+LL CCLET+VP+LVYEF+ NG LF+H+H+ + W R+RIA + +G
Sbjct: 503 SQINHRHVVKLLGCCLETEVPILVYEFIPNGNLFQHLHEEFDDYTALWGVRMRIAVDISG 562
Query: 174 VLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYI 233
SYLH+ PI HRD+KS NILLDE Y KVSDFG S+ V ID TV+ GT+GY+
Sbjct: 563 AFSYLHTAACSPIYHRDIKSTNILLDEKYRAKVSDFGTSRSVSIDHTHWTTVISGTVGYV 622
Query: 234 DPEY 237
DPEY
Sbjct: 623 DPEY 626
|
Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8VYA3|WAKLJ_ARATH Wall-associated receptor kinase-like 10 OS=Arabidopsis thaliana GN=WAKL10 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 249 bits (635), Expect = 2e-65, Method: Compositional matrix adjust.
Identities = 127/244 (52%), Positives = 172/244 (70%), Gaps = 7/244 (2%)
Query: 3 ISFVVAIMSISWLHFLWTRRRHMKLKEKFFKQNGGSILRQELSKLQGRSSEKAKIFIEEE 62
S +V I I WL+ R+R + K+KFFK+NGG +L+Q+L+ +G + + ++F E
Sbjct: 367 FSTLVFIGGIYWLYKFIRRQRRLNQKKKFFKRNGGLLLQQQLTTTEG-NVDSTRVFNSRE 425
Query: 63 IKTVTNNYA--DVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQIN 120
++ T N++ ++G GG G VYKG L D VAVKKSK+VD+ K++EFINE+V++SQIN
Sbjct: 426 LEKATENFSLTRILGEGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVVILSQIN 485
Query: 121 RRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGN----LTWERRLRIAAETAGVLS 176
RN+V+LL CCLET VP+LVYEF+ NG LFEH+H + + TWE RLRIA + AG LS
Sbjct: 486 HRNIVKLLGCCLETDVPILVYEFIPNGNLFEHLHDDSDDYTMTTWEVRLRIAVDIAGALS 545
Query: 177 YLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPE 236
YLHS + PI HRD+KS NI+LDE + KVSDFG S+ V +D TVV GT+GY+DPE
Sbjct: 546 YLHSAASSPIYHRDIKSTNIMLDEKHRAKVSDFGTSRTVTVDHTHLTTVVSGTVGYMDPE 605
Query: 237 YLQT 240
Y Q+
Sbjct: 606 YFQS 609
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 241 | ||||||
| 255558508 | 1433 | ATP binding protein, putative [Ricinus c | 0.995 | 0.167 | 0.631 | 1e-82 | |
| 359492355 | 745 | PREDICTED: wall-associated receptor kina | 0.991 | 0.320 | 0.628 | 1e-81 | |
| 359492347 | 722 | PREDICTED: wall-associated receptor kina | 0.987 | 0.329 | 0.614 | 2e-80 | |
| 356554681 | 749 | PREDICTED: wall-associated receptor kina | 0.987 | 0.317 | 0.594 | 6e-80 | |
| 356551203 | 766 | PREDICTED: wall-associated receptor kina | 0.991 | 0.312 | 0.579 | 1e-79 | |
| 356518583 | 752 | PREDICTED: wall-associated receptor kina | 0.987 | 0.316 | 0.595 | 1e-79 | |
| 359492353 | 820 | PREDICTED: wall-associated receptor kina | 0.991 | 0.291 | 0.608 | 2e-79 | |
| 449453099 | 876 | PREDICTED: wall-associated receptor kina | 0.991 | 0.272 | 0.589 | 3e-79 | |
| 449516601 | 766 | PREDICTED: LOW QUALITY PROTEIN: wall-ass | 0.991 | 0.312 | 0.589 | 4e-79 | |
| 449507461 | 825 | PREDICTED: wall-associated receptor kina | 0.970 | 0.283 | 0.606 | 6e-79 |
| >gi|255558508|ref|XP_002520279.1| ATP binding protein, putative [Ricinus communis] gi|223540498|gb|EEF42065.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 311 bits (798), Expect = 1e-82, Method: Compositional matrix adjust.
Identities = 156/247 (63%), Positives = 196/247 (79%), Gaps = 7/247 (2%)
Query: 1 IGISFVVA--IMSISWLHFLWTRRRHMKLKEKFFKQNGGSILRQELSKLQGRSSEKAKIF 58
IG++ V ++ I+WL++ + + + MKLKE+FF+QNGG +L+Q+LSK +G ++E AKIF
Sbjct: 349 IGVATGVTALLVGITWLYWGFKKWKLMKLKERFFRQNGGIMLQQQLSKREGSTNETAKIF 408
Query: 59 IEEEIKTVTNNYAD--VIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVV 116
EE++ TN+Y + ++G GG G VYKG L D VA+KKSKIVDQ++ ++FINE+VV+
Sbjct: 409 TAEELENATNSYDESRILGTGGYGTVYKGTLKDGRVVAIKKSKIVDQSQTEQFINEVVVL 468
Query: 117 SQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIH---KNGNLTWERRLRIAAETAG 173
SQIN RNVV+LL CCLET+VPLLVYEFV NGTLFEHIH K L+WE RLRIAAETAG
Sbjct: 469 SQINHRNVVKLLGCCLETEVPLLVYEFVTNGTLFEHIHNKIKASALSWEIRLRIAAETAG 528
Query: 174 VLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYI 233
VLSYLHS NVPIIHRD+KS NILLDENY KVSDFG S+LVP+D + T+VQGTLGY+
Sbjct: 529 VLSYLHSAANVPIIHRDIKSTNILLDENYIAKVSDFGTSRLVPLDQDELSTLVQGTLGYL 588
Query: 234 DPEYLQT 240
DPEYL T
Sbjct: 589 DPEYLHT 595
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359492355|ref|XP_002284688.2| PREDICTED: wall-associated receptor kinase 2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 308 bits (789), Expect = 1e-81, Method: Compositional matrix adjust.
Identities = 154/245 (62%), Positives = 194/245 (79%), Gaps = 6/245 (2%)
Query: 1 IGISFVVAIMSISWLHFLWTRRRHMKLKEKFFKQNGGSILRQELSKLQGRSSEKAKIFIE 60
I I + +++ SWL++ +R+ +KLKEKFF+QNGG +L+Q+L +G SSE KIF
Sbjct: 347 IFIGLIALLITSSWLYWGLKKRKFIKLKEKFFQQNGGLMLQQQLHGREG-SSESVKIFTA 405
Query: 61 EEIKTVTNNYAD--VIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQ 118
EE++ TN Y + +IG GG G VYKG L D VA+KKSK+VDQT+I++FINE+VV+SQ
Sbjct: 406 EELEKATNKYDEDTIIGRGGYGTVYKGILADGRVVAIKKSKLVDQTQIEQFINEVVVLSQ 465
Query: 119 INRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIH---KNGNLTWERRLRIAAETAGVL 175
IN RNVV+LL CCLET+VPLLVYEF+ NGTLF++IH K +++WE RLRIAAETAGVL
Sbjct: 466 INHRNVVKLLGCCLETEVPLLVYEFITNGTLFDYIHNKSKASSISWETRLRIAAETAGVL 525
Query: 176 SYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDP 235
SYLHS ++PIIHRDVKS NILLD+NYT KVSDFGAS+LVP+D Q T+VQGTLGY+DP
Sbjct: 526 SYLHSSASIPIIHRDVKSTNILLDDNYTAKVSDFGASRLVPLDQTQLSTMVQGTLGYLDP 585
Query: 236 EYLQT 240
EYL T
Sbjct: 586 EYLHT 590
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359492347|ref|XP_003634400.1| PREDICTED: wall-associated receptor kinase 2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 304 bits (779), Expect = 2e-80, Method: Compositional matrix adjust.
Identities = 150/244 (61%), Positives = 195/244 (79%), Gaps = 6/244 (2%)
Query: 2 GISFVVAIMSISWLHFLWTRRRHMKLKEKFFKQNGGSILRQELSKLQGRSSEKAKIFIEE 61
GI F++ ++SISWL++ +R+ ++LKEKFF+QNGG +L+Q+LS+ +G S E KIF
Sbjct: 333 GIGFMILLLSISWLYWGLKKRKFIRLKEKFFQQNGGLMLQQQLSRQEG-SDETIKIFTAG 391
Query: 62 EIKTVTNNY--ADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQI 119
E++ TN Y ++++G GG G VYKG L + VAVKKSK++D+++I++FINE++V+SQI
Sbjct: 392 ELEKATNKYDESNIVGRGGYGTVYKGTLTNGRIVAVKKSKMIDKSQIEQFINEVLVLSQI 451
Query: 120 NRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIH---KNGNLTWERRLRIAAETAGVLS 176
N RNVV+LL CCLET+VPLLVYEF+ NGTLF +IH K ++WE RLRIA ETAGVLS
Sbjct: 452 NHRNVVKLLGCCLETEVPLLVYEFITNGTLFNYIHGERKASTISWEVRLRIATETAGVLS 511
Query: 177 YLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPE 236
YLHS T+ PIIHRDVKS NILLD+NYT KVSDFGAS+LVP+D Q T+VQGTLGY+DPE
Sbjct: 512 YLHSATSTPIIHRDVKSTNILLDDNYTAKVSDFGASRLVPLDQAQLSTLVQGTLGYLDPE 571
Query: 237 YLQT 240
YL T
Sbjct: 572 YLLT 575
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356554681|ref|XP_003545672.1| PREDICTED: wall-associated receptor kinase 2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 302 bits (774), Expect = 6e-80, Method: Compositional matrix adjust.
Identities = 145/244 (59%), Positives = 190/244 (77%), Gaps = 6/244 (2%)
Query: 2 GISFVVAIMSISWLHFLWTRRRHMKLKEKFFKQNGGSILRQELSKLQGRSSEKAKIFIEE 61
G+ + M ISW++ + +R+ +KLKEKFF+QNGG ILRQ+LS + SS+ IF E
Sbjct: 352 GVGLIALFMGISWVYLIKQKRKVLKLKEKFFQQNGGIILRQQLSTRK-DSSQSTTIFTAE 410
Query: 62 EIKTVTNNYAD--VIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQI 119
+++ TN + + VIG GG G V+KGFL D VA+KKSKIVDQ++I++FINE++V+SQI
Sbjct: 411 QLEKATNYFDEKLVIGKGGYGTVFKGFLSDNRVVAIKKSKIVDQSQIEQFINEVIVLSQI 470
Query: 120 NRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIH---KNGNLTWERRLRIAAETAGVLS 176
N RNVV+LL CCLET+VPLLVYEFV NGTLF+++H K N++W+ RLR+A E AG LS
Sbjct: 471 NHRNVVKLLGCCLETEVPLLVYEFVNNGTLFDYLHNEHKVANVSWKTRLRVATEVAGALS 530
Query: 177 YLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPE 236
YLHS ++PIIHRDVK+ANILLD+ YT KVSDFGAS+LVP+D + T+VQGT GY+DPE
Sbjct: 531 YLHSAASIPIIHRDVKTANILLDDTYTAKVSDFGASRLVPLDQTELATIVQGTFGYLDPE 590
Query: 237 YLQT 240
Y+QT
Sbjct: 591 YMQT 594
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356551203|ref|XP_003543967.1| PREDICTED: wall-associated receptor kinase 5-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 301 bits (772), Expect = 1e-79, Method: Compositional matrix adjust.
Identities = 142/245 (57%), Positives = 191/245 (77%), Gaps = 6/245 (2%)
Query: 1 IGISFVVAIMSISWLHFLWTRRRHMKLKEKFFKQNGGSILRQELSKLQGRSSEKAKIFIE 60
+G+ + M SWL+ ++ +R+ +KLKEKFF+QNGG IL+Q+LS + S++ A IF
Sbjct: 368 VGVGLLGLFMGTSWLYLIYQKRKVLKLKEKFFQQNGGMILKQQLSARE-DSTQSATIFTA 426
Query: 61 EEIKTVTNNYAD--VIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQ 118
E++K TNN+ + +IG GG G V+KG L + T VA+KKSK VDQ+++++FINE++V+SQ
Sbjct: 427 EQLKKATNNFDESLIIGKGGYGTVFKGVLSNNTIVAIKKSKTVDQSQVEQFINEVIVLSQ 486
Query: 119 INRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNG---NLTWERRLRIAAETAGVL 175
IN RNVV+LL CCLET+VPLLVYEFV NGTLF ++H G N+ W+ RLRIA E AG L
Sbjct: 487 INHRNVVKLLGCCLETEVPLLVYEFVSNGTLFHYLHNEGQLANVCWKTRLRIATEAAGAL 546
Query: 176 SYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDP 235
SYLHSE ++PIIHRDVK+ANILLD+ T KVSDFGAS+L+P+D + T+VQGT+GY+DP
Sbjct: 547 SYLHSEASIPIIHRDVKTANILLDDACTAKVSDFGASRLIPLDQTELATIVQGTIGYLDP 606
Query: 236 EYLQT 240
EY+QT
Sbjct: 607 EYMQT 611
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356518583|ref|XP_003527958.1| PREDICTED: wall-associated receptor kinase 2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 301 bits (771), Expect = 1e-79, Method: Compositional matrix adjust.
Identities = 144/242 (59%), Positives = 189/242 (78%), Gaps = 4/242 (1%)
Query: 2 GISFVVAIMSISWLHFLWTRRRHMKLKEKFFKQNGGSILRQELSKLQGRSSEKAKIFIEE 61
GI ++ ++ WL+ ++ +R+ ++L ++FKQNGG +L+Q++S ++G SSE+AKIF
Sbjct: 349 GIGLMLLLIGSGWLYHVFRKRKRVRLTTRYFKQNGGLMLQQQISNMEG-SSERAKIFTAR 407
Query: 62 EIKTVTNNYAD--VIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQI 119
E+K T N+ + +IG GG G VY+G LPD VA+KKSK+VD ++ ++FINE+VV+SQI
Sbjct: 408 ELKKATENFHESRIIGRGGYGTVYRGILPDDHVVAIKKSKLVDHSQTEQFINEVVVLSQI 467
Query: 120 NRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIH-KNGNLTWERRLRIAAETAGVLSYL 178
N RNVV+LL CCLET++PLLVYEFV NGTLF+HIH KN L WE RLRIAAETAGVL+YL
Sbjct: 468 NHRNVVKLLGCCLETEMPLLVYEFVNNGTLFDHIHNKNTTLPWEARLRIAAETAGVLAYL 527
Query: 179 HSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYL 238
HS ++PIIHRD KS NILLD+ YT KVSDFG S+LVP D Q T+VQGTLGY+DPEY
Sbjct: 528 HSAASIPIIHRDFKSTNILLDDKYTAKVSDFGTSRLVPRDKCQLTTLVQGTLGYLDPEYF 587
Query: 239 QT 240
Q+
Sbjct: 588 QS 589
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359492353|ref|XP_002284691.2| PREDICTED: wall-associated receptor kinase 3-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 301 bits (770), Expect = 2e-79, Method: Compositional matrix adjust.
Identities = 149/245 (60%), Positives = 192/245 (78%), Gaps = 6/245 (2%)
Query: 1 IGISFVVAIMSISWLHFLWTRRRHMKLKEKFFKQNGGSILRQELSKLQGRSSEKAKIFIE 60
+GI + ++ SWL++ +R+ +KLKE+FF+QNGG +L+++LSK +G S+E KIF
Sbjct: 423 VGIGLISLLIGSSWLYWGLKKRKFIKLKEEFFQQNGGLMLQKQLSKREG-STETIKIFTG 481
Query: 61 EEIKTVTNNY--ADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQ 118
E++ TN Y + +IG GG G VYKG L D VA+KKSK+VD+++I++FINE++V+SQ
Sbjct: 482 AELEKATNKYNESKIIGHGGYGTVYKGTLTDGRIVAIKKSKMVDKSQIEQFINEVLVLSQ 541
Query: 119 INRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGN---LTWERRLRIAAETAGVL 175
IN RNVV+LL CCLET+VPLLVYEF+ NGTLF+HIH N + WE RLRIA ETAGVL
Sbjct: 542 INHRNVVKLLGCCLETKVPLLVYEFITNGTLFDHIHNKSNTSIIPWEIRLRIATETAGVL 601
Query: 176 SYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDP 235
SYLHS ++PIIHRDVKS NILLD+NYT KVSDFGAS+LVP+D Q T+VQGTLGY+DP
Sbjct: 602 SYLHSAASIPIIHRDVKSTNILLDDNYTAKVSDFGASRLVPLDQTQLSTMVQGTLGYLDP 661
Query: 236 EYLQT 240
EYL T
Sbjct: 662 EYLLT 666
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449453099|ref|XP_004144296.1| PREDICTED: wall-associated receptor kinase 5-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 300 bits (769), Expect = 3e-79, Method: Compositional matrix adjust.
Identities = 145/246 (58%), Positives = 189/246 (76%), Gaps = 7/246 (2%)
Query: 1 IGISFVVAIMSISWLHFLWTRRRHMKLKEKFFKQNGGSILRQELSKLQGRSSEKAKIFIE 60
+ + F V ++ +WL+ + + + +KLKEKFF++NGG +L+Q LS+ Q S + +IF +
Sbjct: 364 VTVGFTVLVIGSAWLYLGYKKWKFLKLKEKFFQKNGGLMLQQHLSQWQA-SPDLVRIFTQ 422
Query: 61 EEIKTVTNNYAD--VIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQ 118
EE+ TN Y D V+G GG G VYKG L D + +A+KKSK+VDQ++ D+FINE++V+SQ
Sbjct: 423 EELDKATNKYDDSAVVGKGGFGTVYKGVLDDGSVLAIKKSKLVDQSQTDQFINEVIVLSQ 482
Query: 119 INRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGN----LTWERRLRIAAETAGV 174
IN RNVV+LL CCLET+VPLLVYEF+ NGTL+E++H N L+WE RLRIAAETAGV
Sbjct: 483 INHRNVVKLLGCCLETEVPLLVYEFISNGTLYEYVHDKTNGRNFLSWEARLRIAAETAGV 542
Query: 175 LSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYID 234
+SYLHS + PIIHRD+K+ NILLD NYT KVSDFGASKLVP+D Q T+VQGTLGY+D
Sbjct: 543 ISYLHSSASTPIIHRDIKTTNILLDHNYTAKVSDFGASKLVPMDQTQLSTMVQGTLGYLD 602
Query: 235 PEYLQT 240
PEYL T
Sbjct: 603 PEYLLT 608
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449516601|ref|XP_004165335.1| PREDICTED: LOW QUALITY PROTEIN: wall-associated receptor kinase 2-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 300 bits (768), Expect = 4e-79, Method: Compositional matrix adjust.
Identities = 145/246 (58%), Positives = 188/246 (76%), Gaps = 7/246 (2%)
Query: 1 IGISFVVAIMSISWLHFLWTRRRHMKLKEKFFKQNGGSILRQELSKLQGRSSEKAKIFIE 60
+ + F V ++ +WL+ + + + +KLKEKFF+ NGG +L+Q LS+ Q S + +IF +
Sbjct: 364 VTVGFTVLVIGSAWLYLGYKKWKFLKLKEKFFRXNGGLMLQQHLSQWQA-SPDLVRIFTQ 422
Query: 61 EEIKTVTNNYAD--VIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQ 118
EE+ TN Y D V+G GG G VYKG L D + +A+KKSK+VDQ++ D+FINE++V+SQ
Sbjct: 423 EELDKATNKYDDSAVVGKGGFGTVYKGVLDDGSVLAIKKSKLVDQSQTDQFINEVIVLSQ 482
Query: 119 INRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGN----LTWERRLRIAAETAGV 174
IN RNVV+LL CCLET+VPLLVYEF+ NGTL+E++H N L+WE RLRIAAETAGV
Sbjct: 483 INHRNVVKLLGCCLETEVPLLVYEFISNGTLYEYVHDKTNGRNFLSWEARLRIAAETAGV 542
Query: 175 LSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYID 234
+SYLHS + PIIHRD+K+ NILLD NYT KVSDFGASKLVP+D Q T+VQGTLGY+D
Sbjct: 543 ISYLHSSASTPIIHRDIKTTNILLDHNYTAKVSDFGASKLVPMDQTQLSTMVQGTLGYLD 602
Query: 235 PEYLQT 240
PEYL T
Sbjct: 603 PEYLLT 608
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449507461|ref|XP_004163038.1| PREDICTED: wall-associated receptor kinase 2-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 299 bits (766), Expect = 6e-79, Method: Compositional matrix adjust.
Identities = 148/244 (60%), Positives = 190/244 (77%), Gaps = 10/244 (4%)
Query: 6 VVAIM----SISWLHFLWTRRRHMKLKEKFFKQNGGSILRQELSKLQGRSSEKAKIFIEE 61
VV IM S SWL+ + R + +KLK KFF++NGG +L Q+L ++ +++ AKIF E
Sbjct: 431 VVGIMGLMVSCSWLYIGFKRWKLIKLKAKFFRRNGGLMLEQQL-PIRDEAAQTAKIFTAE 489
Query: 62 EIKTVTNNYAD--VIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQI 119
E++ TNNY+D ++G GG G VYKG LP+ VA+KKSKIVD+T+ +F+NE++V+SQI
Sbjct: 490 ELQKATNNYSDDRIVGKGGFGTVYKGILPNGAAVAIKKSKIVDKTQTKQFVNEVIVLSQI 549
Query: 120 NRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGN---LTWERRLRIAAETAGVLS 176
N RN V+LL CCLE +VPLLVYEFV NGTLF+HIHK + + W+ RL+IA+ETAGVLS
Sbjct: 550 NHRNTVKLLGCCLEEEVPLLVYEFVSNGTLFDHIHKRKSQRSIPWKTRLKIASETAGVLS 609
Query: 177 YLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPE 236
YLHS ++PIIHRDVKS NILLDEN+T KVSDFGASKLVP+D + T+VQGTLGY+DPE
Sbjct: 610 YLHSSASIPIIHRDVKSTNILLDENFTAKVSDFGASKLVPLDQVDLNTIVQGTLGYLDPE 669
Query: 237 YLQT 240
YLQT
Sbjct: 670 YLQT 673
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 241 | ||||||
| TAIR|locus:2014897 | 741 | WAK3 "wall associated kinase 3 | 0.983 | 0.319 | 0.530 | 2e-65 | |
| TAIR|locus:2014902 | 735 | WAK1 "cell wall-associated kin | 0.983 | 0.322 | 0.522 | 5.2e-65 | |
| TAIR|locus:2014962 | 733 | WAK5 "wall associated kinase 5 | 0.983 | 0.323 | 0.522 | 6.7e-65 | |
| TAIR|locus:2014912 | 732 | WAK2 "wall-associated kinase 2 | 0.983 | 0.323 | 0.522 | 1.8e-64 | |
| TAIR|locus:2014952 | 738 | WAK4 "wall associated kinase 4 | 0.983 | 0.321 | 0.514 | 3.7e-64 | |
| TAIR|locus:2019843 | 769 | WAKL10 "WALL ASSOCIATED KINASE | 0.983 | 0.308 | 0.516 | 2.1e-61 | |
| TAIR|locus:2016377 | 788 | AT1G19390 [Arabidopsis thalian | 0.979 | 0.299 | 0.516 | 3.4e-61 | |
| TAIR|locus:2126316 | 786 | AT4G31100 [Arabidopsis thalian | 0.987 | 0.302 | 0.506 | 1.9e-60 | |
| TAIR|locus:2126271 | 793 | AT4G31110 [Arabidopsis thalian | 0.987 | 0.300 | 0.506 | 3.9e-60 | |
| TAIR|locus:2200552 | 730 | WAKL1 "wall associated kinase- | 0.983 | 0.324 | 0.497 | 8.1e-60 |
| TAIR|locus:2014897 WAK3 "wall associated kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 666 (239.5 bits), Expect = 2.0e-65, P = 2.0e-65
Identities = 129/243 (53%), Positives = 174/243 (71%)
Query: 3 ISFVVAIMSISWLHFLWTRRRHMKLKEKFFKQNGGSILRQELSKLQGRSSXXXXXXXXXX 62
I +V +++ + +R++ KL+ +FF+QNGG +L Q LS G S+
Sbjct: 349 IGVLVLLLAAICIQHATKQRKYTKLRRQFFEQNGGGMLIQRLSGA-GLSNIDFKIFTEEG 407
Query: 63 XXTVTNNYAD--VIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQIN 120
TN Y + ++G GG G VYKG LPD T VA+KK+++ D ++D+FI+E++V+SQIN
Sbjct: 408 MKEATNGYDESRILGQGGQGTVYKGILPDNTIVAIKKARLADSRQVDQFIHEVLVLSQIN 467
Query: 121 RRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKN---GNLTWERRLRIAAETAGVLSY 177
RNVV++L CCLET+VPLLVYEF+ NGTLF+H+H + +LTWE RLRIA E AG L+Y
Sbjct: 468 HRNVVKILGCCLETEVPLLVYEFITNGTLFDHLHGSIFDSSLTWEHRLRIAIEVAGTLAY 527
Query: 178 LHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEY 237
LHS ++PIIHRD+K+ANILLDEN T KV+DFGASKL+P+D Q T+VQGTLGY+DPEY
Sbjct: 528 LHSSASIPIIHRDIKTANILLDENLTAKVADFGASKLIPMDKEQLTTMVQGTLGYLDPEY 587
Query: 238 LQT 240
T
Sbjct: 588 YTT 590
|
|
| TAIR|locus:2014902 WAK1 "cell wall-associated kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 662 (238.1 bits), Expect = 5.2e-65, P = 5.2e-65
Identities = 127/243 (52%), Positives = 175/243 (72%)
Query: 3 ISFVVAIMSISWLHFLWTRRRHMKLKEKFFKQNGGSILRQELSKLQGRSSXXXXXXXXXX 62
I F+V ++ ++ + + KL+E+FF+QNGG +L Q LS G S+
Sbjct: 343 IGFLVILLGVACIQQRMKHLKDTKLREQFFEQNGGGMLTQRLSGA-GPSNVDVKIFTEDG 401
Query: 63 XXTVTNNYAD--VIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQIN 120
TN YA+ ++G GG G VYKG LPD + VA+KK+++ D +++++FINE++V+SQIN
Sbjct: 402 MKKATNGYAESRILGQGGQGTVYKGILPDNSIVAIKKARLGDSSQVEQFINEVLVLSQIN 461
Query: 121 RRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKN---GNLTWERRLRIAAETAGVLSY 177
RNVV+LL CCLET+VPLLVYEF+ NGTLF+H+H + +LTWE RL+IA E AG L+Y
Sbjct: 462 HRNVVKLLGCCLETEVPLLVYEFITNGTLFDHLHGSMIDSSLTWEHRLKIAIEVAGTLAY 521
Query: 178 LHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEY 237
LHS ++PIIHRD+K+ANILLD N T KV+DFGAS+L+P+D + T+VQGTLGY+DPEY
Sbjct: 522 LHSSASIPIIHRDIKTANILLDVNLTAKVADFGASRLIPMDKEELETMVQGTLGYLDPEY 581
Query: 238 LQT 240
T
Sbjct: 582 YNT 584
|
|
| TAIR|locus:2014962 WAK5 "wall associated kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 661 (237.7 bits), Expect = 6.7e-65, P = 6.7e-65
Identities = 127/243 (52%), Positives = 179/243 (73%)
Query: 3 ISFVVAIMSISWLHFLWTRRRHMKLKEKFFKQNGGSILRQELSKLQGRSSXXXXXXXXXX 62
I F++ +++IS++ R++ +L+++FF+QNGG +L Q LS G S+
Sbjct: 342 IGFLIILLTISYIQQKMRHRKNTELRQQFFEQNGGGMLIQRLSGA-GPSNVDVKIFTEEG 400
Query: 63 XXTVTNNYAD--VIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQIN 120
T+ Y + ++G GG G VYKG L D + VA+KK+++ D++++++FINE++V+SQIN
Sbjct: 401 MKEATDGYNESRILGQGGQGTVYKGILQDNSIVAIKKARLGDRSQVEQFINEVLVLSQIN 460
Query: 121 RRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKN---GNLTWERRLRIAAETAGVLSY 177
RNVV+LL CCLET+VPLLVYEF+ +GTLF+H+H + +LTWE RLRIA E AG L+Y
Sbjct: 461 HRNVVKLLGCCLETEVPLLVYEFISSGTLFDHLHGSMFDSSLTWEHRLRIAIEVAGTLAY 520
Query: 178 LHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEY 237
LHS ++PIIHRDVK+ANILLDEN T KV+DFGAS+L+P+D Q T+VQGTLGY+DPEY
Sbjct: 521 LHSYASIPIIHRDVKTANILLDENLTAKVADFGASRLIPMDQEQLTTMVQGTLGYLDPEY 580
Query: 238 LQT 240
T
Sbjct: 581 YNT 583
|
|
| TAIR|locus:2014912 WAK2 "wall-associated kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 657 (236.3 bits), Expect = 1.8e-64, P = 1.8e-64
Identities = 127/243 (52%), Positives = 177/243 (72%)
Query: 3 ISFVVAIMSISWLHFLWTRRRHMKLKEKFFKQNGGSILRQELSKLQGRSSXXXXXXXXXX 62
I F V ++ IS L R++ +L++KFF+QNGG +L Q +S G S+
Sbjct: 338 IGFSVIMLGISCLQQKIKHRKNTELRQKFFEQNGGGMLIQRVSGA-GPSNVDVKIFTEKG 396
Query: 63 XXTVTNNYAD--VIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQIN 120
TN Y + ++G GG G VYKG LPD + VA+KK+++ +++++++FINE++V+SQIN
Sbjct: 397 MKEATNGYHESRILGQGGQGTVYKGILPDNSIVAIKKARLGNRSQVEQFINEVLVLSQIN 456
Query: 121 RRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKN---GNLTWERRLRIAAETAGVLSY 177
RNVV++L CCLET+VPLLVYEF+ +GTLF+H+H + +LTWE RLRIA E AG L+Y
Sbjct: 457 HRNVVKVLGCCLETEVPLLVYEFINSGTLFDHLHGSLYDSSLTWEHRLRIATEVAGSLAY 516
Query: 178 LHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEY 237
LHS ++PIIHRD+K+ANILLD+N T KV+DFGAS+L+P+D Q T+VQGTLGY+DPEY
Sbjct: 517 LHSSASIPIIHRDIKTANILLDKNLTAKVADFGASRLIPMDKEQLTTIVQGTLGYLDPEY 576
Query: 238 LQT 240
T
Sbjct: 577 YNT 579
|
|
| TAIR|locus:2014952 WAK4 "wall associated kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 654 (235.3 bits), Expect = 3.7e-64, P = 3.7e-64
Identities = 125/243 (51%), Positives = 175/243 (72%)
Query: 3 ISFVVAIMSISWLHFLWTRRRHMKLKEKFFKQNGGSILRQELSKLQGRSSXXXXXXXXXX 62
I F+V +++IS + + +L+++FF+QNGG +L Q LS G S+
Sbjct: 344 IGFLVILLAISCIEHKMKNTKDTELRQQFFEQNGGGMLMQRLSGA-GPSNVDVKIFTEEG 402
Query: 63 XXTVTNNYAD--VIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQIN 120
T+ Y + ++G GG G VYKG LPD + VA+KK+++ D +++++FINE++V+SQIN
Sbjct: 403 MKEATDGYDENRILGQGGQGTVYKGILPDNSIVAIKKARLGDNSQVEQFINEVLVLSQIN 462
Query: 121 RRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKN---GNLTWERRLRIAAETAGVLSY 177
RNVV+LL CCLET+VPLLVYEF+ +GTLF+H+H + +LTWE RLR+A E AG L+Y
Sbjct: 463 HRNVVKLLGCCLETEVPLLVYEFISSGTLFDHLHGSMFDSSLTWEHRLRMAVEIAGTLAY 522
Query: 178 LHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEY 237
LHS ++PIIHRD+K+ANILLDEN T KV+DFGAS+L+P+D T+VQGTLGY+DPEY
Sbjct: 523 LHSSASIPIIHRDIKTANILLDENLTAKVADFGASRLIPMDKEDLATMVQGTLGYLDPEY 582
Query: 238 LQT 240
T
Sbjct: 583 YNT 585
|
|
| TAIR|locus:2019843 WAKL10 "WALL ASSOCIATED KINASE (WAK)-LIKE 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 628 (226.1 bits), Expect = 2.1e-61, P = 2.1e-61
Identities = 125/242 (51%), Positives = 163/242 (67%)
Query: 4 SFVVAIMSISWLHFLWTRRRHMKLKEKFFKQNGGSILRQELSKLQGR-SSXXXXXXXXXX 62
S +V I I WL+ R+R + K+KFFK+NGG +L+Q+L+ +G S
Sbjct: 368 STLVFIGGIYWLYKFIRRQRRLNQKKKFFKRNGGLLLQQQLTTTEGNVDSTRVFNSRELE 427
Query: 63 XXTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRR 122
T + ++G GG G VYKG L D VAVKKSK+VD+ K++EFINE+V++SQIN R
Sbjct: 428 KATENFSLTRILGEGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVVILSQINHR 487
Query: 123 NVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGN----LTWERRLRIAAETAGVLSYL 178
N+V+LL CCLET VP+LVYEF+ NG LFEH+H + + TWE RLRIA + AG LSYL
Sbjct: 488 NIVKLLGCCLETDVPILVYEFIPNGNLFEHLHDDSDDYTMTTWEVRLRIAVDIAGALSYL 547
Query: 179 HSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYL 238
HS + PI HRD+KS NI+LDE + KVSDFG S+ V +D TVV GT+GY+DPEY
Sbjct: 548 HSAASSPIYHRDIKSTNIMLDEKHRAKVSDFGTSRTVTVDHTHLTTVVSGTVGYMDPEYF 607
Query: 239 QT 240
Q+
Sbjct: 608 QS 609
|
|
| TAIR|locus:2016377 AT1G19390 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 626 (225.4 bits), Expect = 3.4e-61, P = 3.4e-61
Identities = 126/244 (51%), Positives = 165/244 (67%)
Query: 1 IGISF--VVAIMSISWLHFLWTRRRHMKLKEKFFKQNGGSILRQELSKLQGRSSXXXXXX 58
+G +F +V ++ I WL +RR K K KFFK+NGG +L+Q+L+ +G
Sbjct: 381 VGSAFGILVLVVGIWWLRKFLKKRRMSKRKRKFFKRNGGLLLQQQLNTNKGNVEKTRIFS 440
Query: 59 XXXXXXTVTNNYAD--VIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVV 116
T+N+++ ++G GG G VYKG L D VAVKKSK+VD+ K++EFINE+V++
Sbjct: 441 SRELEKA-TDNFSESRILGQGGQGTVYKGMLVDGRTVAVKKSKVVDEDKLEEFINEVVIL 499
Query: 117 SQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGN---LTWERRLRIAAETAG 173
SQIN R+VV+LL CCLET+VP LVYEF+ NG LF+HIH+ + TW RLRIA + AG
Sbjct: 500 SQINHRHVVKLLGCCLETEVPTLVYEFIPNGNLFQHIHEESDDYTKTWGMRLRIAVDIAG 559
Query: 174 VLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYI 233
LSYLHS + PI HRD+KS NILLDE Y KVSDFG S+ V ID TV+ GT+GY+
Sbjct: 560 ALSYLHSAASSPIYHRDIKSTNILLDEKYRTKVSDFGTSRSVTIDHTHWTTVISGTVGYV 619
Query: 234 DPEY 237
DPEY
Sbjct: 620 DPEY 623
|
|
| TAIR|locus:2126316 AT4G31100 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 619 (223.0 bits), Expect = 1.9e-60, P = 1.9e-60
Identities = 124/245 (50%), Positives = 162/245 (66%)
Query: 2 GISFVVAIMSISWLHFLWTRRRHMKLKEKFFKQNGGSILRQELSKLQGRSSXXXXXXXXX 61
G +V + + WL +RR K K+KFFK+NGG +L+QEL+ QG
Sbjct: 377 GFGVLVLVGGVWWLRKFLVKRRMAKRKKKFFKRNGGLLLQQELNTRQGVVEKARIFTSKE 436
Query: 62 XXXTVTNNYAD--VIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQI 119
T N+++ V+G GG G VYKG L D VAVKKSK++D+ K+ EFINE+V++SQI
Sbjct: 437 LEKA-TENFSENRVLGHGGQGTVYKGMLVDGRTVAVKKSKVIDEDKLQEFINEVVILSQI 495
Query: 120 NRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNG----NLTWERRLRIAAETAGVL 175
N R+VV+LL CCLET+VP+LVYEF+ NG LF+HIH+ + W RLRIA + AG L
Sbjct: 496 NHRHVVKLLGCCLETEVPILVYEFIINGNLFKHIHEEEADDYTMIWGMRLRIAVDIAGAL 555
Query: 176 SYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDP 235
SYLHS + PI HRD+KS NILLDE Y KV+DFG S+ V ID TV+ GT+GY+DP
Sbjct: 556 SYLHSAASSPIYHRDIKSTNILLDEKYRAKVADFGTSRSVTIDQTHWTTVISGTVGYVDP 615
Query: 236 EYLQT 240
EY ++
Sbjct: 616 EYYRS 620
|
|
| TAIR|locus:2126271 AT4G31110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 616 (221.9 bits), Expect = 3.9e-60, P = 3.9e-60
Identities = 124/245 (50%), Positives = 162/245 (66%)
Query: 2 GISFVVAIMSISWLHFLWTRRRHMKLKEKFFKQNGGSILRQELSKLQGRSSXXXXXXXXX 61
G +V + + WL +RR K K+KFFK+NGG +L QEL+ +G
Sbjct: 386 GFGVLVLVGGLWWLRKFLIKRRITKRKKKFFKRNGGLLLLQELNTREGYVEKTRVFNSRE 445
Query: 62 XXXTVTNNYAD--VIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQI 119
T N+++ V+G GG G VYKG L D VAVKKSK++D+ K+ EFINE+V++SQI
Sbjct: 446 LEKA-TENFSENRVLGHGGQGTVYKGMLVDGRTVAVKKSKVIDEDKLQEFINEVVILSQI 504
Query: 120 NRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGN----LTWERRLRIAAETAGVL 175
N R+VV+LL CCLET+VP+LVYEF+ NG LF+HIH+ + + W RLRIA + AG L
Sbjct: 505 NHRHVVKLLGCCLETEVPMLVYEFIINGNLFKHIHEEESDDYTMLWGMRLRIAVDIAGAL 564
Query: 176 SYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDP 235
SYLHS + PI HRD+KS NILLDE Y KV+DFG S+ V ID TV+ GT+GY+DP
Sbjct: 565 SYLHSSASSPIYHRDIKSTNILLDEKYRAKVADFGTSRSVTIDQTHWTTVISGTVGYVDP 624
Query: 236 EYLQT 240
EY Q+
Sbjct: 625 EYYQS 629
|
|
| TAIR|locus:2200552 WAKL1 "wall associated kinase-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 613 (220.8 bits), Expect = 8.1e-60, P = 8.1e-60
Identities = 120/241 (49%), Positives = 162/241 (67%)
Query: 1 IGISFVVAIMSISWLHFLWTRRRHMKLKEKFFKQNGGSILRQELSKLQGRSSXXXXXXXX 60
IG+S +V + + WL L +RR++ +KFFK+NGG +L+Q+L+ G
Sbjct: 361 IGLSGLVFFVGLFWLFKLIKKRRNINRSKKFFKRNGGLLLKQQLTTKDGNVEMSKIFSSK 420
Query: 61 XXXXTVTNNYAD-VIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQI 119
N D V+G GG G VYKG L D + VAVK+SK+VD+ K++EFINE+V++SQI
Sbjct: 421 ELRKATDNFSIDRVLGQGGQGTVYKGMLVDGSIVAVKRSKVVDEDKMEEFINEIVLLSQI 480
Query: 120 NRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGN---LTWERRLRIAAETAGVLS 176
N RN+V+LL CCLET+VP+LVYE++ NG LF+ +H + +TWE RLRIA E AG L+
Sbjct: 481 NHRNIVKLLGCCLETEVPILVYEYIPNGDLFKRLHDESDDYTMTWEVRLRIAIEIAGALT 540
Query: 177 YLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPE 236
Y+HS + PI HRD+K+ NILLDE Y KVSDFG S+ V +D T+V GT GY+DPE
Sbjct: 541 YMHSAASFPIFHRDIKTTNILLDEKYRAKVSDFGTSRSVTLDQTHLTTLVAGTFGYMDPE 600
Query: 237 Y 237
Y
Sbjct: 601 Y 601
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00015469001 | SubName- Full=Chromosome chr18 scaffold_1, whole genome shotgun sequence; (625 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 241 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-39 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 7e-38 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 7e-35 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-33 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-32 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-32 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-30 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-27 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-25 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-23 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-21 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-21 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-21 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 7e-21 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-20 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-20 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-19 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-19 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-18 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-17 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-17 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-17 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-17 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-17 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-16 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-16 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-16 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-16 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-16 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-16 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-16 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-16 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 8e-16 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-15 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-15 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-15 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-15 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-15 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-14 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-14 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-14 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-14 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-14 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-14 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-14 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-14 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-13 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-13 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-13 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-13 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-13 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 8e-13 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 8e-13 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 8e-13 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 9e-13 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-12 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-12 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-12 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-12 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-12 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-12 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-12 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-12 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-12 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-12 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-12 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 8e-12 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-11 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-11 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-11 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-11 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-11 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-11 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-11 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-11 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-11 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 8e-11 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 8e-11 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-10 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-10 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-10 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-10 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-10 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-10 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-10 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-10 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-10 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-10 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-10 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-10 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-10 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-10 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-10 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 6e-10 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-10 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-10 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 7e-10 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-09 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-09 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-09 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-09 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-09 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-09 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-09 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-09 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-09 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-09 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-09 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-09 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-09 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-09 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-09 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-09 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-09 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-09 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-09 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 9e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-08 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-08 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-08 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-08 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-08 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-08 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-08 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-08 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-08 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 6e-08 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 7e-08 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-08 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 8e-08 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 9e-08 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-07 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-07 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-07 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-07 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-07 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-07 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-07 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-07 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-07 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-07 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-07 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-07 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-07 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-07 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-07 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 7e-07 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 8e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 8e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-06 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-06 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-06 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-06 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-06 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-06 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-06 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-06 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-06 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-06 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-06 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-06 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-06 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-06 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-06 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 7e-06 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-05 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-05 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-05 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-05 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-05 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-05 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-05 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-05 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-05 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-05 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-05 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-05 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-05 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-05 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-05 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-05 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-05 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 7e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 9e-05 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-04 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-04 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-04 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-04 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-04 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-04 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-04 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-04 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-04 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 6e-04 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 8e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 0.001 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 0.001 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 0.001 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 0.002 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 0.002 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 0.002 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 0.002 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 0.003 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 0.003 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.003 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 3e-39
Identities = 60/170 (35%), Positives = 88/170 (51%), Gaps = 8/170 (4%)
Query: 74 IGCGGSGNVYKGF-LPDRTPVAVKK-SKIVDQTKIDEFINELVVVSQINRRNVVRLLACC 131
+G GG G VY VA+K K + ++E + E+ ++ ++N N+V+L
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 132 LETQVPLLVYEFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRD 190
+ LV E+ G+L + + +N G L+ + LRI + L YLHS IIHRD
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRD 117
Query: 191 VKSANILLDE-NYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
+K NILLD N K++DFG SKL+ D T+V GT Y+ PE L
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLL 166
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 7e-38
Identities = 57/172 (33%), Positives = 85/172 (49%), Gaps = 7/172 (4%)
Query: 73 VIGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQ--TKIDEFINELVVVSQINRRNVVRLLA 129
+G G G VYK VAVK K + K E+ ++ +++ N+VRL+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 130 CCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHR 189
+ LV E+ G LF+++ + G L+ + +IA + L YLHS IIHR
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN---GIIHR 122
Query: 190 DVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQTC 241
D+K NILLDEN K++DFG +K + + + T GT Y+ PE L
Sbjct: 123 DLKPENILLDENGVVKIADFGLAKKLLKSS-SSLTTFVGTPWYMAPEVLLGG 173
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 7e-35
Identities = 52/167 (31%), Positives = 80/167 (47%), Gaps = 7/167 (4%)
Query: 72 DVIGCGGSGNVYKG-FLPDRTPVAVKKSKIVDQTKIDE-FINELVVVSQINRRNVVRLLA 129
+ +G G G VY VA+K K K E + E+ ++ ++ N+VRL
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 130 CCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHR 189
+ LV E+ G LF+ + K G L+ + + L YLHS+ I+HR
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG---IVHR 121
Query: 190 DVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPE 236
D+K NILLDE+ K++DFG ++ +D + T GT Y+ PE
Sbjct: 122 DLKPENILLDEDGHVKLADFGLARQ--LDPGEKLTTFVGTPEYMAPE 166
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-33
Identities = 53/165 (32%), Positives = 84/165 (50%), Gaps = 12/165 (7%)
Query: 73 VIGCGGSGNVYKGFL-----PDRTPVAVKKSK-IVDQTKIDEFINELVVVSQINRRNVVR 126
+G G G VYKG L T VAVK K + + +EF+ E ++ +++ N+VR
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 127 LLACCLETQVPLLVYEFVGNGTLFEHIHKNG-NLTWERRLRIAAETAGVLSYLHSETNVP 185
LL C + + +V E++ G L + + K+G LT + L++A + A + YL S
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLES---KN 122
Query: 186 IIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTL 230
+HRD+ + N L+ EN K+SDFG S+ + D Y G
Sbjct: 123 FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDD--YYRKRGGGK 165
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 1e-32
Identities = 55/167 (32%), Positives = 85/167 (50%), Gaps = 13/167 (7%)
Query: 72 DVIGCGGSGNVYKGFL-----PDRTPVAVKKSK-IVDQTKIDEFINELVVVSQINRRNVV 125
+G G G VYKG L VAVK K + +I+EF+ E ++ +++ N+V
Sbjct: 5 KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIV 64
Query: 126 RLLACCLETQVPLLVYEFVGNGTLFEHIHKNGN--LTWERRLRIAAETAGVLSYLHSETN 183
+LL C E + ++V E++ G L +++ KN L+ L A + A + YL S+
Sbjct: 65 KLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK-- 122
Query: 184 VPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTL 230
IHRD+ + N L+ EN K+SDFG S+ + D Y V G L
Sbjct: 123 -NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY--YKVKGGKL 166
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-32
Identities = 54/165 (32%), Positives = 83/165 (50%), Gaps = 13/165 (7%)
Query: 72 DVIGCGGSGNVYKGFL-----PDRTPVAVKKSK-IVDQTKIDEFINELVVVSQINRRNVV 125
+G G G VYKG L + VAVK K + +I+EF+ E ++ +++ NVV
Sbjct: 5 KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVV 64
Query: 126 RLLACCLETQVPLLVYEFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNV 184
+LL C E + +V E++ G L ++ KN L+ L A + A + YL S+
Sbjct: 65 KLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK--- 121
Query: 185 PIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGT 229
IHRD+ + N L+ EN K+SDFG S+ + D Y +G
Sbjct: 122 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD---YYRKRGG 163
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 3e-30
Identities = 52/161 (32%), Positives = 79/161 (49%), Gaps = 17/161 (10%)
Query: 72 DVIGCGGSGNVYKGFLPDR----TPVAVKKSK-IVDQTKIDEFINELVVVSQINRRNVVR 126
+G G G VYKG L + T VAVK K + + +F+ E V+ ++ NVVR
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 127 LLACCLETQVPLLVYEFVGNGTLFEHIHKN---------GNLTWERRLRIAAETAGVLSY 177
LL C E + LV E++ G L +++ K+ L+ + L A + A + Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 178 LHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPID 218
L S +HRD+ + N L+ E+ K+SDFG S+ V D
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 6e-27
Identities = 52/172 (30%), Positives = 87/172 (50%), Gaps = 13/172 (7%)
Query: 73 VIGCGGSGNVYKGFLPDRTP--VAVKKSKI--VDQTKIDEFINELVVVSQINRRNVVRLL 128
++G G G+VY D T +AVK ++ + +++ E+ ++S + N+VR
Sbjct: 7 LLGRGSFGSVYLALDKD-TGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 129 ACCL-ETQVPLLVY-EFVGNGTLFEHIHKNGNLTWERRLRI-AAETAGVLSYLHSETNVP 185
E + L ++ E+V G+L + K G L E +R + L+YLHS
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLP-EPVIRKYTRQILEGLAYLHSNG--- 121
Query: 186 IIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTV-VQGTLGYIDPE 236
I+HRD+K ANIL+D + K++DFG +K + T V+GT ++ PE
Sbjct: 122 IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE 173
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 98.4 bits (246), Expect = 7e-25
Identities = 55/172 (31%), Positives = 83/172 (48%), Gaps = 11/172 (6%)
Query: 72 DVIGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLAC 130
+ IG GG G VYK VA+K K+ + K ++ INE+ ++ + N+V+
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65
Query: 131 CLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGV---LSYLHSETNVPII 187
L+ +V EF G+L + + E + IA + L YLHS II
Sbjct: 66 YLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQ--IAYVCKELLKGLEYLHSNG---II 120
Query: 188 HRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
HRD+K+ANILL + K+ DFG S + D T+V GT ++ PE +
Sbjct: 121 HRDIKAANILLTSDGEVKLIDFGLSAQL-SDTKARNTMV-GTPYWMAPEVIN 170
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.3 bits (238), Expect = 1e-23
Identities = 53/145 (36%), Positives = 79/145 (54%), Gaps = 6/145 (4%)
Query: 96 KKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPL-LVYEFVGNGTLFEHIH 154
KK KI+ + +++ + E ++S+IN +V+L +T+ L LV E+ G LF H+
Sbjct: 27 KKKKIIKRKEVEHTLTERNILSRINHPFIVKL-HYAFQTEEKLYLVLEYAPGGELFSHLS 85
Query: 155 KNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKL 214
K G + ER AAE L YLHS II+RD+K NILLD + K++DFG +K
Sbjct: 86 KEGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKE 142
Query: 215 VPIDAIQNYTVVQGTLGYIDPEYLQ 239
+ + + T GT Y+ PE L
Sbjct: 143 LSSEGSRTNTFC-GTPEYLAPEVLL 166
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 1e-21
Identities = 46/155 (29%), Positives = 77/155 (49%), Gaps = 10/155 (6%)
Query: 72 DVIGCGGSGNVYKGFL-PDRTPVAVK---KSKIVDQTKIDEFINELVVVSQINR-RNVVR 126
+IG G V A+K K +++ + K+ E V++++N +++
Sbjct: 7 KIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIK 66
Query: 127 LLACCLETQVPL-LVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVP 185
L + + L V E+ NG L ++I K G+L + AAE L YLHS
Sbjct: 67 LY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS---KG 122
Query: 186 IIHRDVKSANILLDENYTPKVSDFGASKLVPIDAI 220
IIHRD+K NILLD++ K++DFG +K++ ++
Sbjct: 123 IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 2e-21
Identities = 52/143 (36%), Positives = 81/143 (56%), Gaps = 7/143 (4%)
Query: 74 IGCGGSGNVYKGFLPDRTPVAVK--KSKIVDQTKIDEFINELVVVSQINRRNVVRLLACC 131
IG G G+VYKG L T VAVK +S + K +F+ E ++ Q + N+V+L+ C
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKR-KFLQEAEILKQYDHPNIVKLIGVC 61
Query: 132 LETQVPLLVYEFVGNGTLFEHIHKNGN-LTWERRLRIAAETAGVLSYLHSETNVPIIHRD 190
++ Q +V E V G+L + K N LT ++ L+++ + A + YL S+ IHRD
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRD 118
Query: 191 VKSANILLDENYTPKVSDFGASK 213
+ + N L+ EN K+SDFG S+
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 90.2 bits (222), Expect = 5e-21
Identities = 59/180 (32%), Positives = 87/180 (48%), Gaps = 18/180 (10%)
Query: 73 VIGCGGSGNVYKGFLPDRTPVAVK---KSKIVDQTKIDEFINELVVVSQIN-RRNVVRLL 128
+G G G VY DR VA+K K +++ F+ E+ +++ +N N+V+L
Sbjct: 7 KLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 129 ACCLETQVPLLVYEFVGNGTLFEHIHKNG---NLTWERRLRIAAETAGVLSYLHSETNVP 185
+ LV E+V G+L + + K G L+ L I A+ L YLHS+
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---G 121
Query: 186 IIHRDVKSANILLDENYT-PKVSDFGASKLVPIDAI-----QNYTVVQGTLGYIDPEYLQ 239
IIHRD+K NILLD + K+ DFG +KL+P + GT GY+ PE L
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181
|
Length = 384 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 7e-21
Identities = 44/144 (30%), Positives = 73/144 (50%), Gaps = 7/144 (4%)
Query: 72 DVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACC 131
IG G G+V G + VAVK K D T F+ E V++ + N+V+LL
Sbjct: 12 ATIGKGEFGDVMLGDYRGQK-VAVKCLK-DDSTAAQAFLAEASVMTTLRHPNLVQLLGVV 69
Query: 132 LETQVPLLVYEFVGNGTLFEHIHKNGN--LTWERRLRIAAETAGVLSYLHSETNVPIIHR 189
L+ +V E++ G+L +++ G +T ++L A + + YL + +HR
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHR 126
Query: 190 DVKSANILLDENYTPKVSDFGASK 213
D+ + N+L+ E+ KVSDFG +K
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 2e-20
Identities = 46/171 (26%), Positives = 86/171 (50%), Gaps = 7/171 (4%)
Query: 72 DVIGCGGSGNVYKGF-LPDRTPVAVKKSKI--VDQTKIDEFINELVVVSQINRRNVVRLL 128
D+IG G G VYKG L VA+K+ + + + + + E+ ++ + N+V+ +
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 129 ACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIH 188
+ ++ E+ NG+L + I K G + L+YLH + +IH
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG---VIH 122
Query: 189 RDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
RD+K+ANIL ++ K++DFG + + + + +VV GT ++ PE ++
Sbjct: 123 RDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV-GTPYWMAPEVIE 172
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 5e-20
Identities = 50/145 (34%), Positives = 83/145 (57%), Gaps = 7/145 (4%)
Query: 72 DVIGCGGSGNVYKGFLPDRTPVAVK--KSKIVDQTKIDEFINELVVVSQINRRNVVRLLA 129
+++G G G V+KG L D+TPVAVK K + + KI +F++E ++ Q + N+V+L+
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKI-KFLSEARILKQYDHPNIVKLIG 59
Query: 130 CCLETQVPLLVYEFVGNGTLFEHIHKNGN-LTWERRLRIAAETAGVLSYLHSETNVPIIH 188
C + Q +V E V G + K + L ++ ++ A + A ++YL S+ IH
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIH 116
Query: 189 RDVKSANILLDENYTPKVSDFGASK 213
RD+ + N L+ EN K+SDFG S+
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 82.5 bits (205), Expect = 5e-19
Identities = 50/175 (28%), Positives = 78/175 (44%), Gaps = 11/175 (6%)
Query: 72 DVIGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKID--EFINELVVVSQINRRNVVRLL 128
IG G G VY D +K+ + + ++ + + +NE+ ++ ++N N+++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 129 ACCLETQVPLLVYEFVGNGTLFEHIHK----NGNLTWERRLRIAAETAGVLSYLHSETNV 184
E +V E+ G L + I K E+ L + L YLHS
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK-- 123
Query: 185 PIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
I+HRD+K NI L N K+ DFG SK++ TVV GT Y+ PE Q
Sbjct: 124 -ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPELCQ 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 6e-19
Identities = 55/172 (31%), Positives = 88/172 (51%), Gaps = 9/172 (5%)
Query: 72 DVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVDQTKIDEFI-NELVVVSQINRRNVVRLL- 128
V+G G SG VYK P A+KK + + + + EL + VV+
Sbjct: 7 KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 129 ACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRL-RIAAETAGVLSYLHSETNVPII 187
A E ++ + V E++ G+L + + K G + E L IA + L YLH++ + II
Sbjct: 67 AFYKEGEISI-VLEYMDGGSLADLLKKVGKIP-EPVLAYIARQILKGLDYLHTKRH--II 122
Query: 188 HRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
HRD+K +N+L++ K++DFG SK++ Q T V GT+ Y+ PE +Q
Sbjct: 123 HRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQ 173
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 7e-18
Identities = 47/152 (30%), Positives = 75/152 (49%), Gaps = 17/152 (11%)
Query: 74 IGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTK-----IDEFINELVVVSQINRRNVVRL 127
+G G G+VY+G L D AVK+ + D + + + E+ ++S++ N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 128 LACCLETQVPLLVY-EFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLS---YLHSETN 183
L E L ++ E V G+L + + K G+ I T +L YLH
Sbjct: 68 LGTEREED-NLYIFLELVPGGSLAKLLKKYGSFPEPV---IRLYTRQILLGLEYLHDRN- 122
Query: 184 VPIIHRDVKSANILLDENYTPKVSDFGASKLV 215
+HRD+K ANIL+D N K++DFG +K V
Sbjct: 123 --TVHRDIKGANILVDTNGVVKLADFGMAKQV 152
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 1e-17
Identities = 44/150 (29%), Positives = 82/150 (54%), Gaps = 11/150 (7%)
Query: 73 VIGCGGSGNVYKGFL--PDRT--PVAVK--KSKIVDQTKIDEFINELVVVSQINRRNVVR 126
VIG G G V +G L P + VA+K K+ D+ ++D F+ E ++ Q + N++R
Sbjct: 11 VIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD-FLTEASIMGQFDHPNIIR 69
Query: 127 LLACCLETQVPLLVYEFVGNGTLFEHI-HKNGNLTWERRLRIAAETAGVLSYLHSETNVP 185
L +++ +++ E++ NG+L + + +G T + + + A + YL + +
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYL---SEMN 126
Query: 186 IIHRDVKSANILLDENYTPKVSDFGASKLV 215
+HRD+ + NIL++ N KVSDFG S+ +
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRL 156
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 2e-17
Identities = 52/170 (30%), Positives = 80/170 (47%), Gaps = 11/170 (6%)
Query: 74 IGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTK--IDEFINELVVVSQINRRNVVRLLAC 130
IG G G VY L +AVK+ +I D I E +E+ V+ + N+V+
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 131 CLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRI-AAETAGVLSYLHSETNVPIIHR 189
+ + + E+ GTL E + ++G + E +R+ + L+YLHS I+HR
Sbjct: 68 EVHREKVYIFMEYCSGGTLEE-LLEHGRILDEHVIRVYTLQLLEGLAYLHSHG---IVHR 123
Query: 190 DVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLG---YIDPE 236
D+K ANI LD N K+ DFG + + + VQ G Y+ PE
Sbjct: 124 DIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPE 173
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 4e-17
Identities = 55/178 (30%), Positives = 95/178 (53%), Gaps = 13/178 (7%)
Query: 73 VIGCGGSGNVYKGFLPD----RTPVAVKK-SKIVDQTKIDEFINELVVVSQINRRNVVRL 127
VIG G G VY G L D + AVK ++I D ++++F+ E +++ + NV+ L
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 128 LACCLETQ-VPLLVYEFVGNGTLFEHIHK-NGNLTWERRLRIAAETAGVLSYLHSETNVP 185
L CL ++ PL+V ++ +G L I N T + + + A + YL S+ V
Sbjct: 62 LGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFV- 120
Query: 186 IIHRDVKSANILLDENYTPKVSDFGASKLV---PIDAIQNYTVVQGTLGYIDPEYLQT 240
HRD+ + N +LDE++T KV+DFG ++ + ++ N+T + + ++ E LQT
Sbjct: 121 --HRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQT 176
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 6e-17
Identities = 41/144 (28%), Positives = 77/144 (53%), Gaps = 6/144 (4%)
Query: 74 IGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLE 133
+G G G V++G + TPVAVK K +F+ E ++ ++ +++L A C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLK-PGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 134 TQVPLLVYEFVGNGTLFEHIHKNG--NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDV 191
+ +V E + G+L E++ L + + +AA+ A ++YL ++ IHRD+
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDL 129
Query: 192 KSANILLDENYTPKVSDFGASKLV 215
+ N+L+ EN KV+DFG ++++
Sbjct: 130 AARNVLVGENNICKVADFGLARVI 153
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 6e-17
Identities = 39/144 (27%), Positives = 74/144 (51%), Gaps = 5/144 (3%)
Query: 74 IGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLE 133
+G G G V++G +R VA+K K D K +F E+ + ++ ++++ L A C
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73
Query: 134 TQVPLLVYEFVGNGTLFEHIH--KNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDV 191
+ ++ E + G+L + + L + +A + A ++YL + IHRD+
Sbjct: 74 GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDL 130
Query: 192 KSANILLDENYTPKVSDFGASKLV 215
+ NIL+ E+ KV+DFG ++L+
Sbjct: 131 AARNILVGEDLVCKVADFGLARLI 154
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 1e-16
Identities = 56/180 (31%), Positives = 85/180 (47%), Gaps = 19/180 (10%)
Query: 72 DVIGCGGSGNVYKGF-LPDRTPVAVKKSKIVD----QTKIDEFINELVVVSQINRRNVVR 126
+VIG G + VY LP+ VA+K+ +D QT +DE E+ +SQ N NVV+
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKR---IDLEKCQTSVDELRKEVQAMSQCNHPNVVK 63
Query: 127 LLACCLETQVPLLVYEFVGNGTLFE---HIHKNGNLTWERRLRIAAETAGVLSYLHSETN 183
+ LV ++ G+L + + G L + E L YLHS
Sbjct: 64 YYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ 123
Query: 184 VPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQN----YTVVQGTLGYIDPEYLQ 239
IHRD+K+ NILL E+ + K++DFG S + + T V GT ++ PE ++
Sbjct: 124 ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFV-GTPCWMAPEVME 179
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 1e-16
Identities = 49/157 (31%), Positives = 83/157 (52%), Gaps = 8/157 (5%)
Query: 74 IGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLE 133
IG G G V+ G+ ++ VA+K + ++ ++FI E V+ +++ +V+L C E
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE-EDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 134 TQVPLLVYEFVGNGTLFEHIH-KNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVK 192
LV+EF+ +G L +++ + G + E L + + ++YL S +IHRD+
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLA 127
Query: 193 SANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGT 229
+ N L+ EN KVSDFG ++ V D YT GT
Sbjct: 128 ARNCLVGENQVVKVSDFGMTRFVLDD---QYTSSTGT 161
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-16
Identities = 48/173 (27%), Positives = 82/173 (47%), Gaps = 13/173 (7%)
Query: 74 IGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKID-----EFINELVVVSQINRRNVVRLL 128
IG G G V+K V K +D +K++ E I+E V+++++ ++R
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQ--IDLSKMNRREREEAIDEARVLAKLDSSYIIRYY 65
Query: 129 ACCLETQVPLLVYEFVGNGTLFEHIHKNGN--LTWERRLRIAAETAGVLSYLHSETNVPI 186
L+ +V E+ NG L + + L ++ R + L++LHS+ I
Sbjct: 66 ESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---I 122
Query: 187 IHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
+HRD+KS N+ LD K+ D G +KL+ + T+V GT Y+ PE +
Sbjct: 123 LHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV-GTPYYLSPELCE 174
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 2e-16
Identities = 50/159 (31%), Positives = 80/159 (50%), Gaps = 12/159 (7%)
Query: 74 IGCGGSGNVYKGFLP--DRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACC 131
+G G G VY+G T VAVK K D +++EF+ E V+ +I N+V+LL C
Sbjct: 14 LGGGQYGEVYEGVWKKYSLT-VAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 71
Query: 132 LETQVPLLVYEFVGNGTLFEHIHKNGN--LTWERRLRIAAETAGVLSYLHSETNVPIIHR 189
++ EF+ G L +++ + + L +A + + + YL + IHR
Sbjct: 72 TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHR 128
Query: 190 DVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQG 228
D+ + N L+ EN+ KV+DFG S+L+ D YT G
Sbjct: 129 DLAARNCLVGENHLVKVADFGLSRLMTGDT---YTAHAG 164
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 2e-16
Identities = 53/172 (30%), Positives = 78/172 (45%), Gaps = 9/172 (5%)
Query: 73 VIGCGGSGNVYKGFLPD-RTPVAVK---KSKIVDQTKIDEFINELVVVSQINRRNVVRLL 128
VIG G G V D + A+K K K V++ + +NE ++ ++N +V L
Sbjct: 7 VIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLW 66
Query: 129 ACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIH 188
+ + LV + + G L H+ + + E+ E L YLHS+ IIH
Sbjct: 67 YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG---IIH 123
Query: 189 RDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQT 240
RD+K NILLDE ++DF + V D T GT GY+ PE L
Sbjct: 124 RDIKPDNILLDEQGHVHITDFNIATKVTPD--TLTTSTSGTPGYMAPEVLCR 173
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 4e-16
Identities = 45/147 (30%), Positives = 72/147 (48%), Gaps = 13/147 (8%)
Query: 74 IGCGGSGNVYKGFL----PDRTPVAVK---KSKIVDQTKIDEFINELVVVSQINRRNVVR 126
+G G G+V KG VAVK + I K EF+ E V++Q++ +VR
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKK--EFLREASVMAQLDHPCIVR 60
Query: 127 LLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPI 186
L+ C + +LV E G L +++ K + +A + A ++YL S+ V
Sbjct: 61 LIGVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV-- 117
Query: 187 IHRDVKSANILLDENYTPKVSDFGASK 213
HRD+ + N+LL + K+SDFG S+
Sbjct: 118 -HRDLAARNVLLVNRHQAKISDFGMSR 143
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 5e-16
Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 10/151 (6%)
Query: 92 PVAVK---KSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGT 148
A+K K+KIV +++ +NE ++ I +V L + LV E+V G
Sbjct: 28 YYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGE 87
Query: 149 LFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSD 208
LF H+ K+G AA+ L YLHS I++RD+K N+LLD + K++D
Sbjct: 88 LFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITD 144
Query: 209 FGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
FG +K V YT+ GT Y+ PE +
Sbjct: 145 FGFAKRVKGRT---YTLC-GTPEYLAPEIIL 171
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 5e-16
Identities = 44/141 (31%), Positives = 70/141 (49%), Gaps = 6/141 (4%)
Query: 72 DVIGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLAC 130
+ IG G SG VYK VA+KK ++ Q + INE++++ N+V
Sbjct: 25 EKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDS 83
Query: 131 CLETQVPLLVYEFVGNGTLFEHI-HKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHR 189
L +V E++ G+L + I + + + E L YLHS+ +IHR
Sbjct: 84 YLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHR 140
Query: 190 DVKSANILLDENYTPKVSDFG 210
D+KS NILL ++ + K++DFG
Sbjct: 141 DIKSDNILLSKDGSVKLADFG 161
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 6e-16
Identities = 47/158 (29%), Positives = 79/158 (50%), Gaps = 9/158 (5%)
Query: 74 IGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLE 133
+G G G V+ G T VAVK K + F+ E ++ ++ +V+L A C E
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEA-FLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 134 TQVPLLVYEFVGNGTLFEHIHKNG--NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDV 191
+ +V E++ G+L + + L + + +AA+ A ++YL S IHRD+
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDL 129
Query: 192 KSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGT 229
+ NIL+ EN K++DFG ++L+ D YT +G
Sbjct: 130 AARNILVGENLVCKIADFGLARLIEDD---EYTAREGA 164
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 8e-16
Identities = 50/161 (31%), Positives = 80/161 (49%), Gaps = 11/161 (6%)
Query: 74 IGCGGSGNVYKGFLPDRT---PVAVK--KSKIVDQTKIDEFINELVVVSQINRRNVVRLL 128
+G G G V KG + VAVK K+ D DE + E V+ Q++ +VR++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 129 ACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIH 188
C E + +LV E G L + + KN ++T + + + + + YL ETN +H
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLE-ETN--FVH 118
Query: 189 RDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGT 229
RD+ + N+LL + K+SDFG SK + D +NY +
Sbjct: 119 RDLAARNVLLVTQHYAKISDFGLSKALGAD--ENYYKAKTH 157
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 1e-15
Identities = 49/171 (28%), Positives = 91/171 (53%), Gaps = 16/171 (9%)
Query: 55 AKIFIEEEIKTVTNNYADVIGCGGSGNVYKG-FLPD----RTPVAVKK-SKIVDQTKIDE 108
+I E E++ + V+G G G VYKG ++P+ + PVA+K + E
Sbjct: 1 LRILKETELEKIK-----VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKE 55
Query: 109 FINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKN-GNLTWERRLRI 167
++E V++ ++ +VVRLL CL +QV L+ + + G L +++ + N+ + L
Sbjct: 56 ILDEAYVMASVDHPHVVRLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNW 114
Query: 168 AAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPID 218
+ A +SYL + ++HRD+ + N+L+ K++DFG +KL+ +D
Sbjct: 115 CVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-15
Identities = 45/161 (27%), Positives = 78/161 (48%), Gaps = 21/161 (13%)
Query: 73 VIGCGGSGNVYKGFL--PDRTP--VAVK--KSKIVDQTKIDEFINELVVVSQINRRNVVR 126
++G G G+V +G L D + VAVK K I ++I+EF++E + + NV++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 127 LLACCLETQ------VPLLVYEFVGNGTLFEHIHKN------GNLTWERRLRIAAETAGV 174
L+ C E P+++ F+ +G L + + L + L+ + A
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 175 LSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLV 215
+ YL + IHRD+ + N +L E+ T V+DFG SK +
Sbjct: 126 MEYLSNRN---FIHRDLAARNCMLREDMTVCVADFGLSKKI 163
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-15
Identities = 46/143 (32%), Positives = 70/143 (48%), Gaps = 6/143 (4%)
Query: 74 IGCGGSGNVYKGFL-PDRTPVAVKKSKIVDQTKI-DEFINELVVVSQINRRNVVRLLACC 131
IG G G V+ G L D TPVAVK + + +F+ E ++ Q + N+VRL+ C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 132 LETQVPLLVYEFVGNGTLFEHIHKNG-NLTWERRLRIAAETAGVLSYLHSETNVPIIHRD 190
+ Q +V E V G + G L + +++ A + YL S+ IHRD
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRD 119
Query: 191 VKSANILLDENYTPKVSDFGASK 213
+ + N L+ E K+SDFG S+
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSR 142
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-15
Identities = 53/158 (33%), Positives = 75/158 (47%), Gaps = 21/158 (13%)
Query: 70 YADV--IGCGGSGNVYKGFLPD---RTPVAVKK---SKIVDQTKIDEFINELVVVSQINR 121
+ D+ IG G G VY F D VA+KK S K + I E+ + Q+
Sbjct: 17 FTDLREIGHGSFGAVY--FARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRH 74
Query: 122 RNVVRLLACCLETQVPLLVYEF-VGNGTLFEHIHKNGNLTWERRLRIAAETAGVL---SY 177
N + C L LV E+ +G+ + +HK + + IAA G L +Y
Sbjct: 75 PNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKP----LQEVEIAAICHGALQGLAY 130
Query: 178 LHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLV 215
LHS IHRD+K+ NILL E T K++DFG++ LV
Sbjct: 131 LHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLV 165
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 3e-15
Identities = 46/159 (28%), Positives = 78/159 (49%), Gaps = 20/159 (12%)
Query: 74 IGCGGSGNVYKGFLPD------RTPVAVKK-SKIVDQTKIDEFINELVVVSQINRRNVVR 126
+G G G VY+G T VA+K ++ + EF+NE V+ + N +VVR
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 127 LLACCLETQVPLLVYEFVGNGTL----------FEHIHKNGNLTWERRLRIAAETAGVLS 176
LL Q L+V E + G L E+ G T ++ +++AAE A ++
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 177 YLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLV 215
YL ++ +HRD+ + N ++ E+ T K+ DFG ++ +
Sbjct: 134 YLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDI 169
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 4e-15
Identities = 46/147 (31%), Positives = 68/147 (46%), Gaps = 5/147 (3%)
Query: 94 AVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPL-LVYEFVGNGTLFEH 152
+KK I+ ++ + E V++ + + L C +T+ L V E+V G L H
Sbjct: 27 VLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFH 86
Query: 153 IHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGAS 212
I ++G R AAE L +LH II+RD+K N+LLD K++DFG
Sbjct: 87 IQRSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMC 143
Query: 213 KLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
K + + T GT YI PE L
Sbjct: 144 KEGILGGVTTSTFC-GTPDYIAPEILS 169
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 1e-14
Identities = 45/148 (30%), Positives = 74/148 (50%), Gaps = 11/148 (7%)
Query: 99 KIVDQTKIDE-----FINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHI 153
K V+ T++ E +NE+V++S + N++ ++ L+ E+ GTL++ I
Sbjct: 31 KEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKI 90
Query: 154 -HKNGNLTWERR-LRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGA 211
+ G L E L + +SY+H I+HRD+K+ NI L + K+ DFG
Sbjct: 91 VRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGI 147
Query: 212 SKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
SK++ + TVV GT Y+ PE Q
Sbjct: 148 SKILGSEYSMAETVV-GTPYYMSPELCQ 174
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-14
Identities = 60/186 (32%), Positives = 92/186 (49%), Gaps = 16/186 (8%)
Query: 60 EEEIKTVTNNYADVIGCGGSGNV----YKGFLPDRTPVAVK---KSKIVDQTKIDEFINE 112
+ ++K N+ +G G G V YK D PVA+K KSKI+ Q ++D +E
Sbjct: 24 KNKMKYEDFNFIRTLGTGSFGRVILATYKN--EDFPPVAIKRFEKSKIIKQKQVDHVFSE 81
Query: 113 LVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETA 172
+++ IN V L + LV EFV G F + +N + AA+
Sbjct: 82 RKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIV 141
Query: 173 GVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGY 232
+ YL S + I++RD+K N+LLD++ K++DFG +K+V + YT+ GT Y
Sbjct: 142 LIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV---DTRTYTLC-GTPEY 194
Query: 233 IDPEYL 238
I PE L
Sbjct: 195 IAPEIL 200
|
Length = 340 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 2e-14
Identities = 50/171 (29%), Positives = 74/171 (43%), Gaps = 10/171 (5%)
Query: 73 VIGCGGSGNVYKGFLPDRTP--VAVKKSKIVDQTKIDEFI--NELVVVSQINRRNVVRLL 128
V+G G G V K T VA+KK K + + + E+ V+ Q+ N+V L
Sbjct: 8 VVGEGAYGVVLKCRNKA-TGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 129 ACCLETQVPLLVYEFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPII 187
LV+E+V TL E + + G L + + ++Y HS II
Sbjct: 67 EAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN---II 122
Query: 188 HRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYL 238
HRD+K NIL+ E+ K+ DFG ++ + T T Y PE L
Sbjct: 123 HRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELL 173
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 2e-14
Identities = 46/147 (31%), Positives = 69/147 (46%), Gaps = 16/147 (10%)
Query: 73 VIGCGGSGNVYKGFLPDRT---PVAVKKSKIVD----QTKIDEFINELVVVSQINRRNVV 125
IG G G VYK D+ VA+K ++D + +I++ E+ +SQ +
Sbjct: 8 CIGKGSFGEVYKAI--DKRTNQVVAIK---VIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 126 RLLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVP 185
+ L+ ++ E+ G G+ + + K G L I E L YLH E
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSCLDLL-KPGKLDETYIAFILREVLLGLEYLHEEGK-- 119
Query: 186 IIHRDVKSANILLDENYTPKVSDFGAS 212
IHRD+K+ANILL E K++DFG S
Sbjct: 120 -IHRDIKAANILLSEEGDVKLADFGVS 145
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 2e-14
Identities = 53/176 (30%), Positives = 86/176 (48%), Gaps = 20/176 (11%)
Query: 72 DVIGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLAC 130
+ +G G G+VYK VA+K + + + E I E+ ++ Q + +V+
Sbjct: 9 EKLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVKYYGS 66
Query: 131 CLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRL---RIAAETAGV---LSYLHSETNV 184
+ +V E+ G G++ + + +T + L IAA L YLHS
Sbjct: 67 YFKNTDLWIVMEYCGAGSVSDIM----KIT-NKTLTEEEIAAILYQTLKGLEYLHSNK-- 119
Query: 185 PIIHRDVKSANILLDENYTPKVSDFGAS-KLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
IHRD+K+ NILL+E K++DFG S +L A +N TV+ GT ++ PE +Q
Sbjct: 120 -KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRN-TVI-GTPFWMAPEVIQ 172
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 4e-14
Identities = 47/165 (28%), Positives = 88/165 (53%), Gaps = 11/165 (6%)
Query: 73 VIGCGGSGNVYKGFL--PDR--TPVAVK--KSKIVDQTKIDEFINELVVVSQINRRNVVR 126
VIG G G V++G L P R VA+K K ++ + D F++E ++ Q + N++R
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQD-FLSEASIMGQFSHHNIIR 70
Query: 127 LLACCLETQVPLLVYEFVGNGTLFEHIH-KNGNLTWERRLRIAAETAGVLSYLHSETNVP 185
L + + +++ E++ NG L +++ +G + + + + A + YL +++
Sbjct: 71 LEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL---SDMN 127
Query: 186 IIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTL 230
+HRD+ + NIL++ N KVSDFG S+++ D YT G +
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI 172
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-14
Identities = 53/170 (31%), Positives = 89/170 (52%), Gaps = 16/170 (9%)
Query: 56 KIFIEEEIKTVTNNYADVIGCGGSGNVYKG-FLPD----RTPVAVKKSKIVDQTKID-EF 109
+I E E+K V V+G G G VYKG ++PD + PVA+K + K + E
Sbjct: 2 RILKETELKKVK-----VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEI 56
Query: 110 INELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKN-GNLTWERRLRIA 168
++E V++ + V RLL CL + V L V + + G L +++ +N + + L
Sbjct: 57 LDEAYVMAGVGSPYVCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWC 115
Query: 169 AETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPID 218
+ A +SYL V ++HRD+ + N+L+ K++DFG ++L+ ID
Sbjct: 116 VQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 5e-14
Identities = 49/170 (28%), Positives = 92/170 (54%), Gaps = 16/170 (9%)
Query: 56 KIFIEEEIKTVTNNYADVIGCGGSGNVYKG-FLPD----RTPVAVKKSKIVDQTKID-EF 109
+I E E+K V V+G G G VYKG ++P+ + PVA+K K + EF
Sbjct: 2 RILKETELKRVK-----VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEF 56
Query: 110 INELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKN-GNLTWERRLRIA 168
++E ++++ ++ ++VRLL CL + L V + + +G L +++H++ N+ + L
Sbjct: 57 MDEALIMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWC 115
Query: 169 AETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPID 218
+ A + YL ++HRD+ + N+L+ K++DFG ++L+ D
Sbjct: 116 VQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 7e-14
Identities = 55/172 (31%), Positives = 85/172 (49%), Gaps = 11/172 (6%)
Query: 72 DVIGCGGSGNVYKGFLPDRTPVAVKKSKIVD----QTKIDEFINELVVVSQINRRNVVRL 127
+ IG G G VYKG D V KI+D + +I++ E+ V+SQ + + R
Sbjct: 10 ERIGKGSFGEVYKGI--DNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRY 67
Query: 128 LACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPII 187
L+ ++ E++G G+ + + K G L I E L YLHSE I
Sbjct: 68 YGSYLKGTKLWIIMEYLGGGSALDLL-KPGPLEETYIATILREILKGLDYLHSERK---I 123
Query: 188 HRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
HRD+K+AN+LL E K++DFG + + I+ T V GT ++ PE ++
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIK 174
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-13
Identities = 49/174 (28%), Positives = 81/174 (46%), Gaps = 12/174 (6%)
Query: 74 IGCGGSGNVYKGF-LPDRTPVAVKKSKI---VDQTKIDEFINELVVVSQINRRNVVRLLA 129
IG G VYK L D VA+KK +I +D + + E+ ++ Q++ NV++ LA
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69
Query: 130 CCLETQVPLLVYEFVGNGTL---FEHIHKNGNLTWERRL-RIAAETAGVLSYLHSETNVP 185
+E +V E G L +H K L ER + + + L ++HS+
Sbjct: 70 SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--- 126
Query: 186 IIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
I+HRD+K AN+ + K+ D G + +++V GT Y+ PE +
Sbjct: 127 IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIH 179
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 2e-13
Identities = 49/146 (33%), Positives = 67/146 (45%), Gaps = 5/146 (3%)
Query: 95 VKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLL-VYEFVGNGTLFEHI 153
+KK I+ ++ + E ++S + L CC +T L V EFV G L HI
Sbjct: 28 LKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHI 87
Query: 154 HKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASK 213
K+ R AAE L +LH + II+RD+K N+LLD K++DFG K
Sbjct: 88 QKSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK 144
Query: 214 LVPIDAIQNYTVVQGTLGYIDPEYLQ 239
+ T GT YI PE LQ
Sbjct: 145 EGIFNGKTTSTFC-GTPDYIAPEILQ 169
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-13
Identities = 45/173 (26%), Positives = 87/173 (50%), Gaps = 20/173 (11%)
Query: 55 AKIFIEEEIKTVTNNYADVIGCGGSGNVYKGF-LPD----RTPVAVKKSKIVDQT---KI 106
A+I E E++ + ++G G G V+KG +P+ + PVA+K I D++
Sbjct: 1 ARILKETELRKLK-----LLGSGVFGTVHKGIWIPEGDSIKIPVAIKT--IQDRSGRQTF 53
Query: 107 DEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKN-GNLTWERRL 165
E + ++ + ++ +VRLL C + L V + G+L +H+ ++ +L +R L
Sbjct: 54 QEITDHMLAMGSLDHAYIVRLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRLL 112
Query: 166 RIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPID 218
+ A + YL ++HR++ + NILL + +++DFG + L+ D
Sbjct: 113 NWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-13
Identities = 38/134 (28%), Positives = 71/134 (52%), Gaps = 16/134 (11%)
Query: 93 VAVKKSKI-VDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTL-- 149
VAVK + V +T ++F+ E+ ++S++ N++RLL C+ ++ E++ NG L
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106
Query: 150 ----------FEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLD 199
F H + +++ L +A + A + YL S + +HRD+ + N L+
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCLVG 163
Query: 200 ENYTPKVSDFGASK 213
+YT K++DFG S+
Sbjct: 164 NHYTIKIADFGMSR 177
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 3e-13
Identities = 37/133 (27%), Positives = 68/133 (51%), Gaps = 15/133 (11%)
Query: 93 VAVKKSKI-VDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGT--- 148
VAVK + ++F+ E+ ++S+++ N+ RLL C ++ E++ NG
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108
Query: 149 -LFEHIHKNGN-------LTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDE 200
L +H+ + L++ L +A + A + YL N +HRD+ + N L+ +
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL-ESLN--FVHRDLATRNCLVGK 165
Query: 201 NYTPKVSDFGASK 213
NYT K++DFG S+
Sbjct: 166 NYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-13
Identities = 42/170 (24%), Positives = 80/170 (47%), Gaps = 10/170 (5%)
Query: 73 VIGCGGSGNVYKGFL----PDRTPVAVKKSKI-VDQTKIDEFINELVVVSQINRRNVVRL 127
IG G G+VY+G ++ VAVK K + ++F+ E ++ Q + ++V+L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 128 LACCLETQVPLLVYEFVGNGTLFEHIHKNGN-LTWERRLRIAAETAGVLSYLHSETNVPI 186
+ E V +V E G L ++ N L + + + + L+YL S+ V
Sbjct: 73 IGVITENPV-WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFV-- 129
Query: 187 IHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPE 236
HRD+ + N+L+ K+ DFG S+ + ++ + + + ++ PE
Sbjct: 130 -HRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPE 178
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-13
Identities = 44/163 (26%), Positives = 74/163 (45%), Gaps = 26/163 (15%)
Query: 73 VIGCGGSGNVYKGFL------PDRTPVAVK--KSKIVDQTKIDEFINELVVVSQINRRNV 124
+G G G V+ G D+ VAVK K + + D F E +++ N+
Sbjct: 12 ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKD-FEREAELLTNFQHENI 70
Query: 125 VRLLACCLETQVPLLVYEFVGNGTLFEHIHKNG--------------NLTWERRLRIAAE 170
V+ C E P++V+E++ +G L + + +G LT + L+IA +
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 171 TAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASK 213
A + YL S+ V HRD+ + N L+ + K+ DFG S+
Sbjct: 131 IASGMVYLASQHFV---HRDLATRNCLVGYDLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 4e-13
Identities = 46/141 (32%), Positives = 68/141 (48%), Gaps = 5/141 (3%)
Query: 74 IGCGGSGNVYKG-FLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCL 132
IG G G+VYK + VA+K K+ + E+ ++ + N+V L
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 133 ETQVPLLVYEFVGNGTLFEHIHK-NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDV 191
+V E+ G G+L + G L+ + + ET L+YLH ET IHRD+
Sbjct: 71 RRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH-ETGK--IHRDI 127
Query: 192 KSANILLDENYTPKVSDFGAS 212
K ANILL E+ K++DFG S
Sbjct: 128 KGANILLTEDGDVKLADFGVS 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 5e-13
Identities = 44/158 (27%), Positives = 73/158 (46%), Gaps = 12/158 (7%)
Query: 74 IGCGGSGNVYKG----FLPDRTPVAVKKSK-IVDQTKIDEFINELVVVSQINRRNVVRLL 128
+G G G V +G PVAVK K +D+F+ E ++ ++ N++RL
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 129 ACCLETQVPLLVYEFVGNGTLFEHIHKN--GNLTWERRLRIAAETAGVLSYLHSETNVPI 186
L T ++V E G+L + + K+ G+ A + A + YL S+
Sbjct: 63 GVVL-THPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---F 118
Query: 187 IHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYT 224
IHRD+ + NILL + K+ DFG + +P + +Y
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQNE-DHYV 155
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 8e-13
Identities = 48/170 (28%), Positives = 90/170 (52%), Gaps = 16/170 (9%)
Query: 56 KIFIEEEIKTVTNNYADVIGCGGSGNVYKG-FLPD----RTPVAVKKSKIVDQTKID-EF 109
+I E E K + V+G G G VYKG ++P+ + PVA+K+ + K + E
Sbjct: 2 RILKETEFKKIK-----VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI 56
Query: 110 INELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKN-GNLTWERRLRIA 168
++E V++ ++ +V RLL CL + V L + + + G L +++ ++ N+ + L
Sbjct: 57 LDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWC 115
Query: 169 AETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPID 218
+ A ++YL ++HRD+ + N+L+ K++DFG +KL+ D
Sbjct: 116 VQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 8e-13
Identities = 49/155 (31%), Positives = 83/155 (53%), Gaps = 11/155 (7%)
Query: 72 DVIGCGGSGNVYKGFL--PDR--TPVAVK--KSKIVDQTKIDEFINELVVVSQINRRNVV 125
+VIG G G V +G L P + VA+K KS ++ + D F++E ++ Q + N++
Sbjct: 10 EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRD-FLSEASIMGQFDHPNII 68
Query: 126 RLLACCLETQVPLLVYEFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNV 184
L +++ +++ EF+ NG L + +N G T + + + A + YL SE N
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL-SEMNY 127
Query: 185 PIIHRDVKSANILLDENYTPKVSDFGASKLVPIDA 219
+HRD+ + NIL++ N KVSDFG S+ + D
Sbjct: 128 --VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 8e-13
Identities = 42/155 (27%), Positives = 79/155 (50%), Gaps = 14/155 (9%)
Query: 74 IGCGGSGNVYKG---FLPDRT--PVAVKKSKI--VDQTKIDEFINELVVVSQINRRNVVR 126
+G G G V L D T VAVK +Q + D F E+ ++ ++ N+V+
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD-FEREIEILRTLDHENIVK 70
Query: 127 LLACCLET--QVPLLVYEFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETN 183
C + + L+ E++ +G+L +++ ++ + +R L +++ + YL S+
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR- 129
Query: 184 VPIIHRDVKSANILLDENYTPKVSDFGASKLVPID 218
IHRD+ + NIL++ K+SDFG +K++P D
Sbjct: 130 --YIHRDLAARNILVESEDLVKISDFGLAKVLPED 162
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 9e-13
Identities = 49/174 (28%), Positives = 78/174 (44%), Gaps = 34/174 (19%)
Query: 70 YADVIGCGGSGNVYK----GFLPDR--TPVAVK--KSKIVDQTKIDEFINELVVVSQINR 121
Y IG G G V++ G LP T VAVK K + + D F E ++++ +
Sbjct: 9 YVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD-FQREAALMAEFDH 67
Query: 122 RNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNG----------------------NL 159
N+V+LL C + L++E++ G L E + L
Sbjct: 68 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPL 127
Query: 160 TWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASK 213
+ +L IA + A ++YL SE +HRD+ + N L+ EN K++DFG S+
Sbjct: 128 SCTEQLCIAKQVAAGMAYL-SERK--FVHRDLATRNCLVGENMVVKIADFGLSR 178
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 1e-12
Identities = 54/169 (31%), Positives = 87/169 (51%), Gaps = 9/169 (5%)
Query: 73 VIGCGGSGNVY--KGFLPDRTPVAVKKSKIVDQTKIDEF--INELVVVSQINRRNVVRLL 128
V+G G G V+ + D+ V +K+ + TK + NE V+ ++ N++
Sbjct: 7 VVGRGAFGIVHLCRR-KADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYY 65
Query: 129 ACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIH 188
LE + ++V E+ GTL E+I K N + + +L+ H T + I+H
Sbjct: 66 ENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL-ILH 124
Query: 189 RDVKSANILLDENYTP-KVSDFGASKLVPIDAIQNYTVVQGTLGYIDPE 236
RD+K+ NILLD++ K+ DFG SK++ + + YTVV GT YI PE
Sbjct: 125 RDLKTQNILLDKHKMVVKIGDFGISKILSSKS-KAYTVV-GTPCYISPE 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 1e-12
Identities = 46/158 (29%), Positives = 84/158 (53%), Gaps = 12/158 (7%)
Query: 74 IGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLE 133
+G G G V+ G+ T VA+K K + F+ E ++ Q+ +VRL A
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLK-QGSMSPEAFLAEANLMKQLQHPRLVRLYAVV-- 70
Query: 134 TQVPL-LVYEFVGNGTLFEHIHKNG--NLTWERRLRIAAETAGVLSYLHSETNVPIIHRD 190
TQ P+ ++ E++ NG+L + + LT + + +AA+ A ++++ + IHRD
Sbjct: 71 TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRD 127
Query: 191 VKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQG 228
+++ANIL+ E K++DFG ++L+ + YT +G
Sbjct: 128 LRAANILVSETLCCKIADFGLARLIEDN---EYTAREG 162
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-12
Identities = 43/144 (29%), Positives = 73/144 (50%), Gaps = 5/144 (3%)
Query: 93 VAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEH 152
VAVKK + Q + + NE+V++ N+V + + L +V EF+ G L +
Sbjct: 47 VAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTD- 105
Query: 153 IHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGAS 212
I + + E+ + LS+LH++ +IHRD+KS +ILL + K+SDFG
Sbjct: 106 IVTHTRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFC 162
Query: 213 KLVPIDAIQNYTVVQGTLGYIDPE 236
V + + ++V GT ++ PE
Sbjct: 163 AQVSKEVPRRKSLV-GTPYWMAPE 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-12
Identities = 52/172 (30%), Positives = 85/172 (49%), Gaps = 11/172 (6%)
Query: 72 DVIGCGGSGNVYKGFLPDRTPVAVKKSKIVD----QTKIDEFINELVVVSQINRRNVVRL 127
+ IG G G V+KG D V KI+D + +I++ E+ V+SQ + V +
Sbjct: 10 ERIGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKY 67
Query: 128 LACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPII 187
L+ ++ E++G G+ + + + G + + E L YLHSE I
Sbjct: 68 YGSYLKGTKLWIIMEYLGGGSALDLL-RAGPFDEFQIATMLKEILKGLDYLHSEKK---I 123
Query: 188 HRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
HRD+K+AN+LL E K++DFG + + I+ T V GT ++ PE +Q
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQ 174
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-12
Identities = 44/146 (30%), Positives = 73/146 (50%), Gaps = 7/146 (4%)
Query: 95 VKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIH 154
+KK +I+ ++ E ++ +++ +V ++ + + EFV G LF H+
Sbjct: 51 LKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLR 110
Query: 155 KNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKL 214
K G + AE YLHS+ II+RD+K N+LLD KV+DFG +K
Sbjct: 111 KAGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKK 167
Query: 215 VPIDAIQNYTVVQGTLGYIDPEYLQT 240
VP + +T+ GT Y+ PE +Q+
Sbjct: 168 VP---DRTFTLC-GTPEYLAPEVIQS 189
|
Length = 329 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-12
Identities = 50/162 (30%), Positives = 74/162 (45%), Gaps = 18/162 (11%)
Query: 70 YADVIGCGGSGNVYKGFLPD---RTPVAVKKSK-IVDQTKIDEFINELVVVSQIN-RRNV 124
+ DVIG G G V K + R A+K+ K + +F EL V+ ++ N+
Sbjct: 11 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 70
Query: 125 VRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLS---YLHSE 181
+ LL C L E+ +G L + + K+ L + IA TA LS LH
Sbjct: 71 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130
Query: 182 TNVP----------IIHRDVKSANILLDENYTPKVSDFGASK 213
+V IHRD+ + NIL+ ENY K++DFG S+
Sbjct: 131 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-12
Identities = 43/170 (25%), Positives = 86/170 (50%), Gaps = 14/170 (8%)
Query: 61 EEIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQIN 120
E IK V +G G G V+ G+ + T VAVK K + F+ E ++ +
Sbjct: 6 ESIKLVKK-----LGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQ 59
Query: 121 RRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKN--GNLTWERRLRIAAETAGVLSYL 178
+VRL A + + ++ E++ G+L + + + G + + + +A+ A ++Y+
Sbjct: 60 HDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI 119
Query: 179 HSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQG 228
+ IHRD+++AN+L+ E+ K++DFG ++++ + YT +G
Sbjct: 120 ERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDN---EYTAREG 163
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-12
Identities = 49/165 (29%), Positives = 87/165 (52%), Gaps = 11/165 (6%)
Query: 73 VIGCGGSGNVYKGFL--PDR--TPVAVKKSKI--VDQTKIDEFINELVVVSQINRRNVVR 126
VIG G G V G L P + PVA+K K ++ + D F++E ++ Q + N++
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRD-FLSEASIMGQFDHPNIIH 69
Query: 127 LLACCLETQVPLLVYEFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVP 185
L +++ ++V E++ NG+L + K+ G T + + + A + YL +++
Sbjct: 70 LEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYL---SDMG 126
Query: 186 IIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTL 230
+HRD+ + NIL++ N KVSDFG S+++ D YT G +
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 171
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 4e-12
Identities = 39/127 (30%), Positives = 66/127 (51%), Gaps = 7/127 (5%)
Query: 93 VAVKKSKIVDQTKIDE-FINELVVVSQINRRNVVRLLACCLET--QVPLLVYEFVGNGTL 149
VAVK K + + E+ ++ + N+V+ CC E + L+ E+V G+L
Sbjct: 36 VAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSL 95
Query: 150 FEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDF 209
+++ K+ L + L A + ++YLHS+ IHRD+ + N+LLD + K+ DF
Sbjct: 96 RDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDF 151
Query: 210 GASKLVP 216
G +K VP
Sbjct: 152 GLAKAVP 158
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 4e-12
Identities = 45/145 (31%), Positives = 67/145 (46%), Gaps = 4/145 (2%)
Query: 94 AVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHI 153
++K+ IV ++++ + E V++Q+N +V L + LV F+ G LF H+
Sbjct: 25 TIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHL 84
Query: 154 HKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASK 213
+ G R AE L LH +I+RD+K NILLD + DFG K
Sbjct: 85 QREGRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCK 141
Query: 214 LVPIDAIQNYTVVQGTLGYIDPEYL 238
L D + T GT Y+ PE L
Sbjct: 142 LNMKDDDKTNTFC-GTPEYLAPELL 165
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 5e-12
Identities = 49/165 (29%), Positives = 76/165 (46%), Gaps = 26/165 (15%)
Query: 74 IGCGGSGNVYKG--FLPDR----TPVAVKKSKIVDQTKI-DEFINELVVVSQINRRNVVR 126
+G G G VYKG P+ T VA+K K + K+ EF E ++S + N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 127 LLACCLETQVPLLVYEFVGNGTLFEHI-----HKNGNLTWERR-----------LRIAAE 170
LL C + Q +++E++ +G L E + H + L IA +
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 171 TAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLV 215
A + YL S +HRD+ + N L+ E T K+SDFG S+ +
Sbjct: 133 IAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDI 174
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-12
Identities = 44/148 (29%), Positives = 75/148 (50%), Gaps = 17/148 (11%)
Query: 73 VIGCGGSGNV----YKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLL 128
IG G G+V Y+G VAVK K + F+ E V++Q+ N+V+LL
Sbjct: 13 TIGKGEFGDVMLGDYRG-----NKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLL 65
Query: 129 ACCLETQVPL-LVYEFVGNGTLFEHIHKNGN--LTWERRLRIAAETAGVLSYLHSETNVP 185
+E + L +V E++ G+L +++ G L + L+ + + + YL +
Sbjct: 66 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN--- 122
Query: 186 IIHRDVKSANILLDENYTPKVSDFGASK 213
+HRD+ + N+L+ E+ KVSDFG +K
Sbjct: 123 FVHRDLAARNVLVSEDNVAKVSDFGLTK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 6e-12
Identities = 53/169 (31%), Positives = 85/169 (50%), Gaps = 12/169 (7%)
Query: 72 DVIGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLAC 130
+ IG G SG VY + VA+K+ + Q K + INE++V+ + N+V L
Sbjct: 25 EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDS 84
Query: 131 CLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAA---ETAGVLSYLHSETNVPII 187
L +V E++ G+L + + + T +IAA E L +LHS +I
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VI 137
Query: 188 HRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPE 236
HRD+KS NILL + + K++DFG + + + T+V GT ++ PE
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPE 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 6e-12
Identities = 49/157 (31%), Positives = 81/157 (51%), Gaps = 8/157 (5%)
Query: 74 IGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLE 133
+G G G V+ G + VA+K + ++ D+FI E V+ +++ N+V+L C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE-DDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 134 TQVPLLVYEFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVK 192
+ +V E++ NG L ++ + G L E L + ++ + YL S IHRD+
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLA 127
Query: 193 SANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGT 229
+ N L+ E+ KVSDFG ++ V D YT QGT
Sbjct: 128 ARNCLVGEDNVVKVSDFGLARYVLDD---QYTSSQGT 161
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 6e-12
Identities = 54/171 (31%), Positives = 85/171 (49%), Gaps = 13/171 (7%)
Query: 74 IGCGGSGNVYKGFLPDRTPVAVKKSKIVD----QTKIDEFINELVVVSQINRRNVVRLLA 129
IG G G V+KG D V KI+D + +I++ E+ V+SQ + V +
Sbjct: 12 IGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 130 CCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHR 189
L+ ++ E++G G+ + + G L + I E L YLHSE IHR
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKK---IHR 125
Query: 190 DVKSANILLDENYTPKVSDFG-ASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
D+K+AN+LL E+ K++DFG A +L +N V GT ++ PE ++
Sbjct: 126 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV--GTPFWMAPEVIK 174
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 8e-12
Identities = 46/149 (30%), Positives = 74/149 (49%), Gaps = 7/149 (4%)
Query: 95 VKKSKIVDQTKIDEFI-NELVVVSQINRRNVVRLLACCLETQVPL-LVYEFVGNGTLFEH 152
+KK+ IV + K E E V+ + R + L +T L L+ ++V G LF H
Sbjct: 36 LKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTH 95
Query: 153 IHKNGNLTWERRLRI-AAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGA 211
+++ + T E +R+ AE L +LH + II+RD+K NILLD ++DFG
Sbjct: 96 LYQREHFT-ESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGL 151
Query: 212 SKLVPIDAIQNYTVVQGTLGYIDPEYLQT 240
SK + + GT+ Y+ PE ++
Sbjct: 152 SKEFLAEEEERAYSFCGTIEYMAPEVIRG 180
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-11
Identities = 51/148 (34%), Positives = 69/148 (46%), Gaps = 9/148 (6%)
Query: 95 VKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPL-LVYEFVGNGTLFEHI 153
VKK + D ID E V Q + + L C +T L LV E+V G L H+
Sbjct: 28 VKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHM 87
Query: 154 HKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASK 213
+ L E AAE L++LH II+RD+K N+LLD + K++D+G K
Sbjct: 88 QRQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCK 144
Query: 214 --LVPIDAIQNYTVVQGTLGYIDPEYLQ 239
L P D + GT YI PE L+
Sbjct: 145 EGLGPGDTTSTFC---GTPNYIAPEILR 169
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (153), Expect = 1e-11
Identities = 52/174 (29%), Positives = 87/174 (50%), Gaps = 19/174 (10%)
Query: 74 IGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKIDEF----INELVVVSQINRRNVVRLL 128
+G G G VYK VA+KK ++ D + + + E+ ++ ++ N+V+LL
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRL-DNEE-EGIPSTALREISLLKELKHPNIVKLL 64
Query: 129 -ACCLETQVPLLVYEFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPI 186
E ++ LV+E+ L +++ K G L+ I + L+Y HS I
Sbjct: 65 DVIHTERKL-YLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS---HRI 119
Query: 187 IHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYT--VVQGTLGYIDPEYL 238
+HRD+K NIL++ + K++DFG ++ I ++ YT VV TL Y PE L
Sbjct: 120 LHRDLKPQNILINRDGVLKLADFGLARAFGI-PLRTYTHEVV--TLWYRAPEIL 170
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 1e-11
Identities = 50/176 (28%), Positives = 80/176 (45%), Gaps = 21/176 (11%)
Query: 74 IGCGGSGNVYKGFL--PDRTPV--AVKKSKIVDQTKIDEFI-NELVVVSQINRRNVVRLL 128
+G GG G V + +RT VKK IV +T E I +E ++ + N +V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIV-ETGQQEHIFSEKEILEECNHPFIVKLY 59
Query: 129 ACCLETQVPLLVYEFVGNGTLFEHIHKNGNL-TWERRLRIAAETAGVLSYLHSETNVPII 187
+ + ++ E+ G L+ + G + R IA YLH+ II
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLA-FEYLHNRG---II 115
Query: 188 HRDVKSANILLDENYTPKVSDFGASKLVPIDAIQN----YTVVQGTLGYIDPEYLQ 239
+RD+K N+LLD N K+ DFG +K +++ +T GT Y+ PE +
Sbjct: 116 YRDLKPENLLLDSNGYVKLVDFGFAK-----KLKSGQKTWTFC-GTPEYVAPEIIL 165
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-11
Identities = 50/148 (33%), Positives = 69/148 (46%), Gaps = 9/148 (6%)
Query: 95 VKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLL-VYEFVGNGTLFEHI 153
VKK + D ID E V Q + + L C +T+ L V E+V G L H+
Sbjct: 28 VKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM 87
Query: 154 HKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASK 213
+ L E +AE + L+YLH II+RD+K N+LLD K++D+G K
Sbjct: 88 QRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK 144
Query: 214 --LVPIDAIQNYTVVQGTLGYIDPEYLQ 239
L P D + GT YI PE L+
Sbjct: 145 EGLRPGDTTSTFC---GTPNYIAPEILR 169
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-11
Identities = 48/164 (29%), Positives = 76/164 (46%), Gaps = 5/164 (3%)
Query: 74 IGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCL 132
IG G G+VYK + A+K K+ E++++ N+V L
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 133 ETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVK 192
+ EF G G+L + H G L+ + ++ ET L YLHS+ +HRD+K
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK---MHRDIK 133
Query: 193 SANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPE 236
ANILL +N K++DFG S + + + + GT ++ PE
Sbjct: 134 GANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPE 176
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-11
Identities = 53/167 (31%), Positives = 84/167 (50%), Gaps = 12/167 (7%)
Query: 74 IGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCL 132
IG G SG VY + VA+K+ + Q K + INE++V+ + N+V L L
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 133 ETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAA---ETAGVLSYLHSETNVPIIHR 189
+V E++ G+L + + + T +IAA E L +LHS +IHR
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHR 139
Query: 190 DVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPE 236
D+KS NILL + + K++DFG + + + T+V GT ++ PE
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPE 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-11
Identities = 54/186 (29%), Positives = 83/186 (44%), Gaps = 15/186 (8%)
Query: 59 IEEEIKTVTNNYADVIGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKIDEFINELVVVS 117
+E E + N V+G G G VY L + +A+K+ D + E+ + S
Sbjct: 1 LEYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHS 60
Query: 118 QINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLS- 176
+ RN+V+ L E + E V G+L + + I T +L
Sbjct: 61 YLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEG 120
Query: 177 --YLHSETNVPIIHRDVKSANILLDENYTP--KVSDFGASK-LVPID-AIQNYTVVQGTL 230
YLH I+HRD+K N+L++ Y+ K+SDFG SK L I+ + +T GTL
Sbjct: 121 LKYLHDNQ---IVHRDIKGDNVLVN-TYSGVVKISDFGTSKRLAGINPCTETFT---GTL 173
Query: 231 GYIDPE 236
Y+ PE
Sbjct: 174 QYMAPE 179
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-11
Identities = 53/190 (27%), Positives = 80/190 (42%), Gaps = 23/190 (12%)
Query: 69 NYA--DVIGCGGSGNVYK--------GFLPDR----TPVAVKKSKIVDQTKIDEFINELV 114
YA + +G G G VYK L + A K K I + ++E+
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 115 VV-SQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHI----HKNGNLTWERRLRIAA 169
++ Q+ N+VR LE +V + + L EH K T ER I
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120
Query: 170 ETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGT 229
+ L YLH E I+HRD+ NI+L E+ ++DFG +K ++ T V GT
Sbjct: 121 QMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES--KLTSVVGT 176
Query: 230 LGYIDPEYLQ 239
+ Y PE ++
Sbjct: 177 ILYSCPEIVK 186
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-11
Identities = 50/173 (28%), Positives = 87/173 (50%), Gaps = 15/173 (8%)
Query: 74 IGCGGSGNVYKGFLPDRTP---VAVKKSKI---VDQTKIDEFINELVVVSQINRRNVVRL 127
+G G G V+ + DR A+K I + + NE V+ +++ ++RL
Sbjct: 9 VGTGTFGRVHL--VRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL 66
Query: 128 LACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPII 187
+ + ++ E+V G LF ++ +G + L A+E L YLHS+ I+
Sbjct: 67 FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE---IV 123
Query: 188 HRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQT 240
+RD+K NILLD+ K++DFG +K + D + +T+ GT Y+ PE +Q+
Sbjct: 124 YRDLKPENILLDKEGHIKLTDFGFAKKL-RD--RTWTLC-GTPEYLAPEVIQS 172
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-11
Identities = 56/176 (31%), Positives = 87/176 (49%), Gaps = 20/176 (11%)
Query: 50 RSSEKAKIFIEEEIKTVTNNYADVIGCGGSGNVYKGFLPD-RTP--VAVKK---SKIVDQ 103
+ E A++F +E+ + + + + IG G G VY F D RT VA+KK S
Sbjct: 10 KDPEIAELFFKEDPEKLFTDLRE-IGHGSFGAVY--FARDVRTNEVVAIKKMSYSGKQSN 66
Query: 104 TKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF-VGNGTLFEHIHKNGNLTWE 162
K + I E+ + +I N + C L LV E+ +G+ + +HK
Sbjct: 67 EKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKP----L 122
Query: 163 RRLRIAAETAGVL---SYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLV 215
+ + IAA T G L +YLHS +IHRD+K+ NILL E K++DFG++ +
Sbjct: 123 QEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIA 175
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-11
Identities = 48/174 (27%), Positives = 80/174 (45%), Gaps = 12/174 (6%)
Query: 74 IGCGGSGNVYKG-FLPDRTPVAVKKSKI---VDQTKIDEFINELVVVSQINRRNVVRLLA 129
IG G VY+ L D PVA+KK +I +D + I E+ ++ Q+N NV++ A
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 130 CCLETQVPLLVYEFVGNGTL---FEHIHKNGNLTWERRL-RIAAETAGVLSYLHSETNVP 185
+E +V E G L +H K L E+ + + + L ++HS
Sbjct: 70 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--- 126
Query: 186 IIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
++HRD+K AN+ + K+ D G + +++V GT Y+ PE +
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIH 179
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-11
Identities = 46/157 (29%), Positives = 83/157 (52%), Gaps = 20/157 (12%)
Query: 74 IGCGGSGNVYKGFLPDRT---PVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLL 128
+G G G+V +G L VAVK KI ++++++F++E V + + + NV+RL+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 129 ACCLETQ------VPLLVYEFVGNGTLFEHI--HKNGN----LTWERRLRIAAETAGVLS 176
CL+T P+++ F+ +G L + + G+ L + ++ + A +
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 177 YLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASK 213
YL S++ IHRD+ + N +L+EN V+DFG SK
Sbjct: 127 YLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSK 160
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 4e-11
Identities = 47/157 (29%), Positives = 79/157 (50%), Gaps = 8/157 (5%)
Query: 74 IGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLE 133
+G G G V G + VA+K K ++ DEFI E V+ +++ +V+L C +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 134 TQVPLLVYEFVGNGTLFEHIHKNGN-LTWERRLRIAAETAGVLSYLHSETNVPIIHRDVK 192
+ +V E++ NG L ++ ++G + L + + ++YL S+ IHRD+
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLA 127
Query: 193 SANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGT 229
+ N L+D+ KVSDFG S+ V D YT G+
Sbjct: 128 ARNCLVDDQGCVKVSDFGLSRYVLDD---EYTSSVGS 161
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 5e-11
Identities = 41/148 (27%), Positives = 76/148 (51%), Gaps = 11/148 (7%)
Query: 72 DVIGCGGSGNVYKG-FLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLAC 130
++IG G G V +G + + V K + Q F+ E V+++++ +N+VRLL
Sbjct: 12 EIIGEGEFGAVLQGEYTGQKVAVKNIKCDVTAQA----FLEETAVMTKLHHKNLVRLLGV 67
Query: 131 CLETQVPLLVYEFVGNGTLFEHIHKNGN--LTWERRLRIAAETAGVLSYLHSETNVPIIH 188
L + +V E + G L + G ++ + L+ + + A + YL S+ ++H
Sbjct: 68 ILHNGL-YIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVH 123
Query: 189 RDVKSANILLDENYTPKVSDFGASKLVP 216
RD+ + NIL+ E+ KVSDFG +++
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGS 151
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-11
Identities = 48/134 (35%), Positives = 70/134 (52%), Gaps = 11/134 (8%)
Query: 110 INELVVVSQINRRNVVRLLACCLETQVPL-LVYEFVGNGTLFEHIHKNGN--LTWERRLR 166
+NE ++ ++N + VV L A ET+ L LV + G L HI+ GN ER L
Sbjct: 48 LNEKQILEKVNSQFVVNL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALF 106
Query: 167 IAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPI-DAIQNYTV 225
AAE L LH E ++RD+K NILLD+ ++SD G + +P ++I+
Sbjct: 107 YAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV- 162
Query: 226 VQGTLGYIDPEYLQ 239
GT+GY+ PE L
Sbjct: 163 --GTVGYMAPEVLN 174
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 5e-11
Identities = 50/154 (32%), Positives = 78/154 (50%), Gaps = 14/154 (9%)
Query: 94 AVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHI 153
+KK+ ++ + ++D+ + E ++SQ VV+L + LV E++ G L +
Sbjct: 25 VIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLL 84
Query: 154 HKNGNLTWERRLRI-AAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGAS 212
G+L E RI AE L YLH + IIHRD+K NIL+D N K++DFG S
Sbjct: 85 ENVGSLD-EDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLS 140
Query: 213 KL--------VPIDAIQNYTVVQGTLGYIDPEYL 238
K+ + D ++ +V GT YI PE +
Sbjct: 141 KVGLVRRQINLNDDEKEDKRIV-GTPDYIAPEVI 173
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 6e-11
Identities = 53/173 (30%), Positives = 84/173 (48%), Gaps = 15/173 (8%)
Query: 72 DVIGCGGSGNVYK-GFLPDRTPVAVKKSKI--VDQTKIDEFINELVVVSQINRRNVVRLL 128
+G G G+VYK L D A+K+ + + Q + ++ +NE+ +++ +N N++
Sbjct: 6 KKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYK 65
Query: 129 ACCLETQVPLLVYEFVGNGTLFEHIHKN---GNLTWERRL-RIAAETAGVLSYLHSETNV 184
L+ +V E+ G L + I K L E+ + RI + L LH +
Sbjct: 66 EAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK-- 123
Query: 185 PIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQ-GTLGYIDPE 236
I+HRD+KSANILL N K+ D G SK+ +N Q GT Y+ PE
Sbjct: 124 -ILHRDLKSANILLVANDLVKIGDLGISKV----LKKNMAKTQIGTPHYMAPE 171
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-11
Identities = 48/133 (36%), Positives = 70/133 (52%), Gaps = 9/133 (6%)
Query: 110 INELVVVSQINRRNVVRLLACCLETQVPL-LVYEFVGNGTLFEHIHKNGNLTWE--RRLR 166
+NE ++ ++N R VV L A ET+ L LV + G L HI+ G +E R +
Sbjct: 48 LNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVF 106
Query: 167 IAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVV 226
AAE L LH E I++RD+K NILLD++ ++SD G + VP Q
Sbjct: 107 YAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG--QTIKGR 161
Query: 227 QGTLGYIDPEYLQ 239
GT+GY+ PE ++
Sbjct: 162 VGTVGYMAPEVVK 174
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 8e-11
Identities = 52/175 (29%), Positives = 86/175 (49%), Gaps = 12/175 (6%)
Query: 70 YADVIGCGGSGNVYKG-FLPDRTPVAVKKSKI-VDQTKIDEFINELVVVSQINRRNVVRL 127
Y +G G SG V K P +AVK ++ +++ + + EL ++ + N +V
Sbjct: 5 YLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGF 64
Query: 128 L-ACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTW-ERRL-RIAAETAGVLSYLHSETNV 184
A + + + E++ G+L + I K ER L +IA L+YLH +
Sbjct: 65 YGAFYNNGDISICM-EYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK- 121
Query: 185 PIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
IIHRDVK +NIL++ K+ DFG S + ++++ V GT Y+ PE +Q
Sbjct: 122 -IIHRDVKPSNILVNSRGQIKLCDFGVSGQL-VNSLAKTFV--GTSSYMAPERIQ 172
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-10
Identities = 46/158 (29%), Positives = 82/158 (51%), Gaps = 12/158 (7%)
Query: 74 IGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLE 133
+G G G V+ G T VAVK K + + F+ E ++ ++ +V+L A E
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP-ESFLEEAQIMKKLRHDKLVQLYAVVSE 72
Query: 134 TQVPLLVYEFVGNGTLFEHIHKNG---NLTWERRLRIAAETAGVLSYLHSETNVPIIHRD 190
+ +V E++ G+L + + K+G L + +AA+ A ++Y+ + IHRD
Sbjct: 73 EPI-YIVTEYMSKGSLLDFL-KDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRD 127
Query: 191 VKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQG 228
++SANIL+ + K++DFG ++L+ + YT QG
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLIEDN---EYTARQG 162
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-10
Identities = 43/161 (26%), Positives = 76/161 (47%), Gaps = 24/161 (14%)
Query: 74 IGCGGSGNVY----KGFLP--DRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRL 127
+G G G V+ LP D+ VAVK K ++ +F E +++ + +++VR
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 128 LACCLETQVPLLVYEFVGNGTLFEHIHKN---------------GNLTWERRLRIAAETA 172
C E + L+V+E++ +G L + + G LT + L IA++ A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 173 GVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASK 213
+ YL S + +HRD+ + N L+ + K+ DFG S+
Sbjct: 133 SGMVYLAS---LHFVHRDLATRNCLVGQGLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-10
Identities = 45/157 (28%), Positives = 81/157 (51%), Gaps = 10/157 (6%)
Query: 74 IGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLE 133
+G G G V+ G T VA+K K + + F+ E V+ ++ +V+L A E
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 134 TQVPLLVYEFVGNGTLFEHIHKNGN--LTWERRLRIAAETAGVLSYLHSETNVPIIHRDV 191
+ +V E++ G+L + + L + + +AA+ A ++Y+ + +HRD+
Sbjct: 73 EPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 128
Query: 192 KSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQG 228
++ANIL+ EN KV+DFG ++L+ + YT QG
Sbjct: 129 RAANILVGENLVCKVADFGLARLIEDN---EYTARQG 162
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-10
Identities = 50/167 (29%), Positives = 85/167 (50%), Gaps = 12/167 (7%)
Query: 74 IGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCL 132
IG G SG V+ + VA+K+ + Q K + INE++V+ ++ N+V L L
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 133 ETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAA---ETAGVLSYLHSETNVPIIHR 189
+V E++ G+L + + + T +IAA E L +LH+ +IHR
Sbjct: 87 VGDELFVVMEYLAGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHR 139
Query: 190 DVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPE 236
D+KS N+LL + + K++DFG + + + T+V GT ++ PE
Sbjct: 140 DIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPE 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-10
Identities = 46/159 (28%), Positives = 80/159 (50%), Gaps = 21/159 (13%)
Query: 73 VIGCGGSGNVYKGFLPDR----TPVAVK--KSKIVDQTKIDEFINELVVVSQINRRNVVR 126
++G G G+V + L VAVK K+ I + I+EF+ E + + + NV++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 127 LLACCLETQ------VPLLVYEFVGNGTL--FEHIHKNG----NLTWERRLRIAAETAGV 174
L+ L ++ +P+++ F+ +G L F + + G L + +R + A
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 175 LSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASK 213
+ YL S+ IHRD+ + N +L+EN T V+DFG SK
Sbjct: 126 MEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-10
Identities = 47/148 (31%), Positives = 68/148 (45%), Gaps = 9/148 (6%)
Query: 95 VKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPL-LVYEFVGNGTLFEHI 153
+KK + D ID E V + + L C +T+ L V EFV G L H+
Sbjct: 28 IKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHM 87
Query: 154 HKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASK 213
+ L E +AE + L++LH II+RD+K N+LLD K++D+G K
Sbjct: 88 QRQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK 144
Query: 214 --LVPIDAIQNYTVVQGTLGYIDPEYLQ 239
+ P D + GT YI PE L+
Sbjct: 145 EGIRPGDTTSTFC---GTPNYIAPEILR 169
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-10
Identities = 47/158 (29%), Positives = 83/158 (52%), Gaps = 12/158 (7%)
Query: 74 IGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLE 133
+G G G V+ G T VA+K K + F+ E ++ ++ +V L A E
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP-EAFLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 134 TQVPLLVYEFVGNGTLFEHIHKNGN---LTWERRLRIAAETAGVLSYLHSETNVPIIHRD 190
+ +V EF+G G+L + + K G+ L + + +AA+ A ++Y+ + IHRD
Sbjct: 73 EPI-YIVTEFMGKGSLLDFL-KEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRD 127
Query: 191 VKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQG 228
+++ANIL+ +N K++DFG ++L+ + YT QG
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDN---EYTARQG 162
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-10
Identities = 44/157 (28%), Positives = 80/157 (50%), Gaps = 20/157 (12%)
Query: 74 IGCGGSGNVY----KGFLPDR--TPVAVKK-SKIVDQTKIDEFINELVVVSQINRRNVVR 126
+G G G VY KG + D T VA+K ++ + EF+NE V+ + N +VVR
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 127 LLACCLETQVPLLVYEFVGNGTLFEHIHK-----NGNL-----TWERRLRIAAETAGVLS 176
LL + Q L++ E + G L ++ N + ++ +++A E A ++
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 177 YLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASK 213
YL++ +HRD+ + N ++ E++T K+ DFG ++
Sbjct: 134 YLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 2e-10
Identities = 53/187 (28%), Positives = 82/187 (43%), Gaps = 30/187 (16%)
Query: 72 DVIGCGGSGNVYKGFLPDRTPVAVKKS--KIVDQTKID----------EFINELVVVSQI 119
+ IG G G V K +KS KI+ +ID + ++E+ ++ ++
Sbjct: 6 ETIGKGSFGTVRK---------VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILREL 56
Query: 120 NRRNVVRLLACCL--ETQVPLLVYEFVGNGTLFEHIHK----NGNLTWERRLRIAAETAG 173
N+VR + Q +V E+ G L + I K + E RI +
Sbjct: 57 KHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLL 116
Query: 174 VLSYLH--SETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLG 231
L H S+ ++HRD+K ANI LD N K+ DFG +K++ D+ T V GT
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPY 175
Query: 232 YIDPEYL 238
Y+ PE L
Sbjct: 176 YMSPEQL 182
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-10
Identities = 51/167 (30%), Positives = 81/167 (48%), Gaps = 11/167 (6%)
Query: 74 IGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFI---NELVVVSQINRRNVVRLLAC 130
+G G G+VYK +A KI+ D+F E+ +V + N+V
Sbjct: 17 VGSGTYGDVYKARNLHTGELAA--VKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGS 74
Query: 131 CLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRD 190
L + + E+ G G+L + H G L+ + + ET L+YLHS+ +HRD
Sbjct: 75 YLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGK---MHRD 131
Query: 191 VKSANILLDENYTPKVSDFG-ASKLVPIDAIQNYTVVQGTLGYIDPE 236
+K ANILL +N K++DFG A+K+ A + + GT ++ PE
Sbjct: 132 IKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI--GTPYWMAPE 176
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 59.4 bits (143), Expect = 2e-10
Identities = 52/168 (30%), Positives = 86/168 (51%), Gaps = 14/168 (8%)
Query: 74 IGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCL 132
IG G SG VY + VA+++ + Q K + INE++V+ + N+V L L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 133 ETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAA---ETAGVLSYLHSETNVPIIHR 189
+V E++ G+L + + + T +IAA E L +LHS +IHR
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHR 140
Query: 190 DVKSANILLDENYTPKVSDFG-ASKLVPIDAIQNYTVVQGTLGYIDPE 236
D+KS NILL + + K++DFG +++ P + ++ V GT ++ PE
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV--GTPYWMAPE 186
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-10
Identities = 46/174 (26%), Positives = 79/174 (45%), Gaps = 13/174 (7%)
Query: 74 IGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKIDEFIN--ELVVVSQINRRNVVRLLAC 130
IG G G VYK VA+KK K+ +++ E+ ++ ++N N+++LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 131 CLETQVPLLVYEFVGNGTLFEHI-HKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHR 189
LV+EF+ + L++ I + L + L++ HS I+HR
Sbjct: 67 FRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHR 122
Query: 190 DVKSANILLDENYTPKVSDFGASKLV--PIDAIQNYTVVQGTLGYIDPEYLQTC 241
D+K N+L++ K++DFG ++ P+ +Y V T Y PE L
Sbjct: 123 DLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV---TRWYRAPELLLGD 173
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 2e-10
Identities = 44/171 (25%), Positives = 76/171 (44%), Gaps = 12/171 (7%)
Query: 74 IGCGGSGNVYKGFLPDRT---PVAVKK--SKIVDQTKIDEFINELVVVSQINRRNVVRLL 128
IG G G V+K DR VA+KK + ++ ++ + E+ + VV+LL
Sbjct: 8 IGEGAHGIVFKAK--DRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL 65
Query: 129 ACCLETQVPLLVYEFVGNGTLFEHIHKNGN-LTWERRLRIAAETAGVLSYLHSETNVPII 187
+LV E++ L E + L + ++Y+H+ I+
Sbjct: 66 DVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG---IM 121
Query: 188 HRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYL 238
HRD+K AN+L+ + K++DFG ++L + + Y+ T Y PE L
Sbjct: 122 HRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELL 172
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (143), Expect = 3e-10
Identities = 48/180 (26%), Positives = 78/180 (43%), Gaps = 28/180 (15%)
Query: 74 IGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKIDEF----INELVVVSQINRRNVVRLL 128
IG G G VYK VA+KK ++ ++ + F I E+ ++ ++ N+VRL
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEK--EGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 129 ACCLETQVP--LLVYEFVGNGTLFEH------IHKNGNLTWERRLRIAAETAGVLSYLHS 180
+V+E+ +H T + + L YLHS
Sbjct: 65 EIVTSKGKGSIYMVFEY------MDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS 118
Query: 181 ETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYT--VVQGTLGYIDPEYL 238
I+HRD+K +NIL++ + K++DFG ++ +YT V+ TL Y PE L
Sbjct: 119 NG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI--TLWYRPPELL 173
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 3e-10
Identities = 47/133 (35%), Positives = 70/133 (52%), Gaps = 9/133 (6%)
Query: 110 INELVVVSQINRRNVVRLLACCLETQVPL-LVYEFVGNGTLFEHIHKNGNLTWE--RRLR 166
+NE ++ ++N R VV L A ET+ L LV + G L HI+ GN ++ R +
Sbjct: 48 LNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVF 106
Query: 167 IAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVV 226
AAE L LH E I++RD+K NILLD+ ++SD G + +P V
Sbjct: 107 YAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV- 162
Query: 227 QGTLGYIDPEYLQ 239
GT+GY+ PE ++
Sbjct: 163 -GTVGYMAPEVVK 174
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-10
Identities = 46/149 (30%), Positives = 76/149 (51%), Gaps = 11/149 (7%)
Query: 95 VKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPL-LVYEFVGNGTLFEHI 153
+KK IV + ++ + E V+ Q +R + L +T L V E+ G LF H+
Sbjct: 28 LKKEVIVAKDEVAHTLTENRVL-QNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL 86
Query: 154 HKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASK 213
+ + +R AE L YLHSE NV ++RD+K N++LD++ K++DFG K
Sbjct: 87 SRERVFSEDRARFYGAEIVSALDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCK 144
Query: 214 LVPIDAIQNYTVVQ---GTLGYIDPEYLQ 239
+ I++ ++ GT Y+ PE L+
Sbjct: 145 ----EGIKDGATMKTFCGTPEYLAPEVLE 169
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-10
Identities = 47/171 (27%), Positives = 80/171 (46%), Gaps = 12/171 (7%)
Query: 74 IGCGGSGNVYKGF-LPDRTPVAVKKSKI---VDQTKIDEFINELVVVSQINRRNVVRLLA 129
IG G VY+ L DR PVA+KK +I +D + + E+ ++ Q+N NV++ L
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 130 CCLETQVPLLVYEFVGNGTL---FEHIHKNGNLTWERRL-RIAAETAGVLSYLHSETNVP 185
+E +V E G L ++ K L ER + + + + ++HS
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--- 126
Query: 186 IIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPE 236
++HRD+K AN+ + K+ D G + +++V GT Y+ PE
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPE 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 3e-10
Identities = 46/173 (26%), Positives = 84/173 (48%), Gaps = 10/173 (5%)
Query: 72 DVIGCGGSGNVYKGF-LPDRTPVAVKKSKI-VDQTKIDEFINELVVVSQINR---RNVVR 126
++IG G G VY+G +P VA+K + + + E+ ++SQ+ + N+ +
Sbjct: 7 ELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITK 66
Query: 127 LLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPI 186
L+ ++ E+ G++ + K G + + I E L Y+H V +
Sbjct: 67 YYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISVIIREVLVALKYIHK---VGV 122
Query: 187 IHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
IHRD+K+ANIL+ K+ DFG + L+ ++ + T V GT ++ PE +
Sbjct: 123 IHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVIT 174
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 3e-10
Identities = 38/164 (23%), Positives = 75/164 (45%), Gaps = 14/164 (8%)
Query: 82 VYKGFLPDRTPVAV---KKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPL 138
+YKG + V + KK + ID NE+ + +I+ N++++ ++ L
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 139 ----LVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSA 194
L+ E+ G L E + K +L+++ +L +A + L L+ TN P ++++ S
Sbjct: 95 PRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSV 152
Query: 195 NILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYL 238
+ L+ ENY K+ G K++ +N + Y + L
Sbjct: 153 SFLVTENYKLKIICHGLEKILSSPPFKNVN----FMVYFSYKML 192
|
Length = 283 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 4e-10
Identities = 37/133 (27%), Positives = 73/133 (54%), Gaps = 15/133 (11%)
Query: 93 VAVKKSKI-VDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTL-- 149
VAVK + ++ ++F+ E+ ++S++ N++RLLA C+ + ++ E++ NG L
Sbjct: 49 VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108
Query: 150 FEHIHKNGN---------LTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDE 200
F H+ +++ + +A + A + YL S + +HRD+ + N L+ +
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGK 165
Query: 201 NYTPKVSDFGASK 213
NYT K++DFG S+
Sbjct: 166 NYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-10
Identities = 53/175 (30%), Positives = 87/175 (49%), Gaps = 24/175 (13%)
Query: 53 EKAKIFIEEEIKTVTNNYADV--IGCGGSGNVYKGFLPD---RTPVAVKK---SKIVDQT 104
+ A++F +++ + + ++D+ IG G G VY F D VA+KK S
Sbjct: 3 DVAELFFKDDPEKL---FSDLREIGHGSFGAVY--FARDVRNSEVVAIKKMSYSGKQSNE 57
Query: 105 KIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF-VGNGTLFEHIHKNGNLTWER 163
K + I E+ + ++ N ++ C L LV E+ +G+ + +HK +
Sbjct: 58 KWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP----LQ 113
Query: 164 RLRIAAETAGVL---SYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLV 215
+ IAA T G L +YLHS +IHRDVK+ NILL E K+ DFG++ ++
Sbjct: 114 EVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM 165
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-10
Identities = 60/176 (34%), Positives = 85/176 (48%), Gaps = 26/176 (14%)
Query: 74 IGCGGSGNVYKGFLPDRTP---VAVKK-SKIVDQT--KIDEFINELVVVSQINRRNVVRL 127
IG G G VY F + VAVKK S QT K + I E+ + Q+ N +
Sbjct: 29 IGHGSFGAVY--FATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86
Query: 128 LACCLETQVPLLVYEF-VGNGTLFEHIHKNGNLTWERRLRIAAETAGVL---SYLHSETN 183
C L+ LV E+ +G+ + +HK + + IAA T G L +YLHS
Sbjct: 87 KGCYLKEHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAITHGALQGLAYLHSHN- 141
Query: 184 VPIIHRDVKSANILLDENYTPKVSDFG-ASKLVPIDAIQNYTVVQGTLGYIDPEYL 238
+IHRD+K+ NILL E K++DFG ASK P ++ GT ++ PE +
Sbjct: 142 --MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSF------VGTPYWMAPEVI 189
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 4e-10
Identities = 50/157 (31%), Positives = 71/157 (45%), Gaps = 24/157 (15%)
Query: 72 DVIGCGGSGNVYKGFLPDRTP-VAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLL 128
+VIG G G VYK VA+K I+ ++ +I E N L S N N+
Sbjct: 12 EVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYS--NHPNIATFY 69
Query: 129 ACCLETQVPL-------LVYEFVGNGTLFEHIHKNGNLTWERRLR------IAAETAGVL 175
++ + P LV E G G++ + + G +RL+ I ET L
Sbjct: 70 GAFIK-KNPPGNDDQLWLVMELCGGGSVTDLV--KGLRKKGKRLKEEWIAYILRETLRGL 126
Query: 176 SYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGAS 212
+YLH +IHRD+K NILL +N K+ DFG S
Sbjct: 127 AYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVS 160
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 5e-10
Identities = 48/149 (32%), Positives = 69/149 (46%), Gaps = 11/149 (7%)
Query: 95 VKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLL-VYEFVGNGTLFEHI 153
+KK I+ +D + E +++ + + L CC +T+ L V E+V G L I
Sbjct: 28 LKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQI 87
Query: 154 HKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASK 213
++ R AAE L +LH +I+RD+K NILLD K++DFG K
Sbjct: 88 QRSRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCK 144
Query: 214 LVPIDAIQN---YTVVQGTLGYIDPEYLQ 239
+ I N T GT YI PE LQ
Sbjct: 145 ----EGILNGVTTTTFCGTPDYIAPEILQ 169
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 5e-10
Identities = 42/149 (28%), Positives = 67/149 (44%), Gaps = 15/149 (10%)
Query: 74 IGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRR----NVVRLLA 129
+G G G+V K L + + K+ D + +++ +IN+ +V+
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYG 66
Query: 130 CCLETQVPLL--VYEFVGNGTL---FEHIHKNGNLTWERRL-RIAAETAGVLSYLHSETN 183
L+ + E+ G+L ++ + K G E+ L +IA LSYLHS
Sbjct: 67 AFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK- 125
Query: 184 VPIIHRDVKSANILLDENYTPKVSDFGAS 212
IIHRD+K +NILL K+ DFG S
Sbjct: 126 --IIHRDIKPSNILLTRKGQVKLCDFGVS 152
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 5e-10
Identities = 46/179 (25%), Positives = 80/179 (44%), Gaps = 18/179 (10%)
Query: 73 VIGCGGSGNVYKGFLPD----------RTPVAVKKSKIVDQTKIDEFINELVVVSQINRR 122
+IG G G+VY G P SK ++ +D E+ ++ ++
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 123 NVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSET 182
N+V+ L L+ + E+V G++ ++ G + L+YLH+
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG 126
Query: 183 NVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAI-----QNYTVVQGTLGYIDPE 236
IIHRD+K ANIL+D K+SDFG SK + +++ +QG++ ++ PE
Sbjct: 127 ---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE 182
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 5e-10
Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 4/100 (4%)
Query: 140 VYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLD 199
V E+ G LF H+ + + +R AE L YLHS +++RD+K N++LD
Sbjct: 73 VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLD 129
Query: 200 ENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
++ K++DFG K D T GT Y+ PE L+
Sbjct: 130 KDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLE 168
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 6e-10
Identities = 45/157 (28%), Positives = 79/157 (50%), Gaps = 20/157 (12%)
Query: 74 IGCGGSGNVYKGFLPD------RTPVAVKK-SKIVDQTKIDEFINELVVVSQINRRNVVR 126
+G G G VY+G D T VAVK ++ + EF+NE V+ +VVR
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 127 LLACCLETQVPLLVYEFVGNGTLFEHI--------HKNGNL--TWERRLRIAAETAGVLS 176
LL + Q L+V E + +G L ++ + G T + +++AAE A ++
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 177 YLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASK 213
YL+++ +HRD+ + N ++ ++T K+ DFG ++
Sbjct: 134 YLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 6e-10
Identities = 38/140 (27%), Positives = 67/140 (47%), Gaps = 16/140 (11%)
Query: 89 DRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGT 148
D+ VAVK K +F E +++ + ++V+ C+E ++V+E++ +G
Sbjct: 34 DKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGD 93
Query: 149 LFEHIHKNG-------------NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSAN 195
L + + +G LT + L IA + A + YL S+ +HRD+ + N
Sbjct: 94 LNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRN 150
Query: 196 ILLDENYTPKVSDFGASKLV 215
L+ EN K+ DFG S+ V
Sbjct: 151 CLVGENLLVKIGDFGMSRDV 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-10
Identities = 45/146 (30%), Positives = 74/146 (50%), Gaps = 5/146 (3%)
Query: 93 VAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEH 152
VAVKK + Q + + NE+V++ + NVV + L +V EF+ G L +
Sbjct: 50 VAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTD- 108
Query: 153 IHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGAS 212
I + + E+ + LSYLH++ +IHRD+KS +ILL + K+SDFG
Sbjct: 109 IVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFC 165
Query: 213 KLVPIDAIQNYTVVQGTLGYIDPEYL 238
V + + ++V GT ++ PE +
Sbjct: 166 AQVSKEVPKRKSLV-GTPYWMAPEVI 190
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 7e-10
Identities = 40/142 (28%), Positives = 74/142 (52%), Gaps = 25/142 (17%)
Query: 93 VAVKKSKIVDQTK--IDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLF 150
VAVK + D K ++F+ E+ ++S++ N++RLL C++ ++ E++ NG L
Sbjct: 49 VAVKILR-PDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107
Query: 151 EHIH--------KNGN-----------LTWERRLRIAAETAGVLSYLHSETNVPIIHRDV 191
+ + +NGN +++ L +A + A + YL S + +HRD+
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDL 164
Query: 192 KSANILLDENYTPKVSDFGASK 213
+ N L+ EN T K++DFG S+
Sbjct: 165 ATRNCLVGENLTIKIADFGMSR 186
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 1e-09
Identities = 57/183 (31%), Positives = 81/183 (44%), Gaps = 29/183 (15%)
Query: 74 IGCGGSGNVYKG-FLPDRTPVAVKK-SKIVDQTKIDEFINEL-VVVSQINRRNVVRLLA- 129
IG G G V K P T +AVK+ VD+ + + +L VV+ + +V+
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 130 ------C--CLE---TQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYL 178
C C+E + Y++V + + E +IA T L+YL
Sbjct: 72 LFREGDCWICMELMDISLDKF-YKYV-------YEVLKSVIPEEILGKIAVATVKALNYL 123
Query: 179 HSETNVPIIHRDVKSANILLDENYTPKVSDFGAS-KLVPIDAIQNYTVVQGTLGYIDPEY 237
E IIHRDVK +NILLD N K+ DFG S +LV D+I T G Y+ PE
Sbjct: 124 KEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLV--DSIAK-TRDAGCRPYMAPER 178
Query: 238 LQT 240
+
Sbjct: 179 IDP 181
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-09
Identities = 43/143 (30%), Positives = 69/143 (48%), Gaps = 5/143 (3%)
Query: 95 VKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPL-LVYEFVGNGTLFEHI 153
+KK ++ ++ + E V++ ++ + L C +T L V E+V G L HI
Sbjct: 33 LKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI 92
Query: 154 HKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASK 213
+ G + + AAE + L +LH II+RD+K N++LD K++DFG K
Sbjct: 93 QQVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 149
Query: 214 LVPIDAIQNYTVVQGTLGYIDPE 236
+D + T GT YI PE
Sbjct: 150 EHMVDGVTTRTFC-GTPDYIAPE 171
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 57.2 bits (139), Expect = 1e-09
Identities = 50/181 (27%), Positives = 81/181 (44%), Gaps = 30/181 (16%)
Query: 74 IGCGGSGNVYKGFLPDR---TPVAVKKSKIVDQTKIDEFIN-----ELVVVSQINRRNVV 125
+G G VYK D+ VA+KK K+ ++ + + IN E+ ++ ++ N++
Sbjct: 8 LGEGTYAVVYKAR--DKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 126 RLLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLR------IAAETAGVLSYLH 179
LL LV+EF+ T E + K+ ++ L T L YLH
Sbjct: 66 GLLDVFGHKSNINLVFEFME--TDLEKVIKDKSI----VLTPADIKSYMLMTLRGLEYLH 119
Query: 180 SETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYT--VVQGTLGYIDPEY 237
S I+HRD+K N+L+ + K++DFG ++ + T VV T Y PE
Sbjct: 120 SNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFG-SPNRKMTHQVV--TRWYRAPEL 173
Query: 238 L 238
L
Sbjct: 174 L 174
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-09
Identities = 39/112 (34%), Positives = 54/112 (48%), Gaps = 9/112 (8%)
Query: 128 LACCLETQVPL-LVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPI 186
L C +T L V E+V G L HI + G + AAE A L +LHS+ I
Sbjct: 66 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG---I 122
Query: 187 IHRDVKSANILLDENYTPKVSDFGASK--LVPIDAIQNYTVVQGTLGYIDPE 236
I+RD+K N++LD K++DFG K + + + GT YI PE
Sbjct: 123 IYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFC---GTPDYIAPE 171
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-09
Identities = 39/98 (39%), Positives = 52/98 (53%), Gaps = 4/98 (4%)
Query: 139 LVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILL 198
L+ +F+ G LF + K T E AE A L +LHS + II+RD+K NILL
Sbjct: 75 LILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILL 131
Query: 199 DENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPE 236
DE K++DFG SK ID + GT+ Y+ PE
Sbjct: 132 DEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMAPE 168
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-09
Identities = 44/173 (25%), Positives = 76/173 (43%), Gaps = 15/173 (8%)
Query: 74 IGCGGSGNVYKGFLPDR-TPVAVKKSKIVDQTK-----IDEFINELVVVSQINRRNVVRL 127
+G G G VY + D +AVK+ + ++ E+ ++ + +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 128 LACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPII 187
C + + + E++ G++ + + G LT + + + YLHS I+
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM---IV 126
Query: 188 HRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTV----VQGTLGYIDPE 236
HRD+K ANIL D K+ DFGASK + I + V GT ++ PE
Sbjct: 127 HRDIKGANILRDSAGNVKLGDFGASK--RLQTICSSGTGMKSVTGTPYWMSPE 177
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-09
Identities = 45/157 (28%), Positives = 78/157 (49%), Gaps = 14/157 (8%)
Query: 93 VAVKKSK-IVDQTKIDEFINELVVVSQI-NRRNVVRLLACCLETQVPLLVYEFVGNGTLF 150
VAVK K ++ + ++EL ++S + N N+V LL C L++ E+ G L
Sbjct: 68 VAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLL 127
Query: 151 EHIHKNGN--LTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSD 208
+ + LT E L + + A +++L S+ IHRD+ + N+LL K+ D
Sbjct: 128 NFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICD 184
Query: 209 FGASKLVPIDAIQNYTVVQGT----LGYIDPEYLQTC 241
FG ++ + D+ NY VV+G + ++ PE + C
Sbjct: 185 FGLARDIMNDS--NY-VVKGNARLPVKWMAPESIFNC 218
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-09
Identities = 45/146 (30%), Positives = 71/146 (48%), Gaps = 6/146 (4%)
Query: 95 VKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPL-LVYEFVGNGTLFEHI 153
+KK I+ + ++ + E V+ R + L +T+ L V E+V G LF H+
Sbjct: 28 LKKEVIIAKDEVAHTLTESRVLKN-TRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHL 86
Query: 154 HKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASK 213
+ + +R AE L YLHS I++RD+K N++LD++ K++DFG K
Sbjct: 87 SRERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCK 143
Query: 214 LVPIDAIQNYTVVQGTLGYIDPEYLQ 239
DA T GT Y+ PE L+
Sbjct: 144 EGITDAATMKTFC-GTPEYLAPEVLE 168
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 1e-09
Identities = 54/182 (29%), Positives = 82/182 (45%), Gaps = 27/182 (14%)
Query: 74 IGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKIDE------FINELVVVSQINRR---N 123
IG G G VYK L VA+KK ++ + E + E+ ++ Q+ N
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRV----PLSEEGIPLSTLREIALLKQLESFEHPN 62
Query: 124 VVRLLACC----LETQVPL-LVYEFVGN--GTLFEHIHKNGNLTWERRLRIAAETAGVLS 176
+VRLL C + ++ L LV+E V T K G L E + + +
Sbjct: 63 IVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG-LPPETIKDLMRQLLRGVD 121
Query: 177 YLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPE 236
+LHS I+HRD+K NIL+ + K++DFG +++ + VV TL Y PE
Sbjct: 122 FLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV--TLWYRAPE 176
Query: 237 YL 238
L
Sbjct: 177 VL 178
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-09
Identities = 44/144 (30%), Positives = 71/144 (49%), Gaps = 5/144 (3%)
Query: 93 VAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEH 152
VAVK + Q + + NE+V++ +NVV + L + ++ EF+ G L +
Sbjct: 49 VAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTD- 107
Query: 153 IHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGAS 212
I L E+ + L YLHS+ +IHRD+KS +ILL + K+SDFG
Sbjct: 108 IVSQTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFC 164
Query: 213 KLVPIDAIQNYTVVQGTLGYIDPE 236
+ D + ++V GT ++ PE
Sbjct: 165 AQISKDVPKRKSLV-GTPYWMAPE 187
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-09
Identities = 42/144 (29%), Positives = 68/144 (47%), Gaps = 5/144 (3%)
Query: 95 VKKSKIVDQTKIDEFI-NELVVVSQINRRNVVRLLACCLETQVPL-LVYEFVGNGTLFEH 152
+KK+ IV + K E E V+ I + + L +T L L+ +++ G LF H
Sbjct: 36 LKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTH 95
Query: 153 IHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGAS 212
+ + + + E L +LH + II+RD+K NILLD N ++DFG S
Sbjct: 96 LSQRERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLS 152
Query: 213 KLVPIDAIQNYTVVQGTLGYIDPE 236
K D ++ GT+ Y+ P+
Sbjct: 153 KEFHEDEVERAYSFCGTIEYMAPD 176
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-09
Identities = 37/101 (36%), Positives = 50/101 (49%), Gaps = 4/101 (3%)
Query: 139 LVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILL 198
V +FV G LF H+ + + R AAE A L YLHS + I++RD+K NILL
Sbjct: 73 FVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILL 129
Query: 199 DENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
D ++DFG K I T GT Y+ PE ++
Sbjct: 130 DSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAPEVIR 169
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-09
Identities = 41/113 (36%), Positives = 55/113 (48%), Gaps = 5/113 (4%)
Query: 128 LACCLETQVPLL-VYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPI 186
L C +T+ L V EF+ G L HI G R AAE L +LHS+ I
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG---I 117
Query: 187 IHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
I+RD+K N++LD + K++DFG K + + GT YI PE LQ
Sbjct: 118 IYRDLKLDNVMLDRDGHIKIADFGMCK-ENVFGDNRASTFCGTPDYIAPEILQ 169
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-09
Identities = 46/133 (34%), Positives = 68/133 (51%), Gaps = 9/133 (6%)
Query: 110 INELVVVSQINRRNVVRLLACCLETQVPL-LVYEFVGNGTLFEHIHKNGNLTW--ERRLR 166
+NE ++ ++N R VV L A ET+ L LV + G L HI+ GN + +R +
Sbjct: 48 LNEKRILEKVNSRFVVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIF 106
Query: 167 IAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVV 226
AAE L L E I++RD+K NILLD+ ++SD G + +P V
Sbjct: 107 YAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV- 162
Query: 227 QGTLGYIDPEYLQ 239
GT+GY+ PE +
Sbjct: 163 -GTVGYMAPEVIN 174
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-09
Identities = 42/174 (24%), Positives = 75/174 (43%), Gaps = 34/174 (19%)
Query: 73 VIGCGGSGNVYKGF------LPDRTPVAVKKSKI-VDQTKIDEFINELVVVSQINRRNVV 125
+G G G V K T VAVK K +++ + ++E ++ Q+N +V+
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 126 RLLACCLETQVPLLVYEFVGNGTLFE-----------HIHKNGN-------------LTW 161
+L C + LL+ E+ G+L ++ +GN LT
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 162 ERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLV 215
+ A + + + YL + ++HRD+ + N+L+ E K+SDFG S+ V
Sbjct: 127 GDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-09
Identities = 41/157 (26%), Positives = 68/157 (43%), Gaps = 19/157 (12%)
Query: 73 VIGCGGSGNVYKGFLP------DRTPVAVKK-SKIVDQTKIDEFINELVVVSQINRRNVV 125
+G G G V+ T V VK K D+ EF EL + +++ +NVV
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 126 RLLACCLETQVPLLVYEFVGNGTL--FEHIHKNG-------NLTWERRLRIAAETAGVLS 176
RLL C E + ++ E+ G L F K+ L+ ++++ + + A +
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 177 YLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASK 213
+L +N +HRD+ + N L+ KVS SK
Sbjct: 132 HL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK 165
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-09
Identities = 39/114 (34%), Positives = 57/114 (50%), Gaps = 7/114 (6%)
Query: 128 LACCLETQVPLL-VYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPI 186
L C +T+ L V E++ G L HI +G R AAE L +LH + I
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG---I 117
Query: 187 IHRDVKSANILLDENYTPKVSDFGASKL-VPIDAIQNYTVVQGTLGYIDPEYLQ 239
I+RD+K N+LLD++ K++DFG K + + + GT YI PE L+
Sbjct: 118 IYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAS--TFCGTPDYIAPEILK 169
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-09
Identities = 43/133 (32%), Positives = 68/133 (51%), Gaps = 9/133 (6%)
Query: 110 INELVVVSQINRRNVVRLLACCLETQVPL-LVYEFVGNGTLFEHIHKNGNLTW-ERRLRI 167
+NE ++ +++ R +V L A ET+ L LV + G L HI+ G + E R
Sbjct: 41 LNEKKILEKVSSRFIVSL-AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIF 99
Query: 168 -AAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVV 226
AA+ L +LH I++RD+K N+LLD++ ++SD G + V + +
Sbjct: 100 YAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGR 154
Query: 227 QGTLGYIDPEYLQ 239
GT GY+ PE LQ
Sbjct: 155 AGTPGYMAPEVLQ 167
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-09
Identities = 42/150 (28%), Positives = 73/150 (48%), Gaps = 9/150 (6%)
Query: 74 IGCGGSGNVYKGFLPDRTP---VAVKKSKIVDQTKI-DEFINELVVVSQINRRNVVRLLA 129
+G G G V KG R VA+K K ++ + DE + E ++ Q++ +VR++
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 130 CCLETQVPLLVYEFVGNGTLFEHIH-KNGNLTWERRLRIAAETAGVLSYLHSETNVPIIH 188
C E + +LV E G L + + K +T + + + + + YL + +H
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVH 118
Query: 189 RDVKSANILLDENYTPKVSDFGASKLVPID 218
RD+ + N+LL + K+SDFG SK + D
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSKALGAD 148
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-09
Identities = 45/159 (28%), Positives = 70/159 (44%), Gaps = 22/159 (13%)
Query: 73 VIGCGGSGNVYKGFL------PDRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNV 124
+G G G VY+G VAVK +Q + D F+ E +++S+ N +N+
Sbjct: 13 ALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESD-FLMEALIMSKFNHQNI 71
Query: 125 VRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGN-------LTWERRLRIAAETAGVLSY 177
VRL+ E ++ E + G L + +N LT + L A + A Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 178 LHSETNVPIIHRDVKSANILLD---ENYTPKVSDFGASK 213
L E N IHRD+ + N LL K++DFG ++
Sbjct: 132 L--EEN-HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-09
Identities = 37/148 (25%), Positives = 71/148 (47%), Gaps = 9/148 (6%)
Query: 72 DVIGCGGSGNVYKGFLPDRTPVAVKK------SKIVDQTKIDEFINELVVVSQINRRNVV 125
+V+G G G VY G +AVK+ + + + + ++ E+ ++ + N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 126 RLLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVP 185
+ L CL+ + EFV G++ +++ G L + + ++YLH V
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLH-NNCV- 123
Query: 186 IIHRDVKSANILLDENYTPKVSDFGASK 213
+HRD+K N++L N K+ DFG ++
Sbjct: 124 -VHRDIKGNNVMLMPNGIIKLIDFGCAR 150
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 3e-09
Identities = 40/165 (24%), Positives = 76/165 (46%), Gaps = 29/165 (17%)
Query: 74 IGCGGSGNVYKGFL------PDRTPVAVKKSKIVDQTKID--EFINELVVVSQINR-RNV 124
+G G G V K + + VAVK K D T+ D + ++E+ ++ I + +N+
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLK-DDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 125 VRLLACCLETQVPLLVYEFVGNGTLFEHIHKN----------------GNLTWERRLRIA 168
+ LL C + +V E+ +G L + + LT + + A
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 169 AETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASK 213
+ A + +L S+ IHRD+ + N+L+ E++ K++DFG ++
Sbjct: 139 YQVARGMEFLASKK---CIHRDLAARNVLVTEDHVMKIADFGLAR 180
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 3e-09
Identities = 37/99 (37%), Positives = 51/99 (51%), Gaps = 4/99 (4%)
Query: 140 VYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLD 199
V ++V G LF H+ + + R AAE A L YLHS + II+RD+K NILLD
Sbjct: 74 VLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLD 130
Query: 200 ENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYL 238
++DFG K I+ + + GT Y+ PE L
Sbjct: 131 SQGHVVLTDFGLCK-EGIEHSKTTSTFCGTPEYLAPEVL 168
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-09
Identities = 52/176 (29%), Positives = 78/176 (44%), Gaps = 15/176 (8%)
Query: 69 NYADVIGCGGSGNVYKGFLPDRTPV-------AVKKSKIVDQTKIDEFINELVVVSQINR 121
N+ V+G G G V L +R +KK ++ ++ + E V++ +
Sbjct: 3 NFLMVLGKGSFGKV---MLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGK 59
Query: 122 RNVVRLLACCLETQVPL-LVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHS 180
+ L C +T L V E+V G L I + G + AAE A L +LHS
Sbjct: 60 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHS 119
Query: 181 ETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPE 236
+ II+RD+K N++LD K++DFG K D + T GT YI PE
Sbjct: 120 KG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFC-GTPDYIAPE 171
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-09
Identities = 43/149 (28%), Positives = 72/149 (48%), Gaps = 12/149 (8%)
Query: 95 VKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPL-LVYEFVGNGTLFEHI 153
++K I+ + ++ + E V+ Q R + L +T L V E+ G LF H+
Sbjct: 28 LRKEVIIAKDEVAHTVTESRVL-QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL 86
Query: 154 HKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASK 213
+ T ER AE L YLHS +++RD+K N++LD++ K++DFG K
Sbjct: 87 SRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK 143
Query: 214 LVPIDAIQNYTVVQ---GTLGYIDPEYLQ 239
+ I + ++ GT Y+ PE L+
Sbjct: 144 ----EGISDGATMKTFCGTPEYLAPEVLE 168
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-09
Identities = 45/183 (24%), Positives = 85/183 (46%), Gaps = 19/183 (10%)
Query: 72 DVIGCGGSGNVYKGFLPDRTPV-AVKKSKI----------VDQTKIDEFINELVVVSQIN 120
++IG G G VY + AVK+ ++ + + +E+ + ++
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 121 RRNVVRLLACCLETQVPLLVY-EFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLH 179
N+V+ L T+ L ++ E+V G++ + G + + L+YLH
Sbjct: 67 HLNIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH 125
Query: 180 SETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNY--TVVQGTLGYIDPEY 237
S+ I+HRD+K+ N+L+D + K+SDFG SK D N +QG++ ++ PE
Sbjct: 126 SKG---ILHRDLKADNLLVDADGICKISDFGISKKSD-DIYDNDQNMSMQGSVFWMAPEV 181
Query: 238 LQT 240
+ +
Sbjct: 182 IHS 184
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-09
Identities = 44/146 (30%), Positives = 72/146 (49%), Gaps = 5/146 (3%)
Query: 93 VAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEH 152
VAVKK + Q + + NE+V++ NVV + L +V EF+ G L +
Sbjct: 48 VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD- 106
Query: 153 IHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGAS 212
I + + E+ + LS LH++ +IHRD+KS +ILL + K+SDFG
Sbjct: 107 IVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFC 163
Query: 213 KLVPIDAIQNYTVVQGTLGYIDPEYL 238
V + + ++V GT ++ PE +
Sbjct: 164 AQVSKEVPRRKSLV-GTPYWMAPELI 188
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 6e-09
Identities = 43/161 (26%), Positives = 74/161 (45%), Gaps = 17/161 (10%)
Query: 91 TPVAVKKSKIVDQTKID------EFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFV 144
T +AVK+ V T + E+ +++++N +++R+L E L E++
Sbjct: 26 TLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWM 85
Query: 145 GNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDEN-YT 203
G++ + K G + + LSYLH IIHRDVK AN+L+D
Sbjct: 86 AGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQR 142
Query: 204 PKVSDFGA-----SKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
+++DFGA +K Q + GT+ ++ PE L+
Sbjct: 143 LRIADFGAAARLAAKGTGAGEFQGQLL--GTIAFMAPEVLR 181
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 7e-09
Identities = 46/161 (28%), Positives = 70/161 (43%), Gaps = 25/161 (15%)
Query: 74 IGCGGSGNVYKGFLPD-------RTPVAVK--KSKIVDQTKIDEFINELVVVSQINRRNV 124
+G G G VY+G D VAVK + DQ K EF+ E ++S N N+
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKK-EFLKEAHLMSNFNHPNI 61
Query: 125 VRLLACCLETQVPLLVYEFVGNGTLFEHIHK-------NGNLTWERRLRIAAETAGVLSY 177
V+LL CL + ++ E + G L ++ LT + L I + A Y
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 178 LHSETNVPIIHRDVKSANILLDE-----NYTPKVSDFGASK 213
L + IHRD+ + N L+ E + K+ DFG ++
Sbjct: 122 LE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 8e-09
Identities = 39/143 (27%), Positives = 71/143 (49%), Gaps = 5/143 (3%)
Query: 74 IGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLE 133
+G G G V+ G + VA+K ++ ++FI E V+ +++ +V+L C +
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSE-EDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 134 TQVPLLVYEFVGNGTLFEHI-HKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVK 192
+ +V EF+ NG L ++ + G L+ + L + + + YL + IHRD+
Sbjct: 71 QKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLA 127
Query: 193 SANILLDENYTPKVSDFGASKLV 215
+ N L+ KVSDFG ++ V
Sbjct: 128 ARNCLVSSTGVVKVSDFGMTRYV 150
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 9e-09
Identities = 37/124 (29%), Positives = 55/124 (44%), Gaps = 9/124 (7%)
Query: 94 AVKKSKIVDQTKIDEFINE---LVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLF 150
A+KK I+ + +++ + E + +V L AC V E+ G L
Sbjct: 31 ALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLM 90
Query: 151 EHIHKNGNLTWERRLRI-AAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDF 209
HIH + + E R AA L YLH I++RD+K N+LLD K++DF
Sbjct: 91 MHIHTD--VFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADF 145
Query: 210 GASK 213
G K
Sbjct: 146 GLCK 149
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-08
Identities = 36/103 (34%), Positives = 50/103 (48%), Gaps = 8/103 (7%)
Query: 139 LVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILL 198
V ++V G LF H+ + R AAE A + YLHS II+RD+K NILL
Sbjct: 73 FVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILL 129
Query: 199 DENYTPKVSDFGASK--LVPIDAIQNYTVVQGTLGYIDPEYLQ 239
D ++DFG K + P + + GT Y+ PE L+
Sbjct: 130 DSQGHVVLTDFGLCKEGVEPEETTSTFC---GTPEYLAPEVLR 169
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-08
Identities = 54/183 (29%), Positives = 84/183 (45%), Gaps = 38/183 (20%)
Query: 74 IGCGGSGNVYKGF-LPDRTPVAVKKSKIV-----DQTKIDEFINELVVVSQINRRNVVRL 127
IG G G VYK P A+K V + T + E+ ++ +N NVV+
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALK----VIYGNHEDTVRRQICREIEILRDVNHPNVVK- 136
Query: 128 LACCL-------ETQVPLLVYEFVGNGTL-FEHIHKNGNLTWERRLRIAAETAGVLSYLH 179
C E QV L EF+ G+L HI L +A + ++YLH
Sbjct: 137 ---CHDMFDHNGEIQVLL---EFMDGGSLEGTHIADEQFLA-----DVARQILSGIAYLH 185
Query: 180 SETNVPIIHRDVKSANILLDENYTPKVSDFGASKLV--PIDAIQNYTVVQGTLGYIDPEY 237
I+HRD+K +N+L++ K++DFG S+++ +D N +V GT+ Y+ PE
Sbjct: 186 RRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC-NSSV--GTIAYMSPER 239
Query: 238 LQT 240
+ T
Sbjct: 240 INT 242
|
Length = 353 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-08
Identities = 42/165 (25%), Positives = 73/165 (44%), Gaps = 24/165 (14%)
Query: 70 YADVIGCGGSGNVYKGFLP---DRTPVAVKKSK-IVDQTKIDEFINELVVVSQINRR-NV 124
+ DVIG G G V + + + A+K K + +F EL V+ ++ N+
Sbjct: 6 FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNI 65
Query: 125 VRLLACCLETQVPLLVYEFVGNGTLFEHIHKN----------------GNLTWERRLRIA 168
+ LL C + E+ G L + + K+ LT ++ L+ A
Sbjct: 66 INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125
Query: 169 AETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASK 213
++ A + YL + IHRD+ + N+L+ EN K++DFG S+
Sbjct: 126 SDVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSR 167
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-08
Identities = 52/172 (30%), Positives = 81/172 (47%), Gaps = 14/172 (8%)
Query: 72 DVIGCGGSGNVYKGF-LPDRTPVAVKKSKI-VDQTKIDEFINELVVVSQINRRNVVRLLA 129
D +G G G+VYK P +A+K+ ++ +D++K ++ I EL ++ + +V
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYG 66
Query: 130 CCLETQVPLLVYEFVGNGTLFEHIHKNGNLTW---ERRL-RIAAETAGVLSYLHSETNVP 185
+ E++ G+L + ++ G T E L RI L +L E N
Sbjct: 67 AFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN-- 123
Query: 186 IIHRDVKSANILLDENYTPKVSDFGAS-KLVPIDAIQNYTVVQGTLGYIDPE 236
IIHRDVK N+L++ N K+ DFG S LV A N G Y+ PE
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI----GCQSYMAPE 171
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-08
Identities = 48/182 (26%), Positives = 84/182 (46%), Gaps = 24/182 (13%)
Query: 73 VIGCGGSGNVY---KGFLPD----------RTPVAVKKSKIVDQTKIDEFINELVVVSQI 119
V+G G G V+ K D + V+K+K V+ T+ E V+ +
Sbjct: 7 VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTR-----TERNVLEHV 61
Query: 120 NRRNVVRLLACCLETQVPL-LVYEFVGNGTLFEHIHKNGNLTWERRLRI-AAETAGVLSY 177
+ + L +T+ L L+ ++V G +F H+++ N + E +R + E L +
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFS-EDEVRFYSGEIILALEH 120
Query: 178 LHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEY 237
LH + I++RD+K NILLD ++DFG SK + + GT+ Y+ PE
Sbjct: 121 LH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEI 177
Query: 238 LQ 239
++
Sbjct: 178 IR 179
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-08
Identities = 33/103 (32%), Positives = 51/103 (49%), Gaps = 4/103 (3%)
Query: 139 LVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILL 198
L+ E++ G LF H+ + G + +E + L +LH + II+RD+K NILL
Sbjct: 77 LILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILL 133
Query: 199 DENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQTC 241
D K++DFG K + +T GT+ Y+ PE L
Sbjct: 134 DAQGHVKLTDFGLCKESIHEGTVTHTFC-GTIEYMAPEILMRS 175
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-08
Identities = 49/179 (27%), Positives = 84/179 (46%), Gaps = 23/179 (12%)
Query: 73 VIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDE----FINELVVVSQINRRNVVRLL 128
+IG GG G VY D + K + K+ + +NE +++S ++ + ++
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 129 ACCLETQVP---LLVYEFVGNGTLFEHIHKNGNLTWERRLRI-AAETAGVLSYLHSETNV 184
P + + + G L H+ ++G + E+ +R A E L ++H N
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFS-EKEMRFYATEIILGLEHMH---NR 116
Query: 185 PIIHRDVKSANILLDENYTPKVSDFGA----SKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
+++RD+K ANILLDE+ ++SD G SK P ++ GT GY+ PE LQ
Sbjct: 117 FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-------GTHGYMAPEVLQ 168
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-08
Identities = 38/148 (25%), Positives = 63/148 (42%), Gaps = 13/148 (8%)
Query: 94 AVKKSKIVDQTKIDEFINE-LVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEH 152
+KKS ++ + ++ E +++ Q V +L LV E++ G
Sbjct: 28 VLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASL 87
Query: 153 IHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGAS 212
I G L + + AE + LH IIHRD+K N+L+D+ K++DFG S
Sbjct: 88 IKTLGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLS 144
Query: 213 K--LVPIDAIQNYTVVQGTLGYIDPEYL 238
+ L + GT Y+ PE +
Sbjct: 145 RNGLENKKFV-------GTPDYLAPETI 165
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 3e-08
Identities = 51/176 (28%), Positives = 79/176 (44%), Gaps = 13/176 (7%)
Query: 72 DVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINR-RNVVRLLAC 130
+++G G G VYKG +A K V + +E E+ ++ + + RN+
Sbjct: 12 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 71
Query: 131 CLETQVP------LLVYEFVGNGTLFEHIH--KNGNLTWERRLRIAAETAGVLSYLHSET 182
++ P LV EF G G++ + I K L E I E LS+LH
Sbjct: 72 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK 131
Query: 183 NVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYL 238
+IHRD+K N+LL EN K+ DFG S + + T + GT ++ PE +
Sbjct: 132 ---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVI 183
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 3e-08
Identities = 40/112 (35%), Positives = 54/112 (48%), Gaps = 5/112 (4%)
Query: 128 LACCLETQVPLL-VYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPI 186
L C +T+ L V E++ G L HI R AAE L +LHS+ I
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG---I 117
Query: 187 IHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYL 238
++RD+K NILLD + K++DFG K + + T GT YI PE L
Sbjct: 118 VYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC-GTPDYIAPEIL 168
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 3e-08
Identities = 49/200 (24%), Positives = 76/200 (38%), Gaps = 35/200 (17%)
Query: 72 DVIGCGGSGNVYKGFLPD-RTPVAVK---KSKIVDQTKIDEFINELVVVSQINRRNVVRL 127
VIG G G V+ D A+K KS ++ + +I E +++ + +V+L
Sbjct: 7 KVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKL 66
Query: 128 LACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPII 187
+ + LV E++ G L + + E AE L +H + I
Sbjct: 67 YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHK---LGFI 123
Query: 188 HRDVKSANILLDENYTPKVSDFGASK------------------------LVPIDAIQNY 223
HRD+K NIL+D + K++DFG K LV +
Sbjct: 124 HRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQR 183
Query: 224 TVVQ----GTLGYIDPEYLQ 239
V GT YI PE L+
Sbjct: 184 RVRANSTVGTPDYIAPEVLR 203
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 3e-08
Identities = 51/181 (28%), Positives = 85/181 (46%), Gaps = 27/181 (14%)
Query: 73 VIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDE------FINELVVVSQINRRNVVR 126
+IG GG G VY D + K +D+ +I +NE +++S ++ +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKC--LDKKRIKMKQGETLALNERIMLSLVSTGDCPF 58
Query: 127 LLACCLETQVP---LLVYEFVGNGTLFEHIHKNGNLTWERRLRI-AAETAGVLSYLHSET 182
++ P + + + G L H+ ++G + E +R AAE L ++H
Sbjct: 59 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS-EAEMRFYAAEIILGLEHMH--- 114
Query: 183 NVPIIHRDVKSANILLDENYTPKVSDFGA----SKLVPIDAIQNYTVVQGTLGYIDPEYL 238
N +++RD+K ANILLDE+ ++SD G SK P ++ GT GY+ PE L
Sbjct: 115 NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-------GTHGYMAPEVL 167
Query: 239 Q 239
Q
Sbjct: 168 Q 168
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-08
Identities = 42/140 (30%), Positives = 69/140 (49%), Gaps = 18/140 (12%)
Query: 103 QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPL-LVYEFVGNGTLFEHIHKNGN--L 159
+ +I E +N +V+ LA E++ L LV + G L HI+ G L
Sbjct: 43 EKEILEKVNSPFIVN----------LAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGL 92
Query: 160 TWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDA 219
ER + +A+ + +LHS + I++RD+K N+LLD+ ++SD G + V +
Sbjct: 93 EMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLA--VELKD 147
Query: 220 IQNYTVVQGTLGYIDPEYLQ 239
+ T GT GY+ PE L+
Sbjct: 148 GKTITQRAGTNGYMAPEILK 167
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 6e-08
Identities = 47/163 (28%), Positives = 74/163 (45%), Gaps = 24/163 (14%)
Query: 72 DVIGCGGSGNVYKGFLPD---RTPVAVKKSK-IVDQTKIDEFINELVVVSQINRR-NVVR 126
DVIG G G V K + R A+K+ K + +F EL V+ ++ N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 127 LLACCLETQVPLLVYEFVGNGTLFEHIHKN----------------GNLTWERRLRIAAE 170
LL C L E+ +G L + + K+ L+ ++ L AA+
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 171 TAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASK 213
A + YL + IHRD+ + NIL+ ENY K++DFG S+
Sbjct: 121 VARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR 160
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 6e-08
Identities = 37/131 (28%), Positives = 64/131 (48%), Gaps = 7/131 (5%)
Query: 112 ELVVVSQINRRNVVRLLACCLE-TQVPLLVY-EFVGNGTLFEHIHKNGNLTWERRLRIAA 169
E+ ++ + +V+ C + + L ++ E++ G++ + + G LT R
Sbjct: 54 EIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTR 113
Query: 170 ETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTV--VQ 227
+ +SYLHS I+HRD+K ANIL D K+ DFGASK + + + V
Sbjct: 114 QILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT 170
Query: 228 GTLGYIDPEYL 238
GT ++ PE +
Sbjct: 171 GTPYWMSPEVI 181
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 7e-08
Identities = 35/101 (34%), Positives = 49/101 (48%), Gaps = 4/101 (3%)
Query: 139 LVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILL 198
V +++ G LF H+ + R AAE A L YLHS + I++RD+K NILL
Sbjct: 73 FVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILL 129
Query: 199 DENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
D ++DFG K I+ + GT Y+ PE L
Sbjct: 130 DSQGHIVLTDFGLCK-ENIEHNGTTSTFCGTPEYLAPEVLH 169
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 7e-08
Identities = 45/150 (30%), Positives = 71/150 (47%), Gaps = 12/150 (8%)
Query: 72 DVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINR-RNVVRLLAC 130
+V+G G G VYKG +A K V + + +E E+ ++ + + RN+
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81
Query: 131 CLETQVP------LLVYEFVGNGTLFEHIHKN-GNLTWERRLR-IAAETAGVLSYLHSET 182
++ P LV EF G G++ + + GN E + I E L++LH+
Sbjct: 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK 141
Query: 183 NVPIIHRDVKSANILLDENYTPKVSDFGAS 212
+IHRD+K N+LL EN K+ DFG S
Sbjct: 142 ---VIHRDIKGQNVLLTENAEVKLVDFGVS 168
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 7e-08
Identities = 56/188 (29%), Positives = 88/188 (46%), Gaps = 32/188 (17%)
Query: 72 DVIGCGGSGNVYKGFLPDRTP-VAVKKSKIVDQTKIDEF----INELVVVSQINRRNVVR 126
IG G G VYK D VA+KK ++ D K + F I E+ ++ Q+N RN+V
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALKKVRL-DNEK-EGFPITAIREIKILRQLNHRNIVN 70
Query: 127 LLACCLETQVPL----------LVYEFVGNGT--LFE----HIHKNGNLTWERRLRIAAE 170
L + Q L LV+E++ + L E H ++ ++ ++L
Sbjct: 71 LKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEG-- 128
Query: 171 TAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTL 230
L+Y H + +HRD+K +NILL+ K++DFG ++L + + YT TL
Sbjct: 129 ----LNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITL 181
Query: 231 GYIDPEYL 238
Y PE L
Sbjct: 182 WYRPPELL 189
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 8e-08
Identities = 35/101 (34%), Positives = 49/101 (48%), Gaps = 6/101 (5%)
Query: 139 LVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILL 198
LV +++ G LF H+ K G + +R AE L +LH I++RD+K NILL
Sbjct: 73 LVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILL 129
Query: 199 DENYTPKVSDFGASKL-VPIDAIQNYTVVQGTLGYIDPEYL 238
D + DFG SK + + N GT Y+ PE L
Sbjct: 130 DATGHIALCDFGLSKANLTDNKTTN--TFCGTTEYLAPEVL 168
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 9e-08
Identities = 38/143 (26%), Positives = 69/143 (48%), Gaps = 9/143 (6%)
Query: 74 IGCGGSGNVYKGFLPDRTPVAVKKSKIVD---QTKIDEFINELVVVSQINRRNVVRLLAC 130
+G G G VYK + +KI+ + ++++F+ E+ ++S+ N+V L
Sbjct: 13 LGDGAFGKVYKA--QHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEA 70
Query: 131 CLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLR-IAAETAGVLSYLHSETNVPIIHR 189
++ EF G L + + E ++R + + L++LHS +IHR
Sbjct: 71 YFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK---VIHR 127
Query: 190 DVKSANILLDENYTPKVSDFGAS 212
D+K+ NILL + K++DFG S
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVS 150
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-07
Identities = 37/145 (25%), Positives = 75/145 (51%), Gaps = 9/145 (6%)
Query: 74 IGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLE 133
+G G G V+ T VAVK K ++ F+ E V+ + +V+L A
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVV-- 70
Query: 134 TQVPL-LVYEFVGNGTLFEHIHKN-GN-LTWERRLRIAAETAGVLSYLHSETNVPIIHRD 190
T+ P+ ++ EF+ G+L + + + G+ + + +A+ A ++++ IHRD
Sbjct: 71 TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRD 127
Query: 191 VKSANILLDENYTPKVSDFGASKLV 215
+++ANIL+ + K++DFG ++++
Sbjct: 128 LRAANILVSASLVCKIADFGLARVI 152
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-07
Identities = 49/173 (28%), Positives = 80/173 (46%), Gaps = 17/173 (9%)
Query: 74 IGCGGSGNVYK------GFLPDRTPVAVK-KSKIVDQTKIDEFINELVVVSQINRRNVVR 126
+G G G V+K G + R + ++ K I +Q I EL V+ + N +V
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQ-----IIRELQVLHECNSPYIVG 67
Query: 127 LLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPI 186
+ E + G+L + + K G + + +++ L+YL + I
Sbjct: 68 FYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--I 125
Query: 187 IHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
+HRDVK +NIL++ K+ DFG S + ID++ N V GT Y+ PE LQ
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFV--GTRSYMSPERLQ 175
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-07
Identities = 31/89 (34%), Positives = 49/89 (55%), Gaps = 5/89 (5%)
Query: 149 LFEHIHKNGNLTWERRL-RIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVS 207
++ ++ G E L +IA L YLHS+ +V IHRDVK +N+L++ N K+
Sbjct: 89 FYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSV--IHRDVKPSNVLINRNGQVKLC 146
Query: 208 DFGASKLVPIDAIQNYTVVQGTLGYIDPE 236
DFG S + +D++ T+ G Y+ PE
Sbjct: 147 DFGISGYL-VDSVAK-TIDAGCKPYMAPE 173
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-07
Identities = 36/141 (25%), Positives = 63/141 (44%), Gaps = 19/141 (13%)
Query: 89 DRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGT 148
D+ VAVK K +F E +++ + ++V+ C + ++V+E++ +G
Sbjct: 34 DKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGD 93
Query: 149 L--FEHIH--------------KNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVK 192
L F H G L + L IA++ A + YL S+ +HRD+
Sbjct: 94 LNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLA 150
Query: 193 SANILLDENYTPKVSDFGASK 213
+ N L+ N K+ DFG S+
Sbjct: 151 TRNCLVGANLLVKIGDFGMSR 171
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-07
Identities = 28/65 (43%), Positives = 39/65 (60%), Gaps = 5/65 (7%)
Query: 175 LSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYID 234
L+YL + I+HRDVK +NIL++ K+ DFG S + ID++ N V GT Y+
Sbjct: 112 LTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFV--GTRSYMS 166
Query: 235 PEYLQ 239
PE LQ
Sbjct: 167 PERLQ 171
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-07
Identities = 37/138 (26%), Positives = 69/138 (50%), Gaps = 8/138 (5%)
Query: 93 VAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVP--LLVYEFVGNGTLF 150
VAVKK + + +F E+ ++ + N+V+ C LV E++ G+L
Sbjct: 36 VAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLR 95
Query: 151 EHIHKNGN-LTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDF 209
+++ K+ L + L A++ + YL S+ +HRD+ + NIL++ K+ DF
Sbjct: 96 DYLQKHRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDF 152
Query: 210 GASKLVPIDAIQNYTVVQ 227
G +K++P D + Y V+
Sbjct: 153 GLTKVLPQD--KEYYKVR 168
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-07
Identities = 57/187 (30%), Positives = 83/187 (44%), Gaps = 23/187 (12%)
Query: 65 TVTNNYADV--IGCGGSGNVYKGFLPDRT---PVAVKK--SKIVDQTKIDEFINELVVVS 117
TV Y + IG G G V F D VAVKK +QT ELV++
Sbjct: 18 TVLKRYQQLKPIGSGAQGIVCAAF--DTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLK 75
Query: 118 QINRRNVVRLL------ACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAET 171
+N +N++ LL E Q LV E + + L + IH L ER + +
Sbjct: 76 CVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIHME--LDHERMSYLLYQM 132
Query: 172 AGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLG 231
+ +LHS IIHRD+K +NI++ + T K+ DFG ++ + + VV T
Sbjct: 133 LCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV--TRY 187
Query: 232 YIDPEYL 238
Y PE +
Sbjct: 188 YRAPEVI 194
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 3e-07
Identities = 44/154 (28%), Positives = 70/154 (45%), Gaps = 18/154 (11%)
Query: 93 VAVKK------SKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGN 146
VA+KK K+V KI + E+ ++ Q+ N+V L+ + LV+EFV +
Sbjct: 29 VAIKKFLESEDDKMVK--KIA--MREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDH 84
Query: 147 GTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKV 206
L + L R + + + + HS IIHRD+K NIL+ ++ K+
Sbjct: 85 TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKL 141
Query: 207 SDFGASKLV--PIDAIQNYTVVQGTLGYIDPEYL 238
DFG ++ + P + YT T Y PE L
Sbjct: 142 CDFGFARTLAAPGEV---YTDYVATRWYRAPELL 172
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-07
Identities = 40/131 (30%), Positives = 65/131 (49%), Gaps = 12/131 (9%)
Query: 115 VVSQINRRNVVRLLACCLETQVPL-LVYEFVGNGTLFEHIH----KNGNLTWERRLRIAA 169
++++++ R +V L A +T+ L LV + G L HI+ +N R A
Sbjct: 46 ILAKVHSRFIVSL-AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTA 104
Query: 170 ETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTV-VQG 228
+ L +LH II+RD+K N+LLD + ++SD G + V + Q+ T G
Sbjct: 105 QIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKTKGYAG 159
Query: 229 TLGYIDPEYLQ 239
T G++ PE LQ
Sbjct: 160 TPGFMAPELLQ 170
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-07
Identities = 44/167 (26%), Positives = 77/167 (46%), Gaps = 26/167 (15%)
Query: 70 YADVIGCGGSGNVYKG--FLPDRTP---VAVKKSK-IVDQTKIDEFINELVVVSQINRRN 123
+ + +G G +YKG +LP VA+K K I + + EF E ++++++ N
Sbjct: 9 FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPN 68
Query: 124 VVRLLACCLETQVPLLVYEFVGNGTLFEHI-----HKN------------GNLTWERRLR 166
+V LL + Q +++E++ G L E + H + +L L
Sbjct: 69 IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128
Query: 167 IAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASK 213
IA + A + YL S +H+D+ + NIL+ E K+SD G S+
Sbjct: 129 IAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 3e-07
Identities = 52/176 (29%), Positives = 85/176 (48%), Gaps = 22/176 (12%)
Query: 74 IGCGGSGNVYKG--FLPDRTPVAVKKSKIVDQTKIDE-----FINELVVVSQINRRNVVR 126
IG G G VYK L VA+KK ++ + DE I E+ ++ ++N N+VR
Sbjct: 7 IGEGTYGVVYKARDKLTGEI-VALKKIRLETE---DEGVPSTAIREISLLKELNHPNIVR 62
Query: 127 LLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRL--RIAAETAGVLSYLHSETNV 184
LL LV+EF+ + L +++ + + L + ++Y HS
Sbjct: 63 LLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR-- 119
Query: 185 PIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYT--VVQGTLGYIDPEYL 238
++HRD+K N+L+D K++DFG ++ + ++ YT VV TL Y PE L
Sbjct: 120 -VLHRDLKPQNLLIDREGALKLADFGLARAFGV-PVRTYTHEVV--TLWYRAPEIL 171
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 3e-07
Identities = 46/182 (25%), Positives = 80/182 (43%), Gaps = 33/182 (18%)
Query: 74 IGCGGSGNVYKGFLPDRTP---VAVKKSKIVDQTKIDE-----FINELVVVSQINRRNVV 125
IG G G VYKG ++ VA+KK ++ + +E I E+ ++ ++ N+V
Sbjct: 8 IGEGTYGVVYKG--RNKKTGQIVAMKKIRLESE---EEGVPSTAIREISLLKELQHPNIV 62
Query: 126 RLLACCLETQVPLLVYEFVGNG--TLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETN 183
L ++ L++EF+ + + K + + V SYL+
Sbjct: 63 CLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYM----------DAELVKSYLYQILQ 112
Query: 184 V-------PIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPE 236
++HRD+K N+L+D K++DFG ++ I ++ YT TL Y PE
Sbjct: 113 GILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI-PVRVYTHEVVTLWYRAPE 171
Query: 237 YL 238
L
Sbjct: 172 VL 173
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 4e-07
Identities = 34/98 (34%), Positives = 53/98 (54%), Gaps = 5/98 (5%)
Query: 142 EFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDEN 201
EF+ G+L K G + E +IA L+YL++ I+HRD+K +NIL++
Sbjct: 83 EFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSR 140
Query: 202 YTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
K+ DFG S + I++I + V GT Y+ PE +Q
Sbjct: 141 GQIKLCDFGVSGEL-INSIADTFV--GTSTYMSPERIQ 175
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 4e-07
Identities = 45/176 (25%), Positives = 80/176 (45%), Gaps = 13/176 (7%)
Query: 73 VIGCGGSGNVYKGFLPDR-TPVAVKKSKIVDQT-----KIDEFINELVVVSQINRRNVVR 126
++G G G VY + D +AVK+ + ++ +++ E+ ++ + +V+
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 127 LLACCLETQVPLL--VYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNV 184
C + L E + G++ + + G LT + + +SYLHS
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM-- 126
Query: 185 PIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTV--VQGTLGYIDPEYL 238
I+HRD+K ANIL D K+ DFGASK + + + V GT ++ PE +
Sbjct: 127 -IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 4e-07
Identities = 36/131 (27%), Positives = 64/131 (48%), Gaps = 7/131 (5%)
Query: 112 ELVVVSQINRRNVVRLLACCLE-TQVPLLVY-EFVGNGTLFEHIHKNGNLTWERRLRIAA 169
E+ ++ + +V+ C + + L ++ E++ G++ + + G LT +
Sbjct: 54 EIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTR 113
Query: 170 ETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTV--VQ 227
+ +SYLHS I+HRD+K ANIL D K+ DFGASK + + + V
Sbjct: 114 QILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT 170
Query: 228 GTLGYIDPEYL 238
GT ++ PE +
Sbjct: 171 GTPYWMSPEVI 181
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 5e-07
Identities = 40/144 (27%), Positives = 77/144 (53%), Gaps = 11/144 (7%)
Query: 74 IGCGGSGNVYKGFLPDRTPVAVKKSKIVD---QTKIDEFINELVVVSQINRRNVVRLL-A 129
+G G G VYK ++ + +K++D + ++++++ E+ +++ + N+V+LL A
Sbjct: 13 LGDGAFGKVYKA--QNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 70
Query: 130 CCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAA-ETAGVLSYLHSETNVPIIH 188
E + +L+ EF G + + + E ++R+ +T L+YLH IIH
Sbjct: 71 FYYENNLWILI-EFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK---IIH 126
Query: 189 RDVKSANILLDENYTPKVSDFGAS 212
RD+K+ NIL + K++DFG S
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVS 150
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 7e-07
Identities = 44/142 (30%), Positives = 62/142 (43%), Gaps = 15/142 (10%)
Query: 109 FINELVVVSQINRRNVVRLLACCLETQVPLL--VYEFVGNGTLFEHIHKNGNLTWERRLR 166
F E + +++ N+V LL E LL V+E+V TL E + +G L R
Sbjct: 25 FRRETALCARLYHPNIVALLDSG-EAPPGLLFAVFEYVPGRTLREVLAADGALPAGETGR 83
Query: 167 IAAETAGVLSYLHSETNVPIIHRDVKSANILL---DENYTPKVSDFGASKLVP----IDA 219
+ + L+ H N I+HRD+K NI++ KV DFG L+P D
Sbjct: 84 LMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADV 140
Query: 220 IQ--NYTVVQGTLGYIDPEYLQ 239
T V GT Y PE L+
Sbjct: 141 ATLTRTTEVLGTPTYCAPEQLR 162
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 8e-07
Identities = 46/172 (26%), Positives = 83/172 (48%), Gaps = 25/172 (14%)
Query: 88 PDR-TPVAVKKSKIVDQTKID--EFINELVVVSQINR-RNVVRLLACCLETQVPLLVYEF 143
P+R T VAVK K D T+ D + I+E+ ++ I + +N++ LL C + ++ E+
Sbjct: 47 PNRVTKVAVKMLK-SDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEY 105
Query: 144 VGNGTLFEHIH----------------KNGNLTWERRLRIAAETAGVLSYLHSETNVPII 187
G L E++ L+++ + A + A + YL S+ I
Sbjct: 106 ASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CI 162
Query: 188 HRDVKSANILLDENYTPKVSDFG-ASKLVPIDAIQNYTVVQGTLGYIDPEYL 238
HRD+ + N+L+ E+ K++DFG A + ID + T + + ++ PE L
Sbjct: 163 HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL 214
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 8e-07
Identities = 39/162 (24%), Positives = 73/162 (45%), Gaps = 9/162 (5%)
Query: 46 KLQGRSSEKAKIFIEEEIKTVTNNYADVIGCGGSGNVYKG-FLPDRTPVAVKKSKIVDQT 104
+LQ S+ +K +I + +VI G G YKG + + VK+ V+
Sbjct: 671 ELQFFDSKVSKSITINDILSSLKE-ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI 729
Query: 105 KIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERR 164
I ++ ++ N+V+L+ C + L++E++ L E + NL+WERR
Sbjct: 730 P-SSEIADM---GKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR---NLSWERR 782
Query: 165 LRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKV 206
+IA A L +LH + ++ ++ I++D P +
Sbjct: 783 RKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL 824
|
Length = 968 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 8e-07
Identities = 49/153 (32%), Positives = 74/153 (48%), Gaps = 14/153 (9%)
Query: 89 DRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLL-ACCLETQVPLLVYEFVGNG 147
R V VK V K E+ ++ I+ R ++ L+ A ++ V +++ ++ +
Sbjct: 118 QRKKVIVK---AVTGGKTPG--REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCD- 171
Query: 148 TLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVS 207
LF ++ ++G L E+ + I L+YLH IIHRDVK+ NI LDE +
Sbjct: 172 -LFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLG 227
Query: 208 DFGAS-KL-VPIDAIQNYTVVQGTLGYIDPEYL 238
DFGA+ KL D Q Y GTL PE L
Sbjct: 228 DFGAACKLDAHPDTPQCYGWS-GTLETNSPELL 259
|
Length = 392 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 1e-06
Identities = 43/164 (26%), Positives = 78/164 (47%), Gaps = 23/164 (14%)
Query: 70 YADV--IGCGGSGNVYKGFLPD-RTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVR 126
Y D+ +GCG +G V+ D VAVKK + D + + E+ ++ +++ N+V+
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66
Query: 127 LLACCLETQVPLLVYEFVGNGTLFEHIHKNGNL--TWERRL----RIAAETAGV------ 174
+ + L E VG+ T ++ T + ++ E A +
Sbjct: 67 VYEVLGPSGSDL--TEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLL 124
Query: 175 --LSYLHSETNVPIIHRDVKSANILLD-ENYTPKVSDFGASKLV 215
L Y+HS NV +HRD+K AN+ ++ E+ K+ DFG +++V
Sbjct: 125 RGLKYIHS-ANV--LHRDLKPANVFINTEDLVLKIGDFGLARIV 165
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 1e-06
Identities = 34/89 (38%), Positives = 47/89 (52%), Gaps = 10/89 (11%)
Query: 130 CCLETQVPL-LVYEFVGNG---TLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVP 185
C ET+ L +V E+V G TL ++I G L + AET L YLH N
Sbjct: 68 CSFETKRHLCMVMEYVEGGDCATLLKNI---GALPVDMARMYFAETVLALEYLH---NYG 121
Query: 186 IIHRDVKSANILLDENYTPKVSDFGASKL 214
I+HRD+K N+L+ K++DFG SK+
Sbjct: 122 IVHRDLKPDNLLITSMGHIKLTDFGLSKI 150
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-06
Identities = 39/137 (28%), Positives = 70/137 (51%), Gaps = 8/137 (5%)
Query: 93 VAVKKSKIVD-QTKIDEFINELVVVSQINRRNVVRLLACCLET--QVPLLVYEFVGNGTL 149
VAVK K I + E+ ++ + N+V+ C E L+ EF+ +G+L
Sbjct: 36 VAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSL 95
Query: 150 FEHIHKNGN-LTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSD 208
E++ +N N + +++L+ A + + YL S V HRD+ + N+L++ + K+ D
Sbjct: 96 KEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYV---HRDLAARNVLVESEHQVKIGD 152
Query: 209 FGASKLVPIDAIQNYTV 225
FG +K + D + YTV
Sbjct: 153 FGLTKAIETDK-EYYTV 168
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-06
Identities = 42/174 (24%), Positives = 78/174 (44%), Gaps = 10/174 (5%)
Query: 73 VIGCGGSGNVYKGFLPDRTPVAV------KKSKIVDQTKIDEFINELVVVSQINRRNVVR 126
++G G G V + ++ + KKS ++ Q + F E ++S N + +
Sbjct: 8 LVGRGHFGEVQ--VVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQ 65
Query: 127 LLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPI 186
L + LV E+ G L +++ + E + A ++ +HS +
Sbjct: 66 LQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFY--LAELVLAIHSVHQMGY 123
Query: 187 IHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQT 240
+HRD+K N+L+D K++DFG++ + + + N + GT YI PE L T
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTT 177
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (115), Expect = 1e-06
Identities = 38/147 (25%), Positives = 69/147 (46%), Gaps = 19/147 (12%)
Query: 74 IGCGGSGNVYKGFLPDRTP---VAVKKSKIVDQ--TKIDEFIN--ELVVVSQINR-RNVV 125
+G G G+VY ++ VA+KK K + +E +N E+ + ++N N+V
Sbjct: 7 LGDGTFGSVYLA--RNKETGELVAIKKMK---KKFYSWEECMNLREVKSLRKLNEHPNIV 61
Query: 126 RLLACCLETQVPLLVYEFVGNGTLFEHI-HKNGNLTWERRLR-IAAETAGVLSYLHSETN 183
+L E V+E++ G L++ + + G E +R I + L+++H
Sbjct: 62 KLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG- 119
Query: 184 VPIIHRDVKSANILLDENYTPKVSDFG 210
HRD+K N+L+ K++DFG
Sbjct: 120 --FFHRDLKPENLLVSGPEVVKIADFG 144
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-06
Identities = 38/143 (26%), Positives = 72/143 (50%), Gaps = 9/143 (6%)
Query: 74 IGCGGSGNVYKGFLPDRTPVAVKKSKIVD---QTKIDEFINELVVVSQINRRNVVRLLAC 130
+G G G VYK ++ A+ +K+++ + ++++++ E+ +++ N +V+LL
Sbjct: 20 LGDGAFGKVYKA--KNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGA 77
Query: 131 CLETQVPLLVYEFVGNGTLFE-HIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHR 189
++ EF G + + + LT + I + L YLHS IIHR
Sbjct: 78 FYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK---IIHR 134
Query: 190 DVKSANILLDENYTPKVSDFGAS 212
D+K+ N+LL + K++DFG S
Sbjct: 135 DLKAGNVLLTLDGDIKLADFGVS 157
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 2e-06
Identities = 47/171 (27%), Positives = 77/171 (45%), Gaps = 13/171 (7%)
Query: 74 IGCGGSGNVYKGFLPDRTPVA----VKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLA 129
+G GG G V+ D + +KKS + ++ + E +++ +V+LL
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 130 CCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRI-AAETAGVLSYLHSETNVPIIH 188
+ + L E+V G F + N + E R AE + LH + IH
Sbjct: 69 AFQDDEYLYLAMEYVPGGD-FRTLLNNLGVLSEDHARFYMAEMFEAVDALH---ELGYIH 124
Query: 189 RDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
RD+K N L+D + K++DFG SK + A +VV G+ Y+ PE L+
Sbjct: 125 RDLKPENFLIDASGHIKLTDFGLSKGIVTYA---NSVV-GSPDYMAPEVLR 171
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-06
Identities = 41/176 (23%), Positives = 83/176 (47%), Gaps = 15/176 (8%)
Query: 73 VIGCGGSGNVYKGFL--PDRT--PVAVK--KSKIVDQTKIDEFINELVVVSQINRRNVVR 126
++G G G + +G L P + PVA+ ++ D+ + F+ E + + Q + N+VR
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRG-FLAEALTLGQFDHSNIVR 70
Query: 127 LLACCLETQVPLLVYEFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVP 185
L ++V E++ NG L + K+ G L + + + A + YL + +
Sbjct: 71 LEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYL---SEMG 127
Query: 186 IIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQG--TLGYIDPEYLQ 239
+H+ + + +L++ + K+S F + +AI YT + G + + PE +Q
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAI--YTTMSGKSPVLWAAPEAIQ 181
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-06
Identities = 24/62 (38%), Positives = 35/62 (56%)
Query: 178 LHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEY 237
+HS + +HRD+K N+LLD N +++DFG+ + D +V GT YI PE
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEI 174
Query: 238 LQ 239
LQ
Sbjct: 175 LQ 176
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 3e-06
Identities = 39/161 (24%), Positives = 73/161 (45%), Gaps = 24/161 (14%)
Query: 74 IGCGGSGNVYKGFLPD--------RTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVV 125
+G G ++KG + +T V +K + + F ++SQ++ +++V
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 126 RLLACCLETQVPLLVYEFVGNGTLFEHIHKNGNL---TWERRLRIAAETAGVLSYLHSET 182
C+ ++V E+V G+L ++ KN NL +W +L +A + A L +L +
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDKG 120
Query: 183 NVPIIHRDVKSANILL-----DENYTP---KVSDFGASKLV 215
+ H +V + N+LL + P K+SD G S V
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV 158
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 3e-06
Identities = 51/182 (28%), Positives = 90/182 (49%), Gaps = 28/182 (15%)
Query: 74 IGCGGSGNVYKGFLPDRTP---VAVKKSKIVDQTK--IDEFINELVVVSQINRRNVVRLL 128
IG G G VYK ++ VA+KK ++ +T+ I E+ ++ ++N N+V+LL
Sbjct: 8 IGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 65
Query: 129 ACCLETQVPL-LVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGV------LSYLHSE 181
+ T+ L LV+EF L + + K + + + + + + L++ HS
Sbjct: 66 DV-IHTENKLYLVFEF-----LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119
Query: 182 TNVPIIHRDVKSANILLDENYTPKVSDFGASKL--VPIDAIQNYTVVQGTLGYIDPEYLQ 239
++HRD+K N+L++ K++DFG ++ VP ++ YT TL Y PE L
Sbjct: 120 R---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP---VRTYTHEVVTLWYRAPEILL 173
Query: 240 TC 241
C
Sbjct: 174 GC 175
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 4e-06
Identities = 18/36 (50%), Positives = 24/36 (66%), Gaps = 3/36 (8%)
Query: 175 LSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFG 210
L YLHS +IHRD+K +NIL++ N K+ DFG
Sbjct: 116 LKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFG 148
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 4e-06
Identities = 49/174 (28%), Positives = 87/174 (50%), Gaps = 22/174 (12%)
Query: 70 YADVIGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKID-EFINELVVVSQINRRNVVRL 127
Y +++G G G VYK + L R +AVK + ++ + ++EL ++ + + ++
Sbjct: 5 YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGF 64
Query: 128 L-ACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTW---ERRL-RIAAETAGVLSYLHSET 182
A +E ++ + EF+ G+L ++ E L RIA L+YL S
Sbjct: 65 YGAFFVENRISICT-EFMDGGSL--------DVYRKIPEHVLGRIAVAVVKGLTYLWS-- 113
Query: 183 NVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPE 236
+ I+HRDVK +N+L++ K+ DFG S + +++I V GT Y+ PE
Sbjct: 114 -LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL-VNSIAKTYV--GTNAYMAPE 163
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 4e-06
Identities = 43/168 (25%), Positives = 79/168 (47%), Gaps = 24/168 (14%)
Query: 91 TPVAVKKSKIVDQTKID--EFINELVVVSQINR-RNVVRLLACCLETQVPLLVYEFVGNG 147
VAVK K D T D + ++E+ ++ I + +N++ LL C + ++ E+ G
Sbjct: 45 VTVAVKMLKD-DATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKG 103
Query: 148 TLFEHIHK----------------NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDV 191
L E++ LT++ + A + A + YL S+ IHRD+
Sbjct: 104 NLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDL 160
Query: 192 KSANILLDENYTPKVSDFGASKLV-PIDAIQNYTVVQGTLGYIDPEYL 238
+ N+L+ E+ K++DFG ++ V ID + T + + ++ PE L
Sbjct: 161 AARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEAL 208
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 4e-06
Identities = 47/168 (27%), Positives = 77/168 (45%), Gaps = 7/168 (4%)
Query: 74 IGCGGSGNVYK-GFLPDRTPVAVKKSKIVDQTKI-DEFINELVVVSQINRRNVVRLLACC 131
+G G G V K P +A K + + I ++ I EL V+ + N +V
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 132 LETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDV 191
+ E + G+L + + + + E +++ L+YL + I+HRDV
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDV 130
Query: 192 KSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
K +NIL++ K+ DFG S + ID++ N V GT Y+ PE LQ
Sbjct: 131 KPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFV--GTRSYMSPERLQ 175
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 5e-06
Identities = 42/165 (25%), Positives = 79/165 (47%), Gaps = 23/165 (13%)
Query: 72 DVIGCGGSGNVYKGFLPDRTP-----VAVKKSKIVD---QTKIDEFINELVVVSQINRRN 123
D++ G G ++ G L D P V VK + D + ++ + E ++ ++ +N
Sbjct: 12 DLLQEGTFGRIFYGILIDEKPGKEEEVFVKT--VKDHASEIQVTLLLQESCLLYGLSHQN 69
Query: 124 VVRLLACCLE-TQVPLLVYEF--VGNGTLFEHIHKNGNLTWERRLR------IAAETAGV 174
++ +L C+E + P ++Y + GN LF + G + L +A + A
Sbjct: 70 ILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACG 129
Query: 175 LSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASK-LVPID 218
+SYLH +IH+D+ + N ++DE K++D S+ L P+D
Sbjct: 130 MSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMD 171
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 5e-06
Identities = 54/181 (29%), Positives = 80/181 (44%), Gaps = 25/181 (13%)
Query: 74 IGCGGSGNVYKGFLPDRTP-VAVKKSKIVDQTKIDEF----INELVVV---SQINRRNVV 125
IG G G VYK P VA+K ++ QT D + E+ ++ + N+V
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRV--QTNEDGLPLSTVREVALLKRLEAFDHPNIV 65
Query: 126 RLLACCL------ETQVPLLVYEFVGNG--TLFEHIHKNGNLTWERRLRIAAETAGVLSY 177
RL+ C ET+V L V+E V T + + G L E + + L +
Sbjct: 66 RLMDVCATSRTDRETKVTL-VFEHVDQDLRTYLDKVPPPG-LPAETIKDLMRQFLRGLDF 123
Query: 178 LHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEY 237
LH+ I+HRD+K NIL+ K++DFG +++ VV TL Y PE
Sbjct: 124 LHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV--TLWYRAPEV 178
Query: 238 L 238
L
Sbjct: 179 L 179
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 5e-06
Identities = 39/148 (26%), Positives = 69/148 (46%), Gaps = 24/148 (16%)
Query: 88 PDRT-PVAVK--KSKIVDQTKIDEFINELVVVSQINR-RNVVRLLACCLETQVPLLVYEF 143
PD+T VAVK K D+ D I+E+ ++ I + +N++ LL C + ++ E+
Sbjct: 41 PDQTVTVAVKMLKDNATDKDLAD-LISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEY 99
Query: 144 VGNGTLFEHIH----------------KNGNLTWERRLRIAAETAGVLSYLHSETNVPII 187
G L E + L+++ + A + A + YL S I
Sbjct: 100 AAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CI 156
Query: 188 HRDVKSANILLDENYTPKVSDFGASKLV 215
HRD+ + N+L+ E+ K++DFG ++ V
Sbjct: 157 HRDLAARNVLVTEDNVMKIADFGLARGV 184
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 6e-06
Identities = 28/65 (43%), Positives = 35/65 (53%), Gaps = 6/65 (9%)
Query: 175 LSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGAS-KLVPIDAIQNYTVVQGTLGYI 233
L YL + V IHRDVK +NILLD + K+ DFG S +LV A T G Y+
Sbjct: 127 LHYLKEKHGV--IHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA---KTRSAGCAAYM 181
Query: 234 DPEYL 238
PE +
Sbjct: 182 APERI 186
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 6e-06
Identities = 55/191 (28%), Positives = 83/191 (43%), Gaps = 41/191 (21%)
Query: 74 IGCGGSGNVYKGFLPDRTP---VAVKKSKIVDQTKIDEF----INELVVVSQINRRNVVR 126
IG G G V+K + VA+KK +++ K + F + E+ ++ + NVV
Sbjct: 20 IGQGTFGEVFKA--RHKKTKQIVALKKV-LMENEK-EGFPITALREIKILQLLKHENVVN 75
Query: 127 LLACCLETQVP--------LLVYEFVGNGTLFEH------IHKNGNLTWERRLRIAAETA 172
L+ C P LV+EF EH +KN T ++
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFEFC------EHDLAGLLSNKNVKFTLSEIKKVMKMLL 129
Query: 173 GVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASK---LVPIDAIQNYT--VVQ 227
L Y+H I+HRD+K+ANIL+ ++ K++DFG ++ L YT VV
Sbjct: 130 NGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV- 185
Query: 228 GTLGYIDPEYL 238
TL Y PE L
Sbjct: 186 -TLWYRPPELL 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 7e-06
Identities = 42/166 (25%), Positives = 80/166 (48%), Gaps = 24/166 (14%)
Query: 93 VAVKKSKIVDQTKID--EFINELVVVSQINR-RNVVRLLACCLETQVPLLVYEFVGNGTL 149
VAVK K D T+ D + ++E+ ++ I + +N++ LL C + ++ E+ G L
Sbjct: 50 VAVKMLKD-DATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 108
Query: 150 FEHIH----------------KNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKS 193
E++ + +T++ + + A + YL S+ IHRD+ +
Sbjct: 109 REYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAA 165
Query: 194 ANILLDENYTPKVSDFGASKLV-PIDAIQNYTVVQGTLGYIDPEYL 238
N+L+ EN K++DFG ++ V ID + T + + ++ PE L
Sbjct: 166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEAL 211
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-05
Identities = 36/132 (27%), Positives = 63/132 (47%), Gaps = 7/132 (5%)
Query: 111 NELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERR--LRIA 168
E+++++++ N+V A E +V E+ G L + I++ + + L
Sbjct: 48 KEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWF 107
Query: 169 AETAGVLSYLHSETNVPIIHRDVKSANILLDEN-YTPKVSDFGASKLVPIDAIQNYTVVQ 227
+ + L ++H I+HRD+KS NI L +N K+ DFG ++ + YT V
Sbjct: 108 VQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV- 163
Query: 228 GTLGYIDPEYLQ 239
GT Y+ PE Q
Sbjct: 164 GTPYYLSPEICQ 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 1e-05
Identities = 22/53 (41%), Positives = 31/53 (58%)
Query: 187 IHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
+HRD+K N+LLD+N +++DFG+ + D V GT YI PE LQ
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQ 176
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 1e-05
Identities = 26/72 (36%), Positives = 38/72 (52%), Gaps = 3/72 (4%)
Query: 169 AETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQG 228
AE L +HS + IHRDVK N+LLD++ K++DFG + + + G
Sbjct: 149 AEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVG 205
Query: 229 TLGYIDPEYLQT 240
T YI PE L++
Sbjct: 206 TPDYISPEVLKS 217
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 1e-05
Identities = 50/174 (28%), Positives = 83/174 (47%), Gaps = 17/174 (9%)
Query: 74 IGCGGSGNVYKGFLPDRTP---VAVKKSKI--VDQTKIDEFINELVVVSQINRRNVVRLL 128
IG G G VYK DR +A+KK ++ D+ I E+ ++ ++ N+VRL
Sbjct: 10 IGEGTYGVVYKA--RDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQ 67
Query: 129 ACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLS---YLHSETNVP 185
+ LV+E++ + L +H+ + + RL I +L Y HS
Sbjct: 68 DVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRL-IKTYLYQILRGIAYCHSHR--- 122
Query: 186 IIHRDVKSANILLDE-NYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYL 238
++HRD+K N+L+D K++DFG ++ I ++ +T TL Y PE L
Sbjct: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGI-PVRTFTHEVVTLWYRAPEIL 175
|
Length = 294 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-05
Identities = 43/150 (28%), Positives = 64/150 (42%), Gaps = 16/150 (10%)
Query: 72 DVIGCGGSGNVYKG---FLPDRTPVAVKKSKIVDQTKIDE---FINELVVVSQINRRNVV 125
D IG G G V G + V VK+ + DE F+ E+ ++N NV+
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELR--ASATPDEQLLFLQEVQPYRELNHPNVL 58
Query: 126 RLLACCLETQVPLLVYEFVGNGTLFEHIHKN-----GNLTWERRLRIAAETAGVLSYLHS 180
+ L C+E+ LLV EF G L ++ N + R+A E A L +LH
Sbjct: 59 QCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ 118
Query: 181 ETNVPIIHRDVKSANILLDENYTPKVSDFG 210
IH D+ N L + + K+ D+G
Sbjct: 119 AD---FIHSDLALRNCQLTADLSVKIGDYG 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-05
Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 8/148 (5%)
Query: 95 VKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIH 154
+ K +++ ++ F E +++ N VV+L + + +V E++ G L ++
Sbjct: 76 LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLM 134
Query: 155 KNGNL--TWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGAS 212
N ++ W R AE L +HS + IHRDVK N+LLD++ K++DFG
Sbjct: 135 SNYDVPEKWARFY--TAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTC 189
Query: 213 KLVPIDAIQNYTVVQGTLGYIDPEYLQT 240
+ + + GT YI PE L++
Sbjct: 190 MKMNKEGMVRCDTAVGTPDYISPEVLKS 217
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-05
Identities = 50/190 (26%), Positives = 79/190 (41%), Gaps = 42/190 (22%)
Query: 74 IGCGGSGNVYKG--FLPDRTPVAVKKSKIVDQTKIDEF----INELVVVSQIN---RRNV 124
IG G G V+K VA+K+ ++ QT + I E+ V+ + NV
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRV--QTGEEGMPLSTIREVAVLRHLETFEHPNV 66
Query: 125 VRLLACCL------ETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGV---- 174
VRL C ET++ L+ FEH+ ++ ++ T +
Sbjct: 67 VRLFDVCTVSRTDRETKLTLV----------FEHVDQDLTTYLDKVPEPGVPTETIKDMM 116
Query: 175 ------LSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQG 228
L +LHS ++HRD+K NIL+ + K++DFG +++ VV
Sbjct: 117 FQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV-- 171
Query: 229 TLGYIDPEYL 238
TL Y PE L
Sbjct: 172 TLWYRAPEVL 181
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 1e-05
Identities = 27/76 (35%), Positives = 40/76 (52%), Gaps = 3/76 (3%)
Query: 139 LVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILL 198
LV E++ G + +H G E ++ +E A L YLH IIHRD+K N+L+
Sbjct: 81 LVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLI 137
Query: 199 DENYTPKVSDFGASKL 214
K++DFG SK+
Sbjct: 138 SNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 2e-05
Identities = 28/72 (38%), Positives = 38/72 (52%), Gaps = 7/72 (9%)
Query: 174 VLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKL----VPIDAIQNYTVVQGT 229
VL +H + +IHRD+KSANILL N K+ DFG SK+ V D + + GT
Sbjct: 152 VLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC---GT 208
Query: 230 LGYIDPEYLQTC 241
Y+ PE +
Sbjct: 209 PYYVAPEIWRRK 220
|
Length = 496 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 2e-05
Identities = 22/53 (41%), Positives = 31/53 (58%)
Query: 187 IHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
+HRD+K NIL+D N +++DFG+ + D +V GT YI PE LQ
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 176
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 2e-05
Identities = 49/161 (30%), Positives = 76/161 (47%), Gaps = 19/161 (11%)
Query: 65 TVTNNYADV--IGCGGSGNVYKGF--LPDRTPVAVKK--SKIVDQTKIDEFINELVVVSQ 118
TV Y ++ IG G G V + + DR VA+KK +QT ELV++
Sbjct: 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN-VAIKKLSRPFQNQTHAKRAYRELVLMKC 72
Query: 119 INRRNVVRLL------ACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETA 172
+N +N++ LL E Q LV E + + L + I L ER + +
Sbjct: 73 VNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQME--LDHERMSYLLYQML 129
Query: 173 GVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASK 213
+ +LHS IIHRD+K +NI++ + T K+ DFG ++
Sbjct: 130 CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-05
Identities = 38/136 (27%), Positives = 66/136 (48%), Gaps = 16/136 (11%)
Query: 109 FINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGN-LTWERRLRI 167
F ++ Q++ +++V L C+ ++V EFV G L +H+ + LT + ++
Sbjct: 51 FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKV 110
Query: 168 AAETAGVLSYLHSETNVPIIHRDVKSANILL-----DENYTP--KVSDFGASKLVPIDAI 220
A + A LSYL + ++H +V + NILL D P K+SD G +PI +
Sbjct: 111 AKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDPG----IPITVL 163
Query: 221 QNYTVVQGTLGYIDPE 236
V+ + +I PE
Sbjct: 164 SRQECVE-RIPWIAPE 178
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-05
Identities = 51/199 (25%), Positives = 91/199 (45%), Gaps = 24/199 (12%)
Query: 32 FKQNGGSILRQELSKLQGRS-SEKAKIFIEEEIKTVTN---NYADVIGCGGSGNVYKGFL 87
F+ N + +E S E + I+ +I N ++IG G G VY+
Sbjct: 28 FEMNDKKLDEEERSHNNNAGEDEDEEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAIC 87
Query: 88 PDRTP-VAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRL-----LACCLETQVPL--- 138
D + VA+KK Q K EL+++ +N N++ L C + + +
Sbjct: 88 IDTSEKVAIKKVLQDPQYKN----RELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLN 143
Query: 139 LVYEFVGNGT--LFEHIHKNGNLTWERRLRIAA-ETAGVLSYLHSETNVPIIHRDVKSAN 195
+V EF+ +H +N + +++ + + L+Y+HS+ I HRD+K N
Sbjct: 144 VVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQN 200
Query: 196 ILLDEN-YTPKVSDFGASK 213
+L+D N +T K+ DFG++K
Sbjct: 201 LLIDPNTHTLKLCDFGSAK 219
|
Length = 440 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-05
Identities = 41/174 (23%), Positives = 77/174 (44%), Gaps = 30/174 (17%)
Query: 62 EIKTVTNNYADVIGCGGSGNVYKGFLPDRTP------VAVKKSKIVDQTKI---DEFINE 112
EI T + + +G G VYKG L P VA+K K D+ + +EF +E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK--DKAEGPLREEFKHE 58
Query: 113 LVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHI-----HKNGNLTWERR--- 164
++ S++ N+V LL + Q +++ + + L E + H + T + +
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 165 --------LRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFG 210
+ I + A + +L S ++H+D+ + N+L+ + K+SD G
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLG 169
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-05
Identities = 49/179 (27%), Positives = 82/179 (45%), Gaps = 21/179 (11%)
Query: 74 IGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEF-INELV-------VVSQINRRNVV 125
+G G G VY + D+ VA ++ K++ + + E NE V ++S+++ +V
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 126 RLLACCLETQVPLLVYEFVGNGTL---FEHIHKNGNLTWERRL--RIAAETAGVLSYLHS 180
+ A LE ++ E+ L E + G E ++ GV Y+H
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGV-HYMHQ 124
Query: 181 ETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
I+HRD+K+ NI L N K+ DFG S+L+ + + T GT Y+ PE L+
Sbjct: 125 RR---ILHRDLKAKNIFLKNNLL-KIGDFGVSRLL-MGSCDLATTFTGTPYYMSPEALK 178
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 3e-05
Identities = 17/36 (47%), Positives = 25/36 (69%), Gaps = 3/36 (8%)
Query: 175 LSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFG 210
L Y+HS +IHRD+K +NILL+ + K++DFG
Sbjct: 120 LKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFG 152
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 3e-05
Identities = 17/40 (42%), Positives = 28/40 (70%), Gaps = 3/40 (7%)
Query: 175 LSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKL 214
L Y+HS ++HRD+K +NIL++EN K+ DFG +++
Sbjct: 121 LKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARI 157
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-05
Identities = 42/144 (29%), Positives = 62/144 (43%), Gaps = 17/144 (11%)
Query: 80 GNVYKGFLPDRTPVAVKKSK----IVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQ 135
G V G+ P V VK+ + + +Q K F+ E + N+++ L C E
Sbjct: 14 GEVNSGYTP--AQVVVKELRVSASVQEQMK---FLEEAQPYRSLQHSNLLQCLGQCTEVT 68
Query: 136 VPLLVYEFVGNGTLFEHIH---KNGNLTWERRL--RIAAETAGVLSYLHSETNVPIIHRD 190
LLV EF G L ++ K +T + R+A E A L +LH IH D
Sbjct: 69 PYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSD 125
Query: 191 VKSANILLDENYTPKVSDFGASKL 214
+ N LL + T K+ D+G S
Sbjct: 126 LALRNCLLTADLTVKIGDYGLSHN 149
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 3e-05
Identities = 45/181 (24%), Positives = 80/181 (44%), Gaps = 33/181 (18%)
Query: 74 IGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKIDEFI-----NELVVVSQINRRNVVRL 127
IG G G V+K VA+K+ ++ D DE + E+ ++ ++ +N+VRL
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDD---DEGVPSSALREICLLKELKHKNIVRL 64
Query: 128 LACCLETQVPLLVYEFVG----------NGTLFEHIHKNGNLTWERRLRIAAETAGVLSY 177
+ LV+E+ NG + I K+ + L +
Sbjct: 65 YDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLA----------F 114
Query: 178 LHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEY 237
HS ++HRD+K N+L+++N K++DFG ++ I ++ Y+ TL Y P+
Sbjct: 115 CHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGI-PVRCYSAEVVTLWYRPPDV 170
Query: 238 L 238
L
Sbjct: 171 L 171
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 4e-05
Identities = 27/68 (39%), Positives = 33/68 (48%), Gaps = 6/68 (8%)
Query: 175 LSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFG-ASKLVPIDAIQNYTVVQGTLGYI 233
L YLH IIHRD+K +N+LL + K++DFG A VV TL Y
Sbjct: 121 LQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV--TLWYR 175
Query: 234 DPEYLQTC 241
PE L C
Sbjct: 176 APELLLGC 183
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 4e-05
Identities = 30/116 (25%), Positives = 56/116 (48%), Gaps = 3/116 (2%)
Query: 95 VKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIH 154
++K+ ++++ ++ E ++ + + VV++ + L+ EF+ G + +
Sbjct: 34 LRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM 93
Query: 155 KNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFG 210
K LT E AET + +H + IHRD+K N+LLD K+SDFG
Sbjct: 94 KKDTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFG 146
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 4e-05
Identities = 38/146 (26%), Positives = 70/146 (47%), Gaps = 4/146 (2%)
Query: 95 VKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIH 154
+ K +++ ++ F E +++ N VV+L + + +V E++ G L ++
Sbjct: 76 LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLV-NLM 134
Query: 155 KNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKL 214
N ++ + AE L +HS + +IHRDVK N+LLD++ K++DFG
Sbjct: 135 SNYDVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMK 191
Query: 215 VPIDAIQNYTVVQGTLGYIDPEYLQT 240
+ + GT YI PE L++
Sbjct: 192 MDETGMVRCDTAVGTPDYISPEVLKS 217
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 4e-05
Identities = 22/67 (32%), Positives = 36/67 (53%), Gaps = 6/67 (8%)
Query: 175 LSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLV---PIDAIQNYTVVQGTLG 231
L Y+HS +IHRD+K +N+L++E+ ++ DFG ++ + P + T T
Sbjct: 120 LKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176
Query: 232 YIDPEYL 238
Y PE L
Sbjct: 177 YRAPELL 183
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 4e-05
Identities = 47/157 (29%), Positives = 71/157 (45%), Gaps = 17/157 (10%)
Query: 65 TVTNNYAD--VIGCGGSGNVYKGF-LPDRTPVAVKK--SKIVDQTKIDEFINELVVVSQI 119
TV Y + IG G G V + VA+KK + T ELV++ +
Sbjct: 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLV 72
Query: 120 NRRNVVRLLAC-----CLET-QVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAG 173
N +N++ LL LE Q LV E + + L + I + L ER + +
Sbjct: 73 NHKNIIGLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMD--LDHERMSYLLYQMLC 129
Query: 174 VLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFG 210
+ +LHS IIHRD+K +NI++ + T K+ DFG
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 163
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 4e-05
Identities = 17/36 (47%), Positives = 25/36 (69%), Gaps = 3/36 (8%)
Query: 175 LSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFG 210
++YLH I+HRD+K+ANIL+D K++DFG
Sbjct: 128 INYLHENH---ILHRDIKAANILIDNQGILKIADFG 160
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 4e-05
Identities = 24/65 (36%), Positives = 33/65 (50%), Gaps = 5/65 (7%)
Query: 175 LSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQN-YTVVQGTLGYI 233
+ YLH IIHRD+K+ NI ++ + DFGA+ P+D N Y GT+
Sbjct: 195 IQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAA-CFPVDINANKYYGWAGTIATN 250
Query: 234 DPEYL 238
PE L
Sbjct: 251 APELL 255
|
Length = 391 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 5e-05
Identities = 55/179 (30%), Positives = 80/179 (44%), Gaps = 18/179 (10%)
Query: 72 DVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTK-IDEFINEL--VVVSQINRRNVVRLL 128
+ IG G G VYK + ++ ++ KI+D +DE I ++ S N NVV+
Sbjct: 28 ETIGKGTYGKVYK--VTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFY 85
Query: 129 AC------CLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLR---IAAETAGVLSYLH 179
+ Q+ LV E G++ E + G L +RL I+ G L L
Sbjct: 86 GMFYKADKLVGGQL-WLVLELCNGGSVTELV--KGLLICGQRLDEAMISYILYGALLGLQ 142
Query: 180 SETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYL 238
N IIHRDVK NILL K+ DFG S + ++ T V GT ++ PE +
Sbjct: 143 HLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVI 200
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 5e-05
Identities = 23/64 (35%), Positives = 35/64 (54%), Gaps = 5/64 (7%)
Query: 175 LSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYID 234
L YLH++ IIHRDVK+ NI +++ + D GA++ P+ A + GT+
Sbjct: 170 LRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQF-PVVAPAFLGLA-GTVETNA 224
Query: 235 PEYL 238
PE L
Sbjct: 225 PEVL 228
|
Length = 357 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 5e-05
Identities = 24/64 (37%), Positives = 35/64 (54%), Gaps = 3/64 (4%)
Query: 175 LSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYID 234
L YLHS I+HRD+K N+L++ N K+ DFG +++ D ++ T T Y
Sbjct: 116 LKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRA 172
Query: 235 PEYL 238
PE L
Sbjct: 173 PEIL 176
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 6e-05
Identities = 39/132 (29%), Positives = 64/132 (48%), Gaps = 10/132 (7%)
Query: 110 INELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAA 169
I E+ ++ + N+V L + LV+E++ + L +++ GNL ++I
Sbjct: 51 IREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFM 109
Query: 170 -ETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFG--ASKLVPIDAIQNYTVV 226
+ LSY H I+HRD+K N+L++E K++DFG +K VP N V
Sbjct: 110 FQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV- 165
Query: 227 QGTLGYIDPEYL 238
TL Y P+ L
Sbjct: 166 --TLWYRPPDVL 175
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 7e-05
Identities = 29/116 (25%), Positives = 57/116 (49%), Gaps = 3/116 (2%)
Query: 95 VKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIH 154
++K+ ++++ ++ E ++ + + VV++ + + L+ EF+ G + +
Sbjct: 34 LRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM 93
Query: 155 KNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFG 210
K L+ E AET + +H + IHRD+K N+LLD K+SDFG
Sbjct: 94 KKDTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFG 146
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 9e-05
Identities = 49/176 (27%), Positives = 81/176 (46%), Gaps = 19/176 (10%)
Query: 50 RSSEKAKIFIEEEIKTVTNNYADV--IGCGGSGNVYKGF--LPDRTPVAVKK--SKIVDQ 103
R + + I + TV Y ++ IG G G V + + +R VA+KK +Q
Sbjct: 6 RDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN-VAIKKLSRPFQNQ 64
Query: 104 TKIDEFINELVVVSQINRRNVVRLL------ACCLETQVPLLVYEFVGNGTLFEHIHKNG 157
T ELV++ +N +N++ LL E Q +V E + + L + I
Sbjct: 65 THAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME- 122
Query: 158 NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASK 213
L ER + + + +LHS IIHRD+K +NI++ + T K+ DFG ++
Sbjct: 123 -LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 1e-04
Identities = 49/201 (24%), Positives = 82/201 (40%), Gaps = 50/201 (24%)
Query: 72 DVIGCGGSGN---VYKGFL---PDRTPVAVKKSKIVDQTKIDEF----INELVVVSQINR 121
++ GC G G VYK D A+KK K D+ + E+ ++ ++
Sbjct: 3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFK-GDKEQYTGISQSACREIALLRELKH 61
Query: 122 RNVVRLLACCLE--TQVPLLVYEFVGNGTLFEH-----IHKNGNLTWERRLRIAAETAGV 174
NVV L+ LE + L++++ EH I + R+ + + +
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYA------EHDLWQIIK------FHRQAKRVSIPPSM 109
Query: 175 -----------LSYLHSETNVPIIHRDVKSANILL----DENYTPKVSDFGASKLV--PI 217
+ YLHS ++HRD+K ANIL+ E K+ D G ++L P+
Sbjct: 110 VKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPL 166
Query: 218 DAIQNYTVVQGTLGYIDPEYL 238
+ + V T+ Y PE L
Sbjct: 167 KPLADLDPVVVTIWYRAPELL 187
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 46/193 (23%), Positives = 77/193 (39%), Gaps = 32/193 (16%)
Query: 74 IGCGGSGNVYKGF-LPDRTPVAVKKSKIV--------DQTKIDE------FINELVVVSQ 118
+G G G V K + VA+KK KI+ D+ + + EL ++++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 119 INRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYL 178
I N++ L+ +E LV + + L + + + LT + I + L+ L
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCILLQILNGLNVL 135
Query: 179 HSETNVPIIHRDVKSANILLDENYTPKVSDFG-------------ASKLVPIDAIQNYTV 225
H +HRD+ ANI ++ K++DFG SK + + T
Sbjct: 136 H---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTS 192
Query: 226 VQGTLGYIDPEYL 238
TL Y PE L
Sbjct: 193 KVVTLWYRAPELL 205
|
Length = 335 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 42.2 bits (100), Expect = 1e-04
Identities = 24/66 (36%), Positives = 38/66 (57%), Gaps = 8/66 (12%)
Query: 175 LSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYT--VVQGTLGY 232
+++LH I+HRD+K++N+LL+ K+ DFG ++ ++ YT VV TL Y
Sbjct: 119 VAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG-SPLKPYTQLVV--TLWY 172
Query: 233 IDPEYL 238
PE L
Sbjct: 173 RAPELL 178
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 1e-04
Identities = 49/173 (28%), Positives = 77/173 (44%), Gaps = 17/173 (9%)
Query: 74 IGCGGSGNVYKGFLPD-RTPVAVKKSKIVDQTKIDEFIN-----ELVVVSQINRRNVVRL 127
IG G G V+K + VA+KK +++ D I E+ ++ Q+ N+V L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKK---FVESEDDPVIKKIALREIRMLKQLKHPNLVNL 65
Query: 128 LACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLR-IAAETAGVLSYLHSETNVPI 186
+ + LV+E+ + T+ + KN E ++ I +T +++ H
Sbjct: 66 IEVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN---C 121
Query: 187 IHRDVKSANILLDENYTPKVSDFG-ASKLVPIDAIQNYTVVQGTLGYIDPEYL 238
IHRDVK NIL+ + K+ DFG A L +YT T Y PE L
Sbjct: 122 IHRDVKPENILITKQGQIKLCDFGFARILTGPGD--DYTDYVATRWYRAPELL 172
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 24/75 (32%), Positives = 35/75 (46%), Gaps = 3/75 (4%)
Query: 139 LVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILL 198
L+ E++ G + + K T E AET + +H + IHRD+K N+LL
Sbjct: 78 LIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLL 134
Query: 199 DENYTPKVSDFGASK 213
D K+SDFG
Sbjct: 135 DAKGHIKLSDFGLCT 149
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 34/141 (24%), Positives = 57/141 (40%), Gaps = 16/141 (11%)
Query: 77 GGSGNVYKGFLPDRTPVAVKKSKIVDQTKID--EFINELVVVSQINRRNVVRLLACCLET 134
++ K P T VAVKK + +K D E++ Q+ N++ + +
Sbjct: 13 LMIVHLAK-HKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD 71
Query: 135 QVPLLVYEFVGNGT---LFEHIHKNGNLTWERRLRIAAETAGVLS---YLHSETNVPIIH 188
+V + G+ L + G L IA VL+ Y+HS+ IH
Sbjct: 72 SELYVVSPLMAYGSCEDLLKTHFPEG----LPELAIAFILKDVLNALDYIHSKG---FIH 124
Query: 189 RDVKSANILLDENYTPKVSDF 209
R VK+++ILL + +S
Sbjct: 125 RSVKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 2e-04
Identities = 44/146 (30%), Positives = 65/146 (44%), Gaps = 14/146 (9%)
Query: 74 IGCGGSGNVYKGFLPD-RTPVAVKKSKIVDQTKID--EFINELVVVSQINRRNVVRLL-- 128
+G G G V F VA+KK Q+ I EL ++ ++ NV+ LL
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV 82
Query: 129 ---ACCLET-QVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNV 184
A LE Q LV +G +I K L+ + + + L Y+HS
Sbjct: 83 FTPASSLEDFQDVYLVTHLMG--ADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHS---A 137
Query: 185 PIIHRDVKSANILLDENYTPKVSDFG 210
IIHRD+K +NI ++E+ K+ DFG
Sbjct: 138 GIIHRDLKPSNIAVNEDCELKILDFG 163
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 2e-04
Identities = 39/137 (28%), Positives = 65/137 (47%), Gaps = 16/137 (11%)
Query: 107 DEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKN-GNLTWERR- 164
+E E+ V+S + N+V+ E +V ++ G L++ I+ G L E +
Sbjct: 44 EESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQI 103
Query: 165 LRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYT 224
L + L ++H I+HRD+KS NI L ++ T K+ DFG ++++ N T
Sbjct: 104 LDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVL------NST 154
Query: 225 V-----VQGTLGYIDPE 236
V GT Y+ PE
Sbjct: 155 VELARTCIGTPYYLSPE 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 3e-04
Identities = 18/36 (50%), Positives = 25/36 (69%), Gaps = 3/36 (8%)
Query: 175 LSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFG 210
L Y+HS NV +HRD+K +N+LL+ N K+ DFG
Sbjct: 119 LKYIHS-ANV--LHRDLKPSNLLLNTNCDLKICDFG 151
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 3e-04
Identities = 21/51 (41%), Positives = 31/51 (60%), Gaps = 1/51 (1%)
Query: 186 IIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPE 236
++HRD+KS NI L +N K+ DFG+++L+ T V GT Y+ PE
Sbjct: 121 VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPE 170
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 4e-04
Identities = 40/149 (26%), Positives = 66/149 (44%), Gaps = 7/149 (4%)
Query: 93 VAVKKSKIVDQTK--IDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTL- 149
VA+KK K ++ + + + EL ++ + + N+V L LV+E+V L
Sbjct: 29 VAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLE 88
Query: 150 FEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDF 209
NG + R I + + + H I+HRD+K N+L+ N K+ DF
Sbjct: 89 LLEEMPNGVPPEKVRSYIY-QLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDF 144
Query: 210 GASKLVPIDAIQNYTVVQGTLGYIDPEYL 238
G ++ + + NYT T Y PE L
Sbjct: 145 GFARNLSEGSNANYTEYVATRWYRSPELL 173
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 39.8 bits (94), Expect = 6e-04
Identities = 30/104 (28%), Positives = 51/104 (49%), Gaps = 17/104 (16%)
Query: 138 LLVYEFVGNGTLFEHIHKNGNLTWERRLR-IAAETAGVLSYLHSETNVPIIHRDVKSANI 196
+L+ +++ +G LF+ + K G L+ E ++ I + L+ LH IIH D+K N+
Sbjct: 85 VLIMDYIKDGDLFDLLKKEGKLS-EAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENV 140
Query: 197 LLDEN----YTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPE 236
L D Y + D+G K++ + + GTL Y PE
Sbjct: 141 LYDRAKDRIY---LCDYGLCKIIGTPSCYD-----GTLDYFSPE 176
|
Length = 267 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 8e-04
Identities = 25/69 (36%), Positives = 36/69 (52%), Gaps = 8/69 (11%)
Query: 175 LSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASK--LVPIDAIQNYTVVQGTLGY 232
L Y+HS ++HRD+K +N+LL+ N K+ DFG ++ D + Y V T Y
Sbjct: 121 LKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV---TRWY 174
Query: 233 IDPEYLQTC 241
PE L C
Sbjct: 175 RAPELLLNC 183
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.001
Identities = 42/158 (26%), Positives = 69/158 (43%), Gaps = 29/158 (18%)
Query: 108 EFINELVVVSQINRRNVVRLLACCLE--TQVPLLVYEFVGNGTLFEHIHKN----GNLTW 161
+ + E+ V+ ++ +N+VR + L Q ++ EF G L +I K G +
Sbjct: 58 QLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEE 117
Query: 162 ERRLRIAAETAGVLSYLHSETNVP----IIHRDVKSANILLDE---------------NY 202
+ I + L+Y H+ + P ++HRD+K NI L N
Sbjct: 118 HAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG 177
Query: 203 TP--KVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYL 238
P K+ DFG SK + I+++ + V GT Y PE L
Sbjct: 178 RPIAKIGDFGLSKNIGIESMAHSCV--GTPYYWSPELL 213
|
Length = 1021 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.001
Identities = 28/78 (35%), Positives = 36/78 (46%), Gaps = 3/78 (3%)
Query: 123 NVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSET 182
N+V L + LV + G L+ HI K N+ E R AAE L LH E
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREG 105
Query: 183 NVPIIHRDVKSANILLDE 200
I+ RD+ NILLD+
Sbjct: 106 ---IVCRDLNPNNILLDD 120
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.001
Identities = 29/100 (29%), Positives = 48/100 (48%), Gaps = 6/100 (6%)
Query: 139 LVYEFVGNGTLFEHI-HKNGNLTWERR-LRIAAETAGVLSYLHSETNVPIIHRDVKSANI 196
+V F G L+ + + G L E + + + A L YLH + I+HRD+K+ N+
Sbjct: 77 IVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNV 133
Query: 197 LLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPE 236
L KV D G ++++ T++ GT Y+ PE
Sbjct: 134 FLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPYYMSPE 172
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.002
Identities = 36/132 (27%), Positives = 64/132 (48%), Gaps = 10/132 (7%)
Query: 110 INELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRI-A 168
I E+ ++ + N+V L + LV+E++ + L +++ GN+ ++I
Sbjct: 52 IREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFL 110
Query: 169 AETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFG--ASKLVPIDAIQNYTVV 226
+ L+Y H ++HRD+K N+L++E K++DFG +K VP N V
Sbjct: 111 YQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV- 166
Query: 227 QGTLGYIDPEYL 238
TL Y P+ L
Sbjct: 167 --TLWYRPPDVL 176
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 38.4 bits (90), Expect = 0.002
Identities = 21/56 (37%), Positives = 29/56 (51%), Gaps = 3/56 (5%)
Query: 186 IIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQTC 241
I HRD+K NIL+ + K++DFG+ + I + YT T Y PE L T
Sbjct: 121 IFHRDIKPENILIK-DDILKLADFGSCR--GIYSKPPYTEYISTRWYRAPECLLTD 173
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.002
Identities = 46/173 (26%), Positives = 81/173 (46%), Gaps = 14/173 (8%)
Query: 72 DVIGCGGSGNVYKGF--LPDRTPVAVKKSKIVDQTKID-EFINELVVVSQINRRNVVRLL 128
D +G G VYKG L D VA+K+ ++ + I E+ ++ + N+V L
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 129 ACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRI-AAETAGVLSYLHSETNVPII 187
+ LV+E++ + L +++ GN +++ + L+Y H ++
Sbjct: 71 DIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK---VL 126
Query: 188 HRDVKSANILLDENYTPKVSDFG--ASKLVPIDAIQNYTVVQGTLGYIDPEYL 238
HRD+K N+L++E K++DFG +K +P N V TL Y P+ L
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV---TLWYRPPDIL 176
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.002
Identities = 34/111 (30%), Positives = 49/111 (44%), Gaps = 22/111 (19%)
Query: 138 LLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSY--------LHSETNVPIIHR 189
LL+ E+ G L + I + + L G+L Y +HS ++HR
Sbjct: 141 LLIMEYGSGGDLNKQIKQR----LKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHR 193
Query: 190 DVKSANILLDENYTPKVSDFGASKL----VPIDAIQNYTVVQGTLGYIDPE 236
D+KSANI L K+ DFG SK V +D ++ GT Y+ PE
Sbjct: 194 DLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFC---GTPYYLAPE 241
|
Length = 478 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 37.7 bits (88), Expect = 0.003
Identities = 24/66 (36%), Positives = 34/66 (51%), Gaps = 8/66 (12%)
Query: 175 LSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFG--ASKLVPIDAIQNYTVVQGTLGY 232
L+Y H ++HRD+K N+L+ E K++DFG +K VP N V TL Y
Sbjct: 116 LAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV---TLWY 169
Query: 233 IDPEYL 238
P+ L
Sbjct: 170 RPPDVL 175
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 37.5 bits (87), Expect = 0.003
Identities = 27/95 (28%), Positives = 44/95 (46%), Gaps = 13/95 (13%)
Query: 123 NVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERR-------LRIAAETAGVL 175
N+++ L C+E LLV+E+ G L ++ W RR R+A E A +
Sbjct: 56 NILQCLGQCVEAIPYLLVFEYCELGDLKSYL---SQEQWHRRNSQLLLLQRMACEIAAGV 112
Query: 176 SYLHSETNVPIIHRDVKSANILLDENYTPKVSDFG 210
+++H +H D+ N L + T KV D+G
Sbjct: 113 THMHKHN---FLHSDLALRNCFLTSDLTVKVGDYG 144
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.003
Identities = 23/108 (21%), Positives = 48/108 (44%), Gaps = 15/108 (13%)
Query: 111 NELVVVSQINRRNVVRLLACC--------LETQVPLLVYEFVGNGTLFEHIHKNGNLTWE 162
NE++ + ++N N++++ + + +Y F+ + K+ L +
Sbjct: 212 NEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAF---DWKDRPLLKQ 268
Query: 163 RRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFG 210
R I + + Y+H + +IHRD+K NI L+ + + DFG
Sbjct: 269 TR-AIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCDGKIVLGDFG 312
|
Length = 501 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 37.5 bits (87), Expect = 0.004
Identities = 16/42 (38%), Positives = 24/42 (57%), Gaps = 3/42 (7%)
Query: 169 AETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFG 210
AE + +H + IHRD+K NIL+D + K++DFG
Sbjct: 108 AELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFG 146
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 241 | |||
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.98 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.98 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.98 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.98 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.98 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.98 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.98 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.98 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.98 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.98 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.98 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.98 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.97 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.97 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.97 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.97 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.97 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.97 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.97 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.97 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.97 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.97 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.97 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.97 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.97 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.97 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.97 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.97 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.97 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.97 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.97 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.97 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.97 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.97 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.97 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.97 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.97 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.97 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.97 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.97 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.97 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.97 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.97 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.97 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.97 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.97 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.97 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.97 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.97 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.97 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.97 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.96 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.96 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.96 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.96 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.96 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.96 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.96 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.96 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.96 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.96 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.96 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.96 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.96 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.96 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.96 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.96 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.96 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.96 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.96 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.96 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.96 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.96 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.96 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.96 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.96 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.96 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.96 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.96 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.96 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.96 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.96 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.96 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.96 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.96 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.96 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.96 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.96 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.96 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.96 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.96 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.96 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.96 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.96 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.96 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.96 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.96 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.96 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.96 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.96 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.95 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.95 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.95 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.95 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.95 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.95 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.95 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.95 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.95 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.95 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.95 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.95 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.95 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.95 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.95 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.95 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.95 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.95 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.95 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.95 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.95 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.95 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.95 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.95 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.95 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.95 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.95 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.95 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.95 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.95 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.94 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.94 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.94 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.94 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.94 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.94 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.94 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.94 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.94 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.94 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.94 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.94 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.94 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.94 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.93 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.93 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.93 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.93 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.92 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.92 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.92 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.91 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.9 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.9 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.89 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.89 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.88 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.87 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.86 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.86 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.85 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.85 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.84 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.84 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.84 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.84 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.8 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.79 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.76 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.76 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.76 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.75 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.73 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.69 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.68 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.68 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.57 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.56 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.56 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.51 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.5 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.48 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.47 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.46 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.46 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.45 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.43 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.39 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.28 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.27 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.23 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.23 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.22 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.18 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.06 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 99.05 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.03 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.0 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.95 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.95 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.92 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.84 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.72 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.7 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.69 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.67 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.65 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.52 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.51 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.47 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.39 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.32 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.32 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.31 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.27 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 98.2 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.14 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.13 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.94 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.84 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.69 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.66 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.65 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.58 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.58 | |
| PLN02236 | 344 | choline kinase | 97.46 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.45 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.43 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.42 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.41 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.29 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 97.2 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.11 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.89 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.87 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 96.81 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.78 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.52 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.23 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.9 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.75 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.66 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.48 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.33 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 95.07 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.02 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 94.9 | |
| PF03109 | 119 | ABC1: ABC1 family; InterPro: IPR004147 This entry | 94.89 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 94.68 |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=288.06 Aligned_cols=169 Identities=28% Similarity=0.469 Sum_probs=151.1
Q ss_pred hhcccccccccCceeEEEEEeC-CCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
.|.+.+.||+|+||.||+|+++ ++..||||.+... ..+..+.+..|+.+|+.++|||||.+++++..++..|+||||
T Consensus 11 ~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEy 90 (429)
T KOG0595|consen 11 DYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEY 90 (429)
T ss_pred cceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEe
Confidence 3455667999999999999954 5789999987654 566777889999999999999999999999999999999999
Q ss_pred cCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC------CCeEEccCCCcccccC
Q 039310 144 VGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDEN------YTPKVSDFGASKLVPI 217 (241)
Q Consensus 144 ~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~------~~~kl~Dfgla~~~~~ 217 (241)
|.||||.+|++..+.+++..+..++.|++.||++||+++ ||||||||.|||++.. -.+||+|||+|+.+..
T Consensus 91 C~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~ 167 (429)
T KOG0595|consen 91 CNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP 167 (429)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc
Confidence 999999999999999999999999999999999999999 9999999999999864 4589999999999864
Q ss_pred CccceeeeecccccccccccccC
Q 039310 218 DAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 218 ~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
. ....+.||+|-|||||+++.
T Consensus 168 ~--~~a~tlcGSplYMAPEV~~~ 188 (429)
T KOG0595|consen 168 G--SMAETLCGSPLYMAPEVIMS 188 (429)
T ss_pred h--hHHHHhhCCccccCHHHHHh
Confidence 3 34566789999999999864
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=289.91 Aligned_cols=187 Identities=45% Similarity=0.749 Sum_probs=164.0
Q ss_pred cccccCHHHHHHhhhcccc--cccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEE
Q 039310 54 KAKIFIEEEIKTVTNNYAD--VIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACC 131 (241)
Q Consensus 54 ~~~~~~~~~~~~~~~~~~~--~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~ 131 (241)
....|...++..++.+|.+ .||+|+||.||+|...++..||||++.........+|.+|+.++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 5677899999999999985 89999999999999988899999987764433145699999999999999999999999
Q ss_pred ecCC-cceEEEEecCCCCchHHhhcCC--CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEcc
Q 039310 132 LETQ-VPLLVYEFVGNGTLFEHIHKNG--NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSD 208 (241)
Q Consensus 132 ~~~~-~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~D 208 (241)
.+.+ ..++|+|||++|+|.+.|.... +++|..+.+|+.++|+||+|||+...++||||||||+|||+|+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9998 4999999999999999998665 899999999999999999999998878999999999999999999999999
Q ss_pred CCCcccccCCccceeeee-cccccccccccccCC
Q 039310 209 FGASKLVPIDAIQNYTVV-QGTLGYIDPEYLQTC 241 (241)
Q Consensus 209 fgla~~~~~~~~~~~~~~-~gt~~y~aPE~l~~~ 241 (241)
||+|+..+.. ....... .||.+|+|||++++|
T Consensus 221 FGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g 253 (361)
T KOG1187|consen 221 FGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTG 253 (361)
T ss_pred ccCcccCCcc-ccceeeecCCCCccCChhhhccC
Confidence 9999765431 1112222 799999999998754
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=270.84 Aligned_cols=172 Identities=27% Similarity=0.383 Sum_probs=150.5
Q ss_pred HHhhhcccccccccCceeEEEEE-eCCCCeEEEEecccC---C----hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCC
Q 039310 64 KTVTNNYADVIGCGGSGNVYKGF-LPDRTPVAVKKSKIV---D----QTKIDEFINELVVVSQINRRNVVRLLACCLETQ 135 (241)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavk~~~~~---~----~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 135 (241)
....|-.++.||+|+||.|-+|. .++++.||||.++.. . ........+|+++|++++|||||++.+++..++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 34456667899999999999998 557999999976531 1 112234579999999999999999999999999
Q ss_pred cceEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC---CCeEEccCCCc
Q 039310 136 VPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDEN---YTPKVSDFGAS 212 (241)
Q Consensus 136 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~---~~~kl~Dfgla 212 (241)
..||||||++||+|.+++-.++.+.+..-..++.|++.|+.|||++| |+||||||+|||+..+ ..+||+|||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccchh
Confidence 99999999999999999999999999999999999999999999999 9999999999999766 78999999999
Q ss_pred ccccCCccceeeeecccccccccccccC
Q 039310 213 KLVPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 213 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
+... ......+.||||.|.|||+|.+
T Consensus 327 K~~g--~~sfm~TlCGTpsYvAPEVl~~ 352 (475)
T KOG0615|consen 327 KVSG--EGSFMKTLCGTPSYVAPEVLAS 352 (475)
T ss_pred hccc--cceehhhhcCCccccChhheec
Confidence 9875 3456777899999999999875
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=275.00 Aligned_cols=176 Identities=36% Similarity=0.506 Sum_probs=149.5
Q ss_pred HHHHhhhcccccccccCceeEEEEEeCCCCeEEEEecccCC--hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCC-cce
Q 039310 62 EIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVD--QTKIDEFINELVVVSQINRRNVVRLLACCLETQ-VPL 138 (241)
Q Consensus 62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~-~~~ 138 (241)
.+......+.+.+|+|+||+||+|.+.+...||||.+.... ....+.|.+|+.+|+.++|||||+++|++.++. .++
T Consensus 37 ~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~ 116 (362)
T KOG0192|consen 37 EIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLC 116 (362)
T ss_pred ecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceE
Confidence 33333444555699999999999999766669999877533 222569999999999999999999999999988 799
Q ss_pred EEEEecCCCCchHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC-CeEEccCCCcccc
Q 039310 139 LVYEFVGNGTLFEHIHK--NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENY-TPKVSDFGASKLV 215 (241)
Q Consensus 139 lv~e~~~~g~L~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~-~~kl~Dfgla~~~ 215 (241)
+||||+++|+|.+++.. ...+++..++.++.||+.||.|||++++ ||||||||+|+|++.++ ++||+|||+++..
T Consensus 117 iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~ 194 (362)
T KOG0192|consen 117 IVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREK 194 (362)
T ss_pred EEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceee
Confidence 99999999999999987 5689999999999999999999999875 99999999999999997 9999999999876
Q ss_pred cCCccceeeeecccccccccccccC
Q 039310 216 PIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 216 ~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
.... .......||+.|||||++.+
T Consensus 195 ~~~~-~~~~~~~GT~~wMAPEv~~~ 218 (362)
T KOG0192|consen 195 VISK-TSMTSVAGTYRWMAPEVLRG 218 (362)
T ss_pred cccc-ccccCCCCCccccChhhhcC
Confidence 4321 22233569999999999974
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=267.82 Aligned_cols=171 Identities=31% Similarity=0.390 Sum_probs=152.4
Q ss_pred hhhcccccccccCceeEEEEEe-CCCCeEEEEeccc---CChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKI---VDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVY 141 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~---~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~ 141 (241)
....+.+.||+|+||+||.++. ++++-+|+|.++. ......+...+|..+|..++||.||+++..|++.+.+|+|+
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl 104 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL 104 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence 4456678999999999999984 4578889886543 44556788999999999999999999999999999999999
Q ss_pred EecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc
Q 039310 142 EFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ 221 (241)
Q Consensus 142 e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~ 221 (241)
||+.||.|...|.+.+.+++..+..++.+|+.||.|||+++ ||||||||+|||+|.+|+++|+|||||+....+ ..
T Consensus 105 d~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~-~~ 180 (357)
T KOG0598|consen 105 DYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD-GD 180 (357)
T ss_pred eccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccC-CC
Confidence 99999999999999999999999999999999999999999 999999999999999999999999999965333 34
Q ss_pred eeeeecccccccccccccC
Q 039310 222 NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~~ 240 (241)
.+.++|||+.|||||++..
T Consensus 181 ~t~tfcGT~eYmAPEil~~ 199 (357)
T KOG0598|consen 181 ATRTFCGTPEYMAPEILLG 199 (357)
T ss_pred ccccccCCccccChHHHhc
Confidence 5566899999999999875
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=275.55 Aligned_cols=170 Identities=27% Similarity=0.394 Sum_probs=156.6
Q ss_pred hhhcccccccccCceeEEEEEe-CCCCeEEEEeccc---CChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKI---VDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVY 141 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~---~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~ 141 (241)
.+|...++||+|+|+.||.++. ..|..||+|.+.. ......+...+|+++.+.|+|||||+++++|++.++.|+|+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 6677888999999999999996 7899999998654 35566788999999999999999999999999999999999
Q ss_pred EecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc
Q 039310 142 EFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ 221 (241)
Q Consensus 142 e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~ 221 (241)
|+|+.++|..+++..+.+++.+++.++.||+.||.|||+.+ |+|||||..|+|++++.++||+|||||..+..++ +
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~-E 173 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG-E 173 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCcc-c
Confidence 99999999999998889999999999999999999999999 9999999999999999999999999999886543 4
Q ss_pred eeeeeccccccccccccc
Q 039310 222 NYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~ 239 (241)
...+.||||-|.|||++.
T Consensus 174 rk~TlCGTPNYIAPEVl~ 191 (592)
T KOG0575|consen 174 RKKTLCGTPNYIAPEVLN 191 (592)
T ss_pred ccceecCCCcccChhHhc
Confidence 556789999999999986
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=260.49 Aligned_cols=167 Identities=25% Similarity=0.375 Sum_probs=148.5
Q ss_pred cccccccccCceeEEEEEeC-CCCeEEEEeccc-CChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCc-ceEEEEecC
Q 039310 69 NYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKI-VDQTKIDEFINELVVVSQINRRNVVRLLACCLETQV-PLLVYEFVG 145 (241)
Q Consensus 69 ~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~-~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~-~~lv~e~~~ 145 (241)
...+.||+|+.|+||++.++ ++..+|+|.+.. .+....+++.+|+++++.++||+||.+||+|..++. ..++||||+
T Consensus 82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMD 161 (364)
T KOG0581|consen 82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMD 161 (364)
T ss_pred hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcC
Confidence 34457999999999999965 577789998744 345566889999999999999999999999999985 999999999
Q ss_pred CCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceee
Q 039310 146 NGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHS-ETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYT 224 (241)
Q Consensus 146 ~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~ 224 (241)
+|+|.+++...+++++....+++.++++||.|||+ .+ ||||||||+|+|++..|.+||||||.+..+.+. ...
T Consensus 162 gGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~a~ 235 (364)
T KOG0581|consen 162 GGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---IAN 235 (364)
T ss_pred CCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh---hcc
Confidence 99999999988999999999999999999999996 66 999999999999999999999999999987533 445
Q ss_pred eecccccccccccccCC
Q 039310 225 VVQGTLGYIDPEYLQTC 241 (241)
Q Consensus 225 ~~~gt~~y~aPE~l~~~ 241 (241)
++.||..|||||.++++
T Consensus 236 tfvGT~~YMsPERi~g~ 252 (364)
T KOG0581|consen 236 TFVGTSAYMSPERISGE 252 (364)
T ss_pred cccccccccChhhhcCC
Confidence 66799999999998863
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=254.10 Aligned_cols=166 Identities=30% Similarity=0.365 Sum_probs=151.4
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEeccc---CChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKI---VDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~---~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
+++.+.||.|+||.|.+++.+ ++..+|+|.+.. .+.++.+...+|..+|+.+.||+++++++.|.+.+.+||||||
T Consensus 46 fe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmey 125 (355)
T KOG0616|consen 46 FERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEY 125 (355)
T ss_pred hhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEec
Confidence 344567999999999999854 578899997654 4566778899999999999999999999999999999999999
Q ss_pred cCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcccee
Q 039310 144 VGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNY 223 (241)
Q Consensus 144 ~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~ 223 (241)
.+||.|..++++.+++++..++.++.||+.||+|||+.+ |++|||||+|||+|++|.+||+|||+|+.+.. .+
T Consensus 126 v~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~----rT 198 (355)
T KOG0616|consen 126 VPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG----RT 198 (355)
T ss_pred cCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC----cE
Confidence 999999999999999999999999999999999999999 99999999999999999999999999998743 36
Q ss_pred eeecccccccccccccC
Q 039310 224 TVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 224 ~~~~gt~~y~aPE~l~~ 240 (241)
.+.||||.|+|||+++.
T Consensus 199 ~TlCGTPeYLAPEii~s 215 (355)
T KOG0616|consen 199 WTLCGTPEYLAPEIIQS 215 (355)
T ss_pred EEecCCccccChHHhhc
Confidence 77899999999999875
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=264.40 Aligned_cols=202 Identities=26% Similarity=0.340 Sum_probs=169.3
Q ss_pred hcCCchhHHHHhhhhCCCCccccccCHHHHHHhhhcccccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHH
Q 039310 34 QNGGSILRQELSKLQGRSSEKAKIFIEEEIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINEL 113 (241)
Q Consensus 34 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~ 113 (241)
..+++.+.+.++.+..+.+.+-..+..+........+.+.||+|.||+||+|.| .|..||||.+...+ .+.+.+|.
T Consensus 179 ~~~~stl~Dll~~~~tSGSGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srd---E~SWfrEt 254 (513)
T KOG2052|consen 179 LAGDSTLKDLLDDLETSGSGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRD---ERSWFRET 254 (513)
T ss_pred ccCCccHHHHHHhhccCCCCCCchhHhHHhhhheeEEEEEecCccccceeeccc-cCCceEEEEecccc---hhhhhhHH
Confidence 456677788887777777777777777777778888999999999999999999 46789999876443 36678899
Q ss_pred HHHHcC--CCCCceeEEEEEecCC----cceEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhh-----cCC
Q 039310 114 VVVSQI--NRRNVVRLLACCLETQ----VPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLH-----SET 182 (241)
Q Consensus 114 ~~l~~l--~h~ni~~l~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh-----~~~ 182 (241)
+++++. +|+||+.+++.-..++ .+|||++|.+.|||.|||.. ..++....++++..++.||++|| .+|
T Consensus 255 EIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqg 333 (513)
T KOG2052|consen 255 EIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQG 333 (513)
T ss_pred HHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCC
Confidence 999884 9999999998865433 67999999999999999987 47999999999999999999999 457
Q ss_pred CCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc---eeeeecccccccccccccC
Q 039310 183 NVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ---NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 183 ~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~l~~ 240 (241)
++.|.|||||++|||+..++.+.|+|+|||.....+... ......||.+|||||+|.+
T Consensus 334 KPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLde 394 (513)
T KOG2052|consen 334 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDE 394 (513)
T ss_pred CchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhh
Confidence 788999999999999999999999999999876544211 2334569999999999874
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=269.59 Aligned_cols=180 Identities=28% Similarity=0.399 Sum_probs=155.9
Q ss_pred cCHHHHHHhhhcccccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcc
Q 039310 58 FIEEEIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVP 137 (241)
Q Consensus 58 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~ 137 (241)
...+++......+.+.||+|.||.||+|.+++...||+|.++.... ..++|.+|+.+|++|+|+|||+++++|...+..
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~pi 276 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPI 276 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEEEEEecCCce
Confidence 3455666677778889999999999999998888999998876533 347888999999999999999999999999999
Q ss_pred eEEEEecCCCCchHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccc
Q 039310 138 LLVYEFVGNGTLFEHIHK--NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLV 215 (241)
Q Consensus 138 ~lv~e~~~~g~L~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~ 215 (241)
+||||||+.|+|.++|+. ...++..+.+.++.|||+||+||++++ +|||||.++|||++++..+||+|||||+..
T Consensus 277 yIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~ 353 (468)
T KOG0197|consen 277 YIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLI 353 (468)
T ss_pred EEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEccccccccc
Confidence 999999999999999986 457999999999999999999999999 999999999999999999999999999955
Q ss_pred cCCccceeeeecccccccccccccCC
Q 039310 216 PIDAIQNYTVVQGTLGYIDPEYLQTC 241 (241)
Q Consensus 216 ~~~~~~~~~~~~gt~~y~aPE~l~~~ 241 (241)
..+.+.......-...|.|||.+..+
T Consensus 354 ~d~~Y~~~~~~kfPIkWtAPEa~~~~ 379 (468)
T KOG0197|consen 354 GDDEYTASEGGKFPIKWTAPEALNYG 379 (468)
T ss_pred CCCceeecCCCCCCceecCHHHHhhC
Confidence 44443333333346789999998753
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=261.47 Aligned_cols=170 Identities=28% Similarity=0.375 Sum_probs=150.0
Q ss_pred hhcccccccccCceeEEEEE-eCCCCeEEEEecccCC--hhhHHHHHHHHHHHHcCCCCCceeEEEEEecC--CcceEEE
Q 039310 67 TNNYADVIGCGGSGNVYKGF-LPDRTPVAVKKSKIVD--QTKIDEFINELVVVSQINRRNVVRLLACCLET--QVPLLVY 141 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~--~~~~lv~ 141 (241)
.++..+.||+|.||.||+|+ ..++..||+|++.... .....-+.+|+.+|++|+||||++|.+...+. ..+|||+
T Consensus 118 ~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVF 197 (560)
T KOG0600|consen 118 SFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVF 197 (560)
T ss_pred HHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEE
Confidence 34455689999999999998 5578899999987654 45567788999999999999999999998876 6899999
Q ss_pred EecCCCCchHHhhcCC-CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcc
Q 039310 142 EFVGNGTLFEHIHKNG-NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAI 220 (241)
Q Consensus 142 e~~~~g~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~ 220 (241)
|||++ ||.-++...+ .+++.++..++.|++.||+|||+++ ++|||||.+|||||++|.+||+|||||+.+.....
T Consensus 198 eYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~ 273 (560)
T KOG0600|consen 198 EYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS 273 (560)
T ss_pred ecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccCCCC
Confidence 99987 8888887654 7999999999999999999999999 99999999999999999999999999998876665
Q ss_pred ceeeeecccccccccccccC
Q 039310 221 QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 221 ~~~~~~~gt~~y~aPE~l~~ 240 (241)
...+...-|+.|.|||.|.+
T Consensus 274 ~~~T~rVvTLWYRpPELLLG 293 (560)
T KOG0600|consen 274 APYTSRVVTLWYRPPELLLG 293 (560)
T ss_pred cccccceEEeeccChHHhcC
Confidence 55666778999999999875
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=258.45 Aligned_cols=168 Identities=31% Similarity=0.414 Sum_probs=143.9
Q ss_pred hcccccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcC--CCCCceeEEEEEecCC----cceEEE
Q 039310 68 NNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQI--NRRNVVRLLACCLETQ----VPLLVY 141 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l--~h~ni~~l~~~~~~~~----~~~lv~ 141 (241)
..+.+++|+|.||.||+|.+. ++.||||++. ..+.+.|.+|-++++.. +|+||++++++-.... .++||+
T Consensus 212 l~l~eli~~Grfg~V~KaqL~-~~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLD-NRLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred hhhHHHhhcCccceeehhhcc-CceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 345678999999999999984 4889999866 44567888898888875 7999999999976655 789999
Q ss_pred EecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC------CCCeEecCCCCCCeeeCCCCCeEEccCCCcccc
Q 039310 142 EFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSET------NVPIIHRDVKSANILLDENYTPKVSDFGASKLV 215 (241)
Q Consensus 142 e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~------~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~ 215 (241)
||.+.|+|.++|..+ .++|....+++..+++||+|||+.. +++|+|||||++|||+.+|+++.|+|||+|..+
T Consensus 288 ~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~ 366 (534)
T KOG3653|consen 288 EFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRL 366 (534)
T ss_pred eeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEe
Confidence 999999999999876 6899999999999999999999753 357999999999999999999999999999988
Q ss_pred cCCccc-eeeeecccccccccccccC
Q 039310 216 PIDAIQ-NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 216 ~~~~~~-~~~~~~gt~~y~aPE~l~~ 240 (241)
..+... ......||.+|||||+|++
T Consensus 367 ~p~~~~~d~~~qVGT~RYMAPEvLEg 392 (534)
T KOG3653|consen 367 EPGKPQGDTHGQVGTRRYMAPEVLEG 392 (534)
T ss_pred cCCCCCcchhhhhhhhhhcCHHHHhh
Confidence 644322 3333569999999999976
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=249.80 Aligned_cols=172 Identities=28% Similarity=0.408 Sum_probs=147.7
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCC--cceEEEE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQ--VPLLVYE 142 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~--~~~lv~e 142 (241)
..+...+.||+|+||.||++... ++...|||.....+....+.+.+|+.+|++++|||||+++|...... .++++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 34667788999999999999854 48889999877654444677899999999999999999999854444 6899999
Q ss_pred ecCCCCchHHhhcCC-CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC-CCCeEEccCCCcccccC--C
Q 039310 143 FVGNGTLFEHIHKNG-NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDE-NYTPKVSDFGASKLVPI--D 218 (241)
Q Consensus 143 ~~~~g~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~-~~~~kl~Dfgla~~~~~--~ 218 (241)
|+++|+|.+++...+ .+++..+..+..|+++||.|||+++ ++||||||+|||++. ++.+||+|||++..... .
T Consensus 97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 999999999999877 7999999999999999999999999 999999999999999 79999999999987653 1
Q ss_pred ccceeeeecccccccccccccC
Q 039310 219 AIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 219 ~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
.........||+.|||||++.+
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~ 195 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRN 195 (313)
T ss_pred cccccccccCCccccCchhhcC
Confidence 1222334669999999999874
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=257.67 Aligned_cols=173 Identities=27% Similarity=0.376 Sum_probs=151.3
Q ss_pred HHhhhcccccccccCceeEEEEEe-CCCCeEEEEecccC----Ch-hhHHHHHHHHHHHHcCC-CCCceeEEEEEecCCc
Q 039310 64 KTVTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIV----DQ-TKIDEFINELVVVSQIN-RRNVVRLLACCLETQV 136 (241)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~----~~-~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~~~~ 136 (241)
....|.+.+.||+|+||+|+.|.. .++..||+|..... .. ...+...+|+.+++.++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 345677888999999999999974 46799999964432 11 23455668999999998 9999999999999999
Q ss_pred ceEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC-CCeEEccCCCcccc
Q 039310 137 PLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDEN-YTPKVSDFGASKLV 215 (241)
Q Consensus 137 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~-~~~kl~Dfgla~~~ 215 (241)
.++||||+.+|+|.+++...+++++.++..++.|++.|++|||+.+ |+||||||+|+|+|.+ +++||+|||++...
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred EEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 9999999999999999999889999999999999999999999999 9999999999999999 99999999999987
Q ss_pred cCCccceeeeecccccccccccccC
Q 039310 216 PIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 216 ~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
. .......+.+||+.|+|||++.+
T Consensus 172 ~-~~~~~l~t~cGsp~Y~aPEvl~~ 195 (370)
T KOG0583|consen 172 P-GEDGLLKTFCGSPAYAAPEVLSG 195 (370)
T ss_pred C-CCCCcccCCCCCcccCCHHHhCC
Confidence 4 22345667789999999999975
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=248.32 Aligned_cols=174 Identities=28% Similarity=0.389 Sum_probs=146.5
Q ss_pred hhhcccccccccCceeEEEEE-eCCCCeEEEEeccc--CChhhHHHHHHHHHHHHcCCCCCceeEEEE-EecCC-cceEE
Q 039310 66 VTNNYADVIGCGGSGNVYKGF-LPDRTPVAVKKSKI--VDQTKIDEFINELVVVSQINRRNVVRLLAC-CLETQ-VPLLV 140 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavk~~~~--~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~-~~~~~-~~~lv 140 (241)
..+...+.||+|+||+||++. ..++..+|.|++.. .+....++...|+.+|++++||||++++++ +.+++ .+++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 345567789999999999997 56789999998764 456677889999999999999999999984 54444 48999
Q ss_pred EEecCCCCchHHhh----cCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEecCCCCCCeeeCCCCCeEEccCCCcccc
Q 039310 141 YEFVGNGTLFEHIH----KNGNLTWERRLRIAAETAGVLSYLHSETN-VPIIHRDVKSANILLDENYTPKVSDFGASKLV 215 (241)
Q Consensus 141 ~e~~~~g~L~~~l~----~~~~l~~~~~~~~~~~i~~~l~~lh~~~~-~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~ 215 (241)
||+|..|+|..+++ ....++++.+++++.|++.||..+|++-+ ..++||||||.||+++.+|.+||+||||++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 99999999999985 34569999999999999999999998321 23999999999999999999999999999988
Q ss_pred cCCccceeeeecccccccccccccC
Q 039310 216 PIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 216 ~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
.... .......|||.||+||.+.+
T Consensus 179 ~s~~-tfA~S~VGTPyYMSPE~i~~ 202 (375)
T KOG0591|consen 179 SSKT-TFAHSLVGTPYYMSPERIHE 202 (375)
T ss_pred cchh-HHHHhhcCCCcccCHHHHhc
Confidence 5443 23444679999999999865
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=252.06 Aligned_cols=174 Identities=23% Similarity=0.394 Sum_probs=156.4
Q ss_pred HHHHhhhcccccccccCceeEEEEE-eCCCCeEEEEeccc---CChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcc
Q 039310 62 EIKTVTNNYADVIGCGGSGNVYKGF-LPDRTPVAVKKSKI---VDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVP 137 (241)
Q Consensus 62 ~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavk~~~~---~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~ 137 (241)
...+-+|.+.+.||+|.||+|-+|+ ...|..||||.+.. .+..+.-.+.+|+++|+.++||||++++.+|+..+..
T Consensus 49 hnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKI 128 (668)
T KOG0611|consen 49 HNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKI 128 (668)
T ss_pred cchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceE
Confidence 3445678888999999999999998 56799999996543 4555666788999999999999999999999999999
Q ss_pred eEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccC
Q 039310 138 LLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPI 217 (241)
Q Consensus 138 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~ 217 (241)
.+||||..+|.|.+|+.+.+.+++.++..++.||..|+.|+|..+ ++|||||.+|||+|+++++||+|||++..+..
T Consensus 129 vivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 129 VIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 999999999999999999999999999999999999999999999 99999999999999999999999999987753
Q ss_pred CccceeeeecccccccccccccC
Q 039310 218 DAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 218 ~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
+ ....++||+|-|.+||++.+
T Consensus 206 ~--kfLqTFCGSPLYASPEIvNG 226 (668)
T KOG0611|consen 206 K--KFLQTFCGSPLYASPEIVNG 226 (668)
T ss_pred c--cHHHHhcCCcccCCccccCC
Confidence 3 34567899999999999865
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=254.03 Aligned_cols=143 Identities=25% Similarity=0.322 Sum_probs=131.8
Q ss_pred hcccccccccCceeEEEEE-eCCCCeEEEEecccC---ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 68 NNYADVIGCGGSGNVYKGF-LPDRTPVAVKKSKIV---DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
+....+||+|+||.||+|+ ..+|..+|+|+++.. ...+.+....|-.+|...++|+||+++..|++.+.+||||||
T Consensus 143 Fe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEy 222 (550)
T KOG0605|consen 143 FELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEY 222 (550)
T ss_pred chhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEe
Confidence 3445689999999999998 446889999987754 345667888999999999999999999999999999999999
Q ss_pred cCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcc
Q 039310 144 VGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASK 213 (241)
Q Consensus 144 ~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~ 213 (241)
++||++..+|...+.+++..+..++.+++.|++.||+.| +|||||||+|+|||..|++||+|||||.
T Consensus 223 lPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~ 289 (550)
T KOG0605|consen 223 LPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLST 289 (550)
T ss_pred cCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccc
Confidence 999999999999999999999999999999999999999 9999999999999999999999999985
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=255.21 Aligned_cols=173 Identities=28% Similarity=0.414 Sum_probs=151.0
Q ss_pred hhhcccccccccCceeEEEEE-eCCCCeEEEEeccc---CChhhHHHHHHHHHHHHcC-CCCCceeEEEEEecCCcceEE
Q 039310 66 VTNNYADVIGCGGSGNVYKGF-LPDRTPVAVKKSKI---VDQTKIDEFINELVVVSQI-NRRNVVRLLACCLETQVPLLV 140 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavk~~~~---~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv 140 (241)
..+.|++.||.|+|++|++|+ ...+..+|||.+.. ..+...+....|-+.|..| .||.|++|+..|++...+|+|
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv 152 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV 152 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence 446688999999999999998 44688999996542 3444556677899999999 899999999999999999999
Q ss_pred EEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcc
Q 039310 141 YEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAI 220 (241)
Q Consensus 141 ~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~ 220 (241)
+||+++|+|.++|.+-+.+++...+.++.+|++||+|||+.| ||||||||+|||+|+|++++|+|||.|+.+.....
T Consensus 153 Le~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~ 229 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSPSQK 229 (604)
T ss_pred EEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCChhhc
Confidence 999999999999999999999999999999999999999999 99999999999999999999999999998743211
Q ss_pred ----------cee--eeecccccccccccccCC
Q 039310 221 ----------QNY--TVVQGTLGYIDPEYLQTC 241 (241)
Q Consensus 221 ----------~~~--~~~~gt~~y~aPE~l~~~ 241 (241)
... ..+.||..|.+||+|.++
T Consensus 230 ~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~ 262 (604)
T KOG0592|consen 230 SQENPVDPNQASSRRSSFVGTAEYVSPELLNDS 262 (604)
T ss_pred cccCccCcccccCcccceeeeecccCHHHhcCC
Confidence 111 447799999999999763
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=232.09 Aligned_cols=169 Identities=25% Similarity=0.292 Sum_probs=146.4
Q ss_pred hhcccccccccCceeEEEEE-eCCCCeEEEEecccCChh--hHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 67 TNNYADVIGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQT--KIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavk~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
+|...+.+|+|.||.||+|+ ..+++.||||+++..+.. -.....+|+..|+.++|+||+.++++|...+...+|+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 34556689999999999998 557899999998765433 245678999999999999999999999999999999999
Q ss_pred cCCCCchHHhhcCC-CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccce
Q 039310 144 VGNGTLFEHIHKNG-NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQN 222 (241)
Q Consensus 144 ~~~g~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~ 222 (241)
++. +|...++... .++..++..++.++++|++|||++. |+||||||.|+|++++|.+||+|||+|+.........
T Consensus 83 m~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~ 158 (318)
T KOG0659|consen 83 MPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ 158 (318)
T ss_pred ccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCccc
Confidence 975 9999998665 6999999999999999999999999 9999999999999999999999999999886544333
Q ss_pred eeeecccccccccccccC
Q 039310 223 YTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 223 ~~~~~gt~~y~aPE~l~~ 240 (241)
... .-|..|.|||.|-+
T Consensus 159 ~~~-V~TRWYRAPELLfG 175 (318)
T KOG0659|consen 159 THQ-VVTRWYRAPELLFG 175 (318)
T ss_pred ccc-eeeeeccChHHhcc
Confidence 322 47899999998754
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=255.12 Aligned_cols=176 Identities=32% Similarity=0.452 Sum_probs=148.0
Q ss_pred HHHHHhhhcccccccccCceeEEEEEeCC--C---CeEEEEeccc---CChhhHHHHHHHHHHHHcCCCCCceeEEEEEe
Q 039310 61 EEIKTVTNNYADVIGCGGSGNVYKGFLPD--R---TPVAVKKSKI---VDQTKIDEFINELVVVSQINRRNVVRLLACCL 132 (241)
Q Consensus 61 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~--~---~~vavk~~~~---~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 132 (241)
+++......+.+.||+|+||+||+|.+.. + ..||+|..+. .......++++|+++|++++||||+++||++.
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV 231 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 34444445566899999999999998543 2 2389998764 45677889999999999999999999999999
Q ss_pred cCCcceEEEEecCCCCchHHhhcCC-CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCC
Q 039310 133 ETQVPLLVYEFVGNGTLFEHIHKNG-NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGA 211 (241)
Q Consensus 133 ~~~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgl 211 (241)
...++++|||+|+||+|.++|++++ .++..+...++.+.+.||+|||+++ ++||||.++|+|++.++.+||+|||+
T Consensus 232 ~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGL 308 (474)
T KOG0194|consen 232 LEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGL 308 (474)
T ss_pred CCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcccc
Confidence 9999999999999999999999887 4999999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCccceee-eecccccccccccccCC
Q 039310 212 SKLVPIDAIQNYT-VVQGTLGYIDPEYLQTC 241 (241)
Q Consensus 212 a~~~~~~~~~~~~-~~~gt~~y~aPE~l~~~ 241 (241)
++.-. ...... ...-..+|+|||.++++
T Consensus 309 s~~~~--~~~~~~~~~klPirWLAPEtl~~~ 337 (474)
T KOG0194|consen 309 SRAGS--QYVMKKFLKKLPIRWLAPETLNTG 337 (474)
T ss_pred ccCCc--ceeeccccccCcceecChhhhccC
Confidence 87642 111111 11245799999999864
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=239.12 Aligned_cols=166 Identities=25% Similarity=0.322 Sum_probs=141.9
Q ss_pred ccccccccCceeEEEEEeC-CCCeEEEEecccCC--hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCC
Q 039310 70 YADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD--QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGN 146 (241)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~ 146 (241)
-...+|+|+||.||+++.+ +|+-||||++.... +.-.+-.++|+.+|++++|||+|.++++|.....+++|+|||+.
T Consensus 6 ~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh 85 (396)
T KOG0593|consen 6 KLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH 85 (396)
T ss_pred hhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch
Confidence 3446899999999999955 58999999976543 34456689999999999999999999999999999999999987
Q ss_pred CCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeee
Q 039310 147 GTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTV 225 (241)
Q Consensus 147 g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~ 225 (241)
++.+-|... ..++...+..++.|++.|+.|+|+.+ +|||||||+||||+.+|.+||||||+|+.+.. .....+.
T Consensus 86 -TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd~YTD 160 (396)
T KOG0593|consen 86 -TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGDNYTD 160 (396)
T ss_pred -HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC-Ccchhhh
Confidence 454455443 46999999999999999999999999 99999999999999999999999999999863 2334455
Q ss_pred ecccccccccccccC
Q 039310 226 VQGTLGYIDPEYLQT 240 (241)
Q Consensus 226 ~~gt~~y~aPE~l~~ 240 (241)
...|.+|.|||.|-+
T Consensus 161 YVATRWYRaPELLvG 175 (396)
T KOG0593|consen 161 YVATRWYRAPELLVG 175 (396)
T ss_pred hhhhhhccChhhhcc
Confidence 568999999998754
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=265.30 Aligned_cols=177 Identities=28% Similarity=0.407 Sum_probs=150.8
Q ss_pred HHHHhhhcccccccccCceeEEEEEeC------CCCeEEEEecccCChh-hHHHHHHHHHHHHcCCCCCceeEEEEEecC
Q 039310 62 EIKTVTNNYADVIGCGGSGNVYKGFLP------DRTPVAVKKSKIVDQT-KIDEFINELVVVSQINRRNVVRLLACCLET 134 (241)
Q Consensus 62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 134 (241)
++......+.+.||+|+||+||+|+.. ....||||.++..... ...+|.+|++++..++|||||+|+|+|..+
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG 561 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence 444455566778999999999999843 3567999998876555 678999999999999999999999999999
Q ss_pred CcceEEEEecCCCCchHHhhcCC--------------CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC
Q 039310 135 QVPLLVYEFVGNGTLFEHIHKNG--------------NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDE 200 (241)
Q Consensus 135 ~~~~lv~e~~~~g~L~~~l~~~~--------------~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~ 200 (241)
+.++||+|||..|||.+||+... +++..+.+.++.|||.||.||-+.. +|||||.++|+||.+
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGE 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceecc
Confidence 99999999999999999997322 2888999999999999999999999 999999999999999
Q ss_pred CCCeEEccCCCcccccCCccceee-eecccccccccccccCC
Q 039310 201 NYTPKVSDFGASKLVPIDAIQNYT-VVQGTLGYIDPEYLQTC 241 (241)
Q Consensus 201 ~~~~kl~Dfgla~~~~~~~~~~~~-~~~gt~~y~aPE~l~~~ 241 (241)
+..|||+||||++..-..++++.. ...-..+|||||.|..|
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~ 680 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYG 680 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcC
Confidence 999999999999976544544433 22346799999998754
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=241.42 Aligned_cols=174 Identities=29% Similarity=0.411 Sum_probs=149.7
Q ss_pred HHhhhcccccccccCceeEEEEE-eCCCCeEEEEecccCChh-hHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEE
Q 039310 64 KTVTNNYADVIGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQT-KIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVY 141 (241)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~ 141 (241)
....|.+.+.||.|..+.||+|+ .+.+..||||++...+.. ....+.+|+..|+.++||||++++.+|..+..+|+||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 34567888899999999999998 556789999998764433 3588999999999999999999999999999999999
Q ss_pred EecCCCCchHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCc
Q 039310 142 EFVGNGTLFEHIHKN--GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDA 219 (241)
Q Consensus 142 e~~~~g~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~ 219 (241)
.||.+|++.++++.. ..+++..+..+..++++||.|||.+| .||||+|+.||||+++|.+||+|||.+..+....
T Consensus 104 pfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 999999999999754 34999999999999999999999999 9999999999999999999999999766553322
Q ss_pred cc---eeeeecccccccccccccC
Q 039310 220 IQ---NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 220 ~~---~~~~~~gt~~y~aPE~l~~ 240 (241)
.. ....+.|||+|||||+|++
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q 204 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQ 204 (516)
T ss_pred ceeeEeeccccCcccccChHHhhh
Confidence 11 1144579999999999543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=250.93 Aligned_cols=169 Identities=29% Similarity=0.457 Sum_probs=150.0
Q ss_pred hhcccccccccCceeEEEEEeC-CCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
.|...+.||+|+||.||+|+.+ +.+.||+|.+... ..++.+.+.+|+++++.++||||+.++++|+....+|+|+||
T Consensus 3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~ 82 (808)
T KOG0597|consen 3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEY 82 (808)
T ss_pred chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehh
Confidence 3556778999999999999854 5778999976543 344567899999999999999999999999999999999999
Q ss_pred cCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcccee
Q 039310 144 VGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNY 223 (241)
Q Consensus 144 ~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~ 223 (241)
+.| +|..++...+.+++..+..++.+++.||.|||+.+ |+|||+||.|||++..+.+|+||||+|+.+..+. ...
T Consensus 83 a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t-~vl 157 (808)
T KOG0597|consen 83 AVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT-SVL 157 (808)
T ss_pred hhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc-eee
Confidence 976 99999999999999999999999999999999999 9999999999999999999999999999876543 334
Q ss_pred eeecccccccccccccC
Q 039310 224 TVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 224 ~~~~gt~~y~aPE~l~~ 240 (241)
....|||-|||||++.+
T Consensus 158 tsikGtPlYmAPElv~e 174 (808)
T KOG0597|consen 158 TSIKGTPLYMAPELVEE 174 (808)
T ss_pred eeccCcccccCHHHHcC
Confidence 45679999999999875
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=247.96 Aligned_cols=170 Identities=24% Similarity=0.284 Sum_probs=145.5
Q ss_pred HhhhcccccccccCceeEEEEE-eCCCCeEEEEecccCChhhHH-HHHHHHHHHHcCC-CCCceeEEEEEecCC-cceEE
Q 039310 65 TVTNNYADVIGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKID-EFINELVVVSQIN-RRNVVRLLACCLETQ-VPLLV 140 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavk~~~~~~~~~~~-~~~~E~~~l~~l~-h~ni~~l~~~~~~~~-~~~lv 140 (241)
-.+|...+.||.|+||.||+|. ...+..||||+++.....+.+ .-++|+.-|++++ ||||+++.+++.+.+ .+|+|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 3567778899999999999998 456888999987754333322 3468999999998 999999999999887 89999
Q ss_pred EEecCCCCchHHhhcCC-CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCc
Q 039310 141 YEFVGNGTLFEHIHKNG-NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDA 219 (241)
Q Consensus 141 ~e~~~~g~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~ 219 (241)
||||+. +|.++++... .+++..+..|+.||++||+|+|..| +.|||+||+|||+..+..+||+|||+|+.+....
T Consensus 89 fE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~Skp 164 (538)
T KOG0661|consen 89 FEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRSKP 164 (538)
T ss_pred HHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccccCC
Confidence 999987 9999997654 6999999999999999999999999 9999999999999999999999999999876544
Q ss_pred cceeeeecccccccccccccC
Q 039310 220 IQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 220 ~~~~~~~~gt~~y~aPE~l~~ 240 (241)
++ +....|..|.|||+|..
T Consensus 165 PY--TeYVSTRWYRAPEvLLr 183 (538)
T KOG0661|consen 165 PY--TEYVSTRWYRAPEVLLR 183 (538)
T ss_pred Cc--chhhhcccccchHHhhh
Confidence 43 44457999999999753
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=247.61 Aligned_cols=165 Identities=29% Similarity=0.462 Sum_probs=149.1
Q ss_pred cccccccCceeEEEEE-eCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCCCCc
Q 039310 71 ADVIGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTL 149 (241)
Q Consensus 71 ~~~lg~G~~g~V~~~~-~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~g~L 149 (241)
...||+|+.|.||.|. ..+++.||||.+....+...+-+++|+.+|+..+|+|||+++..|...+.+|+|||||+||+|
T Consensus 278 ~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsL 357 (550)
T KOG0578|consen 278 FKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSL 357 (550)
T ss_pred hhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCch
Confidence 4579999999999998 456888999999888888888899999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeeeeccc
Q 039310 150 FEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGT 229 (241)
Q Consensus 150 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt 229 (241)
.+.+... .+++.++..++.++++||+|||.++ |+|||||.+|||++.+|.+||+|||+|..+..... +..+..||
T Consensus 358 TDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR~TmVGT 432 (550)
T KOG0578|consen 358 TDVVTKT-RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KRSTMVGT 432 (550)
T ss_pred hhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC-ccccccCC
Confidence 9988654 5999999999999999999999999 99999999999999999999999999998765443 44455699
Q ss_pred ccccccccccC
Q 039310 230 LGYIDPEYLQT 240 (241)
Q Consensus 230 ~~y~aPE~l~~ 240 (241)
|.|||||++..
T Consensus 433 PYWMAPEVvtr 443 (550)
T KOG0578|consen 433 PYWMAPEVVTR 443 (550)
T ss_pred CCccchhhhhh
Confidence 99999999764
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=249.35 Aligned_cols=170 Identities=26% Similarity=0.330 Sum_probs=147.0
Q ss_pred hhcccccccccCceeEEEEEeC-CCCeEEEEeccc---CChhhHHHHHHHHHHHHcC-CCCCceeEEEEEecCCcceEEE
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKI---VDQTKIDEFINELVVVSQI-NRRNVVRLLACCLETQVPLLVY 141 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~---~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~ 141 (241)
...+.++||+|+||+|+++..+ +++.+|||.++. ......+....|..++... +||.+++++.+|++.+++|+||
T Consensus 369 ~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvm 448 (694)
T KOG0694|consen 369 DFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVM 448 (694)
T ss_pred ceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEE
Confidence 3456779999999999999965 467889987654 3456678888999998888 5999999999999999999999
Q ss_pred EecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc
Q 039310 142 EFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ 221 (241)
Q Consensus 142 e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~ 221 (241)
||+.||++.. +...+.+++..+..++.+++.||+|||+.+ |||||||.+|||+|.+|.+||+|||+++...... .
T Consensus 449 ey~~Ggdm~~-~~~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g-~ 523 (694)
T KOG0694|consen 449 EYVAGGDLMH-HIHTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG-D 523 (694)
T ss_pred EecCCCcEEE-EEecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccCCCC-C
Confidence 9999999543 334468999999999999999999999999 9999999999999999999999999999754333 3
Q ss_pred eeeeecccccccccccccCC
Q 039310 222 NYTVVQGTLGYIDPEYLQTC 241 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~~~ 241 (241)
.+.++||||.|||||+|.++
T Consensus 524 ~TsTfCGTpey~aPEil~e~ 543 (694)
T KOG0694|consen 524 RTSTFCGTPEFLAPEVLTEQ 543 (694)
T ss_pred ccccccCChhhcChhhhccC
Confidence 67789999999999999863
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=249.33 Aligned_cols=170 Identities=26% Similarity=0.336 Sum_probs=151.9
Q ss_pred hhhcccccccccCceeEEEEE-eCCCCeEEEEecccC---ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEE
Q 039310 66 VTNNYADVIGCGGSGNVYKGF-LPDRTPVAVKKSKIV---DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVY 141 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~ 141 (241)
.-|.+++.||+|+-|.|.+|+ ..+|+.+|||.+... .........+|+.+|+.+.|||++++|++|+....+|+|+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 346778899999999999998 457999999976543 2334566789999999999999999999999999999999
Q ss_pred EecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc
Q 039310 142 EFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ 221 (241)
Q Consensus 142 e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~ 221 (241)
||+++|.|++++...+++++.++.+++.||+.|+.|+|..+ |+||||||+|+|+|..+++||+|||+|..-..+ .
T Consensus 92 Eyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g--k 166 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG--K 166 (786)
T ss_pred EecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC--c
Confidence 99999999999999999999999999999999999999999 999999999999999999999999999865433 3
Q ss_pred eeeeecccccccccccccC
Q 039310 222 NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~~ 240 (241)
...+.||+|.|.|||++++
T Consensus 167 lLeTSCGSPHYA~PEIV~G 185 (786)
T KOG0588|consen 167 LLETSCGSPHYAAPEIVSG 185 (786)
T ss_pred cccccCCCcccCCchhhcC
Confidence 4556789999999999876
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=256.43 Aligned_cols=176 Identities=28% Similarity=0.455 Sum_probs=152.5
Q ss_pred HHHHHhhhcccccccccCceeEEEEEeCC----CCeEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCC
Q 039310 61 EEIKTVTNNYADVIGCGGSGNVYKGFLPD----RTPVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCLETQ 135 (241)
Q Consensus 61 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 135 (241)
.|+......+.++||.|.||+|++|+++- ...||||.++.. .+++..+|+.|+.+|-+++||||++|.|+.....
T Consensus 624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~ 703 (996)
T KOG0196|consen 624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK 703 (996)
T ss_pred hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCc
Confidence 34555556667799999999999998542 457999998874 4567789999999999999999999999999999
Q ss_pred cceEEEEecCCCCchHHhhcCC-CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCccc
Q 039310 136 VPLLVYEFVGNGTLFEHIHKNG-NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKL 214 (241)
Q Consensus 136 ~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~ 214 (241)
..++|+|||++|+|+.||+.+. .++..++..+...|+.||.||.+.+ +|||||.++|||++++..+|++|||+++.
T Consensus 704 PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRv 780 (996)
T KOG0196|consen 704 PVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 780 (996)
T ss_pred eeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceee
Confidence 9999999999999999998764 6999999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCccceeeeecc--ccccccccccc
Q 039310 215 VPIDAIQNYTVVQG--TLGYIDPEYLQ 239 (241)
Q Consensus 215 ~~~~~~~~~~~~~g--t~~y~aPE~l~ 239 (241)
+.++......+..| ..+|.|||.+.
T Consensus 781 ledd~~~~ytt~GGKIPiRWTAPEAIa 807 (996)
T KOG0196|consen 781 LEDDPEAAYTTLGGKIPIRWTAPEAIA 807 (996)
T ss_pred cccCCCccccccCCccceeecChhHhh
Confidence 76665333333333 47899999874
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=243.88 Aligned_cols=176 Identities=23% Similarity=0.348 Sum_probs=151.3
Q ss_pred HHHHhhhcccccccccCceeEEEEEeCCCCeEEEEecccCChhh-HHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEE
Q 039310 62 EIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTK-IDEFINELVVVSQINRRNVVRLLACCLETQVPLLV 140 (241)
Q Consensus 62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~-~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv 140 (241)
+.......+.+.||+|-||+|.++...++..||||+++...... ..+|.+|+.+|.+++||||+.++|+|..++.++++
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 34444556778999999999999999888999999998866554 48999999999999999999999999999999999
Q ss_pred EEecCCCCchHHhhcCC--CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCC
Q 039310 141 YEFVGNGTLFEHIHKNG--NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPID 218 (241)
Q Consensus 141 ~e~~~~g~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~ 218 (241)
+|||++|+|.+|+..+. .+.-....+++.||+.||+||.+.+ +||||+.++|+|+|.++++||+|||+++.+-..
T Consensus 614 ~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccC
Confidence 99999999999998773 3455667789999999999999999 999999999999999999999999999977555
Q ss_pred ccceeee-ecccccccccccccC
Q 039310 219 AIQNYTV-VQGTLGYIDPEYLQT 240 (241)
Q Consensus 219 ~~~~~~~-~~gt~~y~aPE~l~~ 240 (241)
+++.... ..-..+|||||.+-.
T Consensus 691 ~yy~vqgr~vlpiRwmawEsill 713 (807)
T KOG1094|consen 691 DYYRVQGRAVLPIRWMAWESILL 713 (807)
T ss_pred CceeeecceeeeeeehhHHHHHh
Confidence 5443332 224679999998754
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=239.05 Aligned_cols=169 Identities=30% Similarity=0.413 Sum_probs=146.9
Q ss_pred HhhhcccccccccCceeEEEEEeCC--CCeEEEEecccC---ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceE
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFLPD--RTPVAVKKSKIV---DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLL 139 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~l 139 (241)
...+.+.+.||+|+||.||+|...+ +..||+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3457778899999999999998543 357999976532 23345678899999999999999999999999999999
Q ss_pred EEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCc
Q 039310 140 VYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDA 219 (241)
Q Consensus 140 v~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~ 219 (241)
||||+++|+|.+++.....+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++......
T Consensus 109 v~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~- 184 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR- 184 (340)
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCCC-
Confidence 9999999999999998888999999999999999999999999 999999999999999999999999999865322
Q ss_pred cceeeeecccccccccccccC
Q 039310 220 IQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 220 ~~~~~~~~gt~~y~aPE~l~~ 240 (241)
.....||+.|||||++.+
T Consensus 185 ---~~~~~gt~~y~aPE~~~~ 202 (340)
T PTZ00426 185 ---TYTLCGTPEYIAPEILLN 202 (340)
T ss_pred ---cceecCChhhcCHHHHhC
Confidence 234569999999999754
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=235.64 Aligned_cols=165 Identities=25% Similarity=0.322 Sum_probs=142.9
Q ss_pred ccccccCceeEEEEEe-CCCCeEEEEecccC---ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCCC
Q 039310 72 DVIGCGGSGNVYKGFL-PDRTPVAVKKSKIV---DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNG 147 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~g 147 (241)
+.||+|+||.||+|.. .++..+|+|.+... .......+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3689999999999985 46889999977642 2334567789999999999999999999999999999999999999
Q ss_pred CchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeeeec
Q 039310 148 TLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQ 227 (241)
Q Consensus 148 ~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 227 (241)
+|.+++.....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~~ 156 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFC 156 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Cccccee
Confidence 99999988888999999999999999999999999 9999999999999999999999999987542221 2233456
Q ss_pred ccccccccccccC
Q 039310 228 GTLGYIDPEYLQT 240 (241)
Q Consensus 228 gt~~y~aPE~l~~ 240 (241)
||+.|||||++.+
T Consensus 157 gt~~y~aPE~~~~ 169 (323)
T cd05571 157 GTPEYLAPEVLED 169 (323)
T ss_pred cCccccChhhhcC
Confidence 9999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=240.61 Aligned_cols=145 Identities=26% Similarity=0.299 Sum_probs=130.5
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
+.+.+.||+|+||+||+|... +++.+|+|.+... .......+.+|+.++..++||||+++++++.+.+..|+||||
T Consensus 3 y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~ 82 (363)
T cd05628 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEF 82 (363)
T ss_pred ceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcC
Confidence 456678999999999999854 5789999987542 223445678899999999999999999999999999999999
Q ss_pred cCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccc
Q 039310 144 VGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLV 215 (241)
Q Consensus 144 ~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~ 215 (241)
+++|+|.+++...+.+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+
T Consensus 83 ~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~ 151 (363)
T cd05628 83 LPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGL 151 (363)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccc
Confidence 999999999988889999999999999999999999999 999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=246.46 Aligned_cols=176 Identities=28% Similarity=0.488 Sum_probs=148.4
Q ss_pred CHHHHHHhhhcccccccccCceeEEEEEeCCCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCc
Q 039310 59 IEEEIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLETQV 136 (241)
Q Consensus 59 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~ 136 (241)
.++++......+.+.||+|+||+||+|+|- ..||||.++.. ...+.+.|.+|+..+++-+|.||+-+.|+|..++.
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 455666666667889999999999999984 35999987764 45578899999999999999999999999998887
Q ss_pred ceEEEEecCCCCchHHhhcCC-CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccc
Q 039310 137 PLLVYEFVGNGTLFEHIHKNG-NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLV 215 (241)
Q Consensus 137 ~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~ 215 (241)
.+|+-+|+|.+|+.+++... .+...+.+.|+.|+++||.|||.++ |||||||..||++.++++|||+||||+..-
T Consensus 463 -AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk 538 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVK 538 (678)
T ss_pred -eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeee
Confidence 99999999999999998554 6899999999999999999999999 999999999999999999999999998643
Q ss_pred cCC-ccceeeeecccccccccccccC
Q 039310 216 PID-AIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 216 ~~~-~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
..- .........|...|||||+++.
T Consensus 539 ~~w~g~~q~~qp~gsilwmAPEvIRm 564 (678)
T KOG0193|consen 539 TRWSGEQQLEQPHGSLLWMAPEVIRM 564 (678)
T ss_pred eeeccccccCCCccchhhhcHHHHhh
Confidence 211 1111222347889999999864
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=260.11 Aligned_cols=176 Identities=28% Similarity=0.497 Sum_probs=150.0
Q ss_pred HHHhhhcccccccccCceeEEEEEeCC--CC----eEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCC
Q 039310 63 IKTVTNNYADVIGCGGSGNVYKGFLPD--RT----PVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCLETQ 135 (241)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~~--~~----~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 135 (241)
+......+.+.||+|+||.||.|...+ +. .||||.+... +..+..+|++|..+|+.++||||++++|++.+..
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 445566678899999999999998543 32 4899987764 5677889999999999999999999999999999
Q ss_pred cceEEEEecCCCCchHHhhcC-------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEcc
Q 039310 136 VPLLVYEFVGNGTLFEHIHKN-------GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSD 208 (241)
Q Consensus 136 ~~~lv~e~~~~g~L~~~l~~~-------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~D 208 (241)
..++++|||++|+|..||++. ..++..+++.++.|||+|+.||++++ +|||||.++|+|++....+||+|
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcc
Confidence 999999999999999999876 24999999999999999999999999 99999999999999999999999
Q ss_pred CCCcccccCCccceeeee-cccccccccccccCC
Q 039310 209 FGASKLVPIDAIQNYTVV-QGTLGYIDPEYLQTC 241 (241)
Q Consensus 209 fgla~~~~~~~~~~~~~~-~gt~~y~aPE~l~~~ 241 (241)
||+|+..-..+++..... .-..+|||||++++|
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~ 879 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDG 879 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhc
Confidence 999995544444333322 234689999999864
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=235.29 Aligned_cols=173 Identities=26% Similarity=0.342 Sum_probs=140.3
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEecccCC---------h-----hhHHHHHHHHHHHHcCCCCCceeEEEE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD---------Q-----TKIDEFINELVVVSQINRRNVVRLLAC 130 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~---------~-----~~~~~~~~E~~~l~~l~h~ni~~l~~~ 130 (241)
..|.+.+.||+|.||.|-+|+.. +++.||||.+.... + ...+...+|+.+|+++.|||||+|+.+
T Consensus 97 Nqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEv 176 (576)
T KOG0585|consen 97 NQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEV 176 (576)
T ss_pred hheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEe
Confidence 44566778999999999999844 58889999764310 1 123578899999999999999999999
Q ss_pred EecC--CcceEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEcc
Q 039310 131 CLET--QVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSD 208 (241)
Q Consensus 131 ~~~~--~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~D 208 (241)
..+. +..|||+|||..|.+...--...-+++.+++.++.++..||+|||.++ ||||||||+|+|++++|++||+|
T Consensus 177 LDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~VKIsD 253 (576)
T KOG0585|consen 177 LDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTVKISD 253 (576)
T ss_pred ecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcEEeec
Confidence 8764 588999999998887655433333999999999999999999999999 99999999999999999999999
Q ss_pred CCCcccccCC----ccceeeeecccccccccccccCC
Q 039310 209 FGASKLVPID----AIQNYTVVQGTLGYIDPEYLQTC 241 (241)
Q Consensus 209 fgla~~~~~~----~~~~~~~~~gt~~y~aPE~l~~~ 241 (241)
||.+...... .........|||.|||||...+|
T Consensus 254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~ 290 (576)
T KOG0585|consen 254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGG 290 (576)
T ss_pred cceeeecccCCccccHHHHhhcCCCccccchHhhcCC
Confidence 9998765221 11122235699999999987663
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=236.55 Aligned_cols=168 Identities=28% Similarity=0.394 Sum_probs=147.3
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVY 141 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~ 141 (241)
..+.+.+.||+|+||.||+|... +++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 34667789999999999999865 5788999986542 2234567889999999999999999999999999999999
Q ss_pred EecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc
Q 039310 142 EFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ 221 (241)
Q Consensus 142 e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~ 221 (241)
||+++++|.+++...+.+++..+..++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||++......
T Consensus 98 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--- 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR--- 171 (329)
T ss_pred cCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC---
Confidence 99999999999998888999999999999999999999999 999999999999999999999999999876432
Q ss_pred eeeeecccccccccccccC
Q 039310 222 NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~~ 240 (241)
.....||+.|+|||++.+
T Consensus 172 -~~~~~gt~~y~aPE~~~~ 189 (329)
T PTZ00263 172 -TFTLCGTPEYLAPEVIQS 189 (329)
T ss_pred -cceecCChhhcCHHHHcC
Confidence 223469999999998764
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=234.76 Aligned_cols=165 Identities=26% Similarity=0.333 Sum_probs=142.5
Q ss_pred ccccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCCC
Q 039310 72 DVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNG 147 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~g 147 (241)
+.||+|+||.||++... ++..||+|.+... .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 35899999999999854 6889999987542 2334567788999999999999999999999999999999999999
Q ss_pred CchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeeeec
Q 039310 148 TLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQ 227 (241)
Q Consensus 148 ~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 227 (241)
+|..++.....+++..+..++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||++....... .......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~ 156 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFC 156 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Ccccccc
Confidence 99999988888999999999999999999999999 9999999999999999999999999987542222 1223356
Q ss_pred ccccccccccccC
Q 039310 228 GTLGYIDPEYLQT 240 (241)
Q Consensus 228 gt~~y~aPE~l~~ 240 (241)
||+.|+|||++.+
T Consensus 157 gt~~y~aPE~~~~ 169 (323)
T cd05595 157 GTPEYLAPEVLED 169 (323)
T ss_pred CCcCcCCcccccC
Confidence 9999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=239.35 Aligned_cols=170 Identities=26% Similarity=0.323 Sum_probs=145.6
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEeccc---CChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKI---VDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVY 141 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~---~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~ 141 (241)
..+.+.+.||+|+||.||++... ++..+|+|.+.. ........+.+|+.+++.++||||+++++++.+++..|+||
T Consensus 43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05621 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM 122 (370)
T ss_pred HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 45677889999999999999865 577899997643 22233456788999999999999999999999999999999
Q ss_pred EecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc
Q 039310 142 EFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ 221 (241)
Q Consensus 142 e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~ 221 (241)
||+++|+|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+|.........
T Consensus 123 Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~ 198 (370)
T cd05621 123 EYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV 198 (370)
T ss_pred cCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecccCCce
Confidence 999999999999654 5899999999999999999999999 999999999999999999999999999876433322
Q ss_pred eeeeeccccccccccccc
Q 039310 222 NYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~ 239 (241)
......||+.|||||++.
T Consensus 199 ~~~~~~gt~~Y~aPE~~~ 216 (370)
T cd05621 199 RCDTAVGTPDYISPEVLK 216 (370)
T ss_pred ecccCCCCcccCCHHHHh
Confidence 334456999999999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=239.80 Aligned_cols=144 Identities=19% Similarity=0.245 Sum_probs=130.0
Q ss_pred hcccccccccCceeEEEEEe-CCCCeEEEEecccC---ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 68 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIV---DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
+.+.+.||+|+||+||+|.. .++..+|+|.+... .......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~ 82 (381)
T cd05626 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (381)
T ss_pred ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEec
Confidence 45567899999999999985 45788999987542 234456788999999999999999999999999999999999
Q ss_pred cCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCccc
Q 039310 144 VGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKL 214 (241)
Q Consensus 144 ~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~ 214 (241)
+++|+|.+++.....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 83 ~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~ 150 (381)
T cd05626 83 IPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTG 150 (381)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcc
Confidence 999999999988888999999999999999999999999 99999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=239.95 Aligned_cols=145 Identities=26% Similarity=0.300 Sum_probs=131.0
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
+...+.||+|+||+||+|... +++.||||.+... .......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (364)
T cd05599 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEY 82 (364)
T ss_pred ceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECC
Confidence 456778999999999999864 5888999987642 233445678899999999999999999999999999999999
Q ss_pred cCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccc
Q 039310 144 VGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLV 215 (241)
Q Consensus 144 ~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~ 215 (241)
+++|+|.+++...+.+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++..+
T Consensus 83 ~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 151 (364)
T cd05599 83 LPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGL 151 (364)
T ss_pred CCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceec
Confidence 999999999988888999999999999999999999999 999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=226.86 Aligned_cols=168 Identities=27% Similarity=0.346 Sum_probs=142.7
Q ss_pred hcccccccccCceeEEEEE-eCCCCeEEEEecccCCh--hhHHHHHHHHHHHHcCCCCC-ceeEEEEEecCC------cc
Q 039310 68 NNYADVIGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQ--TKIDEFINELVVVSQINRRN-VVRLLACCLETQ------VP 137 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~h~n-i~~l~~~~~~~~------~~ 137 (241)
+...+.||.|+||+||+|+ ..+|+.||+|++..... .-.....+|+.+++.++|+| |+.+++++...+ .+
T Consensus 13 ~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l 92 (323)
T KOG0594|consen 13 YEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKL 92 (323)
T ss_pred HHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceE
Confidence 3445569999999999998 44688999999876543 23456789999999999999 999999998877 88
Q ss_pred eEEEEecCCCCchHHhhcCC----CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcc
Q 039310 138 LLVYEFVGNGTLFEHIHKNG----NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASK 213 (241)
Q Consensus 138 ~lv~e~~~~g~L~~~l~~~~----~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~ 213 (241)
++|+||++. +|.+++.... .++...+..++.|++.||+|||+.+ |+||||||.|+||+++|.+||+|||+|+
T Consensus 93 ~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 93 YLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred EEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchHH
Confidence 999999965 9999997655 4788899999999999999999999 9999999999999999999999999999
Q ss_pred cccCCccceeeeecccccccccccccC
Q 039310 214 LVPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 214 ~~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
...... .......+|..|.|||+|-+
T Consensus 169 a~~ip~-~~yt~evvTlWYRaPEvLlG 194 (323)
T KOG0594|consen 169 AFSIPM-RTYTPEVVTLWYRAPEVLLG 194 (323)
T ss_pred HhcCCc-ccccccEEEeeccCHHHhcC
Confidence 764322 22444568999999999865
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=233.26 Aligned_cols=165 Identities=27% Similarity=0.343 Sum_probs=142.9
Q ss_pred ccccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCCC
Q 039310 72 DVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNG 147 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~g 147 (241)
+.||+|+||.||++... ++..||+|.+... .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 35899999999999854 5889999987542 2344567889999999999999999999999999999999999999
Q ss_pred CchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeeeec
Q 039310 148 TLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQ 227 (241)
Q Consensus 148 ~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 227 (241)
+|.+++.....+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++...... .......
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~~ 156 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKTFC 156 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccccccc
Confidence 99999988888999999999999999999999999 9999999999999999999999999987543222 2223456
Q ss_pred ccccccccccccC
Q 039310 228 GTLGYIDPEYLQT 240 (241)
Q Consensus 228 gt~~y~aPE~l~~ 240 (241)
||+.|+|||++.+
T Consensus 157 gt~~y~aPE~~~~ 169 (328)
T cd05593 157 GTPEYLAPEVLED 169 (328)
T ss_pred CCcCccChhhhcC
Confidence 9999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=220.53 Aligned_cols=168 Identities=26% Similarity=0.379 Sum_probs=147.0
Q ss_pred hhcccccccccCceeEEEEEe-CCCCeEEEEecccC---ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEE
Q 039310 67 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIV---DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYE 142 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e 142 (241)
..+.++.||+|-||.||.|+. +++.-||+|.+... .....+++.+|+++-+.++||||+++|++|.+....|+++|
T Consensus 23 dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilE 102 (281)
T KOG0580|consen 23 DFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILE 102 (281)
T ss_pred hccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEE
Confidence 345678999999999999984 45778899976532 22234678899999999999999999999999999999999
Q ss_pred ecCCCCchHHhh--cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcc
Q 039310 143 FVGNGTLFEHIH--KNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAI 220 (241)
Q Consensus 143 ~~~~g~L~~~l~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~ 220 (241)
|.+.|++...|. ...++++.....++.|++.|+.|+|.++ ++|||+||+|+|++.++.+||+|||.+..-+ .
T Consensus 103 ya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p---~ 176 (281)
T KOG0580|consen 103 YAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP---S 176 (281)
T ss_pred ecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC---C
Confidence 999999999998 5567999999999999999999999999 9999999999999999999999999987543 3
Q ss_pred ceeeeecccccccccccccC
Q 039310 221 QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 221 ~~~~~~~gt~~y~aPE~l~~ 240 (241)
....+.|||..|.+||..++
T Consensus 177 ~kR~tlcgt~dyl~pEmv~~ 196 (281)
T KOG0580|consen 177 NKRKTLCGTLDYLPPEMVEG 196 (281)
T ss_pred CCceeeecccccCCHhhcCC
Confidence 45566789999999998765
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=235.09 Aligned_cols=166 Identities=26% Similarity=0.342 Sum_probs=146.1
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
|.+.+.||+|+||.||+|... ++..||+|.+... .......+.+|+.++..++||||+++++++...+..|+||||
T Consensus 3 y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 82 (333)
T cd05600 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEY 82 (333)
T ss_pred cEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeC
Confidence 566788999999999999965 5789999987642 223456788999999999999999999999999999999999
Q ss_pred cCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcccee
Q 039310 144 VGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNY 223 (241)
Q Consensus 144 ~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~ 223 (241)
+++++|.+++.....+++..+..++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||++..... ..
T Consensus 83 ~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----~~ 155 (333)
T cd05600 83 VPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----YA 155 (333)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc----cc
Confidence 999999999988888999999999999999999999999 99999999999999999999999999886532 22
Q ss_pred eeecccccccccccccC
Q 039310 224 TVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 224 ~~~~gt~~y~aPE~l~~ 240 (241)
....||+.|+|||++.+
T Consensus 156 ~~~~gt~~y~aPE~~~~ 172 (333)
T cd05600 156 NSVVGSPDYMAPEVLRG 172 (333)
T ss_pred CCcccCccccChhHhcC
Confidence 33468999999999764
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=231.94 Aligned_cols=163 Identities=29% Similarity=0.387 Sum_probs=141.8
Q ss_pred ccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCCCCc
Q 039310 74 IGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTL 149 (241)
Q Consensus 74 lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~g~L 149 (241)
||+|+||.||+|... ++..||+|.+... .......+.+|+.+++.++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999864 5778999987532 334456788999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeeeeccc
Q 039310 150 FEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGT 229 (241)
Q Consensus 150 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt 229 (241)
.+++...+.+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++....... .......||
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt 156 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCGT 156 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC-CccccccCC
Confidence 999988888999999999999999999999999 9999999999999999999999999987643222 223345699
Q ss_pred ccccccccccC
Q 039310 230 LGYIDPEYLQT 240 (241)
Q Consensus 230 ~~y~aPE~l~~ 240 (241)
+.|+|||++.+
T Consensus 157 ~~y~aPE~~~~ 167 (312)
T cd05585 157 PEYLAPELLLG 167 (312)
T ss_pred cccCCHHHHcC
Confidence 99999998754
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=231.37 Aligned_cols=165 Identities=25% Similarity=0.326 Sum_probs=141.5
Q ss_pred ccccccCceeEEEEEe-CCCCeEEEEecccC---ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCCC
Q 039310 72 DVIGCGGSGNVYKGFL-PDRTPVAVKKSKIV---DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNG 147 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~g 147 (241)
+.||+|+||.||++.. .++..||+|.+... .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3689999999999985 46889999987542 2334567788999999999999999999999999999999999999
Q ss_pred CchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeeee
Q 039310 148 TLFEHIHKNGNLTWERRLRIAAETAGVLSYLHS-ETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVV 226 (241)
Q Consensus 148 ~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 226 (241)
+|..++.....+++..+..++.|++.||.|||+ .+ ++||||||+|||+++++.+||+|||++....... ......
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~ 156 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-ATMKTF 156 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-cccccc
Confidence 999999888889999999999999999999997 67 9999999999999999999999999987543222 122334
Q ss_pred cccccccccccccC
Q 039310 227 QGTLGYIDPEYLQT 240 (241)
Q Consensus 227 ~gt~~y~aPE~l~~ 240 (241)
.||+.|||||++.+
T Consensus 157 ~gt~~y~aPE~~~~ 170 (325)
T cd05594 157 CGTPEYLAPEVLED 170 (325)
T ss_pred cCCcccCCHHHHcc
Confidence 69999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=237.57 Aligned_cols=144 Identities=26% Similarity=0.266 Sum_probs=129.7
Q ss_pred hcccccccccCceeEEEEEe-CCCCeEEEEecccC---ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 68 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIV---DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
|.+.+.||+|+||.||++.. .++..||+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..|+||||
T Consensus 3 y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~ 82 (377)
T cd05629 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEF 82 (377)
T ss_pred ceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeC
Confidence 45667899999999999985 46888999986532 233456788899999999999999999999999999999999
Q ss_pred cCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCccc
Q 039310 144 VGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKL 214 (241)
Q Consensus 144 ~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~ 214 (241)
+++|+|.+++...+.+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 83 ~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~ 150 (377)
T cd05629 83 LPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTG 150 (377)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccc
Confidence 999999999988888999999999999999999999999 99999999999999999999999999863
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=238.28 Aligned_cols=144 Identities=21% Similarity=0.271 Sum_probs=129.5
Q ss_pred hcccccccccCceeEEEEEe-CCCCeEEEEecccC---ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 68 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIV---DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
+...+.||+|+||+||+|.. .++..+|+|.+... .......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 3 f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~ 82 (382)
T cd05625 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 82 (382)
T ss_pred cEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeC
Confidence 45667899999999999985 45788999987542 233456788999999999999999999999999999999999
Q ss_pred cCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCccc
Q 039310 144 VGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKL 214 (241)
Q Consensus 144 ~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~ 214 (241)
+++|+|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|..
T Consensus 83 ~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~ 150 (382)
T cd05625 83 IPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTG 150 (382)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcc
Confidence 999999999988888999999999999999999999999 99999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=238.59 Aligned_cols=172 Identities=27% Similarity=0.325 Sum_probs=146.9
Q ss_pred HHhhhcccccccccCceeEEEEEeC-CCCeEEEEeccc---CChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceE
Q 039310 64 KTVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKI---VDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLL 139 (241)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~---~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~l 139 (241)
....+.+.+.||+|+||.||+|... ++..+|+|.+.. ........+.+|..+++.++||||+++++++.+.+..++
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 120 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 3456777889999999999999865 577899997653 223334567889999999999999999999999999999
Q ss_pred EEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCc
Q 039310 140 VYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDA 219 (241)
Q Consensus 140 v~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~ 219 (241)
||||+++|+|.+++... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 121 v~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~ 196 (371)
T cd05622 121 VMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 196 (371)
T ss_pred EEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC
Confidence 99999999999998754 5899999999999999999999999 9999999999999999999999999998764333
Q ss_pred cceeeeeccccccccccccc
Q 039310 220 IQNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 220 ~~~~~~~~gt~~y~aPE~l~ 239 (241)
........||+.|||||++.
T Consensus 197 ~~~~~~~~gt~~y~aPE~l~ 216 (371)
T cd05622 197 MVRCDTAVGTPDYISPEVLK 216 (371)
T ss_pred cccccCcccCccccCHHHHh
Confidence 33334456999999999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=237.35 Aligned_cols=143 Identities=21% Similarity=0.262 Sum_probs=128.9
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
|.+.+.||+|+||.||+|... ++..||+|.+... .......+.+|+++++.++||||+++++.+.+.+..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (376)
T cd05598 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (376)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeC
Confidence 556778999999999999854 5788999986532 223346678999999999999999999999999999999999
Q ss_pred cCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcc
Q 039310 144 VGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASK 213 (241)
Q Consensus 144 ~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~ 213 (241)
+++|+|.+++...+.+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|.
T Consensus 83 ~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~ 149 (376)
T cd05598 83 IPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCT 149 (376)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCc
Confidence 999999999988888999999999999999999999999 9999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=231.93 Aligned_cols=166 Identities=28% Similarity=0.359 Sum_probs=145.4
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
+.+.+.||+|+||.||+|... +++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 82 (291)
T cd05612 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEY 82 (291)
T ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeC
Confidence 556778999999999999865 5888999987542 223456788999999999999999999999999999999999
Q ss_pred cCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcccee
Q 039310 144 VGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNY 223 (241)
Q Consensus 144 ~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~ 223 (241)
+++++|.+++...+.+++.....++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||++...... .
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~----~ 155 (291)
T cd05612 83 VPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----T 155 (291)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC----c
Confidence 999999999988888999999999999999999999999 999999999999999999999999998865322 2
Q ss_pred eeecccccccccccccC
Q 039310 224 TVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 224 ~~~~gt~~y~aPE~l~~ 240 (241)
....||+.|+|||++.+
T Consensus 156 ~~~~gt~~y~aPE~~~~ 172 (291)
T cd05612 156 WTLCGTPEYLAPEVIQS 172 (291)
T ss_pred ccccCChhhcCHHHHcC
Confidence 23458999999998764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=232.71 Aligned_cols=170 Identities=24% Similarity=0.303 Sum_probs=145.5
Q ss_pred hcccccccccCceeEEEEEe----CCCCeEEEEecccC----ChhhHHHHHHHHHHHHcC-CCCCceeEEEEEecCCcce
Q 039310 68 NNYADVIGCGGSGNVYKGFL----PDRTPVAVKKSKIV----DQTKIDEFINELVVVSQI-NRRNVVRLLACCLETQVPL 138 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~----~~~~~vavk~~~~~----~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~ 138 (241)
+.+.+.||+|+||.||+++. .++..+|+|.+... .....+.+.+|+.+++.+ +||||+++++++...+..+
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH 81 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence 45677899999999999874 35788999976532 223345678899999999 5999999999999999999
Q ss_pred EEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCC
Q 039310 139 LVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPID 218 (241)
Q Consensus 139 lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~ 218 (241)
++|||+++|+|.+++.....+++..+..++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||++......
T Consensus 82 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~ 158 (332)
T cd05614 82 LILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE 158 (332)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence 99999999999999988888999999999999999999999999 999999999999999999999999999865433
Q ss_pred ccceeeeecccccccccccccC
Q 039310 219 AIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 219 ~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
.........||+.|||||++.+
T Consensus 159 ~~~~~~~~~gt~~y~aPE~~~~ 180 (332)
T cd05614 159 EKERTYSFCGTIEYMAPEIIRG 180 (332)
T ss_pred CCCccccccCCccccCHHHhcC
Confidence 3333344569999999998753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=233.77 Aligned_cols=175 Identities=27% Similarity=0.368 Sum_probs=141.3
Q ss_pred HHHhhhcccccccccCceeEEEEEe------CCCCeEEEEecccCC-hhhHHHHHHHHHHHHcC-CCCCceeEEEEEecC
Q 039310 63 IKTVTNNYADVIGCGGSGNVYKGFL------PDRTPVAVKKSKIVD-QTKIDEFINELVVVSQI-NRRNVVRLLACCLET 134 (241)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavk~~~~~~-~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~ 134 (241)
+...++.+.+.||+|+||.||+|.+ .++..||+|.+.... ......+.+|+.+++.+ +||||+++++++...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 3445677888999999999999973 234679999876432 33456789999999999 899999999988764
Q ss_pred -CcceEEEEecCCCCchHHhhcC---------------------------------------------------------
Q 039310 135 -QVPLLVYEFVGNGTLFEHIHKN--------------------------------------------------------- 156 (241)
Q Consensus 135 -~~~~lv~e~~~~g~L~~~l~~~--------------------------------------------------------- 156 (241)
+..+++|||+++|+|.+++...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 4678999999999999998642
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc-eeeeecccc
Q 039310 157 -----GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ-NYTVVQGTL 230 (241)
Q Consensus 157 -----~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~ 230 (241)
.++++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++....+... ......+|+
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 23778888999999999999999998 999999999999999999999999999865332211 122234568
Q ss_pred cccccccccC
Q 039310 231 GYIDPEYLQT 240 (241)
Q Consensus 231 ~y~aPE~l~~ 240 (241)
.|||||++.+
T Consensus 241 ~y~aPE~~~~ 250 (338)
T cd05102 241 KWMAPESIFD 250 (338)
T ss_pred cccCcHHhhc
Confidence 8999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=229.76 Aligned_cols=164 Identities=29% Similarity=0.375 Sum_probs=136.7
Q ss_pred hhcccccccccCceeEEEEEeC-CCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecC--C---cceEE
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLET--Q---VPLLV 140 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~--~---~~~lv 140 (241)
.+.-.+++|+|+||.||+|... ++..||||+........ -+|+++|+.++|||||++..+|... + ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k----nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK----NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC----cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 3444668999999999999854 46899999876544322 3799999999999999999888642 2 34589
Q ss_pred EEecCCCCchHHhhc----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC-CCeEEccCCCcccc
Q 039310 141 YEFVGNGTLFEHIHK----NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDEN-YTPKVSDFGASKLV 215 (241)
Q Consensus 141 ~e~~~~g~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~-~~~kl~Dfgla~~~ 215 (241)
|||++. +|...++. +..++...+.-+..|+++||.|||+.+ |+||||||.|+|+|.+ |.+||||||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999976 99998874 567999999999999999999999998 9999999999999965 89999999999998
Q ss_pred cCCccceeeeecccccccccccccC
Q 039310 216 PIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 216 ~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
..++.. ....+|..|.|||.|-+
T Consensus 177 ~~~epn--iSYicSRyYRaPELifg 199 (364)
T KOG0658|consen 177 VKGEPN--ISYICSRYYRAPELIFG 199 (364)
T ss_pred ccCCCc--eeEEEeccccCHHHHcC
Confidence 766554 33347999999999865
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=236.22 Aligned_cols=171 Identities=25% Similarity=0.315 Sum_probs=145.6
Q ss_pred HhhhcccccccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEE
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLV 140 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv 140 (241)
...+.+.+.||+|+||.||+|... ++..+|+|.+... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 445677889999999999999854 5788999987532 223345577899999999999999999999999999999
Q ss_pred EEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcc
Q 039310 141 YEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAI 220 (241)
Q Consensus 141 ~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~ 220 (241)
|||+++|+|.+++... .+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||++........
T Consensus 122 ~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~ 197 (370)
T cd05596 122 MEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM 197 (370)
T ss_pred EcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 9999999999998654 5889999999999999999999998 99999999999999999999999999987643332
Q ss_pred ceeeeeccccccccccccc
Q 039310 221 QNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 221 ~~~~~~~gt~~y~aPE~l~ 239 (241)
.......||+.|||||++.
T Consensus 198 ~~~~~~~gt~~y~aPE~~~ 216 (370)
T cd05596 198 VRCDTAVGTPDYISPEVLK 216 (370)
T ss_pred ccCCCCCCCcCeECHHHhc
Confidence 2233456999999999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=232.72 Aligned_cols=169 Identities=27% Similarity=0.313 Sum_probs=145.2
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEeccc---CChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKI---VDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~---~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
|.+.+.||+|+||.||++... ++..||+|.+.. ......+.+.+|..+++.++|+||+++++++.+++..|+||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (331)
T cd05597 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDY 82 (331)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEec
Confidence 566788999999999999854 578899998753 2233445688899999999999999999999999999999999
Q ss_pred cCCCCchHHhhc-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccce
Q 039310 144 VGNGTLFEHIHK-NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQN 222 (241)
Q Consensus 144 ~~~g~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~ 222 (241)
+++|+|.+++.. ...+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++..........
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (331)
T cd05597 83 YVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ 159 (331)
T ss_pred CCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcc
Confidence 999999999976 457999999999999999999999999 9999999999999999999999999987654333323
Q ss_pred eeeeccccccccccccc
Q 039310 223 YTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 223 ~~~~~gt~~y~aPE~l~ 239 (241)
.....||+.|||||++.
T Consensus 160 ~~~~~gt~~y~aPE~~~ 176 (331)
T cd05597 160 SNVAVGTPDYISPEILQ 176 (331)
T ss_pred ccceeccccccCHHHHh
Confidence 33346999999999975
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=231.75 Aligned_cols=169 Identities=25% Similarity=0.287 Sum_probs=145.0
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
|.+.+.||+|+||.||++... ++..+|+|.+... .......+.+|..++..++|+||+++++++.+.+..|+||||
T Consensus 3 y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey 82 (331)
T cd05624 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDY 82 (331)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 566788999999999999854 5778999976532 223345678899999999999999999999999999999999
Q ss_pred cCCCCchHHhhc-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccce
Q 039310 144 VGNGTLFEHIHK-NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQN 222 (241)
Q Consensus 144 ~~~g~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~ 222 (241)
+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++..........
T Consensus 83 ~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 159 (331)
T cd05624 83 YVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ 159 (331)
T ss_pred CCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCCcee
Confidence 999999999986 457999999999999999999999999 9999999999999999999999999998764433333
Q ss_pred eeeeccccccccccccc
Q 039310 223 YTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 223 ~~~~~gt~~y~aPE~l~ 239 (241)
.....||+.|||||++.
T Consensus 160 ~~~~~gt~~y~aPE~~~ 176 (331)
T cd05624 160 SSVAVGTPDYISPEILQ 176 (331)
T ss_pred eccccCCcccCCHHHHh
Confidence 33456999999999875
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=231.19 Aligned_cols=169 Identities=24% Similarity=0.280 Sum_probs=146.5
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
+.+.+.||+|+||.||+|... ++..+|+|.+... .......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (330)
T cd05601 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEY 82 (330)
T ss_pred ceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECC
Confidence 556778999999999999854 6888999987642 223446688899999999999999999999999999999999
Q ss_pred cCCCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccce
Q 039310 144 VGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQN 222 (241)
Q Consensus 144 ~~~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~ 222 (241)
+++|+|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++..........
T Consensus 83 ~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 159 (330)
T cd05601 83 QPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVN 159 (330)
T ss_pred CCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCCcee
Confidence 9999999999876 57999999999999999999999999 9999999999999999999999999998765443333
Q ss_pred eeeeccccccccccccc
Q 039310 223 YTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 223 ~~~~~gt~~y~aPE~l~ 239 (241)
.....||+.|+|||++.
T Consensus 160 ~~~~~gt~~y~aPE~~~ 176 (330)
T cd05601 160 SKLPVGTPDYIAPEVLT 176 (330)
T ss_pred eecccCCccccCHHHhc
Confidence 33456899999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=223.15 Aligned_cols=164 Identities=24% Similarity=0.271 Sum_probs=139.9
Q ss_pred ccccccCceeEEEEEeC-CCCeEEEEecccCChh--hHHHHHHHHHHHHcCCCCCceeEEEEEec--CCcceEEEEecCC
Q 039310 72 DVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQT--KIDEFINELVVVSQINRRNVVRLLACCLE--TQVPLLVYEFVGN 146 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~l~~~~~~--~~~~~lv~e~~~~ 146 (241)
..|++|+||.||+|+.+ ++..||+|+++..... ..-..++|+.+|.+++|||||.+-.+... -+..|+|||||++
T Consensus 82 nrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh 161 (419)
T KOG0663|consen 82 NRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH 161 (419)
T ss_pred hhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh
Confidence 36999999999999954 5778899988764322 23356899999999999999999888765 3578999999987
Q ss_pred CCchHHhhcCC-CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeee
Q 039310 147 GTLFEHIHKNG-NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTV 225 (241)
Q Consensus 147 g~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~ 225 (241)
+|..++..-+ ++...++..++.|+++|+.|||... |+|||||++|+|++..|.+||+|||+|+.++... ...+.
T Consensus 162 -DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~-k~~T~ 236 (419)
T KOG0663|consen 162 -DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL-KPYTP 236 (419)
T ss_pred -hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCCc-ccCcc
Confidence 9999997665 8999999999999999999999999 9999999999999999999999999999886442 33444
Q ss_pred ecccccccccccccC
Q 039310 226 VQGTLGYIDPEYLQT 240 (241)
Q Consensus 226 ~~gt~~y~aPE~l~~ 240 (241)
..-|..|.|||.|.+
T Consensus 237 lVVTLWYRaPELLLG 251 (419)
T KOG0663|consen 237 LVVTLWYRAPELLLG 251 (419)
T ss_pred eEEEeeecCHHHhcC
Confidence 567999999999865
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=226.93 Aligned_cols=173 Identities=23% Similarity=0.367 Sum_probs=142.4
Q ss_pred HhhhcccccccccCceeEEEEEeCC-----------------CCeEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCcee
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFLPD-----------------RTPVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVR 126 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~ 126 (241)
...+.+.+.||+|+||.||+|.+++ +..||+|.+... ......++.+|+.+++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3466778899999999999997532 236899987654 2334567899999999999999999
Q ss_pred EEEEEecCCcceEEEEecCCCCchHHhhcC-------------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 039310 127 LLACCLETQVPLLVYEFVGNGTLFEHIHKN-------------------GNLTWERRLRIAAETAGVLSYLHSETNVPII 187 (241)
Q Consensus 127 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-------------------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~ii 187 (241)
+++++.+.+..+++|||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 999999999999999999999999998542 13678889999999999999999998 99
Q ss_pred ecCCCCCCeeeCCCCCeEEccCCCcccccCCccce-eeeecccccccccccccC
Q 039310 188 HRDVKSANILLDENYTPKVSDFGASKLVPIDAIQN-YTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 188 H~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~ 240 (241)
||||||+|||+++++.+||+|||++..+....... .....++..|||||++.+
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 214 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM 214 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc
Confidence 99999999999999999999999998654332211 122335789999998754
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=229.40 Aligned_cols=165 Identities=27% Similarity=0.366 Sum_probs=141.3
Q ss_pred ccccccCceeEEEEEe----CCCCeEEEEecccC----ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 72 DVIGCGGSGNVYKGFL----PDRTPVAVKKSKIV----DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~----~~~~~vavk~~~~~----~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
+.||+|+||.||++.. .++..||+|.+... +......+.+|+.+++.++||||+++++++..++..|++|||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 4699999999999974 35788999986542 223345678899999999999999999999999999999999
Q ss_pred cCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcccee
Q 039310 144 VGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNY 223 (241)
Q Consensus 144 ~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~ 223 (241)
+++++|.+++...+.+++..+..++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||+++...... ...
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 157 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-TVT 157 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-Ccc
Confidence 999999999988888999999999999999999999999 9999999999999999999999999987542222 223
Q ss_pred eeecccccccccccccC
Q 039310 224 TVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 224 ~~~~gt~~y~aPE~l~~ 240 (241)
....||+.|+|||++.+
T Consensus 158 ~~~~gt~~y~aPE~~~~ 174 (323)
T cd05584 158 HTFCGTIEYMAPEILMR 174 (323)
T ss_pred cccCCCccccChhhccC
Confidence 33569999999998754
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=233.21 Aligned_cols=145 Identities=25% Similarity=0.299 Sum_probs=130.5
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
++..+.||+|+||.||++... ++..||+|.+... .......+.+|+.++..++||||+++++++.+.+..++||||
T Consensus 3 f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~ 82 (360)
T cd05627 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEF 82 (360)
T ss_pred ceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 455678999999999999854 5888999987542 233456778899999999999999999999999999999999
Q ss_pred cCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccc
Q 039310 144 VGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLV 215 (241)
Q Consensus 144 ~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~ 215 (241)
+++|+|.+++...+.+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++...
T Consensus 83 ~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~ 151 (360)
T cd05627 83 LPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGL 151 (360)
T ss_pred CCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccc
Confidence 999999999988888999999999999999999999999 999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=224.61 Aligned_cols=168 Identities=29% Similarity=0.330 Sum_probs=142.1
Q ss_pred hcccccccccCceeEEEEEe-CCCCeEEEEecccCC---hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 68 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVD---QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
+...+.||+|+||+||+|.. .++..||+|.+.... ......+.+|+.+++.++|+||+++++++.+.+..+++|||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 34567899999999999985 468899999765422 22334678999999999999999999999999999999999
Q ss_pred cCCCCchHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc
Q 039310 144 VGNGTLFEHIHKN--GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ 221 (241)
Q Consensus 144 ~~~g~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~ 221 (241)
+++|+|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+|||+++++.++|+|||++.......
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-- 156 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--
Confidence 9999998887543 36899999999999999999999999 9999999999999999999999999998653322
Q ss_pred eeeeecccccccccccccC
Q 039310 222 NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~~ 240 (241)
......||+.|||||++.+
T Consensus 157 ~~~~~~g~~~y~aPE~~~~ 175 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINN 175 (285)
T ss_pred eecCCCCCCCccCHhhhcC
Confidence 2233468999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=231.56 Aligned_cols=170 Identities=26% Similarity=0.365 Sum_probs=149.7
Q ss_pred HHhhhcccccccccCceeEEEEEeCC-CCeEEEEecccCC---hhhHHHHHHHHHHHHcCC-CCCceeEEEEEecCCcce
Q 039310 64 KTVTNNYADVIGCGGSGNVYKGFLPD-RTPVAVKKSKIVD---QTKIDEFINELVVVSQIN-RRNVVRLLACCLETQVPL 138 (241)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~~~~~~ 138 (241)
....|.+.+.||+|.||.||++..+. |..+|+|.+.... ........+|+.+|+++. ||||+.+.+++++....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 34567788899999999999999654 8999999765432 234568899999999998 999999999999999999
Q ss_pred EEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC----CCCeEEccCCCccc
Q 039310 139 LVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDE----NYTPKVSDFGASKL 214 (241)
Q Consensus 139 lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~----~~~~kl~Dfgla~~ 214 (241)
+|||++.||.|.+.+... .+++..+..++.|++.++.|||+.+ ++||||||+|+|+.. ++.+|++|||+|..
T Consensus 113 lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred EEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 999999999999999776 4999999999999999999999999 999999999999963 35799999999998
Q ss_pred ccCCccceeeeeccccccccccccc
Q 039310 215 VPIDAIQNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 215 ~~~~~~~~~~~~~gt~~y~aPE~l~ 239 (241)
... .......+|||.|+|||++.
T Consensus 189 ~~~--~~~~~~~~Gtp~y~APEvl~ 211 (382)
T KOG0032|consen 189 IKP--GERLHTIVGTPEYVAPEVLG 211 (382)
T ss_pred ccC--CceEeeecCCccccCchhhc
Confidence 765 45667788999999999987
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=241.22 Aligned_cols=159 Identities=28% Similarity=0.403 Sum_probs=139.8
Q ss_pred ccccccCceeEEEEEe-CCCCeEEEEecccCC---hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCCC
Q 039310 72 DVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVD---QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNG 147 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~g 147 (241)
+.||.|+||-||-|+. .+...||||++.-.. ....++++.|+..|++++|||++.+-|||......|+|||||- |
T Consensus 32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl-G 110 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL-G 110 (948)
T ss_pred HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh-c
Confidence 3689999999999984 467789999987543 3456789999999999999999999999999999999999995 5
Q ss_pred CchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeeee
Q 039310 148 TLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVV 226 (241)
Q Consensus 148 ~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 226 (241)
+..|++.-. +++.+-++..|..+.++||.|||+.+ .||||||+.|||+++.|.|||+|||.|.++. ....+
T Consensus 111 SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~-----PAnsF 182 (948)
T KOG0577|consen 111 SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMA-----PANSF 182 (948)
T ss_pred cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcC-----chhcc
Confidence 888888644 47999999999999999999999999 9999999999999999999999999998763 23446
Q ss_pred ccccccccccccc
Q 039310 227 QGTLGYIDPEYLQ 239 (241)
Q Consensus 227 ~gt~~y~aPE~l~ 239 (241)
.|||.|||||++.
T Consensus 183 vGTPywMAPEVIL 195 (948)
T KOG0577|consen 183 VGTPYWMAPEVIL 195 (948)
T ss_pred cCCccccchhHhe
Confidence 7999999999974
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=222.07 Aligned_cols=174 Identities=21% Similarity=0.339 Sum_probs=145.2
Q ss_pred HHhhhcccccccccCceeEEEEEeC----CCCeEEEEecccCC-hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcce
Q 039310 64 KTVTNNYADVIGCGGSGNVYKGFLP----DRTPVAVKKSKIVD-QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPL 138 (241)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~ 138 (241)
....+.+.+.||+|+||.||+|.+. .+..||+|...... ......+.+|+..++.++||||+++++++...+..+
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 3456778889999999999999753 35689999876542 334467899999999999999999999999999999
Q ss_pred EEEEecCCCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccC
Q 039310 139 LVYEFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPI 217 (241)
Q Consensus 139 lv~e~~~~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~ 217 (241)
+||||+++|+|.+++... ..+++..+..++.|++.||+|||+++ ++||||||+||++++++.++++|||.+.....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 83 IVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 999999999999999764 47899999999999999999999998 99999999999999999999999998765432
Q ss_pred CccceeeeecccccccccccccC
Q 039310 218 DAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 218 ~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
..........++..|+|||++.+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~ 182 (266)
T cd05064 160 EAIYTTMSGKSPVLWAAPEAIQY 182 (266)
T ss_pred cchhcccCCCCceeecCHHHHhh
Confidence 22222222335678999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=229.02 Aligned_cols=165 Identities=32% Similarity=0.373 Sum_probs=141.5
Q ss_pred ccccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHHHHHcC-CCCCceeEEEEEecCCcceEEEEecCC
Q 039310 72 DVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELVVVSQI-NRRNVVRLLACCLETQVPLLVYEFVGN 146 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~ 146 (241)
+.||+|+||.||+|... ++..||+|.+... .......+..|..++..+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36899999999999854 5788999987642 233445678899999998 799999999999999999999999999
Q ss_pred CCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeeee
Q 039310 147 GTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVV 226 (241)
Q Consensus 147 g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 226 (241)
|+|.+++...+++++..+..++.|++.||.|||+++ ++||||||+|||+++++.+||+|||++....... ......
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~~~~ 156 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTTSTF 156 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC-Cccccc
Confidence 999999988888999999999999999999999999 9999999999999999999999999987532111 223345
Q ss_pred cccccccccccccC
Q 039310 227 QGTLGYIDPEYLQT 240 (241)
Q Consensus 227 ~gt~~y~aPE~l~~ 240 (241)
.||+.|+|||++.+
T Consensus 157 ~gt~~y~aPE~~~~ 170 (329)
T cd05588 157 CGTPNYIAPEILRG 170 (329)
T ss_pred cCCccccCHHHHcC
Confidence 69999999998764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=236.36 Aligned_cols=169 Identities=28% Similarity=0.426 Sum_probs=151.4
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecC
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVG 145 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~ 145 (241)
+.-.+.||+|+||.||+|... .++.||+|.+... .....++..+|+.++.+++++||.++|+.+..+..++++||||.
T Consensus 15 ~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~ 94 (467)
T KOG0201|consen 15 YTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCG 94 (467)
T ss_pred cccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhc
Confidence 334468999999999999854 5778999987753 44567888999999999999999999999999999999999999
Q ss_pred CCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeee
Q 039310 146 NGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTV 225 (241)
Q Consensus 146 ~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~ 225 (241)
||++.+.++....+.+.....++.+++.|+.|||.++ .+|||||+.|||+..+|.+|++|||.+..+....... .+
T Consensus 95 gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr-~t 170 (467)
T KOG0201|consen 95 GGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR-KT 170 (467)
T ss_pred CcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhhcc-cc
Confidence 9999999998887899999999999999999999999 9999999999999999999999999999887655444 67
Q ss_pred ecccccccccccccC
Q 039310 226 VQGTLGYIDPEYLQT 240 (241)
Q Consensus 226 ~~gt~~y~aPE~l~~ 240 (241)
+.|||.|||||++.+
T Consensus 171 fvGTPfwMAPEVI~~ 185 (467)
T KOG0201|consen 171 FVGTPFWMAPEVIKQ 185 (467)
T ss_pred ccccccccchhhhcc
Confidence 789999999999874
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=235.14 Aligned_cols=176 Identities=26% Similarity=0.363 Sum_probs=156.2
Q ss_pred HHHHHHhhhcccccccccCceeEEEEEe-CCCCeEEEEeccc--CChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCc
Q 039310 60 EEEIKTVTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKI--VDQTKIDEFINELVVVSQINRRNVVRLLACCLETQV 136 (241)
Q Consensus 60 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~--~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~ 136 (241)
.+......|.+.+.||+|.|++|.+|+. .++..||||.+.. .+....+.+.+|+++|+.++||||++++.+......
T Consensus 50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ 129 (596)
T KOG0586|consen 50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEAT 129 (596)
T ss_pred cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecce
Confidence 3444455667788999999999999984 4688999997654 344555668999999999999999999999999999
Q ss_pred ceEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCccccc
Q 039310 137 PLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVP 216 (241)
Q Consensus 137 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~ 216 (241)
+|+||||+.+|.+.+++.++++..+..+..++.|+..+++|||++. |+|||||++|+|++.+.++||+|||++..+.
T Consensus 130 lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 130 LYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred eEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec
Confidence 9999999999999999999999999999999999999999999999 9999999999999999999999999998875
Q ss_pred CCccceeeeecccccccccccccC
Q 039310 217 IDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 217 ~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
......+.+|++.|.|||+.++
T Consensus 207 --~~~~lqt~cgsppyAaPEl~~g 228 (596)
T KOG0586|consen 207 --YGLMLQTFCGSPPYAAPELFNG 228 (596)
T ss_pred --ccccccccCCCCCccChHhhcC
Confidence 3345667789999999999875
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=237.56 Aligned_cols=155 Identities=29% Similarity=0.508 Sum_probs=140.6
Q ss_pred cccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCCCCchHH
Q 039310 73 VIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEH 152 (241)
Q Consensus 73 ~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~g~L~~~ 152 (241)
-||.|+.|.||+|++. +..||||+++...+ .++.-|++|+||||+.|.|+|.....+|||||||..|-|...
T Consensus 131 WlGSGaQGAVF~Grl~-netVAVKKV~elkE-------TdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~V 202 (904)
T KOG4721|consen 131 WLGSGAQGAVFLGRLH-NETVAVKKVRELKE-------TDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEV 202 (904)
T ss_pred hhccCcccceeeeecc-CceehhHHHhhhhh-------hhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHH
Confidence 4999999999999984 56799998775433 467789999999999999999999999999999999999999
Q ss_pred hhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeeeecccccc
Q 039310 153 IHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGY 232 (241)
Q Consensus 153 l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y 232 (241)
|+...+++......|..+||.||+|||... |||||||.-||||..+..+||+|||-++..... .....++||..|
T Consensus 203 Lka~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFaGTVaW 277 (904)
T KOG4721|consen 203 LKAGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSFAGTVAW 277 (904)
T ss_pred HhccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhhhhhHhh
Confidence 999999999999999999999999999998 999999999999999999999999999877533 445667899999
Q ss_pred cccccccC
Q 039310 233 IDPEYLQT 240 (241)
Q Consensus 233 ~aPE~l~~ 240 (241)
||||++.+
T Consensus 278 MAPEvIrn 285 (904)
T KOG4721|consen 278 MAPEVIRN 285 (904)
T ss_pred hCHHHhhc
Confidence 99999976
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=224.59 Aligned_cols=166 Identities=27% Similarity=0.331 Sum_probs=144.0
Q ss_pred cccccccCceeEEEEEe-CCCCeEEEEecc--cCChhhHHHHHHHHHHHHcCCCCCceeEEEEEec-----CCcceEEEE
Q 039310 71 ADVIGCGGSGNVYKGFL-PDRTPVAVKKSK--IVDQTKIDEFINELVVVSQINRRNVVRLLACCLE-----TQVPLLVYE 142 (241)
Q Consensus 71 ~~~lg~G~~g~V~~~~~-~~~~~vavk~~~--~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~-----~~~~~lv~e 142 (241)
.+.||+|+||.|+.|.. .++..||||++. ..+....++..+|+.+|+.++|+||+.+.+.+.. -+..|+|+|
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e 106 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE 106 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence 56799999999999984 468999999987 4566778899999999999999999999999865 346899999
Q ss_pred ecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCc-cc
Q 039310 143 FVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDA-IQ 221 (241)
Q Consensus 143 ~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~-~~ 221 (241)
+|+ .+|...++.+..++......++.|++.||.|+|+.+ ++||||||+|+|++.+..+||||||+|+.....+ ..
T Consensus 107 lMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~ 182 (359)
T KOG0660|consen 107 LME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDG 182 (359)
T ss_pred HHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceeeccccCccc
Confidence 994 599999999888999999999999999999999999 9999999999999999999999999999875321 11
Q ss_pred eeeeecccccccccccccC
Q 039310 222 NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~~ 240 (241)
..+....|..|.|||++.+
T Consensus 183 ~mTeYVaTRWYRAPElll~ 201 (359)
T KOG0660|consen 183 FMTEYVATRWYRAPELLLN 201 (359)
T ss_pred chhcceeeeeecCHHHHhc
Confidence 2233457999999999854
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=227.70 Aligned_cols=165 Identities=28% Similarity=0.362 Sum_probs=139.1
Q ss_pred ccccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHHHHHcC-CCCCceeEEEEEecCCcceEEEEecCC
Q 039310 72 DVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELVVVSQI-NRRNVVRLLACCLETQVPLLVYEFVGN 146 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~ 146 (241)
+.||+|+||.||+|... ++..||+|.+... .....+....|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999864 4778999976542 223345566677777654 899999999999999999999999999
Q ss_pred CCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeeee
Q 039310 147 GTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVV 226 (241)
Q Consensus 147 g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 226 (241)
|+|.+++.....+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++....... ......
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~~ 156 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKASTF 156 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cccccc
Confidence 999999988888999999999999999999999998 9999999999999999999999999997643222 223345
Q ss_pred cccccccccccccC
Q 039310 227 QGTLGYIDPEYLQT 240 (241)
Q Consensus 227 ~gt~~y~aPE~l~~ 240 (241)
.||+.|+|||++.+
T Consensus 157 ~gt~~y~aPE~~~~ 170 (316)
T cd05592 157 CGTPDYIAPEILKG 170 (316)
T ss_pred cCCccccCHHHHcC
Confidence 69999999998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=232.77 Aligned_cols=171 Identities=25% Similarity=0.292 Sum_probs=147.5
Q ss_pred hhcccccccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEE
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYE 142 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e 142 (241)
.|.+.+.||+|+||.||+|... ++..||+|.+... .......+.+|+.++..++||||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 3566788999999999999965 6889999987642 22345678899999999999999999999999999999999
Q ss_pred ecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCc---
Q 039310 143 FVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDA--- 219 (241)
Q Consensus 143 ~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~--- 219 (241)
|+++++|.+++.....+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 82 YMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 9999999999988888999999999999999999999998 9999999999999999999999999988654332
Q ss_pred -------------------------cceeeeecccccccccccccC
Q 039310 220 -------------------------IQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 220 -------------------------~~~~~~~~gt~~y~aPE~l~~ 240 (241)
........||+.|+|||++.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 204 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG 204 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcC
Confidence 112233458999999998764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=228.09 Aligned_cols=165 Identities=32% Similarity=0.375 Sum_probs=140.9
Q ss_pred ccccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHHHHHcC-CCCCceeEEEEEecCCcceEEEEecCC
Q 039310 72 DVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELVVVSQI-NRRNVVRLLACCLETQVPLLVYEFVGN 146 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~ 146 (241)
+.||+|+||+||+|... ++..+|+|.+... .......+.+|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36899999999999854 5778999987642 333445677899888876 899999999999999999999999999
Q ss_pred CCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeeee
Q 039310 147 GTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVV 226 (241)
Q Consensus 147 g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 226 (241)
|+|..++.....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++....... ......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~~~~ 156 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTSTF 156 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Cccccc
Confidence 999999988888999999999999999999999999 9999999999999999999999999987532211 223345
Q ss_pred cccccccccccccC
Q 039310 227 QGTLGYIDPEYLQT 240 (241)
Q Consensus 227 ~gt~~y~aPE~l~~ 240 (241)
.||+.|+|||++.+
T Consensus 157 ~gt~~y~aPE~~~~ 170 (329)
T cd05618 157 CGTPNYIAPEILRG 170 (329)
T ss_pred cCCccccCHHHHcC
Confidence 69999999999764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=239.30 Aligned_cols=169 Identities=26% Similarity=0.409 Sum_probs=144.4
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEeccc----CChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCc--ceEE
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKI----VDQTKIDEFINELVVVSQINRRNVVRLLACCLETQV--PLLV 140 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~----~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~--~~lv 140 (241)
..|.+.||+|+|=+||+|.+. +|-.||...++. .+....++|..|+++|+.|+||||+++|.+|.+... ..+|
T Consensus 42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i 121 (632)
T KOG0584|consen 42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI 121 (632)
T ss_pred eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence 345668999999999999864 477787654332 245566899999999999999999999999988665 7789
Q ss_pred EEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC-CCCeEEccCCCcccccCCc
Q 039310 141 YEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDE-NYTPKVSDFGASKLVPIDA 219 (241)
Q Consensus 141 ~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~-~~~~kl~Dfgla~~~~~~~ 219 (241)
+|.+..|+|..|+++.++++.+.+..|+.||++||.|||++. +||||||||.+||+|+. .|.|||+|+|||..+...
T Consensus 122 TEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s- 199 (632)
T KOG0584|consen 122 TELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS- 199 (632)
T ss_pred eecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcc-
Confidence 999999999999999999999999999999999999999986 78999999999999984 689999999999876422
Q ss_pred cceeeeecccccccccccccC
Q 039310 220 IQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 220 ~~~~~~~~gt~~y~aPE~l~~ 240 (241)
......|||.|||||..+.
T Consensus 200 --~aksvIGTPEFMAPEmYEE 218 (632)
T KOG0584|consen 200 --HAKSVIGTPEFMAPEMYEE 218 (632)
T ss_pred --ccceeccCccccChHHHhh
Confidence 2233579999999998653
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=237.95 Aligned_cols=171 Identities=22% Similarity=0.225 Sum_probs=145.7
Q ss_pred hhcccccccccCceeEEEEEeC-C-CCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEec
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP-D-RTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~-~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
.|.+.+.||+|++|.||+|... + +..|++|.....+......+.+|+.+++.++||||+++++++...+..|+||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3677889999999999999743 3 5678888776655556667888999999999999999999999999999999999
Q ss_pred CCCCchHHhhc----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcc
Q 039310 145 GNGTLFEHIHK----NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAI 220 (241)
Q Consensus 145 ~~g~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~ 220 (241)
++|+|.+++.. ..++++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||++........
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 99999988753 346899999999999999999999998 99999999999999999999999999987643221
Q ss_pred -ceeeeecccccccccccccC
Q 039310 221 -QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 221 -~~~~~~~gt~~y~aPE~l~~ 240 (241)
......+||+.|||||++.+
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~ 245 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWER 245 (478)
T ss_pred cccccccCCCccccCHhHhCC
Confidence 12334569999999998764
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=227.97 Aligned_cols=165 Identities=32% Similarity=0.410 Sum_probs=140.9
Q ss_pred ccccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHHHHHcC-CCCCceeEEEEEecCCcceEEEEecCC
Q 039310 72 DVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELVVVSQI-NRRNVVRLLACCLETQVPLLVYEFVGN 146 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~ 146 (241)
+.||+|+||.||+|... +++.||+|.+... .....+.+..|..++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999864 5788999986532 233456677888888876 699999999999999999999999999
Q ss_pred CCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeeee
Q 039310 147 GTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVV 226 (241)
Q Consensus 147 g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 226 (241)
|+|.+++.....+++..+..++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||++....... ......
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~~~ 156 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTSTF 156 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cccccc
Confidence 999999988888999999999999999999999999 9999999999999999999999999987542222 223345
Q ss_pred cccccccccccccC
Q 039310 227 QGTLGYIDPEYLQT 240 (241)
Q Consensus 227 ~gt~~y~aPE~l~~ 240 (241)
.||+.|+|||++.+
T Consensus 157 ~gt~~y~aPE~~~~ 170 (320)
T cd05590 157 CGTPDYIAPEILQE 170 (320)
T ss_pred ccCccccCHHHHcC
Confidence 69999999998764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=228.59 Aligned_cols=169 Identities=26% Similarity=0.286 Sum_probs=143.9
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
+.+.+.||+|+||.||++..+ ++..+|+|.+... .......+.+|..++..++|+||+++++++.+.+..++||||
T Consensus 3 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey 82 (332)
T cd05623 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDY 82 (332)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEec
Confidence 556778999999999999865 4677899976431 223345578899999999999999999999999999999999
Q ss_pred cCCCCchHHhhc-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccce
Q 039310 144 VGNGTLFEHIHK-NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQN 222 (241)
Q Consensus 144 ~~~g~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~ 222 (241)
+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++..........
T Consensus 83 ~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~ 159 (332)
T cd05623 83 YVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ 159 (332)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCCcce
Confidence 999999999976 457899999999999999999999999 9999999999999999999999999987654333333
Q ss_pred eeeeccccccccccccc
Q 039310 223 YTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 223 ~~~~~gt~~y~aPE~l~ 239 (241)
.....||+.|||||++.
T Consensus 160 ~~~~~gt~~y~aPE~~~ 176 (332)
T cd05623 160 SSVAVGTPDYISPEILQ 176 (332)
T ss_pred ecccccCccccCHHHHh
Confidence 33456999999999875
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=226.72 Aligned_cols=169 Identities=28% Similarity=0.344 Sum_probs=143.4
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHHHHHcCCCC-CceeEEEEEecCCcceEEEE
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELVVVSQINRR-NVVRLLACCLETQVPLLVYE 142 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h~-ni~~l~~~~~~~~~~~lv~e 142 (241)
+.+.+.||+|+||.||+|... +++.||+|.+... .....+.+..|..++..++|+ +|+.+++++...+..|+|||
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 81 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence 456788999999999999855 4678999986532 233456788899999999765 68889999999999999999
Q ss_pred ecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccce
Q 039310 143 FVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQN 222 (241)
Q Consensus 143 ~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~ 222 (241)
|+++|+|.+++.....+++..+..++.|++.||.|||+++ ++||||||+|||+++++.+||+|||++....... ..
T Consensus 82 ~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~ 157 (324)
T cd05587 82 YVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG-KT 157 (324)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-Cc
Confidence 9999999999988888999999999999999999999998 9999999999999999999999999987532222 22
Q ss_pred eeeecccccccccccccC
Q 039310 223 YTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 223 ~~~~~gt~~y~aPE~l~~ 240 (241)
.....||+.|+|||++.+
T Consensus 158 ~~~~~gt~~y~aPE~~~~ 175 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAY 175 (324)
T ss_pred eeeecCCccccChhhhcC
Confidence 334569999999999864
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=227.29 Aligned_cols=165 Identities=30% Similarity=0.384 Sum_probs=138.4
Q ss_pred ccccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHH-HHHcCCCCCceeEEEEEecCCcceEEEEecCC
Q 039310 72 DVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELV-VVSQINRRNVVRLLACCLETQVPLLVYEFVGN 146 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~-~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~ 146 (241)
+.||+|+||+||+|... +++.+|+|.+... .......+..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 35899999999999854 6889999976532 2233345555654 56779999999999999999999999999999
Q ss_pred CCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeeee
Q 039310 147 GTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVV 226 (241)
Q Consensus 147 g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 226 (241)
|+|..++.....+++..+..++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||++....... ......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~ 156 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTTTTF 156 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCcccc
Confidence 999999988888999999999999999999999999 9999999999999999999999999987542221 223345
Q ss_pred cccccccccccccC
Q 039310 227 QGTLGYIDPEYLQT 240 (241)
Q Consensus 227 ~gt~~y~aPE~l~~ 240 (241)
.||+.|||||++.+
T Consensus 157 ~gt~~y~aPE~~~~ 170 (325)
T cd05604 157 CGTPEYLAPEVIRK 170 (325)
T ss_pred cCChhhCCHHHHcC
Confidence 69999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=227.14 Aligned_cols=165 Identities=30% Similarity=0.372 Sum_probs=140.9
Q ss_pred ccccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHHHHHcC-CCCCceeEEEEEecCCcceEEEEecCC
Q 039310 72 DVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELVVVSQI-NRRNVVRLLACCLETQVPLLVYEFVGN 146 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~ 146 (241)
+.||+|+||.||+|... ++..||+|.+... .....+.+..|.+++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 35899999999999865 4788999986542 233445677899998876 799999999999999999999999999
Q ss_pred CCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeeee
Q 039310 147 GTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVV 226 (241)
Q Consensus 147 g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 226 (241)
++|...+.....+++..+..++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||++....... ......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~~ 156 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTTTTF 156 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC-cccccc
Confidence 999999988888999999999999999999999999 9999999999999999999999999987543222 223345
Q ss_pred cccccccccccccC
Q 039310 227 QGTLGYIDPEYLQT 240 (241)
Q Consensus 227 ~gt~~y~aPE~l~~ 240 (241)
.||+.|+|||++.+
T Consensus 157 ~gt~~y~aPE~~~~ 170 (321)
T cd05591 157 CGTPDYIAPEILQE 170 (321)
T ss_pred ccCccccCHHHHcC
Confidence 68999999998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=226.36 Aligned_cols=165 Identities=30% Similarity=0.369 Sum_probs=138.4
Q ss_pred ccccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHH-HHHcCCCCCceeEEEEEecCCcceEEEEecCC
Q 039310 72 DVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELV-VVSQINRRNVVRLLACCLETQVPLLVYEFVGN 146 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~-~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~ 146 (241)
+.||+|+||+||+|... ++..||+|.+... .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36899999999999864 6889999987542 1223344555554 56789999999999999999999999999999
Q ss_pred CCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeeee
Q 039310 147 GTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVV 226 (241)
Q Consensus 147 g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 226 (241)
|+|..++.....+++..+..++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||++....... ......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 156 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTTSTF 156 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Cccccc
Confidence 999999988888999999999999999999999999 9999999999999999999999999987542222 223345
Q ss_pred cccccccccccccC
Q 039310 227 QGTLGYIDPEYLQT 240 (241)
Q Consensus 227 ~gt~~y~aPE~l~~ 240 (241)
.||+.|+|||++.+
T Consensus 157 ~gt~~y~aPE~~~~ 170 (323)
T cd05575 157 CGTPEYLAPEVLRK 170 (323)
T ss_pred cCChhhcChhhhcC
Confidence 69999999998764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=233.18 Aligned_cols=170 Identities=25% Similarity=0.341 Sum_probs=148.9
Q ss_pred hhcccccccccCceeEEEEEeC-CCCeEEEEecccCC--hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCc-ceEEEE
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD--QTKIDEFINELVVVSQINRRNVVRLLACCLETQV-PLLVYE 142 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~-~~lv~e 142 (241)
.|...+++|+|+||.++..+.+ +...+++|++.... ....+...+|+.++++++||||+.+.+.|..++. .+++|+
T Consensus 5 ~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~ 84 (426)
T KOG0589|consen 5 NYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVME 84 (426)
T ss_pred hhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEe
Confidence 4566788999999999998754 46789999876543 3445578999999999999999999999999888 999999
Q ss_pred ecCCCCchHHhhcCC--CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcc
Q 039310 143 FVGNGTLFEHIHKNG--NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAI 220 (241)
Q Consensus 143 ~~~~g~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~ 220 (241)
||+||++.+.+...+ .++++.+..|+.|++.|+.|||+.+ |+|||||+.|||++.++.++|.|||+|+.+..+.
T Consensus 85 Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~- 160 (426)
T KOG0589|consen 85 YCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED- 160 (426)
T ss_pred ecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCch-
Confidence 999999999997554 5999999999999999999999888 9999999999999999999999999999987654
Q ss_pred ceeeeecccccccccccccC
Q 039310 221 QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 221 ~~~~~~~gt~~y~aPE~l~~ 240 (241)
....+..|||.||+||++++
T Consensus 161 ~~a~tvvGTp~YmcPEil~d 180 (426)
T KOG0589|consen 161 SLASTVVGTPYYMCPEILSD 180 (426)
T ss_pred hhhheecCCCcccCHHHhCC
Confidence 23455679999999999876
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=233.27 Aligned_cols=165 Identities=21% Similarity=0.260 Sum_probs=141.7
Q ss_pred hhhcccccccccCceeEEEEEe-CCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEec
Q 039310 66 VTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
..|.+.+.||+|+||.||+|.. .+++.||+|... ...+.+|+.+++.++||||+++++++......++++|++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 4567778999999999999985 457889999643 245678999999999999999999999999999999999
Q ss_pred CCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceee
Q 039310 145 GNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYT 224 (241)
Q Consensus 145 ~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~ 224 (241)
. ++|..++.....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|............
T Consensus 166 ~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~ 241 (391)
T PHA03212 166 K-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241 (391)
T ss_pred C-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccccccc
Confidence 5 689999888778999999999999999999999998 999999999999999999999999999754322222333
Q ss_pred eecccccccccccccC
Q 039310 225 VVQGTLGYIDPEYLQT 240 (241)
Q Consensus 225 ~~~gt~~y~aPE~l~~ 240 (241)
...||+.|+|||++..
T Consensus 242 ~~~gt~~y~aPE~~~~ 257 (391)
T PHA03212 242 GWAGTIATNAPELLAR 257 (391)
T ss_pred cccCccCCCChhhhcC
Confidence 4569999999999754
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=226.03 Aligned_cols=165 Identities=30% Similarity=0.302 Sum_probs=141.9
Q ss_pred ccccccCceeEEEEEe----CCCCeEEEEecccCC--hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecC
Q 039310 72 DVIGCGGSGNVYKGFL----PDRTPVAVKKSKIVD--QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVG 145 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~----~~~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~ 145 (241)
+.||+|+||.||++.. .++..+|+|.+.... ......+.+|++++++++||||+++++++.+++..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 4689999999999874 357889999876422 2234567789999999999999999999999999999999999
Q ss_pred CCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeee
Q 039310 146 NGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTV 225 (241)
Q Consensus 146 ~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~ 225 (241)
+++|.+++.....+++..+..++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||++....... .....
T Consensus 82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 157 (318)
T cd05582 82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKAYS 157 (318)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cceec
Confidence 9999999988888999999999999999999999999 9999999999999999999999999988653322 22334
Q ss_pred ecccccccccccccC
Q 039310 226 VQGTLGYIDPEYLQT 240 (241)
Q Consensus 226 ~~gt~~y~aPE~l~~ 240 (241)
..||+.|+|||++.+
T Consensus 158 ~~g~~~y~aPE~~~~ 172 (318)
T cd05582 158 FCGTVEYMAPEVVNR 172 (318)
T ss_pred ccCChhhcCHHHHcC
Confidence 569999999998753
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=217.84 Aligned_cols=167 Identities=26% Similarity=0.406 Sum_probs=146.0
Q ss_pred hcccccccccCceeEEEEE-eCCCCeEEEEecccCC--------hhhHHHHHHHHHHHHcC-CCCCceeEEEEEecCCcc
Q 039310 68 NNYADVIGCGGSGNVYKGF-LPDRTPVAVKKSKIVD--------QTKIDEFINELVVVSQI-NRRNVVRLLACCLETQVP 137 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavk~~~~~~--------~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~ 137 (241)
+.-.+.+|.|..+.|.++. ..++...|+|++.... ..-.+...+|+.+|+++ .||+|+++.++++.+...
T Consensus 19 y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~ 98 (411)
T KOG0599|consen 19 YEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFV 98 (411)
T ss_pred cChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchh
Confidence 3445679999999998876 4467889998765421 12245677899999998 699999999999999999
Q ss_pred eEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccC
Q 039310 138 LLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPI 217 (241)
Q Consensus 138 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~ 217 (241)
++|.|.|+.|.|.++|.+.-.++++...+++.|+.+|++|||..+ ||||||||+|||+|++.++||+|||+|..+..
T Consensus 99 FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa~~l~~ 175 (411)
T KOG0599|consen 99 FLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFACQLEP 175 (411)
T ss_pred hhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccceeeccCC
Confidence 999999999999999998888999999999999999999999999 99999999999999999999999999998754
Q ss_pred Cccceeeeeccccccccccccc
Q 039310 218 DAIQNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 218 ~~~~~~~~~~gt~~y~aPE~l~ 239 (241)
+ .+....||||+|+|||.+.
T Consensus 176 G--ekLrelCGTPgYLAPEtik 195 (411)
T KOG0599|consen 176 G--EKLRELCGTPGYLAPETIK 195 (411)
T ss_pred c--hhHHHhcCCCcccChhhee
Confidence 3 5667789999999999874
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-32 Score=223.90 Aligned_cols=171 Identities=25% Similarity=0.308 Sum_probs=144.5
Q ss_pred hhcccccccccCceeEEEEEeC-CCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
.|.+.+.||+|+||.||+|+.+ ++..+|+|++... .....+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY 81 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence 3566788999999999999965 5778999987643 233456788999999999999999999999999999999999
Q ss_pred cCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcccee
Q 039310 144 VGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNY 223 (241)
Q Consensus 144 ~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~ 223 (241)
++++++..+......+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...........
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (287)
T cd07848 82 VEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY 158 (287)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccccccc
Confidence 998777666555567999999999999999999999998 99999999999999999999999999987643333233
Q ss_pred eeecccccccccccccC
Q 039310 224 TVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 224 ~~~~gt~~y~aPE~l~~ 240 (241)
....||+.|+|||++.+
T Consensus 159 ~~~~~~~~y~aPE~~~~ 175 (287)
T cd07848 159 TEYVATRWYRSPELLLG 175 (287)
T ss_pred cccccccccCCcHHHcC
Confidence 34568999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.8e-32 Score=225.08 Aligned_cols=165 Identities=29% Similarity=0.363 Sum_probs=137.6
Q ss_pred ccccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHH-HHHcCCCCCceeEEEEEecCCcceEEEEecCC
Q 039310 72 DVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELV-VVSQINRRNVVRLLACCLETQVPLLVYEFVGN 146 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~-~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~ 146 (241)
+.||+|+||.||+|... ++..+|+|.+... .......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999864 5788999976532 2223344555554 67889999999999999999999999999999
Q ss_pred CCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeeee
Q 039310 147 GTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVV 226 (241)
Q Consensus 147 g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 226 (241)
++|...+.....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....... ......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 156 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTSTF 156 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cccccc
Confidence 999999988788999999999999999999999998 9999999999999999999999999987532221 223345
Q ss_pred cccccccccccccC
Q 039310 227 QGTLGYIDPEYLQT 240 (241)
Q Consensus 227 ~gt~~y~aPE~l~~ 240 (241)
.||+.|+|||++.+
T Consensus 157 ~gt~~y~aPE~~~~ 170 (321)
T cd05603 157 CGTPEYLAPEVLRK 170 (321)
T ss_pred cCCcccCCHHHhcC
Confidence 68999999998754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.3e-32 Score=225.53 Aligned_cols=165 Identities=33% Similarity=0.375 Sum_probs=141.3
Q ss_pred ccccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHHHHHcC-CCCCceeEEEEEecCCcceEEEEecCC
Q 039310 72 DVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELVVVSQI-NRRNVVRLLACCLETQVPLLVYEFVGN 146 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~ 146 (241)
+.||+|+||+||+|... ++..+|+|.+... .....+.+.+|..++..+ +||||+.+++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36899999999999854 5788999987642 233456678899999888 699999999999999999999999999
Q ss_pred CCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeeee
Q 039310 147 GTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVV 226 (241)
Q Consensus 147 g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 226 (241)
|+|..++...+.+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++....... ......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 156 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTSTF 156 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cceecc
Confidence 999999988788999999999999999999999999 9999999999999999999999999987532211 223345
Q ss_pred cccccccccccccC
Q 039310 227 QGTLGYIDPEYLQT 240 (241)
Q Consensus 227 ~gt~~y~aPE~l~~ 240 (241)
.||+.|+|||++.+
T Consensus 157 ~gt~~y~aPE~~~~ 170 (327)
T cd05617 157 CGTPNYIAPEILRG 170 (327)
T ss_pred cCCcccCCHHHHCC
Confidence 69999999999764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.6e-32 Score=225.69 Aligned_cols=170 Identities=25% Similarity=0.312 Sum_probs=146.1
Q ss_pred HhhhcccccccccCceeEEEEEeC-CCCeEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEE
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYE 142 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e 142 (241)
...|...+.||+|+||.||+|... ++..+|+|.+... .......+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 345677889999999999999865 5777888876543 33345678999999999999999999999999999999999
Q ss_pred ecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc
Q 039310 143 FVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSE-TNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ 221 (241)
Q Consensus 143 ~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~-~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~ 221 (241)
|+++++|.+++...+.+++..+..++.|++.||.|||+. + ++|+||||+|||+++++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--- 157 (333)
T cd06650 84 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 157 (333)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhhh---
Confidence 999999999998888899999999999999999999974 5 999999999999999999999999998765322
Q ss_pred eeeeecccccccccccccC
Q 039310 222 NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~~ 240 (241)
......||+.|+|||.+.+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~ 176 (333)
T cd06650 158 MANSFVGTRSYMSPERLQG 176 (333)
T ss_pred ccccCCCCccccCHHHhcC
Confidence 1223458999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-32 Score=229.88 Aligned_cols=177 Identities=27% Similarity=0.371 Sum_probs=144.5
Q ss_pred HHHHHhhhcccccccccCceeEEEEEe------CCCCeEEEEecccCC-hhhHHHHHHHHHHHHcC-CCCCceeEEEEEe
Q 039310 61 EEIKTVTNNYADVIGCGGSGNVYKGFL------PDRTPVAVKKSKIVD-QTKIDEFINELVVVSQI-NRRNVVRLLACCL 132 (241)
Q Consensus 61 ~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavk~~~~~~-~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~ 132 (241)
.++....+.+.+.||+|+||.||+|.+ .++..||+|.++... ....+.+.+|+.+++.+ +||||+++++++.
T Consensus 30 ~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~ 109 (375)
T cd05104 30 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT 109 (375)
T ss_pred cccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence 344455678889999999999999963 235679999876432 33456788999999999 8999999999999
Q ss_pred cCCcceEEEEecCCCCchHHhhcCC-------------------------------------------------------
Q 039310 133 ETQVPLLVYEFVGNGTLFEHIHKNG------------------------------------------------------- 157 (241)
Q Consensus 133 ~~~~~~lv~e~~~~g~L~~~l~~~~------------------------------------------------------- 157 (241)
..+..++||||+++|+|.+++....
T Consensus 110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 9999999999999999999986421
Q ss_pred --------------------CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccC
Q 039310 158 --------------------NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPI 217 (241)
Q Consensus 158 --------------------~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~ 217 (241)
.+++..+..++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||++.....
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 3678889999999999999999998 99999999999999999999999999986643
Q ss_pred Cccce-eeeecccccccccccccC
Q 039310 218 DAIQN-YTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 218 ~~~~~-~~~~~gt~~y~aPE~l~~ 240 (241)
..... .....+++.|+|||++.+
T Consensus 267 ~~~~~~~~~~~~~~~y~aPE~~~~ 290 (375)
T cd05104 267 DSNYVVKGNARLPVKWMAPESIFN 290 (375)
T ss_pred cccccccCCCCCCcceeChhHhcC
Confidence 32211 111234678999998754
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=223.93 Aligned_cols=165 Identities=28% Similarity=0.345 Sum_probs=139.5
Q ss_pred ccccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHHHHHc-CCCCCceeEEEEEecCCcceEEEEecCC
Q 039310 72 DVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELVVVSQ-INRRNVVRLLACCLETQVPLLVYEFVGN 146 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~-l~h~ni~~l~~~~~~~~~~~lv~e~~~~ 146 (241)
+.||+|+||+||+|... ++..||+|.+... ..........|..+++. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 35899999999999965 4778999987642 12334556778888876 4899999999999999999999999999
Q ss_pred CCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeeee
Q 039310 147 GTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVV 226 (241)
Q Consensus 147 g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 226 (241)
|+|.+++.....+++..+..++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||++....... ......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 156 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTCTF 156 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cceeee
Confidence 999999988778999999999999999999999998 9999999999999999999999999987532222 123345
Q ss_pred cccccccccccccC
Q 039310 227 QGTLGYIDPEYLQT 240 (241)
Q Consensus 227 ~gt~~y~aPE~l~~ 240 (241)
.||+.|+|||++.+
T Consensus 157 ~gt~~y~aPE~~~~ 170 (316)
T cd05619 157 CGTPDYIAPEILLG 170 (316)
T ss_pred cCCccccCHHHHcC
Confidence 69999999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=224.80 Aligned_cols=165 Identities=28% Similarity=0.362 Sum_probs=136.8
Q ss_pred ccccccCceeEEEEEeC-CCCeEEEEecccCC---hhhHHHHHHHH-HHHHcCCCCCceeEEEEEecCCcceEEEEecCC
Q 039310 72 DVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD---QTKIDEFINEL-VVVSQINRRNVVRLLACCLETQVPLLVYEFVGN 146 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~---~~~~~~~~~E~-~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~ 146 (241)
+.||+|+||.||+|... ++..+|+|.+.... ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36899999999999865 56789999765321 22223444444 456788999999999999999999999999999
Q ss_pred CCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeeee
Q 039310 147 GTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVV 226 (241)
Q Consensus 147 g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 226 (241)
++|.+++.....+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++....... ......
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~~~~ 156 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTTSTF 156 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCcccc
Confidence 999999988888999999999999999999999999 9999999999999999999999999987543222 223345
Q ss_pred cccccccccccccC
Q 039310 227 QGTLGYIDPEYLQT 240 (241)
Q Consensus 227 ~gt~~y~aPE~l~~ 240 (241)
.||+.|||||++.+
T Consensus 157 ~gt~~y~aPE~~~~ 170 (325)
T cd05602 157 CGTPEYLAPEVLHK 170 (325)
T ss_pred cCCccccCHHHHcC
Confidence 69999999998764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=225.00 Aligned_cols=170 Identities=24% Similarity=0.283 Sum_probs=145.8
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
..+...+.||+|+||.||++... ++..+|+|..... .......+.+|+++++.++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence 34566778999999999999865 5778888876643 334456789999999999999999999999999999999999
Q ss_pred cCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcccee
Q 039310 144 VGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNY 223 (241)
Q Consensus 144 ~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~ 223 (241)
+++++|.+++.....+++..+..++.|++.||.|||++++ ++||||||+|||+++++.++|+|||++...... ..
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~ 159 (331)
T cd06649 85 MDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MA 159 (331)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCC--EEcCCCChhhEEEcCCCcEEEccCccccccccc---cc
Confidence 9999999999888889999999999999999999998532 999999999999999999999999998765322 12
Q ss_pred eeecccccccccccccC
Q 039310 224 TVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 224 ~~~~gt~~y~aPE~l~~ 240 (241)
....||+.|+|||++.+
T Consensus 160 ~~~~g~~~y~aPE~~~~ 176 (331)
T cd06649 160 NSFVGTRSYMSPERLQG 176 (331)
T ss_pred ccCCCCcCcCCHhHhcC
Confidence 33458999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.1e-32 Score=226.00 Aligned_cols=169 Identities=28% Similarity=0.347 Sum_probs=143.0
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHHHHHcCC-CCCceeEEEEEecCCcceEEEE
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELVVVSQIN-RRNVVRLLACCLETQVPLLVYE 142 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~~~~~~lv~e 142 (241)
+++.+.||+|+||.||+|... ++..||+|.+... .....+.+..|..+++.+. |++|+++++++.+.+..|+|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 456778999999999999854 5888999987642 2234456778999998885 5778889999999999999999
Q ss_pred ecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccce
Q 039310 143 FVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQN 222 (241)
Q Consensus 143 ~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~ 222 (241)
|+++|+|.+++.....+++.++..++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||++....... ..
T Consensus 82 y~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-~~ 157 (323)
T cd05615 82 YVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-VT 157 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCC-cc
Confidence 9999999999988888999999999999999999999998 9999999999999999999999999987543222 12
Q ss_pred eeeecccccccccccccC
Q 039310 223 YTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 223 ~~~~~gt~~y~aPE~l~~ 240 (241)
.....||+.|+|||++.+
T Consensus 158 ~~~~~gt~~y~aPE~~~~ 175 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAY 175 (323)
T ss_pred ccCccCCccccCHHHHcC
Confidence 334568999999998764
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.7e-32 Score=221.20 Aligned_cols=169 Identities=25% Similarity=0.351 Sum_probs=141.1
Q ss_pred hhcccccccccCceeEEEEEeC-CCCeEEEEecccCC-hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEec
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD-QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
.|.+.+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 6 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 85 (288)
T cd07871 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL 85 (288)
T ss_pred cceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCC
Confidence 3566778999999999999854 57889999876432 223456779999999999999999999999999999999999
Q ss_pred CCCCchHHhhcCC-CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcccee
Q 039310 145 GNGTLFEHIHKNG-NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNY 223 (241)
Q Consensus 145 ~~g~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~ 223 (241)
++ +|.+++...+ .+++..+..++.|++.||.|||+++ ++||||||+|||+++++.+||+|||++....... ...
T Consensus 86 ~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-~~~ 160 (288)
T cd07871 86 DS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-KTY 160 (288)
T ss_pred Cc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC-ccc
Confidence 75 8998886544 5799999999999999999999999 9999999999999999999999999987643222 122
Q ss_pred eeecccccccccccccC
Q 039310 224 TVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 224 ~~~~gt~~y~aPE~l~~ 240 (241)
....||+.|+|||++.+
T Consensus 161 ~~~~~~~~y~aPE~~~~ 177 (288)
T cd07871 161 SNEVVTLWYRPPDVLLG 177 (288)
T ss_pred cCceecccccChHHhcC
Confidence 23458999999998753
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.5e-32 Score=224.16 Aligned_cols=165 Identities=30% Similarity=0.368 Sum_probs=139.6
Q ss_pred ccccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHHHHHcC-CCCCceeEEEEEecCCcceEEEEecCC
Q 039310 72 DVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELVVVSQI-NRRNVVRLLACCLETQVPLLVYEFVGN 146 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~ 146 (241)
+.||+|+||.||+|... ++..||+|.+... ..........|..++... +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36899999999999865 5788999987542 123345667788888754 899999999999999999999999999
Q ss_pred CCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeeee
Q 039310 147 GTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVV 226 (241)
Q Consensus 147 g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 226 (241)
|+|..++.....+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.++|+|||++....... ......
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 156 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRASTF 156 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cceecc
Confidence 999999988888999999999999999999999999 9999999999999999999999999987532221 223345
Q ss_pred cccccccccccccC
Q 039310 227 QGTLGYIDPEYLQT 240 (241)
Q Consensus 227 ~gt~~y~aPE~l~~ 240 (241)
.||+.|+|||++.+
T Consensus 157 ~gt~~y~aPE~~~~ 170 (316)
T cd05620 157 CGTPDYIAPEILQG 170 (316)
T ss_pred CCCcCccCHHHHcC
Confidence 69999999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=224.10 Aligned_cols=169 Identities=28% Similarity=0.328 Sum_probs=142.5
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHHHHHcC-CCCCceeEEEEEecCCcceEEEE
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELVVVSQI-NRRNVVRLLACCLETQVPLLVYE 142 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e 142 (241)
+.+.+.||+|+||.||+|... ++..+|+|.+... ..........|..++..+ +|++|+++++++...+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME 81 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence 456778999999999999865 4678999976542 223345567788888887 58999999999999999999999
Q ss_pred ecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccce
Q 039310 143 FVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQN 222 (241)
Q Consensus 143 ~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~ 222 (241)
|+++|+|.+++.....+++..+..++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||++....... ..
T Consensus 82 ~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~-~~ 157 (323)
T cd05616 82 YVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-VT 157 (323)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCCC-Cc
Confidence 9999999999988888999999999999999999999998 9999999999999999999999999987543222 12
Q ss_pred eeeecccccccccccccC
Q 039310 223 YTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 223 ~~~~~gt~~y~aPE~l~~ 240 (241)
.....||+.|+|||++.+
T Consensus 158 ~~~~~gt~~y~aPE~~~~ 175 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAY 175 (323)
T ss_pred cccCCCChhhcCHHHhcC
Confidence 334569999999999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7e-32 Score=226.76 Aligned_cols=173 Identities=28% Similarity=0.416 Sum_probs=144.7
Q ss_pred HHHHhhhccc-ccccccCceeEEEEE-eCCCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcc
Q 039310 62 EIKTVTNNYA-DVIGCGGSGNVYKGF-LPDRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVP 137 (241)
Q Consensus 62 ~~~~~~~~~~-~~lg~G~~g~V~~~~-~~~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~ 137 (241)
++.....-|. +.||+|-||+||-|. .++|+.||||.+... ..++...+.+|+.+|+.+.||.||.+-..|+..+..
T Consensus 559 d~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~erv 638 (888)
T KOG4236|consen 559 DISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERV 638 (888)
T ss_pred hHHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceE
Confidence 3333333443 489999999999998 457999999976542 234457889999999999999999999999999999
Q ss_pred eEEEEecCCCCchHHhh--cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC---CCCeEEccCCCc
Q 039310 138 LLVYEFVGNGTLFEHIH--KNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDE---NYTPKVSDFGAS 212 (241)
Q Consensus 138 ~lv~e~~~~g~L~~~l~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~---~~~~kl~Dfgla 212 (241)
++|||.+. |+..+++. +.++++++....++.||+.||.|||.++ |+|+||||+|||+.+ ..++||||||+|
T Consensus 639 FVVMEKl~-GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfA 714 (888)
T KOG4236|consen 639 FVVMEKLH-GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFA 714 (888)
T ss_pred EEEehhhc-chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccce
Confidence 99999994 57777764 4568999999999999999999999999 999999999999964 457999999999
Q ss_pred ccccCCccceeeeecccccccccccccC
Q 039310 213 KLVPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 213 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
++.+..+. .....|||.|+|||+|++
T Consensus 715 RiIgEksF--RrsVVGTPAYLaPEVLrn 740 (888)
T KOG4236|consen 715 RIIGEKSF--RRSVVGTPAYLAPEVLRN 740 (888)
T ss_pred eecchhhh--hhhhcCCccccCHHHHhh
Confidence 99875544 345679999999999975
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.9e-32 Score=225.88 Aligned_cols=169 Identities=25% Similarity=0.351 Sum_probs=140.9
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCC-----cceE
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLETQ-----VPLL 139 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~-----~~~l 139 (241)
|.+.+.||+|+||.||+|... ++..||+|++... .......+.+|+.+++.++||||+++++++...+ ..|+
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence 566788999999999999854 6889999987642 2234457889999999999999999999886432 4799
Q ss_pred EEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCc
Q 039310 140 VYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDA 219 (241)
Q Consensus 140 v~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~ 219 (241)
+|||++ ++|.+++.....+++..+..++.|++.||.|||+++ ++||||||+|||+++++.+||+|||++.......
T Consensus 82 v~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 157 (338)
T cd07859 82 VFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDT 157 (338)
T ss_pred EEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccccccc
Confidence 999995 699999988888999999999999999999999999 9999999999999999999999999997653222
Q ss_pred cc--eeeeecccccccccccccC
Q 039310 220 IQ--NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 220 ~~--~~~~~~gt~~y~aPE~l~~ 240 (241)
.. ......||+.|+|||++.+
T Consensus 158 ~~~~~~~~~~~t~~y~aPE~~~~ 180 (338)
T cd07859 158 PTAIFWTDYVATRWYRAPELCGS 180 (338)
T ss_pred CccccccCCCCCCCcCCHHHHhc
Confidence 11 1233468999999998753
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.4e-34 Score=224.18 Aligned_cols=167 Identities=26% Similarity=0.414 Sum_probs=147.1
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCC
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGN 146 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~ 146 (241)
.+..+.||.|+||.||+|.++ .|+.+|||++.. ..+.++...|+.+|++++.|++|++||.+.....+|+|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 344567999999999999854 588999998775 34568889999999999999999999999999999999999999
Q ss_pred CCchHHhhc-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeee
Q 039310 147 GTLFEHIHK-NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTV 225 (241)
Q Consensus 147 g~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~ 225 (241)
|+..+.++- ++++++.++..+....++||+|||... -+|||||+.|||++.+|.+||+|||.|..+.. ...+..+
T Consensus 113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD-TMAKRNT 188 (502)
T KOG0574|consen 113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTD-TMAKRNT 188 (502)
T ss_pred CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhh-hHHhhCc
Confidence 999999974 567999999999999999999999988 89999999999999999999999999998753 3334455
Q ss_pred ecccccccccccccC
Q 039310 226 VQGTLGYIDPEYLQT 240 (241)
Q Consensus 226 ~~gt~~y~aPE~l~~ 240 (241)
+.|||.|||||+++.
T Consensus 189 VIGTPFWMAPEVI~E 203 (502)
T KOG0574|consen 189 VIGTPFWMAPEVIEE 203 (502)
T ss_pred cccCcccccHHHHHH
Confidence 679999999999864
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=222.00 Aligned_cols=169 Identities=26% Similarity=0.359 Sum_probs=140.9
Q ss_pred hhcccccccccCceeEEEEEeC-CCCeEEEEecccCC-hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEec
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD-QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
.|.+.+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++||||+++++++.+....++||||+
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 85 (303)
T cd07869 6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYV 85 (303)
T ss_pred cceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECC
Confidence 4667788999999999999965 67889999876432 223346778999999999999999999999999999999999
Q ss_pred CCCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcccee
Q 039310 145 GNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNY 223 (241)
Q Consensus 145 ~~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~ 223 (241)
+ ++|.+++... +.+++..+..++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||++....... ...
T Consensus 86 ~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~ 160 (303)
T cd07869 86 H-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-HTY 160 (303)
T ss_pred C-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC-ccC
Confidence 6 5787777654 46899999999999999999999999 9999999999999999999999999987543221 122
Q ss_pred eeecccccccccccccC
Q 039310 224 TVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 224 ~~~~gt~~y~aPE~l~~ 240 (241)
....||+.|+|||++.+
T Consensus 161 ~~~~~~~~y~aPE~~~~ 177 (303)
T cd07869 161 SNEVVTLWYRPPDVLLG 177 (303)
T ss_pred CCCcccCCCCChHHHcC
Confidence 33458999999998753
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=228.56 Aligned_cols=176 Identities=25% Similarity=0.400 Sum_probs=143.7
Q ss_pred HHHHhhhcccccccccCceeEEEEEeC------CCCeEEEEecccC-ChhhHHHHHHHHHHHHcC-CCCCceeEEEEEec
Q 039310 62 EIKTVTNNYADVIGCGGSGNVYKGFLP------DRTPVAVKKSKIV-DQTKIDEFINELVVVSQI-NRRNVVRLLACCLE 133 (241)
Q Consensus 62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~ 133 (241)
......+.+.+.||+|+||.||+|.+. ++..||+|.+... .....+.+.+|+.+++.+ +||||+++++++..
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 445556778899999999999998742 2357999987653 334456788999999999 89999999999999
Q ss_pred CCcceEEEEecCCCCchHHhhcC---------------------------------------------------------
Q 039310 134 TQVPLLVYEFVGNGTLFEHIHKN--------------------------------------------------------- 156 (241)
Q Consensus 134 ~~~~~lv~e~~~~g~L~~~l~~~--------------------------------------------------------- 156 (241)
.+..+++|||+++|+|.+++...
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 99999999999999999988532
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccce-
Q 039310 157 -------------GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQN- 222 (241)
Q Consensus 157 -------------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~- 222 (241)
.++++..+..++.|++.||.|||+++ ++||||||+|||+++++.+||+|||++..........
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~ 270 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence 13778889999999999999999998 9999999999999999999999999998654332211
Q ss_pred eeeecccccccccccccC
Q 039310 223 YTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 223 ~~~~~gt~~y~aPE~l~~ 240 (241)
.....+++.|||||++.+
T Consensus 271 ~~~~~~~~~y~aPE~~~~ 288 (374)
T cd05106 271 KGNARLPVKWMAPESIFD 288 (374)
T ss_pred ccCCCCccceeCHHHhcC
Confidence 111235678999998754
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=218.31 Aligned_cols=163 Identities=26% Similarity=0.309 Sum_probs=138.0
Q ss_pred ccccCceeEEEEEeC-CCCeEEEEecccCC---hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCCCCc
Q 039310 74 IGCGGSGNVYKGFLP-DRTPVAVKKSKIVD---QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTL 149 (241)
Q Consensus 74 lg~G~~g~V~~~~~~-~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~g~L 149 (241)
||+|+||+||++... +++.+|+|.+.... ....+.+..|+.+++.++||||+++.+++......+++|||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999854 57889999875422 22335677899999999999999999999999999999999999999
Q ss_pred hHHhh----cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeee
Q 039310 150 FEHIH----KNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTV 225 (241)
Q Consensus 150 ~~~l~----~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~ 225 (241)
.+++. .+..+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 88774 2346999999999999999999999998 99999999999999999999999999876543222 2233
Q ss_pred ecccccccccccccC
Q 039310 226 VQGTLGYIDPEYLQT 240 (241)
Q Consensus 226 ~~gt~~y~aPE~l~~ 240 (241)
..||+.|+|||++.+
T Consensus 157 ~~g~~~y~aPE~~~~ 171 (280)
T cd05608 157 YAGTPGFMAPELLQG 171 (280)
T ss_pred cCCCcCccCHHHhcC
Confidence 468999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=213.83 Aligned_cols=170 Identities=25% Similarity=0.390 Sum_probs=144.0
Q ss_pred hhcccccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCC
Q 039310 67 TNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGN 146 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~ 146 (241)
.+.+.+.||+|+||.||++.+.++..+++|...... .....+.+|+.+++.++||||+++++++...+..+++|||+++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred HcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 456678899999999999998888889999866432 2346788999999999999999999999999999999999999
Q ss_pred CCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeee
Q 039310 147 GTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTV 225 (241)
Q Consensus 147 g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~ 225 (241)
|+|.+++... +.+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.............
T Consensus 84 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05114 84 GCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSG 160 (256)
T ss_pred CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCC
Confidence 9999998753 46899999999999999999999998 9999999999999999999999999988654332222222
Q ss_pred ecccccccccccccC
Q 039310 226 VQGTLGYIDPEYLQT 240 (241)
Q Consensus 226 ~~gt~~y~aPE~l~~ 240 (241)
..++..|+|||.+.+
T Consensus 161 ~~~~~~y~aPE~~~~ 175 (256)
T cd05114 161 AKFPVKWSPPEVFNF 175 (256)
T ss_pred CCCchhhCChhhccc
Confidence 235678999998753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=223.25 Aligned_cols=167 Identities=27% Similarity=0.333 Sum_probs=138.5
Q ss_pred cccccccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHHHH---HcCCCCCceeEEEEEecCCcceEEE
Q 039310 69 NYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELVVV---SQINRRNVVRLLACCLETQVPLLVY 141 (241)
Q Consensus 69 ~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~~l---~~l~h~ni~~l~~~~~~~~~~~lv~ 141 (241)
.+.+.||+|+||.||+|... ++..||+|.+... .....+.+.+|..++ +.++||||+++++++...+..|+||
T Consensus 2 ~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~ 81 (324)
T cd05589 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVM 81 (324)
T ss_pred eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEE
Confidence 45678999999999999854 5889999987642 223345666776655 5668999999999999999999999
Q ss_pred EecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc
Q 039310 142 EFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ 221 (241)
Q Consensus 142 e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~ 221 (241)
||+++++|...+.. ..+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++....... .
T Consensus 82 E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~ 156 (324)
T cd05589 82 EYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG-D 156 (324)
T ss_pred cCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCCC-C
Confidence 99999999988865 46999999999999999999999999 9999999999999999999999999987542221 2
Q ss_pred eeeeecccccccccccccC
Q 039310 222 NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~~ 240 (241)
......||+.|||||++.+
T Consensus 157 ~~~~~~g~~~y~aPE~~~~ 175 (324)
T cd05589 157 RTSTFCGTPEFLAPEVLTE 175 (324)
T ss_pred cccccccCccccCHhHhcC
Confidence 2334569999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=221.71 Aligned_cols=165 Identities=30% Similarity=0.382 Sum_probs=140.9
Q ss_pred ccccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHHHHHcC-CCCCceeEEEEEecCCcceEEEEecCC
Q 039310 72 DVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELVVVSQI-NRRNVVRLLACCLETQVPLLVYEFVGN 146 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~ 146 (241)
+.||+|+||+||+|... ++..+|+|.+... .......+.+|..+++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999865 4778999987642 233456677899999888 799999999999999999999999999
Q ss_pred CCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeeee
Q 039310 147 GTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVV 226 (241)
Q Consensus 147 g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 226 (241)
++|..++.....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++....... ......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 156 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTTSTF 156 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Ccccce
Confidence 999999988888999999999999999999999999 9999999999999999999999999987532222 122334
Q ss_pred cccccccccccccC
Q 039310 227 QGTLGYIDPEYLQT 240 (241)
Q Consensus 227 ~gt~~y~aPE~l~~ 240 (241)
.||+.|+|||++.+
T Consensus 157 ~g~~~y~aPE~~~~ 170 (318)
T cd05570 157 CGTPDYIAPEILSY 170 (318)
T ss_pred ecCccccCHHHhcC
Confidence 68999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=222.97 Aligned_cols=163 Identities=29% Similarity=0.351 Sum_probs=136.6
Q ss_pred ccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHHHHHcC---CCCCceeEEEEEecCCcceEEEEecCC
Q 039310 74 IGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELVVVSQI---NRRNVVRLLACCLETQVPLLVYEFVGN 146 (241)
Q Consensus 74 lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l---~h~ni~~l~~~~~~~~~~~lv~e~~~~ 146 (241)
||+|+||+||+|... ++..||+|.+... ..........|..++... +||||++++.++...+..|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999854 5889999986532 122334455677777665 699999999999999999999999999
Q ss_pred CCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeeee
Q 039310 147 GTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVV 226 (241)
Q Consensus 147 g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 226 (241)
|+|.+++...+.+++..+..++.|++.||+|||+++ ++||||||+|||++.++.++|+|||++....... ......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~~~ 156 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTNTF 156 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCccCc
Confidence 999999988888999999999999999999999999 9999999999999999999999999987543222 223345
Q ss_pred cccccccccccccC
Q 039310 227 QGTLGYIDPEYLQT 240 (241)
Q Consensus 227 ~gt~~y~aPE~l~~ 240 (241)
+||+.|||||++.+
T Consensus 157 ~gt~~y~aPE~~~~ 170 (330)
T cd05586 157 CGTTEYLAPEVLLD 170 (330)
T ss_pred cCCccccCHHHHcC
Confidence 69999999998753
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=217.63 Aligned_cols=144 Identities=27% Similarity=0.293 Sum_probs=128.9
Q ss_pred hcccccccccCceeEEEEEeCC-CCeEEEEeccc---CChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 68 NNYADVIGCGGSGNVYKGFLPD-RTPVAVKKSKI---VDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavk~~~~---~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
.++.+.||+|.-|+||+++..+ +..+|+|.+.. .......+...|-+||+.++||.++.||..++.+...|++|||
T Consensus 79 f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~mey 158 (459)
T KOG0610|consen 79 FRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEY 158 (459)
T ss_pred HHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEec
Confidence 3445679999999999999765 57899998654 2345567788899999999999999999999999999999999
Q ss_pred cCCCCchHHhhcCC--CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCccc
Q 039310 144 VGNGTLFEHIHKNG--NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKL 214 (241)
Q Consensus 144 ~~~g~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~ 214 (241)
|+||+|..+++++. .+++..++.++.+++.||+|||..| ||+|||||+||||.++|++.|+||.|+..
T Consensus 159 CpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~ 228 (459)
T KOG0610|consen 159 CPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLR 228 (459)
T ss_pred CCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeecccccc
Confidence 99999999987653 6999999999999999999999999 99999999999999999999999998653
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-33 Score=249.12 Aligned_cols=172 Identities=27% Similarity=0.305 Sum_probs=154.3
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEeccc---CChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKI---VDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVY 141 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~---~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~ 141 (241)
..+.+.+.||+|+||.|...+.+ +++.+|+|++.. ........|..|-.+|..-+.+.|+++..+|++++++|+||
T Consensus 75 ~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVM 154 (1317)
T KOG0612|consen 75 EDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVM 154 (1317)
T ss_pred HhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEE
Confidence 34556678999999999999865 466779997765 33445677889999999999999999999999999999999
Q ss_pred EecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc
Q 039310 142 EFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ 221 (241)
Q Consensus 142 e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~ 221 (241)
||++||+|..++.+..++|+..+..++..|.-||.-||+.| +|||||||+|||+|.+|++||+|||.|-.+..++.-
T Consensus 155 dY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V 231 (1317)
T KOG0612|consen 155 DYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTV 231 (1317)
T ss_pred ecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHhcCCCCcE
Confidence 99999999999998889999999999999999999999999 999999999999999999999999999988877766
Q ss_pred eeeeecccccccccccccC
Q 039310 222 NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~~ 240 (241)
......|||.|.|||+|+.
T Consensus 232 ~s~~aVGTPDYISPEvLqs 250 (1317)
T KOG0612|consen 232 RSSVAVGTPDYISPEVLQS 250 (1317)
T ss_pred EeccccCCCCccCHHHHHh
Confidence 6777789999999999975
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=218.54 Aligned_cols=169 Identities=26% Similarity=0.336 Sum_probs=150.9
Q ss_pred hcccccccccCceeEEEEE-eCCCCeEEEEeccc---CChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 68 NNYADVIGCGGSGNVYKGF-LPDRTPVAVKKSKI---VDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavk~~~~---~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
.+|.++||+|.||+|.+++ ..+++.+|+|.++. .........+.|-++|+..+||.+..+-..|+..+++|+||||
T Consensus 170 FdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMey 249 (516)
T KOG0690|consen 170 FDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEY 249 (516)
T ss_pred hhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEE
Confidence 4567799999999999998 44688899997653 3455667788999999999999999999999999999999999
Q ss_pred cCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcccee
Q 039310 144 VGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNY 223 (241)
Q Consensus 144 ~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~ 223 (241)
..||.|.-+|.....+++...+.+..+|+.||.|||+++ ||+||||.+|.|+|.+|++||+|||+++.-. ......
T Consensus 250 anGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-~~g~t~ 325 (516)
T KOG0690|consen 250 ANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI-KYGDTT 325 (516)
T ss_pred ccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc-ccccee
Confidence 999999999998888999999999999999999999999 9999999999999999999999999998643 233467
Q ss_pred eeecccccccccccccC
Q 039310 224 TVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 224 ~~~~gt~~y~aPE~l~~ 240 (241)
.++||||.|+|||+|++
T Consensus 326 kTFCGTPEYLAPEVleD 342 (516)
T KOG0690|consen 326 KTFCGTPEYLAPEVLED 342 (516)
T ss_pred ccccCChhhcCchhhcc
Confidence 78899999999999975
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=213.42 Aligned_cols=173 Identities=22% Similarity=0.436 Sum_probs=146.5
Q ss_pred HHhhhcccccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 64 KTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
....+.+.+.||+|+||.||+|...++..|++|...... ...+.+.+|+.+++.++|+||+++++++.+.+..+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 345567788999999999999998788889999876433 2357889999999999999999999999999999999999
Q ss_pred cCCCCchHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc
Q 039310 144 VGNGTLFEHIHKN--GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ 221 (241)
Q Consensus 144 ~~~g~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~ 221 (241)
+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.........
T Consensus 83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 9999999998653 46889999999999999999999998 999999999999999999999999999876433222
Q ss_pred eeeeecccccccccccccC
Q 039310 222 NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~~ 240 (241)
......++..|+|||.+..
T Consensus 160 ~~~~~~~~~~y~aPE~~~~ 178 (261)
T cd05072 160 AREGAKFPIKWTAPEAINF 178 (261)
T ss_pred ccCCCccceecCCHHHhcc
Confidence 2222335678999998754
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=213.41 Aligned_cols=173 Identities=25% Similarity=0.429 Sum_probs=145.9
Q ss_pred HHhhhcccccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 64 KTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
....+.+.+.||+|++|.||+|...++..||+|...... ...+.+.+|+.+++.++||||+++++++...+..+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 345677888999999999999998778889999876533 2346788999999999999999999999999999999999
Q ss_pred cCCCCchHHhhcCC--CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc
Q 039310 144 VGNGTLFEHIHKNG--NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ 221 (241)
Q Consensus 144 ~~~g~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~ 221 (241)
+++++|.+++.... .+++..+..++.|++.|+.|||+.+ ++|+||||+||++++++.++|+|||++.........
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 99999999997654 6899999999999999999999998 999999999999999999999999999876432222
Q ss_pred eeeeecccccccccccccC
Q 039310 222 NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~~ 240 (241)
.......+..|+|||++.+
T Consensus 160 ~~~~~~~~~~y~aPE~~~~ 178 (261)
T cd05068 160 AREGAKFPIKWTAPEAALY 178 (261)
T ss_pred ccCCCcCceeccCcccccc
Confidence 1111223457999998753
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=212.59 Aligned_cols=171 Identities=27% Similarity=0.380 Sum_probs=144.7
Q ss_pred hhhcccccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecC
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVG 145 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~ 145 (241)
..+.+.+.||+|+||.||+|.+.++..+|+|.+.... .....+.+|+.+++.++||||+++++++...+..+++|||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 3466778899999999999998777789999876432 234678999999999999999999999999999999999999
Q ss_pred CCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceee
Q 039310 146 NGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYT 224 (241)
Q Consensus 146 ~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~ 224 (241)
+++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||.++...........
T Consensus 83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05113 83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV 159 (256)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceeecC
Confidence 99999999764 36899999999999999999999998 999999999999999999999999998865433322222
Q ss_pred eecccccccccccccC
Q 039310 225 VVQGTLGYIDPEYLQT 240 (241)
Q Consensus 225 ~~~gt~~y~aPE~l~~ 240 (241)
...++..|+|||.+..
T Consensus 160 ~~~~~~~y~~pe~~~~ 175 (256)
T cd05113 160 GSKFPVRWSPPEVLLY 175 (256)
T ss_pred CCccChhhCCHHHHhc
Confidence 2235678999998753
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=236.99 Aligned_cols=173 Identities=23% Similarity=0.352 Sum_probs=143.2
Q ss_pred hhhcccccccccCceeEEEEEeCCC-CeEEEEecccCChhhHHHHHHHHHHHHcCC-CCCceeEEEE-Eec---C---Cc
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLPDR-TPVAVKKSKIVDQTKIDEFINELVVVSQIN-RRNVVRLLAC-CLE---T---QV 136 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~-~~vavk~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~l~~~-~~~---~---~~ 136 (241)
-+..+.+.|.+|+|+.||+|....+ ..+|+|++-..++...+...+|+++|+.|+ |+|||.+++. ... . -.
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 3455677899999999999997665 999999988888999999999999999996 9999999994 221 1 25
Q ss_pred ceEEEEecCCCCchHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCccc
Q 039310 137 PLLVYEFVGNGTLFEHIHK--NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKL 214 (241)
Q Consensus 137 ~~lv~e~~~~g~L~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~ 214 (241)
.+|+||||.||.|-+++.. ...|++.++++|+.|+++|+.+||.+. +||||||||.+||||+.++..||||||.|..
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSatt 195 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSATT 195 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccccccc
Confidence 6799999999999999974 346999999999999999999999985 7899999999999999999999999998765
Q ss_pred ccCCccc--------eeeeeccccccccccccc
Q 039310 215 VPIDAIQ--------NYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 215 ~~~~~~~--------~~~~~~gt~~y~aPE~l~ 239 (241)
....... .....--|+.|.|||.+.
T Consensus 196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMID 228 (738)
T KOG1989|consen 196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMID 228 (738)
T ss_pred ccCCCccHHHHHHHHHHHHhhCCccccChHHHh
Confidence 3221100 011122589999999875
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=225.66 Aligned_cols=168 Identities=27% Similarity=0.303 Sum_probs=142.3
Q ss_pred cccccccccCceeEEEEEe-CCCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCC-----cceEE
Q 039310 69 NYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLETQ-----VPLLV 140 (241)
Q Consensus 69 ~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~-----~~~lv 140 (241)
...+.||+|+||.||+|.. .++..||+|++... +....+++.+|+.+++.++||||+++++++...+ ..|+|
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 82 (372)
T cd07853 3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVV 82 (372)
T ss_pred cccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEE
Confidence 4567899999999999985 46889999987542 2334567889999999999999999999998776 78999
Q ss_pred EEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcc
Q 039310 141 YEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAI 220 (241)
Q Consensus 141 ~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~ 220 (241)
+||+. ++|.+.+.....+++..+..++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||++........
T Consensus 83 ~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~ 158 (372)
T cd07853 83 TELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES 158 (372)
T ss_pred eeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence 99996 588888887788999999999999999999999999 99999999999999999999999999986543332
Q ss_pred ceeeeecccccccccccccC
Q 039310 221 QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 221 ~~~~~~~gt~~y~aPE~l~~ 240 (241)
.......+|+.|+|||++.+
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~ 178 (372)
T cd07853 159 KHMTQEVVTQYYRAPEILMG 178 (372)
T ss_pred ccCCCCCcCCCcCCHHHHcC
Confidence 22333457899999998753
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=222.91 Aligned_cols=164 Identities=24% Similarity=0.365 Sum_probs=138.1
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecC
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVG 145 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~ 145 (241)
+...+.||+|+||.||+|... +++.||+|.+... .......+.+|+++++.++|+||+++++++...+..+++|||++
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 155 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD 155 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence 445678999999999999854 5889999987543 23345678999999999999999999999999999999999999
Q ss_pred CCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeee
Q 039310 146 NGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTV 225 (241)
Q Consensus 146 ~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~ 225 (241)
+++|.+.. ..++..+..++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||++....... .....
T Consensus 156 ~~~L~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~ 227 (353)
T PLN00034 156 GGSLEGTH----IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-DPCNS 227 (353)
T ss_pred CCcccccc----cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc-ccccc
Confidence 99986532 4567888899999999999999999 9999999999999999999999999998653221 12233
Q ss_pred eccccccccccccc
Q 039310 226 VQGTLGYIDPEYLQ 239 (241)
Q Consensus 226 ~~gt~~y~aPE~l~ 239 (241)
..||+.|+|||++.
T Consensus 228 ~~gt~~y~aPE~~~ 241 (353)
T PLN00034 228 SVGTIAYMSPERIN 241 (353)
T ss_pred cccCccccCccccc
Confidence 46899999999874
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=225.68 Aligned_cols=176 Identities=24% Similarity=0.353 Sum_probs=143.4
Q ss_pred HHHHhhhcccccccccCceeEEEEEeCC------CCeEEEEecccC-ChhhHHHHHHHHHHHHcCC-CCCceeEEEEEec
Q 039310 62 EIKTVTNNYADVIGCGGSGNVYKGFLPD------RTPVAVKKSKIV-DQTKIDEFINELVVVSQIN-RRNVVRLLACCLE 133 (241)
Q Consensus 62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~ 133 (241)
+.....+.+.+.||+|+||.||+|.... ...||+|.+... .....+.+.+|+.+++.++ ||||++++++|..
T Consensus 33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~ 112 (400)
T cd05105 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK 112 (400)
T ss_pred eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence 3445566778899999999999997421 346999988653 3344567899999999996 9999999999999
Q ss_pred CCcceEEEEecCCCCchHHhhcC---------------------------------------------------------
Q 039310 134 TQVPLLVYEFVGNGTLFEHIHKN--------------------------------------------------------- 156 (241)
Q Consensus 134 ~~~~~lv~e~~~~g~L~~~l~~~--------------------------------------------------------- 156 (241)
.+..++||||+++|+|.+++..+
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 99999999999999999988542
Q ss_pred ---------------------------------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCee
Q 039310 157 ---------------------------------------GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANIL 197 (241)
Q Consensus 157 ---------------------------------------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nil 197 (241)
..+++..+..++.|++.||.|||+.+ ++|+||||+|||
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nil 269 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEE
Confidence 13677888999999999999999998 999999999999
Q ss_pred eCCCCCeEEccCCCcccccCCccc-eeeeecccccccccccccC
Q 039310 198 LDENYTPKVSDFGASKLVPIDAIQ-NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 198 i~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~ 240 (241)
+++++.+||+|||++......... ......+++.|||||.+.+
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 313 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD 313 (400)
T ss_pred EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC
Confidence 999999999999998865432221 1122346788999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=215.83 Aligned_cols=168 Identities=36% Similarity=0.555 Sum_probs=139.2
Q ss_pred ccccccccCceeEEEEEeC-----CCCeEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 70 YADVIGCGGSGNVYKGFLP-----DRTPVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~~-----~~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
..+.||.|+||.||+|.+. .+..|+||.+... .....+.+.+|++.++.++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4568999999999999976 2567999988653 344578999999999999999999999999988889999999
Q ss_pred cCCCCchHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcc-
Q 039310 144 VGNGTLFEHIHKN--GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAI- 220 (241)
Q Consensus 144 ~~~g~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~- 220 (241)
+++|+|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+++||++++++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred ccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 9999999999886 67999999999999999999999998 99999999999999999999999999887632221
Q ss_pred ceeeeecccccccccccccC
Q 039310 221 QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 221 ~~~~~~~gt~~y~aPE~l~~ 240 (241)
.......+...|+|||.+.+
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~ 179 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKD 179 (259)
T ss_dssp EESTTSESGGGGS-HHHHHH
T ss_pred cccccccccccccccccccc
Confidence 22222346789999998754
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=216.21 Aligned_cols=168 Identities=30% Similarity=0.338 Sum_probs=141.8
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccCC---hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD---QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
|+..+.||+|+||+||++... ++..||+|.+.... ......+.+|+.+++.++||||+++++++..++..+++|||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 445678999999999999854 57899999875422 22234577899999999999999999999999999999999
Q ss_pred cCCCCchHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc
Q 039310 144 VGNGTLFEHIHKN--GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ 221 (241)
Q Consensus 144 ~~~g~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~ 221 (241)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 156 (285)
T cd05605 82 MNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-- 156 (285)
T ss_pred cCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC--
Confidence 9999999888643 35899999999999999999999998 9999999999999999999999999988654322
Q ss_pred eeeeecccccccccccccC
Q 039310 222 NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~~ 240 (241)
......||+.|+|||++.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~ 175 (285)
T cd05605 157 TIRGRVGTVGYMAPEVVKN 175 (285)
T ss_pred ccccccCCCCccCcHHhcC
Confidence 2223468999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=216.36 Aligned_cols=161 Identities=20% Similarity=0.311 Sum_probs=138.8
Q ss_pred ccccccCceeEEEEEeCCCCeEEEEecccCChhh---HHHHHHHHHHHHcCCCCCceeEEEEEec----CCcceEEEEec
Q 039310 72 DVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTK---IDEFINELVVVSQINRRNVVRLLACCLE----TQVPLLVYEFV 144 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~---~~~~~~E~~~l~~l~h~ni~~l~~~~~~----~~~~~lv~e~~ 144 (241)
..||+|++|.||+|.+ ++..||||.+....... .+.+.+|+.++++++||||+++++++.+ ....+++|||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 3689999999999998 67889999876543322 4678899999999999999999999876 34678999999
Q ss_pred CCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcccee
Q 039310 145 GNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSE-TNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNY 223 (241)
Q Consensus 145 ~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~-~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~ 223 (241)
++|+|.+++.....+++.....++.|++.||.|||+. + ++||||||+|||+++++.+||+|||+++.+....
T Consensus 105 ~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~---- 177 (283)
T PHA02988 105 TRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP---- 177 (283)
T ss_pred CCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc----
Confidence 9999999999888899999999999999999999984 6 8899999999999999999999999988654321
Q ss_pred eeecccccccccccccC
Q 039310 224 TVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 224 ~~~~gt~~y~aPE~l~~ 240 (241)
....||+.|+|||++.+
T Consensus 178 ~~~~~~~~y~aPE~~~~ 194 (283)
T PHA02988 178 FKNVNFMVYFSYKMLND 194 (283)
T ss_pred ccccCcccccCHHHhhh
Confidence 22358899999999853
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=232.10 Aligned_cols=169 Identities=27% Similarity=0.427 Sum_probs=143.7
Q ss_pred hhhcccccccccCceeEEEEE-eCCCCeEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCC------cc
Q 039310 66 VTNNYADVIGCGGSGNVYKGF-LPDRTPVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCLETQ------VP 137 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~------~~ 137 (241)
..+...+.||+|+||.||+|+ ..+|..||||..... .....+...+|+++|++++|||||++++.-.+.. ..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 345566789999999999999 556999999977653 3445677889999999999999999998865543 56
Q ss_pred eEEEEecCCCCchHHhhcCC---CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC--CCC--CeEEccCC
Q 039310 138 LLVYEFVGNGTLFEHIHKNG---NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLD--ENY--TPKVSDFG 210 (241)
Q Consensus 138 ~lv~e~~~~g~L~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~--~~~--~~kl~Dfg 210 (241)
.++||||.+|||...+.+.. .+++.+.+.+..++..||.|||+.+ |+||||||.||++- .+| .-||+|||
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 89999999999999997644 5999999999999999999999999 99999999999983 334 46999999
Q ss_pred CcccccCCccceeeeeccccccccccccc
Q 039310 211 ASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 211 la~~~~~~~~~~~~~~~gt~~y~aPE~l~ 239 (241)
.|+.+..++ ......||+.|.+||..+
T Consensus 170 ~Arel~d~s--~~~S~vGT~~YLhPel~E 196 (732)
T KOG4250|consen 170 AARELDDNS--LFTSLVGTEEYLHPELYE 196 (732)
T ss_pred ccccCCCCC--eeeeecCchhhcChHHHh
Confidence 999886554 566678999999999876
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-31 Score=211.43 Aligned_cols=170 Identities=27% Similarity=0.421 Sum_probs=142.5
Q ss_pred hhcccccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCC
Q 039310 67 TNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGN 146 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~ 146 (241)
.+.+.+.||+|+||.||+|.+.++..+++|....... ....+.+|+.+++.++||||+++++++...+..+++|||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 4567788999999999999987777899998653322 335688899999999999999999999999999999999999
Q ss_pred CCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeee
Q 039310 147 GTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTV 225 (241)
Q Consensus 147 g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~ 225 (241)
++|.+++..+ ..+++.....++.|++.|+.|||+.+ ++|+||||+||++++++.+||+|||+++............
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~ 160 (256)
T cd05059 84 GCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQG 160 (256)
T ss_pred CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccccCC
Confidence 9999999754 46899999999999999999999999 9999999999999999999999999987654322221122
Q ss_pred ecccccccccccccC
Q 039310 226 VQGTLGYIDPEYLQT 240 (241)
Q Consensus 226 ~~gt~~y~aPE~l~~ 240 (241)
..++..|+|||.+.+
T Consensus 161 ~~~~~~y~~Pe~~~~ 175 (256)
T cd05059 161 TKFPVKWAPPEVFDY 175 (256)
T ss_pred CCCCccccCHHHhcc
Confidence 224567999998754
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=211.96 Aligned_cols=169 Identities=28% Similarity=0.395 Sum_probs=146.9
Q ss_pred hhcccccccccCceeEEEEEeC-CCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecC
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVG 145 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~ 145 (241)
.+.+.+.||+|+||.||+|... ++..+++|.+..........+.+|+.+++.++||||+++++++...+..+++|||++
T Consensus 10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 89 (267)
T cd06645 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCG 89 (267)
T ss_pred HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccC
Confidence 4566778999999999999854 588899998776555555678899999999999999999999999999999999999
Q ss_pred CCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeee
Q 039310 146 NGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTV 225 (241)
Q Consensus 146 ~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~ 225 (241)
+++|.+++...+.+++.++..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++....... .....
T Consensus 90 ~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~ 165 (267)
T cd06645 90 GGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI-AKRKS 165 (267)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc-ccccc
Confidence 9999999988888999999999999999999999998 9999999999999999999999999987653221 22233
Q ss_pred eccccccccccccc
Q 039310 226 VQGTLGYIDPEYLQ 239 (241)
Q Consensus 226 ~~gt~~y~aPE~l~ 239 (241)
..|++.|+|||++.
T Consensus 166 ~~~~~~y~aPE~~~ 179 (267)
T cd06645 166 FIGTPYWMAPEVAA 179 (267)
T ss_pred ccCcccccChhhhc
Confidence 45899999999873
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-32 Score=223.21 Aligned_cols=166 Identities=29% Similarity=0.341 Sum_probs=144.6
Q ss_pred cccccccCceeEEEEEe-CCCCeEEEEecccC---ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCC
Q 039310 71 ADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIV---DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGN 146 (241)
Q Consensus 71 ~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~ 146 (241)
.+.||+|+||.||-++. .+|+.+|.|++... ........++|-.+|++++.+.||.+-.+|++.+.+++|+..|.|
T Consensus 190 ~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNG 269 (591)
T KOG0986|consen 190 YRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNG 269 (591)
T ss_pred eEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecC
Confidence 34899999999999884 46888888876432 223345678999999999999999999999999999999999999
Q ss_pred CCchHHhhcCC--CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceee
Q 039310 147 GTLFEHIHKNG--NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYT 224 (241)
Q Consensus 147 g~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~ 224 (241)
|+|.-+|...+ .+++..++.++.+|+.||++||..+ ||+|||||+|||+|+.|+++|+|+|||..+..... ..
T Consensus 270 GDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~--~~ 344 (591)
T KOG0986|consen 270 GDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKP--IR 344 (591)
T ss_pred CceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCCCc--cc
Confidence 99999997766 6999999999999999999999999 99999999999999999999999999988765433 33
Q ss_pred eecccccccccccccCC
Q 039310 225 VVQGTLGYIDPEYLQTC 241 (241)
Q Consensus 225 ~~~gt~~y~aPE~l~~~ 241 (241)
...||.+|||||+++++
T Consensus 345 ~rvGT~GYMAPEvl~ne 361 (591)
T KOG0986|consen 345 GRVGTVGYMAPEVLQNE 361 (591)
T ss_pred cccCcccccCHHHHcCC
Confidence 34799999999999874
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=211.28 Aligned_cols=170 Identities=28% Similarity=0.381 Sum_probs=146.9
Q ss_pred hhhcccccccccCceeEEEEEe-CCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEec
Q 039310 66 VTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
..+.+.+.||+|+||.||+|.. .++..+|+|............+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 4566778899999999999985 467889999876554445567889999999999999999999999999999999999
Q ss_pred CCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceee
Q 039310 145 GNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYT 224 (241)
Q Consensus 145 ~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~ 224 (241)
++++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+|++|+||++++++.++|+|||++........ ...
T Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~~ 164 (267)
T cd06646 89 GGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-KRK 164 (267)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc-ccC
Confidence 99999999987788999999999999999999999998 99999999999999999999999999886532221 122
Q ss_pred eeccccccccccccc
Q 039310 225 VVQGTLGYIDPEYLQ 239 (241)
Q Consensus 225 ~~~gt~~y~aPE~l~ 239 (241)
...|++.|+|||.+.
T Consensus 165 ~~~~~~~y~~PE~~~ 179 (267)
T cd06646 165 SFIGTPYWMAPEVAA 179 (267)
T ss_pred ccccCccccCHhHcc
Confidence 345889999999873
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=216.47 Aligned_cols=172 Identities=24% Similarity=0.420 Sum_probs=140.8
Q ss_pred HhhhcccccccccCceeEEEEEeC-CCC----eEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcce
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFLP-DRT----PVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPL 138 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~ 138 (241)
...+...+.||+|+||.||+|.+. ++. .||+|..... .....+++.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 345666778999999999999853 233 4899987653 334557888999999999999999999998765 567
Q ss_pred EEEEecCCCCchHHhhcCC-CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccC
Q 039310 139 LVYEFVGNGTLFEHIHKNG-NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPI 217 (241)
Q Consensus 139 lv~e~~~~g~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~ 217 (241)
+++||+++|+|.+++.... .+++.....++.|++.||+|||+++ ++||||||+|||+++++.+||+|||+++....
T Consensus 85 ~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 85 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccccC
Confidence 9999999999999998654 6899999999999999999999998 99999999999999999999999999987654
Q ss_pred Cccce-eeeecccccccccccccC
Q 039310 218 DAIQN-YTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 218 ~~~~~-~~~~~gt~~y~aPE~l~~ 240 (241)
..... .....++..|+|||.+.+
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~ 185 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILH 185 (316)
T ss_pred CCcceeccCCccceeecChHHhcc
Confidence 33221 112234678999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=206.84 Aligned_cols=166 Identities=32% Similarity=0.489 Sum_probs=140.3
Q ss_pred ccccccCceeEEEEEeCCCCeEEEEecccCC-hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCCCCch
Q 039310 72 DVIGCGGSGNVYKGFLPDRTPVAVKKSKIVD-QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLF 150 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~g~L~ 150 (241)
+.||+|+||.||+|...++..+|+|...... ......+.+|+++++.++||||+++++++...+..+++|||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3689999999999998788899999876543 333457889999999999999999999999999999999999999999
Q ss_pred HHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeeeeccc
Q 039310 151 EHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGT 229 (241)
Q Consensus 151 ~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt 229 (241)
+++... ..+++..+..++.|++.+|.|+|+.+ ++|+||+|+||++++++.++++|||++...............++
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence 998754 45899999999999999999999998 99999999999999999999999999876433222222222346
Q ss_pred ccccccccccC
Q 039310 230 LGYIDPEYLQT 240 (241)
Q Consensus 230 ~~y~aPE~l~~ 240 (241)
+.|+|||++.+
T Consensus 158 ~~y~aPE~~~~ 168 (250)
T cd05085 158 IKWTAPEALNY 168 (250)
T ss_pred ccccCHHHhcc
Confidence 78999998764
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=210.69 Aligned_cols=172 Identities=24% Similarity=0.401 Sum_probs=148.8
Q ss_pred HhhhcccccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEec
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
...+.+.+.||.|+||.||+|...++..+++|.+..........+.+|+.+++.++||||+++++++.+.+..+++|||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 34567788999999999999998888999999887666656678899999999999999999999999999999999999
Q ss_pred CCCCchHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccce
Q 039310 145 GNGTLFEHIHKN--GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQN 222 (241)
Q Consensus 145 ~~g~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~ 222 (241)
++++|.+++... ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||++.........
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~- 160 (261)
T cd05148 85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL- 160 (261)
T ss_pred ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcccc-
Confidence 999999999753 36899999999999999999999998 999999999999999999999999999876433221
Q ss_pred eeeecccccccccccccC
Q 039310 223 YTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 223 ~~~~~gt~~y~aPE~l~~ 240 (241)
.....+++.|+|||.+.+
T Consensus 161 ~~~~~~~~~~~~PE~~~~ 178 (261)
T cd05148 161 SSDKKIPYKWTAPEAASH 178 (261)
T ss_pred ccCCCCceEecCHHHHcc
Confidence 223346778999998753
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=211.19 Aligned_cols=162 Identities=28% Similarity=0.330 Sum_probs=136.8
Q ss_pred ccccCceeEEEEEeC-CCCeEEEEecccCC---hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCCCCc
Q 039310 74 IGCGGSGNVYKGFLP-DRTPVAVKKSKIVD---QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTL 149 (241)
Q Consensus 74 lg~G~~g~V~~~~~~-~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~g~L 149 (241)
||+|+||.||++... ++..+|+|.+.... ......+..|+++++.++||||+++++++......+++|||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999854 58899999875321 12234556799999999999999999999999999999999999999
Q ss_pred hHHhhcCC--CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeeeec
Q 039310 150 FEHIHKNG--NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQ 227 (241)
Q Consensus 150 ~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 227 (241)
.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++....... ......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~ 155 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRA 155 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccC
Confidence 98886443 5889999999999999999999998 9999999999999999999999999987664322 223345
Q ss_pred ccccccccccccC
Q 039310 228 GTLGYIDPEYLQT 240 (241)
Q Consensus 228 gt~~y~aPE~l~~ 240 (241)
||+.|+|||++.+
T Consensus 156 ~~~~y~aPE~~~~ 168 (277)
T cd05607 156 GTNGYMAPEILKE 168 (277)
T ss_pred CCCCccCHHHHcc
Confidence 8999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=212.11 Aligned_cols=173 Identities=25% Similarity=0.392 Sum_probs=144.3
Q ss_pred HhhhcccccccccCceeEEEEEeC------CCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcce
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFLP------DRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPL 138 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~ 138 (241)
...+.+.+.||+|+||+||++... ++..+++|.+........+.+.+|+++++.++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 345567788999999999999742 24568889877665566678999999999999999999999999999999
Q ss_pred EEEEecCCCCchHHhhcCC-------------CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeE
Q 039310 139 LVYEFVGNGTLFEHIHKNG-------------NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPK 205 (241)
Q Consensus 139 lv~e~~~~g~L~~~l~~~~-------------~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~k 205 (241)
++|||+++++|.+++...+ .+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 9999999999999987443 3899999999999999999999998 99999999999999999999
Q ss_pred EccCCCcccccCCcc-ceeeeecccccccccccccC
Q 039310 206 VSDFGASKLVPIDAI-QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 206 l~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~ 240 (241)
|+|||++........ .......+++.|+|||.+.+
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 196 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY 196 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhcc
Confidence 999999886533221 11122335778999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=211.65 Aligned_cols=174 Identities=25% Similarity=0.382 Sum_probs=142.5
Q ss_pred HHhhhcccccccccCceeEEEEEeC------CCCeEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCc
Q 039310 64 KTVTNNYADVIGCGGSGNVYKGFLP------DRTPVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCLETQV 136 (241)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~ 136 (241)
....+.+.+.||+|+||.||+|.+. .+..||+|..... ......++.+|+.+++.++||||+++++++...+.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4456778889999999999998753 2457999987543 23345678899999999999999999999999999
Q ss_pred ceEEEEecCCCCchHHhhcCC----------CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEE
Q 039310 137 PLLVYEFVGNGTLFEHIHKNG----------NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKV 206 (241)
Q Consensus 137 ~~lv~e~~~~g~L~~~l~~~~----------~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl 206 (241)
.+++|||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 999999999999999986422 3577889999999999999999998 999999999999999999999
Q ss_pred ccCCCcccccCCccce-eeeecccccccccccccC
Q 039310 207 SDFGASKLVPIDAIQN-YTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 207 ~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~ 240 (241)
+|||++.......... .....+++.|||||++.+
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 195 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD 195 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhc
Confidence 9999987654332211 112235788999998754
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-31 Score=211.74 Aligned_cols=168 Identities=35% Similarity=0.515 Sum_probs=144.6
Q ss_pred hcccccccccCceeEEEEEeCC-CCeEEEEecccCChhhHH--HHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEec
Q 039310 68 NNYADVIGCGGSGNVYKGFLPD-RTPVAVKKSKIVDQTKID--EFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavk~~~~~~~~~~~--~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
|++.+.||+|+||+||++.... ++.+|+|........... ...+|+.+++.++||||+++++++...+..+++||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 4567889999999999999655 558999988765544322 3456999999999999999999999999999999999
Q ss_pred CCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceee
Q 039310 145 GNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYT 224 (241)
Q Consensus 145 ~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~ 224 (241)
++++|.+++.....+++..+..++.|++.||.+||+.+ ++|+||||+||++++++.++|+|||.+.... .......
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~~~ 156 (260)
T PF00069_consen 81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNENFN 156 (260)
T ss_dssp TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSEBS
T ss_pred cccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc-ccccccc
Confidence 99999999997778999999999999999999999998 9999999999999999999999999987541 2223344
Q ss_pred eeccccccccccccc
Q 039310 225 VVQGTLGYIDPEYLQ 239 (241)
Q Consensus 225 ~~~gt~~y~aPE~l~ 239 (241)
...+|+.|+|||++.
T Consensus 157 ~~~~~~~y~aPE~~~ 171 (260)
T PF00069_consen 157 PFVGTPEYMAPEVLQ 171 (260)
T ss_dssp SSSSSGGGSCHHHHT
T ss_pred ccccccccccccccc
Confidence 456899999999976
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=212.05 Aligned_cols=173 Identities=26% Similarity=0.402 Sum_probs=144.2
Q ss_pred HhhhcccccccccCceeEEEEEeCC------CCeEEEEecccCChh-hHHHHHHHHHHHHcCCCCCceeEEEEEecCCcc
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFLPD------RTPVAVKKSKIVDQT-KIDEFINELVVVSQINRRNVVRLLACCLETQVP 137 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~ 137 (241)
..++.+.+.||+|+||.||+|...+ +..||+|........ ..+.+.+|+++++.++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3456677889999999999998532 468999987654433 457899999999999999999999999999999
Q ss_pred eEEEEecCCCCchHHhhcCC--------------CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCC
Q 039310 138 LLVYEFVGNGTLFEHIHKNG--------------NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYT 203 (241)
Q Consensus 138 ~lv~e~~~~g~L~~~l~~~~--------------~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~ 203 (241)
+++|||+++++|.+++...+ .+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 99999999999999997542 3788899999999999999999998 999999999999999999
Q ss_pred eEEccCCCcccccCCccc-eeeeecccccccccccccC
Q 039310 204 PKVSDFGASKLVPIDAIQ-NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 204 ~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~ 240 (241)
++|+|||++......... ......+++.|+|||++.+
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 198 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY 198 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhcc
Confidence 999999998765322211 1122335788999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=211.63 Aligned_cols=171 Identities=30% Similarity=0.454 Sum_probs=142.2
Q ss_pred hhcccccccccCceeEEEEEeCCC------CeEEEEecccCC-hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceE
Q 039310 67 TNNYADVIGCGGSGNVYKGFLPDR------TPVAVKKSKIVD-QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLL 139 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~~~------~~vavk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~l 139 (241)
.+.+.+.||+|+||.||+|..... ..|++|.+.... ......+.+|+.+++.++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 456678899999999999985432 468999876433 3345678999999999999999999999999999999
Q ss_pred EEEecCCCCchHHhhcC----------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCC
Q 039310 140 VYEFVGNGTLFEHIHKN----------------GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYT 203 (241)
Q Consensus 140 v~e~~~~g~L~~~l~~~----------------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~ 203 (241)
+|||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCCc
Confidence 99999999999999754 34788999999999999999999998 999999999999999999
Q ss_pred eEEccCCCcccccCCcc-ceeeeecccccccccccccC
Q 039310 204 PKVSDFGASKLVPIDAI-QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 204 ~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~ 240 (241)
++|+|||++........ .......+++.|+|||.+.+
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 200 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY 200 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhcc
Confidence 99999999876532221 12223346789999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=211.98 Aligned_cols=168 Identities=29% Similarity=0.330 Sum_probs=141.3
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccCC---hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD---QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
+...+.||+|+||+||+|... +++.+|+|.+.... ......+.+|+.+++.++|+|++.+.+++..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 344567999999999999854 57889999875422 22334578899999999999999999999999999999999
Q ss_pred cCCCCchHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc
Q 039310 144 VGNGTLFEHIHKN--GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ 221 (241)
Q Consensus 144 ~~~g~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~ 221 (241)
+++++|.+++... .++++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-- 156 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence 9999999888643 36999999999999999999999998 9999999999999999999999999987653222
Q ss_pred eeeeecccccccccccccC
Q 039310 222 NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~~ 240 (241)
......|++.|+|||++.+
T Consensus 157 ~~~~~~g~~~~~aPE~~~~ 175 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNN 175 (285)
T ss_pred cccCCCCCcCccChHHhcC
Confidence 2233468999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=208.43 Aligned_cols=160 Identities=26% Similarity=0.384 Sum_probs=135.0
Q ss_pred ccccccCceeEEEEEeCC-------------CCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcce
Q 039310 72 DVIGCGGSGNVYKGFLPD-------------RTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPL 138 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~-------------~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~ 138 (241)
+.||+|+||.||+|.+.. ...|++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 358999999999998532 2257888776655555667889999999999999999999999999999
Q ss_pred EEEEecCCCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCC-------eEEccCC
Q 039310 139 LVYEFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYT-------PKVSDFG 210 (241)
Q Consensus 139 lv~e~~~~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~-------~kl~Dfg 210 (241)
++|||+++++|..++... ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++. ++++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999988753 56899999999999999999999998 999999999999987664 8999999
Q ss_pred CcccccCCccceeeeeccccccccccccc
Q 039310 211 ASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 211 la~~~~~~~~~~~~~~~gt~~y~aPE~l~ 239 (241)
++...... ....++..|+|||.+.
T Consensus 158 ~~~~~~~~-----~~~~~~~~y~aPE~~~ 181 (262)
T cd05077 158 IPITVLSR-----QECVERIPWIAPECVE 181 (262)
T ss_pred CCccccCc-----ccccccccccChhhhc
Confidence 98755321 2234788999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-33 Score=212.93 Aligned_cols=169 Identities=25% Similarity=0.373 Sum_probs=143.9
Q ss_pred hhcccccccccCceeEEEEE-eCCCCeEEEEeccc--CChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 67 TNNYADVIGCGGSGNVYKGF-LPDRTPVAVKKSKI--VDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavk~~~~--~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
.|++.+.||+|+|+.|+++. ..+|+.+|+|.++. ......+++.+|+.+-+.++||||+++..........|+|+|+
T Consensus 12 ~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~ 91 (355)
T KOG0033|consen 12 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 91 (355)
T ss_pred hhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEec
Confidence 35566789999999999986 45688888886543 3344668889999999999999999999999999999999999
Q ss_pred cCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC---CCCeEEccCCCcccccCCcc
Q 039310 144 VGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDE---NYTPKVSDFGASKLVPIDAI 220 (241)
Q Consensus 144 ~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~---~~~~kl~Dfgla~~~~~~~~ 220 (241)
+.|++|..=+-...-.++..+-.+++||+++|.|+|..+ |||||+||.|+|+.+ ...+|++|||+|..+. +.
T Consensus 92 m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~--~g 166 (355)
T KOG0033|consen 92 VTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN--DG 166 (355)
T ss_pred ccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeC--Cc
Confidence 999999766655556889999999999999999999999 999999999999953 3458999999999886 34
Q ss_pred ceeeeecccccccccccccC
Q 039310 221 QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 221 ~~~~~~~gt~~y~aPE~l~~ 240 (241)
.......|||.|||||++..
T Consensus 167 ~~~~G~~GtP~fmaPEvvrk 186 (355)
T KOG0033|consen 167 EAWHGFAGTPGYLSPEVLKK 186 (355)
T ss_pred cccccccCCCcccCHHHhhc
Confidence 45566779999999999853
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=208.54 Aligned_cols=172 Identities=26% Similarity=0.378 Sum_probs=143.7
Q ss_pred hhhcccccccccCceeEEEEEeCC----CCeEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLPD----RTPVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLV 140 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv 140 (241)
..+.+.+.||+|+||.||+|.+.. ...|++|..... ......++.+|+.+++.++||||+++++++...+..+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 346677899999999999998642 457899987643 334456788999999999999999999999999999999
Q ss_pred EEecCCCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCc
Q 039310 141 YEFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDA 219 (241)
Q Consensus 141 ~e~~~~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~ 219 (241)
|||+++++|.+++... +.+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 9999999999999764 46899999999999999999999998 9999999999999999999999999998764211
Q ss_pred -cceeeeecccccccccccccC
Q 039310 220 -IQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 220 -~~~~~~~~gt~~y~aPE~l~~ 240 (241)
........+++.|+|||.+.+
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~ 182 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAY 182 (266)
T ss_pred cceeccCCCCCccccChhhhcc
Confidence 112222235678999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=236.38 Aligned_cols=171 Identities=23% Similarity=0.353 Sum_probs=142.0
Q ss_pred hhcccccccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEE
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYE 142 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e 142 (241)
+|.+.+.||+|+||.||+|... ++..||+|++... .....+++.+|+.+++.++||||+++++++.+.+..+++||
T Consensus 3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVME 82 (932)
T PRK13184 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP 82 (932)
T ss_pred CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEE
Confidence 4567789999999999999864 5889999987542 23345678999999999999999999999999999999999
Q ss_pred ecCCCCchHHhhcC-----------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCC
Q 039310 143 FVGNGTLFEHIHKN-----------GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGA 211 (241)
Q Consensus 143 ~~~~g~L~~~l~~~-----------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgl 211 (241)
|+++++|.+++... ...++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||+
T Consensus 83 Y~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 83 YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred cCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecCc
Confidence 99999999988631 23566788899999999999999998 99999999999999999999999999
Q ss_pred cccccCCc-----------------cceeeeecccccccccccccC
Q 039310 212 SKLVPIDA-----------------IQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 212 a~~~~~~~-----------------~~~~~~~~gt~~y~aPE~l~~ 240 (241)
+....... ........||+.|||||.+.+
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g 205 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG 205 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC
Confidence 98652110 001112458999999998764
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=209.12 Aligned_cols=171 Identities=28% Similarity=0.430 Sum_probs=143.6
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEec
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
..+.+.+.||+|+||.||+|.+. .+..+++|..... ......+.+|+.+++.++||||+++++++...+..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 44566778999999999999854 4778999987643 334567889999999999999999999999999999999999
Q ss_pred CCCCchHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccce
Q 039310 145 GNGTLFEHIHKN--GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQN 222 (241)
Q Consensus 145 ~~g~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~ 222 (241)
++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++..........
T Consensus 85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence 999999998654 35899999999999999999999998 9999999999999999999999999998765433222
Q ss_pred eeeecccccccccccccC
Q 039310 223 YTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 223 ~~~~~gt~~y~aPE~l~~ 240 (241)
.....+++.|+|||.+.+
T Consensus 162 ~~~~~~~~~y~aPE~~~~ 179 (263)
T cd05052 162 HAGAKFPIKWTAPESLAY 179 (263)
T ss_pred cCCCCCccccCCHHHhcc
Confidence 222234678999998753
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=228.10 Aligned_cols=172 Identities=25% Similarity=0.299 Sum_probs=143.4
Q ss_pred hhhcccccccccCceeEEEEEe-CCCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCC-------
Q 039310 66 VTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLETQ------- 135 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~------- 135 (241)
.+|.+.+.||+|+||+||+|.. .++..||+|.+... +......+.+|+.++..++|+|++++...+...+
T Consensus 32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~ 111 (496)
T PTZ00283 32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV 111 (496)
T ss_pred CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence 4777888999999999999984 46889999987543 3455667889999999999999999988775432
Q ss_pred -cceEEEEecCCCCchHHhhc----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCC
Q 039310 136 -VPLLVYEFVGNGTLFEHIHK----NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFG 210 (241)
Q Consensus 136 -~~~lv~e~~~~g~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfg 210 (241)
..++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||
T Consensus 112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEecc
Confidence 36799999999999999864 246899999999999999999999998 9999999999999999999999999
Q ss_pred CcccccCCcc-ceeeeecccccccccccccC
Q 039310 211 ASKLVPIDAI-QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 211 la~~~~~~~~-~~~~~~~gt~~y~aPE~l~~ 240 (241)
+++....... .......||+.|+|||++.+
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~ 219 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRR 219 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCC
Confidence 9986543211 12234569999999999864
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=212.72 Aligned_cols=168 Identities=29% Similarity=0.368 Sum_probs=135.4
Q ss_pred hhcccccccccCceeEEEEEeC--CCCeEEEEecccCC--hhhHHHHHHHHHHHHcC---CCCCceeEEEEEec-----C
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP--DRTPVAVKKSKIVD--QTKIDEFINELVVVSQI---NRRNVVRLLACCLE-----T 134 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~--~~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l---~h~ni~~l~~~~~~-----~ 134 (241)
+|.+.+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.+ +||||+++++++.. .
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 3566778999999999999853 46789999765432 22334566787777765 69999999999853 4
Q ss_pred CcceEEEEecCCCCchHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCc
Q 039310 135 QVPLLVYEFVGNGTLFEHIHKN--GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGAS 212 (241)
Q Consensus 135 ~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla 212 (241)
...+++|||++ ++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||++
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLA 157 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccce
Confidence 56899999996 5899888653 35899999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCccceeeeecccccccccccccC
Q 039310 213 KLVPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 213 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
...... .......||+.|+|||.+.+
T Consensus 158 ~~~~~~--~~~~~~~~~~~y~aPE~~~~ 183 (290)
T cd07862 158 RIYSFQ--MALTSVVVTLWYRAPEVLLQ 183 (290)
T ss_pred EeccCC--cccccccccccccChHHHhC
Confidence 865433 22334458999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=208.97 Aligned_cols=171 Identities=25% Similarity=0.372 Sum_probs=142.4
Q ss_pred HhhhcccccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEec
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
..++.+.+.||+|+||.||+|...+...|++|.+..... ..+.+.+|+.+++.++||||+++++.+. .+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 456788889999999999999987777899998764332 3357889999999999999999999875 45679999999
Q ss_pred CCCCchHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccce
Q 039310 145 GNGTLFEHIHKN--GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQN 222 (241)
Q Consensus 145 ~~g~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~ 222 (241)
++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~ 159 (262)
T cd05071 83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 159 (262)
T ss_pred CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence 999999999753 35899999999999999999999998 9999999999999999999999999997664333222
Q ss_pred eeeecccccccccccccC
Q 039310 223 YTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 223 ~~~~~gt~~y~aPE~l~~ 240 (241)
.....++..|+|||++..
T Consensus 160 ~~~~~~~~~y~~PE~~~~ 177 (262)
T cd05071 160 RQGAKFPIKWTAPEAALY 177 (262)
T ss_pred ccCCcccceecCHhHhcc
Confidence 222346678999998753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-30 Score=207.25 Aligned_cols=170 Identities=25% Similarity=0.398 Sum_probs=144.5
Q ss_pred hcccccccccCceeEEEEEe-CCCCeEEEEecccCC-----hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEE
Q 039310 68 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVD-----QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVY 141 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~-----~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~ 141 (241)
+...+.||+|++|.||.|.. .++..+++|.+.... ......+.+|+.+++.++||||+++++++...+..++++
T Consensus 4 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 83 (263)
T cd06625 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFM 83 (263)
T ss_pred ccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEE
Confidence 55677899999999999985 458899999765422 223457889999999999999999999999999999999
Q ss_pred EecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc
Q 039310 142 EFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ 221 (241)
Q Consensus 142 e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~ 221 (241)
||+++++|.+.+...+.+++.....++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.........
T Consensus 84 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~ 160 (263)
T cd06625 84 EYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS 160 (263)
T ss_pred EECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence 99999999999988888999999999999999999999999 999999999999999999999999998765322211
Q ss_pred ee--eeecccccccccccccC
Q 039310 222 NY--TVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 222 ~~--~~~~gt~~y~aPE~l~~ 240 (241)
.. ....|++.|+|||.+.+
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~ 181 (263)
T cd06625 161 GTGMKSVTGTPYWMSPEVISG 181 (263)
T ss_pred cccccCCCcCccccCcceecc
Confidence 11 23457889999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=211.70 Aligned_cols=166 Identities=28% Similarity=0.377 Sum_probs=145.9
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
|.+.+.||+|+||.||++... +++.+|+|..... .......+.+|+++++.++||||+++++++...+..+++|||
T Consensus 3 y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (290)
T cd05580 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEY 82 (290)
T ss_pred eEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEec
Confidence 566788999999999999854 5788999976542 234456788999999999999999999999999999999999
Q ss_pred cCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcccee
Q 039310 144 VGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNY 223 (241)
Q Consensus 144 ~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~ 223 (241)
+++++|.+++.....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++...... .
T Consensus 83 ~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~----~ 155 (290)
T cd05580 83 VPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----T 155 (290)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC----C
Confidence 999999999988888999999999999999999999998 999999999999999999999999998876433 2
Q ss_pred eeecccccccccccccC
Q 039310 224 TVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 224 ~~~~gt~~y~aPE~l~~ 240 (241)
....|++.|+|||.+.+
T Consensus 156 ~~~~~~~~y~aPE~~~~ 172 (290)
T cd05580 156 YTLCGTPEYLAPEIILS 172 (290)
T ss_pred CCCCCCccccChhhhcC
Confidence 33458999999998754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=210.71 Aligned_cols=172 Identities=25% Similarity=0.400 Sum_probs=141.7
Q ss_pred hhhcccccccccCceeEEEEEe-----CCCCeEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFL-----PDRTPVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLL 139 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~l 139 (241)
..+.+.+.||+|+||.||+|.+ ..+..+++|..... .......+.+|+.+++.++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 3456678899999999999974 24578999987643 33445678899999999999999999999999999999
Q ss_pred EEEecCCCCchHHhhcC-----------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC
Q 039310 140 VYEFVGNGTLFEHIHKN-----------------GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENY 202 (241)
Q Consensus 140 v~e~~~~g~L~~~l~~~-----------------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~ 202 (241)
+|||+++++|.+++... ..+++.....++.|++.||.|||+++ ++|+||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 99999999999998532 24788899999999999999999998 99999999999999999
Q ss_pred CeEEccCCCcccccCCcc-ceeeeecccccccccccccC
Q 039310 203 TPKVSDFGASKLVPIDAI-QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 203 ~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~ 240 (241)
.+||+|||++........ .......++..|+|||++.+
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 200 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY 200 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhcc
Confidence 999999999976533221 11222335678999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-32 Score=231.62 Aligned_cols=169 Identities=24% Similarity=0.362 Sum_probs=144.4
Q ss_pred hhcccccccccCceeEEEEEeCCCCe-EEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecC
Q 039310 67 TNNYADVIGCGGSGNVYKGFLPDRTP-VAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVG 145 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~~~~~-vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~ 145 (241)
.|.+...||.|+||+||+|..++... .|.|.+........++++-|+++|+.++||+|+++++.|...+.+|++.|||.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 34455568999999999998765443 45676666777788999999999999999999999999999999999999999
Q ss_pred CCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceee
Q 039310 146 NGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYT 224 (241)
Q Consensus 146 ~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~ 224 (241)
||-...++..- ..+++.++.-++.|+++||.|||++. |||||||+.|||++.+|.++|+|||.+..... ......
T Consensus 113 GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~qkRD 188 (1187)
T KOG0579|consen 113 GGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQKRD 188 (1187)
T ss_pred CchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh-HHhhhc
Confidence 99888877554 46999999999999999999999999 99999999999999999999999998765421 223444
Q ss_pred eeccccccccccccc
Q 039310 225 VVQGTLGYIDPEYLQ 239 (241)
Q Consensus 225 ~~~gt~~y~aPE~l~ 239 (241)
.+.|||.|||||++.
T Consensus 189 sFIGTPYWMAPEVvm 203 (1187)
T KOG0579|consen 189 SFIGTPYWMAPEVVM 203 (1187)
T ss_pred cccCCcccccchhee
Confidence 567999999999974
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=209.17 Aligned_cols=164 Identities=26% Similarity=0.324 Sum_probs=133.7
Q ss_pred cccccCceeEEEEEeCC---CCeEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCCCC
Q 039310 73 VIGCGGSGNVYKGFLPD---RTPVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGT 148 (241)
Q Consensus 73 ~lg~G~~g~V~~~~~~~---~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~g~ 148 (241)
.||+|+||.||+|...+ ...+++|..... .......+.+|+.+++.++||||+++++.+...+..+++|||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997433 346788876543 23344678899999999999999999999999999999999999999
Q ss_pred chHHhhcCC-----CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccce-
Q 039310 149 LFEHIHKNG-----NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQN- 222 (241)
Q Consensus 149 L~~~l~~~~-----~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~- 222 (241)
|.+++.... ..++.....++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||++..........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 999997643 2467788899999999999999998 9999999999999999999999999987543322111
Q ss_pred eeeeccccccccccccc
Q 039310 223 YTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 223 ~~~~~gt~~y~aPE~l~ 239 (241)
.....+++.|+|||++.
T Consensus 159 ~~~~~~~~~y~aPE~~~ 175 (269)
T cd05042 159 KDCHAVPLRWLAPELVE 175 (269)
T ss_pred cCCCCCcccccCHHHHh
Confidence 12223567899999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=207.84 Aligned_cols=168 Identities=25% Similarity=0.358 Sum_probs=143.8
Q ss_pred hcccccccccCceeEEEEEeCC-CCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCC
Q 039310 68 NNYADVIGCGGSGNVYKGFLPD-RTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGN 146 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~ 146 (241)
|+..+.||+|+||.||+|.... +..+++|..........+.+.+|+++++.++|||++++++++...+..++++||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 4556779999999999998654 667788887665666677889999999999999999999999999999999999999
Q ss_pred CCchHHhhc-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeee
Q 039310 147 GTLFEHIHK-NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTV 225 (241)
Q Consensus 147 g~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~ 225 (241)
++|..++.. ..++++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~ 162 (282)
T cd06643 87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRDS 162 (282)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc-ccccc
Confidence 999988764 457999999999999999999999998 9999999999999999999999999987643221 22233
Q ss_pred eccccccccccccc
Q 039310 226 VQGTLGYIDPEYLQ 239 (241)
Q Consensus 226 ~~gt~~y~aPE~l~ 239 (241)
..+|+.|+|||++.
T Consensus 163 ~~~~~~y~aPE~~~ 176 (282)
T cd06643 163 FIGTPYWMAPEVVM 176 (282)
T ss_pred ccccccccCHhhcc
Confidence 45899999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-30 Score=207.61 Aligned_cols=164 Identities=27% Similarity=0.298 Sum_probs=135.5
Q ss_pred cccccCceeEEEEEeCC---CCeEEEEecccCC-hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCCCC
Q 039310 73 VIGCGGSGNVYKGFLPD---RTPVAVKKSKIVD-QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGT 148 (241)
Q Consensus 73 ~lg~G~~g~V~~~~~~~---~~~vavk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~g~ 148 (241)
.||+|+||.||+|.+.+ +..+++|++.... ......+.+|+.+++.++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 58999999999998543 4568899876543 2334578899999999999999999999999999999999999999
Q ss_pred chHHhhcCC-----CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccce-
Q 039310 149 LFEHIHKNG-----NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQN- 222 (241)
Q Consensus 149 L~~~l~~~~-----~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~- 222 (241)
|.+++.... ..++..+..++.|++.|++|||+.+ ++|+||||+||+++.++.++|+|||++..........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 999986432 4567788899999999999999998 9999999999999999999999999987543332211
Q ss_pred eeeeccccccccccccc
Q 039310 223 YTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 223 ~~~~~gt~~y~aPE~l~ 239 (241)
.....+++.|+|||++.
T Consensus 159 ~~~~~~~~~y~aPE~~~ 175 (269)
T cd05087 159 PDQLWVPLRWIAPELVD 175 (269)
T ss_pred CCCcCCcccccCHhHhc
Confidence 12234778999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=207.33 Aligned_cols=159 Identities=26% Similarity=0.401 Sum_probs=134.3
Q ss_pred ccccccCceeEEEEEeCCCC-----------eEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEE
Q 039310 72 DVIGCGGSGNVYKGFLPDRT-----------PVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLV 140 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~-----------~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv 140 (241)
+.||+|+||.||+|...+.. .+++|........ ...+.+|+.+++.++||||+++++++.. ...+++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 36899999999999865433 4677765543332 5788899999999999999999999988 778999
Q ss_pred EEecCCCCchHHhhcCC-CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC-------CeEEccCCCc
Q 039310 141 YEFVGNGTLFEHIHKNG-NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENY-------TPKVSDFGAS 212 (241)
Q Consensus 141 ~e~~~~g~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~-------~~kl~Dfgla 212 (241)
|||+++|+|.+++.... .+++..+..++.|++.||.|||+++ ++|+||||+||+++.++ .++|+|||++
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999998765 7899999999999999999999998 99999999999999887 7999999998
Q ss_pred ccccCCccceeeeecccccccccccccC
Q 039310 213 KLVPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 213 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
..... .....++..|+|||++..
T Consensus 156 ~~~~~-----~~~~~~~~~y~aPE~~~~ 178 (259)
T cd05037 156 ITVLS-----REERVERIPWIAPECIRN 178 (259)
T ss_pred ccccc-----ccccccCCCccChhhhcC
Confidence 86533 122346778999999764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-30 Score=209.36 Aligned_cols=172 Identities=24% Similarity=0.306 Sum_probs=144.0
Q ss_pred hhhcccccccccCceeEEEEEeC------CCCeEEEEecccCChh-hHHHHHHHHHHHHcCCCCCceeEEEEEecCCcce
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP------DRTPVAVKKSKIVDQT-KIDEFINELVVVSQINRRNVVRLLACCLETQVPL 138 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~ 138 (241)
..+...+.||.|+||.||+|+.. +...+++|........ ....+.+|+.+++.++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 34556678999999999999853 2456888876654333 4578899999999999999999999999999999
Q ss_pred EEEEecCCCCchHHhhcCC---------CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccC
Q 039310 139 LVYEFVGNGTLFEHIHKNG---------NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDF 209 (241)
Q Consensus 139 lv~e~~~~g~L~~~l~~~~---------~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Df 209 (241)
++|||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999997655 6899999999999999999999999 999999999999999999999999
Q ss_pred CCcccccCCccceeeeecccccccccccccC
Q 039310 210 GASKLVPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 210 gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
|++...............++..|+|||.+.+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~ 192 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQE 192 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhcc
Confidence 9987553333333333446788999998754
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-30 Score=205.22 Aligned_cols=166 Identities=30% Similarity=0.475 Sum_probs=138.1
Q ss_pred ccccccCceeEEEEEeC-CCCeEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCCCCc
Q 039310 72 DVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTL 149 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~g~L 149 (241)
+.||+|+||.||+|... +++.+|+|..... .......+.+|+++++.++||||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36899999999999864 6888999976543 334456789999999999999999999999999999999999999999
Q ss_pred hHHhhcCC-CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcccee-eeec
Q 039310 150 FEHIHKNG-NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNY-TVVQ 227 (241)
Q Consensus 150 ~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~-~~~~ 227 (241)
.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++........... ....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 99997543 6899999999999999999999998 99999999999999999999999999876532211111 1112
Q ss_pred ccccccccccccC
Q 039310 228 GTLGYIDPEYLQT 240 (241)
Q Consensus 228 gt~~y~aPE~l~~ 240 (241)
++..|+|||.+.+
T Consensus 158 ~~~~y~aPE~~~~ 170 (252)
T cd05084 158 IPVKWTAPEALNY 170 (252)
T ss_pred CceeecCchhhcC
Confidence 3457999998764
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-30 Score=210.86 Aligned_cols=168 Identities=30% Similarity=0.344 Sum_probs=141.0
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccCC---hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD---QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
+...+.||+|+||.||++... ++..+|+|.+.... ......+.+|+.+++.++|+|++.+++.+.+.+..+++|||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 345568999999999999854 57889999765422 22234577899999999999999999999999999999999
Q ss_pred cCCCCchHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc
Q 039310 144 VGNGTLFEHIHKN--GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ 221 (241)
Q Consensus 144 ~~~g~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~ 221 (241)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 156 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-- 156 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence 9999999988543 35899999999999999999999998 9999999999999999999999999987653322
Q ss_pred eeeeecccccccccccccC
Q 039310 222 NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~~ 240 (241)
......||+.|+|||++.+
T Consensus 157 ~~~~~~g~~~y~aPE~~~~ 175 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKN 175 (285)
T ss_pred cccCCCCCccccChHHHcC
Confidence 1223458999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=211.66 Aligned_cols=174 Identities=23% Similarity=0.349 Sum_probs=142.0
Q ss_pred HHhhhcccccccccCceeEEEEEeCC---------------CCeEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeE
Q 039310 64 KTVTNNYADVIGCGGSGNVYKGFLPD---------------RTPVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRL 127 (241)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~~---------------~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l 127 (241)
...++.+.+.||+|+||.||++...+ ...||+|..... .......+.+|+++++.++|||++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 34567788899999999999987532 224889987653 33445678999999999999999999
Q ss_pred EEEEecCCcceEEEEecCCCCchHHhhcCC------------CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCC
Q 039310 128 LACCLETQVPLLVYEFVGNGTLFEHIHKNG------------NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSAN 195 (241)
Q Consensus 128 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~N 195 (241)
++++...+..+++|||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+|
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~N 159 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRN 159 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhh
Confidence 999999999999999999999999986432 3688899999999999999999998 9999999999
Q ss_pred eeeCCCCCeEEccCCCcccccCCccce-eeeecccccccccccccC
Q 039310 196 ILLDENYTPKVSDFGASKLVPIDAIQN-YTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 196 ili~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~ 240 (241)
|++++++.+||+|||++.......... .....+++.|+|||++.+
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 205 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL 205 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhcc
Confidence 999999999999999987653322211 122235678999998754
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=209.77 Aligned_cols=160 Identities=25% Similarity=0.336 Sum_probs=132.9
Q ss_pred cccccCceeEEEEEeCC-------------------------CCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeE
Q 039310 73 VIGCGGSGNVYKGFLPD-------------------------RTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRL 127 (241)
Q Consensus 73 ~lg~G~~g~V~~~~~~~-------------------------~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l 127 (241)
.||+|+||.||+|.+.. ...|++|.+..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999997421 13478887765544455678899999999999999999
Q ss_pred EEEEecCCcceEEEEecCCCCchHHhhc-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC----
Q 039310 128 LACCLETQVPLLVYEFVGNGTLFEHIHK-NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENY---- 202 (241)
Q Consensus 128 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~---- 202 (241)
++++.+.+..++||||+++|+|..++.. .+.+++..+..++.|++.||+|||+++ ++||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999865 457899999999999999999999998 99999999999997543
Q ss_pred ---CeEEccCCCcccccCCccceeeeecccccccccccccC
Q 039310 203 ---TPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 203 ---~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
.++++|||++...... ....++..|+|||.+.+
T Consensus 159 ~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~ 194 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPG 194 (274)
T ss_pred ccceeeecCCccccccccc-----cccccCCcccCchhhcC
Confidence 3899999987654221 12247788999998754
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-30 Score=219.46 Aligned_cols=179 Identities=23% Similarity=0.348 Sum_probs=145.4
Q ss_pred CHHHHHHhhhcccccccccCceeEEEEEeC------CCCeEEEEecccCC-hhhHHHHHHHHHHHHcCC-CCCceeEEEE
Q 039310 59 IEEEIKTVTNNYADVIGCGGSGNVYKGFLP------DRTPVAVKKSKIVD-QTKIDEFINELVVVSQIN-RRNVVRLLAC 130 (241)
Q Consensus 59 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavk~~~~~~-~~~~~~~~~E~~~l~~l~-h~ni~~l~~~ 130 (241)
...++....+.+.+.||+|+||.||+|.+. .+..||+|++.... ....+.+.+|+.++..+. ||||++++++
T Consensus 30 ~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~ 109 (401)
T cd05107 30 SAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGA 109 (401)
T ss_pred CcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence 345566667777889999999999999853 24579999887542 333457889999999997 9999999999
Q ss_pred EecCCcceEEEEecCCCCchHHhhcCC-----------------------------------------------------
Q 039310 131 CLETQVPLLVYEFVGNGTLFEHIHKNG----------------------------------------------------- 157 (241)
Q Consensus 131 ~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------- 157 (241)
+...+..++||||+++|+|.++++.++
T Consensus 110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 999999999999999999999986431
Q ss_pred ---------------------------------------------CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCC
Q 039310 158 ---------------------------------------------NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVK 192 (241)
Q Consensus 158 ---------------------------------------------~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk 192 (241)
.+++..+..++.|++.||.|||+.+ ++|||||
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlk 266 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLA 266 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCC
Confidence 2567778899999999999999988 9999999
Q ss_pred CCCeeeCCCCCeEEccCCCcccccCCcc-ceeeeecccccccccccccC
Q 039310 193 SANILLDENYTPKVSDFGASKLVPIDAI-QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 193 ~~Nili~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~ 240 (241)
|+|||+++++.++|+|||++........ .......+++.|||||.+.+
T Consensus 267 p~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 315 (401)
T cd05107 267 ARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN 315 (401)
T ss_pred cceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC
Confidence 9999999999999999999986532221 11122346788999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=226.96 Aligned_cols=178 Identities=28% Similarity=0.419 Sum_probs=154.3
Q ss_pred cCHHHHHHhhhcccccccccCceeEEEEEeCC-CCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCc
Q 039310 58 FIEEEIKTVTNNYADVIGCGGSGNVYKGFLPD-RTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQV 136 (241)
Q Consensus 58 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~ 136 (241)
...++++.....+-..||-|-||.||.|.|+. ...||||.++.. .-..++|+.|..+|+.++|||+|+|+|+|.....
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 45667777777777799999999999999875 678999988854 4456899999999999999999999999999999
Q ss_pred ceEEEEecCCCCchHHhhcCCC--CCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCccc
Q 039310 137 PLLVYEFVGNGTLFEHIHKNGN--LTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKL 214 (241)
Q Consensus 137 ~~lv~e~~~~g~L~~~l~~~~~--l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~ 214 (241)
.|||+|||..|+|.+||++..+ ++.--++.++.||..||+||..++ +|||||.++|+|+.++..+|++||||++.
T Consensus 338 FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhh
Confidence 9999999999999999987653 677778899999999999999999 99999999999999999999999999999
Q ss_pred ccCCccceeeeeccccccccccccc
Q 039310 215 VPIDAIQNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 215 ~~~~~~~~~~~~~gt~~y~aPE~l~ 239 (241)
+..+.+.......-...|.|||.|.
T Consensus 415 MtgDTYTAHAGAKFPIKWTAPEsLA 439 (1157)
T KOG4278|consen 415 MTGDTYTAHAGAKFPIKWTAPESLA 439 (1157)
T ss_pred hcCCceecccCccCcccccCccccc
Confidence 9766544333223357899999874
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-30 Score=208.99 Aligned_cols=171 Identities=25% Similarity=0.384 Sum_probs=142.1
Q ss_pred hhcccccccccCceeEEEEEeC-----CCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEec--CCcceE
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP-----DRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLE--TQVPLL 139 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~--~~~~~l 139 (241)
.+.+.+.||+|+||.||+|... ++..|++|.+........+.+.+|+.+++.++||||+++++++.. ....++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 84 (284)
T cd05081 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRL 84 (284)
T ss_pred cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEE
Confidence 4566788999999999999742 477899999877666667789999999999999999999998754 346789
Q ss_pred EEEecCCCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCC
Q 039310 140 VYEFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPID 218 (241)
Q Consensus 140 v~e~~~~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~ 218 (241)
++||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++......
T Consensus 85 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 161 (284)
T cd05081 85 VMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLPQD 161 (284)
T ss_pred EEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence 99999999999999754 46899999999999999999999998 999999999999999999999999999876433
Q ss_pred ccceee--eecccccccccccccC
Q 039310 219 AIQNYT--VVQGTLGYIDPEYLQT 240 (241)
Q Consensus 219 ~~~~~~--~~~gt~~y~aPE~l~~ 240 (241)
...... ...++..|+|||.+.+
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~ 185 (284)
T cd05081 162 KEYYKVREPGESPIFWYAPESLTE 185 (284)
T ss_pred CcceeecCCCCCceEeeCHHHhcc
Confidence 221111 1123456999998754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-30 Score=206.96 Aligned_cols=173 Identities=25% Similarity=0.423 Sum_probs=145.0
Q ss_pred HHHhhhcccccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEE
Q 039310 63 IKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYE 142 (241)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e 142 (241)
+....+.+.+.||+|+||.||+|...++..+|+|....... ...++.+|+.+++.++|||++++++++. .+..+++||
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 44567788889999999999999988889999998764332 3467889999999999999999998864 557899999
Q ss_pred ecCCCCchHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcc
Q 039310 143 FVGNGTLFEHIHKN--GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAI 220 (241)
Q Consensus 143 ~~~~g~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~ 220 (241)
|+++++|.+++... ..+++.++..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 81 YMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 99999999998653 36899999999999999999999998 99999999999999999999999999876643322
Q ss_pred ceeeeecccccccccccccC
Q 039310 221 QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 221 ~~~~~~~gt~~y~aPE~l~~ 240 (241)
.......++..|+|||++..
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~ 177 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINY 177 (260)
T ss_pred ccccCCcccccccCHHHhcc
Confidence 22223345678999998753
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=207.59 Aligned_cols=174 Identities=27% Similarity=0.430 Sum_probs=147.1
Q ss_pred HHHhhhcccccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEE
Q 039310 63 IKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYE 142 (241)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e 142 (241)
+....+.+.+.||+|+||.||+|..+++..+++|.+.... ....++.+|+.+++.++|||++++++++......+++||
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 3445667788999999999999998788889999876433 234678899999999999999999999999899999999
Q ss_pred ecCCCCchHHhhcCC--CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcc
Q 039310 143 FVGNGTLFEHIHKNG--NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAI 220 (241)
Q Consensus 143 ~~~~g~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~ 220 (241)
|+++++|.+++.... .+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++++|||++.....+..
T Consensus 82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 999999999997643 6899999999999999999999998 99999999999999999999999999887643322
Q ss_pred ceeeeecccccccccccccC
Q 039310 221 QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 221 ~~~~~~~gt~~y~aPE~l~~ 240 (241)
.......++..|+|||.+.+
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~ 178 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANY 178 (261)
T ss_pred hhhhccCCCccccCHHHhcc
Confidence 22222234678999998754
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=211.19 Aligned_cols=167 Identities=26% Similarity=0.317 Sum_probs=143.1
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecC
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVG 145 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~ 145 (241)
+.+.+.||+|+||.||++... ++..+++|..... ......++.+|+++++.++||||+++++++..++..+++|||++
T Consensus 3 ~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~ 82 (308)
T cd06615 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMD 82 (308)
T ss_pred ceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccC
Confidence 456678999999999999854 5677888876543 33345678899999999999999999999999999999999999
Q ss_pred CCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceee
Q 039310 146 NGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHS-ETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYT 224 (241)
Q Consensus 146 ~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~ 224 (241)
+++|.+++...+.+++..+..++.|++.||.|||+ .+ ++|+||+|+|||+++++.++|+|||++....... ..
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---~~ 156 (308)
T cd06615 83 GGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---AN 156 (308)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccccc---cc
Confidence 99999999888889999999999999999999997 46 9999999999999999999999999987653221 22
Q ss_pred eecccccccccccccC
Q 039310 225 VVQGTLGYIDPEYLQT 240 (241)
Q Consensus 225 ~~~gt~~y~aPE~l~~ 240 (241)
...|++.|+|||.+.+
T Consensus 157 ~~~~~~~~~aPE~~~~ 172 (308)
T cd06615 157 SFVGTRSYMSPERLQG 172 (308)
T ss_pred cCCCCcCccChhHhcC
Confidence 3458899999998754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-30 Score=207.09 Aligned_cols=171 Identities=24% Similarity=0.383 Sum_probs=142.2
Q ss_pred HhhhcccccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEec
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
...+.+.+.||+|+||.||+|...++..+++|....... ..+.+.+|+.+++.++|||++++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 345677889999999999999988888899998765333 3467889999999999999999999875 45678999999
Q ss_pred CCCCchHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccce
Q 039310 145 GNGTLFEHIHKN--GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQN 222 (241)
Q Consensus 145 ~~g~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~ 222 (241)
++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence 999999999753 35899999999999999999999998 9999999999999999999999999998664332222
Q ss_pred eeeecccccccccccccC
Q 039310 223 YTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 223 ~~~~~gt~~y~aPE~l~~ 240 (241)
.....++..|+|||.+.+
T Consensus 160 ~~~~~~~~~y~aPE~~~~ 177 (260)
T cd05070 160 RQGAKFPIKWTAPEAALY 177 (260)
T ss_pred ccCCCCCccccChHHHhc
Confidence 222235668999998643
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=206.39 Aligned_cols=172 Identities=28% Similarity=0.437 Sum_probs=142.7
Q ss_pred hhhcccccccccCceeEEEEEeC-C---CCeEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-D---RTPVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLV 140 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~---~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv 140 (241)
.++.+.+.||+|+||.||+|... + +..+++|.+... .....+.+.+|+.+++.++||||+++++++...+..+++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 45667789999999999999853 2 336889987643 234456889999999999999999999999999999999
Q ss_pred EEecCCCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCc
Q 039310 141 YEFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDA 219 (241)
Q Consensus 141 ~e~~~~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~ 219 (241)
|||+++++|.+++... +.+++.++..++.|++.|+.|||+.+ ++|+||||+||++++++.++++|||++.......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999999999764 46899999999999999999999999 9999999999999999999999999998765432
Q ss_pred cceeee--ecccccccccccccC
Q 039310 220 IQNYTV--VQGTLGYIDPEYLQT 240 (241)
Q Consensus 220 ~~~~~~--~~gt~~y~aPE~l~~ 240 (241)
...... ..++..|+|||.+.+
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~ 183 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAY 183 (267)
T ss_pred ceeeecCCCccceeecCHhHhcc
Confidence 221111 123568999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=213.31 Aligned_cols=169 Identities=23% Similarity=0.333 Sum_probs=140.1
Q ss_pred hhcccccccccCceeEEEEEeC-CCCeEEEEecccCC-hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEec
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD-QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
.|...+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++||||+++++++..++..+++|||+
T Consensus 7 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 86 (309)
T cd07872 7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL 86 (309)
T ss_pred ceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCC
Confidence 3566778999999999999854 57789999876432 223346778999999999999999999999999999999999
Q ss_pred CCCCchHHhhcCC-CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcccee
Q 039310 145 GNGTLFEHIHKNG-NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNY 223 (241)
Q Consensus 145 ~~g~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~ 223 (241)
++ +|.+++...+ .+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++........ ..
T Consensus 87 ~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~ 161 (309)
T cd07872 87 DK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-TY 161 (309)
T ss_pred CC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc-cc
Confidence 75 8888876543 5899999999999999999999998 99999999999999999999999999876432221 12
Q ss_pred eeecccccccccccccC
Q 039310 224 TVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 224 ~~~~gt~~y~aPE~l~~ 240 (241)
....+|+.|+|||++.+
T Consensus 162 ~~~~~~~~y~aPE~~~~ 178 (309)
T cd07872 162 SNEVVTLWYRPPDVLLG 178 (309)
T ss_pred ccccccccccCCHHHhC
Confidence 23357899999998753
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=209.26 Aligned_cols=172 Identities=24% Similarity=0.363 Sum_probs=143.8
Q ss_pred hhhcccccccccCceeEEEEEeC------CCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP------DRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLL 139 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~l 139 (241)
..+.+.+.||+|+||.||+|... ++..+++|..........+.+.+|+.+++.++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 34566778999999999999742 345688888776666566788999999999999999999999999999999
Q ss_pred EEEecCCCCchHHhhcCC----------------CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCC
Q 039310 140 VYEFVGNGTLFEHIHKNG----------------NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYT 203 (241)
Q Consensus 140 v~e~~~~g~L~~~l~~~~----------------~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~ 203 (241)
||||+++++|.+++...+ .+++..+..++.|++.|+.|||+.+ ++||||||+||++++++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999996532 3789999999999999999999999 999999999999999999
Q ss_pred eEEccCCCcccccCCcc-ceeeeecccccccccccccC
Q 039310 204 PKVSDFGASKLVPIDAI-QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 204 ~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~ 240 (241)
++|+|||++........ .......+++.|+|||.+.+
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 199 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY 199 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhcc
Confidence 99999999876533221 11222346789999998753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=222.29 Aligned_cols=174 Identities=26% Similarity=0.448 Sum_probs=148.6
Q ss_pred HHHHhhhcccccccccCceeEEEEEeCC---C--CeEEEEeccc-CChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCC
Q 039310 62 EIKTVTNNYADVIGCGGSGNVYKGFLPD---R--TPVAVKKSKI-VDQTKIDEFINELVVVSQINRRNVVRLLACCLETQ 135 (241)
Q Consensus 62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~---~--~~vavk~~~~-~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 135 (241)
++......+.+.||.|-||.||+|.+.+ | -.||||.-+. ......+.|+.|.-+|++++||||++++|.|.+.
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~- 463 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ- 463 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-
Confidence 3444455567789999999999998533 2 3578886443 4455678999999999999999999999999764
Q ss_pred cceEEEEecCCCCchHHhhcCC-CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCccc
Q 039310 136 VPLLVYEFVGNGTLFEHIHKNG-NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKL 214 (241)
Q Consensus 136 ~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~ 214 (241)
..|+|||.++.|.|..||..++ .++......++.|++.||.|||+.+ +|||||.++|||+.+...+|++|||+++.
T Consensus 464 P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRY 540 (974)
T ss_pred ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhh
Confidence 6699999999999999998765 6999999999999999999999999 99999999999999999999999999999
Q ss_pred ccCCccceeeeeccccccccccccc
Q 039310 215 VPIDAIQNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 215 ~~~~~~~~~~~~~gt~~y~aPE~l~ 239 (241)
+..+.+++.....-...|||||.+.
T Consensus 541 ~ed~~yYkaS~~kLPIKWmaPESIN 565 (974)
T KOG4257|consen 541 LEDDAYYKASRGKLPIKWMAPESIN 565 (974)
T ss_pred ccccchhhccccccceeecCccccc
Confidence 9888877766555567899999874
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=204.76 Aligned_cols=166 Identities=34% Similarity=0.498 Sum_probs=143.4
Q ss_pred ccccccCceeEEEEEeCC----CCeEEEEecccCChh-hHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCC
Q 039310 72 DVIGCGGSGNVYKGFLPD----RTPVAVKKSKIVDQT-KIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGN 146 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~----~~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~ 146 (241)
+.||+|+||.||+|.... +..+++|........ ..+.+.+|+..++.++|+|++++++++......+++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 368999999999998653 778999987764433 367889999999999999999999999999999999999999
Q ss_pred CCchHHhhcC---------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccC
Q 039310 147 GTLFEHIHKN---------GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPI 217 (241)
Q Consensus 147 g~L~~~l~~~---------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~ 217 (241)
++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999875 67999999999999999999999998 99999999999999999999999999987654
Q ss_pred Ccc-ceeeeecccccccccccccC
Q 039310 218 DAI-QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 218 ~~~-~~~~~~~gt~~y~aPE~l~~ 240 (241)
... .......+++.|+|||.+.+
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~ 181 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKD 181 (262)
T ss_pred ccccccccCCCcCccccCHHHhcc
Confidence 321 12233447889999998764
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=205.41 Aligned_cols=171 Identities=25% Similarity=0.386 Sum_probs=141.4
Q ss_pred HhhhcccccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEec
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
..++.+.+.||+|++|.||+|...++..+++|...... ...+.+.+|+.+++.++|||++++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 34577788999999999999998777789999766433 23467889999999999999999998875 45678999999
Q ss_pred CCCCchHHhhcCC--CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccce
Q 039310 145 GNGTLFEHIHKNG--NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQN 222 (241)
Q Consensus 145 ~~g~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~ 222 (241)
++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 83 GKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence 9999999997543 4889999999999999999999998 9999999999999999999999999997654332222
Q ss_pred eeeecccccccccccccC
Q 039310 223 YTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 223 ~~~~~gt~~y~aPE~l~~ 240 (241)
.....++..|+|||.+.+
T Consensus 160 ~~~~~~~~~y~~Pe~~~~ 177 (260)
T cd05069 160 RQGAKFPIKWTAPEAALY 177 (260)
T ss_pred cCCCccchhhCCHHHhcc
Confidence 222336678999998753
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=213.91 Aligned_cols=191 Identities=25% Similarity=0.320 Sum_probs=156.1
Q ss_pred hCCCCccccccCHHHHHHhhhcccccccccCceeEEEEE-eCCCCeEEEEecccC---C----hhhHHHHHHHHHHHHcC
Q 039310 48 QGRSSEKAKIFIEEEIKTVTNNYADVIGCGGSGNVYKGF-LPDRTPVAVKKSKIV---D----QTKIDEFINELVVVSQI 119 (241)
Q Consensus 48 ~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavk~~~~~---~----~~~~~~~~~E~~~l~~l 119 (241)
.....+....|.+-.....+|-+..+||+|+|+.||+|. ......||+|.-... . ....+...+|.++-+.+
T Consensus 445 KRi~NEdnSQFkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeL 524 (775)
T KOG1151|consen 445 KRIHNEDNSQFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKEL 524 (775)
T ss_pred HhhcccchhhhccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhcc
Confidence 333444555666666667778888899999999999998 445777888853321 1 11234678999999999
Q ss_pred CCCCceeEEEEEe-cCCcceEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee
Q 039310 120 NRRNVVRLLACCL-ETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILL 198 (241)
Q Consensus 120 ~h~ni~~l~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili 198 (241)
+||.||++|+++. +.+..|-|+|||+|.+|.-||+.+..+++++++.|+.||+.||.||.+.. +||||-||||.|||+
T Consensus 525 DHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILL 603 (775)
T KOG1151|consen 525 DHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILL 603 (775)
T ss_pred CcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEE
Confidence 9999999999986 56678899999999999999999999999999999999999999999874 789999999999999
Q ss_pred C---CCCCeEEccCCCcccccCCccc------eeeeeccccccccccccc
Q 039310 199 D---ENYTPKVSDFGASKLVPIDAIQ------NYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 199 ~---~~~~~kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~l~ 239 (241)
- ..|.+||+||||++++..++.. .+....||.+|++||.+-
T Consensus 604 v~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFv 653 (775)
T KOG1151|consen 604 VNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFV 653 (775)
T ss_pred ecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceee
Confidence 5 4578999999999998655433 345567999999999763
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-31 Score=225.93 Aligned_cols=165 Identities=28% Similarity=0.377 Sum_probs=145.9
Q ss_pred cccccCceeEEEEEeC-CCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCCCCchH
Q 039310 73 VIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFE 151 (241)
Q Consensus 73 ~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~g~L~~ 151 (241)
+||+|.||+||-|+.. ++..+|||.+...+....+-+..|+.+-++++|.|||++.|++..++..-+.||-.+||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 7999999999999954 466789999888777777888999999999999999999999999999999999999999999
Q ss_pred Hhhc-CCCC--CHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC-CCCCeEEccCCCcccccCCccceeeeec
Q 039310 152 HIHK-NGNL--TWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLD-ENYTPKVSDFGASKLVPIDAIQNYTVVQ 227 (241)
Q Consensus 152 ~l~~-~~~l--~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 227 (241)
+++. .+++ ++.+.-.+..||++||.|||+.. |||||||-+|+||+ -.|.+||+|||-++.+..- ...+-++.
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~TETFT 737 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPCTETFT 737 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC-Cccccccc
Confidence 9975 4677 88889999999999999999999 99999999999997 4789999999998877432 23344566
Q ss_pred ccccccccccccCC
Q 039310 228 GTLGYIDPEYLQTC 241 (241)
Q Consensus 228 gt~~y~aPE~l~~~ 241 (241)
||+-|||||++.+|
T Consensus 738 GTLQYMAPEvIDqG 751 (1226)
T KOG4279|consen 738 GTLQYMAPEVIDQG 751 (1226)
T ss_pred cchhhhChHhhccC
Confidence 99999999999876
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=208.68 Aligned_cols=175 Identities=26% Similarity=0.358 Sum_probs=141.9
Q ss_pred HHHhhhcccccccccCceeEEEEEeC------CCCeEEEEecccCC-hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCC
Q 039310 63 IKTVTNNYADVIGCGGSGNVYKGFLP------DRTPVAVKKSKIVD-QTKIDEFINELVVVSQINRRNVVRLLACCLETQ 135 (241)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 135 (241)
+...++.+.+.||+|+||.||+|..+ .+..||+|...... ......+.+|+.+++.++||||+++++++.+.+
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 34567778889999999999999743 24578999765433 233456789999999999999999999999999
Q ss_pred cceEEEEecCCCCchHHhhcC----------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeE
Q 039310 136 VPLLVYEFVGNGTLFEHIHKN----------GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPK 205 (241)
Q Consensus 136 ~~~lv~e~~~~g~L~~~l~~~----------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~k 205 (241)
..+++|||+++|+|.+++... ...+...+..++.|++.||.|||+.+ ++||||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEE
Confidence 999999999999999999642 23567788999999999999999998 99999999999999999999
Q ss_pred EccCCCcccccCCccce-eeeecccccccccccccC
Q 039310 206 VSDFGASKLVPIDAIQN-YTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 206 l~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~ 240 (241)
|+|||+++......... .....++..|+|||.+.+
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~ 195 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD 195 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhcc
Confidence 99999988653322211 111235678999998764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=210.82 Aligned_cols=176 Identities=24% Similarity=0.351 Sum_probs=144.0
Q ss_pred HHHHhhhcccccccccCceeEEEEEeCC--------CCeEEEEecccC-ChhhHHHHHHHHHHHHcC-CCCCceeEEEEE
Q 039310 62 EIKTVTNNYADVIGCGGSGNVYKGFLPD--------RTPVAVKKSKIV-DQTKIDEFINELVVVSQI-NRRNVVRLLACC 131 (241)
Q Consensus 62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~--------~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~ 131 (241)
++....+.+.+.||+|+||.||+|...+ ...+|+|..... .......+.+|+.+++.+ +||||+++++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 4445678889999999999999997422 346899987653 234456788999999999 799999999999
Q ss_pred ecCCcceEEEEecCCCCchHHhhcC----------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCC
Q 039310 132 LETQVPLLVYEFVGNGTLFEHIHKN----------------GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSAN 195 (241)
Q Consensus 132 ~~~~~~~lv~e~~~~g~L~~~l~~~----------------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~N 195 (241)
...+..+++|||+++++|.+++... ..+++.++..++.|++.||+|||+.+ ++||||||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~N 170 (307)
T cd05098 94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARN 170 (307)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHh
Confidence 9999999999999999999999753 24889999999999999999999998 9999999999
Q ss_pred eeeCCCCCeEEccCCCcccccCCccc-eeeeecccccccccccccC
Q 039310 196 ILLDENYTPKVSDFGASKLVPIDAIQ-NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 196 ili~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~ 240 (241)
|++++++.++|+|||++......... ......+++.|||||++.+
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 216 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD 216 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhcc
Confidence 99999999999999998765322211 1112224578999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=205.75 Aligned_cols=170 Identities=24% Similarity=0.421 Sum_probs=144.7
Q ss_pred hcccccccccCceeEEEEEeCCCCeEEEEecccCC------hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEE
Q 039310 68 NNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVD------QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVY 141 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~------~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~ 141 (241)
|...+.||+|+||.||+|...++..+|+|.+.... ......+.+|+++++.++|+||+++++++.+.+..++++
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM 81 (265)
T ss_pred ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence 45667899999999999998788899999765321 223456889999999999999999999999999999999
Q ss_pred EecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCc--
Q 039310 142 EFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDA-- 219 (241)
Q Consensus 142 e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~-- 219 (241)
||+++++|.+++....++++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 158 (265)
T cd06631 82 EFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH 158 (265)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence 99999999999988778999999999999999999999998 9999999999999999999999999987642211
Q ss_pred ---cceeeeecccccccccccccC
Q 039310 220 ---IQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 220 ---~~~~~~~~gt~~y~aPE~l~~ 240 (241)
........|++.|+|||++.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~pe~~~~ 182 (265)
T cd06631 159 GTHSNMLKSMHGTPYWMAPEVINE 182 (265)
T ss_pred ccccccccccCCCccccChhhhcC
Confidence 111223458899999998754
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=207.46 Aligned_cols=169 Identities=25% Similarity=0.341 Sum_probs=147.0
Q ss_pred hhcccccccccCceeEEEEEeC-CCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecC
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVG 145 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~ 145 (241)
.|.+.+.||+|+||.||+|... ++..+++|..........+.+.+|+.+++.++||||+++++.+..++..++||||++
T Consensus 6 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (280)
T cd06611 6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCD 85 (280)
T ss_pred HHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccC
Confidence 4666778999999999999864 578899998876666677789999999999999999999999999999999999999
Q ss_pred CCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceee
Q 039310 146 NGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYT 224 (241)
Q Consensus 146 ~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~ 224 (241)
+++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 86 ~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~ 161 (280)
T cd06611 86 GGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-KRD 161 (280)
T ss_pred CCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc-ccc
Confidence 99999998764 46999999999999999999999999 99999999999999999999999999876532221 223
Q ss_pred eeccccccccccccc
Q 039310 225 VVQGTLGYIDPEYLQ 239 (241)
Q Consensus 225 ~~~gt~~y~aPE~l~ 239 (241)
...+|+.|+|||.+.
T Consensus 162 ~~~~~~~y~~PE~~~ 176 (280)
T cd06611 162 TFIGTPYWMAPEVVA 176 (280)
T ss_pred eeecchhhcCHHHHh
Confidence 345899999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=206.06 Aligned_cols=170 Identities=25% Similarity=0.401 Sum_probs=143.3
Q ss_pred hhcccccccccCceeEEEEEeC-CCCeEEEEeccc---CChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEE
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKI---VDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYE 142 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~---~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e 142 (241)
.+.+.+.||+|+||.||+|... ++..||+|.... .+......+.+|+.+++.++||||+++++++.+.+..++++|
T Consensus 3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08228 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEE
Confidence 3566788999999999999854 688999997653 234445678899999999999999999999999999999999
Q ss_pred ecCCCCchHHhhc----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCC
Q 039310 143 FVGNGTLFEHIHK----NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPID 218 (241)
Q Consensus 143 ~~~~g~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~ 218 (241)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 83 LADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 9999999988752 335899999999999999999999998 999999999999999999999999998876433
Q ss_pred ccceeeeecccccccccccccC
Q 039310 219 AIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 219 ~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
.. ......|++.|+|||.+.+
T Consensus 160 ~~-~~~~~~~~~~~~aPE~~~~ 180 (267)
T cd08228 160 TT-AAHSLVGTPYYMSPERIHE 180 (267)
T ss_pred hH-HHhcCCCCccccChhhhcc
Confidence 22 1223358889999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=206.19 Aligned_cols=170 Identities=27% Similarity=0.450 Sum_probs=143.5
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccCCh---------hhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcc
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQ---------TKIDEFINELVVVSQINRRNVVRLLACCLETQVP 137 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~---------~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~ 137 (241)
|.+...||+|++|.||+|... ++..+++|....... ...+.+.+|+.+++.++||||+++++++...+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 556778999999999999854 578899997653221 1235688999999999999999999999999999
Q ss_pred eEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccC
Q 039310 138 LLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPI 217 (241)
Q Consensus 138 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~ 217 (241)
+++|||+++++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred EEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 999999999999999988888999999999999999999999998 99999999999999999999999999887642
Q ss_pred Cccc-----eeeeecccccccccccccC
Q 039310 218 DAIQ-----NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 218 ~~~~-----~~~~~~gt~~y~aPE~l~~ 240 (241)
.... ......|++.|+|||.+.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~ 186 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQ 186 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhcc
Confidence 2111 1122347899999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=205.86 Aligned_cols=173 Identities=21% Similarity=0.392 Sum_probs=144.6
Q ss_pred HHHhhhcccccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEE
Q 039310 63 IKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYE 142 (241)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e 142 (241)
+...++.+.+.||+|+||.||+|...++..+++|..... ....+.+.+|+.+++.++|+||+++++.+.. ...+++||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 445667788899999999999999777788999977643 3345678899999999999999999999887 77899999
Q ss_pred ecCCCCchHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcc
Q 039310 143 FVGNGTLFEHIHKN--GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAI 220 (241)
Q Consensus 143 ~~~~g~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~ 220 (241)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 81 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred eCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 99999999999753 35788999999999999999999998 99999999999999999999999999876543322
Q ss_pred ceeeeecccccccccccccC
Q 039310 221 QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 221 ~~~~~~~gt~~y~aPE~l~~ 240 (241)
.......++..|+|||++..
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~ 177 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINF 177 (260)
T ss_pred ccccCCcccccccCHhHhcc
Confidence 22222335678999998754
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-30 Score=212.39 Aligned_cols=164 Identities=24% Similarity=0.320 Sum_probs=131.6
Q ss_pred cccccccCceeEEEEEeC---CCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEec--CCcceEEEEecC
Q 039310 71 ADVIGCGGSGNVYKGFLP---DRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLE--TQVPLLVYEFVG 145 (241)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~---~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~--~~~~~lv~e~~~ 145 (241)
+..||+|+||.||+|... ++..+|+|.+.... ....+.+|+.+++.++||||+++++++.. ....++++||++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 347999999999999854 45789999875432 22456789999999999999999999864 456789999995
Q ss_pred CCCchHHhhcC---------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee----CCCCCeEEccCCCc
Q 039310 146 NGTLFEHIHKN---------GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILL----DENYTPKVSDFGAS 212 (241)
Q Consensus 146 ~g~L~~~l~~~---------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili----~~~~~~kl~Dfgla 212 (241)
++|.+++... ..+++..+..++.|++.||.|||+++ ++||||||+|||+ +.++.+||+|||+|
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 4888877532 24899999999999999999999999 9999999999999 45678999999999
Q ss_pred ccccCCcc--ceeeeecccccccccccccC
Q 039310 213 KLVPIDAI--QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 213 ~~~~~~~~--~~~~~~~gt~~y~aPE~l~~ 240 (241)
+....... .......||+.|+|||++.+
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 189 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLG 189 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcC
Confidence 87543221 12233568999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=209.10 Aligned_cols=172 Identities=25% Similarity=0.369 Sum_probs=143.8
Q ss_pred hhhcccccccccCceeEEEEEeCC-----------------CCeEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLPD-----------------RTPVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRL 127 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l 127 (241)
..+.+.+.||+|+||.||+|.... +..||+|.+... .....+.+.+|+++++.++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 456778899999999999987542 245788986643 33456788999999999999999999
Q ss_pred EEEEecCCcceEEEEecCCCCchHHhhcCC-----------CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCe
Q 039310 128 LACCLETQVPLLVYEFVGNGTLFEHIHKNG-----------NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANI 196 (241)
Q Consensus 128 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Ni 196 (241)
++++..++..+++||++++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhce
Confidence 999999999999999999999999997655 6899999999999999999999998 99999999999
Q ss_pred eeCCCCCeEEccCCCcccccCCccc-eeeeecccccccccccccC
Q 039310 197 LLDENYTPKVSDFGASKLVPIDAIQ-NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 197 li~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~ 240 (241)
++++++.++|+|||++......... ......+++.|||||.+.+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 206 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL 206 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhc
Confidence 9999999999999998765333221 1222346778999998754
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=204.57 Aligned_cols=168 Identities=28% Similarity=0.409 Sum_probs=145.6
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccCC-----hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEE
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD-----QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVY 141 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~-----~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~ 141 (241)
|...+.||+|++|.||+|... ++..|++|.+.... ....+.+.+|+.+++.++||||+++++++......++++
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 455678999999999999865 68899999765432 334567899999999999999999999999999999999
Q ss_pred EecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc
Q 039310 142 EFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ 221 (241)
Q Consensus 142 e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~ 221 (241)
||+++++|.+++.....+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-- 156 (258)
T cd06632 82 ELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-- 156 (258)
T ss_pred EecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccccc--
Confidence 99999999999988878999999999999999999999998 9999999999999999999999999987654332
Q ss_pred eeeeecccccccccccccC
Q 039310 222 NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~~ 240 (241)
......|++.|+|||.+..
T Consensus 157 ~~~~~~~~~~y~~pe~~~~ 175 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQ 175 (258)
T ss_pred cccccCCCcceeCHHHhcC
Confidence 2233458899999998753
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=209.97 Aligned_cols=176 Identities=24% Similarity=0.353 Sum_probs=144.6
Q ss_pred HHHHhhhcccccccccCceeEEEEEeC--------CCCeEEEEecccC-ChhhHHHHHHHHHHHHcC-CCCCceeEEEEE
Q 039310 62 EIKTVTNNYADVIGCGGSGNVYKGFLP--------DRTPVAVKKSKIV-DQTKIDEFINELVVVSQI-NRRNVVRLLACC 131 (241)
Q Consensus 62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~ 131 (241)
++....+.+.+.||+|+||.||+|... ++..|++|..... .....+.+.+|+.+++.+ +||||+++++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 344566778889999999999999731 2346899987643 234557889999999999 899999999999
Q ss_pred ecCCcceEEEEecCCCCchHHhhcC----------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCC
Q 039310 132 LETQVPLLVYEFVGNGTLFEHIHKN----------------GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSAN 195 (241)
Q Consensus 132 ~~~~~~~lv~e~~~~g~L~~~l~~~----------------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~N 195 (241)
......+++|||+++++|.+++... ..+++.++..++.|++.||.|||+.+ ++||||||+|
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~N 167 (304)
T cd05101 91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARN 167 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccce
Confidence 9999999999999999999998753 24788889999999999999999998 9999999999
Q ss_pred eeeCCCCCeEEccCCCcccccCCccc-eeeeecccccccccccccC
Q 039310 196 ILLDENYTPKVSDFGASKLVPIDAIQ-NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 196 ili~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~ 240 (241)
|++++++.+||+|||+++........ ......+++.|+|||++.+
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 213 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD 213 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhcc
Confidence 99999999999999999876433222 1222335678999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-30 Score=219.35 Aligned_cols=168 Identities=27% Similarity=0.327 Sum_probs=141.7
Q ss_pred HHhhhcccccccccCceeEEEEEeC---CCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEE
Q 039310 64 KTVTNNYADVIGCGGSGNVYKGFLP---DRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLV 140 (241)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~---~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv 140 (241)
....|.+.+.||+|+||.||+|... .+..|++|.+... ....+|+.+++.++||||+++++++......+++
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 3455778889999999999999743 3567889876532 2345899999999999999999999999999999
Q ss_pred EEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcc
Q 039310 141 YEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAI 220 (241)
Q Consensus 141 ~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~ 220 (241)
||++. ++|.+++.....+++.++..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++........
T Consensus 165 ~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 165 MPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred ehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 99995 689999877778999999999999999999999999 99999999999999999999999999876543322
Q ss_pred c-eeeeecccccccccccccC
Q 039310 221 Q-NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 221 ~-~~~~~~gt~~y~aPE~l~~ 240 (241)
. ......||+.|+|||++..
T Consensus 241 ~~~~~~~~gt~~y~aPE~~~~ 261 (392)
T PHA03207 241 TPQCYGWSGTLETNSPELLAL 261 (392)
T ss_pred cccccccccccCccCHhHhcC
Confidence 1 2223469999999999864
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=203.99 Aligned_cols=166 Identities=27% Similarity=0.412 Sum_probs=144.0
Q ss_pred hhhcccccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecC
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVG 145 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~ 145 (241)
..+.+.+.||+|+||.||+|... ++.|++|....... ..+++.+|+.+++.++|+||+++++++.+.+..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 45667788999999999999874 78899998775544 56788999999999999999999999999999999999999
Q ss_pred CCCchHHhhcCC--CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcccee
Q 039310 146 NGTLFEHIHKNG--NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNY 223 (241)
Q Consensus 146 ~g~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~ 223 (241)
+++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~---- 156 (256)
T cd05039 84 KGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ---- 156 (256)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc----
Confidence 999999997665 6999999999999999999999999 9999999999999999999999999998763221
Q ss_pred eeecccccccccccccC
Q 039310 224 TVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 224 ~~~~gt~~y~aPE~l~~ 240 (241)
....++..|+|||.+.+
T Consensus 157 ~~~~~~~~~~ape~~~~ 173 (256)
T cd05039 157 DSGKLPVKWTAPEALRE 173 (256)
T ss_pred ccCCCcccccCchhhcC
Confidence 12234567999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-29 Score=205.90 Aligned_cols=170 Identities=25% Similarity=0.336 Sum_probs=145.9
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEec
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
..|.+.+.||+|+||.||+|... ++..+++|.....+....+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 34667778999999999999865 47889999887666666788899999999999999999999999999999999999
Q ss_pred CCCCchHHhhc-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcccee
Q 039310 145 GNGTLFEHIHK-NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNY 223 (241)
Q Consensus 145 ~~g~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~ 223 (241)
++++|..++.. ...+++..+..++.|++.++.|||+.+ ++|+||+|+||+++.++.++|+|||++...... ....
T Consensus 92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-~~~~ 167 (292)
T cd06644 92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-LQRR 167 (292)
T ss_pred CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc-cccc
Confidence 99999888754 456899999999999999999999998 999999999999999999999999998754222 1222
Q ss_pred eeeccccccccccccc
Q 039310 224 TVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 224 ~~~~gt~~y~aPE~l~ 239 (241)
....+++.|+|||++.
T Consensus 168 ~~~~~~~~y~aPE~~~ 183 (292)
T cd06644 168 DSFIGTPYWMAPEVVM 183 (292)
T ss_pred ceecCCccccCceeec
Confidence 3345889999999874
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=203.58 Aligned_cols=169 Identities=27% Similarity=0.393 Sum_probs=145.2
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEeccc--CChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEec
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKI--VDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~--~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
+.+.+.||+|++|.||+|... ++..+++|.+.. ........+.+|+.+++.++|||++++++++...+..+++|||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA 81 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence 445678999999999999864 578899998654 23455678899999999999999999999999999999999999
Q ss_pred CCCCchHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccce
Q 039310 145 GNGTLFEHIHKN--GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQN 222 (241)
Q Consensus 145 ~~g~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~ 222 (241)
++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++........ .
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~-~ 157 (256)
T cd08529 82 ENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN-F 157 (256)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc-h
Confidence 999999999764 46899999999999999999999998 99999999999999999999999999887643322 2
Q ss_pred eeeecccccccccccccC
Q 039310 223 YTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 223 ~~~~~gt~~y~aPE~l~~ 240 (241)
.....|++.|+|||++.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~ 175 (256)
T cd08529 158 ANTIVGTPYYLSPELCED 175 (256)
T ss_pred hhccccCccccCHHHhcC
Confidence 233458899999998764
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-30 Score=221.54 Aligned_cols=164 Identities=22% Similarity=0.271 Sum_probs=137.9
Q ss_pred hhcccccccccCceeEEEEEeC-CCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecC
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVG 145 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~ 145 (241)
.+.+.+.||+|+||.||+|... .+..||+|.... ..+.+|+.+++.++|+||+++++++...+..+++||++.
T Consensus 170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~ 243 (461)
T PHA03211 170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR 243 (461)
T ss_pred CeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC
Confidence 4556678999999999999865 477899995332 345689999999999999999999999999999999995
Q ss_pred CCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc-ee
Q 039310 146 NGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ-NY 223 (241)
Q Consensus 146 ~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~-~~ 223 (241)
++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++........ ..
T Consensus 244 -~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 319 (461)
T PHA03211 244 -SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH 319 (461)
T ss_pred -CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccccccc
Confidence 6888888654 46999999999999999999999999 999999999999999999999999999865332211 12
Q ss_pred eeecccccccccccccC
Q 039310 224 TVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 224 ~~~~gt~~y~aPE~l~~ 240 (241)
....||+.|||||++.+
T Consensus 320 ~~~~GT~~Y~APE~~~~ 336 (461)
T PHA03211 320 YGIAGTVDTNAPEVLAG 336 (461)
T ss_pred cccCCCcCCcCHHHHcC
Confidence 23469999999998764
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=208.39 Aligned_cols=172 Identities=23% Similarity=0.340 Sum_probs=141.3
Q ss_pred hhhcccccccccCceeEEEEEeCC------CCeEEEEecccCCh-hhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcce
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLPD------RTPVAVKKSKIVDQ-TKIDEFINELVVVSQINRRNVVRLLACCLETQVPL 138 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~ 138 (241)
..+.+.+.||+|+||.||+|...+ +..||+|.+..... ...+.+.+|+.+++.++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 345667789999999999998532 46799998775432 33467889999999999999999999999999999
Q ss_pred EEEEecCCCCchHHhhcC----------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC
Q 039310 139 LVYEFVGNGTLFEHIHKN----------------GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENY 202 (241)
Q Consensus 139 lv~e~~~~g~L~~~l~~~----------------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~ 202 (241)
+++||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 999999999999998521 24788889999999999999999998 99999999999999999
Q ss_pred CeEEccCCCcccccCCcc-ceeeeecccccccccccccC
Q 039310 203 TPKVSDFGASKLVPIDAI-QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 203 ~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~ 240 (241)
.+||+|||+++....... .......+++.|+|||.+.+
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 200 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY 200 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhc
Confidence 999999999886533221 11222335789999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-29 Score=203.01 Aligned_cols=163 Identities=26% Similarity=0.419 Sum_probs=134.0
Q ss_pred ccccCceeEEEEEeC---CCCeEEEEecccCC-hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCCCCc
Q 039310 74 IGCGGSGNVYKGFLP---DRTPVAVKKSKIVD-QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTL 149 (241)
Q Consensus 74 lg~G~~g~V~~~~~~---~~~~vavk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~g~L 149 (241)
||+|+||.||+|.+. ++..||+|...... ....+.+.+|+.++++++||||+++++++.. +..++||||+++++|
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L 81 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPL 81 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCH
Confidence 899999999999753 34568999876543 3345678999999999999999999998864 567999999999999
Q ss_pred hHHhhc-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcccee--eee
Q 039310 150 FEHIHK-NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNY--TVV 226 (241)
Q Consensus 150 ~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~--~~~ 226 (241)
.+++.. ...+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++.....+..... ...
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 82 NKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence 999875 446899999999999999999999998 99999999999999999999999999886543322111 112
Q ss_pred cccccccccccccC
Q 039310 227 QGTLGYIDPEYLQT 240 (241)
Q Consensus 227 ~gt~~y~aPE~l~~ 240 (241)
.+++.|+|||.+.+
T Consensus 159 ~~~~~y~aPE~~~~ 172 (257)
T cd05115 159 KWPLKWYAPECINF 172 (257)
T ss_pred CCCcccCCHHHHcc
Confidence 23578999998753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-29 Score=206.25 Aligned_cols=163 Identities=26% Similarity=0.368 Sum_probs=138.8
Q ss_pred hcccccccccCceeEEEEEe-CCCCeEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecC
Q 039310 68 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVG 145 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~ 145 (241)
+.+.+.||+|+||.||+|.. .++..+|+|..... .....+.+.+|+.+++.++||||+++++++...+..+++|||++
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 82 (279)
T cd06619 3 IQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMD 82 (279)
T ss_pred chheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCC
Confidence 45667899999999999984 46788999976543 33445678899999999999999999999999999999999999
Q ss_pred CCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeee
Q 039310 146 NGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTV 225 (241)
Q Consensus 146 ~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~ 225 (241)
+++|..+. .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++...... ....
T Consensus 83 ~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~~~~ 152 (279)
T cd06619 83 GGSLDVYR----KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAKT 152 (279)
T ss_pred CCChHHhh----cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc---cccC
Confidence 99886543 4788999999999999999999998 999999999999999999999999998765322 1223
Q ss_pred ecccccccccccccC
Q 039310 226 VQGTLGYIDPEYLQT 240 (241)
Q Consensus 226 ~~gt~~y~aPE~l~~ 240 (241)
..||+.|+|||++.+
T Consensus 153 ~~~~~~y~aPE~~~~ 167 (279)
T cd06619 153 YVGTNAYMAPERISG 167 (279)
T ss_pred CCCChhhcCceeecC
Confidence 468999999998754
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=205.72 Aligned_cols=164 Identities=24% Similarity=0.310 Sum_probs=133.3
Q ss_pred cccccCceeEEEEEeCCC---CeEEEEecccCC-hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCCCC
Q 039310 73 VIGCGGSGNVYKGFLPDR---TPVAVKKSKIVD-QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGT 148 (241)
Q Consensus 73 ~lg~G~~g~V~~~~~~~~---~~vavk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~g~ 148 (241)
.||+|+||.||+|...++ ..+++|...... ....+.+.+|+.+++.++||||+++++.+.+....+++|||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999974333 345566555432 3445789999999999999999999999999999999999999999
Q ss_pred chHHhhcC----CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCc-ccee
Q 039310 149 LFEHIHKN----GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDA-IQNY 223 (241)
Q Consensus 149 L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~-~~~~ 223 (241)
|.+++... ...++..+..++.|++.||.|||+.+ ++|+||||+|||++.++.++|+|||++....... ....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 99999753 24667778899999999999999998 9999999999999999999999999986432211 1122
Q ss_pred eeeccccccccccccc
Q 039310 224 TVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 224 ~~~~gt~~y~aPE~l~ 239 (241)
....+++.|+|||++.
T Consensus 159 ~~~~~~~~y~aPE~~~ 174 (268)
T cd05086 159 DDKCVPLRWLAPELVG 174 (268)
T ss_pred cCCcCcccccCchhcc
Confidence 2345788999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=215.07 Aligned_cols=167 Identities=30% Similarity=0.342 Sum_probs=137.8
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEeccc--CChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCC------c
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKI--VDQTKIDEFINELVVVSQINRRNVVRLLACCLETQ------V 136 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~--~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~------~ 136 (241)
..|...+.||+|+||.||+|... ++..||+|.+.. ........+.+|+.+++.++||||+++++++...+ .
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 100 (359)
T cd07876 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQD 100 (359)
T ss_pred hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccce
Confidence 45677889999999999999854 588999998753 23344567889999999999999999999986543 4
Q ss_pred ceEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCccccc
Q 039310 137 PLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVP 216 (241)
Q Consensus 137 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~ 216 (241)
.|++|||+++ ++.+.+.. .+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++....
T Consensus 101 ~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~ 174 (359)
T cd07876 101 VYLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174 (359)
T ss_pred eEEEEeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence 6999999975 66666643 4889999999999999999999999 9999999999999999999999999997643
Q ss_pred CCccceeeeecccccccccccccC
Q 039310 217 IDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 217 ~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
... ......||+.|+|||++.+
T Consensus 175 ~~~--~~~~~~~t~~y~aPE~~~~ 196 (359)
T cd07876 175 TNF--MMTPYVVTRYYRAPEVILG 196 (359)
T ss_pred cCc--cCCCCcccCCCCCchhccC
Confidence 221 2233458999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=206.73 Aligned_cols=172 Identities=25% Similarity=0.375 Sum_probs=144.0
Q ss_pred hhhcccccccccCceeEEEEEeC------CCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP------DRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLL 139 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~l 139 (241)
..+.+.+.||+|+||.||++... ++..+++|............+.+|+++++.++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 44566788999999999999632 355788898776666667789999999999999999999999999999999
Q ss_pred EEEecCCCCchHHhhcCC---------------CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCe
Q 039310 140 VYEFVGNGTLFEHIHKNG---------------NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTP 204 (241)
Q Consensus 140 v~e~~~~g~L~~~l~~~~---------------~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~ 204 (241)
+|||+++++|.+++...+ .+++..+..++.|++.|+.|||+.+ ++|+||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 999999999999987542 4789999999999999999999998 9999999999999999999
Q ss_pred EEccCCCcccccCCccce-eeeecccccccccccccC
Q 039310 205 KVSDFGASKLVPIDAIQN-YTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 205 kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~ 240 (241)
+|+|||++.......... .....+++.|+|||.+.+
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 198 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY 198 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhcc
Confidence 999999987653322111 122235788999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=209.32 Aligned_cols=169 Identities=27% Similarity=0.427 Sum_probs=145.2
Q ss_pred hhcccccccccCceeEEEEEe-CCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecC
Q 039310 67 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVG 145 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~ 145 (241)
++...+.||+|+||.||+|.. .++..+++|.+..........+.+|+.+++.++|||++++++.+......++||||++
T Consensus 21 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~ 100 (296)
T cd06654 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (296)
T ss_pred ceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccC
Confidence 456667899999999999984 4678999998776555556788899999999999999999999999999999999999
Q ss_pred CCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeee
Q 039310 146 NGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTV 225 (241)
Q Consensus 146 ~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~ 225 (241)
+++|.+++... .+++.++..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 101 ~~~L~~~~~~~-~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~ 175 (296)
T cd06654 101 GGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRST 175 (296)
T ss_pred CCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc-ccCc
Confidence 99999998653 6899999999999999999999998 99999999999999999999999999876533221 1223
Q ss_pred ecccccccccccccC
Q 039310 226 VQGTLGYIDPEYLQT 240 (241)
Q Consensus 226 ~~gt~~y~aPE~l~~ 240 (241)
..|++.|+|||.+.+
T Consensus 176 ~~~~~~y~aPE~~~~ 190 (296)
T cd06654 176 MVGTPYWMAPEVVTR 190 (296)
T ss_pred ccCCccccCHHHHcC
Confidence 358899999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-29 Score=203.17 Aligned_cols=169 Identities=32% Similarity=0.501 Sum_probs=144.1
Q ss_pred cccccccccCceeEEEEEeCC-----CCeEEEEecccCChh-hHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEE
Q 039310 69 NYADVIGCGGSGNVYKGFLPD-----RTPVAVKKSKIVDQT-KIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYE 142 (241)
Q Consensus 69 ~~~~~lg~G~~g~V~~~~~~~-----~~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e 142 (241)
.+.+.||.|+||.||++...+ +..+|+|........ ..+.+.+|+.+++.++|+||+++++++.+.+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 356789999999999998654 378999988755433 56788999999999999999999999999999999999
Q ss_pred ecCCCCchHHhhcCCC--CCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcc
Q 039310 143 FVGNGTLFEHIHKNGN--LTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAI 220 (241)
Q Consensus 143 ~~~~g~L~~~l~~~~~--l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~ 220 (241)
|+++++|.+++..... +++..+..++.|++.|++|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 82 YMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred ccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 9999999999976554 999999999999999999999998 99999999999999999999999999987654432
Q ss_pred ceeeeecccccccccccccC
Q 039310 221 QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 221 ~~~~~~~gt~~y~aPE~l~~ 240 (241)
.......+++.|+|||.+.+
T Consensus 159 ~~~~~~~~~~~y~~Pe~~~~ 178 (258)
T smart00219 159 YKKKGGKLPIRWMAPESLKD 178 (258)
T ss_pred cccccCCCcccccChHHhcc
Confidence 22212236789999998743
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-29 Score=202.40 Aligned_cols=164 Identities=28% Similarity=0.393 Sum_probs=136.8
Q ss_pred cccccCceeEEEEEe---CCCCeEEEEecccCC--hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCCC
Q 039310 73 VIGCGGSGNVYKGFL---PDRTPVAVKKSKIVD--QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNG 147 (241)
Q Consensus 73 ~lg~G~~g~V~~~~~---~~~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~g 147 (241)
.||+|+||.||+|.+ .++..+|+|.+.... ....+.+.+|+.+++.++||||+++++++. .+..+++|||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999964 356789999875432 334567899999999999999999999875 45678999999999
Q ss_pred CchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccce--eee
Q 039310 148 TLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQN--YTV 225 (241)
Q Consensus 148 ~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~--~~~ 225 (241)
+|.+++.....+++..+..++.|++.||.|||+++ ++|+||||.||++++++.++|+|||++..+....... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05116 81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH 157 (257)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence 99999988778999999999999999999999999 9999999999999999999999999998764332211 112
Q ss_pred ecccccccccccccC
Q 039310 226 VQGTLGYIDPEYLQT 240 (241)
Q Consensus 226 ~~gt~~y~aPE~l~~ 240 (241)
..+++.|+|||.+..
T Consensus 158 ~~~~~~y~aPE~~~~ 172 (257)
T cd05116 158 GKWPVKWYAPECMNY 172 (257)
T ss_pred CCCCccccCHhHhcc
Confidence 234578999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=213.80 Aligned_cols=174 Identities=26% Similarity=0.332 Sum_probs=140.5
Q ss_pred HHhhhcccccccccCceeEEEEEeC------CCCeEEEEecccCC-hhhHHHHHHHHHHHHcC-CCCCceeEEEEEec-C
Q 039310 64 KTVTNNYADVIGCGGSGNVYKGFLP------DRTPVAVKKSKIVD-QTKIDEFINELVVVSQI-NRRNVVRLLACCLE-T 134 (241)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavk~~~~~~-~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~-~ 134 (241)
...++.+.+.||+|+||.||+|... ++..||+|++.... ....+.+.+|+.+++.+ +||||+++++++.. .
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 3456778899999999999999632 24689999876432 33446788999999999 89999999998865 4
Q ss_pred CcceEEEEecCCCCchHHhhcC----------------------------------------------------------
Q 039310 135 QVPLLVYEFVGNGTLFEHIHKN---------------------------------------------------------- 156 (241)
Q Consensus 135 ~~~~lv~e~~~~g~L~~~l~~~---------------------------------------------------------- 156 (241)
...+++|||+++++|.+++...
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 5678999999999999998532
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc-eeeeecccccc
Q 039310 157 ---GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ-NYTVVQGTLGY 232 (241)
Q Consensus 157 ---~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y 232 (241)
..+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.++|+|||++..+...... ......++..|
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 25789999999999999999999998 999999999999999999999999999876433221 11223356789
Q ss_pred cccccccC
Q 039310 233 IDPEYLQT 240 (241)
Q Consensus 233 ~aPE~l~~ 240 (241)
||||++.+
T Consensus 242 ~aPE~~~~ 249 (337)
T cd05054 242 MAPESIFD 249 (337)
T ss_pred cCcHHhcC
Confidence 99998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=208.65 Aligned_cols=170 Identities=28% Similarity=0.419 Sum_probs=146.7
Q ss_pred hhhcccccccccCceeEEEEEe-CCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEec
Q 039310 66 VTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
..|...+.||+|+||.||+|.. .++..||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 4566778899999999999985 468899999887655556677889999999999999999999999999999999999
Q ss_pred CCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceee
Q 039310 145 GNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYT 224 (241)
Q Consensus 145 ~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~ 224 (241)
++++|.+++.+ ..+++.++..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 99 ~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-~~~ 173 (297)
T cd06656 99 AGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRS 173 (297)
T ss_pred CCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc-CcC
Confidence 99999999865 35899999999999999999999998 99999999999999999999999999876543321 122
Q ss_pred eecccccccccccccC
Q 039310 225 VVQGTLGYIDPEYLQT 240 (241)
Q Consensus 225 ~~~gt~~y~aPE~l~~ 240 (241)
...+++.|+|||.+.+
T Consensus 174 ~~~~~~~y~aPE~~~~ 189 (297)
T cd06656 174 TMVGTPYWMAPEVVTR 189 (297)
T ss_pred cccCCccccCHHHHcC
Confidence 3458899999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-29 Score=205.55 Aligned_cols=172 Identities=24% Similarity=0.343 Sum_probs=142.1
Q ss_pred hhhcccccccccCceeEEEEEe-----CCCCeEEEEecccCC-hhhHHHHHHHHHHHHcCCCCCceeEEEEEecC--Ccc
Q 039310 66 VTNNYADVIGCGGSGNVYKGFL-----PDRTPVAVKKSKIVD-QTKIDEFINELVVVSQINRRNVVRLLACCLET--QVP 137 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~--~~~ 137 (241)
..+...+.||+|+||.||++.+ .++..|++|.+.... ......+.+|+.+++.++|||++++.+++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3455667899999999999973 347789999876543 44456789999999999999999999998775 568
Q ss_pred eEEEEecCCCCchHHhhcCC-CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCccccc
Q 039310 138 LLVYEFVGNGTLFEHIHKNG-NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVP 216 (241)
Q Consensus 138 ~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~ 216 (241)
+++|||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++....
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccccc
Confidence 89999999999999996643 5899999999999999999999999 9999999999999999999999999988664
Q ss_pred CCccc--eeeeecccccccccccccC
Q 039310 217 IDAIQ--NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 217 ~~~~~--~~~~~~gt~~y~aPE~l~~ 240 (241)
..... ......++..|+|||++.+
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~ 186 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQ 186 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhcc
Confidence 32211 1122346778999998754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-30 Score=221.48 Aligned_cols=165 Identities=26% Similarity=0.324 Sum_probs=132.6
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecC--------Cc
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLET--------QV 136 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~--------~~ 136 (241)
..|.+.+.||+|+||.||+|... ++..||||++.... ....+|+.+++.++||||+++++++... ..
T Consensus 66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence 35677889999999999999854 57899999865322 2234799999999999999998886432 24
Q ss_pred ceEEEEecCCCCchHHhh----cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC-CeEEccCCC
Q 039310 137 PLLVYEFVGNGTLFEHIH----KNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENY-TPKVSDFGA 211 (241)
Q Consensus 137 ~~lv~e~~~~g~L~~~l~----~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~-~~kl~Dfgl 211 (241)
.++||||+++ ++.+++. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++ .+||+|||+
T Consensus 142 l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFGl 217 (440)
T PTZ00036 142 LNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGS 217 (440)
T ss_pred EEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecccc
Confidence 6789999975 7766654 3457999999999999999999999999 99999999999999665 799999999
Q ss_pred cccccCCccceeeeecccccccccccccC
Q 039310 212 SKLVPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 212 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
|+.+.... ......||+.|||||++.+
T Consensus 218 a~~~~~~~--~~~~~~~t~~y~aPE~~~~ 244 (440)
T PTZ00036 218 AKNLLAGQ--RSVSYICSRFYRAPELMLG 244 (440)
T ss_pred chhccCCC--CcccCCCCcCccCHHHhcC
Confidence 98764322 2223458999999998753
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-29 Score=205.06 Aligned_cols=171 Identities=23% Similarity=0.381 Sum_probs=141.3
Q ss_pred HhhhcccccccccCceeEEEEEeCC----CCeEEEEecccCC-hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceE
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFLPD----RTPVAVKKSKIVD-QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLL 139 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~l 139 (241)
...+.+.+.||+|+||.||+|...+ ...|++|...... ....+.+.+|+.+++.++||||+++++++.+ +..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 4456678899999999999998533 3468889766543 4556788999999999999999999998875 45689
Q ss_pred EEEecCCCCchHHhhcCC-CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCC
Q 039310 140 VYEFVGNGTLFEHIHKNG-NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPID 218 (241)
Q Consensus 140 v~e~~~~g~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~ 218 (241)
+|||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 84 VMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecccc
Confidence 999999999999997644 5899999999999999999999998 999999999999999999999999998876443
Q ss_pred ccceeeeeccccccccccccc
Q 039310 219 AIQNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 219 ~~~~~~~~~gt~~y~aPE~l~ 239 (241)
.........+++.|+|||.+.
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~ 181 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESIN 181 (270)
T ss_pred cceecCCCCccccccChhhhc
Confidence 322222233456899999875
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-29 Score=202.77 Aligned_cols=169 Identities=26% Similarity=0.373 Sum_probs=145.1
Q ss_pred hcccccccccCceeEEEEEe-CCCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEec
Q 039310 68 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
|++.+.||.|+||.||.+.. .++..+++|++... +.....++.+|+.++++++|+||+++++++.+.+..+++|||+
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~ 81 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA 81 (256)
T ss_pred ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence 56678899999999999884 45788999986543 3455677899999999999999999999999999999999999
Q ss_pred CCCCchHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccce
Q 039310 145 GNGTLFEHIHKN--GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQN 222 (241)
Q Consensus 145 ~~g~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~ 222 (241)
++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++........ .
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-~ 157 (256)
T cd08221 82 NGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-M 157 (256)
T ss_pred CCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc-c
Confidence 999999999764 46899999999999999999999998 99999999999999999999999999886643331 2
Q ss_pred eeeecccccccccccccC
Q 039310 223 YTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 223 ~~~~~gt~~y~aPE~l~~ 240 (241)
.....|++.|+|||.+.+
T Consensus 158 ~~~~~~~~~y~ape~~~~ 175 (256)
T cd08221 158 AETVVGTPYYMSPELCQG 175 (256)
T ss_pred ccccCCCccccCHhhcCC
Confidence 233458999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-29 Score=204.40 Aligned_cols=172 Identities=26% Similarity=0.406 Sum_probs=142.2
Q ss_pred hhhcccccccccCceeEEEEEeCC-C---CeEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLPD-R---TPVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLV 140 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~-~---~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv 140 (241)
..+.+.+.||+|+||.||+|.... + ..|++|..... .......+..|+.+++.++||||+++++++...+..+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 346678899999999999998543 2 35999987653 344567899999999999999999999999999999999
Q ss_pred EEecCCCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCc
Q 039310 141 YEFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDA 219 (241)
Q Consensus 141 ~e~~~~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~ 219 (241)
|||+++++|.+++... +.+++.++..++.|++.|+.|||+.+ ++|+||+|+||++++++.++++|||++.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999999754 46899999999999999999999998 9999999999999999999999999987654322
Q ss_pred cce--eeeec--ccccccccccccC
Q 039310 220 IQN--YTVVQ--GTLGYIDPEYLQT 240 (241)
Q Consensus 220 ~~~--~~~~~--gt~~y~aPE~l~~ 240 (241)
... ..... .+..|+|||.+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~ 185 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAY 185 (269)
T ss_pred cccccccccCCCcceeecCHhHhcc
Confidence 111 11111 2457999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-29 Score=203.29 Aligned_cols=170 Identities=28% Similarity=0.382 Sum_probs=147.4
Q ss_pred hhcccccccccCceeEEEEEeC-CCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecC
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVG 145 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~ 145 (241)
.+.+.+.||.|+||.||+|... ++..+++|..........+.+.+|+.+++.++||||+++++++.+.+..+++|||++
T Consensus 4 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~ 83 (262)
T cd06613 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCG 83 (262)
T ss_pred ceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCC
Confidence 4566778999999999999854 577899998776555566888999999999999999999999999999999999999
Q ss_pred CCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceee
Q 039310 146 NGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYT 224 (241)
Q Consensus 146 ~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~ 224 (241)
+++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++....... ....
T Consensus 84 ~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~ 159 (262)
T cd06613 84 GGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-AKRK 159 (262)
T ss_pred CCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh-hccc
Confidence 99999998776 68999999999999999999999998 9999999999999999999999999987654321 1223
Q ss_pred eecccccccccccccC
Q 039310 225 VVQGTLGYIDPEYLQT 240 (241)
Q Consensus 225 ~~~gt~~y~aPE~l~~ 240 (241)
...++..|+|||.+.+
T Consensus 160 ~~~~~~~y~~Pe~~~~ 175 (262)
T cd06613 160 SFIGTPYWMAPEVAAV 175 (262)
T ss_pred cccCCccccCchhhcc
Confidence 3457889999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-31 Score=208.07 Aligned_cols=166 Identities=22% Similarity=0.369 Sum_probs=142.3
Q ss_pred cccccccCceeEEEEE-eCCCCeEEEEecccCChhhHHHHHHHHHHHHcC-CCCCceeEEEEEecCCcceEEEEecCCCC
Q 039310 71 ADVIGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKIDEFINELVVVSQI-NRRNVVRLLACCLETQVPLLVYEFVGNGT 148 (241)
Q Consensus 71 ~~~lg~G~~g~V~~~~-~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~g~ 148 (241)
++.||+|+|+.|-.+. ..++..+|||.+....-....+.++|++++.++ .|+||++++++|+++.+.|+|+|-|.||+
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 4579999999999886 678999999987665555667899999999999 59999999999999999999999999999
Q ss_pred chHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC---CeEEccCCCcccccCC------c
Q 039310 149 LFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENY---TPKVSDFGASKLVPID------A 219 (241)
Q Consensus 149 L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~---~~kl~Dfgla~~~~~~------~ 219 (241)
|...+.+...+++.++.++..+|+.||.|||.++ |.||||||+|||-.+.. .+|||||.+..-.... +
T Consensus 163 lLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spas 239 (463)
T KOG0607|consen 163 LLSHIQKRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAS 239 (463)
T ss_pred HHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCC
Confidence 9999999999999999999999999999999999 99999999999976443 5899999987644211 1
Q ss_pred cceeeeeccccccccccccc
Q 039310 220 IQNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 220 ~~~~~~~~gt~~y~aPE~l~ 239 (241)
.....+.+|+..|||||+..
T Consensus 240 tP~L~tPvGSAEfMAPEVVd 259 (463)
T KOG0607|consen 240 TPELLTPVGSAEFMAPEVVD 259 (463)
T ss_pred CccccCcccchhhcchhHHh
Confidence 12233456899999999864
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-30 Score=219.13 Aligned_cols=168 Identities=26% Similarity=0.325 Sum_probs=142.4
Q ss_pred HHhhhcccccccccCceeEEEEE-eCCCCeEEEEecccCChhhHHHHHHHHHHHHcCC-C-----CCceeEEEEEecCCc
Q 039310 64 KTVTNNYADVIGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKIDEFINELVVVSQIN-R-----RNVVRLLACCLETQV 136 (241)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~-h-----~ni~~l~~~~~~~~~ 136 (241)
...+|...+.||+|+||+|-+|. ..+++.||||.++.. .....+...|+.+|..++ | -|+|+++++|...++
T Consensus 184 i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 184 IAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred eEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 34466778899999999999998 456899999988753 344466778999999997 5 389999999999999
Q ss_pred ceEEEEecCCCCchHHhhcCC--CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC--CCeEEccCCCc
Q 039310 137 PLLVYEFVGNGTLFEHIHKNG--NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDEN--YTPKVSDFGAS 212 (241)
Q Consensus 137 ~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~--~~~kl~Dfgla 212 (241)
.|||.|.++ .+|.++++.+. .++...++.++.||+.||.+||+.+ |||+||||+|||+.+. ..+||+|||+|
T Consensus 263 lciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 263 LCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred eeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccc
Confidence 999999995 59999998775 5899999999999999999999998 9999999999999754 46999999999
Q ss_pred ccccCCccceeeeecccccccccccccC
Q 039310 213 KLVPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 213 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
....... ....-+..|.|||+|-+
T Consensus 339 c~~~q~v----ytYiQSRfYRAPEVILG 362 (586)
T KOG0667|consen 339 CFESQRV----YTYIQSRFYRAPEVILG 362 (586)
T ss_pred cccCCcc----eeeeeccccccchhhcc
Confidence 8754322 23446789999999876
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=207.50 Aligned_cols=166 Identities=25% Similarity=0.376 Sum_probs=142.4
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecC
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVG 145 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~ 145 (241)
+++.+.||+|+||.||++... ++..+|+|.+... .......+.+|+.+++.++||||+++++++...+..+++|||++
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (286)
T cd06622 3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMD 82 (286)
T ss_pred hhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecC
Confidence 556778999999999999865 6889999977643 33445788999999999999999999999999999999999999
Q ss_pred CCCchHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcC-CCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc
Q 039310 146 NGTLFEHIHKN---GNLTWERRLRIAAETAGVLSYLHSE-TNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ 221 (241)
Q Consensus 146 ~g~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~-~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~ 221 (241)
+++|..++... ..+++..+..++.|++.||.|||++ + ++|+||+|+||++++++.++|+|||++.......
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 157 (286)
T cd06622 83 AGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-- 157 (286)
T ss_pred CCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc--
Confidence 99999988763 3689999999999999999999974 6 9999999999999999999999999987653221
Q ss_pred eeeeeccccccccccccc
Q 039310 222 NYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~ 239 (241)
.....+++.|+|||.+.
T Consensus 158 -~~~~~~~~~y~aPE~~~ 174 (286)
T cd06622 158 -AKTNIGCQSYMAPERIK 174 (286)
T ss_pred -cccCCCccCccCcchhc
Confidence 22234788999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-29 Score=203.49 Aligned_cols=170 Identities=25% Similarity=0.406 Sum_probs=141.3
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccC-----ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecC--CcceE
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV-----DQTKIDEFINELVVVSQINRRNVVRLLACCLET--QVPLL 139 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~-----~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~--~~~~l 139 (241)
+...+.||+|+||.||.|... ++..|++|.+... .....+.+.+|+.+++.++||||+++++++.+. ...++
T Consensus 4 ~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (265)
T cd06652 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSI 83 (265)
T ss_pred ceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEE
Confidence 455678999999999999854 5889999976432 123456788999999999999999999998764 46789
Q ss_pred EEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCc
Q 039310 140 VYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDA 219 (241)
Q Consensus 140 v~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~ 219 (241)
+|||+++++|.+++.....+++.....++.|++.||.|||+++ ++|+||+|+||++++++.++|+|||++.......
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~ 160 (265)
T cd06652 84 FMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC 160 (265)
T ss_pred EEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence 9999999999999987778899999999999999999999999 9999999999999999999999999987653211
Q ss_pred c--ceeeeecccccccccccccC
Q 039310 220 I--QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 220 ~--~~~~~~~gt~~y~aPE~l~~ 240 (241)
. .......|+..|+|||.+.+
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~ 183 (265)
T cd06652 161 LSGTGMKSVTGTPYWMSPEVISG 183 (265)
T ss_pred ccccccccCCCCccccChhhhcC
Confidence 1 11223458899999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-29 Score=205.21 Aligned_cols=170 Identities=24% Similarity=0.400 Sum_probs=137.2
Q ss_pred hhcccccccccCceeEEEEEeC-CCC----eEEEEecccCC-hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEE
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP-DRT----PVAVKKSKIVD-QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLV 140 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv 140 (241)
.+...+.||+|+||.||+|.+. ++. .+++|...... .....++..|+..++.++||||+++++++.. ...+++
T Consensus 8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i 86 (279)
T cd05111 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLV 86 (279)
T ss_pred hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEE
Confidence 3455678999999999999864 333 47777765332 2334677888889999999999999998764 456889
Q ss_pred EEecCCCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCc
Q 039310 141 YEFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDA 219 (241)
Q Consensus 141 ~e~~~~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~ 219 (241)
+||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++......
T Consensus 87 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T cd05111 87 TQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDD 163 (279)
T ss_pred EEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccCCC
Confidence 9999999999999754 46899999999999999999999998 9999999999999999999999999998654332
Q ss_pred c-ceeeeecccccccccccccC
Q 039310 220 I-QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 220 ~-~~~~~~~gt~~y~aPE~l~~ 240 (241)
. .......++..|+|||.+.+
T Consensus 164 ~~~~~~~~~~~~~y~~pE~~~~ 185 (279)
T cd05111 164 KKYFYSEHKTPIKWMALESILF 185 (279)
T ss_pred cccccCCCCCcccccCHHHhcc
Confidence 1 12223346778999998754
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-29 Score=207.01 Aligned_cols=169 Identities=25% Similarity=0.321 Sum_probs=144.4
Q ss_pred hcccccccccCceeEEEEEe----CCCCeEEEEecccCC----hhhHHHHHHHHHHHHcC-CCCCceeEEEEEecCCcce
Q 039310 68 NNYADVIGCGGSGNVYKGFL----PDRTPVAVKKSKIVD----QTKIDEFINELVVVSQI-NRRNVVRLLACCLETQVPL 138 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~----~~~~~vavk~~~~~~----~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~ 138 (241)
+.+.+.||+|+||.||.+.. .++..||+|.+.... ....+.+.+|+.+++.+ +|+||+++++++..+...+
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH 81 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence 45667899999999999985 367889999876422 22346678899999999 5999999999999999999
Q ss_pred EEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCC
Q 039310 139 LVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPID 218 (241)
Q Consensus 139 lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~ 218 (241)
+++||+++++|.+++.....+++..+..++.|++.||.|||+.+ ++||||+|+|||+++++.++|+|||++......
T Consensus 82 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 82 LILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHED 158 (290)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence 99999999999999988888999999999999999999999998 999999999999999999999999998876443
Q ss_pred ccceeeeeccccccccccccc
Q 039310 219 AIQNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 219 ~~~~~~~~~gt~~y~aPE~l~ 239 (241)
.........|+..|+|||.+.
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~ 179 (290)
T cd05613 159 EVERAYSFCGTIEYMAPDIVR 179 (290)
T ss_pred cccccccccCCcccCChhhcc
Confidence 333333455899999999875
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-29 Score=205.06 Aligned_cols=174 Identities=28% Similarity=0.388 Sum_probs=143.7
Q ss_pred HHhhhcccccccccCceeEEEEEeCC------CCeEEEEecccCC-hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCc
Q 039310 64 KTVTNNYADVIGCGGSGNVYKGFLPD------RTPVAVKKSKIVD-QTKIDEFINELVVVSQINRRNVVRLLACCLETQV 136 (241)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~ 136 (241)
....+.+.+.||+|+||.||+|...+ +..|++|...... ......+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 34566677899999999999998542 3679999876432 3445678899999999999999999999999999
Q ss_pred ceEEEEecCCCCchHHhhcC----------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEE
Q 039310 137 PLLVYEFVGNGTLFEHIHKN----------GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKV 206 (241)
Q Consensus 137 ~~lv~e~~~~g~L~~~l~~~----------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl 206 (241)
.+++|||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEE
Confidence 99999999999999998642 23678899999999999999999998 999999999999999999999
Q ss_pred ccCCCcccccCCccc-eeeeecccccccccccccC
Q 039310 207 SDFGASKLVPIDAIQ-NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 207 ~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~ 240 (241)
+|||+++.+...... ......+|..|+|||.+.+
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 195 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD 195 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhc
Confidence 999998765433221 2223346789999998754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=215.12 Aligned_cols=163 Identities=23% Similarity=0.394 Sum_probs=137.0
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEec
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
..|.+.+.||+|+||.||+|... ++..||+|.... .....|+.+++.++||||+++++++...+..++|||++
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 139 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY 139 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence 45677889999999999999865 467888886432 22356999999999999999999999999999999999
Q ss_pred CCCCchHHhhc-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcccee
Q 039310 145 GNGTLFEHIHK-NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNY 223 (241)
Q Consensus 145 ~~g~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~ 223 (241)
. ++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++...... ...
T Consensus 140 ~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~~ 213 (357)
T PHA03209 140 S-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--PAF 213 (357)
T ss_pred C-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC--ccc
Confidence 5 588888764 457999999999999999999999998 999999999999999999999999998754322 122
Q ss_pred eeecccccccccccccC
Q 039310 224 TVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 224 ~~~~gt~~y~aPE~l~~ 240 (241)
....||+.|+|||++.+
T Consensus 214 ~~~~gt~~y~aPE~~~~ 230 (357)
T PHA03209 214 LGLAGTVETNAPEVLAR 230 (357)
T ss_pred ccccccccccCCeecCC
Confidence 33458999999999864
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=204.26 Aligned_cols=165 Identities=28% Similarity=0.379 Sum_probs=140.4
Q ss_pred ccccccCceeEEEEEeC-CCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCCCCch
Q 039310 72 DVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLF 150 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~g~L~ 150 (241)
..||+|+||.||+|... ++..|++|..........+.+.+|+.+++.++|+||+++++++...+..++++||+++++|.
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS 93 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence 47999999999999854 57789999877666666778999999999999999999999999999999999999999999
Q ss_pred HHhhcC-CCC--CHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC-CCCeEEccCCCcccccCCccceeeee
Q 039310 151 EHIHKN-GNL--TWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDE-NYTPKVSDFGASKLVPIDAIQNYTVV 226 (241)
Q Consensus 151 ~~l~~~-~~l--~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~-~~~~kl~Dfgla~~~~~~~~~~~~~~ 226 (241)
+++... ..+ ++..+..++.|++.||.|||+.+ ++|+||||+||+++. ++.++|+|||++........ .....
T Consensus 94 ~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 169 (268)
T cd06624 94 ALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-CTETF 169 (268)
T ss_pred HHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccCCC-ccccC
Confidence 999764 445 88889999999999999999998 999999999999986 67899999999876532221 12223
Q ss_pred cccccccccccccC
Q 039310 227 QGTLGYIDPEYLQT 240 (241)
Q Consensus 227 ~gt~~y~aPE~l~~ 240 (241)
.|++.|+|||++.+
T Consensus 170 ~~~~~~~aPE~~~~ 183 (268)
T cd06624 170 TGTLQYMAPEVIDK 183 (268)
T ss_pred CCCccccChhhhcc
Confidence 47899999998743
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=203.14 Aligned_cols=169 Identities=28% Similarity=0.475 Sum_probs=136.1
Q ss_pred cccccccccCceeEEEEEeCCCC---eEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecC------Ccc
Q 039310 69 NYADVIGCGGSGNVYKGFLPDRT---PVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLET------QVP 137 (241)
Q Consensus 69 ~~~~~lg~G~~g~V~~~~~~~~~---~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~------~~~ 137 (241)
.+.+.||+|+||.||+|.+.+.. .+|+|..... .....+.+.+|+.+++.++||||+++++.+... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 35678999999999999865432 5889976543 345567889999999999999999999987532 256
Q ss_pred eEEEEecCCCCchHHhhc------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCC
Q 039310 138 LLVYEFVGNGTLFEHIHK------NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGA 211 (241)
Q Consensus 138 ~lv~e~~~~g~L~~~l~~------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgl 211 (241)
+++|||+++|+|.+++.. ...+++.....++.|++.||.|||+.+ ++||||||+|||+++++.++|+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence 899999999999988742 234889999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCccce-eeeecccccccccccccC
Q 039310 212 SKLVPIDAIQN-YTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 212 a~~~~~~~~~~-~~~~~gt~~y~aPE~l~~ 240 (241)
+.......... .....+++.|+|||.+.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 188 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLAD 188 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccC
Confidence 98764332211 122235678999998753
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-30 Score=206.23 Aligned_cols=161 Identities=23% Similarity=0.360 Sum_probs=135.5
Q ss_pred ccccccCceeEEEEEeCC--------CCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 72 DVIGCGGSGNVYKGFLPD--------RTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~--------~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
+.||+|+||.||+|.... ..++++|..........+.+.+|..+++.++|||++++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 368999999999997532 234777876554445557788999999999999999999999999999999999
Q ss_pred cCCCCchHHhhcCC-CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCC--------eEEccCCCccc
Q 039310 144 VGNGTLFEHIHKNG-NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYT--------PKVSDFGASKL 214 (241)
Q Consensus 144 ~~~g~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~--------~kl~Dfgla~~ 214 (241)
+++|+|.+++..++ .+++.....++.|++.||.|||+++ ++||||||+||+++.++. ++++|||++..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 99999999997654 5899999999999999999999999 999999999999987765 69999999875
Q ss_pred ccCCccceeeeecccccccccccccC
Q 039310 215 VPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 215 ~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
... .....+++.|+|||++.+
T Consensus 158 ~~~-----~~~~~~~~~y~aPE~~~~ 178 (258)
T cd05078 158 VLP-----KEILLERIPWVPPECIEN 178 (258)
T ss_pred cCC-----chhccccCCccCchhccC
Confidence 432 122357889999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=208.44 Aligned_cols=170 Identities=29% Similarity=0.473 Sum_probs=138.3
Q ss_pred hhhcccccccccCceeEEEEEeC-CCC--eEEEEecccC-ChhhHHHHHHHHHHHHcC-CCCCceeEEEEEecCCcceEE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRT--PVAVKKSKIV-DQTKIDEFINELVVVSQI-NRRNVVRLLACCLETQVPLLV 140 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavk~~~~~-~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv 140 (241)
..+.+.+.||+|+||.||+|.+. ++. .+++|..... .......+.+|++++..+ +||||+++++++...+..+++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 45667788999999999999854 343 4577765543 334456788999999999 899999999999999999999
Q ss_pred EEecCCCCchHHhhcCC----------------CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCe
Q 039310 141 YEFVGNGTLFEHIHKNG----------------NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTP 204 (241)
Q Consensus 141 ~e~~~~g~L~~~l~~~~----------------~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~ 204 (241)
|||+++++|.+++.... .+++.++..++.|++.|++|||+.+ ++||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 99999999999996432 4789999999999999999999998 9999999999999999999
Q ss_pred EEccCCCcccccCCccceeeeecccccccccccccC
Q 039310 205 KVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 205 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
||+|||++..... ........++..|+|||++.+
T Consensus 164 kl~dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~ 197 (303)
T cd05088 164 KIADFGLSRGQEV--YVKKTMGRLPVRWMAIESLNY 197 (303)
T ss_pred EeCccccCcccch--hhhcccCCCcccccCHHHHhc
Confidence 9999999864321 111111224678999998653
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=206.38 Aligned_cols=175 Identities=23% Similarity=0.358 Sum_probs=143.3
Q ss_pred HHHhhhcccccccccCceeEEEEEeC------CCCeEEEEecccC-ChhhHHHHHHHHHHHHcC-CCCCceeEEEEEecC
Q 039310 63 IKTVTNNYADVIGCGGSGNVYKGFLP------DRTPVAVKKSKIV-DQTKIDEFINELVVVSQI-NRRNVVRLLACCLET 134 (241)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~ 134 (241)
+....+.+.+.||+|+||.||++... ....+++|..... ......++.+|+.+++.+ +||||+++++++...
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 34455667789999999999999853 2357899987643 334456788999999999 899999999999999
Q ss_pred CcceEEEEecCCCCchHHhhc----------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee
Q 039310 135 QVPLLVYEFVGNGTLFEHIHK----------------NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILL 198 (241)
Q Consensus 135 ~~~~lv~e~~~~g~L~~~l~~----------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili 198 (241)
+..+++|||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEE
Confidence 999999999999999999853 235889999999999999999999998 9999999999999
Q ss_pred CCCCCeEEccCCCcccccCCccce-eeeecccccccccccccC
Q 039310 199 DENYTPKVSDFGASKLVPIDAIQN-YTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 199 ~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~ 240 (241)
++++.+||+|||+++.+....... .....++..|+|||.+.+
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 208 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD 208 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhcc
Confidence 999999999999998764332211 122234678999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=204.21 Aligned_cols=171 Identities=26% Similarity=0.424 Sum_probs=139.3
Q ss_pred hhhcccccccccCceeEEEEEeC-CCC----eEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRT----PVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLL 139 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~l 139 (241)
..+.+.+.||+|+||.||+|.+. ++. +||+|..... .......+.+|..+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEE
Confidence 44566778999999999999853 333 4789987643 344456788999999999999999999998754 5678
Q ss_pred EEEecCCCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCC
Q 039310 140 VYEFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPID 218 (241)
Q Consensus 140 v~e~~~~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~ 218 (241)
++||+++|+|.+++..+ +.+++..+..++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||+++.....
T Consensus 86 ~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 86 VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162 (279)
T ss_pred EEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecccc
Confidence 99999999999999764 46899999999999999999999998 999999999999999999999999999876433
Q ss_pred ccce-eeeecccccccccccccC
Q 039310 219 AIQN-YTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 219 ~~~~-~~~~~gt~~y~aPE~l~~ 240 (241)
.... .....+++.|+|||.+.+
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~ 185 (279)
T cd05109 163 ETEYHADGGKVPIKWMALESILH 185 (279)
T ss_pred cceeecCCCccchhhCCHHHhcc
Confidence 2211 111234678999998754
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=203.07 Aligned_cols=170 Identities=28% Similarity=0.388 Sum_probs=146.9
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccCCh--hhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEec
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQ--TKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
|...+.||+|+||.||+|... ++..+++|.+..... ...+.+.+|+.+++.++|+||+++++.+...+..++++||+
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC 81 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence 556678999999999999854 678899998765433 36678999999999999999999999999999999999999
Q ss_pred CCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcccee-
Q 039310 145 GNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNY- 223 (241)
Q Consensus 145 ~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~- 223 (241)
++++|.+++.....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++...........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~ 158 (264)
T cd06626 82 SGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGE 158 (264)
T ss_pred CCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccc
Confidence 99999999988777999999999999999999999998 99999999999999999999999999887643322211
Q ss_pred --eeecccccccccccccC
Q 039310 224 --TVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 224 --~~~~gt~~y~aPE~l~~ 240 (241)
....+++.|+|||++.+
T Consensus 159 ~~~~~~~~~~~~~PE~~~~ 177 (264)
T cd06626 159 EVQSLAGTPAYMAPEVITG 177 (264)
T ss_pred cccCCcCCcCccChhhccC
Confidence 12457899999999764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=206.92 Aligned_cols=175 Identities=25% Similarity=0.370 Sum_probs=143.9
Q ss_pred HHHhhhcccccccccCceeEEEEEeC------CCCeEEEEecccCC-hhhHHHHHHHHHHHHcC-CCCCceeEEEEEecC
Q 039310 63 IKTVTNNYADVIGCGGSGNVYKGFLP------DRTPVAVKKSKIVD-QTKIDEFINELVVVSQI-NRRNVVRLLACCLET 134 (241)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavk~~~~~~-~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~ 134 (241)
.....+.+.+.||+|+||.||+|... .+..+|+|...... ....+.+.+|+.+++++ +||||+++++++...
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 44456777889999999999999731 24478999776433 33456788999999999 799999999999999
Q ss_pred CcceEEEEecCCCCchHHhhcCC--CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCc
Q 039310 135 QVPLLVYEFVGNGTLFEHIHKNG--NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGAS 212 (241)
Q Consensus 135 ~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla 212 (241)
+..+++|||+++++|.+++.... .+++.++..++.|++.||.|||+++ ++|+||||+|||+++++.++++|||++
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccc
Confidence 99999999999999999997543 3899999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCccc-eeeeecccccccccccccC
Q 039310 213 KLVPIDAIQ-NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 213 ~~~~~~~~~-~~~~~~gt~~y~aPE~l~~ 240 (241)
......... ......+++.|+|||.+.+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 217 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFN 217 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhcc
Confidence 865433211 1112235778999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-30 Score=219.21 Aligned_cols=143 Identities=22% Similarity=0.302 Sum_probs=127.8
Q ss_pred hcccccccccCceeEEEEE-eCCCCeEEEEecccC---ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 68 NNYADVIGCGGSGNVYKGF-LPDRTPVAVKKSKIV---DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
....+.||-|+||+|.+++ .++...+|+|.+... ...+......|-.||..-+.+.||+||..|++.+.+|+||||
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY 710 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 710 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence 3345679999999999987 444566788866543 344556778899999999999999999999999999999999
Q ss_pred cCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcc
Q 039310 144 VGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASK 213 (241)
Q Consensus 144 ~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~ 213 (241)
++||++..+|-+.+-+.+..++.++.++.+|+++.|..| +|||||||+|||||.+|.+||+|||||.
T Consensus 711 IPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCT 777 (1034)
T KOG0608|consen 711 IPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCT 777 (1034)
T ss_pred cCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccc
Confidence 999999999999889999999999999999999999999 9999999999999999999999999975
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=202.33 Aligned_cols=170 Identities=28% Similarity=0.452 Sum_probs=143.3
Q ss_pred hhcccccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCC
Q 039310 67 TNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGN 146 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~ 146 (241)
.+.+.+.||+|+||.||+|.+.++..+++|....... ....+.+|+++++.++|||++++++++......+++|||+++
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 4567788999999999999987778899998764322 335788999999999999999999999999999999999999
Q ss_pred CCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeee
Q 039310 147 GTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTV 225 (241)
Q Consensus 147 g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~ 225 (241)
++|.+++... +.+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++.............
T Consensus 84 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05112 84 GCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTG 160 (256)
T ss_pred CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccccCC
Confidence 9999998754 46899999999999999999999998 9999999999999999999999999987654332222222
Q ss_pred ecccccccccccccC
Q 039310 226 VQGTLGYIDPEYLQT 240 (241)
Q Consensus 226 ~~gt~~y~aPE~l~~ 240 (241)
..++..|+|||.+.+
T Consensus 161 ~~~~~~~~aPe~~~~ 175 (256)
T cd05112 161 TKFPVKWSSPEVFSF 175 (256)
T ss_pred CccchhhcCHhHhcc
Confidence 235678999998764
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=212.46 Aligned_cols=174 Identities=26% Similarity=0.333 Sum_probs=139.5
Q ss_pred HHhhhcccccccccCceeEEEEEe------CCCCeEEEEecccCC-hhhHHHHHHHHHHHHcC-CCCCceeEEEEEecC-
Q 039310 64 KTVTNNYADVIGCGGSGNVYKGFL------PDRTPVAVKKSKIVD-QTKIDEFINELVVVSQI-NRRNVVRLLACCLET- 134 (241)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavk~~~~~~-~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~- 134 (241)
...++.+.+.||+|+||.||+|.+ .+++.||||.+.... ......+.+|+.++..+ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 345678889999999999999973 246789999876532 33456788999999999 689999999988654
Q ss_pred CcceEEEEecCCCCchHHhhcC----------------------------------------------------------
Q 039310 135 QVPLLVYEFVGNGTLFEHIHKN---------------------------------------------------------- 156 (241)
Q Consensus 135 ~~~~lv~e~~~~g~L~~~l~~~---------------------------------------------------------- 156 (241)
...+++|||+++|+|.+++...
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 5678999999999999998642
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc-eeeee
Q 039310 157 ---------GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ-NYTVV 226 (241)
Q Consensus 157 ---------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~-~~~~~ 226 (241)
..+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++......... .....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 13677888999999999999999998 999999999999999999999999998765322211 11122
Q ss_pred cccccccccccccC
Q 039310 227 QGTLGYIDPEYLQT 240 (241)
Q Consensus 227 ~gt~~y~aPE~l~~ 240 (241)
.+++.|+|||.+.+
T Consensus 242 ~~~~~y~aPE~~~~ 255 (343)
T cd05103 242 RLPLKWMAPETIFD 255 (343)
T ss_pred CCCcceECcHHhcC
Confidence 35678999998743
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=207.87 Aligned_cols=176 Identities=24% Similarity=0.347 Sum_probs=142.7
Q ss_pred HHHHhhhcccccccccCceeEEEEEeC--------CCCeEEEEecccC-ChhhHHHHHHHHHHHHcC-CCCCceeEEEEE
Q 039310 62 EIKTVTNNYADVIGCGGSGNVYKGFLP--------DRTPVAVKKSKIV-DQTKIDEFINELVVVSQI-NRRNVVRLLACC 131 (241)
Q Consensus 62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~ 131 (241)
++...++.+.+.||+|+||.||+|... ....+|+|..... .......+.+|+.+++.+ +||||+++++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 344456778889999999999999742 2446888876643 234456788999999999 699999999999
Q ss_pred ecCCcceEEEEecCCCCchHHhhcC----------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCC
Q 039310 132 LETQVPLLVYEFVGNGTLFEHIHKN----------------GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSAN 195 (241)
Q Consensus 132 ~~~~~~~lv~e~~~~g~L~~~l~~~----------------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~N 195 (241)
...+..+++|||+++|+|.+++... ..+++.++..++.|++.||.|||+.+ ++|+||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~N 164 (314)
T cd05099 88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARN 164 (314)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecccccee
Confidence 9999999999999999999999653 24889999999999999999999998 9999999999
Q ss_pred eeeCCCCCeEEccCCCcccccCCccc-eeeeecccccccccccccC
Q 039310 196 ILLDENYTPKVSDFGASKLVPIDAIQ-NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 196 ili~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~ 240 (241)
||+++++.+||+|||+++........ ......+++.|||||.+.+
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 210 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD 210 (314)
T ss_pred EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHcc
Confidence 99999999999999999865432211 1122234568999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=206.92 Aligned_cols=169 Identities=26% Similarity=0.440 Sum_probs=145.8
Q ss_pred hhcccccccccCceeEEEEEe-CCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecC
Q 039310 67 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVG 145 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~ 145 (241)
++.+.+.||.|++|.||+|.. .+++.|++|.+........+.+.+|+.+++.++|||++++++++...+..++++||++
T Consensus 20 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 99 (296)
T cd06655 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLA 99 (296)
T ss_pred eEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecC
Confidence 356677899999999999984 4688999998776555556788899999999999999999999999999999999999
Q ss_pred CCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeee
Q 039310 146 NGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTV 225 (241)
Q Consensus 146 ~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~ 225 (241)
+++|..++... .+++.++..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++......... ...
T Consensus 100 ~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-~~~ 174 (296)
T cd06655 100 GGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK-RST 174 (296)
T ss_pred CCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccccc-CCC
Confidence 99999988654 6899999999999999999999999 999999999999999999999999998765433221 223
Q ss_pred ecccccccccccccC
Q 039310 226 VQGTLGYIDPEYLQT 240 (241)
Q Consensus 226 ~~gt~~y~aPE~l~~ 240 (241)
..+++.|+|||.+.+
T Consensus 175 ~~~~~~y~aPE~~~~ 189 (296)
T cd06655 175 MVGTPYWMAPEVVTR 189 (296)
T ss_pred cCCCccccCcchhcC
Confidence 358899999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-30 Score=215.16 Aligned_cols=171 Identities=25% Similarity=0.314 Sum_probs=149.3
Q ss_pred HhhhcccccccccCceeEEEEE-eCCCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEE
Q 039310 65 TVTNNYADVIGCGGSGNVYKGF-LPDRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVY 141 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~ 141 (241)
...|++.+.||+|.|..|-+|+ .-+|..||||.+... +.-....+++|++.|+.++|||||++|.+......+|+|+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 3456777889999999999998 347899999987653 3445578899999999999999999999999999999999
Q ss_pred EecCCCCchHHhhcCC-CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee-CCCCCeEEccCCCcccccCCc
Q 039310 142 EFVGNGTLFEHIHKNG-NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILL-DENYTPKVSDFGASKLVPIDA 219 (241)
Q Consensus 142 e~~~~g~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili-~~~~~~kl~Dfgla~~~~~~~ 219 (241)
|+-++|+|++|+-++. .+.+..+.+++.||+.|+.|+|+.+ +|||||||+|+++ ..-|-+||.|||++..+. .
T Consensus 97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~--P 171 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ--P 171 (864)
T ss_pred EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCC--C
Confidence 9999999999997654 6999999999999999999999999 9999999999886 467899999999988764 3
Q ss_pred cceeeeecccccccccccccC
Q 039310 220 IQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 220 ~~~~~~~~gt~~y~aPE~l~~ 240 (241)
..+..+.||++.|-|||+|.+
T Consensus 172 G~kL~TsCGSLAYSAPEILLG 192 (864)
T KOG4717|consen 172 GKKLTTSCGSLAYSAPEILLG 192 (864)
T ss_pred cchhhcccchhhccCchhhhc
Confidence 356677899999999999865
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-29 Score=202.20 Aligned_cols=169 Identities=27% Similarity=0.467 Sum_probs=137.9
Q ss_pred cccccccccCceeEEEEEeCC----CCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCc------
Q 039310 69 NYADVIGCGGSGNVYKGFLPD----RTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLETQV------ 136 (241)
Q Consensus 69 ~~~~~lg~G~~g~V~~~~~~~----~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~------ 136 (241)
.+.+.||+|+||.||+|.... +..||+|.+... .......+.+|+..++.++||||+++++++...+.
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 81 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK 81 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence 456789999999999998532 367999987643 33445688999999999999999999998866543
Q ss_pred ceEEEEecCCCCchHHhhcC------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCC
Q 039310 137 PLLVYEFVGNGTLFEHIHKN------GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFG 210 (241)
Q Consensus 137 ~~lv~e~~~~g~L~~~l~~~------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfg 210 (241)
.++++||+++++|..++... ..+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||
T Consensus 82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCcc
Confidence 78999999999999988432 35899999999999999999999998 9999999999999999999999999
Q ss_pred CcccccCCccce-eeeecccccccccccccC
Q 039310 211 ASKLVPIDAIQN-YTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 211 la~~~~~~~~~~-~~~~~gt~~y~aPE~l~~ 240 (241)
+++......... .....++..|+|||++.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 189 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLAD 189 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhccc
Confidence 998764332221 112235678999998753
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=203.87 Aligned_cols=170 Identities=25% Similarity=0.392 Sum_probs=143.9
Q ss_pred hhcccccccccCceeEEEEEe-CCCCeEEEEecccC---ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEE
Q 039310 67 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIV---DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYE 142 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e 142 (241)
.+.+.+.||+|+||.||+|.. .++..+++|..... +.....++.+|+.+++.++||||+++++++..++..+++||
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 355677899999999999984 47889999976542 33445688899999999999999999999999999999999
Q ss_pred ecCCCCchHHhhc----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCC
Q 039310 143 FVGNGTLFEHIHK----NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPID 218 (241)
Q Consensus 143 ~~~~g~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~ 218 (241)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 9999999998863 346899999999999999999999998 999999999999999999999999998766433
Q ss_pred ccceeeeecccccccccccccC
Q 039310 219 AIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 219 ~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
.. ......|++.|+|||.+.+
T Consensus 160 ~~-~~~~~~~~~~~~ape~~~~ 180 (267)
T cd08229 160 TT-AAHSLVGTPYYMSPERIHE 180 (267)
T ss_pred Cc-ccccccCCcCccCHHHhcC
Confidence 22 1223458899999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=212.52 Aligned_cols=166 Identities=25% Similarity=0.294 Sum_probs=137.5
Q ss_pred hhhcccccccccCceeEEEEEe-CCCCeEEEEecccCC--hhhHHHHHHHHHHHHcCCCCCceeEEEEEecC------Cc
Q 039310 66 VTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVD--QTKIDEFINELVVVSQINRRNVVRLLACCLET------QV 136 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~------~~ 136 (241)
.+|...+.||+|+||.||+|.. .++..||+|++.... ......+.+|+.+++.++||||+++++++... ..
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE 94 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence 3466677899999999999985 467889999876422 23345678999999999999999999987543 34
Q ss_pred ceEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCccccc
Q 039310 137 PLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVP 216 (241)
Q Consensus 137 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~ 216 (241)
.++++|++ +++|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||++....
T Consensus 95 ~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 169 (343)
T cd07878 95 VYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQAD 169 (343)
T ss_pred EEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccceecC
Confidence 68999988 6789887754 46999999999999999999999999 9999999999999999999999999998654
Q ss_pred CCccceeeeecccccccccccccC
Q 039310 217 IDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 217 ~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
.. .....||+.|+|||++.+
T Consensus 170 ~~----~~~~~~t~~y~aPE~~~~ 189 (343)
T cd07878 170 DE----MTGYVATRWYRAPEIMLN 189 (343)
T ss_pred CC----cCCccccccccCchHhcC
Confidence 32 223458999999998754
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-29 Score=200.13 Aligned_cols=169 Identities=22% Similarity=0.327 Sum_probs=143.4
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEeccc-CChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecC
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKI-VDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVG 145 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~-~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~ 145 (241)
+.+.+.||.|+||.||++... ++..+++|.+.. ......+.+.+|+.+++.++||||+++++++.+.+..+++|||++
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCD 81 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCC
Confidence 456778999999999999854 578899998654 234455778899999999999999999999999999999999999
Q ss_pred CCCchHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcccee
Q 039310 146 NGTLFEHIHKN--GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNY 223 (241)
Q Consensus 146 ~g~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~ 223 (241)
+++|.+++... ..+++.....++.|++.||.|||+.+ ++|+||+|+||++++++.++++|||++........ ..
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~ 157 (255)
T cd08219 82 GGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-YA 157 (255)
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-cc
Confidence 99999988643 35899999999999999999999998 99999999999999999999999999876643221 12
Q ss_pred eeecccccccccccccC
Q 039310 224 TVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 224 ~~~~gt~~y~aPE~l~~ 240 (241)
....|++.|+|||++.+
T Consensus 158 ~~~~~~~~~~aPE~~~~ 174 (255)
T cd08219 158 CTYVGTPYYVPPEIWEN 174 (255)
T ss_pred ccccCCccccCHHHHcc
Confidence 23458899999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=204.94 Aligned_cols=170 Identities=25% Similarity=0.288 Sum_probs=143.7
Q ss_pred hhcccccccccCceeEEEEEeC-CCCeEEEEecccCC--hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD--QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
.|++.+.||+|+||.||+|... +++.|++|+..... ....+.+.+|+.+++.++|||++++++++...+..+++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 81 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY 81 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence 3566778999999999999865 58899999765432 22335678999999999999999999999999999999999
Q ss_pred cCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcccee
Q 039310 144 VGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNY 223 (241)
Q Consensus 144 ~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~ 223 (241)
+++++|..++.....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++........ ..
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~ 157 (286)
T cd07847 82 CDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-DY 157 (286)
T ss_pred cCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcc-cc
Confidence 999888888777678999999999999999999999998 99999999999999999999999999987643321 12
Q ss_pred eeecccccccccccccC
Q 039310 224 TVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 224 ~~~~gt~~y~aPE~l~~ 240 (241)
....++..|+|||++.+
T Consensus 158 ~~~~~~~~~~aPE~~~~ 174 (286)
T cd07847 158 TDYVATRWYRAPELLVG 174 (286)
T ss_pred cCcccccccCCHHHHhC
Confidence 22347889999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=213.49 Aligned_cols=167 Identities=29% Similarity=0.332 Sum_probs=137.8
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecC------Cc
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLET------QV 136 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~------~~ 136 (241)
.+|...+.||+|+||.||+|... .+..+|+|++... .......+.+|+.+++.++||||+++++++... ..
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 96 (355)
T cd07874 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQD 96 (355)
T ss_pred hceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccce
Confidence 45667789999999999999854 5788999987642 334456788999999999999999999998653 34
Q ss_pred ceEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCccccc
Q 039310 137 PLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVP 216 (241)
Q Consensus 137 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~ 216 (241)
.+++|||+++ ++.+.+.. .+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++...
T Consensus 97 ~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 97 VYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_pred eEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence 6899999965 67666653 4889999999999999999999999 9999999999999999999999999998653
Q ss_pred CCccceeeeecccccccccccccC
Q 039310 217 IDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 217 ~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
.. .......||+.|+|||++.+
T Consensus 171 ~~--~~~~~~~~t~~y~aPE~~~~ 192 (355)
T cd07874 171 TS--FMMTPYVVTRYYRAPEVILG 192 (355)
T ss_pred Cc--cccCCccccCCccCHHHHcC
Confidence 22 22233468999999998754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=204.59 Aligned_cols=168 Identities=25% Similarity=0.315 Sum_probs=144.4
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccCC--hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEec
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD--QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
|.+.+.||+|++|.||+|... ++..|++|.+.... ......+.+|+.+++.++|||++++++++...+..++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM 81 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence 556778999999999999864 68899999876543 334567899999999999999999999999999999999999
Q ss_pred CCCCchHHhhc-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcccee
Q 039310 145 GNGTLFEHIHK-NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNY 223 (241)
Q Consensus 145 ~~g~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~ 223 (241)
+++|.+++.. ...+++.++..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++...........
T Consensus 82 -~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (286)
T cd07832 82 -PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY 157 (286)
T ss_pred -CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcc
Confidence 9999999864 356999999999999999999999998 99999999999999999999999999887654332223
Q ss_pred eeeccccccccccccc
Q 039310 224 TVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 224 ~~~~gt~~y~aPE~l~ 239 (241)
....|+..|+|||.+.
T Consensus 158 ~~~~~~~~y~aPE~~~ 173 (286)
T cd07832 158 SHQVATRWYRAPELLY 173 (286)
T ss_pred ccccCcccccCceeee
Confidence 3345899999999874
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-29 Score=201.07 Aligned_cols=170 Identities=25% Similarity=0.384 Sum_probs=144.6
Q ss_pred hhcccccccccCceeEEEEEeC-CCCeEEEEeccc---CChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEE
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKI---VDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYE 142 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~---~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e 142 (241)
.|.+.+.||+|+||.||+|... +++.+++|.... .+....+.+.+|+.+++.++|+|++++++++...+..+++||
T Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 82 (267)
T cd08224 3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence 4667889999999999999965 788999997653 233345788999999999999999999999999999999999
Q ss_pred ecCCCCchHHhhc----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCC
Q 039310 143 FVGNGTLFEHIHK----NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPID 218 (241)
Q Consensus 143 ~~~~g~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~ 218 (241)
|+++++|.+++.. ...+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 9999999998864 235899999999999999999999998 999999999999999999999999998765432
Q ss_pred ccceeeeecccccccccccccC
Q 039310 219 AIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 219 ~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
... .....+++.|+|||.+.+
T Consensus 160 ~~~-~~~~~~~~~y~apE~~~~ 180 (267)
T cd08224 160 TTA-AHSLVGTPYYMSPERIHE 180 (267)
T ss_pred Ccc-cceecCCccccCHHHhcc
Confidence 221 223458899999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-29 Score=201.80 Aligned_cols=172 Identities=26% Similarity=0.432 Sum_probs=142.0
Q ss_pred hhhcccccccccCceeEEEEEeCC-C---CeEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLPD-R---TPVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLV 140 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~-~---~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv 140 (241)
..++..+.||+|+||.||+|.... + ..+++|..... .....+.+.+|+.+++.++|||++++.+++...+..+++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 345567789999999999998642 2 26889987654 344567789999999999999999999999999999999
Q ss_pred EEecCCCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCc
Q 039310 141 YEFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDA 219 (241)
Q Consensus 141 ~e~~~~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~ 219 (241)
|||+++++|.+++... +.+++..+..++.|++.|+.|||+.+ ++|+||||+||++++++.++++|||++.......
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 85 TEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 9999999999999754 57899999999999999999999998 9999999999999999999999999987664322
Q ss_pred cceeee--ecccccccccccccC
Q 039310 220 IQNYTV--VQGTLGYIDPEYLQT 240 (241)
Q Consensus 220 ~~~~~~--~~gt~~y~aPE~l~~ 240 (241)
...... ...++.|+|||++..
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~ 184 (268)
T cd05063 162 EGTYTTSGGKIPIRWTAPEAIAY 184 (268)
T ss_pred ccceeccCCCcCceecCHHHhhc
Confidence 211111 123457999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-29 Score=201.11 Aligned_cols=170 Identities=25% Similarity=0.393 Sum_probs=141.3
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccC-----ChhhHHHHHHHHHHHHcCCCCCceeEEEEEec--CCcceE
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV-----DQTKIDEFINELVVVSQINRRNVVRLLACCLE--TQVPLL 139 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~-----~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~--~~~~~l 139 (241)
+...+.||+|+||.||+|... ++..+++|.+... .......+.+|+.+++.++||||+++++++.. ....++
T Consensus 4 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 83 (266)
T cd06651 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTI 83 (266)
T ss_pred ccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEE
Confidence 455678999999999999854 5788999976532 12344678899999999999999999999875 356789
Q ss_pred EEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCc
Q 039310 140 VYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDA 219 (241)
Q Consensus 140 v~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~ 219 (241)
++||+++++|.+++.....+++.....++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 84 ~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd06651 84 FMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 160 (266)
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence 9999999999999988778999999999999999999999998 9999999999999999999999999987653211
Q ss_pred --cceeeeecccccccccccccC
Q 039310 220 --IQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 220 --~~~~~~~~gt~~y~aPE~l~~ 240 (241)
........++..|+|||.+.+
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~ 183 (266)
T cd06651 161 MSGTGIRSVTGTPYWMSPEVISG 183 (266)
T ss_pred ccCCccccCCccccccCHHHhCC
Confidence 111122348899999998754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=202.88 Aligned_cols=170 Identities=24% Similarity=0.353 Sum_probs=142.7
Q ss_pred hcccccccccCceeEEEEEe-CCCCeEEEEecccCC----------hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCc
Q 039310 68 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVD----------QTKIDEFINELVVVSQINRRNVVRLLACCLETQV 136 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~----------~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~ 136 (241)
|...+.||.|+||.||+|.. .++..+|+|...... ....+.+.+|+.+++.++|||++++++++...+.
T Consensus 3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 82 (272)
T cd06629 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEY 82 (272)
T ss_pred eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCc
Confidence 44567899999999999984 358889999765311 1123467889999999999999999999999999
Q ss_pred ceEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCccccc
Q 039310 137 PLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVP 216 (241)
Q Consensus 137 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~ 216 (241)
.++||||+++++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++++|||++....
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 159 (272)
T cd06629 83 LSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSD 159 (272)
T ss_pred eEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccccccc
Confidence 9999999999999999988888999999999999999999999998 9999999999999999999999999987653
Q ss_pred CCcc-ceeeeecccccccccccccC
Q 039310 217 IDAI-QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 217 ~~~~-~~~~~~~gt~~y~aPE~l~~ 240 (241)
.... .......|+..|+|||.+..
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~ 184 (272)
T cd06629 160 DIYDNDQNMSMQGSVFWMAPEVIHS 184 (272)
T ss_pred ccccccccccccCCccccCHHHhcc
Confidence 2211 11223458899999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=205.37 Aligned_cols=170 Identities=26% Similarity=0.320 Sum_probs=145.2
Q ss_pred HhhhcccccccccCceeEEEEEeC-CCCeEEEEecccCC-hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEE
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD-QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYE 142 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e 142 (241)
...+++.+.||+|+||+||++... ++..+|+|...... ......+.+|+++++.++||||+++++++...+..++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 345666778999999999999854 57888998765432 3345788999999999999999999999999999999999
Q ss_pred ecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc
Q 039310 143 FVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHS-ETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ 221 (241)
Q Consensus 143 ~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~ 221 (241)
|+++++|.+++...+.+++..+..++.+++.+|.|||+ .+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-- 158 (284)
T cd06620 84 FMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-- 158 (284)
T ss_pred cCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhhc--
Confidence 99999999999887889999999999999999999997 46 9999999999999999999999999987542221
Q ss_pred eeeeecccccccccccccC
Q 039310 222 NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~~ 240 (241)
.....|+..|+|||++.+
T Consensus 159 -~~~~~~~~~~~aPE~~~~ 176 (284)
T cd06620 159 -ADTFVGTSTYMSPERIQG 176 (284)
T ss_pred -cCccccCcccCCHHHHcc
Confidence 223458999999998754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-29 Score=203.44 Aligned_cols=172 Identities=25% Similarity=0.375 Sum_probs=139.9
Q ss_pred hhhcccccccccCceeEEEEEeCC------CCeEEEEecccCC-hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcce
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLPD------RTPVAVKKSKIVD-QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPL 138 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~ 138 (241)
..+.+.+.||+|++|.||+|.+.+ +..|++|...... ......+.+|+.+++.++|+||+++++++.+.+..+
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRF 85 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcE
Confidence 446667889999999999998643 5678888776433 334467899999999999999999999999999999
Q ss_pred EEEEecCCCCchHHhhcCC-------CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC---CeEEcc
Q 039310 139 LVYEFVGNGTLFEHIHKNG-------NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENY---TPKVSD 208 (241)
Q Consensus 139 lv~e~~~~g~L~~~l~~~~-------~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~---~~kl~D 208 (241)
++|||+++++|.+++.... .+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++ .+||+|
T Consensus 86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEecc
Confidence 9999999999999987543 4899999999999999999999998 99999999999998654 589999
Q ss_pred CCCcccccCCccce-eeeecccccccccccccC
Q 039310 209 FGASKLVPIDAIQN-YTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 209 fgla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~ 240 (241)
||+++......... ......++.|+|||++.+
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 195 (277)
T cd05036 163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD 195 (277)
T ss_pred CccccccCCccceecCCCCCccHhhCCHHHHhc
Confidence 99998763222111 111123568999998754
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-29 Score=208.68 Aligned_cols=178 Identities=24% Similarity=0.344 Sum_probs=144.2
Q ss_pred HHHHHHhhhcccccccccCceeEEEEEeCC--------CCeEEEEecccC-ChhhHHHHHHHHHHHHcC-CCCCceeEEE
Q 039310 60 EEEIKTVTNNYADVIGCGGSGNVYKGFLPD--------RTPVAVKKSKIV-DQTKIDEFINELVVVSQI-NRRNVVRLLA 129 (241)
Q Consensus 60 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~--------~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l-~h~ni~~l~~ 129 (241)
..++...++.+.+.||+|+||.||+|...+ ...+|+|..... .....+.+.+|+.+++++ +||||+++++
T Consensus 6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (334)
T cd05100 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLG 85 (334)
T ss_pred ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence 344555678888999999999999997421 236889976643 234457889999999999 7999999999
Q ss_pred EEecCCcceEEEEecCCCCchHHhhcC----------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCC
Q 039310 130 CCLETQVPLLVYEFVGNGTLFEHIHKN----------------GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKS 193 (241)
Q Consensus 130 ~~~~~~~~~lv~e~~~~g~L~~~l~~~----------------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~ 193 (241)
++...+..++++||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp 162 (334)
T cd05100 86 ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAA 162 (334)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eecccccc
Confidence 999999999999999999999998643 24788899999999999999999998 99999999
Q ss_pred CCeeeCCCCCeEEccCCCcccccCCccc-eeeeecccccccccccccC
Q 039310 194 ANILLDENYTPKVSDFGASKLVPIDAIQ-NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 194 ~Nili~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~ 240 (241)
+|||+++++.+||+|||+++........ ......++..|||||++.+
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 210 (334)
T cd05100 163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD 210 (334)
T ss_pred ceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhcc
Confidence 9999999999999999998765432211 1122234568999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=202.10 Aligned_cols=171 Identities=26% Similarity=0.419 Sum_probs=140.5
Q ss_pred hhhcccccccccCceeEEEEEeCC-CC----eEEEEecccCC-hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLPD-RT----PVAVKKSKIVD-QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLL 139 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~-~~----~vavk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~l 139 (241)
..+.+.+.||+|+||.||+|.++. +. .+++|...... ......+.+|+.+++.++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 455677899999999999998543 22 58888765443 3445678899999999999999999999987 78899
Q ss_pred EEEecCCCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCC
Q 039310 140 VYEFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPID 218 (241)
Q Consensus 140 v~e~~~~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~ 218 (241)
+|||+++|+|.+++..+ ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+++.....
T Consensus 86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 99999999999999764 46999999999999999999999988 999999999999999999999999999876433
Q ss_pred cccee-eeecccccccccccccC
Q 039310 219 AIQNY-TVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 219 ~~~~~-~~~~gt~~y~aPE~l~~ 240 (241)
..... ....++..|+|||.+..
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~ 185 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILH 185 (279)
T ss_pred ccceecCCCcccccccCHHHhhc
Confidence 22111 11223578999998753
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=206.53 Aligned_cols=167 Identities=27% Similarity=0.278 Sum_probs=142.0
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccCCh-----hhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEE
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQ-----TKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVY 141 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~-----~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~ 141 (241)
+.+.+.||+|++|.||+|... ++..|++|.+..... .....+..|+.+++.++|+||+++++++.+.+..++||
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 456678999999999999854 588999998765332 23355678999999999999999999999999999999
Q ss_pred EecCCCCchHHhhcCC-CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcc
Q 039310 142 EFVGNGTLFEHIHKNG-NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAI 220 (241)
Q Consensus 142 e~~~~g~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~ 220 (241)
||+ +++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 82 e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 82 EFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR 157 (298)
T ss_pred ccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence 999 889999998776 7999999999999999999999999 99999999999999999999999999987643321
Q ss_pred ceeeeeccccccccccccc
Q 039310 221 QNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 221 ~~~~~~~gt~~y~aPE~l~ 239 (241)
......+++.|+|||.+.
T Consensus 158 -~~~~~~~~~~y~aPE~~~ 175 (298)
T cd07841 158 -KMTHQVVTRWYRAPELLF 175 (298)
T ss_pred -cccccccceeeeCHHHHh
Confidence 122234678899999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-29 Score=203.82 Aligned_cols=168 Identities=26% Similarity=0.339 Sum_probs=139.8
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEec
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
|.+.+.||+|++|.||+|... ++..|++|++... +......+.+|+.+++.++||||+++++++.+++..++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL 81 (285)
T ss_pred ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence 445678999999999999864 6889999987543 2233467789999999999999999999999999999999999
Q ss_pred CCCCchHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc
Q 039310 145 GNGTLFEHIHKN---GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ 221 (241)
Q Consensus 145 ~~g~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~ 221 (241)
+ ++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++....... .
T Consensus 82 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~ 156 (285)
T cd07861 82 S-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-R 156 (285)
T ss_pred C-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc-c
Confidence 7 5888887542 46899999999999999999999998 9999999999999999999999999987653221 1
Q ss_pred eeeeecccccccccccccC
Q 039310 222 NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~~ 240 (241)
......+++.|+|||++.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~ 175 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLG 175 (285)
T ss_pred cccCCcccccccChHHhcC
Confidence 1222347889999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-29 Score=207.65 Aligned_cols=168 Identities=21% Similarity=0.228 Sum_probs=137.7
Q ss_pred cccccccc--CceeEEEEEe-CCCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEec
Q 039310 70 YADVIGCG--GSGNVYKGFL-PDRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 70 ~~~~lg~G--~~g~V~~~~~-~~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
+.+.||+| +|++||++.. .++..||+|.+... .....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45679999 7899999985 46888999987643 2334466778999999999999999999999999999999999
Q ss_pred CCCCchHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc-
Q 039310 145 GNGTLFEHIHKN--GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ- 221 (241)
Q Consensus 145 ~~g~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~- 221 (241)
++|+|.+++..+ ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.++++||+.+.........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999999653 45899999999999999999999999 999999999999999999999999865443211110
Q ss_pred -----eeeeecccccccccccccC
Q 039310 222 -----NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 222 -----~~~~~~gt~~y~aPE~l~~ 240 (241)
......++..|+|||++.+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~ 182 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQ 182 (327)
T ss_pred cccccccccccceecccChHHhhc
Confidence 0112246778999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=198.37 Aligned_cols=166 Identities=32% Similarity=0.487 Sum_probs=139.7
Q ss_pred ccccccCceeEEEEEeCCCCeEEEEecccCCh-hhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCCCCch
Q 039310 72 DVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQ-TKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLF 150 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~g~L~ 150 (241)
+.||+|+||.||+|...+++.|++|....... .....+.+|+.+++.++||||+++++++.+.+..+++|||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 36899999999999976689999998765433 35568899999999999999999999999999999999999999999
Q ss_pred HHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcccee-eeecc
Q 039310 151 EHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNY-TVVQG 228 (241)
Q Consensus 151 ~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~-~~~~g 228 (241)
+++... ..+++..+..++.+++.++.|||+.+ ++||||+|+||+++.++.++|+|||++........... ....+
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 998653 46899999999999999999999998 99999999999999999999999999876532221111 11223
Q ss_pred cccccccccccC
Q 039310 229 TLGYIDPEYLQT 240 (241)
Q Consensus 229 t~~y~aPE~l~~ 240 (241)
+..|+|||.+.+
T Consensus 158 ~~~y~~PE~~~~ 169 (251)
T cd05041 158 PIKWTAPEALNY 169 (251)
T ss_pred eeccCChHhhcc
Confidence 567999998764
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-29 Score=206.81 Aligned_cols=163 Identities=25% Similarity=0.329 Sum_probs=130.5
Q ss_pred ccccccCceeEEEEEeC---CCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEec--CCcceEEEEecCC
Q 039310 72 DVIGCGGSGNVYKGFLP---DRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLE--TQVPLLVYEFVGN 146 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~---~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~--~~~~~lv~e~~~~ 146 (241)
..||+|+||.||+|... ++..+|+|.+.... ....+.+|+.+++.++||||+++++++.. ....++++||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 46999999999999854 35679999765432 23457789999999999999999999854 5577899999964
Q ss_pred CCchHHhhcC---------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee----CCCCCeEEccCCCcc
Q 039310 147 GTLFEHIHKN---------GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILL----DENYTPKVSDFGASK 213 (241)
Q Consensus 147 g~L~~~l~~~---------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili----~~~~~~kl~Dfgla~ 213 (241)
+|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+|||+ ++++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 777776421 24889999999999999999999999 9999999999999 566789999999998
Q ss_pred cccCCcc--ceeeeecccccccccccccC
Q 039310 214 LVPIDAI--QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 214 ~~~~~~~--~~~~~~~gt~~y~aPE~l~~ 240 (241)
....... .......||+.|+|||++.+
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 189 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLG 189 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcC
Confidence 7643221 12233458999999998754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=200.64 Aligned_cols=164 Identities=30% Similarity=0.480 Sum_probs=134.1
Q ss_pred ccccccCceeEEEEEeCC-CC--eEEEEecccC-ChhhHHHHHHHHHHHHcC-CCCCceeEEEEEecCCcceEEEEecCC
Q 039310 72 DVIGCGGSGNVYKGFLPD-RT--PVAVKKSKIV-DQTKIDEFINELVVVSQI-NRRNVVRLLACCLETQVPLLVYEFVGN 146 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~-~~--~vavk~~~~~-~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~ 146 (241)
+.||+|+||.||+|...+ +. .+++|..... .....+.+.+|+++++.+ +||||+++++++...+..+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999998644 33 4678876643 344556788999999999 799999999999999999999999999
Q ss_pred CCchHHhhcCC----------------CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCC
Q 039310 147 GTLFEHIHKNG----------------NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFG 210 (241)
Q Consensus 147 g~L~~~l~~~~----------------~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfg 210 (241)
++|.+++.... .+++.....++.|++.|++|||+.+ ++|+||||+||++++++.+|++|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999986532 4789999999999999999999998 9999999999999999999999999
Q ss_pred CcccccCCccceeeeecccccccccccccC
Q 039310 211 ASKLVPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 211 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
++..... .........+..|+|||++..
T Consensus 158 l~~~~~~--~~~~~~~~~~~~y~apE~~~~ 185 (270)
T cd05047 158 LSRGQEV--YVKKTMGRLPVRWMAIESLNY 185 (270)
T ss_pred Cccccch--hhhccCCCCccccCChHHHcc
Confidence 9864321 111111224567999998743
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-29 Score=203.52 Aligned_cols=170 Identities=25% Similarity=0.343 Sum_probs=138.5
Q ss_pred hcccccccccCceeEEEEEeC------CCCeEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEE
Q 039310 68 NNYADVIGCGGSGNVYKGFLP------DRTPVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLV 140 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~------~~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv 140 (241)
+.+.+.||+|+||.||+|... +...+++|..... ......++.+|+.+++.++||||+++++.+...+..+++
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLI 81 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEE
Confidence 345678999999999999743 2346788876543 234457789999999999999999999999999999999
Q ss_pred EEecCCCCchHHhhcC------------------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCe
Q 039310 141 YEFVGNGTLFEHIHKN------------------------GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANI 196 (241)
Q Consensus 141 ~e~~~~g~L~~~l~~~------------------------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Ni 196 (241)
+||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~ni 158 (290)
T cd05045 82 VEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARNV 158 (290)
T ss_pred EEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhheE
Confidence 9999999999988642 24788999999999999999999998 99999999999
Q ss_pred eeCCCCCeEEccCCCcccccCCccc-eeeeecccccccccccccC
Q 039310 197 LLDENYTPKVSDFGASKLVPIDAIQ-NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 197 li~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~ 240 (241)
|+++++.++|+|||+++........ ......++..|+|||.+.+
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~ 203 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD 203 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc
Confidence 9999999999999998765322211 1222345678999998643
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-29 Score=200.56 Aligned_cols=165 Identities=27% Similarity=0.436 Sum_probs=139.4
Q ss_pred ccccccCceeEEEEEeCC--C--CeEEEEecccCCh-hhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCC
Q 039310 72 DVIGCGGSGNVYKGFLPD--R--TPVAVKKSKIVDQ-TKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGN 146 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~--~--~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~ 146 (241)
+.||+|++|.||+|.+.+ + ..||+|....... ...+.+.+|+.++++++||||+++++.+.. ...+++|||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999998643 2 3589998776554 566789999999999999999999999988 889999999999
Q ss_pred CCchHHhhcCC--CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc--e
Q 039310 147 GTLFEHIHKNG--NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ--N 222 (241)
Q Consensus 147 g~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~--~ 222 (241)
++|.+.+.... .+++.....++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++......... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999997654 6899999999999999999999998 999999999999999999999999999876442211 1
Q ss_pred eeeecccccccccccccC
Q 039310 223 YTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 223 ~~~~~gt~~y~aPE~l~~ 240 (241)
.....++..|+|||.+.+
T Consensus 157 ~~~~~~~~~y~~pE~~~~ 174 (257)
T cd05040 157 EEHLKVPFAWCAPESLRT 174 (257)
T ss_pred ccCCCCCceecCHHHhcc
Confidence 112346788999998753
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-29 Score=202.38 Aligned_cols=169 Identities=25% Similarity=0.399 Sum_probs=142.6
Q ss_pred hcccccccccCceeEEEEEe-CCCCeEEEEecccCC------hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEE
Q 039310 68 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVD------QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLV 140 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~------~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv 140 (241)
|...+.||+|++|.||+|.. .++..+++|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..+++
T Consensus 2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 81 (268)
T cd06630 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLF 81 (268)
T ss_pred ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEE
Confidence 34567899999999999984 568899999875422 12356789999999999999999999999999999999
Q ss_pred EEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC-CeEEccCCCcccccCCc
Q 039310 141 YEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENY-TPKVSDFGASKLVPIDA 219 (241)
Q Consensus 141 ~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~-~~kl~Dfgla~~~~~~~ 219 (241)
+||+++++|.+++...+++++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++ .++|+|||++.......
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 82 VEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred EeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 999999999999988888999999999999999999999999 99999999999998776 59999999987764331
Q ss_pred cc---eeeeeccccccccccccc
Q 039310 220 IQ---NYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 220 ~~---~~~~~~gt~~y~aPE~l~ 239 (241)
.. ......||..|+|||.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~PE~~~ 181 (268)
T cd06630 159 TGAGEFQGQLLGTIAFMAPEVLR 181 (268)
T ss_pred ccCCccccccccccceeCHhHhc
Confidence 11 112235788999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-29 Score=203.07 Aligned_cols=162 Identities=26% Similarity=0.304 Sum_probs=133.2
Q ss_pred cccccCceeEEEEEeC-CCCeEEEEecccCC---hhhHHHHHHHHHHHHc---CCCCCceeEEEEEecCCcceEEEEecC
Q 039310 73 VIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD---QTKIDEFINELVVVSQ---INRRNVVRLLACCLETQVPLLVYEFVG 145 (241)
Q Consensus 73 ~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~---l~h~ni~~l~~~~~~~~~~~lv~e~~~ 145 (241)
.||+|+||.||++... ++..+|+|.+.... ......+.+|..+++. .+|||++.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999854 57889999765321 1222334455544443 479999999999999999999999999
Q ss_pred CCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeee
Q 039310 146 NGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTV 225 (241)
Q Consensus 146 ~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~ 225 (241)
+++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||||+|||+++++.++|+|||++....... ...
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~ 154 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHA 154 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---ccC
Confidence 9999999988888999999999999999999999999 9999999999999999999999999987543221 223
Q ss_pred ecccccccccccccC
Q 039310 226 VQGTLGYIDPEYLQT 240 (241)
Q Consensus 226 ~~gt~~y~aPE~l~~ 240 (241)
..||+.|+|||.+.+
T Consensus 155 ~~~~~~y~aPE~~~~ 169 (279)
T cd05633 155 SVGTHGYMAPEVLQK 169 (279)
T ss_pred cCCCcCccCHHHhcC
Confidence 458999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=231.51 Aligned_cols=160 Identities=25% Similarity=0.422 Sum_probs=131.5
Q ss_pred hcccccccccCceeEEEEEe-CCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCC
Q 039310 68 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGN 146 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~ 146 (241)
....+.||+|+||.||+|.. .++..||+|++....... ..|++.+++++||||+++++++.+.+..++||||+++
T Consensus 692 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~ 767 (968)
T PLN00113 692 LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEG 767 (968)
T ss_pred CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc----HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCC
Confidence 34456899999999999985 578899999876443222 2468899999999999999999999999999999999
Q ss_pred CCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeeee
Q 039310 147 GTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVV 226 (241)
Q Consensus 147 g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 226 (241)
|+|.++++. +++..+..++.|++.||+|||.....+++|||+||+||+++.++..++. ||.+.....+ ...
T Consensus 768 g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~ 838 (968)
T PLN00113 768 KNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKC 838 (968)
T ss_pred CcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----CCc
Confidence 999999963 8999999999999999999996544459999999999999999888875 6655433211 122
Q ss_pred cccccccccccccC
Q 039310 227 QGTLGYIDPEYLQT 240 (241)
Q Consensus 227 ~gt~~y~aPE~l~~ 240 (241)
.||+.|||||++.+
T Consensus 839 ~~t~~y~aPE~~~~ 852 (968)
T PLN00113 839 FISSAYVAPETRET 852 (968)
T ss_pred cccccccCcccccC
Confidence 57899999999864
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=203.96 Aligned_cols=169 Identities=27% Similarity=0.448 Sum_probs=137.4
Q ss_pred hhcccccccccCceeEEEEEeCC-C--CeEEEEecccC-ChhhHHHHHHHHHHHHcC-CCCCceeEEEEEecCCcceEEE
Q 039310 67 TNNYADVIGCGGSGNVYKGFLPD-R--TPVAVKKSKIV-DQTKIDEFINELVVVSQI-NRRNVVRLLACCLETQVPLLVY 141 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~~-~--~~vavk~~~~~-~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~ 141 (241)
.+.+.+.||+|+||.||+|...+ + ..+++|.++.. .....+.+.+|+.+++++ +||||+++++++...+..++++
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 82 (297)
T cd05089 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAI 82 (297)
T ss_pred cceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEE
Confidence 35667889999999999998643 3 24688876642 334456789999999999 7999999999999999999999
Q ss_pred EecCCCCchHHhhcCC----------------CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeE
Q 039310 142 EFVGNGTLFEHIHKNG----------------NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPK 205 (241)
Q Consensus 142 e~~~~g~L~~~l~~~~----------------~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~k 205 (241)
||+++++|.+++.... .+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.+|
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 83 EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeEE
Confidence 9999999999996532 4888999999999999999999998 99999999999999999999
Q ss_pred EccCCCcccccCCccceeeeecccccccccccccC
Q 039310 206 VSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 206 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
|+|||++...... ........+..|+|||++..
T Consensus 160 l~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~ 192 (297)
T cd05089 160 IADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNY 192 (297)
T ss_pred ECCcCCCccccce--eccCCCCcCccccCchhhcc
Confidence 9999998643211 11111223567999998753
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-29 Score=204.86 Aligned_cols=170 Identities=27% Similarity=0.314 Sum_probs=142.1
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccCC---hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD---QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
+.+.+.||+|+||.||++... .+..|++|.+.... ......+.+|+++++.++||||+++++.+..++..+++|||
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (305)
T cd05609 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEY 82 (305)
T ss_pred ceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEec
Confidence 455678999999999999854 47789999766432 23456788999999999999999999999999999999999
Q ss_pred cCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcc---
Q 039310 144 VGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAI--- 220 (241)
Q Consensus 144 ~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~--- 220 (241)
+++++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++++|||+++.......
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (305)
T cd05609 83 VEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL 159 (305)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCccccc
Confidence 999999999988888999999999999999999999998 99999999999999999999999999864211000
Q ss_pred -----------ceeeeecccccccccccccC
Q 039310 221 -----------QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 221 -----------~~~~~~~gt~~y~aPE~l~~ 240 (241)
.......+++.|+|||.+.+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 190 (305)
T cd05609 160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILR 190 (305)
T ss_pred cccccccchhhccccCCccCccccCchhccC
Confidence 01112347889999998753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=229.31 Aligned_cols=176 Identities=26% Similarity=0.365 Sum_probs=142.1
Q ss_pred HHHHhhhcccccccccCceeEEEEEeC-CCCeEEEEeccc--CChhhHHHHHHHHHHHHcCCCCCceeEEEEEec--CCc
Q 039310 62 EIKTVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKI--VDQTKIDEFINELVVVSQINRRNVVRLLACCLE--TQV 136 (241)
Q Consensus 62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~--~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~--~~~ 136 (241)
+.....|.+.+.||+|+||+||+|... ++..+++|.+.. ........+..|+.+++.++||||++++++|.. .+.
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 344456778889999999999999854 466788887654 234456778999999999999999999999865 456
Q ss_pred ceEEEEecCCCCchHHhhc----CCCCCHHHHHHHHHHHHHHHHHhhcCCC----CCeEecCCCCCCeeeCC--------
Q 039310 137 PLLVYEFVGNGTLFEHIHK----NGNLTWERRLRIAAETAGVLSYLHSETN----VPIIHRDVKSANILLDE-------- 200 (241)
Q Consensus 137 ~~lv~e~~~~g~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~~~----~~iiH~dlk~~Nili~~-------- 200 (241)
+|+||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+. .+|+||||||+|||++.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 8999999999999999864 2469999999999999999999998431 23999999999999964
Q ss_pred ---------CCCeEEccCCCcccccCCccceeeeeccccccccccccc
Q 039310 201 ---------NYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 201 ---------~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~ 239 (241)
.+.+||+|||++..+.... ......||+.|+|||++.
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ 214 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLL 214 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHh
Confidence 2358999999998664332 223346899999999874
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=201.92 Aligned_cols=174 Identities=21% Similarity=0.350 Sum_probs=143.5
Q ss_pred HHhhhcccccccccCceeEEEEEeCC-----CCeEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEec-CCc
Q 039310 64 KTVTNNYADVIGCGGSGNVYKGFLPD-----RTPVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCLE-TQV 136 (241)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~-~~~ 136 (241)
...++.+.+.||+|+||.||+|.+.+ +..|++|.+... .......+.+|+.+++.++||||+++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 34566778899999999999998655 678889876643 34456778999999999999999999998766 567
Q ss_pred ceEEEEecCCCCchHHhhcC--------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEcc
Q 039310 137 PLLVYEFVGNGTLFEHIHKN--------GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSD 208 (241)
Q Consensus 137 ~~lv~e~~~~g~L~~~l~~~--------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~D 208 (241)
.++++||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998653 35899999999999999999999998 99999999999999999999999
Q ss_pred CCCcccccCCccc-eeeeecccccccccccccC
Q 039310 209 FGASKLVPIDAIQ-NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 209 fgla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~ 240 (241)
||+++.+...... ......++..|+|||++.+
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~ 193 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVN 193 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhc
Confidence 9999865433221 1122335778999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-29 Score=202.77 Aligned_cols=168 Identities=28% Similarity=0.372 Sum_probs=137.9
Q ss_pred cccccccccCceeEEEEEe-----CCCCeEEEEecccCC-hhhHHHHHHHHHHHHcCCCCCceeEEEEEecC--CcceEE
Q 039310 69 NYADVIGCGGSGNVYKGFL-----PDRTPVAVKKSKIVD-QTKIDEFINELVVVSQINRRNVVRLLACCLET--QVPLLV 140 (241)
Q Consensus 69 ~~~~~lg~G~~g~V~~~~~-----~~~~~vavk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~--~~~~lv 140 (241)
.+.+.||+|+||+||++.. .++..||+|...... ......+.+|+++++.++||||+++++++... ...+++
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 5677899999999988652 356789999876532 33456788999999999999999999988653 457899
Q ss_pred EEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcc
Q 039310 141 YEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAI 220 (241)
Q Consensus 141 ~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~ 220 (241)
|||+++++|.+++... .+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++........
T Consensus 87 ~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 162 (283)
T cd05080 87 MEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 162 (283)
T ss_pred ecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence 9999999999999764 5999999999999999999999998 99999999999999999999999999886643221
Q ss_pred c--eeeeecccccccccccccC
Q 039310 221 Q--NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 221 ~--~~~~~~gt~~y~aPE~l~~ 240 (241)
. ......++..|+|||.+.+
T Consensus 163 ~~~~~~~~~~~~~~~~PE~~~~ 184 (283)
T cd05080 163 YYRVREDGDSPVFWYAVECLKE 184 (283)
T ss_pred hhccCCCCCCCceeeCHhHhcc
Confidence 1 1112235677999998754
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=207.00 Aligned_cols=165 Identities=28% Similarity=0.395 Sum_probs=141.7
Q ss_pred cccccccCceeEEEEEeC-CCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCCCCc
Q 039310 71 ADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTL 149 (241)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~g~L 149 (241)
...||+|+||.||+|... ++..|++|.+........+.+.+|+.+++.++|||++++++++...+..++++||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 336999999999999854 6889999987655555556788999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeeeeccc
Q 039310 150 FEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGT 229 (241)
Q Consensus 150 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt 229 (241)
..++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....+. .......|+
T Consensus 106 ~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~~ 180 (297)
T cd06659 106 TDIVSQ-TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKSLVGT 180 (297)
T ss_pred HHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccccceecC
Confidence 987754 46899999999999999999999998 9999999999999999999999999987553322 122334589
Q ss_pred ccccccccccC
Q 039310 230 LGYIDPEYLQT 240 (241)
Q Consensus 230 ~~y~aPE~l~~ 240 (241)
+.|+|||++.+
T Consensus 181 ~~y~aPE~~~~ 191 (297)
T cd06659 181 PYWMAPEVISR 191 (297)
T ss_pred ccccCHHHHcc
Confidence 99999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-29 Score=204.42 Aligned_cols=167 Identities=29% Similarity=0.399 Sum_probs=133.7
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccCC--hhhHHHHHHHHHHHHcC---CCCCceeEEEEEecC-----Cc
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD--QTKIDEFINELVVVSQI---NRRNVVRLLACCLET-----QV 136 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l---~h~ni~~l~~~~~~~-----~~ 136 (241)
|...+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.+ +||||+++++++... ..
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 456678999999999999854 58889999776422 22223456777777665 799999999998642 35
Q ss_pred ceEEEEecCCCCchHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCccc
Q 039310 137 PLLVYEFVGNGTLFEHIHKN--GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKL 214 (241)
Q Consensus 137 ~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~ 214 (241)
.+++||++++ +|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++..
T Consensus 82 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 82 VTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARI 157 (288)
T ss_pred EEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcccc
Confidence 7899999974 888888654 34899999999999999999999999 99999999999999999999999999986
Q ss_pred ccCCccceeeeecccccccccccccC
Q 039310 215 VPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 215 ~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
..... ......||+.|+|||++.+
T Consensus 158 ~~~~~--~~~~~~~~~~y~aPE~~~~ 181 (288)
T cd07863 158 YSCQM--ALTPVVVTLWYRAPEVLLQ 181 (288)
T ss_pred ccCcc--cCCCccccccccCchHhhC
Confidence 54222 1223458999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-29 Score=204.19 Aligned_cols=171 Identities=23% Similarity=0.394 Sum_probs=139.8
Q ss_pred hhhcccccccccCceeEEEEEeC-----------------CCCeEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-----------------DRTPVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRL 127 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-----------------~~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l 127 (241)
..+.+.+.||+|+||.||++... +...+|+|..... ......++.+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 45677889999999999998532 2345888887643 33445688999999999999999999
Q ss_pred EEEEecCCcceEEEEecCCCCchHHhhcCC-----------CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCe
Q 039310 128 LACCLETQVPLLVYEFVGNGTLFEHIHKNG-----------NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANI 196 (241)
Q Consensus 128 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Ni 196 (241)
++++...+..+++|||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 999999999999999999999999987542 3677889999999999999999998 99999999999
Q ss_pred eeCCCCCeEEccCCCcccccCCccce-eeeeccccccccccccc
Q 039310 197 LLDENYTPKVSDFGASKLVPIDAIQN-YTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 197 li~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~l~ 239 (241)
|+++++.++|+|||++..+....... .....+++.|+|||...
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 205 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESIL 205 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHh
Confidence 99999999999999988653332211 11122467899999754
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=198.46 Aligned_cols=165 Identities=28% Similarity=0.404 Sum_probs=136.4
Q ss_pred ccccccCceeEEEEEeCC----CCeEEEEecccCCh-hhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCC
Q 039310 72 DVIGCGGSGNVYKGFLPD----RTPVAVKKSKIVDQ-TKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGN 146 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~----~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~ 146 (241)
+.||+|+||.||+|.+.. +..+++|....... ...+.+.+|+.+++.++||||+++++++.. +..+++|||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence 368999999999997432 26799998765433 345678999999999999999999998764 467999999999
Q ss_pred CCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcccee--e
Q 039310 147 GTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNY--T 224 (241)
Q Consensus 147 g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~--~ 224 (241)
++|.+++.....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~ 156 (257)
T cd05060 80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT 156 (257)
T ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCccccccc
Confidence 999999988878999999999999999999999998 99999999999999999999999999887643322111 1
Q ss_pred eecccccccccccccC
Q 039310 225 VVQGTLGYIDPEYLQT 240 (241)
Q Consensus 225 ~~~gt~~y~aPE~l~~ 240 (241)
...++..|+|||.+.+
T Consensus 157 ~~~~~~~y~aPE~~~~ 172 (257)
T cd05060 157 AGRWPLKWYAPECINY 172 (257)
T ss_pred CccccccccCHHHhcC
Confidence 1223568999998754
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=205.94 Aligned_cols=165 Identities=29% Similarity=0.401 Sum_probs=141.7
Q ss_pred cccccccCceeEEEEEeC-CCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCCCCc
Q 039310 71 ADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTL 149 (241)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~g~L 149 (241)
...||+|+||.||++... ++..||+|++........+.+.+|+.+++.++|||++++++.+...+..+++|||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 346899999999999854 5788999987765555667789999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeeeeccc
Q 039310 150 FEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGT 229 (241)
Q Consensus 150 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt 229 (241)
.+++.. +.+++.++..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||++....... .......|+
T Consensus 107 ~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~~ 181 (292)
T cd06658 107 TDIVTH-TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-PKRKSLVGT 181 (292)
T ss_pred HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc-ccCceeecC
Confidence 998854 46899999999999999999999998 9999999999999999999999999987653322 222334588
Q ss_pred ccccccccccC
Q 039310 230 LGYIDPEYLQT 240 (241)
Q Consensus 230 ~~y~aPE~l~~ 240 (241)
+.|+|||.+.+
T Consensus 182 ~~y~aPE~~~~ 192 (292)
T cd06658 182 PYWMAPEVISR 192 (292)
T ss_pred ccccCHHHHcc
Confidence 99999998743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=211.80 Aligned_cols=167 Identities=28% Similarity=0.330 Sum_probs=138.0
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecC------Cc
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLET------QV 136 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~------~~ 136 (241)
.+|...+.||+|+||.||+|... .+..||||++... +......+.+|+.+++.++||||+++++++... ..
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~ 103 (364)
T cd07875 24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 103 (364)
T ss_pred cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCe
Confidence 45677889999999999999854 5788999987642 334456788999999999999999999987643 35
Q ss_pred ceEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCccccc
Q 039310 137 PLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVP 216 (241)
Q Consensus 137 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~ 216 (241)
.|+||||+++ +|.+.+.. .+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++...
T Consensus 104 ~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 104 VYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred EEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 7999999965 77777753 4889999999999999999999998 9999999999999999999999999998653
Q ss_pred CCccceeeeecccccccccccccC
Q 039310 217 IDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 217 ~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
... ......||+.|+|||++.+
T Consensus 178 ~~~--~~~~~~~t~~y~aPE~~~~ 199 (364)
T cd07875 178 TSF--MMTPYVVTRYYRAPEVILG 199 (364)
T ss_pred CCC--cccCCcccCCcCCHHHHhC
Confidence 221 2233458999999998754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=204.53 Aligned_cols=171 Identities=28% Similarity=0.300 Sum_probs=145.4
Q ss_pred hhcccccccccCceeEEEEEeC-CCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
++++.+.||+|+||.||+|..+ +++.|++|.+... .....+.+.+|+++++.++|+||+++++++...+..+++|||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 3567788999999999999865 5788999976542 333457789999999999999999999999999999999999
Q ss_pred cCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcccee
Q 039310 144 VGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNY 223 (241)
Q Consensus 144 ~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~ 223 (241)
++++.+..+......+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++...........
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (288)
T cd07833 82 VERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL 158 (288)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCccccc
Confidence 998777777766667999999999999999999999998 99999999999999999999999999887654432222
Q ss_pred eeecccccccccccccC
Q 039310 224 TVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 224 ~~~~gt~~y~aPE~l~~ 240 (241)
....+++.|+|||++.+
T Consensus 159 ~~~~~~~~~~~PE~~~~ 175 (288)
T cd07833 159 TDYVATRWYRAPELLVG 175 (288)
T ss_pred cCcccccCCcCCchhcC
Confidence 33457899999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=199.03 Aligned_cols=166 Identities=31% Similarity=0.485 Sum_probs=134.4
Q ss_pred ccccccCceeEEEEEeC----CCCeEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEe-cCCcceEEEEecC
Q 039310 72 DVIGCGGSGNVYKGFLP----DRTPVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCL-ETQVPLLVYEFVG 145 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~----~~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~-~~~~~~lv~e~~~ 145 (241)
+.||+|+||.||+|.+. ....+|+|..... .....+.+.+|+.+++.++||||+++++++. .++..+++|||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 35899999999999853 2356899987543 3445678889999999999999999999775 4556889999999
Q ss_pred CCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc---
Q 039310 146 NGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ--- 221 (241)
Q Consensus 146 ~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~--- 221 (241)
+++|.+++... ...++..+..++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||++.........
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 99999999764 35678888999999999999999998 999999999999999999999999998765332111
Q ss_pred eeeeecccccccccccccC
Q 039310 222 NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~~ 240 (241)
......+++.|+|||.+.+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~ 176 (262)
T cd05058 158 NHTGAKLPVKWMALESLQT 176 (262)
T ss_pred ccccCcCCccccChhHhcc
Confidence 1112335778999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-29 Score=205.14 Aligned_cols=168 Identities=24% Similarity=0.334 Sum_probs=140.2
Q ss_pred hhcccccccccCceeEEEEEeC-CCCeEEEEecccCC-hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEec
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD-QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
.|...+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++||||+++++++...+..+++|||+
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~ 86 (301)
T cd07873 7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 86 (301)
T ss_pred ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEecc
Confidence 4566778999999999999854 57889999876432 223456778999999999999999999999999999999999
Q ss_pred CCCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcccee
Q 039310 145 GNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNY 223 (241)
Q Consensus 145 ~~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~ 223 (241)
+ ++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++........ ..
T Consensus 87 ~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~ 161 (301)
T cd07873 87 D-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-TY 161 (301)
T ss_pred c-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-cc
Confidence 7 5888888654 46899999999999999999999998 99999999999999999999999999876432221 12
Q ss_pred eeeccccccccccccc
Q 039310 224 TVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 224 ~~~~gt~~y~aPE~l~ 239 (241)
....+++.|+|||.+.
T Consensus 162 ~~~~~~~~y~~PE~~~ 177 (301)
T cd07873 162 SNEVVTLWYRPPDILL 177 (301)
T ss_pred cccceeecccCcHHHh
Confidence 2234789999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=199.69 Aligned_cols=162 Identities=25% Similarity=0.325 Sum_probs=141.1
Q ss_pred ccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCCCCc
Q 039310 74 IGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTL 149 (241)
Q Consensus 74 lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~g~L 149 (241)
||.|++|.||+|... ++..+++|..... .....+.+.+|+.+++.++||||+++++.+.+++..++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999965 4788999986542 223456789999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeeeeccc
Q 039310 150 FEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGT 229 (241)
Q Consensus 150 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt 229 (241)
.+++.....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++....... ......++
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~~ 155 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCGT 155 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccCC
Confidence 999988778999999999999999999999998 9999999999999999999999999988764432 22334588
Q ss_pred ccccccccccC
Q 039310 230 LGYIDPEYLQT 240 (241)
Q Consensus 230 ~~y~aPE~l~~ 240 (241)
+.|+|||.+.+
T Consensus 156 ~~~~~PE~~~~ 166 (262)
T cd05572 156 PEYVAPEIILN 166 (262)
T ss_pred cCccChhHhcC
Confidence 99999998753
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=198.57 Aligned_cols=169 Identities=23% Similarity=0.350 Sum_probs=141.5
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEec-CCcceEEEEe
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLE-TQVPLLVYEF 143 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~-~~~~~lv~e~ 143 (241)
|.+.+.||+|++|.||++... +++.+++|++... .....+.+.+|+++++.++|||++++++.+.. ....+++|||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence 567788999999999999854 4778999987542 33455678899999999999999999998865 4467899999
Q ss_pred cCCCCchHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc
Q 039310 144 VGNGTLFEHIHKN--GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ 221 (241)
Q Consensus 144 ~~~g~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~ 221 (241)
+++++|.+++... ..+++.++..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||++....... .
T Consensus 82 ~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~-~ 157 (257)
T cd08223 82 CEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-D 157 (257)
T ss_pred cCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC-C
Confidence 9999999998753 35899999999999999999999999 9999999999999999999999999988664322 1
Q ss_pred eeeeecccccccccccccC
Q 039310 222 NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~~ 240 (241)
......+++.|+|||++.+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~ 176 (257)
T cd08223 158 MASTLIGTPYYMSPELFSN 176 (257)
T ss_pred ccccccCCcCccChhHhcC
Confidence 2233458899999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=199.41 Aligned_cols=171 Identities=26% Similarity=0.420 Sum_probs=142.3
Q ss_pred hhcccccccccCceeEEEEEeC-CCCeEEEEecccC-----ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecC--Ccce
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV-----DQTKIDEFINELVVVSQINRRNVVRLLACCLET--QVPL 138 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~-----~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~--~~~~ 138 (241)
.+.+.+.||+|+||.||+|... ++..+++|..... .......+.+|+++++.++||||+++++++.+. ...+
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS 82 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence 3566789999999999999854 5889999976431 233456788999999999999999999998764 4578
Q ss_pred EEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCC
Q 039310 139 LVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPID 218 (241)
Q Consensus 139 lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~ 218 (241)
+++||+++++|.+++...+.+++.....++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 83 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 83 IFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTI 159 (264)
T ss_pred EEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence 99999999999999988778999999999999999999999999 999999999999999999999999998765321
Q ss_pred cc--ceeeeecccccccccccccC
Q 039310 219 AI--QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 219 ~~--~~~~~~~gt~~y~aPE~l~~ 240 (241)
.. .......|+..|+|||.+.+
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~ 183 (264)
T cd06653 160 CMSGTGIKSVTGTPYWMSPEVISG 183 (264)
T ss_pred cccCccccccCCcccccCHhhhcC
Confidence 11 11123458899999998754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-30 Score=205.36 Aligned_cols=170 Identities=25% Similarity=0.330 Sum_probs=139.4
Q ss_pred hhcccccccccCceeEEEEEeCC-----CCeEEEEecccCCh--hhHHHHHHHHHHHHcCCCCCceeEEEEEec-CCcce
Q 039310 67 TNNYADVIGCGGSGNVYKGFLPD-----RTPVAVKKSKIVDQ--TKIDEFINELVVVSQINRRNVVRLLACCLE-TQVPL 138 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~-~~~~~ 138 (241)
.|+....||+|.||.||+|...+ ...+|+|+++.... .-.....+|+.+++.++|||++.+..++.. +...+
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~ 104 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW 104 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence 45667789999999999995222 33689998765422 223567899999999999999999999877 77899
Q ss_pred EEEEecCCCCchHHhhcC-----CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC----CCeEEccC
Q 039310 139 LVYEFVGNGTLFEHIHKN-----GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDEN----YTPKVSDF 209 (241)
Q Consensus 139 lv~e~~~~g~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~----~~~kl~Df 209 (241)
+++||.+. +|.++++.+ ..++...+..++.|++.|+.|||+.- ++||||||.|||+..+ |.+||+||
T Consensus 105 l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 105 LLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred EEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeecc
Confidence 99999987 999998643 25999999999999999999999999 9999999999999877 89999999
Q ss_pred CCcccccCCc--cceeeeecccccccccccccC
Q 039310 210 GASKLVPIDA--IQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 210 gla~~~~~~~--~~~~~~~~gt~~y~aPE~l~~ 240 (241)
|+|+.+.+.- ......+.-|..|.|||.|.+
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLG 213 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLG 213 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcc
Confidence 9999874321 122333457999999999865
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=223.69 Aligned_cols=168 Identities=26% Similarity=0.298 Sum_probs=145.5
Q ss_pred hhcccccccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEE
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYE 142 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e 142 (241)
.|.+.+.||+|+||.||+|... ++..||+|.+... .......+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 5 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmE 84 (669)
T cd05610 5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVME 84 (669)
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEe
Confidence 4566788999999999999965 5889999987542 23345678899999999999999999999999999999999
Q ss_pred ecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccce
Q 039310 143 FVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQN 222 (241)
Q Consensus 143 ~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~ 222 (241)
|+++++|.+++...+.+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 85 y~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~~~~~~~~-~ 160 (669)
T cd05610 85 YLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNREL-N 160 (669)
T ss_pred CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCccccCCcc-c
Confidence 9999999999988778999999999999999999999998 99999999999999999999999999987643322 2
Q ss_pred eeeecccccccccccc
Q 039310 223 YTVVQGTLGYIDPEYL 238 (241)
Q Consensus 223 ~~~~~gt~~y~aPE~l 238 (241)
.....+|+.|++||..
T Consensus 161 ~~~~~~t~~~~~pe~~ 176 (669)
T cd05610 161 MMDILTTPSMAKPKND 176 (669)
T ss_pred ccccccCccccCcccc
Confidence 3345689999999853
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=200.62 Aligned_cols=169 Identities=27% Similarity=0.393 Sum_probs=145.4
Q ss_pred hhcccccccccCceeEEEEEeC-CCCeEEEEecccCC-hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEec
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD-QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
+|.+.+.||.|++|.||+|... ++..+++|...... ......+.+|+.+++.++|||++++++++.+....++++||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 3556678999999999999854 57889999876432 344567889999999999999999999999999999999999
Q ss_pred CCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceee
Q 039310 145 GNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYT 224 (241)
Q Consensus 145 ~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~ 224 (241)
++++|.+++... ++++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||++....... ....
T Consensus 82 ~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~ 156 (274)
T cd06609 82 GGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-SKRN 156 (274)
T ss_pred CCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-cccc
Confidence 999999999865 7899999999999999999999998 9999999999999999999999999998764332 2223
Q ss_pred eecccccccccccccC
Q 039310 225 VVQGTLGYIDPEYLQT 240 (241)
Q Consensus 225 ~~~gt~~y~aPE~l~~ 240 (241)
...+++.|+|||.+.+
T Consensus 157 ~~~~~~~y~~PE~~~~ 172 (274)
T cd06609 157 TFVGTPFWMAPEVIKQ 172 (274)
T ss_pred cccCCccccChhhhcc
Confidence 3458889999998764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=220.09 Aligned_cols=171 Identities=18% Similarity=0.240 Sum_probs=133.3
Q ss_pred HhhhcccccccccCceeEEEEEeCC--CCeEEEE------------------ecccCChhhHHHHHHHHHHHHcCCCCCc
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFLPD--RTPVAVK------------------KSKIVDQTKIDEFINELVVVSQINRRNV 124 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavk------------------~~~~~~~~~~~~~~~E~~~l~~l~h~ni 124 (241)
...|.+.+.||+|+||+||+|..+. +...+.| ... ........+.+|+.+++.++||||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCCc
Confidence 4567788899999999999986432 1111111 111 122234567899999999999999
Q ss_pred eeEEEEEecCCcceEEEEecCCCCchHHhhcCC-----CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC
Q 039310 125 VRLLACCLETQVPLLVYEFVGNGTLFEHIHKNG-----NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLD 199 (241)
Q Consensus 125 ~~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~ 199 (241)
+++++++...+..|+++|++. +++.+++.... ......+..++.|++.||.|||+++ |+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence 999999999999999999995 57777765321 2345677889999999999999998 99999999999999
Q ss_pred CCCCeEEccCCCcccccCCccceeeeecccccccccccccC
Q 039310 200 ENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 200 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
.++.+||+|||++..+............||+.|+|||++.+
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 342 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG 342 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcC
Confidence 99999999999998765433333334569999999999864
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=197.88 Aligned_cols=168 Identities=30% Similarity=0.446 Sum_probs=144.8
Q ss_pred hhcccccccccCceeEEEEEeCC-CCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecC
Q 039310 67 TNNYADVIGCGGSGNVYKGFLPD-RTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVG 145 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~~-~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~ 145 (241)
.+.+.+.||+|+||.||+|...+ +..+++|.+..... .+++.+|+++++.++||||+++++++.+....++++||++
T Consensus 4 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 81 (256)
T cd06612 4 VFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG 81 (256)
T ss_pred cchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence 45667789999999999999664 78899998764332 6789999999999999999999999999999999999999
Q ss_pred CCCchHHhhc-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceee
Q 039310 146 NGTLFEHIHK-NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYT 224 (241)
Q Consensus 146 ~g~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~ 224 (241)
+++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++........ ...
T Consensus 82 ~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~ 157 (256)
T cd06612 82 AGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-KRN 157 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-ccc
Confidence 9999999975 446899999999999999999999998 99999999999999999999999999887643321 223
Q ss_pred eecccccccccccccC
Q 039310 225 VVQGTLGYIDPEYLQT 240 (241)
Q Consensus 225 ~~~gt~~y~aPE~l~~ 240 (241)
...++..|+|||++.+
T Consensus 158 ~~~~~~~y~~PE~~~~ 173 (256)
T cd06612 158 TVIGTPFWMAPEVIQE 173 (256)
T ss_pred cccCCccccCHHHHhc
Confidence 3447899999998754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=202.70 Aligned_cols=168 Identities=29% Similarity=0.361 Sum_probs=146.1
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
+.+.+.||.|+||.||+|... ++..+++|..... .....+.+.+|++++++++||||+++++++.+....++++||
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL 81 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence 456778999999999999865 5888999977542 224567889999999999999999999999999999999999
Q ss_pred cCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcccee
Q 039310 144 VGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNY 223 (241)
Q Consensus 144 ~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~ 223 (241)
+++++|.+++....++++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++....... ..
T Consensus 82 ~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~ 156 (258)
T cd05578 82 LLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LT 156 (258)
T ss_pred CCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc--cc
Confidence 999999999988778999999999999999999999998 9999999999999999999999999987654332 22
Q ss_pred eeecccccccccccccC
Q 039310 224 TVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 224 ~~~~gt~~y~aPE~l~~ 240 (241)
....|+..|+|||.+.+
T Consensus 157 ~~~~~~~~y~~PE~~~~ 173 (258)
T cd05578 157 TSTSGTPGYMAPEVLCR 173 (258)
T ss_pred cccCCChhhcCHHHHcc
Confidence 33458899999998753
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=205.30 Aligned_cols=168 Identities=26% Similarity=0.317 Sum_probs=142.9
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccCC--hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEec
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD--QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
+...+.||+|+||.||+|..+ +++.+|+|...... ....+.+.+|+++++.++||||+++++++...+..++++||+
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 82 (286)
T cd07846 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFV 82 (286)
T ss_pred eeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecC
Confidence 556778999999999999975 57889999765422 223456889999999999999999999999999999999999
Q ss_pred CCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceee
Q 039310 145 GNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYT 224 (241)
Q Consensus 145 ~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~ 224 (241)
++++|..+......+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++....... ....
T Consensus 83 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~~~ 158 (286)
T cd07846 83 DHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYT 158 (286)
T ss_pred CccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-cccC
Confidence 99899888776667999999999999999999999998 9999999999999999999999999988654322 2222
Q ss_pred eeccccccccccccc
Q 039310 225 VVQGTLGYIDPEYLQ 239 (241)
Q Consensus 225 ~~~gt~~y~aPE~l~ 239 (241)
...++..|+|||++.
T Consensus 159 ~~~~~~~y~aPE~~~ 173 (286)
T cd07846 159 DYVATRWYRAPELLV 173 (286)
T ss_pred cccceeeccCcHHhc
Confidence 334788999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=205.46 Aligned_cols=168 Identities=26% Similarity=0.385 Sum_probs=139.9
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEec
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
|.+.+.||+|+||.||+|... ++..+++|.+... .......+.+|+.+++.++||||+++++++.+.+..++++||+
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC 81 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence 456678999999999999864 5888999987543 2223356778999999999999999999999999999999999
Q ss_pred CCCCchHHhhc-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcccee
Q 039310 145 GNGTLFEHIHK-NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNY 223 (241)
Q Consensus 145 ~~g~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~ 223 (241)
+ ++|.+++.. ...+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 82 ~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~ 156 (284)
T cd07839 82 D-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-RCY 156 (284)
T ss_pred C-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC-CCc
Confidence 7 478777754 457999999999999999999999999 9999999999999999999999999988653322 112
Q ss_pred eeecccccccccccccC
Q 039310 224 TVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 224 ~~~~gt~~y~aPE~l~~ 240 (241)
....+++.|+|||.+.+
T Consensus 157 ~~~~~~~~y~aPE~~~~ 173 (284)
T cd07839 157 SAEVVTLWYRPPDVLFG 173 (284)
T ss_pred CCCccccCCcChHHHhC
Confidence 22347899999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=197.47 Aligned_cols=169 Identities=28% Similarity=0.394 Sum_probs=147.5
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccCCh-hhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecC
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQ-TKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVG 145 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~ 145 (241)
+.+.+.||+|++|.||+|... ++..+++|+...... .....+.+|+..++.++|+|++++++++...+..++++||++
T Consensus 3 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (264)
T cd06623 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMD 82 (264)
T ss_pred ceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecC
Confidence 445678999999999999865 488999998766543 456789999999999999999999999999999999999999
Q ss_pred CCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceee
Q 039310 146 NGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHS-ETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYT 224 (241)
Q Consensus 146 ~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~ 224 (241)
+++|.+++.....+++.....++.|++.|+.|||+ .+ ++|+||+|+||+++.++.++|+|||++......... ..
T Consensus 83 ~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~-~~ 158 (264)
T cd06623 83 GGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ-CN 158 (264)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCCc-cc
Confidence 99999999887889999999999999999999999 88 999999999999999999999999998876433322 12
Q ss_pred eecccccccccccccC
Q 039310 225 VVQGTLGYIDPEYLQT 240 (241)
Q Consensus 225 ~~~gt~~y~aPE~l~~ 240 (241)
...++..|+|||.+.+
T Consensus 159 ~~~~~~~y~~pE~~~~ 174 (264)
T cd06623 159 TFVGTVTYMSPERIQG 174 (264)
T ss_pred ceeecccccCHhhhCC
Confidence 3457899999998764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=200.38 Aligned_cols=168 Identities=24% Similarity=0.404 Sum_probs=143.4
Q ss_pred hcccccccccCceeEEEEEe-CCCCeEEEEecccC-ChhhHHHHHHHHHHHHcCC---CCCceeEEEEEecCCcceEEEE
Q 039310 68 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIV-DQTKIDEFINELVVVSQIN---RRNVVRLLACCLETQVPLLVYE 142 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~---h~ni~~l~~~~~~~~~~~lv~e 142 (241)
|...+.||+|+||.||+|.. .++..+++|.+... ......++.+|+.+++.++ |||++++++++......+++||
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e 82 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME 82 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence 44566899999999999985 46888999986543 3345567889999999996 9999999999999999999999
Q ss_pred ecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccce
Q 039310 143 FVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQN 222 (241)
Q Consensus 143 ~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~ 222 (241)
|+++++|.+++... .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++........ .
T Consensus 83 ~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~ 157 (277)
T cd06917 83 YAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS-K 157 (277)
T ss_pred cCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc-c
Confidence 99999999998664 7899999999999999999999998 99999999999999999999999999887654332 2
Q ss_pred eeeecccccccccccccC
Q 039310 223 YTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 223 ~~~~~gt~~y~aPE~l~~ 240 (241)
.....|++.|+|||.+.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~ 175 (277)
T cd06917 158 RSTFVGTPYWMAPEVITE 175 (277)
T ss_pred cccccCCcceeCHHHhcc
Confidence 233458899999998754
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=197.79 Aligned_cols=165 Identities=27% Similarity=0.410 Sum_probs=138.0
Q ss_pred hhhcccccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEe-cCCcceEEEEec
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCL-ETQVPLLVYEFV 144 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~-~~~~~~lv~e~~ 144 (241)
..+.+.+.||+|+||.||+|... +..+++|..... ...+.+.+|+.+++.++|+|++++++++. .++..+++|||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 35667789999999999999874 677999976532 23467889999999999999999999764 456789999999
Q ss_pred CCCCchHHhhcCC--CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccce
Q 039310 145 GNGTLFEHIHKNG--NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQN 222 (241)
Q Consensus 145 ~~g~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~ 222 (241)
++++|.+++.... .+++..+..++.|++.||+|||+++ ++|+||||+||++++++.+||+|||++.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--- 156 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence 9999999997644 4889999999999999999999998 9999999999999999999999999987643221
Q ss_pred eeeecccccccccccccC
Q 039310 223 YTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 223 ~~~~~gt~~y~aPE~l~~ 240 (241)
....++..|+|||++.+
T Consensus 157 -~~~~~~~~y~aPE~~~~ 173 (256)
T cd05082 157 -DTGKLPVKWTAPEALRE 173 (256)
T ss_pred -CCCccceeecCHHHHcc
Confidence 12235678999998754
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=201.61 Aligned_cols=168 Identities=30% Similarity=0.447 Sum_probs=142.2
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecC
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVG 145 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~ 145 (241)
+...+.||+|+||.||+|... ++..||+|..... .....+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 444567999999999999854 5778999976643 23455678899999999999999999999999999999999999
Q ss_pred CCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeee
Q 039310 146 NGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTV 225 (241)
Q Consensus 146 ~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~ 225 (241)
+++|.+++.. ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++++|||++........ ....
T Consensus 86 ~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~~ 160 (277)
T cd06642 86 GGSALDLLKP-GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRNT 160 (277)
T ss_pred CCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch-hhhc
Confidence 9999998865 46899999999999999999999998 99999999999999999999999999876543221 1222
Q ss_pred ecccccccccccccC
Q 039310 226 VQGTLGYIDPEYLQT 240 (241)
Q Consensus 226 ~~gt~~y~aPE~l~~ 240 (241)
..|+..|+|||.+.+
T Consensus 161 ~~~~~~y~aPE~~~~ 175 (277)
T cd06642 161 FVGTPFWMAPEVIKQ 175 (277)
T ss_pred ccCcccccCHHHhCc
Confidence 357889999998764
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=201.15 Aligned_cols=169 Identities=25% Similarity=0.315 Sum_probs=138.5
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEecccCChhhHHHHHHHHHHHHcC-CCCCceeEEEEEe-----cCCcce
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQTKIDEFINELVVVSQI-NRRNVVRLLACCL-----ETQVPL 138 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~-----~~~~~~ 138 (241)
..+.+.+.||+|+||.||+|... ++..+++|....... ....+.+|+.+++.+ +||||+++++++. ..+..+
T Consensus 18 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~ 96 (286)
T cd06638 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLW 96 (286)
T ss_pred cceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEE
Confidence 45566778999999999999854 577899997654322 235677899999999 6999999999874 345689
Q ss_pred EEEEecCCCCchHHhh----cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCccc
Q 039310 139 LVYEFVGNGTLFEHIH----KNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKL 214 (241)
Q Consensus 139 lv~e~~~~g~L~~~l~----~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~ 214 (241)
++|||+++++|.+++. ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++..
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~ 173 (286)
T cd06638 97 LVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQ 173 (286)
T ss_pred EEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEccCCceee
Confidence 9999999999998875 2346889999999999999999999998 99999999999999999999999999876
Q ss_pred ccCCccceeeeeccccccccccccc
Q 039310 215 VPIDAIQNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 215 ~~~~~~~~~~~~~gt~~y~aPE~l~ 239 (241)
...... ......|++.|+|||++.
T Consensus 174 ~~~~~~-~~~~~~~~~~y~aPE~~~ 197 (286)
T cd06638 174 LTSTRL-RRNTSVGTPFWMAPEVIA 197 (286)
T ss_pred cccCCC-ccccccCCCcccChhhhc
Confidence 543221 222345899999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=203.99 Aligned_cols=145 Identities=27% Similarity=0.317 Sum_probs=129.1
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccCC---hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD---QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
+...+.||+|++|.||+|... ++..+++|...... ....+.+.+|+++++.++||||+++++.+...+..+++|||
T Consensus 3 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (316)
T cd05574 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDY 82 (316)
T ss_pred eEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEe
Confidence 456678999999999999865 48899999876432 23556788999999999999999999999999999999999
Q ss_pred cCCCCchHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccc
Q 039310 144 VGNGTLFEHIHKN--GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLV 215 (241)
Q Consensus 144 ~~~g~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~ 215 (241)
+.+++|.+++... ..+++.....++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++...
T Consensus 83 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 153 (316)
T cd05574 83 CPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQS 153 (316)
T ss_pred cCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcc
Confidence 9999999998754 46899999999999999999999998 999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=202.01 Aligned_cols=172 Identities=27% Similarity=0.399 Sum_probs=141.0
Q ss_pred hhhcccccccccCceeEEEEEeC------CCCeEEEEecccCC-hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcce
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP------DRTPVAVKKSKIVD-QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPL 138 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~ 138 (241)
..+...+.||+|+||.||+|... ++..+++|.+.... ......+.+|+.+++.++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMC 84 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccE
Confidence 34566778999999999999853 36789999876533 334567889999999999999999999999999999
Q ss_pred EEEEecCCCCchHHhhcCC----------------------CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCe
Q 039310 139 LVYEFVGNGTLFEHIHKNG----------------------NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANI 196 (241)
Q Consensus 139 lv~e~~~~g~L~~~l~~~~----------------------~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Ni 196 (241)
+++||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||+|+||
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~ni 161 (288)
T cd05050 85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRNC 161 (288)
T ss_pred EEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhhe
Confidence 9999999999999996431 3778889999999999999999998 99999999999
Q ss_pred eeCCCCCeEEccCCCcccccCCccc-eeeeecccccccccccccC
Q 039310 197 LLDENYTPKVSDFGASKLVPIDAIQ-NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 197 li~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~ 240 (241)
++++++.++|+|||++..+...... ......+++.|+|||.+.+
T Consensus 162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 206 (288)
T cd05050 162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY 206 (288)
T ss_pred EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhc
Confidence 9999999999999998765332211 1112234678999998653
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-30 Score=211.56 Aligned_cols=174 Identities=30% Similarity=0.365 Sum_probs=150.5
Q ss_pred HHHHhhhcccccccccCceeEEEEEeCC-CCeEEEEeccc---CChhhHHHHHHHHHHHHcC-CCCCceeEEEEEecCCc
Q 039310 62 EIKTVTNNYADVIGCGGSGNVYKGFLPD-RTPVAVKKSKI---VDQTKIDEFINELVVVSQI-NRRNVVRLLACCLETQV 136 (241)
Q Consensus 62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavk~~~~---~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~ 136 (241)
.+.....+|..+||+|+||+|.+|..++ ...+|||.++. ....+.+-.+.|-++|+.. +-|.++++..+|+.-++
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 4555667888999999999999998654 55678886653 2333456667888999887 57899999999999999
Q ss_pred ceEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCccccc
Q 039310 137 PLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVP 216 (241)
Q Consensus 137 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~ 216 (241)
+|+||||+.||+|...+..-+++.+..+..++.+|+-||-+||+++ ||+||||.+|||+|.+|.+||+|||+++.-.
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc
Confidence 9999999999999999999999999999999999999999999999 9999999999999999999999999998643
Q ss_pred CCccceeeeeccccccccccccc
Q 039310 217 IDAIQNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 217 ~~~~~~~~~~~gt~~y~aPE~l~ 239 (241)
.+. ..+.+++|||.|+|||++.
T Consensus 502 ~~~-~TTkTFCGTPdYiAPEIi~ 523 (683)
T KOG0696|consen 502 FDG-VTTKTFCGTPDYIAPEIIA 523 (683)
T ss_pred cCC-cceeeecCCCcccccceEE
Confidence 333 4567789999999999974
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=200.72 Aligned_cols=162 Identities=28% Similarity=0.331 Sum_probs=137.7
Q ss_pred ccccCceeEEEEEeC-CCCeEEEEecccCC---hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCCCCc
Q 039310 74 IGCGGSGNVYKGFLP-DRTPVAVKKSKIVD---QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTL 149 (241)
Q Consensus 74 lg~G~~g~V~~~~~~-~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~g~L 149 (241)
||+|+||+||+|... ++..+++|.+.... ......+.+|+.+++.++||||+++++.+...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999854 57889999765321 22345667899999999999999999999999999999999999999
Q ss_pred hHHhhcCC--CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeeeec
Q 039310 150 FEHIHKNG--NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQ 227 (241)
Q Consensus 150 ~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 227 (241)
.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++....... ......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRA 155 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC--cccccc
Confidence 99997655 6999999999999999999999998 9999999999999999999999999987654321 222334
Q ss_pred ccccccccccccC
Q 039310 228 GTLGYIDPEYLQT 240 (241)
Q Consensus 228 gt~~y~aPE~l~~ 240 (241)
++..|+|||++.+
T Consensus 156 ~~~~y~~PE~~~~ 168 (277)
T cd05577 156 GTPGYMAPEVLQG 168 (277)
T ss_pred CCCCcCCHHHhcC
Confidence 7889999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=202.17 Aligned_cols=169 Identities=24% Similarity=0.305 Sum_probs=138.1
Q ss_pred hhcccccccccCceeEEEEEeC-CCCeEEEEecccCC-hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEec
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD-QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
.|...+.||+|+||.||+|... ++..+++|.+.... ......+.+|+.+++.++|+||+++.+++...+..++++||+
T Consensus 6 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 85 (291)
T cd07870 6 SYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYM 85 (291)
T ss_pred eeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEecc
Confidence 4566778999999999999854 58899999875432 222346678999999999999999999999999999999999
Q ss_pred CCCCchHHhhc-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcccee
Q 039310 145 GNGTLFEHIHK-NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNY 223 (241)
Q Consensus 145 ~~g~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~ 223 (241)
+ +++.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....... ...
T Consensus 86 ~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~ 160 (291)
T cd07870 86 H-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS-QTY 160 (291)
T ss_pred c-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCC-CCC
Confidence 6 577666654 346888999999999999999999998 9999999999999999999999999987643221 112
Q ss_pred eeecccccccccccccC
Q 039310 224 TVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 224 ~~~~gt~~y~aPE~l~~ 240 (241)
....+++.|+|||++.+
T Consensus 161 ~~~~~~~~y~aPE~~~~ 177 (291)
T cd07870 161 SSEVVTLWYRPPDVLLG 177 (291)
T ss_pred CCccccccccCCceeec
Confidence 22347899999998753
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=206.39 Aligned_cols=162 Identities=17% Similarity=0.125 Sum_probs=124.8
Q ss_pred HhhhcccccccccCceeEEEEEeC--CCCeEEEEecccC-----ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcc
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFLP--DRTPVAVKKSKIV-----DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVP 137 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavk~~~~~-----~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~ 137 (241)
...|.+.+.||+|+||+||+|.+. ++..+|||+.... .....+.+.+|+++|+.++|+|++..+.. .+..
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~ 93 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKD 93 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCc
Confidence 345778889999999999999854 4677899875422 22235678999999999999999853322 2457
Q ss_pred eEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCC-CCCCeeeCCCCCeEEccCCCccccc
Q 039310 138 LLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDV-KSANILLDENYTPKVSDFGASKLVP 216 (241)
Q Consensus 138 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dl-k~~Nili~~~~~~kl~Dfgla~~~~ 216 (241)
++||||++|++|.. +.. .. ...++.|++.+|.|||+.+ |+|||| ||+|||++.++.+||+|||+|+.+.
T Consensus 94 ~LVmE~~~G~~L~~-~~~---~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~ 163 (365)
T PRK09188 94 GLVRGWTEGVPLHL-ARP---HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR 163 (365)
T ss_pred EEEEEccCCCCHHH-hCc---cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence 99999999999963 211 11 1467899999999999999 999999 9999999999999999999998764
Q ss_pred CCcc-------ceeeeeccccccccccccc
Q 039310 217 IDAI-------QNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 217 ~~~~-------~~~~~~~gt~~y~aPE~l~ 239 (241)
.... .......+++.|+|||.+.
T Consensus 164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 164 RRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred cCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 3321 1112345788899999985
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-30 Score=235.18 Aligned_cols=168 Identities=29% Similarity=0.381 Sum_probs=145.3
Q ss_pred ccccccccCceeEEEEE-eCCCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCC
Q 039310 70 YADVIGCGGSGNVYKGF-LPDRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGN 146 (241)
Q Consensus 70 ~~~~lg~G~~g~V~~~~-~~~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~ 146 (241)
.+..||.|.||.||.|. .++|.-.|+|.+... .........+|..++..++|||+|+++|+-.+++..+|.||||++
T Consensus 1239 rg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~ 1318 (1509)
T KOG4645|consen 1239 RGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEG 1318 (1509)
T ss_pred cccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhcc
Confidence 34589999999999987 556888899976653 333445678999999999999999999999999999999999999
Q ss_pred CCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcc---cee
Q 039310 147 GTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAI---QNY 223 (241)
Q Consensus 147 g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~---~~~ 223 (241)
|+|.+.+...+..++.....+..|++.|++|||+.| |||||+||.||+++.+|.+|..|||.|..+..... ...
T Consensus 1319 GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el 1395 (1509)
T KOG4645|consen 1319 GSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGEL 1395 (1509)
T ss_pred CcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHH
Confidence 999999998888888888999999999999999999 99999999999999999999999999988754421 112
Q ss_pred eeecccccccccccccC
Q 039310 224 TVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 224 ~~~~gt~~y~aPE~l~~ 240 (241)
....|||-|||||++.+
T Consensus 1396 ~~~~GT~~YMAPEvit~ 1412 (1509)
T KOG4645|consen 1396 QSMMGTPMYMAPEVITG 1412 (1509)
T ss_pred HhhcCCchhcCchhhcc
Confidence 23469999999999864
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-28 Score=199.33 Aligned_cols=165 Identities=28% Similarity=0.392 Sum_probs=143.0
Q ss_pred cccccccCceeEEEEEe-CCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCCCCc
Q 039310 71 ADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTL 149 (241)
Q Consensus 71 ~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~g~L 149 (241)
.+.||+|++|.||++.. .++..+++|..........+.+.+|+.+++.++|||++++++++...+..++++||+++++|
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L 103 (285)
T cd06648 24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103 (285)
T ss_pred ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence 45799999999999985 46788999987665555566788999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeeeeccc
Q 039310 150 FEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGT 229 (241)
Q Consensus 150 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt 229 (241)
.+++.. .++++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++........ ......|+
T Consensus 104 ~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~ 178 (285)
T cd06648 104 TDIVTH-TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRKSLVGT 178 (285)
T ss_pred HHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc-ccccccCC
Confidence 999877 57899999999999999999999999 99999999999999999999999998876543322 22234588
Q ss_pred ccccccccccC
Q 039310 230 LGYIDPEYLQT 240 (241)
Q Consensus 230 ~~y~aPE~l~~ 240 (241)
+.|+|||.+.+
T Consensus 179 ~~y~aPE~~~~ 189 (285)
T cd06648 179 PYWMAPEVISR 189 (285)
T ss_pred ccccCHHHhcC
Confidence 99999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-28 Score=199.11 Aligned_cols=162 Identities=27% Similarity=0.309 Sum_probs=133.0
Q ss_pred cccccCceeEEEEEeC-CCCeEEEEecccCC---hhhHHHHHHHHH---HHHcCCCCCceeEEEEEecCCcceEEEEecC
Q 039310 73 VIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD---QTKIDEFINELV---VVSQINRRNVVRLLACCLETQVPLLVYEFVG 145 (241)
Q Consensus 73 ~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~---~~~~~~~~~E~~---~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~ 145 (241)
.||+|+||.||+|... +++.||+|.+.... ......+..|.. .++...||||+.+.+++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999854 57899999765421 111222334433 4445689999999999999999999999999
Q ss_pred CCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeee
Q 039310 146 NGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTV 225 (241)
Q Consensus 146 ~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~ 225 (241)
+++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~~~ 154 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHA 154 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---CcC
Confidence 9999999988888999999999999999999999998 9999999999999999999999999987553221 223
Q ss_pred ecccccccccccccC
Q 039310 226 VQGTLGYIDPEYLQT 240 (241)
Q Consensus 226 ~~gt~~y~aPE~l~~ 240 (241)
..|++.|+|||.+.+
T Consensus 155 ~~~~~~y~aPE~~~~ 169 (278)
T cd05606 155 SVGTHGYMAPEVLQK 169 (278)
T ss_pred cCCCcCCcCcHHhcC
Confidence 458999999999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=221.57 Aligned_cols=165 Identities=25% Similarity=0.453 Sum_probs=138.7
Q ss_pred cccccccCceeEEEEEe-CCC----CeEEEEeccc-CChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEec
Q 039310 71 ADVIGCGGSGNVYKGFL-PDR----TPVAVKKSKI-VDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 71 ~~~lg~G~~g~V~~~~~-~~~----~~vavk~~~~-~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
.++||+|+||+||+|.| ..+ -+||+|.+.. ...+...+++.|+-.|..++|||+++++++|.... +.||++|+
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m 779 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM 779 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence 45799999999999974 333 3678887554 34555688999999999999999999999998776 78899999
Q ss_pred CCCCchHHhhcCC-CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcccee
Q 039310 145 GNGTLFEHIHKNG-NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNY 223 (241)
Q Consensus 145 ~~g~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~ 223 (241)
++|+|.++++.++ ++..+..+.|..||++||.|||.++ ++||||.++|+|+.+...+||.|||+|+.+..++.+..
T Consensus 780 P~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~ 856 (1177)
T KOG1025|consen 780 PLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYS 856 (1177)
T ss_pred ccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccccccc
Confidence 9999999998654 7999999999999999999999999 99999999999999999999999999998866554322
Q ss_pred ee-eccccccccccccc
Q 039310 224 TV-VQGTLGYIDPEYLQ 239 (241)
Q Consensus 224 ~~-~~gt~~y~aPE~l~ 239 (241)
.. ..-.+.|||=|.+.
T Consensus 857 ~~~gK~pikwmale~i~ 873 (1177)
T KOG1025|consen 857 APGGKVPIKWMALESIR 873 (1177)
T ss_pred ccccccCcHHHHHHHhh
Confidence 22 22356788877654
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=199.70 Aligned_cols=164 Identities=32% Similarity=0.399 Sum_probs=140.6
Q ss_pred ccccCceeEEEEEeC-CCCeEEEEecccCCh---hhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCCCCc
Q 039310 74 IGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQ---TKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTL 149 (241)
Q Consensus 74 lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~g~L 149 (241)
||.|+||.||++... ++..+++|.+..... ...+.+.+|+++++.++||||+++++.+...+..++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 488999998754322 4556788999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcc-------ce
Q 039310 150 FEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAI-------QN 222 (241)
Q Consensus 150 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~-------~~ 222 (241)
.+++...+.+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++........ ..
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 157 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence 999988778999999999999999999999998 99999999999999999999999999876533211 12
Q ss_pred eeeecccccccccccccC
Q 039310 223 YTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 223 ~~~~~gt~~y~aPE~l~~ 240 (241)
.....+++.|+|||.+.+
T Consensus 158 ~~~~~~~~~~~~Pe~~~~ 175 (265)
T cd05579 158 DKRIVGTPDYIAPEVILG 175 (265)
T ss_pred ccCcccCccccCHHHhcC
Confidence 223447889999998654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-28 Score=198.14 Aligned_cols=169 Identities=28% Similarity=0.428 Sum_probs=143.5
Q ss_pred hhcccccccccCceeEEEEEeC-CCCeEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEec
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
.+...+.||+|+||.||+|... ++..||+|..... .......+.+|+.+++.++||||+++++++.+++..++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 3445667999999999999864 5788999976643 2345678899999999999999999999999999999999999
Q ss_pred CCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceee
Q 039310 145 GNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYT 224 (241)
Q Consensus 145 ~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~ 224 (241)
++++|.+++.. .++++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++++|||++........ ...
T Consensus 85 ~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~~ 159 (277)
T cd06640 85 GGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRN 159 (277)
T ss_pred CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-ccc
Confidence 99999999875 46899999999999999999999998 99999999999999999999999999876643322 122
Q ss_pred eecccccccccccccC
Q 039310 225 VVQGTLGYIDPEYLQT 240 (241)
Q Consensus 225 ~~~gt~~y~aPE~l~~ 240 (241)
...++..|+|||++.+
T Consensus 160 ~~~~~~~y~apE~~~~ 175 (277)
T cd06640 160 TFVGTPFWMAPEVIQQ 175 (277)
T ss_pred cccCcccccCHhHhcc
Confidence 2357889999998754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=201.21 Aligned_cols=169 Identities=23% Similarity=0.263 Sum_probs=140.4
Q ss_pred hhcccccccccCceeEEEEEeC-CCCeEEEEecccCC--hhhHHHHHHHHHHHHcCCCCCceeEEEEEecC--CcceEEE
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD--QTKIDEFINELVVVSQINRRNVVRLLACCLET--QVPLLVY 141 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~--~~~~lv~ 141 (241)
.+...+.||.|+||.||+|... ++..+++|.+.... ......+.+|+.+++.++||||+++++++... +..+++|
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~ 85 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM 85 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence 3556678999999999999965 57889999876433 22334567899999999999999999999877 8899999
Q ss_pred EecCCCCchHHhhcCC-CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcc
Q 039310 142 EFVGNGTLFEHIHKNG-NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAI 220 (241)
Q Consensus 142 e~~~~g~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~ 220 (241)
||++ ++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 86 e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~- 160 (293)
T cd07843 86 EYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL- 160 (293)
T ss_pred hhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCCc-
Confidence 9997 48988887544 5899999999999999999999998 9999999999999999999999999988764332
Q ss_pred ceeeeecccccccccccccC
Q 039310 221 QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 221 ~~~~~~~gt~~y~aPE~l~~ 240 (241)
.......+++.|+|||.+.+
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~ 180 (293)
T cd07843 161 KPYTQLVVTLWYRAPELLLG 180 (293)
T ss_pred cccccccccccccCchhhcC
Confidence 12222347889999998753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-28 Score=198.02 Aligned_cols=171 Identities=24% Similarity=0.386 Sum_probs=142.0
Q ss_pred hhcccccccccCceeEEEEEeC-----CCCeEEEEecccCChh-hHHHHHHHHHHHHcCCCCCceeEEEEEec--CCcce
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP-----DRTPVAVKKSKIVDQT-KIDEFINELVVVSQINRRNVVRLLACCLE--TQVPL 138 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~l~~~~~~--~~~~~ 138 (241)
.+.+.+.||+|+||.||+|.+. ++..+|+|.+...... ..+.+.+|+.+++.++||||+++++++.. ....+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 4556678999999999999853 3678999987754443 56789999999999999999999999887 55789
Q ss_pred EEEEecCCCCchHHhhcCC-CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccC
Q 039310 139 LVYEFVGNGTLFEHIHKNG-NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPI 217 (241)
Q Consensus 139 lv~e~~~~g~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~ 217 (241)
++|||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 85 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred EEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 9999999999999997654 6999999999999999999999998 99999999999999999999999999987653
Q ss_pred Cccce--eeeecccccccccccccC
Q 039310 218 DAIQN--YTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 218 ~~~~~--~~~~~gt~~y~aPE~l~~ 240 (241)
..... .....++..|+|||.+.+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~ 186 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRT 186 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHcc
Confidence 22111 111234567999998754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-28 Score=197.13 Aligned_cols=170 Identities=30% Similarity=0.448 Sum_probs=144.7
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccCC-hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecC
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD-QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVG 145 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~ 145 (241)
+.+.+.||.|+||+||+|... ++..+++|.+.... ......+.+|+.+++.++|+|++++++.+...+..++++|+++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~ 82 (267)
T cd06610 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS 82 (267)
T ss_pred ceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccC
Confidence 566788999999999999854 57789999875432 2356788999999999999999999999999999999999999
Q ss_pred CCCchHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc-
Q 039310 146 NGTLFEHIHKN---GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ- 221 (241)
Q Consensus 146 ~g~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~- 221 (241)
+++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.........
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 159 (267)
T cd06610 83 GGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT 159 (267)
T ss_pred CCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence 99999999764 35899999999999999999999998 999999999999999999999999998766433221
Q ss_pred --eeeeecccccccccccccC
Q 039310 222 --NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 222 --~~~~~~gt~~y~aPE~l~~ 240 (241)
......|++.|+|||++..
T Consensus 160 ~~~~~~~~~~~~y~~Pe~~~~ 180 (267)
T cd06610 160 RKVRKTFVGTPCWMAPEVMEQ 180 (267)
T ss_pred ccccccccCChhhcChHHHcc
Confidence 1233458899999998754
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=201.00 Aligned_cols=168 Identities=25% Similarity=0.356 Sum_probs=139.0
Q ss_pred hhcccccccccCceeEEEEEeC-CCCeEEEEecccCCh-hhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEec
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQ-TKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
.+...+.||+|++|.||+|... ++..|++|.+..... .....+.+|+++++.++||||+++++++.+.+..++||||+
T Consensus 6 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (291)
T cd07844 6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL 85 (291)
T ss_pred ceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecC
Confidence 3556778999999999999865 578899998754322 22345678999999999999999999999999999999999
Q ss_pred CCCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcccee
Q 039310 145 GNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNY 223 (241)
Q Consensus 145 ~~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~ 223 (241)
++ +|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++....... ...
T Consensus 86 ~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-~~~ 160 (291)
T cd07844 86 DT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS-KTY 160 (291)
T ss_pred CC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCC-ccc
Confidence 75 899888654 46899999999999999999999998 9999999999999999999999999987543221 111
Q ss_pred eeeccccccccccccc
Q 039310 224 TVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 224 ~~~~gt~~y~aPE~l~ 239 (241)
....+++.|+|||++.
T Consensus 161 ~~~~~~~~~~aPE~~~ 176 (291)
T cd07844 161 SNEVVTLWYRPPDVLL 176 (291)
T ss_pred cccccccccCCcHHhh
Confidence 2224688999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-28 Score=197.28 Aligned_cols=169 Identities=29% Similarity=0.448 Sum_probs=142.9
Q ss_pred hhcccccccccCceeEEEEEeC-CCCeEEEEecccCC-hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEec
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD-QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
.+...+.||+|+||.||+|... ++..+|+|...... ......+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3455668999999999999854 57889999765432 334567889999999999999999999999999999999999
Q ss_pred CCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceee
Q 039310 145 GNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYT 224 (241)
Q Consensus 145 ~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~ 224 (241)
++++|.+++.. ..+++..+..++.|++.++.|||+.+ ++|+||+|+||++++++.++|+|||++........ ...
T Consensus 85 ~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~ 159 (277)
T cd06641 85 GGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KRN 159 (277)
T ss_pred CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh-hhc
Confidence 99999999865 46899999999999999999999998 99999999999999999999999999876543221 122
Q ss_pred eecccccccccccccC
Q 039310 225 VVQGTLGYIDPEYLQT 240 (241)
Q Consensus 225 ~~~gt~~y~aPE~l~~ 240 (241)
...++..|+|||.+.+
T Consensus 160 ~~~~~~~y~~PE~~~~ 175 (277)
T cd06641 160 TFVGTPFWMAPEVIKQ 175 (277)
T ss_pred cccCCccccChhhhcc
Confidence 2357889999998754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=201.32 Aligned_cols=170 Identities=28% Similarity=0.422 Sum_probs=145.2
Q ss_pred hhhcccccccccCceeEEEEEe-CCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEec
Q 039310 66 VTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
.++.+.+.||+|+||.||++.. .++..+++|..........+.+.+|+.+++.++|||++++++.+...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 4566778899999999999984 357889999876555555678899999999999999999999999999999999999
Q ss_pred CCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceee
Q 039310 145 GNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYT 224 (241)
Q Consensus 145 ~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~ 224 (241)
++++|.+++... .+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 99 ~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~~~ 173 (293)
T cd06647 99 AGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRS 173 (293)
T ss_pred CCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc-ccc
Confidence 999999998754 5789999999999999999999999 99999999999999999999999998876543222 122
Q ss_pred eecccccccccccccC
Q 039310 225 VVQGTLGYIDPEYLQT 240 (241)
Q Consensus 225 ~~~gt~~y~aPE~l~~ 240 (241)
...|++.|+|||.+..
T Consensus 174 ~~~~~~~y~~PE~~~~ 189 (293)
T cd06647 174 TMVGTPYWMAPEVVTR 189 (293)
T ss_pred cccCChhhcCchhhcc
Confidence 2358899999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=198.52 Aligned_cols=169 Identities=28% Similarity=0.401 Sum_probs=140.3
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEecccCChhhHHHHHHHHHHHHcC-CCCCceeEEEEEecC------Ccc
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQTKIDEFINELVVVSQI-NRRNVVRLLACCLET------QVP 137 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~------~~~ 137 (241)
..+...+.||+|+||.||+|... ++..+|+|...... .....+.+|+.+++.+ +|||++++++++... ...
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL 84 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence 34556678999999999999854 57788999876433 3346788999999998 799999999998753 457
Q ss_pred eEEEEecCCCCchHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccc
Q 039310 138 LLVYEFVGNGTLFEHIHKN--GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLV 215 (241)
Q Consensus 138 ~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~ 215 (241)
+++|||+++++|.+++... ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||++...
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~~~~ 161 (272)
T cd06637 85 WLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161 (272)
T ss_pred EEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCceec
Confidence 8999999999999998763 36899999999999999999999998 999999999999999999999999998765
Q ss_pred cCCccceeeeeccccccccccccc
Q 039310 216 PIDAIQNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 216 ~~~~~~~~~~~~gt~~y~aPE~l~ 239 (241)
.... .......|++.|+|||++.
T Consensus 162 ~~~~-~~~~~~~g~~~y~aPE~~~ 184 (272)
T cd06637 162 DRTV-GRRNTFIGTPYWMAPEVIA 184 (272)
T ss_pred cccc-ccCCcccccccccCHhHhc
Confidence 3221 2223345899999999874
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=214.79 Aligned_cols=166 Identities=19% Similarity=0.261 Sum_probs=132.5
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEecccCChhhHHHHHHHHHHHHcCCC------CCceeEEEEEecC-Ccc
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQTKIDEFINELVVVSQINR------RNVVRLLACCLET-QVP 137 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h------~ni~~l~~~~~~~-~~~ 137 (241)
..|.+.+.||+|+||+||+|... .+..||||.+.... ........|+.+++.++| ++++.+++++... ...
T Consensus 129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~ 207 (467)
T PTZ00284 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM 207 (467)
T ss_pred CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceE
Confidence 45667789999999999999854 57789999875422 223455667777777655 4588888888764 567
Q ss_pred eEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEecCCCCCCeeeCCCC--------------
Q 039310 138 LLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHS-ETNVPIIHRDVKSANILLDENY-------------- 202 (241)
Q Consensus 138 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~iiH~dlk~~Nili~~~~-------------- 202 (241)
++|||++ +++|.+++...+.+++..+..++.|++.||.|||+ .+ |+||||||+|||++.++
T Consensus 208 ~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~~~~~~~ 283 (467)
T PTZ00284 208 CIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTNRALPPD 283 (467)
T ss_pred EEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccccccccCCC
Confidence 8999988 67899999888889999999999999999999997 47 99999999999998765
Q ss_pred --CeEEccCCCcccccCCccceeeeecccccccccccccC
Q 039310 203 --TPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 203 --~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
.+||+|||++.... .......||+.|||||++.+
T Consensus 284 ~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~ 319 (467)
T PTZ00284 284 PCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLG 319 (467)
T ss_pred CceEEECCCCccccCc----cccccccCCccccCcHHhhc
Confidence 49999999876432 12234569999999999864
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-28 Score=196.43 Aligned_cols=169 Identities=24% Similarity=0.320 Sum_probs=143.4
Q ss_pred hcccccccccCceeEEEEEe-CCCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEec
Q 039310 68 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
|.+.+.||+|+||.+|.+.. .++..+++|.+... ......++.+|+.+++.++||||+++++++.+.+..++++||+
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC 81 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence 55677899999999999984 46788999987642 3344568899999999999999999999999999999999999
Q ss_pred CCCCchHHhhcCC--CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccce
Q 039310 145 GNGTLFEHIHKNG--NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQN 222 (241)
Q Consensus 145 ~~g~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~ 222 (241)
++++|.+++.... .+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++++|||++........ .
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~ 157 (256)
T cd08218 82 EGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-L 157 (256)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-h
Confidence 9999999987543 5889999999999999999999998 99999999999999999999999999876543221 1
Q ss_pred eeeecccccccccccccC
Q 039310 223 YTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 223 ~~~~~gt~~y~aPE~l~~ 240 (241)
.....|++.|+|||++.+
T Consensus 158 ~~~~~~~~~~~~pe~~~~ 175 (256)
T cd08218 158 ARTCIGTPYYLSPEICEN 175 (256)
T ss_pred hhhccCCccccCHHHhCC
Confidence 223347889999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-28 Score=194.50 Aligned_cols=169 Identities=26% Similarity=0.399 Sum_probs=146.9
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccCCh--hhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEec
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQ--TKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
+.+.+.||+|++|.||+|... ++..+++|....... .....+.+|+++++.++|||++++++++.+.+..+++|||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA 81 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence 456778999999999999854 578899998765443 45678999999999999999999999999999999999999
Q ss_pred CCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceee
Q 039310 145 GNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYT 224 (241)
Q Consensus 145 ~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~ 224 (241)
++++|.+++.....+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++......... ..
T Consensus 82 ~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~~ 157 (254)
T cd06627 82 ENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-DA 157 (254)
T ss_pred CCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCccc-cc
Confidence 99999999988788999999999999999999999998 999999999999999999999999999876443321 23
Q ss_pred eecccccccccccccC
Q 039310 225 VVQGTLGYIDPEYLQT 240 (241)
Q Consensus 225 ~~~gt~~y~aPE~l~~ 240 (241)
...++..|+|||.+.+
T Consensus 158 ~~~~~~~y~~pe~~~~ 173 (254)
T cd06627 158 SVVGTPYWMAPEVIEM 173 (254)
T ss_pred ccccchhhcCHhhhcC
Confidence 3458899999998753
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=212.30 Aligned_cols=167 Identities=24% Similarity=0.349 Sum_probs=141.8
Q ss_pred hcccccccccCceeEEEEEeCC-CCeEEEEecccC--------ChhhHHHHHHHHHHHHcCC---CCCceeEEEEEecCC
Q 039310 68 NNYADVIGCGGSGNVYKGFLPD-RTPVAVKKSKIV--------DQTKIDEFINELVVVSQIN---RRNVVRLLACCLETQ 135 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavk~~~~~--------~~~~~~~~~~E~~~l~~l~---h~ni~~l~~~~~~~~ 135 (241)
|.-.+.+|.|+||+|+.|.++. ...|+||.+... ...+....--|+.+|..++ |+||++++.+|++++
T Consensus 563 yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd 642 (772)
T KOG1152|consen 563 YTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDD 642 (772)
T ss_pred ceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCC
Confidence 4445689999999999998654 566778854321 1122233456999999997 999999999999999
Q ss_pred cceEEEEecC-CCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCccc
Q 039310 136 VPLLVYEFVG-NGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKL 214 (241)
Q Consensus 136 ~~~lv~e~~~-~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~ 214 (241)
++|++||-.. +.+|.+++..+.++++.++..|+.|++.|+++||+++ |||||||-+|+.++++|-+||+|||.|..
T Consensus 643 ~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfgsaa~ 719 (772)
T KOG1152|consen 643 YYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFGSAAY 719 (772)
T ss_pred eeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeeccchhh
Confidence 9999999874 5599999999999999999999999999999999999 99999999999999999999999999887
Q ss_pred ccCCccceeeeecccccccccccccC
Q 039310 215 VPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 215 ~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
...+. ...+.||..|.|||+|.+
T Consensus 720 ~ksgp---fd~f~gtv~~aapevl~g 742 (772)
T KOG1152|consen 720 TKSGP---FDVFVGTVDYAAPEVLGG 742 (772)
T ss_pred hcCCC---cceeeeeccccchhhhCC
Confidence 65443 344679999999999976
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=199.20 Aligned_cols=167 Identities=27% Similarity=0.370 Sum_probs=143.7
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccCC-hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecC
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD-QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVG 145 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~ 145 (241)
+.+.+.||+|++|.||++... +++.+++|.+.... .....++.+|+++++.++||||+++++.+...+..++++||++
T Consensus 3 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (265)
T cd06605 3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMD 82 (265)
T ss_pred chHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecC
Confidence 345667999999999999865 57889999876543 3455678999999999999999999999999999999999999
Q ss_pred CCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcccee
Q 039310 146 NGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHS-ETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNY 223 (241)
Q Consensus 146 ~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~ 223 (241)
+++|.+++... ..+++.....++.|++.|+.|||+ .+ ++|+||+|+||++++++.++|+|||.+........
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--- 156 (265)
T cd06605 83 GGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA--- 156 (265)
T ss_pred CCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh---
Confidence 99999999876 679999999999999999999999 88 99999999999999999999999999876532211
Q ss_pred eeecccccccccccccC
Q 039310 224 TVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 224 ~~~~gt~~y~aPE~l~~ 240 (241)
....+++.|+|||.+.+
T Consensus 157 ~~~~~~~~y~~PE~~~~ 173 (265)
T cd06605 157 KTFVGTSSYMAPERIQG 173 (265)
T ss_pred hcccCChhccCHHHHcC
Confidence 11568899999998754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-28 Score=192.49 Aligned_cols=168 Identities=31% Similarity=0.439 Sum_probs=147.1
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCC
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGN 146 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~ 146 (241)
|...+.||+|++|.||++... ++..+++|+...........+.+|++.++.++|||++++++++...+..++++||+++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 81 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG 81 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence 345678999999999999965 6788999988765555667889999999999999999999999999999999999999
Q ss_pred CCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeee
Q 039310 147 GTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTV 225 (241)
Q Consensus 147 g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~ 225 (241)
++|.+++... ..+++..+..++.|++.++.|||+.+ ++|+||+|+||++++++.++|+|||.+........ ...
T Consensus 82 ~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~ 156 (253)
T cd05122 82 GSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNT 156 (253)
T ss_pred CcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--ccc
Confidence 9999999776 57999999999999999999999988 99999999999999999999999999887654321 233
Q ss_pred ecccccccccccccC
Q 039310 226 VQGTLGYIDPEYLQT 240 (241)
Q Consensus 226 ~~gt~~y~aPE~l~~ 240 (241)
..++..|+|||.+..
T Consensus 157 ~~~~~~~~~PE~~~~ 171 (253)
T cd05122 157 MVGTPYWMAPEVING 171 (253)
T ss_pred eecCCcccCHHHHcC
Confidence 458899999998764
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-28 Score=202.08 Aligned_cols=169 Identities=26% Similarity=0.336 Sum_probs=138.3
Q ss_pred hcccccccccCceeEEEEEeC---CCCeEEEEecccCC---hhhHHHHHHHHHHHHcCCCCCceeEEEEEecC--CcceE
Q 039310 68 NNYADVIGCGGSGNVYKGFLP---DRTPVAVKKSKIVD---QTKIDEFINELVVVSQINRRNVVRLLACCLET--QVPLL 139 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~---~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~--~~~~l 139 (241)
+.+.+.||+|+||.||+|... ++..+|+|.+.... ....+.+.+|+.+++.++||||+++++++.+. +..++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 456778999999999999864 47889999876522 33446778899999999999999999999988 78999
Q ss_pred EEEecCCCCchHHhhcC-----CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC----CCCeEEccCC
Q 039310 140 VYEFVGNGTLFEHIHKN-----GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDE----NYTPKVSDFG 210 (241)
Q Consensus 140 v~e~~~~g~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~----~~~~kl~Dfg 210 (241)
||||+++ ++.+.+... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++. ++.+||+|||
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999975 676666422 26899999999999999999999999 999999999999999 8999999999
Q ss_pred CcccccCCcc--ceeeeecccccccccccccC
Q 039310 211 ASKLVPIDAI--QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 211 la~~~~~~~~--~~~~~~~gt~~y~aPE~l~~ 240 (241)
++........ .......+|+.|+|||++.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 189 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLG 189 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhC
Confidence 9886543221 12223457899999997643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-29 Score=184.00 Aligned_cols=165 Identities=27% Similarity=0.406 Sum_probs=141.5
Q ss_pred cccccccCceeEEEEE-eCCCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCCC
Q 039310 71 ADVIGCGGSGNVYKGF-LPDRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNG 147 (241)
Q Consensus 71 ~~~lg~G~~g~V~~~~-~~~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~g 147 (241)
-+.||+|.||+||+|+ +++++.||+|.+... ++.-....++|+-+++.++|.|||+++++...++.+-+|+|||..
T Consensus 7 mekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq- 85 (292)
T KOG0662|consen 7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ- 85 (292)
T ss_pred HHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-
Confidence 4579999999999998 556788999976653 444567889999999999999999999999999999999999964
Q ss_pred CchHHhhc-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeeee
Q 039310 148 TLFEHIHK-NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVV 226 (241)
Q Consensus 148 ~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 226 (241)
+|..+... ++.++...+..++.|++.||.|+|+.+ +.|||+||.|.||+.+|.+|++|||+|+.++... .-....
T Consensus 86 dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipv-rcysae 161 (292)
T KOG0662|consen 86 DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPV-RCYSAE 161 (292)
T ss_pred HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCce-Eeeece
Confidence 88888764 457999999999999999999999999 9999999999999999999999999999775432 233445
Q ss_pred cccccccccccccC
Q 039310 227 QGTLGYIDPEYLQT 240 (241)
Q Consensus 227 ~gt~~y~aPE~l~~ 240 (241)
.-|..|.+|.++-+
T Consensus 162 vvtlwyrppdvlfg 175 (292)
T KOG0662|consen 162 VVTLWYRPPDVLFG 175 (292)
T ss_pred eeeeeccCcceeee
Confidence 57899999998743
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-28 Score=200.65 Aligned_cols=169 Identities=26% Similarity=0.454 Sum_probs=136.2
Q ss_pred hcccccccccCceeEEEEEeC-CCC----eEEEEecccCC-hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEE
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRT----PVAVKKSKIVD-QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVY 141 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~----~vavk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~ 141 (241)
+...+.||+|+||.||+|.+. ++. .+|+|...... ......+.+|+.+++.++||||+++++++... ..++++
T Consensus 9 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~ 87 (303)
T cd05110 9 LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVT 87 (303)
T ss_pred ceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeee
Confidence 445568999999999999853 333 46888766533 23345788999999999999999999998764 467899
Q ss_pred EecCCCCchHHhhcCC-CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcc
Q 039310 142 EFVGNGTLFEHIHKNG-NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAI 220 (241)
Q Consensus 142 e~~~~g~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~ 220 (241)
||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 88 e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 164 (303)
T cd05110 88 QLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 164 (303)
T ss_pred hhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccccCccc
Confidence 9999999999987654 6899999999999999999999998 99999999999999999999999999986643222
Q ss_pred c-eeeeecccccccccccccC
Q 039310 221 Q-NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 221 ~-~~~~~~gt~~y~aPE~l~~ 240 (241)
. ......++..|+|||.+.+
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~ 185 (303)
T cd05110 165 EYNADGGKMPIKWMALECIHY 185 (303)
T ss_pred ccccCCCccccccCCHHHhcc
Confidence 1 1122235678999998753
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=200.39 Aligned_cols=170 Identities=26% Similarity=0.288 Sum_probs=143.2
Q ss_pred hcccccccccCceeEEEEEe----CCCCeEEEEecccCC----hhhHHHHHHHHHHHHcC-CCCCceeEEEEEecCCcce
Q 039310 68 NNYADVIGCGGSGNVYKGFL----PDRTPVAVKKSKIVD----QTKIDEFINELVVVSQI-NRRNVVRLLACCLETQVPL 138 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~----~~~~~vavk~~~~~~----~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~ 138 (241)
+.+.+.||+|++|.||++.. .++..+|+|.+.... ......+.+|+.++..+ +||||+++++++..+...+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 45667899999999999874 246789999765321 22345688999999999 5999999999999999999
Q ss_pred EEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCC
Q 039310 139 LVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPID 218 (241)
Q Consensus 139 lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~ 218 (241)
+||||+++++|.+++.....+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 82 LILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 99999999999999987778999999999999999999999998 999999999999999999999999998875433
Q ss_pred ccceeeeecccccccccccccC
Q 039310 219 AIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 219 ~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
.........|++.|+|||.+.+
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~ 180 (288)
T cd05583 159 EEERAYSFCGTIEYMAPEVIRG 180 (288)
T ss_pred cccccccccCCccccCHHHhcC
Confidence 3222333458899999998753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-28 Score=194.19 Aligned_cols=168 Identities=29% Similarity=0.378 Sum_probs=142.0
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEec
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
|...+.||+|+||.||++... ++..+++|.+... .......+.+|+.+++.++|||++++++.+...+..++||||+
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA 81 (256)
T ss_pred ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence 456778999999999999853 6788999986543 3345678899999999999999999999999999999999999
Q ss_pred CCCCchHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC-CeEEccCCCcccccCCccc
Q 039310 145 GNGTLFEHIHKN--GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENY-TPKVSDFGASKLVPIDAIQ 221 (241)
Q Consensus 145 ~~g~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~-~~kl~Dfgla~~~~~~~~~ 221 (241)
++++|.+++... ..+++..+..++.+++.++.|||+++ ++|+||+|+||++++++ .++++|||++.......
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-- 156 (256)
T cd08220 82 PGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-- 156 (256)
T ss_pred CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc--
Confidence 999999999764 35899999999999999999999998 99999999999998654 57999999998764332
Q ss_pred eeeeecccccccccccccC
Q 039310 222 NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~~ 240 (241)
......|++.|+|||.+..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~ 175 (256)
T cd08220 157 KAYTVVGTPCYISPELCEG 175 (256)
T ss_pred cccccccCCcccCchhccC
Confidence 2223458899999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=193.82 Aligned_cols=176 Identities=27% Similarity=0.362 Sum_probs=149.4
Q ss_pred HHHhhhcccccccccCceeEEEEE-eCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCC-----c
Q 039310 63 IKTVTNNYADVIGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQ-----V 136 (241)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~-----~ 136 (241)
+...+|.+.+.+|.|+|+.||++. ..++..+|+|++...+.++.+..++|++..++++|||+++++++..... .
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 345678889999999999999998 5578889999999888888899999999999999999999998875443 4
Q ss_pred ceEEEEecCCCCchHHhhc----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCc
Q 039310 137 PLLVYEFVGNGTLFEHIHK----NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGAS 212 (241)
Q Consensus 137 ~~lv~e~~~~g~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla 212 (241)
.|++++|...|+|.+.+.. +..+++.+.+.|+.++++||.+||+.. +|++||||||.|||+.+++.+++.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCc
Confidence 8999999999999999863 336999999999999999999999986 58999999999999999999999999998
Q ss_pred ccccCCcc--------ceeeeeccccccccccccc
Q 039310 213 KLVPIDAI--------QNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 213 ~~~~~~~~--------~~~~~~~gt~~y~aPE~l~ 239 (241)
........ +......+|..|.|||.+.
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~ 211 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFN 211 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchhee
Confidence 76532211 1122234799999999864
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-28 Score=199.03 Aligned_cols=164 Identities=29% Similarity=0.396 Sum_probs=141.3
Q ss_pred ccccccCceeEEEEEe-CCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCCCCch
Q 039310 72 DVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLF 150 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~g~L~ 150 (241)
..||+|+||.||++.. .++..|++|+...........+.+|+.+++.++|+|++++++.+...+..+++|||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 4699999999999986 468899999876555555677899999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeeeecccc
Q 039310 151 EHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTL 230 (241)
Q Consensus 151 ~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~ 230 (241)
+++.. ..+++.....++.|++.|++|||+.+ ++|+||+|+||+++.++.++|+|||++........ ......|++
T Consensus 106 ~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~ 180 (292)
T cd06657 106 DIVTH-TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLVGTP 180 (292)
T ss_pred HHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc-cccccccCc
Confidence 98754 46899999999999999999999998 99999999999999999999999999876543321 223345889
Q ss_pred cccccccccC
Q 039310 231 GYIDPEYLQT 240 (241)
Q Consensus 231 ~y~aPE~l~~ 240 (241)
.|+|||.+.+
T Consensus 181 ~y~~pE~~~~ 190 (292)
T cd06657 181 YWMAPELISR 190 (292)
T ss_pred cccCHHHhcC
Confidence 9999998753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-28 Score=199.80 Aligned_cols=164 Identities=30% Similarity=0.384 Sum_probs=138.9
Q ss_pred hhcccccccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEE
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYE 142 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e 142 (241)
.+...+.||+|+||.||+|... +++.|++|..... .....+++.+|+.+++.++|||++++.+++.+.+..++|+|
T Consensus 16 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e 95 (307)
T cd06607 16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVME 95 (307)
T ss_pred hhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHH
Confidence 3666778999999999999854 5889999976532 23344678899999999999999999999999999999999
Q ss_pred ecCCCCchHHhhc-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc
Q 039310 143 FVGNGTLFEHIHK-NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ 221 (241)
Q Consensus 143 ~~~~g~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~ 221 (241)
|++ |++.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 96 ~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--- 168 (307)
T cd06607 96 YCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--- 168 (307)
T ss_pred hhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC---
Confidence 997 577776653 457999999999999999999999998 999999999999999999999999998765322
Q ss_pred eeeeeccccccccccccc
Q 039310 222 NYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~ 239 (241)
....+++.|+|||++.
T Consensus 169 --~~~~~~~~y~aPE~~~ 184 (307)
T cd06607 169 --NSFVGTPYWMAPEVIL 184 (307)
T ss_pred --CCccCCccccCceeee
Confidence 2235788999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.2e-28 Score=194.06 Aligned_cols=164 Identities=28% Similarity=0.457 Sum_probs=137.1
Q ss_pred hhhcccccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecC
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVG 145 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~ 145 (241)
..+.+.+.||+|+||.||++.. ++..+++|...... ..+.+.+|+.+++.++|||++++++++..+. .+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEEEEECCC
Confidence 4567788999999999999975 56779999876432 3467889999999999999999999987654 689999999
Q ss_pred CCCchHHhhcCC--CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcccee
Q 039310 146 NGTLFEHIHKNG--NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNY 223 (241)
Q Consensus 146 ~g~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~ 223 (241)
+++|.+++.... .+++..+..++.|++.|+.|||+.+ ++||||+|+||+++.++.++|+|||++.......
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---- 154 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---- 154 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC----
Confidence 999999997543 5899999999999999999999998 9999999999999999999999999987543211
Q ss_pred eeecccccccccccccC
Q 039310 224 TVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 224 ~~~~gt~~y~aPE~l~~ 240 (241)
.....+..|+|||.+.+
T Consensus 155 ~~~~~~~~y~~pe~~~~ 171 (254)
T cd05083 155 DNSKLPVKWTAPEALKH 171 (254)
T ss_pred CCCCCCceecCHHHhcc
Confidence 11224568999998754
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-28 Score=197.43 Aligned_cols=165 Identities=28% Similarity=0.412 Sum_probs=135.6
Q ss_pred cccccCceeEEEEEeCC-------CCeEEEEecccCC-hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEec
Q 039310 73 VIGCGGSGNVYKGFLPD-------RTPVAVKKSKIVD-QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 73 ~lg~G~~g~V~~~~~~~-------~~~vavk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
.||+|+||.||+|...+ +..+++|.+.... ......+.+|+.+++.++||||+++++++...+..+++|||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 58999999999998543 2468888765432 234567889999999999999999999999999999999999
Q ss_pred CCCCchHHhhcC-------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC-----CeEEccCCCc
Q 039310 145 GNGTLFEHIHKN-------GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENY-----TPKVSDFGAS 212 (241)
Q Consensus 145 ~~g~L~~~l~~~-------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~-----~~kl~Dfgla 212 (241)
++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++ .++++|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999999642 24788999999999999999999998 99999999999999877 8999999998
Q ss_pred ccccCCccc-eeeeecccccccccccccC
Q 039310 213 KLVPIDAIQ-NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 213 ~~~~~~~~~-~~~~~~gt~~y~aPE~l~~ 240 (241)
......... ......++..|+|||++.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 187 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLD 187 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHcc
Confidence 765332211 1122235688999998865
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-27 Score=196.72 Aligned_cols=168 Identities=30% Similarity=0.437 Sum_probs=144.7
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCC
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGN 146 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~ 146 (241)
+...+.||+|++|.||+|..+ ++..+++|.+..... ..+.+.+|+++++.++|+|++++++++...+..++++||+++
T Consensus 21 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 99 (286)
T cd06614 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDG 99 (286)
T ss_pred chHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCC
Confidence 445567999999999999866 578899998775544 557788999999999999999999999999999999999999
Q ss_pred CCchHHhhcCC-CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeee
Q 039310 147 GTLFEHIHKNG-NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTV 225 (241)
Q Consensus 147 g~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~ 225 (241)
++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++........ ....
T Consensus 100 ~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~ 175 (286)
T cd06614 100 GSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-KRNS 175 (286)
T ss_pred CcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccchh-hhcc
Confidence 99999998876 8999999999999999999999988 99999999999999999999999998876533221 1222
Q ss_pred ecccccccccccccC
Q 039310 226 VQGTLGYIDPEYLQT 240 (241)
Q Consensus 226 ~~gt~~y~aPE~l~~ 240 (241)
..+++.|+|||++.+
T Consensus 176 ~~~~~~y~~PE~~~~ 190 (286)
T cd06614 176 VVGTPYWMAPEVIKR 190 (286)
T ss_pred ccCCcccCCHhHhcC
Confidence 347889999998753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-28 Score=194.25 Aligned_cols=169 Identities=28% Similarity=0.386 Sum_probs=140.8
Q ss_pred hcccccccccCceeEEEEEe-CCCCeEEEEeccc--CChhhHHHHHHHHHHHHcCCCCCceeEEEEEec--CCcceEEEE
Q 039310 68 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKI--VDQTKIDEFINELVVVSQINRRNVVRLLACCLE--TQVPLLVYE 142 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~--~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~--~~~~~lv~e 142 (241)
|.+.+.||.|+||.||++.. .++..+++|.+.. ......+.+.+|+.+++.++||||+++++.+.. ....+++||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e 81 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME 81 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence 45567899999999999984 4578899997654 234455678899999999999999999998764 456789999
Q ss_pred ecCCCCchHHhhc----CCCCCHHHHHHHHHHHHHHHHHhh-----cCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcc
Q 039310 143 FVGNGTLFEHIHK----NGNLTWERRLRIAAETAGVLSYLH-----SETNVPIIHRDVKSANILLDENYTPKVSDFGASK 213 (241)
Q Consensus 143 ~~~~g~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh-----~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~ 213 (241)
|+++++|.+++.. ..++++..++.++.|++.||.||| +.+ ++|+||+|+||++++++.++|+|||++.
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~~ 158 (265)
T cd08217 82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLAK 158 (265)
T ss_pred hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEecccccc
Confidence 9999999999865 357899999999999999999999 666 9999999999999999999999999988
Q ss_pred cccCCccceeeeecccccccccccccC
Q 039310 214 LVPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 214 ~~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
....... ......+++.|+|||.+.+
T Consensus 159 ~~~~~~~-~~~~~~~~~~~~~pE~~~~ 184 (265)
T cd08217 159 ILGHDSS-FAKTYVGTPYYMSPEQLNH 184 (265)
T ss_pred cccCCcc-cccccccCCCccChhhhcC
Confidence 7644332 1223458999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-28 Score=197.79 Aligned_cols=167 Identities=28% Similarity=0.347 Sum_probs=140.9
Q ss_pred cccccccccCceeEEEEEeC-CCCeEEEEecccCC--hhhHHHHHHHHHHHHcCCCCCceeEEEEEecC--CcceEEEEe
Q 039310 69 NYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD--QTKIDEFINELVVVSQINRRNVVRLLACCLET--QVPLLVYEF 143 (241)
Q Consensus 69 ~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~--~~~~lv~e~ 143 (241)
.+.+.||.|++|.||+|... ++..+++|.+.... ......+.+|+.+++.++|||++++++++... +..++++||
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07840 2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY 81 (287)
T ss_pred eeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecc
Confidence 45567999999999999865 47889999877542 33456788999999999999999999999888 899999999
Q ss_pred cCCCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccce
Q 039310 144 VGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQN 222 (241)
Q Consensus 144 ~~~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~ 222 (241)
+++ +|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++..........
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 82 MDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD 157 (287)
T ss_pred ccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc
Confidence 975 888888665 57999999999999999999999998 9999999999999999999999999988764433222
Q ss_pred eeeeccccccccccccc
Q 039310 223 YTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 223 ~~~~~gt~~y~aPE~l~ 239 (241)
.....++..|+|||.+.
T Consensus 158 ~~~~~~~~~y~~PE~~~ 174 (287)
T cd07840 158 YTNRVITLWYRPPELLL 174 (287)
T ss_pred ccccccccccCCceeeE
Confidence 23334688999999764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-27 Score=194.03 Aligned_cols=161 Identities=27% Similarity=0.307 Sum_probs=134.5
Q ss_pred ccccccCceeEEEEEeC-CCCeEEEEecccCC---hhhHHHHHHHHHHH-HcCCCCCceeEEEEEecCCcceEEEEecCC
Q 039310 72 DVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD---QTKIDEFINELVVV-SQINRRNVVRLLACCLETQVPLLVYEFVGN 146 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~---~~~~~~~~~E~~~l-~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~ 146 (241)
+.||+|+||.||+|... +++.||+|...... ......+..|..++ ...+|||++++++++...+..++++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999854 57899999865432 12223445555544 445899999999999999999999999999
Q ss_pred CCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeeee
Q 039310 147 GTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVV 226 (241)
Q Consensus 147 g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 226 (241)
++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++..... ....
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~~ 153 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKKF 153 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-----cccC
Confidence 999999988888999999999999999999999998 99999999999999999999999999876432 2223
Q ss_pred cccccccccccccC
Q 039310 227 QGTLGYIDPEYLQT 240 (241)
Q Consensus 227 ~gt~~y~aPE~l~~ 240 (241)
.|++.|+|||.+.+
T Consensus 154 ~~~~~y~~pe~~~~ 167 (260)
T cd05611 154 VGTPDYLAPETILG 167 (260)
T ss_pred CCCcCccChhhhcC
Confidence 57889999998754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.6e-28 Score=197.16 Aligned_cols=168 Identities=23% Similarity=0.351 Sum_probs=140.2
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccCC-hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecC
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD-QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVG 145 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~ 145 (241)
+...+.||.|++|.||+|... ++..|++|.+.... ......+.+|+.+++.++||||+++++++.+.+..+++|||++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (284)
T cd07836 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD 81 (284)
T ss_pred ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC
Confidence 456678999999999999965 58889999876543 2234567789999999999999999999999999999999997
Q ss_pred CCCchHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccce
Q 039310 146 NGTLFEHIHKN---GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQN 222 (241)
Q Consensus 146 ~g~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~ 222 (241)
+ +|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++++|||++....... ..
T Consensus 82 ~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~-~~ 156 (284)
T cd07836 82 K-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV-NT 156 (284)
T ss_pred c-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc-cc
Confidence 5 888887654 35899999999999999999999998 9999999999999999999999999987653221 11
Q ss_pred eeeecccccccccccccC
Q 039310 223 YTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 223 ~~~~~gt~~y~aPE~l~~ 240 (241)
.....+|+.|+|||.+.+
T Consensus 157 ~~~~~~~~~y~~PE~~~~ 174 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLG 174 (284)
T ss_pred cccccccccccChHHhcC
Confidence 222347889999998743
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=194.57 Aligned_cols=169 Identities=29% Similarity=0.409 Sum_probs=141.7
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEecccCChhhHHHHHHHHHHHHcC-CCCCceeEEEEEecCC------cc
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQTKIDEFINELVVVSQI-NRRNVVRLLACCLETQ------VP 137 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~------~~ 137 (241)
.+|.+.+.||+|++|.||+|... ++..+++|....... ..+.+.+|+.+++.+ +|+||+++++++.... ..
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQL 84 (275)
T ss_pred hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEE
Confidence 45677889999999999999964 577899998765433 346788999999999 7999999999997654 48
Q ss_pred eEEEEecCCCCchHHhhc----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcc
Q 039310 138 LLVYEFVGNGTLFEHIHK----NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASK 213 (241)
Q Consensus 138 ~lv~e~~~~g~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~ 213 (241)
+++|||+++++|.+++.. +..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~~~ 161 (275)
T cd06608 85 WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSA 161 (275)
T ss_pred EEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCccce
Confidence 999999999999998864 347999999999999999999999998 9999999999999999999999999987
Q ss_pred cccCCccceeeeeccccccccccccc
Q 039310 214 LVPIDAIQNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 214 ~~~~~~~~~~~~~~gt~~y~aPE~l~ 239 (241)
...... .......|++.|+|||++.
T Consensus 162 ~~~~~~-~~~~~~~~~~~y~aPE~~~ 186 (275)
T cd06608 162 QLDSTL-GRRNTFIGTPYWMAPEVIA 186 (275)
T ss_pred ecccch-hhhcCccccccccCHhHhc
Confidence 653222 2223345889999999874
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=191.70 Aligned_cols=169 Identities=28% Similarity=0.409 Sum_probs=145.4
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccCC--hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEec
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD--QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
|...+.||.|+||.||++... ++..+++|...... ......+.+|+++++.++|||++++.+.+......++++|++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd08215 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYA 81 (258)
T ss_pred ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEec
Confidence 455678999999999999865 57889999876543 355677889999999999999999999999999999999999
Q ss_pred CCCCchHHhhcC----CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcc
Q 039310 145 GNGTLFEHIHKN----GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAI 220 (241)
Q Consensus 145 ~~g~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~ 220 (241)
++++|.+++... ..+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 157 (258)
T cd08215 82 DGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV- 157 (258)
T ss_pred CCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc-
Confidence 999999999763 67999999999999999999999998 9999999999999999999999999988764432
Q ss_pred ceeeeecccccccccccccC
Q 039310 221 QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 221 ~~~~~~~gt~~y~aPE~l~~ 240 (241)
.......|++.|+|||.+.+
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~ 177 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQN 177 (258)
T ss_pred ceecceeeeecccChhHhcc
Confidence 12233458899999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-28 Score=217.61 Aligned_cols=178 Identities=28% Similarity=0.394 Sum_probs=149.4
Q ss_pred HHHHHHhhhcccccccccCceeEEEEEeC--------CCCeEEEEeccc-CChhhHHHHHHHHHHHHcC-CCCCceeEEE
Q 039310 60 EEEIKTVTNNYADVIGCGGSGNVYKGFLP--------DRTPVAVKKSKI-VDQTKIDEFINELVVVSQI-NRRNVVRLLA 129 (241)
Q Consensus 60 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavk~~~~-~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~ 129 (241)
..++......+.+.+|.|.||+|++|... ....||||.++. .+..+.+.+..|+.+|+.+ +||||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 44455555567779999999999999732 145789998775 3446778999999999999 6999999999
Q ss_pred EEecCCcceEEEEecCCCCchHHhhcCC----------------CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCC
Q 039310 130 CCLETQVPLLVYEFVGNGTLFEHIHKNG----------------NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKS 193 (241)
Q Consensus 130 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~ 193 (241)
+|..++..++|+||+..|+|.++++.++ .++..+...++.||+.|++||++.. +|||||.+
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhh
Confidence 9999999999999999999999998765 3889999999999999999999998 99999999
Q ss_pred CCeeeCCCCCeEEccCCCcccccCCccceeeeeccc--ccccccccccC
Q 039310 194 ANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGT--LGYIDPEYLQT 240 (241)
Q Consensus 194 ~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt--~~y~aPE~l~~ 240 (241)
+|||++++..+||+|||+|+.......+......|+ ..|||||.+..
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~ 495 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD 495 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc
Confidence 999999999999999999997655555543333333 45999999864
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.3e-28 Score=198.41 Aligned_cols=171 Identities=28% Similarity=0.376 Sum_probs=139.8
Q ss_pred HhhhcccccccccCceeEEEEEeC-CCCeEEEEecccCC--hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCC------
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD--QTKIDEFINELVVVSQINRRNVVRLLACCLETQ------ 135 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~------ 135 (241)
...+.+.+.||+|+||.||+|..+ ++..|++|.+.... ......+.+|+.+++.++|||++++++++.+..
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 345667789999999999999965 57889999876432 223356778999999999999999999987654
Q ss_pred ----cceEEEEecCCCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCC
Q 039310 136 ----VPLLVYEFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFG 210 (241)
Q Consensus 136 ----~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfg 210 (241)
..++++||+++ ++.+.+... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||
T Consensus 86 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~dfg 161 (302)
T cd07864 86 KDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFG 161 (302)
T ss_pred ccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeCccc
Confidence 78999999976 777777654 46899999999999999999999998 9999999999999999999999999
Q ss_pred CcccccCCccceeeeeccccccccccccc
Q 039310 211 ASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 211 la~~~~~~~~~~~~~~~gt~~y~aPE~l~ 239 (241)
++...............++..|+|||.+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~ 190 (302)
T cd07864 162 LARLYNSEESRPYTNKVITLWYRPPELLL 190 (302)
T ss_pred ccccccCCcccccccceeccCccChHHhc
Confidence 98876443322222234678899999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.8e-29 Score=223.96 Aligned_cols=166 Identities=28% Similarity=0.415 Sum_probs=135.0
Q ss_pred ccccccCceeEEEEEeC-CCCeEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecC---------------
Q 039310 72 DVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCLET--------------- 134 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~--------------- 134 (241)
++||+|+||.||+++.+ +|..+|||++... +........+|+.++++|+|||||+++..|.+.
T Consensus 485 ~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~ 564 (1351)
T KOG1035|consen 485 ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSE 564 (1351)
T ss_pred HHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchh
Confidence 37999999999999954 7999999998764 344556789999999999999999999887410
Q ss_pred --------------------------------------------------------------------------------
Q 039310 135 -------------------------------------------------------------------------------- 134 (241)
Q Consensus 135 -------------------------------------------------------------------------------- 134 (241)
T Consensus 565 ~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~ 644 (1351)
T KOG1035|consen 565 SRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDD 644 (1351)
T ss_pred hhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCc
Confidence
Q ss_pred ------------------------CcceEEEEecCCCCchHHhhcCCCC-CHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 039310 135 ------------------------QVPLLVYEFVGNGTLFEHIHKNGNL-TWERRLRIAAETAGVLSYLHSETNVPIIHR 189 (241)
Q Consensus 135 ------------------------~~~~lv~e~~~~g~L~~~l~~~~~l-~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~ 189 (241)
..+||-||||+..++.++++.+... .....++++.+|+.||.|+|+++ +|||
T Consensus 645 ~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g---iIHR 721 (1351)
T KOG1035|consen 645 TSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG---IIHR 721 (1351)
T ss_pred chhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc---eeec
Confidence 0146788999887777777766443 47788999999999999999999 9999
Q ss_pred CCCCCCeeeCCCCCeEEccCCCccccc-----------------CCccceeeeecccccccccccccC
Q 039310 190 DVKSANILLDENYTPKVSDFGASKLVP-----------------IDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 190 dlk~~Nili~~~~~~kl~Dfgla~~~~-----------------~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
||||.||++|+++.|||+|||+|.... .......+...||.-|+|||++.+
T Consensus 722 DLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 722 DLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred cCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 999999999999999999999998721 011113444569999999999865
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=193.26 Aligned_cols=168 Identities=27% Similarity=0.447 Sum_probs=139.3
Q ss_pred hcccccccccCceeEEEEEeCC--CCeEEEEecccC----------ChhhHHHHHHHHHHHHc-CCCCCceeEEEEEecC
Q 039310 68 NNYADVIGCGGSGNVYKGFLPD--RTPVAVKKSKIV----------DQTKIDEFINELVVVSQ-INRRNVVRLLACCLET 134 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~~--~~~vavk~~~~~----------~~~~~~~~~~E~~~l~~-l~h~ni~~l~~~~~~~ 134 (241)
|.+.+.||+|+||.||+|.... +..+++|.+... ......++.+|+.++.. ++||||+++++++..+
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 4456789999999999999654 678999975432 22344567789988875 7999999999999999
Q ss_pred CcceEEEEecCCCCchHHhhc----CCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEecCCCCCCeeeCCCCCeEEccC
Q 039310 135 QVPLLVYEFVGNGTLFEHIHK----NGNLTWERRLRIAAETAGVLSYLHS-ETNVPIIHRDVKSANILLDENYTPKVSDF 209 (241)
Q Consensus 135 ~~~~lv~e~~~~g~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~iiH~dlk~~Nili~~~~~~kl~Df 209 (241)
+..+++|||+++++|.+++.. ...+++..++.++.|++.||.|||+ .+ ++|+||+|+||++++++.++|+||
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEecc
Confidence 999999999999999988742 3468999999999999999999996 56 999999999999999999999999
Q ss_pred CCcccccCCccceeeeecccccccccccccC
Q 039310 210 GASKLVPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 210 gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
|++....... ......|+..|+|||.+.+
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~ 187 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKN 187 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcC
Confidence 9988754332 2334458899999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=195.72 Aligned_cols=169 Identities=28% Similarity=0.313 Sum_probs=139.0
Q ss_pred hhhcccccccccCceeEEEEEe-CCCCeEEEEecccCChhhHHHHHHHHHHHHcC-CCCCceeEEEEEecC-----Ccce
Q 039310 66 VTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVDQTKIDEFINELVVVSQI-NRRNVVRLLACCLET-----QVPL 138 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~-----~~~~ 138 (241)
..+.+.+.||+|+||.||++.. .+++.+++|...... .....+.+|+.+++.+ +|||++++++++... +..+
T Consensus 22 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~ 100 (291)
T cd06639 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLW 100 (291)
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeE
Confidence 3456677899999999999985 467889999875432 2235677899999998 899999999998753 3579
Q ss_pred EEEEecCCCCchHHhhc----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCccc
Q 039310 139 LVYEFVGNGTLFEHIHK----NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKL 214 (241)
Q Consensus 139 lv~e~~~~g~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~ 214 (241)
+||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++..
T Consensus 101 lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~dfg~~~~ 177 (291)
T cd06639 101 LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177 (291)
T ss_pred EEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEeecccchh
Confidence 99999999999998752 356899999999999999999999998 99999999999999999999999999886
Q ss_pred ccCCccceeeeeccccccccccccc
Q 039310 215 VPIDAIQNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 215 ~~~~~~~~~~~~~gt~~y~aPE~l~ 239 (241)
...... ......|+..|+|||.+.
T Consensus 178 ~~~~~~-~~~~~~~~~~y~aPE~~~ 201 (291)
T cd06639 178 LTSTRL-RRNTSVGTPFWMAPEVIA 201 (291)
T ss_pred cccccc-cccCccCCccccChhhhc
Confidence 543221 122235889999999874
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.9e-30 Score=213.42 Aligned_cols=164 Identities=26% Similarity=0.347 Sum_probs=148.7
Q ss_pred ccccccCceeEEEEEeCCCC-eEEEE---ecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCCC
Q 039310 72 DVIGCGGSGNVYKGFLPDRT-PVAVK---KSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNG 147 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~-~vavk---~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~g 147 (241)
..||-|+||.|=+...++.. .+|+| +.+..+..+.+....|-.+|..++.|.||++|..|.+....|++||-|-||
T Consensus 426 aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGG 505 (732)
T KOG0614|consen 426 ATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGG 505 (732)
T ss_pred hhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCc
Confidence 36999999999998865443 35655 455677888889999999999999999999999999999999999999999
Q ss_pred CchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeeeec
Q 039310 148 TLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQ 227 (241)
Q Consensus 148 ~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 227 (241)
.++..++..+.+...+...++..++.|++|||+++ ||+|||||+|.++|.+|-+||.|||+|+.+. ...++.++|
T Consensus 506 ElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~--~g~KTwTFc 580 (732)
T KOG0614|consen 506 ELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIG--SGRKTWTFC 580 (732)
T ss_pred hhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhc--cCCceeeec
Confidence 99999999999999999999999999999999999 9999999999999999999999999999875 446788899
Q ss_pred ccccccccccccC
Q 039310 228 GTLGYIDPEYLQT 240 (241)
Q Consensus 228 gt~~y~aPE~l~~ 240 (241)
|||.|.|||++.+
T Consensus 581 GTpEYVAPEIILn 593 (732)
T KOG0614|consen 581 GTPEYVAPEIILN 593 (732)
T ss_pred CCcccccchhhhc
Confidence 9999999999864
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=201.28 Aligned_cols=167 Identities=26% Similarity=0.317 Sum_probs=138.6
Q ss_pred ccccccccCceeEEEEEeC-CCCeEEEEecccCChhh--------------HHHHHHHHHHHHcCCCCCceeEEEEEecC
Q 039310 70 YADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQTK--------------IDEFINELVVVSQINRRNVVRLLACCLET 134 (241)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~~--------------~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 134 (241)
+.+.||.|+||.||+|... +++.||+|+........ ...+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 92 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG 92 (335)
T ss_pred hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence 4567999999999999854 68899999765432111 12467899999999999999999999999
Q ss_pred CcceEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCccc
Q 039310 135 QVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKL 214 (241)
Q Consensus 135 ~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~ 214 (241)
+..+++|||++ ++|.+++.....+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 93 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~dfg~~~~ 168 (335)
T PTZ00024 93 DFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARR 168 (335)
T ss_pred CcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECCccceee
Confidence 99999999996 599999988778999999999999999999999998 99999999999999999999999999876
Q ss_pred ccCCc-------------cceeeeecccccccccccccC
Q 039310 215 VPIDA-------------IQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 215 ~~~~~-------------~~~~~~~~gt~~y~aPE~l~~ 240 (241)
..... ........+++.|+|||.+.+
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 207 (335)
T PTZ00024 169 YGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMG 207 (335)
T ss_pred cccccccccccccccccccccccccccccCCCCChhccc
Confidence 54111 011122346889999998754
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=195.26 Aligned_cols=166 Identities=24% Similarity=0.314 Sum_probs=134.5
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccCC-hhhHHHHHHHHHH-HHcCCCCCceeEEEEEecCCcceEEEEec
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD-QTKIDEFINELVV-VSQINRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~-~~~~~~~~~E~~~-l~~l~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
+.+.+.||+|+||.||+|... ++..||+|.+.... ......+..|... ++..+||||+++++++..++..+++|||+
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~ 82 (283)
T cd06617 3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVM 82 (283)
T ss_pred ceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhh
Confidence 456678999999999999865 58899999876432 2233455566665 66678999999999999999999999999
Q ss_pred CCCCchHHhhc----CCCCCHHHHHHHHHHHHHHHHHhhcC-CCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCc
Q 039310 145 GNGTLFEHIHK----NGNLTWERRLRIAAETAGVLSYLHSE-TNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDA 219 (241)
Q Consensus 145 ~~g~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~-~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~ 219 (241)
+ ++|.+++.. ...+++..+..++.|++.||.|||+. + ++||||||+||++++++.+||+|||++.......
T Consensus 83 ~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 158 (283)
T cd06617 83 D-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV 158 (283)
T ss_pred c-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 6 588777753 34689999999999999999999986 7 9999999999999999999999999988653221
Q ss_pred cceeeeeccccccccccccc
Q 039310 220 IQNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 220 ~~~~~~~~gt~~y~aPE~l~ 239 (241)
......|+..|+|||.+.
T Consensus 159 --~~~~~~~~~~y~aPE~~~ 176 (283)
T cd06617 159 --AKTIDAGCKPYMAPERIN 176 (283)
T ss_pred --ccccccCCccccChhhcC
Confidence 112235788999999874
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=201.06 Aligned_cols=170 Identities=27% Similarity=0.344 Sum_probs=139.9
Q ss_pred HhhhcccccccccCceeEEEEEeC-CCCeEEEEeccc--CChhhHHHHHHHHHHHHcC-CCCCceeEEEEEecC--Ccce
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKI--VDQTKIDEFINELVVVSQI-NRRNVVRLLACCLET--QVPL 138 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~--~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~--~~~~ 138 (241)
...+.+.+.||+|+||.||+|... ++..+++|++.. ........+.+|+.+++.+ +||||+++++++... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 345667788999999999999865 578899997643 2333446678899999999 999999999998653 3679
Q ss_pred EEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCC
Q 039310 139 LVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPID 218 (241)
Q Consensus 139 lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~ 218 (241)
+||||++ ++|..++... .+++.....++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 86 lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred EEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 9999997 5999988765 7889999999999999999999998 999999999999999999999999998866433
Q ss_pred cc----ceeeeeccccccccccccc
Q 039310 219 AI----QNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 219 ~~----~~~~~~~gt~~y~aPE~l~ 239 (241)
.. .......||+.|+|||++.
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~ 185 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILL 185 (337)
T ss_pred cccccCcchhcccccccccCceeee
Confidence 21 1122235889999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-28 Score=197.69 Aligned_cols=170 Identities=29% Similarity=0.443 Sum_probs=145.3
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEeccc---CChhhHHHHHHHHHHHHcCC-CCCceeEEEEEecCCcceEEEE
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKI---VDQTKIDEFINELVVVSQIN-RRNVVRLLACCLETQVPLLVYE 142 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~---~~~~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~~~~~~lv~e 142 (241)
|.+.+.||+|+||.||+|... ++..+++|.... ........+.+|..+++.++ ||||+++++++...+..+++||
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd05581 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLE 82 (280)
T ss_pred ceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEc
Confidence 556778999999999999854 688999997653 22334567889999999998 9999999999999999999999
Q ss_pred ecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcc--
Q 039310 143 FVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAI-- 220 (241)
Q Consensus 143 ~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~-- 220 (241)
++++++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++++|||++........
T Consensus 83 ~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~ 159 (280)
T cd05581 83 YAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE 159 (280)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCccccc
Confidence 9999999999998888999999999999999999999998 99999999999999999999999999876543221
Q ss_pred -----------------ceeeeecccccccccccccC
Q 039310 221 -----------------QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 221 -----------------~~~~~~~gt~~y~aPE~l~~ 240 (241)
.......++..|+|||++.+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~ 196 (280)
T cd05581 160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE 196 (280)
T ss_pred cCCCCCccccccccccccccccccCCccccCHHHhCC
Confidence 12223347889999998653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.7e-28 Score=196.91 Aligned_cols=168 Identities=26% Similarity=0.351 Sum_probs=139.4
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccCC--hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEec
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD--QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
++..+.||.|++|.||+|... ++..|++|++.... ......+.+|+++++.++||||+++++++.+.+..+++|||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 81 (284)
T ss_pred ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeecc
Confidence 345668999999999999864 58889999876432 223457889999999999999999999999999999999999
Q ss_pred CCCCchHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccce
Q 039310 145 GNGTLFEHIHK--NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQN 222 (241)
Q Consensus 145 ~~g~L~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~ 222 (241)
. ++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++....... ..
T Consensus 82 ~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~-~~ 156 (284)
T cd07860 82 H-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RT 156 (284)
T ss_pred c-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc-cc
Confidence 6 588888865 346899999999999999999999998 9999999999999999999999999987653221 11
Q ss_pred eeeecccccccccccccC
Q 039310 223 YTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 223 ~~~~~gt~~y~aPE~l~~ 240 (241)
.....+++.|+|||.+.+
T Consensus 157 ~~~~~~~~~y~aPE~~~~ 174 (284)
T cd07860 157 YTHEVVTLWYRAPEILLG 174 (284)
T ss_pred cccccccccccCCeEEec
Confidence 222346889999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.1e-28 Score=211.72 Aligned_cols=168 Identities=28% Similarity=0.388 Sum_probs=142.1
Q ss_pred hhcccccccccCceeEEEEE-eCCCCeEEEEecccCChhhHHHHHHHHHHHHcC-CCCCceeEEEEEec-----CCcceE
Q 039310 67 TNNYADVIGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKIDEFINELVVVSQI-NRRNVVRLLACCLE-----TQVPLL 139 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~-----~~~~~l 139 (241)
.+.+.+.||+|.+|.||++. .++++.+|+|........ .++...|.++++.. .|||++.++|++.- ++.+|+
T Consensus 20 ~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWL 98 (953)
T KOG0587|consen 20 IFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWL 98 (953)
T ss_pred ccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEE
Confidence 45678899999999999998 456888888877654333 35667888899887 69999999999853 568999
Q ss_pred EEEecCCCCchHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccC
Q 039310 140 VYEFVGNGTLFEHIHK--NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPI 217 (241)
Q Consensus 140 v~e~~~~g~L~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~ 217 (241)
|||||.+|+..++++. ..++.|.....|+..++.|+.+||... ++|||+|-.|||++.++.+|++|||++..+..
T Consensus 99 VMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvSaQlds 175 (953)
T KOG0587|consen 99 VMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDS 175 (953)
T ss_pred EeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeeeeeeec
Confidence 9999999999999874 347999999999999999999999998 99999999999999999999999999887743
Q ss_pred Cccceeeeeccccccccccccc
Q 039310 218 DAIQNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 218 ~~~~~~~~~~gt~~y~aPE~l~ 239 (241)
.. ....+..|||.|||||++.
T Consensus 176 T~-grRnT~iGtP~WMAPEVia 196 (953)
T KOG0587|consen 176 TV-GRRNTFIGTPYWMAPEVIA 196 (953)
T ss_pred cc-ccccCcCCCcccccceeee
Confidence 32 2334456999999999974
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=212.56 Aligned_cols=172 Identities=24% Similarity=0.378 Sum_probs=143.9
Q ss_pred HhhhcccccccccCceeEEEEEeCC--C--CeEEEEecccCChh-hHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceE
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFLPD--R--TPVAVKKSKIVDQT-KIDEFINELVVVSQINRRNVVRLLACCLETQVPLL 139 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~--~--~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~l 139 (241)
.....+.+.||+|+||.|++|.|+. | -.||||.+...... ...+|++|+.+|.+|+|||+++|||+..+ ....|
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mM 187 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMM 187 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhH
Confidence 3344567789999999999999763 3 36899988765443 66899999999999999999999999988 78899
Q ss_pred EEEecCCCCchHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccC
Q 039310 140 VYEFVGNGTLFEHIHKN--GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPI 217 (241)
Q Consensus 140 v~e~~~~g~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~ 217 (241)
|+|+++.|+|.+.|++. ..+....+..++.||+.||.||.+++ +|||||.++|+|+-..-.+||+||||.+.+..
T Consensus 188 V~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred HhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCC
Confidence 99999999999999872 35888899999999999999999999 99999999999999999999999999998865
Q ss_pred Cccceeee--ecccccccccccccC
Q 039310 218 DAIQNYTV--VQGTLGYIDPEYLQT 240 (241)
Q Consensus 218 ~~~~~~~~--~~gt~~y~aPE~l~~ 240 (241)
++...... ..-...|.|||.|..
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh 289 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRH 289 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhcc
Confidence 43222111 113457999999864
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=195.93 Aligned_cols=167 Identities=28% Similarity=0.357 Sum_probs=139.7
Q ss_pred cccccccccCceeEEEEEeC-CCCeEEEEecccCC--hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecC
Q 039310 69 NYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD--QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVG 145 (241)
Q Consensus 69 ~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~ 145 (241)
...+.||.|++|.||+|... ++..|++|++.... ......+.+|+++++.++|||++++++++.+.+..+++|||++
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~ 81 (283)
T cd07835 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD 81 (283)
T ss_pred chheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC
Confidence 34567999999999999854 68899999876432 2234578899999999999999999999999999999999995
Q ss_pred CCCchHHhhcCC--CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcccee
Q 039310 146 NGTLFEHIHKNG--NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNY 223 (241)
Q Consensus 146 ~g~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~ 223 (241)
++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++........ ..
T Consensus 82 -~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~ 156 (283)
T cd07835 82 -LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-TY 156 (283)
T ss_pred -cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-cc
Confidence 68999987665 6899999999999999999999998 99999999999999999999999999876532211 11
Q ss_pred eeecccccccccccccC
Q 039310 224 TVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 224 ~~~~gt~~y~aPE~l~~ 240 (241)
....+++.|+|||++.+
T Consensus 157 ~~~~~~~~~~aPE~~~~ 173 (283)
T cd07835 157 THEVVTLWYRAPEILLG 173 (283)
T ss_pred CccccccCCCCCceeec
Confidence 22246889999998743
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=195.57 Aligned_cols=168 Identities=26% Similarity=0.355 Sum_probs=136.7
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccCC--hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEec
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD--QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
+...+.||+|++|.||+|... +++.|++|...... ......+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (294)
T PLN00009 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL 83 (294)
T ss_pred eEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecc
Confidence 556778999999999999865 57889999875432 233456789999999999999999999999999999999999
Q ss_pred CCCCchHHhhcCC--CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC-CCCeEEccCCCcccccCCccc
Q 039310 145 GNGTLFEHIHKNG--NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDE-NYTPKVSDFGASKLVPIDAIQ 221 (241)
Q Consensus 145 ~~g~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~-~~~~kl~Dfgla~~~~~~~~~ 221 (241)
+ +++.+.+.... .+++..+..++.|++.||+|||+++ ++|+||+|+||+++. ++.+||+|||++....... .
T Consensus 84 ~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~-~ 158 (294)
T PLN00009 84 D-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV-R 158 (294)
T ss_pred c-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCc-c
Confidence 6 57887776543 3578888899999999999999998 999999999999985 5679999999997653321 1
Q ss_pred eeeeecccccccccccccC
Q 039310 222 NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~~ 240 (241)
......+++.|+|||++.+
T Consensus 159 ~~~~~~~~~~y~~PE~~~~ 177 (294)
T PLN00009 159 TFTHEVVTLWYRAPEILLG 177 (294)
T ss_pred ccccCceeecccCHHHHhC
Confidence 1222347889999998753
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=201.16 Aligned_cols=167 Identities=28% Similarity=0.335 Sum_probs=138.3
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEeccc--CChhhHHHHHHHHHHHHcCCCCCceeEEEEEecC------Cc
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKI--VDQTKIDEFINELVVVSQINRRNVVRLLACCLET------QV 136 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~--~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~------~~ 136 (241)
.+|...+.||+|+||.||+|... ++..||+|.+.. .+......+.+|+.+++.++||||+++++++... ..
T Consensus 16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 95 (353)
T cd07850 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD 95 (353)
T ss_pred cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence 45666788999999999999854 688999998753 2334456778999999999999999999998644 35
Q ss_pred ceEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCccccc
Q 039310 137 PLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVP 216 (241)
Q Consensus 137 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~ 216 (241)
.|+||||++ ++|.+.+... ++...+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++....
T Consensus 96 ~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 96 VYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred EEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 699999996 4888887654 899999999999999999999998 9999999999999999999999999998754
Q ss_pred CCccceeeeecccccccccccccC
Q 039310 217 IDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 217 ~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
... ......+|+.|+|||.+.+
T Consensus 170 ~~~--~~~~~~~~~~y~aPE~~~~ 191 (353)
T cd07850 170 TSF--MMTPYVVTRYYRAPEVILG 191 (353)
T ss_pred CCC--CCCCCcccccccCHHHHhC
Confidence 322 1223457899999998754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-27 Score=190.08 Aligned_cols=170 Identities=26% Similarity=0.402 Sum_probs=146.4
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccCC--hhhHHHHHHHHHHHHcCCCCCceeEEEEEecC--CcceEEEE
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD--QTKIDEFINELVVVSQINRRNVVRLLACCLET--QVPLLVYE 142 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~--~~~~lv~e 142 (241)
+...+.||+|++|.||+|... ++..+++|...... ....+.+.+|+.+++.++||||+++++.+... +..++++|
T Consensus 2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 81 (260)
T cd06606 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLE 81 (260)
T ss_pred ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEE
Confidence 345678999999999999965 68889999876543 34567889999999999999999999999988 88999999
Q ss_pred ecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc-
Q 039310 143 FVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ- 221 (241)
Q Consensus 143 ~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~- 221 (241)
|+++++|.+++.....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+.........
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 158 (260)
T cd06606 82 YVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE 158 (260)
T ss_pred ecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccccccc
Confidence 9999999999988778999999999999999999999988 999999999999999999999999998876443221
Q ss_pred eeeeecccccccccccccC
Q 039310 222 NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~~ 240 (241)
......++..|+|||.+.+
T Consensus 159 ~~~~~~~~~~y~~pE~~~~ 177 (260)
T cd06606 159 GTGSVRGTPYWMAPEVIRG 177 (260)
T ss_pred cccCCCCCccccCHhhhcC
Confidence 1233458899999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-27 Score=196.12 Aligned_cols=163 Identities=28% Similarity=0.370 Sum_probs=137.7
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
+...+.||+|+||.||+|... ++..+++|.+... .......+.+|+.+++.++|||++++++++.+.+..+++|||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 445668999999999999854 5788999987532 223446788999999999999999999999999999999999
Q ss_pred cCCCCchHHhhc-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccce
Q 039310 144 VGNGTLFEHIHK-NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQN 222 (241)
Q Consensus 144 ~~~g~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~ 222 (241)
+++ ++.+.+.. ..++++.++..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 107 ~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~----- 177 (317)
T cd06635 107 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP----- 177 (317)
T ss_pred CCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC-----
Confidence 975 77777653 456999999999999999999999998 99999999999999999999999999875432
Q ss_pred eeeeccccccccccccc
Q 039310 223 YTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 223 ~~~~~gt~~y~aPE~l~ 239 (241)
.....|++.|+|||++.
T Consensus 178 ~~~~~~~~~y~aPE~~~ 194 (317)
T cd06635 178 ANSFVGTPYWMAPEVIL 194 (317)
T ss_pred cccccCCccccChhhhh
Confidence 12335889999999873
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=194.53 Aligned_cols=167 Identities=28% Similarity=0.313 Sum_probs=138.9
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccCC-hhhHHHHHHHHHHHHcCCCCCceeEEEEEecC--CcceEEEEe
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD-QTKIDEFINELVVVSQINRRNVVRLLACCLET--QVPLLVYEF 143 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~--~~~~lv~e~ 143 (241)
+...+.||.|++|.||++... +++.+++|...... ......+.+|+++++.++||||+++++++... +..+++|||
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 82 (287)
T cd06621 3 IVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEY 82 (287)
T ss_pred eEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEe
Confidence 445678999999999999964 57889999876432 23456789999999999999999999998653 468999999
Q ss_pred cCCCCchHHhhc----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCc
Q 039310 144 VGNGTLFEHIHK----NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDA 219 (241)
Q Consensus 144 ~~~g~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~ 219 (241)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 83 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (287)
T cd06621 83 CEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL 159 (287)
T ss_pred cCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence 999999888653 345899999999999999999999998 9999999999999999999999999987653221
Q ss_pred cceeeeecccccccccccccC
Q 039310 220 IQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 220 ~~~~~~~~gt~~y~aPE~l~~ 240 (241)
.....++..|+|||.+.+
T Consensus 160 ---~~~~~~~~~y~~pE~~~~ 177 (287)
T cd06621 160 ---AGTFTGTSFYMAPERIQG 177 (287)
T ss_pred ---cccccCCccccCHHHhcC
Confidence 123347889999998754
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-27 Score=191.97 Aligned_cols=169 Identities=27% Similarity=0.420 Sum_probs=135.4
Q ss_pred cccccccccCceeEEEEEeC----CCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCC------c
Q 039310 69 NYADVIGCGGSGNVYKGFLP----DRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLETQ------V 136 (241)
Q Consensus 69 ~~~~~lg~G~~g~V~~~~~~----~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~------~ 136 (241)
.+.+.||+|+||.||+|.+. ++..+|+|.+... +....+++.+|+.+++.++||||+++++++...+ .
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 81 (273)
T cd05074 2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI 81 (273)
T ss_pred cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence 35668999999999999743 3678999976542 3445677889999999999999999999886532 2
Q ss_pred ceEEEEecCCCCchHHhhcC------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCC
Q 039310 137 PLLVYEFVGNGTLFEHIHKN------GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFG 210 (241)
Q Consensus 137 ~~lv~e~~~~g~L~~~l~~~------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfg 210 (241)
.++++||+++|+|.+++... ..+++.....++.|++.||+|||+.+ ++|+||||+||++++++.+|++|||
T Consensus 82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECccc
Confidence 47889999999998887422 24789999999999999999999998 9999999999999999999999999
Q ss_pred CcccccCCccc-eeeeecccccccccccccC
Q 039310 211 ASKLVPIDAIQ-NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 211 la~~~~~~~~~-~~~~~~gt~~y~aPE~l~~ 240 (241)
+++........ ......+++.|++||.+.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 189 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLAD 189 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhc
Confidence 98876433211 1222335678999998753
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.9e-28 Score=201.64 Aligned_cols=168 Identities=24% Similarity=0.313 Sum_probs=140.2
Q ss_pred hhcccccccccCceeEEEEEe-CCCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecC-----Ccce
Q 039310 67 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLET-----QVPL 138 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~-----~~~~ 138 (241)
+|...+.||+|+||.||+|.. .++..|++|.+... .......+.+|+.+++.++||||+++++++... ...+
T Consensus 6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 85 (337)
T cd07858 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVY 85 (337)
T ss_pred ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEE
Confidence 455677899999999999985 45889999987642 233345678899999999999999999988654 3479
Q ss_pred EEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCC
Q 039310 139 LVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPID 218 (241)
Q Consensus 139 lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~ 218 (241)
+++||+. ++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++......
T Consensus 86 lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 161 (337)
T cd07858 86 IVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161 (337)
T ss_pred EEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence 9999995 689999988888999999999999999999999998 999999999999999999999999999876432
Q ss_pred ccceeeeeccccccccccccc
Q 039310 219 AIQNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 219 ~~~~~~~~~gt~~y~aPE~l~ 239 (241)
. .......++..|+|||.+.
T Consensus 162 ~-~~~~~~~~~~~y~aPE~~~ 181 (337)
T cd07858 162 G-DFMTEYVVTRWYRAPELLL 181 (337)
T ss_pred c-ccccccccccCccChHHHh
Confidence 2 2222345788999999865
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.4e-28 Score=201.30 Aligned_cols=169 Identities=27% Similarity=0.308 Sum_probs=143.6
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccCC--hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCC-----cceE
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD--QTKIDEFINELVVVSQINRRNVVRLLACCLETQ-----VPLL 139 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~-----~~~l 139 (241)
+.+.+.||.|++|.||+|... ++..+++|++.... ....+.+.+|+.+++.++||||+++.+++...+ ..|+
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 81 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI 81 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence 566788999999999999965 48899999876533 445578899999999999999999999988765 7899
Q ss_pred EEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCc
Q 039310 140 VYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDA 219 (241)
Q Consensus 140 v~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~ 219 (241)
+|||++ ++|.+++.....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++.......
T Consensus 82 v~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~ 157 (330)
T cd07834 82 VTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157 (330)
T ss_pred Eecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeecccc
Confidence 999997 589999988778999999999999999999999999 9999999999999999999999999988764432
Q ss_pred c--ceeeeecccccccccccccC
Q 039310 220 I--QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 220 ~--~~~~~~~gt~~y~aPE~l~~ 240 (241)
. .......+|+.|+|||.+.+
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~ 180 (330)
T cd07834 158 DEKGFLTEYVVTRWYRAPELLLS 180 (330)
T ss_pred cccccccccccccCcCCceeeec
Confidence 1 11223347889999998764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=197.06 Aligned_cols=169 Identities=25% Similarity=0.305 Sum_probs=137.7
Q ss_pred hhcccccccccCceeEEEEEeC-CCCeEEEEecccCC--hhhHHHHHHHHHHHHcCCCCCceeEEEEEecC--CcceEEE
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD--QTKIDEFINELVVVSQINRRNVVRLLACCLET--QVPLLVY 141 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~--~~~~lv~ 141 (241)
.+...+.||+|+||.||+|... ++..||+|...... ......+.+|+.+++.++|+|++++++++... +..++||
T Consensus 8 ~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 87 (309)
T cd07845 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVM 87 (309)
T ss_pred ceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEE
Confidence 4566778999999999999854 58899999876432 22233566899999999999999999998765 5689999
Q ss_pred EecCCCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcc
Q 039310 142 EFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAI 220 (241)
Q Consensus 142 e~~~~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~ 220 (241)
||+++ +|.+++... ..+++.++..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 88 e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~ 163 (309)
T cd07845 88 EYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK 163 (309)
T ss_pred ecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCCccC
Confidence 99964 888887653 56899999999999999999999999 99999999999999999999999999887643321
Q ss_pred ceeeeecccccccccccccC
Q 039310 221 QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 221 ~~~~~~~gt~~y~aPE~l~~ 240 (241)
......+++.|+|||.+.+
T Consensus 164 -~~~~~~~~~~y~aPE~~~~ 182 (309)
T cd07845 164 -PMTPKVVTLWYRAPELLLG 182 (309)
T ss_pred -CCCcccccccccChhhhcC
Confidence 1122235788999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=194.99 Aligned_cols=167 Identities=25% Similarity=0.316 Sum_probs=135.4
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccCC--hhhHHHHHHHHHHHHcCC-CCCceeEEEEEecCCc-----ce
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD--QTKIDEFINELVVVSQIN-RRNVVRLLACCLETQV-----PL 138 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~~~~-----~~ 138 (241)
+...+.||+|+||.||+|... ++..||+|...... ......+.+|+.+++.++ ||||+++++++...+. .|
T Consensus 3 y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~ 82 (295)
T cd07837 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLY 82 (295)
T ss_pred ceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEE
Confidence 455678999999999999854 58899999765432 223457788999999995 6999999999887665 79
Q ss_pred EEEEecCCCCchHHhhcC-----CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC-CCCeEEccCCCc
Q 039310 139 LVYEFVGNGTLFEHIHKN-----GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDE-NYTPKVSDFGAS 212 (241)
Q Consensus 139 lv~e~~~~g~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~-~~~~kl~Dfgla 212 (241)
++|||+++ +|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++. ++.++|+|||++
T Consensus 83 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 83 LVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred EEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecccc
Confidence 99999985 888887542 35899999999999999999999998 999999999999998 889999999998
Q ss_pred ccccCCccceeeeeccccccccccccc
Q 039310 213 KLVPIDAIQNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 213 ~~~~~~~~~~~~~~~gt~~y~aPE~l~ 239 (241)
........ ......+++.|+|||++.
T Consensus 159 ~~~~~~~~-~~~~~~~~~~~~aPE~~~ 184 (295)
T cd07837 159 RAFSIPVK-SYTHEIVTLWYRAPEVLL 184 (295)
T ss_pred eecCCCcc-ccCCcccccCCCChHHhh
Confidence 76532211 112234688999999874
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=199.94 Aligned_cols=168 Identities=24% Similarity=0.349 Sum_probs=137.2
Q ss_pred hhcccccccccCceeEEEEEe-CCCCeEEEEecccCC-hhhHHHHHHHHHHHHcCCCCCceeEEEEEecC-----CcceE
Q 039310 67 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVD-QTKIDEFINELVVVSQINRRNVVRLLACCLET-----QVPLL 139 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~-----~~~~l 139 (241)
.|.+.+.||+|+||.||+|.. .++..||+|.+.... ......+.+|+.+++.++||||+++++++... ...++
T Consensus 6 ~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 85 (336)
T cd07849 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYI 85 (336)
T ss_pred ceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEE
Confidence 466778899999999999985 468899999876432 33446678899999999999999999887654 35789
Q ss_pred EEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCc
Q 039310 140 VYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDA 219 (241)
Q Consensus 140 v~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~ 219 (241)
++||++ +++.+.+.. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 86 v~e~~~-~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 160 (336)
T cd07849 86 VQELME-TDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160 (336)
T ss_pred Eehhcc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence 999996 488877754 46899999999999999999999999 9999999999999999999999999987653322
Q ss_pred cc--eeeeeccccccccccccc
Q 039310 220 IQ--NYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 220 ~~--~~~~~~gt~~y~aPE~l~ 239 (241)
.. ......||+.|+|||++.
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~ 182 (336)
T cd07849 161 DHTGFLTEYVATRWYRAPEIML 182 (336)
T ss_pred cccCCcCCcCcCCCccChHHhh
Confidence 11 112245889999999864
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-28 Score=182.49 Aligned_cols=165 Identities=25% Similarity=0.365 Sum_probs=135.3
Q ss_pred cccccccCceeEEEEE-eCCCCeEEEEeccc-CChhhHHHHHHHHHHHHcC-CCCCceeEEEEEecCCcceEEEEecCCC
Q 039310 71 ADVIGCGGSGNVYKGF-LPDRTPVAVKKSKI-VDQTKIDEFINELVVVSQI-NRRNVVRLLACCLETQVPLLVYEFVGNG 147 (241)
Q Consensus 71 ~~~lg~G~~g~V~~~~-~~~~~~vavk~~~~-~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~g 147 (241)
...||+|++|.|-+-+ ..+|...|+|.+.. .+.+..++.++|+.+.... ..|.+|.+||...+....|+.||.|+.
T Consensus 51 i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t- 129 (282)
T KOG0984|consen 51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT- 129 (282)
T ss_pred hhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh-
Confidence 4469999999998876 45788899998664 3444556778888876665 689999999999999999999999964
Q ss_pred CchHHh----hcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcccee
Q 039310 148 TLFEHI----HKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNY 223 (241)
Q Consensus 148 ~L~~~l----~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~ 223 (241)
||..+- ..++.+++.-+-+++..+..||.|||++- .++|||+||+||||+.+|++|+||||.+..+.+. ...+
T Consensus 130 Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS-iAkt 206 (282)
T KOG0984|consen 130 SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDS-IAKT 206 (282)
T ss_pred hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhh-hHHH
Confidence 776653 45678999999999999999999999964 4999999999999999999999999999877432 2222
Q ss_pred eeecccccccccccccC
Q 039310 224 TVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 224 ~~~~gt~~y~aPE~l~~ 240 (241)
.-.|...|||||.+..
T Consensus 207 -~daGCkpYmaPEri~~ 222 (282)
T KOG0984|consen 207 -MDAGCKPYMAPERINP 222 (282)
T ss_pred -HhcCCCccCChhhcCc
Confidence 1247889999999864
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-27 Score=190.98 Aligned_cols=160 Identities=23% Similarity=0.337 Sum_probs=130.5
Q ss_pred hccccc--ccccCceeEEEEEeC-CCCeEEEEecccCChhhHHHHHHHHHHHHcC-CCCCceeEEEEEecCCcceEEEEe
Q 039310 68 NNYADV--IGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQTKIDEFINELVVVSQI-NRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 68 ~~~~~~--lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
+.+.+. +|+|+||.||++... ++..+++|......... .|......+ +|||++++++++...+..++||||
T Consensus 16 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~ 90 (267)
T PHA03390 16 CEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDY 90 (267)
T ss_pred hccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEc
Confidence 344444 599999999999854 57778888765322111 133333323 799999999999999999999999
Q ss_pred cCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC-CeEEccCCCcccccCCccce
Q 039310 144 VGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENY-TPKVSDFGASKLVPIDAIQN 222 (241)
Q Consensus 144 ~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~-~~kl~Dfgla~~~~~~~~~~ 222 (241)
+++++|.+++..+..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++ .++|+|||++......
T Consensus 91 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~---- 163 (267)
T PHA03390 91 IKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP---- 163 (267)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecCCC----
Confidence 999999999988778999999999999999999999999 99999999999999988 9999999998765322
Q ss_pred eeeecccccccccccccC
Q 039310 223 YTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 223 ~~~~~gt~~y~aPE~l~~ 240 (241)
....|+..|+|||++.+
T Consensus 164 -~~~~~~~~y~aPE~~~~ 180 (267)
T PHA03390 164 -SCYDGTLDYFSPEKIKG 180 (267)
T ss_pred -ccCCCCCcccChhhhcC
Confidence 22358899999999864
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-27 Score=192.48 Aligned_cols=164 Identities=25% Similarity=0.294 Sum_probs=134.4
Q ss_pred cccccccccCceeEEEEEeC-CCCeEEEEecccCC-hhhHHHHHHHHHHHHcCC-CCCceeEEEEEecC--CcceEEEEe
Q 039310 69 NYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD-QTKIDEFINELVVVSQIN-RRNVVRLLACCLET--QVPLLVYEF 143 (241)
Q Consensus 69 ~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~-~~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~~--~~~~lv~e~ 143 (241)
.+.+.||+|+||.||+|... ++..+|+|...... ........+|+.+++.+. |||++++++++.+. +..++||||
T Consensus 2 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~ 81 (282)
T cd07831 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL 81 (282)
T ss_pred ceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEec
Confidence 45678999999999999854 57889999866432 222234567999999885 99999999999887 889999999
Q ss_pred cCCCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccce
Q 039310 144 VGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQN 222 (241)
Q Consensus 144 ~~~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~ 222 (241)
++ +++.+.+... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++ +.+||+|||++........
T Consensus 82 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-- 154 (282)
T cd07831 82 MD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-- 154 (282)
T ss_pred CC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCCC--
Confidence 97 4788777653 56899999999999999999999998 999999999999999 9999999999987643322
Q ss_pred eeeeccccccccccccc
Q 039310 223 YTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 223 ~~~~~gt~~y~aPE~l~ 239 (241)
.....+++.|+|||.+.
T Consensus 155 ~~~~~~~~~y~aPE~~~ 171 (282)
T cd07831 155 YTEYISTRWYRAPECLL 171 (282)
T ss_pred cCCCCCCcccCChhHhh
Confidence 12234789999999764
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=191.34 Aligned_cols=169 Identities=24% Similarity=0.373 Sum_probs=141.3
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEec
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
+.+.+.||+|+||.||+|..+ ++..+++|..... .....+.+.+|+.+++.++|+|++++++.+...+..++++||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC 81 (257)
T ss_pred ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence 456778999999999999865 4788999986543 2234567789999999999999999999999999999999999
Q ss_pred CCCCchHHhhcCC--CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCC-eEEccCCCcccccCCccc
Q 039310 145 GNGTLFEHIHKNG--NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYT-PKVSDFGASKLVPIDAIQ 221 (241)
Q Consensus 145 ~~g~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~-~kl~Dfgla~~~~~~~~~ 221 (241)
++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++. ++++|||.+....... .
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-~ 157 (257)
T cd08225 82 DGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM-E 157 (257)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc-c
Confidence 9999999986543 4799999999999999999999998 999999999999998864 6999999987664322 2
Q ss_pred eeeeecccccccccccccC
Q 039310 222 NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~~ 240 (241)
......|++.|+|||++.+
T Consensus 158 ~~~~~~~~~~~~ape~~~~ 176 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQN 176 (257)
T ss_pred cccccCCCccccCHHHHcC
Confidence 2223458899999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=200.72 Aligned_cols=171 Identities=24% Similarity=0.310 Sum_probs=140.5
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEecccCC--hhhHHHHHHHHHHHHcCCCCCceeEEEEEec----CCcce
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD--QTKIDEFINELVVVSQINRRNVVRLLACCLE----TQVPL 138 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~----~~~~~ 138 (241)
..+.+.+.||+|+||.||+|... ++..|++|++.... ......+.+|+.+++.++||||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 34556678999999999999854 58899999876432 2345677889999999999999999988753 34679
Q ss_pred EEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCC
Q 039310 139 LVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPID 218 (241)
Q Consensus 139 lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~ 218 (241)
+||||+. ++|.+++.....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++......
T Consensus 85 lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 85 VVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred EEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 9999995 589999987778999999999999999999999998 999999999999999999999999998765432
Q ss_pred ccc---eeeeecccccccccccccC
Q 039310 219 AIQ---NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 219 ~~~---~~~~~~gt~~y~aPE~l~~ 240 (241)
... ......|+..|+|||.+.+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~ 185 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLS 185 (334)
T ss_pred CcCCCcccccccccccccChHHhcC
Confidence 211 1122358899999998743
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-27 Score=197.25 Aligned_cols=169 Identities=22% Similarity=0.274 Sum_probs=136.9
Q ss_pred hcccccccccCceeEEEEEeC-C--CCeEEEEecccC--ChhhHHHHHHHHHHHHcC-CCCCceeEEEEEecC----Ccc
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-D--RTPVAVKKSKIV--DQTKIDEFINELVVVSQI-NRRNVVRLLACCLET----QVP 137 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~--~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~----~~~ 137 (241)
+.+.+.||+|+||.||++... . +..+|+|.+... .....+.+.+|+.+++.+ +||||+++++.+... ...
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence 456778999999999999854 3 678999986542 223356778999999999 599999999875432 456
Q ss_pred eEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccC
Q 039310 138 LLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPI 217 (241)
Q Consensus 138 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~ 217 (241)
++++|++. ++|.+.+.....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++.....
T Consensus 82 ~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~ 157 (332)
T cd07857 82 YLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSE 157 (332)
T ss_pred EEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCceeccc
Confidence 88889885 689999988888999999999999999999999999 99999999999999999999999999986542
Q ss_pred Cccc---eeeeecccccccccccccC
Q 039310 218 DAIQ---NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 218 ~~~~---~~~~~~gt~~y~aPE~l~~ 240 (241)
.... ......||+.|+|||++.+
T Consensus 158 ~~~~~~~~~~~~~g~~~y~aPE~~~~ 183 (332)
T cd07857 158 NPGENAGFMTEYVATRWYRAPEIMLS 183 (332)
T ss_pred ccccccccccCcccCccccCcHHHhC
Confidence 2111 1122458999999998643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-27 Score=194.52 Aligned_cols=169 Identities=27% Similarity=0.378 Sum_probs=136.2
Q ss_pred hhcccccccccCceeEEEEEeC-CCCeEEEEecccCC--hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCC--------
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD--QTKIDEFINELVVVSQINRRNVVRLLACCLETQ-------- 135 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~-------- 135 (241)
.|...+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 92 (310)
T cd07865 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKG 92 (310)
T ss_pred heEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCc
Confidence 4666778999999999999854 58899999765432 222345678999999999999999999987654
Q ss_pred cceEEEEecCCCCchHHhhcCC-CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCccc
Q 039310 136 VPLLVYEFVGNGTLFEHIHKNG-NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKL 214 (241)
Q Consensus 136 ~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~ 214 (241)
..+++|||+. ++|.+.+.... .+++.++..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++..
T Consensus 93 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 168 (310)
T cd07865 93 SFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARA 168 (310)
T ss_pred eEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCCccc
Confidence 3499999996 47887776543 6899999999999999999999998 99999999999999999999999999876
Q ss_pred ccCCccc---eeeeeccccccccccccc
Q 039310 215 VPIDAIQ---NYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 215 ~~~~~~~---~~~~~~gt~~y~aPE~l~ 239 (241)
....... ......++..|+|||.+.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 196 (310)
T cd07865 169 FSLSKNSKPNRYTNRVVTLWYRPPELLL 196 (310)
T ss_pred ccCCcccCCCCccCcccCccccCcHHhc
Confidence 5332211 112234788999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-27 Score=191.76 Aligned_cols=169 Identities=27% Similarity=0.397 Sum_probs=139.2
Q ss_pred hhhcccccccccCceeEEEEEe-CCCCeEEEEecccCChhhHHHHHHHHHHHHcC-CCCCceeEEEEEec------CCcc
Q 039310 66 VTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVDQTKIDEFINELVVVSQI-NRRNVVRLLACCLE------TQVP 137 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~------~~~~ 137 (241)
..+.+.+.||+|+||.||+|.. .++..+++|..... ......+..|+.+++.+ +|||++++++++.. .+..
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 94 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQL 94 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEE
Confidence 4566777899999999999985 45788899976543 23446788899999998 79999999999853 4577
Q ss_pred eEEEEecCCCCchHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccc
Q 039310 138 LLVYEFVGNGTLFEHIHKN--GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLV 215 (241)
Q Consensus 138 ~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~ 215 (241)
+++|||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++...
T Consensus 95 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~dfg~~~~~ 171 (282)
T cd06636 95 WLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQL 171 (282)
T ss_pred EEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCcchhhh
Confidence 9999999999999998653 35888889999999999999999998 999999999999999999999999998755
Q ss_pred cCCccceeeeeccccccccccccc
Q 039310 216 PIDAIQNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 216 ~~~~~~~~~~~~gt~~y~aPE~l~ 239 (241)
.... .......|++.|+|||.+.
T Consensus 172 ~~~~-~~~~~~~~~~~y~aPE~l~ 194 (282)
T cd06636 172 DRTV-GRRNTFIGTPYWMAPEVIA 194 (282)
T ss_pred hccc-cCCCcccccccccCHhhcC
Confidence 3211 1223345899999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.4e-27 Score=192.22 Aligned_cols=165 Identities=28% Similarity=0.323 Sum_probs=134.4
Q ss_pred ccccccccCceeEEEEEeC-CCCeEEEEecccCC-hhhHHHHHHHHHHHHcCC-CCCceeEEEEEecCCcceEEEEecCC
Q 039310 70 YADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD-QTKIDEFINELVVVSQIN-RRNVVRLLACCLETQVPLLVYEFVGN 146 (241)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~-~~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~~~~~~lv~e~~~~ 146 (241)
..+.||+|+||.||++... ++..+|+|...... ......+.+|+.++.++. ||||+++++++..++..+++|||+..
T Consensus 8 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~ 87 (288)
T cd06616 8 DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI 87 (288)
T ss_pred HHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC
Confidence 3457999999999999854 57899999876432 344567889999999996 99999999999999999999999864
Q ss_pred CCchHHhh-----cCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcc
Q 039310 147 GTLFEHIH-----KNGNLTWERRLRIAAETAGVLSYLHSE-TNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAI 220 (241)
Q Consensus 147 g~L~~~l~-----~~~~l~~~~~~~~~~~i~~~l~~lh~~-~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~ 220 (241)
++.++.. ....+++..+..++.|++.||+|||+. + ++||||||+||++++++.++|+|||++.......
T Consensus 88 -~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~- 162 (288)
T cd06616 88 -SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI- 162 (288)
T ss_pred -CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhccCC-
Confidence 5554432 235799999999999999999999974 7 9999999999999999999999999987653322
Q ss_pred ceeeeecccccccccccccC
Q 039310 221 QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 221 ~~~~~~~gt~~y~aPE~l~~ 240 (241)
......|++.|+|||++.+
T Consensus 163 -~~~~~~~~~~y~aPE~~~~ 181 (288)
T cd06616 163 -AKTRDAGCRPYMAPERIDP 181 (288)
T ss_pred -ccccccCccCccCHHHhcc
Confidence 1122358899999998764
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.7e-27 Score=188.37 Aligned_cols=163 Identities=33% Similarity=0.416 Sum_probs=140.6
Q ss_pred ccccCceeEEEEEeC-CCCeEEEEecccCC---hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCCCCc
Q 039310 74 IGCGGSGNVYKGFLP-DRTPVAVKKSKIVD---QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTL 149 (241)
Q Consensus 74 lg~G~~g~V~~~~~~-~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~g~L 149 (241)
||+|+||.||++... ++..+++|.+.... ......+.+|+.+++.++|||++++++.+..++..+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999865 48889999765432 23456788999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeeeeccc
Q 039310 150 FEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGT 229 (241)
Q Consensus 150 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt 229 (241)
.+++.....+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......++
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~ 156 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCGT 156 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcCC
Confidence 999988878999999999999999999999988 9999999999999999999999999987654322 122334578
Q ss_pred ccccccccccC
Q 039310 230 LGYIDPEYLQT 240 (241)
Q Consensus 230 ~~y~aPE~l~~ 240 (241)
..|+|||.+.+
T Consensus 157 ~~~~~Pe~~~~ 167 (250)
T cd05123 157 PEYLAPEVLLG 167 (250)
T ss_pred ccccChHHhCC
Confidence 89999998753
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.1e-27 Score=196.96 Aligned_cols=165 Identities=24% Similarity=0.293 Sum_probs=136.8
Q ss_pred hhcccccccccCceeEEEEEe-CCCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCC------cc
Q 039310 67 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLETQ------VP 137 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~------~~ 137 (241)
+|...+.||+|+||.||+|.. .++..||+|..... .......+.+|+.+++.++||||+++++++.... ..
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07880 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDF 95 (343)
T ss_pred ceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceE
Confidence 455677899999999999984 46889999986432 2333456889999999999999999999987654 34
Q ss_pred eEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccC
Q 039310 138 LLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPI 217 (241)
Q Consensus 138 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~ 217 (241)
++||||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++++|||++.....
T Consensus 96 ~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 170 (343)
T cd07880 96 YLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDS 170 (343)
T ss_pred EEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence 8999999 6788888764 47899999999999999999999998 99999999999999999999999999886532
Q ss_pred CccceeeeecccccccccccccC
Q 039310 218 DAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 218 ~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
. .....+++.|+|||.+.+
T Consensus 171 ~----~~~~~~~~~y~aPE~~~~ 189 (343)
T cd07880 171 E----MTGYVVTRWYRAPEVILN 189 (343)
T ss_pred C----ccccccCCcccCHHHHhC
Confidence 2 122347889999998753
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.5e-27 Score=195.24 Aligned_cols=165 Identities=18% Similarity=0.232 Sum_probs=134.2
Q ss_pred ccccc--CceeEEEEEeC-CCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCCC
Q 039310 73 VIGCG--GSGNVYKGFLP-DRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNG 147 (241)
Q Consensus 73 ~lg~G--~~g~V~~~~~~-~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~g 147 (241)
.||+| +||+||+|... +++.||+|..... .....+.+.+|+.+++.++||||+++++++...+..++++||++++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 99999999854 6899999987643 2334567889999999999999999999999999999999999999
Q ss_pred CchHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc----
Q 039310 148 TLFEHIHKN--GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ---- 221 (241)
Q Consensus 148 ~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~---- 221 (241)
++.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++++||+.+.........
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence 999998764 35899999999999999999999998 999999999999999999999999865433211110
Q ss_pred --eeeeecccccccccccccC
Q 039310 222 --NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 222 --~~~~~~gt~~y~aPE~l~~ 240 (241)
......++..|||||++.+
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~ 182 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQ 182 (328)
T ss_pred ccccccccCccCccChhhhcC
Confidence 0111225677999999854
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-27 Score=194.22 Aligned_cols=173 Identities=20% Similarity=0.252 Sum_probs=127.0
Q ss_pred HHhhhcccccccccCceeEEEEEeCCC----CeEEEEecccCChhh-----------HHHHHHHHHHHHcCCCCCceeEE
Q 039310 64 KTVTNNYADVIGCGGSGNVYKGFLPDR----TPVAVKKSKIVDQTK-----------IDEFINELVVVSQINRRNVVRLL 128 (241)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~~~----~~vavk~~~~~~~~~-----------~~~~~~E~~~l~~l~h~ni~~l~ 128 (241)
....|.+.+.||+|+||.||+|...++ ..+++|......... ......+...+..++|+|+++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 335677888999999999999986543 445666433222111 01122344556677899999999
Q ss_pred EEEecCC----cceEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCe
Q 039310 129 ACCLETQ----VPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTP 204 (241)
Q Consensus 129 ~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~ 204 (241)
+++.... ..++++|++. .++.+.+......++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred EeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCcE
Confidence 9876543 3467788774 477777766556788899999999999999999998 9999999999999999999
Q ss_pred EEccCCCcccccCCcc------ceeeeecccccccccccccC
Q 039310 205 KVSDFGASKLVPIDAI------QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 205 kl~Dfgla~~~~~~~~------~~~~~~~gt~~y~aPE~l~~ 240 (241)
+|+|||+|+....... .......||+.|+|||+..+
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~ 207 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG 207 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCC
Confidence 9999999986632211 11122459999999998754
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-27 Score=189.48 Aligned_cols=167 Identities=29% Similarity=0.367 Sum_probs=143.0
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEec
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
+...+.||+|+||.||++... ++..+++|..... .......+.+|+.+++.++|+||+++++++.+....++++||+
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA 81 (256)
T ss_pred ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence 455678999999999999754 5788999987643 3344567889999999999999999999999999999999999
Q ss_pred CCCCchHHhhc----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcc
Q 039310 145 GNGTLFEHIHK----NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAI 220 (241)
Q Consensus 145 ~~g~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~ 220 (241)
++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++++|||++......
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-- 156 (256)
T cd08530 82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN-- 156 (256)
T ss_pred CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC--
Confidence 99999999865 346899999999999999999999998 999999999999999999999999999876543
Q ss_pred ceeeeecccccccccccccC
Q 039310 221 QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 221 ~~~~~~~gt~~y~aPE~l~~ 240 (241)
......+++.|+|||.+.+
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~ 175 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKG 175 (256)
T ss_pred -CcccccCCccccCHHHHCC
Confidence 1222447899999998754
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.3e-27 Score=194.25 Aligned_cols=166 Identities=20% Similarity=0.201 Sum_probs=134.5
Q ss_pred cccccccCceeEEEEEeCCCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCCCC
Q 039310 71 ADVIGCGGSGNVYKGFLPDRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGT 148 (241)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~g~ 148 (241)
++.+|.|+++.|+++.. ++..||+|+.... .......+.+|+.+++.++||||+++++++...+..+++|||+++++
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 33445555555555544 6889999987643 34556789999999999999999999999999999999999999999
Q ss_pred chHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcc------
Q 039310 149 LFEHIHKN--GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAI------ 220 (241)
Q Consensus 149 L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~------ 220 (241)
|.+++... ..+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.++++|||.+........
T Consensus 86 l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 99999753 45899999999999999999999998 99999999999999999999999998875532211
Q ss_pred ceeeeecccccccccccccC
Q 039310 221 QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 221 ~~~~~~~gt~~y~aPE~l~~ 240 (241)
.......++..|+|||++..
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~ 182 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQ 182 (314)
T ss_pred cccccccccccccCHHHhcC
Confidence 11122346788999998753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-26 Score=191.09 Aligned_cols=160 Identities=29% Similarity=0.402 Sum_probs=135.3
Q ss_pred cccccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCC
Q 039310 71 ADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGN 146 (241)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~ 146 (241)
.+.||+|+||.||+|... ++..+++|.+... .......+.+|+++++.++|||++++++++.+.+..|++|||+.
T Consensus 26 ~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 104 (313)
T cd06633 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL- 104 (313)
T ss_pred ceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-
Confidence 456999999999999854 5788999987542 23344678899999999999999999999999999999999996
Q ss_pred CCchHHhhc-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeee
Q 039310 147 GTLFEHIHK-NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTV 225 (241)
Q Consensus 147 g~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~ 225 (241)
+++.+++.. ..++++.++..++.|++.++.|||+.+ ++|+||+|+||++++++.++|+|||++..... ...
T Consensus 105 ~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-----~~~ 176 (313)
T cd06633 105 GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP-----ANS 176 (313)
T ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC-----CCC
Confidence 577777754 457899999999999999999999998 99999999999999999999999999865321 123
Q ss_pred eccccccccccccc
Q 039310 226 VQGTLGYIDPEYLQ 239 (241)
Q Consensus 226 ~~gt~~y~aPE~l~ 239 (241)
..|+..|+|||++.
T Consensus 177 ~~~~~~y~aPE~~~ 190 (313)
T cd06633 177 FVGTPYWMAPEVIL 190 (313)
T ss_pred ccccccccChhhcc
Confidence 45889999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.2e-27 Score=191.67 Aligned_cols=165 Identities=24% Similarity=0.300 Sum_probs=138.2
Q ss_pred cccccccccCceeEEEEEeC-CCCeEEEEecccCCh-hhHHHHHHHHHHHHcCC-CCCceeEEEEEecCCcceEEEEecC
Q 039310 69 NYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQ-TKIDEFINELVVVSQIN-RRNVVRLLACCLETQVPLLVYEFVG 145 (241)
Q Consensus 69 ~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~~~~~~lv~e~~~ 145 (241)
.+.+.||+|++|.||+|... ++..|++|++..... .......+|+..++.++ |||++++++++.+.+..++||||+
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~- 80 (283)
T cd07830 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM- 80 (283)
T ss_pred eeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-
Confidence 45678999999999999965 477899998654322 22234567999999998 999999999999999999999999
Q ss_pred CCCchHHhhcCC--CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcccee
Q 039310 146 NGTLFEHIHKNG--NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNY 223 (241)
Q Consensus 146 ~g~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~ 223 (241)
+++|.+++.... .+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||++........ .
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 155 (283)
T cd07830 81 EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--Y 155 (283)
T ss_pred CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC--c
Confidence 779998887654 7899999999999999999999998 99999999999999999999999999876543221 2
Q ss_pred eeeccccccccccccc
Q 039310 224 TVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 224 ~~~~gt~~y~aPE~l~ 239 (241)
....++..|+|||++.
T Consensus 156 ~~~~~~~~~~aPE~~~ 171 (283)
T cd07830 156 TDYVSTRWYRAPEILL 171 (283)
T ss_pred CCCCCcccccCceeee
Confidence 2234788999999874
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.9e-27 Score=203.08 Aligned_cols=170 Identities=22% Similarity=0.267 Sum_probs=127.8
Q ss_pred hhcccccccccCceeEEEEEe-----------------CCCCeEEEEecccCChhhHHHH--------------HHHHHH
Q 039310 67 TNNYADVIGCGGSGNVYKGFL-----------------PDRTPVAVKKSKIVDQTKIDEF--------------INELVV 115 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~-----------------~~~~~vavk~~~~~~~~~~~~~--------------~~E~~~ 115 (241)
.+...+.||+|+||.||+|.. ..+..||||++........++| ..|+..
T Consensus 146 ~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~ 225 (507)
T PLN03224 146 DFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYM 225 (507)
T ss_pred CceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHH
Confidence 456677899999999999963 2346799998775443333333 346667
Q ss_pred HHcCCCCCc-----eeEEEEEec--------CCcceEEEEecCCCCchHHhhcCC------------------------C
Q 039310 116 VSQINRRNV-----VRLLACCLE--------TQVPLLVYEFVGNGTLFEHIHKNG------------------------N 158 (241)
Q Consensus 116 l~~l~h~ni-----~~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~------------------------~ 158 (241)
+..++|.++ ++++++|.. .+..++||||+++++|.++++... .
T Consensus 226 l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~ 305 (507)
T PLN03224 226 CAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDK 305 (507)
T ss_pred HHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccccc
Confidence 777766543 667777653 356799999999999999886321 2
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeeeecccccccccccc
Q 039310 159 LTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYL 238 (241)
Q Consensus 159 l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l 238 (241)
+++..+..++.|++.+|.|||+.+ ++||||||+|||++.++.+||+|||++...............+|+.|+|||.+
T Consensus 306 ~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 306 RDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL 382 (507)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence 456778899999999999999998 99999999999999999999999999976543322222223358999999987
Q ss_pred c
Q 039310 239 Q 239 (241)
Q Consensus 239 ~ 239 (241)
.
T Consensus 383 ~ 383 (507)
T PLN03224 383 V 383 (507)
T ss_pred c
Confidence 4
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=191.22 Aligned_cols=163 Identities=28% Similarity=0.392 Sum_probs=136.8
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
+...+.||+|+||.||+|... ++..+++|..... ......++.+|+.+++.++|+|++++.+++......++||||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 96 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence 444567999999999999854 5778999976532 233446788999999999999999999999999999999999
Q ss_pred cCCCCchHHhhc-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccce
Q 039310 144 VGNGTLFEHIHK-NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQN 222 (241)
Q Consensus 144 ~~~g~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~ 222 (241)
+. |++.+.+.. ...+++.++..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 97 ~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---- 168 (308)
T cd06634 97 CL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---- 168 (308)
T ss_pred cC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc----
Confidence 96 577777643 446899999999999999999999998 999999999999999999999999998765322
Q ss_pred eeeeccccccccccccc
Q 039310 223 YTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 223 ~~~~~gt~~y~aPE~l~ 239 (241)
....+++.|+|||.+.
T Consensus 169 -~~~~~~~~y~aPE~~~ 184 (308)
T cd06634 169 -NXFVGTPYWMAPEVIL 184 (308)
T ss_pred -ccccCCccccCHHHHh
Confidence 2235789999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-27 Score=191.27 Aligned_cols=167 Identities=31% Similarity=0.366 Sum_probs=145.2
Q ss_pred ccccccccCceeEEEEEeC-CCCeEEEEeccc---CChhhHHHHHHHHHHHHcC-CCCCceeEEEEEecCCcceEEEEec
Q 039310 70 YADVIGCGGSGNVYKGFLP-DRTPVAVKKSKI---VDQTKIDEFINELVVVSQI-NRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~---~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
+..+||+|+|.+|..+++. +.+.+|+|.++. .+.........|-.+..+- +||.+|.+..+|+...++++|.||.
T Consensus 254 ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv 333 (593)
T KOG0695|consen 254 LLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYV 333 (593)
T ss_pred eeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEe
Confidence 4458999999999999854 466778876543 3444556667788888776 7999999999999999999999999
Q ss_pred CCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceee
Q 039310 145 GNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYT 224 (241)
Q Consensus 145 ~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~ 224 (241)
+||+|.-.+....+++++.++.+..+|+-||.|||+.+ ||+||||..|+|+|..|.+|++|+|+++.- ......+.
T Consensus 334 ~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~-l~~gd~ts 409 (593)
T KOG0695|consen 334 NGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG-LGPGDTTS 409 (593)
T ss_pred cCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcC-CCCCcccc
Confidence 99999988888889999999999999999999999999 999999999999999999999999999864 23445677
Q ss_pred eecccccccccccccC
Q 039310 225 VVQGTLGYIDPEYLQT 240 (241)
Q Consensus 225 ~~~gt~~y~aPE~l~~ 240 (241)
++||||.|.|||+|.+
T Consensus 410 tfcgtpnyiapeilrg 425 (593)
T KOG0695|consen 410 TFCGTPNYIAPEILRG 425 (593)
T ss_pred cccCCCcccchhhhcc
Confidence 8899999999999976
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-26 Score=188.11 Aligned_cols=166 Identities=30% Similarity=0.395 Sum_probs=135.8
Q ss_pred cccccccccCceeEEEEEeCC-CCeEEEEecccCC--hhhHHHHHHHHHHHHcC---CCCCceeEEEEEecCCc-----c
Q 039310 69 NYADVIGCGGSGNVYKGFLPD-RTPVAVKKSKIVD--QTKIDEFINELVVVSQI---NRRNVVRLLACCLETQV-----P 137 (241)
Q Consensus 69 ~~~~~lg~G~~g~V~~~~~~~-~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l---~h~ni~~l~~~~~~~~~-----~ 137 (241)
...+.||+|+||.||+|..+. +..+|+|.+.... ......+.+|+.+++.+ +|||++++++++...+. .
T Consensus 2 ~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~ 81 (287)
T cd07838 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL 81 (287)
T ss_pred eEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCcee
Confidence 456689999999999999764 8899999876432 22234566788877666 59999999999988776 8
Q ss_pred eEEEEecCCCCchHHhhcCC--CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccc
Q 039310 138 LLVYEFVGNGTLFEHIHKNG--NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLV 215 (241)
Q Consensus 138 ~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~ 215 (241)
+++|||+++ +|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++...
T Consensus 82 ~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 82 TLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIY 157 (287)
T ss_pred EEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcceec
Confidence 999999974 8988886543 5899999999999999999999998 999999999999999999999999998876
Q ss_pred cCCccceeeeecccccccccccccC
Q 039310 216 PIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 216 ~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
..... .....+++.|+|||++.+
T Consensus 158 ~~~~~--~~~~~~~~~~~~PE~~~~ 180 (287)
T cd07838 158 SFEMA--LTSVVVTLWYRAPEVLLQ 180 (287)
T ss_pred cCCcc--cccccccccccChHHhcc
Confidence 43322 222347889999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=195.10 Aligned_cols=165 Identities=25% Similarity=0.307 Sum_probs=135.1
Q ss_pred hhhcccccccccCceeEEEEEe-CCCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecC------Cc
Q 039310 66 VTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLET------QV 136 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~------~~ 136 (241)
.++...+.||+|+||.||+|.. .++..||+|+.... +....+.+.+|+.+++.++||||+++++++... +.
T Consensus 17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (345)
T cd07877 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 96 (345)
T ss_pred CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccccc
Confidence 3455567899999999999984 46889999987642 223346778899999999999999999988643 34
Q ss_pred ceEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCccccc
Q 039310 137 PLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVP 216 (241)
Q Consensus 137 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~ 216 (241)
.+++++++ +++|.+++... .+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++....
T Consensus 97 ~~lv~~~~-~~~L~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~ 171 (345)
T cd07877 97 VYLVTHLM-GADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTD 171 (345)
T ss_pred EEEEehhc-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEeccccccccc
Confidence 67788877 77998877654 6899999999999999999999999 9999999999999999999999999987643
Q ss_pred CCccceeeeeccccccccccccc
Q 039310 217 IDAIQNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 217 ~~~~~~~~~~~gt~~y~aPE~l~ 239 (241)
.. .....+|+.|+|||++.
T Consensus 172 ~~----~~~~~~~~~y~aPE~~~ 190 (345)
T cd07877 172 DE----MTGYVATRWYRAPEIML 190 (345)
T ss_pred cc----ccccccCCCccCHHHHh
Confidence 21 22335789999999864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.6e-29 Score=194.23 Aligned_cols=167 Identities=28% Similarity=0.311 Sum_probs=144.1
Q ss_pred ccccccccCceeEEEEEeC-CCCeEEEEecccCCh--hhHHHHHHHHHHHHcCCCCCceeEEEEEecC-----CcceEEE
Q 039310 70 YADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQ--TKIDEFINELVVVSQINRRNVVRLLACCLET-----QVPLLVY 141 (241)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~-----~~~~lv~ 141 (241)
-.+.||-|+||.||..+.. +++.|+.|++...-+ ...+.+.+|+.++..++|.|++...+..... +..|+++
T Consensus 57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T 136 (449)
T KOG0664|consen 57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT 136 (449)
T ss_pred CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence 3558999999999998854 688999998775433 3457889999999999999999998887654 3568899
Q ss_pred EecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc
Q 039310 142 EFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ 221 (241)
Q Consensus 142 e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~ 221 (241)
|.|. .+|.+++-....++...+.-+..||+.||.|||+.+ |.||||||.|.|++++..+||||||+|+.-..+...
T Consensus 137 ELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~ 212 (449)
T KOG0664|consen 137 ELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRL 212 (449)
T ss_pred HHHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchhhhh
Confidence 9995 499999988888999999999999999999999999 999999999999999999999999999987666555
Q ss_pred eeeeecccccccccccccC
Q 039310 222 NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~~ 240 (241)
..+...-|..|.|||+|++
T Consensus 213 hMTqEVVTQYYRAPEiLMG 231 (449)
T KOG0664|consen 213 NMTHEVVTQYYRAPELLMG 231 (449)
T ss_pred hhHHHHHHHHhccHHHhhc
Confidence 5555667899999999976
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.5e-27 Score=190.57 Aligned_cols=167 Identities=29% Similarity=0.372 Sum_probs=141.3
Q ss_pred cccccccccCceeEEEEEeC-CCCeEEEEecccCC--hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecC
Q 039310 69 NYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD--QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVG 145 (241)
Q Consensus 69 ~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~ 145 (241)
...+.||+|.+|.||+|... +++.+++|...... ....+.+.+|+.+++.++|+|++++++++...+..++++||++
T Consensus 2 ~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (282)
T cd07829 2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD 81 (282)
T ss_pred eeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC
Confidence 34567999999999999865 48899999876542 3345677899999999999999999999999999999999997
Q ss_pred CCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceee
Q 039310 146 NGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYT 224 (241)
Q Consensus 146 ~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~ 224 (241)
++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++........ ...
T Consensus 82 -~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~ 156 (282)
T cd07829 82 -MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYT 156 (282)
T ss_pred -cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-ccC
Confidence 5999999876 57999999999999999999999998 99999999999999999999999999887643221 222
Q ss_pred eecccccccccccccC
Q 039310 225 VVQGTLGYIDPEYLQT 240 (241)
Q Consensus 225 ~~~gt~~y~aPE~l~~ 240 (241)
...++..|+|||.+.+
T Consensus 157 ~~~~~~~~~aPE~~~~ 172 (282)
T cd07829 157 HEVVTLWYRAPEILLG 172 (282)
T ss_pred ccccCcCcCChHHhcC
Confidence 2346788999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.5e-27 Score=193.25 Aligned_cols=170 Identities=26% Similarity=0.315 Sum_probs=135.9
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEecccCC--hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCC-------
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD--QTKIDEFINELVVVSQINRRNVVRLLACCLETQ------- 135 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~------- 135 (241)
..+.+.+.||.|+||.||+|... +++.+++|.+.... ......+.+|+++++.++||||+++++++....
T Consensus 8 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 87 (311)
T cd07866 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKR 87 (311)
T ss_pred ccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccC
Confidence 45667788999999999999854 57889999765432 222345678999999999999999999875533
Q ss_pred -cceEEEEecCCCCchHHhhc-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcc
Q 039310 136 -VPLLVYEFVGNGTLFEHIHK-NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASK 213 (241)
Q Consensus 136 -~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~ 213 (241)
..++++||+.+ ++...+.. ...+++..+..++.|+++||.|||+.+ ++|+||||+||++++++.++|+|||++.
T Consensus 88 ~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 88 GSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred ceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCccch
Confidence 46899999965 67766654 447999999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCccc----------eeeeeccccccccccccc
Q 039310 214 LVPIDAIQ----------NYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 214 ~~~~~~~~----------~~~~~~gt~~y~aPE~l~ 239 (241)
........ ......+++.|+|||.+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 199 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLL 199 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhh
Confidence 65332211 112234688899999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-28 Score=189.08 Aligned_cols=163 Identities=28% Similarity=0.358 Sum_probs=133.2
Q ss_pred cccccCceeEEEEEe-CCCCeEEEEecccCC-hhhHHHHHHHHHHHHcC-CCCCceeEEEEEecCCcceEEEEecCCCCc
Q 039310 73 VIGCGGSGNVYKGFL-PDRTPVAVKKSKIVD-QTKIDEFINELVVVSQI-NRRNVVRLLACCLETQVPLLVYEFVGNGTL 149 (241)
Q Consensus 73 ~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~-~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~g~L 149 (241)
.||.|+||+|++-.+ +.++..|||++.... ..+.++++.|.+...+- +-||||++||.+..++..|+.||+|+- |+
T Consensus 71 ~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~-Sl 149 (361)
T KOG1006|consen 71 EIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI-SL 149 (361)
T ss_pred HhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-hH
Confidence 699999999999764 468899999987654 35667888888866655 689999999999999999999999963 66
Q ss_pred hHHhh-----cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceee
Q 039310 150 FEHIH-----KNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYT 224 (241)
Q Consensus 150 ~~~l~-----~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~ 224 (241)
..+-+ ....+++.-+-.+....++||.||-..- .|||||+||+|||+|..|.+||||||.+..+... . ..+
T Consensus 150 DklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S-i-AkT 225 (361)
T KOG1006|consen 150 DKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS-I-AKT 225 (361)
T ss_pred HHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH-H-Hhh
Confidence 55432 3457999999999999999999998754 3999999999999999999999999999877422 2 223
Q ss_pred eecccccccccccccC
Q 039310 225 VVQGTLGYIDPEYLQT 240 (241)
Q Consensus 225 ~~~gt~~y~aPE~l~~ 240 (241)
.-.|...|||||-+..
T Consensus 226 ~daGCrpYmAPERi~p 241 (361)
T KOG1006|consen 226 VDAGCRPYMAPERIDP 241 (361)
T ss_pred hccCCccccChhccCC
Confidence 3358889999998864
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-27 Score=188.33 Aligned_cols=159 Identities=26% Similarity=0.326 Sum_probs=133.3
Q ss_pred ccccccCceeEEEEEe-CCCCeEEEEecccCChhhHHHHHHHHHHHHcC-CCCCceeEEEEEec----CCcceEEEEecC
Q 039310 72 DVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVDQTKIDEFINELVVVSQI-NRRNVVRLLACCLE----TQVPLLVYEFVG 145 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~----~~~~~lv~e~~~ 145 (241)
+.||-|-.|+|-.+.. .+++.+|+|.+... ....+|+++--.. .|||||++++++.. ...+.+|||.|+
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~me 142 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECME 142 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeeccc
Confidence 4799999999999874 46888999976532 4456788876655 69999999999854 457789999999
Q ss_pred CCCchHHhhcCC--CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC---CCCeEEccCCCcccccCCcc
Q 039310 146 NGTLFEHIHKNG--NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDE---NYTPKVSDFGASKLVPIDAI 220 (241)
Q Consensus 146 ~g~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~---~~~~kl~Dfgla~~~~~~~~ 220 (241)
||.|.+.+...+ .++++++..|+.||+.|+.|||+.+ |.||||||+|+|... |..+||+|||+|+... ..
T Consensus 143 GGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~--~~ 217 (400)
T KOG0604|consen 143 GGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQ--EP 217 (400)
T ss_pred chHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccccccccC--CC
Confidence 999999998776 4999999999999999999999999 999999999999964 5578999999999753 23
Q ss_pred ceeeeecccccccccccccC
Q 039310 221 QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 221 ~~~~~~~gt~~y~aPE~l~~ 240 (241)
....+-+-||.|.|||++..
T Consensus 218 ~~L~TPc~TPyYvaPevlg~ 237 (400)
T KOG0604|consen 218 GDLMTPCFTPYYVAPEVLGP 237 (400)
T ss_pred ccccCCcccccccCHHHhCc
Confidence 44555678999999999853
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8e-27 Score=197.08 Aligned_cols=169 Identities=24% Similarity=0.308 Sum_probs=143.0
Q ss_pred hhcccccccccCceeEEEEEeCCCCeEEEEeccc--CChhhHHHHHHHHHHHHcC-CCCCceeEEEEEecCCcceEEEEe
Q 039310 67 TNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKI--VDQTKIDEFINELVVVSQI-NRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~--~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
.|...+.||+|+.++||++...+.+-+|+|++.. .+.....-|.+|+.+|.+| .|.+|++++++-..++.+|||||+
T Consensus 362 ~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~ 441 (677)
T KOG0596|consen 362 EYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMEC 441 (677)
T ss_pred hhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeec
Confidence 3455678999999999999987777888887543 5677788999999999999 499999999999999999999998
Q ss_pred cCCCCchHHhhcCCC-CCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccce
Q 039310 144 VGNGTLFEHIHKNGN-LTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQN 222 (241)
Q Consensus 144 ~~~g~L~~~l~~~~~-l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~ 222 (241)
-+. +|.++|++... .+.-.++.+..||+.++.++|+.| |||.||||.|+|+- .|.+||+|||.|..+..+....
T Consensus 442 Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTsI 516 (677)
T KOG0596|consen 442 GDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTSI 516 (677)
T ss_pred ccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccCccccce
Confidence 754 99999987654 333478899999999999999999 99999999999987 4589999999999887665443
Q ss_pred ee-eecccccccccccccC
Q 039310 223 YT-VVQGTLGYIDPEYLQT 240 (241)
Q Consensus 223 ~~-~~~gt~~y~aPE~l~~ 240 (241)
.. ..+||+-|||||.+..
T Consensus 517 ~kdsQvGT~NYMsPEAl~~ 535 (677)
T KOG0596|consen 517 VKDSQVGTVNYMSPEALTD 535 (677)
T ss_pred eeccccCcccccCHHHHhh
Confidence 22 2459999999999864
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.7e-26 Score=188.59 Aligned_cols=168 Identities=24% Similarity=0.342 Sum_probs=136.5
Q ss_pred hhcccccccccCceeEEEEEeCC-CCeEEEEecccCC-hhhHHHHHHHHHHHHcC-CCCCceeEEEEEecCCcceEEEEe
Q 039310 67 TNNYADVIGCGGSGNVYKGFLPD-RTPVAVKKSKIVD-QTKIDEFINELVVVSQI-NRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~~-~~~vavk~~~~~~-~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
.+.+.+.||+|+||.||+|.+++ +..+|+|.+.... ......+..|+.++... .||||+++++++.+....+++|||
T Consensus 16 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 95 (296)
T cd06618 16 DLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMEL 95 (296)
T ss_pred hheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeec
Confidence 45667789999999999999764 8889999876432 23445667788777666 499999999999999999999999
Q ss_pred cCCCCchHHhhc-CCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc
Q 039310 144 VGNGTLFEHIHK-NGNLTWERRLRIAAETAGVLSYLHS-ETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ 221 (241)
Q Consensus 144 ~~~g~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~ 221 (241)
++ +++.+++.. ...+++..+..++.|++.||.|||+ .+ ++||||+|+||++++++.++|+|||++........
T Consensus 96 ~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~- 170 (296)
T cd06618 96 MS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA- 170 (296)
T ss_pred cC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCCCc-
Confidence 85 477777654 4478999999999999999999997 46 99999999999999999999999999876533221
Q ss_pred eeeeecccccccccccccC
Q 039310 222 NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~~ 240 (241)
.....+++.|+|||.+..
T Consensus 171 -~~~~~~~~~y~aPE~~~~ 188 (296)
T cd06618 171 -KTRSAGCAAYMAPERIDP 188 (296)
T ss_pred -ccCCCCCccccCHhhcCC
Confidence 122347889999998753
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.8e-27 Score=183.59 Aligned_cols=164 Identities=24% Similarity=0.339 Sum_probs=135.4
Q ss_pred cccccccCceeEEEEEeC-CCCeEEEEeccc-CChhhHHHHHHHHHHHHcCC-CCCceeEEEEEecCCcceEEEEecCCC
Q 039310 71 ADVIGCGGSGNVYKGFLP-DRTPVAVKKSKI-VDQTKIDEFINELVVVSQIN-RRNVVRLLACCLETQVPLLVYEFVGNG 147 (241)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~-~~~~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~~~~~~lv~e~~~~g 147 (241)
...||.|+.|.||+++.. ++...|||.+.. .+..+.++.+..+.++.... .|.||+.+|+|..+...++.||.|. .
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs-~ 175 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS-T 175 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-H
Confidence 446899999999999865 477889998765 45566778888888887764 8999999999999999999999984 3
Q ss_pred CchHHhhc-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeeee
Q 039310 148 TLFEHIHK-NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVV 226 (241)
Q Consensus 148 ~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 226 (241)
-+..+++. .+++++.-+-++...+++||.||-++++ ++|||+||+|||+|+.|++|+||||.+..+... ......
T Consensus 176 C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS--kAhtrs 251 (391)
T KOG0983|consen 176 CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGNIKLCDFGISGRLVDS--KAHTRS 251 (391)
T ss_pred HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEEccCCCEEeecccccceeecc--cccccc
Confidence 45555543 3579999999999999999999998765 999999999999999999999999999887533 223334
Q ss_pred ccccccccccccc
Q 039310 227 QGTLGYIDPEYLQ 239 (241)
Q Consensus 227 ~gt~~y~aPE~l~ 239 (241)
.|.+.|||||-|.
T Consensus 252 AGC~~YMaPERid 264 (391)
T KOG0983|consen 252 AGCAAYMAPERID 264 (391)
T ss_pred cCCccccCccccC
Confidence 5899999999875
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=195.46 Aligned_cols=169 Identities=24% Similarity=0.377 Sum_probs=137.2
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecC----------
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLET---------- 134 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~---------- 134 (241)
.++...+.||.|+||.||+|... ++..|++|+....+....+.+.+|+++++.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 35667788999999999999854 5889999987766555667788999999999999999999876553
Q ss_pred ----CcceEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC-CCCCeEEccC
Q 039310 135 ----QVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLD-ENYTPKVSDF 209 (241)
Q Consensus 135 ----~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~-~~~~~kl~Df 209 (241)
...+++|||++ ++|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++ +++.++++||
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl~df 159 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDF 159 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEECCc
Confidence 35789999997 588888764 36899999999999999999999998 99999999999997 4567899999
Q ss_pred CCcccccCCccc--eeeeeccccccccccccc
Q 039310 210 GASKLVPIDAIQ--NYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 210 gla~~~~~~~~~--~~~~~~gt~~y~aPE~l~ 239 (241)
|++..+...... ......++..|+|||.+.
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 191 (342)
T cd07854 160 GLARIVDPHYSHKGYLSEGLVTKWYRSPRLLL 191 (342)
T ss_pred ccceecCCccccccccccccccccccCHHHHh
Confidence 998765321111 112234788999999764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-26 Score=190.45 Aligned_cols=166 Identities=23% Similarity=0.273 Sum_probs=137.0
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEeccc--CChhhHHHHHHHHHHHHcCCCCCceeEEEEEec-CCcceEEE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKI--VDQTKIDEFINELVVVSQINRRNVVRLLACCLE-TQVPLLVY 141 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~--~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~-~~~~~lv~ 141 (241)
..|.+.+.||.|+||.||+|... ++..||+|++.. ......+.+.+|+.+++.++||||+++.+++.. .+..++++
T Consensus 10 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~ 89 (328)
T cd07856 10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVT 89 (328)
T ss_pred cceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEe
Confidence 34666789999999999999844 688999997643 223344677899999999999999999999876 56788999
Q ss_pred EecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc
Q 039310 142 EFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ 221 (241)
Q Consensus 142 e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~ 221 (241)
||+ +++|..++.. .++++.....++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 90 e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~--- 161 (328)
T cd07856 90 ELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQ--- 161 (328)
T ss_pred ehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccccCCC---
Confidence 998 5688888764 35788889999999999999999999 999999999999999999999999998754321
Q ss_pred eeeeecccccccccccccC
Q 039310 222 NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~~ 240 (241)
.....+++.|+|||.+.+
T Consensus 162 -~~~~~~~~~y~aPE~~~~ 179 (328)
T cd07856 162 -MTGYVSTRYYRAPEIMLT 179 (328)
T ss_pred -cCCCcccccccCceeeec
Confidence 122347889999998754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=188.31 Aligned_cols=167 Identities=27% Similarity=0.336 Sum_probs=140.0
Q ss_pred cccccccccCceeEEEEEeC-CCCeEEEEecccCCh--hhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecC
Q 039310 69 NYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQ--TKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVG 145 (241)
Q Consensus 69 ~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~ 145 (241)
...+.||+|++|.||+|... ++..+++|....... .....+.+|+.+++.++||||+++++++...+..++++||++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (283)
T cd05118 2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD 81 (283)
T ss_pred ccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC
Confidence 34567999999999999864 688899998765322 345678899999999999999999999999999999999997
Q ss_pred CCCchHHhhc-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceee
Q 039310 146 NGTLFEHIHK-NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYT 224 (241)
Q Consensus 146 ~g~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~ 224 (241)
+ ++.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+....... ....
T Consensus 82 ~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~~ 156 (283)
T cd05118 82 T-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYT 156 (283)
T ss_pred C-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cccc
Confidence 5 88888765 357999999999999999999999999 9999999999999999999999999987764432 1122
Q ss_pred eecccccccccccccC
Q 039310 225 VVQGTLGYIDPEYLQT 240 (241)
Q Consensus 225 ~~~gt~~y~aPE~l~~ 240 (241)
...++..|+|||.+..
T Consensus 157 ~~~~~~~~~~PE~~~~ 172 (283)
T cd05118 157 HYVVTRWYRAPELLLG 172 (283)
T ss_pred CccCcccccCcHHHhc
Confidence 2347889999998753
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-26 Score=182.67 Aligned_cols=151 Identities=25% Similarity=0.216 Sum_probs=127.5
Q ss_pred cCceeEEEEEeC-CCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCCCCchHHhhc
Q 039310 77 GGSGNVYKGFLP-DRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHK 155 (241)
Q Consensus 77 G~~g~V~~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 155 (241)
|.+|.||++... +++.+|+|.+.... ...+|...+....||||+++++++.+.+..+++|||+++++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999854 67889999876432 223455555566799999999999999999999999999999999988
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeeeeccccccccc
Q 039310 156 NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDP 235 (241)
Q Consensus 156 ~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aP 235 (241)
...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++++|||.+...... .....++..|+||
T Consensus 79 ~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~aP 151 (237)
T cd05576 79 FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYCAP 151 (237)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccccCC
Confidence 778999999999999999999999998 999999999999999999999999987655322 1223457789999
Q ss_pred cccc
Q 039310 236 EYLQ 239 (241)
Q Consensus 236 E~l~ 239 (241)
|.+.
T Consensus 152 E~~~ 155 (237)
T cd05576 152 EVGG 155 (237)
T ss_pred cccC
Confidence 9875
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.6e-29 Score=191.41 Aligned_cols=166 Identities=26% Similarity=0.367 Sum_probs=134.9
Q ss_pred cccccccCceeEEEEEe-CCCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEec--------CCcceE
Q 039310 71 ADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLE--------TQVPLL 139 (241)
Q Consensus 71 ~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~--------~~~~~l 139 (241)
...||+|.||+||+|+. ++++.||+|+.... .........+|+.+|..++|+|++.+++.|.. ....|+
T Consensus 22 ~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~yl 101 (376)
T KOG0669|consen 22 LAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYL 101 (376)
T ss_pred HHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeee
Confidence 44799999999999984 45778898865432 23344667899999999999999999888743 235799
Q ss_pred EEEecCCCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCC
Q 039310 140 VYEFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPID 218 (241)
Q Consensus 140 v~e~~~~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~ 218 (241)
|+++|+. +|.-++... .+++..++.+++.++..||.|+|... |+|||+||.|+||+.++.+||+|||+++.+...
T Consensus 102 Vf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar~fs~~ 177 (376)
T KOG0669|consen 102 VFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLARAFSTS 177 (376)
T ss_pred eHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccccceecc
Confidence 9999986 888888765 47999999999999999999999988 999999999999999999999999999765322
Q ss_pred cc---ceeeeecccccccccccccC
Q 039310 219 AI---QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 219 ~~---~~~~~~~gt~~y~aPE~l~~ 240 (241)
.. ...+...-|+.|.+||.|.+
T Consensus 178 ~n~~kprytnrvvTLwYrppEllLG 202 (376)
T KOG0669|consen 178 KNVVKPRYTNRVVTLWYRPPELLLG 202 (376)
T ss_pred cccCCCCcccceeeeecCCHHHhhc
Confidence 11 11223345999999998864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.8e-28 Score=207.65 Aligned_cols=168 Identities=29% Similarity=0.393 Sum_probs=147.8
Q ss_pred hhcccccccccCceeEEEEEe-CCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecC
Q 039310 67 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVG 145 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~ 145 (241)
.|.+...+|.|+||.||+|+. ..+...|+|.++..-.....-..+|+-+++..+||||+.++|.+..++..|+.||||.
T Consensus 16 dyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycg 95 (829)
T KOG0576|consen 16 DYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCG 95 (829)
T ss_pred chhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecC
Confidence 355666799999999999994 4578889998776555555666789999999999999999999999999999999999
Q ss_pred CCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeee
Q 039310 146 NGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTV 225 (241)
Q Consensus 146 ~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~ 225 (241)
+|+|++.-+-.+++++.+.....++.++|+.|||+++ -+|||||-.|||+++.|.+|++|||.+..+..- ..+...
T Consensus 96 ggslQdiy~~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat-i~Krks 171 (829)
T KOG0576|consen 96 GGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT-IAKRKS 171 (829)
T ss_pred CCcccceeeecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh-hhhhhc
Confidence 9999999988889999999999999999999999999 899999999999999999999999998776432 234555
Q ss_pred ecccccccccccc
Q 039310 226 VQGTLGYIDPEYL 238 (241)
Q Consensus 226 ~~gt~~y~aPE~l 238 (241)
+.|||.|||||+-
T Consensus 172 fiGtpywmapEva 184 (829)
T KOG0576|consen 172 FIGTPYWMAPEVA 184 (829)
T ss_pred ccCCccccchhHH
Confidence 6799999999974
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.3e-26 Score=190.06 Aligned_cols=164 Identities=24% Similarity=0.301 Sum_probs=133.5
Q ss_pred hhcccccccccCceeEEEEEeC-CCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCC------cc
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLETQ------VP 137 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~------~~ 137 (241)
.+...+.||+|+||.||+|... ++..||+|++... .......+.+|+.+++.++||||+++++++.... ..
T Consensus 16 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 95 (342)
T cd07879 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDF 95 (342)
T ss_pred ceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceE
Confidence 3445678999999999999854 6889999986532 2233456789999999999999999999987543 45
Q ss_pred eEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccC
Q 039310 138 LLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPI 217 (241)
Q Consensus 138 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~ 217 (241)
++++||+.. +|..+.. ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++.....
T Consensus 96 ~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~ 169 (342)
T cd07879 96 YLVMPYMQT-DLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADA 169 (342)
T ss_pred EEEeccccc-CHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence 899999964 7776653 36899999999999999999999998 99999999999999999999999999876532
Q ss_pred CccceeeeecccccccccccccC
Q 039310 218 DAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 218 ~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
. .....+|+.|+|||.+.+
T Consensus 170 ~----~~~~~~~~~y~aPE~~~~ 188 (342)
T cd07879 170 E----MTGYVVTRWYRAPEVILN 188 (342)
T ss_pred C----CCCceeeecccChhhhcC
Confidence 2 122347889999998754
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.4e-26 Score=184.51 Aligned_cols=167 Identities=23% Similarity=0.295 Sum_probs=134.3
Q ss_pred hcccccccccCceeEEEEEeCC-CCeEEEEeccc-----CChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEE
Q 039310 68 NNYADVIGCGGSGNVYKGFLPD-RTPVAVKKSKI-----VDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVY 141 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavk~~~~-----~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~ 141 (241)
|.+.+.||+|+||.||++.... +..+++|..+. ........+..|+.+++.++||||+++++++.+.+..++++
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 5667889999999999998543 33344444332 12233456778999999999999999999999999999999
Q ss_pred EecCCCCchHHhhc----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccC
Q 039310 142 EFVGNGTLFEHIHK----NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPI 217 (241)
Q Consensus 142 e~~~~g~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~ 217 (241)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++ +.++|+|||++.....
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecCC
Confidence 99999999988853 346999999999999999999999998 999999999999975 5699999999876533
Q ss_pred Cccceeeeeccccccccccccc
Q 039310 218 DAIQNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 218 ~~~~~~~~~~gt~~y~aPE~l~ 239 (241)
.. .......|++.|+|||.+.
T Consensus 158 ~~-~~~~~~~~~~~~~~pe~~~ 178 (260)
T cd08222 158 SC-DLATTFTGTPYYMSPEALK 178 (260)
T ss_pred Cc-ccccCCCCCcCccCHHHHc
Confidence 22 2223345789999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-26 Score=192.31 Aligned_cols=164 Identities=25% Similarity=0.322 Sum_probs=137.5
Q ss_pred hhcccccccccCceeEEEEEeC-CCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCc------c
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLETQV------P 137 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~------~ 137 (241)
.|.....||+|++|.||+|... ++..|++|.+... +......+.+|+.+++.++|||++++.+++...+. .
T Consensus 16 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07851 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDV 95 (343)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccE
Confidence 3556678999999999999865 5788999986542 23344667889999999999999999988766554 8
Q ss_pred eEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccC
Q 039310 138 LLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPI 217 (241)
Q Consensus 138 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~ 217 (241)
++++||+ +++|.+++.. .++++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 96 ~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~ 170 (343)
T cd07851 96 YLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDD 170 (343)
T ss_pred EEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccccccccc
Confidence 9999998 5699988875 46999999999999999999999998 99999999999999999999999999886533
Q ss_pred Cccceeeeeccccccccccccc
Q 039310 218 DAIQNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 218 ~~~~~~~~~~gt~~y~aPE~l~ 239 (241)
. .....+|+.|+|||.+.
T Consensus 171 ~----~~~~~~~~~y~aPE~~~ 188 (343)
T cd07851 171 E----MTGYVATRWYRAPEIML 188 (343)
T ss_pred c----ccCCcccccccCHHHHh
Confidence 2 22335788999999874
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-26 Score=202.84 Aligned_cols=161 Identities=28% Similarity=0.412 Sum_probs=132.2
Q ss_pred ccccccCcee-EEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcC-CCCCceeEEEEEecCCcceEEEEecCCCCc
Q 039310 72 DVIGCGGSGN-VYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQI-NRRNVVRLLACCLETQVPLLVYEFVGNGTL 149 (241)
Q Consensus 72 ~~lg~G~~g~-V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~g~L 149 (241)
+.+|.|+.|+ ||+|.+ +++.||||++-. ....-+.+|+.+|+.- +||||+++++.-.+++..|+..|.|.. +|
T Consensus 515 eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-sL 589 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVY-EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-SL 589 (903)
T ss_pred HHcccCCCCcEEEEEee-CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-hH
Confidence 4789998876 789998 677999997653 2334567899999998 599999999999999999999999976 99
Q ss_pred hHHhhcCC----CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC---C--CCeEEccCCCcccccCCcc
Q 039310 150 FEHIHKNG----NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDE---N--YTPKVSDFGASKLVPIDAI 220 (241)
Q Consensus 150 ~~~l~~~~----~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~---~--~~~kl~Dfgla~~~~~~~~ 220 (241)
.+++.... ...-...+....|+++||++||+.+ ||||||||.||||+. + ..++|+|||+++.+..+..
T Consensus 590 ~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s 666 (903)
T KOG1027|consen 590 QDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS 666 (903)
T ss_pred HHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCCCcc
Confidence 99998741 1222456788999999999999998 999999999999975 3 4689999999999865533
Q ss_pred c--eeeeecccccccccccccC
Q 039310 221 Q--NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 221 ~--~~~~~~gt~~y~aPE~l~~ 240 (241)
. ......||-+|+|||.|+.
T Consensus 667 S~~r~s~~sGt~GW~APE~L~~ 688 (903)
T KOG1027|consen 667 SFSRLSGGSGTSGWQAPEQLRE 688 (903)
T ss_pred hhhcccCCCCcccccCHHHHhc
Confidence 2 3344569999999999875
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=174.12 Aligned_cols=139 Identities=17% Similarity=0.173 Sum_probs=109.5
Q ss_pred cccccccCceeEEEEEeCCCCeEEEEecccCChh--h------------------------HHHHHHHHHHHHcCCCCCc
Q 039310 71 ADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQT--K------------------------IDEFINELVVVSQINRRNV 124 (241)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~--~------------------------~~~~~~E~~~l~~l~h~ni 124 (241)
...||+|+||.||+|...+|++||+|..+..... . .....+|+..+..+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3579999999999999878999999987643211 0 1123459999999988876
Q ss_pred eeEEEEEecCCcceEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHh-hcCCCCCeEecCCCCCCeeeCCCCC
Q 039310 125 VRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYL-HSETNVPIIHRDVKSANILLDENYT 203 (241)
Q Consensus 125 ~~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~l-h~~~~~~iiH~dlk~~Nili~~~~~ 203 (241)
........ ...++||||++++++.........++..++..++.|++.+|.|+ |+.+ ++||||||+|||++ ++.
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-CCc
Confidence 44333222 23389999999887766544456799999999999999999999 6888 99999999999998 478
Q ss_pred eEEccCCCcccc
Q 039310 204 PKVSDFGASKLV 215 (241)
Q Consensus 204 ~kl~Dfgla~~~ 215 (241)
++|+|||+|...
T Consensus 156 v~LiDFG~a~~~ 167 (190)
T cd05147 156 LYIIDVSQSVEH 167 (190)
T ss_pred EEEEEccccccC
Confidence 999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=6e-25 Score=173.42 Aligned_cols=167 Identities=31% Similarity=0.458 Sum_probs=144.7
Q ss_pred cccccccccCceeEEEEEeCC-CCeEEEEecccCChh-hHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCC
Q 039310 69 NYADVIGCGGSGNVYKGFLPD-RTPVAVKKSKIVDQT-KIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGN 146 (241)
Q Consensus 69 ~~~~~lg~G~~g~V~~~~~~~-~~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~ 146 (241)
.+.+.||.|++|.||++...+ +..+++|........ ..+.+.+|++.++.++|+|++++++++...+..++++|++++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~ 81 (225)
T smart00221 2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEG 81 (225)
T ss_pred ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCC
Confidence 456789999999999999664 788999987765444 567889999999999999999999999999999999999999
Q ss_pred CCchHHhhcCCC-CCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeee
Q 039310 147 GTLFEHIHKNGN-LTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTV 225 (241)
Q Consensus 147 g~L~~~l~~~~~-l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~ 225 (241)
++|.+++..... +++.....++.+++.++.+||+.+ ++|+|++|+||+++.++.++|+|||.+.............
T Consensus 82 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~ 158 (225)
T smart00221 82 GDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKT 158 (225)
T ss_pred CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccc
Confidence 999999987666 899999999999999999999998 9999999999999999999999999988764432112233
Q ss_pred ecccccccccccc
Q 039310 226 VQGTLGYIDPEYL 238 (241)
Q Consensus 226 ~~gt~~y~aPE~l 238 (241)
..++..|++||.+
T Consensus 159 ~~~~~~~~~pe~~ 171 (225)
T smart00221 159 VKGTPFYLAPEVL 171 (225)
T ss_pred eeccCCcCCHhHh
Confidence 4578899999986
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=200.06 Aligned_cols=166 Identities=23% Similarity=0.230 Sum_probs=117.6
Q ss_pred hhhcccccccccCceeEEEEEeC-C----CCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEE------EecC
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-D----RTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLAC------CLET 134 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~----~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~------~~~~ 134 (241)
..+.+.+.||+|+||.||+|... + +..||+|++...... +...+| .+....+.++..+... ....
T Consensus 132 ~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~ 207 (566)
T PLN03225 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSKKE 207 (566)
T ss_pred CCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccccC
Confidence 34667789999999999999864 3 688999986543221 111111 1122222222222211 2455
Q ss_pred CcceEEEEecCCCCchHHhhcCCC--------------------CCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCC
Q 039310 135 QVPLLVYEFVGNGTLFEHIHKNGN--------------------LTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSA 194 (241)
Q Consensus 135 ~~~~lv~e~~~~g~L~~~l~~~~~--------------------l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~ 194 (241)
...++|+||+++++|.+++..... .....+..++.|++.||.|||+.+ |+||||||+
T Consensus 208 ~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLKP~ 284 (566)
T PLN03225 208 DEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQ 284 (566)
T ss_pred CceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCCHH
Confidence 678999999999999999865421 112345679999999999999998 999999999
Q ss_pred CeeeCC-CCCeEEccCCCcccccCCccceeeeecccccccccccc
Q 039310 195 NILLDE-NYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYL 238 (241)
Q Consensus 195 Nili~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l 238 (241)
|||+++ ++.+||+|||+|..+............+|+.|||||.+
T Consensus 285 NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~ 329 (566)
T PLN03225 285 NIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQY 329 (566)
T ss_pred HEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHh
Confidence 999986 57999999999986644333334456789999999965
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=168.49 Aligned_cols=141 Identities=21% Similarity=0.189 Sum_probs=111.9
Q ss_pred cccccccCceeEEEEEeCCCCeEEEEecccCChh--------------------------hHHHHHHHHHHHHcCCCCCc
Q 039310 71 ADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQT--------------------------KIDEFINELVVVSQINRRNV 124 (241)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~--------------------------~~~~~~~E~~~l~~l~h~ni 124 (241)
.+.||+|++|+||+|...+|+.||||........ ....+.+|...+..+.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 3579999999999999778999999986643210 01234578999999999987
Q ss_pred eeEEEEEecCCcceEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEecCCCCCCeeeCCCCC
Q 039310 125 VRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHS-ETNVPIIHRDVKSANILLDENYT 203 (241)
Q Consensus 125 ~~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~iiH~dlk~~Nili~~~~~ 203 (241)
.....+... ..++||||++++++.........++......++.|++.++.++|+ .+ ++||||||+||+++ ++.
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~~~ 155 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-DGK 155 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-CCC
Confidence 544444333 248999999887554443334568889999999999999999999 88 99999999999999 889
Q ss_pred eEEccCCCcccccC
Q 039310 204 PKVSDFGASKLVPI 217 (241)
Q Consensus 204 ~kl~Dfgla~~~~~ 217 (241)
++|+|||+|.....
T Consensus 156 ~~liDFG~a~~~~~ 169 (190)
T cd05145 156 PYIIDVSQAVELDH 169 (190)
T ss_pred EEEEEcccceecCC
Confidence 99999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-23 Score=163.67 Aligned_cols=163 Identities=36% Similarity=0.540 Sum_probs=139.6
Q ss_pred ccccCceeEEEEEeCC-CCeEEEEecccCChh-hHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCCCCchH
Q 039310 74 IGCGGSGNVYKGFLPD-RTPVAVKKSKIVDQT-KIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFE 151 (241)
Q Consensus 74 lg~G~~g~V~~~~~~~-~~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~g~L~~ 151 (241)
||+|.+|.||++...+ +..+++|........ ..+.+.+|+..++.++|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999754 889999987754432 35678999999999999999999999999999999999999899999
Q ss_pred HhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC-CCCeEEccCCCcccccCCccceeeeeccc
Q 039310 152 HIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDE-NYTPKVSDFGASKLVPIDAIQNYTVVQGT 229 (241)
Q Consensus 152 ~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~gt 229 (241)
++... ..+++..+..++.+++.++.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ ......+.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~ 156 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGT 156 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCC
Confidence 99765 47899999999999999999999998 999999999999999 89999999999876543221 12223478
Q ss_pred ccccccccccC
Q 039310 230 LGYIDPEYLQT 240 (241)
Q Consensus 230 ~~y~aPE~l~~ 240 (241)
..|++||.+..
T Consensus 157 ~~~~~pe~~~~ 167 (215)
T cd00180 157 PAYMAPEVLLG 167 (215)
T ss_pred CCccChhHhcc
Confidence 89999998754
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-24 Score=171.01 Aligned_cols=157 Identities=32% Similarity=0.470 Sum_probs=137.4
Q ss_pred CceeEEEEEeCC-CCeEEEEecccCChhh-HHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCCCCchHHhhc
Q 039310 78 GSGNVYKGFLPD-RTPVAVKKSKIVDQTK-IDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHK 155 (241)
Q Consensus 78 ~~g~V~~~~~~~-~~~vavk~~~~~~~~~-~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 155 (241)
+||.||+|...+ +..+++|......... .+.+.+|+..++.++|+|++++++++......++++|++++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999764 8899999877654443 67899999999999999999999999999999999999999999999987
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeeeeccccccccc
Q 039310 156 NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDP 235 (241)
Q Consensus 156 ~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aP 235 (241)
...+++..+..++.+++.++.|||+.+ ++|+||+|+||++++++.++++|||.+....... ......++..|+||
T Consensus 81 ~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~p 155 (244)
T smart00220 81 RGRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMAP 155 (244)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCCH
Confidence 766899999999999999999999998 9999999999999999999999999988764332 23334578899999
Q ss_pred cccc
Q 039310 236 EYLQ 239 (241)
Q Consensus 236 E~l~ 239 (241)
|.+.
T Consensus 156 E~~~ 159 (244)
T smart00220 156 EVLL 159 (244)
T ss_pred HHHc
Confidence 9864
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-24 Score=175.43 Aligned_cols=176 Identities=22% Similarity=0.305 Sum_probs=144.1
Q ss_pred cccCHHHHHHhhhcccccccccCceeEEEEEeC-CCCeEEEEecccCChhhHHHHHHHHHHHHcCCC--C----CceeEE
Q 039310 56 KIFIEEEIKTVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQTKIDEFINELVVVSQINR--R----NVVRLL 128 (241)
Q Consensus 56 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h--~----ni~~l~ 128 (241)
.++...+....++...+.+|+|.||.|-.+... .+..||+|.++..... .+...-|+++++++.+ | -++++.
T Consensus 79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~ 157 (415)
T KOG0671|consen 79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMR 157 (415)
T ss_pred EEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeee
Confidence 445555666778888889999999999999744 3688999987765443 3566789999999942 3 388888
Q ss_pred EEEecCCcceEEEEecCCCCchHHhhcCC--CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC------
Q 039310 129 ACCLETQVPLLVYEFVGNGTLFEHIHKNG--NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDE------ 200 (241)
Q Consensus 129 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~------ 200 (241)
+||...+..++|.|.+ |.|+.+++..++ +++...+..++.|++.++.|||+.+ ++|-||||+|||+.+
T Consensus 158 ~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~ 233 (415)
T KOG0671|consen 158 DWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKT 233 (415)
T ss_pred hhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEE
Confidence 9999999999999998 669999998875 6999999999999999999999999 999999999999831
Q ss_pred --------------CCCeEEccCCCcccccCCccceeeeecccccccccccccC
Q 039310 201 --------------NYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 201 --------------~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
+..++++|||.|.....+ ......|..|.|||++.+
T Consensus 234 ~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~----hs~iVsTRHYRAPEViLg 283 (415)
T KOG0671|consen 234 YNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH----HSTIVSTRHYRAPEVILG 283 (415)
T ss_pred eccCCccceeccCCCcceEEEecCCcceeccC----cceeeeccccCCchheec
Confidence 345899999999864322 244557899999999865
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6e-24 Score=173.51 Aligned_cols=174 Identities=20% Similarity=0.312 Sum_probs=141.6
Q ss_pred HHhhhcccccccccCceeEEEEEeC------CCCeEEEEeccc-CChhhHHHHHHHHHHHHcCCCCCceeEEEEEe-cCC
Q 039310 64 KTVTNNYADVIGCGGSGNVYKGFLP------DRTPVAVKKSKI-VDQTKIDEFINELVVVSQINRRNVVRLLACCL-ETQ 135 (241)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavk~~~~-~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~-~~~ 135 (241)
.+.+.+...++.+|.||.||.|.|. +.+.|.+|.++. .++-+...++.|.-++..+.|||+.++.+++. +..
T Consensus 282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~ 361 (563)
T KOG1024|consen 282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYA 361 (563)
T ss_pred hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccC
Confidence 3344455668999999999999654 345567786654 45667788999999999999999999999975 466
Q ss_pred cceEEEEecCCCCchHHhhcC--------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEc
Q 039310 136 VPLLVYEFVGNGTLFEHIHKN--------GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVS 207 (241)
Q Consensus 136 ~~~lv~e~~~~g~L~~~l~~~--------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~ 207 (241)
.+++++.++..|+|..|+... ..++..+...++.|++.|++|||+.+ +||.||.++|++||+..++||+
T Consensus 362 ~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVklt 438 (563)
T KOG1024|consen 362 TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKLT 438 (563)
T ss_pred cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEec
Confidence 889999999999999999721 24788889999999999999999999 9999999999999999999999
Q ss_pred cCCCcccccCCccceeee-ecccccccccccccC
Q 039310 208 DFGASKLVPIDAIQNYTV-VQGTLGYIDPEYLQT 240 (241)
Q Consensus 208 Dfgla~~~~~~~~~~~~~-~~gt~~y~aPE~l~~ 240 (241)
|=.+++.+...++.-... ...+..|||||.|++
T Consensus 439 DsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n 472 (563)
T KOG1024|consen 439 DSALSRDLFPGDYHCLGDNENRPVKWMSLEALQN 472 (563)
T ss_pred cchhccccCcccccccCCCCCCcccccCHHHHhh
Confidence 999999875444332222 235678999999864
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.4e-23 Score=159.33 Aligned_cols=136 Identities=19% Similarity=0.245 Sum_probs=106.0
Q ss_pred cccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcC-----CCCCceeEEEEEecCC---cce-EEE
Q 039310 71 ADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQI-----NRRNVVRLLACCLETQ---VPL-LVY 141 (241)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l-----~h~ni~~l~~~~~~~~---~~~-lv~ 141 (241)
.++||+|+||.||. ++.....+||..........+.+.+|+.+++.+ +||||+++++++.++. ..+ +|+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred cceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 45799999999996 433333468877654444557889999999999 5799999999998863 333 789
Q ss_pred Ee--cCCCCchHHhhcCCCCCHHHHHHHHHHHHHHH-HHhhcCCCCCeEecCCCCCCeeeCC----CCCeEEcc-CCCcc
Q 039310 142 EF--VGNGTLFEHIHKNGNLTWERRLRIAAETAGVL-SYLHSETNVPIIHRDVKSANILLDE----NYTPKVSD-FGASK 213 (241)
Q Consensus 142 e~--~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l-~~lh~~~~~~iiH~dlk~~Nili~~----~~~~kl~D-fgla~ 213 (241)
|| +++++|.+++.+. .+++. ..++.+++.++ .|||+.+ |+||||||+|||++. +..++|+| ||.+.
T Consensus 85 e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~~ 158 (210)
T PRK10345 85 DFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNIGEST 158 (210)
T ss_pred cCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECCCCcc
Confidence 99 5578999999764 45555 35678888777 9999999 999999999999973 34799999 45443
Q ss_pred c
Q 039310 214 L 214 (241)
Q Consensus 214 ~ 214 (241)
.
T Consensus 159 ~ 159 (210)
T PRK10345 159 F 159 (210)
T ss_pred e
Confidence 3
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.8e-23 Score=159.93 Aligned_cols=170 Identities=22% Similarity=0.293 Sum_probs=136.7
Q ss_pred HHHHHHhhhcccccccccCceeEEEEE-eCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCC-CCceeEEEEEecCCcc
Q 039310 60 EEEIKTVTNNYADVIGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINR-RNVVRLLACCLETQVP 137 (241)
Q Consensus 60 ~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h-~ni~~l~~~~~~~~~~ 137 (241)
.+.+....+.+.+.||.|+||.+|.|. ..+|..||||.-.. .....++..|..++..+++ ..|+.+..+..+....
T Consensus 9 ~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~--~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 9 EELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESS--KAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred hhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecc--cCCCcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 344556678888999999999999998 66799999996432 2223567789999999976 6899998899999999
Q ss_pred eEEEEecCCCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC---CCCCeEEccCCCcc
Q 039310 138 LLVYEFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLD---ENYTPKVSDFGASK 213 (241)
Q Consensus 138 ~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~---~~~~~kl~Dfgla~ 213 (241)
.+|||.+ |.+|.++..-. ..++.++++.++.|++.-++|+|.++ +|||||||+|+|.. ....+.++|||+|+
T Consensus 87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchh
Confidence 9999998 77999988754 36999999999999999999999999 99999999999986 34568999999998
Q ss_pred cccCCcc------ceeeeeccccccccc
Q 039310 214 LVPIDAI------QNYTVVQGTLGYIDP 235 (241)
Q Consensus 214 ~~~~~~~------~~~~~~~gt~~y~aP 235 (241)
.+-+... .......||.+|.+-
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASi 190 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASI 190 (341)
T ss_pred hhccccccccCccccCCccceeeeehhh
Confidence 7632211 122334588888764
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-23 Score=180.58 Aligned_cols=162 Identities=24% Similarity=0.324 Sum_probs=133.5
Q ss_pred hhhcccccccccCceeEEEEE-eCCCCeEEEEecccCChhhHHHHHHHHHHHHcC-CCCCceeEEEEEecCCcceEEEEe
Q 039310 66 VTNNYADVIGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKIDEFINELVVVSQI-NRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
..|.+...+|.|+|+.|..+. ..+.+..++|.+... ..+..+|+.++... +|||++++.+.+.+....|+|||.
T Consensus 322 ~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~ 397 (612)
T KOG0603|consen 322 ESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMEL 397 (612)
T ss_pred hhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeehh
Confidence 345566679999999999987 445777889976543 12334677666666 799999999999999999999999
Q ss_pred cCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee-CCCCCeEEccCCCcccccCCccce
Q 039310 144 VGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILL-DENYTPKVSDFGASKLVPIDAIQN 222 (241)
Q Consensus 144 ~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili-~~~~~~kl~Dfgla~~~~~~~~~~ 222 (241)
+.++-+.+.+....... .++..|+.+++.++.|||+++ +|||||||+|||+ ++.++++|+|||.++.+..+
T Consensus 398 l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~---- 469 (612)
T KOG0603|consen 398 LDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS---- 469 (612)
T ss_pred ccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh----
Confidence 99998888887665444 788889999999999999999 9999999999999 69999999999999987544
Q ss_pred eeeeccccccccccccc
Q 039310 223 YTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 223 ~~~~~gt~~y~aPE~l~ 239 (241)
....+-|..|.|||++.
T Consensus 470 ~~tp~~t~~y~APEvl~ 486 (612)
T KOG0603|consen 470 CDTPALTLQYVAPEVLA 486 (612)
T ss_pred hcccchhhcccChhhhc
Confidence 22335688999999986
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-23 Score=163.78 Aligned_cols=164 Identities=20% Similarity=0.335 Sum_probs=130.2
Q ss_pred hhcccccccccCceeEEEEEeCC-CCeEEEEecccCChhhHHHHHHHHHHHHcC-CCCCceeEEEE-EecCCcceEEEEe
Q 039310 67 TNNYADVIGCGGSGNVYKGFLPD-RTPVAVKKSKIVDQTKIDEFINELVVVSQI-NRRNVVRLLAC-CLETQVPLLVYEF 143 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~~-~~~vavk~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~-~~~~~~~~lv~e~ 143 (241)
.|++.+.+|+|.||.+-+++++. ++.+++|.+. .......+|.+|..---.| .|.||+.-|++ |+..+.+++++||
T Consensus 25 ~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp-~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~ 103 (378)
T KOG1345|consen 25 VYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVP-RPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEF 103 (378)
T ss_pred hhhHHHHhcccceeeEEeeeccCCceEEEeeccC-cchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeecc
Confidence 35667789999999999999765 5566777554 3445568899998877677 48999988765 6777888999999
Q ss_pred cCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC--CCCCeEEccCCCcccccCCccc
Q 039310 144 VGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLD--ENYTPKVSDFGASKLVPIDAIQ 221 (241)
Q Consensus 144 ~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~--~~~~~kl~Dfgla~~~~~~~~~ 221 (241)
++.|+|..-+... .+.+.....++.|++.|+.|+|+++ +||||||.+||||- +..++|+||||++...+.-
T Consensus 104 aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t--- 176 (378)
T KOG1345|consen 104 APRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT--- 176 (378)
T ss_pred CccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCce---
Confidence 9999999888664 4788889999999999999999999 99999999999983 3457999999998765321
Q ss_pred eeeeeccccccccccccc
Q 039310 222 NYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~ 239 (241)
.....-+..|.+||...
T Consensus 177 -V~~~~~~~~y~~pe~~~ 193 (378)
T KOG1345|consen 177 -VKYLEYVNNYHAPELCD 193 (378)
T ss_pred -ehhhhhhcccCCcHHHh
Confidence 11122466788998764
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-23 Score=161.14 Aligned_cols=162 Identities=23% Similarity=0.379 Sum_probs=132.1
Q ss_pred hhcccccccccCceeEEEEE-eCCCCeEEEEecccCChhhHHHHHHHHHHHHcCC-CCCceeEEEEEecC--CcceEEEE
Q 039310 67 TNNYADVIGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKIDEFINELVVVSQIN-RRNVVRLLACCLET--QVPLLVYE 142 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~~--~~~~lv~e 142 (241)
.|++.+.+|+|.|++||.|. ..+..+++||.+++... +...+|+.+|..++ ||||+++++...++ ..+.++.|
T Consensus 39 dYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk---kKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE 115 (338)
T KOG0668|consen 39 DYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK---KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFE 115 (338)
T ss_pred hHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH---HHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhh
Confidence 34556679999999999998 55678899998887644 55678999999996 99999999998775 46789999
Q ss_pred ecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC-CCeEEccCCCcccccCCccc
Q 039310 143 FVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDEN-YTPKVSDFGASKLVPIDAIQ 221 (241)
Q Consensus 143 ~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~-~~~kl~Dfgla~~~~~~~~~ 221 (241)
|..+.+...+- ..++..++..++.++++||.|||+.| |.|||+||.|++||.. -.++|+|+|+|........
T Consensus 116 ~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~e- 188 (338)
T KOG0668|consen 116 YVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE- 188 (338)
T ss_pred hhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCCCce-
Confidence 99876665444 35888899999999999999999999 9999999999999964 4699999999988744322
Q ss_pred eeeeeccccccccccccc
Q 039310 222 NYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~ 239 (241)
......+..|--||.|-
T Consensus 189 -YnVRVASRyfKGPELLV 205 (338)
T KOG0668|consen 189 -YNVRVASRYFKGPELLV 205 (338)
T ss_pred -eeeeeehhhcCCchhee
Confidence 23334567778899874
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.2e-23 Score=163.85 Aligned_cols=166 Identities=20% Similarity=0.286 Sum_probs=136.6
Q ss_pred HHhhhcccccccccCceeEEEEE-eCCCCeEEEEecccCChhhHHHHHHHHHHHHcCC-CCCceeEEEEEecCCcceEEE
Q 039310 64 KTVTNNYADVIGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKIDEFINELVVVSQIN-RRNVVRLLACCLETQVPLLVY 141 (241)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~~~~~~lv~ 141 (241)
....+..++.||.|+||.++.|. .-++++||||--.. .....++..|...++.|. -++|+..+.+....-...||+
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 34567788999999999999998 55789999996442 334467778999999985 689999999999999999999
Q ss_pred EecCCCCchHHhhcCC-CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC-----CCeEEccCCCcccc
Q 039310 142 EFVGNGTLFEHIHKNG-NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDEN-----YTPKVSDFGASKLV 215 (241)
Q Consensus 142 e~~~~g~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~-----~~~kl~Dfgla~~~ 215 (241)
|++ |.+|.|+..-.+ +++.+++..++.|++.-++|+|++. +|+|||||+|+||... ..+.++|||+|+.+
T Consensus 104 dLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred hhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 999 779999887554 6999999999999999999999999 9999999999999743 35899999999987
Q ss_pred cCCccc------eeeeeccccccccc
Q 039310 216 PIDAIQ------NYTVVQGTLGYIDP 235 (241)
Q Consensus 216 ~~~~~~------~~~~~~gt~~y~aP 235 (241)
.+.... ......||.+||+-
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSI 205 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSI 205 (449)
T ss_pred cCccccccCccccccccccceeeeEe
Confidence 533221 22334599999984
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.5e-23 Score=164.92 Aligned_cols=161 Identities=30% Similarity=0.339 Sum_probs=131.2
Q ss_pred cccccccCceeEEEEEe-CCCCeEEEEeccc--CChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCC------cceEEE
Q 039310 71 ADVIGCGGSGNVYKGFL-PDRTPVAVKKSKI--VDQTKIDEFINELVVVSQINRRNVVRLLACCLETQ------VPLLVY 141 (241)
Q Consensus 71 ~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~--~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~------~~~lv~ 141 (241)
.+.+|.|.- .|..|.. -.+.+|++|++.. .+....++..+|..++..++|+||++++.++.... ..|+||
T Consensus 22 L~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~ 100 (369)
T KOG0665|consen 22 LKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVM 100 (369)
T ss_pred ecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHH
Confidence 446787776 5656553 2578899997543 34556678899999999999999999999997643 578999
Q ss_pred EecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc
Q 039310 142 EFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ 221 (241)
Q Consensus 142 e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~ 221 (241)
|+|. .+|...+.. .++-..+..+..|++.|+.|||+.+ |+||||||+||++..++.+||.|||+|+.-..+ -
T Consensus 101 e~m~-~nl~~vi~~--elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~--~ 172 (369)
T KOG0665|consen 101 ELMD-ANLCQVILM--ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD--F 172 (369)
T ss_pred Hhhh-hHHHHHHHH--hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcccCcc--c
Confidence 9995 488888763 4778888999999999999999999 999999999999999999999999999865333 2
Q ss_pred eeeeecccccccccccccC
Q 039310 222 NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~~ 240 (241)
..+....|..|.|||++-+
T Consensus 173 ~mtpyVvtRyyrapevil~ 191 (369)
T KOG0665|consen 173 MMTPYVVTRYYRAPEVILG 191 (369)
T ss_pred ccCchhheeeccCchheec
Confidence 3444567899999999754
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-22 Score=170.44 Aligned_cols=171 Identities=22% Similarity=0.234 Sum_probs=138.9
Q ss_pred HHHHhhhcccccccccCceeEEEEEeC-CCCeEEEEecccCChhhHHHHHHHHHHHHcCCC------CCceeEEEEEecC
Q 039310 62 EIKTVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQTKIDEFINELVVVSQINR------RNVVRLLACCLET 134 (241)
Q Consensus 62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h------~ni~~l~~~~~~~ 134 (241)
++...+|......|+|-|++|..|... .++.||||.+... +...+.=+.|+++|++|+. -++++|+..|...
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk 506 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK 506 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence 444455556667899999999999854 4779999987743 3333455789999999963 3799999999999
Q ss_pred CcceEEEEecCCCCchHHhhcCC---CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC-CeEEccCC
Q 039310 135 QVPLLVYEFVGNGTLFEHIHKNG---NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENY-TPKVSDFG 210 (241)
Q Consensus 135 ~~~~lv~e~~~~g~L~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~-~~kl~Dfg 210 (241)
+++|||+|-+. .+|.+.|++-+ .|....+..++.|+.-||..|-.++ ++|.||||.|||+++.. .+||||||
T Consensus 507 nHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 507 NHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred ceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCc
Confidence 99999999884 58999998654 4889999999999999999999999 99999999999999754 57999999
Q ss_pred CcccccCCccceeeeecccccccccccccC
Q 039310 211 ASKLVPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 211 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
.|.....+.... ..-+..|.|||++.+
T Consensus 583 SA~~~~eneitP---YLVSRFYRaPEIiLG 609 (752)
T KOG0670|consen 583 SASFASENEITP---YLVSRFYRAPEIILG 609 (752)
T ss_pred cccccccccccH---HHHHHhccCcceeec
Confidence 998876544322 235678999999864
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.9e-21 Score=152.90 Aligned_cols=135 Identities=21% Similarity=0.309 Sum_probs=114.0
Q ss_pred ccccccCceeEEEEEeCCCCeEEEEecccCCh--------hhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 72 DVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQ--------TKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~--------~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
+.||+|++|.||+|.+ .+..+++|....... .....+.+|+.++..++|++++....++.+.+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4689999999999987 567788987543211 1234678899999999999988877777778888999999
Q ss_pred cCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccc
Q 039310 144 VGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLV 215 (241)
Q Consensus 144 ~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~ 215 (241)
++|++|.+.+.... . ....++.+++.+|.++|+.+ ++|+|++|.|||++ ++.++++|||.+...
T Consensus 81 ~~G~~L~~~~~~~~---~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 81 IEGEPLKDLINSNG---M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred eCCcCHHHHHHhcc---H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 99999999986543 2 78899999999999999999 99999999999999 789999999998753
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=163.55 Aligned_cols=168 Identities=25% Similarity=0.304 Sum_probs=132.2
Q ss_pred hhcccccccccCceeEEEEEeCCC--CeEEEEecccCChhhHHHHHHHHHHHHcCCC----CCceeEEEEE-ecCCcceE
Q 039310 67 TNNYADVIGCGGSGNVYKGFLPDR--TPVAVKKSKIVDQTKIDEFINELVVVSQINR----RNVVRLLACC-LETQVPLL 139 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~~~--~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h----~ni~~l~~~~-~~~~~~~l 139 (241)
.|.+.+.||+|+||.||.+..... ..+|+|............+..|..++..+.. ++++.++... ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 677888999999999999996553 4678886554333222266788888888863 6899999998 57788899
Q ss_pred EEEecCCCCchHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC-----CCeEEccCCCc
Q 039310 140 VYEFVGNGTLFEHIHKN--GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDEN-----YTPKVSDFGAS 212 (241)
Q Consensus 140 v~e~~~~g~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~-----~~~kl~Dfgla 212 (241)
||+.+ |.+|.++.... +.++..++..++.|++.+|.+||+.| ++||||||.|+++... ..+.+.|||+|
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99988 77999988544 47999999999999999999999999 9999999999999854 46899999999
Q ss_pred c--cccCCccc------e-eeeecccccccccccc
Q 039310 213 K--LVPIDAIQ------N-YTVVQGTLGYIDPEYL 238 (241)
Q Consensus 213 ~--~~~~~~~~------~-~~~~~gt~~y~aPE~l 238 (241)
+ ........ . .....||.+|+++..-
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H 209 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVH 209 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHh
Confidence 8 43222111 1 2234599999998754
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.1e-21 Score=153.36 Aligned_cols=142 Identities=20% Similarity=0.180 Sum_probs=111.3
Q ss_pred hcccccccccCceeEEEEE--eCCCCeEEEEecccCChh------------------------hHHHHHHHHHHHHcCCC
Q 039310 68 NNYADVIGCGGSGNVYKGF--LPDRTPVAVKKSKIVDQT------------------------KIDEFINELVVVSQINR 121 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~--~~~~~~vavk~~~~~~~~------------------------~~~~~~~E~~~l~~l~h 121 (241)
+.+.+.||+|++|.||+|. ..+++.||+|........ ....+.+|+.+++.+.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 4567789999999999998 567999999976642210 11235689999999976
Q ss_pred C--CceeEEEEEecCCcceEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC
Q 039310 122 R--NVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLD 199 (241)
Q Consensus 122 ~--ni~~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~ 199 (241)
. .++++++. ...++||||++++++.........+.......++.|++.++.+||+.++ ++|+|+||+||+++
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH~Dikp~NIli~ 183 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGE--LVHGDLSEYNILVH 183 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCC--EEeCCCChhhEEEE
Confidence 3 34455543 2358999999998887665444556667778999999999999998764 99999999999999
Q ss_pred CCCCeEEccCCCccccc
Q 039310 200 ENYTPKVSDFGASKLVP 216 (241)
Q Consensus 200 ~~~~~kl~Dfgla~~~~ 216 (241)
++.++|+|||.|....
T Consensus 184 -~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 184 -DGKVVIIDVSQSVELD 199 (237)
T ss_pred -CCCEEEEEChhhhccC
Confidence 8899999999988654
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.9e-21 Score=151.08 Aligned_cols=143 Identities=12% Similarity=0.132 Sum_probs=115.3
Q ss_pred HHHHHHhhhcccccccccCceeEEEEEeCCCCeEEEEecccCChhh---HHH------HHHHHHHHHcCCCCCceeEEEE
Q 039310 60 EEEIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTK---IDE------FINELVVVSQINRRNVVRLLAC 130 (241)
Q Consensus 60 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~---~~~------~~~E~~~l~~l~h~ni~~l~~~ 130 (241)
.+++...++...+++|.|+||.||+... ++..+++|.+....... ... +.+|+..+.+++||+|+.+..+
T Consensus 25 ~~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~ 103 (232)
T PRK10359 25 FDDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDF 103 (232)
T ss_pred HHHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEe
Confidence 4455667788888999999999999766 56689999876533222 222 5789999999999999999888
Q ss_pred EecC--------CcceEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC
Q 039310 131 CLET--------QVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENY 202 (241)
Q Consensus 131 ~~~~--------~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~ 202 (241)
+... +..+++|||++|.+|.++.. ++. ....+++.++..+|+.+ ++|+|++|+||++++++
T Consensus 104 ~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g 172 (232)
T PRK10359 104 YLLAERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG 172 (232)
T ss_pred eeecccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC
Confidence 6543 35789999999999988742 333 24569999999999999 99999999999999988
Q ss_pred CeEEccCCCcccc
Q 039310 203 TPKVSDFGASKLV 215 (241)
Q Consensus 203 ~~kl~Dfgla~~~ 215 (241)
++++|||.....
T Consensus 173 -i~liDfg~~~~~ 184 (232)
T PRK10359 173 -LRIIDLSGKRCT 184 (232)
T ss_pred -EEEEECCCcccc
Confidence 999999987765
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.7e-21 Score=148.48 Aligned_cols=131 Identities=19% Similarity=0.300 Sum_probs=107.2
Q ss_pred cccccCceeEEEEEeCCCCeEEEEecccCC--------hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEec
Q 039310 73 VIGCGGSGNVYKGFLPDRTPVAVKKSKIVD--------QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 73 ~lg~G~~g~V~~~~~~~~~~vavk~~~~~~--------~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
.||+|+||.||+|.+ ++..+++|...... .....++.+|++++..++|+++.....++...+..+++|||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999996 56779998744321 112356778999999999887665555556667779999999
Q ss_pred CCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccc
Q 039310 145 GNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLV 215 (241)
Q Consensus 145 ~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~ 215 (241)
+|++|.+.+..... .++.+++.+|.++|+.+ ++|+|++|+||+++ ++.++++|||++...
T Consensus 80 ~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGND-------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 99999988755321 88999999999999999 99999999999999 889999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-21 Score=161.07 Aligned_cols=138 Identities=22% Similarity=0.334 Sum_probs=120.2
Q ss_pred hcccccccccCceeEEEEEeC----CCCeEEEEecccCChhhHHHHHHHHHHHHcC-CCCCceeEEEEEecCCcceEEEE
Q 039310 68 NNYADVIGCGGSGNVYKGFLP----DRTPVAVKKSKIVDQTKIDEFINELVVVSQI-NRRNVVRLLACCLETQVPLLVYE 142 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e 142 (241)
+...+.||.|+|+.||+|... ....||+|.+...+ ...+..+|+++|..+ .+.||+++.+++..++...+|+|
T Consensus 38 ~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp 115 (418)
T KOG1167|consen 38 YKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLP 115 (418)
T ss_pred hhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEec
Confidence 334568999999999999743 46789999866533 346688999999999 59999999999999999999999
Q ss_pred ecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC-CCCeEEccCCCcc
Q 039310 143 FVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDE-NYTPKVSDFGASK 213 (241)
Q Consensus 143 ~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~-~~~~kl~Dfgla~ 213 (241)
|+++-+..++... ++...+..++..++.||.++|..| |||||+||+|+|.+. .+.-.|+|||+|.
T Consensus 116 ~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 116 YFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred ccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHH
Confidence 9999888888764 679999999999999999999999 999999999999984 5678999999987
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.7e-20 Score=152.03 Aligned_cols=168 Identities=33% Similarity=0.474 Sum_probs=141.4
Q ss_pred hcccccccccCceeEEEEEeCCCCeEEEEecccCChh---hHHHHHHHHHHHHcCCCC-CceeEEEEEecCCcceEEEEe
Q 039310 68 NNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQT---KIDEFINELVVVSQINRR-NVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~---~~~~~~~E~~~l~~l~h~-ni~~l~~~~~~~~~~~lv~e~ 143 (241)
+...+.||.|+||.||++... ..+++|.+...... ....+.+|..+++.+.|+ +++++...+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 345667899999999999976 77888876653322 467889999999999988 799999999777778999999
Q ss_pred cCCCCchHHhhcCC---CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC-CeEEccCCCcccccCCc
Q 039310 144 VGNGTLFEHIHKNG---NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENY-TPKVSDFGASKLVPIDA 219 (241)
Q Consensus 144 ~~~g~L~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~-~~kl~Dfgla~~~~~~~ 219 (241)
+.++++.+++.... .++......++.|++.++.|+|+.+ ++|||+||+||+++..+ .++++|||++.......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999998887665 7999999999999999999999999 99999999999999988 79999999998654333
Q ss_pred cc-----eeeeecccccccccccccC
Q 039310 220 IQ-----NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 220 ~~-----~~~~~~gt~~y~aPE~l~~ 240 (241)
.. ......||..|+|||.+..
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~ 182 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLG 182 (384)
T ss_pred ccccccccccccccccccCCHHHhcC
Confidence 21 2345569999999998764
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.7e-20 Score=145.11 Aligned_cols=136 Identities=20% Similarity=0.250 Sum_probs=107.3
Q ss_pred hcccccccccCceeEEEEEeCCCCeEEEEecccCCh----------------------hhHHHHHHHHHHHHcCCCCC--
Q 039310 68 NNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQ----------------------TKIDEFINELVVVSQINRRN-- 123 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~----------------------~~~~~~~~E~~~l~~l~h~n-- 123 (241)
+...+.||+|+||.||+|...++..||||....... .....+.+|..++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 555678999999999999987899999997543210 01123677899999998774
Q ss_pred ceeEEEEEecCCcceEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCC
Q 039310 124 VVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYT 203 (241)
Q Consensus 124 i~~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~ 203 (241)
++..++ ....+++|||+++++|...... .....++.+++.++.++|+.+ ++|+||+|+||++++++.
T Consensus 97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~~~ 163 (198)
T cd05144 97 VPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDDEK 163 (198)
T ss_pred CCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCCCc
Confidence 444443 2455899999999888765431 345678899999999999998 999999999999999999
Q ss_pred eEEccCCCccccc
Q 039310 204 PKVSDFGASKLVP 216 (241)
Q Consensus 204 ~kl~Dfgla~~~~ 216 (241)
++|+|||++....
T Consensus 164 ~~liDfg~~~~~~ 176 (198)
T cd05144 164 IYIIDWPQMVSTD 176 (198)
T ss_pred EEEEECCccccCC
Confidence 9999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.3e-20 Score=165.92 Aligned_cols=133 Identities=19% Similarity=0.315 Sum_probs=109.6
Q ss_pred ccccccccCceeEEEEEeCCCCeEEEEe-cc-cCC------hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEE
Q 039310 70 YADVIGCGGSGNVYKGFLPDRTPVAVKK-SK-IVD------QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVY 141 (241)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~~~~~~vavk~-~~-~~~------~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~ 141 (241)
..+.||+|+||.||+|.+.+.. +++|+ .. ... ....+++.+|+++++.++|++++....++.+.+..++||
T Consensus 337 ~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 415 (535)
T PRK09605 337 PDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVM 415 (535)
T ss_pred ccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEE
Confidence 4568999999999999875544 44442 21 111 112356889999999999999998888887777889999
Q ss_pred EecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccc
Q 039310 142 EFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLV 215 (241)
Q Consensus 142 e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~ 215 (241)
||+++++|.+++. ....++.+++.+|.+||+.+ ++|||+||+|||+ +++.++|+|||+++..
T Consensus 416 E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 416 EYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 9999999998885 35678999999999999999 9999999999999 6779999999999864
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.3e-20 Score=142.51 Aligned_cols=131 Identities=17% Similarity=0.155 Sum_probs=103.5
Q ss_pred cccccccCceeEEEEEeCCCCeEEEEecccCCh----hhHHHHHHHHHHHHcCC-CCCceeEEEEEecCCcceEEEEecC
Q 039310 71 ADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQ----TKIDEFINELVVVSQIN-RRNVVRLLACCLETQVPLLVYEFVG 145 (241)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~----~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~~~~~~lv~e~~~ 145 (241)
...|++|+||+|+.+.. .+.+++.+.+..... .....+.+|+++|+++. |+++++++++ +..+++|||+.
T Consensus 7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 34699999999998766 567777665554322 11225789999999995 5889999886 34689999999
Q ss_pred CCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCC-CCCCeeeCCCCCeEEccCCCccccc
Q 039310 146 NGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDV-KSANILLDENYTPKVSDFGASKLVP 216 (241)
Q Consensus 146 ~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dl-k~~Nili~~~~~~kl~Dfgla~~~~ 216 (241)
|.+|...+.. ....++.|++.+|.++|+.+ ++|||| ||.|||++.++.++|+|||+|....
T Consensus 82 G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~ 143 (218)
T PRK12274 82 GAAMYQRPPR-------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGN 143 (218)
T ss_pred CccHHhhhhh-------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecC
Confidence 9888654321 12357889999999999999 999999 7999999999999999999998543
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.80 E-value=7.9e-19 Score=129.97 Aligned_cols=133 Identities=22% Similarity=0.238 Sum_probs=112.3
Q ss_pred ccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCC--CCceeEEEEEecCCcceEEEEecCCCCc
Q 039310 72 DVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINR--RNVVRLLACCLETQVPLLVYEFVGNGTL 149 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h--~ni~~l~~~~~~~~~~~lv~e~~~~g~L 149 (241)
+.+|+|.++.||++...+ ..+++|....... ...+.+|...++.++| .++++++.+....+..+++|||++++++
T Consensus 4 ~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 4 KLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred eecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 468999999999999755 6789997655433 4678899999999976 5899999988888889999999988777
Q ss_pred hHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCccc
Q 039310 150 FEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKL 214 (241)
Q Consensus 150 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~ 214 (241)
..+ +......++.+++.++.++|.....+++|+|++|+||++++.+.++++|||.+..
T Consensus 81 ~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 81 DEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 654 5667778899999999999986434499999999999999989999999999875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=1e-18 Score=134.86 Aligned_cols=136 Identities=21% Similarity=0.274 Sum_probs=98.4
Q ss_pred cccccccCceeEEEEEeCCCCeEEEEecccCChh--hHHH----------------------HHHHHHHHHcCCCC--Cc
Q 039310 71 ADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQT--KIDE----------------------FINELVVVSQINRR--NV 124 (241)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~--~~~~----------------------~~~E~~~l~~l~h~--ni 124 (241)
.+.||+|+||+||+|...+++.||||........ .... ...|...+..+.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4579999999999999878999999976542211 1111 13566666666443 34
Q ss_pred eeEEEEEecCCcceEEEEecCCCCchHH-hhcCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEecCCCCCCeeeCCCC
Q 039310 125 VRLLACCLETQVPLLVYEFVGNGTLFEH-IHKNGNLTWERRLRIAAETAGVLSYLHS-ETNVPIIHRDVKSANILLDENY 202 (241)
Q Consensus 125 ~~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~iiH~dlk~~Nili~~~~ 202 (241)
++.+++ ...+++|||++++++... +... ... .....++.+++.++.++|. .+ ++|+||+|+||+++ ++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-DG 151 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-CC
Confidence 555543 245899999998543221 2111 111 6678899999999999999 88 99999999999999 88
Q ss_pred CeEEccCCCccccc
Q 039310 203 TPKVSDFGASKLVP 216 (241)
Q Consensus 203 ~~kl~Dfgla~~~~ 216 (241)
.++++|||.+....
T Consensus 152 ~~~liDfg~a~~~~ 165 (187)
T cd05119 152 KVYIIDVPQAVEID 165 (187)
T ss_pred cEEEEECccccccc
Confidence 99999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.6e-19 Score=166.12 Aligned_cols=119 Identities=15% Similarity=0.185 Sum_probs=87.2
Q ss_pred cCCC-CCceeEEEEE-------ecCCcceEEEEecCCCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 039310 118 QINR-RNVVRLLACC-------LETQVPLLVYEFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIH 188 (241)
Q Consensus 118 ~l~h-~ni~~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH 188 (241)
.++| +||.++++++ ......+.++|++ +++|.+++... ..+++.++..++.||+.||.|||+++ |+|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---IvH 103 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG---IVV 103 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC---eee
Confidence 3444 5777777776 2334677888988 56999999753 46999999999999999999999999 999
Q ss_pred cCCCCCCeeeCC-------------------CCCeEEccCCCcccccCCc---------------cceeeeecccccccc
Q 039310 189 RDVKSANILLDE-------------------NYTPKVSDFGASKLVPIDA---------------IQNYTVVQGTLGYID 234 (241)
Q Consensus 189 ~dlk~~Nili~~-------------------~~~~kl~Dfgla~~~~~~~---------------~~~~~~~~gt~~y~a 234 (241)
|||||+|||++. ++.+|++|||+++...... ........||+.|||
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 999999999954 4456677777765421100 000111347899999
Q ss_pred cccccC
Q 039310 235 PEYLQT 240 (241)
Q Consensus 235 PE~l~~ 240 (241)
||++.+
T Consensus 184 PE~~~~ 189 (793)
T PLN00181 184 PEEDNG 189 (793)
T ss_pred hhhhcc
Confidence 999764
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.1e-17 Score=133.92 Aligned_cols=135 Identities=18% Similarity=0.243 Sum_probs=104.2
Q ss_pred cccc-ccCceeEEEEEeCCCCeEEEEecccC-------------ChhhHHHHHHHHHHHHcCCCCCc--eeEEEEEecCC
Q 039310 72 DVIG-CGGSGNVYKGFLPDRTPVAVKKSKIV-------------DQTKIDEFINELVVVSQINRRNV--VRLLACCLETQ 135 (241)
Q Consensus 72 ~~lg-~G~~g~V~~~~~~~~~~vavk~~~~~-------------~~~~~~~~~~E~~~l~~l~h~ni--~~l~~~~~~~~ 135 (241)
..|| .|+.|+||..... +..+++|..... .......+.+|++++..++|+++ +..+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 3577 7888999998874 667888865321 11233567899999999998875 66776644322
Q ss_pred ----cceEEEEecCC-CCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCC
Q 039310 136 ----VPLLVYEFVGN-GTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFG 210 (241)
Q Consensus 136 ----~~~lv~e~~~~-g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfg 210 (241)
..++|||++++ .+|.+++... +++... +.+++.++.+||+.+ |+|+||||.|||++.++.++|+|||
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~-~l~~~~----~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LIDfg 187 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA-PLSEEQ----WQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLIDFD 187 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC-CCCHHH----HHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEECC
Confidence 23599999997 6898888653 455543 568999999999999 9999999999999999999999999
Q ss_pred Ccccc
Q 039310 211 ASKLV 215 (241)
Q Consensus 211 la~~~ 215 (241)
.+...
T Consensus 188 ~~~~~ 192 (239)
T PRK01723 188 RGELR 192 (239)
T ss_pred CcccC
Confidence 98764
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=8.5e-19 Score=160.17 Aligned_cols=172 Identities=22% Similarity=0.230 Sum_probs=129.6
Q ss_pred HHHhhhcccccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCC---CCCceeEEEEEecCCcceE
Q 039310 63 IKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQIN---RRNVVRLLACCLETQVPLL 139 (241)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~---h~ni~~l~~~~~~~~~~~l 139 (241)
+....+.+...+|+|+||+||.|...+++.||+|.-++.+.-+ |.-=.+++.+|+ -+-|+.+..+..-.+..++
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l 771 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASVL 771 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence 3344455677899999999999997789999999766543211 011112222232 2445566666666777889
Q ss_pred EEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC-------CCCCeEEccCCCc
Q 039310 140 VYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLD-------ENYTPKVSDFGAS 212 (241)
Q Consensus 140 v~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~-------~~~~~kl~Dfgla 212 (241)
|+||.+.|+|.+++..++.+++..++.++.|++..+..||..+ |||+||||+|+||. +..-++|+|||-|
T Consensus 772 v~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~s 848 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFGRS 848 (974)
T ss_pred eeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEecccc
Confidence 9999999999999998888999999999999999999999999 99999999999994 2345899999987
Q ss_pred ccccCC-ccceeeeecccccccccccccC
Q 039310 213 KLVPID-AIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 213 ~~~~~~-~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
-.+..- +..+.....+|-.+-++|...+
T Consensus 849 iDm~lfp~~~~F~~~~~td~f~C~EM~~g 877 (974)
T KOG1166|consen 849 IDMKLFPDGTKFKAVWHTDLFDCIEMREG 877 (974)
T ss_pred eeeeEcCCCcEEeeeeccccchhHHHhcC
Confidence 655321 2235556667888888887654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=9.1e-19 Score=156.07 Aligned_cols=167 Identities=26% Similarity=0.307 Sum_probs=127.1
Q ss_pred ccccccccCceeEEEEEeC-CCCeEEEEecc----c-CChhhH-HHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEE
Q 039310 70 YADVIGCGGSGNVYKGFLP-DRTPVAVKKSK----I-VDQTKI-DEFINELVVVSQINRRNVVRLLACCLETQVPLLVYE 142 (241)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~----~-~~~~~~-~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e 142 (241)
....+|.|++|.|+..... .......|... . ....+. ..+..|+-+-..+.|||++.....+.+.....-.||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 3457999999977776532 23333333221 1 111111 125667778888999999777666666555555599
Q ss_pred ecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcc--
Q 039310 143 FVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAI-- 220 (241)
Q Consensus 143 ~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~-- 220 (241)
||++ +|..++...+.++..++..++.|++.|+.|+|+.+ +.|||+|++|++++.+|.+||+|||.+........
T Consensus 402 ~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred cccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence 9999 99999988888999999999999999999999999 99999999999999999999999999876533322
Q ss_pred -ceeeeecccccccccccccC
Q 039310 221 -QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 221 -~~~~~~~gt~~y~aPE~l~~ 240 (241)
......+|+.+|+|||++..
T Consensus 478 ~~~~~g~~gS~pY~apE~~~~ 498 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVLTG 498 (601)
T ss_pred hhhhcCcccCCcCcCcccccc
Confidence 33455679999999999864
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.9e-17 Score=138.84 Aligned_cols=134 Identities=25% Similarity=0.333 Sum_probs=110.0
Q ss_pred HHhhhcccccccccCceeEEEEEe-CCCCeEEEEecccCChhhHHHHHHHHHHHHcCC-----C---CCceeEEEEEec-
Q 039310 64 KTVTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVDQTKIDEFINELVVVSQIN-----R---RNVVRLLACCLE- 133 (241)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~-----h---~ni~~l~~~~~~- 133 (241)
...+|...+.||=|.|++||+|.. .+.+.||+|..+.. +...+..+.|+.+|++++ | ..||+|++.|..
T Consensus 76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 336777788999999999999984 45678999987643 344577889999999984 2 259999999965
Q ss_pred ---CCcceEEEEecCCCCchHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC
Q 039310 134 ---TQVPLLVYEFVGNGTLFEHIHKN--GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDEN 201 (241)
Q Consensus 134 ---~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~ 201 (241)
+.+.+||+|++ |-+|..+|... ..++...+..|+.|++.||.|||.+. +|||-||||+|||+..+
T Consensus 155 GpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST 224 (590)
T ss_pred CCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence 45789999999 56888888654 36999999999999999999999864 39999999999999644
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.6e-16 Score=137.40 Aligned_cols=139 Identities=19% Similarity=0.178 Sum_probs=98.3
Q ss_pred ccccccCceeEEEEEeCCCCeEEEEecccCChhhH----------------------------------------HHHHH
Q 039310 72 DVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKI----------------------------------------DEFIN 111 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~----------------------------------------~~~~~ 111 (241)
+.||.|++|+||+|+..+|+.||||...+...... -++.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 37999999999999998999999998655321110 02445
Q ss_pred HHHHHHcCC-----CCCceeEEEEEecCCcceEEEEecCCCCchHHhhcC-CCCCHHHHHHHHHHHHH-HHHHhhcCCCC
Q 039310 112 ELVVVSQIN-----RRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKN-GNLTWERRLRIAAETAG-VLSYLHSETNV 184 (241)
Q Consensus 112 E~~~l~~l~-----h~ni~~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~~~~~i~~-~l~~lh~~~~~ 184 (241)
|...+..++ ++++.-..-++...+..+++|||++|++|.++.... ...+ ...++..++. .+..+|..+
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g-- 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDG-- 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCC--
Confidence 665555542 333322122223345679999999999998876532 1222 3445566555 467889888
Q ss_pred CeEecCCCCCCeeeCCCCCeEEccCCCccccc
Q 039310 185 PIIHRDVKSANILLDENYTPKVSDFGASKLVP 216 (241)
Q Consensus 185 ~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~ 216 (241)
++|+|++|.||++++++.++++|||++..+.
T Consensus 278 -~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 -FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred -ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999998764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.9e-18 Score=147.04 Aligned_cols=158 Identities=26% Similarity=0.255 Sum_probs=132.8
Q ss_pred ccccCceeEEEEE----eCCCCeEEEEecccCC--hhhHHHHHHHHHHHHcCC-CCCceeEEEEEecCCcceEEEEecCC
Q 039310 74 IGCGGSGNVYKGF----LPDRTPVAVKKSKIVD--QTKIDEFINELVVVSQIN-RRNVVRLLACCLETQVPLLVYEFVGN 146 (241)
Q Consensus 74 lg~G~~g~V~~~~----~~~~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~~~~~~lv~e~~~~ 146 (241)
+|+|+||.|++++ .+.+..+++|...... .........|-.++...+ ||.++++..+++.+...++++++..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 7999999999865 3345666776543311 111125567888899996 99999999999999999999999999
Q ss_pred CCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeeee
Q 039310 147 GTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVV 226 (241)
Q Consensus 147 g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 226 (241)
|++...+.....+.+.....+...++-++.++|+.+ ++|||+|++||+++.+|.+++.|||+++........
T Consensus 82 g~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~----- 153 (612)
T KOG0603|consen 82 GDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA----- 153 (612)
T ss_pred chhhhccccCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc-----
Confidence 999999988888999999999999999999999999 999999999999999999999999999876433222
Q ss_pred ccccccccccccc
Q 039310 227 QGTLGYIDPEYLQ 239 (241)
Q Consensus 227 ~gt~~y~aPE~l~ 239 (241)
|||..|||||++.
T Consensus 154 cgt~eymApEI~~ 166 (612)
T KOG0603|consen 154 CGTYEYRAPEIIN 166 (612)
T ss_pred ccchhhhhhHhhh
Confidence 8999999999986
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.2e-17 Score=131.36 Aligned_cols=165 Identities=19% Similarity=0.316 Sum_probs=128.7
Q ss_pred hhhcccccccccCceeEEEEEeCCCCeEEEEeccc--CChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKI--VDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~--~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
...++...|.....|+.|+|+|+++ .+++|.+.. ......++|..|.-.|+.+.||||+.+++.|..+.++.++..|
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~ 268 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQY 268 (448)
T ss_pred hhhhhhhhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeee
Confidence 3444555788899999999999654 466665443 3444557888999999999999999999999999999999999
Q ss_pred cCCCCchHHhhcCCC--CCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEc--cCCCcccccCCc
Q 039310 144 VGNGTLFEHIHKNGN--LTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVS--DFGASKLVPIDA 219 (241)
Q Consensus 144 ~~~g~L~~~l~~~~~--l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~--Dfgla~~~~~~~ 219 (241)
|+.|+|...+++... ++..++.+++.+++.|++|||+..+ .|----|.+..++||++.+.+|+ |--++..
T Consensus 269 mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarismad~kfsfq----- 342 (448)
T KOG0195|consen 269 MPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISMADTKFSFQ----- 342 (448)
T ss_pred ccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheecccceeeee-----
Confidence 999999999987764 7788999999999999999999763 23344688999999999988774 2222111
Q ss_pred cceeeeecccccccccccccC
Q 039310 220 IQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 220 ~~~~~~~~gt~~y~aPE~l~~ 240 (241)
.....-+|.|||||.|+.
T Consensus 343 ---e~gr~y~pawmspealqr 360 (448)
T KOG0195|consen 343 ---EVGRAYSPAWMSPEALQR 360 (448)
T ss_pred ---ccccccCcccCCHHHHhc
Confidence 111224689999999874
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.8e-14 Score=109.21 Aligned_cols=130 Identities=17% Similarity=0.147 Sum_probs=95.7
Q ss_pred ccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCc-eeEEEEEecCCcceEEEEecCCCCch
Q 039310 72 DVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNV-VRLLACCLETQVPLLVYEFVGNGTLF 150 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni-~~l~~~~~~~~~~~lv~e~~~~g~L~ 150 (241)
+.++.|.++.||+++.. +..+++|....... ....+.+|+..++.+.+.++ ++++.+. .+..++||||++|.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 46788999999999874 67899997654321 12345789999998865554 4555443 33458999999998776
Q ss_pred HHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC--CCCeEecCCCCCCeeeCCCCCeEEccCCCccc
Q 039310 151 EHIHKNGNLTWERRLRIAAETAGVLSYLHSET--NVPIIHRDVKSANILLDENYTPKVSDFGASKL 214 (241)
Q Consensus 151 ~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~ 214 (241)
+.- ........+++.+|..||+.+ +..++|+|++|.||+++ ++.++++|||.+..
T Consensus 80 ~~~--------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TED--------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc--------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 430 112345678999999999876 22359999999999999 66899999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.56 E-value=5.7e-16 Score=140.83 Aligned_cols=167 Identities=22% Similarity=0.268 Sum_probs=129.2
Q ss_pred hhcccccccccCceeEEEEEeCCCCeEEEEecccCC-hhhH---HHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEE
Q 039310 67 TNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVD-QTKI---DEFINELVVVSQINRRNVVRLLACCLETQVPLLVYE 142 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~-~~~~---~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e 142 (241)
.+.+.+.||.+.|=+|.+|..++|. |+||.+...+ .... .+.+.|+. ...++|||++++..+-.....-|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 3556778999999999999988887 8888654322 2233 33344555 666799999999888777788888888
Q ss_pred ecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccc--cCCcc
Q 039310 143 FVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLV--PIDAI 220 (241)
Q Consensus 143 ~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~--~~~~~ 220 (241)
|..+ +|.|.+....-+..-+...|+.|++.|+.-+|..+ |.|+|||.+||||++-+-+.|+||..-+.. +.+.+
T Consensus 102 yvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 8855 99999988877888899999999999999999999 999999999999999999999999865432 23322
Q ss_pred ceee----eeccccccccccccc
Q 039310 221 QNYT----VVQGTLGYIDPEYLQ 239 (241)
Q Consensus 221 ~~~~----~~~gt~~y~aPE~l~ 239 (241)
.... +...-.+|+|||-+-
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv 200 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFV 200 (1431)
T ss_pred ccceEEEecCCceeeecChHhhh
Confidence 2211 122345799999764
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.56 E-value=4.6e-15 Score=130.27 Aligned_cols=135 Identities=15% Similarity=0.103 Sum_probs=90.0
Q ss_pred ccccccCceeEEEEEeCC-CCeEEEEecccCChh----------------------------------hHH------HHH
Q 039310 72 DVIGCGGSGNVYKGFLPD-RTPVAVKKSKIVDQT----------------------------------KID------EFI 110 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~-~~~vavk~~~~~~~~----------------------------------~~~------~~~ 110 (241)
+.+|+|++|+||+|+..+ |+.||||...+.-.. ..+ ++.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 379999999999999877 999999987642110 011 234
Q ss_pred HHHHHHHcCC----CCCceeEEEEEe-cCCcceEEEEecCCCCchHH--hhcCC----CCCHHHHHHHHHHHHHHHHHhh
Q 039310 111 NELVVVSQIN----RRNVVRLLACCL-ETQVPLLVYEFVGNGTLFEH--IHKNG----NLTWERRLRIAAETAGVLSYLH 179 (241)
Q Consensus 111 ~E~~~l~~l~----h~ni~~l~~~~~-~~~~~~lv~e~~~~g~L~~~--l~~~~----~l~~~~~~~~~~~i~~~l~~lh 179 (241)
+|...+.+++ +.+.+.+=.++. .....++||||++|+++.++ +...+ .+....+..++.|+.
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif------- 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF------- 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------
Confidence 4444444442 333333222322 24567899999999999775 33322 133333444444443
Q ss_pred cCCCCCeEecCCCCCCeeeCCCC----CeEEccCCCccccc
Q 039310 180 SETNVPIIHRDVKSANILLDENY----TPKVSDFGASKLVP 216 (241)
Q Consensus 180 ~~~~~~iiH~dlk~~Nili~~~~----~~kl~Dfgla~~~~ 216 (241)
..+ ++|+|++|.||+++.++ .++++|||++..++
T Consensus 278 ~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 278 RDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred hCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 466 99999999999999888 99999999988764
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.51 E-value=7.7e-13 Score=101.96 Aligned_cols=136 Identities=17% Similarity=0.146 Sum_probs=98.9
Q ss_pred ccccccCceeEEEEEeCC-------CCeEEEEecccC-------------C---------hhhHH----HHHHHHHHHHc
Q 039310 72 DVIGCGGSGNVYKGFLPD-------RTPVAVKKSKIV-------------D---------QTKID----EFINELVVVSQ 118 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~-------~~~vavk~~~~~-------------~---------~~~~~----~~~~E~~~l~~ 118 (241)
..||.|--+.||.|...+ +..+|||..+.. + ..... ...+|...|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997542 478999943320 0 01112 23489999999
Q ss_pred CCC--CCceeEEEEEecCCcceEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHh-hcCCCCCeEecCCCCCC
Q 039310 119 INR--RNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYL-HSETNVPIIHRDVKSAN 195 (241)
Q Consensus 119 l~h--~ni~~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~l-h~~~~~~iiH~dlk~~N 195 (241)
+.. -+++..+.+ ...++||||+.+..+....-....++..+...+..+++.+|..+ |+.+ ++|+||++.|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs~~N 155 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLSEYN 155 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHH
Confidence 964 467777765 56789999997644432222222456666778889999999998 8888 9999999999
Q ss_pred eeeCCCCCeEEccCCCcccc
Q 039310 196 ILLDENYTPKVSDFGASKLV 215 (241)
Q Consensus 196 ili~~~~~~kl~Dfgla~~~ 215 (241)
|+++ ++.++++|||.|...
T Consensus 156 IL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 156 MLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred EEEE-CCcEEEEECCCceeC
Confidence 9997 468999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.50 E-value=3.4e-13 Score=101.13 Aligned_cols=132 Identities=20% Similarity=0.312 Sum_probs=104.3
Q ss_pred ccccccCceeEEEEEeCCCCeEEEEeccc--C-----Ch-hhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 72 DVIGCGGSGNVYKGFLPDRTPVAVKKSKI--V-----DQ-TKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~~vavk~~~~--~-----~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
..+++|+-+.++.+.+. +.++++|.-.+ . +. -...+..+|+.++..++-..|..-.-+..+.+...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999774 34466774222 1 11 1235678999999999887777777777888888999999
Q ss_pred cCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccc
Q 039310 144 VGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLV 215 (241)
Q Consensus 144 ~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~ 215 (241)
++|..|.+.+... ...++..+-.-+.-||..+ |+|+||.++||++.++. +.++||||+...
T Consensus 81 I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 81 IEGELLKDALEEA-------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred eCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCccccc
Confidence 9998898898765 2556677777788999999 99999999999998775 999999998753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.48 E-value=6.4e-15 Score=131.60 Aligned_cols=173 Identities=24% Similarity=0.304 Sum_probs=138.2
Q ss_pred HhhhcccccccccCceeEEEEEeCC--CCeEEEEecccCC--hhhHHHHHHHHHHHHcCC-CCCceeEEEEEecCCcceE
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFLPD--RTPVAVKKSKIVD--QTKIDEFINELVVVSQIN-RRNVVRLLACCLETQVPLL 139 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~~~~~~l 139 (241)
...+.+.+.||+|+|+.|-...... ...+++|...... .........|..+-+.+. |+|++.+++.....+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 3445566779999999998876533 4445566544332 223344455777777776 9999999999999999999
Q ss_pred EEEecCCCCchHHh-hcCC-CCCHHHHHHHHHHHHHHHHHhh-cCCCCCeEecCCCCCCeeeCCCC-CeEEccCCCcccc
Q 039310 140 VYEFVGNGTLFEHI-HKNG-NLTWERRLRIAAETAGVLSYLH-SETNVPIIHRDVKSANILLDENY-TPKVSDFGASKLV 215 (241)
Q Consensus 140 v~e~~~~g~L~~~l-~~~~-~l~~~~~~~~~~~i~~~l~~lh-~~~~~~iiH~dlk~~Nili~~~~-~~kl~Dfgla~~~ 215 (241)
++++..++++.+.+ .... ..+......++.|+..++.|+| ..+ +.|+|+||+|.+++..+ ..+++|||+|...
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 99999999999988 5554 6778888999999999999999 877 99999999999999999 9999999999877
Q ss_pred cC--Cccceeeeecc-cccccccccccC
Q 039310 216 PI--DAIQNYTVVQG-TLGYIDPEYLQT 240 (241)
Q Consensus 216 ~~--~~~~~~~~~~g-t~~y~aPE~l~~ 240 (241)
.. +........+| ++.|+|||...+
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~ 203 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSG 203 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccc
Confidence 55 33445555678 999999998754
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.47 E-value=1e-12 Score=103.65 Aligned_cols=142 Identities=21% Similarity=0.261 Sum_probs=109.4
Q ss_pred ccccccCceeEEEEEeCCCCeEEEEecccCCh-hhHHHHHHHHHHHHcCCC--CCceeEEEEEecC---CcceEEEEecC
Q 039310 72 DVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQ-TKIDEFINELVVVSQINR--RNVVRLLACCLET---QVPLLVYEFVG 145 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~h--~ni~~l~~~~~~~---~~~~lv~e~~~ 145 (241)
+.++.|..+.+|++...++..+++|....... .....+.+|..+++.+++ .++++++.+.... +..+++|||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 46899999999999876667899997654322 134577899999999976 4467788777654 36689999999
Q ss_pred CCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC-------------------------------------------
Q 039310 146 NGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSET------------------------------------------- 182 (241)
Q Consensus 146 ~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~------------------------------------------- 182 (241)
|.++.+.+.. ..++......++.+++++|..||+..
T Consensus 84 G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (223)
T cd05154 84 GRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLR 162 (223)
T ss_pred CEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHH
Confidence 9888776532 35677778888888888888888531
Q ss_pred ----------CCCeEecCCCCCCeeeCC--CCCeEEccCCCccc
Q 039310 183 ----------NVPIIHRDVKSANILLDE--NYTPKVSDFGASKL 214 (241)
Q Consensus 183 ----------~~~iiH~dlk~~Nili~~--~~~~kl~Dfgla~~ 214 (241)
+..++|+|+.+.||++++ ++.+.|+||+.+..
T Consensus 163 ~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 163 WLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 134799999999999998 66789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.3e-13 Score=105.13 Aligned_cols=77 Identities=22% Similarity=0.207 Sum_probs=66.0
Q ss_pred CCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeee
Q 039310 147 GTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTV 225 (241)
Q Consensus 147 g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~ 225 (241)
|+|.+++... ..+++..+..++.|++.||.|||+.+ ||+|||++.++.+++ ||++.......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc------
Confidence 6899999864 46999999999999999999999875 999999999999999 99987653321
Q ss_pred ecccccccccccccC
Q 039310 226 VQGTLGYIDPEYLQT 240 (241)
Q Consensus 226 ~~gt~~y~aPE~l~~ 240 (241)
..||+.|||||++.+
T Consensus 64 ~~g~~~y~aPE~~~~ 78 (176)
T smart00750 64 SRVDPYFMAPEVIQG 78 (176)
T ss_pred CCCcccccChHHhcC
Confidence 258999999999865
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.1e-13 Score=114.19 Aligned_cols=115 Identities=25% Similarity=0.333 Sum_probs=87.6
Q ss_pred CCCCceeEEEEEecC---------------------------CcceEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHH
Q 039310 120 NRRNVVRLLACCLET---------------------------QVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETA 172 (241)
Q Consensus 120 ~h~ni~~l~~~~~~~---------------------------~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~ 172 (241)
+||||+++.++|.+. ..+|+||...+. +|..++..+ ..+.....-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-HRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-CCchHHHHHHHHHHH
Confidence 699999999988642 246888887765 899988765 357777888999999
Q ss_pred HHHHHhhcCCCCCeEecCCCCCCeee--CCCC--CeEEccCCCcccccCC-----ccceeeeeccccccccccccc
Q 039310 173 GVLSYLHSETNVPIIHRDVKSANILL--DENY--TPKVSDFGASKLVPID-----AIQNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 173 ~~l~~lh~~~~~~iiH~dlk~~Nili--~~~~--~~kl~Dfgla~~~~~~-----~~~~~~~~~gt~~y~aPE~l~ 239 (241)
+|+.|||.++ +.|||+|++|||+ |+|+ .+.|+|||.+--.... -.+......|...-||||+..
T Consensus 352 Eav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 352 EAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 9999999999 9999999999998 4444 4789999976432221 112223345778899999865
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.1e-12 Score=98.29 Aligned_cols=141 Identities=21% Similarity=0.263 Sum_probs=107.1
Q ss_pred cccccccCceeEEEEEeCCCCeEEEEecccC-------C-hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEE
Q 039310 71 ADVIGCGGSGNVYKGFLPDRTPVAVKKSKIV-------D-QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYE 142 (241)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~-------~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e 142 (241)
..++-+|+-+.|+++.+ .|+...||.-... + +-..++..+|+..+.+++--.|.--.-++.+...-.++||
T Consensus 12 l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 12 LELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred ceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 34688999999999998 4666777753321 1 2234678899999999987777766667777778889999
Q ss_pred ecCC-CCchHHhhcCC-C-CCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCC---eEEccCCCcccc
Q 039310 143 FVGN-GTLFEHIHKNG-N-LTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYT---PKVSDFGASKLV 215 (241)
Q Consensus 143 ~~~~-g~L~~~l~~~~-~-l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~---~kl~Dfgla~~~ 215 (241)
|++| .++.+++.... . ........++..+-..+.-||..+ ++|+||.++||++.+++. +.++|||++...
T Consensus 91 ~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred eccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhcc
Confidence 9976 37888886432 2 222233688899999999999999 999999999999976553 589999998653
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.43 E-value=2e-13 Score=117.60 Aligned_cols=123 Identities=21% Similarity=0.399 Sum_probs=101.3
Q ss_pred HHcCCCCCceeEEEEEecCCcceEEEEecCCCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCC
Q 039310 116 VSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSA 194 (241)
Q Consensus 116 l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~ 194 (241)
|+.+.|.|+.+++|.+.+....+.|.+||..|+|.+.+... ..+++.-...++.+++.||.|+|+.. -..|+.++++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeeccc
Confidence 35689999999999999999999999999999999999873 46888889999999999999999865 1399999999
Q ss_pred CeeeCCCCCeEEccCCCcccccCC-ccceeeeecccccccccccccC
Q 039310 195 NILLDENYTPKVSDFGASKLVPID-AIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 195 Nili~~~~~~kl~Dfgla~~~~~~-~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
|+++|....+|++|||+....... .........-..-|.|||.+.+
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~ 125 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRG 125 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcc
Confidence 999999999999999998776421 1111111123457999999875
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.8e-12 Score=105.22 Aligned_cols=162 Identities=19% Similarity=0.262 Sum_probs=98.7
Q ss_pred cccccccccCceeEEEEEeCC-CCeEEEEecccC---ChhhHHHHHHHHHHHHcCCC----------CCceeEEEEEe--
Q 039310 69 NYADVIGCGGSGNVYKGFLPD-RTPVAVKKSKIV---DQTKIDEFINELVVVSQINR----------RNVVRLLACCL-- 132 (241)
Q Consensus 69 ~~~~~lg~G~~g~V~~~~~~~-~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h----------~ni~~l~~~~~-- 132 (241)
...+.||.|+++.||.+++.+ ++++|+|..... .....+++.+|.-....+.+ -.++-.++...
T Consensus 15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~ 94 (288)
T PF14531_consen 15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence 345689999999999999654 889999964432 22345666666655544332 11221222211
Q ss_pred ----------cCC-----cceEEEEecCCCCchHHhhc---CCC----CCHHHHHHHHHHHHHHHHHhhcCCCCCeEecC
Q 039310 133 ----------ETQ-----VPLLVYEFVGNGTLFEHIHK---NGN----LTWERRLRIAAETAGVLSYLHSETNVPIIHRD 190 (241)
Q Consensus 133 ----------~~~-----~~~lv~e~~~~g~L~~~l~~---~~~----l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~d 190 (241)
+.+ +.+++|+-+. +||.+++.. ... +.......+..|+++.+++||+.+ ++|+|
T Consensus 95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgd 170 (288)
T PF14531_consen 95 GKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGD 170 (288)
T ss_dssp TS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST
T ss_pred CCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEecc
Confidence 111 3367888774 588888642 111 233344567789999999999999 99999
Q ss_pred CCCCCeeeCCCCCeEEccCCCcccccCCccceeeeecccccccccccc
Q 039310 191 VKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYL 238 (241)
Q Consensus 191 lk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l 238 (241)
|+|+|++++++|.+.|+||+.....+.. ......+..|.+||..
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~----~~~~~~~~~~~PPe~~ 214 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAGTR----YRCSEFPVAFTPPELE 214 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETTEE----EEGGGS-TTTS-HHHH
T ss_pred cceeeEEEcCCCCEEEcChHHHeecCce----eeccCCCcccCChhhh
Confidence 9999999999999999999876654221 1112345778999864
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.28 E-value=4e-11 Score=92.05 Aligned_cols=125 Identities=23% Similarity=0.262 Sum_probs=82.9
Q ss_pred eEEEEEeCCCCeEEEEecccC---------------C-----------hhhHHHHHHHHHHHHcCCCC--CceeEEEEEe
Q 039310 81 NVYKGFLPDRTPVAVKKSKIV---------------D-----------QTKIDEFINELVVVSQINRR--NVVRLLACCL 132 (241)
Q Consensus 81 ~V~~~~~~~~~~vavk~~~~~---------------~-----------~~~~~~~~~E~~~l~~l~h~--ni~~l~~~~~ 132 (241)
.||.|...++..+|+|..... . ........+|.+.|..+... ++++.+.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 389999888889999953320 0 01124577899999999866 577777553
Q ss_pred cCCcceEEEEecC--CCCchHHhhcCCCCCHHHHHHHHHHHHHHHHH-hhcCCCCCeEecCCCCCCeeeCCCCCeEEccC
Q 039310 133 ETQVPLLVYEFVG--NGTLFEHIHKNGNLTWERRLRIAAETAGVLSY-LHSETNVPIIHRDVKSANILLDENYTPKVSDF 209 (241)
Q Consensus 133 ~~~~~~lv~e~~~--~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~-lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Df 209 (241)
..++||||++ |..+..+.... ++......+..+++..+.. +|..+ ++|+||.+.||+++++ .+.++||
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE--G
T ss_pred ---CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEEec
Confidence 4579999998 54444333221 2244556677778775555 57888 9999999999999988 9999999
Q ss_pred CCcccc
Q 039310 210 GASKLV 215 (241)
Q Consensus 210 gla~~~ 215 (241)
|.+...
T Consensus 151 ~qav~~ 156 (188)
T PF01163_consen 151 GQAVDS 156 (188)
T ss_dssp TTEEET
T ss_pred Ccceec
Confidence 987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.4e-10 Score=94.18 Aligned_cols=138 Identities=14% Similarity=0.073 Sum_probs=98.9
Q ss_pred cccccCceeEEEEEeCCCCeEEEEecccCChh-----------hHHHHHHHHHHHHcCCCCCc--eeEEEEEec-----C
Q 039310 73 VIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQT-----------KIDEFINELVVVSQINRRNV--VRLLACCLE-----T 134 (241)
Q Consensus 73 ~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~-----------~~~~~~~E~~~l~~l~h~ni--~~l~~~~~~-----~ 134 (241)
.+-......|.+..+ +|+.+.||........ ....+.+|...+..+...+| +..+++... .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 344334444667666 5668999965432211 01147789999988854443 344555543 2
Q ss_pred CcceEEEEecCCC-CchHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC-------CCCe
Q 039310 135 QVPLLVYEFVGNG-TLFEHIHK--NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDE-------NYTP 204 (241)
Q Consensus 135 ~~~~lv~e~~~~g-~L~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~-------~~~~ 204 (241)
...++|||++++. +|.+++.. ....+......++.+++..+.-||..+ ++|+|++++|||++. +..+
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceE
Confidence 3468999999876 89888853 234566778899999999999999999 999999999999975 4679
Q ss_pred EEccCCCccc
Q 039310 205 KVSDFGASKL 214 (241)
Q Consensus 205 kl~Dfgla~~ 214 (241)
.++||+.+..
T Consensus 185 ~LIDl~r~~~ 194 (268)
T PRK15123 185 SVIDLHRAQI 194 (268)
T ss_pred EEEECCcccc
Confidence 9999998754
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.23 E-value=5e-12 Score=115.27 Aligned_cols=131 Identities=29% Similarity=0.375 Sum_probs=87.8
Q ss_pred cccccccccCceeEEEEEeCC-CCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCCC
Q 039310 69 NYADVIGCGGSGNVYKGFLPD-RTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNG 147 (241)
Q Consensus 69 ~~~~~lg~G~~g~V~~~~~~~-~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~g 147 (241)
+-.+.+..|+||.||..+++. .+.+|+|.-+. ..+.+- ++.....| +.| |
T Consensus 86 ~~IklisngAygavylvrh~~trqrfa~kiNkq------~lilRn--ilt~a~np---------------fvv------g 136 (1205)
T KOG0606|consen 86 NTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ------NLILRN--ILTFAGNP---------------FVV------G 136 (1205)
T ss_pred ceeEeeccCCCCceeeeeccccccchhhccccc------chhhhc--cccccCCc---------------cee------c
Confidence 345689999999999998653 56677742111 000110 11111222 222 4
Q ss_pred CchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCC--------c
Q 039310 148 TLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPID--------A 219 (241)
Q Consensus 148 ~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~--------~ 219 (241)
+-...++..++++... +.+++|+|+.+ |+|||+||+|.+|+.-|.+|+.|||+++..... .
T Consensus 137 Dc~tllk~~g~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~ 205 (1205)
T KOG0606|consen 137 DCATLLKNIGPLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGH 205 (1205)
T ss_pred hhhhhcccCCCCcchh--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcc
Confidence 5566666655555433 78899999999 999999999999999999999999998753110 0
Q ss_pred ------cceeeeeccccccccccccc
Q 039310 220 ------IQNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 220 ------~~~~~~~~gt~~y~aPE~l~ 239 (241)
.-.....+|||.|.|||++.
T Consensus 206 I~k~t~Ef~dKqvcgTPeyiaPeVil 231 (1205)
T KOG0606|consen 206 IEKDTHEFQDKQVCGTPEYIAPEVIL 231 (1205)
T ss_pred hHHHHHHhhhccccCCccccChhhhh
Confidence 01223467999999999974
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.2e-11 Score=106.85 Aligned_cols=174 Identities=25% Similarity=0.270 Sum_probs=134.8
Q ss_pred HHHhhhcccccccc--cCceeEEEEEe---CCCCeEEEEeccc--CChhhHHHHHHHHHHHHcC-CCCCceeEEEEEecC
Q 039310 63 IKTVTNNYADVIGC--GGSGNVYKGFL---PDRTPVAVKKSKI--VDQTKIDEFINELVVVSQI-NRRNVVRLLACCLET 134 (241)
Q Consensus 63 ~~~~~~~~~~~lg~--G~~g~V~~~~~---~~~~~vavk~~~~--~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~ 134 (241)
..........-+|. |.+|.+|.+.. .++..+|+|+-+. .......+-.+|+.-.+.+ .|+|.++.+..|...
T Consensus 111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~ 190 (524)
T KOG0601|consen 111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS 190 (524)
T ss_pred hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccC
Confidence 34444455667899 99999999875 3577888886332 2222333445677777777 499999999999999
Q ss_pred CcceEEEEecCCCCchHHhhcCCC-CCHHHHHHHHHHHHH----HHHHhhcCCCCCeEecCCCCCCeeeCCC-CCeEEcc
Q 039310 135 QVPLLVYEFVGNGTLFEHIHKNGN-LTWERRLRIAAETAG----VLSYLHSETNVPIIHRDVKSANILLDEN-YTPKVSD 208 (241)
Q Consensus 135 ~~~~lv~e~~~~g~L~~~l~~~~~-l~~~~~~~~~~~i~~----~l~~lh~~~~~~iiH~dlk~~Nili~~~-~~~kl~D 208 (241)
+..++-+|++. .+|..+.....+ ++...+.....+... |+.++|+.. ++|-|+||.||+...+ ..++++|
T Consensus 191 ~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~d 266 (524)
T KOG0601|consen 191 GILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTD 266 (524)
T ss_pred Ccceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCC
Confidence 99999999995 688888876655 888888888888888 999999999 9999999999999999 8899999
Q ss_pred CCCcccccCCccce----eeeecccccccccccccC
Q 039310 209 FGASKLVPIDAIQN----YTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 209 fgla~~~~~~~~~~----~~~~~gt~~y~aPE~l~~ 240 (241)
||+...+....... .....|-..|++||.+++
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~ 302 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG 302 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhhcc
Confidence 99987765443221 112247788999999864
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.5e-12 Score=110.93 Aligned_cols=99 Identities=25% Similarity=0.379 Sum_probs=83.0
Q ss_pred cceEEEEecCCCCchHHhhcCC---CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCc
Q 039310 136 VPLLVYEFVGNGTLFEHIHKNG---NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGAS 212 (241)
Q Consensus 136 ~~~lv~e~~~~g~L~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla 212 (241)
.+|+.|++|...+|.+.+.... ..++.....++.|++.|+.| ++ .+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 5789999999999999997543 46778889999999999999 77 999999999999999999999999997
Q ss_pred ccccCCc-----cceeeeecccccccccccccC
Q 039310 213 KLVPIDA-----IQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 213 ~~~~~~~-----~~~~~~~~gt~~y~aPE~l~~ 240 (241)
....... ......-.||+.||+||.|.+
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g 436 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRG 436 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhh
Confidence 7665444 223344569999999998863
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.6e-10 Score=101.45 Aligned_cols=122 Identities=18% Similarity=0.149 Sum_probs=103.0
Q ss_pred eCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCCCCchHHhhcCCCCCHHHHHH
Q 039310 87 LPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLR 166 (241)
Q Consensus 87 ~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~ 166 (241)
..++.+|.|...+...........+.+..|+.++||||++++..+...+..|+|+|.+. .|..++++. ....+..
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l---~~~~v~~ 108 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL---GKEEVCL 108 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh---HHHHHHH
Confidence 44678888887766555555667788999999999999999999999999999999985 677777764 4677778
Q ss_pred HHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccc
Q 039310 167 IAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLV 215 (241)
Q Consensus 167 ~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~ 215 (241)
-+.||+.||.|||+.+. ++|+++....|+++..|..||.+|.++...
T Consensus 109 Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~ 155 (690)
T KOG1243|consen 109 GLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKA 155 (690)
T ss_pred HHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEecc
Confidence 88999999999985443 999999999999999999999999876543
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.8e-09 Score=86.00 Aligned_cols=135 Identities=21% Similarity=0.219 Sum_probs=97.0
Q ss_pred hcccccccccCceeEEEEEeCCCCeEEEEeccc----------CC------------hhhHHHHHHHHHHHHcCCCC--C
Q 039310 68 NNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKI----------VD------------QTKIDEFINELVVVSQINRR--N 123 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~----------~~------------~~~~~~~~~E~~~l~~l~h~--n 123 (241)
..+++.||-|--+.||.|..+.+.+++||--.. .. .-......+|.+.|+.+... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 345779999999999999999999999993111 00 01123467899999999654 6
Q ss_pred ceeEEEEEecCCcceEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCC
Q 039310 124 VVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYT 203 (241)
Q Consensus 124 i~~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~ 203 (241)
+++.+++ ++..+|||+++|-.|...- ++....-.++..|+.-+.-+-..| +||+|+++=||+++++|.
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTEDGD 240 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecCCC
Confidence 7766544 4668999999886655332 123334445555555555555667 999999999999999999
Q ss_pred eEEccCCCccc
Q 039310 204 PKVSDFGASKL 214 (241)
Q Consensus 204 ~kl~Dfgla~~ 214 (241)
+.++||--+..
T Consensus 241 ~~vIDwPQ~v~ 251 (304)
T COG0478 241 IVVIDWPQAVP 251 (304)
T ss_pred EEEEeCccccc
Confidence 99999976544
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.9e-09 Score=93.45 Aligned_cols=142 Identities=14% Similarity=0.154 Sum_probs=96.2
Q ss_pred ccc-ccccccCceeEEEEEeCCCCeEEEEecccCChhh------------------------------H----H------
Q 039310 69 NYA-DVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTK------------------------------I----D------ 107 (241)
Q Consensus 69 ~~~-~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~------------------------------~----~------ 107 (241)
+|. +.|+.++-|+||+|++.+|+.||||...+.-... . +
T Consensus 127 eF~~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~El 206 (517)
T COG0661 127 EFEPEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREEL 206 (517)
T ss_pred HcCCCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHh
Confidence 344 4899999999999999999999999655421110 0 0
Q ss_pred HHHHHHHHHHcCC-----CCCceeEEEEEecCCcceEEEEecCCCCchHHh--hcCCCCCHHHHHHHHHHHHHHHHHhhc
Q 039310 108 EFINELVVVSQIN-----RRNVVRLLACCLETQVPLLVYEFVGNGTLFEHI--HKNGNLTWERRLRIAAETAGVLSYLHS 180 (241)
Q Consensus 108 ~~~~E~~~l~~l~-----h~ni~~l~~~~~~~~~~~lv~e~~~~g~L~~~l--~~~~~l~~~~~~~~~~~i~~~l~~lh~ 180 (241)
++.+|..-+.+++ .|++.----+|...+..+++|||++|-.+.+.. +. ...+.+.+.....++.--.-+-
T Consensus 207 Dy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f~~q~~~-- 283 (517)
T COG0661 207 DYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAFLRQLLR-- 283 (517)
T ss_pred CHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHHHHHHHh--
Confidence 2344555555542 344443334455566778999999998888874 33 3455444444333332222222
Q ss_pred CCCCCeEecCCCCCCeeeCCCCCeEEccCCCccccc
Q 039310 181 ETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVP 216 (241)
Q Consensus 181 ~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~ 216 (241)
.+ +.|.|..|.||+++.+|.+.+.|||+...+.
T Consensus 284 dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 284 DG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred cC---ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 44 9999999999999999999999999987654
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.03 E-value=2e-09 Score=92.28 Aligned_cols=139 Identities=17% Similarity=0.171 Sum_probs=109.2
Q ss_pred CceeEEEEE-eCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEec----CCcceEEEEecCC-CCchH
Q 039310 78 GSGNVYKGF-LPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLE----TQVPLLVYEFVGN-GTLFE 151 (241)
Q Consensus 78 ~~g~V~~~~-~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~----~~~~~lv~e~~~~-g~L~~ 151 (241)
--.+.|++. ..+|..+++|+++.........-..-++.++++.|+|+|++..++.. +..+++|++|.++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 346688887 45788999998854333332233456888999999999999999873 4578999999985 47766
Q ss_pred Hhhc---------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCccccc
Q 039310 152 HIHK---------------NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVP 216 (241)
Q Consensus 152 ~l~~---------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~ 216 (241)
+-.. +...++..++.++.|+..||.++|+.| +.-+-|.+++|+++.+.+++|+..|....+.
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeec
Confidence 5421 224788999999999999999999999 9999999999999999999999888776665
Q ss_pred CCc
Q 039310 217 IDA 219 (241)
Q Consensus 217 ~~~ 219 (241)
.+.
T Consensus 445 ~d~ 447 (655)
T KOG3741|consen 445 EDP 447 (655)
T ss_pred CCC
Confidence 443
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.00 E-value=3.9e-09 Score=82.72 Aligned_cols=107 Identities=17% Similarity=0.184 Sum_probs=86.7
Q ss_pred HHHHHHHHHHHHcCCCC--CceeEEEEEecCC----cceEEEEecCCC-CchHHhhcCCCCCHHHHHHHHHHHHHHHHHh
Q 039310 106 IDEFINELVVVSQINRR--NVVRLLACCLETQ----VPLLVYEFVGNG-TLFEHIHKNGNLTWERRLRIAAETAGVLSYL 178 (241)
Q Consensus 106 ~~~~~~E~~~l~~l~h~--ni~~l~~~~~~~~----~~~lv~e~~~~g-~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~l 178 (241)
...+.+|...+..+... .++..+++..... ..++|+|++++. +|.+++......+......++.+++..+.-|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 45678898888888543 3455666665532 347999999874 8999998755577788889999999999999
Q ss_pred hcCCCCCeEecCCCCCCeeeCCCC---CeEEccCCCcccc
Q 039310 179 HSETNVPIIHRDVKSANILLDENY---TPKVSDFGASKLV 215 (241)
Q Consensus 179 h~~~~~~iiH~dlk~~Nili~~~~---~~kl~Dfgla~~~ 215 (241)
|..+ ++|+|+++.|||++.++ .+.++||+-++..
T Consensus 135 H~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 135 HDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999 99999999999999887 8999999987754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=5.1e-10 Score=90.83 Aligned_cols=93 Identities=22% Similarity=0.353 Sum_probs=80.8
Q ss_pred HHHHcCCCCCceeEEEEEecCC-----cceEEEEecCCCCchHHhhcC----CCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 039310 114 VVVSQINRRNVVRLLACCLETQ-----VPLLVYEFVGNGTLFEHIHKN----GNLTWERRLRIAAETAGVLSYLHSETNV 184 (241)
Q Consensus 114 ~~l~~l~h~ni~~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~~~~ 184 (241)
.-+-++.|.|++++..+|.+.. +..+++|||..|++..+|++. ..+....+.+|+.||+.||.|||+.. +
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-P 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-C
Confidence 4455567999999999997643 568899999999999999753 35888999999999999999999986 7
Q ss_pred CeEecCCCCCCeeeCCCCCeEEc
Q 039310 185 PIIHRDVKSANILLDENYTPKVS 207 (241)
Q Consensus 185 ~iiH~dlk~~Nili~~~~~~kl~ 207 (241)
|++|+++..+-|++..+|-+|+.
T Consensus 198 piihgnlTc~tifiq~ngLIkig 220 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIG 220 (458)
T ss_pred ccccCCcchhheeecCCceEEec
Confidence 89999999999999999999984
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.95 E-value=2.9e-08 Score=77.07 Aligned_cols=137 Identities=15% Similarity=0.071 Sum_probs=102.1
Q ss_pred ccccCceeEEEEEeCCCCeEEEEecccC------ChhhHHHHHHHHHHHHcCCCC--CceeEEEEEecC----CcceEEE
Q 039310 74 IGCGGSGNVYKGFLPDRTPVAVKKSKIV------DQTKIDEFINELVVVSQINRR--NVVRLLACCLET----QVPLLVY 141 (241)
Q Consensus 74 lg~G~~g~V~~~~~~~~~~vavk~~~~~------~~~~~~~~~~E~~~l~~l~h~--ni~~l~~~~~~~----~~~~lv~ 141 (241)
-|+|+.+-|+.-...+. .+-+|.-... .+.....|.+|+..+..+... .+++...+.... -.-+||+
T Consensus 26 ~~rgG~SgV~r~~~~g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERNGK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeCCc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 46688888999776444 6888864411 133457899999999998643 355555222221 1357999
Q ss_pred EecCC-CCchHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCC--eEEccCCCccc
Q 039310 142 EFVGN-GTLFEHIHKN--GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYT--PKVSDFGASKL 214 (241)
Q Consensus 142 e~~~~-g~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~--~kl~Dfgla~~ 214 (241)
|-+++ .+|.+++... .+.+......+..+++..+.-||+.+ +.|+|+-+.||+++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 98864 4888888653 35678888899999999999999999 999999999999986667 99999987664
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.92 E-value=8.3e-10 Score=95.70 Aligned_cols=142 Identities=22% Similarity=0.226 Sum_probs=115.4
Q ss_pred ccccccccCceeEEEEEe--CCCCeEEEEecccCChhhHH--HHHHHHHHHHcC-CCCCceeEEEEEecCCcceEEEEec
Q 039310 70 YADVIGCGGSGNVYKGFL--PDRTPVAVKKSKIVDQTKID--EFINELVVVSQI-NRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~--~~~~~vavk~~~~~~~~~~~--~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
+...||.|.|+.|+.... .++..+++|.+......... .-+.|+.+...+ .|.+++.++..|......|+=.|||
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~ 348 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFC 348 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhh
Confidence 344799999999998763 46778888876654333222 234677777776 5899999999999888888999999
Q ss_pred CCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC-CCeEEccCCCccc
Q 039310 145 GNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDEN-YTPKVSDFGASKL 214 (241)
Q Consensus 145 ~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~-~~~kl~Dfgla~~ 214 (241)
+++++...+.....+.+...+++..|++.++.++|+.. ++|+|++|+||++..+ +..++.|||....
T Consensus 349 ~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 349 EGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred cCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccc
Confidence 99988877755556888899999999999999999998 9999999999999886 7889999998754
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.84 E-value=1.1e-07 Score=75.44 Aligned_cols=137 Identities=14% Similarity=0.156 Sum_probs=84.3
Q ss_pred ccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCC--ceeEEEEEecCCcceEEEEecCCCC-
Q 039310 72 DVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRN--VVRLLACCLETQVPLLVYEFVGNGT- 148 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~n--i~~l~~~~~~~~~~~lv~e~~~~g~- 148 (241)
.+||+|..+.||+. .+..+++|...... ......+|.++++.+..-+ +++.+.+....+...++||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 36899999999984 24457788765422 2345688999999986443 4777888878888889999998853
Q ss_pred chHHh---------------------hcC--CCCCHHHHH-HHHH----------HHHH-HHHHhhc-CCCCCeEecCCC
Q 039310 149 LFEHI---------------------HKN--GNLTWERRL-RIAA----------ETAG-VLSYLHS-ETNVPIIHRDVK 192 (241)
Q Consensus 149 L~~~l---------------------~~~--~~l~~~~~~-~~~~----------~i~~-~l~~lh~-~~~~~iiH~dlk 192 (241)
+...+ +.. ...+..... .+.. .+.. ...+|.. ..+..++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 21111 110 001111000 0000 0111 1122221 112347899999
Q ss_pred CCCeeeCCCCCeEEccCCCccc
Q 039310 193 SANILLDENYTPKVSDFGASKL 214 (241)
Q Consensus 193 ~~Nili~~~~~~kl~Dfgla~~ 214 (241)
|.|+++++++ +.++||+.+..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999888 99999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.72 E-value=2.3e-07 Score=73.29 Aligned_cols=134 Identities=21% Similarity=0.220 Sum_probs=93.0
Q ss_pred cccccCceeEEEEEeCCCCeEEEEecccCChhh------------------------HHHHHHHHHHHHcCC--CCCcee
Q 039310 73 VIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTK------------------------IDEFINELVVVSQIN--RRNVVR 126 (241)
Q Consensus 73 ~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~------------------------~~~~~~E~~~l~~l~--h~ni~~ 126 (241)
.|++|--+.||+|...++..+|+|......... .....+|..-|+++. +=.+++
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 678888899999998788999999755421110 123456777777764 234444
Q ss_pred EEEEEecCCcceEEEEecCCC-CchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEecCCCCCCeeeCCCCCe
Q 039310 127 LLACCLETQVPLLVYEFVGNG-TLFEHIHKNGNLTWERRLRIAAETAGVLSYLHS-ETNVPIIHRDVKSANILLDENYTP 204 (241)
Q Consensus 127 l~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~iiH~dlk~~Nili~~~~~~ 204 (241)
-+.+. ...+||||+... .-.-.|+.- ++...+...+..++++.+.-|-. .+ +||+||+.=|||+. ++.+
T Consensus 135 Pi~~~----~nVLvMEfIg~~g~pAP~LkDv-~~e~~e~~~~~~~~v~~~~~l~~~a~---LVHgDLSEyNiL~~-~~~p 205 (268)
T COG1718 135 PIAFR----NNVLVMEFIGDDGLPAPRLKDV-PLELEEAEGLYEDVVEYMRRLYKEAG---LVHGDLSEYNILVH-DGEP 205 (268)
T ss_pred ceeec----CCeEEEEeccCCCCCCCCcccC-CcCchhHHHHHHHHHHHHHHHHHhcC---cccccchhhheEEE-CCeE
Confidence 44443 447999999543 222223222 23333677888889998888776 66 99999999999999 8899
Q ss_pred EEccCCCcccc
Q 039310 205 KVSDFGASKLV 215 (241)
Q Consensus 205 kl~Dfgla~~~ 215 (241)
.|+|||-|...
T Consensus 206 ~iID~~QaV~~ 216 (268)
T COG1718 206 YIIDVSQAVTI 216 (268)
T ss_pred EEEECcccccc
Confidence 99999987654
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.70 E-value=4.2e-07 Score=73.01 Aligned_cols=132 Identities=17% Similarity=0.115 Sum_probs=81.8
Q ss_pred ceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCC-CCCceeEEEEEecCCcceEEEEecCCCCchHHh----
Q 039310 79 SGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQIN-RRNVVRLLACCLETQVPLLVYEFVGNGTLFEHI---- 153 (241)
Q Consensus 79 ~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~~~~~~lv~e~~~~g~L~~~l---- 153 (241)
-..||+.... +..+.+|...... .....+|+++++.+. +--+++++++....+..++|||+++|.++....
T Consensus 12 ~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~~~ 87 (244)
T cd05150 12 GATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAALWEELE 87 (244)
T ss_pred cCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHhhcccC
Confidence 3778998764 4678888765432 345667998888883 455778888887777789999999987665331
Q ss_pred ---------------hcCC----CCCHH--HHHHHHH--------------------HHHHHHHHhhc----CCCCCeEe
Q 039310 154 ---------------HKNG----NLTWE--RRLRIAA--------------------ETAGVLSYLHS----ETNVPIIH 188 (241)
Q Consensus 154 ---------------~~~~----~l~~~--~~~~~~~--------------------~i~~~l~~lh~----~~~~~iiH 188 (241)
+.-. +.... ....... .....+..|-. ...+.++|
T Consensus 88 ~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~H 167 (244)
T cd05150 88 PERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEEDLVVTH 167 (244)
T ss_pred HHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCceEEEC
Confidence 0000 01100 0000000 01111222211 12234999
Q ss_pred cCCCCCCeeeCCCCCeEEccCCCccc
Q 039310 189 RDVKSANILLDENYTPKVSDFGASKL 214 (241)
Q Consensus 189 ~dlk~~Nili~~~~~~kl~Dfgla~~ 214 (241)
+|+.|.|||++++..+.|+||+.|..
T Consensus 168 gD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 168 GDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CCCCCccEEEeCCcEEEEEEcccccc
Confidence 99999999999987788999998864
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.69 E-value=2.4e-07 Score=81.43 Aligned_cols=137 Identities=18% Similarity=0.154 Sum_probs=89.7
Q ss_pred ccccccCceeEEEEEeCCCCeEEEEecccCChhh-------------------------------HH------HHHHHHH
Q 039310 72 DVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTK-------------------------------ID------EFINELV 114 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~-------------------------------~~------~~~~E~~ 114 (241)
+.||.-+.|+||+|+.++|+.||||.-++.-... .+ +|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 4799999999999999999999999644311100 01 1333443
Q ss_pred HHH----cCCCCC------ceeEEEEEecCCcceEEEEecCCCCchHH--hhcCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 039310 115 VVS----QINRRN------VVRLLACCLETQVPLLVYEFVGNGTLFEH--IHKNGNLTWERRLRIAAETAGVLSYLHSET 182 (241)
Q Consensus 115 ~l~----~l~h~n------i~~l~~~~~~~~~~~lv~e~~~~g~L~~~--l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~ 182 (241)
-.. .+.|-+ |++++- .......|+||||+|..+.+. +.+. .++...+..-+.+...-+-+. .|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~-gi~~~~i~~~l~~~~~~qIf~--~G 321 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKR-GISPHDILNKLVEAYLEQIFK--TG 321 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHc-CCCHHHHHHHHHHHHHHHHHh--cC
Confidence 332 334444 444432 334567899999999866555 3333 466665555554443333333 34
Q ss_pred CCCeEecCCCCCCeeeCC----CCCeEEccCCCccccc
Q 039310 183 NVPIIHRDVKSANILLDE----NYTPKVSDFGASKLVP 216 (241)
Q Consensus 183 ~~~iiH~dlk~~Nili~~----~~~~kl~Dfgla~~~~ 216 (241)
++|+|-.|.||+++. ++.+.+-|||+.....
T Consensus 322 ---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 322 ---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred ---CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 999999999999984 6689999999977553
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.5e-07 Score=74.48 Aligned_cols=140 Identities=21% Similarity=0.232 Sum_probs=82.5
Q ss_pred ccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCC--CceeEEEEEec---CCcceEEEEecCC
Q 039310 72 DVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRR--NVVRLLACCLE---TQVPLLVYEFVGN 146 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~--ni~~l~~~~~~---~~~~~lv~e~~~~ 146 (241)
+.++.|..+.||+....+ ..+++|..... .....+.+|..+++.+... .+++++..... ....+++|+++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 457889999999998766 58999975543 4556778899999888533 35677765433 3356899999998
Q ss_pred CCchH----------------Hh---hcC----CCCCHHH---------HHHH------------HHHHHH-HHHHhhc-
Q 039310 147 GTLFE----------------HI---HKN----GNLTWER---------RLRI------------AAETAG-VLSYLHS- 180 (241)
Q Consensus 147 g~L~~----------------~l---~~~----~~l~~~~---------~~~~------------~~~i~~-~l~~lh~- 180 (241)
.++.. .+ +.. ....... .... ...+.. .+..+++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 77776 11 011 1111000 0000 111111 2222321
Q ss_pred ---CCCCCeEecCCCCCCeeeC-CCCCeEEccCCCccc
Q 039310 181 ---ETNVPIIHRDVKSANILLD-ENYTPKVSDFGASKL 214 (241)
Q Consensus 181 ---~~~~~iiH~dlk~~Nili~-~~~~~kl~Dfgla~~ 214 (241)
..+..++|+|+.|.||+++ +++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 1234499999999999999 666678999998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.65 E-value=6.9e-07 Score=69.76 Aligned_cols=136 Identities=13% Similarity=0.131 Sum_probs=82.7
Q ss_pred hhhcccccccccCceeEEEEEeCCCCeEEEEecccCChhhHHH---------HHHHHHHHHcCCC---CCceeEEEEEec
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDE---------FINELVVVSQINR---RNVVRLLACCLE 133 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~---------~~~E~~~l~~l~h---~ni~~l~~~~~~ 133 (241)
..+...+.+-......|.+-.. ++..+++|..........+. ..+++..+..++. .....++.+...
T Consensus 31 ~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ek 109 (229)
T PF06176_consen 31 NNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEK 109 (229)
T ss_pred CCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeee
Confidence 3344444555555555555444 46778888655433222111 2233333333322 233333333322
Q ss_pred -----CCcceEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEcc
Q 039310 134 -----TQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSD 208 (241)
Q Consensus 134 -----~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~D 208 (241)
....+++|||++|..|.++.. +++ .+...+.+++.-||+.| +.|+|..|.|+++++++ ++++|
T Consensus 110 k~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~-i~iID 177 (229)
T PF06176_consen 110 KIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG-IRIID 177 (229)
T ss_pred eeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-EEEEE
Confidence 235568999999988876542 222 24566778899999999 99999999999999654 99999
Q ss_pred CCCccc
Q 039310 209 FGASKL 214 (241)
Q Consensus 209 fgla~~ 214 (241)
|+..+.
T Consensus 178 ~~~k~~ 183 (229)
T PF06176_consen 178 TQGKRM 183 (229)
T ss_pred Cccccc
Confidence 987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.52 E-value=3.1e-06 Score=79.40 Aligned_cols=78 Identities=12% Similarity=0.218 Sum_probs=56.3
Q ss_pred ccccccCceeEEEEEeCCC---CeEEEEecccCC-hhhHHHHHHHHHHHHcCC-CCCc--eeEEEEEecC---CcceEEE
Q 039310 72 DVIGCGGSGNVYKGFLPDR---TPVAVKKSKIVD-QTKIDEFINELVVVSQIN-RRNV--VRLLACCLET---QVPLLVY 141 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~---~~vavk~~~~~~-~~~~~~~~~E~~~l~~l~-h~ni--~~l~~~~~~~---~~~~lv~ 141 (241)
+.++.|.+..+|+....++ ..+++|+..... ......+.+|..+++.+. |+++ ++++.++.+. +..|+||
T Consensus 44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM 123 (822)
T PLN02876 44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM 123 (822)
T ss_pred EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence 4578899999999876543 367777654422 123356789999999995 6665 7888887764 4678999
Q ss_pred EecCCCCc
Q 039310 142 EFVGNGTL 149 (241)
Q Consensus 142 e~~~~g~L 149 (241)
||++|..+
T Consensus 124 E~v~G~~~ 131 (822)
T PLN02876 124 EYLEGRIF 131 (822)
T ss_pred EecCCccc
Confidence 99987543
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.51 E-value=8.6e-07 Score=68.31 Aligned_cols=100 Identities=23% Similarity=0.333 Sum_probs=81.0
Q ss_pred HHHHHHHcCCC-CCceeEEEEEecCCcceEEEEecCCCCchHH---hhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 039310 111 NELVVVSQINR-RNVVRLLACCLETQVPLLVYEFVGNGTLFEH---IHKNGNLTWERRLRIAAETAGVLSYLHSETNVPI 186 (241)
Q Consensus 111 ~E~~~l~~l~h-~ni~~l~~~~~~~~~~~lv~e~~~~g~L~~~---l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i 186 (241)
+|.-+++.+++ +++++++|+|- .++++||.+.+++... +..-..-+|..+.+++.++++.+.++++...-.+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 58888999976 69999999993 3679999987655421 1122246899999999999999999998544458
Q ss_pred EecCCCCCCeeeCCCCCeEEccCCCccc
Q 039310 187 IHRDVKSANILLDENYTPKVSDFGASKL 214 (241)
Q Consensus 187 iH~dlk~~Nili~~~~~~kl~Dfgla~~ 214 (241)
.-.|++++|+-+++++++|++|...+..
T Consensus 84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEeecchHHeEEeCCCcEEEEechhcch
Confidence 8999999999999999999999987654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.47 E-value=5.1e-06 Score=64.45 Aligned_cols=134 Identities=22% Similarity=0.305 Sum_probs=92.6
Q ss_pred cccccccCceeEEEEEeCCCCeEEEEecccCC----------------hhhHHHHHHHHHHHHcCC------CCCceeEE
Q 039310 71 ADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVD----------------QTKIDEFINELVVVSQIN------RRNVVRLL 128 (241)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~ni~~l~ 128 (241)
..+||+|+.-.||. +++.....||...... .....+..+|+.-...+. +..|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 45799999998887 4555667788765544 122455667776666655 78899999
Q ss_pred EEEecCCcceEEEEecCC------CCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC-
Q 039310 129 ACCLETQVPLLVYEFVGN------GTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDEN- 201 (241)
Q Consensus 129 ~~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~- 201 (241)
|+.+++.-.-+|+|.+.. .+|.+++... .++. .....+.+ -..||-+.+ |+.+|++|.||++...
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~-~~~~~L~~---f~~~l~~~~---Iv~~dl~~~NIv~~~~~ 155 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-GLTE-ELRQALDE---FKRYLLDHH---IVIRDLNPHNIVVQRRD 155 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-CccH-HHHHHHHH---HHHHHHHcC---CeecCCCcccEEEEecC
Confidence 999999888999998642 2778888554 3555 33333333 355666666 9999999999999632
Q ss_pred -C--CeEEcc-CCCccc
Q 039310 202 -Y--TPKVSD-FGASKL 214 (241)
Q Consensus 202 -~--~~kl~D-fgla~~ 214 (241)
+ .+.|+| ||-...
T Consensus 156 ~~~~~lvlIDG~G~~~~ 172 (199)
T PF10707_consen 156 SGEFRLVLIDGLGEKEL 172 (199)
T ss_pred CCceEEEEEeCCCCccc
Confidence 2 467776 565443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.39 E-value=1.2e-05 Score=66.50 Aligned_cols=76 Identities=8% Similarity=-0.001 Sum_probs=55.5
Q ss_pred cccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCC---CCceeEEEEEec---CCcceEEEEec
Q 039310 71 ADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINR---RNVVRLLACCLE---TQVPLLVYEFV 144 (241)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h---~ni~~l~~~~~~---~~~~~lv~e~~ 144 (241)
.+.||.|..+.||.....++ .+.+|..+. ......+..|.+.++.+.. -.++++++++.. .+..++|||++
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i 95 (297)
T PRK10593 19 VECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL 95 (297)
T ss_pred eeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence 34699999999999876555 466665332 1123578899999999853 368899988754 36689999999
Q ss_pred CCCCc
Q 039310 145 GNGTL 149 (241)
Q Consensus 145 ~~g~L 149 (241)
++.++
T Consensus 96 ~G~~~ 100 (297)
T PRK10593 96 RGVSV 100 (297)
T ss_pred CCEec
Confidence 98654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.32 E-value=1.9e-07 Score=82.22 Aligned_cols=153 Identities=20% Similarity=0.097 Sum_probs=104.8
Q ss_pred cccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCC-ceeEEEEEecCCcceEEEEecCCC-Cch
Q 039310 73 VIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRN-VVRLLACCLETQVPLLVYEFVGNG-TLF 150 (241)
Q Consensus 73 ~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~n-i~~l~~~~~~~~~~~lv~e~~~~g-~L~ 150 (241)
-.++++++++++.+-........+.+... ....-++++|.+++||| .+..++-+..+...++.++++.++ +-.
T Consensus 249 ~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~ 323 (829)
T KOG0576|consen 249 NFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSA 323 (829)
T ss_pred HHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcccc
Confidence 46889999999987433333333332221 33346899999999999 666677777788889999999876 222
Q ss_pred -HHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeeeeccc
Q 039310 151 -EHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGT 229 (241)
Q Consensus 151 -~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt 229 (241)
..-...-.+...+...+...-.++++++|+.. -+|+| ||+..+ +..+..||+....+.... ......+|
T Consensus 324 ~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t~~~~ 393 (829)
T KOG0576|consen 324 LEMTVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPRTAIGT 393 (829)
T ss_pred ccCChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc--ccccCCCC
Confidence 11111112444445566677778899999864 58998 776665 678999999988765432 44556699
Q ss_pred ccccccccccC
Q 039310 230 LGYIDPEYLQT 240 (241)
Q Consensus 230 ~~y~aPE~l~~ 240 (241)
+.|+|||+.++
T Consensus 394 ~~~~~pev~~~ 404 (829)
T KOG0576|consen 394 PEPLAPEVIQE 404 (829)
T ss_pred CCCCCchhhcc
Confidence 99999998764
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.32 E-value=8.8e-06 Score=64.99 Aligned_cols=73 Identities=14% Similarity=0.172 Sum_probs=45.3
Q ss_pred ccccccCce-eEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCC---CceeEEEEEecC---CcceEEEEec
Q 039310 72 DVIGCGGSG-NVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRR---NVVRLLACCLET---QVPLLVYEFV 144 (241)
Q Consensus 72 ~~lg~G~~g-~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~---ni~~l~~~~~~~---~~~~lv~e~~ 144 (241)
+.++.|+.. .||+. +..+++|.... ......+.+|..++..+... -++.+++..... ...+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 346666665 48874 23466775432 22335788899999888532 455555554432 2458899999
Q ss_pred CCCCch
Q 039310 145 GNGTLF 150 (241)
Q Consensus 145 ~~g~L~ 150 (241)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 987664
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.31 E-value=8.3e-08 Score=88.41 Aligned_cols=137 Identities=19% Similarity=0.221 Sum_probs=102.5
Q ss_pred ccccccCceeEEEEEeC-CCCeEEEEe---cccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCCC
Q 039310 72 DVIGCGGSGNVYKGFLP-DRTPVAVKK---SKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNG 147 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavk~---~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~g 147 (241)
+.+..|+++.++.+.-. .+...+.+. .........+....+-.++-..++|.++...-.+......+++++|..++
T Consensus 810 ~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~ 889 (1205)
T KOG0606|consen 810 KPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGG 889 (1205)
T ss_pred ccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccC
Confidence 36788999999887622 232223222 11122222233344444554556677776666666778899999999999
Q ss_pred CchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCC
Q 039310 148 TLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGA 211 (241)
Q Consensus 148 ~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgl 211 (241)
+|...++..+..+..-.......+..+.+|||+.. +.|+|++|.|.++..++..+++|||.
T Consensus 890 ~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t 950 (1205)
T KOG0606|consen 890 DLPSKLHNSGCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGT 950 (1205)
T ss_pred CchhhhhcCCCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccc
Confidence 99999998887888888888999999999999987 89999999999999999999999984
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.27 E-value=9e-06 Score=61.15 Aligned_cols=128 Identities=15% Similarity=0.143 Sum_probs=85.7
Q ss_pred ccccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCc-eeEEEEEecCCcceEEEEecCCCC
Q 039310 70 YADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNV-VRLLACCLETQVPLLVYEFVGNGT 148 (241)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni-~~l~~~~~~~~~~~lv~e~~~~g~ 148 (241)
..+.|++|.+|.||+|.+.+ ..+|+|.-.. ......+..|++++..+.-.++ ++++.+..+ ++.|||+.|..
T Consensus 26 v~~~L~KG~~s~Vyl~~~~~-~~~a~Kvrr~--ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~~ 98 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWRG-GEVALKVRRR--DSPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGRP 98 (201)
T ss_pred hhhhhhcccccEEEEeeccC-ceEEEEEecC--CcchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCcc
Confidence 34579999999999999954 4788886543 2334678889999999876554 345544333 34599998878
Q ss_pred chHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCC-CCCeeeCCCCCeEEccCCCccc
Q 039310 149 LFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVK-SANILLDENYTPKVSDFGASKL 214 (241)
Q Consensus 149 L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk-~~Nili~~~~~~kl~Dfgla~~ 214 (241)
|.+.-... +.+++.. ++..---|...| |-|..+. |...++.+++.+.|+||..|..
T Consensus 99 L~~~~~~~---~rk~l~~----vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 99 LGKLEIGG---DRKHLLR----VLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhcc---cHHHHHH----HHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 87655332 2333333 333333344555 8888775 5555666666999999998874
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.20 E-value=7.3e-05 Score=64.11 Aligned_cols=74 Identities=16% Similarity=0.125 Sum_probs=53.8
Q ss_pred ccccccCceeEEEEEeCCC-CeEEEEecccC----C---hhhHHHHHHHHHHHHcCC---CCCceeEEEEEecCCcceEE
Q 039310 72 DVIGCGGSGNVYKGFLPDR-TPVAVKKSKIV----D---QTKIDEFINELVVVSQIN---RRNVVRLLACCLETQVPLLV 140 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~-~~vavk~~~~~----~---~~~~~~~~~E~~~l~~l~---h~ni~~l~~~~~~~~~~~lv 140 (241)
+.||.|.+..||+....+| +.++||...+. . .-..++...|.+.|+.+. ...+++++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 3689999999999998766 48999974421 1 124466778888888863 3467788777 44667899
Q ss_pred EEecCCC
Q 039310 141 YEFVGNG 147 (241)
Q Consensus 141 ~e~~~~g 147 (241)
||++++.
T Consensus 110 ME~L~~~ 116 (401)
T PRK09550 110 MEDLSDH 116 (401)
T ss_pred EecCCCc
Confidence 9999763
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.14 E-value=3.1e-05 Score=62.62 Aligned_cols=135 Identities=10% Similarity=0.080 Sum_probs=76.5
Q ss_pred ccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCc-eeEEEEEecCCcceEEEEecCCCCchHH
Q 039310 74 IGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNV-VRLLACCLETQVPLLVYEFVGNGTLFEH 152 (241)
Q Consensus 74 lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni-~~l~~~~~~~~~~~lv~e~~~~g~L~~~ 152 (241)
+..|-...+|+... ++..+++|..........-...+|..+++.+...++ ++++.... .++|+||++|..+..-
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 45677788998874 566788886443221110134678888888864333 45554432 3689999998655321
Q ss_pred -----------------hhcCC----CCCHHH-HHHHHHHH---------HHHHHHhhcC-----CCCCeEecCCCCCCe
Q 039310 153 -----------------IHKNG----NLTWER-RLRIAAET---------AGVLSYLHSE-----TNVPIIHRDVKSANI 196 (241)
Q Consensus 153 -----------------l~~~~----~l~~~~-~~~~~~~i---------~~~l~~lh~~-----~~~~iiH~dlk~~Ni 196 (241)
++... +++... ...+..++ ...+..+-.. .+..++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 11111 112111 11111111 1112222111 122489999999999
Q ss_pred eeCCCCCeEEccCCCccc
Q 039310 197 LLDENYTPKVSDFGASKL 214 (241)
Q Consensus 197 li~~~~~~kl~Dfgla~~ 214 (241)
++++++ +.++||..|..
T Consensus 159 l~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEeCCC-CEEEeccccCc
Confidence 999877 78999998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.13 E-value=6.5e-05 Score=59.85 Aligned_cols=72 Identities=21% Similarity=0.168 Sum_probs=46.3
Q ss_pred cccccCceeEEEEEeCC--CCeEEEEecccCChhhHHHHHHHHHHHHcCCC-CCceeEEEEEecCCcceEEEEecCCCCc
Q 039310 73 VIGCGGSGNVYKGFLPD--RTPVAVKKSKIVDQTKIDEFINELVVVSQINR-RNVVRLLACCLETQVPLLVYEFVGNGTL 149 (241)
Q Consensus 73 ~lg~G~~g~V~~~~~~~--~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h-~ni~~l~~~~~~~~~~~lv~e~~~~g~L 149 (241)
.|..|-...+|+....+ +..+++|........ .-...+|..+++.+.. .-.+++++.+. ..++|||++|.++
T Consensus 5 ~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~l 79 (235)
T cd05157 5 RFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRTL 79 (235)
T ss_pred EcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCcC
Confidence 46777788999987654 567888865532221 1233478888888853 33455554432 2479999998765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.94 E-value=0.00016 Score=55.92 Aligned_cols=125 Identities=26% Similarity=0.334 Sum_probs=86.0
Q ss_pred hhhcccccccccCc-eeEEEEEeCCCCeEEEEeccc---CCh------------------hhHHHHHHHHHHHHcCC---
Q 039310 66 VTNNYADVIGCGGS-GNVYKGFLPDRTPVAVKKSKI---VDQ------------------TKIDEFINELVVVSQIN--- 120 (241)
Q Consensus 66 ~~~~~~~~lg~G~~-g~V~~~~~~~~~~vavk~~~~---~~~------------------~~~~~~~~E~~~l~~l~--- 120 (241)
...++.+.||.|.- |.||++.. +|..+|+|.... ... ....-|..|.+...+++
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 56778889999999 99999998 566899997221 000 11234667777776664
Q ss_pred CCCc--eeEEEEEecC------------------CcceEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhc
Q 039310 121 RRNV--VRLLACCLET------------------QVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHS 180 (241)
Q Consensus 121 h~ni--~~l~~~~~~~------------------~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~ 180 (241)
+.++ ++++||..-. ..+.||.||.+... .++. .-+.+|.+-+..+|.
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~----~~~~~~~~dl~~~~k 182 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQI----RDIPQMLRDLKILHK 182 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccch----hHHHHHHHHHHHHHH
Confidence 4566 8999997322 11246777765432 2233 335566677889999
Q ss_pred CCCCCeEecCCCCCCeeeCCCCCeEEccCCCc
Q 039310 181 ETNVPIIHRDVKSANILLDENYTPKVSDFGAS 212 (241)
Q Consensus 181 ~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla 212 (241)
.+ |+-+|+++.|.. .-+|+|||.+
T Consensus 183 ~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 183 LG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred CC---eeeccCcccccc-----CCEEEecccC
Confidence 98 999999999976 3478899864
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00023 Score=58.76 Aligned_cols=138 Identities=22% Similarity=0.220 Sum_probs=82.2
Q ss_pred cccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCC--ceeEEEE------EecCCcceEEEEec
Q 039310 73 VIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRN--VVRLLAC------CLETQVPLLVYEFV 144 (241)
Q Consensus 73 ~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~n--i~~l~~~------~~~~~~~~lv~e~~ 144 (241)
.+..|....+|+....+ ..+++|.... ........|+.++..+.+.+ +++++.. ....+..+++++++
T Consensus 21 ~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i 96 (296)
T cd05153 21 GISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL 96 (296)
T ss_pred cccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence 57778778899987644 4688887654 22355667888888885433 4555432 12345668999999
Q ss_pred CCCCchH----Hh----------hc---C---C-----CCCHHHHH----------HHHHHHHHHHHHhhc----CCCCC
Q 039310 145 GNGTLFE----HI----------HK---N---G-----NLTWERRL----------RIAAETAGVLSYLHS----ETNVP 185 (241)
Q Consensus 145 ~~g~L~~----~l----------~~---~---~-----~l~~~~~~----------~~~~~i~~~l~~lh~----~~~~~ 185 (241)
+|..+.. .. +. . . ...+.... .....+..++.++.+ ..+..
T Consensus 97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~ 176 (296)
T cd05153 97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRG 176 (296)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc
Confidence 9866532 11 00 0 0 00111100 011112334444443 11234
Q ss_pred eEecCCCCCCeeeCCCCCeEEccCCCccc
Q 039310 186 IIHRDVKSANILLDENYTPKVSDFGASKL 214 (241)
Q Consensus 186 iiH~dlk~~Nili~~~~~~kl~Dfgla~~ 214 (241)
++|+|+.|.|+++++++.+.|+||+.+..
T Consensus 177 l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 177 VIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 99999999999999987788999988764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.0014 Score=54.79 Aligned_cols=138 Identities=17% Similarity=0.130 Sum_probs=74.6
Q ss_pred cccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCC--CceeEEEE------EecCCcceEEEEec
Q 039310 73 VIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRR--NVVRLLAC------CLETQVPLLVYEFV 144 (241)
Q Consensus 73 ~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~--ni~~l~~~------~~~~~~~~lv~e~~ 144 (241)
.++.|....+|.....++ .+++|...... .+....|..++..+... .+++.+.. ....+..++++||+
T Consensus 29 ~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l 104 (319)
T PRK05231 29 GIAEGIENSNFFLTTTQG-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFL 104 (319)
T ss_pred hhccccccceEEEEeCCC-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEec
Confidence 466777778999876555 57888654212 23334455666665322 23444421 12345678999999
Q ss_pred CCCCch-----------HHh---hcC-C--------C--CCH-HHHHH------------HHHH-HHHHHHHhhcC----
Q 039310 145 GNGTLF-----------EHI---HKN-G--------N--LTW-ERRLR------------IAAE-TAGVLSYLHSE---- 181 (241)
Q Consensus 145 ~~g~L~-----------~~l---~~~-~--------~--l~~-~~~~~------------~~~~-i~~~l~~lh~~---- 181 (241)
+|..+. ..+ +.. . . +.+ ..... ...+ +...+..+.+.
T Consensus 105 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 184 (319)
T PRK05231 105 EGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPA 184 (319)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccccc
Confidence 886432 111 000 0 0 111 11110 1111 11122233211
Q ss_pred CCCCeEecCCCCCCeeeCCCCCeEEccCCCccc
Q 039310 182 TNVPIIHRDVKSANILLDENYTPKVSDFGASKL 214 (241)
Q Consensus 182 ~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~ 214 (241)
-+..++|+|+.|.||+++++...-|+||+.+..
T Consensus 185 lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 185 LPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred CCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 223599999999999999776568999998753
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00081 Score=55.09 Aligned_cols=30 Identities=27% Similarity=0.551 Sum_probs=25.4
Q ss_pred CeEecCCCCCCeeeCCCCC-eEEccCCCccc
Q 039310 185 PIIHRDVKSANILLDENYT-PKVSDFGASKL 214 (241)
Q Consensus 185 ~iiH~dlk~~Nili~~~~~-~kl~Dfgla~~ 214 (241)
.++|+|+.+.||++++++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997565 46999998765
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00029 Score=57.97 Aligned_cols=72 Identities=19% Similarity=0.216 Sum_probs=46.8
Q ss_pred ccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCC---CCCceeEEEEEecCCcceEEEEecCCC
Q 039310 72 DVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQIN---RRNVVRLLACCLETQVPLLVYEFVGNG 147 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~---h~ni~~l~~~~~~~~~~~lv~e~~~~g 147 (241)
+.++.|....+|+.. .++..+.||.-. ......|..|.+-|+.|. --.+++.+++....+..+++|||++.+
T Consensus 23 ~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 23 EPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred EecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 468889999999877 567789999654 233356778888888883 346889999988887889999999765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.0016 Score=54.15 Aligned_cols=139 Identities=21% Similarity=0.200 Sum_probs=79.0
Q ss_pred ccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCC--ceeEEEEE------ecCCcceEEEEe
Q 039310 72 DVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRN--VVRLLACC------LETQVPLLVYEF 143 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~n--i~~l~~~~------~~~~~~~lv~e~ 143 (241)
+.++.|....+|+....++ .+++|...... .......|.+++..+...+ +++++... ...+..++++||
T Consensus 28 ~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~ 104 (307)
T TIGR00938 28 KGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEF 104 (307)
T ss_pred cccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEe
Confidence 3577777788998876445 57778654321 1234456777777774322 44544421 124567899999
Q ss_pred cCCCCchH-----------Hh---hc--CC---C----C---CHHHHH------------HHHHHHHHHHHHhhc----C
Q 039310 144 VGNGTLFE-----------HI---HK--NG---N----L---TWERRL------------RIAAETAGVLSYLHS----E 181 (241)
Q Consensus 144 ~~~g~L~~-----------~l---~~--~~---~----l---~~~~~~------------~~~~~i~~~l~~lh~----~ 181 (241)
++|..+.. .+ +. .+ . . .|.... .....+.+.++++.. .
T Consensus 105 i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~ 184 (307)
T TIGR00938 105 LQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRD 184 (307)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 98854321 01 10 00 0 0 011000 001122334555532 1
Q ss_pred CCCCeEecCCCCCCeeeCCCCCeEEccCCCcc
Q 039310 182 TNVPIIHRDVKSANILLDENYTPKVSDFGASK 213 (241)
Q Consensus 182 ~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~ 213 (241)
.+..++|+|+.+.|+++++++.+.|+||+.+.
T Consensus 185 ~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 185 LPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 22459999999999999988877899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.0016 Score=55.02 Aligned_cols=72 Identities=17% Similarity=0.159 Sum_probs=48.1
Q ss_pred cccccCceeEEEEEeCCC-CeEEEEeccc-------CChhhHHHHHHHHHHHHcCC--CC-CceeEEEEEecCCcceEEE
Q 039310 73 VIGCGGSGNVYKGFLPDR-TPVAVKKSKI-------VDQTKIDEFINELVVVSQIN--RR-NVVRLLACCLETQVPLLVY 141 (241)
Q Consensus 73 ~lg~G~~g~V~~~~~~~~-~~vavk~~~~-------~~~~~~~~~~~E~~~l~~l~--h~-ni~~l~~~~~~~~~~~lv~ 141 (241)
.||.|....||++..+++ ..|+||...+ ...-...+..-|.+.|+... -| .+++++. .+++...++|
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 478999999999987654 5899995332 11334456667888887763 23 4555543 3555667899
Q ss_pred EecCC
Q 039310 142 EFVGN 146 (241)
Q Consensus 142 e~~~~ 146 (241)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99964
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.0026 Score=53.86 Aligned_cols=138 Identities=20% Similarity=0.223 Sum_probs=78.2
Q ss_pred cccccCceeEEEEEeCC-----CCeEEEEecccCChhhHHHHHHHHHHHHcCCCCC-ceeEEEEEecCCcceEEEEecCC
Q 039310 73 VIGCGGSGNVYKGFLPD-----RTPVAVKKSKIVDQTKIDEFINELVVVSQINRRN-VVRLLACCLETQVPLLVYEFVGN 146 (241)
Q Consensus 73 ~lg~G~~g~V~~~~~~~-----~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~n-i~~l~~~~~~~~~~~lv~e~~~~ 146 (241)
.+..|-.-.+|+..+.+ +..+++|.......... +..+|..+++.+...+ -+++++.+... .|+||+++
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g 117 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA 117 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence 34446677889887532 35788887654332222 2357888888885433 34556665332 58999987
Q ss_pred CCchHH-------h----------hcCC------CCCHHHHHHHHHHH-----------------HHHHHH----hhc-C
Q 039310 147 GTLFEH-------I----------HKNG------NLTWERRLRIAAET-----------------AGVLSY----LHS-E 181 (241)
Q Consensus 147 g~L~~~-------l----------~~~~------~l~~~~~~~~~~~i-----------------~~~l~~----lh~-~ 181 (241)
.++..- + +... ...+.....+..++ ...+.. +.. .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 665421 0 1110 11122222332111 111111 221 1
Q ss_pred CCCCeEecCCCCCCeeeCC-CCCeEEccCCCcccc
Q 039310 182 TNVPIIHRDVKSANILLDE-NYTPKVSDFGASKLV 215 (241)
Q Consensus 182 ~~~~iiH~dlk~~Nili~~-~~~~kl~Dfgla~~~ 215 (241)
.+..++|+|+++.||++++ ++.+.++||..|...
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~ 232 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN 232 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence 2234899999999999986 468999999987753
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.0039 Score=53.66 Aligned_cols=72 Identities=11% Similarity=0.122 Sum_probs=49.5
Q ss_pred ccccccCceeEEEEEeCCCCeEEEEeccc----CCh---hhHHHHHHHHHHHHcCC---CCCceeEEEEEecCCcceEEE
Q 039310 72 DVIGCGGSGNVYKGFLPDRTPVAVKKSKI----VDQ---TKIDEFINELVVVSQIN---RRNVVRLLACCLETQVPLLVY 141 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~~vavk~~~~----~~~---~~~~~~~~E~~~l~~l~---h~ni~~l~~~~~~~~~~~lv~ 141 (241)
+.+|.|..-.||+.... +..++||.... ... ....+-..|.+.|+.+. ...+++++.++. +..+++|
T Consensus 38 ~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlvM 114 (418)
T PLN02756 38 KEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIGM 114 (418)
T ss_pred EEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEEE
Confidence 46899999999998764 45688996542 111 13344455677776653 357888888877 4467889
Q ss_pred EecCC
Q 039310 142 EFVGN 146 (241)
Q Consensus 142 e~~~~ 146 (241)
|++++
T Consensus 115 E~L~~ 119 (418)
T PLN02756 115 RYLEP 119 (418)
T ss_pred eecCC
Confidence 99976
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.0022 Score=53.17 Aligned_cols=137 Identities=25% Similarity=0.270 Sum_probs=79.6
Q ss_pred cccccCceeEEEEEeCC-------CCeEEEEecccCChhhHHHHHHHHHHHHcCCCCC-ceeEEEEEecCCcceEEEEec
Q 039310 73 VIGCGGSGNVYKGFLPD-------RTPVAVKKSKIVDQTKIDEFINELVVVSQINRRN-VVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 73 ~lg~G~~g~V~~~~~~~-------~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~n-i~~l~~~~~~~~~~~lv~e~~ 144 (241)
.+..|-.-.+|+....+ +..+++|...... ....+..+|..++..+...+ .+++++++.. .+|+||+
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i 79 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFI 79 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhee
Confidence 34556666888887554 4678888755432 22234567888888885332 4455665542 3589999
Q ss_pred CCCCchHH-------h----------hc---C--C----CCC--HHHHHH--------------------------HHHH
Q 039310 145 GNGTLFEH-------I----------HK---N--G----NLT--WERRLR--------------------------IAAE 170 (241)
Q Consensus 145 ~~g~L~~~-------l----------~~---~--~----~l~--~~~~~~--------------------------~~~~ 170 (241)
+|..+... + +. . . ..+ +..... ....
T Consensus 80 ~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (302)
T cd05156 80 PSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLED 159 (302)
T ss_pred CCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHH
Confidence 88665431 0 00 0 0 000 001100 1112
Q ss_pred HHHHHHHhhc------CCCCCeEecCCCCCCeeeCCC----CCeEEccCCCccc
Q 039310 171 TAGVLSYLHS------ETNVPIIHRDVKSANILLDEN----YTPKVSDFGASKL 214 (241)
Q Consensus 171 i~~~l~~lh~------~~~~~iiH~dlk~~Nili~~~----~~~kl~Dfgla~~ 214 (241)
+...+.++.. ..+..++|+|+.+.||+++++ +.++++||..|..
T Consensus 160 ~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 160 EAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 2223334432 123459999999999999985 8899999998875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0035 Score=52.16 Aligned_cols=126 Identities=17% Similarity=0.242 Sum_probs=74.9
Q ss_pred EEEEEeCCCCeEEEEeccc--CChhhHHHHHHHHHHHHcCCC--CCceeEEEEEecCC--cceEEEEecCCCCchHHhhc
Q 039310 82 VYKGFLPDRTPVAVKKSKI--VDQTKIDEFINELVVVSQINR--RNVVRLLACCLETQ--VPLLVYEFVGNGTLFEHIHK 155 (241)
Q Consensus 82 V~~~~~~~~~~vavk~~~~--~~~~~~~~~~~E~~~l~~l~h--~ni~~l~~~~~~~~--~~~lv~e~~~~g~L~~~l~~ 155 (241)
+|..... +++.++. ... ..........+|..+++.+.- --++..++.|.++. ..+.||+|++|..+.+.+..
T Consensus 41 t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~ 118 (321)
T COG3173 41 TFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPP 118 (321)
T ss_pred eEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCc
Confidence 4443332 6677777 331 233344566678888888743 23455567776655 77999999988432222111
Q ss_pred CCCCCHHHHHHHH-HHHHHHHHHhh--------------------------------------------------cC---
Q 039310 156 NGNLTWERRLRIA-AETAGVLSYLH--------------------------------------------------SE--- 181 (241)
Q Consensus 156 ~~~l~~~~~~~~~-~~i~~~l~~lh--------------------------------------------------~~--- 181 (241)
. +.. ..++ ..+++.|.-|| ..
T Consensus 119 ~---~~~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~ 193 (321)
T COG3173 119 E---SLG--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPP 193 (321)
T ss_pred c---cch--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCC
Confidence 0 000 1111 13333333333 22
Q ss_pred --CCCCeEecCCCCCCeeeCCCCCeEEccCCCccc
Q 039310 182 --TNVPIIHRDVKSANILLDENYTPKVSDFGASKL 214 (241)
Q Consensus 182 --~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~ 214 (241)
++..++|+|+.+.|++++++..+=+.||+++..
T Consensus 194 ~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 194 WAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred cCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 224699999999999999988899999999864
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.00025 Score=58.70 Aligned_cols=132 Identities=17% Similarity=0.228 Sum_probs=89.4
Q ss_pred hcccccccccCceeEEEEEeCCCCeEEEEecccC----------C--------hh----hHHHHHHHHHHHHcCCC-C-C
Q 039310 68 NNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIV----------D--------QT----KIDEFINELVVVSQINR-R-N 123 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~----------~--------~~----~~~~~~~E~~~l~~l~h-~-n 123 (241)
+.++.+||-|--+.||.+-..+|++.++|.-... . .. ..-...+|...|+.+.. . -
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 3457789999999999999888999888831110 0 00 11234678888988853 2 2
Q ss_pred ceeEEEEEecCCcceEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCC
Q 039310 124 VVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYT 203 (241)
Q Consensus 124 i~~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~ 203 (241)
+++.+ +.++.++|||++.+-.|...-+- .+. ..+...+..-+--|...| +||+|..-=||++++++.
T Consensus 174 VPkpi----D~~RH~Vvmelv~g~Pl~~v~~v---~d~---~~ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~dd~~ 240 (465)
T KOG2268|consen 174 VPKPI----DHNRHCVVMELVDGYPLRQVRHV---EDP---PTLYDDLMGLIVRLANHG---LIHGDFNEFNIMVKDDDK 240 (465)
T ss_pred CCCcc----cccceeeHHHhhcccceeeeeec---CCh---HHHHHHHHHHHHHHHHcC---ceecccchheeEEecCCC
Confidence 44433 34567899999988777544321 122 223334444455566777 999999999999999999
Q ss_pred eEEccCCCc
Q 039310 204 PKVSDFGAS 212 (241)
Q Consensus 204 ~kl~Dfgla 212 (241)
++++||--.
T Consensus 241 i~vIDFPQm 249 (465)
T KOG2268|consen 241 IVVIDFPQM 249 (465)
T ss_pred EEEeechHh
Confidence 999999743
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0031 Score=53.21 Aligned_cols=137 Identities=19% Similarity=0.225 Sum_probs=92.8
Q ss_pred ccccccCceeEEEEEeCCCCeEEEEecccC------------------------Chh--hHHHHHHHHHHHHcCCCCCce
Q 039310 72 DVIGCGGSGNVYKGFLPDRTPVAVKKSKIV------------------------DQT--KIDEFINELVVVSQINRRNVV 125 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~~vavk~~~~~------------------------~~~--~~~~~~~E~~~l~~l~h~ni~ 125 (241)
.+|..|--+.||-|.-.+|..+|||..+-. ++. -.-+...|++-|++++...|+
T Consensus 150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP 229 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP 229 (520)
T ss_pred cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 478899999999999888999999954320 000 012456788888888766654
Q ss_pred eEEEEEecCCcceEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeE
Q 039310 126 RLLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPK 205 (241)
Q Consensus 126 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~k 205 (241)
..--... ...+|||+++.......-..+.-.++...+..+-.|++.-|.-|-+..+ +||.||+-=|+|+.+ |.+.
T Consensus 230 ~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~Lyhd-G~ly 304 (520)
T KOG2270|consen 230 CPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNLLYHD-GKLY 304 (520)
T ss_pred CCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhheEEC-CEEE
Confidence 2111111 2346899999532222222233457777888888888888887765432 999999999999874 5888
Q ss_pred EccCCCcc
Q 039310 206 VSDFGASK 213 (241)
Q Consensus 206 l~Dfgla~ 213 (241)
|+|-+-+.
T Consensus 305 iIDVSQSV 312 (520)
T KOG2270|consen 305 IIDVSQSV 312 (520)
T ss_pred EEEccccc
Confidence 99987654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.00025 Score=63.43 Aligned_cols=68 Identities=22% Similarity=0.375 Sum_probs=49.8
Q ss_pred HHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCc------cc--eeeeeccccccccccccc
Q 039310 170 ETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDA------IQ--NYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 170 ~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~------~~--~~~~~~gt~~y~aPE~l~ 239 (241)
++++|+.|+|...+ +||+++.|++|.++.++..||+.|+.+....... +. ...-..-...|.|||++.
T Consensus 107 ~v~dgl~flh~sAk--~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 107 NVADGLAFLHRSAK--VVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred cccchhhhhccCcc--eeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 44499999998654 9999999999999999999999999876543311 00 011112356799999874
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0032 Score=53.87 Aligned_cols=73 Identities=16% Similarity=0.109 Sum_probs=49.8
Q ss_pred ccccccCceeEEEEEeC-CCCeEEEEeccc------CChhhHHHHHHHHHHHHcCC--CC-CceeEEEEEecCCcceEEE
Q 039310 72 DVIGCGGSGNVYKGFLP-DRTPVAVKKSKI------VDQTKIDEFINELVVVSQIN--RR-NVVRLLACCLETQVPLLVY 141 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavk~~~~------~~~~~~~~~~~E~~~l~~l~--h~-ni~~l~~~~~~~~~~~lv~ 141 (241)
+.||.|.-.-||++... ++..|+||...+ ...-..++..-|.+.|+... -| .+++++.+ +++...+||
T Consensus 35 ~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~vM 112 (409)
T PRK12396 35 KEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCVM 112 (409)
T ss_pred eEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHHH
Confidence 46899999999999874 356899995332 12334567777888888763 23 56666543 555667899
Q ss_pred EecCC
Q 039310 142 EFVGN 146 (241)
Q Consensus 142 e~~~~ 146 (241)
|+++.
T Consensus 113 EdL~~ 117 (409)
T PRK12396 113 EDLSD 117 (409)
T ss_pred HhCcc
Confidence 99864
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.015 Score=45.97 Aligned_cols=73 Identities=18% Similarity=0.238 Sum_probs=50.7
Q ss_pred ccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCC---CCCceeEEEEEecCCcceEEEEecCCCCch
Q 039310 74 IGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQIN---RRNVVRLLACCLETQVPLLVYEFVGNGTLF 150 (241)
Q Consensus 74 lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~---h~ni~~l~~~~~~~~~~~lv~e~~~~g~L~ 150 (241)
+.-|.--+.|... .+..++-+|. ........|..|+.-|..|. --++++++.+..+.+..|+||||++.+.+.
T Consensus 24 v~gG~inea~~v~-dg~~~~FvK~---n~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 24 VSGGDINEAWRLR-DGTDPFFVKC---NQREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred cCCccccceeEee-cCCcceEEEe---cchhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 3334333344433 3567888884 33455677888887777664 356889999999999999999999976554
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.0031 Score=53.12 Aligned_cols=71 Identities=24% Similarity=0.259 Sum_probs=55.8
Q ss_pred cceEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCccc
Q 039310 136 VPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKL 214 (241)
Q Consensus 136 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~ 214 (241)
..|+++++. |+++.- + ....+.+...++.+.+..+.-+..+- ++-|||+.-.||||+ .|++.|+||-+|+.
T Consensus 300 y~yl~~kdh-gt~is~-i---k~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 300 YLYLHFKDH-GTPISI-I---KADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred EEEEEEecC-Cceeee-e---ecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeeeec
Confidence 456777765 444432 2 23578899999999888888777643 599999999999999 99999999999984
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.0027 Score=54.33 Aligned_cols=157 Identities=15% Similarity=0.164 Sum_probs=94.8
Q ss_pred cccccccccCceeEEEE-EeCCCCeEEEEecccCChhhHHHHHHHHHHHHcC-CCCCceeEEEEEec-------C-Ccce
Q 039310 69 NYADVIGCGGSGNVYKG-FLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQI-NRRNVVRLLACCLE-------T-QVPL 138 (241)
Q Consensus 69 ~~~~~lg~G~~g~V~~~-~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~-------~-~~~~ 138 (241)
..+..||+|+-+.+|-- ...+ .| .|....-..... .+.++.|... .||-+-. .-.|.. . ...-
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~d--~V-AKIYh~Pppa~~---aqk~a~la~~p~~p~~~~-rvaWPqa~L~G~~~~~~iG 86 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVRD--QV-AKIYHAPPPAAQ---AQKVAELAATPDAPLLNY-RVAWPQATLHGGRRGKVIG 86 (637)
T ss_pred CCCccccCCccceeeecchhhc--hh-heeecCCCchHH---HHHHHHhccCCCCcchhh-hhcccHHHhhCCCccceeE
Confidence 34567999999999973 3322 12 233221111111 1223334443 5654332 222321 1 1245
Q ss_pred EEEEecCCC-CchHHhh------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCC
Q 039310 139 LVYEFVGNG-TLFEHIH------KNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGA 211 (241)
Q Consensus 139 lv~e~~~~g-~L~~~l~------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgl 211 (241)
++|..+++. ....+.+ ......|.-.++.+..++.+.+-||+.| .+-+|+.++|+|+++++.+.+.|=..
T Consensus 87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDs 163 (637)
T COG4248 87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDS 163 (637)
T ss_pred EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccc
Confidence 677777654 2222322 1123889999999999999999999999 99999999999999999999987543
Q ss_pred cccccCCccceeeeeccccccccccc
Q 039310 212 SKLVPIDAIQNYTVVQGTLGYIDPEY 237 (241)
Q Consensus 212 a~~~~~~~~~~~~~~~gt~~y~aPE~ 237 (241)
-....++ .......|.+.|.+||.
T Consensus 164 fqi~~ng--~~~~cpVg~~eftPPEl 187 (637)
T COG4248 164 FQINANG--TLHLCPVGVSEFTPPEL 187 (637)
T ss_pred eeeccCC--ceEecccCccccCCHHH
Confidence 2221111 12222348899999995
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.033 Score=46.40 Aligned_cols=30 Identities=17% Similarity=0.317 Sum_probs=27.3
Q ss_pred CeEecCCCCCCeeeCCCCCeEEccCCCccc
Q 039310 185 PIIHRDVKSANILLDENYTPKVSDFGASKL 214 (241)
Q Consensus 185 ~iiH~dlk~~Nili~~~~~~kl~Dfgla~~ 214 (241)
.++|+|+.+.|+|+++++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 499999999999999999999999987764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.044 Score=46.14 Aligned_cols=136 Identities=18% Similarity=0.209 Sum_probs=74.2
Q ss_pred ccccCceeEEEEEeCC----CCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCc-eeEEEEEecCCcceEEEEecCCCC
Q 039310 74 IGCGGSGNVYKGFLPD----RTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNV-VRLLACCLETQVPLLVYEFVGNGT 148 (241)
Q Consensus 74 lg~G~~g~V~~~~~~~----~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni-~~l~~~~~~~~~~~lv~e~~~~g~ 148 (241)
+..|=.-.+|+....+ +..++++....... ..-+..+|..+++.+...++ +++++++. .+ +|.+|+++.+
T Consensus 22 l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g~~ 96 (330)
T PLN02421 22 ISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINART 96 (330)
T ss_pred eCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcCCC
Confidence 4435556678776433 23788886554322 11223578888888865444 45565553 22 5889987765
Q ss_pred chH-------Hh----------hcCC------CCCHHHHHHHHHHH----------------------HH---HHH-Hhh
Q 039310 149 LFE-------HI----------HKNG------NLTWERRLRIAAET----------------------AG---VLS-YLH 179 (241)
Q Consensus 149 L~~-------~l----------~~~~------~l~~~~~~~~~~~i----------------------~~---~l~-~lh 179 (241)
+.. .+ +... +-.+.....+..++ .. .+. ++.
T Consensus 97 l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~~ 176 (330)
T PLN02421 97 LTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEITD 176 (330)
T ss_pred CChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHhc
Confidence 521 11 1111 11122222222221 11 111 121
Q ss_pred cC-CCCCeEecCCCCCCeeeCC-CCCeEEccCCCccc
Q 039310 180 SE-TNVPIIHRDVKSANILLDE-NYTPKVSDFGASKL 214 (241)
Q Consensus 180 ~~-~~~~iiH~dlk~~Nili~~-~~~~kl~Dfgla~~ 214 (241)
+. .+.-+.|.|+.+.|||+++ ++.++++||..|..
T Consensus 177 ~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 177 SLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred cCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11 1223789999999999974 57899999998765
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.23 E-value=0.014 Score=55.73 Aligned_cols=129 Identities=21% Similarity=0.142 Sum_probs=92.3
Q ss_pred HHHHHHHHHHHHcCCCCCceeEEEEEecCCc----ceEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 039310 106 IDEFINELVVVSQINRRNVVRLLACCLETQV----PLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSE 181 (241)
Q Consensus 106 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~----~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~ 181 (241)
.....-|...+....|+|++.++.+-..... ..+..+++..-++...+..-+.++....+.+..+..+||.|+|+.
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 3445567788888999999999998765432 234567888889999898888999999999999999999999997
Q ss_pred CCCCeEecCCCCC---CeeeCCCCCeEEc--cCCCcccccCCccceeeeeccccccccccccc
Q 039310 182 TNVPIIHRDVKSA---NILLDENYTPKVS--DFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 182 ~~~~iiH~dlk~~---Nili~~~~~~kl~--Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~ 239 (241)
. ..|.-+..+ +.-.+..+...++ ||+.+........ ......+..|.|||.+.
T Consensus 306 ~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~--~~~~~~~~~~~~~e~~~ 363 (1351)
T KOG1035|consen 306 S---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK--SFSDLLAEIRNADEDLK 363 (1351)
T ss_pred c---cceeEEecccccccccCccceeecchhhhcccccCCCccc--chhhcCccccccccccc
Confidence 5 666555555 5555666667766 8888776543322 12222345566666543
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.90 E-value=0.31 Score=40.97 Aligned_cols=70 Identities=14% Similarity=0.052 Sum_probs=41.3
Q ss_pred CceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCC--ceeEE---E--EEecCCcceEEEEecCCCC
Q 039310 78 GSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRN--VVRLL---A--CCLETQVPLLVYEFVGNGT 148 (241)
Q Consensus 78 ~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~n--i~~l~---~--~~~~~~~~~lv~e~~~~g~ 148 (241)
.--.||+....++..+++|...... ........|++.+..+.... ++... | ....++..+.++++++|..
T Consensus 37 ~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 37 YENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred ccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 3456898887777788888765322 23455667777777763221 22211 1 1222456778999998754
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.75 E-value=0.11 Score=44.79 Aligned_cols=73 Identities=16% Similarity=0.149 Sum_probs=42.9
Q ss_pred cccccCceeEEEEEeCCC--Ce-----EEEEecccCChhhHHHHHHHHHHHHcCCCC-CceeEEEEEecCCcceEEEEec
Q 039310 73 VIGCGGSGNVYKGFLPDR--TP-----VAVKKSKIVDQTKIDEFINELVVVSQINRR-NVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 73 ~lg~G~~g~V~~~~~~~~--~~-----vavk~~~~~~~~~~~~~~~E~~~l~~l~h~-ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
.+..|-...+|++...++ .. |.++......... -+-.+|..+++.+... .-+++++.+. .+++.||+
T Consensus 57 ~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~-IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~efI 131 (383)
T PTZ00384 57 KMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLV-IDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQEWV 131 (383)
T ss_pred EeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceE-eccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEEEe
Confidence 454577788999875432 12 4444322211111 1235689999998644 4456666664 26899999
Q ss_pred CCCCch
Q 039310 145 GNGTLF 150 (241)
Q Consensus 145 ~~g~L~ 150 (241)
+|.++.
T Consensus 132 eGr~l~ 137 (383)
T PTZ00384 132 EGNTMG 137 (383)
T ss_pred ccccCC
Confidence 987654
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.66 E-value=0.091 Score=41.59 Aligned_cols=100 Identities=18% Similarity=0.143 Sum_probs=63.1
Q ss_pred EEEEecccCChh-hHHHHHHHHHHHHcCCCCCceeEEEEEecCC-cceEEEEecCCCCchHHhhcCCCCCHHHHHHHHHH
Q 039310 93 VAVKKSKIVDQT-KIDEFINELVVVSQINRRNVVRLLACCLETQ-VPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAE 170 (241)
Q Consensus 93 vavk~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~ 170 (241)
..+|++...... ...-|.++..+++++. .|+++. .+++ .+-++.|+|-.... . ...++.-
T Consensus 88 L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~---NDn~~~yGvIlE~Cy~~~i------------~-~~N~i~a 149 (308)
T PF07387_consen 88 LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLK---NDNNYKYGVILERCYKIKI------------N-FSNFITA 149 (308)
T ss_pred hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEee---cCCCceeEEEEeeccCccc------------c-hhHHHHH
Confidence 345555443333 3456678888888764 466665 3333 34588898842111 0 1112222
Q ss_pred HHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCC
Q 039310 171 TAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGA 211 (241)
Q Consensus 171 i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgl 211 (241)
=+..|.-.|+.. ...+|+|..|+||+-|..|.+||.|=+.
T Consensus 150 gi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 150 GIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred hHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhh
Confidence 245677778543 3499999999999999999999999873
|
The function of this family is unknown. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.48 E-value=0.08 Score=45.59 Aligned_cols=59 Identities=15% Similarity=0.210 Sum_probs=39.7
Q ss_pred ceEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHH-hhcCCCCCeEecCCCCCCeeeC
Q 039310 137 PLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSY-LHSETNVPIIHRDVKSANILLD 199 (241)
Q Consensus 137 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~-lh~~~~~~iiH~dlk~~Nili~ 199 (241)
..++-+|..|-++..++... ..++.-..+++.-.+.|+-- +--.+ ++|.|+.|.||++.
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~-~~pe~l~kkva~lg~~AllkMl~vDN---FvHaDlHPGNVlir 379 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWK-SQPEALVKKVAKLGVNALLKMLIVDN---FVHADLHPGNVLIR 379 (565)
T ss_pred ceeeeeccccccHHhhhhcc-cChHHHHHHHHHHHHHHHHHHHHhhc---ceecccCCCcEEEE
Confidence 34566677777888888654 34555555666555555433 22334 99999999999995
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.33 E-value=0.31 Score=47.32 Aligned_cols=138 Identities=17% Similarity=0.225 Sum_probs=75.1
Q ss_pred cccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCC--CCC--ceeEEEE--------Eec-CC--cc
Q 039310 73 VIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQIN--RRN--VVRLLAC--------CLE-TQ--VP 137 (241)
Q Consensus 73 ~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~--h~n--i~~l~~~--------~~~-~~--~~ 137 (241)
.|+ |..-.+|+....++..+++|..+.... ......|...+..+. ++. +++++-. ... ++ ..
T Consensus 32 ~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~--~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~~ 108 (1013)
T PRK06148 32 PLD-GERDLNFRLTTDDGADYILKIVNPSEP--RVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPRL 108 (1013)
T ss_pred ecC-CcCCceEEEEeCCCCeEEEEEcCCccc--hhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceEE
Confidence 454 345678888877777899998775422 233344555665552 233 3333221 111 22 45
Q ss_pred eEEEEecCCCCchHH-------hh--------------c--C----CCCCHH-----------------HHHHHHHHHHH
Q 039310 138 LLVYEFVGNGTLFEH-------IH--------------K--N----GNLTWE-----------------RRLRIAAETAG 173 (241)
Q Consensus 138 ~lv~e~~~~g~L~~~-------l~--------------~--~----~~l~~~-----------------~~~~~~~~i~~ 173 (241)
+.+++|++|..+.+. +. . . ..+.|. ....++.+++.
T Consensus 109 vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~~ 188 (1013)
T PRK06148 109 LRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFLA 188 (1013)
T ss_pred EEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHHH
Confidence 678999998766541 00 0 0 011111 11122223332
Q ss_pred HHH-----HhhcCCCCCeEecCCCCCCeeeCCCC--CeE-EccCCCccc
Q 039310 174 VLS-----YLHSETNVPIIHRDVKSANILLDENY--TPK-VSDFGASKL 214 (241)
Q Consensus 174 ~l~-----~lh~~~~~~iiH~dlk~~Nili~~~~--~~k-l~Dfgla~~ 214 (241)
... .+.+ -+..+||+|+.+.|||++.++ .+. |+|||-+..
T Consensus 189 ~~~~~v~p~l~~-Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 189 RFERNVAPRLAA-LPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHhc-CCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 221 1211 123499999999999999875 555 999997653
|
|
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=95.07 E-value=0.27 Score=39.70 Aligned_cols=78 Identities=22% Similarity=0.114 Sum_probs=52.3
Q ss_pred ccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEec-CCCCch
Q 039310 72 DVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFV-GNGTLF 150 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~-~~g~L~ 150 (241)
..+..|..+.|+.++..+|.++++|...+......+ . .....|+..+=...|+++..-. ..-.|++|.+ ++.+|.
T Consensus 8 ~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~~E-~-~g~~~L~~w~G~GaVrll~~d~--~~~AlLLErl~~g~~L~ 83 (253)
T PF04655_consen 8 GPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAEHE-A-RGEAALRWWNGRGAVRLLAADP--ERGALLLERLDPGRSLA 83 (253)
T ss_pred CCCCCCcceEEEEEEcCCCCeEEEEecCCcccchhh-h-hHHhHhheeCCCCceeeecccc--ccchhhhhhccCCCchh
Confidence 346778999999999889999999986654322111 1 1124577777777888887653 3445788888 444776
Q ss_pred HHh
Q 039310 151 EHI 153 (241)
Q Consensus 151 ~~l 153 (241)
+..
T Consensus 84 ~~~ 86 (253)
T PF04655_consen 84 SLP 86 (253)
T ss_pred hcc
Confidence 554
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.02 E-value=0.052 Score=44.98 Aligned_cols=29 Identities=31% Similarity=0.338 Sum_probs=25.1
Q ss_pred CCeEecCCCCCCeeeCCCCCeEEccCCCcc
Q 039310 184 VPIIHRDVKSANILLDENYTPKVSDFGASK 213 (241)
Q Consensus 184 ~~iiH~dlk~~Nili~~~~~~kl~Dfgla~ 213 (241)
..++|+|+.+.|+++++ +.+.++||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 34999999999999998 678999999654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.90 E-value=0.02 Score=43.89 Aligned_cols=29 Identities=17% Similarity=0.240 Sum_probs=25.6
Q ss_pred CeEecCCCCCCeeeCCCCCeEEccCCCccc
Q 039310 185 PIIHRDVKSANILLDENYTPKVSDFGASKL 214 (241)
Q Consensus 185 ~iiH~dlk~~Nili~~~~~~kl~Dfgla~~ 214 (241)
..+|+|+.|.|+++++++ ++++||+.|..
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 378999999999998877 88999998764
|
|
| >PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli [] | Back alignment and domain information |
|---|
Probab=94.89 E-value=0.016 Score=41.14 Aligned_cols=44 Identities=18% Similarity=0.218 Sum_probs=32.8
Q ss_pred ccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHc
Q 039310 72 DVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQ 118 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~ 118 (241)
+.|+.|+.|+||+|++.+|+.||||...+. -.+.+..++.+++.
T Consensus 17 ~PlasASiaQVh~a~l~~g~~VaVKV~rP~---i~~~i~~Dl~~l~~ 60 (119)
T PF03109_consen 17 EPLASASIAQVHRARLKDGEEVAVKVQRPG---IEEQIEADLRILRR 60 (119)
T ss_pred chhhheehhhheeeeecccchhhhhhcchH---HHHHHHHHHHHHHH
Confidence 379999999999999989999999976543 22344455555543
|
These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins. |
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.68 E-value=0.044 Score=45.79 Aligned_cols=53 Identities=21% Similarity=0.187 Sum_probs=34.3
Q ss_pred HHHHHHHHHHHHHHHhhc-CCCCCeEecCCCCCCeeeCC-C-----------------CCeEEccCCCcccc
Q 039310 163 RRLRIAAETAGVLSYLHS-ETNVPIIHRDVKSANILLDE-N-----------------YTPKVSDFGASKLV 215 (241)
Q Consensus 163 ~~~~~~~~i~~~l~~lh~-~~~~~iiH~dlk~~Nili~~-~-----------------~~~kl~Dfgla~~~ 215 (241)
-+..+..||+--.-.+-+ .+...++|-||||.|||+-+ + -.++|.||.+|+.-
T Consensus 280 YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~ 351 (444)
T PHA03111 280 YIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLKDATYVFNEPIKACLNDFDFSQVA 351 (444)
T ss_pred HHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEECCeEEEeccchhhhhcccCHHHHc
Confidence 455677777655433422 22335999999999999832 2 13567888887653
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 241 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-29 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 6e-28 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 8e-27 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 6e-26 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-19 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-19 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-19 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-18 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-18 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-17 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-15 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-15 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-14 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-13 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-13 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-13 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-13 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-13 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-13 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-13 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-13 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-13 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-13 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-13 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-13 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-13 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-13 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-13 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-13 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-13 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-13 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-13 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-13 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-13 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-13 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-13 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-13 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-13 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-13 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-13 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-13 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-13 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-13 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-13 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 7e-13 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 7e-13 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 7e-13 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-13 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 7e-13 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 7e-13 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 7e-13 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 8e-13 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 8e-13 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 8e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-13 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-12 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-12 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-12 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-12 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-12 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-12 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-12 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-12 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-12 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-12 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-12 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-12 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-12 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-12 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-12 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-12 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-12 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-12 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-12 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 7e-12 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 7e-12 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-12 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 8e-12 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-11 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-11 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-11 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-11 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-11 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-11 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-11 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-11 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-11 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-11 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-11 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 6e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 6e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 6e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 6e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 6e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-11 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-11 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 7e-11 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-11 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 7e-11 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 7e-11 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 9e-11 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-10 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-10 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-10 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-10 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-10 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-10 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-10 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-10 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-10 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-10 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-10 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-10 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-10 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-10 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-10 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-10 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-10 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-10 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-10 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-10 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-10 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-10 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-10 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-10 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-10 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-10 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-10 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-10 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-10 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-10 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-10 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 6e-10 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-10 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 7e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 7e-10 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-10 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 8e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 8e-10 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 8e-10 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 8e-10 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 8e-10 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 9e-10 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 9e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 9e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 9e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 9e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 9e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 9e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-09 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-09 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-09 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-09 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-09 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-09 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-09 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-09 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-09 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-09 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-09 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-09 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-09 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-09 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-09 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-09 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-09 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-09 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-09 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-09 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-09 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-09 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-09 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-09 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-09 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-09 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-09 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-09 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-09 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-09 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-09 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-09 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-09 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-09 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-09 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-09 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-09 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-09 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-09 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-09 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-09 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 5e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-09 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-09 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 6e-09 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 6e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-09 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 7e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 7e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 7e-09 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 7e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 7e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 7e-09 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 7e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-09 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 8e-09 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 8e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 8e-09 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 8e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 8e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 8e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 9e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 9e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 9e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-08 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-08 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-08 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-08 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-08 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-08 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-08 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-08 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-08 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-08 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-08 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-08 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-08 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-08 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-08 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-08 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-08 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-08 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-08 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 6e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 6e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 7e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 9e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 9e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-07 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-07 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-07 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-07 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-07 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-07 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-07 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-07 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-07 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-07 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-07 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-07 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-07 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-07 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-07 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-07 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-07 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-07 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-07 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 4e-07 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-07 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 4e-07 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-07 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 5e-07 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-07 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-07 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-07 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-07 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-07 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-07 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-07 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-07 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 6e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 6e-07 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 8e-07 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 9e-07 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-07 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 9e-07 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-06 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-06 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-06 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-06 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-06 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-06 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-06 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-06 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-06 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-06 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-06 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-06 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-06 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-06 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-06 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-06 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-06 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-06 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-06 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-06 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-06 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-06 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-06 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-06 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-06 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-06 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-06 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-06 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-06 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-06 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-06 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-06 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-06 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-06 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-06 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-06 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-06 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-06 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-06 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 6e-06 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-06 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-06 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-06 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-06 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-06 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-06 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-06 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-06 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-06 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-06 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 7e-06 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-06 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 7e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 7e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 7e-06 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 7e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 7e-06 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 8e-06 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 8e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 8e-06 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-06 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 8e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 8e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 8e-06 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 9e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 9e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 9e-06 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 9e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-05 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-05 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-05 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-05 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-05 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-05 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-05 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-05 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-05 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-05 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-05 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-05 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-05 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-05 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-05 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-05 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-05 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-05 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-05 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-05 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-05 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-05 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-05 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-05 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-05 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-05 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-05 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-05 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-05 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-05 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-05 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-05 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-05 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-05 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-05 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-05 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-05 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-05 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-05 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-05 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-05 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-05 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-05 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-05 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-05 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-05 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-05 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-05 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-05 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-05 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 4e-05 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-05 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-05 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-05 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-05 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 5e-05 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-05 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-05 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-05 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 6e-05 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-05 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-05 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-05 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 6e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 7e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 7e-05 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 7e-05 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 8e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 8e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 8e-05 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-05 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 9e-05 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 9e-05 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 9e-05 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 9e-05 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 9e-05 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 9e-05 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-04 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-04 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-04 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-04 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-04 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-04 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-04 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-04 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-04 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-04 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-04 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-04 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-04 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-04 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-04 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-04 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-04 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-04 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-04 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-04 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-04 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-04 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-04 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-04 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-04 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-04 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-04 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-04 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-04 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-04 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-04 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-04 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-04 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-04 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-04 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-04 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-04 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-04 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-04 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-04 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-04 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-04 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-04 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-04 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-04 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-04 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-04 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-04 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-04 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-04 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-04 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-04 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-04 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-04 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-04 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-04 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-04 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-04 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-04 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-04 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-04 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-04 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-04 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-04 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-04 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-04 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-04 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-04 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-04 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-04 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-04 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-04 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-04 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-04 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-04 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-04 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-04 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-04 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-04 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-04 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-04 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-04 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-04 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-04 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-04 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-04 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-04 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-04 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-04 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 7e-04 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-04 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-04 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-04 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 8e-04 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 8e-04 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 8e-04 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 3e-72
Identities = 78/216 (36%), Positives = 114/216 (52%), Gaps = 12/216 (5%)
Query: 33 KQNGGSILRQELSKLQGRSSEKAKIFIEEEIKTVTNNYAD--VIGCGGSGNVYKGFLPDR 90
K + + + ++ +++ TNN+ +IG G G VYKG L D
Sbjct: 4 KYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG 63
Query: 91 TPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLF 150
VA+K+ I+EF E+ +S ++V L+ C E +L+Y+++ NG L
Sbjct: 64 AKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLK 123
Query: 151 EHIHKNGN----LTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKV 206
H++ + ++WE+RL I A L YLH+ IIHRDVKS NILLDEN+ PK+
Sbjct: 124 RHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKI 180
Query: 207 SDFGASKLVPIDAIQNY--TVVQGTLGYIDPEYLQT 240
+DFG SK + Q + TVV+GTLGYIDPEY
Sbjct: 181 TDFGISKKGT-ELDQTHLSTVVKGTLGYIDPEYFIK 215
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 2e-71
Identities = 76/193 (39%), Positives = 110/193 (56%), Gaps = 7/193 (3%)
Query: 55 AKIFIEEEIKTVTNNYAD--VIGCGGSGNVYKGFLPDRTPVAVKK-SKIVDQTKIDEFIN 111
K F E++ ++N+++ ++G GG G VYKG L D T VAVK+ + Q +F
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76
Query: 112 ELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIH----KNGNLTWERRLRI 167
E+ ++S RN++RL C+ LLVY ++ NG++ + L W +R RI
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 168 AAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQ 227
A +A L+YLH + IIHRDVK+ANILLDE + V DFG +KL+ T V+
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 196
Query: 228 GTLGYIDPEYLQT 240
GT+G+I PEYL T
Sbjct: 197 GTIGHIAPEYLST 209
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 203 bits (520), Expect = 3e-65
Identities = 69/204 (33%), Positives = 102/204 (50%), Gaps = 20/204 (9%)
Query: 51 SSEKAKIFIEEEIKTVTNN--------YADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVD 102
S + F E+K VTNN + +G GG G VYKG++ + T VAVKK +
Sbjct: 8 SDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMV 66
Query: 103 QTKI----DEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGN 158
+F E+ V+++ N+V LL + LVY ++ NG+L + +
Sbjct: 67 DITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG 126
Query: 159 ---LTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLV 215
L+W R +IA A +++LH IHRD+KSANILLDE +T K+SDFG ++
Sbjct: 127 TPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARAS 183
Query: 216 PIDAIQ-NYTVVQGTLGYIDPEYL 238
A + + GT Y+ PE L
Sbjct: 184 EKFAQTVMTSRIVGTTAYMAPEAL 207
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 1e-48
Identities = 49/191 (25%), Positives = 79/191 (41%), Gaps = 15/191 (7%)
Query: 62 EIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINR 121
+++ +V G G V+K L + VAVK I D+ + E+ + +
Sbjct: 20 YFQSMPLQLLEVKARGRFGCVWKAQLLNEY-VAVKIFPIQDKQS-WQNEYEVYSLPGMKH 77
Query: 122 RNVVRLLACCLETQVP----LLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSY 177
N+++ + L+ F G+L + + N ++W IA A L+Y
Sbjct: 78 ENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAY 136
Query: 178 LHSET-------NVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQ-GT 229
LH + I HRD+KS N+LL N T ++DFG + T Q GT
Sbjct: 137 LHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGT 196
Query: 230 LGYIDPEYLQT 240
Y+ PE L+
Sbjct: 197 RRYMAPEVLEG 207
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 4e-45
Identities = 55/172 (31%), Positives = 94/172 (54%), Gaps = 8/172 (4%)
Query: 73 VIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTK--IDEFINELVVVSQINRRNVVRLLAC 130
IG G G V++ + VAVK D ++EF+ E+ ++ ++ N+V +
Sbjct: 44 KIGAGSFGTVHRAEWHG-SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 131 CLETQVPLLVYEFVGNGTLFEHIHKNGN---LTWERRLRIAAETAGVLSYLHSETNVPII 187
+ +V E++ G+L+ +HK+G L RRL +A + A ++YLH+ N PI+
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIV 161
Query: 188 HRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
HR++KS N+L+D+ YT KV DFG S+L + + + GT ++ PE L+
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA-GTPEWMAPEVLR 212
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 4e-44
Identities = 50/173 (28%), Positives = 84/173 (48%), Gaps = 15/173 (8%)
Query: 72 DVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACC 131
+V+G G G V K VA+K+ I +++ FI EL +S++N N+V+L C
Sbjct: 14 EVVGRGAFGVVCKAKWRA-KDVAIKQ--IESESERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 132 LETQVPL-LVYEFVGNGTLFEHIHKNGN---LTWERRLRIAAETAGVLSYLHSETNVPII 187
L P+ LV E+ G+L+ +H T + + + ++YLHS +I
Sbjct: 71 LN---PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 188 HRDVKSANILLDENYT-PKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
HRD+K N+LL T K+ DFG + + + T +G+ ++ PE +
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTACDIQ----THMTNNKGSAAWMAPEVFE 176
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 6e-44
Identities = 52/179 (29%), Positives = 84/179 (46%), Gaps = 21/179 (11%)
Query: 72 DVIGCGGSGNVYKGFLPDR-TPVAVKK-------SKIVDQTKIDEFINELVVVSQINRRN 123
IG GG G V+KG L + VA+K + K EF E+ ++S +N N
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 124 VVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGN-LTWERRLRIAAETAGVLSYLHSET 182
+V+L P +V EFV G L+ + + + W +LR+ + A + Y+ ++
Sbjct: 85 IVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ- 141
Query: 183 NVPIIHRDVKSANILLDE-----NYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPE 236
N PI+HRD++S NI L KV+DFG S+ + + + G ++ PE
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV----HSVSGLLGNFQWMAPE 196
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 2e-42
Identities = 34/173 (19%), Positives = 71/173 (41%), Gaps = 14/173 (8%)
Query: 73 VIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQT--KIDEFINELVVVSQINRRNVVRLLAC 130
+ SG ++KG + VK K+ D + K +F E + + NV+ +L
Sbjct: 17 KLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75
Query: 131 CLETQVPLL--VYEFVGNGTLFEHIHKNGN--LTWERRLRIAAETAGVLSYLHSETNVPI 186
C P + ++ G+L+ +H+ N + + ++ A + A +++LH+ I
Sbjct: 76 CQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEP-LI 134
Query: 187 IHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
+ S ++++DE+ T ++S ++ PE LQ
Sbjct: 135 PRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAPAWVAPEALQ 181
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 7e-41
Identities = 56/187 (29%), Positives = 82/187 (43%), Gaps = 25/187 (13%)
Query: 73 VIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVV--VSQINRRNVVRLLAC 130
+IG G G VYKG L D PVAVK + FINE + V + N+ R +
Sbjct: 20 LIGRGRYGAVYKGSL-DERPVAVK---VFSFANRQNFINEKNIYRVPLMEHDNIARFIVG 75
Query: 131 CLETQVP-----LLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNV- 184
LLV E+ NG+L +++ + W R+A L+YLH+E
Sbjct: 76 DERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRG 134
Query: 185 -----PIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNY-------TVVQGTLGY 232
I HRD+ S N+L+ + T +SDFG S + + + GT+ Y
Sbjct: 135 DHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRY 194
Query: 233 IDPEYLQ 239
+ PE L+
Sbjct: 195 MAPEVLE 201
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-40
Identities = 50/179 (27%), Positives = 80/179 (44%), Gaps = 17/179 (9%)
Query: 73 VIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQT----KIDEFINELVVVSQINRRNVVRLL 128
+IG GG G VY+ F VAVK ++ I+ E + + + N++ L
Sbjct: 14 IIGIGGFGKVYRAFWIG-DEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 129 ACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIH 188
CL+ LV EF G L + + + + A + A ++YLH E VPIIH
Sbjct: 73 GVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMNYLHDEAIVPIIH 131
Query: 189 RDVKSANILLDE--------NYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
RD+KS+NIL+ + N K++DFG ++ G ++ PE ++
Sbjct: 132 RDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT---TKMSAAGAYAWMAPEVIR 187
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-40
Identities = 45/204 (22%), Positives = 84/204 (41%), Gaps = 14/204 (6%)
Query: 45 SKLQGRSSEKAKIFIEE-EIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQ 103
++ R + + IF++E +I ++IG G G VY G VA++ I
Sbjct: 11 ARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRW--HGEVAIRLIDIERD 68
Query: 104 TK--IDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGN-LT 160
+ + F E++ Q NVV + C+ ++ TL+ + L
Sbjct: 69 NEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLD 128
Query: 161 WERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAI 220
+ +IA E + YLH++ I+H+D+KS N+ D ++DFG + +
Sbjct: 129 VNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQA 184
Query: 221 QN----YTVVQGTLGYIDPEYLQT 240
+ G L ++ PE ++
Sbjct: 185 GRREDKLRIQNGWLCHLAPEIIRQ 208
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 3e-40
Identities = 49/171 (28%), Positives = 84/171 (49%), Gaps = 12/171 (7%)
Query: 74 IGCGGSGNVYKGFLPDRTPVAVKKSKI--VDQTKIDEFINELVVVSQINRRNVVRLLACC 131
IG G G VYKG VAVK + ++ F NE+ V+ + N++ +
Sbjct: 32 IGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 132 LETQVPL-LVYEFVGNGTLFEHIHKNGN-LTWERRLRIAAETAGVLSYLHSETNVPIIHR 189
T L +V ++ +L+ H+H + ++ + IA +TA + YLH++ IIHR
Sbjct: 90 --TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SIIHR 144
Query: 190 DVKSANILLDENYTPKVSDFGASKL-VPIDAIQNYTVVQGTLGYIDPEYLQ 239
D+KS NI L E+ T K+ DFG + + + G++ ++ PE ++
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 7e-38
Identities = 41/158 (25%), Positives = 73/158 (46%), Gaps = 5/158 (3%)
Query: 73 VIGCGGSGNVYKGFLPDRT-PVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACC 131
V+G G G K + + +K+ D+ F+ E+ V+ + NV++ +
Sbjct: 17 VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 132 LETQVPLLVYEFVGNGTLFEHIHKNGN-LTWERRLRIAAETAGVLSYLHSETNVPIIHRD 190
+ + + E++ GTL I + W +R+ A + A ++YLHS IIHRD
Sbjct: 77 YKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRD 133
Query: 191 VKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQG 228
+ S N L+ EN V+DFG ++L+ + Q +
Sbjct: 134 LNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSL 171
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-37
Identities = 53/218 (24%), Positives = 90/218 (41%), Gaps = 23/218 (10%)
Query: 37 GSILRQELSKLQGRSSEKAKIFIEEEIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVK 96
G LR + + Q S + + IG G G V+ G VAVK
Sbjct: 8 GESLRDLIEQSQSSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWRG-EKVAVK 66
Query: 97 KSKIVDQTKIDEFINELVVVSQINRR--NVVRLLACCLETQVP----LLVYEFVGNGTLF 150
+ T+ + E + + R N++ +A ++ L+ ++ NG+L+
Sbjct: 67 ---VFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLY 123
Query: 151 EHIHKNGNLTWERRLRIAAETAGVLSYLHSET-----NVPIIHRDVKSANILLDENYTPK 205
+++ L + L++A + L +LH+E I HRD+KS NIL+ +N T
Sbjct: 124 DYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC 182
Query: 206 VSDFGASKLV-----PIDAIQNYTVVQGTLGYIDPEYL 238
++D G + +D N V GT Y+ PE L
Sbjct: 183 IADLGLAVKFISDTNEVDIPPNTRV--GTKRYMPPEVL 218
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-36
Identities = 47/184 (25%), Positives = 79/184 (42%), Gaps = 23/184 (12%)
Query: 72 DVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRR--NVVRLLA 129
+ +G G G V++G VAVK I + E + + + R N++ +A
Sbjct: 14 ECVGKGRYGEVWRGSWQG-ENVAVK---IFSSRDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 130 CCLETQVP----LLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSET--- 182
+ ++ L+ + G+L++++ L LRI A L++LH E
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHIEIFGT 128
Query: 183 --NVPIIHRDVKSANILLDENYTPKVSDFGASKL-----VPIDAIQNYTVVQGTLGYIDP 235
I HRD+KS NIL+ +N ++D G + + +D N V GT Y+ P
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV--GTKRYMAP 186
Query: 236 EYLQ 239
E L
Sbjct: 187 EVLD 190
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-36
Identities = 55/219 (25%), Positives = 95/219 (43%), Gaps = 23/219 (10%)
Query: 36 GGSILRQELSKLQGRSSEKAKIFIEEEIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAV 95
G+ L+ + + S + + T + IG G G V++G VAV
Sbjct: 12 EGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEE-VAV 70
Query: 96 KKSKIVDQTKIDEFINELVV--VSQINRRNVVRLLACCLETQVP----LLVYEFVGNGTL 149
K I + + E + + N++ +A + LV ++ +G+L
Sbjct: 71 K---IFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSL 127
Query: 150 FEHIHKNGNLTWERRLRIAAETAGVLSYLHSET-----NVPIIHRDVKSANILLDENYTP 204
F+++++ +T E +++A TA L++LH E I HRD+KS NIL+ +N T
Sbjct: 128 FDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 186
Query: 205 KVSDFGASKLV-----PIDAIQNYTVVQGTLGYIDPEYL 238
++D G + ID N+ V GT Y+ PE L
Sbjct: 187 CIADLGLAVRHDSATDTIDIAPNHRV--GTKRYMAPEVL 223
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-28
Identities = 47/207 (22%), Positives = 79/207 (38%), Gaps = 12/207 (5%)
Query: 41 RQELSKLQGRSSEKAKIFIEEEIKTVTNNYADVIGCGGSGNVYKGF-LPDRTPVAVKKSK 99
++E ++ Q E + + IG G VYKG VA + +
Sbjct: 1 QEERNQQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQ 60
Query: 100 IVDQTK--IDEFINELVVVSQINRRNVVRLLACCLETQVP----LLVYEFVGNGTLFEHI 153
TK F E ++ + N+VR T +LV E + +GTL ++
Sbjct: 61 DRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL 120
Query: 154 HKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLD-ENYTPKVSDFGAS 212
+ + + + L +LH+ PIIHRD+K NI + + K+ D G +
Sbjct: 121 KRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179
Query: 213 KLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
L + V GT ++ PE +
Sbjct: 180 TLKRASFAKA---VIGTPEFMAPEMYE 203
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-28
Identities = 45/188 (23%), Positives = 87/188 (46%), Gaps = 18/188 (9%)
Query: 49 GRSSEKAKIFIEEEIKTVTNNYADVIGCGGSGNVYKGFLPD-----RTPVAVKKSKIVDQ 103
G A+IF E E++ + V+G G G V+KG + PV +K +
Sbjct: 1 GAMKVLARIFKETELRKL-----KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG 55
Query: 104 TK-IDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKN-GNLTW 161
+ + ++ + ++ ++VRLL C + + LV +++ G+L +H+ ++ G L
Sbjct: 56 RQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSL-QLVTQYLPLGSLLDHVRQHRGALGP 114
Query: 162 ERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ 221
+ L + A + YL E ++HR++ + N+LL +V+DFG + L+P D
Sbjct: 115 QLLLNWGVQIAKGMYYL-EEHG--MVHRNLAARNVLLKSPSQVQVADFGVADLLPPD--D 169
Query: 222 NYTVVQGT 229
+
Sbjct: 170 KQLLYSEA 177
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-28
Identities = 46/183 (25%), Positives = 88/183 (48%), Gaps = 18/183 (9%)
Query: 54 KAKIFIEEEIKTVTNNYADVIGCGGSGNVYKGFL-----PDRTPVAVKKSK-IVDQTKID 107
+I E E K + V+G G G VYKG + PVA+K+ +
Sbjct: 8 LLRILKETEFKKI-----KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK 62
Query: 108 EFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKN-GNLTWERRLR 166
E ++E V++ ++ +V RLL CL + V L+ + + G L +++ ++ N+ + L
Sbjct: 63 EILDEAYVMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGSQYLLN 121
Query: 167 IAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVV 226
+ A ++YL + ++HRD+ + N+L+ K++DFG +KL+ + +
Sbjct: 122 WCVQIAKGMNYL-EDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE--EKEYHA 176
Query: 227 QGT 229
+G
Sbjct: 177 EGG 179
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 5e-28
Identities = 42/160 (26%), Positives = 72/160 (45%), Gaps = 8/160 (5%)
Query: 72 DVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACC 131
+G G G V G + VA+K K DEFI E V+ ++ +V+L C
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 132 LETQVPLLVYEFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRD 190
+ + ++ E++ NG L ++ + ++ L + + + YL +HRD
Sbjct: 89 TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL-ESKQF--LHRD 145
Query: 191 VKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTL 230
+ + N L+++ KVSDFG S+ V D YT G+
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVGSK 182
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-28
Identities = 43/159 (27%), Positives = 70/159 (44%), Gaps = 8/159 (5%)
Query: 72 DVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACC 131
+G G G V G + VAVK K DEF E + +++ +V+ C
Sbjct: 14 KELGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 132 LETQVPLLVYEFVGNGTLFEHIHKNG-NLTWERRLRIAAETAGVLSYLHSETNVPIIHRD 190
+ +V E++ NG L ++ +G L + L + + +++L IHRD
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL-ESHQF--IHRD 129
Query: 191 VKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGT 229
+ + N L+D + KVSDFG ++ V D Y GT
Sbjct: 130 LAARNCLVDRDLCVKVSDFGMTRYVLDD---QYVSSVGT 165
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 8e-28
Identities = 48/161 (29%), Positives = 73/161 (45%), Gaps = 9/161 (5%)
Query: 72 DVIGCGGSGNVYKGFL-PDRTPVAVKKSK-IVDQTKIDEFINELVVVSQINRRNVVRLLA 129
+ IG G G V+ G L D T VAVK + + +F+ E ++ Q + N+VRL+
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 130 CCLETQVPLLVYEFVGNGTLFEHIHKNG-NLTWERRLRIAAETAGVLSYLHSETNVPIIH 188
C + Q +V E V G + G L + L++ + A + YL S+ IH
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK---CCIH 236
Query: 189 RDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGT 229
RD+ + N L+ E K+SDFG S+ Y G
Sbjct: 237 RDLAARNCLVTEKNVLKISDFGMSREEADG---VYAASGGL 274
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 9e-28
Identities = 45/162 (27%), Positives = 78/162 (48%), Gaps = 10/162 (6%)
Query: 73 VIGCGGSGNVYKGFLPDR---TPVAVK--KSKIVDQTKIDEFINELVVVSQINRRNVVRL 127
+G G G V KG+ + VAVK K++ D DE + E V+ Q++ +VR+
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 128 LACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPII 187
+ C +LV E G L +++ +N ++ + + + + + + YL E+N +
Sbjct: 84 IGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL-EESN--FV 139
Query: 188 HRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGT 229
HRD+ + N+LL + K+SDFG SK + D Y
Sbjct: 140 HRDLAARNVLLVTQHYAKISDFGLSKALRADE-NYYKAQTHG 180
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-27
Identities = 50/161 (31%), Positives = 86/161 (53%), Gaps = 12/161 (7%)
Query: 73 VIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCL 132
+G G G V+ G+ T VAVK K D F+ E ++ Q+ + +VRL A
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV- 77
Query: 133 ETQVPLL-VYEFVGNGTLFEHIHKNG--NLTWERRLRIAAETAGVLSYLHSETNVPIIHR 189
TQ P+ + E++ NG+L + + LT + L +AA+ A ++++ E N IHR
Sbjct: 78 -TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI-EERNY--IHR 133
Query: 190 DVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTL 230
D+++ANIL+ + + K++DFG ++L+ + YT +G
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDN---EYTAREGAK 171
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 2e-27
Identities = 51/159 (32%), Positives = 79/159 (49%), Gaps = 8/159 (5%)
Query: 72 DVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACC 131
IG G G V+ G+ ++ VA+K + ++FI E V+ +++ +V+L C
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 132 LETQVPLLVYEFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRD 190
LE LV EF+ +G L +++ G E L + + ++YL E V IHRD
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL-EEACV--IHRD 129
Query: 191 VKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGT 229
+ + N L+ EN KVSDFG ++ V D YT GT
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFVLDDQ---YTSSTGT 165
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-27
Identities = 50/160 (31%), Positives = 81/160 (50%), Gaps = 10/160 (6%)
Query: 73 VIGCGGSGNVYKGFLPDR-TPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACC 131
+G G G VY+G VAVK K D +++EF+ E V+ +I N+V+LL C
Sbjct: 20 KLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 132 LETQVPLLVYEFVGNGTLFEHIHKNG--NLTWERRLRIAAETAGVLSYLHSETNVPIIHR 189
++ EF+ G L +++ + ++ L +A + + + YL + N IHR
Sbjct: 79 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL-EKKNF--IHR 135
Query: 190 DVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGT 229
D+ + N L+ EN+ KV+DFG S+L+ D YT G
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAGA 172
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-27
Identities = 46/164 (28%), Positives = 80/164 (48%), Gaps = 10/164 (6%)
Query: 59 IEEEIKTVTNNYADVIGCGGSGNVYKGFLPDR----TPVAVKKSK-IVDQTKIDEFINEL 113
+ ++ ++ +VIG G G VY G L D AVK I D ++ +F+ E
Sbjct: 18 VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEG 77
Query: 114 VVVSQINRRNVVRLLACCLETQVPLL-VYEFVGNGTLFEHIHKNG-NLTWERRLRIAAET 171
+++ + NV+ LL CL ++ L V ++ +G L I N T + + +
Sbjct: 78 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 137
Query: 172 AGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLV 215
A + YL + +HRD+ + N +LDE +T KV+DFG ++ +
Sbjct: 138 AKGMKYL-ASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDM 178
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-27
Identities = 52/208 (25%), Positives = 83/208 (39%), Gaps = 14/208 (6%)
Query: 42 QELSKLQGRSSEKAKIFIEEEIKTVTNNYA--DVIGCGGSGNVYKGF-LPDRTPVAVKKS 98
Q + + K + N+ IG G VY+ L D PVA+KK
Sbjct: 6 QGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKV 65
Query: 99 KIVDQTKIDE---FINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHI-- 153
+I D I E+ ++ Q+N NV++ A +E +V E G L I
Sbjct: 66 QIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKH 125
Query: 154 -HKNGNLTWERR-LRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGA 211
K L ER + + L ++HS ++HRD+K AN+ + K+ D G
Sbjct: 126 FKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGL 182
Query: 212 SKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
+ +++V GT Y+ PE +
Sbjct: 183 GRFFSSKTTAAHSLV-GTPYYMSPERIH 209
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 9e-27
Identities = 39/161 (24%), Positives = 78/161 (48%), Gaps = 12/161 (7%)
Query: 72 DVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACC 131
+G G G V+ T VAVK K ++ F+ E V+ + +V+L A
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 132 LETQVPL-LVYEFVGNGTLFEHI--HKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIH 188
T+ P+ ++ EF+ G+L + + + + + +A+ A ++++ IH
Sbjct: 253 --TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIH 307
Query: 189 RDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGT 229
RD+++ANIL+ + K++DFG ++++ + YT +G
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGA 345
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-26
Identities = 42/150 (28%), Positives = 78/150 (52%), Gaps = 10/150 (6%)
Query: 73 VIGCGGSGNVYKGFLPDR----TPVAVKKSK-IVDQTKIDEFINELVVVSQINRRNVVRL 127
VIG G G VY G D+ A+K I + +++ F+ E +++ +N NV+ L
Sbjct: 28 VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 128 LACCLETQ-VPLLVYEFVGNGTLFEHIHKNG-NLTWERRLRIAAETAGVLSYLHSETNVP 185
+ L + +P ++ ++ +G L + I N T + + + A + YL +E
Sbjct: 88 IGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL-AEQK-- 144
Query: 186 IIHRDVKSANILLDENYTPKVSDFGASKLV 215
+HRD+ + N +LDE++T KV+DFG ++ +
Sbjct: 145 FVHRDLAARNCMLDESFTVKVADFGLARDI 174
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-26
Identities = 45/164 (27%), Positives = 80/164 (48%), Gaps = 10/164 (6%)
Query: 59 IEEEIKTVTNNYADVIGCGGSGNVYKGFLPDR----TPVAVKKSK-IVDQTKIDEFINEL 113
+ ++ ++ +VIG G G VY G L D AVK I D ++ +F+ E
Sbjct: 82 VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEG 141
Query: 114 VVVSQINRRNVVRLLACCLETQVPLL-VYEFVGNGTLFEHIHKN-GNLTWERRLRIAAET 171
+++ + NV+ LL CL ++ L V ++ +G L I N T + + +
Sbjct: 142 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 201
Query: 172 AGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLV 215
A + +L + +HRD+ + N +LDE +T KV+DFG ++ +
Sbjct: 202 AKGMKFL-ASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDM 242
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-26
Identities = 43/162 (26%), Positives = 78/162 (48%), Gaps = 21/162 (12%)
Query: 72 DVIGCGGSGNVYKGFLPDR----TPVAVK--KSKIVDQTKIDEFINELVVVSQINRRNVV 125
++G G G+V + L VAVK K+ I+ + I+EF+ E + + + +V
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 126 RLLACCLETQ------VPLLVYEFVGNGTLFEHI------HKNGNLTWERRLRIAAETAG 173
+L+ L ++ +P+++ F+ +G L + NL + +R + A
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 174 VLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLV 215
+ YL S N IHRD+ + N +L E+ T V+DFG S+ +
Sbjct: 149 GMEYL-SSRN--FIHRDLAARNCMLAEDMTVCVADFGLSRKI 187
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-26
Identities = 42/165 (25%), Positives = 82/165 (49%), Gaps = 13/165 (7%)
Query: 72 DVIGCGGSGNVYKGFLPD-----RTPVAVKKSK-IVDQTKIDEFINELVVVSQINRRNVV 125
V+G G G VYKG + PVA+K+ + E ++E V++ ++ +V
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 126 RLLACCLETQVPLLVYEFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNV 184
RLL CL + V L+ + + G L +++ ++ N+ + L + A ++YL +
Sbjct: 81 RLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL-EDRR- 137
Query: 185 PIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGT 229
++HRD+ + N+L+ K++DFG +KL+ + + +G
Sbjct: 138 -LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE--EKEYHAEGG 179
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-26
Identities = 45/161 (27%), Positives = 78/161 (48%), Gaps = 20/161 (12%)
Query: 72 DVIGCGGSGNVYKGFLPDR----TPVAVK--KSKIVDQTKIDEFINELVVVSQINRRNVV 125
++G G G+V +G L VAVK K Q +I+EF++E + + NV+
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 126 RLLACCLETQ-----VPLLVYEFVGNGTLFEHIHKN------GNLTWERRLRIAAETAGV 174
RLL C+E P+++ F+ G L ++ + ++ + L+ + A
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 175 LSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLV 215
+ YL S N +HRD+ + N +L ++ T V+DFG SK +
Sbjct: 160 MEYL-SNRN--FLHRDLAARNCMLRDDMTVCVADFGLSKKI 197
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-26
Identities = 46/189 (24%), Positives = 86/189 (45%), Gaps = 18/189 (9%)
Query: 48 QGRSSEKAKIFIEEEIKTVTNNYADVIGCGGSGNVYKGFLP-----DRTPVAVKKSKIVD 102
Q + + IF E +K Y +G G G+V VAVK+ +
Sbjct: 10 QLYACQDPTIFEERHLK-----YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG 64
Query: 103 QTKIDEFINELVVVSQINRRNVVRLLACCLETQV-PL-LVYEFVGNGTLFEHIHKN-GNL 159
+ +F E+ ++ ++ +V+ L LV E++ +G L + + ++ L
Sbjct: 65 PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARL 124
Query: 160 TWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDA 219
R L +++ + YL S +HRD+ + NIL++ K++DFG +KL+P+D
Sbjct: 125 DASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLD- 180
Query: 220 IQNYTVVQG 228
++Y VV+
Sbjct: 181 -KDYYVVRE 188
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-26
Identities = 48/161 (29%), Positives = 80/161 (49%), Gaps = 10/161 (6%)
Query: 72 DVIGCGGSGNVYKGFLPDR-TPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLAC 130
+G G G VY+G VAVK K D +++EF+ E V+ +I N+V+LL
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 131 CLETQVPLLVYEFVGNGTLFEHIHKNG--NLTWERRLRIAAETAGVLSYLHSETNVPIIH 188
C ++ EF+ G L +++ + ++ L +A + + + YL + IH
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIH 341
Query: 189 RDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGT 229
R++ + N L+ EN+ KV+DFG S+L+ D YT G
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMTGDT---YTAHAGA 379
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-26
Identities = 40/173 (23%), Positives = 72/173 (41%), Gaps = 9/173 (5%)
Query: 72 DVIGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTK--IDEFINELVVVSQINRRNVVRLL 128
IG G G D +K+ I + +E E+ V++ + N+V+
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 129 ACCLETQVPLLVYEFVGNGTLFEHI--HKNGNLTWERRLRIAAETAGVLSYLHSETNVPI 186
E +V ++ G LF+ I K ++ L + L ++H I
Sbjct: 90 ESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---I 146
Query: 187 IHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
+HRD+KS NI L ++ T ++ DFG ++++ + GT Y+ PE +
Sbjct: 147 LHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICE 198
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 9e-26
Identities = 54/196 (27%), Positives = 84/196 (42%), Gaps = 32/196 (16%)
Query: 72 DVIGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLAC 130
V+G G G V K D A+KK + + K+ ++E+++++ +N + VVR A
Sbjct: 12 AVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAA 70
Query: 131 CLETQVPL-------------LVYEFVGNGTLFEHIHKNGNLTWERR-LRIAAETAGVLS 176
LE + + + E+ NGTL++ IH R+ + LS
Sbjct: 71 WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALS 130
Query: 177 YLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQ--------- 227
Y+HS+ IIHRD+K NI +DE+ K+ DFG +K V Q
Sbjct: 131 YIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 228 ----GTLGYIDPEYLQ 239
GT Y+ E L
Sbjct: 188 TSAIGTAMYVATEVLD 203
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 9e-26
Identities = 43/183 (23%), Positives = 84/183 (45%), Gaps = 17/183 (9%)
Query: 55 AKIFIEEEIKTVTNNYADVIGCGGSGNVYKGF---LPDR--TPVAVKKSKIVDQTKIDEF 109
F E +K + +G G G+V L D VAVKK + + + +F
Sbjct: 4 PTQFEERHLK-----FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF 58
Query: 110 INELVVVSQINRRNVVRLLACCLETQV-PL-LVYEFVGNGTLFEHIHKN-GNLTWERRLR 166
E+ ++ + N+V+ C L L+ E++ G+L +++ K+ + + L+
Sbjct: 59 EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ 118
Query: 167 IAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVV 226
++ + YL ++ IHRD+ + NIL++ K+ DFG +K++P D + + V
Sbjct: 119 YTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EFFKVK 174
Query: 227 QGT 229
+
Sbjct: 175 EPG 177
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 9e-26
Identities = 42/181 (23%), Positives = 83/181 (45%), Gaps = 17/181 (9%)
Query: 57 IFIEEEIKTVTNNYADVIGCGGSGNVYKGFLP-----DRTPVAVKKSKIVDQTKIDEFIN 111
F E +K + +G G G+V VAVKK + + + +F
Sbjct: 37 QFEERHLK-----FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 91
Query: 112 ELVVVSQINRRNVVRLLACCLET-QVPL-LVYEFVGNGTLFEHIHKN-GNLTWERRLRIA 168
E+ ++ + N+V+ C + L L+ E++ G+L +++ K+ + + L+
Sbjct: 92 EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 151
Query: 169 AETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQG 228
++ + YL ++ IHRD+ + NIL++ K+ DFG +K++P D + Y V +
Sbjct: 152 SQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EYYKVKEP 207
Query: 229 T 229
Sbjct: 208 G 208
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-25
Identities = 42/188 (22%), Positives = 80/188 (42%), Gaps = 16/188 (8%)
Query: 61 EEIKTVTNNYA--DVIGCGGSGNVYKGFLPDRTPVAVK---KSKIVDQTKIDEFINELVV 115
+ + Y+ IG GGS V++ + A+K + D +D + NE+
Sbjct: 21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAY 79
Query: 116 VSQIN--RRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAG 173
++++ ++RL + Q +V E GN L + K ++ R
Sbjct: 80 LNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLE 138
Query: 174 VLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPID--AIQNYTVVQGTLG 231
+ +H I+H D+K AN L+ + K+ DFG + + D ++ + V GT+
Sbjct: 139 AVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV-GTVN 193
Query: 232 YIDPEYLQ 239
Y+ PE ++
Sbjct: 194 YMPPEAIK 201
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-25
Identities = 46/207 (22%), Positives = 84/207 (40%), Gaps = 16/207 (7%)
Query: 42 QELSKLQGRSSEKAKIFIEEEIKTVTNNYA--DVIGCGGSGNVYKGFLPDRTPVAVK--- 96
+ L +KA E I Y+ IG GGS V++ + A+K
Sbjct: 30 MDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVN 89
Query: 97 KSKIVDQTKIDEFINELVVVSQIN--RRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIH 154
+ D +D + NE+ ++++ ++RL + Q +V E GN L +
Sbjct: 90 LEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLK 147
Query: 155 KNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKL 214
K ++ R + +H I+H D+K AN L+ + K+ DFG +
Sbjct: 148 KKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQ 203
Query: 215 VPID--AIQNYTVVQGTLGYIDPEYLQ 239
+ D ++ + V G + Y+ PE ++
Sbjct: 204 MQPDTTSVVKDSQV-GAVNYMPPEAIK 229
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-25
Identities = 45/160 (28%), Positives = 79/160 (49%), Gaps = 10/160 (6%)
Query: 72 DVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACC 131
+G G G V+ G T VA+K K + F+ E V+ ++ +V+L A
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 132 LETQVPLLVYEFVGNGTLFEHIHKNG--NLTWERRLRIAAETAGVLSYLHSETNVPIIHR 189
E + +V E++ G+L + + L + + +AA+ A ++Y+ +HR
Sbjct: 249 SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 304
Query: 190 DVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGT 229
D+++ANIL+ EN KV+DFG ++L+ + YT QG
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGA 341
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 2e-25
Identities = 45/161 (27%), Positives = 79/161 (49%), Gaps = 10/161 (6%)
Query: 72 DVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACC 131
+G G G V+ G T VA+K K + F+ E V+ ++ +V+L A
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 132 LETQVPLLVYEFVGNGTLFEHIHKNG--NLTWERRLRIAAETAGVLSYLHSETNVPIIHR 189
E + +V E++ G+L + + L + + +AA+ A ++Y+ +HR
Sbjct: 332 SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 387
Query: 190 DVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTL 230
D+++ANIL+ EN KV+DFG ++L+ + YT QG
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAK 425
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-25
Identities = 45/195 (23%), Positives = 83/195 (42%), Gaps = 18/195 (9%)
Query: 44 LSKLQGRSSEKAKIFIEEEIKTVTNNYADVIGCGGSGNVYKGFLP-----DRTPVAVKKS 98
+S+ + + F + +K +G G G V VAVK
Sbjct: 4 VSEKKPATEVDPTHFEKRFLK-----RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL 58
Query: 99 KIVDQTK-IDEFINELVVVSQINRRNVVRLLACCLETQVP--LLVYEFVGNGTLFEHIHK 155
K I + E+ ++ + N+V+ C E L+ EF+ +G+L E++ K
Sbjct: 59 KPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK 118
Query: 156 N-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKL 214
N + +++L+ A + + YL S +HRD+ + N+L++ + K+ DFG +K
Sbjct: 119 NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 175
Query: 215 VPIDAIQNYTVVQGT 229
+ D + YTV
Sbjct: 176 IETD-KEYYTVKDDR 189
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-25
Identities = 47/189 (24%), Positives = 82/189 (43%), Gaps = 13/189 (6%)
Query: 49 GRSSEKAKIFIEEEIKTVTNNYADVIGCGGSGNVYKGFL----PDRTPVAVK--KSKIVD 102
G + E + I + +G G G V +G VAVK K ++
Sbjct: 1 GSAGEGPLQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS 60
Query: 103 QTK-IDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKN-GNLT 160
Q + +D+FI E+ + ++ RN++RL L + +V E G+L + + K+ G+
Sbjct: 61 QPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHFL 119
Query: 161 WERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAI 220
R A + A + YL IHRD+ + N+LL K+ DFG + +P +
Sbjct: 120 LGTLSRYAVQVAEGMGYL-ESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQND- 175
Query: 221 QNYTVVQGT 229
+Y + +
Sbjct: 176 DHYVMQEHR 184
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 2e-25
Identities = 48/170 (28%), Positives = 80/170 (47%), Gaps = 9/170 (5%)
Query: 72 DVIGCGGSGNVYKGF--LPDRTPVAVK--KSKIV-DQTKIDEFINELVVVSQINRRNVVR 126
D +G GG VY + + VA+K + + F E+ SQ++ +N+V
Sbjct: 17 DKLGGGGMSTVYLAEDTILNI-KVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 127 LLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPI 186
++ E LV E++ TL E+I +G L+ + + + + + H I
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR---I 132
Query: 187 IHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPE 236
+HRD+K NIL+D N T K+ DFG +K + ++ V GT+ Y PE
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE 182
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-25
Identities = 41/175 (23%), Positives = 76/175 (43%), Gaps = 14/175 (8%)
Query: 72 DVIGCGGSGNVYKGFLPDRTPVAVK---KSKIVDQTKIDEFINELVVVSQIN--RRNVVR 126
IG GGS V++ + A+K + D +D + NE+ ++++ ++R
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIR 73
Query: 127 LLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPI 186
L + Q +V E GN L + K ++ R + +H I
Sbjct: 74 LYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---I 129
Query: 187 IHRDVKSANILLDENYTPKVSDFGASKLVPID--AIQNYTVVQGTLGYIDPEYLQ 239
+H D+K AN L+ + K+ DFG + + D ++ + V GT+ Y+ PE ++
Sbjct: 130 VHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEAIK 182
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 3e-25
Identities = 42/178 (23%), Positives = 69/178 (38%), Gaps = 29/178 (16%)
Query: 72 DVIGCGGSGNVYKGF---LPDRTPVAVKKSKIV-----DQTKIDEFINELVVVSQINRRN 123
I GG G +Y + R PV +K D + E ++++ +
Sbjct: 86 GCIAHGGLGWIYLALDRNVNGR-PVVLK----GLVHSGDAEAQAMAMAERQFLAEVVHPS 140
Query: 124 VVRLL-----ACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYL 178
+V++ V +V E+VG +L L + E LSYL
Sbjct: 141 IVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--QKLPVAEAIAYLLEILPALSYL 198
Query: 179 HSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPE 236
HS + +++ D+K NI+L E K+ D GA I ++ + GT G+ PE
Sbjct: 199 HS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVS-----RINSFGYLYGTPGFQAPE 247
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 3e-25
Identities = 47/172 (27%), Positives = 79/172 (45%), Gaps = 12/172 (6%)
Query: 73 VIGCGGSGNVYKG-FLPDRTPVAVK---KSKIVDQTKIDEFINELVVVSQINRRNVVRLL 128
+G G GNVY + +A+K K+++ + E+ + S + N++RL
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75
Query: 129 ACCLETQVPL-LVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPII 187
+ L+ E+ GT++ + K +R E A LSY HS+ +I
Sbjct: 76 GY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VI 131
Query: 188 HRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
HRD+K N+LL K++DFG S P + + + GTL Y+ PE ++
Sbjct: 132 HRDIKPENLLLGSAGELKIADFGWSVHAP--SSRRTDLC-GTLDYLPPEMIE 180
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-25
Identities = 46/173 (26%), Positives = 69/173 (39%), Gaps = 11/173 (6%)
Query: 72 DVIGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKID--EFINELVVVSQINR-RNVVRL 127
+G G G V+K D AVK+S + D + E+ ++ + VRL
Sbjct: 63 SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRL 122
Query: 128 LACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLR-IAAETAGVLSYLHSETNVPI 186
E + L E G +L +H G E ++ +T L++LHS+ +
Sbjct: 123 EQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG---L 178
Query: 187 IHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
+H DVK ANI L K+ DFG + G Y+ PE LQ
Sbjct: 179 VHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGE-VQE-GDPRYMAPELLQ 229
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-25
Identities = 46/165 (27%), Positives = 81/165 (49%), Gaps = 12/165 (7%)
Query: 72 DVIGCGGSGNVYKGFLPDR----TPVAVK--KSKIVDQTKIDEFINELVVVSQINRRNVV 125
+IG G SG V G L PVA+K K+ ++ + D F++E ++ Q + N++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRD-FLSEASIMGQFDHPNII 113
Query: 126 RLLACCLETQVPLLVYEFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNV 184
RL ++ ++V E++ NG+L + + G T + + + + YL S+
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL-SDLGY 172
Query: 185 PIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGT 229
+HRD+ + N+L+D N KVSDFG S+++ D G
Sbjct: 173 --VHRDLAARNVLVDSNLVCKVSDFGLSRVLE-DDPDAAYTTTGG 214
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 4e-25
Identities = 42/180 (23%), Positives = 79/180 (43%), Gaps = 19/180 (10%)
Query: 57 IFIEEEIKTVTNNYADVIGCGGSGNVYKGFL-----PDRTPVAVKKSKIVDQTK-IDEFI 110
+F + +K +G G G V VAVK K + +
Sbjct: 27 VFHKRYLK-----KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWK 81
Query: 111 NELVVVSQINRRNVVRLLACCLETQVP--LLVYEFVGNGTLFEHIHKNGNLTWERRLRIA 168
E+ ++ + ++++ CC + LV E+V G+L +++ ++ ++ + L A
Sbjct: 82 QEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFA 140
Query: 169 AETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQG 228
+ ++YLH++ IHRD+ + N+LLD + K+ DFG +K VP Y V+
Sbjct: 141 QQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG--HEYYRVRE 195
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 5e-25
Identities = 47/166 (28%), Positives = 84/166 (50%), Gaps = 13/166 (7%)
Query: 72 DVIGCGGSGNVYKGFL-----PDRTPVAVK--KSKIVDQTKIDEFINELVVVSQINRRNV 124
VIG G G VYKG L PVA+K K+ ++ ++D F+ E ++ Q + N+
Sbjct: 50 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD-FLGEAGIMGQFSHHNI 108
Query: 125 VRLLACCLETQVPLLVYEFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETN 183
+RL + + +++ E++ NG L + + + G + + + + A + YL + N
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL-ANMN 167
Query: 184 VPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGT 229
+HRD+ + NIL++ N KVSDFG S+++ D + G
Sbjct: 168 Y--VHRDLAARNILVNSNLVCKVSDFGLSRVLE-DDPEATYTTSGG 210
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 8e-25
Identities = 52/192 (27%), Positives = 82/192 (42%), Gaps = 11/192 (5%)
Query: 51 SSEKAKIFIEEEIKTVTNNYADVIGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKIDEF 109
+ +E + + N V+G G G VY G L ++ +A+K+ D
Sbjct: 7 EGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPL 66
Query: 110 INELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHI-HKNGNLTWERRLRIA 168
E+ + + +N+V+ L E + E V G+L + K G L + I
Sbjct: 67 HEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQT-IG 125
Query: 169 AETAGVLS---YLHSETNVPIIHRDVKSANILLD-ENYTPKVSDFGASKLVPIDAIQNYT 224
T +L YLH I+HRD+K N+L++ + K+SDFG SK + T
Sbjct: 126 FYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET 182
Query: 225 VVQGTLGYIDPE 236
GTL Y+ PE
Sbjct: 183 FT-GTLQYMAPE 193
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 1e-24
Identities = 45/160 (28%), Positives = 79/160 (49%), Gaps = 11/160 (6%)
Query: 72 DVIGCGGSGNVYKGFLP----DRTPVAVK--KSKIVDQTKIDEFINELVVVSQINRRNVV 125
V+G G G V G L VA+K K ++ + D F+ E ++ Q + N++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD-FLGEASIMGQFDHPNII 109
Query: 126 RLLACCLETQVPLLVYEFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNV 184
RL +++ ++V E++ NG+L + K+ T + + + A + YL S+
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL-SDMGY 168
Query: 185 PIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYT 224
+HRD+ + NIL++ N KVSDFG +++ D YT
Sbjct: 169 --VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYT 206
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-24
Identities = 40/151 (26%), Positives = 72/151 (47%), Gaps = 9/151 (5%)
Query: 73 VIGCGGSGNVYKGFLP---DRTPVAVKKSKI-VDQTKIDEFINELVVVSQINRRNVVRLL 128
+GCG G+V +G + VA+K K ++ +E + E ++ Q++ +VRL+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 129 ACCLETQVPLLVYEFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPII 187
C + +LV E G G L + + + + + + + YL E N +
Sbjct: 403 GVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL-EEKN--FV 458
Query: 188 HRDVKSANILLDENYTPKVSDFGASKLVPID 218
HR++ + N+LL + K+SDFG SK + D
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGAD 489
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-24
Identities = 43/161 (26%), Positives = 74/161 (45%), Gaps = 10/161 (6%)
Query: 74 IGCGGSGNVYKGFL---PDRTPVAVKKSKI-VDQTKIDEFINELVVVSQINRRNVVRLLA 129
+GCG G+V +G + VA+K K ++ +E + E ++ Q++ +VRL+
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 130 CCLETQVPLLVYEFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIH 188
C + +LV E G G L + + + + + + + YL E N +H
Sbjct: 78 VCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL-EEKN--FVH 133
Query: 189 RDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGT 229
RD+ + N+LL + K+SDFG SK + D YT
Sbjct: 134 RDLAARNVLLVNRHYAKISDFGLSKALGADDSY-YTARSAG 173
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 1e-24
Identities = 47/181 (25%), Positives = 74/181 (40%), Gaps = 20/181 (11%)
Query: 73 VIGCGGSGNVYKG-FLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACC 131
+G GG V L D A+K+ +Q +E E + N N++RL+A C
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 132 LETQVP----LLVYEFVGNGTLFEHI----HKNGNLTWERRLRIAAETAGVLSYLHSETN 183
L + L+ F GTL+ I K LT ++ L + L +H++
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK-- 153
Query: 184 VPIIHRDVKSANILLDENYTPKVSDFGASKLVPID--------AIQNYTVVQGTLGYIDP 235
HRD+K NILL + P + D G+ I +Q++ + T+ Y P
Sbjct: 154 -GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 236 E 236
E
Sbjct: 213 E 213
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-24
Identities = 44/178 (24%), Positives = 73/178 (41%), Gaps = 12/178 (6%)
Query: 73 VIGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTK--IDEFINELVVVSQINRRNVVRLLA 129
IG G G K D + K+ T+ ++E+ ++ ++ N+VR
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 130 CCLETQVPLL--VYEFVGNGTLFEHI----HKNGNLTWERRLRIAAETAGVLSYLHS--E 181
++ L V E+ G L I + L E LR+ + L H +
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 182 TNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
++HRD+K AN+ LD K+ DFG ++++ D T V GT Y+ PE +
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQMN 189
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-24
Identities = 49/203 (24%), Positives = 83/203 (40%), Gaps = 11/203 (5%)
Query: 33 KQNGGSILRQELSKLQGRSSEKAKIFIEEEIKTVTN---NYADV--IGCGGSGNVYKGF- 86
+G + + L G + + + + IG G +G V
Sbjct: 7 HSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLARE 66
Query: 87 LPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGN 146
VAVK + Q + + NE+V++ NVV + L + ++ EF+
Sbjct: 67 KHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG 126
Query: 147 GTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKV 206
G L + I L E+ + L+YLH++ +IHRD+KS +ILL + K+
Sbjct: 127 GALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKL 182
Query: 207 SDFGASKLVPIDAIQNYTVVQGT 229
SDFG + D + ++V GT
Sbjct: 183 SDFGFCAQISKDVPKRKSLV-GT 204
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-24
Identities = 49/165 (29%), Positives = 85/165 (51%), Gaps = 8/165 (4%)
Query: 74 IGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCL 132
IG G SG VY + VA+++ + Q K + INE++V+ + N+V L L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 133 ETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVK 192
+V E++ G+L + + + + + E L +LHS +IHRD+K
Sbjct: 88 VGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIK 143
Query: 193 SANILLDENYTPKVSDFG-ASKLVPIDAIQNYTVVQGTLGYIDPE 236
S NILL + + K++DFG +++ P + ++ T+V GT ++ PE
Sbjct: 144 SDNILLGMDGSVKLTDFGFCAQITPEQSKRS-TMV-GTPYWMAPE 186
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-24
Identities = 43/145 (29%), Positives = 72/145 (49%), Gaps = 9/145 (6%)
Query: 72 DVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACC 131
IG G G+V G VAVK K + F+ E V++Q+ N+V+LL
Sbjct: 27 QTIGKGEFGDVMLGDYRG-NKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 132 LETQVPL-LVYEFVGNGTLFEHIHKNG--NLTWERRLRIAAETAGVLSYLHSETNVPIIH 188
+E + L +V E++ G+L +++ G L + L+ + + + YL +H
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVH 140
Query: 189 RDVKSANILLDENYTPKVSDFGASK 213
RD+ + N+L+ E+ KVSDFG +K
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTK 165
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 4e-24
Identities = 41/161 (25%), Positives = 76/161 (47%), Gaps = 22/161 (13%)
Query: 73 VIGCGGSGNVYKGFLPD------RTPVAVK--KSKIVDQTKIDEFINELVVVSQINRRNV 124
+G G G VY+G T VA+K + +I+ F+NE V+ + N +V
Sbjct: 32 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNEASVMKEFNCHHV 90
Query: 125 VRLLACCLETQVPLLVYEFVGNGTL----------FEHIHKNGNLTWERRLRIAAETAGV 174
VRLL + Q L++ E + G L + + + +++A E A
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 175 LSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLV 215
++YL++ +HRD+ + N ++ E++T K+ DFG ++ +
Sbjct: 151 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI 188
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 4e-24
Identities = 43/145 (29%), Positives = 72/145 (49%), Gaps = 9/145 (6%)
Query: 72 DVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACC 131
IG G G+V G VAVK K + F+ E V++Q+ N+V+LL
Sbjct: 199 QTIGKGEFGDVMLGDYRG-NKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 132 LETQVPL-LVYEFVGNGTLFEHIHKNG--NLTWERRLRIAAETAGVLSYLHSETNVPIIH 188
+E + L +V E++ G+L +++ G L + L+ + + + YL +H
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVH 312
Query: 189 RDVKSANILLDENYTPKVSDFGASK 213
RD+ + N+L+ E+ KVSDFG +K
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTK 337
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 5e-24
Identities = 49/217 (22%), Positives = 88/217 (40%), Gaps = 23/217 (10%)
Query: 35 NGGSILRQELSKLQGRSSEKAKIFIEEEIKTVTNNYAD---------VIGCGGSGNVYKG 85
S +L +L + + + + E++K V Y + +G G G V++
Sbjct: 18 KTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRM 77
Query: 86 F-LPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFV 144
AVKK ++ ELV + ++ +V L E + E +
Sbjct: 78 KDKQTGFQCAVKKVRLEVFRV-----EELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132
Query: 145 GNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTP 204
G+L + I + G L +R L + L YLH+ I+H DVK+ N+LL + +
Sbjct: 133 EGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSR 189
Query: 205 -KVSDFGASKLVPIDAIQNYTV----VQGTLGYIDPE 236
+ DFG + + D + + + GT ++ PE
Sbjct: 190 AALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 226
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 5e-24
Identities = 39/166 (23%), Positives = 75/166 (45%), Gaps = 15/166 (9%)
Query: 72 DVIGCGGSGNVYKGFL----PDRTPVAVK--KSKIVDQTKIDEFINELVVVSQINRRNVV 125
++G G G VY+G ++ VAVK K K ++F++E V++ ++ ++V
Sbjct: 18 RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK-EKFMSEAVIMKNLDHPHIV 76
Query: 126 RLLACCLETQVPLLVYEFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNV 184
+L+ E ++ E G L ++ +N +L + + + ++YL N
Sbjct: 77 KLIGIIEEEPT-WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL-ESINC 134
Query: 185 PIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTL 230
+HRD+ NIL+ K+ DFG S+ + + +Y T
Sbjct: 135 --VHRDIAVRNILVASPECVKLGDFGLSRYIEDE---DYYKASVTR 175
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 8e-24
Identities = 43/172 (25%), Positives = 71/172 (41%), Gaps = 12/172 (6%)
Query: 74 IGCGGSGNVYKGF-LPDRTPVAVK---KSKIVDQTKIDEFINELVVVSQINRRNVVRLLA 129
+G GG ++ + A K KS ++ + ++ E+ + + ++VV
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 130 CCLETQVPL-LVYEFVGNGTLFEHIHKNGNLT-WERRLRIAAETAGVLSYLHSETNVPII 187
E + +V E +L E + LT E R + YLH +I
Sbjct: 109 F-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLHRNR---VI 163
Query: 188 HRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
HRD+K N+ L+E+ K+ DFG + V D + + GT YI PE L
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVLS 214
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-23
Identities = 39/196 (19%), Positives = 79/196 (40%), Gaps = 31/196 (15%)
Query: 72 DVIGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTK-IDEFINELVVVSQINRRNVVRLLA 129
+G GG G V++ D A+K+ ++ ++ ++ + E+ ++++ +VR
Sbjct: 11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70
Query: 130 CCLE---------TQVPLLVY---EFVGNGTLFEHIHKNGNLTWERR---LRIAAETAGV 174
LE + + +Y + L + ++ + R L I + A
Sbjct: 71 AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEA 130
Query: 175 LSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQ------- 227
+ +LHS+ ++HRD+K +NI + KV DFG + D + +
Sbjct: 131 VEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187
Query: 228 ----GTLGYIDPEYLQ 239
GT Y+ PE +
Sbjct: 188 TGQVGTKLYMSPEQIH 203
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 1e-23
Identities = 41/171 (23%), Positives = 69/171 (40%), Gaps = 10/171 (5%)
Query: 74 IGCGGSGNVYKGF-LPDRTPVAVK---KSKIVDQTKIDEFINELVVVSQINRRNVVRLLA 129
+G GG ++ + A K KS ++ + ++ E+ + + ++VV
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 130 CCLETQVPL-LVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIH 188
E + +V E +L E + LT + YLH +IH
Sbjct: 83 F-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIH 138
Query: 189 RDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
RD+K N+ L+E+ K+ DFG + V D + + GT YI PE L
Sbjct: 139 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVLS 188
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-23
Identities = 37/165 (22%), Positives = 68/165 (41%), Gaps = 13/165 (7%)
Query: 72 DVIGCGGSGNVYKGFLPD----RTPVAVKKSKI-VDQTKIDEFINELVVVSQINRRNVVR 126
IG G G+V++G VA+K K + ++F+ E + + Q + ++V+
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 127 LLACCLETQVPLLVYEFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVP 185
L+ E V ++ E G L + +L + A + + L+YL
Sbjct: 81 LIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL-ESKR-- 136
Query: 186 IIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTL 230
+HRD+ + N+L+ N K+ DFG S+ + Y
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS---TYYKASKGK 178
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-23
Identities = 35/161 (21%), Positives = 77/161 (47%), Gaps = 8/161 (4%)
Query: 72 DVIGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLAC 130
+G G G VYK A K + + +++++I E+ +++ + +V+LL
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA 84
Query: 131 CLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLR-IAAETAGVLSYLHSETNVPIIHR 189
++ EF G + + + E +++ + + L++LHS+ IIHR
Sbjct: 85 YYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHR 141
Query: 190 DVKSANILLDENYTPKVSDFG-ASKLVPIDAIQNYTVVQGT 229
D+K+ N+L+ +++DFG ++K + ++ + + GT
Sbjct: 142 DLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRD-SFI-GT 180
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-23
Identities = 49/164 (29%), Positives = 73/164 (44%), Gaps = 26/164 (15%)
Query: 72 DVIGCGGSGNVYKGFL---PDRTPVAVK--KSKIVDQTKIDEFINELVVVSQINR-RNVV 125
DVIG G G V K + R A+K K D F EL V+ ++ N++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD-FAGELEVLCKLGHHPNII 89
Query: 126 RLLACCLETQVPLLVYEFVGNGTLFEHIHKN----------------GNLTWERRLRIAA 169
LL C L E+ +G L + + K+ L+ ++ L AA
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 170 ETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASK 213
+ A + YL S+ IHRD+ + NIL+ ENY K++DFG S+
Sbjct: 150 DVARGMDYL-SQKQ--FIHRDLAARNILVGENYVAKIADFGLSR 190
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 2e-23
Identities = 47/204 (23%), Positives = 83/204 (40%), Gaps = 14/204 (6%)
Query: 45 SKLQGRSSEKAKIFIEEEIKTVTNNYA--DVIGCGGSGNVYKGF-LPDRTPVAVK---KS 98
+ +F++ ++ Y V+G G G V AVK K
Sbjct: 3 GSMMDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKR 62
Query: 99 KIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGN 158
++ +T + + E+ ++ Q++ N+++L + LV E G LF+ I
Sbjct: 63 QVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR 122
Query: 159 LTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILL---DENYTPKVSDFGASKLV 215
+ RI + ++Y+H I+HRD+K N+LL ++ ++ DFG S
Sbjct: 123 FSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH- 178
Query: 216 PIDAIQNYTVVQGTLGYIDPEYLQ 239
+A + GT YI PE L
Sbjct: 179 -FEASKKMKDKIGTAYYIAPEVLH 201
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 2e-23
Identities = 47/172 (27%), Positives = 83/172 (48%), Gaps = 12/172 (6%)
Query: 73 VIGCGGSGNVYKG-FLPDRTPVAVK---KSKIVDQTKIDEFINELVVVSQINRRNVVRLL 128
+G G GNVY ++ +A+K KS++ + + E+ + S + N++R+
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 129 ACCLETQVPL-LVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPII 187
+ + L+ EF G L++ + K+G +R E A L Y H +I
Sbjct: 81 NY-FHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK---VI 136
Query: 188 HRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
HRD+K N+L+ K++DFG S P +++ T+ GTL Y+ PE ++
Sbjct: 137 HRDIKPENLLMGYKGELKIADFGWSVHAP--SLRRRTMC-GTLDYLPPEMIE 185
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 3e-23
Identities = 51/177 (28%), Positives = 83/177 (46%), Gaps = 17/177 (9%)
Query: 72 DVIGCGGSGNVYKGF--LPDRTPVAVK--KSKIV-DQTKIDEFINELVVVSQINRRNVVR 126
+++G GG V+ R VAVK ++ + D + F E + +N +V
Sbjct: 18 EILGFGGMSEVHLARDLRDHR-DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 127 LL----ACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSET 182
+ A +P +V E+V TL + +H G +T +R + + A+ L++ H
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG 136
Query: 183 NVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYT---VVQGTLGYIDPE 236
IIHRDVK ANI++ KV DFG ++ + D+ + T V GT Y+ PE
Sbjct: 137 ---IIHRDVKPANIMISATNAVKVMDFGIARAIA-DSGNSVTQTAAVIGTAQYLSPE 189
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 5e-23
Identities = 42/161 (26%), Positives = 72/161 (44%), Gaps = 22/161 (13%)
Query: 73 VIGCGGSGNVYKGFL------PDRTPVAVK--KSKIVDQTKIDEFINELVVVSQINRRNV 124
+G G G VY+G + P VAVK +Q ++D F+ E +++S+ N +N+
Sbjct: 37 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQNI 95
Query: 125 VRLLACCLETQVPLLVYEFVGNGTLFE-------HIHKNGNLTWERRLRIAAETAGVLSY 177
VR + L++ ++ E + G L + +L L +A + A Y
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 178 LHSETNVPIIHRDVKSANILLD---ENYTPKVSDFGASKLV 215
L E + IHRD+ + N LL K+ DFG ++ +
Sbjct: 156 L-EENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 193
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 6e-23
Identities = 37/151 (24%), Positives = 69/151 (45%), Gaps = 12/151 (7%)
Query: 72 DVIGCGGSGNVYKGFLPDR----TPVAVK--KSKIVDQTKIDEFINELVVVSQINRRNVV 125
IG G G+V++G VA+K K+ D + ++F+ E + + Q + ++V
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR-EKFLQEALTMRQFDHPHIV 454
Query: 126 RLLACCLETQVPLLVYEFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNV 184
+L+ E V ++ E G L + +L + A + + L+YL
Sbjct: 455 KLIGVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYL-ESKR- 511
Query: 185 PIIHRDVKSANILLDENYTPKVSDFGASKLV 215
+HRD+ + N+L+ N K+ DFG S+ +
Sbjct: 512 -FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 6e-23
Identities = 53/196 (27%), Positives = 87/196 (44%), Gaps = 19/196 (9%)
Query: 44 LSKLQGRSSEKAKIFIEEEIKTVTN---NYADV--IGCGGSGNVYKGF-LPDRTPVAVKK 97
L +Q R+ + ++ +E + + +G G G+VYK VA+K+
Sbjct: 2 LETVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQ 61
Query: 98 SKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNG 157
+ + E I E+ ++ Q + +VV+ + +V E+ G G++ + I
Sbjct: 62 VPVESD--LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN 119
Query: 158 NLTWERRLRIAA---ETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFG-ASK 213
E IA T L YLH IHRD+K+ NILL+ K++DFG A +
Sbjct: 120 KTLTEDE--IATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQ 174
Query: 214 LVPIDAIQNYTVVQGT 229
L A +N TV+ GT
Sbjct: 175 LTDTMAKRN-TVI-GT 188
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 9e-23
Identities = 38/164 (23%), Positives = 72/164 (43%), Gaps = 24/164 (14%)
Query: 73 VIGCGGSGNVYKGFL------PDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVR 126
+G G G V+ D+ VAVK K ++ +F E +++ + +++VR
Sbjct: 48 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 127 LLACCLETQVPLLVYEFVGNGTL---------------FEHIHKNGNLTWERRLRIAAET 171
C E + L+V+E++ +G L G L + L +A++
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 172 AGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLV 215
A + YL + + +HRD+ + N L+ + K+ DFG S+ +
Sbjct: 168 AAGMVYL-AGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDI 208
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 9e-23
Identities = 44/143 (30%), Positives = 73/143 (51%), Gaps = 6/143 (4%)
Query: 72 DVIGCGGSGNVYKGF-LPDRTPVAVKKSKI-VDQTKIDEFINELVVVSQINRRNVVRLLA 129
+ IG G G V+KG + VA+K + + +I++ E+ V+SQ + V +
Sbjct: 28 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87
Query: 130 CCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHR 189
L+ ++ E++G G+ + + G L + I E L YLHSE IHR
Sbjct: 88 SYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREILKGLDYLHSEK---KIHR 143
Query: 190 DVKSANILLDENYTPKVSDFGAS 212
D+K+AN+LL E+ K++DFG +
Sbjct: 144 DIKAANVLLSEHGEVKLADFGVA 166
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 1e-22
Identities = 42/161 (26%), Positives = 72/161 (44%), Gaps = 22/161 (13%)
Query: 73 VIGCGGSGNVYKGFL------PDRTPVAVK--KSKIVDQTKIDEFINELVVVSQINRRNV 124
+G G G VY+G + P VAVK +Q ++D F+ E +++S+ N +N+
Sbjct: 78 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQNI 136
Query: 125 VRLLACCLETQVPLLVYEFVGNGTLFE-------HIHKNGNLTWERRLRIAAETAGVLSY 177
VR + L++ ++ E + G L + +L L +A + A Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 178 LHSETNVPIIHRDVKSANILLD---ENYTPKVSDFGASKLV 215
L E + IHRD+ + N LL K+ DFG ++ +
Sbjct: 197 L-EENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 234
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 1e-22
Identities = 44/172 (25%), Positives = 74/172 (43%), Gaps = 11/172 (6%)
Query: 74 IGCGGSGNVYKGF-LPDRTPVAVK---KSKIVDQTKIDEFINELVVVSQINRRNVVRLLA 129
+G G VY+ + VA+K K + + NE+ + Q+ +++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 130 CCLETQVPL-LVYEFVGNGTLFEHIHKNGNLTWERRLR-IAAETAGVLSYLHSETNVPII 187
E + LV E NG + ++ E R + + YLHS I+
Sbjct: 79 Y-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---IL 134
Query: 188 HRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
HRD+ +N+LL N K++DFG + + + ++YT+ GT YI PE
Sbjct: 135 HRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC-GTPNYISPEIAT 185
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 2e-22
Identities = 43/181 (23%), Positives = 84/181 (46%), Gaps = 20/181 (11%)
Query: 72 DVIGCGGSGNVYKGF-LPDRTPVAVK---KSKIVDQTKIDEFINELVVVSQINRRNVVRL 127
D++G G + NV++G A+K + +D + E V+ ++N +N+V+L
Sbjct: 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKL 72
Query: 128 LAC--CLETQVPLLVYEFVGNGTLFEHIHKNGNLTW--ERRLR-IAAETAGVLSYLHSET 182
A T+ +L+ EF G+L+ + + N E + + G +++L
Sbjct: 73 FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG 132
Query: 183 NVPIIHRDVKSANILL----DENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYL 238
I+HR++K NI+ D K++DFGA++ + D ++ GT Y+ P+
Sbjct: 133 ---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV-SLY-GTEEYLHPDMY 187
Query: 239 Q 239
+
Sbjct: 188 E 188
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-22
Identities = 35/170 (20%), Positives = 68/170 (40%), Gaps = 31/170 (18%)
Query: 73 VIGCGGSGNVYKGFLPD--------RTPVAVK--KSKIVDQTKIDEFINELVVVSQINR- 121
+G G G V VAVK K ++ D ++E+ ++ I +
Sbjct: 42 PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMIGKH 100
Query: 122 RNVVRLLACCLETQVPLLVYEFVGNGTL----------------FEHIHKNGNLTWERRL 165
+N++ LL C + ++ E+ G L + +T++ +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 166 RIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLV 215
+ A + YL + IHRD+ + N+L+ EN K++DFG ++ +
Sbjct: 161 SCTYQLARGMEYL-ASQK--CIHRDLAARNVLVTENNVMKIADFGLARDI 207
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-22
Identities = 39/161 (24%), Positives = 69/161 (42%), Gaps = 20/161 (12%)
Query: 72 DVIGCGGSGNVYKGFL--------PDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRN 123
+ +G G ++KG T V +K + + F ++S+++ ++
Sbjct: 14 ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73
Query: 124 VVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGN-LTWERRLRIAAETAGVLSYLHSET 182
+V C+ +LV EFV G+L ++ KN N + +L +A + A + +L E
Sbjct: 74 LVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFL-EEN 132
Query: 183 NVPIIHRDVKSANILLDENYTP--------KVSDFGASKLV 215
+ IH +V + NILL K+SD G S V
Sbjct: 133 TL--IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV 171
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-22
Identities = 43/169 (25%), Positives = 63/169 (37%), Gaps = 30/169 (17%)
Query: 73 VIGCGGSGNVYKGFL------PDRTPVAVK--KSKIVDQTKIDEFINELVVVSQINR-RN 123
+G G G V + VAVK K ++EL ++ I N
Sbjct: 34 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA-LMSELKILIHIGHHLN 92
Query: 124 VVRLLACCLETQVPLLV-YEFVGNGTL----------------FEHIHKNGNLTWERRLR 166
VV LL C + PL+V EF G L LT E +
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 167 IAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLV 215
+ + A + +L + IHRD+ + NILL E K+ DFG ++ +
Sbjct: 153 YSFQVAKGMEFL-ASRK--CIHRDLAARNILLSEKNVVKICDFGLARDI 198
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 3e-22
Identities = 49/207 (23%), Positives = 84/207 (40%), Gaps = 15/207 (7%)
Query: 42 QELSKLQGRSSEKAKIFIEEEIKTVTNNYA--DVIGCGGSGNVYKGF-LPDRTPVAVK-- 96
+E QG +FI + ++ Y +G G G V A+K
Sbjct: 11 RENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKII 70
Query: 97 -KSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHK 155
K+ V + + + E+ V+ ++ N+++L + + LV E G LF+ I
Sbjct: 71 RKTS-VSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIH 129
Query: 156 NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILL---DENYTPKVSDFGAS 212
I + ++YLH I+HRD+K N+LL +++ K+ DFG S
Sbjct: 130 RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLS 186
Query: 213 KLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
+ + + GT YI PE L+
Sbjct: 187 AV--FENQKKMKERLGTAYYIAPEVLR 211
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 4e-22
Identities = 40/161 (24%), Positives = 64/161 (39%), Gaps = 27/161 (16%)
Query: 73 VIGCGGSGNVYKGFLPD------RTPVAVK--KSKIVDQTKIDEFINELVVVSQINR-RN 123
+G G G V + VAVK KS K ++EL ++S + + N
Sbjct: 53 TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEA-LMSELKIMSHLGQHEN 111
Query: 124 VVRLLACCLETQVPLLVYEFVGNGTL--------------FEHIHKNGNLTWERRLRIAA 169
+V LL C L++ E+ G L N + L ++
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 170 ETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFG 210
+ A +++L + N IHRDV + N+LL + K+ DFG
Sbjct: 172 QVAQGMAFL-ASKN--CIHRDVAARNVLLTNGHVAKIGDFG 209
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 6e-22
Identities = 38/164 (23%), Positives = 71/164 (43%), Gaps = 25/164 (15%)
Query: 74 IGCGGSGNVYKGFL------PDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRL 127
+G G G V+ D+ VAVK K +F E +++ + ++V+
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 128 LACCLETQVPLLVYEFVGNGTLFEHIHKN----------------GNLTWERRLRIAAET 171
C + ++V+E++ +G L + + + G L + L IA++
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 172 AGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLV 215
A + YL + + +HRD+ + N L+ N K+ DFG S+ V
Sbjct: 143 ASGMVYL-ASQH--FVHRDLATRNCLVGANLLVKIGDFGMSRDV 183
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 7e-22
Identities = 44/175 (25%), Positives = 68/175 (38%), Gaps = 36/175 (20%)
Query: 73 VIGCGGSGNVYKGFLPD------RTPVAVK--KSKIVDQTKIDEFINELVVVSQINRRNV 124
+G G G V K T VAVK K D ++E V+ Q+N +V
Sbjct: 30 TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRD-LLSEFNVLKQVNHPHV 88
Query: 125 VRLLACCLETQVPLLVYEFVGNGTL------------------------FEHIHKNGNLT 160
++L C + LL+ E+ G+L LT
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 161 WERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLV 215
+ A + + + YL +E ++HRD+ + NIL+ E K+SDFG S+ V
Sbjct: 149 MGDLISFAWQISQGMQYL-AEMK--LVHRDLAARNILVAEGRKMKISDFGLSRDV 200
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 7e-22
Identities = 43/186 (23%), Positives = 74/186 (39%), Gaps = 28/186 (15%)
Query: 73 VIGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACC 131
+IG GG G V+K D +K+ V ++ E+ +++++ N+V C
Sbjct: 18 LIGSGGFGQVFKAKHRIDGKTYVIKR---VKYNN-EKAEREVKALAKLDHVNIVHYNGCW 73
Query: 132 LETQVPL----------------LVYEFVGNGTLFEHI--HKNGNLTWERRLRIAAETAG 173
+ EF GTL + I + L L + +
Sbjct: 74 DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITK 133
Query: 174 VLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYI 233
+ Y+HS+ +I+RD+K +NI L + K+ DFG + D + GTL Y+
Sbjct: 134 GVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG-KRTRSK-GTLRYM 188
Query: 234 DPEYLQ 239
PE +
Sbjct: 189 SPEQIS 194
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 7e-22
Identities = 35/170 (20%), Positives = 69/170 (40%), Gaps = 31/170 (18%)
Query: 73 VIGCGGSGNVYKGFL--------PDRTPVAVK--KSKIVDQTKIDEFINELVVVSQINR- 121
+G G G V + VAVK K ++ D ++E+ ++ I +
Sbjct: 88 PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMIGKH 146
Query: 122 RNVVRLLACCLETQVPLLVYEFVGNGTL----------------FEHIHKNGNLTWERRL 165
+N++ LL C + ++ E+ G L + +T++ +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 166 RIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLV 215
+ A + YL + IHRD+ + N+L+ EN K++DFG ++ +
Sbjct: 207 SCTYQLARGMEYL-ASQK--CIHRDLAARNVLVTENNVMKIADFGLARDI 253
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 7e-22
Identities = 38/170 (22%), Positives = 64/170 (37%), Gaps = 9/170 (5%)
Query: 72 DVIGCGGSGNVYKGF--LPDRTPVAVK--KSKIV-DQTKIDEFINELVVVSQINRRNVVR 126
++G GG G+VY+ + +R VA+K + D E ++ +VV
Sbjct: 40 RLVGRGGMGDVYEAEDTVRER-IVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 127 LLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPI 186
+ + + L + + G L R + I + L H+
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG---A 155
Query: 187 IHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPE 236
HRDVK NIL+ + + DFG + + + GTL Y+ PE
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPE 205
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 8e-22
Identities = 43/181 (23%), Positives = 84/181 (46%), Gaps = 20/181 (11%)
Query: 72 DVIGCGGSGNVYKGF-LPDRTPVAVK---KSKIVDQTKIDEFINELVVVSQINRRNVVRL 127
D++G G + NV++G A+K + +D + E V+ ++N +N+V+L
Sbjct: 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKL 72
Query: 128 LAC--CLETQVPLLVYEFVGNGTLFEHIHKNGNLTW--ERRLR-IAAETAGVLSYLHSET 182
A T+ +L+ EF G+L+ + + N E + + G +++L
Sbjct: 73 FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG 132
Query: 183 NVPIIHRDVKSANILL----DENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYL 238
I+HR++K NI+ D K++DFGA++ + D ++ GT Y+ P+
Sbjct: 133 ---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV-SLY-GTEEYLHPDMY 187
Query: 239 Q 239
+
Sbjct: 188 E 188
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 91.6 bits (227), Expect = 9e-22
Identities = 30/205 (14%), Positives = 58/205 (28%), Gaps = 45/205 (21%)
Query: 72 DVIGCGGSGNVYKGF-LPDRTPVAVK--------KSKIVDQTK----------------- 105
V+G + V S + Q K
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 106 ---IDEFINELVVVSQINRRNVVRLLACCLETQVP---LLVYEFVGN-----GTLFEHIH 154
FI +V ++ ++R+ + V L N L H
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 155 KNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKL 214
+ +L RL++ + +L+ LH ++H ++ +I+LD+ ++ F
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV- 254
Query: 215 VPIDAIQNYTVVQGTLGYIDPEYLQ 239
V + G+ PE
Sbjct: 255 ----RDGARVVSSVSRGFEPPELEA 275
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-21
Identities = 38/167 (22%), Positives = 70/167 (41%), Gaps = 28/167 (16%)
Query: 73 VIGCGGSGNVYKGFL------PDRTPVAVK--KSKIVDQTKIDEFINELVVVSQINRRNV 124
+G G VYKG L VA+K K K + + F +E ++ +++ NV
Sbjct: 16 ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREE-FRHEAMLRARLQHPNV 74
Query: 125 VRLLACCLETQVPLLVYEFVGNGTLFEHIHKN----------------GNLTWERRLRIA 168
V LL + Q +++ + +G L E + L + +
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 169 AETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLV 215
A+ A + YL S + ++H+D+ + N+L+ + K+SD G + V
Sbjct: 135 AQIAAGMEYL-SSHH--VVHKDLATRNVLVYDKLNVKISDLGLFREV 178
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 1e-21
Identities = 38/170 (22%), Positives = 70/170 (41%), Gaps = 31/170 (18%)
Query: 73 VIGCGGSGNVYKGFLPD--------RTPVAVK--KSKIVDQTKIDEFINELVVVSQINR- 121
+G G G V T VAVK KS ++ D I+E+ ++ I +
Sbjct: 76 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD-LISEMEMMKMIGKH 134
Query: 122 RNVVRLLACCLETQVPLLVYEFVGNGTL----------------FEHIHKNGNLTWERRL 165
+N++ LL C + ++ E+ G L + L+ + +
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 166 RIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLV 215
A + A + YL + IHRD+ + N+L+ E+ K++DFG ++ +
Sbjct: 195 SCAYQVARGMEYL-ASKK--CIHRDLAARNVLVTEDNVMKIADFGLARDI 241
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-21
Identities = 40/170 (23%), Positives = 63/170 (37%), Gaps = 31/170 (18%)
Query: 73 VIGCGGSGNVYKGFLPD------RTPVAVK--KSKIVDQTKIDEFINELVVVSQINR-RN 123
+G G G V + VAVK K + ++EL V+S + N
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA-LMSELKVLSYLGNHMN 88
Query: 124 VVRLLACCLETQVPLLVYEFVGNGTL------------------FEHIHKNGNLTWERRL 165
+V LL C L++ E+ G L L E L
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 166 RIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLV 215
+ + A +++L + N IHRD+ + NILL K+ DFG ++ +
Sbjct: 149 SFSYQVAKGMAFL-ASKN--CIHRDLAARNILLTHGRITKICDFGLARDI 195
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-21
Identities = 46/155 (29%), Positives = 72/155 (46%), Gaps = 21/155 (13%)
Query: 72 DVIGCGGSGNVYKGF-LPDRTPVAVKKSKIVD----QTKIDEFINELVVVSQINRRNVVR 126
+VIG G + V + P + VA+K ++ QT +DE + E+ +SQ + N+V
Sbjct: 21 EVIGSGATAVVQAAYCAPKKEKVAIK---RINLEKCQTSMDELLKEIQAMSQCHHPNIVS 77
Query: 127 LLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLR------IAA---ETAGVLSY 177
+ LV + + G++ I K+ E + IA E L Y
Sbjct: 78 YYTSFVVKDELWLVMKLLSGGSVL-DIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 136
Query: 178 LHSETNVPIIHRDVKSANILLDENYTPKVSDFGAS 212
LH IHRDVK+ NILL E+ + +++DFG S
Sbjct: 137 LHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS 168
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 2e-21
Identities = 48/206 (23%), Positives = 79/206 (38%), Gaps = 20/206 (9%)
Query: 47 LQGRSSEKAKIFIEEEIKTVTNNY----ADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVD 102
+ S + EE + DV+G G G + + D VAVK +
Sbjct: 1 MGSSPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVK---RIL 57
Query: 103 QTKIDEFINELVVVSQINR-RNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTW 161
E+ ++ + + NV+R + Q + E TL E++ +
Sbjct: 58 PECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHL 116
Query: 162 ERRLR-IAAETAGVLSYLHSETNVPIIHRDVKSANILLDE-----NYTPKVSDFGASKLV 215
+ +T L++LHS I+HRD+K NIL+ +SDFG K +
Sbjct: 117 GLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173
Query: 216 PID--AIQNYTVVQGTLGYIDPEYLQ 239
+ + + V GT G+I PE L
Sbjct: 174 AVGRHSFSRRSGVPGTEGWIAPEMLS 199
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 90.0 bits (223), Expect = 3e-21
Identities = 40/228 (17%), Positives = 71/228 (31%), Gaps = 31/228 (13%)
Query: 40 LRQELSKLQGRSSEKAK---IFIEEEIKTVTNNYA--DVIGCGGSGNVYKGFLPDRTPVA 94
L + +S + K I + E + + ++G G VY+ D
Sbjct: 34 LSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAK 93
Query: 95 VKKS---KIVDQTKIDEF---INELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGT 148
K+ K+ EF + + + ++ + L +LV E GT
Sbjct: 94 NKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGT 153
Query: 149 LFEHIHKNGNLTWER-----RLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYT 203
L I+ N + + A ++ +H IIH D+K N +L +
Sbjct: 154 LLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFL 210
Query: 204 P-----------KVSDFGASK-LVPIDAIQNYTVVQGTLGYIDPEYLQ 239
+ D G S + +T T G+ E L
Sbjct: 211 EQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLS 258
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 90.1 bits (223), Expect = 4e-21
Identities = 24/204 (11%), Positives = 55/204 (26%), Gaps = 45/204 (22%)
Query: 72 DVIGCGGSGNVYKGF-LPDRTPVAVK---KSKIVDQTKIDEFINE--------------- 112
V+G + V ++ I + E
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 113 -------LVVVSQINRRNVVRLLACCLETQVPLLVYEFV-----------GNGTLFEHIH 154
+ + +++ L+ + ++ F L H
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 155 KNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKL 214
+ +L RL++ + +L+ LH ++H ++ +I+LD+ ++ F
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV- 259
Query: 215 VPIDAIQNYTVVQGTLGYIDPEYL 238
V G+ PE
Sbjct: 260 ----RDGASAVSPIGRGFAPPETT 279
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 6e-21
Identities = 40/175 (22%), Positives = 67/175 (38%), Gaps = 36/175 (20%)
Query: 73 VIGCGGSGNVYKGFLPD------RTPVAVK--KSKIVDQTKIDEFINELVVVSQINR-RN 123
V+G G G V VAVK K K + ++EL +++Q+ N
Sbjct: 52 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREA-LMSELKMMTQLGSHEN 110
Query: 124 VVRLLACCLETQVPLLVYEFVGNGTL-----------------------FEHIHKNGNLT 160
+V LL C + L++E+ G L E LT
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 161 WERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLV 215
+E L A + A + +L + +HRD+ + N+L+ K+ DFG ++ +
Sbjct: 171 FEDLLCFAYQVAKGMEFL-EFKS--CVHRDLAARNVLVTHGKVVKICDFGLARDI 222
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 6e-21
Identities = 43/192 (22%), Positives = 74/192 (38%), Gaps = 31/192 (16%)
Query: 73 VIGCGGSGNVY----------------KGFLPDRTPVAVKKSKIVDQTKIDEFINELVVV 116
+ G + R KI ++K D+F NEL ++
Sbjct: 38 TLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 117 SQINRRNVVRLLACCLETQVPL-LVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGV- 174
+ I + + + ++YE++ N ++ + L I +
Sbjct: 98 TDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 175 -------LSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQ 227
SY+H+E N I HRDVK +NIL+D+N K+SDFG S+ + I+
Sbjct: 157 IKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK--GSR- 211
Query: 228 GTLGYIDPEYLQ 239
GT ++ PE+
Sbjct: 212 GTYEFMPPEFFS 223
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 7e-21
Identities = 39/145 (26%), Positives = 60/145 (41%), Gaps = 7/145 (4%)
Query: 72 DVIGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKIDEF---INELVVVSQINRRNVVRL 127
IG G G VY + + VA+KK + +++ I E+ + ++ N ++
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 128 LACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPII 187
C L LV E+ L + L+YLHS +I
Sbjct: 120 RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MI 176
Query: 188 HRDVKSANILLDENYTPKVSDFGAS 212
HRDVK+ NILL E K+ DFG++
Sbjct: 177 HRDVKAGNILLSEPGLVKLGDFGSA 201
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 89.2 bits (221), Expect = 1e-20
Identities = 53/176 (30%), Positives = 86/176 (48%), Gaps = 17/176 (9%)
Query: 73 VIGCGGSGNVYKGFLPDRTPV-AVK---KSKIVDQTKIDEFINE---LVVVSQINRRNVV 125
+IG GG G VY D + A+K K +I + +NE L +VS + +V
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255
Query: 126 RLLACCLETQVPL-LVYEFVGNGTLFEHIHKNGNLTWERRLRI-AAETAGVLSYLHSETN 183
+ + T L + + + G L H+ ++G + E +R AAE L ++H+
Sbjct: 256 CM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS-EADMRFYAAEIILGLEHMHNRF- 312
Query: 184 VPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
+++RD+K ANILLDE+ ++SD G + + + V GT GY+ PE LQ
Sbjct: 313 --VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASV-GTHGYMAPEVLQ 363
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 2e-20
Identities = 45/175 (25%), Positives = 74/175 (42%), Gaps = 36/175 (20%)
Query: 73 VIGCGGSGNVYKGFLPD------RTPVAVK--KSKIVDQTKIDEFINELVVVSQINRRNV 124
IG G G V++ P T VAVK K + + D F E ++++ + N+
Sbjct: 54 DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD-FQREAALMAEFDNPNI 112
Query: 125 VRLLACCLETQVPLLVYEFVGNGTL------------------------FEHIHKNGNLT 160
V+LL C + L++E++ G L L+
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 161 WERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLV 215
+L IA + A ++YL SE +HRD+ + N L+ EN K++DFG S+ +
Sbjct: 173 CAEQLCIARQVAAGMAYL-SERK--FVHRDLATRNCLVGENMVVKIADFGLSRNI 224
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 2e-20
Identities = 53/210 (25%), Positives = 95/210 (45%), Gaps = 14/210 (6%)
Query: 37 GSILRQELSKLQGRSSEKAKIFIEEEIKTVTNN---YADVIGCGGSGNVYKGFL-PDRTP 92
G L + Q R +A + ++++ + ++ +G G G V+K P
Sbjct: 1 GKKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLV 60
Query: 93 VAVKKSKI-VDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFE 151
+A K + + ++ I EL V+ + N +V + E + G+L +
Sbjct: 61 MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-D 119
Query: 152 HIHKNGNLTWERRL-RIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFG 210
+ K E+ L +++ L+YL + I+HRDVK +NIL++ K+ DFG
Sbjct: 120 QVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFG 177
Query: 211 AS-KLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
S +L+ D++ N + V GT Y+ PE LQ
Sbjct: 178 VSGQLI--DSMAN-SFV-GTRSYMSPERLQ 203
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 5e-20
Identities = 55/221 (24%), Positives = 87/221 (39%), Gaps = 29/221 (13%)
Query: 40 LRQELSKLQGRSSEKAKIFIE------EEIKTVTNNYAD-----VIGCGGSGNVY----K 84
+ QEL + + F++ +K V D VIG G V K
Sbjct: 24 VHQELGASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMK 83
Query: 85 GFLPDRTPVAVK---KSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPL-LV 140
A+K K ++ + ++ F E V+ +RR + +L + + L LV
Sbjct: 84 Q---TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL-HFAFQDENYLYLV 139
Query: 141 YEFVGNGTLFEHIHKNGNLTWERRLRI-AAETAGVLSYLHSETNVPIIHRDVKSANILLD 199
E+ G L + K G R AE + +H +HRD+K NILLD
Sbjct: 140 MEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLD 196
Query: 200 ENYTPKVSDFGASK-LVPIDAIQNYTVVQGTLGYIDPEYLQ 239
+++DFG+ L +++ V GT Y+ PE LQ
Sbjct: 197 RCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQ 236
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 6e-20
Identities = 47/189 (24%), Positives = 78/189 (41%), Gaps = 23/189 (12%)
Query: 64 KTVTNNYA--DVIGCGGSGNVYKGF-LPDRTPVAVK---KSKIVDQTKIDEFINELVVVS 117
T Y ++G G G V K + AVK K+ ++ + E+ ++
Sbjct: 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLK 76
Query: 118 QINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAET----AG 173
+++ N+++L ++ +V E G LF+ I K + E AA
Sbjct: 77 KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFS-EHD---AARIIKQVFS 132
Query: 174 VLSYLHSETNVPIIHRDVKSANILL---DENYTPKVSDFGASKLVPIDAIQNYTVVQGTL 230
++Y+H I+HRD+K NILL +++ K+ DFG S GT
Sbjct: 133 GITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC--FQQNTKMKDRIGTA 187
Query: 231 GYIDPEYLQ 239
YI PE L+
Sbjct: 188 YYIAPEVLR 196
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 87.0 bits (215), Expect = 7e-20
Identities = 46/182 (25%), Positives = 80/182 (43%), Gaps = 19/182 (10%)
Query: 72 DVIGCGGSGNVYKGF-LPDRTPVAVKK-SKIVDQTKIDEFINELVVVSQINRRNVVRLLA 129
+ +G GG G V + VA+K+ + + + + E+ ++ ++N NVV
Sbjct: 20 ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE 79
Query: 130 C------CLETQVPLLVYEFVGNGTLFEHIHKNGN---LTWERRLRIAAETAGVLSYLHS 180
+PLL E+ G L +++++ N L + ++ + L YLH
Sbjct: 80 VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE 139
Query: 181 ETNVPIIHRDVKSANILLD---ENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEY 237
IIHRD+K NI+L + K+ D G +K + + T GTL Y+ PE
Sbjct: 140 NR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG--ELCTEFVGTLQYLAPEL 194
Query: 238 LQ 239
L+
Sbjct: 195 LE 196
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 7e-20
Identities = 32/151 (21%), Positives = 54/151 (35%), Gaps = 16/151 (10%)
Query: 72 DVIGCGGS--GNVYKGF-LPDRTPVAVKKSKIVDQTK--IDEFINELVVVSQINRRNVVR 126
VIG G V P V V++ + + + EL V N N+V
Sbjct: 31 TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVP 90
Query: 127 LLACCLETQVPLLVYEFVGNGTLFE--HIHKNGNLTWERRLRIAA---ETAGVLSYLHSE 181
A + +V F+ G+ + H + E IA L Y+H
Sbjct: 91 YRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMN-ELA--IAYILQGVLKALDYIHHM 147
Query: 182 TNVPIIHRDVKSANILLDENYTPKVSDFGAS 212
+HR VK+++IL+ + +S ++
Sbjct: 148 G---YVHRSVKASHILISVDGKVYLSGLRSN 175
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 8e-20
Identities = 45/152 (29%), Positives = 69/152 (45%), Gaps = 16/152 (10%)
Query: 72 DVIGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINR-RNVVRLLA 129
+++G G G VYKG + A+K V + +E E+ ++ + + RN+
Sbjct: 30 ELVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTGDEEEEIKQEINMLKKYSHHRNIATYYG 88
Query: 130 CCLETQVPL------LVYEFVGNGTLFE--HIHKNGNLTWERRLR-IAAETAGVLSYLHS 180
++ P LV EF G G++ + K L E + I E LS+LH
Sbjct: 89 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLK-EEWIAYICREILRGLSHLHQ 147
Query: 181 ETNVPIIHRDVKSANILLDENYTPKVSDFGAS 212
+IHRD+K N+LL EN K+ DFG S
Sbjct: 148 HK---VIHRDIKGQNVLLTENAEVKLVDFGVS 176
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 1e-19
Identities = 50/206 (24%), Positives = 79/206 (38%), Gaps = 32/206 (15%)
Query: 57 IFIEEEIKTVTNNYA--DVIGCGGSGNVYKGF-LPDRTPVAVK---KSKIVD-------- 102
+++ ++ + +Y +G G G V + A+K KS+
Sbjct: 25 MYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNK 84
Query: 103 --QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLT 160
+ +E NE+ ++ ++ N+++L + + LV EF G LFE I
Sbjct: 85 NIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFD 144
Query: 161 WERRLRIAAET----AGVLSYLHSETNVPIIHRDVKSANILL---DENYTPKVSDFGASK 213
E AA + YLH I+HRD+K NILL + K+ DFG S
Sbjct: 145 -ECD---AANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSS 197
Query: 214 LVPIDAIQNYTVVQGTLGYIDPEYLQ 239
GT YI PE L+
Sbjct: 198 F--FSKDYKLRDRLGTAYYIAPEVLK 221
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-19
Identities = 42/187 (22%), Positives = 79/187 (42%), Gaps = 24/187 (12%)
Query: 73 VIGCGGSGNVYKG-FLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINR-RNVVRLLAC 130
V+ GG VY+ + A+K+ ++ K I E+ + +++ N+V+ +
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 131 CLETQVP-------LLVYEFVGNGTLFEHIHK---NGNLTWERRLRIAAETAGVLSYLHS 180
+ L+ + G L E + K G L+ + L+I +T + ++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 181 ETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQ-----------GT 229
+ PIIHRD+K N+LL T K+ DFG++ + +++ + T
Sbjct: 155 Q-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 230 LGYIDPE 236
Y PE
Sbjct: 214 PMYRTPE 220
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 2e-19
Identities = 46/176 (26%), Positives = 79/176 (44%), Gaps = 14/176 (7%)
Query: 73 VIGCGGSGNVYKGFLPDRTPV-AVK---KSKIVDQTKIDEFINELVVVSQINRRNVVRLL 128
V+G GG G V+ + + A K K ++ + + E ++++++ R +V L
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL- 250
Query: 129 ACCLETQVPL-LVYEFVGNGTLFEHIHKNGNLTW---ERRLRI-AAETAGVLSYLHSETN 183
A ET+ L LV + G + HI+ E R A+ L +LH
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN- 309
Query: 184 VPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
II+RD+K N+LLD++ ++SD G + + + GT G++ PE L
Sbjct: 310 --IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPELLL 362
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 2e-19
Identities = 47/193 (24%), Positives = 74/193 (38%), Gaps = 33/193 (17%)
Query: 72 DVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINR-RNVVRLLAC 130
++G G SG V PVAVK + D + E+ ++++ + NV+R C
Sbjct: 21 KILGYGSSGTVVFQGSFQGRPVAVK---RMLIDFCDIALMEIKLLTESDDHPNVIRYY-C 76
Query: 131 CLETQVPL-LVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGV-------LSYLHSET 182
T L + E L + + +L+ + +++LHS
Sbjct: 77 SETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK 135
Query: 183 NVPIIHRDVKSANILLD-------------ENYTPKVSDFGASKLVPIDAIQNYTVVQ-- 227
IIHRD+K NIL+ EN +SDFG K + T +
Sbjct: 136 ---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNP 192
Query: 228 -GTLGYIDPEYLQ 239
GT G+ PE L+
Sbjct: 193 SGTSGWRAPELLE 205
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-19
Identities = 44/195 (22%), Positives = 78/195 (40%), Gaps = 35/195 (17%)
Query: 72 DVIGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKIDE--FINELVVVSQINR-RNVVRL 127
+ IG G G+V+K D A+K+SK +DE + E+ + + + +VVR
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 76
Query: 128 LACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTW---ERRLR-IAAETAGVLSYLHSETN 183
+ E L+ E+ G+L + I +N + E L+ + + L Y+HS +
Sbjct: 77 FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS- 135
Query: 184 VPIIHRDVKSANILLDEN-------------------YTPKVSDFGASKLVPIDAIQNYT 224
++H D+K +NI + K+ D G I +
Sbjct: 136 --LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR-----ISSPQ 188
Query: 225 VVQGTLGYIDPEYLQ 239
V +G ++ E LQ
Sbjct: 189 VEEGDSRFLANEVLQ 203
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 3e-19
Identities = 58/174 (33%), Positives = 85/174 (48%), Gaps = 13/174 (7%)
Query: 73 VIGCGGSGNVYKGFLPDRTPV-AVK---KSKIVDQTKIDEFINELVVVSQINRRNVVRLL 128
V+G GG G V + + A K K +I + +NE ++ ++N R VV L
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL- 249
Query: 129 ACCLETQVPL-LVYEFVGNGTLFEHIHKNGNLTW-ERRLRI-AAETAGVLSYLHSETNVP 185
A ET+ L LV + G L HI+ G + E R AAE L LH E
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--- 306
Query: 186 IIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
I++RD+K NILLD++ ++SD G + VP + V GT+GY+ PE ++
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAVHVP-EGQTIKGRV-GTVGYMAPEVVK 358
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 3e-19
Identities = 51/178 (28%), Positives = 81/178 (45%), Gaps = 20/178 (11%)
Query: 73 VIGCGGSGNVY----KGFLPDRTPVAVK---KSKIVDQTKIDEFINELVVVSQINRRNVV 125
++G G V A+K K I+ + K+ E V+S+++ V
Sbjct: 37 ILGEGSFSTVVLARELA---TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 93
Query: 126 RLLACCLETQVPL-LVYEFVGNGTLFEHIHKNGNLTWERRLRI-AAETAGVLSYLHSETN 183
+L + L + NG L ++I K G+ E R AE L YLH +
Sbjct: 94 KLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-ETCTRFYTAEIVSALEYLHGKG- 150
Query: 184 VPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQN--YTVVQGTLGYIDPEYLQ 239
IIHRD+K NILL+E+ +++DFG +K++ ++ Q + V GT Y+ PE L
Sbjct: 151 --IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-GTAQYVSPELLT 205
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-19
Identities = 47/189 (24%), Positives = 78/189 (41%), Gaps = 23/189 (12%)
Query: 64 KTVTNNYA--DVIGCGGSGNVYKGF-LPDRTPVAVK---KSKIVDQTKIDEFINELVVVS 117
T Y ++G G G V K + AVK K+ ++ + E+ ++
Sbjct: 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLK 76
Query: 118 QINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAET----AG 173
+++ N+++L ++ +V E G LF+ I K + E AA
Sbjct: 77 KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFS-EHD---AARIIKQVFS 132
Query: 174 VLSYLHSETNVPIIHRDVKSANILL---DENYTPKVSDFGASKLVPIDAIQNYTVVQGTL 230
++Y+H I+HRD+K NILL +++ K+ DFG S GT
Sbjct: 133 GITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC--FQQNTKMKDRIGTA 187
Query: 231 GYIDPEYLQ 239
YI PE L+
Sbjct: 188 YYIAPEVLR 196
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 4e-19
Identities = 42/172 (24%), Positives = 71/172 (41%), Gaps = 12/172 (6%)
Query: 72 DVIGCGGSGNVYKG-FLPDRTPVAVKK-SKIVDQTKIDEFINEL-VVVSQINRRNVVRLL 128
+G G G V K +P +AVK+ V+ + + +L + + ++ V
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 72
Query: 129 ACCLETQVPLLVYEFVGNGT--LFEHIHKNGNLTWERRL-RIAAETAGVLSYLHSETNVP 185
+ E + ++ + G E L +IA L +LHS+ +
Sbjct: 73 GALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS-- 130
Query: 186 IIHRDVKSANILLDENYTPKVSDFGAS-KLVPIDAIQNYTVVQGTLGYIDPE 236
+IHRDVK +N+L++ K+ DFG S LV D + G Y+ PE
Sbjct: 131 VIHRDVKPSNVLINALGQVKMCDFGISGYLV--DDVAKDIDA-GCKPYMAPE 179
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 4e-19
Identities = 54/188 (28%), Positives = 88/188 (46%), Gaps = 37/188 (19%)
Query: 73 VIGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKIDEFIN---------ELVVVSQIN-- 120
++G GG G+VY G + D PVA+K V++ +I ++ E+V++ +++
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIK---HVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 106
Query: 121 RRNVVRLLACCLETQVPL-LVYEFV-GNGTLFEHIHKNGNLTWERRLR------IAAETA 172
V+RLL E L+ E LF+ I + G L E R + A
Sbjct: 107 FSGVIRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQ-EELARSFFWQVLEA--- 161
Query: 173 GVLSYLHSETNVPIIHRDVKSANILLDENY-TPKVSDFGASKLVPIDAIQNYTVVQGTLG 231
+ + H+ ++HRD+K NIL+D N K+ DFG+ L+ D YT GT
Sbjct: 162 --VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK-D--TVYTDFDGTRV 213
Query: 232 YIDPEYLQ 239
Y PE+++
Sbjct: 214 YSPPEWIR 221
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 83.9 bits (207), Expect = 5e-19
Identities = 20/204 (9%), Positives = 49/204 (24%), Gaps = 43/204 (21%)
Query: 72 DVIGCGGSGNVYKGF-LPDRTPVAVK---KSKIVDQTKIDEFINELVVVSQINRRNVVRL 127
+ + G V+ + A+K +++++ +++ +
Sbjct: 68 EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127
Query: 128 LACCLETQVP--------------------------LLVYEFVG------NGTLFEHIHK 155
LL+ TL
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVF 187
Query: 156 NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLV 215
G+ + A+ + + L S+ ++H N+ + + + D A V
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244
Query: 216 PIDAIQNYTVVQGTLGYIDPEYLQ 239
+ Y E+L
Sbjct: 245 G----TRGPASSVPVTYAPREFLN 264
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 1e-18
Identities = 48/177 (27%), Positives = 81/177 (45%), Gaps = 17/177 (9%)
Query: 74 IGCGGSGNVYKGF-LPDRTPVAVK---KSKIVDQTKIDEFIN-----ELVVVSQINRRNV 124
+G G G V+ V VK K K+++ I++ E+ ++S++ N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 125 VRLLACCLETQVPL-LVYEFVGNGT-LFEHIHKNGNLTWERRLRIAAETAGVLSYLHSET 182
+++L E Q LV E G+G LF I ++ L I + + YL +
Sbjct: 92 IKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD 150
Query: 183 NVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
IIHRD+K NI++ E++T K+ DFG++ + + GT+ Y PE L
Sbjct: 151 ---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC--GTIEYCAPEVLM 202
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 1e-18
Identities = 45/183 (24%), Positives = 77/183 (42%), Gaps = 24/183 (13%)
Query: 73 VIGCGGSGNVYKGFLPDRT---PVAVK---KSKIV-----DQTKIDEFINELVVVSQINR 121
+G G G V F +R VA++ K K + E+ ++ ++N
Sbjct: 142 TLGSGACGEVKLAF--ERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH 199
Query: 122 RNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLR-IAAETAGVLSYLHS 180
++++ +V E + G LF+ + N L E + + + YLH
Sbjct: 200 PCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLK-EATCKLYFYQMLLAVQYLHE 257
Query: 181 ETNVPIIHRDVKSANILL---DENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEY 237
IIHRD+K N+LL +E+ K++DFG SK+ + + GT Y+ PE
Sbjct: 258 NG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTLCGTPTYLAPEV 312
Query: 238 LQT 240
L +
Sbjct: 313 LVS 315
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 2e-18
Identities = 49/245 (20%), Positives = 79/245 (32%), Gaps = 56/245 (22%)
Query: 48 QGRSSEKAKIFIEEEIKTVTNNYA--DVIGCGGSGNVYKGF-LPDRTPVAVK---KSKIV 101
S + F + + Y IG G G V R A+K K+KI
Sbjct: 6 HHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIR 65
Query: 102 DQTKIDE--FINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGNL 159
D E+ ++ +++ N+ RL + Q LV E G L + ++ +
Sbjct: 66 QINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDD 125
Query: 160 TWERRLRIAAETA----------------------------------------GVLSYLH 179
+ + +T L YLH
Sbjct: 126 STGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185
Query: 180 SETNVPIIHRDVKSANILL--DENYTPKVSDFGASKLVPI---DAIQNYTVVQGTLGYID 234
++ I HRD+K N L ++++ K+ DFG SK T GT ++
Sbjct: 186 NQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVA 242
Query: 235 PEYLQ 239
PE L
Sbjct: 243 PEVLN 247
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 3e-18
Identities = 44/180 (24%), Positives = 67/180 (37%), Gaps = 25/180 (13%)
Query: 72 DVIGCGGSGNVYKGF-LPDRTPVAVK---KSKIVDQTKIDEFINELVVVSQINRRNVVRL 127
+ IG G G V R A K K + D +D F E+ ++ ++ N++RL
Sbjct: 15 NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRL 71
Query: 128 LACCLETQVPL-LVYEFVGNGTLFEHIHKNGNLTWERRLRIAAET----AGVLSYLHSET 182
E + LV E G LFE + E AA ++Y H
Sbjct: 72 YETF-EDNTDIYLVMELCTGGELFERVVHKRVFR-ESD---AARIMKDVLSAVAYCHKLN 126
Query: 183 NVPIIHRDVKSANILL---DENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
+ HRD+K N L + K+ DFG + + GT Y+ P+ L+
Sbjct: 127 ---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR--FKPGKMMRTKVGTPYYVSPQVLE 181
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 3e-18
Identities = 55/187 (29%), Positives = 90/187 (48%), Gaps = 33/187 (17%)
Query: 73 VIGCGGSGNVYKGF-LPDRTPVAVK---KSKIVDQTKIDEFIN---ELVVVSQINRR--- 122
++G GG G V+ G L DR VA+K +++++ + + + + E+ ++ ++
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 123 -NVVRLLACCLETQVPL-LVYEFVGNGT-LFEHIHKNGNLTWERRLR------IAAETAG 173
V+RLL ETQ LV E LF++I + G L E R +AA
Sbjct: 98 PGVIRLLDW-FETQEGFMLVLERPLPAQDLFDYITEKGPLG-EGPSRCFFGQVVAA---- 151
Query: 174 VLSYLHSETNVPIIHRDVKSANILLD-ENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGY 232
+ + HS ++HRD+K NIL+D K+ DFG+ L+ D + YT GT Y
Sbjct: 152 -IQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLH-D--EPYTDFDGTRVY 204
Query: 233 IDPEYLQ 239
PE++
Sbjct: 205 SPPEWIS 211
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 3e-18
Identities = 50/208 (24%), Positives = 82/208 (39%), Gaps = 23/208 (11%)
Query: 45 SKLQGRSSEKAKIFIEEEIKTVTNNYA--DVIGCGGSGNVYKGF-LPDRTPVAVK---KS 98
S G+ + F+ ++NY + +G G V + A K
Sbjct: 6 SMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTK 65
Query: 99 KIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGN 158
K+ + E + ++ N+VRL E LV++ V G LFE I
Sbjct: 66 KL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF 124
Query: 159 LTWERRLRIAAET----AGVLSYLHSETNVPIIHRDVKSANILL---DENYTPKVSDFGA 211
+ E A+ ++Y HS I+HR++K N+LL + K++DFG
Sbjct: 125 YS-EAD---ASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGL 177
Query: 212 SKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
+ V D+ + GT GY+ PE L+
Sbjct: 178 AIEVN-DSEAWHGFA-GTPGYLSPEVLK 203
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 3e-18
Identities = 45/173 (26%), Positives = 72/173 (41%), Gaps = 11/173 (6%)
Query: 72 DVIGCGGSGNVYKGF-LPDRTPVAVKKSKI-VDQTKIDEFINEL-VVVSQINRRNVVRLL 128
+G G G V+K +AVK+ + ++ + + +L VV+ + +V+
Sbjct: 31 GEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCF 90
Query: 129 ACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRL-RIAAETAGVLSYLHSETNVPII 187
+ + E +G G + ER L ++ L YL + +I
Sbjct: 91 GTFITNTDVFIAMELMGTCAEKLKKRMQGPIP-ERILGKMTVAIVKALYYLKEKHG--VI 147
Query: 188 HRDVKSANILLDENYTPKVSDFGAS-KLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
HRDVK +NILLDE K+ DFG S +LV D G Y+ PE +
Sbjct: 148 HRDVKPSNILLDERGQIKLCDFGISGRLV--DDKAKDRSA-GCAAYMAPERID 197
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 4e-18
Identities = 45/176 (25%), Positives = 69/176 (39%), Gaps = 20/176 (11%)
Query: 72 DVIGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKIDEFINELVVVSQI-NRRNVVRLLA 129
+G G K AVK I+ + E+ + N+V+L
Sbjct: 17 KPLGEGSFSICRKCVHKKSNQAFAVK---IISKRMEANTQKEITALKLCEGHPNIVKLHE 73
Query: 130 CCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAET----AGVLSYLHSETNVP 185
+ LV E + G LFE I K + + E A+ +S++H
Sbjct: 74 VFHDQLHTFLVMELLNGGELFERIKKKKHFS-ETE---ASYIMRKLVSAVSHMHDVG--- 126
Query: 186 IIHRDVKSANILL---DENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYL 238
++HRD+K N+L ++N K+ DFG ++L P D T TL Y PE L
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELL 181
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 4e-18
Identities = 48/178 (26%), Positives = 75/178 (42%), Gaps = 18/178 (10%)
Query: 73 VIGCGGSGNVY----KGFLPDRTPVAVK---KSKIVDQTKIDEFINELVVVSQINRRNVV 125
VIG G G V K A+K K +++ + + F E V+ + + +
Sbjct: 81 VIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWIT 137
Query: 126 RLLACCLETQVPL-LVYEFVGNGTLFEHIHKNGNLTWERRLRI-AAETAGVLSYLHSETN 183
L + L LV ++ G L + K + E R AE + +H
Sbjct: 138 TLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH- 195
Query: 184 VPIIHRDVKSANILLDENYTPKVSDFGASKLVPID-AIQNYTVVQGTLGYIDPEYLQT 240
+HRD+K NIL+D N +++DFG+ + D +Q+ V GT YI PE LQ
Sbjct: 196 --YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQA 250
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 5e-18
Identities = 46/190 (24%), Positives = 82/190 (43%), Gaps = 20/190 (10%)
Query: 64 KTVTNNYA--DVIGCGGSGNVYKGF-LPDRTPVAVK---KSKIVDQTKIDEFINELVVVS 117
NY +++G G S V + P AVK + + + +
Sbjct: 13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLK 72
Query: 118 QIN--RR-----NVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAE 170
+++ R+ N+++L LV++ + G LF+++ + L+ E+ R
Sbjct: 73 EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLS-EKETRKIMR 131
Query: 171 T-AGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGT 229
V+ LH I+HRD+K NILLD++ K++DFG S +D + V GT
Sbjct: 132 ALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQ--LDPGEKLREVCGT 186
Query: 230 LGYIDPEYLQ 239
Y+ PE ++
Sbjct: 187 PSYLAPEIIE 196
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 9e-18
Identities = 20/144 (13%), Positives = 48/144 (33%), Gaps = 11/144 (7%)
Query: 72 DVIGCGGSGNVYKGF--LPDRTPVAVK---KSKIVDQTKIDEFINELVVVSQINRRNVVR 126
G ++ DR VA+ ++ + E ++ + +S+I++ V R
Sbjct: 37 IFHGGVPPLQFWQALDTALDR-QVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 127 LLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPI 186
+L L+V E++ G+L E + + +R A H +
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVAD--TSPSPVGAIRAMQSLAAAADAAHRA---GV 150
Query: 187 IHRDVKSANILLDENYTPKVSDFG 210
+ + + + ++
Sbjct: 151 ALSIDHPSRVRVSIDGDVVLAYPA 174
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 9e-18
Identities = 40/181 (22%), Positives = 67/181 (37%), Gaps = 17/181 (9%)
Query: 72 DVIGCGGSGNVYKGF-LPDRTPVAVK---KSKIVDQTKIDE--FINELVVVSQINRRNVV 125
+VIG G V + AVK +K + E + + ++V
Sbjct: 30 EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 126 RLLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAET----AGVLSYLHSE 181
LL + +V+EF+ L I K + + +A+ L Y H
Sbjct: 90 ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN 149
Query: 182 TNVPIIHRDVKSANILL---DENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYL 238
IIHRDVK +LL + + K+ FG + + + V GT ++ PE +
Sbjct: 150 N---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFMAPEVV 205
Query: 239 Q 239
+
Sbjct: 206 K 206
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 1e-17
Identities = 39/147 (26%), Positives = 71/147 (48%), Gaps = 9/147 (6%)
Query: 96 KKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPL-LVYEFVGNGTLFEHIH 154
K K V++ ++ EL ++ + +V L + + + +V + + G L H+
Sbjct: 49 NKQKCVERNEVRNVFKELQIMQGLEHPFLVNL-WYSFQDEEDMFMVVDLLLGGDLRYHLQ 107
Query: 155 KNGNLTWERRLRI-AAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASK 213
+N + E +++ E L YL ++ IIHRD+K NILLDE+ ++DF +
Sbjct: 108 QNVHFK-EETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAA 163
Query: 214 LVPIDAIQNYTVVQGTLGYIDPEYLQT 240
++P Q T+ GT Y+ PE +
Sbjct: 164 MLP-RETQITTMA-GTKPYMAPEMFSS 188
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 2e-17
Identities = 49/180 (27%), Positives = 73/180 (40%), Gaps = 28/180 (15%)
Query: 74 IGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKIDEFIN----ELVVVSQINRRNVVRLL 128
+G G G V VAVK IVD + + E+ + +N NVV+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 129 ACCLETQVPL-LVYEFVGNGTLFEHIHKNGNLTWERRLR------IAAETAGVLSYLHSE 181
L E+ G LF+ I + + E + +A + YLH
Sbjct: 72 GH-RREGNIQYLFLEYCSGGELFDRIEPDIGMP-EPDAQRFFHQLMAG-----VVYLHGI 124
Query: 182 TNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNY--TVVQGTLGYIDPEYLQ 239
I HRD+K N+LLDE K+SDFG + + + + + GTL Y+ PE L+
Sbjct: 125 G---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLK 180
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-17
Identities = 49/180 (27%), Positives = 73/180 (40%), Gaps = 28/180 (15%)
Query: 74 IGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKIDEFIN----ELVVVSQINRRNVVRLL 128
+G G G V VAVK IVD + + E+ + +N NVV+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 129 ACCLETQVPL-LVYEFVGNGTLFEHIHKNGNLTWERRLR------IAAETAGVLSYLHSE 181
L E+ G LF+ I + + E + +A + YLH
Sbjct: 72 GH-RREGNIQYLFLEYCSGGELFDRIEPDIGMP-EPDAQRFFHQLMAG-----VVYLHGI 124
Query: 182 TNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNY--TVVQGTLGYIDPEYLQ 239
I HRD+K N+LLDE K+SDFG + + + + + GTL Y+ PE L+
Sbjct: 125 G---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLK 180
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 2e-17
Identities = 50/177 (28%), Positives = 79/177 (44%), Gaps = 18/177 (10%)
Query: 73 VIGCGGSGNVY----KGFLPDRTPVAVK---KSKIVDQTKIDEFINELVVVSQINRRNVV 125
VIG G G V K R A+K K +++ ++ F E +++ N VV
Sbjct: 76 VIGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVV 132
Query: 126 RLLACCLETQVPL-LVYEFVGNGTLFEHIHKNGNLTWERRLRI-AAETAGVLSYLHSETN 183
+L + L +V E++ G L + ++ E+ R AE L +HS
Sbjct: 133 QLF-YAFQDDRYLYMVMEYMPGGDLVNLMSN-YDVP-EKWARFYTAEVVLALDAIHSMG- 188
Query: 184 VPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQT 240
IHRDVK N+LLD++ K++DFG + + + GT YI PE L++
Sbjct: 189 --FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 243
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-17
Identities = 44/173 (25%), Positives = 80/173 (46%), Gaps = 16/173 (9%)
Query: 74 IGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKIDEF-----INELVVVSQINRRNVVRL 127
IG G V + VA+K I+D+T+++ E+ ++ +N N+V+L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIK---IIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL 79
Query: 128 LACCLETQVPL-LVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPI 186
+ET+ L L+ E+ G +F+++ +G + + + + Y H + I
Sbjct: 80 FEV-IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR---I 135
Query: 187 IHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
+HRD+K+ N+LLD + K++DFG S + + G Y PE Q
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC--GAPPYAAPELFQ 186
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 2e-17
Identities = 52/179 (29%), Positives = 78/179 (43%), Gaps = 26/179 (14%)
Query: 73 VIGCGGSGNVYKGF-LPDRTPVAVK---KSKIVDQTKIDEFINELVVVSQINRRNVVRLL 128
V+G G V+ A+K KS + ++ NE+ V+ +I N+V L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE---NEIAVLKKIKHENIVTLE 72
Query: 129 ACCLETQVPL-LVYEFVGNGTLFEHIHKNGNLTWERRLRIAAET----AGVLSYLHSETN 183
E+ LV + V G LF+ I + G T E+ A+ + YLH
Sbjct: 73 DIY-ESTTHYYLVMQLVSGGELFDRILERGVYT-EKD---ASLVIQQVLSAVKYLHENG- 126
Query: 184 VPIIHRDVKSANILL---DENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
I+HRD+K N+L +EN ++DFG SK+ + T GT GY+ PE L
Sbjct: 127 --IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM--STAC-GTPGYVAPEVLA 180
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-17
Identities = 53/200 (26%), Positives = 84/200 (42%), Gaps = 21/200 (10%)
Query: 50 RSSEKAKIFIEEEIKTVTNNYA--DVIGCGGSGNVYKG-FLPDRTPVAVKKSKI-VDQTK 105
SS K KI E+ + IG G G+V K P +AVK+ + VD+ +
Sbjct: 4 ESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKE 63
Query: 106 IDEFINEL-VVVSQINRRNVVRLLACCL-ETQVPLLVYEFVGNGTLFEHIHKNGNLTWER 163
+ + +L VV+ + +V+ E + E + F+ +K +
Sbjct: 64 QKQLLMDLDVVMRSSDCPYIVQFYGALFREGDC-WICMELMSTS--FDKFYKYVYSVLDD 120
Query: 164 RL------RIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGAS-KLVP 216
+ +I T L++L IIHRD+K +NILLD + K+ DFG S +LV
Sbjct: 121 VIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVD 178
Query: 217 IDAIQNYTVVQGTLGYIDPE 236
A + G Y+ PE
Sbjct: 179 SIA-KTRDA--GCRPYMAPE 195
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 3e-17
Identities = 51/226 (22%), Positives = 94/226 (41%), Gaps = 31/226 (13%)
Query: 33 KQNGGSILRQELSKLQGRSSEKAKIFIEEEIKTVTNNYA--DVIGCGGSGNVYKGFLPDR 90
K+ + + + + ++ K Y DVIG G S V + R
Sbjct: 59 KKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCV--HR 116
Query: 91 T---PVAVK---KSKI-----VDQTKIDEFINELVVVSQINR-RNVVRLLACCLETQVPL 138
AVK + + + E ++ Q+ +++ L+ E+ +
Sbjct: 117 ATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY-ESSSFM 175
Query: 139 -LVYEFVGNGTLFEHIHKNGNLTWERRLRIAAET----AGVLSYLHSETNVPIIHRDVKS 193
LV++ + G LF+++ + L+ E+ +S+LH+ I+HRD+K
Sbjct: 176 FLVFDLMRKGELFDYLTEKVALS-EKE---TRSIMRSLLEAVSFLHANN---IVHRDLKP 228
Query: 194 ANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
NILLD+N ++SDFG S ++ + + GT GY+ PE L+
Sbjct: 229 ENILLDDNMQIRLSDFGFSCH--LEPGEKLRELCGTPGYLAPEILK 272
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 3e-17
Identities = 43/194 (22%), Positives = 81/194 (41%), Gaps = 30/194 (15%)
Query: 64 KTVTNNYA--DVIGCGGSGNVYKGF-LPDRTPVAVK---KSKIVDQTKIDEFINELVVVS 117
T+ + + +G G G+V+ +K K + Q +++ E+ V+
Sbjct: 18 GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLK 75
Query: 118 QINRRNVVRLLACCLETQVPL-LVYEFVGNGTLFEHI----HKNGNLTWERRLRIAAET- 171
++ N++++ E + +V E G L E I + L+ E AE
Sbjct: 76 SLDHPNIIKIFEVF-EDYHNMYIVMETCEGGELLERIVSAQARGKALS-EGY---VAELM 130
Query: 172 ---AGVLSYLHSETNVPIIHRDVKSANILL---DENYTPKVSDFGASKLVPIDAIQNYTV 225
L+Y HS+ ++H+D+K NIL + K+ DFG ++L + ++ T
Sbjct: 131 KQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL--FKSDEHSTN 185
Query: 226 VQGTLGYIDPEYLQ 239
GT Y+ PE +
Sbjct: 186 AAGTALYMAPEVFK 199
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 4e-17
Identities = 53/178 (29%), Positives = 76/178 (42%), Gaps = 27/178 (15%)
Query: 74 IGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKI-DEFIN-ELVVVSQINRRNVVRLLAC 130
IG G G + VAVK +++ DE + E++ + N+VR
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVK---YIERGAAIDENVQREIINHRSLRHPNIVRFKEV 84
Query: 131 CLETQVPL-LVYEFVGNGTLFEHIHKNGNLTWERRLR------IAAETAGVLSYLHSETN 183
+ T L ++ E+ G L+E I G + E R ++ +SY HS
Sbjct: 85 -ILTPTHLAIIMEYASGGELYERICNAGRFS-EDEARFFFQQLLSG-----VSYCHSMQ- 136
Query: 184 VPIIHRDVKSANILLDENYTP--KVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
I HRD+K N LLD + P K+ DFG SK + + TV GT YI PE L
Sbjct: 137 --ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--GTPAYIAPEVLL 190
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 4e-17
Identities = 39/178 (21%), Positives = 69/178 (38%), Gaps = 18/178 (10%)
Query: 72 DVIGCGGSGNVYKGF-LPDRTPVAVK--KSKIVDQTKIDEFINELVVVSQINRRNVVRLL 128
+ +G G V + + A +K + + E + + N+VRL
Sbjct: 17 EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 76
Query: 129 ACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAET----AGVLSYLHSETNV 184
E L+++ V G LFE I + E A+ + + H
Sbjct: 77 DSISEEGHHYLIFDLVTGGELFEDIVAREYYS-EAD---ASHCIQQILEAVLHCHQMG-- 130
Query: 185 PIIHRDVKSANILL---DENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
++HR++K N+LL + K++DFG + V + + GT GY+ PE L+
Sbjct: 131 -VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLSPEVLR 186
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 5e-17
Identities = 46/148 (31%), Positives = 70/148 (47%), Gaps = 7/148 (4%)
Query: 94 AVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPL-LVYEFVGNGTLFEH 152
+KK IV + ++ + E V+ + L +T L V E+ G LF H
Sbjct: 180 ILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFH 238
Query: 153 IHKNGNLTWERRLRI-AAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGA 211
+ + + E R R AE L YLHSE N +++RD+K N++LD++ K++DFG
Sbjct: 239 LSRERVFS-EDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGL 295
Query: 212 SKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
K D T GT Y+ PE L+
Sbjct: 296 CKEGIKDGATMKTFC-GTPEYLAPEVLE 322
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 5e-17
Identities = 49/187 (26%), Positives = 75/187 (40%), Gaps = 30/187 (16%)
Query: 72 DVIGCGGSGNVYKGF-LPDRTPVAVK---KSKIVDQTKIDEFINELVVVSQI-NRRNVVR 126
DV+G G V L AVK K + E+ ++ Q RNV+
Sbjct: 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIR---SRVFREVEMLYQCQGHRNVLE 75
Query: 127 LLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAET----AGVLSYLHSET 182
L+ E LV+E + G++ HIHK + E A+ A L +LH++
Sbjct: 76 LIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFN-ELE---ASVVVQDVASALDFLHNKG 131
Query: 183 NVPIIHRDVKSANILL---DENYTPKVSDFGASKLV-------PIDAIQNYTVVQGTLGY 232
I HRD+K NIL ++ K+ DF + PI + T G+ Y
Sbjct: 132 ---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-GSAEY 187
Query: 233 IDPEYLQ 239
+ PE ++
Sbjct: 188 MAPEVVE 194
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 7e-17
Identities = 39/144 (27%), Positives = 66/144 (45%), Gaps = 9/144 (6%)
Query: 74 IGCGGSGNVYKGF-LPDRTPVAVK---KSKIVDQTKIDEFINELVVVSQINRRNVVRLLA 129
+G G G V G VAVK + KI + + E+ + ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 130 CCLETQVPL-LVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIH 188
+ T +V E+V G LF++I K+G + R+ + + Y H ++H
Sbjct: 79 V-ISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM---VVH 134
Query: 189 RDVKSANILLDENYTPKVSDFGAS 212
RD+K N+LLD + K++DFG S
Sbjct: 135 RDLKPENVLLDAHMNAKIADFGLS 158
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 8e-17
Identities = 48/196 (24%), Positives = 80/196 (40%), Gaps = 32/196 (16%)
Query: 64 KTVTNNYA--DVIGCGGSGNVYKGFLPDRT---PVAVK---KSKIV-----DQTKIDEFI 110
K + + Y +G G G V F +R VA+K K K +
Sbjct: 6 KALRDEYIMSKTLGSGACGEVKLAF--ERKTCKKVAIKIISKRKFAIGSAREADPALNVE 63
Query: 111 NELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAE 170
E+ ++ ++N ++++ + + +V E + G LF+ + N L E
Sbjct: 64 TEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLK-EA---TCKL 118
Query: 171 T----AGVLSYLHSETNVPIIHRDVKSANILL---DENYTPKVSDFGASKLVPIDAIQNY 223
+ YLH IIHRD+K N+LL +E+ K++DFG SK+ +
Sbjct: 119 YFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLM 173
Query: 224 TVVQGTLGYIDPEYLQ 239
+ GT Y+ PE L
Sbjct: 174 RTLCGTPTYLAPEVLV 189
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-16
Identities = 42/192 (21%), Positives = 77/192 (40%), Gaps = 22/192 (11%)
Query: 59 IEEEIKTVTNNYA--DVIGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKIDEFINELVV 115
+ T+ Y + IG G + AVK I+D++K D ++
Sbjct: 13 LHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVK---IIDKSKRDPTEEIEIL 69
Query: 116 VSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAET---- 171
+ N++ L + + +V E + G L + I + + ER A+
Sbjct: 70 LRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFS-ERE---ASAVLFTI 125
Query: 172 AGVLSYLHSETNVPIIHRDVKSANILL---DENYTP-KVSDFGASKLVPIDAIQNYTVVQ 227
+ YLH++ ++HRD+K +NIL N ++ DFG +K + + T
Sbjct: 126 TKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC- 181
Query: 228 GTLGYIDPEYLQ 239
T ++ PE L+
Sbjct: 182 YTANFVAPEVLE 193
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 3e-16
Identities = 42/152 (27%), Positives = 70/152 (46%), Gaps = 21/152 (13%)
Query: 74 IGCGGSGNVYKGF-LPDRTPVAVK---KSKIVDQTKIDEFINELVVVSQINRRNVVRLLA 129
+G G G V G VAVK + KI + + E+ + ++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 130 CCLETQVPL-LVYEFVGNGTLFEHIHKNGNLTWERRLR------IAAETAGVLSYLHSET 182
+ T + +V E+V G LF++I KNG L E+ R ++ + Y H
Sbjct: 84 V-ISTPSDIFMVMEYVSGGELFDYICKNGRLD-EKESRRLFQQILSG-----VDYCHRHM 136
Query: 183 NVPIIHRDVKSANILLDENYTPKVSDFGASKL 214
++HRD+K N+LLD + K++DFG S +
Sbjct: 137 ---VVHRDLKPENVLLDAHMNAKIADFGLSNM 165
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 5e-16
Identities = 46/191 (24%), Positives = 79/191 (41%), Gaps = 27/191 (14%)
Query: 64 KTVTNNYA--DVIGCGGSGNVYKGFLPDRT---PVAVK---KSKIVDQTKIDEFINELVV 115
++NY + +G G V + +T A K K+ + + E +
Sbjct: 2 TKFSDNYDVKEELGKGAFSVVRRCV--HKTTGLEFAAKIINTKKLSAR-DFQKLEREARI 58
Query: 116 VSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAET---- 171
++ N+VRL E LV++ V G LFE I + E A+
Sbjct: 59 CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYS-EAD---ASHCIQQI 114
Query: 172 AGVLSYLHSETNVPIIHRDVKSANILL---DENYTPKVSDFGASKLVPIDAIQNYTVVQG 228
++Y HS I+HR++K N+LL + K++DFG + ++ + + G
Sbjct: 115 LESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE--VNDSEAWHGFAG 169
Query: 229 TLGYIDPEYLQ 239
T GY+ PE L+
Sbjct: 170 TPGYLSPEVLK 180
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 8e-16
Identities = 36/213 (16%), Positives = 71/213 (33%), Gaps = 22/213 (10%)
Query: 46 KLQGRSSEKAKIFIEEEIKTVTN--NYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQ 103
+L R + K+ E + K +S
Sbjct: 40 RLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPL 99
Query: 104 TKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVY---EFVGNGTLFEHIHKNGNLT 160
+ V + +++ + + + + +Y + L + +++ +L
Sbjct: 100 SSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLE 159
Query: 161 WERR---LRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFG------- 210
L I + A + +LHS+ ++HRD+K +NI + KV DFG
Sbjct: 160 DREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQ 216
Query: 211 ----ASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
+ L P+ A +T GT Y+ PE +
Sbjct: 217 DEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIH 249
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 9e-16
Identities = 39/152 (25%), Positives = 67/152 (44%), Gaps = 22/152 (14%)
Query: 74 IGCGGSGNVYKGF-LPDRTPVAVK---KSKIVDQTKIDEFINELVVVSQINRRNVVRLLA 129
+G G G V + VA+K + + E+ + + ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 130 CCLETQVPL-LVYEFVGNGTLFEHIHKNGNLTWERRLR------IAAETAGVLSYLHSET 182
+ T + +V E+ G G LF++I + +T E R I A + Y H
Sbjct: 77 V-ITTPTDIVMVIEYAG-GELFDYIVEKKRMT-EDEGRRFFQQIICA-----IEYCHRHK 128
Query: 183 NVPIIHRDVKSANILLDENYTPKVSDFGASKL 214
I+HRD+K N+LLD+N K++DFG S +
Sbjct: 129 ---IVHRDLKPENLLLDDNLNVKIADFGLSNI 157
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 1e-15
Identities = 47/194 (24%), Positives = 82/194 (42%), Gaps = 32/194 (16%)
Query: 65 TVTNNYA--DVIGCGGSGNVYKGFLPDRT---PVAVK---KSKIVDQTK---IDEFINEL 113
V ++Y + +G G V K + A K K ++ + +E E+
Sbjct: 2 MVEDHYEMGEELGSGQFAIVRKCR--QKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREV 59
Query: 114 VVVSQINRRNVVRLLACCLETQVPL-LVYEFVGNGTLFEHIHKNGNLTWERRLRIAAET- 171
++ +I N++ L E + + L+ E V G LF+ + + +LT E A +
Sbjct: 60 NILREIRHPNIITLHDIF-ENKTDVVLILELVSGGELFDFLAEKESLT-EDE---ATQFL 114
Query: 172 ---AGVLSYLHSETNVPIIHRDVKSANILL----DENYTPKVSDFGASKLVPIDAIQNYT 224
+ YLHS+ I H D+K NI+L N K+ DFG + I+A +
Sbjct: 115 KQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK--IEAGNEFK 169
Query: 225 VVQGTLGYIDPEYL 238
+ GT ++ PE +
Sbjct: 170 NIFGTPEFVAPEIV 183
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 75.1 bits (184), Expect = 1e-15
Identities = 45/148 (30%), Positives = 68/148 (45%), Gaps = 7/148 (4%)
Query: 94 AVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPL-LVYEFVGNGTLFEH 152
+KK ++ ++ + E V++ + + L C +T L V E+V G L H
Sbjct: 373 ILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYH 432
Query: 153 IHKNGNLTWERRLRI-AAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGA 211
I + G E AAE A L +L S+ II+RD+K N++LD K++DFG
Sbjct: 433 IQQVGRFK-EPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGM 488
Query: 212 SKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
K D + T GT YI PE +
Sbjct: 489 CKENIWDGVTTKTFC-GTPDYIAPEIIA 515
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-15
Identities = 42/192 (21%), Positives = 81/192 (42%), Gaps = 26/192 (13%)
Query: 64 KTVTNNYA--DVIGCGGSGNVYKGFLPDRT---PVAVK---KSKIVDQTK---IDEFINE 112
+ V + Y + +G G V K +++ A K K + + +E E
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCR--EKSTGLEYAAKFIKKRQSRASRRGVCREEIERE 65
Query: 113 LVVVSQINRRNVVRLLACCLETQVPL-LVYEFVGNGTLFEHIHKNGNLTWERRLRIAAET 171
+ ++ Q+ N++ L E + + L+ E V G LF+ + + +L+ E +
Sbjct: 66 VSILRQVLHPNIITLHDVY-ENRTDVVLILELVSGGELFDFLAQKESLS-EEEATSFIKQ 123
Query: 172 -AGVLSYLHSETNVPIIHRDVKSANILL----DENYTPKVSDFGASKLVPIDAIQNYTVV 226
++YLH++ I H D+K NI+L K+ DFG + I+ + +
Sbjct: 124 ILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEFKNI 178
Query: 227 QGTLGYIDPEYL 238
GT ++ PE +
Sbjct: 179 FGTPEFVAPEIV 190
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-15
Identities = 40/182 (21%), Positives = 76/182 (41%), Gaps = 22/182 (12%)
Query: 72 DVIGCGGSGNVYKGF-LPDRTPVAVK---KSKIVDQTKIDEFIN-ELVVVSQINRRNVVR 126
D++G G G V + AVK K K+ + + E+ ++ ++ +NV++
Sbjct: 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 127 LL-ACCLETQVPL-LVYEFVGNGT--LFEHIHKNGNLTWE-RRL---RIAAETAGVLSYL 178
L+ E + + +V E+ G + + + + + I L YL
Sbjct: 71 LVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDG-----LEYL 125
Query: 179 HSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNY-TVVQGTLGYIDPEY 237
HS+ I+H+D+K N+LL T K+S G ++ + A + QG+ + PE
Sbjct: 126 HSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEI 182
Query: 238 LQ 239
Sbjct: 183 AN 184
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-15
Identities = 50/176 (28%), Positives = 82/176 (46%), Gaps = 21/176 (11%)
Query: 73 VIGCGGSGNVY----KGFLPDRTPVAVK---KSKIVDQTKIDEFINELVVVSQINRRNVV 125
+G G G V K A+K K K+V +I+ +NE ++ +N +V
Sbjct: 48 TLGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 126 RLLACCLETQVPL-LVYEFVGNGTLFEHIHKNGNLTWERRLRI-AAETAGVLSYLHSETN 183
+L + L +V E+V G +F H+ + G + E R AA+ YLHS
Sbjct: 105 KLE-FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS-EPHARFYAAQIVLTFEYLHSLD- 161
Query: 184 VPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
+I+RD+K N+L+D+ +V+DFG +K V +T+ GT + PE +
Sbjct: 162 --LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WTLC-GTPEALAPEIIL 211
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-15
Identities = 49/148 (33%), Positives = 67/148 (45%), Gaps = 7/148 (4%)
Query: 94 AVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPL-LVYEFVGNGTLFEH 152
VKK + D ID E V Q + + L C +T+ L V E+V G L H
Sbjct: 84 VVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFH 143
Query: 153 IHKNGNLTWERRLRI-AAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGA 211
+ + L E R +AE + L+YLH II+RD+K N+LLD K++D+G
Sbjct: 144 MQRQRKLP-EEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGM 199
Query: 212 SKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
K T GT YI PE L+
Sbjct: 200 CKEGLRPGDTTSTFC-GTPNYIAPEILR 226
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 2e-15
Identities = 49/148 (33%), Positives = 67/148 (45%), Gaps = 7/148 (4%)
Query: 94 AVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPL-LVYEFVGNGTLFEH 152
VKK + D ID E V Q + + L C +T+ L V E+V G L H
Sbjct: 41 VVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFH 100
Query: 153 IHKNGNLTWERRLRI-AAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGA 211
+ + L E R +AE + L+YLH II+RD+K N+LLD K++D+G
Sbjct: 101 MQRQRKLP-EEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGM 156
Query: 212 SKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
K T GT YI PE L+
Sbjct: 157 CKEGLRPGDTTSTFC-GTPNYIAPEILR 183
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 3e-15
Identities = 47/176 (26%), Positives = 78/176 (44%), Gaps = 19/176 (10%)
Query: 72 DVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTK-IDEFINELVVVSQINRRNVVRLLAC 130
+G G + VY+ + K++ +T E+ V+ +++ N+++L
Sbjct: 59 SELGRGATSIVYRCK--QKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEI 116
Query: 131 CLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAET----AGVLSYLHSETNVPI 186
LV E V G LF+ I + G + ER AA+ ++YLH I
Sbjct: 117 FETPTEISLVLELVTGGELFDRIVEKGYYS-ERD---AADAVKQILEAVAYLHENG---I 169
Query: 187 IHRDVKSANILL---DENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
+HRD+K N+L + K++DFG SK+ ++ V GT GY PE L+
Sbjct: 170 VHRDLKPENLLYATPAPDAPLKIADFGLSKI--VEHQVLMKTVCGTPGYCAPEILR 223
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 4e-15
Identities = 44/192 (22%), Positives = 82/192 (42%), Gaps = 26/192 (13%)
Query: 64 KTVTNNYA--DVIGCGGSGNVYKGFLPDRT---PVAVK---KSKIV---DQTKIDEFINE 112
+ V + Y + +G G V K +++ A K K + +E E
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCR--EKSTGLEYAAKFIKKRQSRASRRGVSREEIERE 65
Query: 113 LVVVSQINRRNVVRLLACCLETQVPL-LVYEFVGNGTLFEHIHKNGNLTWERRLRIAAET 171
+ ++ Q+ NV+ L E + + L+ E V G LF+ + + +L+ E +
Sbjct: 66 VSILRQVLHHNVITLHDVY-ENRTDVVLILELVSGGELFDFLAQKESLS-EEEATSFIKQ 123
Query: 172 -AGVLSYLHSETNVPIIHRDVKSANILLDENYTP----KVSDFGASKLVPIDAIQNYTVV 226
++YLH++ I H D+K NI+L + P K+ DFG + I+ + +
Sbjct: 124 ILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEFKNI 178
Query: 227 QGTLGYIDPEYL 238
GT ++ PE +
Sbjct: 179 FGTPEFVAPEIV 190
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 6e-15
Identities = 42/227 (18%), Positives = 92/227 (40%), Gaps = 15/227 (6%)
Query: 21 RRRHMKLKEKFFKQNGGSILRQELSKLQGRSSEKAKIFIEEEIKTVTNNY--ADVIGCGG 78
RR + ++ + G++ + + + +E + V ++Y + +G G
Sbjct: 110 RRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGA 169
Query: 79 SGNVYKGFLPDRT---PVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQ 135
G V++ +R A K ++ + E+ +S + +V L +
Sbjct: 170 FGVVHRVT--ERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN 227
Query: 136 VPLLVYEFVGNGTLFEHI-HKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSA 194
+++YEF+ G LFE + ++ ++ + + + L ++H +H D+K
Sbjct: 228 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPE 284
Query: 195 NILL--DENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
NI+ + K+ DFG + +D Q+ V GT + PE +
Sbjct: 285 NIMFTTKRSNELKLIDFGLTAH--LDPKQSVKVTTGTAEFAAPEVAE 329
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 6e-15
Identities = 47/194 (24%), Positives = 79/194 (40%), Gaps = 32/194 (16%)
Query: 66 VTNNYA--DVIGCGGSGNVYKGFLPDRT---PVAVK---KSKIVDQTK---IDEFINELV 114
V + Y + +G G V K +++ A K K + + ++ E+
Sbjct: 9 VDDYYDTGEELGSGQFAVVKKCR--EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 115 VVSQINRRNVVRLLACCLETQVPL-LVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETA- 172
++ +I NV+ L E + + L+ E V G LF+ + + +LT E A E
Sbjct: 67 ILKEIQHPNVITLHEVY-ENKTDVILILELVAGGELFDFLAEKESLT-EEE---ATEFLK 121
Query: 173 ---GVLSYLHSETNVPIIHRDVKSANILL----DENYTPKVSDFGASKLVPIDAIQNYTV 225
+ YLHS I H D+K NI+L K+ DFG + ID +
Sbjct: 122 QILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGNEFKN 176
Query: 226 VQGTLGYIDPEYLQ 239
+ GT ++ PE +
Sbjct: 177 IFGTPEFVAPEIVN 190
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 8e-15
Identities = 51/212 (24%), Positives = 86/212 (40%), Gaps = 38/212 (17%)
Query: 48 QGRSSEKAKIFIEEEIKTVTNNY---ADVIGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQ 103
Q K ++ + + ++Y + V+G G +G V + F + A+K ++
Sbjct: 41 QQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK---MLQ- 96
Query: 104 TKIDEFINELVVVSQINRR-----NVVRLLACCLETQVP----LLVYEFVGNGTLFEHIH 154
+ E+ +++ R ++VR++ L+V E + G LF I
Sbjct: 97 -DCPKARREV----ELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ 151
Query: 155 KNGNLTW-ERRLRIAAET----AGVLSYLHSETNVPIIHRDVKSANILL---DENYTPKV 206
G+ + ER A+E + YLHS I HRDVK N+L N K+
Sbjct: 152 DRGDQAFTERE---ASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKL 205
Query: 207 SDFGASKLVPIDAIQNYTVVQGTLGYIDPEYL 238
+DFG +K + T T Y+ PE L
Sbjct: 206 TDFGFAKETTSH--NSLTTPCYTPYYVAPEVL 235
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 8e-15
Identities = 43/148 (29%), Positives = 68/148 (45%), Gaps = 8/148 (5%)
Query: 94 AVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPL-LVYEFVGNGTLFEH 152
++K I+ + ++ + E V+ + L +T L V E+ G LF H
Sbjct: 37 ILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFH 95
Query: 153 IHKNGNLTWERRLRI-AAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGA 211
+ + T E R R AE L YLHS +++RD+K N++LD++ K++DFG
Sbjct: 96 LSRERVFT-EERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGL 151
Query: 212 SKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
K D T GT Y+ PE L+
Sbjct: 152 CKEGISDGATMKTFC-GTPEYLAPEVLE 178
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 9e-15
Identities = 51/148 (34%), Positives = 70/148 (47%), Gaps = 7/148 (4%)
Query: 94 AVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPL-LVYEFVGNGTLFEH 152
+KK I+ ++ + E ++S + L CC +T L V EFV G L H
Sbjct: 55 VLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFH 114
Query: 153 IHKNGNLTWERRLRI-AAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGA 211
I K+ E R R AAE L +LH + II+RD+K N+LLD K++DFG
Sbjct: 115 IQKSRRFD-EARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGM 170
Query: 212 SKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
K + + T GT YI PE LQ
Sbjct: 171 CKEGICNGVTTATFC-GTPDYIAPEILQ 197
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 71.0 bits (175), Expect = 1e-14
Identities = 54/176 (30%), Positives = 87/176 (49%), Gaps = 16/176 (9%)
Query: 73 VIGCGGSGNVY---KGFLPDRTPV-AVK---KSKIVDQTKIDEFINELVVVSQINRRNVV 125
V+G G G V+ K D + A+K K+ + + ++ E ++ ++N +V
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRV-RTKMERDILVEVNHPFIV 89
Query: 126 RLLACCLETQVPL-LVYEFVGNGTLFEHIHKNGNLTWERRLRI-AAETAGVLSYLHSETN 183
+L +T+ L L+ +F+ G LF + K T E ++ AE A L +LHS
Sbjct: 90 KL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFT-EEDVKFYLAELALALDHLHSLG- 146
Query: 184 VPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
II+RD+K NILLDE K++DFG SK + Y+ GT+ Y+ PE +
Sbjct: 147 --IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMAPEVVN 199
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 1e-14
Identities = 37/192 (19%), Positives = 78/192 (40%), Gaps = 31/192 (16%)
Query: 64 KTVTNNY--ADVIGCGGSGNVYKGFLPDRT---PVAVK---KSKIVDQTKIDEFINELVV 115
+V + Y + +G G G V++ ++ K +D NE+ +
Sbjct: 47 GSVYDYYDILEELGSGAFGVVHRCV--EKATGRVFVAKFINTPYPLD---KYTVKNEISI 101
Query: 116 VSQINRRNVVRLLACCLETQVPL-LVYEFVGNGTLFEHI-HKNGNLTWERRLRIAAETA- 172
++Q++ ++ L E + + L+ EF+ G LF+ I ++ ++ E
Sbjct: 102 MNQLHHPKLINLHDAF-EDKYEMVLILEFLSGGELFDRIAAEDYKMS-EAE---VINYMR 156
Query: 173 ---GVLSYLHSETNVPIIHRDVKSANILL--DENYTPKVSDFGASKLVPIDAIQNYTVVQ 227
L ++H + I+H D+K NI+ + + K+ DFG + ++ + V
Sbjct: 157 QACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATK--LNPDEIVKVTT 211
Query: 228 GTLGYIDPEYLQ 239
T + PE +
Sbjct: 212 ATAEFAAPEIVD 223
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 1e-14
Identities = 47/197 (23%), Positives = 88/197 (44%), Gaps = 27/197 (13%)
Query: 58 FIEEEIKTVTNNY----ADVIGCGGSGNVYKGFLPDRT---PVAVK---KSKIVDQTKID 107
+ + V + Y +++G G G V+K + +A K + D +
Sbjct: 77 IVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCE--ETATGLKLAAKIIKTRGMKD---KE 131
Query: 108 EFINELVVVSQINRRNVVRLLACCLETQVPL-LVYEFVGNGTLFEHI-HKNGNLTWERR- 164
E NE+ V++Q++ N+++L E++ + LV E+V G LF+ I ++ NLT E
Sbjct: 132 EVKNEISVMNQLDHANLIQLYDA-FESKNDIVLVMEYVDGGELFDRIIDESYNLT-ELDT 189
Query: 165 LRIAAETAGVLSYLHSETNVPIIHRDVKSANILL--DENYTPKVSDFGASKLVPIDAIQN 222
+ + + ++H I+H D+K NIL + K+ DFG ++ +
Sbjct: 190 ILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARR--YKPREK 244
Query: 223 YTVVQGTLGYIDPEYLQ 239
V GT ++ PE +
Sbjct: 245 LKVNFGTPEFLAPEVVN 261
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 71.0 bits (175), Expect = 1e-14
Identities = 49/176 (27%), Positives = 85/176 (48%), Gaps = 21/176 (11%)
Query: 73 VIGCGGSGNVY----KGFLPDRTPVAVK---KSKIVDQTKIDEFINELVVVSQINRRNVV 125
+G G G V+ + + A+K K +V +++ +E +++S + ++
Sbjct: 13 TLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFII 69
Query: 126 RLLACCLETQVPL-LVYEFVGNGTLFEHIHKNGNLTWERRLRI-AAETAGVLSYLHSETN 183
R+ + + ++ +++ G LF + K+ + AAE L YLHS+
Sbjct: 70 RMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP-NPVAKFYAAEVCLALEYLHSKD- 126
Query: 184 VPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
II+RD+K NILLD+N K++DFG +K VP YT+ GT YI PE +
Sbjct: 127 --IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT---YTLC-GTPDYIAPEVVS 176
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 70.6 bits (174), Expect = 2e-14
Identities = 51/177 (28%), Positives = 80/177 (45%), Gaps = 16/177 (9%)
Query: 73 VIGCGGSGNVY---KGFLPDRTPV-AVK---KSKIVDQTK-IDEFINELVVVSQINRRNV 124
V+G GG G V+ K + + A+K K+ IV K E ++ ++ +
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 125 VRLLACCLETQVPL-LVYEFVGNGTLFEHIHKNGNLTWERRLRI-AAETAGVLSYLHSET 182
V L +T L L+ E++ G LF + + G E AE + L +LH +
Sbjct: 84 VDL-IYAFQTGGKLYLILEYLSGGELFMQLEREGIFM-EDTACFYLAEISMALGHLHQKG 141
Query: 183 NVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
II+RD+K NI+L+ K++DFG K D +T GT+ Y+ PE L
Sbjct: 142 ---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC-GTIEYMAPEILM 194
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-14
Identities = 44/195 (22%), Positives = 76/195 (38%), Gaps = 38/195 (19%)
Query: 64 KTVTNNY--ADVIGCGGSGNVYKGFLPDRTPVAVKKS-------KIVDQTKIDE--FINE 112
K + Y A+ +G G G V++ V+ S K V D+ E
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHR---------CVETSSKKTYMAKFVKVKGTDQVLVKKE 51
Query: 113 LVVVSQINRRNVVRLLACCLETQVPL-LVYEFVGNGTLFEHI-HKNGNLTWERRLRIAAE 170
+ +++ RN++ L E+ L +++EF+ +FE I L ER
Sbjct: 52 ISILNIARHRNILHLHESF-ESMEELVMIFEFISGLDIFERINTSAFELN-ERE---IVS 106
Query: 171 TA----GVLSYLHSETNVPIIHRDVKSANILL--DENYTPKVSDFGASKLVPIDAIQNYT 224
L +LHS I H D++ NI+ + T K+ +FG ++ + N+
Sbjct: 107 YVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQ--LKPGDNFR 161
Query: 225 VVQGTLGYIDPEYLQ 239
++ Y PE Q
Sbjct: 162 LLFTAPEYYAPEVHQ 176
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-14
Identities = 45/148 (30%), Positives = 68/148 (45%), Gaps = 7/148 (4%)
Query: 94 AVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPL-LVYEFVGNGTLFEH 152
+KK ++ ++ + E V++ + + L C +T L V E+V G L H
Sbjct: 52 ILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYH 111
Query: 153 IHKNGNLTWERRLRI-AAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGA 211
I + G E AAE A L +L S+ II+RD+K N++LD K++DFG
Sbjct: 112 IQQVGRFK-EPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGM 167
Query: 212 SKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
K D + T GT YI PE +
Sbjct: 168 CKENIWDGVTTKTFC-GTPDYIAPEIIA 194
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-14
Identities = 40/114 (35%), Positives = 52/114 (45%), Gaps = 7/114 (6%)
Query: 128 LACCLETQVPL-LVYEFVGNGTLFEHIHKNGNLTWERRLRI-AAETAGVLSYLHSETNVP 185
L +T L V +++ G LF H+ + E R R AAE A L YLHS
Sbjct: 104 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFL-EPRARFYAAEIASALGYLHSLN--- 159
Query: 186 IIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
I++RD+K NILLD ++DFG K T GT Y+ PE L
Sbjct: 160 IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC-GTPEYLAPEVLH 212
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 3e-14
Identities = 57/206 (27%), Positives = 89/206 (43%), Gaps = 31/206 (15%)
Query: 51 SSEKAKIFIEEEIKT--VTNNY---ADVIGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQT 104
SS +F E K VT++Y V+G G +G V + F A+K + D
Sbjct: 9 SSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKL--LYDSP 66
Query: 105 KIDEFINELVVVSQINRRNVVRLLACCLETQVP----LLVYEFVGNGTLFEHIHKNGNLT 160
K + ++ S ++V +L L++ E + G LF I + G+
Sbjct: 67 KARQEVDHHWQAS--GGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQA 124
Query: 161 W-ERRLRIAAET----AGVLSYLHSETNVPIIHRDVKSANILL---DENYTPKVSDFGAS 212
+ ER AAE + +LHS I HRDVK N+L +++ K++DFG +
Sbjct: 125 FTERE---AAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178
Query: 213 KLVPIDAIQNYTVVQGTLGYIDPEYL 238
K +A+Q T T Y+ PE L
Sbjct: 179 KETTQNALQ--TPC-YTPYYVAPEVL 201
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 4e-14
Identities = 53/178 (29%), Positives = 85/178 (47%), Gaps = 16/178 (8%)
Query: 73 VIGCGGSGNVY---KGFLPDRTPV-AVK---KSKIVDQTK-IDEFINELVVVSQINRRNV 124
V+G G G V+ K D + A+K K+ IV + K + E V+ I +
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 125 VRLLACCLETQVPL-LVYEFVGNGTLFEHIHKNGNLTWERRLRI-AAETAGVLSYLHSET 182
+ L +T+ L L+ +++ G LF H+ + T E ++I E L +LH
Sbjct: 121 LVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFT-EHEVQIYVGEIVLALEHLHKLG 179
Query: 183 NVPIIHRDVKSANILLDENYTPKVSDFGASKL-VPIDAIQNYTVVQGTLGYIDPEYLQ 239
II+RD+K NILLD N ++DFG SK V + + Y GT+ Y+ P+ ++
Sbjct: 180 ---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GTIEYMAPDIVR 233
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 1e-13
Identities = 45/148 (30%), Positives = 69/148 (46%), Gaps = 7/148 (4%)
Query: 94 AVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPL-LVYEFVGNGTLFEH 152
A+KK ++ ++ + E V+S + + C +T+ L V E++ G L H
Sbjct: 49 ALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYH 108
Query: 153 IHKNGNLTWERRLRI-AAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGA 211
I R AAE L +LHS+ I++RD+K NILLD++ K++DFG
Sbjct: 109 IQSCHKFD-LSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGM 164
Query: 212 SKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
K + + T GT YI PE L
Sbjct: 165 CKENMLGDAKTNTFC-GTPDYIAPEILL 191
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-13
Identities = 43/205 (20%), Positives = 71/205 (34%), Gaps = 31/205 (15%)
Query: 54 KAKIFIEEEIKTVTNNY---ADVIGCGGSGNVYKGFLPDRT---PVAVK--KSKIVDQTK 105
+ + ++ N Y + +G G V + ++ A K K + Q
Sbjct: 14 GTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCI--SKSTGQEYAAKFLKKRRRGQDC 71
Query: 106 IDEFINELVVVSQIN-RRNVVRLLACCLETQVPL-LVYEFVGNGTLFEHI--HKNGNLTW 161
E ++E+ V+ V+ L E + L+ E+ G +F ++
Sbjct: 72 RAEILHEIAVLELAKSCPRVINLHEVY-ENTSEIILILEYAAGGEIFSLCLPELAEMVS- 129
Query: 162 ERRLRIAAETA----GVLSYLHSETNVPIIHRDVKSANILL---DENYTPKVSDFGASKL 214
E + YLH I+H D+K NILL K+ DFG S+
Sbjct: 130 END---VIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK 183
Query: 215 VPIDAIQNYTVVQGTLGYIDPEYLQ 239
I + GT Y+ PE L
Sbjct: 184 --IGHACELREIMGTPEYLAPEILN 206
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 5e-13
Identities = 58/211 (27%), Positives = 86/211 (40%), Gaps = 52/211 (24%)
Query: 68 NNYA--DVIGCGGSGNVYKGF-LPDRTPVAVK---KSKIVDQ-------------TKIDE 108
N Y D IG G G V + D T A+K K K++ Q
Sbjct: 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72
Query: 109 FINELVVVSQINR----------RNVVRL---LACCLETQVPLLVYEFVGNGTLFEHIHK 155
I + Q+ + NVV+L L E + +V+E V G + E +
Sbjct: 73 CIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL-YMVFELVNQGPVME-VPT 130
Query: 156 NGNLTWERRLR------IAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDF 209
L+ E + R I + YLH + IIHRD+K +N+L+ E+ K++DF
Sbjct: 131 LKPLS-EDQARFYFQDLIKG-----IEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADF 181
Query: 210 GASKL-VPIDAIQNYTVVQGTLGYIDPEYLQ 239
G S DA+ + TV GT ++ PE L
Sbjct: 182 GVSNEFKGSDALLSNTV--GTPAFMAPESLS 210
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 1e-09
Identities = 47/181 (25%), Positives = 75/181 (41%), Gaps = 20/181 (11%)
Query: 66 VTNNYADV--IGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINR- 121
++Y V +G G V++ + + V VK K V + KI E+ ++ +
Sbjct: 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI---KREIKILENLRGG 90
Query: 122 RNVVRLLACCL--ETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLH 179
N++ L ++ P LV+E V N + LT E L Y H
Sbjct: 91 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCH 147
Query: 180 SETNVPIIHRDVKSANILLD-ENYTPKVSDFG-ASKLVPIDAIQNYTVVQGTLGYIDPEY 237
S I+HRDVK N+++D E+ ++ D+G A P Q Y V + + PE
Sbjct: 148 SMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP---GQEYNVRVASRYFKGPEL 201
Query: 238 L 238
L
Sbjct: 202 L 202
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 55.6 bits (135), Expect = 2e-09
Identities = 48/181 (26%), Positives = 79/181 (43%), Gaps = 19/181 (10%)
Query: 68 NNYA--DVIGCGGSGNVYKGFLPDRTP---VAVKKSKIVDQTKIDEFIN--ELVVVSQIN 120
Y IG G G V+K +R VA+KK + + + I E+ ++ Q+
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCR--NRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK 60
Query: 121 RRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLR-IAAETAGVLSYLH 179
N+V LL + LV+E+ + T+ + + E ++ I +T +++ H
Sbjct: 61 HPNLVNLLEVFRRKRRLHLVFEYC-DHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 180 SETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYT--VVQGTLGYIDPEY 237
IHRDVK NIL+ ++ K+ DFG ++L+ Y V T Y PE
Sbjct: 120 KHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTG-PSDYYDDEVA--TRWYRSPEL 173
Query: 238 L 238
L
Sbjct: 174 L 174
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 2e-09
Identities = 45/185 (24%), Positives = 82/185 (44%), Gaps = 33/185 (17%)
Query: 72 DVIGCGGSGNVYKGFLPDRTP---VAVKKSKI------VDQTKIDEFINELVVVSQINRR 122
+G G G VYK D VA+K+ ++ V T I E ++ L ++ R
Sbjct: 40 TKLGEGTYGEVYKAI--DTVTNETVAIKRIRLEHEEEGVPGTAIRE-VSLL---KELQHR 93
Query: 123 NVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSET 182
N++ L + L++E+ L +++ KN +++ + +++ HS
Sbjct: 94 NIIELKSVIHHNHRLHLIFEYA-ENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR 152
Query: 183 NVPIIHRDVKSANILLDENYTP-----KVSDFGASKL--VPIDAIQNYT--VVQGTLGYI 233
+HRD+K N+LL + K+ DFG ++ +P I+ +T ++ TL Y
Sbjct: 153 ---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP---IRQFTHEII--TLWYR 204
Query: 234 DPEYL 238
PE L
Sbjct: 205 PPEIL 209
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-09
Identities = 42/158 (26%), Positives = 69/158 (43%), Gaps = 27/158 (17%)
Query: 73 VIGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINR-RNVVRLLAC 130
V+G G +G V + F + A+K ++ + E+ + + ++ ++VR++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALK---MLQ--DCPKARREVELHWRASQCPHIVRIVDV 79
Query: 131 CLETQVP-----LLVYEFVGNGTLFEHIHKNGNLTW-ERRLRIAAET----AGVLSYLHS 180
E L+V E + G LF I G+ + ER A+E + YLHS
Sbjct: 80 Y-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE---ASEIMKSIGEAIQYLHS 135
Query: 181 ETNVPIIHRDVKSANILL---DENYTPKVSDFGASKLV 215
I HRDVK N+L N K++DFG +K
Sbjct: 136 IN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 170
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 4e-09
Identities = 57/214 (26%), Positives = 87/214 (40%), Gaps = 23/214 (10%)
Query: 14 WLHFLWTRRRHMKLKEKFFKQNG-GSILRQELSKLQGRSSEKAKI-FIEEEIK----TVT 67
LHFL+ + F Q + ++K S K F E+ TV
Sbjct: 2 SLHFLYYCSEPTLDVKIAFCQGFDKQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVL 61
Query: 68 NNYADV--IGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKID--EFINELVVVSQINRR 122
Y ++ IG G G V + VA+KK Q + ELV++ +N +
Sbjct: 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 121
Query: 123 NVVRLL-----ACCLETQVPL-LVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLS 176
N++ LL LE + LV E + L + I L ER + + +
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQME--LDHERMSYLLYQMLCGIK 178
Query: 177 YLHSETNVPIIHRDVKSANILLDENYTPKVSDFG 210
+LHS IIHRD+K +NI++ + T K+ DFG
Sbjct: 179 HLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG 209
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 4e-09
Identities = 52/194 (26%), Positives = 80/194 (41%), Gaps = 35/194 (18%)
Query: 64 KTVTNNYAD--VIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFIN-ELVVVSQIN 120
+ Y + VIG G G V++ L + VA+KK V Q K F N EL ++ +
Sbjct: 36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKK---VLQDK--RFKNRELQIMRIVK 90
Query: 121 RRNVVRLLACCLETQVPL------LVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGV 174
NVV L A LV E+V E +++ + + + +
Sbjct: 91 HPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP-----ETVYRASRHYAKLKQTMPMLLIKL 145
Query: 175 --------LSYLHSETNVPIIHRDVKSANILLDEN-YTPKVSDFG-ASKLVPIDAIQNYT 224
L+Y+HS + I HRD+K N+LLD K+ DFG A L+ + +Y
Sbjct: 146 YMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYI 202
Query: 225 VVQGTLGYIDPEYL 238
+ Y PE +
Sbjct: 203 C---SRYYRAPELI 213
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 7e-09
Identities = 49/175 (28%), Positives = 83/175 (47%), Gaps = 17/175 (9%)
Query: 72 DVIGCGGSGNVYKGFLPDRT---PVAVKKSKIVDQTKIDEFIN--ELVVVSQINRRNVVR 126
++G G G V K ++ VA+KK D K+ + I E+ ++ Q+ N+V
Sbjct: 31 GLVGEGSYGMVMKCR--NKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVN 88
Query: 127 LLACCLETQVPLLVYEFVGNGTLFEHIHKNGN-LTWERRLRIAAETAGVLSYLHSETNVP 185
LL C + + LV+EFV + T+ + + N L ++ + + + + HS
Sbjct: 89 LLEVCKKKKRWYLVFEFV-DHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN--- 144
Query: 186 IIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYT--VVQGTLGYIDPEYL 238
IIHRD+K NIL+ ++ K+ DFG ++ + + Y V T Y PE L
Sbjct: 145 IIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYDDEVA--TRWYRAPELL 196
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 54.1 bits (129), Expect = 7e-09
Identities = 32/191 (16%), Positives = 56/191 (29%), Gaps = 51/191 (26%)
Query: 74 IGCGGSGNVYKGFLPDRTPVAVKKSKIVD--------QTKIDEFINELVVVSQINRR--- 122
IG G G V++ D TPVA+K I Q +E + E+++ +++
Sbjct: 28 IGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGE 86
Query: 123 ------NVVRLLACCL------------------------------ETQVPLLVYEFVGN 146
+ L + + +V EF
Sbjct: 87 VCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG 146
Query: 147 GTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKV 206
G E + + I + L+ + HRD+ N+LL + K+
Sbjct: 147 GIDLEQMRTK-LSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNVLLKKTSLKKL 203
Query: 207 SDFGASKLVPI 217
K I
Sbjct: 204 HYTLNGKSSTI 214
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 1e-08
Identities = 48/184 (26%), Positives = 76/184 (41%), Gaps = 30/184 (16%)
Query: 74 IGCGGSGNVYKGFLPDRT--PVAVKKSKI------VDQTKIDEFINELVVVSQINRRNVV 125
IG G G V+K VA+K+ ++ + + I E + L + NVV
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE-VAVLRHLETFEHPNVV 77
Query: 126 RLLACCLETQVPL-----LVYEFVGN--GTLFEHIHKNGNLTWERRLRIAAETAGVLSYL 178
RL C ++ LV+E V T + + E + + L +L
Sbjct: 78 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFL 136
Query: 179 HSETNVPIIHRDVKSANILLDENYTPKVSDFGASKL--VPIDAIQNYT--VVQGTLGYID 234
HS ++HRD+K NIL+ + K++DFG +++ + T VV TL Y
Sbjct: 137 HSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM----ALTSVVV--TLWYRA 187
Query: 235 PEYL 238
PE L
Sbjct: 188 PEVL 191
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 1e-08
Identities = 55/193 (28%), Positives = 83/193 (43%), Gaps = 36/193 (18%)
Query: 64 KTVTNNYAD--VIGCGGSGNVYKGFL-PDRTPVAVKKSKIVDQTKIDEFIN-ELVVVSQI 119
+ +Y D VIG G G VY+ L VA+KK V Q K F N EL ++ ++
Sbjct: 50 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK---VLQDK--RFKNRELQIMRKL 104
Query: 120 NRRNVVRLLACCLETQ-----VPL-LVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAG 173
+ N+VRL + V L LV ++V T++ + +
Sbjct: 105 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHY----SRAKQTLPVIYVK 159
Query: 174 V--------LSYLHSETNVPIIHRDVKSANILLDEN-YTPKVSDFG-ASKLVPIDAIQNY 223
+ L+Y+HS I HRD+K N+LLD + K+ DFG A +LV + +Y
Sbjct: 160 LYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 216
Query: 224 TVVQGTLGYIDPE 236
+ Y PE
Sbjct: 217 IC---SRYYRAPE 226
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-08
Identities = 42/171 (24%), Positives = 68/171 (39%), Gaps = 26/171 (15%)
Query: 58 FIEEEIK----TVTNNYADV--IGCGGSGNVYKGF-LPDRTPVAVKK-----SKIVDQTK 105
F +E+ V Y D+ +G G G V VA+KK + +
Sbjct: 11 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 70
Query: 106 IDEFINELVVVSQINRRNVVRLLACCLETQVPL------LVYEFVGNGTLFEHIHKNGNL 159
EL ++ + NV+ LL + LV F+G T + K+ L
Sbjct: 71 A---YRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMG--TDLGKLMKHEKL 125
Query: 160 TWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFG 210
+R + + L Y+H+ IIHRD+K N+ ++E+ K+ DFG
Sbjct: 126 GEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFG 173
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-08
Identities = 49/182 (26%), Positives = 78/182 (42%), Gaps = 20/182 (10%)
Query: 44 LSKLQGRSSEKAKIFIEEEIK----TVTNNYADV--IGCGGSGNVYKGF-LPDRTPVAVK 96
++ S++ F +E+ V Y ++ +G G G+V F VAVK
Sbjct: 1 MAHHHHHHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK 60
Query: 97 KSKIVDQTKID--EFINELVVVSQINRRNVVRLL-----ACCLETQVPL-LVYEFVGNGT 148
K Q+ I EL ++ + NV+ LL A LE + LV +G
Sbjct: 61 KLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG--A 118
Query: 149 LFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSD 208
+I K LT + + + L Y+HS IIHRD+K +N+ ++E+ K+ D
Sbjct: 119 DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILD 175
Query: 209 FG 210
FG
Sbjct: 176 FG 177
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 3e-08
Identities = 44/196 (22%), Positives = 80/196 (40%), Gaps = 30/196 (15%)
Query: 33 KQNGGSILRQELSKLQGRSSEKAKIFIEEEIKTVTNNYA--DVIGCGGSGNVYKGF-LPD 89
GS + K S A + + + Y +IG G G+V + + +
Sbjct: 18 HTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLE 77
Query: 90 RTPVAVKKSKIVDQTKID--EFINELVVVSQINRRNVVRLLACCLETQVPL-----LVYE 142
+ VA+KK V + ID + E+ +++++N +VV++L + V +V E
Sbjct: 78 KRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLE 137
Query: 143 FVGNGT-LFEHIHKNGNLTWERR-------LRIAAETAGVLSYLHSETNVPIIHRDVKSA 194
+ + LT L + Y+HS + +HRD+K A
Sbjct: 138 IAD--SDFKKLFRTPVYLTELHIKTLLYNLLV-------GVKYVHS-AGI--LHRDLKPA 185
Query: 195 NILLDENYTPKVSDFG 210
N L++++ + KV DFG
Sbjct: 186 NCLVNQDCSVKVCDFG 201
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 52.1 bits (126), Expect = 3e-08
Identities = 45/177 (25%), Positives = 77/177 (43%), Gaps = 26/177 (14%)
Query: 74 IGCGGSGNVYKGFLPDRT--PVAVKKSKI------VDQTKIDEFINELVVVSQINRRNVV 125
IG G G VYK + A+KK ++ + T I E I+ L ++ N+V
Sbjct: 10 IGEGTYGVVYKAQ--NNYGETFALKKIRLEKEDEGIPSTTIRE-ISIL---KELKHSNIV 63
Query: 126 RLLACCLETQVPLLVYEFVGN--GTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETN 183
+L + +LV+E + L + G L + ++Y H
Sbjct: 64 KLYDVIHTKKRLVLVFEHLDQDLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRR- 120
Query: 184 VPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYT--VVQGTLGYIDPEYL 238
++HRD+K N+L++ K++DFG ++ I ++ YT +V TL Y P+ L
Sbjct: 121 --VLHRDLKPQNLLINREGELKIADFGLARAFGIP-VRKYTHEIV--TLWYRAPDVL 172
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 4e-08
Identities = 35/151 (23%), Positives = 55/151 (36%), Gaps = 16/151 (10%)
Query: 72 DVIGCGGSGNVYKGFL------PDRTPVAVKKSK-IVDQTKIDEFINELVVVSQINR-RN 123
+G G G V + VAVK K ++ ++EL ++ I N
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 124 VVRLLACCLETQVPLLV-YEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSET 182
VV LL C + PL+V EF G L ++ N + + A G Y+ +
Sbjct: 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGK-DYVGA-- 144
Query: 183 NVPIIHRDVKSANILLDENYTPKVSDFGASK 213
I D+K + + + S F K
Sbjct: 145 ----IPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 2e-06
Identities = 19/66 (28%), Positives = 30/66 (45%), Gaps = 3/66 (4%)
Query: 150 FEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDF 209
LT E + + + A + +L S IHRD+ + NILL E K+ DF
Sbjct: 181 APEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDF 237
Query: 210 GASKLV 215
G ++ +
Sbjct: 238 GLARDI 243
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 4e-08
Identities = 43/184 (23%), Positives = 75/184 (40%), Gaps = 35/184 (19%)
Query: 48 QGRSSEKAKIFIEEEIK-TVTNNYADV--IGCGGSGNVYKGF-LPDRTPVAVKK-----S 98
SS + ++ + V +NY IG G G VY + VA+KK
Sbjct: 5 HHHSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFE 64
Query: 99 KIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPL-----LVYEFVGNGTLFEHI 153
++D +I + E+ +++++ ++RL + + +V E + L +
Sbjct: 65 DLIDCKRI---LREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLF 120
Query: 154 HKNGNLTWERR-------LRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKV 206
LT E L +++H IIHRD+K AN LL+++ + KV
Sbjct: 121 KTPIFLTEEHIKTILYNLLL-------GENFIHE---SGIIHRDLKPANCLLNQDCSVKV 170
Query: 207 SDFG 210
DFG
Sbjct: 171 CDFG 174
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 6e-08
Identities = 50/189 (26%), Positives = 78/189 (41%), Gaps = 27/189 (14%)
Query: 65 TVTNNYADV--IGCGGSGNVYKGF-LPDRTPVAVKK-----SKIVDQTKIDEFINELVVV 116
TV Y ++ IG G G V + VA+KK + ELV++
Sbjct: 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRA---YRELVLM 78
Query: 117 SQINRRNVVRLL-----ACCLETQVPL-LVYEFVGNGTLFEHIHKNGNLTWERRLRIAAE 170
+N +N++ LL LE + +V E + L + I L ER + +
Sbjct: 79 KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQME--LDHERMSYLLYQ 135
Query: 171 TAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFG-ASKLVPIDAIQNYTVVQGT 229
+ +LHS + IHRD+K +NI++ + T K+ DFG A + Y V T
Sbjct: 136 MLCGIKHLHS-AGI--IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV---T 189
Query: 230 LGYIDPEYL 238
Y PE +
Sbjct: 190 RYYRAPEVI 198
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 51.0 bits (123), Expect = 7e-08
Identities = 49/211 (23%), Positives = 91/211 (43%), Gaps = 32/211 (15%)
Query: 40 LRQELSKLQGRSSEKAKIFIEEEIKTVTNNYADVIGCGGSGNVYKGFLPDRT--PVAVKK 97
+ GR + + +E+ K + +G G G VYK D VA+K+
Sbjct: 1 MHHHHHHSSGRENLYFQGLMEKYQKL------EKVGEGTYGVVYKAK--DSQGRIVALKR 52
Query: 98 SKI------VDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGN--GTL 149
++ + T I E I+ L +++ N+V L+ + LV+EF+ +
Sbjct: 53 IRLDAEDEGIPSTAIRE-ISLL---KELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKV 108
Query: 150 FEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDF 209
+ L + + +++ H I+HRD+K N+L++ + K++DF
Sbjct: 109 LDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADF 163
Query: 210 GASKLVPIDAIQNYT--VVQGTLGYIDPEYL 238
G ++ I +++YT VV TL Y P+ L
Sbjct: 164 GLARAFGIP-VRSYTHEVV--TLWYRAPDVL 191
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 8e-08
Identities = 43/208 (20%), Positives = 75/208 (36%), Gaps = 40/208 (19%)
Query: 59 IEEEIKTVTNNYAD--VIGCGGSGNVYKGFL-PDRTPVAVKKSKIVDQTKIDEF--INEL 113
+E + + + + G G G V G VA+KK V Q + +
Sbjct: 14 ADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKK---VIQDPRFRNRELQIM 70
Query: 114 VVVSQINRRNVVRLLACCLETQVP-------LLVYEFVGNGTLFEHI----HKNGNLTWE 162
++ ++ N+V+L + +V E+V + TL +
Sbjct: 71 QDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPI 129
Query: 163 RR-------LRIAAETAGVLSYLHSETNVPIIHRDVKSANILLD-ENYTPKVSDFG-ASK 213
+R + LH + V + HRD+K N+L++ + T K+ DFG A K
Sbjct: 130 LIKVFLFQLIR-------SIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKK 181
Query: 214 LVPIDAIQNYTVVQGTLGYIDPEYLQTC 241
L P + Y + Y PE +
Sbjct: 182 LSPSEPNVAYIC---SRYYRAPELIFGN 206
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 1e-07
Identities = 51/188 (27%), Positives = 77/188 (40%), Gaps = 36/188 (19%)
Query: 74 IGCGGSGNVYKGFLPDRTP---VAVKKSKI---------VDQTKIDEFINELVVVSQINR 121
IG G G VYK D VA+K ++ + + + E + L +
Sbjct: 17 IGVGAYGTVYKAR--DPHSGHFVALKSVRVPNGGGGGGGLPISTVRE-VALLRRLEAFEH 73
Query: 122 RNVVRLLACCLETQVPL-----LVYEFVGN--GTLFEHIHKNGNLTWERRLRIAAETAGV 174
NVVRL+ C ++ LV+E V T + L E + +
Sbjct: 74 PNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDK-APPPGLPAETIKDLMRQFLRG 132
Query: 175 LSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKL--VPIDAIQNYT--VVQGTL 230
L +LH+ I+HRD+K NIL+ T K++DFG +++ + T VV TL
Sbjct: 133 LDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQM----ALTPVVV--TL 183
Query: 231 GYIDPEYL 238
Y PE L
Sbjct: 184 WYRAPEVL 191
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 1e-07
Identities = 43/194 (22%), Positives = 76/194 (39%), Gaps = 44/194 (22%)
Query: 74 IGCGGSGNVYKGFLPDRTP---VAVKKSKI--VDQTKIDEFINELVVVSQINRRNVVRLL 128
+G G G+VYK D A+K+ + + + E+ ++ ++ NV+ L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC----REIALLRELKHPNVISLQ 84
Query: 129 ACCLETQVPL--LVYEFVGNGTLFEH----IHKNGNLTWERRLRIAAETAGV-------- 174
L L++++ EH I K + + + V
Sbjct: 85 KVFLSHADRKVWLLFDYA------EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 138
Query: 175 --LSYLHSETNVPIIHRDVKSANILLDENYTP----KVSDFGASKL--VPIDAIQNYT-- 224
+ YLH+ ++HRD+K ANIL+ K++D G ++L P+ + +
Sbjct: 139 DGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 195
Query: 225 VVQGTLGYIDPEYL 238
VV T Y PE L
Sbjct: 196 VV--TFWYRAPELL 207
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-07
Identities = 37/160 (23%), Positives = 63/160 (39%), Gaps = 23/160 (14%)
Query: 65 TVTNNYADV--IGCGGSGNVYKGF-LPDRTPVAVKK-----SKIVDQTKIDEFINELVVV 116
+ Y +G G G+V VA+KK + + EL+++
Sbjct: 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRA---YRELLLL 77
Query: 117 SQINRRNVVRLL-----ACCLETQVPL-LVYEFVGNGTLFEHIHKNGNLTWERRLRIAAE 170
+ NV+ LL A L LV F+ L + + + E+ + +
Sbjct: 78 KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLK--FSEEKIQYLVYQ 134
Query: 171 TAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFG 210
L Y+HS V +HRD+K N+ ++E+ K+ DFG
Sbjct: 135 MLKGLKYIHS-AGV--VHRDLKPGNLAVNEDCELKILDFG 171
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 49.4 bits (119), Expect = 2e-07
Identities = 49/180 (27%), Positives = 80/180 (44%), Gaps = 26/180 (14%)
Query: 72 DVIGCGGSGNVYKGFLPDRT---PVAVKKSKI------VDQTKIDEFINELVVVSQINRR 122
+ IG G G VYK ++ VA+KK ++ V T I E I+ L ++N
Sbjct: 9 EKIGEGTYGVVYKAR--NKLTGEVVALKKIRLDTETEGVPSTAIRE-ISLL---KELNHP 62
Query: 123 NVVRLLACCLETQVPLLVYEFVGN--GTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHS 180
N+V+LL LV+EF+ + + + L++ HS
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 181 ETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYT--VVQGTLGYIDPEYL 238
++HRD+K N+L++ K++DFG ++ + ++ YT VV TL Y PE L
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVV--TLWYRAPEIL 175
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 3e-07
Identities = 49/178 (27%), Positives = 82/178 (46%), Gaps = 27/178 (15%)
Query: 74 IGCGGSGNVYKGFLPDRT---PVAVKKSKI------VDQTKIDEFINELVVVSQINRRNV 124
IG G G V+K +R VA+K+ ++ V + + E I L ++ +N+
Sbjct: 10 IGEGTYGTVFKAK--NRETHEIVALKRVRLDDDDEGVPSSALRE-ICLL---KELKHKNI 63
Query: 125 VRLLACCLETQVPLLVYEFVGN--GTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSET 182
VRL + LV+EF F+ NG+L E + L + HS
Sbjct: 64 VRLHDVLHSDKKLTLVFEFCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 183 NVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYT--VVQGTLGYIDPEYL 238
++HRD+K N+L++ N K+++FG ++ I ++ Y+ VV TL Y P+ L
Sbjct: 122 ---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCYSAEVV--TLWYRPPDVL 173
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 3e-07
Identities = 38/170 (22%), Positives = 69/170 (40%), Gaps = 44/170 (25%)
Query: 65 TVTNNYADV--IGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKIDEFIN---------E 112
V Y ++ IG G G V + ++ VA+KK I F + E
Sbjct: 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKK--------ISPFEHQTYCQRTLRE 75
Query: 113 LVVVSQINRRNVVRLL----ACCLETQVPL-LVYEFVGNGTLFEHIHKNGNLTWERR--- 164
+ ++ + N++ + A +E + +V + + T + K +L+ +
Sbjct: 76 IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME--TDLYKLLKTQHLSNDHICYF 133
Query: 165 ----LRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFG 210
LR L Y+HS ++HRD+K +N+LL+ K+ DFG
Sbjct: 134 LYQILR-------GLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFG 173
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 4e-07
Identities = 44/182 (24%), Positives = 74/182 (40%), Gaps = 32/182 (17%)
Query: 72 DVIGCGGSGNVYKGFLPDRT--PVAVKKSKI-----VDQTKIDEFINELVVVSQINRRNV 124
D +G G VYKG T VA+K+ ++ T I E ++ L + N+
Sbjct: 8 DKLGEGTYATVYKGKSK-LTDNLVALKEIRLEHEEGAPCTAIRE-VSLL---KDLKHANI 62
Query: 125 VRLLACCLETQVPLLVYEFVGNGTLFEH------IHKNGNLTWERRLRIAAETAGVLSYL 178
V L + LV+E++ + + + L+Y
Sbjct: 63 VTLHDIIHTEKSLTLVFEYL------DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYC 116
Query: 179 HSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYT--VVQGTLGYIDPE 236
H + ++HRD+K N+L++E K++DFG ++ I + Y VV TL Y P+
Sbjct: 117 HRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSI-PTKTYDNEVV--TLWYRPPD 170
Query: 237 YL 238
L
Sbjct: 171 IL 172
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 4e-07
Identities = 49/189 (25%), Positives = 83/189 (43%), Gaps = 41/189 (21%)
Query: 72 DVIGCGGSGNVYKGFLPDRT---PVAVKKSKI-----VDQTKIDEFINELVVVSQINRRN 123
+ +G G VYKG ++T VA+K+ K+ T I E I+ + ++ N
Sbjct: 11 EKLGNGTYATVYKGL--NKTTGVYVALKEVKLDSEEGTPSTAIRE-ISLM---KELKHEN 64
Query: 124 VVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGV--------- 174
+VRL LV+EF+ + L +++ R L E V
Sbjct: 65 IVRLYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGL----ELNLVKYFQWQLLQ 119
Query: 175 -LSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKL--VPIDAIQNYT--VVQGT 229
L++ H I+HRD+K N+L+++ K+ DFG ++ +P + ++ VV T
Sbjct: 120 GLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP---VNTFSSEVV--T 171
Query: 230 LGYIDPEYL 238
L Y P+ L
Sbjct: 172 LWYRAPDVL 180
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 1e-06
Identities = 55/199 (27%), Positives = 86/199 (43%), Gaps = 40/199 (20%)
Query: 62 EIKTVTNNYA--DVIGCGGSGNVYKGFLPDRT---PVAVKKSKIVDQTKIDEFIN----- 111
++K+ Y D +G G VYK D+ VA+KK K+ +++ + IN
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKAR--DKNTNQIVAIKKIKLGHRSEAKDGINRTALR 61
Query: 112 ELVVVSQINRRNVVRLLACCLETQVPLLVYEFV----------GNGTLFEHIHKNGNLTW 161
E+ ++ +++ N++ LL LV++F+ + L K +
Sbjct: 62 EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIK----AY 117
Query: 162 ERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ 221
G L YLH I+HRD+K N+LLDEN K++DFG +K +
Sbjct: 118 MLMT-----LQG-LEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS-PNR 167
Query: 222 NYT--VVQGTLGYIDPEYL 238
YT VV T Y PE L
Sbjct: 168 AYTHQVV--TRWYRAPELL 184
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-06
Identities = 33/171 (19%), Positives = 67/171 (39%), Gaps = 40/171 (23%)
Query: 72 DVIGCGGSGNVYKGF-LPDRTPVAVK--KSK------IVDQTKIDEFINELVVVSQ--IN 120
+G G V+ + + T VA+K + D+ K+ + +N+ + +
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 121 RRNVVRLLAC-----------CLETQVPLLVYEFVGNGTLFEHIHKNGN--LTWERRLRI 167
++++LL + V+E +G L I K + + +I
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVM-------VFEVLGE-NLLALIKKYEHRGIPLIYVKQI 136
Query: 168 AAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTP------KVSDFGAS 212
+ + L Y+H IIH D+K N+L++ +P K++D G +
Sbjct: 137 SKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-06
Identities = 34/165 (20%), Positives = 63/165 (38%), Gaps = 23/165 (13%)
Query: 65 TVTNNYADV--IGCGGSGNVYKGFLPDRTPVAVKK--SKIVDQTKIDEFIN--------- 111
+ + Y I G G V G + PVA+K+ + + D ++ +
Sbjct: 19 AMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR 78
Query: 112 ELVVVSQINRRNVVRLLACCLETQVPL-----LVYEFVGNGTLFEHIHKN-GNLTWERRL 165
E+ +++ + N++ L + + P LV E + L + IH ++ +
Sbjct: 79 EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQ 137
Query: 166 RIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFG 210
L LH ++HRD+ NILL +N + DF
Sbjct: 138 YFMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFN 179
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 2e-06
Identities = 55/193 (28%), Positives = 74/193 (38%), Gaps = 45/193 (23%)
Query: 74 IGCGGSGNVYKGFLPDRT---PVAVKKSKI------VDQTKIDEFINELVVVSQINRRNV 124
IG G G V+K R VA+KK + T + E I L + NV
Sbjct: 25 IGQGTFGEVFKAR--HRKTGQKVALKKVLMENEKEGFPITALRE-IKIL---QLLKHENV 78
Query: 125 VRLLACCLETQVPL--------LVYEFVGNGTLFEH------IHKNGNLTWERRLRIAAE 170
V L+ C P LV++F EH + T R+
Sbjct: 79 VNLIEICRTKASPYNRCKGSIYLVFDFC------EHDLAGLLSNVLVKFTLSEIKRVMQM 132
Query: 171 TAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFG---ASKLVPIDAIQNYT--V 225
L Y+H I+HRD+K+AN+L+ + K++DFG A L YT V
Sbjct: 133 LLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 189
Query: 226 VQGTLGYIDPEYL 238
V TL Y PE L
Sbjct: 190 V--TLWYRPPELL 200
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-06
Identities = 41/163 (25%), Positives = 60/163 (36%), Gaps = 38/163 (23%)
Query: 72 DVIGCGGSGNVYKGF-LPDRTPVAVK----KSKIVDQTKIDEFINELVVVSQIN------ 120
VIG G G V K + VA+K + + Q E+ ++ +
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAE-----EIRILEHLRKQDKDN 157
Query: 121 RRNVVRLLAC-------CLETQVPLLVYEFVGNGTLFEHIHKNGN--LTWERRLRIAAET 171
NV+ +L C+ +E + L+E I KN + + A
Sbjct: 158 TMNVIHMLENFTFRNHICM-------TFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSI 209
Query: 172 AGVLSYLHSETNVPIIHRDVKSANILLDENYTP--KVSDFGAS 212
L LH IIH D+K NILL + KV DFG+S
Sbjct: 210 LQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS 249
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 3e-06
Identities = 33/170 (19%), Positives = 60/170 (35%), Gaps = 44/170 (25%)
Query: 65 TVTNNYADV--IGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKIDEFIN---------E 112
+++++ +G G G V P VA+KK I+ F E
Sbjct: 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKK--------IEPFDKPLFALRTLRE 59
Query: 113 LVVVSQINRRNVVRLLACCLETQVPL-----LVYEFVGNGTLFEHIHKNGNLTWERR--- 164
+ ++ N++ + ++ E + T + L+ +
Sbjct: 60 IKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ--TDLHRVISTQMLSDDHIQYF 117
Query: 165 ----LRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFG 210
LR + LH +IHRD+K +N+L++ N KV DFG
Sbjct: 118 IYQTLR-------AVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFG 157
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 5e-06
Identities = 37/167 (22%), Positives = 72/167 (43%), Gaps = 29/167 (17%)
Query: 65 TVTNNYADV--IGCGGSGNVYKGF-LPDRTPVAVKK---SKIVDQTKIDEFINELVVVSQ 118
+ + Y D+ +GCGG+G V+ VA+KK + + E+ ++ +
Sbjct: 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHA---LREIKIIRR 64
Query: 119 INRRNVVRLLACCLETQVPL--------------LVYEFVGNGTLFEHIHKNGNLTWERR 164
++ N+V++ + L +V E++ T ++ + G L E
Sbjct: 65 LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME--TDLANVLEQGPLLEEHA 122
Query: 165 LRIAAETAGVLSYLHSETNVPIIHRDVKSANILLD-ENYTPKVSDFG 210
+ L Y+HS ++HRD+K AN+ ++ E+ K+ DFG
Sbjct: 123 RLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFG 166
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 7e-06
Identities = 17/36 (47%), Positives = 24/36 (66%), Gaps = 3/36 (8%)
Query: 175 LSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFG 210
+ YLHS + +HRD+K +NILL+ KV+DFG
Sbjct: 122 IKYLHS-GGL--LHRDMKPSNILLNAECHVKVADFG 154
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 45.6 bits (107), Expect = 9e-06
Identities = 22/167 (13%), Positives = 50/167 (29%), Gaps = 42/167 (25%)
Query: 83 YKGFLPDRTPVAVKKSKIVDQTKIDEFINELV-------VVSQINRRNVVRLLACCLETQ 135
YK L V D + + ++ ++ + + L L ++
Sbjct: 18 YKDILSVFEDAFVDN---FDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSK 74
Query: 136 VPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRD--VKS 193
+V +FV E + N + +E P + ++
Sbjct: 75 QEEMVQKFVE-----EVLRINYKFLMSP--------------IKTEQRQPSMMTRMYIEQ 115
Query: 194 ANILLDENYTPKVSDFGASKLVPIDAIQN---------YTVVQGTLG 231
+ L ++N + + S+L P ++ ++ G LG
Sbjct: 116 RDRLYNDN--QVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLG 160
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-05
Identities = 38/163 (23%), Positives = 67/163 (41%), Gaps = 36/163 (22%)
Query: 72 DVIGCGGSGNVYKGF-LPDRTPVAVK----KSKIVDQTKIDEFINELVVVSQIN------ 120
+IG G G V K + ++ VA+K K ++Q +I E+ ++ +N
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQI-----EVRLLELMNKHDTEM 114
Query: 121 RRNVVRLLAC-------CLETQVPLLVYEFVGNGTLFEHIHKNGN--LTWERRLRIAAET 171
+ +V L CL V+E + L++ + ++ + A +
Sbjct: 115 KYYIVHLKRHFMFRNHLCL-------VFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQM 166
Query: 172 AGVLSYLHSETNVPIIHRDVKSANILLDENYTP--KVSDFGAS 212
L +L + + IIH D+K NILL K+ DFG+S
Sbjct: 167 CTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 1e-05
Identities = 27/149 (18%), Positives = 56/149 (37%), Gaps = 16/149 (10%)
Query: 74 IGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKIDEFINELVVVSQI-NRRNVVRLLACC 131
IG G G +++G L + VA+K ++ + +E + + +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTGIPNVYYFG 75
Query: 132 LETQVPLLVYEFVGN--GTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHR 189
E +LV + +G L + + + A + + +H ++ +++R
Sbjct: 76 QEGLHNVLVIDLLGPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYR 130
Query: 190 DVKSANILLDENYTPK-----VSDFGASK 213
D+K N L+ + V DFG K
Sbjct: 131 DIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 44.6 bits (105), Expect = 1e-05
Identities = 33/147 (22%), Positives = 63/147 (42%), Gaps = 14/147 (9%)
Query: 74 IGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKIDEFINELVVVSQIN-RRNVVRLLACC 131
IG G G +Y G + VA+K + +TK + + E + + + +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENV--KTKHPQLLYESKIYRILQGGTGIPNVRWFG 72
Query: 132 LETQVPLLVYEFVGN--GTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHR 189
+E +LV + +G LF + L+ + L +A + + ++HS++ +HR
Sbjct: 73 VEGDYNVLVMDLLGPSLEDLFNF--CSRKLSLKTVLMLADQMINRVEFVHSKS---FLHR 127
Query: 190 DVKSANILLDENYTPK---VSDFGASK 213
D+K N L+ + DFG +K
Sbjct: 128 DIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 1e-05
Identities = 38/206 (18%), Positives = 69/206 (33%), Gaps = 55/206 (26%)
Query: 65 TVTNNYAD--VIGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINR 121
T + Y+ +G G G V + F + A+KK + K EL ++ ++
Sbjct: 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKN----RELDIMKVLDH 59
Query: 122 RNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGV------- 174
N+++ L T + KN + + I +
Sbjct: 60 VNIIK-LVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118
Query: 175 -----------------------------------LSYLHSETNVPIIHRDVKSANILLD 199
+ ++HS + I HRD+K N+L++
Sbjct: 119 YVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVN 175
Query: 200 -ENYTPKVSDFG-ASKLVPIDAIQNY 223
++ T K+ DFG A KL+P + Y
Sbjct: 176 SKDNTLKLCDFGSAKKLIPSEPSVAY 201
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 1e-05
Identities = 34/161 (21%), Positives = 57/161 (35%), Gaps = 25/161 (15%)
Query: 74 IGCGGSGNVYKGF-LPDRTPVAVKKSKI--------VDQTKI------DEFINELVVVSQ 118
IG GG G +Y F A K+ + K + I + + Q
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 119 INRRNVVRLLAC----CLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGV 174
++ + +V E +G L + +NG L++ V
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQKISGQNGTFKKSTVLQLGIRMLDV 163
Query: 175 LSYLHSETNVPIIHRDVKSANILLDENYTPKV--SDFGASK 213
L Y+H +H D+K+AN+LL +V +D+G S
Sbjct: 164 LEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-05
Identities = 36/147 (24%), Positives = 61/147 (41%), Gaps = 14/147 (9%)
Query: 74 IGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKIDEFINELVVVSQIN-RRNVVRLLACC 131
IG G G++Y G + VA+K + +TK + E + + + + C
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVGIPTIRWCG 74
Query: 132 LETQVPLLVYEFVGN--GTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHR 189
E ++V E +G LF + + + L +A + + Y+HS+ IHR
Sbjct: 75 AEGDYNVMVMELLGPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHR 129
Query: 190 DVKSANILLDENYTPK---VSDFGASK 213
DVK N L+ + DFG +K
Sbjct: 130 DVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 4e-05
Identities = 33/149 (22%), Positives = 60/149 (40%), Gaps = 16/149 (10%)
Query: 74 IGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKIDEFINELVVVSQI-NRRNVVRLLACC 131
IGCG G + G L VA+K + +++ + E Q+ + + ++
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPM--KSRAPQLHLEYRFYKQLGSGDGIPQVYYFG 74
Query: 132 LETQVPLLVYEFVGN--GTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHR 189
+ +V E +G LF+ + + + L IA + + Y+HS+ +I+R
Sbjct: 75 PCGKYNAMVLELLGPSLEDLFDL--CDRTFSLKTVLMIAIQLISRMEYVHSKN---LIYR 129
Query: 190 DVKSANILLDENYTPKVS-----DFGASK 213
DVK N L+ DF +K
Sbjct: 130 DVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 6e-05
Identities = 32/166 (19%), Positives = 57/166 (34%), Gaps = 32/166 (19%)
Query: 74 IGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKID--------EFINELVVVSQINRRNVV 125
IG GG G +Y + V +V D +F QI +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 126 RLLACCLETQVPLLVY--EFVGNGTLF------------EHIHK--NGNLTWERRLRIAA 169
R L VP NG + + I++ + + L+++
Sbjct: 103 RKLKY---LGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSL 159
Query: 170 ETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKV--SDFGASK 213
+L Y+H +H D+K++N+LL+ +V D+G +
Sbjct: 160 RILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 6e-05
Identities = 35/149 (23%), Positives = 62/149 (41%), Gaps = 37/149 (24%)
Query: 74 IGCGGSGNVYKGF-LPDRTPVAVKKSKIV--DQTKIDEFINELVVVSQI--------NRR 122
+G G V+ + + + VA+K +V + + ++E+ ++ + NR
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMK---VVKSAEHYTETALDEIRLLKSVRNSDPNDPNRE 101
Query: 123 NVVRLLAC-----------CLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRL--RIAA 169
VV+LL C+ V+E +G+ L + I K+ +I
Sbjct: 102 MVVQLLDDFKISGVNGTHICM-------VFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQ 153
Query: 170 ETAGVLSYLHSETNVPIIHRDVKSANILL 198
+ L YLH++ IIH D+K NILL
Sbjct: 154 QVLQGLDYLHTKCR--IIHTDIKPENILL 180
|
| >1qzv_F Plant photosystem I: subunit PSAF; photosynthesis,plant photosynthetic reaction center, peripheral antenna; HET: CL1 PQN; 4.44A {Pisum sativum} SCOP: i.5.1.1 Length = 154 | Back alignment and structure |
|---|
Score = 40.3 bits (93), Expect = 1e-04
Identities = 12/59 (20%), Positives = 17/59 (28%), Gaps = 33/59 (55%)
Query: 41 RQELSKLQGRSSEKAKIFIEEEIKTVTNNYADVIGCGGSGNVYKGFLPDRTP-VAVKKS 98
+Q L KLQ +K YA D P +A+K +
Sbjct: 19 KQALKKLQAS------------LKL----YA----------------DDSAPALAIKAT 45
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 39.6 bits (93), Expect = 5e-04
Identities = 32/181 (17%), Positives = 61/181 (33%), Gaps = 56/181 (30%)
Query: 72 DVIGCGGSGNVYKGF--LPDRTPVAVK----KSKIVDQTKIDEFINELVVVSQIN----- 120
+G G G V + ++ VA+K K + ++ E+ V+ +I
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL-----EINVLKKIKEKDKE 79
Query: 121 -RRNVVRLLAC-------CLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRL--RIAAE 170
+ V + C+ +E +G FE + +N + +A +
Sbjct: 80 NKFLCVLMSDWFNFHGHMCI-------AFELLGK-NTFEFLKENNFQPYPLPHVRHMAYQ 131
Query: 171 TAGVLSYLHSETNVPIIHRDVKSANILLDENYTP-------------------KVSDFGA 211
L +LH + H D+K NIL + +V+DFG+
Sbjct: 132 LCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGS 188
Query: 212 S 212
+
Sbjct: 189 A 189
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 241 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.98 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.98 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.98 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.98 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.98 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.98 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.98 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.98 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.98 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.98 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.98 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.98 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.98 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.98 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.98 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.98 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.97 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.97 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.97 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.97 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.97 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.97 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.97 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.97 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.97 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.97 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.97 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.97 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.97 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.97 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.97 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.97 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.97 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.97 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.97 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.97 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.97 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.97 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.97 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.97 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.97 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.97 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.97 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.97 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.97 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.97 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.97 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.97 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.97 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.97 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.97 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.97 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.97 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.96 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.96 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.95 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.95 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.94 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.89 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.78 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.54 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.43 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.38 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 99.0 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.97 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.85 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.84 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.82 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.7 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.67 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.56 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.3 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.29 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.29 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.17 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.77 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.68 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.67 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.67 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.65 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.64 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.5 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.43 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.34 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.92 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.07 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 93.26 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 92.65 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 92.62 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 91.76 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 90.97 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 89.88 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 85.99 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=307.33 Aligned_cols=172 Identities=25% Similarity=0.374 Sum_probs=148.9
Q ss_pred hhhcccccccccCceeEEEEEeC------CCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP------DRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLL 139 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~l 139 (241)
..+.+.+.||+|+||+||+|++. ++..||||.++..+....++|.+|+.+|++++|||||+++|+|.+++..++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 45667889999999999999864 367899999987777777899999999999999999999999999999999
Q ss_pred EEEecCCCCchHHhhcC-------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEE
Q 039310 140 VYEFVGNGTLFEHIHKN-------------GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKV 206 (241)
Q Consensus 140 v~e~~~~g~L~~~l~~~-------------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl 206 (241)
|||||++|+|.++|... ..+++.++..++.|++.||.|||+++ |+||||||+|||+++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 99999999999999753 35999999999999999999999998 999999999999999999999
Q ss_pred ccCCCcccccCCccc-eeeeecccccccccccccC
Q 039310 207 SDFGASKLVPIDAIQ-NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 207 ~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~ 240 (241)
+|||+|+........ ......||+.|||||++.+
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~ 204 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY 204 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcC
Confidence 999999876443322 2223469999999999864
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-46 Score=304.71 Aligned_cols=171 Identities=26% Similarity=0.378 Sum_probs=152.6
Q ss_pred hhcccccccccCceeEEEEEe-CCCCeEEEEecccC---ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEE
Q 039310 67 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIV---DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYE 142 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e 142 (241)
.|.+.+.||+|+||+||+|+. .+++.||||.+... +....+.+.+|+++|+.++||||+++++++.+++..|+|||
T Consensus 33 dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmE 112 (311)
T 4aw0_A 33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 112 (311)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 478889999999999999985 46889999987532 23445788999999999999999999999999999999999
Q ss_pred ecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCc-cc
Q 039310 143 FVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDA-IQ 221 (241)
Q Consensus 143 ~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~-~~ 221 (241)
||+||+|.+++.+.+.+++.++..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|+.+..+. ..
T Consensus 113 y~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~ 189 (311)
T 4aw0_A 113 YAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 189 (311)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCC
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcc
Confidence 9999999999998889999999999999999999999999 9999999999999999999999999999875332 23
Q ss_pred eeeeecccccccccccccC
Q 039310 222 NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~~ 240 (241)
.....+||+.|||||++.+
T Consensus 190 ~~~~~~GTp~YmAPEvl~~ 208 (311)
T 4aw0_A 190 RANSFVGTAQYVSPELLTE 208 (311)
T ss_dssp CBCCCCSCGGGCCHHHHHH
T ss_pred cccCcccCcccCCHHHHcC
Confidence 3455689999999999864
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=305.13 Aligned_cols=175 Identities=23% Similarity=0.354 Sum_probs=149.4
Q ss_pred HHHhhhcccccccccCceeEEEEEeC------CCCeEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCC
Q 039310 63 IKTVTNNYADVIGCGGSGNVYKGFLP------DRTPVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCLETQ 135 (241)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 135 (241)
+....+.|.+.||+|+||+||+|.+. +++.||||.++.. +....++|.+|+.++++++|||||+++|+|.+++
T Consensus 23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~ 102 (308)
T 4gt4_A 23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ 102 (308)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECC
Confidence 34456778889999999999999863 4678999998653 3344678999999999999999999999999999
Q ss_pred cceEEEEecCCCCchHHhhcC----------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC
Q 039310 136 VPLLVYEFVGNGTLFEHIHKN----------------GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLD 199 (241)
Q Consensus 136 ~~~lv~e~~~~g~L~~~l~~~----------------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~ 199 (241)
..++|||||++|+|.++|... ..+++.++..++.|++.||+|||+++ ||||||||+|||++
T Consensus 103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVY 179 (308)
T ss_dssp SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEEC
Confidence 999999999999999999642 35899999999999999999999999 99999999999999
Q ss_pred CCCCeEEccCCCcccccCCcc-ceeeeecccccccccccccC
Q 039310 200 ENYTPKVSDFGASKLVPIDAI-QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 200 ~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~ 240 (241)
+++.+||+|||+|+.+..... .......||++|||||++.+
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~ 221 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY 221 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH
T ss_pred CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhC
Confidence 999999999999987644332 22344569999999999864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=306.56 Aligned_cols=169 Identities=28% Similarity=0.374 Sum_probs=150.2
Q ss_pred hhcccccccccCceeEEEEEeC-CCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecC
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVG 145 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~ 145 (241)
.|...+.||+|+||+||+|... +++.||||++...+....+.+.+|+.+|+.++|||||++++++.+++.+|+|||||+
T Consensus 75 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~ 154 (346)
T 4fih_A 75 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 154 (346)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred hcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCC
Confidence 3666778999999999999964 689999999876555555678899999999999999999999999999999999999
Q ss_pred CCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeee
Q 039310 146 NGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTV 225 (241)
Q Consensus 146 ~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~ 225 (241)
+|+|.+++.. +++++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+.... .....
T Consensus 155 gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~~~ 229 (346)
T 4fih_A 155 GGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKS 229 (346)
T ss_dssp TEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CCBCC
T ss_pred CCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC-Ccccc
Confidence 9999999976 46999999999999999999999999 9999999999999999999999999998765332 23455
Q ss_pred ecccccccccccccC
Q 039310 226 VQGTLGYIDPEYLQT 240 (241)
Q Consensus 226 ~~gt~~y~aPE~l~~ 240 (241)
.+||+.|||||++.+
T Consensus 230 ~~GTp~YmAPEvl~~ 244 (346)
T 4fih_A 230 LVGTPYWMAPELISR 244 (346)
T ss_dssp CCSCGGGCCHHHHTT
T ss_pred cccCcCcCCHHHHCC
Confidence 679999999999864
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=297.00 Aligned_cols=168 Identities=25% Similarity=0.351 Sum_probs=145.5
Q ss_pred cccccccccCceeEEEEEeC-CCCeEEEEeccc--CChhhHHHHHHHHHHHHcCCCCCceeEEEEEec----CCcceEEE
Q 039310 69 NYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKI--VDQTKIDEFINELVVVSQINRRNVVRLLACCLE----TQVPLLVY 141 (241)
Q Consensus 69 ~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~--~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~----~~~~~lv~ 141 (241)
.+.+.||+|+||+||+|.+. ++..||+|++.. ......+.+.+|+.+++.++|||||+++++|.+ .+.+|+||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 56678999999999999864 588999998754 344556789999999999999999999999865 34689999
Q ss_pred EecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC-CCCeEEccCCCcccccCCcc
Q 039310 142 EFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDE-NYTPKVSDFGASKLVPIDAI 220 (241)
Q Consensus 142 e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~-~~~~kl~Dfgla~~~~~~~~ 220 (241)
|||++|+|.+++.+.+.+++..+..++.|++.||+|||+++ ++|+||||||+|||+++ ++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~--- 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--- 184 (290)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT---
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC---
Confidence 99999999999998889999999999999999999999875 46999999999999984 78999999999986432
Q ss_pred ceeeeecccccccccccccC
Q 039310 221 QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 221 ~~~~~~~gt~~y~aPE~l~~ 240 (241)
......+|||.|||||++.+
T Consensus 185 ~~~~~~~GTp~YmAPE~~~~ 204 (290)
T 3fpq_A 185 SFAKAVIGTPEFMAPEMYEE 204 (290)
T ss_dssp TSBEESCSSCCCCCGGGGGT
T ss_pred CccCCcccCccccCHHHcCC
Confidence 23445679999999999864
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=305.64 Aligned_cols=172 Identities=23% Similarity=0.367 Sum_probs=143.3
Q ss_pred hhhcccccccccCceeEEEEEeC------CCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP------DRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLL 139 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~l 139 (241)
..+.+.+.||+|+||+||+|++. ++..||||.++..+....++|.+|+++|++++|||||+++++|.+.+..++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 34556778999999999999864 367899999987777778899999999999999999999999999999999
Q ss_pred EEEecCCCCchHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCe
Q 039310 140 VYEFVGNGTLFEHIHKN---------------GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTP 204 (241)
Q Consensus 140 v~e~~~~g~L~~~l~~~---------------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~ 204 (241)
|||||++|+|.++++.. .++++.++..++.|++.||.|||+++ ||||||||+|||+++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 99999999999999753 35899999999999999999999998 9999999999999999999
Q ss_pred EEccCCCcccccCCcc-ceeeeecccccccccccccC
Q 039310 205 KVSDFGASKLVPIDAI-QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 205 kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~ 240 (241)
||+|||+|+.+..... .......||+.|||||++.+
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~ 234 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY 234 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTT
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcC
Confidence 9999999987644332 22344569999999999875
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=303.99 Aligned_cols=170 Identities=23% Similarity=0.322 Sum_probs=143.6
Q ss_pred hhcccccccccCceeEEEEEe-CCCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 67 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
+|.+.+.||+|+||+||+|+. .+++.||||.+... +....+.+.+|+.+|+.++|||||++++++.+++..|+||||
T Consensus 25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy 104 (350)
T 4b9d_A 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDY 104 (350)
T ss_dssp CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 577888999999999999985 46899999987643 445567899999999999999999999999999999999999
Q ss_pred cCCCCchHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc
Q 039310 144 VGNGTLFEHIHKN--GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ 221 (241)
Q Consensus 144 ~~~g~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~ 221 (241)
|+||+|.+++... ..+++.++..++.|++.||.|||+++ |+||||||+|||+++++.+||+|||+|+.+.... .
T Consensus 105 ~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~ 180 (350)
T 4b9d_A 105 CEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV-E 180 (350)
T ss_dssp CTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-H
T ss_pred CCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc-c
Confidence 9999999999654 35799999999999999999999999 9999999999999999999999999998764321 2
Q ss_pred eeeeecccccccccccccC
Q 039310 222 NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~~ 240 (241)
.....+||+.|||||++.+
T Consensus 181 ~~~~~~GT~~YmAPE~l~~ 199 (350)
T 4b9d_A 181 LARACIGTPYYLSPEICEN 199 (350)
T ss_dssp HHHHHHSCCTTCCHHHHTT
T ss_pred cccccCCCccccCHHHHCC
Confidence 2344679999999999875
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=307.47 Aligned_cols=168 Identities=28% Similarity=0.384 Sum_probs=150.2
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCC
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGN 146 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~ 146 (241)
|.+.+.||+|+||.||+|... +++.||||++...+....+.+.+|+.+|+.++|||||+++++|.+.+.+|+|||||+|
T Consensus 153 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~g 232 (423)
T 4fie_A 153 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 232 (423)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred cEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCC
Confidence 566778999999999999964 5899999998766555567789999999999999999999999999999999999999
Q ss_pred CCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeeee
Q 039310 147 GTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVV 226 (241)
Q Consensus 147 g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 226 (241)
|+|.+++... .+++.++..++.|++.||.|||+++ ||||||||+|||++.+|.+||+|||+|+.+.... ......
T Consensus 233 G~L~~~i~~~-~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~~~~ 307 (423)
T 4fie_A 233 GALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSL 307 (423)
T ss_dssp EEHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-CCBCCC
T ss_pred CcHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC-cccccc
Confidence 9999999754 6999999999999999999999999 9999999999999999999999999998765432 234556
Q ss_pred cccccccccccccC
Q 039310 227 QGTLGYIDPEYLQT 240 (241)
Q Consensus 227 ~gt~~y~aPE~l~~ 240 (241)
+||+.|||||++.+
T Consensus 308 ~GTp~YmAPEvl~~ 321 (423)
T 4fie_A 308 VGTPYWMAPELISR 321 (423)
T ss_dssp EECTTTCCHHHHTT
T ss_pred ccCcCcCCHHHHCC
Confidence 79999999999864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-45 Score=298.83 Aligned_cols=172 Identities=30% Similarity=0.471 Sum_probs=143.1
Q ss_pred HHHHhhhcccccccccCceeEEEEEeCCCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceE
Q 039310 62 EIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLL 139 (241)
Q Consensus 62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~l 139 (241)
++....+.+.+.||+|+||+||+|++++ .||||.++.. +....+.|.+|+.++++++|||||++++++.+ +..++
T Consensus 32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~i 108 (307)
T 3omv_A 32 EIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAI 108 (307)
T ss_dssp BCCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred EEcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEE
Confidence 4444556778899999999999999754 5999987643 34556789999999999999999999998865 56899
Q ss_pred EEEecCCCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCC
Q 039310 140 VYEFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPID 218 (241)
Q Consensus 140 v~e~~~~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~ 218 (241)
|||||++|+|.+++... .++++.++..++.|++.||+|||+++ ||||||||+|||+++++.+||+|||+|+.....
T Consensus 109 VmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 109 VTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp EEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 99999999999999754 57999999999999999999999998 999999999999999999999999999876432
Q ss_pred c-cceeeeeccccccccccccc
Q 039310 219 A-IQNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 219 ~-~~~~~~~~gt~~y~aPE~l~ 239 (241)
. .......+||+.|||||++.
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~ 207 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIR 207 (307)
T ss_dssp --------CCCCTTSCCHHHHH
T ss_pred CcceeecccccCCCccCHHHhh
Confidence 2 22344567999999999985
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=290.78 Aligned_cols=169 Identities=21% Similarity=0.358 Sum_probs=136.8
Q ss_pred hhhcccccccccCceeEEEEEe-CCCCeEEEEecccC---ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIV---DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVY 141 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~ 141 (241)
..|.+.+.||+|+||+||+|.. .+++.||+|.+... +......+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 3578889999999999999985 46899999987542 2334567899999999999999999999999999999999
Q ss_pred EecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc
Q 039310 142 EFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ 221 (241)
Q Consensus 142 e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~ 221 (241)
||+ +|+|.+++...+++++.++..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|+..... .
T Consensus 93 Ey~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--~ 166 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG--N 166 (275)
T ss_dssp ECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred eCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC--C
Confidence 999 6799999998889999999999999999999999999 999999999999999999999999999876432 2
Q ss_pred eeeeecccccccccccccC
Q 039310 222 NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~~ 240 (241)
.....+||+.|||||++.+
T Consensus 167 ~~~~~~GT~~Y~APE~~~~ 185 (275)
T 3hyh_A 167 FLKTSCGSPNYAAPEVISG 185 (275)
T ss_dssp --------CTTSCHHHHSS
T ss_pred ccCCeeECcccCChhhhcC
Confidence 3345679999999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=298.16 Aligned_cols=165 Identities=25% Similarity=0.316 Sum_probs=141.7
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCC
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGN 146 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~ 146 (241)
+.+.+.||+|+||+||+|++. +++.||||+++.... ..+|+.+++.++|||||++++++.+++..|+|||||+|
T Consensus 60 ~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g 134 (336)
T 4g3f_A 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEG 134 (336)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred eEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCC
Confidence 455668999999999999954 588999998764322 24699999999999999999999999999999999999
Q ss_pred CCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC-CeEEccCCCcccccCCccc----
Q 039310 147 GTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENY-TPKVSDFGASKLVPIDAIQ---- 221 (241)
Q Consensus 147 g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~-~~kl~Dfgla~~~~~~~~~---- 221 (241)
|+|.+++...+++++.++..++.|++.||+|||+++ |+||||||+|||++.++ .+||+|||+|+.+..+...
T Consensus 135 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~ 211 (336)
T 4g3f_A 135 GSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLL 211 (336)
T ss_dssp CBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----------
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccccee
Confidence 999999998889999999999999999999999999 99999999999999987 6999999999877543322
Q ss_pred eeeeecccccccccccccC
Q 039310 222 NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~~ 240 (241)
.....+||+.|||||++.+
T Consensus 212 ~~~~~~GT~~YmAPE~~~~ 230 (336)
T 4g3f_A 212 TGDYIPGTETHMAPEVVMG 230 (336)
T ss_dssp --CCCCCCGGGCCHHHHTT
T ss_pred cCCccccCccccCHHHHCC
Confidence 1233579999999999875
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-45 Score=298.11 Aligned_cols=171 Identities=29% Similarity=0.287 Sum_probs=142.4
Q ss_pred hhhcccccccccCceeEEEEEeC----CCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP----DRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLL 139 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~l 139 (241)
..|.+.+.||+|+||+||+|+.. +++.||+|.+... .......+.+|+.+++.++||||+++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 35788899999999999999842 4678999987542 22233467889999999999999999999999999999
Q ss_pred EEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCc
Q 039310 140 VYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDA 219 (241)
Q Consensus 140 v~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~ 219 (241)
|||||+||+|.+++.+.+.+++.++..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|+......
T Consensus 104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 180 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 180 (304)
T ss_dssp EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence 9999999999999998889999999999999999999999999 9999999999999999999999999998653322
Q ss_pred cceeeeecccccccccccccC
Q 039310 220 IQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 220 ~~~~~~~~gt~~y~aPE~l~~ 240 (241)
......+||+.|||||++.+
T Consensus 181 -~~~~~~~GT~~YmAPE~~~~ 200 (304)
T 3ubd_A 181 -KKAYSFCGTVEYMAPEVVNR 200 (304)
T ss_dssp -CCCCSCCCCGGGCCHHHHHT
T ss_pred -ccccccccCcccCCHHHhcc
Confidence 23445679999999999864
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=288.45 Aligned_cols=171 Identities=22% Similarity=0.349 Sum_probs=135.9
Q ss_pred hhcccccccccCceeEEEEEeC-CCCeEEEEecccCC-hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCC---------
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD-QTKIDEFINELVVVSQINRRNVVRLLACCLETQ--------- 135 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~--------- 135 (241)
.|.+.+.||+|+||+||+|+.. +++.||||++...+ ....+.+.+|+.+|+.++||||++++++|.+.+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~ 85 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence 3667789999999999999854 68899999876543 345578899999999999999999999987644
Q ss_pred ---cceEEEEecCCCCchHHhhcCCC---CCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccC
Q 039310 136 ---VPLLVYEFVGNGTLFEHIHKNGN---LTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDF 209 (241)
Q Consensus 136 ---~~~lv~e~~~~g~L~~~l~~~~~---l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Df 209 (241)
..|+|||||++|+|.+++..... .++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC
T ss_pred CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEccC
Confidence 36899999999999999987654 456678899999999999999999 999999999999999999999999
Q ss_pred CCcccccCCccc-----------eeeeecccccccccccccC
Q 039310 210 GASKLVPIDAIQ-----------NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 210 gla~~~~~~~~~-----------~~~~~~gt~~y~aPE~l~~ 240 (241)
|+|+.+..+... .....+||+.|||||++.+
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~ 204 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG 204 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTT
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcC
Confidence 999876443221 1233569999999999865
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=287.72 Aligned_cols=171 Identities=27% Similarity=0.322 Sum_probs=136.7
Q ss_pred hhcccccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCC----cceEEEE
Q 039310 67 TNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQ----VPLLVYE 142 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~----~~~lv~e 142 (241)
++.+.+.||+|+||+||+|.+ +++.||||++..... ....+..|+..+..++||||+++++++.+++ .+|+|||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 456778999999999999998 578999998764322 1122334555667789999999999998654 5799999
Q ss_pred ecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcC-----CCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccC
Q 039310 143 FVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSE-----TNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPI 217 (241)
Q Consensus 143 ~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~-----~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~ 217 (241)
||++|+|.++++.. ++++..+..++.|++.||+|||++ ..++|+||||||+|||+++++.+||+|||+|+....
T Consensus 82 y~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 160 (303)
T 3hmm_A 82 YHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160 (303)
T ss_dssp CCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred CCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccC
Confidence 99999999999765 689999999999999999999987 122499999999999999999999999999987644
Q ss_pred Cccc---eeeeecccccccccccccC
Q 039310 218 DAIQ---NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 218 ~~~~---~~~~~~gt~~y~aPE~l~~ 240 (241)
.... .....+||+.|||||++.+
T Consensus 161 ~~~~~~~~~~~~~GT~~ymAPE~l~~ 186 (303)
T 3hmm_A 161 ATDTIDIAPNHRVGTKRYMAPEVLDD 186 (303)
T ss_dssp TTTEESCC-----CCGGGCCHHHHTT
T ss_pred CCCceeeecccccccccccCHHHhcc
Confidence 3222 1233569999999999864
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=292.61 Aligned_cols=178 Identities=26% Similarity=0.315 Sum_probs=150.2
Q ss_pred HHHHHHhhhcccccccccCceeEEEEEeCC------CCeEEEEecccC-ChhhHHHHHHHHHHHHcCCC-CCceeEEEEE
Q 039310 60 EEEIKTVTNNYADVIGCGGSGNVYKGFLPD------RTPVAVKKSKIV-DQTKIDEFINELVVVSQINR-RNVVRLLACC 131 (241)
Q Consensus 60 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h-~ni~~l~~~~ 131 (241)
.+|+....+.+.+.||+|+||+||+|.+.+ ++.||||.+... .....+.+.+|+.+|++++| ||||+++|+|
T Consensus 58 ~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~ 137 (353)
T 4ase_A 58 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 137 (353)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEE
Confidence 345666778889999999999999998543 357999988654 34456789999999999975 8999999999
Q ss_pred ecC-CcceEEEEecCCCCchHHhhcC----------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCC
Q 039310 132 LET-QVPLLVYEFVGNGTLFEHIHKN----------------GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSA 194 (241)
Q Consensus 132 ~~~-~~~~lv~e~~~~g~L~~~l~~~----------------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~ 194 (241)
... +.+++|||||++|+|.++|+.. ..+++.++..++.|++.||+|||+++ ||||||||+
T Consensus 138 ~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~ 214 (353)
T 4ase_A 138 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAAR 214 (353)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred EecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCcc
Confidence 764 5789999999999999999753 24899999999999999999999999 999999999
Q ss_pred CeeeCCCCCeEEccCCCcccccCCccc-eeeeecccccccccccccC
Q 039310 195 NILLDENYTPKVSDFGASKLVPIDAIQ-NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 195 Nili~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~ 240 (241)
|||+++++.+||+|||+|+.+..+... .....+||+.|||||++.+
T Consensus 215 NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~ 261 (353)
T 4ase_A 215 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD 261 (353)
T ss_dssp GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH
T ss_pred ceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc
Confidence 999999999999999999976544332 3344679999999999864
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=283.88 Aligned_cols=170 Identities=25% Similarity=0.311 Sum_probs=145.4
Q ss_pred hhcccccccccCceeEEEEEe-CCCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEec------CCcc
Q 039310 67 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLE------TQVP 137 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~------~~~~ 137 (241)
.|.+.+.||+|+||+||+|.. .+++.||||++... .....+.+.+|+.+|+.++||||+++++++.. .+..
T Consensus 55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~ 134 (398)
T 4b99_A 55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSV 134 (398)
T ss_dssp SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCE
T ss_pred CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEE
Confidence 467778999999999999985 46899999987643 34455778999999999999999999999764 3578
Q ss_pred eEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccC
Q 039310 138 LLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPI 217 (241)
Q Consensus 138 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~ 217 (241)
|+|||||+ |+|.+++...+++++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 135 ~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~ 210 (398)
T 4b99_A 135 YVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCT 210 (398)
T ss_dssp EEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred EEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence 99999996 689999998889999999999999999999999999 99999999999999999999999999987643
Q ss_pred Cc---cceeeeecccccccccccccC
Q 039310 218 DA---IQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 218 ~~---~~~~~~~~gt~~y~aPE~l~~ 240 (241)
.. .......+||+.|||||++.+
T Consensus 211 ~~~~~~~~~~~~~GT~~Y~APEv~~~ 236 (398)
T 4b99_A 211 SPAEHQYFMTEYVATRWYRAPELMLS 236 (398)
T ss_dssp -----CCCCCSSCCCCTTCCHHHHTT
T ss_pred CccccccccccceeChHhcCHHHhcC
Confidence 22 123345679999999998754
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=295.61 Aligned_cols=167 Identities=26% Similarity=0.267 Sum_probs=143.0
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHH---HHHHHHHcCCCCCceeEEEEEecCCcceEE
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFI---NELVVVSQINRRNVVRLLACCLETQVPLLV 140 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~---~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv 140 (241)
+.+.+.||+|+||+||+|+.. +++.||||.+... ......... .++.+++.++||||++++++|.+.+.+|+|
T Consensus 191 f~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylV 270 (689)
T 3v5w_A 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 270 (689)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred eEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEE
Confidence 445678999999999999854 6889999987531 111222333 346677788999999999999999999999
Q ss_pred EEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcc
Q 039310 141 YEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAI 220 (241)
Q Consensus 141 ~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~ 220 (241)
||||+||+|.+++...+.+++..+..++.||+.||+|||+++ ||||||||+|||++.+|.+||+|||+|+.+...
T Consensus 271 mEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~-- 345 (689)
T 3v5w_A 271 LDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK-- 345 (689)
T ss_dssp ECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeecCCC--
Confidence 999999999999998889999999999999999999999999 999999999999999999999999999876433
Q ss_pred ceeeeecccccccccccccC
Q 039310 221 QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 221 ~~~~~~~gt~~y~aPE~l~~ 240 (241)
.....+||+.|||||++..
T Consensus 346 -~~~t~~GTp~YmAPEvl~~ 364 (689)
T 3v5w_A 346 -KPHASVGTHGYMAPEVLQK 364 (689)
T ss_dssp -CCCSCCSCGGGCCHHHHST
T ss_pred -CCCCccCCcCccCHHHHhC
Confidence 2345689999999999863
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=286.90 Aligned_cols=169 Identities=20% Similarity=0.326 Sum_probs=151.2
Q ss_pred hhcccccccccCceeEEEEEeC-CCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecC
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVG 145 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~ 145 (241)
.|.+.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+|+.++||||+++++++.+.+.+|+|||||+
T Consensus 158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~ 237 (573)
T 3uto_A 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 237 (573)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecC
Confidence 5677889999999999999854 688999998877666677889999999999999999999999999999999999999
Q ss_pred CCCchHHhhc-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC--CCeEEccCCCcccccCCccce
Q 039310 146 NGTLFEHIHK-NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDEN--YTPKVSDFGASKLVPIDAIQN 222 (241)
Q Consensus 146 ~g~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~--~~~kl~Dfgla~~~~~~~~~~ 222 (241)
||+|.+++.. .+.+++.++..++.|++.||.|||+++ |+||||||+|||++.+ +.+||+|||+|+.+... ..
T Consensus 238 gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~--~~ 312 (573)
T 3uto_A 238 GGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--QS 312 (573)
T ss_dssp CCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT--SE
T ss_pred CCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC--Cc
Confidence 9999999864 457999999999999999999999999 9999999999999854 89999999999987533 33
Q ss_pred eeeecccccccccccccC
Q 039310 223 YTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 223 ~~~~~gt~~y~aPE~l~~ 240 (241)
....+||+.|||||++.+
T Consensus 313 ~~~~~GT~~y~APEv~~~ 330 (573)
T 3uto_A 313 VKVTTGTAEFAAPEVAEG 330 (573)
T ss_dssp EEEECSSGGGCCHHHHTT
T ss_pred eeeeEECccccCHHHhCC
Confidence 455679999999999865
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=272.58 Aligned_cols=166 Identities=21% Similarity=0.296 Sum_probs=140.0
Q ss_pred hhcccccccccCceeEEEEEeC----CCCeEEEEecccCChhhHHHHHHHHHHHHcC-CCCCceeEEEEEecCCcceEEE
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP----DRTPVAVKKSKIVDQTKIDEFINELVVVSQI-NRRNVVRLLACCLETQVPLLVY 141 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~----~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~ 141 (241)
.|.+.+.||+|+||+||+|+.+ .++.||+|.+.... ...++.+|+++++.+ +||||+++++++.+.+..|+||
T Consensus 22 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvm 99 (361)
T 4f9c_A 22 VFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAM 99 (361)
T ss_dssp TCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEE
T ss_pred cEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEE
Confidence 4778889999999999999743 46789999875432 345678999999998 6999999999999999999999
Q ss_pred EecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC-CCeEEccCCCcccccCCcc
Q 039310 142 EFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDEN-YTPKVSDFGASKLVPIDAI 220 (241)
Q Consensus 142 e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~-~~~kl~Dfgla~~~~~~~~ 220 (241)
||+++|+|.+++. .+++.++..++.|++.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+.......
T Consensus 100 E~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~ 173 (361)
T 4f9c_A 100 PYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKI 173 (361)
T ss_dssp ECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSC
T ss_pred eCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccc
Confidence 9999999999984 5899999999999999999999999 9999999999999876 7999999999976532211
Q ss_pred ---------------------------ceeeeecccccccccccccC
Q 039310 221 ---------------------------QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 221 ---------------------------~~~~~~~gt~~y~aPE~l~~ 240 (241)
......+||+.|||||++.+
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~ 220 (361)
T 4f9c_A 174 ELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTK 220 (361)
T ss_dssp GGGGGC--------------------------CCCCGGGCCHHHHTT
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcC
Confidence 11233569999999998854
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=262.87 Aligned_cols=171 Identities=26% Similarity=0.292 Sum_probs=148.3
Q ss_pred hhhcccccccccCceeEEEEEeCC-CCeEEEEecccCC---hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLPD-RTPVAVKKSKIVD---QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVY 141 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~ 141 (241)
..+.+.+.||+|+||+||+|.... ++.||+|.+.... ......+.+|..++..++||||+++++++.+.+..|+||
T Consensus 74 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~ 153 (437)
T 4aw2_A 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVM 153 (437)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEE
Confidence 456677899999999999999654 7789999875421 122234788999999999999999999999999999999
Q ss_pred EecCCCCchHHhhc-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcc
Q 039310 142 EFVGNGTLFEHIHK-NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAI 220 (241)
Q Consensus 142 e~~~~g~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~ 220 (241)
||+++|+|.+++.. .+.+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+....+..
T Consensus 154 Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 230 (437)
T 4aw2_A 154 DYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 230 (437)
T ss_dssp CCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred ecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC
Confidence 99999999999987 468999999999999999999999999 99999999999999999999999999987655444
Q ss_pred ceeeeeccccccccccccc
Q 039310 221 QNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 221 ~~~~~~~gt~~y~aPE~l~ 239 (241)
......+||+.|||||++.
T Consensus 231 ~~~~~~~GT~~Y~APE~l~ 249 (437)
T 4aw2_A 231 VQSSVAVGTPDYISPEILQ 249 (437)
T ss_dssp EECCSCCSCGGGCCHHHHH
T ss_pred cccccccCCcCeeChHHHh
Confidence 4444567999999999985
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=248.33 Aligned_cols=172 Identities=26% Similarity=0.398 Sum_probs=150.0
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEec
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
..+.+.+.||+|+||+||+|... ++..||+|.+...+....+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 45677889999999999999864 58899999887777777889999999999999999999999999999999999999
Q ss_pred CCCCchHHhhc-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccce-
Q 039310 145 GNGTLFEHIHK-NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQN- 222 (241)
Q Consensus 145 ~~g~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~- 222 (241)
++++|.+++.. ...+++.++..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++..........
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 166 (310)
T 3s95_A 90 KGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE 166 (310)
T ss_dssp TTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC-------
T ss_pred CCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccccccc
Confidence 99999999987 457999999999999999999999999 9999999999999999999999999998764332211
Q ss_pred ------------eeeecccccccccccccC
Q 039310 223 ------------YTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 223 ------------~~~~~gt~~y~aPE~l~~ 240 (241)
.....||+.|+|||++.+
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 196 (310)
T 3s95_A 167 GLRSLKKPDRKKRYTVVGNPYWMAPEMING 196 (310)
T ss_dssp -------------CCCCSCGGGCCHHHHTT
T ss_pred ccccccccccccccccCCCcceeCHHHhcC
Confidence 113569999999998764
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=253.66 Aligned_cols=170 Identities=23% Similarity=0.382 Sum_probs=151.0
Q ss_pred hhhcccccccccCceeEEEEEe-CCCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYE 142 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e 142 (241)
..|.+.+.||+|+||.||+|.. .+++.||+|.+... +....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 15 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 94 (328)
T 3fe3_A 15 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIME 94 (328)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEE
Confidence 3567788999999999999986 57899999987543 44556788999999999999999999999999999999999
Q ss_pred ecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccce
Q 039310 143 FVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQN 222 (241)
Q Consensus 143 ~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~ 222 (241)
|+++++|.+++...+++++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++....... .
T Consensus 95 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~--~ 169 (328)
T 3fe3_A 95 YASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG--K 169 (328)
T ss_dssp CCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC--G
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCCC--c
Confidence 9999999999988888999999999999999999999999 9999999999999999999999999998764332 2
Q ss_pred eeeecccccccccccccC
Q 039310 223 YTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 223 ~~~~~gt~~y~aPE~l~~ 240 (241)
....+||+.|+|||++.+
T Consensus 170 ~~~~~gt~~y~aPE~~~~ 187 (328)
T 3fe3_A 170 LDAFCGAPPYAAPELFQG 187 (328)
T ss_dssp GGTTSSSGGGCCHHHHHT
T ss_pred cccccCCcceeCcccccC
Confidence 344569999999999764
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=251.75 Aligned_cols=171 Identities=26% Similarity=0.328 Sum_probs=149.5
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVY 141 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~ 141 (241)
..+.+.+.||+|+||+||+|+.. +++.||+|.+... .......+.+|..+++.++||||+++++++.+.+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 34667789999999999999864 5889999987542 2334567889999999999999999999999999999999
Q ss_pred EecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc
Q 039310 142 EFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ 221 (241)
Q Consensus 142 e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~ 221 (241)
||+++|+|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+...... .
T Consensus 85 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-~ 160 (337)
T 1o6l_A 85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-A 160 (337)
T ss_dssp ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-C
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccCC-C
Confidence 99999999999988888999999999999999999999999 9999999999999999999999999998643222 2
Q ss_pred eeeeecccccccccccccC
Q 039310 222 NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~~ 240 (241)
.....+||+.|+|||++.+
T Consensus 161 ~~~~~~gt~~y~aPE~~~~ 179 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLED 179 (337)
T ss_dssp CBCCCEECGGGCCGGGGSS
T ss_pred cccccccChhhCChhhhcC
Confidence 3345679999999999864
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=247.04 Aligned_cols=172 Identities=28% Similarity=0.400 Sum_probs=145.1
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEeccc---CChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKI---VDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVY 141 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~---~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~ 141 (241)
.+|.+.+.||+|+||.||+|... ++..||+|.+.. ......+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 45777889999999999999854 688999998643 23445578899999999999999999999999999999999
Q ss_pred EecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc
Q 039310 142 EFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ 221 (241)
Q Consensus 142 e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~ 221 (241)
||+++++|.+++...+++++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.........
T Consensus 91 e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 167 (294)
T 4eqm_A 91 EYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT 167 (294)
T ss_dssp ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccccccc
Confidence 99999999999998888999999999999999999999999 999999999999999999999999999876544433
Q ss_pred eeeeecccccccccccccC
Q 039310 222 NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~~ 240 (241)
......||+.|+|||.+.+
T Consensus 168 ~~~~~~gt~~y~aPE~~~~ 186 (294)
T 4eqm_A 168 QTNHVLGTVQYFSPEQAKG 186 (294)
T ss_dssp -------CCSSCCHHHHHT
T ss_pred ccCccccCccccCHhHhcC
Confidence 4444569999999998754
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-36 Score=245.56 Aligned_cols=170 Identities=27% Similarity=0.422 Sum_probs=149.9
Q ss_pred hhhcccccccccCceeEEEEEe-CCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEec
Q 039310 66 VTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
.+|...+.||+|+||+||+|.. .++..||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 99 (297)
T 3fxz_A 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (297)
T ss_dssp GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECC
Confidence 4567778999999999999984 568899999887655556678899999999999999999999999999999999999
Q ss_pred CCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceee
Q 039310 145 GNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYT 224 (241)
Q Consensus 145 ~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~ 224 (241)
++++|.+++... .+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++........ ...
T Consensus 100 ~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~ 174 (297)
T 3fxz_A 100 AGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRS 174 (297)
T ss_dssp TTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CBC
T ss_pred CCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-ccC
Confidence 999999999765 6899999999999999999999999 99999999999999999999999999987644332 234
Q ss_pred eecccccccccccccC
Q 039310 225 VVQGTLGYIDPEYLQT 240 (241)
Q Consensus 225 ~~~gt~~y~aPE~l~~ 240 (241)
...||+.|+|||++.+
T Consensus 175 ~~~gt~~y~aPE~~~~ 190 (297)
T 3fxz_A 175 TMVGTPYWMAPEVVTR 190 (297)
T ss_dssp CCCSCGGGCCHHHHHC
T ss_pred CccCCcCccChhhhcC
Confidence 4569999999998754
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=254.91 Aligned_cols=174 Identities=30% Similarity=0.376 Sum_probs=145.1
Q ss_pred HHHHhhhcccccccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHHHHHcC-CCCCceeEEEEEecCCc
Q 039310 62 EIKTVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELVVVSQI-NRRNVVRLLACCLETQV 136 (241)
Q Consensus 62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~ 136 (241)
.+....+.+.+.||+|+||+||+|+.. +++.||+|.+... .....+.+.+|..+++.+ +||||+++++++.+.+.
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 344456778889999999999999854 5889999987642 233456788999999988 79999999999999999
Q ss_pred ceEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCccccc
Q 039310 137 PLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVP 216 (241)
Q Consensus 137 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~ 216 (241)
.|+||||+++|+|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 9999999999999999988888999999999999999999999999 9999999999999999999999999998643
Q ss_pred CCccceeeeeccccccccccccc
Q 039310 217 IDAIQNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 217 ~~~~~~~~~~~gt~~y~aPE~l~ 239 (241)
... ......+||+.|+|||++.
T Consensus 176 ~~~-~~~~~~~gt~~y~aPE~~~ 197 (353)
T 3txo_A 176 CNG-VTTATFCGTPDYIAPEILQ 197 (353)
T ss_dssp C----------CCGGGCCHHHHH
T ss_pred cCC-ccccccCCCcCeEChhhcC
Confidence 222 2344567999999999875
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=254.98 Aligned_cols=170 Identities=25% Similarity=0.352 Sum_probs=150.3
Q ss_pred HhhhcccccccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEE
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLV 140 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv 140 (241)
...|.+.+.||+|+||.||+|... ++..||+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 355777889999999999999854 5788999986532 233457788999999999999999999999999999999
Q ss_pred EEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcc
Q 039310 141 YEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAI 220 (241)
Q Consensus 141 ~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~ 220 (241)
|||+++|+|.+++.....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|......
T Consensus 94 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-- 168 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-- 168 (384)
T ss_dssp ECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT--
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC--
Confidence 999999999999998889999999999999999999999999 999999999999999999999999999876433
Q ss_pred ceeeeeccccccccccccc
Q 039310 221 QNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 221 ~~~~~~~gt~~y~aPE~l~ 239 (241)
......+||+.|+|||++.
T Consensus 169 ~~~~~~~gt~~Y~aPE~~~ 187 (384)
T 4fr4_A 169 TQITTMAGTKPYMAPEMFS 187 (384)
T ss_dssp CCBCCCCSCGGGCCGGGTC
T ss_pred CceeccCCCccccCCeeec
Confidence 2334567999999999985
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=258.35 Aligned_cols=171 Identities=26% Similarity=0.317 Sum_probs=147.5
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVY 141 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~ 141 (241)
..+.+.+.||+|+||+||+|+.. ++..||+|.+... .......+.+|..+++.++||||+++++++.+.+..|+||
T Consensus 69 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 148 (410)
T 3v8s_A 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 148 (410)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 34666789999999999999965 5788999986531 1122345778999999999999999999999999999999
Q ss_pred EecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc
Q 039310 142 EFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ 221 (241)
Q Consensus 142 e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~ 221 (241)
||+++|+|.+++... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|.........
T Consensus 149 E~~~gg~L~~~l~~~-~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~ 224 (410)
T 3v8s_A 149 EYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 224 (410)
T ss_dssp CCCTTEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEE
T ss_pred eCCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEeeccCCcc
Confidence 999999999999764 6899999999999999999999999 999999999999999999999999999877554443
Q ss_pred eeeeecccccccccccccC
Q 039310 222 NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~~ 240 (241)
.....+||+.|||||++.+
T Consensus 225 ~~~~~~gt~~Y~APE~l~~ 243 (410)
T 3v8s_A 225 RCDTAVGTPDYISPEVLKS 243 (410)
T ss_dssp ECCSCCSCGGGCCHHHHHT
T ss_pred cccCCcCCccccCHHHhhc
Confidence 4456679999999999853
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=257.62 Aligned_cols=171 Identities=26% Similarity=0.273 Sum_probs=148.5
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVY 141 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~ 141 (241)
..+.+.+.||+|+||+||+|+.. +++.||+|.+... .....+.+.+|..++..++||||+++++++.+.+..|+||
T Consensus 61 ~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVm 140 (412)
T 2vd5_A 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVM 140 (412)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred hhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 45667789999999999999964 6889999987542 1223345788999999999999999999999999999999
Q ss_pred EecCCCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcc
Q 039310 142 EFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAI 220 (241)
Q Consensus 142 e~~~~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~ 220 (241)
||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|.....+..
T Consensus 141 E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~ 217 (412)
T 2vd5_A 141 EYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT 217 (412)
T ss_dssp CCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred cCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhheeccCCCc
Confidence 999999999999764 47999999999999999999999999 99999999999999999999999999987654443
Q ss_pred ceeeeeccccccccccccc
Q 039310 221 QNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 221 ~~~~~~~gt~~y~aPE~l~ 239 (241)
......+||+.|||||++.
T Consensus 218 ~~~~~~~Gt~~Y~APE~l~ 236 (412)
T 2vd5_A 218 VRSLVAVGTPDYLSPEILQ 236 (412)
T ss_dssp EECSSCCSCGGGCCHHHHH
T ss_pred cccceeccccCcCCHHHHh
Confidence 3344467999999999985
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=246.19 Aligned_cols=168 Identities=29% Similarity=0.369 Sum_probs=148.3
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVY 141 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~ 141 (241)
..+.+.+.||+|+||+||+|... +++.||+|.+... .....+.+.+|..+++.++||||+++++++.+.+..|+||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 34667789999999999999864 6889999987542 2234567889999999999999999999999999999999
Q ss_pred EecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc
Q 039310 142 EFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ 221 (241)
Q Consensus 142 e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~ 221 (241)
||+++|+|.+++.....+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++.....
T Consensus 86 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~---- 158 (318)
T 1fot_A 86 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD---- 158 (318)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS----
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC----
Confidence 99999999999998889999999999999999999999999 99999999999999999999999999987542
Q ss_pred eeeeecccccccccccccC
Q 039310 222 NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~~ 240 (241)
.....+||+.|+|||++.+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~ 177 (318)
T 1fot_A 159 VTYTLCGTPDYIAPEVVST 177 (318)
T ss_dssp CBCCCCSCTTTCCHHHHTT
T ss_pred ccccccCCccccCHhHhcC
Confidence 2234579999999998764
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=245.10 Aligned_cols=172 Identities=42% Similarity=0.660 Sum_probs=150.1
Q ss_pred hhhcccccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecC
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVG 145 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~ 145 (241)
..+...+.||+|+||.||+|.+.++..||+|+.........+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 39 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 118 (321)
T 2qkw_B 39 NNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYME 118 (321)
T ss_dssp CCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCT
T ss_pred hccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCC
Confidence 34566778999999999999988899999998877666667889999999999999999999999999999999999999
Q ss_pred CCCchHHhhcCC----CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCc-c
Q 039310 146 NGTLFEHIHKNG----NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDA-I 220 (241)
Q Consensus 146 ~g~L~~~l~~~~----~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~-~ 220 (241)
+++|.+++.... .+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++....... .
T Consensus 119 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 195 (321)
T 2qkw_B 119 NGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQT 195 (321)
T ss_dssp TCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCC
T ss_pred CCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 999999997543 5899999999999999999999999 9999999999999999999999999998653222 1
Q ss_pred ceeeeecccccccccccccC
Q 039310 221 QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 221 ~~~~~~~gt~~y~aPE~l~~ 240 (241)
.......||+.|+|||++.+
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~ 215 (321)
T 2qkw_B 196 HLSTVVKGTLGYIDPEYFIK 215 (321)
T ss_dssp CCBCCCEEETTTCCHHHHHH
T ss_pred ccccccCCCccccCHHHhcC
Confidence 22233458999999998743
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-36 Score=247.88 Aligned_cols=176 Identities=27% Similarity=0.432 Sum_probs=147.2
Q ss_pred HHHHhhhcccccccccCceeEEEEEeC----CCCeEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCc
Q 039310 62 EIKTVTNNYADVIGCGGSGNVYKGFLP----DRTPVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCLETQV 136 (241)
Q Consensus 62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~ 136 (241)
++...++.+.+.||+|+||.||+|.+. .+..||||.+... .....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 124 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL 124 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGC
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCc
Confidence 344567778889999999999999864 3445999987754 44556789999999999999999999999999999
Q ss_pred ceEEEEecCCCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccc
Q 039310 137 PLLVYEFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLV 215 (241)
Q Consensus 137 ~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~ 215 (241)
.++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++...
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 125 AMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred cEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 99999999999999999754 57999999999999999999999999 999999999999999999999999999876
Q ss_pred cCCccc--eeeeecccccccccccccC
Q 039310 216 PIDAIQ--NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 216 ~~~~~~--~~~~~~gt~~y~aPE~l~~ 240 (241)
...... ......+|+.|+|||++.+
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~ 228 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAF 228 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHH
T ss_pred ccCccceeeccCCCCcccccCHhHhcC
Confidence 433221 2222346788999998753
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-36 Score=254.46 Aligned_cols=171 Identities=30% Similarity=0.343 Sum_probs=146.6
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHHHHHcC-CCCCceeEEEEEecCCcceEE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELVVVSQI-NRRNVVRLLACCLETQVPLLV 140 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv 140 (241)
..+.+.+.||+|+||+||+|+.. +++.||+|.+... .....+.+.+|..++..+ +||||+++++++.+.+..++|
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV 131 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence 45677889999999999999865 4778999987542 223345678899999887 899999999999999999999
Q ss_pred EEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcc
Q 039310 141 YEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAI 220 (241)
Q Consensus 141 ~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~ 220 (241)
|||+++|+|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+..... .
T Consensus 132 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~~-~ 207 (396)
T 4dc2_A 132 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-G 207 (396)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-T
T ss_pred EEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecccC-C
Confidence 999999999999988888999999999999999999999999 999999999999999999999999999863222 2
Q ss_pred ceeeeecccccccccccccC
Q 039310 221 QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 221 ~~~~~~~gt~~y~aPE~l~~ 240 (241)
......+||+.|+|||++.+
T Consensus 208 ~~~~~~~gt~~Y~aPE~l~~ 227 (396)
T 4dc2_A 208 DTTSTFCGTPNYIAPEILRG 227 (396)
T ss_dssp CCBCCCCBCGGGCCHHHHTT
T ss_pred CccccccCCcccCCchhhcC
Confidence 23455679999999999864
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=248.45 Aligned_cols=170 Identities=22% Similarity=0.304 Sum_probs=148.8
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEecccCCh------hhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcce
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQ------TKIDEFINELVVVSQINRRNVVRLLACCLETQVPL 138 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~------~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~ 138 (241)
..|.+.+.||+|+||.||+|... ++..||+|.+..... ...+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 91 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV 91 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence 35777889999999999999865 588999998764322 13577899999999999999999999999999999
Q ss_pred EEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC----CeEEccCCCccc
Q 039310 139 LVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENY----TPKVSDFGASKL 214 (241)
Q Consensus 139 lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~----~~kl~Dfgla~~ 214 (241)
+||||+++|+|.+++...+.+++..+..++.|++.||.|||+.+ ++||||||+|||+++++ .+||+|||++..
T Consensus 92 lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp EEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 99999999999999988888999999999999999999999999 99999999999998777 799999999987
Q ss_pred ccCCccceeeeecccccccccccccC
Q 039310 215 VPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 215 ~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
..... ......||+.|+|||++.+
T Consensus 169 ~~~~~--~~~~~~gt~~y~aPE~~~~ 192 (361)
T 2yab_A 169 IEDGV--EFKNIFGTPEFVAPEIVNY 192 (361)
T ss_dssp CCTTC--CCCCCCSCGGGCCHHHHTT
T ss_pred cCCCC--ccccCCCCccEECchHHcC
Confidence 64332 2344569999999998764
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-36 Score=250.14 Aligned_cols=173 Identities=27% Similarity=0.321 Sum_probs=148.9
Q ss_pred HHhhhcccccccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHHHHHcC-CCCCceeEEEEEecCCcce
Q 039310 64 KTVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELVVVSQI-NRRNVVRLLACCLETQVPL 138 (241)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~ 138 (241)
....+.+.+.||+|+||+||+|+.+ +++.||+|.+... .......+..|..+++.+ +||||+++++++.+.+..|
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 3456777889999999999999965 5788999987642 123456678899999876 9999999999999999999
Q ss_pred EEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCC
Q 039310 139 LVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPID 218 (241)
Q Consensus 139 lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~ 218 (241)
+||||+++|+|.+++.....+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||+|+.....
T Consensus 95 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 171 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 171 (345)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence 99999999999999988788999999999999999999999999 999999999999999999999999999864322
Q ss_pred ccceeeeecccccccccccccC
Q 039310 219 AIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 219 ~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
. ......+||+.|+|||++.+
T Consensus 172 ~-~~~~~~~gt~~y~aPE~~~~ 192 (345)
T 1xjd_A 172 D-AKTNTFCGTPDYIAPEILLG 192 (345)
T ss_dssp T-CCBCCCCSCGGGCCHHHHTT
T ss_pred C-CcccCCCCCcccCChhhhcC
Confidence 2 23445679999999999864
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-36 Score=248.39 Aligned_cols=172 Identities=25% Similarity=0.318 Sum_probs=140.0
Q ss_pred HhhhcccccccccCceeEEEEEe----CCCCeEEEEecccCC----hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCc
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFL----PDRTPVAVKKSKIVD----QTKIDEFINELVVVSQINRRNVVRLLACCLETQV 136 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavk~~~~~~----~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~ 136 (241)
...|.+.+.||+|+||.||+|+. .++..||+|.+.... ......+.+|+.+++.++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 45677888999999999999986 468899999876432 2344567889999999999999999999999999
Q ss_pred ceEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCccccc
Q 039310 137 PLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVP 216 (241)
Q Consensus 137 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~ 216 (241)
.++||||+++++|.+++...+.+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++....
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred EEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 9999999999999999988888999999999999999999999999 9999999999999999999999999987643
Q ss_pred CCccceeeeecccccccccccccC
Q 039310 217 IDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 217 ~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
... .......||+.|+|||++.+
T Consensus 173 ~~~-~~~~~~~gt~~y~aPE~~~~ 195 (327)
T 3a62_A 173 HDG-TVTHTFCGTIEYMAPEILMR 195 (327)
T ss_dssp -------CTTSSCCTTSCHHHHTT
T ss_pred cCC-ccccccCCCcCccCHhhCcC
Confidence 222 22334569999999998754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-35 Score=242.25 Aligned_cols=168 Identities=27% Similarity=0.366 Sum_probs=148.1
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCC
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGN 146 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~ 146 (241)
+...+.||+|+||.||+|... ++..||||.+........+.+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 126 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG 126 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence 445568999999999999965 6899999998766666667889999999999999999999999999999999999999
Q ss_pred CCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeeee
Q 039310 147 GTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVV 226 (241)
Q Consensus 147 g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 226 (241)
++|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++........ .....
T Consensus 127 ~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~~ 201 (321)
T 2c30_A 127 GALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKSL 201 (321)
T ss_dssp CBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CBCCC
T ss_pred CCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc-ccccc
Confidence 999999865 46999999999999999999999998 99999999999999999999999999987644322 23345
Q ss_pred cccccccccccccC
Q 039310 227 QGTLGYIDPEYLQT 240 (241)
Q Consensus 227 ~gt~~y~aPE~l~~ 240 (241)
.||+.|+|||++.+
T Consensus 202 ~gt~~y~aPE~~~~ 215 (321)
T 2c30_A 202 VGTPYWMAPEVISR 215 (321)
T ss_dssp CSCGGGCCHHHHTT
T ss_pred cCCccccCHhhhcC
Confidence 69999999998764
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=247.22 Aligned_cols=171 Identities=31% Similarity=0.354 Sum_probs=148.9
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHHHHHcC-CCCCceeEEEEEecCCcceEE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELVVVSQI-NRRNVVRLLACCLETQVPLLV 140 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv 140 (241)
..+.+.+.||+|+||.||+|+.. +++.||+|.+... .....+.+.+|..+++.+ +||||+++++++.+.+..|+|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 34667789999999999999965 5788999987642 344566788999999988 899999999999999999999
Q ss_pred EEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcc
Q 039310 141 YEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAI 220 (241)
Q Consensus 141 ~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~ 220 (241)
|||+++|+|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 89 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~- 164 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG- 164 (345)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT-
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccCCC-
Confidence 999999999999988788999999999999999999999999 9999999999999999999999999998643222
Q ss_pred ceeeeecccccccccccccC
Q 039310 221 QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 221 ~~~~~~~gt~~y~aPE~l~~ 240 (241)
......+||+.|+|||++.+
T Consensus 165 ~~~~~~~gt~~y~aPE~~~~ 184 (345)
T 3a8x_A 165 DTTSTFCGTPNYIAPEILRG 184 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTT
T ss_pred CcccccCCCccccCccccCC
Confidence 23445679999999999864
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=239.69 Aligned_cols=173 Identities=25% Similarity=0.365 Sum_probs=150.8
Q ss_pred HHhhhcccccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 64 KTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
....+.+.+.||+|+||.||+|...++..||+|.+..... ..+++.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 3456778889999999999999988888899998775432 346789999999999999999999999999999999999
Q ss_pred cCCCCchHHhhcCC-CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccce
Q 039310 144 VGNGTLFEHIHKNG-NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQN 222 (241)
Q Consensus 144 ~~~g~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~ 222 (241)
+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++..........
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 161 (268)
T 3sxs_A 85 ISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS 161 (268)
T ss_dssp CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEE
T ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhhc
Confidence 99999999997654 5999999999999999999999999 9999999999999999999999999998765544444
Q ss_pred eeeecccccccccccccC
Q 039310 223 YTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 223 ~~~~~gt~~y~aPE~l~~ 240 (241)
.....+|+.|+|||.+.+
T Consensus 162 ~~~~~~~~~y~aPE~~~~ 179 (268)
T 3sxs_A 162 SVGTKFPVKWSAPEVFHY 179 (268)
T ss_dssp CCSCCCCGGGCCHHHHHH
T ss_pred ccCCCcCcccCCHHHHhc
Confidence 444557788999998753
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=247.44 Aligned_cols=168 Identities=25% Similarity=0.310 Sum_probs=148.6
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVY 141 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~ 141 (241)
..+.+.+.||+|+||.||+|... ++..||+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 45677789999999999999965 6889999987542 2234567889999999999999999999999999999999
Q ss_pred EecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc
Q 039310 142 EFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ 221 (241)
Q Consensus 142 e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~ 221 (241)
||+++|+|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 121 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--- 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC---
Confidence 99999999999988888999999999999999999999999 999999999999999999999999999876432
Q ss_pred eeeeecccccccccccccC
Q 039310 222 NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~~ 240 (241)
....+||+.|+|||++.+
T Consensus 195 -~~~~~gt~~y~aPE~~~~ 212 (350)
T 1rdq_E 195 -TWTLCGTPEALAPEIILS 212 (350)
T ss_dssp -BCCCEECGGGCCHHHHTT
T ss_pred -cccccCCccccCHHHhcC
Confidence 234569999999998764
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-35 Score=241.63 Aligned_cols=172 Identities=23% Similarity=0.355 Sum_probs=142.5
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEecccCC-hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCC--------
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD-QTKIDEFINELVVVSQINRRNVVRLLACCLETQ-------- 135 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~-------- 135 (241)
..|.+.+.||+|+||.||+|... ++..||||.+.... ....+.+.+|+.+++.++||||++++++|.+.+
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 45677889999999999999965 68899999876433 345678999999999999999999999986543
Q ss_pred -------------------------------------------------cceEEEEecCCCCchHHhhcCCC---CCHHH
Q 039310 136 -------------------------------------------------VPLLVYEFVGNGTLFEHIHKNGN---LTWER 163 (241)
Q Consensus 136 -------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~---l~~~~ 163 (241)
..+++|||+++++|.+++..... .++..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 27999999999999999987643 56667
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcc-----------ceeeeecccccc
Q 039310 164 RLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAI-----------QNYTVVQGTLGY 232 (241)
Q Consensus 164 ~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~-----------~~~~~~~gt~~y 232 (241)
+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++........ .......||+.|
T Consensus 166 ~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 8999999999999999999 99999999999999999999999999987654321 122334699999
Q ss_pred cccccccC
Q 039310 233 IDPEYLQT 240 (241)
Q Consensus 233 ~aPE~l~~ 240 (241)
+|||++.+
T Consensus 243 ~aPE~~~~ 250 (332)
T 3qd2_B 243 MSPEQIHG 250 (332)
T ss_dssp SCHHHHHC
T ss_pred cChHHhcC
Confidence 99998754
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-35 Score=247.44 Aligned_cols=173 Identities=23% Similarity=0.354 Sum_probs=146.5
Q ss_pred HhhhcccccccccCceeEEEEEeC--------CCCeEEEEecccC-ChhhHHHHHHHHHHHHcC-CCCCceeEEEEEecC
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFLP--------DRTPVAVKKSKIV-DQTKIDEFINELVVVSQI-NRRNVVRLLACCLET 134 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~ 134 (241)
...+.+.+.||+|+||.||+|.+. ++..||+|.+... .....+.+.+|+.+++.+ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 455677789999999999999852 3457999987654 344567899999999999 899999999999999
Q ss_pred CcceEEEEecCCCCchHHhhcCC----------------CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee
Q 039310 135 QVPLLVYEFVGNGTLFEHIHKNG----------------NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILL 198 (241)
Q Consensus 135 ~~~~lv~e~~~~g~L~~~l~~~~----------------~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili 198 (241)
+..|+||||+++|+|.+++.... .+++.++..++.|++.||.|||+++ ++||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 99999999999999999997643 4899999999999999999999999 9999999999999
Q ss_pred CCCCCeEEccCCCcccccCCcc-ceeeeecccccccccccccC
Q 039310 199 DENYTPKVSDFGASKLVPIDAI-QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 199 ~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~ 240 (241)
+.++.+||+|||+++....... .......+|+.|+|||++.+
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 279 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD 279 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcC
Confidence 9999999999999986643322 12233447889999998754
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=244.96 Aligned_cols=171 Identities=27% Similarity=0.401 Sum_probs=146.3
Q ss_pred hhcccccccccCceeEEEEEeC-CCCeEEEEecccCC-hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEec
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD-QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
.|.+.+.||+|+||+||+|... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 8 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 87 (323)
T 3tki_A 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 87 (323)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcC
Confidence 4667889999999999999865 68899999876432 223466889999999999999999999999999999999999
Q ss_pred CCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcc-cee
Q 039310 145 GNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAI-QNY 223 (241)
Q Consensus 145 ~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~-~~~ 223 (241)
++++|.+++.....+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++........ ...
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 164 (323)
T 3tki_A 88 SGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164 (323)
T ss_dssp TTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred CCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCccccc
Confidence 99999999988888999999999999999999999999 99999999999999999999999999986532221 222
Q ss_pred eeecccccccccccccC
Q 039310 224 TVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 224 ~~~~gt~~y~aPE~l~~ 240 (241)
....||+.|+|||++.+
T Consensus 165 ~~~~gt~~y~aPE~~~~ 181 (323)
T 3tki_A 165 NKMCGTLPYVAPELLKR 181 (323)
T ss_dssp CSCCSCGGGSCHHHHHC
T ss_pred CCCccCcCccCcHHhcc
Confidence 34569999999998754
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=241.23 Aligned_cols=169 Identities=21% Similarity=0.322 Sum_probs=147.5
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEec
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
..|.+.+.||+|+||.||+|... ++..+|+|.+... ......+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 83 (321)
T 1tki_A 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence 35677889999999999999865 5778999987643 334567889999999999999999999999999999999999
Q ss_pred CCCCchHHhhcCC-CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC--CCCeEEccCCCcccccCCccc
Q 039310 145 GNGTLFEHIHKNG-NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDE--NYTPKVSDFGASKLVPIDAIQ 221 (241)
Q Consensus 145 ~~g~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~--~~~~kl~Dfgla~~~~~~~~~ 221 (241)
++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+|||++. ++.+||+|||++.......
T Consensus 84 ~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~-- 158 (321)
T 1tki_A 84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-- 158 (321)
T ss_dssp CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC--
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC--
Confidence 9999999997654 7999999999999999999999999 999999999999987 7899999999998764332
Q ss_pred eeeeecccccccccccccC
Q 039310 222 NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~~ 240 (241)
......||+.|+|||++.+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~ 177 (321)
T 1tki_A 159 NFRLLFTAPEYYAPEVHQH 177 (321)
T ss_dssp EEEEEESCGGGSCHHHHTT
T ss_pred ccccccCChhhcCcHHhcC
Confidence 3344569999999998764
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=248.38 Aligned_cols=173 Identities=29% Similarity=0.323 Sum_probs=149.3
Q ss_pred HHhhhcccccccccCceeEEEEEeCC-CCeEEEEecccC---ChhhHHHHHHHHHHHHcC-CCCCceeEEEEEecCCcce
Q 039310 64 KTVTNNYADVIGCGGSGNVYKGFLPD-RTPVAVKKSKIV---DQTKIDEFINELVVVSQI-NRRNVVRLLACCLETQVPL 138 (241)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~ 138 (241)
....+.+.+.||+|+||+||+|+... ++.||+|.+... .....+.+.+|..+++.+ +||||+++++++.+.+..|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 34557778899999999999999654 778999987642 223456788999999988 7999999999999999999
Q ss_pred EEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCC
Q 039310 139 LVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPID 218 (241)
Q Consensus 139 lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~ 218 (241)
+||||+++|+|.+++...+.+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|......
T Consensus 98 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence 99999999999999988788999999999999999999999999 999999999999999999999999999864322
Q ss_pred ccceeeeecccccccccccccC
Q 039310 219 AIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 219 ~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
. ......+||+.|+|||++.+
T Consensus 175 ~-~~~~~~~gt~~y~aPE~~~~ 195 (353)
T 2i0e_A 175 G-VTTKTFCGTPDYIAPEIIAY 195 (353)
T ss_dssp T-CCBCCCCSCGGGCCHHHHTT
T ss_pred C-cccccccCCccccChhhhcC
Confidence 2 23445679999999999864
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=241.81 Aligned_cols=171 Identities=23% Similarity=0.316 Sum_probs=149.3
Q ss_pred HhhhcccccccccCceeEEEEEeC-CCCeEEEEecccCCh------hhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcc
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQ------TKIDEFINELVVVSQINRRNVVRLLACCLETQVP 137 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~------~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~ 137 (241)
...|.+.+.||+|+||.||+|... ++..||+|.+..... ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 356778889999999999999865 588999998754321 1357889999999999999999999999999999
Q ss_pred eEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC----CeEEccCCCcc
Q 039310 138 LLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENY----TPKVSDFGASK 213 (241)
Q Consensus 138 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~----~~kl~Dfgla~ 213 (241)
++||||+++++|.+++.....+++..+..++.|++.||.|||+.+ ++||||||+|||++.++ .+||+|||++.
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 999999999999999988888999999999999999999999999 99999999999999887 79999999998
Q ss_pred cccCCccceeeeecccccccccccccC
Q 039310 214 LVPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 214 ~~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
...... ......||+.|+|||++.+
T Consensus 167 ~~~~~~--~~~~~~gt~~y~aPE~~~~ 191 (326)
T 2y0a_A 167 KIDFGN--EFKNIFGTPEFVAPEIVNY 191 (326)
T ss_dssp ECCTTS--CCCCCCSCTTTCCHHHHTT
T ss_pred ECCCCC--ccccccCCcCcCCceeecC
Confidence 764332 2334569999999998764
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=245.75 Aligned_cols=184 Identities=40% Similarity=0.616 Sum_probs=152.1
Q ss_pred ccCHHHHHH--hhhcccccccccCceeEEEEEeCCCCeEEEEecccCCh-hhHHHHHHHHHHHHcCCCCCceeEEEEEec
Q 039310 57 IFIEEEIKT--VTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQ-TKIDEFINELVVVSQINRRNVVRLLACCLE 133 (241)
Q Consensus 57 ~~~~~~~~~--~~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 133 (241)
.+...++.. ..+...+.||+|+||.||+|...++..||+|.+..... .....+.+|+.+++.++||||+++++++..
T Consensus 19 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 98 (326)
T 3uim_A 19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT 98 (326)
T ss_dssp ECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECC
T ss_pred eecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEec
Confidence 344444444 44556779999999999999988899999998765332 222368899999999999999999999999
Q ss_pred CCcceEEEEecCCCCchHHhhcCC----CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccC
Q 039310 134 TQVPLLVYEFVGNGTLFEHIHKNG----NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDF 209 (241)
Q Consensus 134 ~~~~~lv~e~~~~g~L~~~l~~~~----~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Df 209 (241)
.+..++||||+++|+|.+++.... .+++..+..++.|++.||.|||+....+++||||||+|||+++++.+||+||
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Df 178 (326)
T 3uim_A 99 PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 178 (326)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCC
T ss_pred CCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccC
Confidence 999999999999999999997643 4999999999999999999999991112999999999999999999999999
Q ss_pred CCcccccCCccceeeeecccccccccccccC
Q 039310 210 GASKLVPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 210 gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
|++...............||+.|+|||++.+
T Consensus 179 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 209 (326)
T 3uim_A 179 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 209 (326)
T ss_dssp SSCEECCSSSSCEECCCCSCGGGCCHHHHHH
T ss_pred ccccccCcccccccccccCCcCccCHHHhcc
Confidence 9998775554444555569999999998753
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=238.49 Aligned_cols=171 Identities=28% Similarity=0.442 Sum_probs=149.0
Q ss_pred HhhhcccccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEec
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
...+.+.+.||+|+||.||+|.+.++..||+|.+..... ..+++.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 345777889999999999999988888999998775432 3467899999999999999999999999999999999999
Q ss_pred CCCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcccee
Q 039310 145 GNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNY 223 (241)
Q Consensus 145 ~~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~ 223 (241)
++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...........
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (269)
T 4hcu_A 88 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 164 (269)
T ss_dssp TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccccccc
Confidence 999999999654 46899999999999999999999999 99999999999999999999999999987654433333
Q ss_pred eeeccccccccccccc
Q 039310 224 TVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 224 ~~~~gt~~y~aPE~l~ 239 (241)
....+|+.|+|||++.
T Consensus 165 ~~~~~~~~y~aPE~~~ 180 (269)
T 4hcu_A 165 TGTKFPVKWASPEVFS 180 (269)
T ss_dssp TSTTCCGGGCCHHHHH
T ss_pred cCcccccccCCHHHhc
Confidence 4445788999999875
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=241.34 Aligned_cols=174 Identities=26% Similarity=0.397 Sum_probs=148.5
Q ss_pred HHHHhhhcccccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEE
Q 039310 62 EIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVY 141 (241)
Q Consensus 62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~ 141 (241)
++....+.+.+.||+|+||.||+|.+.++..||+|.+..... ..+++.+|+.+++.++||||+++++++.+.+..++||
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 98 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence 344557778889999999999999988888999998875432 3467899999999999999999999999999999999
Q ss_pred EecCCCCchHHhhc-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcc
Q 039310 142 EFVGNGTLFEHIHK-NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAI 220 (241)
Q Consensus 142 e~~~~g~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~ 220 (241)
||+++++|.+++.. ...+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++........
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 99 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp CCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence 99999999999976 457999999999999999999999999 99999999999999999999999999987654433
Q ss_pred ceeeeeccccccccccccc
Q 039310 221 QNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 221 ~~~~~~~gt~~y~aPE~l~ 239 (241)
.......+|+.|+|||++.
T Consensus 176 ~~~~~~~~~~~y~aPE~~~ 194 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLM 194 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHH
T ss_pred ccccCCccCcccCCHHHhc
Confidence 3333445788999999875
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=242.59 Aligned_cols=174 Identities=31% Similarity=0.515 Sum_probs=140.9
Q ss_pred HHhhhcccccccccCceeEEEEEeCCCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEE
Q 039310 64 KTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVY 141 (241)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~ 141 (241)
....+.+.+.||+|+||.||+|.. ++..||+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 345677788999999999999987 5778999987653 3445578899999999999999999999999999999999
Q ss_pred EecCCCCchHHhhcCCC---CCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCC
Q 039310 142 EFVGNGTLFEHIHKNGN---LTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPID 218 (241)
Q Consensus 142 e~~~~g~L~~~l~~~~~---l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~ 218 (241)
||+++++|.+++..... +++..+..++.|++.||.|||+.+ .+++||||||+|||++.++.+||+|||++......
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 192 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST 192 (309)
T ss_dssp ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence 99999999999987653 999999999999999999999975 45999999999999999999999999999765332
Q ss_pred ccceeeeecccccccccccccC
Q 039310 219 AIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 219 ~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
. .......||+.|+|||++.+
T Consensus 193 ~-~~~~~~~gt~~y~aPE~~~~ 213 (309)
T 3p86_A 193 F-LSSKSAAGTPEWMAPEVLRD 213 (309)
T ss_dssp ----------CCTTSCHHHHTT
T ss_pred c-cccccCCCCccccChhhhcC
Confidence 2 22334569999999999764
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=244.95 Aligned_cols=172 Identities=24% Similarity=0.344 Sum_probs=150.0
Q ss_pred HHhhhcccccccccCceeEEEEEeC-CCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEE
Q 039310 64 KTVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLV 140 (241)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv 140 (241)
....|.+.+.||+|+||.||+|... ++..||+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3456888899999999999999864 5889999987643 344567889999999999999999999999999999999
Q ss_pred EEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC---CeEEccCCCcccccC
Q 039310 141 YEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENY---TPKVSDFGASKLVPI 217 (241)
Q Consensus 141 ~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~---~~kl~Dfgla~~~~~ 217 (241)
|||+++|+|.+++.....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++ .+||+|||++.....
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 999999999999988888999999999999999999999999 99999999999998654 599999999987643
Q ss_pred CccceeeeecccccccccccccC
Q 039310 218 DAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 218 ~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
. .......||+.|+|||++.+
T Consensus 184 ~--~~~~~~~gt~~y~aPE~~~~ 204 (362)
T 2bdw_A 184 S--EAWHGFAGTPGYLSPEVLKK 204 (362)
T ss_dssp C--CSCCCSCSCTTTCCHHHHTT
T ss_pred C--cccccCCCCccccCHHHHcc
Confidence 2 22334569999999999864
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=250.91 Aligned_cols=172 Identities=22% Similarity=0.286 Sum_probs=148.1
Q ss_pred HhhhcccccccccCceeEEEEEe-CCCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEE
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVY 141 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~ 141 (241)
...|.+.+.||+|+||.||+|.. .++..+|+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 45677888999999999999985 46888999987643 2345567899999999999999999999999999999999
Q ss_pred EecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC---CCCCeEEccCCCcccccCC
Q 039310 142 EFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLD---ENYTPKVSDFGASKLVPID 218 (241)
Q Consensus 142 e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~---~~~~~kl~Dfgla~~~~~~ 218 (241)
||+++|+|.+.+...+.+++..+..++.|++.||.|||+++ |+||||||+|||++ .++.+||+|||+|......
T Consensus 90 E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~ 166 (444)
T 3soa_A 90 DLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166 (444)
T ss_dssp CCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence 99999999999998889999999999999999999999999 99999999999998 4678999999999876433
Q ss_pred ccceeeeecccccccccccccC
Q 039310 219 AIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 219 ~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
. .......||+.|+|||++.+
T Consensus 167 ~-~~~~~~~gt~~Y~APE~l~~ 187 (444)
T 3soa_A 167 Q-QAWFGFAGTPGYLSPEVLRK 187 (444)
T ss_dssp C-CBCCCSCSCGGGCCHHHHTT
T ss_pred C-ceeecccCCcccCCHHHhcC
Confidence 2 22334569999999999864
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-35 Score=244.84 Aligned_cols=169 Identities=22% Similarity=0.329 Sum_probs=146.9
Q ss_pred hhhcccccccccCceeEEEEEe-CCCCeEEEEecccCC---hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVD---QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVY 141 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~ 141 (241)
..|.+.+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 3567788999999999999995 568899999865321 122357889999999999999999999999999999999
Q ss_pred EecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc
Q 039310 142 EFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ 221 (241)
Q Consensus 142 e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~ 221 (241)
||+ +|+|.+++...+.+++..+..++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||++.......
T Consensus 89 E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~-- 162 (336)
T 3h4j_B 89 EYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-- 162 (336)
T ss_dssp CCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB--
T ss_pred ECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCCc--
Confidence 999 6799999988888999999999999999999999999 9999999999999999999999999998764332
Q ss_pred eeeeecccccccccccccC
Q 039310 222 NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~~ 240 (241)
.....+||+.|+|||++.+
T Consensus 163 ~~~~~~gt~~y~aPE~~~~ 181 (336)
T 3h4j_B 163 FLKTSCGSPNYAAPEVING 181 (336)
T ss_dssp TTCCCTTSTTTSCGGGSCC
T ss_pred ccccccCCcCcCCHHHHcC
Confidence 2344569999999999864
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=256.45 Aligned_cols=175 Identities=22% Similarity=0.382 Sum_probs=149.9
Q ss_pred HHHHHhhhcccccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEE
Q 039310 61 EEIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLV 140 (241)
Q Consensus 61 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv 140 (241)
.++....+.+.+.||+|+||+||+|.++++..||||.+.... ...+.+.+|+.+++.++||||+++++++. .+..++|
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv 260 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII 260 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence 345566777888999999999999999888899999887543 34678999999999999999999999986 6678999
Q ss_pred EEecCCCCchHHhhcCC--CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCC
Q 039310 141 YEFVGNGTLFEHIHKNG--NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPID 218 (241)
Q Consensus 141 ~e~~~~g~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~ 218 (241)
|||+++|+|.+++.... .+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||+++.....
T Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp ECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 99999999999997542 6899999999999999999999999 999999999999999999999999999876433
Q ss_pred ccceeeeecccccccccccccC
Q 039310 219 AIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 219 ~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
.........+|+.|+|||++..
T Consensus 338 ~~~~~~~~~~~~~y~aPE~~~~ 359 (454)
T 1qcf_A 338 EYTAREGAKFPIKWTAPEAINF 359 (454)
T ss_dssp HHHTTCSSSSCGGGSCHHHHHH
T ss_pred ceeccCCCcccccccCHHHhcc
Confidence 3222233446789999998753
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-35 Score=245.96 Aligned_cols=171 Identities=19% Similarity=0.218 Sum_probs=144.3
Q ss_pred HHhhhcccccccccCceeEEEEE------eCCCCeEEEEecccCChhhHHHHHHHHHHHHcCC---CCCceeEEEEEecC
Q 039310 64 KTVTNNYADVIGCGGSGNVYKGF------LPDRTPVAVKKSKIVDQTKIDEFINELVVVSQIN---RRNVVRLLACCLET 134 (241)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~------~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~---h~ni~~l~~~~~~~ 134 (241)
....|.+.+.||+|+||.||+|. ..++..||+|.+.... ..++..|..+++.++ |+||+.+++++...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 34456677899999999999994 4468899999876543 356778888888886 99999999999999
Q ss_pred CcceEEEEecCCCCchHHhhc-----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC---------
Q 039310 135 QVPLLVYEFVGNGTLFEHIHK-----NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDE--------- 200 (241)
Q Consensus 135 ~~~~lv~e~~~~g~L~~~l~~-----~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~--------- 200 (241)
+..++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccc
Confidence 999999999999999999973 457999999999999999999999999 999999999999998
Q ss_pred --CCCeEEccCCCcccccCC-ccceeeeecccccccccccccC
Q 039310 201 --NYTPKVSDFGASKLVPID-AIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 201 --~~~~kl~Dfgla~~~~~~-~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
++.+||+|||+|..+... .........||+.|||||++.+
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 259 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN 259 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC
Confidence 899999999999765322 2233445669999999999865
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=239.69 Aligned_cols=170 Identities=24% Similarity=0.326 Sum_probs=143.6
Q ss_pred hhhcccccccccCceeEEEEEeCCCCeEEEEecccCC--hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVD--QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
.+|.+.+.||+|+||+||+|...+++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 21 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 100 (311)
T 3niz_A 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEF 100 (311)
T ss_dssp CEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEEC
T ss_pred hhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcC
Confidence 4567788999999999999998889999999876432 23356788999999999999999999999999999999999
Q ss_pred cCCCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccce
Q 039310 144 VGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQN 222 (241)
Q Consensus 144 ~~~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~ 222 (241)
+++ +|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++....... ..
T Consensus 101 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~ 175 (311)
T 3niz_A 101 MEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV-RS 175 (311)
T ss_dssp CSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC-C-
T ss_pred CCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCc-cc
Confidence 975 788777654 45999999999999999999999999 9999999999999999999999999998764322 22
Q ss_pred eeeecccccccccccccC
Q 039310 223 YTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 223 ~~~~~gt~~y~aPE~l~~ 240 (241)
.....||+.|+|||++.+
T Consensus 176 ~~~~~~t~~y~aPE~~~~ 193 (311)
T 3niz_A 176 YTHEVVTLWYRAPDVLMG 193 (311)
T ss_dssp --CCCCCCTTCCHHHHTT
T ss_pred ccCCcccCCcCCHHHhcC
Confidence 333468999999998754
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=236.84 Aligned_cols=169 Identities=26% Similarity=0.373 Sum_probs=143.5
Q ss_pred hhcccccccccCceeEEEEEeC-CCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
+|.+.+.||+|+||+||+|... +++.||+|.+... .......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 82 (292)
T 3o0g_A 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEec
Confidence 4567789999999999999864 5889999987643 333457788999999999999999999999999999999999
Q ss_pred cCCCCchHHh-hcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccce
Q 039310 144 VGNGTLFEHI-HKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQN 222 (241)
Q Consensus 144 ~~~g~L~~~l-~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~ 222 (241)
+++ ++.+.+ ...+.+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++....... ..
T Consensus 83 ~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 157 (292)
T 3o0g_A 83 CDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RC 157 (292)
T ss_dssp CSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-SC
T ss_pred CCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc-cc
Confidence 976 555554 44668999999999999999999999999 9999999999999999999999999998764322 22
Q ss_pred eeeecccccccccccccC
Q 039310 223 YTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 223 ~~~~~gt~~y~aPE~l~~ 240 (241)
.....||+.|+|||++.+
T Consensus 158 ~~~~~~t~~y~aPE~~~~ 175 (292)
T 3o0g_A 158 YSAEVVTLWYRPPDVLFG 175 (292)
T ss_dssp CCSCCSCGGGCCHHHHTT
T ss_pred ccCCccccCCcChHHHcC
Confidence 334568999999998754
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=244.49 Aligned_cols=170 Identities=19% Similarity=0.293 Sum_probs=148.9
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEec
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
..|.+.+.||+|+||.||+|... ++..+|+|.+..........+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 130 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 130 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcC
Confidence 35777889999999999999864 57889999887665556678899999999999999999999999999999999999
Q ss_pred CCCCchHHhhcCC-CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC--CCCeEEccCCCcccccCCccc
Q 039310 145 GNGTLFEHIHKNG-NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDE--NYTPKVSDFGASKLVPIDAIQ 221 (241)
Q Consensus 145 ~~g~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~--~~~~kl~Dfgla~~~~~~~~~ 221 (241)
++++|.+++.... .+++..+..++.|++.||.|||+++ ++||||||+|||++. ++.+||+|||++.......
T Consensus 131 ~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~-- 205 (387)
T 1kob_A 131 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-- 205 (387)
T ss_dssp CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS--
T ss_pred CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCCc--
Confidence 9999999997654 7999999999999999999999999 999999999999974 5779999999998765432
Q ss_pred eeeeecccccccccccccC
Q 039310 222 NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~~ 240 (241)
......||+.|+|||++.+
T Consensus 206 ~~~~~~gt~~y~aPE~~~~ 224 (387)
T 1kob_A 206 IVKVTTATAEFAAPEIVDR 224 (387)
T ss_dssp CEEEECSSGGGCCHHHHTT
T ss_pred ceeeeccCCCccCchhccC
Confidence 2334569999999999864
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-35 Score=248.24 Aligned_cols=176 Identities=28% Similarity=0.427 Sum_probs=148.4
Q ss_pred HHHHhhhcccccccccCceeEEEEEeC-CCCeEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceE
Q 039310 62 EIKTVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLL 139 (241)
Q Consensus 62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~l 139 (241)
++....+.+.+.||+|+||.||+|.+. ++..||||.+... .....+.+.+|+.+++.++||||+++++++...+..++
T Consensus 110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 189 (377)
T 3cbl_A 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189 (377)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence 344556777889999999999999975 6889999987653 33445678899999999999999999999999999999
Q ss_pred EEEecCCCCchHHhhcCC-CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCC
Q 039310 140 VYEFVGNGTLFEHIHKNG-NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPID 218 (241)
Q Consensus 140 v~e~~~~g~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~ 218 (241)
||||+++|+|.+++...+ .+++..+..++.|++.||.|||+++ ++||||||+|||+++++.+||+|||+++.....
T Consensus 190 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 999999999999997654 5999999999999999999999999 999999999999999999999999999865332
Q ss_pred cccee-eeecccccccccccccC
Q 039310 219 AIQNY-TVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 219 ~~~~~-~~~~gt~~y~aPE~l~~ 240 (241)
..... ....+|+.|+|||++.+
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~ 289 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNY 289 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHH
T ss_pred ceeecCCCCCCCcCcCCHhHhcc
Confidence 21111 11235788999998753
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=252.59 Aligned_cols=170 Identities=25% Similarity=0.386 Sum_probs=150.0
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEecccCC---hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD---QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVY 141 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~ 141 (241)
..|.+.+.||+|+||.||+|... +++.||||.+.... ......+.+|+.+++.++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 45677889999999999999865 68899999875422 223567889999999999999999999999999999999
Q ss_pred EecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc
Q 039310 142 EFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ 221 (241)
Q Consensus 142 e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~ 221 (241)
||+++|+|.+++..++.+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.......
T Consensus 96 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~-- 170 (476)
T 2y94_A 96 EYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-- 170 (476)
T ss_dssp ECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTTC--
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccccc--
Confidence 99999999999998888999999999999999999999999 9999999999999999999999999998764332
Q ss_pred eeeeecccccccccccccC
Q 039310 222 NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~~ 240 (241)
.....+||+.|+|||++.+
T Consensus 171 ~~~~~~gt~~y~aPE~~~~ 189 (476)
T 2y94_A 171 FLRTSCGSPNYAAPEVISG 189 (476)
T ss_dssp CBCCCCSCSTTCCHHHHTT
T ss_pred cccccCCCcCeEChhhccC
Confidence 2344579999999999864
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=247.88 Aligned_cols=175 Identities=25% Similarity=0.401 Sum_probs=138.5
Q ss_pred HHHhhhcccccccccCceeEEEEEeC----CCCeEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcc
Q 039310 63 IKTVTNNYADVIGCGGSGNVYKGFLP----DRTPVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVP 137 (241)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~ 137 (241)
+....+.+.+.||+|+||.||+|... ++..||||.+... .....+.+.+|+.+++.++||||+++++++...+..
T Consensus 42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 121 (373)
T 2qol_A 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV 121 (373)
T ss_dssp CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence 34456777889999999999999864 4678999988754 445567899999999999999999999999999999
Q ss_pred eEEEEecCCCCchHHhhcCC-CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCccccc
Q 039310 138 LLVYEFVGNGTLFEHIHKNG-NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVP 216 (241)
Q Consensus 138 ~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~ 216 (241)
++||||+++++|.+++...+ .+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++...
T Consensus 122 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 122 MIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 99999999999999998654 6999999999999999999999999 9999999999999999999999999998764
Q ss_pred CCccc--eeeeecccccccccccccC
Q 039310 217 IDAIQ--NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 217 ~~~~~--~~~~~~gt~~y~aPE~l~~ 240 (241)
..... ......+|+.|+|||++.+
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~ 224 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAY 224 (373)
T ss_dssp ---------------CTTSCHHHHHH
T ss_pred cCCccceeccCCCcCCCccChhhhcc
Confidence 33221 1222235788999998753
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-35 Score=244.26 Aligned_cols=173 Identities=21% Similarity=0.262 Sum_probs=146.4
Q ss_pred HHhhhcccccccccCceeEEEEEeC-CCCeEEEEecccCC-----hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcc
Q 039310 64 KTVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD-----QTKIDEFINELVVVSQINRRNVVRLLACCLETQVP 137 (241)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~-----~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~ 137 (241)
....|.+.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 4457888999999999999999854 68899999865321 12457789999999999999999999999999999
Q ss_pred eEEEEecCCCCchHHhhcC----CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCC---eEEccCC
Q 039310 138 LLVYEFVGNGTLFEHIHKN----GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYT---PKVSDFG 210 (241)
Q Consensus 138 ~lv~e~~~~g~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~---~kl~Dfg 210 (241)
|+||||+++++|.+.+... ..+++..+..++.|++.||.|||+++ ++||||||+|||++.++. +||+|||
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCc
Confidence 9999999999998887532 35899999999999999999999999 999999999999986654 9999999
Q ss_pred CcccccCCccceeeeecccccccccccccC
Q 039310 211 ASKLVPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 211 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
++........ ......||+.|+|||++.+
T Consensus 179 ~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~ 207 (351)
T 3c0i_A 179 VAIQLGESGL-VAGGRVGTPHFMAPEVVKR 207 (351)
T ss_dssp TCEECCTTSC-BCCCCCSCGGGCCHHHHTT
T ss_pred ceeEecCCCe-eecCCcCCcCccCHHHHcC
Confidence 9987654322 2334569999999999864
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=244.50 Aligned_cols=169 Identities=27% Similarity=0.323 Sum_probs=139.6
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEec
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
.+|.+.+.||+|+||.||+|... +++.||+|.+..... ..+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 98 (361)
T 3uc3_A 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA 98 (361)
T ss_dssp TTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence 45778889999999999999965 688999998765332 2366789999999999999999999999999999999999
Q ss_pred CCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCC--eEEccCCCcccccCCccce
Q 039310 145 GNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYT--PKVSDFGASKLVPIDAIQN 222 (241)
Q Consensus 145 ~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~--~kl~Dfgla~~~~~~~~~~ 222 (241)
++|+|.+++...+++++..+..++.|++.||.|||+.+ ++||||||+|||++.++. +||+|||+|+..... ..
T Consensus 99 ~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~--~~ 173 (361)
T 3uc3_A 99 SGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--SQ 173 (361)
T ss_dssp CSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC----------
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc--CC
Confidence 99999999988888999999999999999999999999 999999999999987765 999999998754322 22
Q ss_pred eeeecccccccccccccC
Q 039310 223 YTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 223 ~~~~~gt~~y~aPE~l~~ 240 (241)
.....||+.|+|||++.+
T Consensus 174 ~~~~~gt~~y~aPE~~~~ 191 (361)
T 3uc3_A 174 PKSTVGTPAYIAPEVLLR 191 (361)
T ss_dssp -------CTTSCHHHHHC
T ss_pred CCCCcCCCCcCChhhhcC
Confidence 334469999999998754
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-35 Score=256.77 Aligned_cols=177 Identities=27% Similarity=0.426 Sum_probs=151.7
Q ss_pred HHHHHHhhhcccccccccCceeEEEEEeCC-CCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcce
Q 039310 60 EEEIKTVTNNYADVIGCGGSGNVYKGFLPD-RTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPL 138 (241)
Q Consensus 60 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~ 138 (241)
..++....+.+.+.||+|+||.||+|.+.. +..||||.+.... ...+.+.+|+.+++.++||||+++++++...+..+
T Consensus 214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 292 (495)
T 1opk_A 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 292 (495)
T ss_dssp CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEE
Confidence 344555667788899999999999999764 7889999887543 34578999999999999999999999999999999
Q ss_pred EEEEecCCCCchHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCccccc
Q 039310 139 LVYEFVGNGTLFEHIHKN--GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVP 216 (241)
Q Consensus 139 lv~e~~~~g~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~ 216 (241)
+||||+++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 293 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 293 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred EEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceecc
Confidence 999999999999999764 35899999999999999999999999 9999999999999999999999999998765
Q ss_pred CCccceeeeecccccccccccccC
Q 039310 217 IDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 217 ~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
.+.........+|+.|+|||++..
T Consensus 370 ~~~~~~~~~~~~~~~y~aPE~~~~ 393 (495)
T 1opk_A 370 GDTYTAHAGAKFPIKWTAPESLAY 393 (495)
T ss_dssp TCCEECCTTCCCCGGGCCHHHHHH
T ss_pred CCceeecCCCcCCcceeCHhHHhc
Confidence 443333333446789999998753
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=251.73 Aligned_cols=170 Identities=24% Similarity=0.328 Sum_probs=133.8
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEeccc--CChhhHHHHHHHHHHHHcCCCCCceeEEEEEecC-----Ccc
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKI--VDQTKIDEFINELVVVSQINRRNVVRLLACCLET-----QVP 137 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~--~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~-----~~~ 137 (241)
.+|.+.+.||+|+||.||+|... ++..||||++.. .+....+++.+|+.+++.++||||+++++++... ...
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 45778889999999999999854 688999998754 3444567899999999999999999999999543 568
Q ss_pred eEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccC
Q 039310 138 LLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPI 217 (241)
Q Consensus 138 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~ 217 (241)
|+||||+ +++|.+++.....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+....
T Consensus 133 ~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 208 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208 (458)
T ss_dssp EEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred EEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchhccC
Confidence 9999998 4699999998888999999999999999999999999 99999999999999999999999999987642
Q ss_pred Ccc--------------------------ceeeeeccccccccccccc
Q 039310 218 DAI--------------------------QNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 218 ~~~--------------------------~~~~~~~gt~~y~aPE~l~ 239 (241)
... .......||+.|+|||++.
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~ 256 (458)
T 3rp9_A 209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELIL 256 (458)
T ss_dssp CTTCCCCCC---------------------------CCCTTCCHHHHT
T ss_pred ccccccccccCccccccccccccccccccccccCCcccccccChHHhh
Confidence 211 1223346899999999763
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=250.21 Aligned_cols=167 Identities=22% Similarity=0.280 Sum_probs=139.2
Q ss_pred HHHhhhcccccccccCceeEEEEEeCCCCeEEEEecccCC--------hhhHHHHHHHHHHHHcCC---------CCCce
Q 039310 63 IKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVD--------QTKIDEFINELVVVSQIN---------RRNVV 125 (241)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~ni~ 125 (241)
+....|.+.+.||+|+||+||+|+. +++.||||.+.... ....+.+.+|+.+++.++ ||||+
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred cccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 4456678889999999999999998 67899999876532 233477889999998885 88888
Q ss_pred eEEEEEe------------------------------cCCcceEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHH
Q 039310 126 RLLACCL------------------------------ETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVL 175 (241)
Q Consensus 126 ~l~~~~~------------------------------~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l 175 (241)
++.+++. ..+..|+||||+++|++.+.+.. ..+++..+..++.|++.||
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHH
Confidence 8877653 26789999999999977666644 5689999999999999999
Q ss_pred HHhh-cCCCCCeEecCCCCCCeeeCCCC--------------------CeEEccCCCcccccCCccceeeeecccccccc
Q 039310 176 SYLH-SETNVPIIHRDVKSANILLDENY--------------------TPKVSDFGASKLVPIDAIQNYTVVQGTLGYID 234 (241)
Q Consensus 176 ~~lh-~~~~~~iiH~dlk~~Nili~~~~--------------------~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~a 234 (241)
.||| +.+ |+||||||+|||++.++ .+||+|||+|+..... ...||+.|||
T Consensus 175 ~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~a 245 (336)
T 2vuw_A 175 AVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMD 245 (336)
T ss_dssp HHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTC
T ss_pred HHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccC
Confidence 9999 888 99999999999999887 8999999999876422 2369999999
Q ss_pred cccccC
Q 039310 235 PEYLQT 240 (241)
Q Consensus 235 PE~l~~ 240 (241)
||++.+
T Consensus 246 PE~~~g 251 (336)
T 2vuw_A 246 EDLFTG 251 (336)
T ss_dssp SGGGCC
T ss_pred hhhhcC
Confidence 999864
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=240.56 Aligned_cols=174 Identities=22% Similarity=0.381 Sum_probs=145.0
Q ss_pred HHhhhcccccccccCceeEEEEEe-----CCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecC--Cc
Q 039310 64 KTVTNNYADVIGCGGSGNVYKGFL-----PDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLET--QV 136 (241)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~--~~ 136 (241)
....+.+.+.||+|+||.||+|++ .++..||+|++........+.+.+|+.+++.++||||+++++++... ..
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 345677888999999999999984 35788999998877777778899999999999999999999998653 56
Q ss_pred ceEEEEecCCCCchHHhhcCC-CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccc
Q 039310 137 PLLVYEFVGNGTLFEHIHKNG-NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLV 215 (241)
Q Consensus 137 ~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~ 215 (241)
.++||||+++++|.+++.... ++++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++...
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVL 164 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred eEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence 899999999999999998754 5999999999999999999999999 999999999999999999999999999876
Q ss_pred cCCcc--ceeeeecccccccccccccC
Q 039310 216 PIDAI--QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 216 ~~~~~--~~~~~~~gt~~y~aPE~l~~ 240 (241)
..... .......+|+.|+|||++.+
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~ 191 (295)
T 3ugc_A 165 PQDKEFFKVKEPGESPIFWYAPESLTE 191 (295)
T ss_dssp -----------CTTCGGGGCCHHHHHH
T ss_pred cCCcceeeeccCCCCccceeCcHHhcC
Confidence 43322 12223347788999998753
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-35 Score=247.10 Aligned_cols=172 Identities=27% Similarity=0.345 Sum_probs=139.6
Q ss_pred HhhhcccccccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHHH-HHcCCCCCceeEEEEEecCCcceE
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELVV-VSQINRRNVVRLLACCLETQVPLL 139 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~~-l~~l~h~ni~~l~~~~~~~~~~~l 139 (241)
...+.+.+.||+|+||+||+|+.. ++..||+|.+... .......+.+|..+ ++.++||||+++++++.+.+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 345778889999999999999965 4788999987542 22334566777776 567899999999999999999999
Q ss_pred EEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCc
Q 039310 140 VYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDA 219 (241)
Q Consensus 140 v~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~ 219 (241)
||||+++|+|.+++.....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 117 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~ 193 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN 193 (373)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccccCC
Confidence 9999999999999988888999999999999999999999999 9999999999999999999999999998643222
Q ss_pred cceeeeecccccccccccccC
Q 039310 220 IQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 220 ~~~~~~~~gt~~y~aPE~l~~ 240 (241)
......+||+.|+|||++.+
T Consensus 194 -~~~~~~~gt~~y~aPE~~~~ 213 (373)
T 2r5t_A 194 -STTSTFCGTPEYLAPEVLHK 213 (373)
T ss_dssp -CCCCSBSCCCCCCCHHHHTT
T ss_pred -CccccccCCccccCHHHhCC
Confidence 23445679999999999864
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=241.02 Aligned_cols=170 Identities=28% Similarity=0.375 Sum_probs=143.8
Q ss_pred HhhhcccccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCC----cceEE
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQ----VPLLV 140 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~----~~~lv 140 (241)
...+.+.+.||+|+||+||+|++. +..||||.+.... .......+|+.+++.++||||+++++++.... ..++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 346777889999999999999875 6889999876533 33345667999999999999999999998754 36999
Q ss_pred EEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcC----------CCCCeEecCCCCCCeeeCCCCCeEEccCC
Q 039310 141 YEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSE----------TNVPIIHRDVKSANILLDENYTPKVSDFG 210 (241)
Q Consensus 141 ~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~----------~~~~iiH~dlk~~Nili~~~~~~kl~Dfg 210 (241)
|||+++|+|.+++... .+++..+..++.|++.||.|||+. + ++||||||+|||++.++.+||+|||
T Consensus 101 ~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~DFg 176 (322)
T 3soc_A 101 TAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIADFG 176 (322)
T ss_dssp EECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred EecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEccCC
Confidence 9999999999999765 599999999999999999999998 7 9999999999999999999999999
Q ss_pred CcccccCCccc-eeeeecccccccccccccC
Q 039310 211 ASKLVPIDAIQ-NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 211 la~~~~~~~~~-~~~~~~gt~~y~aPE~l~~ 240 (241)
+|......... ......||+.|+|||++.+
T Consensus 177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 207 (322)
T 3soc_A 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEG 207 (322)
T ss_dssp TCEEECTTSCCCCCTTCCCCGGGCCHHHHTT
T ss_pred cccccccccCccccccCccCccccCHhhccc
Confidence 99876443222 2233468999999998864
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=232.80 Aligned_cols=171 Identities=24% Similarity=0.342 Sum_probs=150.7
Q ss_pred HhhhcccccccccCceeEEEEEeC-CCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
...|.+.+.||+|+||.||+|... ++..+|+|++........+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 346778889999999999999865 4678999987765555668899999999999999999999999999999999999
Q ss_pred cCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee---CCCCCeEEccCCCcccccCCcc
Q 039310 144 VGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILL---DENYTPKVSDFGASKLVPIDAI 220 (241)
Q Consensus 144 ~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili---~~~~~~kl~Dfgla~~~~~~~~ 220 (241)
+++++|.+++.....+++..+..++.|++.||.|||+.+ ++|+||||+||++ +.++.++|+|||++.......
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~- 163 (277)
T 3f3z_A 88 CTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK- 163 (277)
T ss_dssp CCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS-
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc-
Confidence 999999999988888999999999999999999999999 9999999999999 788999999999998764332
Q ss_pred ceeeeecccccccccccccC
Q 039310 221 QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 221 ~~~~~~~gt~~y~aPE~l~~ 240 (241)
......||+.|+|||++.+
T Consensus 164 -~~~~~~~t~~y~aPE~~~~ 182 (277)
T 3f3z_A 164 -MMRTKVGTPYYVSPQVLEG 182 (277)
T ss_dssp -CBCCCCSCTTTCCHHHHTT
T ss_pred -chhccCCCCCccChHHhcc
Confidence 2334469999999998754
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=236.02 Aligned_cols=170 Identities=26% Similarity=0.358 Sum_probs=140.6
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEecccCCh--------------------------hhHHHHHHHHHHHHc
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQ--------------------------TKIDEFINELVVVSQ 118 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~--------------------------~~~~~~~~E~~~l~~ 118 (241)
..|.+.+.||+|+||.||+|... ++..||+|.+..... ...+.+.+|+.+++.
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 35777889999999999999854 578899998754321 123568899999999
Q ss_pred CCCCCceeEEEEEec--CCcceEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCe
Q 039310 119 INRRNVVRLLACCLE--TQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANI 196 (241)
Q Consensus 119 l~h~ni~~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Ni 196 (241)
++||||+++++++.+ .+..++||||+++++|.+++. ...+++..+..++.|++.||.|||+.+ ++||||||+||
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Ni 168 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNL 168 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGE
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHE
Confidence 999999999999987 567899999999999988664 347999999999999999999999999 99999999999
Q ss_pred eeCCCCCeEEccCCCcccccCCccceeeeecccccccccccccC
Q 039310 197 LLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 197 li~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
|++.++.+||+|||++....... .......||+.|+|||++.+
T Consensus 169 l~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~ 211 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEFKGSD-ALLSNTVGTPAFMAPESLSE 211 (298)
T ss_dssp EECTTSCEEECCCTTCEECSSSS-CEECCCCSCGGGCCGGGCCT
T ss_pred EECCCCCEEEecCCCcccccccc-ccccCCcCCccccChhhhcc
Confidence 99999999999999998764332 22334569999999999864
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=254.59 Aligned_cols=171 Identities=25% Similarity=0.319 Sum_probs=138.3
Q ss_pred hhhcccccccccCceeEEEEEe-CCCCeEEEEecccC---ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIV---DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVY 141 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~ 141 (241)
..+.+.+.||+|+||.||+|.. .++..||+|.+... .......+.+|+.+++.++||||+++++++...+..++||
T Consensus 148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 227 (446)
T 4ejn_A 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM 227 (446)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence 4566778999999999999985 46889999987642 3344567789999999999999999999999999999999
Q ss_pred EecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcc
Q 039310 142 EFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHS-ETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAI 220 (241)
Q Consensus 142 e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~ 220 (241)
||+++|+|.+++.....+++..+..++.|++.||.|||+ .+ |+||||||+|||++.++.+||+|||+|+......
T Consensus 228 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 303 (446)
T 4ejn_A 228 EYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG- 303 (446)
T ss_dssp CCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred eeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccCCC-
Confidence 999999999999888889999999999999999999998 88 9999999999999999999999999998643222
Q ss_pred ceeeeecccccccccccccC
Q 039310 221 QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 221 ~~~~~~~gt~~y~aPE~l~~ 240 (241)
......+||+.|+|||++.+
T Consensus 304 ~~~~~~~gt~~y~aPE~~~~ 323 (446)
T 4ejn_A 304 ATMKTFCGTPEYLAPEVLED 323 (446)
T ss_dssp ---CCSSSCGGGCCHHHHHT
T ss_pred cccccccCCccccCHhhcCC
Confidence 23344679999999999754
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=255.02 Aligned_cols=168 Identities=30% Similarity=0.357 Sum_probs=146.3
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
+.+.+.||+|+||.||+|... +++.||+|.+... .......+.+|+.+++.++||||+++++++.+.+..|+||||
T Consensus 186 f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy 265 (576)
T 2acx_A 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 265 (576)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEc
Confidence 455678999999999999864 6889999987542 223446788999999999999999999999999999999999
Q ss_pred cCCCCchHHhhcCC--CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc
Q 039310 144 VGNGTLFEHIHKNG--NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ 221 (241)
Q Consensus 144 ~~~g~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~ 221 (241)
+++|+|.+++...+ .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|.......
T Consensus 266 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~-- 340 (576)
T 2acx_A 266 MNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-- 340 (576)
T ss_dssp CCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTTC--
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecccCc--
Confidence 99999999997654 4999999999999999999999999 9999999999999999999999999998764332
Q ss_pred eeeeecccccccccccccC
Q 039310 222 NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~~ 240 (241)
.....+||+.|+|||++.+
T Consensus 341 ~~~~~~GT~~Y~APEvl~~ 359 (576)
T 2acx_A 341 TIKGRVGTVGYMAPEVVKN 359 (576)
T ss_dssp CEECCCSCGGGCCHHHHTT
T ss_pred cccccCCCccccCHHHHcC
Confidence 2334579999999999865
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=243.09 Aligned_cols=165 Identities=26% Similarity=0.346 Sum_probs=140.1
Q ss_pred cccccccCceeEEEEEe-CCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCCCCc
Q 039310 71 ADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTL 149 (241)
Q Consensus 71 ~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~g~L 149 (241)
.+.||+|+||.||+|.. .++..||+|.+........+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 45799999999999985 46889999998876666678899999999999999999999999999999999999999999
Q ss_pred hHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee--CCCCCeEEccCCCcccccCCccceeeee
Q 039310 150 FEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILL--DENYTPKVSDFGASKLVPIDAIQNYTVV 226 (241)
Q Consensus 150 ~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili--~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 226 (241)
.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||+ ++++.+||+|||++....... .....
T Consensus 174 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~~~~~ 248 (373)
T 2x4f_A 174 FDRIIDESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--KLKVN 248 (373)
T ss_dssp HHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--BCCCC
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--ccccc
Confidence 9988654 36999999999999999999999999 9999999999999 677899999999998764332 23334
Q ss_pred cccccccccccccC
Q 039310 227 QGTLGYIDPEYLQT 240 (241)
Q Consensus 227 ~gt~~y~aPE~l~~ 240 (241)
.||+.|+|||++.+
T Consensus 249 ~gt~~y~aPE~~~~ 262 (373)
T 2x4f_A 249 FGTPEFLAPEVVNY 262 (373)
T ss_dssp CSSCTTCCHHHHTT
T ss_pred cCCCcEeChhhccC
Confidence 69999999998764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=244.97 Aligned_cols=178 Identities=24% Similarity=0.336 Sum_probs=150.7
Q ss_pred HHHHHHhhhcccccccccCceeEEEEEeC--------CCCeEEEEecccC-ChhhHHHHHHHHHHHHcC-CCCCceeEEE
Q 039310 60 EEEIKTVTNNYADVIGCGGSGNVYKGFLP--------DRTPVAVKKSKIV-DQTKIDEFINELVVVSQI-NRRNVVRLLA 129 (241)
Q Consensus 60 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l-~h~ni~~l~~ 129 (241)
..++...++.+.+.||+|+||.||+|... .+..||+|.+... .....+.+.+|+++++.+ +||||+++++
T Consensus 63 ~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 142 (382)
T 3tt0_A 63 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLG 142 (382)
T ss_dssp TTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhhee
Confidence 34555677888899999999999999852 2357999987653 344567899999999999 8999999999
Q ss_pred EEecCCcceEEEEecCCCCchHHhhcCC----------------CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCC
Q 039310 130 CCLETQVPLLVYEFVGNGTLFEHIHKNG----------------NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKS 193 (241)
Q Consensus 130 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~ 193 (241)
++...+..++||||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||
T Consensus 143 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp 219 (382)
T 3tt0_A 143 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAA 219 (382)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCG
T ss_pred eeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCc
Confidence 9999999999999999999999997643 4999999999999999999999999 99999999
Q ss_pred CCeeeCCCCCeEEccCCCcccccCCcc-ceeeeecccccccccccccC
Q 039310 194 ANILLDENYTPKVSDFGASKLVPIDAI-QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 194 ~Nili~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~ 240 (241)
+|||+++++.+||+|||+|........ .......+|+.|+|||++.+
T Consensus 220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 267 (382)
T 3tt0_A 220 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD 267 (382)
T ss_dssp GGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS
T ss_pred ceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC
Confidence 999999999999999999987643322 22333457899999998754
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-35 Score=241.77 Aligned_cols=172 Identities=27% Similarity=0.385 Sum_probs=140.3
Q ss_pred hhhcccccccccCceeEEEEEe-CCCCeEEEEecccC---ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcc----
Q 039310 66 VTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIV---DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVP---- 137 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~---- 137 (241)
.+|.+.+.||+|+||.||+|.. .+++.||+|.+... +......+.+|+.+++.++||||+++++++......
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 3577788999999999999995 56889999987653 334456789999999999999999999998776544
Q ss_pred eEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccC
Q 039310 138 LLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPI 217 (241)
Q Consensus 138 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~ 217 (241)
++||||+++++|.+++...+.+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++.....
T Consensus 92 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 168 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIAD 168 (311)
T ss_dssp EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence 999999999999999988888999999999999999999999999 99999999999999999999999999987643
Q ss_pred Ccc--ceeeeecccccccccccccC
Q 039310 218 DAI--QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 218 ~~~--~~~~~~~gt~~y~aPE~l~~ 240 (241)
... .......||+.|+|||++.+
T Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~~ 193 (311)
T 3ork_A 169 SGNSVTQTAAVIGTAQYLSPEQARG 193 (311)
T ss_dssp -------------CCTTCCHHHHHT
T ss_pred cccccccccccCcCcccCCHHHhcC
Confidence 322 22233458999999998764
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-35 Score=252.59 Aligned_cols=174 Identities=26% Similarity=0.387 Sum_probs=143.0
Q ss_pred HHHHhhhcccccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEE
Q 039310 62 EIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVY 141 (241)
Q Consensus 62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~ 141 (241)
++....+.+.+.||+|+||.||+|.++++..||||.+.... ...+.+.+|+.+++.++||||+++++++.+ +..++||
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~ 257 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 257 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEe
Confidence 44556677788999999999999999888889999887543 234788999999999999999999999876 6789999
Q ss_pred EecCCCCchHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCc
Q 039310 142 EFVGNGTLFEHIHKN--GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDA 219 (241)
Q Consensus 142 e~~~~g~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~ 219 (241)
||+++|+|.+++... ..+++..+..++.|++.||.|||+++ ++||||||+|||+++++.+||+|||+++......
T Consensus 258 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred hhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence 999999999999743 46999999999999999999999999 9999999999999999999999999998765433
Q ss_pred cceeeeecccccccccccccC
Q 039310 220 IQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 220 ~~~~~~~~gt~~y~aPE~l~~ 240 (241)
........+|+.|+|||++.+
T Consensus 335 ~~~~~~~~~~~~y~aPE~~~~ 355 (452)
T 1fmk_A 335 YTARQGAKFPIKWTAPEAALY 355 (452)
T ss_dssp --------CCGGGSCHHHHHH
T ss_pred eecccCCcccccccCHhHHhc
Confidence 333334457889999998753
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=246.33 Aligned_cols=172 Identities=26% Similarity=0.301 Sum_probs=149.2
Q ss_pred hhhcccccccccCceeEEEEEe----CCCCeEEEEecccCC----hhhHHHHHHHHHHHHcC-CCCCceeEEEEEecCCc
Q 039310 66 VTNNYADVIGCGGSGNVYKGFL----PDRTPVAVKKSKIVD----QTKIDEFINELVVVSQI-NRRNVVRLLACCLETQV 136 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavk~~~~~~----~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~ 136 (241)
..|.+.+.||+|+||.||+|+. .++..||||.+.... ....+.+.+|+.+++.+ +||||+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 4677788999999999999986 368899999875421 22335567899999999 69999999999999999
Q ss_pred ceEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCccccc
Q 039310 137 PLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVP 216 (241)
Q Consensus 137 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~ 216 (241)
.++||||+++++|.+++.....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred EEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence 9999999999999999988888999999999999999999999999 9999999999999999999999999998765
Q ss_pred CCccceeeeecccccccccccccC
Q 039310 217 IDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 217 ~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
...........||+.|+|||++.+
T Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~ 234 (355)
T 1vzo_A 211 ADETERAYDFCGTIEYMAPDIVRG 234 (355)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTT
T ss_pred cCCCCcccCcccCcCccChhhhcC
Confidence 444334445579999999999863
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=235.48 Aligned_cols=169 Identities=24% Similarity=0.350 Sum_probs=142.2
Q ss_pred hhcccccccccCceeEEEEEeCCCCeEEEEecccCCh--hhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEec
Q 039310 67 TNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQ--TKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
.|.+.+.||+|+||.||+|...+++.||+|++..... ...+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (288)
T 1ob3_A 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL 82 (288)
T ss_dssp SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred cchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEec
Confidence 4567789999999999999987899999998765332 23467889999999999999999999999999999999999
Q ss_pred CCCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcccee
Q 039310 145 GNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNY 223 (241)
Q Consensus 145 ~~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~ 223 (241)
++ +|.+++... +.+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++....... ...
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 157 (288)
T 1ob3_A 83 DQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RKY 157 (288)
T ss_dssp SE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred CC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc-ccc
Confidence 75 898888754 57999999999999999999999999 9999999999999999999999999998654222 223
Q ss_pred eeecccccccccccccC
Q 039310 224 TVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 224 ~~~~gt~~y~aPE~l~~ 240 (241)
....||+.|+|||++.+
T Consensus 158 ~~~~~t~~y~aPE~~~~ 174 (288)
T 1ob3_A 158 THEIVTLWYRAPDVLMG 174 (288)
T ss_dssp ----CCCTTCCHHHHTT
T ss_pred ccccccccccCchheeC
Confidence 33468999999998753
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-34 Score=242.08 Aligned_cols=172 Identities=20% Similarity=0.197 Sum_probs=148.0
Q ss_pred hhhccccccccc--CceeEEEEEeC-CCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEE
Q 039310 66 VTNNYADVIGCG--GSGNVYKGFLP-DRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLV 140 (241)
Q Consensus 66 ~~~~~~~~lg~G--~~g~V~~~~~~-~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv 140 (241)
.+|.+.+.||+| +||.||+|... ++..||||.+... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 104 (389)
T 3gni_B 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV 104 (389)
T ss_dssp GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEE
Confidence 467788899999 99999999965 6889999987643 344567788999999999999999999999999999999
Q ss_pred EEecCCCCchHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCC
Q 039310 141 YEFVGNGTLFEHIHKN--GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPID 218 (241)
Q Consensus 141 ~e~~~~g~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~ 218 (241)
|||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~ 181 (389)
T 3gni_B 105 TSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181 (389)
T ss_dssp EECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred EEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence 9999999999999765 57999999999999999999999999 999999999999999999999999988654222
Q ss_pred cc------ceeeeecccccccccccccC
Q 039310 219 AI------QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 219 ~~------~~~~~~~gt~~y~aPE~l~~ 240 (241)
.. .......||+.|+|||++.+
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 209 (389)
T 3gni_B 182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQ 209 (389)
T ss_dssp TEECSCBCCCCTTCTTTGGGSCHHHHST
T ss_pred cccccccccccccccccccccCHHHHhc
Confidence 11 11122358999999999864
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-34 Score=246.77 Aligned_cols=170 Identities=25% Similarity=0.317 Sum_probs=143.4
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecC-----Ccc
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLET-----QVP 137 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~-----~~~ 137 (241)
..|.+.+.||+|+||.||+|... ++..||||++... +....+++.+|+.+++.++||||+++++++... +..
T Consensus 26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 105 (432)
T 3n9x_A 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL 105 (432)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence 45778889999999999999854 5788999987642 344567889999999999999999999999776 568
Q ss_pred eEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccC
Q 039310 138 LLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPI 217 (241)
Q Consensus 138 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~ 217 (241)
|+||||++ ++|.+++.....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+....
T Consensus 106 ~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 181 (432)
T 3n9x_A 106 YIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181 (432)
T ss_dssp EEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred EEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence 99999996 599999998888999999999999999999999999 99999999999999999999999999987643
Q ss_pred Cccc---------------------eeeeeccccccccccccc
Q 039310 218 DAIQ---------------------NYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 218 ~~~~---------------------~~~~~~gt~~y~aPE~l~ 239 (241)
.... ......||+.|+|||++.
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~ 224 (432)
T 3n9x_A 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELIL 224 (432)
T ss_dssp -----------------------------CCCCCTTCCHHHHT
T ss_pred cccccccccccccccccccccchhccccCCCCCccccCHHHHh
Confidence 3211 124456899999999863
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=239.67 Aligned_cols=173 Identities=27% Similarity=0.389 Sum_probs=146.5
Q ss_pred HhhhcccccccccCceeEEEEEeC------CCCeEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcc
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFLP------DRTPVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVP 137 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~ 137 (241)
...+.+.+.||+|+||.||+|... ++..||+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 125 (343)
T 1luf_A 46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 125 (343)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCce
Confidence 355677789999999999999864 3478999987754 344567899999999999999999999999999999
Q ss_pred eEEEEecCCCCchHHhhcC------------------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCC
Q 039310 138 LLVYEFVGNGTLFEHIHKN------------------------GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKS 193 (241)
Q Consensus 138 ~lv~e~~~~g~L~~~l~~~------------------------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~ 193 (241)
++||||+++++|.+++... ..+++.++..++.|++.||.|||+++ ++||||||
T Consensus 126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp 202 (343)
T 1luf_A 126 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLAT 202 (343)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred EEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCc
Confidence 9999999999999999763 46899999999999999999999999 99999999
Q ss_pred CCeeeCCCCCeEEccCCCcccccCCcc-ceeeeecccccccccccccC
Q 039310 194 ANILLDENYTPKVSDFGASKLVPIDAI-QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 194 ~Nili~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~ 240 (241)
+|||+++++.+||+|||++........ .......||+.|+|||++.+
T Consensus 203 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 250 (343)
T 1luf_A 203 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY 250 (343)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH
T ss_pred ceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhcc
Confidence 999999999999999999986543322 22233458999999998753
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-35 Score=244.47 Aligned_cols=176 Identities=27% Similarity=0.345 Sum_probs=146.6
Q ss_pred HHHHhhhcccccccccCceeEEEEEe------CCCCeEEEEecccC-ChhhHHHHHHHHHHHHcC-CCCCceeEEEEEec
Q 039310 62 EIKTVTNNYADVIGCGGSGNVYKGFL------PDRTPVAVKKSKIV-DQTKIDEFINELVVVSQI-NRRNVVRLLACCLE 133 (241)
Q Consensus 62 ~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~ 133 (241)
++....+.+.+.||+|+||.||+|.+ .++..||||.+... .....+.+.+|+.+++.+ +||||+++++++..
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~ 97 (359)
T 3vhe_A 18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 97 (359)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeec
Confidence 44556777888999999999999973 23578999988653 344557899999999999 79999999999987
Q ss_pred CC-cceEEEEecCCCCchHHhhcCCC------------------------------------------------------
Q 039310 134 TQ-VPLLVYEFVGNGTLFEHIHKNGN------------------------------------------------------ 158 (241)
Q Consensus 134 ~~-~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------ 158 (241)
.+ ..++||||+++|+|.+++.....
T Consensus 98 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (359)
T 3vhe_A 98 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177 (359)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------
T ss_pred CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhh
Confidence 55 48999999999999999976532
Q ss_pred ------------CCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcc-ceeee
Q 039310 159 ------------LTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAI-QNYTV 225 (241)
Q Consensus 159 ------------l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~-~~~~~ 225 (241)
+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++........ .....
T Consensus 178 ~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 254 (359)
T 3vhe_A 178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 254 (359)
T ss_dssp ------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--
T ss_pred hcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccc
Confidence 899999999999999999999999 99999999999999999999999999986643322 23334
Q ss_pred ecccccccccccccC
Q 039310 226 VQGTLGYIDPEYLQT 240 (241)
Q Consensus 226 ~~gt~~y~aPE~l~~ 240 (241)
..||+.|+|||++.+
T Consensus 255 ~~~t~~y~aPE~~~~ 269 (359)
T 3vhe_A 255 ARLPLKWMAPETIFD 269 (359)
T ss_dssp CEECGGGCCHHHHHH
T ss_pred cCCCceeEChhhhcC
Confidence 568999999998753
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=236.09 Aligned_cols=177 Identities=28% Similarity=0.430 Sum_probs=153.4
Q ss_pred CHHHHHHhhhcccccccccCceeEEEEEeCC-CCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcc
Q 039310 59 IEEEIKTVTNNYADVIGCGGSGNVYKGFLPD-RTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVP 137 (241)
Q Consensus 59 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~ 137 (241)
...++....+.+.+.||+|+||.||+|.+.. +..||+|.+... ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 84 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence 3444556678888899999999999999654 778999987643 34557889999999999999999999999999999
Q ss_pred eEEEEecCCCCchHHhhcCC--CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccc
Q 039310 138 LLVYEFVGNGTLFEHIHKNG--NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLV 215 (241)
Q Consensus 138 ~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~ 215 (241)
++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 85 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp EEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred EEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 99999999999999998643 5999999999999999999999999 999999999999999999999999999877
Q ss_pred cCCccceeeeeccccccccccccc
Q 039310 216 PIDAIQNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 216 ~~~~~~~~~~~~gt~~y~aPE~l~ 239 (241)
............+|+.|+|||++.
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~ 185 (288)
T 3kfa_A 162 TGDTYTAHAGAKFPIKWTAPESLA 185 (288)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHH
T ss_pred cCCccccccCCccccCcCChhhhc
Confidence 655444444455788999999875
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-34 Score=235.27 Aligned_cols=175 Identities=23% Similarity=0.337 Sum_probs=145.5
Q ss_pred HHHhhhcccccccccCceeEEEEEe-----CCCCeEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecC--
Q 039310 63 IKTVTNNYADVIGCGGSGNVYKGFL-----PDRTPVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCLET-- 134 (241)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~-- 134 (241)
+....+...+.||+|+||.||+|.+ .++..||+|.+... .....+.+.+|+.+++.++||||+++++++...
T Consensus 18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 97 (302)
T 4e5w_A 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG 97 (302)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence 3445577888999999999999983 35788999987643 333457889999999999999999999999876
Q ss_pred CcceEEEEecCCCCchHHhhc-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcc
Q 039310 135 QVPLLVYEFVGNGTLFEHIHK-NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASK 213 (241)
Q Consensus 135 ~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~ 213 (241)
+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred ceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence 668999999999999999954 457999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCcc--ceeeeecccccccccccccC
Q 039310 214 LVPIDAI--QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 214 ~~~~~~~--~~~~~~~gt~~y~aPE~l~~ 240 (241)
....... .......||+.|+|||++.+
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 203 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQ 203 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecC
Confidence 7654332 12233458889999998753
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-34 Score=236.19 Aligned_cols=162 Identities=26% Similarity=0.348 Sum_probs=125.8
Q ss_pred ccccccCceeEEEEEeC-CCCeEEEEecccCChhhHHHHHHHHHHHHcCC-CCCceeEEEEEecCCcceEEEEecCCCCc
Q 039310 72 DVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQTKIDEFINELVVVSQIN-RRNVVRLLACCLETQVPLLVYEFVGNGTL 149 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~~~~~~lv~e~~~~g~L 149 (241)
+.||+|+||.||+|... +++.||+|.+.. .....+.+|+.+++.+. ||||+++++++.+.+..++||||+++|+|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 67999999999999864 588999998753 23466778999999997 99999999999999999999999999999
Q ss_pred hHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC---CeEEccCCCcccccCCccceeeee
Q 039310 150 FEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENY---TPKVSDFGASKLVPIDAIQNYTVV 226 (241)
Q Consensus 150 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~---~~kl~Dfgla~~~~~~~~~~~~~~ 226 (241)
.+++.....+++..+..++.|++.||.|||+++ ++||||||+|||++.++ .+||+|||++....... ......
T Consensus 94 ~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~ 169 (325)
T 3kn6_A 94 FERIKKKKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QPLKTP 169 (325)
T ss_dssp HHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC---------
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-Cccccc
Confidence 999999889999999999999999999999999 99999999999997665 79999999998654332 223445
Q ss_pred cccccccccccccC
Q 039310 227 QGTLGYIDPEYLQT 240 (241)
Q Consensus 227 ~gt~~y~aPE~l~~ 240 (241)
.||+.|+|||++.+
T Consensus 170 ~~t~~y~aPE~~~~ 183 (325)
T 3kn6_A 170 CFTLHYAAPELLNQ 183 (325)
T ss_dssp --------------
T ss_pred CCCcCccCHHHhcC
Confidence 68999999999864
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=235.06 Aligned_cols=172 Identities=22% Similarity=0.355 Sum_probs=134.6
Q ss_pred HHhhhcccccccccCceeEEEEEeCC----CCeEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcce
Q 039310 64 KTVTNNYADVIGCGGSGNVYKGFLPD----RTPVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPL 138 (241)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~ 138 (241)
...++.+.+.||+|+||.||+|.... +..||+|..... .....+.+.+|+.+++.++||||+++++++. .+..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 34577888999999999999998643 446899987653 3445678899999999999999999999984 56789
Q ss_pred EEEEecCCCCchHHhhcCC-CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccC
Q 039310 139 LVYEFVGNGTLFEHIHKNG-NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPI 217 (241)
Q Consensus 139 lv~e~~~~g~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~ 217 (241)
+||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.....
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccCc
Confidence 9999999999999998654 6999999999999999999999999 99999999999999999999999999987654
Q ss_pred Cccceeeeeccccccccccccc
Q 039310 218 DAIQNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 218 ~~~~~~~~~~gt~~y~aPE~l~ 239 (241)
..........+|+.|+|||++.
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~ 190 (281)
T 1mp8_A 169 STYYKASKGKLPIKWMAPESIN 190 (281)
T ss_dssp ----------CCGGGCCHHHHH
T ss_pred ccccccccCCCcccccChhhcc
Confidence 4333334445788999999875
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-35 Score=237.38 Aligned_cols=168 Identities=25% Similarity=0.379 Sum_probs=146.8
Q ss_pred HhhhcccccccccCceeEEEEEeCC-C-------CeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCc
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFLPD-R-------TPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQV 136 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~-~-------~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~ 136 (241)
...+.+.+.||+|+||.||+|.... + ..||+|.+........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 4567788899999999999998543 2 4699998876666677889999999999999999999999999999
Q ss_pred ceEEEEecCCCCchHHhhcCCC-CCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCC--------eEEc
Q 039310 137 PLLVYEFVGNGTLFEHIHKNGN-LTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYT--------PKVS 207 (241)
Q Consensus 137 ~~lv~e~~~~g~L~~~l~~~~~-l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~--------~kl~ 207 (241)
.++||||+++++|.+++..... +++..+..++.|++.||.|||+++ ++||||||+|||++.++. +||+
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLS 163 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeeec
Confidence 9999999999999999987654 999999999999999999999999 999999999999998887 9999
Q ss_pred cCCCcccccCCccceeeeecccccccccccccC
Q 039310 208 DFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 208 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
|||++...... ....||+.|+|||++.+
T Consensus 164 Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~ 191 (289)
T 4fvq_A 164 DPGISITVLPK-----DILQERIPWVPPECIEN 191 (289)
T ss_dssp CCCSCTTTSCH-----HHHHHTTTTSCHHHHHC
T ss_pred cCcccccccCc-----cccCCcCcccCHHHhCC
Confidence 99998765322 22358999999998764
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=236.80 Aligned_cols=175 Identities=25% Similarity=0.344 Sum_probs=148.3
Q ss_pred HHHhhhcccccccccCceeEEEEEe------CCCCeEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCC
Q 039310 63 IKTVTNNYADVIGCGGSGNVYKGFL------PDRTPVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCLETQ 135 (241)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 135 (241)
+....+.+.+.||+|+||.||+|.. .++..||+|.+... .....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 99 (314)
T 2ivs_A 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG 99 (314)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence 3455677888999999999999985 23578999987653 3455678899999999999999999999999999
Q ss_pred cceEEEEecCCCCchHHhhcCCC------------------------CCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCC
Q 039310 136 VPLLVYEFVGNGTLFEHIHKNGN------------------------LTWERRLRIAAETAGVLSYLHSETNVPIIHRDV 191 (241)
Q Consensus 136 ~~~lv~e~~~~g~L~~~l~~~~~------------------------l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dl 191 (241)
..++||||+++++|.+++..... +++.++..++.|++.||.|||+++ ++||||
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~di 176 (314)
T 2ivs_A 100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDL 176 (314)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Cccccc
Confidence 99999999999999999976533 899999999999999999999999 999999
Q ss_pred CCCCeeeCCCCCeEEccCCCcccccCCccc-eeeeecccccccccccccC
Q 039310 192 KSANILLDENYTPKVSDFGASKLVPIDAIQ-NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 192 k~~Nili~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~ 240 (241)
||+||++++++.+||+|||++......... ......+|+.|+|||++.+
T Consensus 177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 226 (314)
T 2ivs_A 177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD 226 (314)
T ss_dssp SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH
T ss_pred chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcC
Confidence 999999999999999999999876433221 2233447889999998753
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-33 Score=230.11 Aligned_cols=182 Identities=37% Similarity=0.578 Sum_probs=153.0
Q ss_pred ccccCHHHHHHhhhccc--------ccccccCceeEEEEEeCCCCeEEEEecccC----ChhhHHHHHHHHHHHHcCCCC
Q 039310 55 AKIFIEEEIKTVTNNYA--------DVIGCGGSGNVYKGFLPDRTPVAVKKSKIV----DQTKIDEFINELVVVSQINRR 122 (241)
Q Consensus 55 ~~~~~~~~~~~~~~~~~--------~~lg~G~~g~V~~~~~~~~~~vavk~~~~~----~~~~~~~~~~E~~~l~~l~h~ 122 (241)
...+...++...+..|. +.||+|+||.||+|.. ++..||+|++... .....+.+.+|+.+++.++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 35566777777776664 5699999999999997 5788999987542 234467889999999999999
Q ss_pred CceeEEEEEecCCcceEEEEecCCCCchHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC
Q 039310 123 NVVRLLACCLETQVPLLVYEFVGNGTLFEHIHK---NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLD 199 (241)
Q Consensus 123 ni~~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~ 199 (241)
||+++++++.+.+..+++|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~ 167 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLD 167 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEc
Confidence 999999999999999999999999999999863 346999999999999999999999999 99999999999999
Q ss_pred CCCCeEEccCCCcccccCCccc-eeeeecccccccccccccC
Q 039310 200 ENYTPKVSDFGASKLVPIDAIQ-NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 200 ~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~ 240 (241)
+++.+||+|||++......... ......||+.|+|||++.+
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 209 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG 209 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT
T ss_pred CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC
Confidence 9999999999999865432221 2233468999999998753
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=240.02 Aligned_cols=171 Identities=26% Similarity=0.395 Sum_probs=148.0
Q ss_pred HhhhcccccccccCceeEEEEEe-CCCCeEEEEecccCC--------hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCC
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVD--------QTKIDEFINELVVVSQINRRNVVRLLACCLETQ 135 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~--------~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 135 (241)
...|.+.+.||+|+||.||+|.. .++..||+|.+.... ......+.+|+.+++.++||||+++++++.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 45677888999999999999984 468889999876432 113345678999999999999999999999999
Q ss_pred cceEEEEecCCC-CchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCccc
Q 039310 136 VPLLVYEFVGNG-TLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKL 214 (241)
Q Consensus 136 ~~~lv~e~~~~g-~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~ 214 (241)
..++||||+.+| +|.+++.....+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++..
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 179 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAY 179 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecccceE
Confidence 999999999776 99999998889999999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCccceeeeecccccccccccccC
Q 039310 215 VPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 215 ~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
..... ......||+.|+|||++.+
T Consensus 180 ~~~~~--~~~~~~gt~~y~aPE~~~~ 203 (335)
T 3dls_A 180 LERGK--LFYTFCGTIEYCAPEVLMG 203 (335)
T ss_dssp CCTTC--CBCEECSCGGGCCHHHHTT
T ss_pred CCCCC--ceeccCCCccccChhhhcC
Confidence 64432 2334569999999998764
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=233.62 Aligned_cols=173 Identities=25% Similarity=0.251 Sum_probs=142.0
Q ss_pred HHHHhhhcccccccccCceeEEEEEeC-CCCeEEEEecccC--ChhhHHHHHHHHHHHHcC-CCCCceeEEEEEecCCcc
Q 039310 62 EIKTVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV--DQTKIDEFINELVVVSQI-NRRNVVRLLACCLETQVP 137 (241)
Q Consensus 62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~ 137 (241)
+.....+...+.||+|+||+||+|... ++..||||++... ..........|+..+..+ +||||+++++++.+.+..
T Consensus 53 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~ 132 (311)
T 3p1a_A 53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGIL 132 (311)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred chhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEE
Confidence 445567888889999999999999965 6889999986542 233444556666666555 899999999999999999
Q ss_pred eEEEEecCCCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCccccc
Q 039310 138 LLVYEFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVP 216 (241)
Q Consensus 138 ~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~ 216 (241)
++||||+ +++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 133 ~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 133 YLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp EEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred EEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 9999999 66888888654 46999999999999999999999999 9999999999999999999999999988764
Q ss_pred CCccceeeeecccccccccccccC
Q 039310 217 IDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 217 ~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
... ......||+.|+|||++.+
T Consensus 209 ~~~--~~~~~~gt~~y~aPE~~~~ 230 (311)
T 3p1a_A 209 TAG--AGEVQEGDPRYMAPELLQG 230 (311)
T ss_dssp --------CCCCCGGGCCGGGGGT
T ss_pred cCC--CCcccCCCccccCHhHhcC
Confidence 332 2334459999999998864
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=233.51 Aligned_cols=173 Identities=27% Similarity=0.464 Sum_probs=147.6
Q ss_pred HHHHhhhcccccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEE
Q 039310 62 EIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVY 141 (241)
Q Consensus 62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~ 141 (241)
++....+.+.+.||+|+||.||+|...++..||+|.+.... ...+.+.+|+.+++.++||||+++++++.. +..++||
T Consensus 9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~ 86 (279)
T 1qpc_A 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT 86 (279)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEE
Confidence 34445677888999999999999998888899999876533 235778999999999999999999999864 5689999
Q ss_pred EecCCCCchHHhhcCC--CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCc
Q 039310 142 EFVGNGTLFEHIHKNG--NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDA 219 (241)
Q Consensus 142 e~~~~g~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~ 219 (241)
||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++.......
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T 1qpc_A 87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (279)
T ss_dssp ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred ecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence 9999999999997543 6999999999999999999999999 9999999999999999999999999998765443
Q ss_pred cceeeeeccccccccccccc
Q 039310 220 IQNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 220 ~~~~~~~~gt~~y~aPE~l~ 239 (241)
........+|+.|+|||++.
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~ 183 (279)
T 1qpc_A 164 YTAREGAKFPIKWTAPEAIN 183 (279)
T ss_dssp EECCTTCCCCTTTSCHHHHH
T ss_pred cccccCCCCccCccChhhhc
Confidence 33333344788999999875
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-34 Score=258.99 Aligned_cols=173 Identities=29% Similarity=0.323 Sum_probs=149.1
Q ss_pred HHhhhcccccccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHHHHHcC-CCCCceeEEEEEecCCcce
Q 039310 64 KTVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELVVVSQI-NRRNVVRLLACCLETQVPL 138 (241)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~ 138 (241)
....+.+.+.||+|+||+||+|... +++.||||.+... .....+.+..|..++..+ +||||+++++++.+.+..|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3345667789999999999999955 5778999987632 233456788899999988 7999999999999999999
Q ss_pred EEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCC
Q 039310 139 LVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPID 218 (241)
Q Consensus 139 lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~ 218 (241)
+||||+++|+|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 419 lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 495 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 495 (674)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred EEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence 99999999999999998888999999999999999999999999 999999999999999999999999999864332
Q ss_pred ccceeeeecccccccccccccC
Q 039310 219 AIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 219 ~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
. ......+||+.|||||++.+
T Consensus 496 ~-~~~~~~~GT~~Y~APE~l~~ 516 (674)
T 3pfq_A 496 G-VTTKTFCGTPDYIAPEIIAY 516 (674)
T ss_dssp T-CCBCCCCSCSSSCCHHHHTC
T ss_pred C-cccccccCCCcccCHhhhcC
Confidence 2 23445679999999999864
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-34 Score=250.86 Aligned_cols=169 Identities=24% Similarity=0.292 Sum_probs=145.4
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccCC---hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD---QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
+...+.||+|+||+||+|+.. +++.||+|.+.... ......+.+|..+++.++||||+++++++.+.+..|+||||
T Consensus 187 f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~ 266 (543)
T 3c4z_A 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTI 266 (543)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEe
Confidence 334567999999999999964 58899999875422 23356788999999999999999999999999999999999
Q ss_pred cCCCCchHHhhcC----CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCc
Q 039310 144 VGNGTLFEHIHKN----GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDA 219 (241)
Q Consensus 144 ~~~g~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~ 219 (241)
+++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 267 ~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~ 343 (543)
T 3c4z_A 267 MNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ 343 (543)
T ss_dssp CTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred ccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccCCC
Confidence 9999999998753 36999999999999999999999999 9999999999999999999999999998764332
Q ss_pred cceeeeecccccccccccccC
Q 039310 220 IQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 220 ~~~~~~~~gt~~y~aPE~l~~ 240 (241)
. .....+||+.|||||++.+
T Consensus 344 ~-~~~~~~GT~~Y~APE~l~~ 363 (543)
T 3c4z_A 344 T-KTKGYAGTPGFMAPELLLG 363 (543)
T ss_dssp C-CBCCCCSCTTTSCHHHHTT
T ss_pred c-ccccccCCccccChhhhcC
Confidence 2 2334579999999999865
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=235.90 Aligned_cols=174 Identities=25% Similarity=0.349 Sum_probs=142.6
Q ss_pred CHHHHHHhhhcccccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcC--CCCCceeEEEEEecC--
Q 039310 59 IEEEIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQI--NRRNVVRLLACCLET-- 134 (241)
Q Consensus 59 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l--~h~ni~~l~~~~~~~-- 134 (241)
.........+.+.+.||+|+||.||+|... +..||+|.+... ....+.+|.+++... +||||+++++++...
T Consensus 30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp HHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred ccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 344455677889999999999999999985 788999987532 234455666666665 899999999999877
Q ss_pred --CcceEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcC--------CCCCeEecCCCCCCeeeCCCCCe
Q 039310 135 --QVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSE--------TNVPIIHRDVKSANILLDENYTP 204 (241)
Q Consensus 135 --~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~--------~~~~iiH~dlk~~Nili~~~~~~ 204 (241)
...++||||+++|+|.+++... .+++..+..++.|++.||.|||++ + ++||||||+|||++.++.+
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~ 181 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGTC 181 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSCE
T ss_pred CCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCCE
Confidence 6789999999999999999765 699999999999999999999998 7 9999999999999999999
Q ss_pred EEccCCCcccccCCccce---eeeecccccccccccccC
Q 039310 205 KVSDFGASKLVPIDAIQN---YTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 205 kl~Dfgla~~~~~~~~~~---~~~~~gt~~y~aPE~l~~ 240 (241)
||+|||++.......... .....||+.|+|||++.+
T Consensus 182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 220 (337)
T 3mdy_A 182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE 220 (337)
T ss_dssp EECCCTTCEECC---------CCSSCSCGGGCCHHHHTT
T ss_pred EEEeCCCceeeccccccccCCCCCCccCcceeChhhccc
Confidence 999999997664332221 123469999999998754
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-34 Score=235.44 Aligned_cols=169 Identities=26% Similarity=0.439 Sum_probs=144.5
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEecccCC-hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCC--cceEEE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD-QTKIDEFINELVVVSQINRRNVVRLLACCLETQ--VPLLVY 141 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~--~~~lv~ 141 (241)
.+|.+.+.||+|+||+||+|... ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++...+ ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 35677889999999999999965 48899999876432 334577889999999999999999999998755 779999
Q ss_pred EecCCCCchHHhhcCC---CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee----CCCCCeEEccCCCccc
Q 039310 142 EFVGNGTLFEHIHKNG---NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILL----DENYTPKVSDFGASKL 214 (241)
Q Consensus 142 e~~~~g~L~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili----~~~~~~kl~Dfgla~~ 214 (241)
||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+|||+ +.++.+||+|||++..
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 9999999999997644 3999999999999999999999999 9999999999999 7888899999999987
Q ss_pred ccCCccceeeeeccccccccccccc
Q 039310 215 VPIDAIQNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 215 ~~~~~~~~~~~~~gt~~y~aPE~l~ 239 (241)
..... ......||+.|+|||++.
T Consensus 166 ~~~~~--~~~~~~gt~~y~aPE~~~ 188 (319)
T 4euu_A 166 LEDDE--QFVSLYGTEEYLHPDMYE 188 (319)
T ss_dssp CCTTC--CBCCCCSCGGGCCHHHHH
T ss_pred cCCCC--ceeecccCCCccCHHHhh
Confidence 64432 223346999999999874
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=234.54 Aligned_cols=171 Identities=23% Similarity=0.311 Sum_probs=149.3
Q ss_pred HhhhcccccccccCceeEEEEEeC-CCCeEEEEecccCCh------hhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcc
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQ------TKIDEFINELVVVSQINRRNVVRLLACCLETQVP 137 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~------~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~ 137 (241)
...|.+.+.||+|+||.||+|... ++..||+|.+..... ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 456788899999999999999865 588999998764321 1357789999999999999999999999999999
Q ss_pred eEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC----CeEEccCCCcc
Q 039310 138 LLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENY----TPKVSDFGASK 213 (241)
Q Consensus 138 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~----~~kl~Dfgla~ 213 (241)
++||||+++++|.+++.....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++ .+||+|||++.
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 999999999999999998888999999999999999999999999 99999999999999887 79999999998
Q ss_pred cccCCccceeeeecccccccccccccC
Q 039310 214 LVPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 214 ~~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
...... ......||+.|+|||++.+
T Consensus 168 ~~~~~~--~~~~~~gt~~y~aPE~~~~ 192 (321)
T 2a2a_A 168 EIEDGV--EFKNIFGTPEFVAPEIVNY 192 (321)
T ss_dssp ECCTTC--CCCCCCSCGGGCCHHHHTT
T ss_pred ecCccc--cccccCCCCCccCcccccC
Confidence 764332 2234469999999998764
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-34 Score=236.75 Aligned_cols=175 Identities=23% Similarity=0.356 Sum_probs=148.2
Q ss_pred HHHHhhhcccccccccCceeEEEEEeC--------CCCeEEEEecccC-ChhhHHHHHHHHHHHHcC-CCCCceeEEEEE
Q 039310 62 EIKTVTNNYADVIGCGGSGNVYKGFLP--------DRTPVAVKKSKIV-DQTKIDEFINELVVVSQI-NRRNVVRLLACC 131 (241)
Q Consensus 62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~ 131 (241)
++....+.+.+.||+|+||.||+|.+. ++..||+|.+... .....+.+.+|+.+++.+ +||||+++++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 445567888899999999999999853 4678999987653 344567889999999999 899999999999
Q ss_pred ecCCcceEEEEecCCCCchHHhhcCC----------------CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCC
Q 039310 132 LETQVPLLVYEFVGNGTLFEHIHKNG----------------NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSAN 195 (241)
Q Consensus 132 ~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~N 195 (241)
...+..++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+|
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N 187 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARN 187 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccce
Confidence 99999999999999999999997653 3899999999999999999999999 9999999999
Q ss_pred eeeCCCCCeEEccCCCcccccCCccc-eeeeeccccccccccccc
Q 039310 196 ILLDENYTPKVSDFGASKLVPIDAIQ-NYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 196 ili~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~l~ 239 (241)
|+++.++.+||+|||++......... ......+|+.|+|||++.
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 232 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF 232 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHH
T ss_pred EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhc
Confidence 99999999999999999876433221 223344788999999874
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-34 Score=234.03 Aligned_cols=173 Identities=21% Similarity=0.266 Sum_probs=142.6
Q ss_pred HhhhcccccccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEE
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLV 140 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv 140 (241)
...|.+.+.||+|+||.||+|... ++..||+|.+... +....+.+.+|+.+++.++||||+++++++...+..+++
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 345778889999999999999964 6788999987643 233457789999999999999999999999999999999
Q ss_pred EEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcc
Q 039310 141 YEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAI 220 (241)
Q Consensus 141 ~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~ 220 (241)
|||+++++|.+++.....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 189 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEKL 189 (309)
T ss_dssp EECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccccccc
Confidence 999999999999988888999999999999999999999999 99999999999999999999999999987654433
Q ss_pred ceeeeecccccccccccccC
Q 039310 221 QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 221 ~~~~~~~gt~~y~aPE~l~~ 240 (241)
.......||+.|+|||++.+
T Consensus 190 ~~~~~~~~~~~y~aPE~~~~ 209 (309)
T 2h34_A 190 TQLGNTVGTLYYMAPERFSE 209 (309)
T ss_dssp -------CCGGGCCGGGTCC
T ss_pred ccccccCCCcCccCHHHHcC
Confidence 33344568999999999864
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=231.01 Aligned_cols=170 Identities=28% Similarity=0.431 Sum_probs=148.1
Q ss_pred hhhcccccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecC
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVG 145 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~ 145 (241)
..+.+.+.||+|+||.||+|.+.++..||+|.+..... ..+.+.+|+.+++.++||||+++++++.+.+..+++|||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 45677889999999999999988888999998775433 34678999999999999999999999999999999999999
Q ss_pred CCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceee
Q 039310 146 NGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYT 224 (241)
Q Consensus 146 ~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~ 224 (241)
+++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++............
T Consensus 87 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 163 (267)
T 3t9t_A 87 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 163 (267)
T ss_dssp TCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT
T ss_pred CCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccccccc
Confidence 99999999765 46899999999999999999999999 999999999999999999999999999876433322333
Q ss_pred eeccccccccccccc
Q 039310 225 VVQGTLGYIDPEYLQ 239 (241)
Q Consensus 225 ~~~gt~~y~aPE~l~ 239 (241)
...+|+.|+|||++.
T Consensus 164 ~~~~~~~y~aPE~~~ 178 (267)
T 3t9t_A 164 GTKFPVKWASPEVFS 178 (267)
T ss_dssp STTCCGGGCCHHHHH
T ss_pred cccccccccChhhhc
Confidence 345788999999875
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=239.25 Aligned_cols=178 Identities=25% Similarity=0.379 Sum_probs=147.3
Q ss_pred HHHHHHhhhcccccccccCceeEEEEEe------CCCCeEEEEecccC-ChhhHHHHHHHHHHHHcC-CCCCceeEEEEE
Q 039310 60 EEEIKTVTNNYADVIGCGGSGNVYKGFL------PDRTPVAVKKSKIV-DQTKIDEFINELVVVSQI-NRRNVVRLLACC 131 (241)
Q Consensus 60 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~ 131 (241)
..++....+.+.+.||+|+||.||+|.. .++..||+|.+... .....+.+.+|+.+++.+ +||||+++++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 3445566778889999999999999985 23557999987643 233456789999999999 899999999999
Q ss_pred ecCCcceEEEEecCCCCchHHhhcCC-----------------------CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 039310 132 LETQVPLLVYEFVGNGTLFEHIHKNG-----------------------NLTWERRLRIAAETAGVLSYLHSETNVPIIH 188 (241)
Q Consensus 132 ~~~~~~~lv~e~~~~g~L~~~l~~~~-----------------------~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH 188 (241)
...+..++||||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ ++|
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH 195 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVH 195 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccc
Confidence 99999999999999999999997643 2799999999999999999999999 999
Q ss_pred cCCCCCCeeeCCCCCeEEccCCCcccccCCccc-eeeeecccccccccccccC
Q 039310 189 RDVKSANILLDENYTPKVSDFGASKLVPIDAIQ-NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 189 ~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~ 240 (241)
|||||+|||++.++.+||+|||++......... ......||+.|+|||++.+
T Consensus 196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 248 (344)
T 1rjb_A 196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE 248 (344)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH
T ss_pred CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc
Confidence 999999999999999999999999876433322 2233457889999998753
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=234.69 Aligned_cols=169 Identities=24% Similarity=0.357 Sum_probs=132.9
Q ss_pred hhcccccccccCceeEEEEEeC-CCCeEEEEecccCC-hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEec
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD-QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
.|...+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 85 (317)
T 2pmi_A 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFM 85 (317)
T ss_dssp -------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECC
T ss_pred ceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEec
Confidence 4666788999999999999854 58899999876533 233467889999999999999999999999999999999999
Q ss_pred CCCCchHHhhcC------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCC
Q 039310 145 GNGTLFEHIHKN------GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPID 218 (241)
Q Consensus 145 ~~g~L~~~l~~~------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~ 218 (241)
+ ++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++......
T Consensus 86 ~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 161 (317)
T 2pmi_A 86 D-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP 161 (317)
T ss_dssp C-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred C-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence 7 5999988643 35899999999999999999999999 999999999999999999999999999876432
Q ss_pred ccceeeeecccccccccccccC
Q 039310 219 AIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 219 ~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
. .......||+.|+|||++.+
T Consensus 162 ~-~~~~~~~~t~~y~aPE~~~~ 182 (317)
T 2pmi_A 162 V-NTFSSEVVTLWYRAPDVLMG 182 (317)
T ss_dssp C-CCCCCCCSCCTTCCHHHHTT
T ss_pred c-ccCCCCcccccccCchHhhC
Confidence 2 22233468999999998753
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-34 Score=245.64 Aligned_cols=166 Identities=27% Similarity=0.410 Sum_probs=141.3
Q ss_pred HhhhcccccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCC-cceEEEEe
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQ-VPLLVYEF 143 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~-~~~lv~e~ 143 (241)
...+.+.+.||+|+||.||+|.+. +..||||.++... ..+.+.+|+.+++.++||||+++++++...+ ..++||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 345566789999999999999985 6789999877543 4578899999999999999999999987665 78999999
Q ss_pred cCCCCchHHhhcCCC--CCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc
Q 039310 144 VGNGTLFEHIHKNGN--LTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ 221 (241)
Q Consensus 144 ~~~g~L~~~l~~~~~--l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~ 221 (241)
+++|+|.+++...+. +++..+..++.|++.||.|||+++ ++||||||+|||+++++.+||+|||+++.....
T Consensus 269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--- 342 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 342 (450)
T ss_dssp CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc---
Confidence 999999999986543 799999999999999999999999 999999999999999999999999999854321
Q ss_pred eeeeecccccccccccccC
Q 039310 222 NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~~ 240 (241)
.....+|+.|+|||++.+
T Consensus 343 -~~~~~~~~~y~aPE~~~~ 360 (450)
T 1k9a_A 343 -QDTGKLPVKWTAPEALRE 360 (450)
T ss_dssp -----CCCTTTSCHHHHHS
T ss_pred -ccCCCCCcceeCHHHhcC
Confidence 122357899999998754
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=232.01 Aligned_cols=167 Identities=25% Similarity=0.339 Sum_probs=139.0
Q ss_pred hhhcccccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHc--CCCCCceeEEEEEec----CCcceE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQ--INRRNVVRLLACCLE----TQVPLL 139 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~--l~h~ni~~l~~~~~~----~~~~~l 139 (241)
..+.+.+.||+|+||+||+|.+ ++..||||.+... ....+.+|.+++.. ++||||+++++++.. ....++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l 83 (301)
T 3q4u_A 8 RDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL 83 (301)
T ss_dssp GGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred CcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence 4577788999999999999998 6788999987543 33555667777776 799999999999754 346899
Q ss_pred EEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhh--------cCCCCCeEecCCCCCCeeeCCCCCeEEccCCC
Q 039310 140 VYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLH--------SETNVPIIHRDVKSANILLDENYTPKVSDFGA 211 (241)
Q Consensus 140 v~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh--------~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgl 211 (241)
||||+++|+|.+++.. ..+++..+..++.|++.||.||| +.+ ++||||||+|||++.++.+||+|||+
T Consensus 84 v~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~ 159 (301)
T 3q4u_A 84 ITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIADLGL 159 (301)
T ss_dssp EECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECCCTT
T ss_pred ehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEeeCCC
Confidence 9999999999999964 47999999999999999999999 777 99999999999999999999999999
Q ss_pred cccccCCccce---eeeecccccccccccccC
Q 039310 212 SKLVPIDAIQN---YTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 212 a~~~~~~~~~~---~~~~~gt~~y~aPE~l~~ 240 (241)
|.......... .....||+.|+|||++.+
T Consensus 160 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 191 (301)
T 3q4u_A 160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDE 191 (301)
T ss_dssp CEEEETTTTEEECCCCCCCCCGGGCCHHHHTT
T ss_pred eeecccccccccccccccccccceeChhhhcC
Confidence 97654332221 222369999999998764
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=232.97 Aligned_cols=170 Identities=26% Similarity=0.294 Sum_probs=142.5
Q ss_pred hhcccccccccCceeEEEEEeC-CCCeEEEEecccCC--hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD--QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
+|.+.+.||+|+||.||+|... ++..||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (311)
T 4agu_A 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEY 83 (311)
T ss_dssp CEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEe
Confidence 4667789999999999999965 48899999875432 33456788999999999999999999999999999999999
Q ss_pred cCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcccee
Q 039310 144 VGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNY 223 (241)
Q Consensus 144 ~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~ 223 (241)
+++++|.+++.....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....... ...
T Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 159 (311)
T 4agu_A 84 CDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS-DYY 159 (311)
T ss_dssp CSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred CCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc-ccc
Confidence 999999999988888999999999999999999999999 9999999999999999999999999998764322 223
Q ss_pred eeecccccccccccccC
Q 039310 224 TVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 224 ~~~~gt~~y~aPE~l~~ 240 (241)
....||+.|+|||++.+
T Consensus 160 ~~~~~~~~y~aPE~~~~ 176 (311)
T 4agu_A 160 DDEVATRWYRSPELLVG 176 (311)
T ss_dssp ------GGGCCHHHHHT
T ss_pred CCCcCCccccChHHHhc
Confidence 34468999999998753
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-34 Score=239.34 Aligned_cols=168 Identities=27% Similarity=0.378 Sum_probs=132.1
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEec
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
..|.+.+.||+|+||.||+|... ++..||+|.+.... ..+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 130 (349)
T 2w4o_A 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELV 130 (349)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeC
Confidence 44677789999999999999965 47889999876432 3456788999999999999999999999999999999999
Q ss_pred CCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC---CCCeEEccCCCcccccCCccc
Q 039310 145 GNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDE---NYTPKVSDFGASKLVPIDAIQ 221 (241)
Q Consensus 145 ~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~---~~~~kl~Dfgla~~~~~~~~~ 221 (241)
++++|.+++...+.+++.++..++.|++.||.|||+.+ ++||||||+|||++. ++.+||+|||++...... .
T Consensus 131 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~--~ 205 (349)
T 2w4o_A 131 TGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ--V 205 (349)
T ss_dssp CSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-----------
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCcc--c
Confidence 99999999988888999999999999999999999999 999999999999975 889999999999865432 2
Q ss_pred eeeeecccccccccccccC
Q 039310 222 NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~~ 240 (241)
......||+.|+|||++.+
T Consensus 206 ~~~~~~gt~~y~aPE~~~~ 224 (349)
T 2w4o_A 206 LMKTVCGTPGYCAPEILRG 224 (349)
T ss_dssp -------CGGGSCHHHHTT
T ss_pred ccccccCCCCccCHHHhcC
Confidence 2334569999999999864
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-33 Score=226.83 Aligned_cols=172 Identities=27% Similarity=0.395 Sum_probs=149.5
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
..|.+.+.||+|+||.||+|... ++..||+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 46778889999999999999865 6889999987643 233457889999999999999999999999999999999999
Q ss_pred cCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcc-ce
Q 039310 144 VGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAI-QN 222 (241)
Q Consensus 144 ~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~-~~ 222 (241)
+++++|.+++.....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........ ..
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 163 (276)
T 2yex_A 87 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163 (276)
T ss_dssp CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred cCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhc
Confidence 999999999988778999999999999999999999999 99999999999999999999999999986543221 12
Q ss_pred eeeecccccccccccccC
Q 039310 223 YTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 223 ~~~~~gt~~y~aPE~l~~ 240 (241)
.....||+.|+|||++.+
T Consensus 164 ~~~~~~~~~y~aPE~~~~ 181 (276)
T 2yex_A 164 LNKMCGTLPYVAPELLKR 181 (276)
T ss_dssp BCCCCSCGGGCCGGGGTC
T ss_pred ccCCccccCccChHHHhc
Confidence 234568999999999864
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=240.48 Aligned_cols=177 Identities=24% Similarity=0.372 Sum_probs=147.7
Q ss_pred HHHHHhhhcccccccccCceeEEEEEeCC------CCeEEEEecccC-ChhhHHHHHHHHHHHHcC-CCCCceeEEEEEe
Q 039310 61 EEIKTVTNNYADVIGCGGSGNVYKGFLPD------RTPVAVKKSKIV-DQTKIDEFINELVVVSQI-NRRNVVRLLACCL 132 (241)
Q Consensus 61 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~ 132 (241)
.++....+.+.+.||+|+||.||+|.... ...||+|.+... .....+.+.+|+.+++.+ +||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 34445667788899999999999998543 247999987654 344567889999999999 8999999999999
Q ss_pred cCCcceEEEEecCCCCchHHhhc--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee
Q 039310 133 ETQVPLLVYEFVGNGTLFEHIHK--------------NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILL 198 (241)
Q Consensus 133 ~~~~~~lv~e~~~~g~L~~~l~~--------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili 198 (241)
..+..++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+|||+
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLL 197 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEE
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEE
Confidence 99999999999999999999864 235899999999999999999999998 9999999999999
Q ss_pred CCCCCeEEccCCCcccccCCccc-eeeeecccccccccccccC
Q 039310 199 DENYTPKVSDFGASKLVPIDAIQ-NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 199 ~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~ 240 (241)
++++.+||+|||++......... ......||+.|+|||++.+
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 240 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD 240 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhcc
Confidence 99999999999999866433222 2223447889999998653
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=242.50 Aligned_cols=175 Identities=23% Similarity=0.367 Sum_probs=145.8
Q ss_pred HHHhhhcccccccccCceeEEEEEeC------CCCeEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCC
Q 039310 63 IKTVTNNYADVIGCGGSGNVYKGFLP------DRTPVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCLETQ 135 (241)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 135 (241)
+....+.+.+.||+|+||.||+|.+. ++..||||.+... .......+.+|+.+++.++||||+++++++.+.+
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 147 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 147 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 44456778889999999999999843 3567999987643 4455567899999999999999999999999999
Q ss_pred cceEEEEecCCCCchHHhhcC-------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC---CeE
Q 039310 136 VPLLVYEFVGNGTLFEHIHKN-------GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENY---TPK 205 (241)
Q Consensus 136 ~~~lv~e~~~~g~L~~~l~~~-------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~---~~k 205 (241)
..++||||+++|+|.+++... ..+++.++..++.|++.||.|||+++ |+||||||+|||++.++ .+|
T Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEE
Confidence 999999999999999999753 24899999999999999999999999 99999999999999555 599
Q ss_pred EccCCCcccccCCc-cceeeeecccccccccccccC
Q 039310 206 VSDFGASKLVPIDA-IQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 206 l~Dfgla~~~~~~~-~~~~~~~~gt~~y~aPE~l~~ 240 (241)
|+|||+|+...... ........||+.|+|||++.+
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 260 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME 260 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhcC
Confidence 99999997553221 122233457899999998753
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=247.45 Aligned_cols=172 Identities=26% Similarity=0.374 Sum_probs=148.3
Q ss_pred HHhhhcccccccccCceeEEEEEeC-CCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEE
Q 039310 64 KTVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLV 140 (241)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv 140 (241)
...+|.+.+.||+|+||+||+|... ++..||+|.+... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 4567888999999999999999864 6889999987532 233457889999999999999999999999999999999
Q ss_pred EEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC---CCCCeEEccCCCcccccC
Q 039310 141 YEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLD---ENYTPKVSDFGASKLVPI 217 (241)
Q Consensus 141 ~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~---~~~~~kl~Dfgla~~~~~ 217 (241)
|||+++++|.+.+.....+++..+..++.|++.||.|||+.+ |+||||||+|||++ .++.+||+|||+|.....
T Consensus 100 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 999999999999988888999999999999999999999999 99999999999995 456799999999986643
Q ss_pred CccceeeeecccccccccccccC
Q 039310 218 DAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 218 ~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
. .......||+.|+|||++.+
T Consensus 177 ~--~~~~~~~gt~~y~aPE~~~~ 197 (486)
T 3mwu_A 177 N--TKMKDRIGTAYYIAPEVLRG 197 (486)
T ss_dssp C------CCTTGGGGCCGGGGGS
T ss_pred C--CccCCCcCCCCCCCHHHhCC
Confidence 3 22344569999999999864
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=233.11 Aligned_cols=170 Identities=25% Similarity=0.351 Sum_probs=141.5
Q ss_pred hhcc-cccccccCceeEEEEEe-CCCCeEEEEecccCChhhHHHHHHHHHHHHcC-CCCCceeEEEEEecCCcceEEEEe
Q 039310 67 TNNY-ADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVDQTKIDEFINELVVVSQI-NRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 67 ~~~~-~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
.|.+ .+.||+|+||.||+|.. .++..||||.+........+.+.+|+.++..+ +||||+++++++.+.+..++||||
T Consensus 13 ~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 92 (316)
T 2ac3_A 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEK 92 (316)
T ss_dssp SCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEc
Confidence 3445 36799999999999985 46889999988765555567889999999985 799999999999999999999999
Q ss_pred cCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCC---eEEccCCCcccccCCcc
Q 039310 144 VGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYT---PKVSDFGASKLVPIDAI 220 (241)
Q Consensus 144 ~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~---~kl~Dfgla~~~~~~~~ 220 (241)
+++++|.+++.....+++..+..++.|++.||.|||+++ ++||||||+|||++.++. +||+|||++........
T Consensus 93 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 169 (316)
T 2ac3_A 93 MRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169 (316)
T ss_dssp CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------
T ss_pred CCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCc
Confidence 999999999988888999999999999999999999999 999999999999998776 99999999876532211
Q ss_pred ------ceeeeeccccccccccccc
Q 039310 221 ------QNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 221 ------~~~~~~~gt~~y~aPE~l~ 239 (241)
.......||+.|+|||++.
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~ 194 (316)
T 2ac3_A 170 CSPISTPELLTPCGSAEYMAPEVVE 194 (316)
T ss_dssp ------------CCSGGGCCHHHHH
T ss_pred cccccccccccccCCcCccChHHhh
Confidence 1122345999999999875
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-34 Score=235.17 Aligned_cols=177 Identities=26% Similarity=0.375 Sum_probs=150.0
Q ss_pred HHHHHhhhcccccccccCceeEEEEEe------CCCCeEEEEecccCC-hhhHHHHHHHHHHHHcC-CCCCceeEEEEEe
Q 039310 61 EEIKTVTNNYADVIGCGGSGNVYKGFL------PDRTPVAVKKSKIVD-QTKIDEFINELVVVSQI-NRRNVVRLLACCL 132 (241)
Q Consensus 61 ~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavk~~~~~~-~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~ 132 (241)
.++....+.+.+.||+|+||.||+|.+ .++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++.
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 97 (313)
T 1t46_A 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (313)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence 344456778889999999999999984 246789999876543 34567889999999999 9999999999999
Q ss_pred cCCcceEEEEecCCCCchHHhhcCC------------------CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCC
Q 039310 133 ETQVPLLVYEFVGNGTLFEHIHKNG------------------NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSA 194 (241)
Q Consensus 133 ~~~~~~lv~e~~~~g~L~~~l~~~~------------------~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~ 194 (241)
..+..++||||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~ 174 (313)
T 1t46_A 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAAR 174 (313)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccc
Confidence 9999999999999999999997653 4899999999999999999999999 999999999
Q ss_pred CeeeCCCCCeEEccCCCcccccCCccc-eeeeecccccccccccccC
Q 039310 195 NILLDENYTPKVSDFGASKLVPIDAIQ-NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 195 Nili~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~ 240 (241)
||+++.++.+||+|||++......... ......||+.|+|||++.+
T Consensus 175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 221 (313)
T 1t46_A 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN 221 (313)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcC
Confidence 999999999999999999876544322 2223457889999998643
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=231.52 Aligned_cols=170 Identities=29% Similarity=0.400 Sum_probs=146.3
Q ss_pred HhhhcccccccccCceeEEEEEeC-CCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
...|.+.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++.+.+..+++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 456778899999999999999864 6889999988765544556788999999999999999999999999999999999
Q ss_pred cCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee---CCCCCeEEccCCCcccccCCcc
Q 039310 144 VGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILL---DENYTPKVSDFGASKLVPIDAI 220 (241)
Q Consensus 144 ~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili---~~~~~~kl~Dfgla~~~~~~~~ 220 (241)
+++++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||||+||++ ++++.+||+|||++......
T Consensus 88 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-- 162 (304)
T 2jam_A 88 VSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-- 162 (304)
T ss_dssp CCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB--
T ss_pred CCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC--
Confidence 999999999988788999999999999999999999999 9999999999999 78889999999998764322
Q ss_pred ceeeeecccccccccccccC
Q 039310 221 QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 221 ~~~~~~~gt~~y~aPE~l~~ 240 (241)
......||+.|+|||++.+
T Consensus 163 -~~~~~~~~~~y~aPE~~~~ 181 (304)
T 2jam_A 163 -IMSTACGTPGYVAPEVLAQ 181 (304)
T ss_dssp -TTHHHHSCCCBCCTTTBSS
T ss_pred -ccccccCCCCccChHHhcc
Confidence 1223458999999999864
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=239.10 Aligned_cols=171 Identities=27% Similarity=0.332 Sum_probs=135.3
Q ss_pred HhhhcccccccccCceeEEEEEe-CCCCeEEEEeccc--CChhhHHHHHHHHHHHHcCC-CCCceeEEEEEecCC--cce
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKI--VDQTKIDEFINELVVVSQIN-RRNVVRLLACCLETQ--VPL 138 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~--~~~~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~~~--~~~ 138 (241)
..+|.+.+.||+|+||.||+|.. .+++.||+|++.. ........+.+|+.+++.+. ||||+++++++...+ ..|
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 45677888999999999999985 4688999998753 34455678889999999997 999999999997544 689
Q ss_pred EEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCC
Q 039310 139 LVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPID 218 (241)
Q Consensus 139 lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~ 218 (241)
+||||++ ++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 88 lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 88 LVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp EEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred EEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence 9999997 589998876 47999999999999999999999999 999999999999999999999999999865321
Q ss_pred --------------------ccceeeeecccccccccccccC
Q 039310 219 --------------------AIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 219 --------------------~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
.........||+.|+|||++.+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 204 (388)
T 3oz6_A 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG 204 (388)
T ss_dssp CCCCCCGGGCCC---------------CCCGGGGCCHHHHTT
T ss_pred ccccccccccccccccccccccccccCCcccCCcCCHHHhcC
Confidence 1112233569999999998854
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-33 Score=227.06 Aligned_cols=168 Identities=24% Similarity=0.351 Sum_probs=144.5
Q ss_pred HhhhcccccccccCceeEEEEEeC-CCCeEEEEecccC--ChhhHHHHHHHHHHHHcC-CCCCceeEEEEEecCCcceEE
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV--DQTKIDEFINELVVVSQI-NRRNVVRLLACCLETQVPLLV 140 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv 140 (241)
...|.+.+.||+|+||.||+|... ++..||+|.+... .......+.+|+..+..+ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 356777889999999999999965 6889999987653 334557788999999999 999999999999999999999
Q ss_pred EEecCCCCchHHhhcC----CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC---------------
Q 039310 141 YEFVGNGTLFEHIHKN----GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDEN--------------- 201 (241)
Q Consensus 141 ~e~~~~g~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~--------------- 201 (241)
|||+++++|.+++... ..+++..+..++.|++.||.|||+++ ++||||||+|||++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 9999999999999754 56999999999999999999999999 9999999999999844
Q ss_pred ----CCeEEccCCCcccccCCccceeeeecccccccccccccC
Q 039310 202 ----YTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 202 ----~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
..+||+|||++....... ...||+.|+|||++.+
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~ 204 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQE 204 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTT
T ss_pred cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcC
Confidence 479999999998764322 2348999999998764
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=246.97 Aligned_cols=172 Identities=24% Similarity=0.338 Sum_probs=144.9
Q ss_pred HHhhhcccccccccCceeEEEEEeC-CCCeEEEEecccCC--hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEE
Q 039310 64 KTVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD--QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLV 140 (241)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv 140 (241)
....|.+.+.||+|+||+||+|... ++..||+|.+.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3456788899999999999999965 67889999876432 33356788999999999999999999999999999999
Q ss_pred EEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC---CCeEEccCCCcccccC
Q 039310 141 YEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDEN---YTPKVSDFGASKLVPI 217 (241)
Q Consensus 141 ~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~---~~~kl~Dfgla~~~~~ 217 (241)
|||+++|+|.+.+.....+++..+..++.|++.||.|||+++ |+||||||+|||++.. +.+||+|||+|.....
T Consensus 115 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 115 MECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 999999999999988888999999999999999999999999 9999999999999764 4599999999987643
Q ss_pred CccceeeeecccccccccccccC
Q 039310 218 DAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 218 ~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
.. ......||+.|+|||++..
T Consensus 192 ~~--~~~~~~gt~~y~aPE~l~~ 212 (494)
T 3lij_A 192 QK--KMKERLGTAYYIAPEVLRK 212 (494)
T ss_dssp TB--CBCCCCSCTTTCCHHHHTT
T ss_pred Cc--cccccCCCcCeeCHHHHcc
Confidence 32 2344569999999998753
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-33 Score=228.72 Aligned_cols=171 Identities=23% Similarity=0.298 Sum_probs=148.8
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVY 141 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~ 141 (241)
.+|...+.||+|+||.||+|... ++..+|+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 45667889999999999999965 4778999976542 3445678899999999999999999999999999999999
Q ss_pred EecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc
Q 039310 142 EFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ 221 (241)
Q Consensus 142 e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~ 221 (241)
||+++++|.+++.....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 95 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~- 170 (294)
T 2rku_A 95 ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE- 170 (294)
T ss_dssp ECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccCcc-
Confidence 99999999999988788999999999999999999999999 99999999999999999999999999987643322
Q ss_pred eeeeecccccccccccccC
Q 039310 222 NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~~ 240 (241)
......||+.|+|||++.+
T Consensus 171 ~~~~~~~~~~y~aPE~~~~ 189 (294)
T 2rku_A 171 RKKVLCGTPNYIAPEVLSK 189 (294)
T ss_dssp CBCCCCSCCSSCCHHHHTT
T ss_pred ccccccCCCCcCCcchhcc
Confidence 2333568999999998754
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=255.25 Aligned_cols=175 Identities=26% Similarity=0.377 Sum_probs=149.0
Q ss_pred HHHHHhhhcccccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEE
Q 039310 61 EEIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLV 140 (241)
Q Consensus 61 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv 140 (241)
.++....+.+.+.||+|+||.||+|.+.++..||||.+.... ...+.+.+|+.+|+.++||||+++++++.+ +..++|
T Consensus 262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv 339 (535)
T 2h8h_A 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 339 (535)
T ss_dssp SBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred eecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEe
Confidence 345556677888999999999999999888889999887543 234789999999999999999999999876 678999
Q ss_pred EEecCCCCchHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCC
Q 039310 141 YEFVGNGTLFEHIHKN--GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPID 218 (241)
Q Consensus 141 ~e~~~~g~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~ 218 (241)
|||+++|+|.+++... ..+++.++..++.|++.||.|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 340 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 416 (535)
T 2h8h_A 340 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 416 (535)
T ss_dssp ECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred eehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence 9999999999999743 46999999999999999999999999 999999999999999999999999999876433
Q ss_pred ccceeeeecccccccccccccC
Q 039310 219 AIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 219 ~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
.........+|..|+|||++..
T Consensus 417 ~~~~~~~~~~~~~y~aPE~~~~ 438 (535)
T 2h8h_A 417 EYTARQGAKFPIKWTAPEAALY 438 (535)
T ss_dssp HHHTTCSTTSCGGGSCHHHHHH
T ss_pred ceecccCCcCcccccCHHHhcc
Confidence 2222233446789999998753
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-33 Score=231.84 Aligned_cols=190 Identities=25% Similarity=0.315 Sum_probs=154.9
Q ss_pred HHhhhhCCCCccccccCHHHHHHhhhcccccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHc--CC
Q 039310 43 ELSKLQGRSSEKAKIFIEEEIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQ--IN 120 (241)
Q Consensus 43 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~--l~ 120 (241)
.......+.+.........+.....+.+.+.||+|+||.||+|.. +++.||+|.+.. .....+.+|.+++.. ++
T Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~ 94 (342)
T 1b6c_B 19 LIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLR 94 (342)
T ss_dssp HHHHTCCTTCCSSSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHSCCC
T ss_pred eeeeccccCCCCCCceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCc---hhHHHHHHHHHHHHHhhcC
Confidence 333333333333444455566677889999999999999999998 578999998753 334667889999887 78
Q ss_pred CCCceeEEEEEecCC----cceEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhh--------cCCCCCeEe
Q 039310 121 RRNVVRLLACCLETQ----VPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLH--------SETNVPIIH 188 (241)
Q Consensus 121 h~ni~~l~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh--------~~~~~~iiH 188 (241)
||||+++++++...+ ..++||||+++|+|.+++... .+++..+..++.|++.||.||| +.+ ++|
T Consensus 95 h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH 170 (342)
T 1b6c_B 95 HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAH 170 (342)
T ss_dssp CTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EEC
T ss_pred CCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eee
Confidence 999999999998876 789999999999999999764 6899999999999999999999 777 999
Q ss_pred cCCCCCCeeeCCCCCeEEccCCCcccccCCccc---eeeeecccccccccccccC
Q 039310 189 RDVKSANILLDENYTPKVSDFGASKLVPIDAIQ---NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 189 ~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~l~~ 240 (241)
|||||+|||++.++.+||+|||++......... ......||+.|+|||++.+
T Consensus 171 ~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 225 (342)
T 1b6c_B 171 RDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 225 (342)
T ss_dssp SCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTS
T ss_pred CCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcc
Confidence 999999999999999999999999876443321 1233469999999998764
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=236.69 Aligned_cols=169 Identities=24% Similarity=0.359 Sum_probs=142.7
Q ss_pred hhhcccccccccCceeEEEEEeCCCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCC--CCceeEEEEEecCCcceEEE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIV--DQTKIDEFINELVVVSQINR--RNVVRLLACCLETQVPLLVY 141 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h--~ni~~l~~~~~~~~~~~lv~ 141 (241)
..|.+.+.||+|+||.||+|...++..||+|.+... +....+.+.+|+.+++.++| |||+++++++...+..++||
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 88 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 88 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence 346778899999999999999888999999987643 44456788999999999986 99999999999999999999
Q ss_pred EecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc
Q 039310 142 EFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ 221 (241)
Q Consensus 142 e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~ 221 (241)
|+ .+++|.+++.....+++.++..++.|++.||.|||+.+ |+||||||+|||++ ++.+||+|||++.........
T Consensus 89 e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 163 (343)
T 3dbq_A 89 EC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 163 (343)
T ss_dssp CC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC------
T ss_pred eC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCccccc
Confidence 95 57899999999889999999999999999999999999 99999999999997 578999999999876433222
Q ss_pred -eeeeeccccccccccccc
Q 039310 222 -NYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 222 -~~~~~~gt~~y~aPE~l~ 239 (241)
......||+.|+|||++.
T Consensus 164 ~~~~~~~gt~~y~aPE~~~ 182 (343)
T 3dbq_A 164 VVKDSQVGTVNYMPPEAIK 182 (343)
T ss_dssp ------CCCCSSCCHHHHH
T ss_pred ccCCCCcCCcCcCCHHHHh
Confidence 223456999999999974
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=235.50 Aligned_cols=168 Identities=20% Similarity=0.227 Sum_probs=143.3
Q ss_pred hhcccccccccCceeEEEEEe-CCCCeEEEEecccCChhhHHHHHHHHHHHHcC-CCCCceeEEEEEecCCcceEEEEec
Q 039310 67 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVDQTKIDEFINELVVVSQI-NRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
.|.+.+.||+|+||+||+|.. .+++.||||.+..... .+.+.+|+.+++.+ +||||+++++++...+..++||||+
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (330)
T 2izr_A 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL 87 (330)
T ss_dssp TEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC
T ss_pred CeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC
Confidence 466778999999999999985 5688999998764322 24578999999999 9999999999999999999999999
Q ss_pred CCCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCC-----eEEccCCCcccccCC
Q 039310 145 GNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYT-----PKVSDFGASKLVPID 218 (241)
Q Consensus 145 ~~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~-----~kl~Dfgla~~~~~~ 218 (241)
+++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++. +||+|||+|......
T Consensus 88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~ 163 (330)
T 2izr_A 88 -GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP 163 (330)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCT
T ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecC
Confidence 89999999863 57999999999999999999999999 999999999999998887 999999999876433
Q ss_pred ccc------eeeeecccccccccccccC
Q 039310 219 AIQ------NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 219 ~~~------~~~~~~gt~~y~aPE~l~~ 240 (241)
... ......||+.|+|||++.+
T Consensus 164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 191 (330)
T 2izr_A 164 ETKKHIPYREHKSLTGTARYMSINTHLG 191 (330)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTT
T ss_pred CCCccccccccCCcCCCccccChHHHcC
Confidence 221 1234569999999998764
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=239.79 Aligned_cols=168 Identities=23% Similarity=0.359 Sum_probs=143.2
Q ss_pred hhcccccccccCceeEEEEEeCCCCeEEEEecccC--ChhhHHHHHHHHHHHHcCC--CCCceeEEEEEecCCcceEEEE
Q 039310 67 TNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIV--DQTKIDEFINELVVVSQIN--RRNVVRLLACCLETQVPLLVYE 142 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~--h~ni~~l~~~~~~~~~~~lv~e 142 (241)
.|.+.+.||+|+||.||+|...++..||||.+... +....+.+.+|+.+++.++ ||||+++++++...+..++|||
T Consensus 57 ~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E 136 (390)
T 2zmd_A 57 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME 136 (390)
T ss_dssp EEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred ceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe
Confidence 46778899999999999999878999999987543 4455678999999999996 5999999999999999999999
Q ss_pred ecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc-
Q 039310 143 FVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ- 221 (241)
Q Consensus 143 ~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~- 221 (241)
+.+++|.+++.....+++..+..++.|++.||.|||+.+ |+||||||+|||++ ++.+||+|||++.........
T Consensus 137 -~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~ 211 (390)
T 2zmd_A 137 -CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV 211 (390)
T ss_dssp -CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC-------
T ss_pred -cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCCccc
Confidence 557899999998888999999999999999999999999 99999999999996 579999999999876433221
Q ss_pred eeeeeccccccccccccc
Q 039310 222 NYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~ 239 (241)
......||+.|+|||++.
T Consensus 212 ~~~~~~gt~~y~aPE~~~ 229 (390)
T 2zmd_A 212 VKDSQVGAVNYMPPEAIK 229 (390)
T ss_dssp --CCSCCCGGGCCHHHHH
T ss_pred cCCCCCcCCCccChHHhh
Confidence 223456999999999975
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=242.35 Aligned_cols=171 Identities=23% Similarity=0.318 Sum_probs=137.0
Q ss_pred HHHhhhcccccccccCceeEEEEEeC-CCCeEEEEecccCC--------hhhHHHHHHHHHHHHcCCCCCceeEEEEEec
Q 039310 63 IKTVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD--------QTKIDEFINELVVVSQINRRNVVRLLACCLE 133 (241)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~--------~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 133 (241)
.....|.+.+.||+|+||+||+|... ++..||+|.+.... ......+.+|+.+++.++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 34556778889999999999999854 57899999865421 1122357899999999999999999999854
Q ss_pred CCcceEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC---CeEEccCC
Q 039310 134 TQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENY---TPKVSDFG 210 (241)
Q Consensus 134 ~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~---~~kl~Dfg 210 (241)
+..++||||+++|+|.+++.....+++..+..++.|++.||.|||+++ ++||||||+|||++.++ .+||+|||
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~DFG 287 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFG 287 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred -CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEeecc
Confidence 457899999999999999988889999999999999999999999999 99999999999997544 59999999
Q ss_pred CcccccCCccceeeeeccccccccccccc
Q 039310 211 ASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 211 la~~~~~~~~~~~~~~~gt~~y~aPE~l~ 239 (241)
+|...... .......||+.|+|||++.
T Consensus 288 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~ 314 (419)
T 3i6u_A 288 HSKILGET--SLMRTLCGTPTYLAPEVLV 314 (419)
T ss_dssp TTTSCC-------------CTTCCTTTTC
T ss_pred cceecCCC--ccccccCCCCCccCceeee
Confidence 99876432 2334456999999999984
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-33 Score=233.62 Aligned_cols=172 Identities=23% Similarity=0.305 Sum_probs=149.7
Q ss_pred HhhhcccccccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEE
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLV 140 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv 140 (241)
..+|...+.||+|+||.||++... ++..+|+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 455777889999999999999965 4778999976542 344567889999999999999999999999999999999
Q ss_pred EEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcc
Q 039310 141 YEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAI 220 (241)
Q Consensus 141 ~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~ 220 (241)
|||+++++|.+++.....+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++.......
T Consensus 120 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~- 195 (335)
T 2owb_A 120 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG- 195 (335)
T ss_dssp ECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred EecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccCc-
Confidence 999999999999988788999999999999999999999999 9999999999999999999999999998764332
Q ss_pred ceeeeecccccccccccccC
Q 039310 221 QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 221 ~~~~~~~gt~~y~aPE~l~~ 240 (241)
.......||+.|+|||++.+
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~ 215 (335)
T 2owb_A 196 ERKKVLCGTPNYIAPEVLSK 215 (335)
T ss_dssp CCBCCCCSCCSSCCHHHHHT
T ss_pred ccccccCCCccccCHHHhcc
Confidence 22334569999999998754
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-33 Score=227.45 Aligned_cols=170 Identities=24% Similarity=0.348 Sum_probs=147.3
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYE 142 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e 142 (241)
..|.+.+.||+|+||.||+|... ++..||+|.+... .....+.+.+|+.+++.++||||+++++++...+..+++||
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 85 (284)
T 3kk8_A 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 85 (284)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 34667789999999999999854 5889999987542 44456778899999999999999999999999999999999
Q ss_pred ecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCC---eEEccCCCcccccCCc
Q 039310 143 FVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYT---PKVSDFGASKLVPIDA 219 (241)
Q Consensus 143 ~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~---~kl~Dfgla~~~~~~~ 219 (241)
|+++++|.+.+.....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++. +||+|||++.......
T Consensus 86 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (284)
T 3kk8_A 86 LVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 162 (284)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC
T ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc
Confidence 9999999999988888999999999999999999999999 999999999999986655 9999999997664332
Q ss_pred cceeeeecccccccccccccC
Q 039310 220 IQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 220 ~~~~~~~~gt~~y~aPE~l~~ 240 (241)
......||+.|+|||++.+
T Consensus 163 --~~~~~~~~~~y~aPE~~~~ 181 (284)
T 3kk8_A 163 --AWHGFAGTPGYLSPEVLKK 181 (284)
T ss_dssp --BCCCSCSCGGGCCHHHHTT
T ss_pred --cccCCCCCcCCcCchhhcC
Confidence 2234569999999998764
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=233.71 Aligned_cols=173 Identities=24% Similarity=0.346 Sum_probs=148.4
Q ss_pred HhhhcccccccccCceeEEEEEe-----CCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEe--cCCcc
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFL-----PDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCL--ETQVP 137 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~--~~~~~ 137 (241)
...+.+.+.||+|+||.||+|.+ .++..||+|.+........+.+.+|+.+++.++||||+++++++. +.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 35677888999999999999983 357889999988777777788999999999999999999999987 45668
Q ss_pred eEEEEecCCCCchHHhhc-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCccccc
Q 039310 138 LLVYEFVGNGTLFEHIHK-NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVP 216 (241)
Q Consensus 138 ~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~ 216 (241)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++....
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 999999999999999976 346999999999999999999999999 9999999999999999999999999998764
Q ss_pred CCccc--eeeeecccccccccccccC
Q 039310 217 IDAIQ--NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 217 ~~~~~--~~~~~~gt~~y~aPE~l~~ 240 (241)
..... ......||+.|+|||++.+
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~ 204 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSD 204 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHH
T ss_pred cCCccceeeccCCccccccCHHHhcc
Confidence 33221 2223447888999998753
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-33 Score=245.77 Aligned_cols=171 Identities=27% Similarity=0.379 Sum_probs=145.7
Q ss_pred HhhhcccccccccCceeEEEEEeC-CCCeEEEEecccCCh-------------hhHHHHHHHHHHHHcCCCCCceeEEEE
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQ-------------TKIDEFINELVVVSQINRRNVVRLLAC 130 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~-------------~~~~~~~~E~~~l~~l~h~ni~~l~~~ 130 (241)
...|.+.+.||+|+||+||+|... ++..||+|.+..... ...+.+.+|+.+++.++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 456777889999999999999964 578899998754221 235678999999999999999999999
Q ss_pred EecCCcceEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC---CeEEc
Q 039310 131 CLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENY---TPKVS 207 (241)
Q Consensus 131 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~---~~kl~ 207 (241)
+.+.+..++||||+++|+|.+++.....+++..+..++.|++.||.|||+.+ ++||||||+|||++.++ .+||+
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSEEEC
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccEEEE
Confidence 9999999999999999999999988888999999999999999999999999 99999999999998776 69999
Q ss_pred cCCCcccccCCccceeeeecccccccccccccC
Q 039310 208 DFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 208 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
|||+|....... ......||+.|+|||++.+
T Consensus 192 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~ 222 (504)
T 3q5i_A 192 DFGLSSFFSKDY--KLRDRLGTAYYIAPEVLKK 222 (504)
T ss_dssp CCTTCEECCTTS--CBCCCCSCTTTCCHHHHTT
T ss_pred ECCCCEEcCCCC--ccccccCCcCCCCHHHhcc
Confidence 999998764332 2344569999999998763
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=236.84 Aligned_cols=169 Identities=27% Similarity=0.416 Sum_probs=147.3
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEecccCC--------hhhHHHHHHHHHHHHcC-CCCCceeEEEEEecCC
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD--------QTKIDEFINELVVVSQI-NRRNVVRLLACCLETQ 135 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~--------~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~ 135 (241)
..|...+.||+|+||.||+|... ++..||||.+.... ....+.+.+|+.+++.+ +||||+++++++...+
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 44666789999999999999975 68999999875432 11245678999999999 7999999999999999
Q ss_pred cceEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccc
Q 039310 136 VPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLV 215 (241)
Q Consensus 136 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~ 215 (241)
..++||||+++++|.+++.....+++..+..++.|++.||.|||+.+ ++|+||||+|||++.++.+||+|||++..+
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHL 250 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEecCccccc
Confidence 99999999999999999988778999999999999999999999999 999999999999999999999999999876
Q ss_pred cCCccceeeeeccccccccccccc
Q 039310 216 PIDAIQNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 216 ~~~~~~~~~~~~gt~~y~aPE~l~ 239 (241)
.... ......||+.|+|||++.
T Consensus 251 ~~~~--~~~~~~gt~~y~aPE~~~ 272 (365)
T 2y7j_A 251 EPGE--KLRELCGTPGYLAPEILK 272 (365)
T ss_dssp CTTC--CBCCCCSCGGGCCHHHHH
T ss_pred CCCc--ccccCCCCCCccChhhcc
Confidence 4332 234456999999999874
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=237.28 Aligned_cols=174 Identities=24% Similarity=0.379 Sum_probs=131.6
Q ss_pred HHhhhcccccccccCceeEEEEEeCCCC----eEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcc
Q 039310 64 KTVTNNYADVIGCGGSGNVYKGFLPDRT----PVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVP 137 (241)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~----~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~ 137 (241)
....+.+.+.||+|+||.||+|...... .||+|.+... .....+.+.+|+.+++.++||||+++++++...+..
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 3456778889999999999999865432 7999987653 345567899999999999999999999999887655
Q ss_pred ------eEEEEecCCCCchHHhhcCC------CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeE
Q 039310 138 ------LLVYEFVGNGTLFEHIHKNG------NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPK 205 (241)
Q Consensus 138 ------~lv~e~~~~g~L~~~l~~~~------~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~k 205 (241)
+++|||+++++|.+++.... .+++..+..++.|++.||.|||+++ ++||||||+|||+++++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEE
Confidence 99999999999999986432 5999999999999999999999999 99999999999999999999
Q ss_pred EccCCCcccccCCcc-ceeeeecccccccccccccC
Q 039310 206 VSDFGASKLVPIDAI-QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 206 l~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~ 240 (241)
|+|||++........ .......+|+.|+|||.+.+
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 213 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD 213 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHH
T ss_pred EeeccccccccccccccccccccCcccccCchhhcC
Confidence 999999987643322 12233447889999998753
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=236.91 Aligned_cols=173 Identities=25% Similarity=0.316 Sum_probs=141.0
Q ss_pred HhhhcccccccccCceeEEEEEeC-CCCeEEEEecccC-----ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcce
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV-----DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPL 138 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~-----~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~ 138 (241)
..+|.+.+.||+|+||.||+|... ++..||+|.+... +....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 466788899999999999999854 5778999976532 3445678999999999999999999999999999999
Q ss_pred EEEEecCCCCchHHhhc----------------------------------------CCCCCHHHHHHHHHHHHHHHHHh
Q 039310 139 LVYEFVGNGTLFEHIHK----------------------------------------NGNLTWERRLRIAAETAGVLSYL 178 (241)
Q Consensus 139 lv~e~~~~g~L~~~l~~----------------------------------------~~~l~~~~~~~~~~~i~~~l~~l 178 (241)
+||||+++|+|.+++.. ...+++..+..++.|++.||.||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 99999999999999852 11246778889999999999999
Q ss_pred hcCCCCCeEecCCCCCCeeeCCCC--CeEEccCCCcccccCC---ccceeeeecccccccccccccC
Q 039310 179 HSETNVPIIHRDVKSANILLDENY--TPKVSDFGASKLVPID---AIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 179 h~~~~~~iiH~dlk~~Nili~~~~--~~kl~Dfgla~~~~~~---~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
|+.+ ++||||||+|||++.++ .+||+|||++...... .........||+.|+|||++.+
T Consensus 185 H~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 248 (345)
T 3hko_A 185 HNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNT 248 (345)
T ss_dssp HHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTC
T ss_pred HHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhcc
Confidence 9999 99999999999998776 8999999999865321 1122344569999999998853
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-33 Score=226.78 Aligned_cols=171 Identities=23% Similarity=0.320 Sum_probs=145.8
Q ss_pred HhhhcccccccccCceeEEEEEeC-CCCeEEEEecccCCh------hhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcc
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQ------TKIDEFINELVVVSQINRRNVVRLLACCLETQVP 137 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~------~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~ 137 (241)
...|.+.+.||+|+||.||+|... ++..||+|.+..... ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 346778889999999999999965 588999997654321 1357889999999999999999999999999999
Q ss_pred eEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC----CeEEccCCCcc
Q 039310 138 LLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENY----TPKVSDFGASK 213 (241)
Q Consensus 138 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~----~~kl~Dfgla~ 213 (241)
++||||+++++|.+++.....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++ .+||+|||++.
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 999999999999999988778999999999999999999999999 99999999999998877 89999999998
Q ss_pred cccCCccceeeeecccccccccccccC
Q 039310 214 LVPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 214 ~~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
...... ......||+.|+|||++.+
T Consensus 161 ~~~~~~--~~~~~~~~~~y~aPE~~~~ 185 (283)
T 3bhy_A 161 KIEAGN--EFKNIFGTPEFVAPEIVNY 185 (283)
T ss_dssp ECC----------CCCGGGCCHHHHTT
T ss_pred eccCCC--cccccCCCcCccCcceecC
Confidence 764322 2233458999999998764
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-33 Score=228.23 Aligned_cols=170 Identities=22% Similarity=0.339 Sum_probs=142.2
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEecccCC-hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD-QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
..|.+.+.||+|+||.||+|... ++..+|+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 46778899999999999999854 58899999876432 33457889999999999999999999999999999999999
Q ss_pred cCCCCchHHhhc----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee---CCCCCeEEccCCCccccc
Q 039310 144 VGNGTLFEHIHK----NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILL---DENYTPKVSDFGASKLVP 216 (241)
Q Consensus 144 ~~~g~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili---~~~~~~kl~Dfgla~~~~ 216 (241)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||++ +.++.+||+|||++....
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 999999998853 367999999999999999999999999 9999999999999 456789999999998664
Q ss_pred CCccceeeeecccccccccccccC
Q 039310 217 IDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 217 ~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
... ......||+.|+|||++..
T Consensus 179 ~~~--~~~~~~~t~~y~aPE~~~~ 200 (285)
T 3is5_A 179 SDE--HSTNAAGTALYMAPEVFKR 200 (285)
T ss_dssp ----------CTTGGGCCHHHHTT
T ss_pred Ccc--cCcCcccccCcCChHHhcc
Confidence 332 2334569999999998753
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-33 Score=227.15 Aligned_cols=170 Identities=22% Similarity=0.332 Sum_probs=131.8
Q ss_pred hhcccccccccCceeEEEEEe-CCCCeEEEEecccCC---hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEE
Q 039310 67 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVD---QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYE 142 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e 142 (241)
.+.+.+.||+|+||.||+|.. .++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..+++||
T Consensus 12 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 91 (278)
T 3cok_A 12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLE 91 (278)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEe
Confidence 466778999999999999985 468899999875422 2234678899999999999999999999999999999999
Q ss_pred ecCCCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc
Q 039310 143 FVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ 221 (241)
Q Consensus 143 ~~~~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~ 221 (241)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 92 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 167 (278)
T 3cok_A 92 MCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE- 167 (278)
T ss_dssp CCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred cCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC-
Confidence 99999999999865 57999999999999999999999999 99999999999999999999999999987643221
Q ss_pred eeeeecccccccccccccC
Q 039310 222 NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~~ 240 (241)
......||+.|+|||++.+
T Consensus 168 ~~~~~~~~~~y~aPE~~~~ 186 (278)
T 3cok_A 168 KHYTLCGTPNYISPEIATR 186 (278)
T ss_dssp -------------------
T ss_pred cceeccCCCCcCCcchhcC
Confidence 2233568999999998754
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=246.93 Aligned_cols=172 Identities=25% Similarity=0.335 Sum_probs=150.1
Q ss_pred HHhhhcccccccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceE
Q 039310 64 KTVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLL 139 (241)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~l 139 (241)
...+|.+.+.||+|+||.||+|... ++..||||.+... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3457888899999999999999865 6889999987542 23456788999999999999999999999999999999
Q ss_pred EEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee---CCCCCeEEccCCCccccc
Q 039310 140 VYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILL---DENYTPKVSDFGASKLVP 216 (241)
Q Consensus 140 v~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili---~~~~~~kl~Dfgla~~~~ 216 (241)
||||+++++|.+++.....+++..+..++.|++.||.|||+++ ++||||||+|||+ +.++.+||+|||+|....
T Consensus 104 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp EECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 9999999999999988889999999999999999999999999 9999999999999 467899999999998764
Q ss_pred CCccceeeeecccccccccccccC
Q 039310 217 IDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 217 ~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
... ......||+.|+|||++.+
T Consensus 181 ~~~--~~~~~~gt~~y~aPE~~~~ 202 (484)
T 3nyv_A 181 ASK--KMKDKIGTAYYIAPEVLHG 202 (484)
T ss_dssp CCC--SHHHHTTGGGTCCHHHHHT
T ss_pred ccc--ccccCCCCccccCceeecC
Confidence 332 2233469999999998753
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=228.95 Aligned_cols=169 Identities=28% Similarity=0.394 Sum_probs=143.4
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEecccCC---hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD---QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVY 141 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~ 141 (241)
..|.+.+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (279)
T 3fdn_A 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 88 (279)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEE
Confidence 34667789999999999999854 46789999865421 223467889999999999999999999999999999999
Q ss_pred EecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc
Q 039310 142 EFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ 221 (241)
Q Consensus 142 e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~ 221 (241)
||+++++|.+++.....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 89 e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~--- 162 (279)
T 3fdn_A 89 EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--- 162 (279)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC------
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCcc---
Confidence 99999999999988888999999999999999999999998 999999999999999999999999998654322
Q ss_pred eeeeecccccccccccccC
Q 039310 222 NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~~ 240 (241)
......||+.|+|||.+.+
T Consensus 163 ~~~~~~~~~~y~aPE~~~~ 181 (279)
T 3fdn_A 163 RRTDLCGTLDYLPPEMIEG 181 (279)
T ss_dssp -----CCCCTTCCHHHHTT
T ss_pred cccccCCCCCccCHhHhcc
Confidence 2234468999999998754
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=235.54 Aligned_cols=165 Identities=27% Similarity=0.384 Sum_probs=142.8
Q ss_pred hhhcccccccccCceeEEEEEe-CCCCeEEEEecccCC---hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVD---QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVY 141 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~ 141 (241)
..+...+.||+|+||.||+|.. .++..||||++.... ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4466778899999999999985 568899999876432 334567899999999999999999999999999999999
Q ss_pred EecCCCCchHHhh-cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcc
Q 039310 142 EFVGNGTLFEHIH-KNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAI 220 (241)
Q Consensus 142 e~~~~g~L~~~l~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~ 220 (241)
||++ |++.+++. ....+++..+..++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||++......
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-- 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 207 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC--
Confidence 9997 57877775 4567999999999999999999999999 999999999999999999999999999865322
Q ss_pred ceeeeeccccccccccccc
Q 039310 221 QNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 221 ~~~~~~~gt~~y~aPE~l~ 239 (241)
....||+.|+|||++.
T Consensus 208 ---~~~~gt~~y~aPE~~~ 223 (348)
T 1u5q_A 208 ---NSFVGTPYWMAPEVIL 223 (348)
T ss_dssp ---CCCCSCGGGCCHHHHH
T ss_pred ---CcccCCcceeCHhhhc
Confidence 2346999999999873
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=237.35 Aligned_cols=170 Identities=25% Similarity=0.313 Sum_probs=147.5
Q ss_pred HhhhcccccccccCceeEEEEEeC-CCCeEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEE
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYE 142 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e 142 (241)
...|...+.||+|+||.||+|... ++..||+|.+... .....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 345677789999999999999865 5888999987654 34456788999999999999999999999999999999999
Q ss_pred ecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc
Q 039310 143 FVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSE-TNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ 221 (241)
Q Consensus 143 ~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~-~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~ 221 (241)
|+++++|.+++...+.+++..+..++.|++.||.|||++ + ++||||||+|||++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 185 (360)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc---
Confidence 999999999998888899999999999999999999986 7 999999999999999999999999998765322
Q ss_pred eeeeecccccccccccccC
Q 039310 222 NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~~ 240 (241)
......||+.|+|||++.+
T Consensus 186 ~~~~~~gt~~y~aPE~~~~ 204 (360)
T 3eqc_A 186 MANSFVGTRSYMSPERLQG 204 (360)
T ss_dssp C----CCCCTTCCHHHHTT
T ss_pred cccCCCCCCCeECHHHHcC
Confidence 2233468999999998764
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-33 Score=232.10 Aligned_cols=171 Identities=26% Similarity=0.327 Sum_probs=143.1
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYE 142 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e 142 (241)
..|.+.+.||+|+||.||+|... ++..||+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 35677789999999999999965 4889999987543 23345668899999999999999999999999999999999
Q ss_pred ecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccce
Q 039310 143 FVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQN 222 (241)
Q Consensus 143 ~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~ 222 (241)
|+++++|.+++.....+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++....... ..
T Consensus 105 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 180 (331)
T 4aaa_A 105 FVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EV 180 (331)
T ss_dssp CCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred cCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCc-cc
Confidence 9999999998887788999999999999999999999999 9999999999999999999999999998654322 22
Q ss_pred eeeecccccccccccccC
Q 039310 223 YTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 223 ~~~~~gt~~y~aPE~l~~ 240 (241)
.....||+.|+|||++.+
T Consensus 181 ~~~~~~t~~y~aPE~~~~ 198 (331)
T 4aaa_A 181 YDDEVATRWYRAPELLVG 198 (331)
T ss_dssp ---CCCCCTTCCHHHHTT
T ss_pred cCCCcCCccccCcccccC
Confidence 334468999999998754
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-33 Score=226.24 Aligned_cols=170 Identities=24% Similarity=0.374 Sum_probs=141.1
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEecccCC---hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD---QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVY 141 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~ 141 (241)
..|.+.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 45677889999999999999965 68899999875432 223567889999999999999999999999999999999
Q ss_pred EecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc
Q 039310 142 EFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ 221 (241)
Q Consensus 142 e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~ 221 (241)
||+++++|.+++.....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-- 165 (276)
T 2h6d_A 91 EYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-- 165 (276)
T ss_dssp ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----
T ss_pred eccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCCc--
Confidence 99999999999988888999999999999999999999999 9999999999999999999999999998764332
Q ss_pred eeeeecccccccccccccC
Q 039310 222 NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~~ 240 (241)
......||+.|+|||++.+
T Consensus 166 ~~~~~~~~~~y~aPE~~~~ 184 (276)
T 2h6d_A 166 FLRTSCGSPNYAAPEVISG 184 (276)
T ss_dssp -----------CCTGGGTT
T ss_pred ceecccCCccccCHHHHcC
Confidence 2234468999999999864
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=225.47 Aligned_cols=170 Identities=25% Similarity=0.338 Sum_probs=144.6
Q ss_pred hhcccccccccCceeEEEEEeC-CCCeEEEEeccc--CChhhHHHHHHHHHHHHcCCCCCceeEEEEEec----CCcceE
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKI--VDQTKIDEFINELVVVSQINRRNVVRLLACCLE----TQVPLL 139 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~--~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~----~~~~~l 139 (241)
.+.+.+.||+|+||.||+|... ++..||+|.+.. ......+.+.+|+.+++.++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 3566778999999999999854 577899997654 345566788999999999999999999999865 456899
Q ss_pred EEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC-CCCCeEEccCCCcccccCC
Q 039310 140 VYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLD-ENYTPKVSDFGASKLVPID 218 (241)
Q Consensus 140 v~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~-~~~~~kl~Dfgla~~~~~~ 218 (241)
||||+++++|.+++.....+++..+..++.|++.||.|||+.+ .+++|+||||+|||++ +++.+||+|||++......
T Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~ 185 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 185 (290)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred EEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc
Confidence 9999999999999988788999999999999999999999875 3599999999999998 7899999999999754322
Q ss_pred ccceeeeecccccccccccccC
Q 039310 219 AIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 219 ~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
......||+.|+|||++.+
T Consensus 186 ---~~~~~~~t~~y~aPE~~~~ 204 (290)
T 1t4h_A 186 ---FAKAVIGTPEFMAPEMYEE 204 (290)
T ss_dssp ---SBEESCSSCCCCCGGGGGT
T ss_pred ---ccccccCCcCcCCHHHHhc
Confidence 2334569999999998764
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=233.63 Aligned_cols=178 Identities=26% Similarity=0.385 Sum_probs=149.0
Q ss_pred HHHHHHhhhcccccccccCceeEEEEEeC------CCCeEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEe
Q 039310 60 EEEIKTVTNNYADVIGCGGSGNVYKGFLP------DRTPVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCL 132 (241)
Q Consensus 60 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 132 (241)
..++....+.+.+.||+|+||.||+|.+. ++..||+|.+... .......+.+|+.+++.++||||+++++++.
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 34455567888899999999999999754 3678999987653 3345567899999999999999999999999
Q ss_pred cCCcceEEEEecCCCCchHHhhcC----------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC
Q 039310 133 ETQVPLLVYEFVGNGTLFEHIHKN----------GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENY 202 (241)
Q Consensus 133 ~~~~~~lv~e~~~~g~L~~~l~~~----------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~ 202 (241)
+.+..++||||+++++|.+++... ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDF 175 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTC
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCC
Confidence 999999999999999999998642 35799999999999999999999999 99999999999999999
Q ss_pred CeEEccCCCcccccCCccc-eeeeecccccccccccccC
Q 039310 203 TPKVSDFGASKLVPIDAIQ-NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 203 ~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~ 240 (241)
.+||+|||++......... ......+|+.|+|||++.+
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 214 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD 214 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhcc
Confidence 9999999999865433221 1222347889999998753
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-33 Score=235.15 Aligned_cols=176 Identities=22% Similarity=0.224 Sum_probs=149.0
Q ss_pred cccCHHHHHHhhhcccccccccCceeEEEEEe-CCCCeEEEEecccCChhhHHHHHHHHHHHHcCC-----CCCceeEEE
Q 039310 56 KIFIEEEIKTVTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVDQTKIDEFINELVVVSQIN-----RRNVVRLLA 129 (241)
Q Consensus 56 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~-----h~ni~~l~~ 129 (241)
..+...++....|.+.+.||+|+||.||+|.. .++..||||.+.. .....+.+..|+.+++.++ ||||+++++
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 33444445556788889999999999999986 4688899998764 3344567788999999986 999999999
Q ss_pred EEecCCcceEEEEecCCCCchHHhhcCC--CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC-------
Q 039310 130 CCLETQVPLLVYEFVGNGTLFEHIHKNG--NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDE------- 200 (241)
Q Consensus 130 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~------- 200 (241)
++...+..++||||+ +++|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.
T Consensus 104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~ 179 (360)
T 3llt_A 104 KFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSL 179 (360)
T ss_dssp EEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEE
T ss_pred eeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccc
Confidence 999999999999999 889999997654 5999999999999999999999999 999999999999975
Q ss_pred ------------------CCCeEEccCCCcccccCCccceeeeecccccccccccccC
Q 039310 201 ------------------NYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 201 ------------------~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
++.+||+|||+|...... .....||+.|+|||++.+
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~ 233 (360)
T 3llt_A 180 ITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILN 233 (360)
T ss_dssp EEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTT
T ss_pred cchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcC
Confidence 789999999999864322 233468999999999764
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=234.76 Aligned_cols=171 Identities=24% Similarity=0.346 Sum_probs=138.2
Q ss_pred HhhhcccccccccCceeEEEEEe-CCCCeEEEEecccCC--hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEE
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVD--QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVY 141 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~ 141 (241)
..+|.+.+.||+|+||+||+|.. .+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 34677888999999999999984 468899999876533 223456789999999999999999999999999999999
Q ss_pred EecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC-----CCCCeEEccCCCccccc
Q 039310 142 EFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLD-----ENYTPKVSDFGASKLVP 216 (241)
Q Consensus 142 e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~-----~~~~~kl~Dfgla~~~~ 216 (241)
||++ ++|.+++.....+++..+..++.|++.||.|||+++ ++||||||+|||++ +++.+||+|||++....
T Consensus 113 e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 113 EYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp ECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred ecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 9997 499999998888999999999999999999999999 99999999999994 55569999999998764
Q ss_pred CCccceeeeecccccccccccccC
Q 039310 217 IDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 217 ~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
... .......||+.|+|||++.+
T Consensus 189 ~~~-~~~~~~~~t~~y~aPE~~~~ 211 (329)
T 3gbz_A 189 IPI-RQFTHEIITLWYRPPEILLG 211 (329)
T ss_dssp ------------CCTTCCHHHHTT
T ss_pred Ccc-cccCCCcCCccccCHHHhcC
Confidence 322 22333458999999998754
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-33 Score=229.76 Aligned_cols=172 Identities=26% Similarity=0.337 Sum_probs=144.9
Q ss_pred HhhhcccccccccCceeEEEEEe-CCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEe----cCCcceE
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCL----ETQVPLL 139 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~----~~~~~~l 139 (241)
...|.+.+.||+|+||.||+|.. .++..||+|.+........+.+.+|+.+++.++||||+++++++. .....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 45678888999999999999985 568899999887666777788999999999999999999999987 3447899
Q ss_pred EEEecCCCCchHHhhc----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccc
Q 039310 140 VYEFVGNGTLFEHIHK----NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLV 215 (241)
Q Consensus 140 v~e~~~~g~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~ 215 (241)
||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 9999999999999875 467999999999999999999999999 999999999999999999999999998765
Q ss_pred cCCccc--------eeeeeccccccccccccc
Q 039310 216 PIDAIQ--------NYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 216 ~~~~~~--------~~~~~~gt~~y~aPE~l~ 239 (241)
...... ......||+.|+|||++.
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 216 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFS 216 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSS
T ss_pred ccccccccccccccccccccCCcccCCHhHhc
Confidence 321100 112234799999999875
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-33 Score=226.64 Aligned_cols=169 Identities=26% Similarity=0.402 Sum_probs=146.7
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEecccCC---hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD---QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVY 141 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~ 141 (241)
..|.+.+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 45677889999999999999865 57789999865421 223467889999999999999999999999999999999
Q ss_pred EecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc
Q 039310 142 EFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ 221 (241)
Q Consensus 142 e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~ 221 (241)
||+++++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~--- 167 (284)
T 2vgo_A 94 EFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL--- 167 (284)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS---
T ss_pred EeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc---
Confidence 99999999999988888999999999999999999999999 999999999999999999999999998765322
Q ss_pred eeeeecccccccccccccC
Q 039310 222 NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~~ 240 (241)
......||+.|+|||++.+
T Consensus 168 ~~~~~~~~~~y~aPE~~~~ 186 (284)
T 2vgo_A 168 RRRTMCGTLDYLPPEMIEG 186 (284)
T ss_dssp CBCCCCSCGGGCCHHHHTT
T ss_pred ccccccCCCCcCCHHHhcc
Confidence 2233468999999998764
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-33 Score=233.15 Aligned_cols=167 Identities=20% Similarity=0.293 Sum_probs=142.1
Q ss_pred HhhhcccccccccCceeEEEEEeC-CCCeEEEEecccCChhhHHHHHHHHHHHHcC-CCCCceeEEEEEecCCcceEEEE
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQTKIDEFINELVVVSQI-NRRNVVRLLACCLETQVPLLVYE 142 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e 142 (241)
...|.+.+.||+|+||.||+|... ++..||+|.+..... ...+|++++..+ +||||+++++++.+.+..|+|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 446778889999999999999865 578899998764332 234688888887 79999999999999999999999
Q ss_pred ecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC----CCeEEccCCCcccccCC
Q 039310 143 FVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDEN----YTPKVSDFGASKLVPID 218 (241)
Q Consensus 143 ~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~----~~~kl~Dfgla~~~~~~ 218 (241)
|+++|+|.+++...+.+++..+..++.|++.||.|||+.+ ++||||||+|||+.++ +.+||+|||++......
T Consensus 97 ~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~ 173 (342)
T 2qr7_A 97 LMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173 (342)
T ss_dssp CCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence 9999999999998888999999999999999999999999 9999999999998533 35999999999876433
Q ss_pred ccceeeeeccccccccccccc
Q 039310 219 AIQNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 219 ~~~~~~~~~gt~~y~aPE~l~ 239 (241)
. ......+||+.|+|||++.
T Consensus 174 ~-~~~~~~~gt~~y~aPE~~~ 193 (342)
T 2qr7_A 174 N-GLLMTPCYTANFVAPEVLE 193 (342)
T ss_dssp T-CCBCCSSCCSSCCCHHHHH
T ss_pred C-CceeccCCCccccCHHHhc
Confidence 2 2234456899999999875
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-33 Score=238.80 Aligned_cols=169 Identities=26% Similarity=0.439 Sum_probs=144.2
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEecccCC-hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCC--cceEEE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD-QTKIDEFINELVVVSQINRRNVVRLLACCLETQ--VPLLVY 141 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~--~~~lv~ 141 (241)
..|.+.+.||+|+||+||+|... ++..||+|.+.... ....+.+.+|+++++.++||||+++++++...+ ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 35677889999999999999965 48899999876432 334567789999999999999999999998755 679999
Q ss_pred EecCCCCchHHhhcCC---CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee----CCCCCeEEccCCCccc
Q 039310 142 EFVGNGTLFEHIHKNG---NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILL----DENYTPKVSDFGASKL 214 (241)
Q Consensus 142 e~~~~g~L~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili----~~~~~~kl~Dfgla~~ 214 (241)
||+++|+|.+++.... .+++..+..++.|++.||.|||+++ ++||||||+|||+ +.++.+||+|||++..
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 9999999999997643 3999999999999999999999999 9999999999999 7788899999999987
Q ss_pred ccCCccceeeeeccccccccccccc
Q 039310 215 VPIDAIQNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 215 ~~~~~~~~~~~~~gt~~y~aPE~l~ 239 (241)
..... ......||+.|+|||++.
T Consensus 166 ~~~~~--~~~~~~gt~~y~aPE~~~ 188 (396)
T 4eut_A 166 LEDDE--QFVSLYGTEEYLHPDMYE 188 (396)
T ss_dssp CCCGG--GSSCSSSCCTTCCHHHHH
T ss_pred ccCCC--ccccccCCccccCHHHhh
Confidence 64332 223456999999999874
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-33 Score=236.31 Aligned_cols=172 Identities=17% Similarity=0.263 Sum_probs=138.9
Q ss_pred HhhhcccccccccCceeEEEEEeCC------CCeEEEEecccCChhh-----------HHHHHHHHHHHHcCCCCCceeE
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFLPD------RTPVAVKKSKIVDQTK-----------IDEFINELVVVSQINRRNVVRL 127 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavk~~~~~~~~~-----------~~~~~~E~~~l~~l~h~ni~~l 127 (241)
...|.+.+.||+|+||.||+|.+.. +..||+|.+....... ......|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4467788899999999999998654 4689999876543211 1224456667788899999999
Q ss_pred EEEEecC----CcceEEEEecCCCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC--C
Q 039310 128 LACCLET----QVPLLVYEFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLD--E 200 (241)
Q Consensus 128 ~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~--~ 200 (241)
++++... ...++||||+ +++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++ .
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKN 189 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEESSC
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEecCC
Confidence 9998764 4589999999 89999999876 57999999999999999999999998 99999999999999 8
Q ss_pred CCCeEEccCCCcccccCCccc------eeeeecccccccccccccC
Q 039310 201 NYTPKVSDFGASKLVPIDAIQ------NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 201 ~~~~kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~l~~ 240 (241)
++.+||+|||+|+.+...... ......||+.|||||++.+
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 235 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG 235 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC
Confidence 899999999999876433211 1123459999999998764
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-33 Score=232.04 Aligned_cols=173 Identities=23% Similarity=0.372 Sum_probs=147.3
Q ss_pred HhhhcccccccccCceeEEEEEe-----CCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCC--cc
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFL-----PDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQ--VP 137 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~--~~ 137 (241)
...+.+.+.||+|+||.||+|.+ .++..||+|.+........+.+.+|+.+++.++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 45577788999999999999983 357889999988766667788999999999999999999999987654 78
Q ss_pred eEEEEecCCCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCccccc
Q 039310 138 LLVYEFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVP 216 (241)
Q Consensus 138 ~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~ 216 (241)
++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++....
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~ 196 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLP 196 (326)
T ss_dssp EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence 9999999999999999875 46999999999999999999999999 9999999999999999999999999998765
Q ss_pred CCccce--eeeecccccccccccccC
Q 039310 217 IDAIQN--YTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 217 ~~~~~~--~~~~~gt~~y~aPE~l~~ 240 (241)
...... .....+|+.|+|||++.+
T Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~ 222 (326)
T 2w1i_A 197 QDKEYYKVKEPGESPIFWYAPESLTE 222 (326)
T ss_dssp SSCSEEECSSCCSCCGGGCCHHHHHH
T ss_pred ccccccccccCCCCceeEECchhhcC
Confidence 433211 122347788999998753
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=233.12 Aligned_cols=172 Identities=24% Similarity=0.424 Sum_probs=137.6
Q ss_pred HhhhcccccccccCceeEEEEEeC-CCC----eEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcce
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFLP-DRT----PVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPL 138 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~ 138 (241)
...+...+.||+|+||+||+|.+. ++. +||+|.+... .....+.+.+|+.+++.++||||+++++++...+ .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 345777889999999999999854 333 3588876543 3345578999999999999999999999998765 67
Q ss_pred EEEEecCCCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccC
Q 039310 139 LVYEFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPI 217 (241)
Q Consensus 139 lv~e~~~~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~ 217 (241)
+++|++++|+|.+++... ..+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||+|+....
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 899999999999999764 57999999999999999999999999 99999999999999999999999999987643
Q ss_pred Cccc-eeeeecccccccccccccC
Q 039310 218 DAIQ-NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 218 ~~~~-~~~~~~gt~~y~aPE~l~~ 240 (241)
.... ......+|+.|+|||++.+
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~ 193 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILH 193 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHH
T ss_pred CcccccccCCCccccccChHHhcc
Confidence 3222 2233447889999998753
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-33 Score=242.96 Aligned_cols=167 Identities=28% Similarity=0.329 Sum_probs=136.2
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCC------c
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLETQ------V 136 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~------~ 136 (241)
.+|...+.||+|+||+||+|... +++.||||++... .....+++.+|+.+++.++||||+++++++...+ .
T Consensus 62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 141 (464)
T 3ttj_A 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 141 (464)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCe
Confidence 45667789999999999999854 5888999987643 4455678899999999999999999999997654 4
Q ss_pred ceEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCccccc
Q 039310 137 PLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVP 216 (241)
Q Consensus 137 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~ 216 (241)
.|+||||+++ ++.+.+.. .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+...
T Consensus 142 ~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 142 VYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215 (464)
T ss_dssp EEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred EEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence 6999999975 56666654 4899999999999999999999999 9999999999999999999999999998764
Q ss_pred CCccceeeeecccccccccccccC
Q 039310 217 IDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 217 ~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
.. .......||+.|+|||++.+
T Consensus 216 ~~--~~~~~~~gt~~y~aPE~~~~ 237 (464)
T 3ttj_A 216 TS--FMMTPYVVTRYYRAPEVILG 237 (464)
T ss_dssp -C--CCC----CCCTTCCHHHHTT
T ss_pred CC--cccCCCcccccccCHHHHcC
Confidence 32 22344569999999999865
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-33 Score=225.17 Aligned_cols=170 Identities=29% Similarity=0.464 Sum_probs=134.5
Q ss_pred hhhcccccccccCceeEEEEEeCCCCeEEEEecccCC----hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVD----QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVY 141 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~----~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~ 141 (241)
..+.+.+.||+|+||.||+|.+. +..||+|...... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 35667789999999999999974 7889999876432 223567889999999999999999999999999999999
Q ss_pred EecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC--------CCCeEEccCCCcc
Q 039310 142 EFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDE--------NYTPKVSDFGASK 213 (241)
Q Consensus 142 e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~--------~~~~kl~Dfgla~ 213 (241)
||+++++|.+++.. .++++..+..++.|++.||.|||+++..+++||||||+|||++. ++.+||+|||++.
T Consensus 86 e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~ 164 (271)
T 3dtc_A 86 EFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164 (271)
T ss_dssp ECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--
T ss_pred EcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccc
Confidence 99999999999864 47999999999999999999999987555889999999999986 6789999999998
Q ss_pred cccCCccceeeeecccccccccccccC
Q 039310 214 LVPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 214 ~~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
...... .....||+.|+|||.+.+
T Consensus 165 ~~~~~~---~~~~~~~~~y~aPE~~~~ 188 (271)
T 3dtc_A 165 EWHRTT---KMSAAGAYAWMAPEVIRA 188 (271)
T ss_dssp --------------CCGGGSCHHHHHH
T ss_pred cccccc---ccCCCCccceeCHHHhcc
Confidence 654322 223468999999998753
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-33 Score=233.83 Aligned_cols=169 Identities=24% Similarity=0.351 Sum_probs=147.5
Q ss_pred HhhhcccccccccCceeEEEEEeCCCCeEEEEecccCChh-----------------hHHHHHHHHHHHHcCCCCCceeE
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQT-----------------KIDEFINELVVVSQINRRNVVRL 127 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~-----------------~~~~~~~E~~~l~~l~h~ni~~l 127 (241)
...|.+.+.||+|+||.||+|.. ++..||+|.+...... ..+.+.+|+.+++.++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 34677888999999999999999 8899999986542111 12788999999999999999999
Q ss_pred EEEEecCCcceEEEEecCCCCchHH------hhc--CCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEecCCCCCCeee
Q 039310 128 LACCLETQVPLLVYEFVGNGTLFEH------IHK--NGNLTWERRLRIAAETAGVLSYLHS-ETNVPIIHRDVKSANILL 198 (241)
Q Consensus 128 ~~~~~~~~~~~lv~e~~~~g~L~~~------l~~--~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~iiH~dlk~~Nili 198 (241)
++++.+.+..++||||+++++|.++ +.. ...+++..+..++.|++.||.|||+ .+ ++|+||||+||++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEE
Confidence 9999999999999999999999998 665 5679999999999999999999999 88 9999999999999
Q ss_pred CCCCCeEEccCCCcccccCCccceeeeecccccccccccccC
Q 039310 199 DENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 199 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
+.++.+||+|||++...... ......||+.|+|||++.+
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~ 224 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSN 224 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSS
T ss_pred cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcC
Confidence 99999999999999876433 3344568999999999865
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-33 Score=233.29 Aligned_cols=176 Identities=27% Similarity=0.433 Sum_probs=141.2
Q ss_pred HHHHhhhcccccccccCceeEEEEEeCC-----CCeEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCC
Q 039310 62 EIKTVTNNYADVIGCGGSGNVYKGFLPD-----RTPVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCLETQ 135 (241)
Q Consensus 62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 135 (241)
++....+...+.||+|+||.||+|.... +..||+|.+... .......+.+|+.+++.++||||+++++++...+
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 119 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 119 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence 3444566677899999999999998543 235999987653 3445567899999999999999999999999999
Q ss_pred cceEEEEecCCCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCccc
Q 039310 136 VPLLVYEFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKL 214 (241)
Q Consensus 136 ~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~ 214 (241)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++..
T Consensus 120 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 120 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred CcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchh
Confidence 999999999999999999765 57999999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCccc--eeeeecccccccccccccC
Q 039310 215 VPIDAIQ--NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 215 ~~~~~~~--~~~~~~gt~~y~aPE~l~~ 240 (241)
....... ......+|+.|+|||++.+
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 224 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISY 224 (333)
T ss_dssp --------------CCCGGGSCHHHHHS
T ss_pred hccccccccccCCCCccccccCchhccc
Confidence 6433211 1222346789999998754
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-32 Score=228.23 Aligned_cols=169 Identities=24% Similarity=0.353 Sum_probs=143.1
Q ss_pred hcccccccccCceeEEEEEeC-----CCCeEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecC--CcceE
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-----DRTPVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCLET--QVPLL 139 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-----~~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~--~~~~l 139 (241)
+.+.+.||+|+||+||++.+. +++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 477889999999999988643 5788999987754 344567889999999999999999999999874 57799
Q ss_pred EEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCc
Q 039310 140 VYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDA 219 (241)
Q Consensus 140 v~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~ 219 (241)
||||+++++|.+++... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 113 v~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 188 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188 (318)
T ss_dssp EECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECCTTC
T ss_pred EEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccccccc
Confidence 99999999999999765 4999999999999999999999999 9999999999999999999999999998765432
Q ss_pred cc--eeeeecccccccccccccC
Q 039310 220 IQ--NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 220 ~~--~~~~~~gt~~y~aPE~l~~ 240 (241)
.. ......||+.|+|||++.+
T Consensus 189 ~~~~~~~~~~~~~~y~aPE~~~~ 211 (318)
T 3lxp_A 189 EYYRVREDGDSPVFWYAPECLKE 211 (318)
T ss_dssp SEEEC---CCCCGGGCCHHHHHH
T ss_pred cccccccCCCCCceeeChHHhcC
Confidence 21 2233457889999998753
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-33 Score=227.57 Aligned_cols=172 Identities=31% Similarity=0.489 Sum_probs=141.3
Q ss_pred hhhcccccccccCceeEEEEEeCC----CCeEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEe-cCCcceE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLPD----RTPVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCL-ETQVPLL 139 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~-~~~~~~l 139 (241)
..+.+.+.||+|+||.||+|...+ ...+|+|.+... +....+.+.+|+.+++.++||||+++++++. .++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 346677899999999999998543 225788887653 4455678999999999999999999999865 4568899
Q ss_pred EEEecCCCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCC
Q 039310 140 VYEFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPID 218 (241)
Q Consensus 140 v~e~~~~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~ 218 (241)
+|||+++++|.+++... ..+++..+..++.|++.||.|||+++ ++||||||+||++++++.+||+|||++......
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp EEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred EEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccccccc
Confidence 99999999999999764 46899999999999999999999999 999999999999999999999999999876433
Q ss_pred cc---ceeeeecccccccccccccC
Q 039310 219 AI---QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 219 ~~---~~~~~~~gt~~y~aPE~l~~ 240 (241)
.. .......||+.|+|||.+.+
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~ 206 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESLQT 206 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHHHH
T ss_pred chhccccccCCCCCccccChHHhcC
Confidence 22 12233457889999998753
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-33 Score=232.15 Aligned_cols=171 Identities=26% Similarity=0.359 Sum_probs=142.1
Q ss_pred hhhcccccccccCceeEEEEEe-CCCCeEEEEecccCC--hhhHHHHHHHHHHHHcCCCCCceeEEEEEecC--------
Q 039310 66 VTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVD--QTKIDEFINELVVVSQINRRNVVRLLACCLET-------- 134 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~-------- 134 (241)
.+|.+.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.+++.++||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 4677788999999999999996 468899999875432 22345778999999999999999999999873
Q ss_pred CcceEEEEecCCCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcc
Q 039310 135 QVPLLVYEFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASK 213 (241)
Q Consensus 135 ~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~ 213 (241)
+..++||||+++ +|.+.+... ..+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||+|.
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred ceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 468999999975 777766543 57999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCc---cceeeeecccccccccccccC
Q 039310 214 LVPIDA---IQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 214 ~~~~~~---~~~~~~~~gt~~y~aPE~l~~ 240 (241)
...... ........||+.|+|||++.+
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 202 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLG 202 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTT
T ss_pred cccccccccccccCCcccccCccCchhhcC
Confidence 764221 122334568999999998753
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-33 Score=234.47 Aligned_cols=166 Identities=24% Similarity=0.288 Sum_probs=136.8
Q ss_pred hhhcccccccccCceeEEEEEe-CCCCeEEEEeccc--CChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCC------c
Q 039310 66 VTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKI--VDQTKIDEFINELVVVSQINRRNVVRLLACCLETQ------V 136 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~--~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~------~ 136 (241)
..|...+.||+|+||.||+|.. .++..||||++.. .+....+++.+|+.+++.++||||+++++++...+ .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 104 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 104 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence 3566778999999999999986 4688999998754 23445678899999999999999999999998764 4
Q ss_pred ceEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCccccc
Q 039310 137 PLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVP 216 (241)
Q Consensus 137 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~ 216 (241)
.|+||||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++...
T Consensus 105 ~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 105 FYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp CEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 59999999 7799999876 47999999999999999999999999 9999999999999999999999999998754
Q ss_pred CCccceeeeecccccccccccccC
Q 039310 217 IDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 217 ~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
.. .....||+.|+|||++.+
T Consensus 180 ~~----~~~~~~t~~y~aPE~~~~ 199 (367)
T 1cm8_A 180 SE----MTGYVVTRWYRAPEVILN 199 (367)
T ss_dssp SS----CCSSCSCGGGCCTHHHHT
T ss_pred cc----cCcCcCCCCcCCHHHHhC
Confidence 22 233468999999998754
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-33 Score=226.42 Aligned_cols=171 Identities=23% Similarity=0.377 Sum_probs=140.6
Q ss_pred HhhhcccccccccCceeEEEEEeCC----CCeEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceE
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFLPD----RTPVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLL 139 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~l 139 (241)
...+.+.+.||+|+||.||+|.+.+ +..||+|..... .....+.+.+|+.+++.++||||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 3457778899999999999998543 235999987654 34456789999999999999999999999865 45689
Q ss_pred EEEecCCCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCC
Q 039310 140 VYEFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPID 218 (241)
Q Consensus 140 v~e~~~~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~ 218 (241)
+|||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++......
T Consensus 90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 166 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166 (281)
T ss_dssp EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence 99999999999999764 45999999999999999999999999 999999999999999999999999999876544
Q ss_pred ccceeeeeccccccccccccc
Q 039310 219 AIQNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 219 ~~~~~~~~~gt~~y~aPE~l~ 239 (241)
.........+|+.|+|||++.
T Consensus 167 ~~~~~~~~~~~~~y~aPE~~~ 187 (281)
T 3cc6_A 167 DYYKASVTRLPIKWMSPESIN 187 (281)
T ss_dssp ------CCCCCGGGCCHHHHH
T ss_pred cccccccCCCCcceeCchhhc
Confidence 333334455788999999875
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=235.64 Aligned_cols=159 Identities=28% Similarity=0.368 Sum_probs=129.5
Q ss_pred ccccccCceeEEEEEeC-CCCeEEEEecccCChhhHHHHHHHHHHHH-cCCCCCceeEEEEEec----CCcceEEEEecC
Q 039310 72 DVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQTKIDEFINELVVVS-QINRRNVVRLLACCLE----TQVPLLVYEFVG 145 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~-~l~h~ni~~l~~~~~~----~~~~~lv~e~~~ 145 (241)
+.||+|+||+||+|... ++..||||.+... ..+.+|+.++. ..+||||+++++++.. .+..|+||||++
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~ 142 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 142 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCC
Confidence 57999999999999854 5888999987532 45667888874 4589999999999875 567899999999
Q ss_pred CCCchHHhhcCC--CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC---CCCeEEccCCCcccccCCcc
Q 039310 146 NGTLFEHIHKNG--NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDE---NYTPKVSDFGASKLVPIDAI 220 (241)
Q Consensus 146 ~g~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~---~~~~kl~Dfgla~~~~~~~~ 220 (241)
+|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 143 gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~-- 217 (400)
T 1nxk_A 143 GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-- 217 (400)
T ss_dssp SEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCEECC----
T ss_pred CCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccccccCCC--
Confidence 999999998654 5999999999999999999999999 999999999999997 789999999999865432
Q ss_pred ceeeeecccccccccccccC
Q 039310 221 QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 221 ~~~~~~~gt~~y~aPE~l~~ 240 (241)
......+||+.|+|||++.+
T Consensus 218 ~~~~~~~gt~~y~aPE~~~~ 237 (400)
T 1nxk_A 218 NSLTTPCYTPYYVAPEVLGP 237 (400)
T ss_dssp ---------CTTCCGGGSCC
T ss_pred CccccCCCCCCccCHhhcCC
Confidence 22344568999999999864
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-33 Score=228.26 Aligned_cols=172 Identities=29% Similarity=0.382 Sum_probs=139.6
Q ss_pred HHHhhhcccccccccCceeEEEEEe-CCCCeEEEEecccCC-----hhhHHHHHHHHHHHHcCC---CCCceeEEEEEec
Q 039310 63 IKTVTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVD-----QTKIDEFINELVVVSQIN---RRNVVRLLACCLE 133 (241)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~-----~~~~~~~~~E~~~l~~l~---h~ni~~l~~~~~~ 133 (241)
+...+|.+.+.||+|+||+||+|.. .+++.||+|.+.... ......+.+|+.+++.++ ||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 3455678889999999999999995 468899999875322 112245667777777664 9999999999987
Q ss_pred CC-----cceEEEEecCCCCchHHhhcCCC--CCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEE
Q 039310 134 TQ-----VPLLVYEFVGNGTLFEHIHKNGN--LTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKV 206 (241)
Q Consensus 134 ~~-----~~~lv~e~~~~g~L~~~l~~~~~--l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl 206 (241)
.. ..+++|||++ ++|.+++..... +++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 55 4789999996 599999987654 999999999999999999999999 999999999999999999999
Q ss_pred ccCCCcccccCCccceeeeecccccccccccccC
Q 039310 207 SDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 207 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
+|||++....... ......||+.|+|||++.+
T Consensus 162 ~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~ 193 (308)
T 3g33_A 162 ADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQ 193 (308)
T ss_dssp CSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHT
T ss_pred eeCccccccCCCc--ccCCccccccccCchHHcC
Confidence 9999998664322 2334568999999998754
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-33 Score=223.10 Aligned_cols=168 Identities=20% Similarity=0.308 Sum_probs=144.6
Q ss_pred HhhhcccccccccCceeEEEEEeCCCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecC--CcceEE
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLET--QVPLLV 140 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~--~~~~lv 140 (241)
...+.+.+.||+|+||.||+|.++ +..||+|.+... .....+.+.+|+.+++.++||||+++++++.+. +..+++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 345677889999999999999984 788999987653 344567899999999999999999999999887 788999
Q ss_pred EEecCCCCchHHhhcCC--CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCC
Q 039310 141 YEFVGNGTLFEHIHKNG--NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPID 218 (241)
Q Consensus 141 ~e~~~~g~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~ 218 (241)
|||+++++|.+++.... .+++..+..++.|++.||.|||+.+ .+++||||||+||++++++.++|+|||++.....
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~- 165 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS- 165 (271)
T ss_dssp EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-
T ss_pred ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc-
Confidence 99999999999998765 4899999999999999999999865 5699999999999999999999998888654322
Q ss_pred ccceeeeecccccccccccccC
Q 039310 219 AIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 219 ~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
....||+.|+|||++.+
T Consensus 166 -----~~~~~t~~y~aPE~~~~ 182 (271)
T 3kmu_A 166 -----PGRMYAPAWVAPEALQK 182 (271)
T ss_dssp -----TTCBSCGGGSCHHHHHS
T ss_pred -----cCccCCccccChhhhcc
Confidence 12358999999998764
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=233.36 Aligned_cols=171 Identities=23% Similarity=0.414 Sum_probs=138.5
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCe----EEEEecccCC-hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTP----VAVKKSKIVD-QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLL 139 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~----vavk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~l 139 (241)
..+...+.||+|+||.||+|.+. ++.. |++|.+.... ......+.+|+.+++.++||||+++++++. .+..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 35667789999999999999854 3443 7778654322 223356678999999999999999999986 456889
Q ss_pred EEEecCCCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCC
Q 039310 140 VYEFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPID 218 (241)
Q Consensus 140 v~e~~~~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~ 218 (241)
||||+++|+|.+++... +.+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++.....
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 168 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 168 (325)
T ss_dssp EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence 99999999999999765 47999999999999999999999999 999999999999999999999999999876543
Q ss_pred ccc-eeeeecccccccccccccC
Q 039310 219 AIQ-NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 219 ~~~-~~~~~~gt~~y~aPE~l~~ 240 (241)
... ......||+.|+|||++.+
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~ 191 (325)
T 3kex_A 169 DKQLLYSEAKTPIKWMALESIHF 191 (325)
T ss_dssp TTCCC-----CCTTTSCHHHHHH
T ss_pred cccccccCCCCcccccChHHhcc
Confidence 322 2334457889999998753
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=225.79 Aligned_cols=171 Identities=26% Similarity=0.394 Sum_probs=142.5
Q ss_pred hhcccccccccCceeEEEEEeCC-C---CeEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcc-eEE
Q 039310 67 TNNYADVIGCGGSGNVYKGFLPD-R---TPVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVP-LLV 140 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~~-~---~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~-~lv 140 (241)
.+...+.||+|+||.||+|.+.+ + ..+|+|.+... .....+.+.+|+.+++.++||||+++++++.+.+.. +++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 34456789999999999998432 2 26899987653 344567889999999999999999999999876655 999
Q ss_pred EEecCCCCchHHhhc-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCc
Q 039310 141 YEFVGNGTLFEHIHK-NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDA 219 (241)
Q Consensus 141 ~e~~~~g~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~ 219 (241)
|||+.+++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++.......
T Consensus 102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 999999999999986 346899999999999999999999999 9999999999999999999999999998654332
Q ss_pred c---ceeeeecccccccccccccC
Q 039310 220 I---QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 220 ~---~~~~~~~gt~~y~aPE~l~~ 240 (241)
. .......+|+.|+|||.+.+
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~ 202 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQT 202 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTT
T ss_pred ccccccCcCCCCCccccChhhhcc
Confidence 1 12233457899999998764
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-32 Score=225.12 Aligned_cols=169 Identities=25% Similarity=0.385 Sum_probs=147.0
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEecccCC---------hhhHHHHHHHHHHHHcCC-CCCceeEEEEEecC
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD---------QTKIDEFINELVVVSQIN-RRNVVRLLACCLET 134 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~---------~~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~~ 134 (241)
..|...+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.+++.+. ||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (298)
T 1phk_A 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 96 (298)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred hccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccC
Confidence 35667789999999999999965 57889999876432 123467889999999995 99999999999999
Q ss_pred CcceEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCccc
Q 039310 135 QVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKL 214 (241)
Q Consensus 135 ~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~ 214 (241)
+..++||||+++++|.+++.....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++..
T Consensus 97 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 97 TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccchhh
Confidence 999999999999999999988888999999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCccceeeeeccccccccccccc
Q 039310 215 VPIDAIQNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 215 ~~~~~~~~~~~~~gt~~y~aPE~l~ 239 (241)
..... ......||+.|+|||++.
T Consensus 174 ~~~~~--~~~~~~~~~~y~aPE~~~ 196 (298)
T 1phk_A 174 LDPGE--KLREVCGTPSYLAPEIIE 196 (298)
T ss_dssp CCTTC--CBCCCCSCGGGCCHHHHH
T ss_pred cCCCc--ccccccCCccccCHHHhc
Confidence 64332 233456899999999874
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-32 Score=225.81 Aligned_cols=171 Identities=25% Similarity=0.392 Sum_probs=136.6
Q ss_pred hhhcccccccccCceeEEEEEe-CCCCeEEEEeccc---CChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKI---VDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVY 141 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~---~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~ 141 (241)
..|.+.+.||+|+||.||+|.. .++..||+|.+.. .+......+.+|+.+++.++||||+++++++...+..+++|
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 4577888999999999999985 4688999998764 23455678899999999999999999999999999999999
Q ss_pred EecCCCCchHHhhc----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccC
Q 039310 142 EFVGNGTLFEHIHK----NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPI 217 (241)
Q Consensus 142 e~~~~g~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~ 217 (241)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999999864 456999999999999999999999999 99999999999999999999999999886543
Q ss_pred CccceeeeecccccccccccccC
Q 039310 218 DAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 218 ~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
.. .......||+.|+|||++.+
T Consensus 189 ~~-~~~~~~~~~~~y~aPE~~~~ 210 (310)
T 2wqm_A 189 KT-TAAHSLVGTPYYMSPERIHE 210 (310)
T ss_dssp -----------CCSSCCHHHHTT
T ss_pred CC-ccccccCCCeeEeChHHhCC
Confidence 22 12233458999999998754
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=229.72 Aligned_cols=174 Identities=28% Similarity=0.472 Sum_probs=136.8
Q ss_pred HHHHHHhhhcccccccccCceeEEEEEeCCCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcc
Q 039310 60 EEEIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVP 137 (241)
Q Consensus 60 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~ 137 (241)
..++....+.+.+.||+|+||.||+|...+ .+|+|.+... .....+.+.+|+.+++.++||||+++++++ ..+..
T Consensus 18 ~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~ 94 (289)
T 3og7_A 18 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQL 94 (289)
T ss_dssp CCBCCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSC
T ss_pred CCccCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCcc
Confidence 345556678888999999999999998643 5999987643 345567899999999999999999999965 55668
Q ss_pred eEEEEecCCCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCccccc
Q 039310 138 LLVYEFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVP 216 (241)
Q Consensus 138 ~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~ 216 (241)
++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 95 AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp EEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred EEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccc
Confidence 9999999999999999644 46999999999999999999999999 9999999999999999999999999987654
Q ss_pred CCc-cceeeeeccccccccccccc
Q 039310 217 IDA-IQNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 217 ~~~-~~~~~~~~gt~~y~aPE~l~ 239 (241)
... ........||+.|+|||++.
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~ 195 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIR 195 (289)
T ss_dssp ------------CCCTTCCHHHHC
T ss_pred cccccccccccCCCccccCchhhc
Confidence 221 22233456899999999875
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-33 Score=236.66 Aligned_cols=170 Identities=31% Similarity=0.491 Sum_probs=132.7
Q ss_pred hcccccccccCceeEEEEEeC--C--CCeEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEec-CCcceEEE
Q 039310 68 NNYADVIGCGGSGNVYKGFLP--D--RTPVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCLE-TQVPLLVY 141 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~--~--~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~-~~~~~lv~ 141 (241)
+.+.+.||+|+||.||+|.+. + ...||+|.+... +....+++.+|+.+++.++||||+++++++.. .+..++||
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~ 170 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 170 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence 456678999999999999853 2 235789987643 34566789999999999999999999998755 56789999
Q ss_pred EecCCCCchHHhhcCC-CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcc
Q 039310 142 EFVGNGTLFEHIHKNG-NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAI 220 (241)
Q Consensus 142 e~~~~g~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~ 220 (241)
||+++|+|.+++.... .+++..+..++.|++.||.|||+++ ++||||||+|||+++++.+||+|||+++.......
T Consensus 171 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 247 (373)
T 3c1x_A 171 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 247 (373)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred ECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccccccc
Confidence 9999999999997654 5899999999999999999999999 99999999999999999999999999986643322
Q ss_pred c---eeeeecccccccccccccC
Q 039310 221 Q---NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 221 ~---~~~~~~gt~~y~aPE~l~~ 240 (241)
. ......+|+.|+|||++.+
T Consensus 248 ~~~~~~~~~~~~~~y~aPE~~~~ 270 (373)
T 3c1x_A 248 DSVHNKTGAKLPVKWMALESLQT 270 (373)
T ss_dssp ----------CCGGGSCHHHHHH
T ss_pred ccccccCCCCCcccccChHHhcC
Confidence 1 1223447889999998753
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-32 Score=224.64 Aligned_cols=169 Identities=29% Similarity=0.448 Sum_probs=147.0
Q ss_pred hhcccccccccCceeEEEEEe-CCCCeEEEEecccCC-hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEec
Q 039310 67 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVD-QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
.+...+.||+|+||.||+|.. .++..||+|.+.... ....+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 102 (303)
T 3a7i_A 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 102 (303)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeC
Confidence 466778999999999999985 468899999876533 345678899999999999999999999999999999999999
Q ss_pred CCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceee
Q 039310 145 GNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYT 224 (241)
Q Consensus 145 ~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~ 224 (241)
++++|.+++.. +++++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........ ...
T Consensus 103 ~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~ 177 (303)
T 3a7i_A 103 GGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KRN 177 (303)
T ss_dssp TTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-CBC
T ss_pred CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcccc-ccC
Confidence 99999999865 47999999999999999999999999 99999999999999999999999999987643322 223
Q ss_pred eecccccccccccccC
Q 039310 225 VVQGTLGYIDPEYLQT 240 (241)
Q Consensus 225 ~~~gt~~y~aPE~l~~ 240 (241)
...||+.|+|||++.+
T Consensus 178 ~~~~~~~y~aPE~~~~ 193 (303)
T 3a7i_A 178 TFVGTPFWMAPEVIKQ 193 (303)
T ss_dssp CCCSCGGGCCHHHHTT
T ss_pred ccCCCcCccCHHHHhc
Confidence 4568999999999764
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-33 Score=224.99 Aligned_cols=168 Identities=27% Similarity=0.436 Sum_probs=143.7
Q ss_pred HHhhhcccccccccCceeEEEEEeC-CCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEec---------
Q 039310 64 KTVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLE--------- 133 (241)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~--------- 133 (241)
....+...+.||+|+||.||+|... +++.||+|.+.... +.+.+|+.+++.++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4456778889999999999999965 68899999877543 345689999999999999999999864
Q ss_pred -------CCcceEEEEecCCCCchHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCe
Q 039310 134 -------TQVPLLVYEFVGNGTLFEHIHKN--GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTP 204 (241)
Q Consensus 134 -------~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~ 204 (241)
....++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCE
Confidence 34579999999999999999654 57999999999999999999999999 9999999999999999999
Q ss_pred EEccCCCcccccCCccceeeeecccccccccccccC
Q 039310 205 KVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 205 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
||+|||++....... ......||+.|+|||++.+
T Consensus 162 kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~ 195 (284)
T 2a19_B 162 KIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISS 195 (284)
T ss_dssp EECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHC
T ss_pred EECcchhheeccccc--cccccCCcccccChhhhcc
Confidence 999999998764432 2233458999999998754
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-33 Score=229.19 Aligned_cols=175 Identities=27% Similarity=0.432 Sum_probs=135.5
Q ss_pred HHHhhhcccccccccCceeEEEEEeC----CCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCC-
Q 039310 63 IKTVTNNYADVIGCGGSGNVYKGFLP----DRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLETQ- 135 (241)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~- 135 (241)
+....+.+.+.||+|+||.||+|... ++..||+|.+... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 34556778889999999999999753 2447999987643 3445678999999999999999999999998755
Q ss_pred ----cceEEEEecCCCCchHHhh------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeE
Q 039310 136 ----VPLLVYEFVGNGTLFEHIH------KNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPK 205 (241)
Q Consensus 136 ----~~~lv~e~~~~g~L~~~l~------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~k 205 (241)
..+++|||+++++|.+++. ....+++..+..++.|++.||.|||+++ ++||||||+||++++++.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEE
Confidence 3499999999999999984 3356999999999999999999999999 99999999999999999999
Q ss_pred EccCCCcccccCCcc-ceeeeecccccccccccccC
Q 039310 206 VSDFGASKLVPIDAI-QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 206 l~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~ 240 (241)
|+|||++........ .......+++.|+|||.+.+
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 223 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD 223 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHS
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcC
Confidence 999999987643322 12233447889999998754
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=249.93 Aligned_cols=161 Identities=19% Similarity=0.121 Sum_probs=125.8
Q ss_pred cccccCceeEEEEE-eCCCCeEEEEecccC----------ChhhHHHHHHHHHHHHcC-CCCCceeEEEEEecCCcceEE
Q 039310 73 VIGCGGSGNVYKGF-LPDRTPVAVKKSKIV----------DQTKIDEFINELVVVSQI-NRRNVVRLLACCLETQVPLLV 140 (241)
Q Consensus 73 ~lg~G~~g~V~~~~-~~~~~~vavk~~~~~----------~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv 140 (241)
..+.|+.|....++ .-.|+.+++|.+... .+...+++.+|+++|+++ .|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 34556666555543 224778999976432 123456799999999999 699999999999999999999
Q ss_pred EEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcc
Q 039310 141 YEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAI 220 (241)
Q Consensus 141 ~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~ 220 (241)
|||++|++|.++|...++++.. .|+.||+.||+|+|+++ ||||||||+|||+++++.+||+|||+|+....+.
T Consensus 321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~- 393 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC- 393 (569)
T ss_dssp EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC----
T ss_pred EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCCC-
Confidence 9999999999999998888865 47899999999999999 9999999999999999999999999998765432
Q ss_pred ceeeeecccccccccccccC
Q 039310 221 QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 221 ~~~~~~~gt~~y~aPE~l~~ 240 (241)
......+||+.|||||++.+
T Consensus 394 ~~~~t~vGTp~YmAPE~l~g 413 (569)
T 4azs_A 394 SWPTNLVQSFFVFVNELFAE 413 (569)
T ss_dssp CCSHHHHHHHHHHHHHHC--
T ss_pred ccccCceechhhccHHHhCC
Confidence 23344679999999999864
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-33 Score=232.65 Aligned_cols=169 Identities=25% Similarity=0.342 Sum_probs=135.9
Q ss_pred hhcccccccccCceeEEEEEeC-CCCeEEEEecccCChhh-HHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEec
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQTK-IDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~~-~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
.|...+.||+|+||.||+|... ++..||+|.+....... ...+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (324)
T 3mtl_A 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 82 (324)
T ss_dssp SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEeccc
Confidence 4567788999999999999965 68899999876433221 124557999999999999999999999999999999999
Q ss_pred CCCCchHHhhcCC-CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcccee
Q 039310 145 GNGTLFEHIHKNG-NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNY 223 (241)
Q Consensus 145 ~~g~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~ 223 (241)
+ ++|.+++...+ .+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++....... ...
T Consensus 83 ~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~~ 157 (324)
T 3mtl_A 83 D-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KTY 157 (324)
T ss_dssp S-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred c-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc-ccc
Confidence 7 58988887654 5999999999999999999999999 9999999999999999999999999987654222 223
Q ss_pred eeecccccccccccccC
Q 039310 224 TVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 224 ~~~~gt~~y~aPE~l~~ 240 (241)
....||+.|+|||++.+
T Consensus 158 ~~~~~t~~y~aPE~~~~ 174 (324)
T 3mtl_A 158 DNEVVTLWYRPPDILLG 174 (324)
T ss_dssp -----CGGGCCHHHHTT
T ss_pred ccccCcccccChhhhcC
Confidence 33468999999998754
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-33 Score=250.89 Aligned_cols=164 Identities=27% Similarity=0.398 Sum_probs=136.9
Q ss_pred cccccCceeEEEEEeC---CCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCCC
Q 039310 73 VIGCGGSGNVYKGFLP---DRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNG 147 (241)
Q Consensus 73 ~lg~G~~g~V~~~~~~---~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~g 147 (241)
.||+|+||.||+|.+. .+..||||.++.. +....+++.+|+.+++.++||||+++++++.. +..++||||+++|
T Consensus 376 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g 454 (635)
T 4fl3_A 376 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELG 454 (635)
T ss_dssp EEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTE
T ss_pred EeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCCC
Confidence 6999999999999643 4578999987653 33446789999999999999999999999965 4578999999999
Q ss_pred CchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcc--ceeee
Q 039310 148 TLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAI--QNYTV 225 (241)
Q Consensus 148 ~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~--~~~~~ 225 (241)
+|.+++.....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+..+.. .....
T Consensus 455 ~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 531 (635)
T 4fl3_A 455 PLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 531 (635)
T ss_dssp EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----------
T ss_pred CHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccC
Confidence 99999998888999999999999999999999999 99999999999999999999999999987644322 12223
Q ss_pred ecccccccccccccC
Q 039310 226 VQGTLGYIDPEYLQT 240 (241)
Q Consensus 226 ~~gt~~y~aPE~l~~ 240 (241)
..+|+.|+|||++.+
T Consensus 532 ~~~t~~y~APE~~~~ 546 (635)
T 4fl3_A 532 GKWPVKWYAPECINY 546 (635)
T ss_dssp ---CGGGSCHHHHHH
T ss_pred CCCceeeeChhhhcC
Confidence 346889999998753
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-32 Score=227.34 Aligned_cols=182 Identities=23% Similarity=0.269 Sum_probs=148.8
Q ss_pred cccccCHHHHHHhhhccc-ccccccCceeEEEEEeC-CCCeEEEEecccC--ChhhHHHHHHHHHHHHcCC-CCCceeEE
Q 039310 54 KAKIFIEEEIKTVTNNYA-DVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV--DQTKIDEFINELVVVSQIN-RRNVVRLL 128 (241)
Q Consensus 54 ~~~~~~~~~~~~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~-h~ni~~l~ 128 (241)
....+...+.....|.+. +.||+|+||.||+|... +++.||+|.+... .......+.+|+.+++.++ ||||++++
T Consensus 16 ~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~ 95 (327)
T 3lm5_A 16 ENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95 (327)
T ss_dssp CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred hhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence 334455555556666665 78999999999999865 5889999987642 2334578899999999994 69999999
Q ss_pred EEEecCCcceEEEEecCCCCchHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC---CCC
Q 039310 129 ACCLETQVPLLVYEFVGNGTLFEHIHKN--GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDE---NYT 203 (241)
Q Consensus 129 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~---~~~ 203 (241)
+++...+..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+++ ++||||||+|||++. ++.
T Consensus 96 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~ 172 (327)
T 3lm5_A 96 EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGD 172 (327)
T ss_dssp EEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCC
T ss_pred EEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCc
Confidence 9999999999999999999999998653 57999999999999999999999999 999999999999997 789
Q ss_pred eEEccCCCcccccCCccceeeeecccccccccccccC
Q 039310 204 PKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 204 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
+||+|||++....... ......||+.|+|||++.+
T Consensus 173 ~kL~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~ 207 (327)
T 3lm5_A 173 IKIVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNY 207 (327)
T ss_dssp EEECCGGGCEEC-----------CCCGGGCCHHHHTT
T ss_pred EEEeeCccccccCCcc--ccccccCCcCccCCeeecC
Confidence 9999999998764322 2334569999999998764
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-33 Score=230.18 Aligned_cols=175 Identities=26% Similarity=0.340 Sum_probs=146.4
Q ss_pred HHHhhhcccccccccCceeEEEEEe------CCCCeEEEEecccC-ChhhHHHHHHHHHHHHcC-CCCCceeEEEEEecC
Q 039310 63 IKTVTNNYADVIGCGGSGNVYKGFL------PDRTPVAVKKSKIV-DQTKIDEFINELVVVSQI-NRRNVVRLLACCLET 134 (241)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~ 134 (241)
+....+.+.+.||+|+||.||+|.+ .++..||+|.+... .....+.+.+|+.+++.+ +||||+++++++...
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 103 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 103 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence 3455677888999999999999973 24678999987653 334556889999999999 799999999998775
Q ss_pred C-cceEEEEecCCCCchHHhhcCCC----------------CCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCee
Q 039310 135 Q-VPLLVYEFVGNGTLFEHIHKNGN----------------LTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANIL 197 (241)
Q Consensus 135 ~-~~~lv~e~~~~g~L~~~l~~~~~----------------l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nil 197 (241)
+ ..+++|||+++++|.+++..... +++..+..++.|++.||.|||+.+ ++||||||+||+
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil 180 (316)
T 2xir_A 104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNIL 180 (316)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEE
Confidence 4 58999999999999999986543 899999999999999999999999 999999999999
Q ss_pred eCCCCCeEEccCCCcccccCCcc-ceeeeecccccccccccccC
Q 039310 198 LDENYTPKVSDFGASKLVPIDAI-QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 198 i~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~ 240 (241)
++.++.+||+|||++........ .......||+.|+|||++.+
T Consensus 181 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 224 (316)
T 2xir_A 181 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD 224 (316)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH
T ss_pred ECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcc
Confidence 99999999999999987643322 22333458899999998743
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-32 Score=224.34 Aligned_cols=164 Identities=26% Similarity=0.356 Sum_probs=139.7
Q ss_pred ccccccCceeEEEEEe-CCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCCCCch
Q 039310 72 DVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLF 150 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~g~L~ 150 (241)
..||+|+||.||+|.. .++..||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||+++++|.
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence 3799999999999985 457889999887666666678999999999999999999999999999999999999999999
Q ss_pred HHhhcCC---CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC-CCCeEEccCCCcccccCCccceeeee
Q 039310 151 EHIHKNG---NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDE-NYTPKVSDFGASKLVPIDAIQNYTVV 226 (241)
Q Consensus 151 ~~l~~~~---~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~-~~~~kl~Dfgla~~~~~~~~~~~~~~ 226 (241)
+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++. ++.+||+|||++....... ......
T Consensus 108 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 183 (295)
T 2clq_A 108 ALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-PCTETF 183 (295)
T ss_dssp HHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC------CCC
T ss_pred HHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC-Cccccc
Confidence 9997652 4678999999999999999999999 999999999999987 8999999999998764322 122334
Q ss_pred ccccccccccccc
Q 039310 227 QGTLGYIDPEYLQ 239 (241)
Q Consensus 227 ~gt~~y~aPE~l~ 239 (241)
.||+.|+|||++.
T Consensus 184 ~~~~~y~aPE~~~ 196 (295)
T 2clq_A 184 TGTLQYMAPEIID 196 (295)
T ss_dssp CCCGGGCCHHHHH
T ss_pred CCCccccChhhhc
Confidence 6899999999874
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-32 Score=221.09 Aligned_cols=167 Identities=32% Similarity=0.532 Sum_probs=140.2
Q ss_pred hhhcccccccccCceeEEEEEe-CCCCeEEEEecccCChh-------hHHHHHHHHHHHHcCCCCCceeEEEEEecCCcc
Q 039310 66 VTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVDQT-------KIDEFINELVVVSQINRRNVVRLLACCLETQVP 137 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~~~-------~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~ 137 (241)
..+.+.+.||+|+||.||+|.. .++..||+|.+...... ..+.+.+|+.+++.++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 4577788999999999999986 46889999987543221 1167889999999999999999999987654
Q ss_pred eEEEEecCCCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCC-----eEEccCCC
Q 039310 138 LLVYEFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYT-----PKVSDFGA 211 (241)
Q Consensus 138 ~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~-----~kl~Dfgl 211 (241)
++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ .+++||||||+|||++.++. +||+|||+
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~ 175 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL 175 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCTT
T ss_pred eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCCc
Confidence 6999999999998888654 47999999999999999999999975 45999999999999988776 99999999
Q ss_pred cccccCCccceeeeeccccccccccccc
Q 039310 212 SKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 212 a~~~~~~~~~~~~~~~gt~~y~aPE~l~ 239 (241)
+..... ......||+.|+|||++.
T Consensus 176 ~~~~~~----~~~~~~g~~~y~aPE~~~ 199 (287)
T 4f0f_A 176 SQQSVH----SVSGLLGNFQWMAPETIG 199 (287)
T ss_dssp CBCCSS----CEECCCCCCTTSCGGGSS
T ss_pred cccccc----cccccCCCccccCchhhc
Confidence 975432 233456999999999983
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-33 Score=232.19 Aligned_cols=171 Identities=30% Similarity=0.332 Sum_probs=140.5
Q ss_pred HhhhcccccccccCceeEEEEEeC-CCCeEEEEecccCChh-----hHHHHHHHHHHHHcCCCCCceeEEEEEecCCcce
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQT-----KIDEFINELVVVSQINRRNVVRLLACCLETQVPL 138 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~-----~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~ 138 (241)
...|...+.||+|+||.||+|... +++.||+|.+...... ..+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 345777889999999999999964 5889999987643221 1246789999999999999999999999999999
Q ss_pred EEEEecCCCCchHHhhcCC-CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccC
Q 039310 139 LVYEFVGNGTLFEHIHKNG-NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPI 217 (241)
Q Consensus 139 lv~e~~~~g~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~ 217 (241)
+||||+++ +|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.....
T Consensus 89 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164 (346)
T ss_dssp EEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred EEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccceeccC
Confidence 99999976 8888887653 6899999999999999999999999 99999999999999999999999999987643
Q ss_pred CccceeeeecccccccccccccC
Q 039310 218 DAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 218 ~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
.. .......||+.|+|||++.+
T Consensus 165 ~~-~~~~~~~~t~~y~aPE~~~~ 186 (346)
T 1ua2_A 165 PN-RAYTHQVVTRWYRAPELLFG 186 (346)
T ss_dssp CC-CCCCCSCCCCTTCCHHHHTT
T ss_pred Cc-ccCCcccccccccCchHhhC
Confidence 22 22334568999999998753
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-32 Score=224.75 Aligned_cols=171 Identities=33% Similarity=0.484 Sum_probs=139.6
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEec-----------
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLE----------- 133 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~----------- 133 (241)
..|.+.+.||+|+||.||+|... ++..||+|.+.. .....+.+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 45677889999999999999954 688999998754 34455788999999999999999999999865
Q ss_pred --CCcceEEEEecCCCCchHHhhcCC-CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCC
Q 039310 134 --TQVPLLVYEFVGNGTLFEHIHKNG-NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFG 210 (241)
Q Consensus 134 --~~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfg 210 (241)
.+..++||||+++++|.+++.... .+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCC
T ss_pred ccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEeeCc
Confidence 356789999999999999998544 6889999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCc-------------cceeeeecccccccccccccC
Q 039310 211 ASKLVPIDA-------------IQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 211 la~~~~~~~-------------~~~~~~~~gt~~y~aPE~l~~ 240 (241)
++....... ........||+.|+|||++.+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 204 (303)
T 1zy4_A 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDG 204 (303)
T ss_dssp CCSCTTC-------------------------CTTSCHHHHTS
T ss_pred chhhcccccchhccccccccccccccccCCCcccccCcccccC
Confidence 988653211 112234458999999998753
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-32 Score=223.06 Aligned_cols=169 Identities=26% Similarity=0.449 Sum_probs=142.0
Q ss_pred hhcccc-cccccCceeEEEEEeC---CCCeEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEE
Q 039310 67 TNNYAD-VIGCGGSGNVYKGFLP---DRTPVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVY 141 (241)
Q Consensus 67 ~~~~~~-~lg~G~~g~V~~~~~~---~~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~ 141 (241)
.+.+.+ .||+|+||.||+|.+. ++..||+|.+... .....+.+.+|+.+++.++||||+++++++ ..+..++||
T Consensus 10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~ 88 (287)
T 1u59_A 10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVM 88 (287)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEE
T ss_pred HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEE
Confidence 344444 8999999999999853 5778999988764 345567899999999999999999999999 456689999
Q ss_pred EecCCCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcc
Q 039310 142 EFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAI 220 (241)
Q Consensus 142 e~~~~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~ 220 (241)
||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 165 (287)
T 1u59_A 89 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 165 (287)
T ss_dssp ECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred EeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccCcc
Confidence 999999999999654 46999999999999999999999999 99999999999999999999999999987643322
Q ss_pred c--eeeeeccccccccccccc
Q 039310 221 Q--NYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 221 ~--~~~~~~gt~~y~aPE~l~ 239 (241)
. ......+|+.|+|||++.
T Consensus 166 ~~~~~~~~~~~~~y~aPE~~~ 186 (287)
T 1u59_A 166 YYTARSAGKWPLKWYAPECIN 186 (287)
T ss_dssp EECCCCSSCCCGGGCCHHHHH
T ss_pred eeeccccccccccccCHHHhc
Confidence 2 122234689999999875
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-33 Score=233.50 Aligned_cols=173 Identities=20% Similarity=0.249 Sum_probs=138.3
Q ss_pred HHhhhcccccccccCceeEEEEEeC----CCCeEEEEecccCChh-----------hHHHHHHHHHHHHcCCCCCceeEE
Q 039310 64 KTVTNNYADVIGCGGSGNVYKGFLP----DRTPVAVKKSKIVDQT-----------KIDEFINELVVVSQINRRNVVRLL 128 (241)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavk~~~~~~~~-----------~~~~~~~E~~~l~~l~h~ni~~l~ 128 (241)
....|.+.+.||+|+||.||+|... ++..+|+|........ ....+.+|+..++.++||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 3456778889999999999999965 5678999987653321 113466788999999999999999
Q ss_pred EEEec----CCcceEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC--
Q 039310 129 ACCLE----TQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENY-- 202 (241)
Q Consensus 129 ~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~-- 202 (241)
+++.. ....++||||+ +++|.+++...+.+++..+..++.|++.||.|||+++ ++||||||+|||++.++
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSSTT
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCCC
Confidence 99987 77899999999 8999999988778999999999999999999999998 99999999999998877
Q ss_pred CeEEccCCCcccccCCccc------eeeeecccccccccccccC
Q 039310 203 TPKVSDFGASKLVPIDAIQ------NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 203 ~~kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~l~~ 240 (241)
.+||+|||+|+.+...... ......||+.|+|||++.+
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 234 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG 234 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcC
Confidence 9999999999876432211 1133469999999998764
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-33 Score=228.20 Aligned_cols=170 Identities=23% Similarity=0.345 Sum_probs=142.1
Q ss_pred HhhhcccccccccCceeEEEEEeC-CCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
...|.+.+.||+|+||.||+|... ++..||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 345777889999999999999965 4888999988766666678899999999999999999999999999999999999
Q ss_pred cCCCCchHHhhc-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccce
Q 039310 144 VGNGTLFEHIHK-NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQN 222 (241)
Q Consensus 144 ~~~g~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~ 222 (241)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++...... ...
T Consensus 98 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~ 173 (302)
T 2j7t_A 98 CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-LQK 173 (302)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-HHC
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc-ccc
Confidence 999999998865 457999999999999999999999999 999999999999999999999999987643211 112
Q ss_pred eeeecccccccccccc
Q 039310 223 YTVVQGTLGYIDPEYL 238 (241)
Q Consensus 223 ~~~~~gt~~y~aPE~l 238 (241)
.....||+.|+|||++
T Consensus 174 ~~~~~~~~~y~aPE~~ 189 (302)
T 2j7t_A 174 RDSFIGTPYWMAPEVV 189 (302)
T ss_dssp -----CCGGGCCHHHH
T ss_pred cccccCChhhcCCeee
Confidence 2334689999999987
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-32 Score=227.99 Aligned_cols=169 Identities=24% Similarity=0.335 Sum_probs=141.3
Q ss_pred HHhhhcccccccccCceeEEEEEeC-CCCeEEEEecccCC--------hhhHHHHHHHHHHHHcCCCCCceeEEEEEecC
Q 039310 64 KTVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD--------QTKIDEFINELVVVSQINRRNVVRLLACCLET 134 (241)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~--------~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 134 (241)
....|.+.+.||+|+||.||+|... ++..||||.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3456788899999999999999864 57889999875421 12234578999999999999999999998766
Q ss_pred CcceEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCC---eEEccCCC
Q 039310 135 QVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYT---PKVSDFGA 211 (241)
Q Consensus 135 ~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~---~kl~Dfgl 211 (241)
+ .++||||+++++|.+++.....+++..+..++.|++.||.|||+++ ++||||||+|||++.++. +||+|||+
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred c-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 5 7999999999999999988888999999999999999999999999 999999999999987654 99999999
Q ss_pred cccccCCccceeeeecccccccccccc
Q 039310 212 SKLVPIDAIQNYTVVQGTLGYIDPEYL 238 (241)
Q Consensus 212 a~~~~~~~~~~~~~~~gt~~y~aPE~l 238 (241)
+....... ......||+.|+|||++
T Consensus 164 ~~~~~~~~--~~~~~~gt~~y~aPE~~ 188 (322)
T 2ycf_A 164 SKILGETS--LMRTLCGTPTYLAPEVL 188 (322)
T ss_dssp CEECCCCH--HHHHHHSCCTTCCHHHH
T ss_pred ceeccccc--ccccccCCcCccCchhh
Confidence 98764322 22334589999999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2e-32 Score=224.05 Aligned_cols=171 Identities=27% Similarity=0.375 Sum_probs=142.1
Q ss_pred hhhcccc-cccccCceeEEEEEe---CCCCeEEEEecccCC--hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceE
Q 039310 66 VTNNYAD-VIGCGGSGNVYKGFL---PDRTPVAVKKSKIVD--QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLL 139 (241)
Q Consensus 66 ~~~~~~~-~lg~G~~g~V~~~~~---~~~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~l 139 (241)
..+.+.+ .||+|+||.||+|.+ .++..||+|.+.... ....+.+.+|+.+++.++||||+++++++ ..+..++
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l 94 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML 94 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence 4566666 899999999999953 246789999876532 33457899999999999999999999999 5667899
Q ss_pred EEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCc
Q 039310 140 VYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDA 219 (241)
Q Consensus 140 v~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~ 219 (241)
||||+++++|.+++.....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 95 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 171 (291)
T ss_dssp EEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred EEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeeccCC
Confidence 9999999999999998888999999999999999999999999 9999999999999999999999999998764433
Q ss_pred cce--eeeecccccccccccccC
Q 039310 220 IQN--YTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 220 ~~~--~~~~~gt~~y~aPE~l~~ 240 (241)
... .....+|+.|+|||.+.+
T Consensus 172 ~~~~~~~~~~~~~~y~aPE~~~~ 194 (291)
T 1xbb_A 172 NYYKAQTHGKWPVKWYAPECINY 194 (291)
T ss_dssp SEEEC----CCCGGGCCHHHHHH
T ss_pred CcccccccCCCCceeeChHHhcc
Confidence 221 222346789999998753
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.4e-33 Score=239.27 Aligned_cols=165 Identities=14% Similarity=0.138 Sum_probs=134.6
Q ss_pred hhcccccccccCceeEEEEEe-CCCCeEEEEeccc---CChhhHHHHHHHH---HHHHcCCCCCceeEE-------EEEe
Q 039310 67 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKI---VDQTKIDEFINEL---VVVSQINRRNVVRLL-------ACCL 132 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~---~~~~~~~~~~~E~---~~l~~l~h~ni~~l~-------~~~~ 132 (241)
.+.+.+.||+|+||+||+|.. .+++.||||.+.. ......+.+.+|+ ..++.++||||++++ +++.
T Consensus 74 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~ 153 (377)
T 3byv_A 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 153 (377)
T ss_dssp EEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEE
T ss_pred eEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhh
Confidence 455677899999999999995 4688999998763 3344567889999 455556899999998 6666
Q ss_pred cCC-----------------cceEEEEecCCCCchHHhhcCCCCCH-------HHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 039310 133 ETQ-----------------VPLLVYEFVGNGTLFEHIHKNGNLTW-------ERRLRIAAETAGVLSYLHSETNVPIIH 188 (241)
Q Consensus 133 ~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~l~~-------~~~~~~~~~i~~~l~~lh~~~~~~iiH 188 (241)
+.+ ..+++|||+ +|+|.+++...+.+++ ..+..++.|++.||.|||+++ |+|
T Consensus 154 ~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH 229 (377)
T 3byv_A 154 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVH 229 (377)
T ss_dssp CTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred ccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence 553 378999999 5799999986544444 788889999999999999999 999
Q ss_pred cCCCCCCeeeCCCCCeEEccCCCcccccCCccceeeeecccccccccccccC
Q 039310 189 RDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 189 ~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
|||||+|||++.++.+||+|||+|+... .......| +.|+|||++.+
T Consensus 230 rDikp~NIll~~~~~~kL~DFG~a~~~~----~~~~~~~g-~~y~aPE~~~~ 276 (377)
T 3byv_A 230 TYLRPVDIVLDQRGGVFLTGFEHLVRDG----ARVVSSVS-RGFEPPELEAR 276 (377)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETT----CEEECCCC-TTCCCHHHHHH
T ss_pred CCCCHHHEEEcCCCCEEEEechhheecC----CcccCCCC-cCccChhhhcc
Confidence 9999999999999999999999998642 23344567 99999998753
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=3.8e-32 Score=224.52 Aligned_cols=171 Identities=28% Similarity=0.420 Sum_probs=142.5
Q ss_pred HHhhhcccccccccCceeEEEEEeC-CCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEE
Q 039310 64 KTVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYE 142 (241)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e 142 (241)
....+...+.||+|+||.||+|... ++..||+|.+.... ..+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 3445677889999999999999865 48899999876432 34678899999999999999999999999999999999
Q ss_pred ecCCCCchHHhh-cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc
Q 039310 143 FVGNGTLFEHIH-KNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ 221 (241)
Q Consensus 143 ~~~~g~L~~~l~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~ 221 (241)
|+++++|.+++. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++....... .
T Consensus 105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-~ 180 (314)
T 3com_A 105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM-A 180 (314)
T ss_dssp CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB-S
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc-c
Confidence 999999999997 4567999999999999999999999999 9999999999999999999999999997764332 2
Q ss_pred eeeeecccccccccccccC
Q 039310 222 NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~~ 240 (241)
......||+.|+|||++.+
T Consensus 181 ~~~~~~~~~~y~aPE~~~~ 199 (314)
T 3com_A 181 KRNTVIGTPFWMAPEVIQE 199 (314)
T ss_dssp CBCCCCSCGGGCCHHHHSS
T ss_pred ccCccCCCCCccChhhcCC
Confidence 2334468999999998764
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.5e-32 Score=247.86 Aligned_cols=174 Identities=22% Similarity=0.367 Sum_probs=142.6
Q ss_pred HHHHhhhcccccccccCceeEEEEEeCC----CCeEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCc
Q 039310 62 EIKTVTNNYADVIGCGGSGNVYKGFLPD----RTPVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCLETQV 136 (241)
Q Consensus 62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~ 136 (241)
++....+.+.+.||+|+||.||+|.+.. +..||+|..... .....+.+.+|+.+++.++||||+++++++. .+.
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~ 464 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 464 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCc
Confidence 3445567778899999999999998642 456899987653 3445578999999999999999999999985 456
Q ss_pred ceEEEEecCCCCchHHhhcCC-CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccc
Q 039310 137 PLLVYEFVGNGTLFEHIHKNG-NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLV 215 (241)
Q Consensus 137 ~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~ 215 (241)
.++||||+++|+|.+++.... .+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++...
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred eEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 899999999999999998654 6999999999999999999999999 999999999999999999999999999876
Q ss_pred cCCccceeeeeccccccccccccc
Q 039310 216 PIDAIQNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 216 ~~~~~~~~~~~~gt~~y~aPE~l~ 239 (241)
............+|+.|||||++.
T Consensus 542 ~~~~~~~~~~~~~t~~y~aPE~~~ 565 (656)
T 2j0j_A 542 EDSTYYKASKGKLPIKWMAPESIN 565 (656)
T ss_dssp CC----------CCGGGCCHHHHH
T ss_pred CCCcceeccCCCCCcceeCHHHhc
Confidence 544333334445788999999875
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.3e-32 Score=223.08 Aligned_cols=169 Identities=18% Similarity=0.224 Sum_probs=143.8
Q ss_pred hhhcccccccccCceeEEEEEe-CCCCeEEEEecccCChhhHHHHHHHHHHHHcC-CCCCceeEEEEEecCCcceEEEEe
Q 039310 66 VTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVDQTKIDEFINELVVVSQI-NRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
..|.+.+.||+|+||.||+|.. .++..||+|.+.... ..+.+.+|+.+++.+ +|+|++++++++......++||||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 87 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 87 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence 4567788999999999999985 568899999875432 224577899999999 799999999999999999999999
Q ss_pred cCCCCchHHhhcCC-CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCC-----eEEccCCCcccccC
Q 039310 144 VGNGTLFEHIHKNG-NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYT-----PKVSDFGASKLVPI 217 (241)
Q Consensus 144 ~~~g~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~-----~kl~Dfgla~~~~~ 217 (241)
+ +++|.+++...+ ++++..+..++.|++.||.|||+++ ++||||||+|||++.++. +||+|||++.....
T Consensus 88 ~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~ 163 (298)
T 1csn_A 88 L-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 163 (298)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred c-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccccccc
Confidence 9 899999998654 5999999999999999999999999 999999999999987776 99999999987644
Q ss_pred Cccc------eeeeecccccccccccccC
Q 039310 218 DAIQ------NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 218 ~~~~------~~~~~~gt~~y~aPE~l~~ 240 (241)
.... ......||+.|+|||++.+
T Consensus 164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 192 (298)
T 1csn_A 164 PVTKQHIPYREKKNLSGTARYMSINTHLG 192 (298)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTT
T ss_pred ccccccccccCccCCCCCcccCCchhhcC
Confidence 3221 2334569999999998764
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-32 Score=246.82 Aligned_cols=164 Identities=25% Similarity=0.443 Sum_probs=135.7
Q ss_pred cccccCceeEEEEEeC---CCCeEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCCCC
Q 039310 73 VIGCGGSGNVYKGFLP---DRTPVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGT 148 (241)
Q Consensus 73 ~lg~G~~g~V~~~~~~---~~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~g~ 148 (241)
.||+|+||.||+|.+. ++..||||.++.. .....+++.+|+.+++.++||||+++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 6999999999999753 4567999988754 33456889999999999999999999999976 56899999999999
Q ss_pred chHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc--eeee
Q 039310 149 LFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ--NYTV 225 (241)
Q Consensus 149 L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~--~~~~ 225 (241)
|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||+++++.+||+|||+|+....+... ....
T Consensus 422 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 498 (613)
T 2ozo_A 422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 498 (613)
T ss_dssp HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----------
T ss_pred HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccC
Confidence 99999754 46999999999999999999999999 999999999999999999999999999876433221 1122
Q ss_pred ecccccccccccccC
Q 039310 226 VQGTLGYIDPEYLQT 240 (241)
Q Consensus 226 ~~gt~~y~aPE~l~~ 240 (241)
..+|+.|+|||++.+
T Consensus 499 ~~~~~~y~APE~~~~ 513 (613)
T 2ozo_A 499 GKWPLKWYAPECINF 513 (613)
T ss_dssp ---CCTTSCHHHHHH
T ss_pred CCCccceeCHhhhcC
Confidence 335689999998753
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-32 Score=229.93 Aligned_cols=167 Identities=34% Similarity=0.494 Sum_probs=134.2
Q ss_pred hhhcccccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHH--HHcCCCCCceeEEEEEec-----CCcce
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVV--VSQINRRNVVRLLACCLE-----TQVPL 138 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~--l~~l~h~ni~~l~~~~~~-----~~~~~ 138 (241)
..+.+.+.||+|+||.||+|.. ++..||||.+.... ...+..|.++ +..++||||+++++.+.. ....+
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred HHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 4567788999999999999987 67899999876432 2344445555 445899999999986543 23568
Q ss_pred EEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcC---------CCCCeEecCCCCCCeeeCCCCCeEEccC
Q 039310 139 LVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSE---------TNVPIIHRDVKSANILLDENYTPKVSDF 209 (241)
Q Consensus 139 lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~---------~~~~iiH~dlk~~Nili~~~~~~kl~Df 209 (241)
+||||+++|+|.+++.... .++..+..++.|++.||.|||+. + ++||||||+|||+++++.+||+||
T Consensus 89 lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL~DF 164 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVISDF 164 (336)
T ss_dssp EEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEECCC
T ss_pred EEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEEeec
Confidence 9999999999999997654 58999999999999999999998 7 999999999999999999999999
Q ss_pred CCcccccCCcc-------ceeeeecccccccccccccC
Q 039310 210 GASKLVPIDAI-------QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 210 gla~~~~~~~~-------~~~~~~~gt~~y~aPE~l~~ 240 (241)
|++..+..... .......||+.|+|||++.+
T Consensus 165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 202 (336)
T 3g2f_A 165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEG 202 (336)
T ss_dssp TTCEECSSSSCC---------CCTTSCGGGCCHHHHTT
T ss_pred cceeecccccccCccccccccccCCCccceeCchhhcC
Confidence 99987643221 12223459999999999864
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.8e-32 Score=225.16 Aligned_cols=166 Identities=29% Similarity=0.448 Sum_probs=133.6
Q ss_pred hhhcccccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecC
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVG 145 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~ 145 (241)
..+.+.+.||+|+||.||+|.+. +..||+|.+.. ....+.+.+|+.+++.++||||+++++++. +..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 45667789999999999999984 67899998763 334578899999999999999999999876 45899999999
Q ss_pred CCCchHHhhcCC---CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCC-eEEccCCCcccccCCccc
Q 039310 146 NGTLFEHIHKNG---NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYT-PKVSDFGASKLVPIDAIQ 221 (241)
Q Consensus 146 ~g~L~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~-~kl~Dfgla~~~~~~~~~ 221 (241)
+++|.+++.... .+++..+..++.|++.||.|||+.+..+++||||||+|||++.++. +||+|||++......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 999999998665 3789999999999999999999932222999999999999998886 799999998765322
Q ss_pred eeeeecccccccccccccC
Q 039310 222 NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~~ 240 (241)
.....||+.|+|||++.+
T Consensus 160 -~~~~~gt~~y~aPE~~~~ 177 (307)
T 2eva_A 160 -MTNNKGSAAWMAPEVFEG 177 (307)
T ss_dssp ------CCTTSSCHHHHTC
T ss_pred -cccCCCCCceEChhhhCC
Confidence 223458999999998764
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.2e-32 Score=227.45 Aligned_cols=169 Identities=30% Similarity=0.475 Sum_probs=139.5
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCe--EEEEecccC-ChhhHHHHHHHHHHHHcC-CCCCceeEEEEEecCCcceEE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTP--VAVKKSKIV-DQTKIDEFINELVVVSQI-NRRNVVRLLACCLETQVPLLV 140 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~--vavk~~~~~-~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv 140 (241)
..+.+.+.||+|+||.||+|... ++.. +++|.+... .....+.+.+|+.+++.+ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 46778889999999999999854 4544 488876642 334456788999999999 899999999999999999999
Q ss_pred EEecCCCCchHHhhcCC----------------CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCe
Q 039310 141 YEFVGNGTLFEHIHKNG----------------NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTP 204 (241)
Q Consensus 141 ~e~~~~g~L~~~l~~~~----------------~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~ 204 (241)
|||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999997654 6999999999999999999999999 9999999999999999999
Q ss_pred EEccCCCcccccCCccceeeeeccccccccccccc
Q 039310 205 KVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 205 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~ 239 (241)
||+|||++...... .......+|+.|+|||++.
T Consensus 182 kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~ 214 (327)
T 1fvr_A 182 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLN 214 (327)
T ss_dssp EECCTTCEESSCEE--CCC----CCTTTCCHHHHH
T ss_pred EEcccCcCcccccc--ccccCCCCCccccChhhhc
Confidence 99999998753221 1223344788999999875
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=9.2e-33 Score=229.74 Aligned_cols=176 Identities=24% Similarity=0.377 Sum_probs=142.8
Q ss_pred HHHHhhhcccccccccCceeEEEEEeC------CCCeEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecC
Q 039310 62 EIKTVTNNYADVIGCGGSGNVYKGFLP------DRTPVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCLET 134 (241)
Q Consensus 62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 134 (241)
++....+.+.+.||+|+||.||+|.+. ++..||+|.+... ......++.+|+.+++.++||||+++++++...
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 105 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence 344567888899999999999999842 4678999987643 345567889999999999999999999999999
Q ss_pred CcceEEEEecCCCCchHHhhcCC-------CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC---CCCe
Q 039310 135 QVPLLVYEFVGNGTLFEHIHKNG-------NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDE---NYTP 204 (241)
Q Consensus 135 ~~~~lv~e~~~~g~L~~~l~~~~-------~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~---~~~~ 204 (241)
+..++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+|||++. +..+
T Consensus 106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCE
T ss_pred CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceE
Confidence 99999999999999999998653 4899999999999999999999999 999999999999984 4469
Q ss_pred EEccCCCcccccCCcc-ceeeeecccccccccccccC
Q 039310 205 KVSDFGASKLVPIDAI-QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 205 kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~ 240 (241)
||+|||++........ .......||+.|+|||++.+
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 219 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME 219 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHH
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcC
Confidence 9999999876533222 12223457899999998753
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-32 Score=231.37 Aligned_cols=166 Identities=25% Similarity=0.306 Sum_probs=125.8
Q ss_pred hhhcccccccccCceeEEEEEe-CCCCeEEEEeccc--CChhhHHHHHHHHHHHHcCCCCCceeEEEEEecC------Cc
Q 039310 66 VTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKI--VDQTKIDEFINELVVVSQINRRNVVRLLACCLET------QV 136 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~--~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~------~~ 136 (241)
.+|...+.||+|+||.||+|.. .++..||||++.. .+....+.+.+|+.+++.++||||+++++++... ..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 4567778999999999999984 4688999998764 2344567888999999999999999999999754 56
Q ss_pred ceEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCccccc
Q 039310 137 PLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVP 216 (241)
Q Consensus 137 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~ 216 (241)
.++++|++ +++|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++...
T Consensus 109 ~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 109 VYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp CEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC--------
T ss_pred EEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 79999999 6799998875 57999999999999999999999999 9999999999999999999999999998653
Q ss_pred CCccceeeeecccccccccccccC
Q 039310 217 IDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 217 ~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
.. .....||+.|+|||++.+
T Consensus 184 ~~----~~~~~~t~~y~aPE~~~~ 203 (367)
T 2fst_X 184 DE----MTGYVATRWYRAPEIMLN 203 (367)
T ss_dssp -----------CCCTTCCHHHHTT
T ss_pred cc----CCCcCcCcCccChHHHcC
Confidence 22 233468999999998754
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=9e-33 Score=226.85 Aligned_cols=174 Identities=28% Similarity=0.446 Sum_probs=129.0
Q ss_pred HHHhhhcccccccccCceeEEEEEeC-CCCeEEEEecccCC-hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEE
Q 039310 63 IKTVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD-QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLV 140 (241)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv 140 (241)
+....|.+.+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 33456777889999999999999854 68899999876432 33456788999999999999999999999999999999
Q ss_pred EEecCCCCchHHhhc--------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCc
Q 039310 141 YEFVGNGTLFEHIHK--------NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGAS 212 (241)
Q Consensus 141 ~e~~~~g~L~~~l~~--------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla 212 (241)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccch
Confidence 999999999999863 456999999999999999999999999 999999999999999999999999998
Q ss_pred ccccCCcc----ceeeeeccccccccccccc
Q 039310 213 KLVPIDAI----QNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 213 ~~~~~~~~----~~~~~~~gt~~y~aPE~l~ 239 (241)
........ .......||+.|+|||++.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 199 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVME 199 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHH
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhc
Confidence 76543211 1123346899999999874
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.3e-32 Score=221.67 Aligned_cols=174 Identities=25% Similarity=0.364 Sum_probs=149.2
Q ss_pred HHHHhhhcccccccccCceeEEEEEeC-CCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcce
Q 039310 62 EIKTVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPL 138 (241)
Q Consensus 62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~ 138 (241)
.....+|.+.+.||+|+||.||+|... +++.||+|.+... .....+.+.+|+.+++.++||||+++++++...+..+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 344567888999999999999999865 6889999987542 2345678899999999999999999999999999999
Q ss_pred EEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC---CCeEEccCCCcccc
Q 039310 139 LVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDEN---YTPKVSDFGASKLV 215 (241)
Q Consensus 139 lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~---~~~kl~Dfgla~~~ 215 (241)
++|||+++++|.+++.....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.+ +.+||+|||++...
T Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~ 174 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (287)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence 99999999999999987778999999999999999999999999 9999999999999754 46999999998865
Q ss_pred cCCccceeeeecccccccccccccC
Q 039310 216 PIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 216 ~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
.... ......||+.|+|||++.+
T Consensus 175 ~~~~--~~~~~~~~~~y~aPE~~~~ 197 (287)
T 2wei_A 175 QQNT--KMKDRIGTAYYIAPEVLRG 197 (287)
T ss_dssp CCCS--SCSCHHHHHTTCCHHHHTT
T ss_pred cCCC--ccccccCcccccChHHhcC
Confidence 4332 2233458999999998753
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=4.9e-32 Score=228.69 Aligned_cols=169 Identities=22% Similarity=0.331 Sum_probs=142.9
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecC-----Ccce
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCLET-----QVPL 138 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~-----~~~~ 138 (241)
.+|.+.+.||+|+||.||+|... ++..||+|++... .....+.+.+|+.+++.++||||+++++++... ...+
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 106 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 106 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence 35777889999999999999854 5778999987653 344457889999999999999999999999764 3689
Q ss_pred EEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCC
Q 039310 139 LVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPID 218 (241)
Q Consensus 139 lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~ 218 (241)
++|||++ ++|.+++... .+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++......
T Consensus 107 iv~e~~~-~~L~~~l~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 107 IVQDLME-TDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181 (364)
T ss_dssp EEEECCS-EEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEEcccC-cCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence 9999997 5999988764 6999999999999999999999999 999999999999999999999999999876433
Q ss_pred ccce--eeeeccccccccccccc
Q 039310 219 AIQN--YTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 219 ~~~~--~~~~~gt~~y~aPE~l~ 239 (241)
.... .....||+.|+|||++.
T Consensus 182 ~~~~~~~~~~~gt~~y~aPE~~~ 204 (364)
T 3qyz_A 182 HDHTGFLTEYVATRWYRAPEIML 204 (364)
T ss_dssp GCBCCTTCCCCSCGGGCCHHHHH
T ss_pred CCccccccccccccCCCCCHHhc
Confidence 2211 23346999999999864
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=5.4e-32 Score=229.12 Aligned_cols=167 Identities=28% Similarity=0.327 Sum_probs=133.4
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEeccc--CChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCC------c
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKI--VDQTKIDEFINELVVVSQINRRNVVRLLACCLETQ------V 136 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~--~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~------~ 136 (241)
..|.+.+.||+|+||.||+|... ++..||||.+.. ......+.+.+|+.+++.++||||+++++++...+ .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 35677889999999999999854 588899998764 23445677889999999999999999999997665 6
Q ss_pred ceEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCccccc
Q 039310 137 PLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVP 216 (241)
Q Consensus 137 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~ 216 (241)
.++||||+++ +|.+.+.. .+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++....
T Consensus 105 ~~lv~e~~~~-~l~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 105 VYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp EEEEEECCSE-EHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred eEEEEEcCCC-CHHHHHhh--ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 7999999975 78888863 5899999999999999999999999 9999999999999999999999999998654
Q ss_pred CCccceeeeecccccccccccccC
Q 039310 217 IDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 217 ~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
.. .......||+.|+|||++.+
T Consensus 179 ~~--~~~~~~~gt~~y~aPE~~~~ 200 (371)
T 2xrw_A 179 TS--FMMTPYVVTRYYRAPEVILG 200 (371)
T ss_dssp -------------CTTCCHHHHTT
T ss_pred cc--cccCCceecCCccCHHHhcC
Confidence 22 22334569999999999764
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=5.4e-32 Score=225.23 Aligned_cols=174 Identities=25% Similarity=0.343 Sum_probs=132.3
Q ss_pred HHhhhcccccccccCceeEEEEEeC-CCCeEEEEecccCChhhHHHHHHHHHHHHcCC-CCCceeEEEEEe--------c
Q 039310 64 KTVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQTKIDEFINELVVVSQIN-RRNVVRLLACCL--------E 133 (241)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~--------~ 133 (241)
...++.+.+.||+|+||.||+|... ++..||+|.+........+.+.+|+.+++.+. ||||+++++++. .
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 3456778889999999999999954 68899999887666667788999999999996 999999999994 3
Q ss_pred CCcceEEEEecCCCCchHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCC
Q 039310 134 TQVPLLVYEFVGNGTLFEHIHK---NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFG 210 (241)
Q Consensus 134 ~~~~~lv~e~~~~g~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfg 210 (241)
....+++|||++ |+|.+++.. .+.+++..+..++.|++.||.|||+.+ .+++||||||+|||++.++.+||+|||
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCc
Confidence 345789999996 689888864 457999999999999999999999875 459999999999999999999999999
Q ss_pred CcccccCCccc-----------eeeeeccccccccccccc
Q 039310 211 ASKLVPIDAIQ-----------NYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 211 la~~~~~~~~~-----------~~~~~~gt~~y~aPE~l~ 239 (241)
++......... ......||+.|+|||++.
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 223 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIID 223 (337)
T ss_dssp TCBCCSSCC-------------------------------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhh
Confidence 99876433211 111345899999999973
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-32 Score=229.48 Aligned_cols=169 Identities=23% Similarity=0.278 Sum_probs=134.6
Q ss_pred hhhcccccccccCceeEEEEEeCCCCeEEEEecccC-----------ChhhHHHHHHHHHHHHcCCCCCceeEEEEEec-
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIV-----------DQTKIDEFINELVVVSQINRRNVVRLLACCLE- 133 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~-----------~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~- 133 (241)
..|.+.+.||+|+||.||+|...++..||||++... +....+.+.+|+.+++.++||||+++++++..
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 101 (362)
T 3pg1_A 22 SPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHF 101 (362)
T ss_dssp CSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEEC
T ss_pred cceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEec
Confidence 456777899999999999999888999999976432 22234788999999999999999999999854
Q ss_pred ----CCcceEEEEecCCCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEcc
Q 039310 134 ----TQVPLLVYEFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSD 208 (241)
Q Consensus 134 ----~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~D 208 (241)
....++||||++ |+|.+.+... ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|
T Consensus 102 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 102 EEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp CTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred cCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEEcCCCCEEEEe
Confidence 336799999997 5888887654 36999999999999999999999999 99999999999999999999999
Q ss_pred CCCcccccCCccceeeeecccccccccccccC
Q 039310 209 FGASKLVPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 209 fgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
||++....... ......||+.|+|||++.+
T Consensus 178 fg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~ 207 (362)
T 3pg1_A 178 FNLAREDTADA--NKTHYVTHRWYRAPELVMQ 207 (362)
T ss_dssp TTC-----------------CGGGCCHHHHTT
T ss_pred cCccccccccc--ccceecccceecCcHHhcC
Confidence 99997543322 2333468999999998754
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-32 Score=247.41 Aligned_cols=166 Identities=25% Similarity=0.328 Sum_probs=140.6
Q ss_pred HHhhhcccccccccCceeEEEEEeC--CCCeEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCc----
Q 039310 64 KTVTNNYADVIGCGGSGNVYKGFLP--DRTPVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCLETQV---- 136 (241)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~---- 136 (241)
...+|.+.+.||+|+||.||+|.+. ++..||||.+... +......+.+|+.+++.++||||+++++++...+.
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 3456788889999999999999864 5789999987643 34455678999999999999999999999987665
Q ss_pred -ceEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccc
Q 039310 137 -PLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLV 215 (241)
Q Consensus 137 -~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~ 215 (241)
.|+||||+++++|.+++.. .+++.++..++.|++.||.|||+++ |+||||||+|||++++ .+||+|||++...
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRI 231 (681)
T ss_dssp EEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred eeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchhc
Confidence 6999999999999988765 7999999999999999999999999 9999999999999986 8999999999876
Q ss_pred cCCccceeeeecccccccccccccC
Q 039310 216 PIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 216 ~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
... ....||+.|||||++.+
T Consensus 232 ~~~-----~~~~gt~~y~aPE~~~~ 251 (681)
T 2pzi_A 232 NSF-----GYLYGTPGFQAPEIVRT 251 (681)
T ss_dssp TCC-----SCCCCCTTTSCTTHHHH
T ss_pred ccC-----CccCCCccccCHHHHcC
Confidence 432 33469999999998754
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-32 Score=231.85 Aligned_cols=166 Identities=21% Similarity=0.278 Sum_probs=136.0
Q ss_pred HhhhcccccccccCceeEEEEEe-CCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecC---------
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLET--------- 134 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~--------- 134 (241)
..+|.+.+.||+|+||.||+|.. .++..||+|++...... ..+|+.+++.++||||+++++++...
T Consensus 6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 81 (383)
T 3eb0_A 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQ 81 (383)
T ss_dssp CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC---------
T ss_pred cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCcccccccc
Confidence 34677888999999999999985 56899999987643222 23799999999999999999998443
Q ss_pred -----------------------------CcceEEEEecCCCCchHHhh----cCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 039310 135 -----------------------------QVPLLVYEFVGNGTLFEHIH----KNGNLTWERRLRIAAETAGVLSYLHSE 181 (241)
Q Consensus 135 -----------------------------~~~~lv~e~~~~g~L~~~l~----~~~~l~~~~~~~~~~~i~~~l~~lh~~ 181 (241)
...++||||+++ +|.+.+. ....+++..+..++.|++.||.|||+.
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 160 (383)
T 3eb0_A 82 PPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL 160 (383)
T ss_dssp ----------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred cccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 347899999984 7766664 456799999999999999999999999
Q ss_pred CCCCeEecCCCCCCeeeC-CCCCeEEccCCCcccccCCccceeeeecccccccccccccC
Q 039310 182 TNVPIIHRDVKSANILLD-ENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 182 ~~~~iiH~dlk~~Nili~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
+ ++||||||+|||++ .++.+||+|||+|....... ......||+.|+|||++.+
T Consensus 161 g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~ 215 (383)
T 3eb0_A 161 G---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLG 215 (383)
T ss_dssp T---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTT
T ss_pred c---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcC
Confidence 9 99999999999997 68899999999998764332 2334468999999998754
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.7e-33 Score=225.03 Aligned_cols=166 Identities=27% Similarity=0.407 Sum_probs=135.7
Q ss_pred HHhhhcccccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecC-CcceEEEE
Q 039310 64 KTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLET-QVPLLVYE 142 (241)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~-~~~~lv~e 142 (241)
....+.+.+.||+|+||.||+|..+ +..||+|.+.... ..+.+.+|+.+++.++||||+++++++... +..++|||
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred ChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 3456778889999999999999874 7789999876432 457789999999999999999999997654 57899999
Q ss_pred ecCCCCchHHhhcCCC--CCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcc
Q 039310 143 FVGNGTLFEHIHKNGN--LTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAI 220 (241)
Q Consensus 143 ~~~~g~L~~~l~~~~~--l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~ 220 (241)
|+++++|.+++..... +++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++......
T Consensus 96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-- 170 (278)
T 1byg_A 96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 170 (278)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence 9999999999976543 899999999999999999999999 999999999999999999999999998765322
Q ss_pred ceeeeeccccccccccccc
Q 039310 221 QNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 221 ~~~~~~~gt~~y~aPE~l~ 239 (241)
.....+|+.|+|||++.
T Consensus 171 --~~~~~~~~~y~aPE~~~ 187 (278)
T 1byg_A 171 --QDTGKLPVKWTAPEALR 187 (278)
T ss_dssp -------CCTTTSCHHHHH
T ss_pred --ccCCCccccccCHHHhC
Confidence 22335789999999875
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=5.7e-32 Score=221.90 Aligned_cols=169 Identities=26% Similarity=0.354 Sum_probs=141.5
Q ss_pred hhcccccccccCceeEEEEEeC-CCCeEEEEecccCC--hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD--QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
.+...+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (299)
T 2r3i_A 4 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 83 (299)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEEEc
Confidence 4566778999999999999865 68899999876432 22346788999999999999999999999999999999999
Q ss_pred cCCCCchHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc
Q 039310 144 VGNGTLFEHIHKN--GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ 221 (241)
Q Consensus 144 ~~~g~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~ 221 (241)
++ ++|.+++... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++....... .
T Consensus 84 ~~-~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~ 158 (299)
T 2r3i_A 84 LH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-R 158 (299)
T ss_dssp CS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECSTTHHHHHCCCS-B
T ss_pred cc-CCHHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHeEEcCCCCEEECcchhhhhccCCc-c
Confidence 97 5999998765 46899999999999999999999999 9999999999999999999999999987654322 1
Q ss_pred eeeeecccccccccccccC
Q 039310 222 NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~~ 240 (241)
......||+.|+|||++.+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~ 177 (299)
T 2r3i_A 159 TYTHEVVTLWYRAPEILLG 177 (299)
T ss_dssp CTTSCBCCCTTCCHHHHTT
T ss_pred ccCcccccccccCcHHhhc
Confidence 2233458999999998754
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-32 Score=226.44 Aligned_cols=172 Identities=23% Similarity=0.408 Sum_probs=135.6
Q ss_pred HhhhcccccccccCceeEEEEEeC-CCCe----EEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcce
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFLP-DRTP----VAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPL 138 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~----vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~ 138 (241)
...|...+.||+|+||.||+|.+. ++.. |++|.+... .....+.+.+|+.+++.++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 345677889999999999999854 3443 577766432 3445678899999999999999999999998765 78
Q ss_pred EEEEecCCCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccC
Q 039310 139 LVYEFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPI 217 (241)
Q Consensus 139 lv~e~~~~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~ 217 (241)
+++|++++|+|.+++... ..+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++.....
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 899999999999999764 57999999999999999999999999 99999999999999999999999999987643
Q ss_pred Cccc-eeeeecccccccccccccC
Q 039310 218 DAIQ-NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 218 ~~~~-~~~~~~gt~~y~aPE~l~~ 240 (241)
.... ......+|+.|+|||++.+
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~ 193 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILH 193 (327)
T ss_dssp ----------CCCGGGSCHHHHHH
T ss_pred ccccccccCCCccccccCHHHHcC
Confidence 3221 2223346889999998753
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-32 Score=223.34 Aligned_cols=171 Identities=27% Similarity=0.400 Sum_probs=134.8
Q ss_pred HhhhcccccccccCceeEEEEEeC--CCC--eEEEEecccC---ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcc
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFLP--DRT--PVAVKKSKIV---DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVP 137 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~--~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~ 137 (241)
...+.+.+.||+|+||.||+|.+. ++. .||+|.+... .....+.+.+|+.+++.++||||+++++++...+ .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 456778889999999999999853 233 5899977643 3345678899999999999999999999998765 7
Q ss_pred eEEEEecCCCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCccccc
Q 039310 138 LLVYEFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVP 216 (241)
Q Consensus 138 ~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~ 216 (241)
+++|||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++....
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccccc
Confidence 8999999999999999764 46999999999999999999999999 9999999999999999999999999998764
Q ss_pred CCccc--eeeeeccccccccccccc
Q 039310 217 IDAIQ--NYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 217 ~~~~~--~~~~~~gt~~y~aPE~l~ 239 (241)
..... ......+|+.|+|||++.
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~ 197 (291)
T 1u46_A 173 QNDDHYVMQEHRKVPFAWCAPESLK 197 (291)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHH
T ss_pred ccccchhhhccCCCCceeeCchhhc
Confidence 33221 122345788999999875
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-32 Score=222.36 Aligned_cols=168 Identities=22% Similarity=0.261 Sum_probs=129.9
Q ss_pred HhhhcccccccccCceeEEEEEe-CCCCeEEEEecccCC-hh-hHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEE
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVD-QT-KIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVY 141 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~-~~-~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~ 141 (241)
...+.+.+.||+|+||.||+|.. .+++.||+|.+.... .. ..+.+.++...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 34577788999999999999985 468899999876532 22 2334445555688889999999999999999999999
Q ss_pred EecCCCCchHHhh----cCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCCeEecCCCCCCeeeCCCCCeEEccCCCccccc
Q 039310 142 EFVGNGTLFEHIH----KNGNLTWERRLRIAAETAGVLSYLHSE-TNVPIIHRDVKSANILLDENYTPKVSDFGASKLVP 216 (241)
Q Consensus 142 e~~~~g~L~~~l~----~~~~l~~~~~~~~~~~i~~~l~~lh~~-~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~ 216 (241)
||+++ +|.+++. ....+++..+..++.|++.||.|||++ + ++||||||+||+++.++.+||+|||++....
T Consensus 86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99974 8877764 356799999999999999999999997 8 9999999999999999999999999998764
Q ss_pred CCccceeeeecccccccccccc
Q 039310 217 IDAIQNYTVVQGTLGYIDPEYL 238 (241)
Q Consensus 217 ~~~~~~~~~~~gt~~y~aPE~l 238 (241)
... ......||+.|+|||++
T Consensus 162 ~~~--~~~~~~~t~~y~aPE~~ 181 (290)
T 3fme_A 162 DDV--AKDIDAGCKPYMAPERI 181 (290)
T ss_dssp ----------CCCCCCSCHHHH
T ss_pred ccc--cccccCCCccccChhhc
Confidence 332 22334699999999996
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=221.89 Aligned_cols=164 Identities=24% Similarity=0.334 Sum_probs=141.2
Q ss_pred hhhcccccccccCceeEEEEEe-CCCCeEEEEecccCChhhHHHHHHHHHHHHcCC-CCCceeEEEEEec--CCcceEEE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVDQTKIDEFINELVVVSQIN-RRNVVRLLACCLE--TQVPLLVY 141 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~--~~~~~lv~ 141 (241)
..|.+.+.||+|+||.||+|.. .++..||+|.+.... .+.+.+|+.+++.++ ||||+++++++.+ ....+++|
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 4567788999999999999984 568899999876433 467889999999997 9999999999987 56789999
Q ss_pred EecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC-CeEEccCCCcccccCCcc
Q 039310 142 EFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENY-TPKVSDFGASKLVPIDAI 220 (241)
Q Consensus 142 e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~-~~kl~Dfgla~~~~~~~~ 220 (241)
||+++++|.+++.. +++..+..++.|++.||.|||+.+ ++||||||+|||++.++ .+||+|||+|.......
T Consensus 113 e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~- 185 (330)
T 3nsz_A 113 EHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ- 185 (330)
T ss_dssp ECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC-
T ss_pred eccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC-
Confidence 99999999998854 899999999999999999999999 99999999999999776 89999999998764332
Q ss_pred ceeeeecccccccccccccC
Q 039310 221 QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 221 ~~~~~~~gt~~y~aPE~l~~ 240 (241)
......||+.|+|||++.+
T Consensus 186 -~~~~~~~~~~y~aPE~~~~ 204 (330)
T 3nsz_A 186 -EYNVRVASRYFKGPELLVD 204 (330)
T ss_dssp -CCCSCCSCGGGCCHHHHTT
T ss_pred -ccccccccccccChhhhcC
Confidence 2334468999999998754
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-32 Score=232.28 Aligned_cols=164 Identities=24% Similarity=0.320 Sum_probs=124.6
Q ss_pred cccccccCceeEEEEEeC---CCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEec--CCcceEEEEecC
Q 039310 71 ADVIGCGGSGNVYKGFLP---DRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLE--TQVPLLVYEFVG 145 (241)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~---~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~--~~~~~lv~e~~~ 145 (241)
++.||+|+||+||+|... ++..||+|.+.... ....+.+|+.+++.++||||+++++++.. ....++||||++
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~ 103 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 103 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC
Confidence 457999999999999965 47789999876432 22467899999999999999999999954 678899999996
Q ss_pred CCCchHHhhcC---------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee----CCCCCeEEccCCCc
Q 039310 146 NGTLFEHIHKN---------GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILL----DENYTPKVSDFGAS 212 (241)
Q Consensus 146 ~g~L~~~l~~~---------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili----~~~~~~kl~Dfgla 212 (241)
++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||+|
T Consensus 104 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 179 (405)
T 3rgf_A 104 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 179 (405)
T ss_dssp -EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECCTTCC
T ss_pred -CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEECCCc
Confidence 4888877521 24999999999999999999999999 9999999999999 67889999999999
Q ss_pred ccccCCcc--ceeeeecccccccccccccC
Q 039310 213 KLVPIDAI--QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 213 ~~~~~~~~--~~~~~~~gt~~y~aPE~l~~ 240 (241)
........ .......||+.|+|||++.+
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 209 (405)
T 3rgf_A 180 RLFNSPLKPLADLDPVVVTFWYRAPELLLG 209 (405)
T ss_dssp C----------------CCCTTCCHHHHTT
T ss_pred eecCCCCcccccCCCceecCcccCchhhcC
Confidence 87643211 22334568999999998764
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=219.89 Aligned_cols=171 Identities=23% Similarity=0.293 Sum_probs=140.5
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEecccCC----hhhHHHHHHHHHHHHcCCCCCceeEEEEEe--cCCcce
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD----QTKIDEFINELVVVSQINRRNVVRLLACCL--ETQVPL 138 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~----~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~--~~~~~~ 138 (241)
..|.+.+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++||||+++++++. +.+..+
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY 84 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence 35677889999999999999964 57899999876432 234577899999999999999999999984 456789
Q ss_pred EEEEecCCCCchHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCccccc
Q 039310 139 LVYEFVGNGTLFEHIHK--NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVP 216 (241)
Q Consensus 139 lv~e~~~~g~L~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~ 216 (241)
+||||++++ +.+++.. ...+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++....
T Consensus 85 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 85 MVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp EEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 999999875 7777754 346999999999999999999999999 9999999999999999999999999998764
Q ss_pred CCc-cceeeeecccccccccccccC
Q 039310 217 IDA-IQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 217 ~~~-~~~~~~~~gt~~y~aPE~l~~ 240 (241)
... ........||+.|+|||++.+
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~ 185 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANG 185 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTC
T ss_pred ccccccccccCCCCCCCcChhhccC
Confidence 321 222334568999999998753
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=221.89 Aligned_cols=169 Identities=24% Similarity=0.383 Sum_probs=136.2
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEe------------
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCL------------ 132 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~------------ 132 (241)
.+|...+.||+|+||.||+|... +++.||+|.+...+....+.+.+|+.+++.++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 35667789999999999999965 48899999888777777788999999999999999999999874
Q ss_pred --cCCcceEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC-CCCCeEEccC
Q 039310 133 --ETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLD-ENYTPKVSDF 209 (241)
Q Consensus 133 --~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~-~~~~~kl~Df 209 (241)
..+..++||||++ |+|.+++.. +++++..+..++.|++.||.|||+++ ++||||||+||+++ +++.+||+||
T Consensus 91 ~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~Df 165 (320)
T 2i6l_A 91 LTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDF 165 (320)
T ss_dssp CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEECCC
T ss_pred ccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEEccC
Confidence 3467899999997 599999865 47999999999999999999999999 99999999999997 5679999999
Q ss_pred CCcccccCCcc--ceeeeeccccccccccccc
Q 039310 210 GASKLVPIDAI--QNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 210 gla~~~~~~~~--~~~~~~~gt~~y~aPE~l~ 239 (241)
|++........ .......+|+.|+|||++.
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 197 (320)
T 2i6l_A 166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLL 197 (320)
T ss_dssp TTCBCC--------CCCGGGSCCTTCCHHHHH
T ss_pred ccccccCCCcccccccccccccccccCcHHhc
Confidence 99987642211 1122334789999999874
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.4e-32 Score=230.89 Aligned_cols=166 Identities=26% Similarity=0.299 Sum_probs=135.3
Q ss_pred HhhhcccccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCC------cce
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQ------VPL 138 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~------~~~ 138 (241)
..+|...+.||+|+||.||+|....+..+|+|++...... ..+|+.+++.++||||+++++++...+ ..+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 3457778899999999999999877777999987543221 236999999999999999999986543 378
Q ss_pred EEEEecCCCCchHHhh----cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC-CCCCeEEccCCCcc
Q 039310 139 LVYEFVGNGTLFEHIH----KNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLD-ENYTPKVSDFGASK 213 (241)
Q Consensus 139 lv~e~~~~g~L~~~l~----~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~-~~~~~kl~Dfgla~ 213 (241)
+||||++++ +...+. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++ .++.+||+|||+|+
T Consensus 115 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 115 LVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 999999864 433332 3567999999999999999999999999 99999999999999 79999999999998
Q ss_pred cccCCccceeeeecccccccccccccC
Q 039310 214 LVPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 214 ~~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
....... .....||+.|+|||++.+
T Consensus 191 ~~~~~~~--~~~~~~t~~y~aPE~~~~ 215 (394)
T 4e7w_A 191 ILIAGEP--NVSYICSRYYRAPELIFG 215 (394)
T ss_dssp ECCTTCC--CCSSCSCGGGCCHHHHTT
T ss_pred cccCCCC--CcccccCcCccCHHHHcC
Confidence 7643322 233468999999998753
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=224.80 Aligned_cols=169 Identities=21% Similarity=0.292 Sum_probs=140.6
Q ss_pred hhcccccccccCceeEEEEEeC-CCCeEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecC-----CcceE
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCLET-----QVPLL 139 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~-----~~~~l 139 (241)
.|.+.+.||+|+||.||+|... ++..||||.+... .......+.+|+.+++.++||||+++++++... ...++
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 91 (353)
T 2b9h_A 12 DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYI 91 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEE
T ss_pred ceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEE
Confidence 4667789999999999999965 5888999987653 334456788999999999999999999998654 67899
Q ss_pred EEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCc
Q 039310 140 VYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDA 219 (241)
Q Consensus 140 v~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~ 219 (241)
+|||++ ++|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.......
T Consensus 92 v~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (353)
T 2b9h_A 92 IQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166 (353)
T ss_dssp EECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccccccccc
Confidence 999997 589998876 46999999999999999999999999 9999999999999999999999999998764322
Q ss_pred cc---------eeeeecccccccccccccC
Q 039310 220 IQ---------NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 220 ~~---------~~~~~~gt~~y~aPE~l~~ 240 (241)
.. ......||+.|+|||++.+
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 196 (353)
T 2b9h_A 167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLT 196 (353)
T ss_dssp -------------CCCCCCGGGCCHHHHHS
T ss_pred ccccCccccccchhhccccccccCCeeecc
Confidence 11 1122458999999998643
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=222.92 Aligned_cols=169 Identities=28% Similarity=0.404 Sum_probs=139.3
Q ss_pred hhhcccccccccCceeEEEEEe-CCCCeEEEEecccCChhhHHHHHHHHHHHHcC-CCCCceeEEEEEec------CCcc
Q 039310 66 VTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVDQTKIDEFINELVVVSQI-NRRNVVRLLACCLE------TQVP 137 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~------~~~~ 137 (241)
..|.+.+.||+|+||.||+|.. .+++.||+|.+.... .....+.+|+.+++.+ +||||+++++++.. .+..
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~ 102 (326)
T 2x7f_A 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL 102 (326)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEE
T ss_pred CcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceE
Confidence 4567788999999999999996 468899999876533 2346788999999999 79999999999976 4678
Q ss_pred eEEEEecCCCCchHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccc
Q 039310 138 LLVYEFVGNGTLFEHIHKN--GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLV 215 (241)
Q Consensus 138 ~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~ 215 (241)
++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++...
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 179 (326)
T 2x7f_A 103 WLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179 (326)
T ss_dssp EEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCTTTC--
T ss_pred EEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCcCceec
Confidence 9999999999999999764 46999999999999999999999999 999999999999999999999999998865
Q ss_pred cCCccceeeeeccccccccccccc
Q 039310 216 PIDAIQNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 216 ~~~~~~~~~~~~gt~~y~aPE~l~ 239 (241)
.... .......||+.|+|||++.
T Consensus 180 ~~~~-~~~~~~~~~~~y~aPE~~~ 202 (326)
T 2x7f_A 180 DRTV-GRRNTFIGTPYWMAPEVIA 202 (326)
T ss_dssp ------------CCGGGCCHHHHC
T ss_pred CcCc-cccccccCCccccChhhhc
Confidence 4221 1223346899999999875
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-32 Score=222.15 Aligned_cols=174 Identities=24% Similarity=0.329 Sum_probs=142.0
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEec--CCcceEE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLE--TQVPLLV 140 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~--~~~~~lv 140 (241)
..|.+.+.||+|+||.||+|... +++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+ .+..++|
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 85 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 85 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence 35667789999999999999865 6888999987643 34556788999999999999999999998854 5688999
Q ss_pred EEecCCCCchHHhhcC----CCCCHHHHHHHHHHHHHHHHHhhcCC--CCCeEecCCCCCCeeeCCCCCeEEccCCCccc
Q 039310 141 YEFVGNGTLFEHIHKN----GNLTWERRLRIAAETAGVLSYLHSET--NVPIIHRDVKSANILLDENYTPKVSDFGASKL 214 (241)
Q Consensus 141 ~e~~~~g~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~~--~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~ 214 (241)
|||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ..+++|+||||+||++++++.+||+|||++..
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~ 165 (279)
T 2w5a_A 86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 165 (279)
T ss_dssp EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHH
T ss_pred EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhee
Confidence 9999999999999643 34999999999999999999999865 23499999999999999999999999999886
Q ss_pred ccCCccceeeeecccccccccccccC
Q 039310 215 VPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 215 ~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
...... ......||+.|+|||++.+
T Consensus 166 ~~~~~~-~~~~~~~~~~y~aPE~~~~ 190 (279)
T 2w5a_A 166 LNHDTS-FAKTFVGTPYYMSPEQMNR 190 (279)
T ss_dssp C---CH-HHHHHHSCCTTCCHHHHHC
T ss_pred eccccc-cccccCCCccccChHHhcc
Confidence 543221 1223458999999998754
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-32 Score=231.16 Aligned_cols=166 Identities=14% Similarity=0.193 Sum_probs=139.6
Q ss_pred hhhcccccccccCceeEEEEEeCC---------CCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCcee----------
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLPD---------RTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVR---------- 126 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~---------~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~---------- 126 (241)
..|.+.+.||+|+||.||+|.... +..||+|..... +.+.+|+.+++.++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 467788899999999999998653 788999987643 45778999999999999887
Q ss_pred -----EEEEEec-CCcceEEEEecCCCCchHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee
Q 039310 127 -----LLACCLE-TQVPLLVYEFVGNGTLFEHIHKN--GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILL 198 (241)
Q Consensus 127 -----l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili 198 (241)
+++++.. .+..++||||+ +++|.+++... ..+++..+..++.|++.||.|||+++ ++||||||+|||+
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl~ 192 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFV 192 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEEE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEE
Confidence 6777765 77889999999 89999999876 67999999999999999999999999 9999999999999
Q ss_pred CCCC--CeEEccCCCcccccCCccc------eeeeecccccccccccccC
Q 039310 199 DENY--TPKVSDFGASKLVPIDAIQ------NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 199 ~~~~--~~kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~l~~ 240 (241)
+.++ .+||+|||++......... ......||+.|+|||++.+
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 242 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG 242 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc
Confidence 9998 8999999999876432211 1123469999999998764
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=229.83 Aligned_cols=167 Identities=26% Similarity=0.289 Sum_probs=141.5
Q ss_pred HhhhcccccccccCceeEEEEEeC-CCCeEEEEecccCChhhHHHHHHHHHHHHcC------CCCCceeEEEEEecCCcc
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQTKIDEFINELVVVSQI------NRRNVVRLLACCLETQVP 137 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l------~h~ni~~l~~~~~~~~~~ 137 (241)
..+|.+.+.||+|+||.||+|... ++..||||.+... ......+.+|+.+++.+ +|+||+++++++...+..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 445778889999999999999854 5788999987643 34446777888888877 577999999999999999
Q ss_pred eEEEEecCCCCchHHhhcCC--CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCC--eEEccCCCcc
Q 039310 138 LLVYEFVGNGTLFEHIHKNG--NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYT--PKVSDFGASK 213 (241)
Q Consensus 138 ~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~--~kl~Dfgla~ 213 (241)
+++|||+. ++|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++. +||+|||+|.
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccce
Confidence 99999996 69999987654 4999999999999999999999998 999999999999999887 9999999997
Q ss_pred cccCCccceeeeecccccccccccccC
Q 039310 214 LVPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 214 ~~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
..... .....||+.|+|||++.+
T Consensus 251 ~~~~~----~~~~~gt~~y~aPE~~~~ 273 (429)
T 3kvw_A 251 YEHQR----VYTYIQSRFYRAPEVILG 273 (429)
T ss_dssp ETTCC----CCSSCSCGGGCCHHHHHT
T ss_pred ecCCc----ccccCCCCCccChHHHhC
Confidence 64322 233468999999998754
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=220.94 Aligned_cols=172 Identities=24% Similarity=0.356 Sum_probs=142.6
Q ss_pred HHhhhcccccccccCceeEEEEEeCCCCeEEEEecccC--ChhhHHHHHHHHHHHHcCC--CCCceeEEEEEecCCcceE
Q 039310 64 KTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIV--DQTKIDEFINELVVVSQIN--RRNVVRLLACCLETQVPLL 139 (241)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~--h~ni~~l~~~~~~~~~~~l 139 (241)
....|.+.+.||+|+||.||+|...+++.||+|.+... +....+.+.+|+.+++.++ ||||+++++++...+..++
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 34557778899999999999999888999999987643 4455678899999999997 5999999999999999999
Q ss_pred EEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCc
Q 039310 140 VYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDA 219 (241)
Q Consensus 140 v~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~ 219 (241)
+|| +.+++|.+++.....+++..+..++.|++.||.|||+++ ++||||||+|||+++ +.+||+|||++.......
T Consensus 106 v~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~ 180 (313)
T 3cek_A 106 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDT 180 (313)
T ss_dssp EEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC-----
T ss_pred EEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccccccCcc
Confidence 999 557899999998888999999999999999999999999 999999999999964 899999999998764332
Q ss_pred cc-eeeeecccccccccccccC
Q 039310 220 IQ-NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 220 ~~-~~~~~~gt~~y~aPE~l~~ 240 (241)
.. ......||+.|+|||++.+
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~ 202 (313)
T 3cek_A 181 TSVVKDSQVGTVNYMPPEAIKD 202 (313)
T ss_dssp ---------CCGGGCCHHHHTT
T ss_pred ccccccCCCCCCCcCCHHHHhh
Confidence 21 2233468999999999753
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-32 Score=225.25 Aligned_cols=174 Identities=27% Similarity=0.382 Sum_probs=138.4
Q ss_pred HHHHHHhhhcccccccccCceeEEEEEe-CCCCeEEEEecccCCh------hhHHHHHHHHHHHHcC----CCCCceeEE
Q 039310 60 EEEIKTVTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVDQ------TKIDEFINELVVVSQI----NRRNVVRLL 128 (241)
Q Consensus 60 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~~------~~~~~~~~E~~~l~~l----~h~ni~~l~ 128 (241)
..+.....|.+.+.||+|+||.||+|.. .++..||+|.+..... .....+.+|+.++..+ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 3444566788899999999999999985 4688999998765322 1223456799999988 899999999
Q ss_pred EEEecCCcceEEEEe-cCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC-CCCCeEE
Q 039310 129 ACCLETQVPLLVYEF-VGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLD-ENYTPKV 206 (241)
Q Consensus 129 ~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~-~~~~~kl 206 (241)
+++...+..+++||+ +.+++|.+++.....+++..+..++.|++.||.|||+.+ ++||||||+||+++ +++.+||
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEE
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEE
Confidence 999999999999999 788999999988888999999999999999999999999 99999999999999 8899999
Q ss_pred ccCCCcccccCCccceeeeeccccccccccccc
Q 039310 207 SDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 207 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~ 239 (241)
+|||++....... .....||+.|+|||++.
T Consensus 182 ~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~ 211 (312)
T 2iwi_A 182 IDFGSGALLHDEP---YTDFDGTRVYSPPEWIS 211 (312)
T ss_dssp CCCSSCEECCSSC---BCCCCSCTTTSCHHHHH
T ss_pred EEcchhhhcccCc---ccccCCcccccCceeee
Confidence 9999998764332 23345899999999875
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=225.80 Aligned_cols=165 Identities=24% Similarity=0.312 Sum_probs=137.7
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcc-----
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVP----- 137 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~----- 137 (241)
..|...+.||+|+||.||+|... ++..||+|.+... .......+.+|+.+++.++||||+++++++...+..
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 35667788999999999999854 5889999987653 344467889999999999999999999999887655
Q ss_pred -eEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCccccc
Q 039310 138 -LLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVP 216 (241)
Q Consensus 138 -~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~ 216 (241)
++||||++ ++|.+++.. .+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++....
T Consensus 122 ~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 122 FYLVMPFMQ-TDLQKIMGM--EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHAD 195 (371)
T ss_dssp CEEEEECCC-EEHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred EEEEEcccc-ccHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence 99999997 588888743 4999999999999999999999999 9999999999999999999999999998653
Q ss_pred CCccceeeeecccccccccccccC
Q 039310 217 IDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 217 ~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
.. .....||+.|+|||++.+
T Consensus 196 ~~----~~~~~~t~~y~aPE~~~~ 215 (371)
T 4exu_A 196 AE----MTGYVVTRWYRAPEVILS 215 (371)
T ss_dssp --------CTTCCCTTSCHHHHSC
T ss_pred cC----cCCcccCccccCHHHhcC
Confidence 22 233468999999998754
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=228.66 Aligned_cols=165 Identities=27% Similarity=0.299 Sum_probs=134.0
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecC------Ccce
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLET------QVPL 138 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~------~~~~ 138 (241)
..|...+.||+|+||.||+|.+. ++..||||++..... ...+|+++++.++||||+++++++... ...+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 35677889999999999999965 588999998764322 224799999999999999999998542 2367
Q ss_pred EEEEecCCCCchHHhh----cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC-CCeEEccCCCcc
Q 039310 139 LVYEFVGNGTLFEHIH----KNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDEN-YTPKVSDFGASK 213 (241)
Q Consensus 139 lv~e~~~~g~L~~~l~----~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~-~~~kl~Dfgla~ 213 (241)
+||||+++ ++.+.+. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 89999975 6665553 3567999999999999999999999999 9999999999999965 568999999998
Q ss_pred cccCCccceeeeecccccccccccccC
Q 039310 214 LVPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 214 ~~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
....... .....||+.|+|||++.+
T Consensus 206 ~~~~~~~--~~~~~~t~~y~aPE~~~~ 230 (420)
T 1j1b_A 206 QLVRGEP--NVSYICSRYYRAPELIFG 230 (420)
T ss_dssp ECCTTCC--CCSCCSCTTSCCHHHHTT
T ss_pred hcccCCC--ceeeeeCCCcCCHHHHcC
Confidence 7643322 233468999999998753
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=225.85 Aligned_cols=165 Identities=12% Similarity=0.061 Sum_probs=122.1
Q ss_pred hhcccccccccCceeEEEEEeC-CCCeEEEEecccCC---hhhHHHHHHHH---HHHHcCCCCCceeEE-------EEEe
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD---QTKIDEFINEL---VVVSQINRRNVVRLL-------ACCL 132 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~---~~~~~~~~~E~---~~l~~l~h~ni~~l~-------~~~~ 132 (241)
.+...+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|+ ..++. +||||++++ +++.
T Consensus 63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEE
T ss_pred eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhee
Confidence 3667789999999999999954 68899999877643 23455677785 45555 799988765 4444
Q ss_pred cC-----------------CcceEEEEecCCCCchHHhhcCC-CCCHHHH------HHHHHHHHHHHHHhhcCCCCCeEe
Q 039310 133 ET-----------------QVPLLVYEFVGNGTLFEHIHKNG-NLTWERR------LRIAAETAGVLSYLHSETNVPIIH 188 (241)
Q Consensus 133 ~~-----------------~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~------~~~~~~i~~~l~~lh~~~~~~iiH 188 (241)
.. ...++||||++ ++|.+++...+ .+++..+ ..++.|++.||.|||+++ |+|
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---ivH 217 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVH 217 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---Ccc
Confidence 33 33799999998 79999997632 3455555 677799999999999999 999
Q ss_pred cCCCCCCeeeCCCCCeEEccCCCcccccCCccceeeeecccccccccccccC
Q 039310 189 RDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 189 ~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
|||||+|||++.++.+||+|||+|..... ......+|+.|+|||++.+
T Consensus 218 rDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~ 265 (371)
T 3q60_A 218 GHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNA 265 (371)
T ss_dssp TTCSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTC
T ss_pred CcCCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccC
Confidence 99999999999999999999999986532 1223457799999999864
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-31 Score=223.32 Aligned_cols=172 Identities=21% Similarity=0.189 Sum_probs=128.8
Q ss_pred HHHHhhhcccccccccCceeEEEEEeC-CCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCc----
Q 039310 62 EIKTVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQV---- 136 (241)
Q Consensus 62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~---- 136 (241)
......|.+.+.||+|+||.||+|... ++..||||++.... .......+|+..++.++||||+++++++...+.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~ 97 (360)
T 3e3p_A 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR 97 (360)
T ss_dssp HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence 344556778889999999999999964 58899999875432 223456678888899999999999999965433
Q ss_pred ---ceEEEEecCCCCchHHh----hcCCCCCHHHHHHHHHHHHHHHHHhh--cCCCCCeEecCCCCCCeeeCC-CCCeEE
Q 039310 137 ---PLLVYEFVGNGTLFEHI----HKNGNLTWERRLRIAAETAGVLSYLH--SETNVPIIHRDVKSANILLDE-NYTPKV 206 (241)
Q Consensus 137 ---~~lv~e~~~~g~L~~~l----~~~~~l~~~~~~~~~~~i~~~l~~lh--~~~~~~iiH~dlk~~Nili~~-~~~~kl 206 (241)
.++||||+++ +|...+ .....+++..+..++.|++.||.||| +.+ ++||||||+|||++. ++.+||
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~kl 173 (360)
T 3e3p_A 98 DIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLKL 173 (360)
T ss_dssp CEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEEE
T ss_pred ceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEEE
Confidence 7899999986 544433 35567999999999999999999999 888 999999999999996 899999
Q ss_pred ccCCCcccccCCccceeeeecccccccccccccC
Q 039310 207 SDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 207 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
+|||++....... ......||+.|+|||++.+
T Consensus 174 ~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~ 205 (360)
T 3e3p_A 174 CDFGSAKKLSPSE--PNVAYICSRYYRAPELIFG 205 (360)
T ss_dssp CCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTT
T ss_pred eeCCCceecCCCC--CcccccCCcceeCHHHHcC
Confidence 9999998764332 2334468999999998743
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-31 Score=222.23 Aligned_cols=164 Identities=24% Similarity=0.312 Sum_probs=137.3
Q ss_pred hhcccccccccCceeEEEEEeC-CCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCc------c
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLETQV------P 137 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~------~ 137 (241)
.|...+.||+|+||.||+|... ++..||||.+... .....+.+.+|+.+++.++||||+++++++...+. .
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 104 (353)
T 3coi_A 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF 104 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred eEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeE
Confidence 4667788999999999999854 5889999987542 34445788999999999999999999999987654 4
Q ss_pred eEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccC
Q 039310 138 LLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPI 217 (241)
Q Consensus 138 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~ 217 (241)
+++|||++ ++|.+++.. .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 105 ~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 178 (353)
T 3coi_A 105 YLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADA 178 (353)
T ss_dssp EEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred EEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence 99999997 588888754 5999999999999999999999999 99999999999999999999999999986532
Q ss_pred CccceeeeecccccccccccccC
Q 039310 218 DAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 218 ~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
. .....||+.|+|||++.+
T Consensus 179 ~----~~~~~~t~~y~aPE~~~~ 197 (353)
T 3coi_A 179 E----MTGYVVTRWYRAPEVILS 197 (353)
T ss_dssp ---------CCSBCCSCHHHHSC
T ss_pred C----ccccccCcCcCCHHHHhC
Confidence 2 233468999999998754
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-31 Score=219.76 Aligned_cols=167 Identities=25% Similarity=0.356 Sum_probs=142.4
Q ss_pred HhhhcccccccccCceeEEEEEe--CCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCC------ceeEEEEEecCCc
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFL--PDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRN------VVRLLACCLETQV 136 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~n------i~~l~~~~~~~~~ 136 (241)
..+|.+.+.||+|+||.||+|.. .++..||+|.+... ....+.+.+|+.+++.++|+| ++++++++...+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 34677888999999999999985 35788999987643 344577889999999887654 9999999999999
Q ss_pred ceEEEEecCCCCchHHhhcCC--CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC--------------
Q 039310 137 PLLVYEFVGNGTLFEHIHKNG--NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDE-------------- 200 (241)
Q Consensus 137 ~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~-------------- 200 (241)
.++||||+ +++|.+++...+ ++++..+..++.|++.||.|||+++ ++||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccccc
Confidence 99999999 789999998765 6899999999999999999999999 999999999999987
Q ss_pred -----CCCeEEccCCCcccccCCccceeeeecccccccccccccC
Q 039310 201 -----NYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 201 -----~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
++.+||+|||++...... .....||+.|+|||++.+
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~ 208 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILA 208 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTT
T ss_pred cccccCCCceEeeCcccccCccc----cccccCCccccChHHhhC
Confidence 668999999999864322 233468999999998764
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-32 Score=225.22 Aligned_cols=172 Identities=28% Similarity=0.396 Sum_probs=145.2
Q ss_pred HHHHhhhcccccccccCceeEEEEEe-CCCCeEEEEecccCCh------hhHHHHHHHHHHHHcCC--CCCceeEEEEEe
Q 039310 62 EIKTVTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVDQ------TKIDEFINELVVVSQIN--RRNVVRLLACCL 132 (241)
Q Consensus 62 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~~------~~~~~~~~E~~~l~~l~--h~ni~~l~~~~~ 132 (241)
+.....|.+.+.||+|+||.||+|.. .++..||+|.+..... .....+.+|+.+++.++ ||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 33455677888999999999999985 4688899998754321 12245668999999996 599999999999
Q ss_pred cCCcceEEEEecCC-CCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC-CCCCeEEccCC
Q 039310 133 ETQVPLLVYEFVGN-GTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLD-ENYTPKVSDFG 210 (241)
Q Consensus 133 ~~~~~~lv~e~~~~-g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~-~~~~~kl~Dfg 210 (241)
..+..+++||++.+ ++|.+++.....+++..+..++.|++.||.|||+.+ ++||||||+|||++ +++.+||+|||
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Dfg 195 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 195 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCT
T ss_pred cCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence 99999999999976 799999988888999999999999999999999999 99999999999999 78899999999
Q ss_pred CcccccCCccceeeeeccccccccccccc
Q 039310 211 ASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 211 la~~~~~~~~~~~~~~~gt~~y~aPE~l~ 239 (241)
++....... .....||+.|+|||++.
T Consensus 196 ~~~~~~~~~---~~~~~gt~~y~aPE~~~ 221 (320)
T 3a99_A 196 SGALLKDTV---YTDFDGTRVYSPPEWIR 221 (320)
T ss_dssp TCEECCSSC---BCCCCSCGGGSCHHHHH
T ss_pred ccccccccc---ccCCCCCccCCChHHhc
Confidence 998764332 23345999999999875
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=220.72 Aligned_cols=169 Identities=28% Similarity=0.371 Sum_probs=138.8
Q ss_pred hhhcccccccccCceeEEEEEe--CCCCeEEEEecccCC--hhhHHHHHHHHHHHHcC---CCCCceeEEEEEe-----c
Q 039310 66 VTNNYADVIGCGGSGNVYKGFL--PDRTPVAVKKSKIVD--QTKIDEFINELVVVSQI---NRRNVVRLLACCL-----E 133 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l---~h~ni~~l~~~~~-----~ 133 (241)
..|.+.+.||+|+||.||+|.. .++..||+|.+.... ......+.+|+.+++.+ +||||+++++++. .
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~ 90 (326)
T 1blx_A 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 90 (326)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCC
Confidence 4567788999999999999996 457889999765422 12223456777777666 8999999999987 4
Q ss_pred CCcceEEEEecCCCCchHHhhcCC--CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCC
Q 039310 134 TQVPLLVYEFVGNGTLFEHIHKNG--NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGA 211 (241)
Q Consensus 134 ~~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgl 211 (241)
....++||||++ |+|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+
T Consensus 91 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~Dfg~ 166 (326)
T 1blx_A 91 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL 166 (326)
T ss_dssp EEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred CceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEecCcc
Confidence 567899999997 59999997653 4999999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCccceeeeecccccccccccccC
Q 039310 212 SKLVPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 212 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
+....... ......||+.|+|||++.+
T Consensus 167 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~ 193 (326)
T 1blx_A 167 ARIYSFQM--ALTSVVVTLWYRAPEVLLQ 193 (326)
T ss_dssp CCCCCGGG--GGCCCCCCCTTCCHHHHTT
T ss_pred cccccCCC--CccccccccceeCHHHHhc
Confidence 98764322 2334568999999998764
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5.5e-31 Score=215.51 Aligned_cols=169 Identities=21% Similarity=0.289 Sum_probs=137.7
Q ss_pred hhhcccccccccCceeEEEEEe-CCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEE-ecCCcceEEEEe
Q 039310 66 VTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACC-LETQVPLLVYEF 143 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~-~~~~~~~lv~e~ 143 (241)
.+|.+.+.||+|+||.||+|.. .++..||+|...... ..+.+.+|+.+++.++|++++..+..+ ...+..+++|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEc
Confidence 4577888999999999999985 568899999754322 223577899999999988766666555 667788999999
Q ss_pred cCCCCchHHhhc-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee---CCCCCeEEccCCCcccccCCc
Q 039310 144 VGNGTLFEHIHK-NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILL---DENYTPKVSDFGASKLVPIDA 219 (241)
Q Consensus 144 ~~~g~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili---~~~~~~kl~Dfgla~~~~~~~ 219 (241)
+ +++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+|||+ ++++.+||+|||++.......
T Consensus 87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~ 162 (296)
T 4hgt_A 87 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp C-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence 9 8899999974 457999999999999999999999999 9999999999999 788999999999998764432
Q ss_pred c------ceeeeecccccccccccccC
Q 039310 220 I------QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 220 ~------~~~~~~~gt~~y~aPE~l~~ 240 (241)
. .......||+.|+|||++.+
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~ 189 (296)
T 4hgt_A 163 THQHIPYRENKNLTGTARYASINTHLG 189 (296)
T ss_dssp TCCBCCCCCSCCCCSCGGGCCHHHHTT
T ss_pred cCccCCCCcccccCCCccccchHHhcC
Confidence 2 12234569999999998764
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-32 Score=227.20 Aligned_cols=174 Identities=25% Similarity=0.405 Sum_probs=141.3
Q ss_pred HHHHHHhhhcccccccccCceeEEEEEeCCCCeEEEEecccCC--hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcc
Q 039310 60 EEEIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVD--QTKIDEFINELVVVSQINRRNVVRLLACCLETQVP 137 (241)
Q Consensus 60 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~ 137 (241)
..++....+.+.+.||+|+||.||+|...+ .+++|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (319)
T 2y4i_B 27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL 104 (319)
T ss_dssp GSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred cccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence 334445667788899999999999998754 49999876432 23335677899999999999999999999999999
Q ss_pred eEEEEecCCCCchHHhhcCC-CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCccccc
Q 039310 138 LLVYEFVGNGTLFEHIHKNG-NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVP 216 (241)
Q Consensus 138 ~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~ 216 (241)
+++|||+++++|.+++...+ .+++..+..++.|++.||.|||+.+ ++||||||+||+++ ++.+||+|||++....
T Consensus 105 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 105 AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180 (319)
T ss_dssp EEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred EEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence 99999999999999998755 6999999999999999999999999 99999999999998 6799999999987643
Q ss_pred CCc----cceeeeeccccccccccccc
Q 039310 217 IDA----IQNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 217 ~~~----~~~~~~~~gt~~y~aPE~l~ 239 (241)
... ........||+.|+|||++.
T Consensus 181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~ 207 (319)
T 2y4i_B 181 VLQAGRREDKLRIQNGWLCHLAPEIIR 207 (319)
T ss_dssp -------CCSCBCCSGGGGTSCHHHHS
T ss_pred cccccccccccccCCCcccccChHHhh
Confidence 211 11223345899999999875
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.97 E-value=9e-31 Score=214.34 Aligned_cols=168 Identities=21% Similarity=0.291 Sum_probs=138.9
Q ss_pred hhcccccccccCceeEEEEEe-CCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEE-ecCCcceEEEEec
Q 039310 67 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACC-LETQVPLLVYEFV 144 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~-~~~~~~~lv~e~~ 144 (241)
.|.+.+.||+|+||.||+|.. .+++.||+|.+..... .+.+.+|+.+++.++|++++..+..+ ...+..+++|||+
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 87 (296)
T 3uzp_A 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 87 (296)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred EEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec
Confidence 466778999999999999995 5688999998654332 24578999999999988766655554 6677889999999
Q ss_pred CCCCchHHhhc-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee---CCCCCeEEccCCCcccccCCcc
Q 039310 145 GNGTLFEHIHK-NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILL---DENYTPKVSDFGASKLVPIDAI 220 (241)
Q Consensus 145 ~~g~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili---~~~~~~kl~Dfgla~~~~~~~~ 220 (241)
+++|.+++.. ...+++..+..++.|++.||.|||+++ ++||||||+|||+ ++++.+||+|||++........
T Consensus 88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (296)
T 3uzp_A 88 -GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred -CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccc
Confidence 8899999974 457999999999999999999999999 9999999999999 4888999999999987654322
Q ss_pred c------eeeeecccccccccccccC
Q 039310 221 Q------NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 221 ~------~~~~~~gt~~y~aPE~l~~ 240 (241)
. ......||+.|+|||++.+
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~ 189 (296)
T 3uzp_A 164 HQHIPYRENKNLTGTARYASINTHLG 189 (296)
T ss_dssp CCBCCCCCSCCCCSCTTTCCHHHHTT
T ss_pred ccccccccccccccccccCChhhhcC
Confidence 1 1234569999999999765
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-31 Score=225.51 Aligned_cols=169 Identities=25% Similarity=0.305 Sum_probs=139.9
Q ss_pred HHHhhhcccccccccCceeEEEEEe-CCCCeEEEEecccCChhhHHHHHHHHHHHHcCC--------CCCceeEEEEEe-
Q 039310 63 IKTVTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVDQTKIDEFINELVVVSQIN--------RRNVVRLLACCL- 132 (241)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~--------h~ni~~l~~~~~- 132 (241)
+...+|.+.+.||+|+||+||+|.. .+++.||+|.+.. .....+.+.+|+.+++.++ |+||+++++++.
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS-AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred hcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec-CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 3346688888999999999999985 4578899998764 3445577889999999985 788999999987
Q ss_pred ---cCCcceEEEEecCCCCchHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcC-CCCCeEecCCCCCCeeeCCCC----
Q 039310 133 ---ETQVPLLVYEFVGNGTLFEHIHKN--GNLTWERRLRIAAETAGVLSYLHSE-TNVPIIHRDVKSANILLDENY---- 202 (241)
Q Consensus 133 ---~~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~-~~~~iiH~dlk~~Nili~~~~---- 202 (241)
.....++||||+ ++++.+.+... ..+++..+..++.|++.||.|||++ + |+||||||+|||++.++
T Consensus 113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 113 SGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp EETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHH
T ss_pred cCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhh
Confidence 556889999999 55666666543 4699999999999999999999998 8 99999999999999775
Q ss_pred ---------------------------------------------CeEEccCCCcccccCCccceeeeeccccccccccc
Q 039310 203 ---------------------------------------------TPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEY 237 (241)
Q Consensus 203 ---------------------------------------------~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~ 237 (241)
.+||+|||+|...... .....||+.|+|||+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHH
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChh
Confidence 7999999999875422 233468999999998
Q ss_pred ccC
Q 039310 238 LQT 240 (241)
Q Consensus 238 l~~ 240 (241)
+.+
T Consensus 265 ~~~ 267 (397)
T 1wak_A 265 LIG 267 (397)
T ss_dssp HHT
T ss_pred hcC
Confidence 764
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-31 Score=229.22 Aligned_cols=164 Identities=26% Similarity=0.324 Sum_probs=128.0
Q ss_pred ccccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcC-CCCCceeEEEEEecCCcceEEEEecCCCC
Q 039310 70 YADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQI-NRRNVVRLLACCLETQVPLLVYEFVGNGT 148 (241)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~g~ 148 (241)
..+.||+|+||+||.+...++..||||.+... ..+.+.+|+.+++.+ +||||+++++++.+.+..++||||++ |+
T Consensus 19 ~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gs 94 (434)
T 2rio_A 19 SEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LN 94 (434)
T ss_dssp EEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EE
T ss_pred ccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CC
Confidence 45689999999998776667899999987542 235678899999876 89999999999999999999999996 59
Q ss_pred chHHhhcCCCC-------CHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC-------------CCeEEcc
Q 039310 149 LFEHIHKNGNL-------TWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDEN-------------YTPKVSD 208 (241)
Q Consensus 149 L~~~l~~~~~l-------~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~-------------~~~kl~D 208 (241)
|.+++...... ++..+..++.|++.||.|||+++ |+||||||+|||++.+ +.+||+|
T Consensus 95 L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~D 171 (434)
T 2rio_A 95 LQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD 171 (434)
T ss_dssp HHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECC
T ss_pred HHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEEEcc
Confidence 99999865432 23345789999999999999999 9999999999999754 4899999
Q ss_pred CCCcccccCCccc---eeeeecccccccccccccC
Q 039310 209 FGASKLVPIDAIQ---NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 209 fgla~~~~~~~~~---~~~~~~gt~~y~aPE~l~~ 240 (241)
||+|......... ......||+.|+|||++.+
T Consensus 172 FG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 206 (434)
T 2rio_A 172 FGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEE 206 (434)
T ss_dssp CTTCEECCC--------------CCTTSCHHHHSC
T ss_pred cccceecCCCCccceeeecCCCCCCCccCHHHhcc
Confidence 9999876543221 1233569999999999853
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.9e-31 Score=217.67 Aligned_cols=168 Identities=24% Similarity=0.285 Sum_probs=124.9
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEecccC-ChhhHHHHHHHHH-HHHcCCCCCceeEEEEEecCCcceEEEE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV-DQTKIDEFINELV-VVSQINRRNVVRLLACCLETQVPLLVYE 142 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~-~~~~~~~~~~E~~-~l~~l~h~ni~~l~~~~~~~~~~~lv~e 142 (241)
..+...+.||+|+||.||+|... +++.||+|.+... .......+..|.. +++.++||||+++++++...+..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 45667788999999999999964 6889999987654 3334455666666 7777899999999999999999999999
Q ss_pred ecCCCCchHHhhc-----CCCCCHHHHHHHHHHHHHHHHHhhcC-CCCCeEecCCCCCCeeeCCCCCeEEccCCCccccc
Q 039310 143 FVGNGTLFEHIHK-----NGNLTWERRLRIAAETAGVLSYLHSE-TNVPIIHRDVKSANILLDENYTPKVSDFGASKLVP 216 (241)
Q Consensus 143 ~~~~g~L~~~l~~-----~~~l~~~~~~~~~~~i~~~l~~lh~~-~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~ 216 (241)
|+++ +|.+++.. ...+++..+..++.|++.||.|||+. + ++||||||+||+++.++.+||+|||++....
T Consensus 102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 9975 88877753 56799999999999999999999998 8 9999999999999999999999999998764
Q ss_pred CCccceeeeeccccccccccccc
Q 039310 217 IDAIQNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 217 ~~~~~~~~~~~gt~~y~aPE~l~ 239 (241)
... ......||+.|+|||++.
T Consensus 178 ~~~--~~~~~~gt~~y~aPE~~~ 198 (327)
T 3aln_A 178 DSI--AKTRDAGCRPYMAPERID 198 (327)
T ss_dssp -----------------------
T ss_pred ccc--ccccCCCCccccCceeec
Confidence 322 223336999999999983
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.8e-31 Score=218.55 Aligned_cols=165 Identities=24% Similarity=0.309 Sum_probs=117.8
Q ss_pred hhhccc-ccccccCceeEEEEEeC-CCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEec----CCcceE
Q 039310 66 VTNNYA-DVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLE----TQVPLL 139 (241)
Q Consensus 66 ~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~----~~~~~l 139 (241)
..|.+. +.||+|+||.||+|... +++.||+|.+... . .........++.++||||+++++++.. ....++
T Consensus 28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 103 (336)
T 3fhr_A 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-P---KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLI 103 (336)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-H---HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-H---HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEE
Confidence 345553 47999999999999865 6889999987542 1 111223334667799999999999876 445899
Q ss_pred EEEecCCCCchHHhhcCC--CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC---CCCeEEccCCCccc
Q 039310 140 VYEFVGNGTLFEHIHKNG--NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDE---NYTPKVSDFGASKL 214 (241)
Q Consensus 140 v~e~~~~g~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~---~~~~kl~Dfgla~~ 214 (241)
||||+++|+|.+++.... .+++..+..++.|++.||.|||+++ ++||||||+|||++. ++.+||+|||++..
T Consensus 104 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~ 180 (336)
T 3fhr_A 104 IMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180 (336)
T ss_dssp EEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccccee
Confidence 999999999999998654 6999999999999999999999999 999999999999986 45599999999986
Q ss_pred ccCCccceeeeecccccccccccccC
Q 039310 215 VPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 215 ~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
.... ......||+.|+|||++.+
T Consensus 181 ~~~~---~~~~~~~t~~y~aPE~~~~ 203 (336)
T 3fhr_A 181 TTQN---ALQTPCYTPYYVAPEVLGP 203 (336)
T ss_dssp C-------------------------
T ss_pred cccc---ccccCCCCcCccChhhhCC
Confidence 5422 2234468999999999854
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.8e-31 Score=226.98 Aligned_cols=167 Identities=27% Similarity=0.340 Sum_probs=132.0
Q ss_pred hhhcccccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcC-CCCCceeEEEEEecCCcceEEEEec
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQI-NRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
..+...+.||+|+||+|+.....+++.||||++..... ..+.+|+.+++.+ +||||+++++++.+.+..|+||||+
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 34566779999999997665555788999998764322 2345799999999 7999999999999999999999999
Q ss_pred CCCCchHHhhcCC-CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC-----CCCeEEccCCCcccccCC
Q 039310 145 GNGTLFEHIHKNG-NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDE-----NYTPKVSDFGASKLVPID 218 (241)
Q Consensus 145 ~~g~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~-----~~~~kl~Dfgla~~~~~~ 218 (241)
+ |+|.+++.... ..++..+..++.|++.||.|||+.+ |+||||||+|||++. ...+||+|||+|......
T Consensus 101 ~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~ 176 (432)
T 3p23_A 101 A-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176 (432)
T ss_dssp S-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred C-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence 6 59999997654 4566677899999999999999999 999999999999953 235789999999876433
Q ss_pred cc--ceeeeeccccccccccccc
Q 039310 219 AI--QNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 219 ~~--~~~~~~~gt~~y~aPE~l~ 239 (241)
.. .......||+.|+|||++.
T Consensus 177 ~~~~~~~~~~~gt~~y~APE~l~ 199 (432)
T 3p23_A 177 RHSFSRRSGVPGTEGWIAPEMLS 199 (432)
T ss_dssp ---------CCSCTTSCCGGGTS
T ss_pred CcceeeccccCCCcCccChhhhh
Confidence 21 2234456999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-30 Score=224.98 Aligned_cols=169 Identities=19% Similarity=0.282 Sum_probs=140.2
Q ss_pred hhhcccccccccCceeEEEEEe-CCCCeEEEEecccCChhhHHHHHHHHHHHHcCCC-CCceeEEEEEecCCcceEEEEe
Q 039310 66 VTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVDQTKIDEFINELVVVSQINR-RNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h-~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
..|.+.+.||+|+||.||+|.. .++..||||....... ...+.+|+.+++.++| ++++.+..++...+..++||||
T Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~ 84 (483)
T 3sv0_A 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (483)
T ss_dssp TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEEC
Confidence 3567788999999999999985 5688999997654322 2357789999999986 5666666777788889999999
Q ss_pred cCCCCchHHhhc-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee---CCCCCeEEccCCCcccccCCc
Q 039310 144 VGNGTLFEHIHK-NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILL---DENYTPKVSDFGASKLVPIDA 219 (241)
Q Consensus 144 ~~~g~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili---~~~~~~kl~Dfgla~~~~~~~ 219 (241)
+ +++|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||+++......
T Consensus 85 ~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (483)
T 3sv0_A 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (483)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred C-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence 9 8899999975 457999999999999999999999999 9999999999999 588999999999998765432
Q ss_pred cc------eeeeecccccccccccccC
Q 039310 220 IQ------NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 220 ~~------~~~~~~gt~~y~aPE~l~~ 240 (241)
.. ......||+.|+|||++.+
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~ 187 (483)
T 3sv0_A 161 THQHIPYRENKNLTGTARYASVNTHLG 187 (483)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTT
T ss_pred cccccccccccccCCCccccCHHHhcC
Confidence 21 1224569999999999764
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-30 Score=234.03 Aligned_cols=170 Identities=26% Similarity=0.387 Sum_probs=144.4
Q ss_pred hhhcccccccccCceeEEEEEe-CCCCeEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEec------CCcc
Q 039310 66 VTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCLE------TQVP 137 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~------~~~~ 137 (241)
..|.+.+.||+|+||.||+|.. .++..||+|.+... .....+.+.+|+.+++.++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 5678889999999999999986 45889999987653 45556789999999999999999999999765 6778
Q ss_pred eEEEEecCCCCchHHhhcCC---CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCC---eEEccCCC
Q 039310 138 LLVYEFVGNGTLFEHIHKNG---NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYT---PKVSDFGA 211 (241)
Q Consensus 138 ~lv~e~~~~g~L~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~---~kl~Dfgl 211 (241)
++||||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccc
Confidence 99999999999999998654 5899999999999999999999999 999999999999997665 89999999
Q ss_pred cccccCCccceeeeecccccccccccccC
Q 039310 212 SKLVPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 212 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
+....... ......||+.|+|||++.+
T Consensus 171 a~~~~~~~--~~~~~~gt~~Y~APE~l~~ 197 (676)
T 3qa8_A 171 AKELDQGE--LCTEFVGTLQYLAPELLEQ 197 (676)
T ss_dssp CCBTTSCC--CCCCCCSCCTTCSSCSSCC
T ss_pred cccccccc--ccccccCCcccCChHHhcc
Confidence 98764332 2334569999999999864
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-30 Score=215.23 Aligned_cols=167 Identities=22% Similarity=0.278 Sum_probs=139.7
Q ss_pred HhhhcccccccccCceeEEEEEeC-CC-CeEEEEecccCChhhHHHHHHHHHHHHcCCCCC------ceeEEEEEecCCc
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFLP-DR-TPVAVKKSKIVDQTKIDEFINELVVVSQINRRN------VVRLLACCLETQV 136 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~-~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~n------i~~l~~~~~~~~~ 136 (241)
...|.+.+.||+|+||.||+|... ++ ..||+|.+... ....+.+.+|+.+++.++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 456788889999999999999854 33 68999987643 344567888999999987765 9999999999999
Q ss_pred ceEEEEecCCCCchHHhhcCC--CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee----------------
Q 039310 137 PLLVYEFVGNGTLFEHIHKNG--NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILL---------------- 198 (241)
Q Consensus 137 ~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili---------------- 198 (241)
.++||||+ ++++.+++.... .+++..+..++.|++.||.|||+++ ++||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccccc
Confidence 99999999 567777776543 6999999999999999999999998 9999999999999
Q ss_pred ---CCCCCeEEccCCCcccccCCccceeeeecccccccccccccC
Q 039310 199 ---DENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 199 ---~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
+.++.+||+|||++...... .....||+.|+|||++.+
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~ 213 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILE 213 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTT
T ss_pred ccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeec
Confidence 56789999999999864322 233469999999999864
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.6e-30 Score=216.67 Aligned_cols=167 Identities=23% Similarity=0.285 Sum_probs=139.4
Q ss_pred HhhhcccccccccCceeEEEEEeC-CCCeEEEEecccCChhhHHHHHHHHHHHHcCC-CC-----CceeEEEEEecCCcc
Q 039310 65 TVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQTKIDEFINELVVVSQIN-RR-----NVVRLLACCLETQVP 137 (241)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~-h~-----ni~~l~~~~~~~~~~ 137 (241)
...|.+.+.||+|+||+||+|... +++.||||.+.. .......+.+|+.+++.++ |+ +|+++++++...+..
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 131 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN-KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL 131 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS-SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec-cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence 356777889999999999999855 577899998764 3344567788999988885 55 499999999999999
Q ss_pred eEEEEecCCCCchHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhc--CCCCCeEecCCCCCCeeeC--CCCCeEEccCCC
Q 039310 138 LLVYEFVGNGTLFEHIHKN--GNLTWERRLRIAAETAGVLSYLHS--ETNVPIIHRDVKSANILLD--ENYTPKVSDFGA 211 (241)
Q Consensus 138 ~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~--~~~~~iiH~dlk~~Nili~--~~~~~kl~Dfgl 211 (241)
++||||++ ++|.+++... ..+++..+..++.|++.||.|||+ .+ |+||||||+|||++ .++.+||+|||+
T Consensus 132 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 132 CLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp EEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 99999996 5999999765 369999999999999999999995 56 99999999999995 477899999999
Q ss_pred cccccCCccceeeeecccccccccccccC
Q 039310 212 SKLVPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 212 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
|...... .....||+.|+|||++.+
T Consensus 208 a~~~~~~----~~~~~~t~~y~aPE~~~~ 232 (382)
T 2vx3_A 208 SCQLGQR----IYQYIQSRFYRSPEVLLG 232 (382)
T ss_dssp CEETTCC----CCSSCSCGGGCCHHHHTT
T ss_pred ceecccc----cccccCCccccChHHHcC
Confidence 9876422 233468999999999864
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.5e-30 Score=210.89 Aligned_cols=168 Identities=23% Similarity=0.298 Sum_probs=124.5
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEecccCCh-hh-HHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQ-TK-IDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYE 142 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~-~~-~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e 142 (241)
..+.+.+.||+|+||.||+|... ++..||+|.+..... .. .+.+..+..+++.++||||+++++++...+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e 104 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME 104 (318)
T ss_dssp GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence 45667789999999999999965 688999998765432 22 2344455567888899999999999999999999999
Q ss_pred ecCCCCchHHhhc-CCCCCHHHHHHHHHHHHHHHHHhhcC-CCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcc
Q 039310 143 FVGNGTLFEHIHK-NGNLTWERRLRIAAETAGVLSYLHSE-TNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAI 220 (241)
Q Consensus 143 ~~~~g~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lh~~-~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~ 220 (241)
|+ ++.+..+... ...+++..+..++.|++.||.|||++ + ++|+||||+||+++.++.+||+|||++.......
T Consensus 105 ~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~- 179 (318)
T 2dyl_A 105 LM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK- 179 (318)
T ss_dssp CC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred cc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCCc-
Confidence 99 4455555443 46799999999999999999999995 8 9999999999999999999999999997654322
Q ss_pred ceeeeeccccccccccccc
Q 039310 221 QNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 221 ~~~~~~~gt~~y~aPE~l~ 239 (241)
......||+.|+|||++.
T Consensus 180 -~~~~~~~~~~y~aPE~~~ 197 (318)
T 2dyl_A 180 -AKDRSAGCAAYMAPERID 197 (318)
T ss_dssp --------CCTTCCHHHHC
T ss_pred -cccccCCCccccChhhcc
Confidence 223345899999999984
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-30 Score=220.66 Aligned_cols=168 Identities=23% Similarity=0.306 Sum_probs=140.7
Q ss_pred HHhhhcccccccccCceeEEEEEe-CCCCeEEEEecccCChhhHHHHHHHHHHHHcCC-----------CCCceeEEEEE
Q 039310 64 KTVTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVDQTKIDEFINELVVVSQIN-----------RRNVVRLLACC 131 (241)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~-----------h~ni~~l~~~~ 131 (241)
....|.+.+.||+|+||.||+|.. .+++.||+|.+.. +....+.+.+|+.+++.++ ||||+++++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 445688889999999999999985 4688999998764 3344567889999999886 89999999998
Q ss_pred ecCC----cceEEEEecCCCCchHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcC-CCCCeEecCCCCCCeeeC-----
Q 039310 132 LETQ----VPLLVYEFVGNGTLFEHIHKN--GNLTWERRLRIAAETAGVLSYLHSE-TNVPIIHRDVKSANILLD----- 199 (241)
Q Consensus 132 ~~~~----~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~-~~~~iiH~dlk~~Nili~----- 199 (241)
...+ ..+++||++ +++|.+++... ..+++..+..++.|++.||.|||++ + ++||||||+|||++
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred hccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 7654 789999999 88999999763 4599999999999999999999998 8 99999999999994
Q ss_pred -CCCCeEEccCCCcccccCCccceeeeecccccccccccccC
Q 039310 200 -ENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 200 -~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
..+.+||+|||++...... .....||+.|+|||++.+
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~ 209 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLG 209 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHT
T ss_pred cCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhC
Confidence 4458999999999875422 233468999999998754
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-30 Score=230.28 Aligned_cols=156 Identities=16% Similarity=0.217 Sum_probs=122.7
Q ss_pred cccccccCceeEEEEEeCCCCeEEEEecccCC--------hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEE
Q 039310 71 ADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVD--------QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYE 142 (241)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~--------~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e 142 (241)
.+.||+|+||.||+|.. .+..+++|+..... ....+++.+|+++++.++||||+++..++...+..++|||
T Consensus 341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 45899999999999965 46778888643311 1123568999999999999999966666667788899999
Q ss_pred ecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccce
Q 039310 143 FVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQN 222 (241)
Q Consensus 143 ~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~ 222 (241)
|+++++|.+++.. +..++.|++.||.|||+++ |+||||||+|||+++ .+||+|||+|+.........
T Consensus 420 ~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~ 486 (540)
T 3en9_A 420 YINGKLAKDVIED--------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKA 486 (540)
T ss_dssp CCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHH
T ss_pred CCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCccccc
Confidence 9999999999976 5689999999999999999 999999999999999 99999999999875432211
Q ss_pred ------eeeecccccccccccccC
Q 039310 223 ------YTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 223 ------~~~~~gt~~y~aPE~l~~ 240 (241)
.....||+.|||||+++.
T Consensus 487 ~~~~~~~~~~~GT~~y~APEv~~~ 510 (540)
T 3en9_A 487 VDLIVFKKAVLSTHHEKFDEIWER 510 (540)
T ss_dssp HHHHHHHHHHHHHCGGGHHHHHHH
T ss_pred cchhhhhhhhcCCCCcCCHHHHHH
Confidence 234579999999999763
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.95 E-value=4.8e-28 Score=198.00 Aligned_cols=146 Identities=13% Similarity=0.069 Sum_probs=128.6
Q ss_pred HHHhhhcccccccccCceeEEEEEeC-CCCeEEEEecccCC---hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcce
Q 039310 63 IKTVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD---QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPL 138 (241)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~ 138 (241)
+...+|.+.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+..++.++||||+++++++.+.+..|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 34456888899999999999999965 48899999876532 344578899999999999999999999999999999
Q ss_pred EEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcc
Q 039310 139 LVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASK 213 (241)
Q Consensus 139 lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~ 213 (241)
+||||+++++|.+++..+ ....++..++.|++.||.|||+++ ++||||||+|||+++++.+||+++|...
T Consensus 108 lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~~~~ 177 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPATMP 177 (286)
T ss_dssp EEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCCCCT
T ss_pred EEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEeccccC
Confidence 999999999999999653 466678999999999999999999 9999999999999999999999887644
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.8e-28 Score=198.00 Aligned_cols=142 Identities=27% Similarity=0.372 Sum_probs=123.7
Q ss_pred hccc-ccccccCceeEEEEEe-CCCCeEEEEecccCChhhHHHHHHHHHHH-HcCCCCCceeEEEEEec----CCcceEE
Q 039310 68 NNYA-DVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVDQTKIDEFINELVVV-SQINRRNVVRLLACCLE----TQVPLLV 140 (241)
Q Consensus 68 ~~~~-~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~~~~~~~~~~E~~~l-~~l~h~ni~~l~~~~~~----~~~~~lv 140 (241)
|... +.||+|+||.||+|.. .++..||+|.+... ..+.+|+.++ +..+||||+++++++.. ....++|
T Consensus 19 y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv 93 (299)
T 3m2w_A 19 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 93 (299)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred hhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEE
Confidence 3343 6799999999999985 46889999987532 4566888888 56699999999999876 6778999
Q ss_pred EEecCCCCchHHhhcCC--CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC---CCCeEEccCCCcccc
Q 039310 141 YEFVGNGTLFEHIHKNG--NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDE---NYTPKVSDFGASKLV 215 (241)
Q Consensus 141 ~e~~~~g~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~---~~~~kl~Dfgla~~~ 215 (241)
|||+++++|.+++.... .+++..+..++.|++.||.|||+++ ++||||||+|||++. ++.+||+|||++...
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 170 (299)
T 3m2w_A 94 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 170 (299)
T ss_dssp ECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccccccc
Confidence 99999999999998754 6999999999999999999999999 999999999999998 788999999999876
Q ss_pred cC
Q 039310 216 PI 217 (241)
Q Consensus 216 ~~ 217 (241)
..
T Consensus 171 ~~ 172 (299)
T 3m2w_A 171 TG 172 (299)
T ss_dssp TT
T ss_pred cc
Confidence 43
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.8e-28 Score=209.11 Aligned_cols=162 Identities=15% Similarity=0.200 Sum_probs=121.5
Q ss_pred hcccccccccCceeEEEEEe-CCCCeEEEEecccCCh---hhHHHHHHHHHHHHcCCC-CCc------------------
Q 039310 68 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVDQ---TKIDEFINELVVVSQINR-RNV------------------ 124 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~~---~~~~~~~~E~~~l~~l~h-~ni------------------ 124 (241)
+...+.||+|+||.||+|.+ .+++.||||.+..... ...+.+.+|+.+++.++| +|.
T Consensus 80 ~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 159 (413)
T 3dzo_A 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKD 159 (413)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEEC
T ss_pred EEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhccc
Confidence 44567899999999999994 4688999998774322 235678899999999987 221
Q ss_pred ---eeEEEEEec-----CCcceEEEEecCCCCchHHhhc-------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 039310 125 ---VRLLACCLE-----TQVPLLVYEFVGNGTLFEHIHK-------NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHR 189 (241)
Q Consensus 125 ---~~l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~-------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~ 189 (241)
..+..++.. ....+++|+++ +++|.+++.. ...+++..+..++.|++.||.|||+++ |+||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iiHr 235 (413)
T 3dzo_A 160 PQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHT 235 (413)
T ss_dssp CC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred CCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccC
Confidence 111111111 12346677765 6799998841 234788899999999999999999999 9999
Q ss_pred CCCCCCeeeCCCCCeEEccCCCcccccCCccceeeeecccccccccccc
Q 039310 190 DVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYL 238 (241)
Q Consensus 190 dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l 238 (241)
||||+|||++.++.+||+|||+++..... .....| +.|||||++
T Consensus 236 DiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~ 279 (413)
T 3dzo_A 236 YLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETT 279 (413)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHH
T ss_pred CcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhh
Confidence 99999999999999999999998865322 344467 999999998
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.7e-28 Score=196.05 Aligned_cols=141 Identities=16% Similarity=0.155 Sum_probs=113.3
Q ss_pred ccccccccCceeEEEEEeCCCCeEEEEecccCCh------------------hhHHHHHHHHHHHHcCCCCCceeEEEEE
Q 039310 70 YADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQ------------------TKIDEFINELVVVSQINRRNVVRLLACC 131 (241)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~------------------~~~~~~~~E~~~l~~l~h~ni~~l~~~~ 131 (241)
+.+.||+|+||.||+|.+.++..||+|....... .....+.+|+.+++.++| +++.+++
T Consensus 94 ~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~~~~ 170 (282)
T 1zar_A 94 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVPKVY 170 (282)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSCCEE
T ss_pred ecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcCeEE
Confidence 4578999999999999987789999998754221 134678899999999994 5555544
Q ss_pred ecCCcceEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCC
Q 039310 132 LETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGA 211 (241)
Q Consensus 132 ~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgl 211 (241)
. .+..++||||+++++|.+ +.. .....++.|++.||.|||+.+ ++||||||+|||++ ++.+||+|||+
T Consensus 171 ~-~~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~~vkl~DFG~ 238 (282)
T 1zar_A 171 A-WEGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQ 238 (282)
T ss_dssp E-EETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TTEEEECCCTT
T ss_pred e-ccceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CCcEEEEECCC
Confidence 3 356799999999999988 422 234579999999999999999 99999999999999 99999999999
Q ss_pred cccccCCccceeeeeccccccccccccc
Q 039310 212 SKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 212 a~~~~~~~~~~~~~~~gt~~y~aPE~l~ 239 (241)
|.. +..++|||++.
T Consensus 239 a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 239 SVE--------------VGEEGWREILE 252 (282)
T ss_dssp CEE--------------TTSTTHHHHHH
T ss_pred CeE--------------CCCCCHHHHHH
Confidence 874 33467777654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.9e-23 Score=168.27 Aligned_cols=137 Identities=21% Similarity=0.206 Sum_probs=106.4
Q ss_pred hcccccccccCceeEEEEEe-CCCCe--EEEEecccCCh------------------------hhHHHHHHHHHHHHcCC
Q 039310 68 NNYADVIGCGGSGNVYKGFL-PDRTP--VAVKKSKIVDQ------------------------TKIDEFINELVVVSQIN 120 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~-~~~~~--vavk~~~~~~~------------------------~~~~~~~~E~~~l~~l~ 120 (241)
+.+.+.||+|+||.||+|.. .++.. ||||....... .....+.+|+..++.++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 34567899999999999997 67888 99997543211 11236789999999998
Q ss_pred CCCc--eeEEEEEecCCcceEEEEecCC-C----CchHHhhcCCCCCHHHHHHHHHHHHHHHHHhh-cCCCCCeEecCCC
Q 039310 121 RRNV--VRLLACCLETQVPLLVYEFVGN-G----TLFEHIHKNGNLTWERRLRIAAETAGVLSYLH-SETNVPIIHRDVK 192 (241)
Q Consensus 121 h~ni--~~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh-~~~~~~iiH~dlk 192 (241)
|+|+ +.++.+ +..++||||+.+ | +|.+.... .++..+..++.|++.+|.||| +.+ ++|||||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrDlk 198 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAE---LVHADLS 198 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSC---EECSSCS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCC---EEeCCCC
Confidence 8754 444443 367899999942 3 56655432 235567899999999999999 888 9999999
Q ss_pred CCCeeeCCCCCeEEccCCCccccc
Q 039310 193 SANILLDENYTPKVSDFGASKLVP 216 (241)
Q Consensus 193 ~~Nili~~~~~~kl~Dfgla~~~~ 216 (241)
|+|||+++ .++|+|||+|....
T Consensus 199 p~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 199 EYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp TTSEEESS--SEEECCCTTCEETT
T ss_pred HHHEEEcC--cEEEEECcccccCC
Confidence 99999998 99999999998653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.78 E-value=3.8e-20 Score=155.77 Aligned_cols=134 Identities=16% Similarity=0.155 Sum_probs=99.1
Q ss_pred hcccccccccCceeEEEEEeCCCCeEEEEecccCC--------------hhhH--------HHHHHHHHHHHcCCCCCce
Q 039310 68 NNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVD--------------QTKI--------DEFINELVVVSQINRRNVV 125 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~--------------~~~~--------~~~~~E~~~l~~l~h~ni~ 125 (241)
|.+...||+|++|.||+|...+|..||||..+... .... -...+|...|..+.++++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 55677999999999999998889999999754210 0000 1234577777777655443
Q ss_pred --eEEEEEecCCcceEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC-
Q 039310 126 --RLLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENY- 202 (241)
Q Consensus 126 --~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~- 202 (241)
..+.+ ...++||||++|++|..+... .....++.|++.+|.|||+.+ +|||||||.|||+++++
T Consensus 177 vp~p~~~----~~~~LVME~i~G~~L~~l~~~------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd 243 (397)
T 4gyi_A 177 VPEPIAQ----SRHTIVMSLVDALPMRQVSSV------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKD 243 (397)
T ss_dssp CCCEEEE----ETTEEEEECCSCEEGGGCCCC------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEEC
T ss_pred CCeeeec----cCceEEEEecCCccHhhhccc------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCC
Confidence 22322 234799999998888665422 234568899999999999999 99999999999998776
Q ss_pred ---------CeEEccCCCccc
Q 039310 203 ---------TPKVSDFGASKL 214 (241)
Q Consensus 203 ---------~~kl~Dfgla~~ 214 (241)
.+.|+||+-+..
T Consensus 244 ~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SSCTTSEEEEEEECCCTTCEE
T ss_pred cccccccccceEEEEeCCccc
Confidence 389999997654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=2.4e-14 Score=114.88 Aligned_cols=141 Identities=14% Similarity=0.068 Sum_probs=108.1
Q ss_pred hcccccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCC-CCCceeEEEEEecCCcceEEEEecCC
Q 039310 68 NNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQIN-RRNVVRLLACCLETQVPLLVYEFVGN 146 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~~~~~~lv~e~~~~ 146 (241)
+.+...++.|+.+.||+.... +..+++|............+.+|+.+++.+. +..++++++++...+..|+|||+++|
T Consensus 16 ~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 94 (263)
T 3tm0_A 16 YRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADG 94 (263)
T ss_dssp SEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSS
T ss_pred ceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCC
Confidence 445566788888999998864 6789999866422122345788999999984 67889999999988899999999999
Q ss_pred CCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC--------------------------------------------
Q 039310 147 GTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSET-------------------------------------------- 182 (241)
Q Consensus 147 g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~-------------------------------------------- 182 (241)
.+|.+... +......++.++++++..||+..
T Consensus 95 ~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (263)
T 3tm0_A 95 VLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRE 169 (263)
T ss_dssp EEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHH
T ss_pred eehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHH
Confidence 88877532 12233477889999999999810
Q ss_pred ------------CCCeEecCCCCCCeeeCCCCCeEEccCCCccc
Q 039310 183 ------------NVPIIHRDVKSANILLDENYTPKVSDFGASKL 214 (241)
Q Consensus 183 ------------~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~ 214 (241)
+..++|+|++|.||+++++..+.|+||+.+..
T Consensus 170 l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 170 LYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 13389999999999998765667999998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.43 E-value=5.9e-13 Score=106.19 Aligned_cols=129 Identities=17% Similarity=0.164 Sum_probs=96.8
Q ss_pred cccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCC--ceeEEEEEecCCcceEEEEecCCCCchHH
Q 039310 75 GCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRN--VVRLLACCLETQVPLLVYEFVGNGTLFEH 152 (241)
Q Consensus 75 g~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~n--i~~l~~~~~~~~~~~lv~e~~~~g~L~~~ 152 (241)
+.|..+.||+....++..+++|..... ....+.+|+.+++.+.+.+ +++++++....+..++||||++|.++.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence 456669999998767788999986543 2245678999999885444 667888888888889999999988874
Q ss_pred hhcCCCCCHHHHHHHHHHHHHHHHHhhcCC--------------------------------------------------
Q 039310 153 IHKNGNLTWERRLRIAAETAGVLSYLHSET-------------------------------------------------- 182 (241)
Q Consensus 153 l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~-------------------------------------------------- 182 (241)
.. ..+ ...++.+++..|..||+..
T Consensus 104 ~~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 177 (264)
T 1nd4_A 104 SS---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKAR 177 (264)
T ss_dssp TS---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHT
T ss_pred cC---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHh
Confidence 21 122 2356777778888888643
Q ss_pred -----CCCeEecCCCCCCeeeCCCCCeEEccCCCccc
Q 039310 183 -----NVPIIHRDVKSANILLDENYTPKVSDFGASKL 214 (241)
Q Consensus 183 -----~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~ 214 (241)
+..++|+|++|.||++++++.+.|+||+.+..
T Consensus 178 ~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 178 MPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11299999999999998776677999999765
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.38 E-value=3.4e-12 Score=106.98 Aligned_cols=140 Identities=19% Similarity=0.276 Sum_probs=105.0
Q ss_pred ccccccCceeEEEEEeCCCCeEEEEecc--cCC-hhhHHHHHHHHHHHHcCC--CCCceeEEEEEecC---CcceEEEEe
Q 039310 72 DVIGCGGSGNVYKGFLPDRTPVAVKKSK--IVD-QTKIDEFINELVVVSQIN--RRNVVRLLACCLET---QVPLLVYEF 143 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~~vavk~~~--~~~-~~~~~~~~~E~~~l~~l~--h~ni~~l~~~~~~~---~~~~lv~e~ 143 (241)
+.++.|.++.||+....+ ..+++|+.. ... ......+.+|..+++.+. +..+++++.++.+. +..|+||||
T Consensus 44 ~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 368899999999988754 578888765 322 122356788999999997 45688999988776 458999999
Q ss_pred cCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC-----------------------------------------
Q 039310 144 VGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSET----------------------------------------- 182 (241)
Q Consensus 144 ~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~----------------------------------------- 182 (241)
++|..+.+.. ...++..+...++.+++..|..||+..
T Consensus 123 v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (359)
T 3dxp_A 123 VSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSL 200 (359)
T ss_dssp CCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHH
T ss_pred cCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHH
Confidence 9988775422 124778888999999999999999731
Q ss_pred --------------CCCeEecCCCCCCeeeCCCCC--eEEccCCCccc
Q 039310 183 --------------NVPIIHRDVKSANILLDENYT--PKVSDFGASKL 214 (241)
Q Consensus 183 --------------~~~iiH~dlk~~Nili~~~~~--~kl~Dfgla~~ 214 (241)
+..++|+|+++.||+++.++. +.|+||+.+..
T Consensus 201 ~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 201 MDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 234999999999999997753 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.97 E-value=2.8e-09 Score=87.14 Aligned_cols=135 Identities=22% Similarity=0.283 Sum_probs=98.2
Q ss_pred ccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcC-CCCC--ceeEEEEEecCC---cceEEEEecC
Q 039310 72 DVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQI-NRRN--VVRLLACCLETQ---VPLLVYEFVG 145 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l-~h~n--i~~l~~~~~~~~---~~~lv~e~~~ 145 (241)
+.++.|....||+.. ..+++|.... ......+.+|.++++.+ .+.. ++.++......+ ..|+|||+++
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 357889999999853 4688887442 23456788999999887 3433 455655544433 4589999999
Q ss_pred CCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC-------------------------------------------
Q 039310 146 NGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSET------------------------------------------- 182 (241)
Q Consensus 146 ~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~------------------------------------------- 182 (241)
|.++.+.... .++..+...++.+++..+..||+..
T Consensus 100 G~~l~~~~~~--~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 177 (304)
T 3sg8_A 100 GVPLTPLLLN--NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFY 177 (304)
T ss_dssp CEECCHHHHH--TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHH
T ss_pred CeECCccccc--cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHH
Confidence 9888754332 4677778888888888888888511
Q ss_pred ------------CCCeEecCCCCCCeeeCC--CCCeEEccCCCccc
Q 039310 183 ------------NVPIIHRDVKSANILLDE--NYTPKVSDFGASKL 214 (241)
Q Consensus 183 ------------~~~iiH~dlk~~Nili~~--~~~~kl~Dfgla~~ 214 (241)
+..++|+|++|.||++++ +..+.++||+.+..
T Consensus 178 ~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~ 223 (304)
T 3sg8_A 178 RDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAI 223 (304)
T ss_dssp HHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEE
T ss_pred HHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCcc
Confidence 134899999999999998 45678999998764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.85 E-value=4.3e-08 Score=80.24 Aligned_cols=134 Identities=19% Similarity=0.180 Sum_probs=92.5
Q ss_pred cccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCC---CceeEEEEEe-cCCcceEEEEecCCCC
Q 039310 73 VIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRR---NVVRLLACCL-ETQVPLLVYEFVGNGT 148 (241)
Q Consensus 73 ~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~---ni~~l~~~~~-~~~~~~lv~e~~~~g~ 148 (241)
.++.|....||+. +..+++|... .......+.+|..+|+.+.+. .+++.+.+.. ..+..+++||+++|.+
T Consensus 26 ~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~ 99 (306)
T 3tdw_A 26 SLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI 99 (306)
T ss_dssp EEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred ecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence 5778888889886 4668888732 333456788999999999652 3677777774 4566789999999888
Q ss_pred chHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcC-----------------------------------------------
Q 039310 149 LFEHIHKNGNLTWERRLRIAAETAGVLSYLHSE----------------------------------------------- 181 (241)
Q Consensus 149 L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~----------------------------------------------- 181 (241)
+.+.... .++..+...++.+++..|..||+.
T Consensus 100 l~~~~~~--~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~ 177 (306)
T 3tdw_A 100 LGEDGMA--VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQ 177 (306)
T ss_dssp CHHHHHT--TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHH
T ss_pred Cchhhhh--hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHH
Confidence 7663211 234444445555555555555432
Q ss_pred ----------CCCCeEecCCCCCCeeeCC---CCC-eEEccCCCccc
Q 039310 182 ----------TNVPIIHRDVKSANILLDE---NYT-PKVSDFGASKL 214 (241)
Q Consensus 182 ----------~~~~iiH~dlk~~Nili~~---~~~-~kl~Dfgla~~ 214 (241)
.+..++|+|+.+.||+++. ++. +.|+||+.+..
T Consensus 178 ~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 178 SYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2234799999999999997 455 48999998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.82 E-value=4.1e-08 Score=78.65 Aligned_cols=134 Identities=18% Similarity=0.208 Sum_probs=94.6
Q ss_pred ccccCce-eEEEEEeC-CCCeEEEEecccCChhhHHHHHHHHHHHHcCC-CCCceeEEEEEecCCcceEEEEecCCCCch
Q 039310 74 IGCGGSG-NVYKGFLP-DRTPVAVKKSKIVDQTKIDEFINELVVVSQIN-RRNVVRLLACCLETQVPLLVYEFVGNGTLF 150 (241)
Q Consensus 74 lg~G~~g-~V~~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~~~~~~lv~e~~~~g~L~ 150 (241)
+..|..+ .||+.... ++..+++|.... .....+.+|...|+.+. +--+++++.++.+.+..++|||+++|.++.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 3334444 68887644 466788887543 23456788999998884 334788999999999999999999988777
Q ss_pred HHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC------------------------------------------------
Q 039310 151 EHIHKNGNLTWERRLRIAAETAGVLSYLHSET------------------------------------------------ 182 (241)
Q Consensus 151 ~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~------------------------------------------------ 182 (241)
+..... ......+..+++..|.-||+..
T Consensus 109 ~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 184 (272)
T 4gkh_A 109 QVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMH 184 (272)
T ss_dssp HHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHH
T ss_pred ccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHH
Confidence 655321 1223345556666666666431
Q ss_pred -------CCCeEecCCCCCCeeeCCCCCeEEccCCCccc
Q 039310 183 -------NVPIIHRDVKSANILLDENYTPKVSDFGASKL 214 (241)
Q Consensus 183 -------~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~ 214 (241)
+..++|+|+.+.||++++++.+-|+||+.+..
T Consensus 185 ~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 185 KLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp TTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 01389999999999999877777999998764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.67 E-value=2.5e-08 Score=83.17 Aligned_cols=79 Identities=9% Similarity=0.020 Sum_probs=54.1
Q ss_pred ccc-cccCceeEEEEEeC-------CCCeEEEEecccCC---hhhHHHHHHHHHHHHcCC-C--CCceeEEEEEecC---
Q 039310 72 DVI-GCGGSGNVYKGFLP-------DRTPVAVKKSKIVD---QTKIDEFINELVVVSQIN-R--RNVVRLLACCLET--- 134 (241)
Q Consensus 72 ~~l-g~G~~g~V~~~~~~-------~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~-h--~ni~~l~~~~~~~--- 134 (241)
+.| +.|....+|+.... ++..+++|...... ......+.+|..+++.+. + -.+++++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 356 78888999987653 25678888654322 001245678888888884 3 3577888887665
Q ss_pred CcceEEEEecCCCCch
Q 039310 135 QVPLLVYEFVGNGTLF 150 (241)
Q Consensus 135 ~~~~lv~e~~~~g~L~ 150 (241)
+..++|||+++|.++.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3578999999887654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.56 E-value=3.3e-07 Score=77.56 Aligned_cols=74 Identities=18% Similarity=0.172 Sum_probs=48.8
Q ss_pred ccccccCceeEEEEEeC-CCCeEEEEecccCCh-------hhHHHHHHHHHHHHcCCC--C-CceeEEEEEecCCcceEE
Q 039310 72 DVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQ-------TKIDEFINELVVVSQINR--R-NVVRLLACCLETQVPLLV 140 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~-------~~~~~~~~E~~~l~~l~h--~-ni~~l~~~~~~~~~~~lv 140 (241)
+.+|.|..+.||++... ++..+++|....... ....++..|.++++.+.. | .+++++.+ +.+..++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 46899999999999754 467899997543211 123456778888887742 3 45566654 34567899
Q ss_pred EEecCCC
Q 039310 141 YEFVGNG 147 (241)
Q Consensus 141 ~e~~~~g 147 (241)
||++++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.30 E-value=8.7e-06 Score=66.97 Aligned_cols=137 Identities=17% Similarity=0.209 Sum_probs=77.0
Q ss_pred cccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCC--CCceeEEE------EEecCCcceEEEEec
Q 039310 73 VIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINR--RNVVRLLA------CCLETQVPLLVYEFV 144 (241)
Q Consensus 73 ~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h--~ni~~l~~------~~~~~~~~~lv~e~~ 144 (241)
.++.|....||+....++ .+++|.... .. ..+..|..+++.+.. -.+++++. +....+..+++|+|+
T Consensus 39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~-~~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i 113 (346)
T 2q83_A 39 VIQGNQMALVWKVHTDSG-AVCLKRIHR-PE---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI 113 (346)
T ss_dssp ECC----CEEEEEEETTE-EEEEEEECS-CH---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred eccccccCcEEEEEeCCC-CEEEEecCC-CH---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence 466677889999887554 488887664 22 333445555555531 12344443 123456778999999
Q ss_pred CCCCch-----------HH---hh---cCC--C---------CCHHHH-------------------------------H
Q 039310 145 GNGTLF-----------EH---IH---KNG--N---------LTWERR-------------------------------L 165 (241)
Q Consensus 145 ~~g~L~-----------~~---l~---~~~--~---------l~~~~~-------------------------------~ 165 (241)
+|.++. .. ++ ... + -.|... .
T Consensus 114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 193 (346)
T 2q83_A 114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID 193 (346)
T ss_dssp CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence 986542 01 11 000 0 112110 0
Q ss_pred HHHHHHHHHHHHhhc----------CCCCCeEecCCCCCCeeeCCCCCeEEccCCCccc
Q 039310 166 RIAAETAGVLSYLHS----------ETNVPIIHRDVKSANILLDENYTPKVSDFGASKL 214 (241)
Q Consensus 166 ~~~~~i~~~l~~lh~----------~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~ 214 (241)
.+..++..++.+|++ ..+..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 111223345666653 0124499999999999998888999999998754
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.29 E-value=6.5e-06 Score=67.44 Aligned_cols=74 Identities=14% Similarity=0.040 Sum_probs=58.7
Q ss_pred ccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCC---CCCceeEEEEEecCCcceEEEEecCCCC
Q 039310 72 DVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQIN---RRNVVRLLACCLETQVPLLVYEFVGNGT 148 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~---h~ni~~l~~~~~~~~~~~lv~e~~~~g~ 148 (241)
+.++.|....+|+... ++..+++|..... ....+..|...|+.+. ...+++++.+....+..++|||++++..
T Consensus 42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~ 117 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK 117 (312)
T ss_dssp EEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred EEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence 3588999999999876 4667888875432 3567888999998884 3568899999888888999999999875
Q ss_pred c
Q 039310 149 L 149 (241)
Q Consensus 149 L 149 (241)
+
T Consensus 118 ~ 118 (312)
T 3jr1_A 118 N 118 (312)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.29 E-value=8.5e-06 Score=65.81 Aligned_cols=74 Identities=20% Similarity=0.121 Sum_probs=54.2
Q ss_pred ccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCC---CceeEEEEEecCCcceEEEEecCCCC
Q 039310 72 DVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRR---NVVRLLACCLETQVPLLVYEFVGNGT 148 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~---ni~~l~~~~~~~~~~~lv~e~~~~g~ 148 (241)
+.+|.|..+.||+.+..+|+++.+|............+..|...|+.+... -+++++++. ..+++||+++++.
T Consensus 21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDERP 96 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCCC
T ss_pred EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecccC
Confidence 368999999999999989999999986544333335677899999888422 355666542 3478999998764
Q ss_pred c
Q 039310 149 L 149 (241)
Q Consensus 149 L 149 (241)
.
T Consensus 97 ~ 97 (288)
T 3f7w_A 97 P 97 (288)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.17 E-value=1.7e-05 Score=67.60 Aligned_cols=72 Identities=10% Similarity=0.111 Sum_probs=44.0
Q ss_pred ccccccCceeEEEEEeCCCCeEEEEecccC----Chh-----hHHHHHHHHHHHH-cCCCCCceeEEEEEecCCcceEEE
Q 039310 72 DVIGCGGSGNVYKGFLPDRTPVAVKKSKIV----DQT-----KIDEFINELVVVS-QINRRNVVRLLACCLETQVPLLVY 141 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~~vavk~~~~~----~~~-----~~~~~~~E~~~l~-~l~h~ni~~l~~~~~~~~~~~lv~ 141 (241)
+.+|.|....||+... ++..++||...+. ... ....+..|+..+. ......+++++.+. .+..++||
T Consensus 40 ~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv~ 116 (420)
T 2pyw_A 40 KEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIGM 116 (420)
T ss_dssp EECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEEE
T ss_pred EEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEEE
Confidence 3688999999999865 4678999942221 111 2223333333222 12234677777765 56779999
Q ss_pred Eec-CC
Q 039310 142 EFV-GN 146 (241)
Q Consensus 142 e~~-~~ 146 (241)
|++ ++
T Consensus 117 e~l~~g 122 (420)
T 2pyw_A 117 RYLEPP 122 (420)
T ss_dssp CCCCTT
T ss_pred eecCCc
Confidence 999 76
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.77 E-value=0.00025 Score=58.26 Aligned_cols=137 Identities=16% Similarity=0.125 Sum_probs=70.3
Q ss_pred cccccCcee-EEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCC--CCceeEEEEEecCCcceEEEEecCCCCc
Q 039310 73 VIGCGGSGN-VYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINR--RNVVRLLACCLETQVPLLVYEFVGNGTL 149 (241)
Q Consensus 73 ~lg~G~~g~-V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h--~ni~~l~~~~~~~~~~~lv~e~~~~g~L 149 (241)
.++.|.... +|+....++..+++|....... ..+..|+.+++.+.. -.+++++.+.... -+++||++.+.++
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~l 99 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDALF 99 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCBH
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcch
Confidence 455454433 6676654466777775443221 223456777766642 2356777664333 3789999976555
Q ss_pred hHHhhcC--------------------------CCCCHHHHH-------H-HH------------HHHHHHHHHhh---c
Q 039310 150 FEHIHKN--------------------------GNLTWERRL-------R-IA------------AETAGVLSYLH---S 180 (241)
Q Consensus 150 ~~~l~~~--------------------------~~l~~~~~~-------~-~~------------~~i~~~l~~lh---~ 180 (241)
.+.+... ..++..... . +. ..+...+..+. .
T Consensus 100 ~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~ 179 (333)
T 3csv_A 100 TEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQL 179 (333)
T ss_dssp HHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHC
T ss_pred HHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcc
Confidence 4332210 011111110 0 00 01111122221 1
Q ss_pred CCCCCeEecCCCCCCeeeCCC----CCeEEccCCCccc
Q 039310 181 ETNVPIIHRDVKSANILLDEN----YTPKVSDFGASKL 214 (241)
Q Consensus 181 ~~~~~iiH~dlk~~Nili~~~----~~~kl~Dfgla~~ 214 (241)
..+..++|+|+.+.||+++.+ +.+.|+||+.+..
T Consensus 180 ~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 180 EGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred cCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 123349999999999999874 6789999998765
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.68 E-value=5.1e-05 Score=62.03 Aligned_cols=139 Identities=15% Similarity=0.168 Sum_probs=75.8
Q ss_pred cccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCC--ceeEEEE------EecCCcceEEEEec
Q 039310 73 VIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRN--VVRLLAC------CLETQVPLLVYEFV 144 (241)
Q Consensus 73 ~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~n--i~~l~~~------~~~~~~~~lv~e~~ 144 (241)
.++.|....+|+....++ .+++|..... .....+..|..+++.+...+ +++++.. ....+..+++++++
T Consensus 29 ~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l 105 (322)
T 2ppq_A 29 GIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL 105 (322)
T ss_dssp EECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred ccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeC
Confidence 467788888999886555 5788876542 11234456777777764222 3444321 12235678999999
Q ss_pred CCCCchH----H----------hhc---C-C-C----CC---HHHHHH------------HHHHHHHHHHHhhc----CC
Q 039310 145 GNGTLFE----H----------IHK---N-G-N----LT---WERRLR------------IAAETAGVLSYLHS----ET 182 (241)
Q Consensus 145 ~~g~L~~----~----------l~~---~-~-~----l~---~~~~~~------------~~~~i~~~l~~lh~----~~ 182 (241)
+|..+.. . ++. . . + .. |..... +...+...+..+.+ ..
T Consensus 106 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~ 185 (322)
T 2ppq_A 106 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL 185 (322)
T ss_dssp CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred CCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccC
Confidence 8765321 0 111 0 0 0 11 111000 00113334444442 11
Q ss_pred CCCeEecCCCCCCeeeCCCCCeEEccCCCccc
Q 039310 183 NVPIIHRDVKSANILLDENYTPKVSDFGASKL 214 (241)
Q Consensus 183 ~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~ 214 (241)
+..++|+|+.+.|||++++..+.++||+.+..
T Consensus 186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 186 PAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 23499999999999999876668999998754
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.67 E-value=0.00024 Score=59.68 Aligned_cols=137 Identities=19% Similarity=0.221 Sum_probs=81.0
Q ss_pred cccccCceeEEEEEeC--------CCCeEEEEecccCChhhHHHHHHHHHHHHcCC-CCCceeEEEEEecCCcceEEEEe
Q 039310 73 VIGCGGSGNVYKGFLP--------DRTPVAVKKSKIVDQTKIDEFINELVVVSQIN-RRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 73 ~lg~G~~g~V~~~~~~--------~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
.+..|-...+|+.... ++..++++..... ........+|..+++.+. +.-.+++++.+.+ .+||||
T Consensus 57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~ 131 (379)
T 3feg_A 57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY 131 (379)
T ss_dssp EC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred EcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence 4666777889998864 2467888875332 123456678999998884 3334677776653 289999
Q ss_pred cCCCCchHH-----------------hhcC-----CCC--CHHHHHHHHHHHHH-------------------HHHH---
Q 039310 144 VGNGTLFEH-----------------IHKN-----GNL--TWERRLRIAAETAG-------------------VLSY--- 177 (241)
Q Consensus 144 ~~~g~L~~~-----------------l~~~-----~~l--~~~~~~~~~~~i~~-------------------~l~~--- 177 (241)
++|.++..- ++.. ... -+.++.++..++.. .+..
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~ 211 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK 211 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence 997554311 0111 111 23455555544322 1222
Q ss_pred -hhcC-CCCCeEecCCCCCCeeeCCC----CCeEEccCCCccc
Q 039310 178 -LHSE-TNVPIIHRDVKSANILLDEN----YTPKVSDFGASKL 214 (241)
Q Consensus 178 -lh~~-~~~~iiH~dlk~~Nili~~~----~~~kl~Dfgla~~ 214 (241)
|... .+..++|+|+.+.||+++++ +.+.++||..|..
T Consensus 212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2221 22359999999999999876 7899999998764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.67 E-value=0.00012 Score=62.68 Aligned_cols=71 Identities=15% Similarity=0.148 Sum_probs=47.4
Q ss_pred cccccCceeEEEEEeCC--------CCeEEEEecccCChhhHHHHHHHHHHHHcCCCCC-ceeEEEEEecCCcceEEEEe
Q 039310 73 VIGCGGSGNVYKGFLPD--------RTPVAVKKSKIVDQTKIDEFINELVVVSQINRRN-VVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 73 ~lg~G~~g~V~~~~~~~--------~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~n-i~~l~~~~~~~~~~~lv~e~ 143 (241)
.|+.|....+|+....+ +..+++|...... ....+.+|..+++.+...+ .+++++.+.+ .+|+||
T Consensus 80 ~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~ 153 (429)
T 1nw1_A 80 RIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 153 (429)
T ss_dssp EECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEE
Confidence 57778888999988643 4678888763311 1145567999888885333 4677776542 389999
Q ss_pred cCCCCc
Q 039310 144 VGNGTL 149 (241)
Q Consensus 144 ~~~g~L 149 (241)
++|.++
T Consensus 154 l~G~~l 159 (429)
T 1nw1_A 154 IPSRPL 159 (429)
T ss_dssp CCEEEC
T ss_pred eCCccc
Confidence 986443
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.65 E-value=0.0003 Score=57.53 Aligned_cols=138 Identities=18% Similarity=0.202 Sum_probs=78.0
Q ss_pred cccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCC--ceeEEEE-----EecCCcceEEEEecC
Q 039310 73 VIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRN--VVRLLAC-----CLETQVPLLVYEFVG 145 (241)
Q Consensus 73 ~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~n--i~~l~~~-----~~~~~~~~lv~e~~~ 145 (241)
.++ |....||+....++..+++|...... .....+..|..+++.+...+ +++++.. ....+..+++|++++
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 355 77788998877667789999865321 12345667888888774222 4444443 112445678999998
Q ss_pred CCCch-----HH---------hh---c-C-----CCCCHHHH----------------------HHHHHHHHHHHHHhhc
Q 039310 146 NGTLF-----EH---------IH---K-N-----GNLTWERR----------------------LRIAAETAGVLSYLHS 180 (241)
Q Consensus 146 ~g~L~-----~~---------l~---~-~-----~~l~~~~~----------------------~~~~~~i~~~l~~lh~ 180 (241)
|.++. .. ++ . . ...+.... ...+.+++..+.-+-.
T Consensus 111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 190 (328)
T 1zyl_A 111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 190 (328)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence 75432 11 11 0 0 01222111 0111122222221111
Q ss_pred -CCCCCeEecCCCCCCeeeCCCCCeEEccCCCccc
Q 039310 181 -ETNVPIIHRDVKSANILLDENYTPKVSDFGASKL 214 (241)
Q Consensus 181 -~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~ 214 (241)
..+..++|+|+.+.||+++ + .+.++||+.+..
T Consensus 191 ~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 191 EDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1223489999999999999 4 899999987654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.64 E-value=0.00017 Score=58.47 Aligned_cols=71 Identities=14% Similarity=0.167 Sum_probs=42.9
Q ss_pred cccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCc-eeEEEEEecCCcceEEEEec-CCCC
Q 039310 71 ADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNV-VRLLACCLETQVPLLVYEFV-GNGT 148 (241)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni-~~l~~~~~~~~~~~lv~e~~-~~g~ 148 (241)
.+.|+.|....+|+. ..+++|........ .-...+|..+++.+...++ +++++. +.+.-++++||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 456888988999998 45888865532111 1122467777777642222 566654 344457899999 6544
Q ss_pred c
Q 039310 149 L 149 (241)
Q Consensus 149 L 149 (241)
+
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.50 E-value=0.00056 Score=58.95 Aligned_cols=72 Identities=11% Similarity=0.022 Sum_probs=44.9
Q ss_pred cccccCceeEEEEEeCC-CCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCc-eeEEEEEecCCcceEEEEecCCCCc
Q 039310 73 VIGCGGSGNVYKGFLPD-RTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNV-VRLLACCLETQVPLLVYEFVGNGTL 149 (241)
Q Consensus 73 ~lg~G~~g~V~~~~~~~-~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni-~~l~~~~~~~~~~~lv~e~~~~g~L 149 (241)
.|+.|-...+|+....+ +..+++|......... -+..+|..+++.+...++ +++++.+. + .+|+||++|.++
T Consensus 115 ~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~-~---G~v~e~I~G~~l 188 (458)
T 2qg7_A 115 IINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT-N---GRIEEFMDGYAL 188 (458)
T ss_dssp EECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET-T---EEEEECCCSEEC
T ss_pred EcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC-C---eEEEEeeCCccC
Confidence 57778888899988754 4678888654321111 112478888988864444 67777763 2 359999987544
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.43 E-value=0.0012 Score=54.52 Aligned_cols=31 Identities=19% Similarity=0.388 Sum_probs=27.3
Q ss_pred CCeEecCCCCCCeeeCCCCCeEEccCCCccc
Q 039310 184 VPIIHRDVKSANILLDENYTPKVSDFGASKL 214 (241)
Q Consensus 184 ~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~ 214 (241)
..++|+|+.+.||++++++.+.++||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3499999999999999888899999987654
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.34 E-value=0.00075 Score=56.26 Aligned_cols=72 Identities=18% Similarity=0.144 Sum_probs=42.6
Q ss_pred cccccCceeEEEEEeCC---------CCeEEEEecccCChhhHHHHHHHHHHHHcCCCCC-ceeEEEEEecCCcceEEEE
Q 039310 73 VIGCGGSGNVYKGFLPD---------RTPVAVKKSKIVDQTKIDEFINELVVVSQINRRN-VVRLLACCLETQVPLLVYE 142 (241)
Q Consensus 73 ~lg~G~~g~V~~~~~~~---------~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~n-i~~l~~~~~~~~~~~lv~e 142 (241)
.++.|..-.+|+....+ +..+++|....... .......|..+++.+...+ .+++++.. .-++|||
T Consensus 40 ~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v~e 114 (369)
T 3c5i_A 40 QILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRIEE 114 (369)
T ss_dssp EC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEEE
T ss_pred EeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec----CCcEEEE
Confidence 56778778899987643 26788886543211 1112357888888874333 45777554 2378999
Q ss_pred ecCCCCc
Q 039310 143 FVGNGTL 149 (241)
Q Consensus 143 ~~~~g~L 149 (241)
|++|.++
T Consensus 115 ~i~G~~l 121 (369)
T 3c5i_A 115 WLYGDPL 121 (369)
T ss_dssp CCCSEEC
T ss_pred EecCCcC
Confidence 9987543
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.07 E-value=0.023 Score=48.28 Aligned_cols=72 Identities=14% Similarity=0.044 Sum_probs=45.9
Q ss_pred cccccCceeEEEEEeCC--------CCeEEEEecccCChhhHHHHHHHHHHHHcCC-CCCceeEEEEEecCCcceEEEEe
Q 039310 73 VIGCGGSGNVYKGFLPD--------RTPVAVKKSKIVDQTKIDEFINELVVVSQIN-RRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 73 ~lg~G~~g~V~~~~~~~--------~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
.+..|-.-.+|+....+ +..++++....... ..-+..+|..+++.+. +.-.+++++.+. -++||||
T Consensus 77 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ef 151 (424)
T 3mes_A 77 QIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEEF 151 (424)
T ss_dssp EECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEEC
T ss_pred EcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEEE
Confidence 56667778899987653 57788887543221 1112347888888774 333566665442 3789999
Q ss_pred cCCCCc
Q 039310 144 VGNGTL 149 (241)
Q Consensus 144 ~~~g~L 149 (241)
++|.+|
T Consensus 152 I~G~~l 157 (424)
T 3mes_A 152 IDGEPL 157 (424)
T ss_dssp CCSEEC
T ss_pred eCCccC
Confidence 998654
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=93.26 E-value=0.63 Score=35.62 Aligned_cols=86 Identities=13% Similarity=0.066 Sum_probs=62.0
Q ss_pred CCCCceeEEEEEecCCcceEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHH-HhhcCCCCCeEecCCCCCCeee
Q 039310 120 NRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLS-YLHSETNVPIIHRDVKSANILL 198 (241)
Q Consensus 120 ~h~ni~~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~-~lh~~~~~~iiH~dlk~~Nili 198 (241)
.||.+ -...-.+++.+.+.++.-+++.-...++ .++..+.++++..++.... +++. -+|--+.|+|+++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~---~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL~f 117 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR---KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENLMF 117 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH---TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGEEE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH---hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceEEE
Confidence 57777 2233356666666666544442233333 4789999999999988877 6665 5688899999999
Q ss_pred CCCCCeEEccCCCcccc
Q 039310 199 DENYTPKVSDFGASKLV 215 (241)
Q Consensus 199 ~~~~~~kl~Dfgla~~~ 215 (241)
|.++.+++.-.|+-..+
T Consensus 118 ~~~~~p~i~hRGi~~~l 134 (219)
T 4ano_A 118 NRALEPFFLHVGVKESL 134 (219)
T ss_dssp CTTCCEEESCCEETTTB
T ss_pred eCCCcEEEEEcCCcccC
Confidence 99999999999875554
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.65 E-value=0.036 Score=30.82 Aligned_cols=6 Identities=67% Similarity=1.171 Sum_probs=2.2
Q ss_pred HHHHhh
Q 039310 18 LWTRRR 23 (241)
Q Consensus 18 ~~~~~~ 23 (241)
++.|||
T Consensus 33 ~~~RRr 38 (44)
T 2ks1_B 33 LFMRRR 38 (44)
T ss_dssp HHHHTT
T ss_pred HHhhhh
Confidence 333333
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=92.62 E-value=0.47 Score=36.18 Aligned_cols=87 Identities=10% Similarity=0.087 Sum_probs=62.4
Q ss_pred CCCCceeEEEEEecCCcceEEEEecCCC-CchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee
Q 039310 120 NRRNVVRLLACCLETQVPLLVYEFVGNG-TLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILL 198 (241)
Q Consensus 120 ~h~ni~~l~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili 198 (241)
.||+++.. ..-.+.+...+.++.-+.+ ++.. ++ ..+....++++..++....+++. =+|--+.|+|+++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik---~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL~f 112 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK---SFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDELFF 112 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG---GSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGEEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH---hcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceEEE
Confidence 67888876 4555556555555543322 2222 33 47889999999999998877765 3677899999999
Q ss_pred CCCCCeEEccCCCccccc
Q 039310 199 DENYTPKVSDFGASKLVP 216 (241)
Q Consensus 199 ~~~~~~kl~Dfgla~~~~ 216 (241)
+.++.+++.-.|+-..+.
T Consensus 113 ~~~~~p~i~~RGik~~l~ 130 (215)
T 4ann_A 113 TRDGLPIAKTRGLQNVVD 130 (215)
T ss_dssp CTTSCEEESCCEETTTBS
T ss_pred cCCCCEEEEEccCccCCC
Confidence 999999999998755543
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=91.76 E-value=0.017 Score=49.67 Aligned_cols=60 Identities=5% Similarity=0.067 Sum_probs=17.5
Q ss_pred ccccccccCceeEEEEEeCC-CCeEEE------EecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEe
Q 039310 70 YADVIGCGGSGNVYKGFLPD-RTPVAV------KKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCL 132 (241)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~~~-~~~vav------k~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 132 (241)
+.+.+| ||.||+|.+.. ..+||+ |..... .......+.+|..+++..+|||+++.+++..
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 345566 99999999754 467888 654432 2334457888999999999999999988764
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=90.97 E-value=0.12 Score=28.54 Aligned_cols=16 Identities=13% Similarity=0.326 Sum_probs=6.7
Q ss_pred HHHHHHHHHHHHHhhh
Q 039310 9 IMSISWLHFLWTRRRH 24 (241)
Q Consensus 9 ~~~~~~~~~~~~~~~~ 24 (241)
+++++...++|.|||+
T Consensus 24 ~vi~~l~~~~~~RRR~ 39 (44)
T 2jwa_A 24 VVVLGVVFGILIKRRQ 39 (44)
T ss_dssp HHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHhheehhh
Confidence 3333334444444443
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=89.88 E-value=0.16 Score=42.61 Aligned_cols=29 Identities=34% Similarity=0.455 Sum_probs=25.0
Q ss_pred eEecCCCCCCeee------CCCCCeEEccCCCccc
Q 039310 186 IIHRDVKSANILL------DENYTPKVSDFGASKL 214 (241)
Q Consensus 186 iiH~dlk~~Nili------~~~~~~kl~Dfgla~~ 214 (241)
++|+|+.+.|||+ +++..+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999 4567799999998864
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=85.99 E-value=0.37 Score=25.79 Aligned_cols=10 Identities=10% Similarity=0.145 Sum_probs=3.8
Q ss_pred HHHHHHHHHH
Q 039310 12 ISWLHFLWTR 21 (241)
Q Consensus 12 ~~~~~~~~~~ 21 (241)
++.+.|+++|
T Consensus 27 i~~l~~~~~r 36 (38)
T 2k1k_A 27 LLGILVFRSR 36 (38)
T ss_dssp HHHHHHHHHC
T ss_pred HHHHHHHHee
Confidence 3333333433
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 241 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 8e-46 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-44 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-44 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-43 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-43 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-42 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-41 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-41 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-41 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-41 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-40 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-40 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 7e-40 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 9e-40 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-39 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-39 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-39 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-38 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-38 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-38 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-37 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-37 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-36 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-36 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-36 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 8e-36 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-35 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-35 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-35 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-35 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-35 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-34 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-34 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-34 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-34 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-32 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-32 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-32 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-31 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-31 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-31 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-30 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-30 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-30 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-29 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-29 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-29 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-28 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 8e-28 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 9e-27 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-26 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-26 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-26 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-26 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-25 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-24 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-24 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-23 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 9e-23 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-22 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 9e-20 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-15 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-14 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 8e-46
Identities = 45/171 (26%), Positives = 80/171 (46%), Gaps = 6/171 (3%)
Query: 72 DVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACC 131
IG G G VYKG V + ++ F NE+ V+ + N++ +
Sbjct: 14 QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 132 LETQVPLLVYEFVGNGTLFEHIHK-NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRD 190
Q+ +V ++ +L+ H+H + + IA +TA + YLH++ IIHRD
Sbjct: 74 TAPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRD 129
Query: 191 VKSANILLDENYTPKVSDFGASKLVP-IDAIQNYTVVQGTLGYIDPEYLQT 240
+KS NI L E+ T K+ DFG + + + + G++ ++ PE ++
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 2e-44
Identities = 44/171 (25%), Positives = 87/171 (50%), Gaps = 7/171 (4%)
Query: 72 DVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACC 131
+ +G G G V+ G+ T VAVK K + D F+ E ++ Q+ + +VRL A
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 132 LETQVPLLVYEFVGNGTLFEHIHKNGN--LTWERRLRIAAETAGVLSYLHSETNVPIIHR 189
+ + ++ E++ NG+L + + LT + L +AA+ A ++++ IHR
Sbjct: 78 TQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHR 133
Query: 190 DVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQT 240
D+++ANIL+ + + K++DFG ++L+ + + + + PE +
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 2e-44
Identities = 45/183 (24%), Positives = 77/183 (42%), Gaps = 11/183 (6%)
Query: 62 EIKTVTNNY--ADVIGCGGSGNVYKGF-LPDRTPVAVKK-SKIVDQTKIDEFINELVVVS 117
E+K +++ +G G G V+K P +A K + ++ I EL V+
Sbjct: 2 ELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLH 59
Query: 118 QINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSY 177
+ N +V + E + G+L + + K G + + +++ L+Y
Sbjct: 60 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTY 119
Query: 178 LHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEY 237
L + I+HRDVK +NIL++ K+ DFG S + GT Y+ PE
Sbjct: 120 LREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPER 174
Query: 238 LQT 240
LQ
Sbjct: 175 LQG 177
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 147 bits (371), Expect = 1e-43
Identities = 47/195 (24%), Positives = 80/195 (41%), Gaps = 17/195 (8%)
Query: 53 EKAKIFIEEEIKTVTNNYAD--VIGCGGSGNVYKGF-LPDRTPVAVK---KSKIVDQTKI 106
+ A++F +++ + + ++D IG G G VY + + VA+K S K
Sbjct: 3 DVAELFFKDDPEKL---FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW 59
Query: 107 DEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLR 166
+ I E+ + ++ N ++ C L LV E+ L
Sbjct: 60 QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA 119
Query: 167 IAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVV 226
+ L+YLHS +IHRDVK+ NILL E K+ DFG++ + +
Sbjct: 120 VTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASI-----MAPANSF 171
Query: 227 QGTLGYIDPEYLQTC 241
GT ++ PE +
Sbjct: 172 VGTPYWMAPEVILAM 186
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 2e-43
Identities = 48/173 (27%), Positives = 78/173 (45%), Gaps = 10/173 (5%)
Query: 72 DVIGCGGSGNVYKGFLP-DRTPVAVK---KSKIVDQTKIDEFINELVVVSQINRRNVVRL 127
+G G GNVY + +A+K K+++ + E+ + S + N++RL
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71
Query: 128 LACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPII 187
+ L+ E+ GT++ + K +R E A LSY HS+ +I
Sbjct: 72 YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVI 128
Query: 188 HRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQT 240
HRD+K N+LL K++DFG S P T + GTL Y+ PE ++
Sbjct: 129 HRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRTTLCGTLDYLPPEMIEG 178
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 1e-42
Identities = 46/191 (24%), Positives = 91/191 (47%), Gaps = 14/191 (7%)
Query: 57 IFIEEEIKTVTNNYADVIGCGGSGNVYKGFLPDR---TPVAVK--KSKIVDQTKIDEFIN 111
++++ ++ T+ + +G G G V KG+ + VAVK K++ D DE +
Sbjct: 1 VYLDRKLLTLEDK---ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA 57
Query: 112 ELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAET 171
E V+ Q++ +VR++ C E + +LV E G L +++ +N ++ + + + +
Sbjct: 58 EANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 116
Query: 172 AGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYT--VVQGT 229
+ + YL +HRD+ + N+LL + K+SDFG SK + D +
Sbjct: 117 SMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 173
Query: 230 LGYIDPEYLQT 240
+ + PE +
Sbjct: 174 VKWYAPECINY 184
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (355), Expect = 1e-41
Identities = 47/170 (27%), Positives = 82/170 (48%), Gaps = 5/170 (2%)
Query: 72 DVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACC 131
IG G G V+ G+ ++ VA+K + ++ ++FI E V+ +++ +V+L C
Sbjct: 11 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 132 LETQVPLLVYEFVGNGTLFEHIHKNGNL-TWERRLRIAAETAGVLSYLHSETNVPIIHRD 190
LE LV+EF+ +G L +++ L E L + + V + +IHRD
Sbjct: 70 LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLD---VCEGMAYLEEACVIHRD 126
Query: 191 VKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQT 240
+ + N L+ EN KVSDFG ++ V D + T + + + PE
Sbjct: 127 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF 176
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 3e-41
Identities = 43/170 (25%), Positives = 78/170 (45%), Gaps = 5/170 (2%)
Query: 72 DVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACC 131
+G G G V G + VA+K K ++ DEFI E V+ ++ +V+L C
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 132 LETQVPLLVYEFVGNGTLFEHIH-KNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRD 190
+ + ++ E++ NG L ++ ++ L + + + YL S+ +HRD
Sbjct: 69 TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRD 125
Query: 191 VKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQT 240
+ + N L+++ KVSDFG S+ V D + + + + PE L
Sbjct: 126 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 175
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 3e-41
Identities = 43/171 (25%), Positives = 76/171 (44%), Gaps = 6/171 (3%)
Query: 72 DVIGCGGSGNVYKGFLPD-RTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLAC 130
+G G G VYK + A K + ++++++ E+ +++ + N+V+LL
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 131 CLETQVPLLVYEFVGNGTLFEHIHKNGN-LTWERRLRIAAETAGVLSYLHSETNVPIIHR 189
++ EF G + + + LT + + +T L+YLH IIHR
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHR 134
Query: 190 DVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQT 240
D+K+ NIL + K++DFG S IQ GT ++ PE +
Sbjct: 135 DLKAGNILFTLDGDIKLADFGVSAKNT-RTIQRRDSFIGTPYWMAPEVVMC 184
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 3e-41
Identities = 42/175 (24%), Positives = 73/175 (41%), Gaps = 12/175 (6%)
Query: 73 VIGCGGSGNVYKGFLPD-RTPVAVKK--SKIVDQTKIDEFINELVVVSQINRRNVVRLLA 129
IG G VYKG + VA + + + +++ F E ++ + N+VR
Sbjct: 16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 75
Query: 130 CCLET----QVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVP 185
T + +LV E + +GTL ++ + + + + L +LH+ P
Sbjct: 76 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR-TPP 134
Query: 186 IIHRDVKSANILL-DENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
IIHRD+K NI + + K+ D G + L V GT ++ PE +
Sbjct: 135 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS---FAKAVIGTPEFMAPEMYE 186
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 1e-40
Identities = 43/171 (25%), Positives = 81/171 (47%), Gaps = 7/171 (4%)
Query: 72 DVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACC 131
+G G G V+ G T VA+K K + F+ E V+ ++ +V+L A
Sbjct: 23 VKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 81
Query: 132 LETQVPLLVYEFVGNGTLFEHIHKNGN--LTWERRLRIAAETAGVLSYLHSETNVPIIHR 189
E + +V E++ G+L + + L + + +AA+ A ++Y+ + +HR
Sbjct: 82 SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 137
Query: 190 DVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQT 240
D+++ANIL+ EN KV+DFG ++L+ + + + + PE
Sbjct: 138 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 188
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 1e-40
Identities = 46/172 (26%), Positives = 79/172 (45%), Gaps = 13/172 (7%)
Query: 72 DVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACC 131
IG G G+V G VAVK I + F+ E V++Q+ N+V+LL
Sbjct: 13 QTIGKGEFGDVMLGDYRGN-KVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 69
Query: 132 LETQVPL-LVYEFVGNGTLFEHIHKNGN--LTWERRLRIAAETAGVLSYLHSETNVPIIH 188
+E + L +V E++ G+L +++ G L + L+ + + + YL +H
Sbjct: 70 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVH 126
Query: 189 RDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQT 240
RD+ + N+L+ E+ KVSDFG +K + + + PE L+
Sbjct: 127 RDLAARNVLVSEDNVAKVSDFGLTKEAS----STQDTGKLPVKWTAPEALRE 174
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 7e-40
Identities = 45/192 (23%), Positives = 88/192 (45%), Gaps = 14/192 (7%)
Query: 56 KIFIEEEIKTVTNNYADVIGCGGSGNVYKGFLPDR---TPVAVKK-SKIVDQTKIDEFIN 111
K+F++ + + + +GCG G+V +G R VA+K + ++ +E +
Sbjct: 2 KLFLKRDNLLIADI---ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR 58
Query: 112 ELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIH-KNGNLTWERRLRIAAE 170
E ++ Q++ +VRL+ C + + +LV E G G L + + K + + +
Sbjct: 59 EAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 117
Query: 171 TAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNY--TVVQG 228
+ + YL + +HRD+ + N+LL + K+SDFG SK + D + +
Sbjct: 118 VSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 174
Query: 229 TLGYIDPEYLQT 240
L + PE +
Sbjct: 175 PLKWYAPECINF 186
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 9e-40
Identities = 47/172 (27%), Positives = 70/172 (40%), Gaps = 6/172 (3%)
Query: 72 DVIGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKIDE-FINELVVVSQINRRNVVRLLA 129
+G G G V VAVK + E E+ + +N NVV+
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 130 CCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHR 189
E + L E+ G LF+ I + + R + + YLH I HR
Sbjct: 71 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHR 127
Query: 190 DVKSANILLDENYTPKVSDFGASKLVPIDAI-QNYTVVQGTLGYIDPEYLQT 240
D+K N+LLDE K+SDFG + + + + + GTL Y+ PE L+
Sbjct: 128 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 136 bits (342), Expect = 2e-39
Identities = 52/210 (24%), Positives = 91/210 (43%), Gaps = 28/210 (13%)
Query: 56 KIFIE----EEIKTVTNNYAD-----------VIGCGGSGNVYKGFLP----DRTPVAVK 96
KIFI+ E+ +A VIG G G V G L VA+K
Sbjct: 1 KIFIDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIK 60
Query: 97 K-SKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHK 155
+ + +F++E ++ Q + NV+ L ++ +++ EF+ NG+L + +
Sbjct: 61 TLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ 120
Query: 156 N-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKL 214
N G T + + + A + YL ++ +HRD+ + NIL++ N KVSDFG S+
Sbjct: 121 NDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177
Query: 215 VPIDAIQNYTV----VQGTLGYIDPEYLQT 240
+ D + + + PE +Q
Sbjct: 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQY 207
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 134 bits (339), Expect = 4e-39
Identities = 49/172 (28%), Positives = 84/172 (48%), Gaps = 7/172 (4%)
Query: 72 DVIGCGGSGNVYKGFLPD-RTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLAC 130
+G G G VY+G VAVK K D +++EF+ E V+ +I N+V+LL
Sbjct: 23 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 81
Query: 131 CLETQVPLLVYEFVGNGTLFEHIHKNGN--LTWERRLRIAAETAGVLSYLHSETNVPIIH 188
C ++ EF+ G L +++ + ++ L +A + + + YL + IH
Sbjct: 82 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIH 138
Query: 189 RDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQT 240
RD+ + N L+ EN+ KV+DFG S+L+ D + + + + PE L
Sbjct: 139 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 190
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 4e-39
Identities = 42/180 (23%), Positives = 73/180 (40%), Gaps = 12/180 (6%)
Query: 72 DVIGCGGSGNVYKGF-LPDRTPVAVKKSKI--VDQTKIDEFINELVVVSQINRRNVVRLL 128
IG G G K D + K+ + + + ++E+ ++ ++ N+VR
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69
Query: 129 ACCLET--QVPLLVYEFVGNGTLFEHIHKN----GNLTWERRLRIAAETAGVLSYLH--S 180
++ +V E+ G L I K L E LR+ + L H S
Sbjct: 70 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129
Query: 181 ETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQT 240
+ ++HRD+K AN+ LD K+ DFG ++++ D GT Y+ PE +
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKAFVGTPYYMSPEQMNR 188
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 2e-38
Identities = 48/174 (27%), Positives = 78/174 (44%), Gaps = 8/174 (4%)
Query: 72 DVIGCGGSGNVYKGF-LPDRTPVAVK---KSKIVDQTKIDEFINELVVVSQINRRNVVRL 127
++G G V L A+K K I+ + K+ E V+S+++ V+L
Sbjct: 14 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73
Query: 128 LACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPII 187
+ + + NG L ++I K G+ AE L YLH + II
Sbjct: 74 YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GII 130
Query: 188 HRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ-NYTVVQGTLGYIDPEYLQT 240
HRD+K NILL+E+ +++DFG +K++ ++ Q GT Y+ PE L
Sbjct: 131 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 2e-38
Identities = 48/170 (28%), Positives = 83/170 (48%), Gaps = 6/170 (3%)
Query: 72 DVIGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLAC 130
+ IG G SG VY + VA+++ + Q K + INE++V+ + N+V L
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 131 CLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRD 190
L +V E++ G+L + + + + + E L +LHS +IHRD
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCRECLQALEFLHSN---QVIHRD 141
Query: 191 VKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQT 240
+KS NILL + + K++DFG + + + T+V GT ++ PE +
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTR 190
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 5e-38
Identities = 55/211 (26%), Positives = 104/211 (49%), Gaps = 14/211 (6%)
Query: 40 LRQELSKLQGRSSEKAKIFIEEEIKTVTNNYADVIGCGGSGNVYKGFLPD----RTPVAV 95
+ +LS L + + + ++ ++ +VIG G G VY G L D + AV
Sbjct: 2 VHIDLSALNPELVQAVQ-HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAV 60
Query: 96 KK-SKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQ-VPLLVYEFVGNGTLFEHI 153
K ++I D ++ +F+ E +++ + NV+ LL CL ++ PL+V ++ +G L I
Sbjct: 61 KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 120
Query: 154 H-KNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGAS 212
+ N T + + + A + + +HRD+ + N +LDE +T KV+DFG +
Sbjct: 121 RNETHNPTVKDLIGFGLQVA---KGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 177
Query: 213 KLVP---IDAIQNYTVVQGTLGYIDPEYLQT 240
+ + D++ N T + + ++ E LQT
Sbjct: 178 RDMYDKEFDSVHNKTGAKLPVKWMALESLQT 208
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 3e-37
Identities = 46/182 (25%), Positives = 79/182 (43%), Gaps = 15/182 (8%)
Query: 72 DVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACC 131
+ IG G G V++G VAVK ++ E+ + N++ +A
Sbjct: 9 ESIGKGRFGEVWRGKWRGE-EVAVKIFSSREERSW-FREAEIYQTVMLRHENILGFIAAD 66
Query: 132 LETQ----VPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSE-----T 182
+ LV ++ +G+LF+++++ +T E +++A TA L++LH E
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEIVGTQG 125
Query: 183 NVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNY---TVVQGTLGYIDPEYLQ 239
I HRD+KS NIL+ +N T ++D G + GT Y+ PE L
Sbjct: 126 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 185
Query: 240 TC 241
Sbjct: 186 DS 187
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 3e-37
Identities = 42/201 (20%), Positives = 79/201 (39%), Gaps = 35/201 (17%)
Query: 72 DVIGCGGSGNVYKGFLPD------RTPVAVKK-SKIVDQTKIDEFINELVVVSQINR-RN 123
V+G G G V VAVK + D ++ + ++EL +++Q+ N
Sbjct: 43 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 102
Query: 124 VVRLLACCLETQVPLLVYEFVGNGTLFEHIHKN-----------------------GNLT 160
+V LL C + L++E+ G L ++ LT
Sbjct: 103 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 162
Query: 161 WERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAI 220
+E L A + A + +L + +HRD+ + N+L+ K+ DFG ++ + D+
Sbjct: 163 FEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 219
Query: 221 Q-NYTVVQGTLGYIDPEYLQT 240
+ + ++ PE L
Sbjct: 220 YVVRGNARLPVKWMAPESLFE 240
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 129 bits (325), Expect = 2e-36
Identities = 38/188 (20%), Positives = 78/188 (41%), Gaps = 11/188 (5%)
Query: 59 IEEEIKTVTNNYA--DVIGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKIDEFINELVV 115
+E + V ++Y + +G G G V++ A K ++ + E+
Sbjct: 17 VEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQT 76
Query: 116 VSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIH-KNGNLTWERRLRIAAETAGV 174
+S + +V L + +++YEF+ G LFE + ++ ++ + + +
Sbjct: 77 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKG 136
Query: 175 LSYLHSETNVPIIHRDVKSANILL--DENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGY 232
L ++H +H D+K NI+ + K+ DFG + +D Q+ V GT +
Sbjct: 137 LCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAH--LDPKQSVKVTTGTAEF 191
Query: 233 IDPEYLQT 240
PE +
Sbjct: 192 AAPEVAEG 199
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 128 bits (321), Expect = 2e-36
Identities = 45/202 (22%), Positives = 80/202 (39%), Gaps = 35/202 (17%)
Query: 72 DVIGCGGSGNVYKGFLP------DRTPVAVKK-SKIVDQTKIDEFINELVVVSQINRRNV 124
IG G G V++ P T VAVK + +F E ++++ + N+
Sbjct: 19 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 78
Query: 125 VRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGN------------------------LT 160
V+LL C + L++E++ G L E + L+
Sbjct: 79 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 138
Query: 161 WERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVP-IDA 219
+L IA + A ++YL +HRD+ + N L+ EN K++DFG S+ + D
Sbjct: 139 CAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 195
Query: 220 IQNYTVVQGTLGYIDPEYLQTC 241
+ + ++ PE +
Sbjct: 196 YKADGNDAIPIRWMPPESIFYN 217
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 5e-36
Identities = 49/190 (25%), Positives = 83/190 (43%), Gaps = 26/190 (13%)
Query: 72 DVIGCGGSGNVYKGFLPD---RTPVAVKK-SKIVDQTKIDEFINELVVVSQINR-RNVVR 126
DVIG G G V K + R A+K+ + + +F EL V+ ++ N++
Sbjct: 16 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 75
Query: 127 LLACCLETQVPLLVYEFVGNGTLFEHIHKN----------------GNLTWERRLRIAAE 170
LL C L E+ +G L + + K+ L+ ++ L AA+
Sbjct: 76 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 135
Query: 171 TAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTL 230
A + YL + IHRD+ + NIL+ ENY K++DFG S+ + T+ + +
Sbjct: 136 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVY--VKKTMGRLPV 190
Query: 231 GYIDPEYLQT 240
++ E L
Sbjct: 191 RWMAIESLNY 200
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 8e-36
Identities = 47/177 (26%), Positives = 87/177 (49%), Gaps = 12/177 (6%)
Query: 73 VIGCGGSGNVYKGFLPDRT-----PVAVKK-SKIVDQTKIDEFINELVVVSQINRRNVVR 126
VIG G G VYKG L + PVA+K + + +F+ E ++ Q + N++R
Sbjct: 14 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 73
Query: 127 LLACCLETQVPLLVYEFVGNGTLFEHIH-KNGNLTWERRLRIAAETAGVLSYLHSETNVP 185
L + + +++ E++ NG L + + K+G + + + + G+ + + N+
Sbjct: 74 LEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLR---GIAAGMKYLANMN 130
Query: 186 IIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQ--GTLGYIDPEYLQT 240
+HRD+ + NIL++ N KVSDFG S+++ D YT + + PE +
Sbjct: 131 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY 187
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 2e-35
Identities = 38/175 (21%), Positives = 76/175 (43%), Gaps = 10/175 (5%)
Query: 72 DVIGCGGSGNVYKGFLPDR----TPVAVKK-SKIVDQTKIDEFINELVVVSQINRRNVVR 126
IG G G+V++G VA+K + ++F+ E + + Q + ++V+
Sbjct: 13 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 72
Query: 127 LLACCLETQVPLLVYEFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVP 185
L+ E V ++ E G L + +L + A + + L+YL S+
Sbjct: 73 LIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---R 128
Query: 186 IIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQT 240
+HRD+ + N+L+ N K+ DFG S+ + + + + ++ PE +
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 183
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 3e-35
Identities = 44/197 (22%), Positives = 77/197 (39%), Gaps = 30/197 (15%)
Query: 72 DVIGCGGSGNVYKGFL------PDRTPVAVKK-SKIVDQTKIDEFINELVVVSQINR-RN 123
+G G G V + VAVK T+ + ++EL V+S + N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 124 VVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGN------------------LTWERRL 165
+V LL C L++ E+ G L + + + L E L
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 166 RIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDA-IQNYT 224
+ + A +++L S+ IHRD+ + NILL K+ DFG ++ + D+
Sbjct: 149 SFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 225 VVQGTLGYIDPEYLQTC 241
+ + ++ PE + C
Sbjct: 206 NARLPVKWMAPESIFNC 222
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 3e-35
Identities = 41/175 (23%), Positives = 77/175 (44%), Gaps = 10/175 (5%)
Query: 73 VIGCGGSGNVYKGFLPD-----RTPVAVKK-SKIVDQTKIDEFINELVVVSQINRRNVVR 126
V+G G G VYKG + PVA+K+ + E ++E V++ ++ +V R
Sbjct: 16 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 75
Query: 127 LLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPI 186
LL CL + V L+ L N+ + L + A ++YL +
Sbjct: 76 LLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RL 132
Query: 187 IHRDVKSANILLDENYTPKVSDFGASKLV-PIDAIQNYTVVQGTLGYIDPEYLQT 240
+HRD+ + N+L+ K++DFG +KL+ + + + + ++ E +
Sbjct: 133 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 187
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 126 bits (317), Expect = 3e-35
Identities = 37/187 (19%), Positives = 73/187 (39%), Gaps = 11/187 (5%)
Query: 59 IEEEIKTVTNNYA--DVIGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKIDEFINELVV 115
+E + +V + Y + +G G G V++ K NE+ +
Sbjct: 20 VEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISI 79
Query: 116 VSQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGN-LTWERRLRIAAETAGV 174
++Q++ ++ L + +L+ EF+ G LF+ I ++ + +
Sbjct: 80 MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEG 139
Query: 175 LSYLHSETNVPIIHRDVKSANILLDENYTP--KVSDFGASKLVPIDAIQNYTVVQGTLGY 232
L ++H I+H D+K NI+ + K+ DFG + + D I T T +
Sbjct: 140 LKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEF 194
Query: 233 IDPEYLQ 239
PE +
Sbjct: 195 AAPEIVD 201
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 3e-35
Identities = 47/179 (26%), Positives = 79/179 (44%), Gaps = 14/179 (7%)
Query: 72 DVIGCGGSGNVYKGFLPDRT----PVAVK---KSKIVDQTKIDEFINELVVVSQINRRNV 124
+ +G G G V +G + VAVK + +D+FI E+ + ++ RN+
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 125 VRLLACCLETQVPLLVYEFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETN 183
+RL L + +V E G+L + + K+ G+ R A + A + YL S+
Sbjct: 74 IRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK-- 130
Query: 184 VPIIHRDVKSANILLDENYTPKVSDFGASKLVP--IDAIQNYTVVQGTLGYIDPEYLQT 240
IHRD+ + N+LL K+ DFG + +P D + + PE L+T
Sbjct: 131 -RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 123 bits (309), Expect = 1e-34
Identities = 45/180 (25%), Positives = 82/180 (45%), Gaps = 16/180 (8%)
Query: 72 DVIGCGGSGNVYKGF-LPDRTPVAVKK---------SKIVDQTKIDEFINELVVVSQINR 121
+++G G S V + P AVK S Q + + E+ ++ +++
Sbjct: 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68
Query: 122 -RNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHS 180
N+++L LV++ + G LF+++ + L+ + +I V+ LH
Sbjct: 69 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK 128
Query: 181 ETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQT 240
I+HRD+K NILLD++ K++DFG S +D + V GT Y+ PE ++
Sbjct: 129 L---NIVHRDLKPENILLDDDMNIKLTDFGFSCQ--LDPGEKLREVCGTPSYLAPEIIEC 183
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 122 bits (308), Expect = 1e-34
Identities = 49/189 (25%), Positives = 83/189 (43%), Gaps = 15/189 (7%)
Query: 64 KTVTNNYA--DVIGCGGSGNVYKGF-LPDRTPVAVK---KSKIVDQTKIDEFINELVVVS 117
+++ Y +++G GG V+ L VAVK D + F E +
Sbjct: 3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 62
Query: 118 QINRRNVVRLLACCLET----QVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAG 173
+N +V + +P +V E+V TL + +H G +T +R + + A+
Sbjct: 63 ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ 122
Query: 174 VLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLV--PIDAIQNYTVVQGTLG 231
L++ H IIHRDVK ANI++ KV DFG ++ + +++ V GT
Sbjct: 123 ALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 232 YIDPEYLQT 240
Y+ PE +
Sbjct: 180 YLSPEQARG 188
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 123 bits (310), Expect = 2e-34
Identities = 49/173 (28%), Positives = 82/173 (47%), Gaps = 11/173 (6%)
Query: 72 DVIGCGGSGNVYKGF-LPDRTPVAVK---KSKIVDQTKIDEFINELVVVSQINRRNVVRL 127
+G G G V+ + A+K K +V +++ +E +++S + ++R+
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 128 LACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPII 187
+ Q ++ +++ G LF + K+ AAE L YLHS+ II
Sbjct: 70 WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DII 126
Query: 188 HRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQT 240
+RD+K NILLD+N K++DFG +K VP + GT YI PE + T
Sbjct: 127 YRDLKPENILLDKNGHIKITDFGFAKYVP----DVTYTLCGTPDYIAPEVVST 175
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 122 bits (306), Expect = 5e-34
Identities = 48/184 (26%), Positives = 75/184 (40%), Gaps = 6/184 (3%)
Query: 61 EEIKTVTNNYA--DVIGCGGSGNVYKGF-LPDRTPVAVKK-SKIVDQTKIDEFINELVVV 116
++ + + + Y DV+G G V + VA+K +K + K NE+ V+
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61
Query: 117 SQINRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLS 176
+I N+V L L+ + V G LF+ I + G T R+ + +
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVK 121
Query: 177 YLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPE 236
YLH V + LDE+ +SDFG SK+ D + GT GY+ PE
Sbjct: 122 YLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTPGYVAPE 179
Query: 237 YLQT 240
L
Sbjct: 180 VLAQ 183
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 119 bits (300), Expect = 1e-32
Identities = 49/182 (26%), Positives = 80/182 (43%), Gaps = 15/182 (8%)
Query: 68 NNYA--DVIGCGGSGNVYKGFLPD-RTPVAVK---KSKIVDQTKIDEFINE---LVVVSQ 118
N+++ +IG GG G VY D A+K K +I + +NE L +VS
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 119 INRRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYL 178
+ +V + + + + G L H+ ++G + AAE L ++
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123
Query: 179 HSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYL 238
H+ +++RD+K ANILLDE+ ++SD G + GT GY+ PE L
Sbjct: 124 HNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASVGTHGYMAPEVL 177
Query: 239 QT 240
Q
Sbjct: 178 QK 179
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 1e-32
Identities = 45/187 (24%), Positives = 86/187 (45%), Gaps = 21/187 (11%)
Query: 72 DVIGCGGSGNVYKGFL------PDRTPVAVKK-SKIVDQTKIDEFINELVVVSQINRRNV 124
+G G G VY+G T VA+K ++ + EF+NE V+ + N +V
Sbjct: 26 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 85
Query: 125 VRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGN----------LTWERRLRIAAETAGV 174
VRLL + Q L++ E + G L ++ + + +++A E A
Sbjct: 86 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 145
Query: 175 LSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVP-IDAIQNYTVVQGTLGYI 233
++YL++ +HRD+ + N ++ E++T K+ DFG ++ + D + + ++
Sbjct: 146 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 202
Query: 234 DPEYLQT 240
PE L+
Sbjct: 203 SPESLKD 209
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 1e-32
Identities = 46/174 (26%), Positives = 72/174 (41%), Gaps = 9/174 (5%)
Query: 72 DVIGCGGSGNVYKGF-LPDRTPVAVK---KSKIVDQTKIDEFINELVVVS-QINRRNVVR 126
++G G G V+ A+K K ++ ++ + E V+S +
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67
Query: 127 LLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPI 186
+ + V E++ G L HI R AAE L +LHS+ I
Sbjct: 68 MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GI 124
Query: 187 IHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQT 240
++RD+K NILLD++ K++DFG K + + T GT YI PE L
Sbjct: 125 VYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILLG 177
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 1e-31
Identities = 48/176 (27%), Positives = 75/176 (42%), Gaps = 10/176 (5%)
Query: 72 DVIGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKIDE-----FINELVVVSQINRRNVV 125
D +G G VYK VA+KK K+ +++ + + E+ ++ +++ N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 126 RLLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVP 185
LL LV++F+ + LT T L YLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---W 120
Query: 186 IIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQTC 241
I+HRD+K N+LLDEN K++DFG +K + YT T Y PE L
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYTHQVVTRWYRAPELLFGA 175
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 4e-31
Identities = 35/173 (20%), Positives = 71/173 (41%), Gaps = 10/173 (5%)
Query: 72 DVIGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLAC 130
+ +G G G V++ + K K+ T E+ +++ RN++ L
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNILHLHES 69
Query: 131 CLETQVPLLVYEFVGNGTLFEHIHKNGN-LTWERRLRIAAETAGVLSYLHSETNVPIIHR 189
+ ++++EF+ +FE I+ + L + + L +LHS I H
Sbjct: 70 FESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHF 126
Query: 190 DVKSANILLD--ENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQT 240
D++ NI+ + T K+ +FG ++ + N+ ++ Y PE Q
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPG--DNFRLLFTAPEYYAPEVHQH 177
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 113 bits (283), Expect = 6e-31
Identities = 34/171 (19%), Positives = 67/171 (39%), Gaps = 5/171 (2%)
Query: 72 DVIGCGGSGNVYKGFLPDRTPVAVKKSKI--VDQTKIDEFINELVVVSQINRRNVVRLLA 129
+ IG G G VYK A+KK ++ D+ I E+ ++ ++ N+V+L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 130 CCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHR 189
+ +LV+E + G L + ++Y H ++HR
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHR 124
Query: 190 DVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQT 240
D+K N+L++ K++DFG ++ I + + + +
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 113 bits (284), Expect = 2e-30
Identities = 44/172 (25%), Positives = 75/172 (43%), Gaps = 11/172 (6%)
Query: 72 DVIGCGGSGNVYKGF-LPDRTPVAVK---KSKIVDQTKIDEFINELVVVSQINRRNVVRL 127
+G G G V A+K K K+V +I+ +NE ++ +N +V+L
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 128 LACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPII 187
+ +V E+V G +F H+ + G + AA+ YLHS +I
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLI 163
Query: 188 HRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
+RD+K N+L+D+ +V+DFG +K + GT + PE +
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEALAPEIIL 211
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 3e-30
Identities = 46/195 (23%), Positives = 75/195 (38%), Gaps = 29/195 (14%)
Query: 72 DVIGCGGSGNVYKGF------LPDRTPVAVKK-SKIVDQTKIDEFINELVVVSQINRR-N 123
+G G G V + VAVK + ++ ++EL ++ I N
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78
Query: 124 VVRLLACCLETQVPL-LVYEFVGNGTLFEHIHKNGN----------------LTWERRLR 166
VV LL C + PL ++ EF G L ++ N LT E +
Sbjct: 79 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138
Query: 167 IAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVP-IDAIQNYTV 225
+ + A + +L S IHRD+ + NILL E K+ DFG ++ +
Sbjct: 139 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 195
Query: 226 VQGTLGYIDPEYLQT 240
+ L ++ PE +
Sbjct: 196 ARLPLKWMAPETIFD 210
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 5e-30
Identities = 40/185 (21%), Positives = 73/185 (39%), Gaps = 12/185 (6%)
Query: 66 VTNNYA--DVIGCGGSGNVYKGF-LPDRTPVAVKK-SKIVDQTKIDEFINELVVVSQINR 121
V Y IG G G V + ++ VA+KK S QT + E+ ++ +
Sbjct: 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 65
Query: 122 RNVVRLLACCLETQVPLLVYEFVGN---GTLFEHIHKNGNLTWERRLRIAAETAGVLSYL 178
N++ + + + ++ G + K +L+ + + L Y+
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYI 125
Query: 179 HSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQN--YTVVQGTLGYIDPE 236
HS ++HRD+K +N+LL+ K+ DFG +++ D T T Y PE
Sbjct: 126 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 237 YLQTC 241
+
Sbjct: 183 IMLNS 187
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 2e-29
Identities = 51/180 (28%), Positives = 84/180 (46%), Gaps = 17/180 (9%)
Query: 72 DVIGCGGSGNVYKGF-LPDRTPVAVK---KSKIVDQTKID---EFINELVVVSQINR--R 122
++G GG G+VY G + D PVA+K K +I D ++ E+V++ +++
Sbjct: 10 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 123 NVVRLLACCLETQVPLLVYEFV-GNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSE 181
V+RLL +L+ E LF+ I + G L E + + + H+
Sbjct: 70 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 129
Query: 182 TNVPIIHRDVKSANILLDEN-YTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQT 240
++HRD+K NIL+D N K+ DFG+ L+ YT GT Y PE+++
Sbjct: 130 ---GVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRY 183
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 2e-29
Identities = 44/179 (24%), Positives = 74/179 (41%), Gaps = 10/179 (5%)
Query: 68 NNY--ADVIGCGGSGNVYKGF-LPDRTPVAVK---KSKIVDQTKIDEFINELVVVSQINR 121
N++ ++G G G V A+K K I+ + ++ + E V+
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 122 RNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSE 181
+ L V E+ G LF H+ + T ER AE ++S L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE---IVSALEYL 121
Query: 182 TNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQT 240
+ +++RD+K N++LD++ K++DFG K D T GT Y+ PE L+
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLED 179
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 3e-29
Identities = 43/196 (21%), Positives = 82/196 (41%), Gaps = 30/196 (15%)
Query: 72 DVIGCGGSGNVYKGFLP--------DRTPVAVKK-SKIVDQTKIDEFINELVVVSQINR- 121
+G G G V T VAVK + + + I+E+ ++ I +
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 122 RNVVRLLACCLETQVPLLVYEFVGNGTLFEHIH----------------KNGNLTWERRL 165
+N++ LL C + ++ E+ G L E++ L+ + +
Sbjct: 79 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138
Query: 166 RIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVP-IDAIQNYT 224
A + A + YL S+ IHRD+ + N+L+ E+ K++DFG ++ + ID + T
Sbjct: 139 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195
Query: 225 VVQGTLGYIDPEYLQT 240
+ + ++ PE L
Sbjct: 196 NGRLPVKWMAPEALFD 211
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (269), Expect = 1e-28
Identities = 44/183 (24%), Positives = 75/183 (40%), Gaps = 17/183 (9%)
Query: 72 DVIGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTK--IDEFINELVVVSQINRRNVVRLL 128
IG G G V+K VA+KK + ++ + + E+ ++ + NVV L+
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 129 ACCLETQVP--------LLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHS 180
C P LV++F + + T R+ +L+ L+
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM---LLNGLYY 132
Query: 181 ETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPI---DAIQNYTVVQGTLGYIDPEY 237
I+HRD+K+AN+L+ + K++DFG ++ + YT TL Y PE
Sbjct: 133 IHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPEL 192
Query: 238 LQT 240
L
Sbjct: 193 LLG 195
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 8e-28
Identities = 46/190 (24%), Positives = 77/190 (40%), Gaps = 24/190 (12%)
Query: 64 KTVTNNY---ADVIGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKIDEFINELVVVSQI 119
+ ++Y + V+G G +G V + F + A+K + + E+ + +
Sbjct: 7 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRA 61
Query: 120 NR-RNVVRLLACC----LETQVPLLVYEFVGNGTLFEHIHKNGN--LTWERRLRIAAETA 172
++ ++VR++ + L+V E + G LF I G+ T I
Sbjct: 62 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 121
Query: 173 GVLSYLHSETNVPIIHRDVKSANILLD---ENYTPKVSDFGASKLVPIDAIQNYTVVQGT 229
+ YLHS I HRDVK N+L N K++DFG +K + T T
Sbjct: 122 EAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NSLTTPCYT 176
Query: 230 LGYIDPEYLQ 239
Y+ PE L
Sbjct: 177 PYYVAPEVLG 186
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 102 bits (255), Expect = 9e-27
Identities = 40/189 (21%), Positives = 66/189 (34%), Gaps = 18/189 (9%)
Query: 66 VTNNYA--DVIGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRR 122
V N Y IG G G++Y G + VA+K +TK + E + +
Sbjct: 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL--ECVKTKHPQLHIESKIYKMMQGG 62
Query: 123 NVVRLL-ACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSE 181
+ + C E ++V E +G + + + L +A + + Y+HS+
Sbjct: 63 VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK 122
Query: 182 TNVPIIHRDVKSANIL---LDENYTPKVSDFGASKLVPIDAIQNY------TVVQGTLGY 232
IHRDVK N L + + DFG +K + + GT Y
Sbjct: 123 N---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 233 IDPEYLQTC 241
Sbjct: 180 ASINTHLGI 188
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (255), Expect = 1e-26
Identities = 46/182 (25%), Positives = 73/182 (40%), Gaps = 18/182 (9%)
Query: 72 DVIGCGGSGNVYKGF--LPDRTPVAVK--KSKIVDQTKIDEFINELVVVSQINR---RNV 124
IG G G V+K VA+K + + ++ I E+ V+ + NV
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 125 VRLLACCLETQVP-----LLVYEFVGNGTL-FEHIHKNGNLTWERRLRIAAETAGVLSYL 178
VRL C ++ LV+E V + + E + + L +L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 179 HSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYL 238
HS ++HRD+K NIL+ + K++DFG +++ T V TL Y PE L
Sbjct: 133 HSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI--YSFQMALTSVVVTLWYRAPEVL 187
Query: 239 QT 240
Sbjct: 188 LQ 189
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 1e-26
Identities = 37/173 (21%), Positives = 65/173 (37%), Gaps = 7/173 (4%)
Query: 72 DVIGCGGSGNVYKGF-LPDRTPVAVK--KSKIVDQTKIDEFINELVVVSQINRRNVVRLL 128
+ IG G G VYK VA+K + + I E+ ++ ++N N+V+LL
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 129 ACCLETQVPLLVYEFVGNGTL-FEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPII 187
LV+EF+ F + + L++ HS ++
Sbjct: 68 DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVL 124
Query: 188 HRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQT 240
HRD+K N+L++ K++DFG ++ + V L
Sbjct: 125 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 4e-26
Identities = 42/173 (24%), Positives = 78/173 (45%), Gaps = 7/173 (4%)
Query: 72 DVIGCGGSGNVYKGF-LPDRTPVAVKKSKI--VDQTKIDEFINELVVVSQINRRNVVRLL 128
+ IG G G V+K VA+K+ ++ D+ + E+ ++ ++ +N+VRL
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 129 ACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIH 188
+ LV+EF NG+L E + +L L + ++H
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQ---LLKGLGFCHSRNVLH 124
Query: 189 RDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQTC 241
RD+K N+L++ N K+++FG ++ I ++ Y+ TL Y P+ L
Sbjct: 125 RDLKPQNLLINRNGELKLANFGLARAFGIP-VRCYSAEVVTLWYRPPDVLFGA 176
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 6e-26
Identities = 39/179 (21%), Positives = 71/179 (39%), Gaps = 16/179 (8%)
Query: 72 DVIGCGGSGNVYKGF-LPDRTPVAVKK------SKIVDQTKIDEFINELVVVSQINRRNV 124
+ +G G V K A K ++ E+ ++ +I NV
Sbjct: 16 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75
Query: 125 VRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNV 184
+ L +L+ E V G LF+ + + +LT E + +L+ ++ ++
Sbjct: 76 ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ---ILNGVYYLHSL 132
Query: 185 PIIHRDVKSANILLDENYTP----KVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
I H D+K NI+L + P K+ DFG + ID + + GT ++ PE +
Sbjct: 133 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKNIFGTPEFVAPEIVN 189
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 97.6 bits (242), Expect = 6e-25
Identities = 29/181 (16%), Positives = 59/181 (32%), Gaps = 18/181 (9%)
Query: 72 DVIGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKIDEFINELVVVSQI-NRRNVVRLLA 129
IG G G +++G L + VA+K ++ + +E + + +
Sbjct: 11 RRIGEGSFGVIFEGTNLLNNQQVAIKF--EPRRSDAPQLRDEYRTYKLLAGCTGIPNVYY 68
Query: 130 CCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHR 189
E +LV + +G + + A + + +H + +++R
Sbjct: 69 FGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYR 125
Query: 190 DVKSANILLDENYTP-----KVSDFGASKLVPIDA------IQNYTVVQGTLGYIDPEYL 238
D+K N L+ + V DFG K + + GT Y+
Sbjct: 126 DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH 185
Query: 239 Q 239
Sbjct: 186 L 186
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.4 bits (239), Expect = 5e-24
Identities = 41/196 (20%), Positives = 68/196 (34%), Gaps = 24/196 (12%)
Query: 58 FIEEEIKTVTNNYAD------VIGCGGSGNVYKGF-LPDRTPVAVK--KSKIVDQTKIDE 108
F +E+ +G G G V VA+K +
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 109 FINELVVVSQINRRNVVRLLACCLETQVP------LLVYEFVGNGTLFEHIHKNGNLTWE 162
EL ++ + NV+ LL + LV F+G + K+ L +
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT--DLGKLMKHEKLGED 121
Query: 163 RRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQN 222
R + + L Y+H+ IHRD+K N+ ++E+ K+ DFG ++
Sbjct: 122 RIQFLVYQMLKGLRYIHAAGI---IHRDLKPGNLAVNEDCELKILDFGLARQAD----SE 174
Query: 223 YTVVQGTLGYIDPEYL 238
T T Y PE +
Sbjct: 175 MTGYVVTRWYRAPEVI 190
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 95.7 bits (237), Expect = 5e-24
Identities = 40/175 (22%), Positives = 70/175 (40%), Gaps = 16/175 (9%)
Query: 72 DVIGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINR-RNVVRLLA 129
+G G V++ + + V VK I+ K + E+ ++ + N++ L
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVK---ILKPVKKKKIKREIKILENLRGGPNIITLAD 97
Query: 130 CCLE--TQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPII 187
+ ++ P LV+E V N + LT E L Y HS I+
Sbjct: 98 IVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMG---IM 151
Query: 188 HRDVKSANILLD-ENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQTC 241
HRDVK N+++D E+ ++ D+G ++ N V + + PE L
Sbjct: 152 HRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV--ASRYFKGPELLVDY 204
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.1 bits (233), Expect = 3e-23
Identities = 46/180 (25%), Positives = 70/180 (38%), Gaps = 19/180 (10%)
Query: 73 VIGCGGSGNVYKGFLPD-RTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACC 131
VIG G G VY+ L D VA+KK V Q K EL ++ +++ N+VRL
Sbjct: 27 VIGNGSFGVVYQAKLCDSGELVAIKK---VLQDKR-FKNRELQIMRKLDHCNIVRLRYFF 82
Query: 132 LETQVP------LLVYEFVGNGTLFEHIH---KNGNLTWERRLRIAAETAGVLSYLHSET 182
+ LV ++V H L + L+Y+HS
Sbjct: 83 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF- 141
Query: 183 NVPIIHRDVKSANILLD-ENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQTC 241
I HRD+K N+LLD + K+ DFG++K + + N + +
Sbjct: 142 --GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSYICSRYYRAPELIFGAT 198
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.1 bits (230), Expect = 9e-23
Identities = 49/197 (24%), Positives = 76/197 (38%), Gaps = 19/197 (9%)
Query: 56 KIFIEEEIKTVTNNYA--DVIGCGGSGNVYKGF-LPDRTPVAVKK--SKIVDQTKIDEFI 110
+ + + TV Y IG G G V + VA+KK +QT
Sbjct: 5 SVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY 64
Query: 111 NELVVVSQINRRNVVRLLACCL------ETQVPLLVYEFVGNGTLFEHIHKNGNLTWERR 164
ELV++ +N +N++ LL E Q LV E + + ER
Sbjct: 65 RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL---DHERM 121
Query: 165 LRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYT 224
+ + + +LHS IIHRD+K +NI++ + T K+ DFG ++ T
Sbjct: 122 SYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMT 176
Query: 225 VVQGTLGYIDPEYLQTC 241
T Y PE +
Sbjct: 177 PYVVTRYYRAPEVILGM 193
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.1 bits (225), Expect = 2e-22
Identities = 45/177 (25%), Positives = 72/177 (40%), Gaps = 12/177 (6%)
Query: 72 DVIGCGGSGNVYKGFL----PDRTPVAVK---KSKIVDQTK-IDEFINELVVVSQIN-RR 122
V+G G G V+ A+K K+ IV + K + E V+ I
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 123 NVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSET 182
+V L L+ +++ G LF H+ + T E ++ L
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGE---IVLALEHLH 146
Query: 183 NVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQ 239
+ II+RD+K NILLD N ++DFG SK D + GT+ Y+ P+ ++
Sbjct: 147 KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 203
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.6 bits (208), Expect = 9e-20
Identities = 49/191 (25%), Positives = 76/191 (39%), Gaps = 18/191 (9%)
Query: 59 IEEEIKTVTNNYA--DVIGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKID--EFINEL 113
+ + I V Y +G G G+V F VAVKK Q+ I EL
Sbjct: 9 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 68
Query: 114 VVVSQINRRNVVRLLACC-----LETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIA 168
++ + NV+ LL LE + + + G +I K LT + +
Sbjct: 69 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLI 127
Query: 169 AETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVVQG 228
+ L Y+HS IIHRD+K +N+ ++E+ K+ DFG ++ T
Sbjct: 128 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTD----DEMTGYVA 180
Query: 229 TLGYIDPEYLQ 239
T Y PE +
Sbjct: 181 TRWYRAPEIML 191
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 72.4 bits (176), Expect = 2e-15
Identities = 31/188 (16%), Positives = 67/188 (35%), Gaps = 22/188 (11%)
Query: 72 DVIGCGGSGNVYKGF-LPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLAC 130
+G G V+ + + T VA+K + D+ + +E+ ++ ++N + + +
Sbjct: 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSM 77
Query: 131 CLETQVPLLVYEFVGNGT----------------LFEHIHKNGNLTWERRLRIAAETAGV 174
+ LL + +++ + +I+ +
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 175 LSYLHSETNVPIIHRDVKSANILLD-ENYTPKVSDFGASKL-VPIDAIQNYTVVQGTLGY 232
L Y+H IIH D+K N+L++ + + + L ++YT T Y
Sbjct: 138 LDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195
Query: 233 IDPEYLQT 240
PE L
Sbjct: 196 RSPEVLLG 203
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 67.9 bits (165), Expect = 1e-14
Identities = 26/154 (16%), Positives = 47/154 (30%), Gaps = 21/154 (13%)
Query: 72 DVIGCGGSGNVYKGFLPDRTPVAVK----------KSKIVDQTKIDEFINELVVVSQINR 121
++G G V+ + VK K K F + ++
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 122 RNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHKNGN--LTWERRLRIAAETAGVLSYLH 179
R + +L + Y + GN L E I + E + ++ +
Sbjct: 66 RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120
Query: 180 SETNVPIIHRDVKSANILLDENYTPKVSDFGASK 213
I+H D+ N+L+ E + DF S
Sbjct: 121 HR---GIVHGDLSQYNVLVSE-EGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 241 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.95 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.8 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.47 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.28 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.48 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.24 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.87 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-44 Score=289.17 Aligned_cols=171 Identities=27% Similarity=0.401 Sum_probs=148.0
Q ss_pred hhcccccccccCceeEEEEEeC-CCCeEEEEecccCC-hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEec
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD-QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
.|.+.+.||+|+||+||+|... +++.||||.+.... ....+.+.+|+.+++.++||||+++++++.+++..|+||||+
T Consensus 6 dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 85 (271)
T d1nvra_ 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 85 (271)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEecc
Confidence 3667889999999999999864 68899999876433 233467889999999999999999999999999999999999
Q ss_pred CCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcc-cee
Q 039310 145 GNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAI-QNY 223 (241)
Q Consensus 145 ~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~-~~~ 223 (241)
++|+|.+++.....+++.++..++.|++.||.|||+++ |+||||||+|||+++++.+||+|||+|+....... ...
T Consensus 86 ~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~ 162 (271)
T d1nvra_ 86 SGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 162 (271)
T ss_dssp TTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred CCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCccccc
Confidence 99999999988888999999999999999999999999 99999999999999999999999999987643322 223
Q ss_pred eeecccccccccccccC
Q 039310 224 TVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 224 ~~~~gt~~y~aPE~l~~ 240 (241)
...+||+.|||||++.+
T Consensus 163 ~~~~GT~~Y~APE~~~~ 179 (271)
T d1nvra_ 163 NKMCGTLPYVAPELLKR 179 (271)
T ss_dssp CCCCSCGGGSCTHHHHC
T ss_pred cceeeCcCccCHhHhcC
Confidence 44579999999999864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.5e-44 Score=290.68 Aligned_cols=179 Identities=27% Similarity=0.423 Sum_probs=156.0
Q ss_pred cCHHHHHHhhhcccccccccCceeEEEEEeC-CCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCc
Q 039310 58 FIEEEIKTVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQV 136 (241)
Q Consensus 58 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~ 136 (241)
+..+++....+.+.+.||+|+||+||+|.+. ++..||||+++.. ....+++.+|+.+|+.++||||++++++|.+++.
T Consensus 9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (287)
T d1opja_ 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 87 (287)
T ss_dssp CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence 3445566667888899999999999999865 5788999987643 3345789999999999999999999999999999
Q ss_pred ceEEEEecCCCCchHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCccc
Q 039310 137 PLLVYEFVGNGTLFEHIHKN--GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKL 214 (241)
Q Consensus 137 ~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~ 214 (241)
.+++|||+++|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|+.
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~ 164 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRL 164 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceee
Confidence 99999999999999999654 46899999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCccceeeeecccccccccccccC
Q 039310 215 VPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 215 ~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
...+.........||+.|||||++.+
T Consensus 165 ~~~~~~~~~~~~~g~~~y~aPE~~~~ 190 (287)
T d1opja_ 165 MTGDTYTAHAGAKFPIKWTAPESLAY 190 (287)
T ss_dssp CCSSSSEEETTEEECGGGCCHHHHHH
T ss_pred cCCCCceeeccccccccccChHHHcC
Confidence 76554444445568999999998764
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-43 Score=286.66 Aligned_cols=169 Identities=27% Similarity=0.431 Sum_probs=150.4
Q ss_pred hhcccccccccCceeEEEEEe-CCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecC
Q 039310 67 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVG 145 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~ 145 (241)
+|.+.+.||+|+||+||+|.. .+++.||||.+...+....+.+.+|+.+++.++||||+++++++.+.+..|+||||++
T Consensus 21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 100 (293)
T d1yhwa1 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (293)
T ss_dssp TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecC
Confidence 477788999999999999985 4688999998876555566789999999999999999999999999999999999999
Q ss_pred CCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeee
Q 039310 146 NGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTV 225 (241)
Q Consensus 146 ~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~ 225 (241)
+|+|.+++..+ .+++.++..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+..+. .....
T Consensus 101 gg~L~~~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~~~ 175 (293)
T d1yhwa1 101 GGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKRST 175 (293)
T ss_dssp TCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-CCBCC
T ss_pred CCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc-ccccc
Confidence 99999988764 6999999999999999999999999 9999999999999999999999999998764433 23344
Q ss_pred ecccccccccccccC
Q 039310 226 VQGTLGYIDPEYLQT 240 (241)
Q Consensus 226 ~~gt~~y~aPE~l~~ 240 (241)
..||+.|||||++.+
T Consensus 176 ~~gt~~Y~aPE~~~~ 190 (293)
T d1yhwa1 176 MVGTPYWMAPEVVTR 190 (293)
T ss_dssp CCSCGGGCCHHHHSS
T ss_pred cccCCCccChhhhcC
Confidence 569999999999875
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-43 Score=284.25 Aligned_cols=170 Identities=28% Similarity=0.443 Sum_probs=139.7
Q ss_pred hhcccccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCC
Q 039310 67 TNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGN 146 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~ 146 (241)
.+.+.+.||+|+||+||+|.+.++..||||++.... ...+++.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus 6 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~ 84 (263)
T d1sm2a_ 6 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 84 (263)
T ss_dssp CEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred HcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCC
Confidence 356778899999999999999888899999987533 3447899999999999999999999999999999999999999
Q ss_pred CCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeee
Q 039310 147 GTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTV 225 (241)
Q Consensus 147 g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~ 225 (241)
|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||+++++.+||+|||+|+............
T Consensus 85 g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~ 161 (263)
T d1sm2a_ 85 GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 161 (263)
T ss_dssp CBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC---------------
T ss_pred CcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCceeecc
Confidence 9999998755 46899999999999999999999999 9999999999999999999999999998775544444444
Q ss_pred ecccccccccccccC
Q 039310 226 VQGTLGYIDPEYLQT 240 (241)
Q Consensus 226 ~~gt~~y~aPE~l~~ 240 (241)
..||+.|||||++.+
T Consensus 162 ~~gt~~y~aPE~l~~ 176 (263)
T d1sm2a_ 162 TKFPVKWASPEVFSF 176 (263)
T ss_dssp ---CTTSCCHHHHTT
T ss_pred eecCcccCChHHhcC
Confidence 568999999999875
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-43 Score=282.22 Aligned_cols=168 Identities=28% Similarity=0.405 Sum_probs=149.4
Q ss_pred hhcccccccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEE
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYE 142 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e 142 (241)
.|.+.+.||+|+||+||+|+.. +++.||+|.+... +....+.+.+|+.+++.++||||+++++++.+++..|+|||
T Consensus 7 dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmE 86 (263)
T d2j4za1 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE 86 (263)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEe
Confidence 4677889999999999999964 5889999987532 23345678899999999999999999999999999999999
Q ss_pred ecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccce
Q 039310 143 FVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQN 222 (241)
Q Consensus 143 ~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~ 222 (241)
|+++|+|.+++...+.+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|...... .
T Consensus 87 y~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~---~ 160 (263)
T d2j4za1 87 YAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---R 160 (263)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC---C
T ss_pred ecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC---c
Confidence 9999999999998889999999999999999999999999 999999999999999999999999999876432 2
Q ss_pred eeeecccccccccccccC
Q 039310 223 YTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 223 ~~~~~gt~~y~aPE~l~~ 240 (241)
.....||+.|||||++.+
T Consensus 161 ~~~~~Gt~~Y~APE~~~~ 178 (263)
T d2j4za1 161 RTTLCGTLDYLPPEMIEG 178 (263)
T ss_dssp CEETTEEGGGCCHHHHTT
T ss_pred ccccCCCCcccCHHHHcC
Confidence 344579999999999875
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-43 Score=285.66 Aligned_cols=174 Identities=26% Similarity=0.457 Sum_probs=150.5
Q ss_pred HHHHhhhcccccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEE
Q 039310 62 EIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVY 141 (241)
Q Consensus 62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~ 141 (241)
++....+.+.+.||+|+||+||+|.++++..||||++.... ...+.+.+|+.++++++||||+++++++.+ +..++||
T Consensus 9 ei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~ 86 (272)
T d1qpca_ 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT 86 (272)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEE
Confidence 44556778888999999999999999888899999887533 345789999999999999999999998765 5679999
Q ss_pred EecCCCCchHHhhcCC--CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCc
Q 039310 142 EFVGNGTLFEHIHKNG--NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDA 219 (241)
Q Consensus 142 e~~~~g~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~ 219 (241)
||+++|+|.+++.... ++++..+..++.|++.||.|||+++ |+||||||+|||+++++.+||+|||+|+.+....
T Consensus 87 Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred EeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCc
Confidence 9999999999875433 5999999999999999999999998 9999999999999999999999999999876544
Q ss_pred cceeeeecccccccccccccC
Q 039310 220 IQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 220 ~~~~~~~~gt~~y~aPE~l~~ 240 (241)
........||+.|||||++.+
T Consensus 164 ~~~~~~~~gt~~y~APE~~~~ 184 (272)
T d1qpca_ 164 YTAREGAKFPIKWTAPEAINY 184 (272)
T ss_dssp EECCTTCCCCTTTSCHHHHHH
T ss_pred cccccccCCcccccChHHHhC
Confidence 444444568999999999864
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-42 Score=279.20 Aligned_cols=169 Identities=25% Similarity=0.336 Sum_probs=145.2
Q ss_pred hcccccccccCceeEEEEEeC-CCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEec----CCcceEE
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLE----TQVPLLV 140 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~----~~~~~lv 140 (241)
+.+.+.||+|+||+||+|... ++..||+|++... .....+.+.+|+++|++++||||+++++++.+ ....|+|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 356678999999999999965 5788999987543 44556789999999999999999999999865 3467999
Q ss_pred EEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC-CCCCeEEccCCCcccccCCc
Q 039310 141 YEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLD-ENYTPKVSDFGASKLVPIDA 219 (241)
Q Consensus 141 ~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~-~~~~~kl~Dfgla~~~~~~~ 219 (241)
|||+++|+|.+++.+...+++..+..++.|++.||+|||+++ .+|+||||||+|||++ +++.+||+|||+|+....
T Consensus 91 mE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~-- 167 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-- 167 (270)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT--
T ss_pred EeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC--
Confidence 999999999999998888999999999999999999999875 5599999999999996 578999999999986432
Q ss_pred cceeeeecccccccccccccC
Q 039310 220 IQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 220 ~~~~~~~~gt~~y~aPE~l~~ 240 (241)
.......||+.|||||++.+
T Consensus 168 -~~~~~~~GT~~Y~aPE~~~~ 187 (270)
T d1t4ha_ 168 -SFAKAVIGTPEFMAPEMYEE 187 (270)
T ss_dssp -TSBEESCSSCCCCCGGGGGT
T ss_pred -CccCCcccCccccCHHHhCC
Confidence 22345679999999999865
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-43 Score=283.63 Aligned_cols=172 Identities=28% Similarity=0.458 Sum_probs=142.3
Q ss_pred HHHhhhcccccccccCceeEEEEEeCCCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEE
Q 039310 63 IKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLV 140 (241)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv 140 (241)
+....+.+.+.||+|+||+||+|++++ .||||.++.. +....+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv 81 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIV 81 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred cccccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEE
Confidence 344557778899999999999998743 5999987643 45566889999999999999999999998754 567999
Q ss_pred EEecCCCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCc
Q 039310 141 YEFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDA 219 (241)
Q Consensus 141 ~e~~~~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~ 219 (241)
|||+++|+|.+++... .++++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp EECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 9999999999999654 56999999999999999999999998 9999999999999999999999999998764332
Q ss_pred c-ceeeeecccccccccccccC
Q 039310 220 I-QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 220 ~-~~~~~~~gt~~y~aPE~l~~ 240 (241)
. .......||+.|||||++.+
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~ 180 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRM 180 (276)
T ss_dssp -------CCCCGGGCCHHHHTT
T ss_pred CcccccccccCcccCCHHHHhc
Confidence 2 23344569999999999853
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-43 Score=284.39 Aligned_cols=169 Identities=25% Similarity=0.352 Sum_probs=149.1
Q ss_pred hhcccccccccCceeEEEEEeC-CCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecC
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVG 145 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~ 145 (241)
.|++.+.||+|+||+||+|+.. ++..||||.+...+....+.+.+|+++++.++||||+++++++.+.+..++||||++
T Consensus 13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~ 92 (288)
T d2jfla1 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 92 (288)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCC
Confidence 4667788999999999999864 688999999876666667889999999999999999999999999999999999999
Q ss_pred CCCchHHhhc-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceee
Q 039310 146 NGTLFEHIHK-NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYT 224 (241)
Q Consensus 146 ~g~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~ 224 (241)
+|+|.+++.. ..++++.++..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|....... ....
T Consensus 93 ~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~~~ 168 (288)
T d2jfla1 93 GGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRD 168 (288)
T ss_dssp TEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HHHT
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc-cccc
Confidence 9999999764 457999999999999999999999999 9999999999999999999999999997653221 2233
Q ss_pred eeccccccccccccc
Q 039310 225 VVQGTLGYIDPEYLQ 239 (241)
Q Consensus 225 ~~~gt~~y~aPE~l~ 239 (241)
...||+.|||||++.
T Consensus 169 ~~~Gt~~y~APE~l~ 183 (288)
T d2jfla1 169 SFIGTPYWMAPEVVM 183 (288)
T ss_dssp CCCSCCTTCCHHHHT
T ss_pred ccccccccCCHHHHh
Confidence 456999999999974
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-43 Score=292.25 Aligned_cols=169 Identities=25% Similarity=0.315 Sum_probs=148.1
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
..|...+.||+|+||+||+|+.. ++..||+|.++.. +....+.+.+|+.+|+.++||||++++++|.+.+..|+||||
T Consensus 6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy 85 (322)
T d1s9ja_ 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 85 (322)
T ss_dssp GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 35667789999999999999954 6889999987643 344457889999999999999999999999999999999999
Q ss_pred cCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccce
Q 039310 144 VGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSE-TNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQN 222 (241)
Q Consensus 144 ~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~-~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~ 222 (241)
+++|+|.+++.+.+.+++..+..++.|++.||.|||++ + |+||||||+|||+++++.+||+|||+|...... .
T Consensus 86 ~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~---~ 159 (322)
T d1s9ja_ 86 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---M 159 (322)
T ss_dssp CTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---T
T ss_pred CCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC---c
Confidence 99999999999888899999999999999999999975 7 999999999999999999999999999876322 2
Q ss_pred eeeecccccccccccccC
Q 039310 223 YTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 223 ~~~~~gt~~y~aPE~l~~ 240 (241)
.....||+.|||||++.+
T Consensus 160 ~~~~~GT~~Y~APEvl~~ 177 (322)
T d1s9ja_ 160 ANSFVGTRSYMSPERLQG 177 (322)
T ss_dssp C---CCSSCCCCHHHHHC
T ss_pred cccccCCccccCchHHcC
Confidence 334579999999999865
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=282.64 Aligned_cols=171 Identities=26% Similarity=0.377 Sum_probs=148.1
Q ss_pred hhcccccccccCceeEEEEEe-CCCCeEEEEecccC---ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEE
Q 039310 67 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIV---DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYE 142 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e 142 (241)
.|.+.+.||+|+||+||+|.. .+++.||||.+... +....+.+.+|+.++++++||||+++++++.+++..|+|||
T Consensus 9 dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE 88 (288)
T d1uu3a_ 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 88 (288)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEEC
T ss_pred CCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEE
Confidence 478889999999999999986 46889999987532 23345778999999999999999999999999999999999
Q ss_pred ecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcc-c
Q 039310 143 FVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAI-Q 221 (241)
Q Consensus 143 ~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~-~ 221 (241)
|+++|+|.+++...+.+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|+.+..... .
T Consensus 89 y~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 165 (288)
T d1uu3a_ 89 YAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 165 (288)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred ccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCCccc
Confidence 9999999999998889999999999999999999999999 99999999999999999999999999987754322 2
Q ss_pred eeeeecccccccccccccC
Q 039310 222 NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~~ 240 (241)
.....+||+.|||||++.+
T Consensus 166 ~~~~~~GT~~Y~APE~~~~ 184 (288)
T d1uu3a_ 166 RANSFVGTAQYVSPELLTE 184 (288)
T ss_dssp ----CCCCGGGCCHHHHHT
T ss_pred ccccccCCccccCceeecc
Confidence 3344579999999999865
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-42 Score=283.91 Aligned_cols=166 Identities=27% Similarity=0.333 Sum_probs=147.2
Q ss_pred hhhcccccccccCceeEEEEEe-CCCCeEEEEecccCC---hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVD---QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVY 141 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~ 141 (241)
..|...+.||+|+||+||+|+. .++..||||.+.... ....+.+.+|+.+++.++||||+++++++.+++..|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 4577788999999999999985 468889999876432 334567899999999999999999999999999999999
Q ss_pred EecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc
Q 039310 142 EFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ 221 (241)
Q Consensus 142 e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~ 221 (241)
|||++|++..++....++++.++..++.|++.||.|||+++ |+||||||+|||+++++.+||+|||+|.....
T Consensus 95 E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 167 (309)
T ss_dssp ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----
T ss_pred EecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC----
Confidence 99999999888888888999999999999999999999999 99999999999999999999999999986532
Q ss_pred eeeeeccccccccccccc
Q 039310 222 NYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~ 239 (241)
.....||+.|||||++.
T Consensus 168 -~~~~~GT~~Y~APE~~~ 184 (309)
T d1u5ra_ 168 -ANSFVGTPYWMAPEVIL 184 (309)
T ss_dssp -BCCCCSCGGGCCHHHHT
T ss_pred -CCccccCccccCHHHHh
Confidence 23356999999999985
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.2e-42 Score=281.78 Aligned_cols=172 Identities=27% Similarity=0.397 Sum_probs=136.6
Q ss_pred hhhcccccccccCceeEEEEEeCC-C---CeEEEEeccc-CChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLPD-R---TPVAVKKSKI-VDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLV 140 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~-~---~~vavk~~~~-~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv 140 (241)
..+.+.+.||+|+||+||+|.+.. + ..||||.+.. ......++|.+|+.+|++++||||+++++++.+.+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 456677899999999999998643 2 2588888765 3455667899999999999999999999999999999999
Q ss_pred EEecCCCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCc
Q 039310 141 YEFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDA 219 (241)
Q Consensus 141 ~e~~~~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~ 219 (241)
|||+++|+|.+++... +.+++.++..++.|++.||.|||+++ ++||||||+|||+++++.+||+|||+|+.+....
T Consensus 106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 182 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182 (299)
T ss_dssp EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCCC
Confidence 9999999999988764 46999999999999999999999998 9999999999999999999999999998764332
Q ss_pred cce----eeeecccccccccccccC
Q 039310 220 IQN----YTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 220 ~~~----~~~~~gt~~y~aPE~l~~ 240 (241)
... .....||+.|||||++.+
T Consensus 183 ~~~~~~~~~~~~~t~~y~aPE~~~~ 207 (299)
T d1jpaa_ 183 SDPTYTSALGGKIPIRWTAPEAIQY 207 (299)
T ss_dssp -------------CGGGSCHHHHHS
T ss_pred CcceeeecccccCCccccCHHHHhc
Confidence 211 122347999999999865
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-41 Score=282.01 Aligned_cols=170 Identities=26% Similarity=0.336 Sum_probs=151.0
Q ss_pred hhcccccccccCceeEEEEEe-CCCCeEEEEecccC---ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEE
Q 039310 67 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIV---DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYE 142 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e 142 (241)
.|.+.+.||+|+||+||+|+. .+++.||||.+... .....+.+.+|+.+|+.++||||+++++++.+.+..|+|||
T Consensus 6 dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~e 85 (337)
T d1o6la_ 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 85 (337)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccccee
Confidence 366788999999999999995 46899999987532 23346778999999999999999999999999999999999
Q ss_pred ecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccce
Q 039310 143 FVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQN 222 (241)
Q Consensus 143 ~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~ 222 (241)
|+++|+|.+++...+.+++..+..++.|++.||+|||+++ |+||||||+|||++++|.+||+|||+|+...... ..
T Consensus 86 y~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~-~~ 161 (337)
T d1o6la_ 86 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-AT 161 (337)
T ss_dssp CCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-CC
T ss_pred ccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccCC-cc
Confidence 9999999999999889999999999999999999999999 9999999999999999999999999998754322 23
Q ss_pred eeeecccccccccccccC
Q 039310 223 YTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 223 ~~~~~gt~~y~aPE~l~~ 240 (241)
....+||+.|||||++.+
T Consensus 162 ~~~~~GT~~Y~aPE~~~~ 179 (337)
T d1o6la_ 162 MKTFCGTPEYLAPEVLED 179 (337)
T ss_dssp BCCCEECGGGCCGGGGSS
T ss_pred cccceeCHHHhhhhhccC
Confidence 445679999999999875
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.5e-41 Score=283.17 Aligned_cols=169 Identities=20% Similarity=0.329 Sum_probs=150.7
Q ss_pred hhcccccccccCceeEEEEEe-CCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecC
Q 039310 67 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVG 145 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~ 145 (241)
.|.+.+.||+|+||+||+|.. .++..||||++........+.+.+|+.+++.++||||+++++++.+.+..|+|||||+
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 106 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 106 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 578889999999999999985 4688999999877666777889999999999999999999999999999999999999
Q ss_pred CCCchHHhhc-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC--CCCCeEEccCCCcccccCCccce
Q 039310 146 NGTLFEHIHK-NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLD--ENYTPKVSDFGASKLVPIDAIQN 222 (241)
Q Consensus 146 ~g~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~--~~~~~kl~Dfgla~~~~~~~~~~ 222 (241)
+|+|.+++.. .+++++..+..++.|++.||.|||+++ ++||||||+|||++ .++.+||+|||+|..+... ..
T Consensus 107 gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~--~~ 181 (350)
T d1koaa2 107 GGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--QS 181 (350)
T ss_dssp SCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT--SC
T ss_pred CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc--cc
Confidence 9999999854 457999999999999999999999999 99999999999996 4678999999999876433 33
Q ss_pred eeeecccccccccccccC
Q 039310 223 YTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 223 ~~~~~gt~~y~aPE~l~~ 240 (241)
.....||+.|||||++.+
T Consensus 182 ~~~~~gT~~Y~aPEv~~~ 199 (350)
T d1koaa2 182 VKVTTGTAEFAAPEVAEG 199 (350)
T ss_dssp EEEECSCTTTCCHHHHHT
T ss_pred cceecCcccccCHHHHcC
Confidence 445679999999999865
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.2e-42 Score=280.89 Aligned_cols=170 Identities=29% Similarity=0.386 Sum_probs=133.7
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEecccCC-hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD-QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
..|.+.+.||+|+||+||+|+.. +++.||||.+.... ......+.+|+.+++.++||||+++++++.+++..|+||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~ 88 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 45788899999999999999964 58899999876432 23345678999999999999999999999999999999999
Q ss_pred cCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC---CCCCeEEccCCCcccccCCcc
Q 039310 144 VGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLD---ENYTPKVSDFGASKLVPIDAI 220 (241)
Q Consensus 144 ~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~---~~~~~kl~Dfgla~~~~~~~~ 220 (241)
+++|+|.+++...+.+++.++..++.|++.||.|||+++ |+||||||+|||++ +++.+||+|||+|+.....
T Consensus 89 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~-- 163 (307)
T d1a06a_ 89 VSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-- 163 (307)
T ss_dssp CCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred cCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccCC--
Confidence 999999999998889999999999999999999999999 99999999999995 5789999999999865433
Q ss_pred ceeeeecccccccccccccC
Q 039310 221 QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 221 ~~~~~~~gt~~y~aPE~l~~ 240 (241)
......+||+.|||||++.+
T Consensus 164 ~~~~~~~GT~~y~APE~~~~ 183 (307)
T d1a06a_ 164 SVLSTACGTPGYVAPEVLAQ 183 (307)
T ss_dssp ---------CTTSCHHHHTT
T ss_pred CeeeeeeeCccccCcHHHcC
Confidence 23344679999999999875
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-41 Score=272.30 Aligned_cols=169 Identities=25% Similarity=0.393 Sum_probs=149.8
Q ss_pred hcccccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCCC
Q 039310 68 NNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGNG 147 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~g 147 (241)
+.+.+.||+|+||+||+|+++++..||||.++.... ..+++.+|+.+++.++||||++++|++.+++..++||||+++|
T Consensus 6 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g 84 (258)
T d1k2pa_ 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANG 84 (258)
T ss_dssp CCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTE
T ss_pred CEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCC
Confidence 567889999999999999998888999998875433 4478999999999999999999999999999999999999999
Q ss_pred CchHHhhc-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceeeee
Q 039310 148 TLFEHIHK-NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYTVV 226 (241)
Q Consensus 148 ~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 226 (241)
+|.+++.. ...+++..+..++.|+++||.|||+++ |+||||||+|||+++++.+||+|||+|+.............
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 161 (258)
T d1k2pa_ 85 CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS 161 (258)
T ss_dssp EHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCS
T ss_pred cHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCceeeccc
Confidence 99998654 456999999999999999999999998 99999999999999999999999999987755544444456
Q ss_pred cccccccccccccC
Q 039310 227 QGTLGYIDPEYLQT 240 (241)
Q Consensus 227 ~gt~~y~aPE~l~~ 240 (241)
.||+.|||||++.+
T Consensus 162 ~~t~~y~aPE~~~~ 175 (258)
T d1k2pa_ 162 KFPVRWSPPEVLMY 175 (258)
T ss_dssp CCCGGGCCHHHHHH
T ss_pred CCCCCcCCcHHhcC
Confidence 69999999999864
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-41 Score=274.42 Aligned_cols=165 Identities=27% Similarity=0.390 Sum_probs=139.2
Q ss_pred ccccccCceeEEEEEeCC---CCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecCC
Q 039310 72 DVIGCGGSGNVYKGFLPD---RTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVGN 146 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~---~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~ 146 (241)
+.||+|+||+||+|.+.+ ++.||||.++.. +....+++.+|+.+|++++||||++++++|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 369999999999998543 457999987542 33445789999999999999999999999865 457899999999
Q ss_pred CCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc--eee
Q 039310 147 GTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ--NYT 224 (241)
Q Consensus 147 g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~--~~~ 224 (241)
|+|.+++.....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+...... ...
T Consensus 92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~ 168 (277)
T d1xbba_ 92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 168 (277)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence 999999999889999999999999999999999999 999999999999999999999999999876443322 223
Q ss_pred eecccccccccccccC
Q 039310 225 VVQGTLGYIDPEYLQT 240 (241)
Q Consensus 225 ~~~gt~~y~aPE~l~~ 240 (241)
...||+.|||||++.+
T Consensus 169 ~~~gt~~y~APE~l~~ 184 (277)
T d1xbba_ 169 HGKWPVKWYAPECINY 184 (277)
T ss_dssp --CCCGGGCCHHHHHH
T ss_pred ccCCCceecCchhhcC
Confidence 3458999999998754
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-42 Score=275.49 Aligned_cols=173 Identities=24% Similarity=0.344 Sum_probs=135.8
Q ss_pred hhcccccccccCceeEEEEEe-CCCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEec--CCcceEEE
Q 039310 67 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLE--TQVPLLVY 141 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~--~~~~~lv~ 141 (241)
.|.+.+.||+|+||+||+|+. .+++.||+|.+... +....+.+.+|+.+++.++||||+++++++.+ ++..|+||
T Consensus 5 dy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivm 84 (269)
T d2java1 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 84 (269)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEE
T ss_pred hCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEE
Confidence 467788999999999999985 46889999987653 44556789999999999999999999999965 45689999
Q ss_pred EecCCCCchHHhhc----CCCCCHHHHHHHHHHHHHHHHHhhcCCC--CCeEecCCCCCCeeeCCCCCeEEccCCCcccc
Q 039310 142 EFVGNGTLFEHIHK----NGNLTWERRLRIAAETAGVLSYLHSETN--VPIIHRDVKSANILLDENYTPKVSDFGASKLV 215 (241)
Q Consensus 142 e~~~~g~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~~~--~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~ 215 (241)
||+++|+|.+++.. +..+++..++.++.|++.||.|||+++. .+|+||||||+|||+++++.+||+|||+|+.+
T Consensus 85 Ey~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~ 164 (269)
T d2java1 85 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 164 (269)
T ss_dssp ECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC
T ss_pred ecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeec
Confidence 99999999999853 4579999999999999999999998642 24999999999999999999999999999876
Q ss_pred cCCccceeeeecccccccccccccC
Q 039310 216 PIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 216 ~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
..+. .......||+.|||||++.+
T Consensus 165 ~~~~-~~~~~~~gt~~Y~APE~l~~ 188 (269)
T d2java1 165 NHDT-SFAKAFVGTPYYMSPEQMNR 188 (269)
T ss_dssp ------------CCCSCCCHHHHTT
T ss_pred ccCC-CccccCCCCcccCCHHHHcC
Confidence 5332 23345679999999999865
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.4e-41 Score=278.47 Aligned_cols=167 Identities=29% Similarity=0.373 Sum_probs=149.4
Q ss_pred hhcccccccccCceeEEEEEe-CCCCeEEEEecccC---ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEE
Q 039310 67 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIV---DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYE 142 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e 142 (241)
.|.+.+.||+|+||+||+|+. .+++.||||.+... .....+.+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 5 dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 84 (316)
T d1fota_ 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD 84 (316)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred HeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEee
Confidence 366788999999999999996 46889999987532 23345788999999999999999999999999999999999
Q ss_pred ecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccce
Q 039310 143 FVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQN 222 (241)
Q Consensus 143 ~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~ 222 (241)
|++||+|..++.....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 85 ~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~---- 157 (316)
T d1fota_ 85 YIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---- 157 (316)
T ss_dssp CCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC----
T ss_pred ecCCccccccccccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc----
Confidence 9999999999999989999999999999999999999999 999999999999999999999999999876432
Q ss_pred eeeecccccccccccccC
Q 039310 223 YTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 223 ~~~~~gt~~y~aPE~l~~ 240 (241)
....+||+.|||||++.+
T Consensus 158 ~~~~~Gt~~Y~APE~l~~ 175 (316)
T d1fota_ 158 TYTLCGTPDYIAPEVVST 175 (316)
T ss_dssp BCCCCSCTTTCCHHHHTT
T ss_pred cccccCcccccCHHHHcC
Confidence 334679999999999865
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.9e-41 Score=279.76 Aligned_cols=169 Identities=20% Similarity=0.305 Sum_probs=150.5
Q ss_pred hhcccccccccCceeEEEEEe-CCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecC
Q 039310 67 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVG 145 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~ 145 (241)
.|.+.+.||+|+||+||+|.. .+++.||||.+..........+.+|+.+++.++||||+++++++.+++..|+|||||+
T Consensus 30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 109 (352)
T d1koba_ 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 109 (352)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 477888999999999999985 4689999998876666666788999999999999999999999999999999999999
Q ss_pred CCCchHHhhcCC-CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC--CCCCeEEccCCCcccccCCccce
Q 039310 146 NGTLFEHIHKNG-NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLD--ENYTPKVSDFGASKLVPIDAIQN 222 (241)
Q Consensus 146 ~g~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~--~~~~~kl~Dfgla~~~~~~~~~~ 222 (241)
+|+|.+++...+ ++++.++..++.|++.||.|||+++ |+||||||+|||++ .++.+||+|||+|..+..+. .
T Consensus 110 gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~--~ 184 (352)
T d1koba_ 110 GGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--I 184 (352)
T ss_dssp CCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS--C
T ss_pred CChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC--c
Confidence 999998876554 6999999999999999999999999 99999999999998 67899999999998875433 3
Q ss_pred eeeecccccccccccccC
Q 039310 223 YTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 223 ~~~~~gt~~y~aPE~l~~ 240 (241)
.....||+.|||||++.+
T Consensus 185 ~~~~~gt~~y~aPE~~~~ 202 (352)
T d1koba_ 185 VKVTTATAEFAAPEIVDR 202 (352)
T ss_dssp EEEECSSGGGCCHHHHTT
T ss_pred eeeccCcccccCHHHHcC
Confidence 445679999999999865
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-41 Score=275.81 Aligned_cols=172 Identities=27% Similarity=0.426 Sum_probs=139.6
Q ss_pred hhhcccccccccCceeEEEEEeCCC-----CeEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLPDR-----TPVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLL 139 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~-----~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~l 139 (241)
..+...++||+|+||+||+|.+++. ..||||++... ......++.+|+.+++.++||||++++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 3456678999999999999986542 36999987653 44455679999999999999999999999999999999
Q ss_pred EEEecCCCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCC
Q 039310 140 VYEFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPID 218 (241)
Q Consensus 140 v~e~~~~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~ 218 (241)
+|||+.++++.+++... ..+++.++..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|+.+...
T Consensus 87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 99999999999887654 57999999999999999999999999 999999999999999999999999999876443
Q ss_pred ccc--eeeeecccccccccccccC
Q 039310 219 AIQ--NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 219 ~~~--~~~~~~gt~~y~aPE~l~~ 240 (241)
... ......||+.|||||++.+
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~ 187 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISY 187 (283)
T ss_dssp ----------CCCGGGSCHHHHHS
T ss_pred CccceEeccCCCCccccCHHHHcc
Confidence 221 2233458999999998865
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-42 Score=277.45 Aligned_cols=173 Identities=25% Similarity=0.381 Sum_probs=142.7
Q ss_pred HHHhhhcccccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEE
Q 039310 63 IKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYE 142 (241)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e 142 (241)
+....+.+.+.||+|+||+||+|.++++..||||.+.... ...+.|.+|+.++++++||||+++++++.+ +..++|||
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~E 91 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 91 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEE
Confidence 3345688899999999999999999888889999986543 344789999999999999999999999854 56799999
Q ss_pred ecCCCCchHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcc
Q 039310 143 FVGNGTLFEHIHK--NGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAI 220 (241)
Q Consensus 143 ~~~~g~L~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~ 220 (241)
|+++|+|.+++.. ...+++.++..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+|+.......
T Consensus 92 y~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 92 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred ecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence 9999999988864 346999999999999999999999999 99999999999999999999999999987654444
Q ss_pred ceeeeecccccccccccccC
Q 039310 221 QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 221 ~~~~~~~gt~~y~aPE~l~~ 240 (241)
.......||+.|+|||++.+
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~ 188 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALY 188 (285)
T ss_dssp -------CCGGGSCHHHHHH
T ss_pred eeeccccccccccChHHHhC
Confidence 44444569999999999864
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-41 Score=273.54 Aligned_cols=169 Identities=26% Similarity=0.446 Sum_probs=142.7
Q ss_pred hccccc-ccccCceeEEEEEeC---CCCeEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEE
Q 039310 68 NNYADV-IGCGGSGNVYKGFLP---DRTPVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYE 142 (241)
Q Consensus 68 ~~~~~~-lg~G~~g~V~~~~~~---~~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e 142 (241)
+.+.+. ||+|+||+||+|.++ ++..||||.++.. +....+++.+|+.+|++++||||+++++++.+ +..|+|||
T Consensus 10 ~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE 88 (285)
T d1u59a_ 10 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVME 88 (285)
T ss_dssp EEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred eEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEE
Confidence 445564 999999999999754 3457999987653 45566789999999999999999999999875 46789999
Q ss_pred ecCCCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc
Q 039310 143 FVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ 221 (241)
Q Consensus 143 ~~~~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~ 221 (241)
|+++|+|.+++... ..+++.++..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||+|+.+......
T Consensus 89 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 165 (285)
T d1u59a_ 89 MAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 165 (285)
T ss_dssp CCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred eCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccccccc
Confidence 99999999997654 57999999999999999999999999 999999999999999999999999999877543322
Q ss_pred --eeeeecccccccccccccC
Q 039310 222 --NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 222 --~~~~~~gt~~y~aPE~l~~ 240 (241)
......||+.|||||++.+
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~ 186 (285)
T d1u59a_ 166 YTARSAGKWPLKWYAPECINF 186 (285)
T ss_dssp ECCCCSSCCCGGGCCHHHHHH
T ss_pred cccccccccCccccChHHHhC
Confidence 2223458999999999864
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-41 Score=279.59 Aligned_cols=176 Identities=25% Similarity=0.388 Sum_probs=145.7
Q ss_pred HHHHhhhcccccccccCceeEEEEEeCCC------CeEEEEecccC-ChhhHHHHHHHHHHHHcC-CCCCceeEEEEEec
Q 039310 62 EIKTVTNNYADVIGCGGSGNVYKGFLPDR------TPVAVKKSKIV-DQTKIDEFINELVVVSQI-NRRNVVRLLACCLE 133 (241)
Q Consensus 62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~------~~vavk~~~~~-~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~ 133 (241)
++....+.+.+.||+|+||+||+|++.+. ..||+|.+... +......+.+|+.+++++ +||||+++++++.+
T Consensus 33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~ 112 (325)
T d1rjba_ 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 112 (325)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence 34455678889999999999999985432 25889987543 344456789999999998 89999999999999
Q ss_pred CCcceEEEEecCCCCchHHhhcCC-----------------------CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecC
Q 039310 134 TQVPLLVYEFVGNGTLFEHIHKNG-----------------------NLTWERRLRIAAETAGVLSYLHSETNVPIIHRD 190 (241)
Q Consensus 134 ~~~~~lv~e~~~~g~L~~~l~~~~-----------------------~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~d 190 (241)
.+..++|||||++|+|.+++.... .+++..+..++.|++.||.|||+++ |+|||
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRD 189 (325)
T d1rjba_ 113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRD 189 (325)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETT
T ss_pred CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecc
Confidence 999999999999999999997542 4899999999999999999999999 99999
Q ss_pred CCCCCeeeCCCCCeEEccCCCcccccCCccc-eeeeecccccccccccccC
Q 039310 191 VKSANILLDENYTPKVSDFGASKLVPIDAIQ-NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 191 lk~~Nili~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~ 240 (241)
|||+|||++.++.+||+|||+|+........ ......||+.|||||++.+
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE 240 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH
T ss_pred CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC
Confidence 9999999999999999999999876543322 2234568999999998764
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-40 Score=271.84 Aligned_cols=170 Identities=24% Similarity=0.318 Sum_probs=149.3
Q ss_pred hhhcccccccccCceeEEEEEe-CCCCeEEEEecccC------ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcce
Q 039310 66 VTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIV------DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPL 138 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~------~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~ 138 (241)
.+|.+.+.||+|+||+||+|+. .+++.||||.+... .....+.+.+|+.+|+.++||||+++++++.+.+..|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 4678889999999999999996 46889999986532 1224578999999999999999999999999999999
Q ss_pred EEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC----CeEEccCCCccc
Q 039310 139 LVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENY----TPKVSDFGASKL 214 (241)
Q Consensus 139 lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~----~~kl~Dfgla~~ 214 (241)
+|||||++|+|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++ .+|++|||+|..
T Consensus 90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhhhhh
Confidence 99999999999999988889999999999999999999999999 99999999999998776 499999999987
Q ss_pred ccCCccceeeeecccccccccccccC
Q 039310 215 VPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 215 ~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
..... ......||+.|||||++.+
T Consensus 167 ~~~~~--~~~~~~~t~~y~APE~~~~ 190 (293)
T d1jksa_ 167 IDFGN--EFKNIFGTPEFVAPEIVNY 190 (293)
T ss_dssp CTTSC--BCSCCCCCGGGCCHHHHTT
T ss_pred cCCCc--cccccCCCCcccCHHHHcC
Confidence 64332 2344569999999999865
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.3e-40 Score=276.11 Aligned_cols=167 Identities=25% Similarity=0.318 Sum_probs=149.4
Q ss_pred hhcccccccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEE
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYE 142 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e 142 (241)
.|.+.+.||+|+||+||+|+.. +++.||||.+... +....+.+.+|+.+|+.++||||+++++++.+.+..++|||
T Consensus 42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e 121 (350)
T d1rdqe_ 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccc
Confidence 5777889999999999999864 6899999987532 23345678999999999999999999999999999999999
Q ss_pred ecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccce
Q 039310 143 FVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQN 222 (241)
Q Consensus 143 ~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~ 222 (241)
|+.+|+|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 122 ~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~---- 194 (350)
T d1rdqe_ 122 YVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---- 194 (350)
T ss_dssp CCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC----
T ss_pred cccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc----
Confidence 9999999999988889999999999999999999999999 999999999999999999999999999876432
Q ss_pred eeeecccccccccccccC
Q 039310 223 YTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 223 ~~~~~gt~~y~aPE~l~~ 240 (241)
.....||+.|||||++.+
T Consensus 195 ~~~~~Gt~~Y~APE~~~~ 212 (350)
T d1rdqe_ 195 TWTLCGTPEALAPEIILS 212 (350)
T ss_dssp BCCCEECGGGCCHHHHTT
T ss_pred cccccCccccCCHHHHcC
Confidence 234569999999999865
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.6e-40 Score=275.07 Aligned_cols=168 Identities=26% Similarity=0.271 Sum_probs=143.7
Q ss_pred hhcccccccccCceeEEEEEeC-CCCeEEEEecccCC---hhhHHHHH---HHHHHHHcCCCCCceeEEEEEecCCcceE
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVD---QTKIDEFI---NELVVVSQINRRNVVRLLACCLETQVPLL 139 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~---~~~~~~~~---~E~~~l~~l~h~ni~~l~~~~~~~~~~~l 139 (241)
.|.+.+.||+|+||.||+|+.. +++.||||.+.... ......+. +|+.+++.++||||+++++++.+.+..|+
T Consensus 5 dy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~i 84 (364)
T d1omwa3 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF 84 (364)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred hCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEE
Confidence 3667789999999999999964 68899999865321 11222333 44777888899999999999999999999
Q ss_pred EEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCc
Q 039310 140 VYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDA 219 (241)
Q Consensus 140 v~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~ 219 (241)
||||+++|+|.+++.....+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||+|......
T Consensus 85 vmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~- 160 (364)
T d1omwa3 85 ILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK- 160 (364)
T ss_dssp EECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECSSS-
T ss_pred EEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecCCC-
Confidence 9999999999999998889999999999999999999999999 999999999999999999999999999876433
Q ss_pred cceeeeecccccccccccccC
Q 039310 220 IQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 220 ~~~~~~~~gt~~y~aPE~l~~ 240 (241)
......||+.|||||++..
T Consensus 161 --~~~~~~GT~~y~APE~~~~ 179 (364)
T d1omwa3 161 --KPHASVGTHGYMAPEVLQK 179 (364)
T ss_dssp --CCCSCCSCGGGCCHHHHST
T ss_pred --cccccccccccchhHHhhc
Confidence 2344569999999999864
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=6.1e-40 Score=265.27 Aligned_cols=168 Identities=26% Similarity=0.407 Sum_probs=148.1
Q ss_pred hhcccccccccCceeEEEEEe-CCCCeEEEEecccCC---------hhhHHHHHHHHHHHHcCC-CCCceeEEEEEecCC
Q 039310 67 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVD---------QTKIDEFINELVVVSQIN-RRNVVRLLACCLETQ 135 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~---------~~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~~~ 135 (241)
.|.+.+.||+|+||+||+|+. .+++.||||.+.... ....+.+.+|+.+++.++ ||||+++++++.+++
T Consensus 4 ~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 83 (277)
T d1phka_ 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 83 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCc
Confidence 467788999999999999985 468899999865421 112346889999999997 999999999999999
Q ss_pred cceEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccc
Q 039310 136 VPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLV 215 (241)
Q Consensus 136 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~ 215 (241)
..|+||||+++|+|.+++..++++++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|...
T Consensus 84 ~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 160 (277)
T d1phka_ 84 FFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQL 160 (277)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred ceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchheeEc
Confidence 99999999999999999998889999999999999999999999999 999999999999999999999999999876
Q ss_pred cCCccceeeeeccccccccccccc
Q 039310 216 PIDAIQNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 216 ~~~~~~~~~~~~gt~~y~aPE~l~ 239 (241)
.... ......||+.|+|||++.
T Consensus 161 ~~~~--~~~~~~gt~~y~~PE~~~ 182 (277)
T d1phka_ 161 DPGE--KLREVCGTPSYLAPEIIE 182 (277)
T ss_dssp CTTC--CBCCCCSCGGGCCHHHHH
T ss_pred cCCC--ceeeeeccCCCCCHHHhh
Confidence 5432 234456999999999875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-40 Score=266.85 Aligned_cols=174 Identities=22% Similarity=0.349 Sum_probs=135.5
Q ss_pred HHHhhhcccccccccCceeEEEEEeCC----CCeEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcc
Q 039310 63 IKTVTNNYADVIGCGGSGNVYKGFLPD----RTPVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVP 137 (241)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~ 137 (241)
+....+.+.+.||+|+||+||+|.+.. +..||||.+... .....+.+.+|+.+++.++||||+++++++. .+..
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence 334567888999999999999998543 346888887653 3445678999999999999999999999986 4678
Q ss_pred eEEEEecCCCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCccccc
Q 039310 138 LLVYEFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVP 216 (241)
Q Consensus 138 ~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~ 216 (241)
++||||+++|+|.+++... ..+++..+..++.|++.||.|||+++ ++||||||+||++++++.+||+|||+|+...
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence 9999999999999987654 47999999999999999999999999 9999999999999999999999999998765
Q ss_pred CCccceeeeecccccccccccccC
Q 039310 217 IDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 217 ~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
...........||+.|||||++.+
T Consensus 160 ~~~~~~~~~~~gt~~y~apE~l~~ 183 (273)
T d1mp8a_ 160 DSTYYKASKGKLPIKWMAPESINF 183 (273)
T ss_dssp -----------CCGGGCCHHHHHH
T ss_pred CCcceeccceecCcccchhhHhcc
Confidence 444444455568999999999864
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-39 Score=268.01 Aligned_cols=170 Identities=26% Similarity=0.326 Sum_probs=147.4
Q ss_pred hhcccccccccCceeEEEEEeC-CCCeEEEEecccC---ChhhHHHHHHHHHHHH-cCCCCCceeEEEEEecCCcceEEE
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV---DQTKIDEFINELVVVS-QINRRNVVRLLACCLETQVPLLVY 141 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~---~~~~~~~~~~E~~~l~-~l~h~ni~~l~~~~~~~~~~~lv~ 141 (241)
.|.+.+.||+|+||+||+|... +++.||||.+... .....+.+..|..++. .++||||+++++++.+++..|+||
T Consensus 3 dy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivm 82 (320)
T d1xjda_ 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 82 (320)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEE
Confidence 3667889999999999999864 6889999987532 2334566777777765 689999999999999999999999
Q ss_pred EecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc
Q 039310 142 EFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ 221 (241)
Q Consensus 142 e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~ 221 (241)
||+++|+|.+++.....+++.++..++.|++.||+|||+++ ++||||||+|||+++++.+||+|||+|+...... .
T Consensus 83 Ey~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~-~ 158 (320)
T d1xjda_ 83 EYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-A 158 (320)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-C
T ss_pred eecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccccc-c
Confidence 99999999999998889999999999999999999999999 9999999999999999999999999998664332 2
Q ss_pred eeeeecccccccccccccC
Q 039310 222 NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~~ 240 (241)
......||+.|||||++.+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~ 177 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLG 177 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTT
T ss_pred cccccCCCCCcCCHHHHcC
Confidence 3344579999999999876
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-39 Score=264.68 Aligned_cols=168 Identities=21% Similarity=0.327 Sum_probs=146.8
Q ss_pred hhcccccccccCceeEEEEEeC-CCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEecC
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFVG 145 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~ 145 (241)
+|.+.+.||+|+||+||+|... +++.||||.++.... ....+.+|+.+|+.++||||+++++++.+.+..|+|||||+
T Consensus 6 rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~ 84 (321)
T d1tkia_ 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCC
Confidence 4677889999999999999864 578899998875433 34568899999999999999999999999999999999999
Q ss_pred CCCchHHhhcCC-CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC--CCCeEEccCCCcccccCCccce
Q 039310 146 NGTLFEHIHKNG-NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDE--NYTPKVSDFGASKLVPIDAIQN 222 (241)
Q Consensus 146 ~g~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~--~~~~kl~Dfgla~~~~~~~~~~ 222 (241)
+|+|.+++...+ .+++.++..++.|++.||.|||+++ |+||||||+|||++. ...+||+|||++...... ..
T Consensus 85 gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~--~~ 159 (321)
T d1tkia_ 85 GLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--DN 159 (321)
T ss_dssp CCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--CE
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC--Cc
Confidence 999999998765 7999999999999999999999999 999999999999985 457999999999876433 23
Q ss_pred eeeecccccccccccccC
Q 039310 223 YTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 223 ~~~~~gt~~y~aPE~l~~ 240 (241)
.....||+.|+|||.+.+
T Consensus 160 ~~~~~~t~~y~ape~~~~ 177 (321)
T d1tkia_ 160 FRLLFTAPEYYAPEVHQH 177 (321)
T ss_dssp EEEEESCGGGSCHHHHTT
T ss_pred ccccccccccccchhccC
Confidence 444569999999998764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-39 Score=266.39 Aligned_cols=166 Identities=29% Similarity=0.312 Sum_probs=140.7
Q ss_pred cccccccCceeEEEEEeC-CCCeEEEEecccCChh-----hHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEec
Q 039310 71 ADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQT-----KIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~-----~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
.+.||+|+||+||+|+.. +++.||||++...... ..+.+.+|+.+++.++||||+++++++.+++..|+||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 357999999999999954 5889999987643222 1246889999999999999999999999999999999999
Q ss_pred CCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceee
Q 039310 145 GNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYT 224 (241)
Q Consensus 145 ~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~ 224 (241)
+++++..+...+..+++..+..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||+|....... ....
T Consensus 83 ~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~-~~~~ 158 (299)
T d1ua2a_ 83 ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-RAYT 158 (299)
T ss_dssp SEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-CCCC
T ss_pred cchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc-cccc
Confidence 98888777777778999999999999999999999999 9999999999999999999999999998764332 2233
Q ss_pred eecccccccccccccC
Q 039310 225 VVQGTLGYIDPEYLQT 240 (241)
Q Consensus 225 ~~~gt~~y~aPE~l~~ 240 (241)
...||+.|||||++.+
T Consensus 159 ~~~gt~~y~aPE~~~~ 174 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFG 174 (299)
T ss_dssp CSCCCCTTCCHHHHTT
T ss_pred ceecChhhccHHHHcc
Confidence 4569999999998754
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.5e-39 Score=261.98 Aligned_cols=171 Identities=27% Similarity=0.409 Sum_probs=140.8
Q ss_pred hhcccccccccCceeEEEEEe-CCCCeEEEEecccC---ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCC----cce
Q 039310 67 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIV---DQTKIDEFINELVVVSQINRRNVVRLLACCLETQ----VPL 138 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~----~~~ 138 (241)
+|.+.+.||+|+||+||+|+. .+++.||||.+... +......+.+|+.+++.++||||+++++++...+ ..|
T Consensus 8 rY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~ 87 (277)
T d1o6ya_ 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 87 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred eeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEE
Confidence 477888999999999999985 46889999987643 3445567999999999999999999999987644 478
Q ss_pred EEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCC
Q 039310 139 LVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPID 218 (241)
Q Consensus 139 lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~ 218 (241)
+||||+++++|.+++...+++++.++..++.|++.||+|||+++ ++||||||+|||++.++..+++|||.+......
T Consensus 88 lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~ 164 (277)
T d1o6ya_ 88 IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADS 164 (277)
T ss_dssp EEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred EEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhhhccc
Confidence 99999999999999988889999999999999999999999999 999999999999999999999999998765322
Q ss_pred c--cceeeeecccccccccccccC
Q 039310 219 A--IQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 219 ~--~~~~~~~~gt~~y~aPE~l~~ 240 (241)
. ........||+.|||||++.+
T Consensus 165 ~~~~~~~~~~~Gt~~Y~aPE~~~~ 188 (277)
T d1o6ya_ 165 GNSVTQTAAVIGTAQYLSPEQARG 188 (277)
T ss_dssp --------------TTCCHHHHTT
T ss_pred cccccccccccCcccccCHHHHcC
Confidence 2 123344569999999999865
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.6e-39 Score=264.80 Aligned_cols=172 Identities=27% Similarity=0.394 Sum_probs=145.7
Q ss_pred hhhcccccccccCceeEEEEEeC------CCCeEEEEecccCC-hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcce
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP------DRTPVAVKKSKIVD-QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPL 138 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~ 138 (241)
..+++.+.||+|+||+||+|++. ++..||||++.... ....+++.+|+.+++.++||||+++++++...+..+
T Consensus 13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 92 (301)
T d1lufa_ 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC 92 (301)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceE
Confidence 35677889999999999999854 34689999886543 344678999999999999999999999999999999
Q ss_pred EEEEecCCCCchHHhhcCC------------------------CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCC
Q 039310 139 LVYEFVGNGTLFEHIHKNG------------------------NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSA 194 (241)
Q Consensus 139 lv~e~~~~g~L~~~l~~~~------------------------~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~ 194 (241)
++|||+++|+|.+++.... .+++..+..++.|++.||+|||+++ ++||||||+
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp~ 169 (301)
T d1lufa_ 93 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATR 169 (301)
T ss_dssp EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred EEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEccc
Confidence 9999999999999996432 3889999999999999999999999 999999999
Q ss_pred CeeeCCCCCeEEccCCCcccccCCcc-ceeeeecccccccccccccC
Q 039310 195 NILLDENYTPKVSDFGASKLVPIDAI-QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 195 Nili~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~ 240 (241)
|||+|+++.+||+|||+|+....... .......||+.|||||.+.+
T Consensus 170 NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 216 (301)
T d1lufa_ 170 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY 216 (301)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH
T ss_pred ceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc
Confidence 99999999999999999986643322 23334568999999998754
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-39 Score=263.24 Aligned_cols=175 Identities=26% Similarity=0.321 Sum_probs=137.3
Q ss_pred HHHhhhcccccccccCceeEEEEEeC------CCCeEEEEecccC-ChhhHHHHHHHHHHHHcC-CCCCceeEEEEEecC
Q 039310 63 IKTVTNNYADVIGCGGSGNVYKGFLP------DRTPVAVKKSKIV-DQTKIDEFINELVVVSQI-NRRNVVRLLACCLET 134 (241)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~ 134 (241)
+....+.+.+.||+|+||+||+|.+. +++.||||.+... .....+.+.+|...+.++ +|+||+.+++++...
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 44456788899999999999999853 2357999987653 344556788888888777 689999999998764
Q ss_pred -CcceEEEEecCCCCchHHhhcC----------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCee
Q 039310 135 -QVPLLVYEFVGNGTLFEHIHKN----------------GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANIL 197 (241)
Q Consensus 135 -~~~~lv~e~~~~g~L~~~l~~~----------------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nil 197 (241)
+..++|||||++|+|.+++... ..+++.++..++.|++.||.|||+++ |+||||||+|||
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NIL 166 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNIL 166 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCcccee
Confidence 5689999999999999999643 24899999999999999999999999 999999999999
Q ss_pred eCCCCCeEEccCCCcccccCCcc-ceeeeecccccccccccccC
Q 039310 198 LDENYTPKVSDFGASKLVPIDAI-QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 198 i~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~ 240 (241)
+++++.+||+|||+|+....... .......||+.|||||++.+
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 210 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD 210 (299)
T ss_dssp ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH
T ss_pred ECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhc
Confidence 99999999999999987643322 22334569999999998864
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-39 Score=263.00 Aligned_cols=178 Identities=26% Similarity=0.376 Sum_probs=152.7
Q ss_pred HHHHHHhhhcccccccccCceeEEEEEe------CCCCeEEEEecccC-ChhhHHHHHHHHHHHHcC-CCCCceeEEEEE
Q 039310 60 EEEIKTVTNNYADVIGCGGSGNVYKGFL------PDRTPVAVKKSKIV-DQTKIDEFINELVVVSQI-NRRNVVRLLACC 131 (241)
Q Consensus 60 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~ 131 (241)
.+++....+.+.+.||+|+||.||+|++ .++..||||+++.. .......+.+|+.+++.+ +||||+++++++
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~ 96 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 4456667888899999999999999974 23568999998753 345566899999999999 699999999999
Q ss_pred ecCCcceEEEEecCCCCchHHhhcCC------------------CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCC
Q 039310 132 LETQVPLLVYEFVGNGTLFEHIHKNG------------------NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKS 193 (241)
Q Consensus 132 ~~~~~~~lv~e~~~~g~L~~~l~~~~------------------~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~ 193 (241)
.+.+..+++|||+++|+|.+++.... .+++..+..++.|++.||+|||+++ ++||||||
T Consensus 97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp 173 (311)
T d1t46a_ 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAA 173 (311)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccc
Confidence 99999999999999999999997543 5899999999999999999999999 99999999
Q ss_pred CCeeeCCCCCeEEccCCCcccccCCccc-eeeeecccccccccccccC
Q 039310 194 ANILLDENYTPKVSDFGASKLVPIDAIQ-NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 194 ~Nili~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~ 240 (241)
+||+++.++.+|++|||+++........ ......||+.|+|||++.+
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 221 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN 221 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH
T ss_pred ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC
Confidence 9999999999999999999877543322 2334568999999998864
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-38 Score=261.12 Aligned_cols=171 Identities=30% Similarity=0.477 Sum_probs=143.9
Q ss_pred hhcccccccccCceeEEEEEeCCC----CeEEEEeccc-CChhhHHHHHHHHHHHHcCCCCCceeEEEEEec-CCcceEE
Q 039310 67 TNNYADVIGCGGSGNVYKGFLPDR----TPVAVKKSKI-VDQTKIDEFINELVVVSQINRRNVVRLLACCLE-TQVPLLV 140 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~~~----~~vavk~~~~-~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~-~~~~~lv 140 (241)
..+|.++||+|+||+||+|++.++ ..||||+++. .+....+++.+|+++|++++||||++++|++.+ ++..++|
T Consensus 28 ~~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred eeccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence 345677899999999999986432 2589998764 455667889999999999999999999999875 5688999
Q ss_pred EEecCCCCchHHhhcCC-CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCc
Q 039310 141 YEFVGNGTLFEHIHKNG-NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDA 219 (241)
Q Consensus 141 ~e~~~~g~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~ 219 (241)
||||++|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+....
T Consensus 108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 99999999999987544 6889999999999999999999999 9999999999999999999999999998764432
Q ss_pred cc---eeeeecccccccccccccC
Q 039310 220 IQ---NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 220 ~~---~~~~~~gt~~y~aPE~l~~ 240 (241)
.. ......||+.|+|||++.+
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~ 208 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQT 208 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHH
T ss_pred cccceecccccccccccChHHHhc
Confidence 22 2222458999999998764
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-39 Score=263.45 Aligned_cols=169 Identities=24% Similarity=0.432 Sum_probs=138.0
Q ss_pred hcccccccccCceeEEEEEeC-CCC----eEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEE
Q 039310 68 NNYADVIGCGGSGNVYKGFLP-DRT----PVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVY 141 (241)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~----~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~ 141 (241)
|++.+.||+|+||+||+|.+. +++ +||+|++... +....+++.+|+.++++++||||++++++|.++ ..++++
T Consensus 11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~ 89 (317)
T d1xkka_ 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT 89 (317)
T ss_dssp EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEE
Confidence 677789999999999999864 333 5889987643 344567899999999999999999999999875 557888
Q ss_pred EecCCCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcc
Q 039310 142 EFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAI 220 (241)
Q Consensus 142 e~~~~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~ 220 (241)
|++.+|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||+++++.+||+|||+|+.......
T Consensus 90 e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~ 166 (317)
T d1xkka_ 90 QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 166 (317)
T ss_dssp ECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC
T ss_pred EeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecccccc
Confidence 999999999888654 57999999999999999999999998 99999999999999999999999999987654332
Q ss_pred c-eeeeecccccccccccccC
Q 039310 221 Q-NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 221 ~-~~~~~~gt~~y~aPE~l~~ 240 (241)
. ......||+.|||||++.+
T Consensus 167 ~~~~~~~~gt~~y~APE~l~~ 187 (317)
T d1xkka_ 167 EYHAEGGKVPIKWMALESILH 187 (317)
T ss_dssp --------CCTTTSCHHHHHH
T ss_pred cccccccccCccccChHHHhc
Confidence 2 2333458999999998764
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-38 Score=260.14 Aligned_cols=169 Identities=28% Similarity=0.354 Sum_probs=135.9
Q ss_pred hhcccccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHH--HHHHHcCCCCCceeEEEEEecCC----cceEE
Q 039310 67 TNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINE--LVVVSQINRRNVVRLLACCLETQ----VPLLV 140 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E--~~~l~~l~h~ni~~l~~~~~~~~----~~~lv 140 (241)
++.+.+.||+|+||.||+|++ ++..||||++.... .+.+.+| +..+..++||||+++++++.+.+ ..++|
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 456778899999999999997 57899999876432 2344444 44555789999999999997654 57899
Q ss_pred EEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcC-----CCCCeEecCCCCCCeeeCCCCCeEEccCCCcccc
Q 039310 141 YEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSE-----TNVPIIHRDVKSANILLDENYTPKVSDFGASKLV 215 (241)
Q Consensus 141 ~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~-----~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~ 215 (241)
|||+++|+|.+++++. ++++..+..++.|++.||.|+|+. ...+|+||||||+|||++.++.+||+|||+++..
T Consensus 80 ~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~ 158 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp EECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred EecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence 9999999999999875 689999999999999999999974 1123999999999999999999999999999876
Q ss_pred cCCccc---eeeeecccccccccccccC
Q 039310 216 PIDAIQ---NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 216 ~~~~~~---~~~~~~gt~~y~aPE~l~~ 240 (241)
...... ......||+.|||||++.+
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 186 (303)
T d1vjya_ 159 DSATDTIDIAPNHRVGTKRYMAPEVLDD 186 (303)
T ss_dssp ETTTTEECC----CCSCGGGCCHHHHTT
T ss_pred cCCCcceeccccceecccCcCChhhccc
Confidence 433221 2233569999999999764
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-38 Score=261.30 Aligned_cols=177 Identities=25% Similarity=0.380 Sum_probs=149.8
Q ss_pred HHHHHhhhcccccccccCceeEEEEEeC------CCCeEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEec
Q 039310 61 EEIKTVTNNYADVIGCGGSGNVYKGFLP------DRTPVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCLE 133 (241)
Q Consensus 61 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 133 (241)
+++....+.+.+.||+|+||+||+|.+. +++.||||+++.. .......+.+|+.++++++||||+++++++..
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence 4555567778889999999999999863 2568999988653 44455678999999999999999999999999
Q ss_pred CCcceEEEEecCCCCchHHhhcC----------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCC
Q 039310 134 TQVPLLVYEFVGNGTLFEHIHKN----------GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYT 203 (241)
Q Consensus 134 ~~~~~lv~e~~~~g~L~~~l~~~----------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~ 203 (241)
.+..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++++++
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCC
T ss_pred CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCce
Confidence 99999999999999999998632 24789999999999999999999998 999999999999999999
Q ss_pred eEEccCCCcccccCCccc-eeeeecccccccccccccC
Q 039310 204 PKVSDFGASKLVPIDAIQ-NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 204 ~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~ 240 (241)
+||+|||+|+.+...... ......||+.|||||.+.+
T Consensus 172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~ 209 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD 209 (308)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH
T ss_pred EEEeecccceeccCCcceeeccceecccccCCHHHHcc
Confidence 999999999876443322 2233358999999998764
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-38 Score=260.46 Aligned_cols=170 Identities=29% Similarity=0.463 Sum_probs=140.6
Q ss_pred hhhcccccccccCceeEEEEEeCC-CC--eEEEEecccC-ChhhHHHHHHHHHHHHcC-CCCCceeEEEEEecCCcceEE
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLPD-RT--PVAVKKSKIV-DQTKIDEFINELVVVSQI-NRRNVVRLLACCLETQVPLLV 140 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~-~~--~vavk~~~~~-~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv 140 (241)
..+.+.+.||+|+||+||+|.+.+ +. .||||++... .....+.+.+|+++|+++ +||||+++++++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 345677899999999999998654 33 4778876543 344556899999999999 799999999999999999999
Q ss_pred EEecCCCCchHHhhcC----------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCe
Q 039310 141 YEFVGNGTLFEHIHKN----------------GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTP 204 (241)
Q Consensus 141 ~e~~~~g~L~~~l~~~----------------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~ 204 (241)
|||+++|+|.+++... ..+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999999654 46999999999999999999999998 9999999999999999999
Q ss_pred EEccCCCcccccCCccceeeeecccccccccccccC
Q 039310 205 KVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 205 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
||+|||+|+..... .......||+.|+|||.+.+
T Consensus 167 kl~DfG~a~~~~~~--~~~~~~~gt~~y~aPE~l~~ 200 (309)
T d1fvra_ 167 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNY 200 (309)
T ss_dssp EECCTTCEESSCEE--CCC----CCTTTCCHHHHHH
T ss_pred EEcccccccccccc--ccccceecCCcccchHHhcc
Confidence 99999999865322 22334568999999999864
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-39 Score=258.34 Aligned_cols=165 Identities=27% Similarity=0.407 Sum_probs=135.3
Q ss_pred hhhcccccccccCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEec-CCcceEEEEec
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLE-TQVPLLVYEFV 144 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~-~~~~~lv~e~~ 144 (241)
..+.+.+.||+|+||.||+|.++ +..||||+++.. ...+.+.+|+.++++++||||+++++++.+ .+..++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 34667889999999999999984 678999988643 345778999999999999999999999865 45689999999
Q ss_pred CCCCchHHhhcCC--CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccce
Q 039310 145 GNGTLFEHIHKNG--NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQN 222 (241)
Q Consensus 145 ~~g~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~ 222 (241)
++|+|.+++.... .+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+|++|||+++.... .
T Consensus 84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~----~ 156 (262)
T d1byga_ 84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS----T 156 (262)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCC----C
Confidence 9999999996543 5899999999999999999999998 99999999999999999999999999986532 2
Q ss_pred eeeecccccccccccccC
Q 039310 223 YTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 223 ~~~~~gt~~y~aPE~l~~ 240 (241)
.....+|+.|||||++.+
T Consensus 157 ~~~~~~~~~y~aPE~l~~ 174 (262)
T d1byga_ 157 QDTGKLPVKWTAPEALRE 174 (262)
T ss_dssp -----CCTTTSCHHHHHH
T ss_pred CccccccccCCChHHHhC
Confidence 233458999999999864
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-38 Score=260.49 Aligned_cols=164 Identities=27% Similarity=0.340 Sum_probs=137.9
Q ss_pred hhccc-ccccccCceeEEEEEe-CCCCeEEEEecccCChhhHHHHHHHHHHHHc-CCCCCceeEEEEEec----CCcceE
Q 039310 67 TNNYA-DVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVDQTKIDEFINELVVVSQ-INRRNVVRLLACCLE----TQVPLL 139 (241)
Q Consensus 67 ~~~~~-~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~-l~h~ni~~l~~~~~~----~~~~~l 139 (241)
.|.+. +.||+|+||+||+|.. .+++.||||.+... ..+.+|+.++.+ .+||||+++++++.+ .+..|+
T Consensus 12 ~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~i 86 (335)
T d2ozaa1 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 86 (335)
T ss_dssp TEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred CEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEE
Confidence 34444 5699999999999985 56889999987532 456789988765 589999999999875 457899
Q ss_pred EEEecCCCCchHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC---CCCeEEccCCCccc
Q 039310 140 VYEFVGNGTLFEHIHKN--GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDE---NYTPKVSDFGASKL 214 (241)
Q Consensus 140 v~e~~~~g~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~---~~~~kl~Dfgla~~ 214 (241)
|||||+||+|.+++... .++++.++..++.|++.||.|||+++ |+||||||+|||+++ ++.+||+|||+|+.
T Consensus 87 vmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~ 163 (335)
T d2ozaa1 87 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 163 (335)
T ss_dssp EEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccceeee
Confidence 99999999999999764 36999999999999999999999999 999999999999985 56799999999987
Q ss_pred ccCCccceeeeecccccccccccccC
Q 039310 215 VPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 215 ~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
..... ......||+.|||||++.+
T Consensus 164 ~~~~~--~~~~~~gt~~y~aPE~~~~ 187 (335)
T d2ozaa1 164 TTSHN--SLTTPCYTPYYVAPEVLGP 187 (335)
T ss_dssp CCCCC--CCCCCSCCCSSCCCCCCCG
T ss_pred ccCCC--ccccccCCcccCCcHHHcC
Confidence 65432 2344569999999999864
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-39 Score=259.21 Aligned_cols=169 Identities=28% Similarity=0.389 Sum_probs=143.0
Q ss_pred hhhcccccccccCceeEEEEEe-CCCCeEEEEecccCC---h---hhHHHHHHHHHHHHcCC--CCCceeEEEEEecCCc
Q 039310 66 VTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVD---Q---TKIDEFINELVVVSQIN--RRNVVRLLACCLETQV 136 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~---~---~~~~~~~~E~~~l~~l~--h~ni~~l~~~~~~~~~ 136 (241)
.+|.+.+.||+|+||+||+|+. .++..||||.+.... . ....++.+|+.+++.++ ||||+++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 3577889999999999999995 468899999865321 1 11234668999999986 8999999999999999
Q ss_pred ceEEEEecCC-CCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC-CCCeEEccCCCccc
Q 039310 137 PLLVYEFVGN-GTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDE-NYTPKVSDFGASKL 214 (241)
Q Consensus 137 ~~lv~e~~~~-g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~-~~~~kl~Dfgla~~ 214 (241)
.++||||+.+ +++.+++.....+++.++..++.|++.||.|||+++ |+||||||+|||++. ++.+||+|||+|..
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccccee
Confidence 9999999976 588888888888999999999999999999999999 999999999999985 57999999999986
Q ss_pred ccCCccceeeeecccccccccccccC
Q 039310 215 VPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 215 ~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
.... ......||+.|||||++.+
T Consensus 161 ~~~~---~~~~~~GT~~y~aPE~~~~ 183 (273)
T d1xwsa_ 161 LKDT---VYTDFDGTRVYSPPEWIRY 183 (273)
T ss_dssp CCSS---CBCCCCSCGGGSCHHHHHH
T ss_pred cccc---cccccccCCCcCCHHHHcC
Confidence 5432 2334569999999998753
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.6e-38 Score=256.19 Aligned_cols=170 Identities=24% Similarity=0.312 Sum_probs=145.3
Q ss_pred hhcccccccccCceeEEEEEeCCCCeEEEEecccCC--hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEec
Q 039310 67 TNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVD--QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~ 144 (241)
+|...+.||+|+||+||+|+.++++.||||++.... ....+.+.+|+.+|+.++||||+++++++.+.+..++++|++
T Consensus 3 ~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~ 82 (286)
T d1ob3a_ 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL 82 (286)
T ss_dssp SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred CceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEee
Confidence 456778899999999999999889999999876533 333578899999999999999999999999999999999999
Q ss_pred CCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccceee
Q 039310 145 GNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNYT 224 (241)
Q Consensus 145 ~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~~ 224 (241)
.++++..+....+.+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|++|||+|....... ....
T Consensus 83 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~ 158 (286)
T d1ob3a_ 83 DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RKYT 158 (286)
T ss_dssp SEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred hhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCc-cccc
Confidence 88777777777788999999999999999999999999 9999999999999999999999999998764332 2233
Q ss_pred eecccccccccccccC
Q 039310 225 VVQGTLGYIDPEYLQT 240 (241)
Q Consensus 225 ~~~gt~~y~aPE~l~~ 240 (241)
...||+.|+|||.+.+
T Consensus 159 ~~~~~~~y~~pE~~~~ 174 (286)
T d1ob3a_ 159 HEIVTLWYRAPDVLMG 174 (286)
T ss_dssp ---CCCTTCCHHHHTT
T ss_pred eecccchhhhHHHHhC
Confidence 4458999999998753
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-38 Score=254.66 Aligned_cols=171 Identities=27% Similarity=0.400 Sum_probs=133.9
Q ss_pred hhhcccccccccCceeEEEEEeCC--C--CeEEEEecccC---ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcce
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLPD--R--TPVAVKKSKIV---DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPL 138 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~--~--~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~ 138 (241)
..+++.+.||+|+||+||+|++.. + ..||||.+... +....+++.+|+.+++.++||||+++++++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 346778899999999999998532 2 36899987542 33445789999999999999999999999976 4678
Q ss_pred EEEEecCCCCchHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccC
Q 039310 139 LVYEFVGNGTLFEHIHKN-GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPI 217 (241)
Q Consensus 139 lv~e~~~~g~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~ 217 (241)
+||||+++|++.+++... +.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhccc
Confidence 999999999999887643 46999999999999999999999999 99999999999999999999999999997744
Q ss_pred Cccc--eeeeecccccccccccccC
Q 039310 218 DAIQ--NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 218 ~~~~--~~~~~~gt~~y~aPE~l~~ 240 (241)
.... ......||+.|+|||++.+
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~ 188 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKT 188 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHH
T ss_pred CCCcceecCccccCcccCCHHHHhC
Confidence 3222 2233457889999998764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-38 Score=256.26 Aligned_cols=177 Identities=24% Similarity=0.332 Sum_probs=144.5
Q ss_pred HHHHHhhhcccccccccCceeEEEEEeCC--------CCeEEEEecccC-ChhhHHHHHHHHHHHHcC-CCCCceeEEEE
Q 039310 61 EEIKTVTNNYADVIGCGGSGNVYKGFLPD--------RTPVAVKKSKIV-DQTKIDEFINELVVVSQI-NRRNVVRLLAC 130 (241)
Q Consensus 61 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~--------~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~ 130 (241)
+++....+.+.+.||+|+||.||+|+..+ +..||||+++.. ......++.+|...+.++ +||||++++++
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~ 87 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 87 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence 34445577888999999999999998432 246999987653 344567889999999888 89999999999
Q ss_pred EecCCcceEEEEecCCCCchHHhhcC----------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCC
Q 039310 131 CLETQVPLLVYEFVGNGTLFEHIHKN----------------GNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSA 194 (241)
Q Consensus 131 ~~~~~~~~lv~e~~~~g~L~~~l~~~----------------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~ 194 (241)
|.+++..++||||+++|+|.+++... ..+++.++..++.|++.||+|||+.+ ++||||||+
T Consensus 88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~ 164 (299)
T d1fgka_ 88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAAR 164 (299)
T ss_dssp ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeeccc
Confidence 99999999999999999999999644 24899999999999999999999999 999999999
Q ss_pred CeeeCCCCCeEEccCCCcccccCCccc-eeeeecccccccccccccC
Q 039310 195 NILLDENYTPKVSDFGASKLVPIDAIQ-NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 195 Nili~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~ 240 (241)
|||++.++.+||+|||+++........ ......||+.|||||.+.+
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~ 211 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD 211 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH
T ss_pred ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcC
Confidence 999999999999999999877543322 2334568999999998864
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-38 Score=256.07 Aligned_cols=169 Identities=26% Similarity=0.347 Sum_probs=140.4
Q ss_pred hhcccccccccCceeEEEEEe-CCCCeEEEEecccCC--hhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 67 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVD--QTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
.|...+.||+|+||+||+|.. .+++.||||.+.... ....+.+.+|+.++++++||||+++++++.+++..|+||||
T Consensus 3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~ 82 (298)
T d1gz8a_ 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 82 (298)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEee
Confidence 356678899999999999985 568899999876432 23356889999999999999999999999999999999999
Q ss_pred cCCCCchHHhh--cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCccc
Q 039310 144 VGNGTLFEHIH--KNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQ 221 (241)
Q Consensus 144 ~~~g~L~~~l~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~ 221 (241)
+.+ ++.+++. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+...... .
T Consensus 83 ~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-~ 157 (298)
T d1gz8a_ 83 LHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-R 157 (298)
T ss_dssp CSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-B
T ss_pred cCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc-c
Confidence 976 4444443 3456999999999999999999999999 9999999999999999999999999998764322 2
Q ss_pred eeeeecccccccccccccC
Q 039310 222 NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~~ 240 (241)
......||+.|+|||++..
T Consensus 158 ~~~~~~gt~~y~apE~~~~ 176 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLG 176 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTT
T ss_pred cceeecccceeeehhhhcc
Confidence 3344569999999998654
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-36 Score=251.99 Aligned_cols=170 Identities=21% Similarity=0.312 Sum_probs=139.6
Q ss_pred hhcccccccccCceeEEEEEe-CCCCeEEEEecccC-ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCC----cceEE
Q 039310 67 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIV-DQTKIDEFINELVVVSQINRRNVVRLLACCLETQ----VPLLV 140 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~----~~~lv 140 (241)
+|...+.||+|+||+||+|.. .+++.||||++... .....+.+.+|+.+|+.++||||+++++++.... ..+++
T Consensus 9 rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l 88 (345)
T d1pmea_ 9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYL 88 (345)
T ss_dssp TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEE
Confidence 466778999999999999985 57899999987653 3445678899999999999999999999997654 23556
Q ss_pred EEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcc
Q 039310 141 YEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAI 220 (241)
Q Consensus 141 ~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~ 220 (241)
++++.+|+|.+++... ++++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|........
T Consensus 89 ~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~ 164 (345)
T d1pmea_ 89 VTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 164 (345)
T ss_dssp EEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred EEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence 6677789999999764 6999999999999999999999999 99999999999999999999999999986643322
Q ss_pred c--eeeeecccccccccccccC
Q 039310 221 Q--NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 221 ~--~~~~~~gt~~y~aPE~l~~ 240 (241)
. ......||+.|+|||++..
T Consensus 165 ~~~~~~~~~gt~~y~aPE~l~~ 186 (345)
T d1pmea_ 165 HTGFLTEYVATRWYRAPEIMLN 186 (345)
T ss_dssp BCCTTCCCCSCGGGCCGGGTTT
T ss_pred cceeeccccccceechHHHhhc
Confidence 1 2234569999999999854
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-36 Score=246.10 Aligned_cols=172 Identities=26% Similarity=0.319 Sum_probs=141.2
Q ss_pred hhhcccccccccCceeEEEEEe-CCCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEec--------C
Q 039310 66 VTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLE--------T 134 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~--------~ 134 (241)
.+|...+.||+|+||+||+|+. .+++.||||++... ......++.+|+.+|+.++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 4677788999999999999996 46899999986543 33345678899999999999999999999865 3
Q ss_pred CcceEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCccc
Q 039310 135 QVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKL 214 (241)
Q Consensus 135 ~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~ 214 (241)
+..+++|||++++++.........+++..+..++.|++.||.|||+++ |+||||||+|||+++++.+||+|||+|..
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARA 166 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecceeee
Confidence 457899999988777766666678999999999999999999999999 99999999999999999999999999976
Q ss_pred ccCCcc---ceeeeecccccccccccccC
Q 039310 215 VPIDAI---QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 215 ~~~~~~---~~~~~~~gt~~y~aPE~l~~ 240 (241)
...... .......||+.|+|||++.+
T Consensus 167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~ 195 (318)
T d3blha1 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLG 195 (318)
T ss_dssp CCC-----CCCCCSCCSCGGGCCHHHHTT
T ss_pred cccccccccccccceecCHHHhhHHHHcC
Confidence 643221 12233469999999998753
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-36 Score=248.25 Aligned_cols=165 Identities=24% Similarity=0.289 Sum_probs=135.3
Q ss_pred hhcccccccccCceeEEEEEe-CCCCeEEEEeccc--CChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCC------cc
Q 039310 67 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKI--VDQTKIDEFINELVVVSQINRRNVVRLLACCLETQ------VP 137 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~--~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~------~~ 137 (241)
+|...+.||+|+||+||+|.. .+++.||||++.. .+....+.+.+|+.+|+.++||||++++++|...+ ..
T Consensus 19 ~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 98 (346)
T d1cm8a_ 19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 98 (346)
T ss_dssp SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred cEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceE
Confidence 566778899999999999995 4689999998764 34445678899999999999999999999998755 46
Q ss_pred eEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccC
Q 039310 138 LLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPI 217 (241)
Q Consensus 138 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~ 217 (241)
|+||||+ +.+|..+.+. .++++..+..++.|++.||.|||+++ |+||||||+|||++.++.+|++|||+|+....
T Consensus 99 ~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~ 173 (346)
T d1cm8a_ 99 YLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADS 173 (346)
T ss_dssp EEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccceeccCC
Confidence 9999999 5577776654 57999999999999999999999999 99999999999999999999999999987643
Q ss_pred CccceeeeecccccccccccccC
Q 039310 218 DAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 218 ~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
. .....||+.|+|||++.+
T Consensus 174 ~----~~~~~~t~~y~aPE~~~~ 192 (346)
T d1cm8a_ 174 E----MTGYVVTRWYRAPEVILN 192 (346)
T ss_dssp S----CCSSCSCGGGCCTHHHHT
T ss_pred c----cccccccccccCHHHHcC
Confidence 2 234569999999998753
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.3e-35 Score=245.40 Aligned_cols=163 Identities=24% Similarity=0.338 Sum_probs=138.9
Q ss_pred hhcccccccccCceeEEEEEe-CCCCeEEEEecccCChhhHHHHHHHHHHHHcCC-CCCceeEEEEEec--CCcceEEEE
Q 039310 67 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVDQTKIDEFINELVVVSQIN-RRNVVRLLACCLE--TQVPLLVYE 142 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~--~~~~~lv~e 142 (241)
.|.+.+.||+|+||+||+|+. .+++.||||+++... .+++.+|+.+|+.++ ||||+++++++.. ....++|||
T Consensus 36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 577888999999999999996 468899999876433 467889999999995 9999999999975 456899999
Q ss_pred ecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC-CeEEccCCCcccccCCccc
Q 039310 143 FVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENY-TPKVSDFGASKLVPIDAIQ 221 (241)
Q Consensus 143 ~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~-~~kl~Dfgla~~~~~~~~~ 221 (241)
|+++++|..+. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++ .+||+|||+|.......
T Consensus 113 ~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~-- 184 (328)
T d3bqca1 113 HVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-- 184 (328)
T ss_dssp CCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC--
T ss_pred ecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCCC--
Confidence 99999987764 36999999999999999999999999 99999999999998655 69999999998764332
Q ss_pred eeeeecccccccccccccC
Q 039310 222 NYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 222 ~~~~~~gt~~y~aPE~l~~ 240 (241)
......||+.|+|||.+.+
T Consensus 185 ~~~~~~~t~~y~aPE~~~~ 203 (328)
T d3bqca1 185 EYNVRVASRYFKGPELLVD 203 (328)
T ss_dssp CCCSCCSCGGGCCHHHHTT
T ss_pred cccccccCccccCcccccC
Confidence 3344568999999998754
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-35 Score=240.41 Aligned_cols=170 Identities=25% Similarity=0.336 Sum_probs=148.5
Q ss_pred hhcccccccccCceeEEEEEe-CCCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecCCcceEEEEe
Q 039310 67 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
+|+..+.||+|+||+||+|+. .+++.||||+++.. ......++.+|+.+++.++||||+++++++.+....++++|+
T Consensus 3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~ 82 (292)
T d1unla_ 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeee
Confidence 466778999999999999995 46888999987543 344567889999999999999999999999999999999999
Q ss_pred cCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCCcccee
Q 039310 144 VGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPIDAIQNY 223 (241)
Q Consensus 144 ~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~~~~~~ 223 (241)
+.++++..++...+.+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.|........ ..
T Consensus 83 ~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-~~ 158 (292)
T d1unla_ 83 CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-CY 158 (292)
T ss_dssp CSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-CC
T ss_pred ccccccccccccccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCCc-cc
Confidence 999999998888889999999999999999999999999 99999999999999999999999999987654332 22
Q ss_pred eeecccccccccccccC
Q 039310 224 TVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 224 ~~~~gt~~y~aPE~l~~ 240 (241)
....+++.|+|||++.+
T Consensus 159 ~~~~~~~~~~~pe~~~~ 175 (292)
T d1unla_ 159 SAEVVTLWYRPPDVLFG 175 (292)
T ss_dssp CSCCSCGGGCCHHHHTT
T ss_pred eeeccccchhhhhHhcc
Confidence 33447889999998754
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-36 Score=250.73 Aligned_cols=171 Identities=26% Similarity=0.310 Sum_probs=149.9
Q ss_pred hhcccccccccCceeEEEEEe----CCCCeEEEEecccC----ChhhHHHHHHHHHHHHcCCC-CCceeEEEEEecCCcc
Q 039310 67 TNNYADVIGCGGSGNVYKGFL----PDRTPVAVKKSKIV----DQTKIDEFINELVVVSQINR-RNVVRLLACCLETQVP 137 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavk~~~~~----~~~~~~~~~~E~~~l~~l~h-~ni~~l~~~~~~~~~~ 137 (241)
.|.+.+.||+|+||+||+|.. .+++.||||.++.. +....+.+.+|+.++++++| |||+++++++.+.+..
T Consensus 25 ~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~ 104 (322)
T d1vzoa_ 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKL 104 (322)
T ss_dssp GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEE
T ss_pred ceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCce
Confidence 478889999999999999974 24788999986532 22334667899999999976 8999999999999999
Q ss_pred eEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccC
Q 039310 138 LLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPI 217 (241)
Q Consensus 138 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~ 217 (241)
+++|||+.+|+|.+++...+.+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||+|+.+..
T Consensus 105 ~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~ 181 (322)
T d1vzoa_ 105 HLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 181 (322)
T ss_dssp EEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred eeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhhhcc
Confidence 999999999999999998888999999999999999999999999 99999999999999999999999999987755
Q ss_pred CccceeeeecccccccccccccC
Q 039310 218 DAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 218 ~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
..........||+.|+|||.+..
T Consensus 182 ~~~~~~~~~~g~~~~~~pe~~~~ 204 (322)
T d1vzoa_ 182 DETERAYDFCGTIEYMAPDIVRG 204 (322)
T ss_dssp GGGGGGCGGGSCCTTCCHHHHTT
T ss_pred cccccccccccccccchhHHhhc
Confidence 55555555679999999998853
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-35 Score=247.90 Aligned_cols=164 Identities=26% Similarity=0.268 Sum_probs=134.0
Q ss_pred hhcccccccccCceeEEEEEeC-CCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCceeEEEEEecC------CcceE
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVVRLLACCLET------QVPLL 139 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~------~~~~l 139 (241)
+|...++||+|+||+||+|+.. +++.||||++..... ...+|+.+|++++||||+++++++... ...++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5667788999999999999964 688999998765332 224799999999999999999998543 34689
Q ss_pred EEEecCCCCchHH---hhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC-CeEEccCCCcccc
Q 039310 140 VYEFVGNGTLFEH---IHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENY-TPKVSDFGASKLV 215 (241)
Q Consensus 140 v~e~~~~g~L~~~---l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~-~~kl~Dfgla~~~ 215 (241)
||||++++.+..+ ......+++.++..++.|++.||+|||+++ |+||||||+|||++.++ .+||+|||+|...
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999986543333 234567999999999999999999999999 99999999999999775 8999999999876
Q ss_pred cCCccceeeeeccccccccccccc
Q 039310 216 PIDAIQNYTVVQGTLGYIDPEYLQ 239 (241)
Q Consensus 216 ~~~~~~~~~~~~gt~~y~aPE~l~ 239 (241)
.... ......||+.|+|||.+.
T Consensus 174 ~~~~--~~~~~~gt~~y~aPE~~~ 195 (350)
T d1q5ka_ 174 VRGE--PNVSYICSRYYRAPELIF 195 (350)
T ss_dssp CTTS--CCCSCCSCTTSCCHHHHT
T ss_pred cCCc--ccccccccccccChHHhh
Confidence 4433 233456999999999865
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-36 Score=245.13 Aligned_cols=170 Identities=27% Similarity=0.342 Sum_probs=136.3
Q ss_pred hhhcccccccccCceeEEEEEeC-C-CCeEEEEecccC--ChhhHHHHHHHHHHHHcC---CCCCceeEEEEEec-----
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-D-RTPVAVKKSKIV--DQTKIDEFINELVVVSQI---NRRNVVRLLACCLE----- 133 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~-~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l---~h~ni~~l~~~~~~----- 133 (241)
.+|.+.+.||+|+||+||+|+.. + ++.||||++... .......+.+|+.+++.+ +||||+++++++..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 45777889999999999999863 3 567899987542 222233456777777665 79999999999853
Q ss_pred CCcceEEEEecCCCCchHHhh-cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCc
Q 039310 134 TQVPLLVYEFVGNGTLFEHIH-KNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGAS 212 (241)
Q Consensus 134 ~~~~~lv~e~~~~g~L~~~l~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla 212 (241)
....+++||+++++++..... ....+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||++
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg~~ 163 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLA 163 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred CceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchhhh
Confidence 346789999998876654443 3456999999999999999999999999 999999999999999999999999998
Q ss_pred ccccCCccceeeeecccccccccccccC
Q 039310 213 KLVPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 213 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
...... .......||+.|||||++.+
T Consensus 164 ~~~~~~--~~~~~~~gT~~Y~APE~~~~ 189 (305)
T d1blxa_ 164 RIYSFQ--MALTSVVVTLWYRAPEVLLQ 189 (305)
T ss_dssp CCCCGG--GGGCCCCCCCTTCCHHHHTT
T ss_pred hhhccc--ccCCCcccChhhcCcchhcC
Confidence 865433 23345569999999999864
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.1e-35 Score=238.25 Aligned_cols=169 Identities=18% Similarity=0.223 Sum_probs=141.2
Q ss_pred hhhcccccccccCceeEEEEEeC-CCCeEEEEecccCChhhHHHHHHHHHHHHcCCC-CCceeEEEEEecCCcceEEEEe
Q 039310 66 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKIVDQTKIDEFINELVVVSQINR-RNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h-~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
.+|.+.+.||+|+||+||+|++. +++.||||.+.... ....+.+|++.++.++| +|++.+++++......++||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 35778889999999999999954 58899999765432 22456789999999975 8999999999999999999999
Q ss_pred cCCCCchHHhhcCC-CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC-----CCCeEEccCCCcccccC
Q 039310 144 VGNGTLFEHIHKNG-NLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDE-----NYTPKVSDFGASKLVPI 217 (241)
Q Consensus 144 ~~~g~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~-----~~~~kl~Dfgla~~~~~ 217 (241)
+ +++|.+++...+ .++..++..++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||+|+....
T Consensus 83 ~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~ 158 (293)
T d1csna_ 83 L-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 158 (293)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred c-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence 9 679999987654 6999999999999999999999999 999999999999974 57899999999987643
Q ss_pred Ccc------ceeeeecccccccccccccC
Q 039310 218 DAI------QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 218 ~~~------~~~~~~~gt~~y~aPE~l~~ 240 (241)
... .......||+.|||||++.+
T Consensus 159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~ 187 (293)
T d1csna_ 159 PVTKQHIPYREKKNLSGTARYMSINTHLG 187 (293)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTT
T ss_pred CccccceeecccCceEEchhhcCHHHhcC
Confidence 221 12334569999999998865
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-34 Score=236.13 Aligned_cols=168 Identities=21% Similarity=0.286 Sum_probs=134.6
Q ss_pred hhcccccccccCceeEEEEEe-CCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCc-eeEEEEEecCCcceEEEEec
Q 039310 67 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNV-VRLLACCLETQVPLLVYEFV 144 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni-~~l~~~~~~~~~~~lv~e~~ 144 (241)
+|.+.+.||+|+||.||+|++ .+++.||||....... .+++.+|+++++.++|+|+ +.+..++.+.+..++||||+
T Consensus 8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~ 85 (299)
T d1ckia_ 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 85 (299)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence 477889999999999999985 4588999997654322 2457789999999987764 55556667788889999999
Q ss_pred CCCCchHHhh-cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC---CCCCeEEccCCCcccccCCcc
Q 039310 145 GNGTLFEHIH-KNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLD---ENYTPKVSDFGASKLVPIDAI 220 (241)
Q Consensus 145 ~~g~L~~~l~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~---~~~~~kl~Dfgla~~~~~~~~ 220 (241)
. +++.+.+. ....+++..+..++.|++.||+|||+++ |+||||||+|||++ .+..+|++|||+|+.......
T Consensus 86 ~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (299)
T d1ckia_ 86 G-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161 (299)
T ss_dssp C-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred C-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence 5 56666554 4557999999999999999999999999 99999999999986 455799999999987643321
Q ss_pred ------ceeeeecccccccccccccC
Q 039310 221 ------QNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 221 ------~~~~~~~gt~~y~aPE~l~~ 240 (241)
.......||+.|||||++.+
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~ 187 (299)
T d1ckia_ 162 HQHIPYRENKNLTGTARYASINTHLG 187 (299)
T ss_dssp CCBCCCCBCCSCCCCSSSCCHHHHTT
T ss_pred ccceeccccCCcCCCccccCHHHHhC
Confidence 12334569999999998764
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-34 Score=240.26 Aligned_cols=166 Identities=24% Similarity=0.283 Sum_probs=137.7
Q ss_pred hhcccccccccCceeEEEEEe-CCCCeEEEEecccC--ChhhHHHHHHHHHHHHcCCCCCceeEEEEEecC-----Ccce
Q 039310 67 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIV--DQTKIDEFINELVVVSQINRRNVVRLLACCLET-----QVPL 138 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~-----~~~~ 138 (241)
+|...+.||+|+||+||+|+. .+++.||||++... +....+++.+|+.+++.++|||++++++++... ...+
T Consensus 19 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~ 98 (348)
T d2gfsa1 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 98 (348)
T ss_dssp TEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCC
T ss_pred CeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceE
Confidence 477788999999999999985 46899999987643 344556789999999999999999999999643 3446
Q ss_pred EEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccCC
Q 039310 139 LVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPID 218 (241)
Q Consensus 139 lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~~ 218 (241)
++|+++.+|+|.+++.. +++++.++..++.|++.||.|||+++ |+||||||+|||++.++.+|++|||+|.....
T Consensus 99 ~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~- 173 (348)
T d2gfsa1 99 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD- 173 (348)
T ss_dssp EEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----CCTG-
T ss_pred EEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcccCc-
Confidence 77888889999999865 47999999999999999999999999 99999999999999999999999999876532
Q ss_pred ccceeeeecccccccccccccC
Q 039310 219 AIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 219 ~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
......||+.|+|||++.+
T Consensus 174 ---~~~~~~g~~~y~apE~~~~ 192 (348)
T d2gfsa1 174 ---EMTGYVATRWYRAPEIMLN 192 (348)
T ss_dssp ---GGSSSCHHHHTSCHHHHTT
T ss_pred ---ccccccccccccCchhhcC
Confidence 2334569999999998643
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-34 Score=239.98 Aligned_cols=166 Identities=29% Similarity=0.329 Sum_probs=130.2
Q ss_pred hhcccccccccCceeEEEEEeC-CCCeEEEEeccc--CChhhHHHHHHHHHHHHcCCCCCceeEEEEEec------CCcc
Q 039310 67 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKI--VDQTKIDEFINELVVVSQINRRNVVRLLACCLE------TQVP 137 (241)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavk~~~~--~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~------~~~~ 137 (241)
+|...+.||+|+||+||+|.+. +++.||||++.. .+.....++.+|+.+++.++||||++++++|.. .+..
T Consensus 18 ~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~ 97 (355)
T d2b1pa1 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 97 (355)
T ss_dssp TEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred CeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCcee
Confidence 4667789999999999999965 589999998764 345556788999999999999999999999964 3578
Q ss_pred eEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCCCcccccC
Q 039310 138 LLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFGASKLVPI 217 (241)
Q Consensus 138 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~~~~ 217 (241)
|+||||+.++ +.+.+. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+|++|||+++....
T Consensus 98 ~iv~Ey~~~~-l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~ 171 (355)
T d2b1pa1 98 YLVMELMDAN-LCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_dssp EEEEECCSEE-HHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEEeccchH-HHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhcccc
Confidence 9999999764 444443 46899999999999999999999999 99999999999999999999999999886543
Q ss_pred CccceeeeecccccccccccccC
Q 039310 218 DAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 218 ~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
. .......||+.|+|||++.+
T Consensus 172 ~--~~~~~~~~t~~y~aPE~l~~ 192 (355)
T d2b1pa1 172 S--FMMTPYVVTRYYRAPEVILG 192 (355)
T ss_dssp -----------CCTTCCHHHHTT
T ss_pred c--cccccccccccccChhhhcC
Confidence 2 23344569999999999864
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.95 E-value=2.6e-28 Score=203.68 Aligned_cols=167 Identities=22% Similarity=0.226 Sum_probs=130.7
Q ss_pred hhhcccccccccCceeEEEEEe-CCCCeEEEEecccCChhhHHHHHHHHHHHHcCC-----------CCCceeEEEEEec
Q 039310 66 VTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKIVDQTKIDEFINELVVVSQIN-----------RRNVVRLLACCLE 133 (241)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~-----------h~ni~~l~~~~~~ 133 (241)
.+|.+.+.||+|+||+||+|+. .+++.||||+++.. ....+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 4588899999999999999985 46899999987643 334467788999888875 4789999988865
Q ss_pred --CCcceEEEEecCCCCchHH-h--hcCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEecCCCCCCeeeCCCC-----
Q 039310 134 --TQVPLLVYEFVGNGTLFEH-I--HKNGNLTWERRLRIAAETAGVLSYLHS-ETNVPIIHRDVKSANILLDENY----- 202 (241)
Q Consensus 134 --~~~~~lv~e~~~~g~L~~~-l--~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~iiH~dlk~~Nili~~~~----- 202 (241)
....+++++++..+..... . .....+++..+..++.|++.||.|||+ .+ |+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 3456677777655433222 2 234579999999999999999999997 77 99999999999998654
Q ss_pred -CeEEccCCCcccccCCccceeeeecccccccccccccC
Q 039310 203 -TPKVSDFGASKLVPIDAIQNYTVVQGTLGYIDPEYLQT 240 (241)
Q Consensus 203 -~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (241)
.++++|||.|..... ......||+.|+|||++.+
T Consensus 169 ~~~kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~ 203 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLG 203 (362)
T ss_dssp EEEEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHT
T ss_pred ceeeEeeccccccccc----ccccccccccccChhhccc
Confidence 389999999876532 2234569999999998764
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=5.2e-26 Score=173.40 Aligned_cols=133 Identities=18% Similarity=0.210 Sum_probs=106.2
Q ss_pred cccccccccCceeEEEEEeCCCCeEEEEecccCC------------------hhhHHHHHHHHHHHHcCCCCCceeEEEE
Q 039310 69 NYADVIGCGGSGNVYKGFLPDRTPVAVKKSKIVD------------------QTKIDEFINELVVVSQINRRNVVRLLAC 130 (241)
Q Consensus 69 ~~~~~lg~G~~g~V~~~~~~~~~~vavk~~~~~~------------------~~~~~~~~~E~~~l~~l~h~ni~~l~~~ 130 (241)
.+++.||+|+||+||+|...+++.||||..+... ........+|...+..+.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 3567899999999999998889999999754310 0112345678899999999999998766
Q ss_pred EecCCcceEEEEecCCCCchHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCCeEEccCC
Q 039310 131 CLETQVPLLVYEFVGNGTLFEHIHKNGNLTWERRLRIAAETAGVLSYLHSETNVPIIHRDVKSANILLDENYTPKVSDFG 210 (241)
Q Consensus 131 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~iiH~dlk~~Nili~~~~~~kl~Dfg 210 (241)
. ..+++|||+++..+.+ ++......++.|++.++.|||+++ |+||||||+|||++++ .++|+|||
T Consensus 83 ~----~~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liDFG 147 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIIDFP 147 (191)
T ss_dssp E----TTEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECCCT
T ss_pred c----CCEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEECC
Confidence 3 3479999998755433 344556789999999999999999 9999999999999965 48999999
Q ss_pred Cccccc
Q 039310 211 ASKLVP 216 (241)
Q Consensus 211 la~~~~ 216 (241)
+|....
T Consensus 148 ~a~~~~ 153 (191)
T d1zara2 148 QSVEVG 153 (191)
T ss_dssp TCEETT
T ss_pred CcccCC
Confidence 987654
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.80 E-value=9.6e-09 Score=80.00 Aligned_cols=132 Identities=15% Similarity=0.113 Sum_probs=90.3
Q ss_pred cCceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCC-CCCceeEEEEEecCCcceEEEEecCCCCchHHhhc
Q 039310 77 GGSGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQIN-RRNVVRLLACCLETQVPLLVYEFVGNGTLFEHIHK 155 (241)
Q Consensus 77 G~~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 155 (241)
++.+.||+... ++..+.+|............+.+|...+..+. +--+++++.+...++..++||++++|.++.+....
T Consensus 25 ~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~ 103 (263)
T d1j7la_ 25 MSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED 103 (263)
T ss_dssp CSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT
T ss_pred CCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccc
Confidence 44568998765 45567788765443333445678888888774 43478888888888899999999998777654422
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhcCC-----------------------------------------------------
Q 039310 156 NGNLTWERRLRIAAETAGVLSYLHSET----------------------------------------------------- 182 (241)
Q Consensus 156 ~~~l~~~~~~~~~~~i~~~l~~lh~~~----------------------------------------------------- 182 (241)
. .....++.++++.+..||+..
T Consensus 104 ~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 178 (263)
T d1j7la_ 104 E-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEK 178 (263)
T ss_dssp C-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSC
T ss_pred c-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcC
Confidence 1 112234455555555565421
Q ss_pred ---CCCeEecCCCCCCeeeCCCCCeEEccCCCccc
Q 039310 183 ---NVPIIHRDVKSANILLDENYTPKVSDFGASKL 214 (241)
Q Consensus 183 ---~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~ 214 (241)
+..++|+|+.|.||++++++.+-|+||+.+..
T Consensus 179 ~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 179 PEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 01278999999999999876677999998765
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.47 E-value=5.2e-07 Score=69.50 Aligned_cols=130 Identities=18% Similarity=0.155 Sum_probs=84.8
Q ss_pred ccccC-ceeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCC--CCceeEEEEEecCCcceEEEEecCCCCch
Q 039310 74 IGCGG-SGNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINR--RNVVRLLACCLETQVPLLVYEFVGNGTLF 150 (241)
Q Consensus 74 lg~G~-~g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h--~ni~~l~~~~~~~~~~~lv~e~~~~g~L~ 150 (241)
+..|. .+.||+....++..+++|....... ..+..|...++.+.. -.+++++.+..+.+..+++|++++|.++.
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 34443 3678998887788888887554332 345677777777632 34678888888888999999999876553
Q ss_pred HHhhcCCCCCHHHHHHHHHHHHHHHHHhhcC-------------------------------------------------
Q 039310 151 EHIHKNGNLTWERRLRIAAETAGVLSYLHSE------------------------------------------------- 181 (241)
Q Consensus 151 ~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~------------------------------------------------- 181 (241)
+.- .+.. ..+.++...|.-||+.
T Consensus 95 ~~~-----~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 166 (255)
T d1nd4a_ 95 SSH-----LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLK 166 (255)
T ss_dssp TSC-----CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHH
T ss_pred ccc-----ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHH
Confidence 311 1111 1122233333333321
Q ss_pred ------CCCCeEecCCCCCCeeeCCCCCeEEccCCCccc
Q 039310 182 ------TNVPIIHRDVKSANILLDENYTPKVSDFGASKL 214 (241)
Q Consensus 182 ------~~~~iiH~dlk~~Nili~~~~~~kl~Dfgla~~ 214 (241)
.++.++|+|+.|.|||++++..+-|+||+.+..
T Consensus 167 ~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 167 ARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 112389999999999999876678999998764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.28 E-value=2.4e-06 Score=70.29 Aligned_cols=75 Identities=17% Similarity=0.149 Sum_probs=48.1
Q ss_pred ccccccCceeEEEEEeC-CCCeEEEEecccC-------ChhhHHHHHHHHHHHHcCC-C--CCceeEEEEEecCCcceEE
Q 039310 72 DVIGCGGSGNVYKGFLP-DRTPVAVKKSKIV-------DQTKIDEFINELVVVSQIN-R--RNVVRLLACCLETQVPLLV 140 (241)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavk~~~~~-------~~~~~~~~~~E~~~l~~l~-h--~ni~~l~~~~~~~~~~~lv 140 (241)
+.||.|..-.||+.... ++..+++|...+. ......+...|.+.|+.+. + ..+++++.+ +++..+++
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 35899999999998854 4678889864321 1112334566888887663 3 346666654 45567899
Q ss_pred EEecCCCC
Q 039310 141 YEFVGNGT 148 (241)
Q Consensus 141 ~e~~~~g~ 148 (241)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997644
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.48 E-value=0.0002 Score=56.83 Aligned_cols=132 Identities=19% Similarity=0.199 Sum_probs=74.8
Q ss_pred eeEEEEEeCCCCeEEEEecccCChhhHHHHHHHHHHHHcCCCCCce--eEE-----EEEecCCcceEEEEecCCCCch--
Q 039310 80 GNVYKGFLPDRTPVAVKKSKIVDQTKIDEFINELVVVSQINRRNVV--RLL-----ACCLETQVPLLVYEFVGNGTLF-- 150 (241)
Q Consensus 80 g~V~~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~--~l~-----~~~~~~~~~~lv~e~~~~g~L~-- 150 (241)
=.||+.+..+|..+++|...+... ..+++..|...+..|...+++ ... ......+..+.++++++|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 369999988999999997654322 335667788888877533322 111 1123355678899998763321
Q ss_pred ---HHh---------h----cC-----CCCCHH----------------------HHHHHHHHHHHHHHHh-hcCCCCCe
Q 039310 151 ---EHI---------H----KN-----GNLTWE----------------------RRLRIAAETAGVLSYL-HSETNVPI 186 (241)
Q Consensus 151 ---~~l---------~----~~-----~~l~~~----------------------~~~~~~~~i~~~l~~l-h~~~~~~i 186 (241)
.+- + .. ..++.. .....+.++...+.-. .+..+..+
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 110 0 00 011111 1122233333333222 12223458
Q ss_pred EecCCCCCCeeeCCCCCeEEccCCCccc
Q 039310 187 IHRDVKSANILLDENYTPKVSDFGASKL 214 (241)
Q Consensus 187 iH~dlk~~Nili~~~~~~kl~Dfgla~~ 214 (241)
+|+|+.+.|||++++ ..++||+-|..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999754 45899998764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.24 E-value=0.00049 Score=56.00 Aligned_cols=71 Identities=15% Similarity=0.124 Sum_probs=46.3
Q ss_pred cccccCceeEEEEEeCC--------CCeEEEEecccCChhhHHHHHHHHHHHHcCC-CCCceeEEEEEecCCcceEEEEe
Q 039310 73 VIGCGGSGNVYKGFLPD--------RTPVAVKKSKIVDQTKIDEFINELVVVSQIN-RRNVVRLLACCLETQVPLLVYEF 143 (241)
Q Consensus 73 ~lg~G~~g~V~~~~~~~--------~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~~~~~~lv~e~ 143 (241)
.|+.|-.=.+|+...++ ...|.++.... ........+|..+++.+. +.-.+++++++.+ .+|+||
T Consensus 49 ~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ef 122 (395)
T d1nw1a_ 49 RIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 122 (395)
T ss_dssp EECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEE
Confidence 57777777899987543 24566665432 222344568999998884 4445678887743 689999
Q ss_pred cCCCCc
Q 039310 144 VGNGTL 149 (241)
Q Consensus 144 ~~~g~L 149 (241)
++|.++
T Consensus 123 i~g~~l 128 (395)
T d1nw1a_ 123 IPSRPL 128 (395)
T ss_dssp CCEEEC
T ss_pred eccccC
Confidence 987543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.87 E-value=0.0035 Score=48.92 Aligned_cols=30 Identities=20% Similarity=0.205 Sum_probs=26.8
Q ss_pred CeEecCCCCCCeeeCCCCCeEEccCCCccc
Q 039310 185 PIIHRDVKSANILLDENYTPKVSDFGASKL 214 (241)
Q Consensus 185 ~iiH~dlk~~Nili~~~~~~kl~Dfgla~~ 214 (241)
++||+|+.+.|++++++...-|+||+.|..
T Consensus 184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccccCCcchhhhhcccccceeEeccccccc
Confidence 499999999999999987778999998763
|